PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Mattapallil, JJ; Douek, DC; Hill, B; Nishimura, Y; Martin, M; Roederer, M				Mattapallil, JJ; Douek, DC; Hill, B; Nishimura, Y; Martin, M; Roederer, M			Massive infection and loss of memory CD4(+) T cells in multiple tissues during acute SIV infection	NATURE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; GASTROINTESTINAL-TRACT; HIV-1 INFECTION; RHESUS-MONKEYS; EXPRESSION; DEPLETION; DYNAMICS; TRANSMISSION; REPLICATION; LYMPHOCYTES	It has recently been established that both acute human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) infections are accompanied by a dramatic and selective loss of memory CD4(+) T cells predominantly from the mucosal surfaces. The mechanism underlying this depletion of memory CD4(+) T cells (that is, T-helper cells specific to previously encountered pathogens) has not been defined. Using highly sensitive, quantitative polymerase chain reaction together with precise sorting of different subsets of CD4(+) T cells in various tissues, we show that this loss is explained by a massive infection of memory CD4(+) T cells by the virus. Specifically, 30-60% of CD4(+) memory T cells throughout the body are infected by SIV at the peak of infection, and most of these infected cells disappear within four days. Furthermore, our data demonstrate that the depletion of memory CD4(+) T cells occurs to a similar extent in all tissues. As a consequence, over one-half of all memory CD4(+) T cells in SIV-infected macaques are destroyed directly by viral infection during the acute phase-an insult that certainly heralds subsequent immunodeficiency. Our findings point to the importance of reducing the cell-associated viral load during acute infection through therapeutic or vaccination strategies.	NIAID, Immunotechnol Sect, NIH, Bethesda, MD 20892 USA; NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Roederer, M (corresponding author), NIAID, Immunotechnol Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	Roederer@nih.gov	Roederer, Mario/G-1887-2011	Mattapallil, Joseph/0000-0002-7412-9507	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000415, ZIAAI005019, ZIAAI000190, ZIAAI005034, Z01AI005019, Z01AI005034, Z01AI000415, Z01AI000190] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Chen ZW, 1997, J VIROL, V71, P2705, DOI 10.1128/JVI.71.4.2705-2714.1997; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Endo Y, 2000, J VIROL, V74, P6935, DOI 10.1128/JVI.74.15.6935-6945.2000; FOLKS T, 1985, P NATL ACAD SCI USA, V82, P4539, DOI 10.1073/pnas.82.13.4539; FOLKS TM, 1986, J EXP MED, V164, P280, DOI 10.1084/jem.164.1.280; Gratton S, 2000, P NATL ACAD SCI USA, V97, P14566, DOI 10.1073/pnas.97.26.14566; Haase AT, 1996, SCIENCE, V274, P985, DOI 10.1126/science.274.5289.985; Haase AT, 1999, ANNU REV IMMUNOL, V17, P625, DOI 10.1146/annurev.immunol.17.1.625; Jung A, 2002, NATURE, V418, P144, DOI 10.1038/418144a; Lassen K, 2004, TRENDS MOL MED, V10, P525, DOI 10.1016/j.molmed.2004.09.006; Lifson JD, 2001, J VIROL, V75, P10187, DOI 10.1128/JVI.75.21.10187-10199.2001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marcon L, 1997, J VIROL, V71, P2522, DOI 10.1128/JVI.71.3.2522-2527.1997; Mattapallil JJ, 2004, AIDS, V18, P13, DOI 10.1097/00002030-200401020-00002; Mattapallil JJ, 1998, J VIROL, V72, P6421, DOI 10.1128/JVI.72.8.6421-6429.1998; Mengozzi M, 2001, P NATL ACAD SCI USA, V98, P11644, DOI 10.1073/pnas.211205098; MORI K, 1992, J VIROL, V66, P2067, DOI 10.1128/JVI.66.4.2067-2075.1992; Nishimura Y, 2004, P NATL ACAD SCI USA, V101, P12324, DOI 10.1073/pnas.0404620101; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Veazey RS, 2000, J VIROL, V74, P57, DOI 10.1128/JVI.74.1.57-64.2000; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Veazey RS, 2000, J VIROL, V74, P11001, DOI 10.1128/JVI.74.23.11001-11007.2000; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P5640, DOI 10.1073/pnas.0308425101	25	1002	1041	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2005	434	7037					1093	1097		10.1038/nature03501	http://dx.doi.org/10.1038/nature03501			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15793563				2022-12-24	WOS:000228693300033
J	Flegal, KM; Graubard, BI; Williamson, DF; Gail, MH				Flegal, KM; Graubard, BI; Williamson, DF; Gail, MH			Excess deaths associated with underweight, overweight, and obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; FOLLOW-UP; BREAST-CANCER; ALL-CAUSE; MORTALITY; GUIDELINES; FITNESS; PREVALENCE; CHILDREN; SMOKING	Context As the prevalence of obesity increases in the United States, concern over the association of body weight with excess mortality has also increased. Objective To estimate deaths associated with underweight (body mass index [BMI] <18.5), overweight (BMI 25 to <30), and obesity (BMI >= 30) in the United States in 2000. Design, Setting, and Participants We estimated relative risks of mortality associated with different levels of BMI (calculated as weight in kilograms divided by the square of height in meters) from the nationally representative National Health and Nutrition Examination Survey (NHANES) 1 (1971-1975) and NHANES II (1976-1980), with follow-up through 1992, and from NHANES 111 (1988-1994), with follow-up through 2000. These relative risks were applied to the distribution of BMI and other covariates from NHANES 1999-2002 to estimate attributable fractions and number of excess deaths, adjusted for confounding factors and for effect modification by age. Main Outcome Measures Number of excess deaths in 2000 associated with given BMI levels. Results Relative to the normal weight category (BMI 18.5 to <25), obesity (BMI >= 30) was associated with 111 909 excess deaths (95% confidence interval [CI], 53 754170064) and underweight with 33 746 excess deaths (95% Cl, 15726-51766). Overweight was not associated with excess mortality (-86094 deaths; 95% Cl, -161223 to -10966). The relative risks of mortality associated with obesity were lower in NHANES 11 and NHANES III than in NHANES I. Conclusions Underweight and obesity, particularly higher levels of obesity, were associated with increased mortality relative to the normal weight category. The impact of obesity on mortality may have decreased over time, perhaps because of improvements in public health and medical care. These findings are consistent with the increases in life expectancy in the United States and the declining mortality rates from ischemic heart disease.	Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA; Univ Calif Berkeley, Ctr Weight & Hlth, Berkeley, CA 94720 USA; NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centers for Disease Control & Prevention - USA	Flegal, KM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, 3311 Toledo Rd,Room 4311, Hyattsville, MD 20782 USA.	kflegal@cdc.gov	Young, Alexander/A-1523-2009; Flegal, Katherine M/A-4608-2013	Young, Alexander/0000-0002-9367-9213; Flegal, Katherine/0000-0002-0838-469X				Ajani UA, 2004, ANN EPIDEMIOL, V14, P731, DOI 10.1016/j.annepidem.2003.10.008; Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; [Anonymous], 1994, VITAL HLTH STAT, P1; Banegas JR, 2003, EUR J CLIN NUTR, V57, P201, DOI 10.1038/sj.ejcn.1601538; BENICHOU J, 1998, AM J PUBLIC HEALTH, V88, P15; Caraballo RS, 2001, AM J EPIDEMIOL, V153, P807, DOI 10.1093/aje/153.8.807; COHEN JS, 1987, TRADITION, V22, P1; Cox C S, 1997, Vital Health Stat 1, P1; Dorn JM, 1997, AM J EPIDEMIOL, V146, P919, DOI 10.1093/oxfordjournals.aje.a009218; Dyer AR, 2004, ANN EPIDEMIOL, V14, P101, DOI 10.1016/S1047-2797(03)00121-2; Engel A, 1978, Vital Health Stat 1, P1; Farrell SW, 2002, OBES RES, V10, P417, DOI 10.1038/oby.2002.58; Flegal KM, 2004, AM J PUBLIC HEALTH, V94, P1486, DOI 10.2105/AJPH.94.9.1486; Flegal KM, 2004, AM J EPIDEMIOL, V160, P331, DOI 10.1093/aje/kwh222; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; Haapanen-Niemi N, 2000, INT J OBESITY, V24, P1465, DOI 10.1038/sj.ijo.0801426; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Heiat A, 2001, ARCH INTERN MED, V161, P1194, DOI 10.1001/archinte.161.9.1194; Katzmarzyk PT, 2001, J CLIN EPIDEMIOL, V54, P916, DOI 10.1016/S0895-4356(01)00356-0; Korn E. L., 1999, ANAL HLTH SURVEYS; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; LORIA CM, 1999, VITAL HLTH STAT 1, V38, P1; MACHLIN SR, 1989, STAT MED, V8, P997, DOI 10.1002/sim.4780080810; MCDOWELL A, 1981, VITAL HLTH STAT, V1, P15; Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012; Meyer HE, 2002, MED SCI SPORT EXER, V34, P1065, DOI 10.1097/00005768-200207000-00002; MILLIMAN JD, 1973, BIOL GEOLOGY CORAL R, V1, P1; Minino Arialdi M, 2002, Natl Vital Stat Rep, V50, P1; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; *NAT CTR HLTH STAT, HLTH US 2004 CHARTB; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; SHAH BV, 2004, SURV METHODOL, V30, P31; Strawbridge WJ, 2000, AM J PUBLIC HEALTH, V90, P340, DOI 10.2105/AJPH.90.3.340; STURGEON SR, 1995, J NATL CANCER I, V87, P1846, DOI 10.1093/jnci/87.24.1846; Troiano RP, 1996, INT J OBESITY, V20, P63; Visscher TLS, 2004, ARCH INTERN MED, V164, P1413, DOI 10.1001/archinte.164.13.1413; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; 1994, VITAL HLTH STAT, V1, P32	41	2001	2046	3	358	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2005	293	15					1861	1867		10.1001/jama.293.15.1861	http://dx.doi.org/10.1001/jama.293.15.1861			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QW	15840860				2022-12-24	WOS:000228401700024
J	Gregg, EW; Cheng, YLJ; Cadwell, BL; Imperatore, G; Williams, DE; Flegal, KM; Narayan, KMV; Williamson, DF				Gregg, EW; Cheng, YLJ; Cadwell, BL; Imperatore, G; Williams, DE; Flegal, KM; Narayan, KMV; Williamson, DF			Secular trends in cardiovascular disease risk factors according to body mass index in US adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NUTRITION EXAMINATION SURVEY; IMPAIRED GLUCOSE-TOLERANCE; FACTOR SURVEILLANCE SYSTEM; CORONARY-HEART-DISEASE; UNITED-STATES; NATIONAL-HEALTH; PREVALENCE; OBESITY; OVERWEIGHT; DISABILITY	Context Prevalence of obesity in the United States has increased dramatically in recent decades, but the magnitude of change in cardiovascular disease (CVD) risk factors among the growing proportion of overweight and obese Americans remains unknown. Objective To examine 40-year trends in CVD risk factors by body mass index (BMI) groups among US adults aged 20 to 74 years. Design, Setting, and Participants Analysis of 5 cross-sectional, nationally representative surveys: National Health Examination Survey (1960-1962); National Health and Nutrition Examination Survey (NHANES) I (1971-1975), II (1976-1980), and III (1988-1994); and NHANES 1999-2000. Main Outcome Measures Prevalence of high cholesterol level (>= 240 mg/dL [>= 6.2 mmol/L] regardless of treatment), high blood pressure (>= 140/90 mm Hg regardless of treatment), current smoking, and total diabetes (diagnosed and undiagnosed combined) according to BMI group (lean, <25; overweight, 25-29; and obese, >= 30). Results The prevalence of all risk factors except diabetes decreased overtime across all BMI groups, with the greatest reductions observed among overweight and obese groups. Compared with obese persons in 1960-1962, obese persons in 1999-2000 had a 21-percentage-point lower prevalence of high cholesterol level (39% in 19601962 vs 18% in 1999-2000), an 18-percentage-point lower prevalence of high blood pressure (from 42% to 24%), and a 12-percentage-point lower smoking prevalence (from 32% to 20%). Survey X BMI group interaction terms indicated that compared with-the first survey, the prevalence of high cholesterol in the fifth survey had fallen more in obese and overweight persons than in lean persons (P < .05). Survey X BMI changes in blood pressure and smoking were not statistically significant. Changes in risk factors were accompanied by increases in lipid-lowering and antihypertensive medication use, particularly among obese persons. Total diabetes prevalence was stable within BMI groups over time, as nonsignificant 1- to 2-percentage-point increases occurred between 1976-1980 and 1999-2000. Conclusions Except for diabetes, CVD risk factors have declined considerably over the past 40 years in all BMI groups. Although obese persons still have higher risk factor levels than lean persons, the levels of these risk factors are much lower than in previous decades.	Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA; Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Gregg, EW (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy NE,Mailstop K-10, Atlanta, GA 30341 USA.	edg7@cdc.gov	Cheng, Yiling J/A-6547-2009; Narayan, K.M. Venkat/J-9819-2012; Flegal, Katherine M/A-4608-2013	Cheng, Yiling J/0000-0002-5053-0814; Narayan, K.M. Venkat/0000-0001-8621-5405; Flegal, Katherine/0000-0002-0838-469X; Gregg, Edward/0000-0003-2381-6822				[Anonymous], 1994, VITAL HLTH STAT, P1; [Anonymous], 2003, MMWR-MORBID MORTAL W, V52, P833; [Anonymous], 1997, ARCH INTERN MED, V157, P2413; Arnett DK, 2002, AM J EPIDEMIOL, V156, P929, DOI 10.1093/aje/kwf133; Briefel RR, 2004, ANNU REV NUTR, V24, P401, DOI 10.1146/annurev.nutr.23.011702.073349; Brown CD, 2000, OBES RES, V8, P605, DOI 10.1038/oby.2000.79; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; *CDCP, 1980, CDCP PREV DIAGN DIAB; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P986; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P80; Cooper R, 2000, CIRCULATION, V102, P3137; ERNST ND, 1997, AM J CLIN NUTR S, V66, P9725; Fagot-Campagna A, 2000, J PEDIATR-US, V136, P664, DOI 10.1067/mpd.2000.105141; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; FLEGAL KM, 1991, DIABETES CARE, V14, P628, DOI 10.2337/diacare.14.7.628; FLEGAL KM, 1995, NEW ENGL J MED, V333, P1165, DOI 10.1056/NEJM199511023331801; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Gregg EW, 2004, DIABETES CARE, V27, P2806, DOI 10.2337/diacare.27.12.2806; Gross LS, 2004, AM J CLIN NUTR, V79, P774; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; HARRIS MI, 1987, DIABETES, V36, P523, DOI 10.2337/diabetes.36.4.523; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; JOHNSON CL, 1993, JAMA-J AM MED ASSOC, V269, P3002, DOI 10.1001/jama.269.23.3002; Korn E. L., 1999, ANAL HLTH SURVEYS; Kumanyika SK, 1998, AM J EPIDEMIOL, V148, P528; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; LAUNER LJ, 1994, JAMA-J AM MED ASSOC, V271, P1093, DOI 10.1001/jama.271.14.1093; Li RW, 2000, AM J PUBLIC HEALTH, V90, P777, DOI 10.2105/AJPH.90.5.777; *LIP RES CLIN PROG, 1982, MAN LAB OP, V1; MAXWELL MH, 1982, LANCET, V2, P33; McDowell A, 1981, Vital Health Stat 1, P1; Miller SI, 2001, AM J ADDICTION, V10, P1, DOI 10.1080/10550490150504083; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; MYERS GL, 1989, CLIN LAB MED, V9, P105, DOI 10.1016/S0272-2712(18)30645-0; *NHANES NAT CTR HL, 1999 2000 DAT FIL DA; Nielsen Samara Joy, 2003, JAMA (Journal of the American Medical Association), V289, P450, DOI 10.1001/jama.289.4.450; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; *RES TRIANGL I, 2003, SUDAAN US MAN; RISSANEN A, 1990, BRIT MED J, V301, P835, DOI 10.1136/bmj.301.6756.835; Rosamond WD, 1998, NEW ENGL J MED, V339, P861, DOI 10.1056/NEJM199809243391301; *SAS I INC, 1999, SAS PROC GUID; Siegel D, 2000, AM J MED, V108, P496, DOI 10.1016/S0002-9343(00)00319-3; Simpson ME, 2003, AM J PREV MED, V25, P95, DOI 10.1016/S0749-3797(03)00112-0; Sturm R, 2004, HEALTH AFFAIR, V23, P199, DOI 10.1377/hlthaff.23.2.199; Visscher TLS, 2004, ARCH INTERN MED, V164, P1413, DOI 10.1001/archinte.164.13.1413; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867; 1965, VITAL HLTH STAT 1, V4, P1	48	663	684	1	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2005	293	15					1868	1874		10.1001/jama.293.15.1868	http://dx.doi.org/10.1001/jama.293.15.1868			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QW	15840861	Bronze			2022-12-24	WOS:000228401700025
J	Khimich, D; Nouvian, R; Pujol, R; Dieck, ST; Egner, A; Gundelfinger, ED; Moser, T				Khimich, D; Nouvian, R; Pujol, R; Dieck, ST; Egner, A; Gundelfinger, ED; Moser, T			Hair cell synaptic ribbons are essential for synchronous auditory signalling	NATURE			English	Article							ZONE PROTEIN BASSOON; AFFERENT SYNAPSE; TRANSMITTER RELEASE; CALCIUM-DEPENDENCE; ACTIVE ZONES; EXOCYTOSIS; VESICLES; ENDOCYTOSIS; MICROSCOPE; MEMBRANE	Hearing relies on faithful synaptic transmission at the ribbon synapse of cochlear inner hair cells (IHCs)(1-3). At present, the function of presynaptic ribbons at these synapses is still largely unknown(1,4). Here we show that anchoring of IHC ribbons is impaired in mouse mutants for the presynaptic scaffolding protein Bassoon. The lack of active-zone-anchored synaptic ribbons reduced the presynaptic readily releasable vesicle pool, and impaired synchronous auditory signalling as revealed by recordings of exocytic IHC capacitance changes and sound-evoked activation of spiral ganglion neurons. Both exocytosis of the hair cell releasable vesicle pool and the number of synchronously activated spiral ganglion neurons co-varied with the number of anchored ribbons during development. Interestingly, ribbon-deficient IHCs were still capable of sustained exocytosis with normal Ca2+-dependence. Endocytic membrane retrieval was intact, but an accumulation of tubular and cisternal membrane profiles was observed in ribbon-deficient IHCs. We conclude that ribbon-dependent synchronous release of multiple vesicles at the hair cell afferent synapse is essential for normal hearing.	Univ Goettingen, Dept Otolaryngol, D-37099 Gottingen, Germany; Univ Goettingen, Ctr Mol Physiol Brain, D-37099 Gottingen, Germany; Univ Montpellier, INSERM, U583, INM, F-34091 Montpellier, France; Univ Montpellier, CRIC, F-34091 Montpellier, France; Leibniz Inst Neurobiol, Dept Neurochem & Mol Biol, D-39118 Magdeburg, Germany; Max Planck Inst Biophys Chem, Dept Nanobiophoton, D-37077 Gottingen, Germany	University of Gottingen; University of Gottingen; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Leibniz Institut fur Neurobiologie (LIN); Max Planck Society	Moser, T (corresponding author), Univ Goettingen, Dept Otolaryngol, D-37099 Gottingen, Germany.	tmoser@gwdg.de	Nouvian, Regis/AAW-4207-2021; Moser, Tobias/L-5068-2014; Nouvian, Regis/AFQ-8065-2022	Nouvian, Regis/0000-0002-0901-4666; Moser, Tobias/0000-0001-7145-0533; Nouvian, Regis/0000-0002-0901-4666; Pujol, Remy/0000-0002-7837-7129; Egner, Alexander/0000-0001-5248-3858				Altrock WD, 2003, NEURON, V37, P787, DOI 10.1016/S0896-6273(03)00088-6; Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Edmonds BW, 2004, J PHYSIOL-LONDON, V560, P439, DOI 10.1113/jphysiol.2004.066035; Egner A, 2002, P NATL ACAD SCI USA, V99, P3370, DOI 10.1073/pnas.052545099; Fuchs PA, 2003, CURR OPIN NEUROBIOL, V13, P452, DOI 10.1016/S0959-4388(03)00098-9; Glowatzki E, 2002, NAT NEUROSCI, V5, P147, DOI 10.1038/nn796; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HELL S, 1992, J OPT SOC AM A, V9, P2159, DOI 10.1364/JOSAA.9.002159; Holt M, 2003, J NEUROSCI, V23, P1329, DOI 10.1523/JNEUROSCI.23-04-01329.2003; KEMP DT, 1978, J ACOUST SOC AM, V64, P1386, DOI 10.1121/1.382104; Lagnado L, 2003, CURR BIOL, V13, pR631, DOI 10.1016/S0960-9822(03)00566-9; Lenzi D, 2002, NEURON, V36, P649, DOI 10.1016/S0896-6273(02)01025-5; LIBERMAN MC, 1982, SCIENCE, V216, P1239, DOI 10.1126/science.7079757; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Paillart C, 2003, J NEUROSCI, V23, P4092; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Shnerson A, 1981, Brain Res, V254, P77; SMITH CA, 1961, J ULTRA MOL STRUCT R, V5, P184, DOI 10.1016/S0022-5320(61)90013-2; SMITH JE, 1980, J EXP BIOL, V89, P19; Spassova MA, 2004, JARO-J ASSOC RES OTO, V5, P376, DOI 10.1007/s10162-004-5003-8; Starr A, 1996, BRAIN, V119, P741, DOI 10.1093/brain/119.3.741; Sterling P, 2005, TRENDS NEUROSCI, V28, P20, DOI 10.1016/j.tins.2004.11.009; TOMDIECK S, IN PRESS J CELL 0222, DOI DOI 10.1083/JCB.2001.200408157; Trussell LO, 1999, ANNU REV PHYSIOL, V61, P477, DOI 10.1146/annurev.physiol.61.1.477; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500	30	360	382	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2005	434	7035					889	894		10.1038/nature03418	http://dx.doi.org/10.1038/nature03418			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915SV	15829963	Green Published			2022-12-24	WOS:000228327600039
J	Heymann, DL; Sutter, RW; Aylward, RB				Heymann, DL; Sutter, RW; Aylward, RB			A global call for new polio vaccines	NATURE			English	Editorial Material									WHO, Global Polio Eradicat Initiat, CH-1211 Geneva, Switzerland	World Health Organization	Heymann, DL (corresponding author), WHO, Global Polio Eradicat Initiat, 20 Ave Appia, CH-1211 Geneva, Switzerland.							Fine P E, 2001, Dev Biol (Basel), V105, P129; Heymann DL, 2004, LANCET, V363, P1566, DOI 10.1016/S0140-6736(04)16234-X; Heymann DL, 2004, NEW ENGL J MED, V351, P1275, DOI 10.1056/NEJMp048204; Mulders MN, 1997, J INFECT DIS, V176, P617, DOI 10.1086/514081; Savolainen C, 2003, LANCET, V361, P1145, DOI 10.1016/S0140-6736(03)12965-0; *WHO, 2002, GLOB ACT PLAN LAB CO; *WHO, IN PRESS REP WHO CON	7	48	53	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2005	434	7034					699	700		10.1038/434699a	http://dx.doi.org/10.1038/434699a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	913NU	15815604	Bronze, Green Published			2022-12-24	WOS:000228160700017
J	Saadoun, S; Papadopoulos, MC; Hara-Chikuma, M; Verkman, AS				Saadoun, S; Papadopoulos, MC; Hara-Chikuma, M; Verkman, AS			Impairment of angiogenesis and cell migration by targeted aquaporin-1 gene disruption	NATURE			English	Article							WATER CHANNELS; EXPRESSION; RECEPTOR; GROWTH; MICE; PERMEABILITY; PROTEIN	Aquaporin-1 (AQP1) is a water channel protein expressed widely in vascular endothelia, where it increases cell membrane water permeability(1-3). The role of AQP1 in endothelial cell function is unknown. Here we show remarkably impaired tumour growth in AQP1-null mice after subcutaneous or intracranial tumour cell implantation, with reduced tumour vascularity and extensive necrosis. A new mechanism for the impaired angiogenesis was established from cell culture studies. Although adhesion and proliferation were similar in primary cultures of aortic endothelia from wild-type and from AQP1-null mice, cell migration was greatly impaired in AQP1-deficient cells, with abnormal vessel formation in vitro. Stable transfection of non-endothelial cells with AQP1 or with a structurally different water-selective transletters porter (AQP4) accelerated cell migration and wound healing in vitro. Motile AQP1-expressing cells had prominent membrane ruffles at the leading edge with polarization of AQP1 protein to lamellipodia, where rapid water fluxes occur. Our findings support a fundamental role of water channels in cell migration, which is central to diverse biological phenomena including angiogenesis, wound healing, tumour spread and organ regeneration.	Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Cardiovasc Res Inst, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Verkman, AS (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94143 USA.	verkman@itsa.ucsf.edu		Saadoun, Samira/0000-0002-5480-5678; Papadopoulos, Marios/0000-0001-9174-4176				Carter EP, 1998, BIOPHYS J, V74, P2121, DOI 10.1016/S0006-3495(98)77919-6; CONDEELIS J, 1993, ANNU REV CELL BIOL, V9, P411, DOI 10.1146/annurev.cb.09.110193.002211; Egami K, 2003, J CLIN INVEST, V112, P67, DOI 10.1172/JCI200316645; Endo M, 1999, MICROVASC RES, V58, P89, DOI 10.1006/mvre.1999.2158; HASEGAWA H, 1994, AM J PHYSIOL, V266, pC893, DOI 10.1152/ajpcell.1994.266.4.C893; Ishida T, 2003, J BIOL CHEM, V278, P34598, DOI 10.1074/jbc.M304890200; Kawamoto A, 2003, CIRCULATION, V107, P461, DOI 10.1161/01.CIR.0000046450.89986.50; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee H, 2000, AM J PHYSIOL-CELL PH, V278, pC612, DOI 10.1152/ajpcell.2000.278.3.C612; Ma TH, 1998, J BIOL CHEM, V273, P4296, DOI 10.1074/jbc.273.8.4296; Ma TH, 2000, P NATL ACAD SCI USA, V97, P4386, DOI 10.1073/pnas.080499597; Miao WM, 2001, CANCER RES, V61, P7830; Moon C, 2003, ONCOGENE, V22, P6699, DOI 10.1038/sj.onc.1206762; NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P7275, DOI 10.1073/pnas.90.15.7275; Orr AW, 2003, J CELL SCI, V116, P2917, DOI 10.1242/jcs.00600; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Ribatti D, 2002, ANAT REC, V268, P85, DOI 10.1002/ar.10123; ROSENGREN S, 1994, AM J PHYSIOL-CELL PH, V267, pC1623, DOI 10.1152/ajpcell.1994.267.6.C1623; Saadoun S, 2002, BRIT J CANCER, V87, P621, DOI 10.1038/sj.bjc.6600512; Schwab A, 1999, PFLUG ARCH EUR J PHY, V438, P330, DOI 10.1007/s004240050917; Schwab A, 2001, AM J PHYSIOL-RENAL, V280, pF739, DOI 10.1152/ajprenal.2001.280.5.F739; Shi GP, 2003, CIRC RES, V92, P493, DOI 10.1161/01.RES.0000060485.20318.96; Solenov E, 2004, AM J PHYSIOL-CELL PH, V286, pC426, DOI 10.1152/ajpcell.00298.2003; Steinle JJ, 2002, J BIOL CHEM, V277, P43830, DOI 10.1074/jbc.M207221200; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; Vacca A, 2001, BRIT J HAEMATOL, V113, P415, DOI 10.1046/j.1365-2141.2001.02738.x; Yang BX, 1996, J BIOL CHEM, V271, P4577; Yao L, 1999, BLOOD, V93, P1612, DOI 10.1182/blood.V93.5.1612.405a13_1612_1621	28	579	674	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2005	434	7034					786	792		10.1038/nature03460	http://dx.doi.org/10.1038/nature03460			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	913NU	15815633				2022-12-24	WOS:000228160700046
J	Demoly, P; Daures, JP				Demoly, P; Daures, JP			Managing asthma during pregnancy	LANCET			English	Editorial Material							RHINITIS		Univ Hosp Montpellier, Hop Arnaud Villeneuve, INSERM, U454, F-34295 Montpellier, France; Univ Montpellier I, Inst Univ Rech Clin Montpellier, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier	Demoly, P (corresponding author), Univ Hosp Montpellier, Hop Arnaud Villeneuve, INSERM, U454, F-34295 Montpellier, France.	dernoly@rnontp.inserm.fr	Demoly, Pascal/Y-9938-2019	Demoly, Pascal/0000-0001-7827-7964				Bochner BS, 2005, J ALLERGY CLIN IMMUN, V115, P953, DOI 10.1016/j.jaci.2005.02.032; Bousquet J, 2003, ALLERGY, V58, P691, DOI 10.1034/j.1398-9995.2003.00105.x; Demoly P, 2003, DRUGS, V63, P1813, DOI 10.2165/00003495-200363170-00004; Demoly P, 2003, EXPERT OPIN PHARMACO, V4, P1019, DOI 10.1517/14656566.4.7.1019; Dombrowski MP, 2004, OBSTET GYNECOL, V103, P5, DOI 10.1097/01.AOG.0000103994.75162.16; Global Initiative for Asthma, 2004, GLOB STRAT ASTHM MAN; Martel MJ, 2005, BMJ-BRIT MED J, V330, P230, DOI 10.1136/bmj.38313.624352.8F; Wedzicha JA, 2003, THORAX, V58, P1, DOI 10.1136/thorax.58.1.1	8	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2005	365	9466					1212	1213		10.1016/S0140-6736(05)74791-7	http://dx.doi.org/10.1016/S0140-6736(05)74791-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	912VI	15811441				2022-12-24	WOS:000228107600008
J	Griffiths, PD; Paley, MNJ; Whitby, EH				Griffiths, PD; Paley, MNJ; Whitby, EH			Post-mortern MRI as an adjunct to fetal or neonatal autopsy	LANCET			English	Review							PERINATAL PATHOLOGY; CLINICAL-TRIAL; ATTITUDES; CONTEXT	Context Understanding what was wrong with a dead fetus or why a newborn child died can help the parents to grieve, while any findings can be used to inform the parents if there is a risk to future pregnancies and the level of risk. This information is mainly obtained from autopsies, but the number of parents agreeing to autopsy has dropped, which has prompted the search for adjuncts to autopsy. Starting point The UK's Chief Medical Officer outlined the rationale for exploring alternatives to autopsy in 2000 and 2001. After wide consultation, MRI was deemed to offer the most realistic chance of making a contribution. Results so far are promising, but of insufficient depth and quality to make firm recommendations about providing a service in the future. In 2004, the UK Department of Health therefore tendered for this research to be done in fetal and neonatal (and adult) cases, and this work is due to start in 2005. Where next? High-quality anatomical information about the brain and spine of fetuses and neonates can be easily obtained with standard MRI scanners. Most developmental and acquired abnormalities can be seen on postmortem MRI. More work needs to be done on organs not in the central nervous system, and heart malformations, in particular, might present diagnostic problems. A possible outcome could be whole-body MRI plus targeted biopsies of abnormalities taken under image guidance as an adjunct to formal autopsy.	Univ Sheffield, Sect Acad Radiol, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield	Griffiths, PD (corresponding author), Univ Sheffield, Sect Acad Radiol, Sheffield S10 2JF, S Yorkshire, England.	p.griffiths@sheffield.ac.uk	Whitby, Elspeth/G-5517-2010	Whitby, Elspeth/0000-0002-8912-8013				Alderliesten ME, 2003, BJOG-INT J OBSTET GY, V110, P378, DOI 10.1016/S1470-0328(02)02076-1; Brookes JAS, 1996, LANCET, V348, P1139, DOI 10.1016/S0140-6736(96)02287-8; Chief Medical Officer, 2001, REM RET US HUM ORG T; Griffiths PD, 2003, AM J NEURORADIOL, V24, P22; Huisman TAGM, 2002, FETAL DIAGN THER, V17, P58, DOI 10.1159/000048008; Larroche, 1987, DEV CERVEAU FOETAL H; Parker A, 2004, LESS INVASIVE AUTOPS; Snowdon C, 2004, ARCH DIS CHILD-FETAL, V89, pF208, DOI 10.1136/adc.2003.041392; Snowdon C, 2004, ARCH DIS CHILD-FETAL, V89, pF204, DOI 10.1136/adc.2002.012732; The Chief Medical Officer, 2000, REP CENS ORG TISS RE; Whitby EH, 2004, BJOG-INT J OBSTET GY, V111, P784, DOI 10.1111/j.1471-0528.2004.00149.x; Woodward PJ, 1997, AM J ROENTGENOL, V168, P41, DOI 10.2214/ajr.168.1.8976917	12	87	91	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 2	2005	365	9466					1271	1273		10.1016/S0140-6736(05)74816-9	http://dx.doi.org/10.1016/S0140-6736(05)74816-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	912VI	15811461				2022-12-24	WOS:000228107600031
J	Bailis, R; Ezzati, M; Kammen, DM				Bailis, R; Ezzati, M; Kammen, DM			Mortality and greenhouse gas impacts of biomass and petroleum energy futures in Africa	SCIENCE			English	Article							BIRTH-WEIGHT; EXPOSURE; SMOKE	We analyzed the mortality impacts and greenhouse gas (GHG) emissions produced by household energy use in Africa. Under a business-as-usual (BAU) scenario, household indoor air pollution will cause an estimated 9.8 million premature deaths by the year 2030. Gradual and rapid transitions to charcoal would delay 1.0 million and 2.8 million deaths, respectively; similar transitions to petroleum fuels would delay 1.3 million and 3.7 million deaths. Cumulative BAU GHG emissions will be 6.7 billion tons of carbon by 2050, which is 5.6% of Africa's total emissions. Large shifts to the use of fossil fuels would reduce GHG emissions by 1 to 10%. Charcoal-intensive future scenarios using current practices increase emissions by 140 to 190%; the increase can be reduced to 5 to 36% using currently available technologies for sustainable production or potentially reduced even more with investment in technological innovation.	Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA; Univ Calif Berkeley, Goldman Sch Publ Policy, Berkeley, CA 94720 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Ezzati, M (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	mezzati@hsph.harvard.edu; kammen@berkeley.edu	Bailis, Robert/O-6643-2019; Bailis, Rob/B-9779-2015	Bailis, Robert/0000-0002-4111-3760; Bailis, Rob/0000-0002-4111-3760	NIA NIH HHS [P01-AG17625] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG017625] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 1996, GLOBAL BURDEN DIS; [Anonymous], 2004, WORLD POP PROSP 2002; Bailis R, 2003, ENVIRON SCI TECHNOL, V37, P2051, DOI 10.1021/es026058q; Bond T. C., 2004, ENERGY SUSTAIN DEV, V3, P20, DOI DOI 10.1016/S0973-0826(08)60464-0; Boy E, 2002, ENVIRON HEALTH PERSP, V110, P109, DOI 10.1289/ehp.02110109; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ezzati M, 2000, ENVIRON SCI TECHNOL, V34, P578, DOI 10.1021/es9905795; FERREIRA OC, 2000, EC ENERGY        MAY, P20; *GOV IND, 2001, CENS IND 2001; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; IEA, 2002, WORLD EN OUTL, P365; *IEA, 2004, EN STAT NONOECD COUN; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Karekezi S, 2002, ENERG POLICY, V30, P915, DOI 10.1016/S0301-4215(02)00047-2; Ministry of Energy, 2002, STUD KEN EN DEM SUPP; Mishra V, 2004, ANN EPIDEMIOL, V14, P740, DOI 10.1016/j.annepidem.2004.01.009; Smith K.R., 2004, COMP QUANTIFICATION, V18, P1435; Smith KR, 2002, SCIENCE, V298, P1847, DOI 10.1126/science.298.5600.1847; SMITH KR, 2000, GREENHOUSE GASES SMA; SMITH KR, 1999, EPA600R99109 US EPA; *UN FAO, 2004, FAOSTAT DAT; WHO, 2002, RED RISKS PROM HLTH; *WORLD BANK, 2000, AFR DEV IND SER	23	207	215	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2005	308	5718					98	103		10.1126/science.1106881	http://dx.doi.org/10.1126/science.1106881			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914IQ	15802601				2022-12-24	WOS:000228221500041
J	Brown, RH				Brown, RH			Amyotrophic lateral sclerosis - A new role for old drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Brown, RH (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.							Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180	1	7	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2005	352	13					1376	1378		10.1056/NEJMcibr050274	http://dx.doi.org/10.1056/NEJMcibr050274			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	911JL	15800236				2022-12-24	WOS:000227998300019
J	Walsh, B; Steiner, A; Pickering, RM; Ward-Basu, J				Walsh, B; Steiner, A; Pickering, RM; Ward-Basu, J			Economic evaluation of nurse led intermediate care versus standard acute care for post-acute medical patients: cost minimisation analysis of data from a randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							INPATIENT UNIT	Objective To undertake an economic evaluation of nurse led intermediate care compared with standard hospital care for post-acute medical patients. Design Cost minimisation analysis from an NHS perspective, comprising secondary care, primary care, and community care, using data from a pragmatic randomised controlled trial. Setting Nurse led unit and acute general medical wards in large, urban, UK teaching hospital. Participants 238 patients. Outcome measure Costs to acute hospital trusts and to the NHS over six months. Results On an intention to treat basis, nurse led care was associated with higher costs during the initial admission period (nurse led care 7892 pound ($14 970; E11 503), standard care 4810 pound, difference 3082 pound (95% confidence interval 1161 pound to 5002 pound)) pound. During the readmission period, costs were similar (nurse led care 1444 pound, standard care 1879 pound, difference - 435 pound, - 1406 pound to 536 pound) pound. Total costs at six months were significantly higher (nurse led care 10 529 pound, standard care 7819 pound, difference 2710 pound, 518 pound to 4903 pound). Sensitivity analyses suggested that the trend for nurse led care to be more expensive was maintained even with substantial cost reductions, although differences were no longer significant. Conclusion Acute hospitals may not be cost effective settings for nurse led intermediate care. Both inpatient and total costs were significantly higher for nurse led care than for standard care of post-acute medical patients, suggesting that this model of care should not be pursued unless clinical or organisational benefits justify the increased investment.	Univ Southampton, Sch Nursing & Midwifery, Southampton SO17 1BJ, Hants, England; Univ Southampton, Dept Geriatr Med, Southampton SO9 5NH, Hants, England; Southampton Gen Hosp, Med Stat Grp, Hlth Care Res Unit, Southampton SO16 6YD, Hants, England; Southampton Gen Hosp, Dept Geriatr Med, Elderly Care Res Unit, Southampton SO16 6YD, Hants, England	University of Southampton; University of Southampton; University of Southampton; University of Southampton	Walsh, B (corresponding author), Univ Southampton, Sch Nursing & Midwifery, Southampton SO17 1BJ, Hants, England.	b.m.walsh@soton.ac.uk		Walsh, Bronagh/0000-0003-1008-0545				Coast J, 1998, BRIT MED J, V316, P1802, DOI 10.1136/bmj.316.7147.1802; *DEP HLTH, 2001, HLTH SERV CIRC 2001; *DEP HLTH, 2000, NHS PLAN; Department of Health, 2001, NAT SERV FRAM OLD PE; Department of Health, 2000, SHAP FUT NHS LONG TE; Griffiths P, 2001, AGE AGEING, V30, P483, DOI 10.1093/ageing/30.6.483; Griffiths P, 2000, INT J NURS STUD, V37, P153, DOI 10.1016/S0020-7489(99)00061-9; GRIFFITHS P, 1995, EVALUATING NURSE LED; NETTEN A, 1999, UNIT COSTS COMMUNITY; PEARSON A, 1992, NURSING BEDS EVALUAT; Stein RL, 2004, J PALESTINE STUD, V33, P5, DOI 10.1525/jps.2004.33.4.005; Steiner A, 2001, AGE AGEING, V30, P433, DOI 10.1093/ageing/30.6.433; Steiner A, 2001, BRIT MED J, V322, P453, DOI 10.1136/bmj.322.7284.453; Walsh B, 2003, INT J NURS STUD, V40, P307, DOI 10.1016/S0020-7489(02)00091-3; Wiles R, 2001, J ADV NURS, V34, P813, DOI 10.1046/j.1365-2648.2001.01812.x	15	24	24	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 26	2005	330	7493					699	702		10.1136/bmj.38397.633588.8F	http://dx.doi.org/10.1136/bmj.38397.633588.8F			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	912IT	15757959	Green Published, Bronze			2022-12-24	WOS:000228071900015
J	Sauerwald, A; Zhu, WH; Major, TA; Roy, H; Palioura, S; Jahn, D; Whitman, WB; Yates, JR; Ibba, M; Soll, D				Sauerwald, A; Zhu, WH; Major, TA; Roy, H; Palioura, S; Jahn, D; Whitman, WB; Yates, JR; Ibba, M; Soll, D			RNA-Dependent cysteine biosynthesis in archaea	SCIENCE			English	Article							GENETIC-CODE ORIGIN; METHANOCOCCUS-JANNASCHII; IN-VIVO; SYNTHETASE; CYSTEINYL-TRNA(CYS); PYRROLYSINE; ACID	Several methanogenic archaea lack cysteinyl-transfer RNA (tRNA) synthetase (CysRS), the essential enzyme that provides Cys-tRNA(Cys) for translation in most organisms. Partial purification of the corresponding activity from Methanocaldococcus jannaschii indicated that tRNA(Cys) becomes acylated with O-phosphoserine (Sep) but not with cysteine. Further analyses identified a class II-type O-phosphoseryl-tRNA synthetase (SepRS) and Sep-tRNA:Cys-tRNA synthase (SepCysS). SepRS specifically forms Sep-tRNA(Cys), which is then converted to Cys-tRNA(Cys) by SepCysS. Comparative genomic analyses suggest that this pathway, encoded in all organisms lacking CysRS, can also act as the sole route for cysteine biosynthesis. This was proven for Methanococcus maripaludis, where deletion of the SepRS-encoding gene resulted in cysteine auxotrophy. As the conversions of Sep-tRNA to Cys-tRNA or to selenocysteinyl-tRNA are chemically analogous, the catalytic activity of SepCysS provides a means by which both cysteine and selenocysteine may have originally been added to the genetic code.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Chem, New Haven, CT 06520 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; Tech Univ Carolo Wilhelmina Braunschweig, Dept Microbiol, D-38106 Braunschweig, Germany	Yale University; Yale University; Scripps Research Institute; University System of Georgia; University of Georgia; University System of Ohio; Ohio State University; Braunschweig University of Technology	Soll, D (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	soll@trna.chem.yale.edu	Whitman, William/AAC-5896-2020	Whitman, William/0000-0003-1229-0423; Jahn, Dieter/0000-0002-4064-9205				Ambrogelly A, 2004, CELL MOL LIFE SCI, V61, P2437, DOI 10.1007/s00018-004-4194-9; AVALOS J, 1991, FEBS LETT, V286, P176, DOI 10.1016/0014-5793(91)80968-9; BALCH WE, 1979, J BACTERIOL, V137, P264, DOI 10.1128/JB.137.1.264-273.1979; Basurko MJ, 1999, IUBMB LIFE, V48, P525, DOI 10.1080/713803557; Blight SK, 2004, NATURE, V431, P333, DOI 10.1038/nature02895; BOCK A, 2004, AMINOACYL TRNA SYNTH, P320; Brooks DJ, 2002, MOL CELL PROTEOMICS, V1, P125, DOI 10.1074/mcp.M100001-MCP200; CALENDAR R, 1966, PROG NUCL ACID RES M, V1, P375; Carlson BA, 2004, P NATL ACAD SCI USA, V101, P12848, DOI 10.1073/pnas.0402636101; Das R, 1999, BIOCHIMIE, V81, P1037, DOI 10.1016/S0300-9084(99)00332-6; Di Giulio M, 1999, J MOL EVOL, V49, P1, DOI 10.1007/PL00006522; Di Giulio M, 2002, J MOL EVOL, V55, P616, DOI 10.1007/s00239-002-2357-6; Fabrega C, 2001, NATURE, V411, P110, DOI 10.1038/35075121; Farahi K, 2004, J MOL EVOL, V58, P615, DOI 10.1007/s00239-004-2582-2; Giometti CS, 2002, J CHROMATOGR B, V782, P227, DOI 10.1016/S1570-0232(02)00568-8; Ibba M, 2000, TRENDS BIOCHEM SCI, V25, P311, DOI 10.1016/S0968-0004(00)01600-5; Jeffares DC, 1998, J MOL EVOL, V46, P18, DOI 10.1007/PL00006280; Kim HS, 1998, J BACTERIOL, V180, P6446, DOI 10.1128/JB.180.24.6446-6449.1998; Li T, 1999, FEBS LETT, V462, P302, DOI 10.1016/S0014-5793(99)01550-1; Lipman RSA, 2000, BIOCHEMISTRY-US, V39, P7792, DOI 10.1021/bi0004955; Min B, 2002, P NATL ACAD SCI USA, V99, P2678, DOI 10.1073/pnas.012027399; Mino K, 2003, FEBS LETT, V551, P133, DOI 10.1016/S0014-5793(03)00913-X; Polycarpo C, 2004, P NATL ACAD SCI USA, V101, P12450, DOI 10.1073/pnas.0405362101; Ruan BF, 2004, J BACTERIOL, V186, P8, DOI 10.1128/JB.186.1.8-14.2004; SAUERWALD A, UNPUB; Sethi A, 2005, P NATL ACAD SCI USA, V102, P4045, DOI 10.1073/pnas.0409715102; Stathopoulos C, 2000, SCIENCE, V287, P479, DOI 10.1126/science.287.5452.479; Stathopoulos C, 2001, P NATL ACAD SCI USA, V98, P14292, DOI 10.1073/pnas.201540498; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; White RH, 2003, BBA-GEN SUBJECTS, V1624, P46, DOI 10.1016/j.bbagen.2003.09.005; WONG JTF, 1975, P NATL ACAD SCI USA, V72, P1909, DOI 10.1073/pnas.72.5.1909; Zhang Chun-Mei, 2004, RNA Biol, V1, P35	32	185	195	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2005	307	5717					1969	1972		10.1126/science.1108329	http://dx.doi.org/10.1126/science.1108329			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910UI	15790858				2022-12-24	WOS:000227957300059
J	Vezzi, A; Campanaro, S; D'Angelo, M; Simonato, F; Vitulo, N; Lauro, FM; Cestaro, A; Malacrida, G; Simionati, B; Cannata, N; Romualdi, C; Bartlett, DH; Valle, G				Vezzi, A; Campanaro, S; D'Angelo, M; Simonato, F; Vitulo, N; Lauro, FM; Cestaro, A; Malacrida, G; Simionati, B; Cannata, N; Romualdi, C; Bartlett, DH; Valle, G			Life at depth: Photobacterium profundum genome sequence and expression analysis	SCIENCE			English	Article							VIBRIO-CHOLERAE; PRESSURE; CHROMOSOMES; PATHOGEN; BACTERIA; DISTINCT; STRESS; GROWTH	Deep-sea life requires adaptation to high pressure, an extreme yet common condition given that oceans cover 70% of Earth's surface and have an average depth of 3800 meters. Survival at such depths requires specific adaptation but, compared with other extreme conditions, high pressure has received little attention. Recently, Photobacterium profundum strain SS9 has been adopted as a model for piezophily. Here we report its genome sequence (6.4 megabase pairs) and transcriptome analysis. The results provide a first glimpse into the. molecular basis for life in the largest portion of the biosphere, revealing high metabolic versatility.	Univ Padua, CRIBI Biotechnol Ctr, I-35131 Padua, Italy; Univ Padua, Dept Biol, I-35131 Padua, Italy; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of Padua; University of Padua; University of California System; University of California San Diego; Scripps Institution of Oceanography	Valle, G (corresponding author), Univ Padua, CRIBI Biotechnol Ctr, Via Bassi 58-B, I-35131 Padua, Italy.	giorgio.valle@unipd.it	VEZZI, ALESSANDRO/AAB-7686-2022; Romualdi, Chiara/K-1132-2016; Campanaro, Stefano/I-5657-2019; Vitulo, Nicola/GVT-2319-2022; Lauro, Federico/X-2420-2019	VEZZI, ALESSANDRO/0000-0002-8629-6644; Romualdi, Chiara/0000-0003-4792-9047; Lauro, Federico/0000-0002-8373-1014; simionati, barbara/0000-0002-0522-0737; Vitulo, Nicola/0000-0002-9571-0747; CAMPANARO, STEFANO/0000-0002-9431-1648; Cestaro, Alessandro/0000-0003-1439-5165; VALLE, GIORGIO/0000-0003-4377-5685				Abe F, 2000, MOL CELL BIOL, V20, P8093, DOI 10.1128/MCB.20.21.8093-8102.2000; Bartlett DH, 2002, BBA-PROTEIN STRUCT M, V1595, P367, DOI 10.1016/S0167-4838(01)00357-0; Chen CY, 2003, GENOME RES, V13, P2577, DOI 10.1101/gr.1295503; Egan ES, 2003, CELL, V114, P521, DOI 10.1016/S0092-8674(03)00611-1; Graentzdoerffer A, 2001, ARCH MICROBIOL, V175, P8, DOI 10.1007/s002030000232; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kawano H, 2003, BIOSCI BIOTECH BIOCH, V67, P1983, DOI 10.1271/bbb.67.1983; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Nogi Y, 1998, EXTREMOPHILES, V2, P1, DOI 10.1007/s007920050036; Pruss BM, 1999, J BACTERIOL, V181, P2624; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Varela C, 2003, APPL MICROBIOL BIOT, V60, P547, DOI 10.1007/s00253-002-1120-7; WELCH TJ, 1993, J BACTERIOL, V175, P7170, DOI 10.1128/JB.175.22.7170-7177.1993; YAYANOS AA, 1986, P NATL ACAD SCI USA, V83, P9542, DOI 10.1073/pnas.83.24.9542	18	204	824	1	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1459	1461		10.1126/science.1103341	http://dx.doi.org/10.1126/science.1103341			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746425				2022-12-24	WOS:000227503100044
J	He, X; He, X; Dave, VP; Zhang, Y; Hua, X; Nicolas, E; Xu, WH; Roe, BA; Kappes, DJ				He, X; He, X; Dave, VP; Zhang, Y; Hua, X; Nicolas, E; Xu, WH; Roe, BA; Kappes, DJ			The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment	NATURE			English	Article							GENE-EXPRESSION; FACTOR GATA-3; LYMPHOCYTE DEVELOPMENT; THYMOCYTE DEVELOPMENT; TRANSGENIC MICE; SELECTION; DIFFERENTIATION; DNA; PROTEINS; DURATION	Development of immature T-cell precursors (thymocytes) to either the CD4 helper or CD8 killer T-cell lineages correlates precisely with their T-cell receptor specificity for major histocompatibility complex class II or class I molecules, respectively, indicating that the process is carefully regulated. Although intensively studied owing to its importance in determining the composition of the mature T-cell compartment and as a general model of binary lineage decisions, the underlying molecular pathways remain obscure. We have previously reported a spontaneous mouse mutant (HD ( helper deficient) mice) in which lineage commitment is specifically perturbed without affecting positive selection. Here we show that a point mutation in the zinc finger transcription factor Th-POK (T-helper-inducing POZ/Kruppel-like factor) is responsible for redirection of class-II-restricted thymocytes to the CD8 lineage in HD mice. Furthermore, we demonstrate that constitutive expression of this factor during thymic development leads to redirection of class-I-restricted thymocytes to the CD4 lineage, indicating that Th-POK is a master regulator of lineage commitment.	Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA	Fox Chase Cancer Center; University of Oklahoma System; University of Oklahoma - Norman	Kappes, DJ (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	dj_kappes@fccc.edu	He, Xi/GXH-3286-2022	He, Xi/0000-0002-4383-0157; He, Xiao/0000-0002-9286-9859				Aliahmad P, 2004, J EXP MED, V199, P1089, DOI 10.1084/jem.20040051; BLOBEL GA, 1995, MOL CELL BIOL, V15, P626; Dave VP, 1998, P NATL ACAD SCI USA, V95, P8187, DOI 10.1073/pnas.95.14.8187; GALERA P, 1994, P NATL ACAD SCI USA, V91, P9372, DOI 10.1073/pnas.91.20.9372; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Goldrath AW, 1997, IMMUNITY, V6, P633, DOI 10.1016/S1074-7613(00)80351-9; Hendriks RW, 1999, EUR J IMMUNOL, V29, P1912, DOI 10.1002/(SICI)1521-4141(199906)29:06<1912::AID-IMMU1912>3.3.CO;2-4; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Itano A, 1996, J EXP MED, V183, P731, DOI 10.1084/jem.183.3.731; Keefe R, 1999, SCIENCE, V286, P1149, DOI 10.1126/science.286.5442.1149; KILLEEN N, 1993, NATURE, V364, P729, DOI 10.1038/364729a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KLEVIT RE, 1991, SCIENCE, V253, P1367, DOI 10.1126/science.1896847; Legname G, 2000, IMMUNITY, V12, P537, DOI 10.1016/S1074-7613(00)80205-8; Liu XL, 2004, NAT IMMUNOL, V5, P280, DOI 10.1038/ni1040; Matechak EO, 1996, IMMUNITY, V4, P337, DOI 10.1016/S1074-7613(00)80247-2; NARDELLI J, 1991, NATURE, V349, P175, DOI 10.1038/349175a0; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Schmedt C, 1998, NATURE, V394, P901, DOI 10.1038/29802; Singer A, 2004, ADV IMMUNOL, V83, P91; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Tyznik AJ, 2004, J EXP MED, V199, P559, DOI 10.1084/jem.20031961; Widom RL, 2001, MATRIX BIOL, V20, P451, DOI 10.1016/S0945-053X(01)00167-6; Wilkinson B, 2002, NAT IMMUNOL, V3, P272, DOI 10.1038/ni767; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	32	303	312	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2005	433	7028					826	833		10.1038/nature03338	http://dx.doi.org/10.1038/nature03338			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	899VT	15729333	Bronze			2022-12-24	WOS:000227174600033
J	Audibert, F				Audibert, F			Screening for pre-eclampsia: the quest for the Holy Grail?	LANCET			English	Editorial Material							DOPPLER VELOCIMETRY; EARLY PREDICTION; PREVENTION; ULTRASOUND; RISK		Univ Montreal, Hop St Justine, Dept Obstet & Gynecol, Montreal, PQ H3T 1C5, Canada	Universite de Montreal	Audibert, F (corresponding author), Univ Montreal, Hop St Justine, Dept Obstet & Gynecol, Montreal, PQ H3T 1C5, Canada.	francois.audibert@umontreal.ca	Audibert, François/AAL-1265-2020	Audibert, Francois/0000-0002-2697-3826				Audibert F, 2005, FETAL DIAGN THER, V20, P48, DOI 10.1159/000081369; Audibert F, 2001, ULTRASOUND OBST GYN, V18, P26, DOI 10.1046/j.1469-0705.2001.00457.x; Chappell LC, 1999, LANCET, V354, P810, DOI 10.1016/S0140-6736(99)80010-5; Conde-Agudelo A, 2004, OBSTET GYNECOL, V104, P1367, DOI 10.1097/01.AOG.0000147599.47713.5d; Dekker G, 2001, LANCET, V357, P209, DOI 10.1016/S0140-6736(00)03599-6; Florio P, 2003, ULTRASOUND OBST GYN, V21, P165, DOI 10.1002/uog.29; Harrington K, 1997, BRIT J OBSTET GYNAEC, V104, P674, DOI 10.1111/j.1471-0528.1997.tb11977.x; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; Salomon LJ, 2003, AM J OBSTET GYNECOL, V189, P1517, DOI 10.1016/S0002-9378(03)00902-5; Sibai BM, 1998, AM J OBSTET GYNECOL, V179, P1275, DOI 10.1016/S0002-9378(98)70146-2	10	12	12	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 16	2005	365	9468					1367	1369		10.1016/S0140-6736(05)66350-7	http://dx.doi.org/10.1016/S0140-6736(05)66350-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QY	15836870				2022-12-24	WOS:000228401900006
J	Frost, KR				Frost, KR			Ensuring the safety of HIV/AIDS generics	LANCET			English	Editorial Material									Amer Fdn AIDS Res, Global Initiat, New York, NY 10005 USA		Frost, KR (corresponding author), Amer Fdn AIDS Res, Global Initiat, New York, NY 10005 USA.	kevin.frost@amfar.org						ADELMAN C, 2004, WALL STREET J E 1209; *AM FDN AIDS RES, 2004, EXP AV HIV AIDS DRUG; BROWN D, 2004, WASHINGTON POST 0327, P3; BUCKLEY S, 2000, WASHINGTON POST 0917, P22; DSILVA J, 2004, EC TIMES NEW DE 1030; MASON A, 2004, SAN FRANCISCO C 1201, pB11; MCNEIL DG, 2005, NY TIMES        0126, pA9; SOLOMON J, 2004, OFFICIALS KNEW AIDS; VERJEE N, 2004, TIMES LOND      1120, P66; WHALEN J, 2004, WALL STREET J   1110, pB1	10	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 9	2005	365	9467					1290	1291		10.1016/S0140-6736(05)61007-0	http://dx.doi.org/10.1016/S0140-6736(05)61007-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	914HY	15823366				2022-12-24	WOS:000228219600008
J	Rasmann, S; Kollner, TG; Degenhardt, J; Hiltpold, I; Toepfer, S; Kuhlmann, U; Gershenzon, J; Turlings, TCJ				Rasmann, S; Kollner, TG; Degenhardt, J; Hiltpold, I; Toepfer, S; Kuhlmann, U; Gershenzon, J; Turlings, TCJ			Recruitment of entomopathogenic nematodes by insect-damaged maize roots	NATURE			English	Article							CORN-ROOTWORM COLEOPTERA; SESQUITERPENE HYDROCARBONS; VOLATILE EMISSIONS; BIOLOGICAL-CONTROL; PLANTS; STEINERNEMATIDAE; CARPOCAPSAE; VARIABILITY; PARASITISM; EFFICACY	Plants under attack by arthropod herbivores often emit volatile compounds from their leaves that attract natural enemies of the herbivores. Here we report the first identification of an insect-induced belowground plant signal, (E)-beta-caryophyllene, which strongly attracts an entomopathogenic nematode. Maize roots release this sesquiterpene in response to feeding by larvae of the beetle Diabrotica virgifera virgifera, a maize pest that is currently invading Europe. Most North American maize lines do not release (E)-beta-caryophyllene, whereas European lines and the wild maize ancestor, teosinte, readily do so in response to D. v. virgifera attack. This difference was consistent with striking differences in the attractiveness of representative lines in the laboratory. Field experiments showed a fivefold higher nematode infection rate of D. v. virgifera larvae on a maize variety that produces the signal than on a variety that does not, whereas spiking the soil near the latter variety with authentic (E)-beta-caryophyllene decreased the emergence of adult D. v. virgifera to less than half. North American maize lines must have lost the signal during the breeding process. Development of new varieties that release the attractant in adequate amounts should help enhance the efficacy of nematodes as biological control agents against root pests like D. v. virgifera.	Univ Neuchatel, Inst Zool, Lab Anim Ecol & Entomol, CH-2007 Neuchatel, Switzerland; Max Planck Inst Chem Ecol, D-07745 Jena, Germany; CABI Biosci Switzerland Ctr, CH-2800 Delemont, Switzerland	University of Neuchatel; Max Planck Society	Turlings, TCJ (corresponding author), Univ Neuchatel, Inst Zool, Lab Anim Ecol & Entomol, CP 2, CH-2007 Neuchatel, Switzerland.	ted.turlings@unine.ch	Hiltpold, Ivan/D-1666-2016; Hiltpold, Ivan/AAH-6805-2021; Rasmann, Sergio/T-5376-2017; Köllner, Tobias G/H-3375-2014; Turlings, Ted CJ/E-8671-2012; Gershenzon, Jonathan/K-1331-2013	Hiltpold, Ivan/0000-0001-6374-6684; Hiltpold, Ivan/0000-0001-6374-6684; Rasmann, Sergio/0000-0002-3120-6226; Köllner, Tobias G/0000-0002-7037-904X; Turlings, Ted CJ/0000-0002-8315-785X; Gershenzon, Jonathan/0000-0002-1812-1551				Agrawal AA, 1999, INDUCED PLANT DEFENSES AGAINST PATHOGENS AND HERBIVORES, P251; [Anonymous], 1986, METHODS STUDY PEST D; Baufeld P, 2005, WESTERN CORN ROOTWORM: ECOLOGY AND MANAGEMENT, P285, DOI 10.1079/9780851998176.0285; Boff MIC, 2001, ENTOMOL EXP APPL, V98, P329, DOI 10.1023/A:1018907812376; CURRAN J, 1992, J NEMATOL, V24, P631; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; Degen T, 2004, PLANT PHYSIOL, V135, P1928, DOI 10.1104/pp.104.039891; DICKE M, 1988, NETH J ZOOL, V38, P148, DOI 10.1163/156854288X00111; Ellsbury MM, 1996, J ECON ENTOMOL, V89, P74, DOI 10.1093/jee/89.1.74; Fedoroff NV, 2003, SCIENCE, V302, P1158, DOI 10.1126/science.1092042; GAUGLER R, 1988, AGR ECOSYST ENVIRON, V24, P351, DOI 10.1016/0167-8809(88)90078-3; Gouinguene S, 2001, CHEMOECOLOGY, V11, P9, DOI 10.1007/PL00001832; GREWAL PS, 1994, PARASITOLOGY, V108, P207, DOI 10.1017/S003118200006830X; Grewal PS, 1997, J CHEM ECOL, V23, P503, DOI 10.1023/B:JOEC.0000006374.95624.7e; Hammack L, 2001, J CHEM ECOL, V27, P1373, DOI 10.1023/A:1010365225957; Hass B, 1999, J NEMATOL, V31, P508; Jackson JJ, 1996, J ECON ENTOMOL, V89, P366, DOI 10.1093/jee/89.2.366; Jaenicke-Despres V, 2003, SCIENCE, V302, P1206, DOI 10.1126/science.1089056; Journey AM, 2000, ENVIRON ENTOMOL, V29, P822, DOI 10.1603/0046-225X-29.4.822; Karban R, 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; KAYA HK, 1993, ANNU REV ENTOMOL, V38, P181, DOI 10.1146/annurev.en.38.010193.001145; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Khan ZR, 1997, NATURE, V388, P631, DOI 10.1038/41681; Kollner TG, 2004, PHYTOCHEMISTRY, V65, P1895, DOI 10.1016/j.phytochem.2004.05.021; Konig WA, 1999, FLAVOUR FRAG J, V14, P367, DOI 10.1002/(SICI)1099-1026(199911/12)14:6&lt;367::AID-FFJ856&gt;3.0.CO;2-4; Kuhlmann Ulrich, 1998, Biocontrol News and Information, V19, p59N; LEVINE E, 1991, ANNU REV ENTOMOL, V36, P229, DOI 10.1146/annurev.en.36.010191.001305; LEWIS EE, 1995, PARASITOLOGY, V110, P207, DOI 10.1017/S0031182000063976; LEWIS EE, 1993, CAN J ZOOL, V71, P765, DOI 10.1139/z93-101; O'Halloran DM, 2003, PARASITOLOGY, V127, P375, DOI 10.1017/S0031182003003688; OSTEEN C, 2003, AGR RESOURCES ENV IN, P1; POINAR GO, 1983, PROT ECOL, V5, P337; Sotelo A., 1997, FUNCTIONALITY FOOD P, P89; Thaler JS, 1999, NATURE, V399, P686, DOI 10.1038/21420; Turlings TCJ, 1998, PLANTA, V207, P146, DOI 10.1007/s004250050466; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; Turlings TCJ, 2004, PHYSIOL ENTOMOL, V29, P45, DOI 10.1111/j.1365-3032.2004.0362.x; Van der Putten WH, 2001, TRENDS ECOL EVOL, V16, P547, DOI 10.1016/S0169-5347(01)02265-0; van Tol RWHM, 2001, ECOL LETT, V4, P292, DOI 10.1046/j.1461-0248.2001.00227.x; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875	40	868	927	11	473	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2005	434	7034					732	737		10.1038/nature03451	http://dx.doi.org/10.1038/nature03451			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	913NU	15815622	Green Submitted			2022-12-24	WOS:000228160700032
J	Lee, KY; D'Acquisto, F; Hayden, MS; Shim, JH; Ghosh, S				Lee, KY; D'Acquisto, F; Hayden, MS; Shim, JH; Ghosh, S			PDK1 nucleates T cell receptor-induced signaling complex for NF-kappa B activation	SCIENCE			English	Article							KINASE-C-THETA; COSTIMULATION; UBIQUITINATION; INHIBITION; PATHWAY; CARMA1; BCL10	Activation of the transcription factor NF-kappa B after engagement of the T cell receptor (TCR) is important for T cell proliferation and activation during the adaptive immune response. Recent reports have elucidated a signaling pathway that involves the protein kinase C theta (PKC theta), the scaffold protein CARD11 (also called CARMA-1), the caspase recruitment domain (CARD)-containing protein Bcl10, and the paracaspase (protease related to caspases) MALT1 as critical intermediates linking the TCR to the I kappa B kinase (IKK) complex. However, the events proximal to the TCR that initiate the activation of this signaling pathway remain poorly defined. We demonstrate that 3-phosphoinositide-dependent kinase 1 (PDK1) has an essential role in this pathway by regulating the activation of PKC theta and through signal-dependent recruiting of both PKC theta and CARD11 to lipid rafts. PDK1-associated PKC theta recruits the IKK complex, whereas PDK1-associated CARD11 recruits the Bcl10-MALT1 complex, thereby allowing activation of the IKK complex through Bcl10-MALT1-dependent ubiquitination of the IKK complex subunit known as NEMO (NF-kappa B essential modifier). Hence, PDK1 plays a critical role by nucleating the TCR-induced NF-kappa B activation pathway in T cells.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University; Yale University	Ghosh, S (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.	Sankar.ghosh@yale.edu	D'Acquisto, Fulvio/E-7204-2018; Hayden, Matthew/C-1263-2008	D'Acquisto, Fulvio/0000-0002-4513-1608; Shim, Jae-Hyuck/0000-0002-4947-3293	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033443] Funding Source: NIH RePORTER; NIAID NIH HHS [R37 AI033443, R37-AI33443] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Flynn P, 2000, CURR BIOL, V10, P1439, DOI 10.1016/S0960-9822(00)00801-0; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Harriague J, 2002, NAT IMMUNOL, V3, P1090, DOI 10.1038/ni847; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hinton HJ, 2004, NAT IMMUNOL, V5, P539, DOI 10.1038/ni1062; Kane LP, 2002, TRENDS IMMUNOL, V23, P413, DOI 10.1016/S1471-4906(02)02264-0; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Khoshnan A, 2000, J IMMUNOL, V165, P6933, DOI 10.4049/jimmunol.165.12.6933; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Lee K. T., UNPUB; Lin X, 2000, MOL CELL BIOL, V20, P2933, DOI 10.1128/MCB.20.8.2933-2940.2000; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mitsiades CS, 2004, CURR CANCER DRUG TAR, V4, P235, DOI 10.2174/1568009043333032; Pfeifhofer C, 2003, J EXP MED, V197, P1525, DOI 10.1084/jem.20020234; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Sparatore B, 2003, FEBS LETT, V554, P35, DOI 10.1016/S0014-5793(03)01073-1; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	23	198	210	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2005	308	5718					114	118		10.1126/science.1107107	http://dx.doi.org/10.1126/science.1107107			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914IQ	15802604				2022-12-24	WOS:000228221500045
J	Domino, KB; Hornbein, TF; Polissar, NL; Renner, G; Johnson, J; Alberti, S; Hankes, L				Domino, KB; Hornbein, TF; Polissar, NL; Renner, G; Johnson, J; Alberti, S; Hankes, L			Risk factors for relapse in health care professionals with substance use disorders	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMPAIRED PHYSICIANS; ABUSE; ANESTHESIOLOGISTS; PROGRAMS; PREVALENCE; EXPERIENCE; ADDICTION; MODEL	Context Substance use disorders among physicians are important and persistent problems. Considerable debate exists over whether,use of major opioids, especially among anesthesiologists, is associated with a higher relapse rate compared with alcohol and nonopioids. Moreover, the risk factors for relapse with current treatment and monitoring strategies are unknown. Objective To test the hypothesis that chemically dependent healthcare professionals using a major opioid (eg, fentanyl, sufentanil, morphine, meperidine) as drug of choice are at higher risk of relapse. Design, Setting, and Participants Retrospective cohort study of 292 health care professionals enrolled in the Washington Physicians Health Program, an independent posttreatment monitoring program, followed up between January 1, 1991, and December 31, 2001. Main Outcome Measure Factors associated with relapse, defined as the resumption of substance use after initial diagnosis and completion of primary treatment for chemical dependency. Results Twenty-five percent (74 of 292 individuals) had at least 1 relapse. A family history of a substance use disorder increased the risk of relapse (hazard ratio [HR], 2.29; 95% confidence interval [CI], 1.44-3.64). The use of a major opioid increased the risk of relapse significantly in the presence of a coexisting psychiatric disorder (HR, 5.79; 95% Cl, 2.89-11.42) but not in the absence of a coexisting psychiatric disorder (HR, 0.85; 95% Cl, 0.33-2.17). The presence of all 3 factors major opioid use, dual diagnosis, and family history-markedly increased the risk of relapse (HR, 13.25; 95% Cl, 5.22-33.59). The risk of subsequent relapses increased after the first relapse (HR, 1.69; 95% Cl, 1.13-2.53). Conclusions The risk of relapse with substance use was increased in health care professionals who used a major opioid or had a coexisting psychiatric illness or a family history of a substance use disorder. The presence of more than 1 of these risk factors and previous relapse further increased the likelihood of relapse. These observations should be considered in monitoring the recovery of health care professionals.	Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA; Univ Washington, Dept Psychiat, Seattle, WA 98195 USA; Whisper Light Stat Consulting, Seattle, WA USA; Washington Phys Hlth Program, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Domino, KB (corresponding author), Univ Washington, Dept Anesthesiol, Box 356540, Seattle, WA 98195 USA.	kdomino@u.washington.edu						Alexander BH, 2000, ANESTHESIOLOGY, V93, P922, DOI 10.1097/00000542-200010000-00008; Angres D. H., 1998, HEALING HEALER ADDIC, P34; Bohigian G M, 1994, Mo Med, V91, P275; Booth JV, 2002, ANESTH ANALG, V95, P1024, DOI 10.1213/01.ANE.0000026379.66419.DB; GALANTER M, 1990, AM J PSYCHIAT, V147, P64; Gallegos K V, 1988, QRB Qual Rev Bull, V14, P116; Gallegos K V, 1992, Md Med J, V41, P315; HANKES L, 1992, SUBSTANCE ABUSE COMP, P897; HUGHES PH, 1992, JAMA-J AM MED ASSOC, V267, P2333, DOI 10.1001/jama.267.17.2333; Leshner AI, 1999, JAMA-J AM MED ASSOC, V282, P1314, DOI 10.1001/jama.282.14.1314; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; LINK CL, 1984, BIOMETRICS, V40, P601, DOI 10.2307/2530904; MENK EJ, 1990, JAMA-J AM MED ASSOC, V263, P3060, DOI 10.1001/jama.263.22.3060; MORSE RM, 1984, JAMA-J AM MED ASSOC, V251, P743, DOI 10.1001/jama.251.6.743; Paris RT, 1999, J ADDICT DIS, V18, P1, DOI 10.1300/J069v18n01_01; PELTON C, 1991, J PSYCHOACTIVE DRUGS, V23, P427, DOI 10.1080/02791072.1991.10471613; Reading E G, 1992, Md Med J, V41, P325; ROBINS LN, 1984, ARCH GEN PSYCHIAT, V41, P949; SHORE JH, 1987, JAMA-J AM MED ASSOC, V257, P2931; SPIEGELMAN WG, 1984, ANESTHESIOLOGY, V60, P335, DOI 10.1097/00000542-198404000-00009; TALBOTT GD, 1987, JAMA-J AM MED ASSOC, V257, P2927, DOI 10.1001/jama.257.21.2927; TALBOTT GD, 2003, PRINCIPLES ADDICTION, P1009; Zacny JP, 1999, ANESTHESIOLOGY, V90, P269, DOI 10.1097/00000542-199901000-00033	23	132	139	2	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2005	293	12					1453	1460		10.1001/jama.293.12.1453	http://dx.doi.org/10.1001/jama.293.12.1453			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	908KA	15784868				2022-12-24	WOS:000227784700024
J	De Serres, G; Duval, B				De Serres, G; Duval, B			Pertussis vaccination beyond childhood	LANCET			English	Editorial Material							COMPUTER-SIMULATIONS; STRATEGIES; INFANCY		Quebec Natl Inst Publ Hlth, Quebec City, PQ G1E 7G9, Canada; Univ Laval, Quebec City, PQ, Canada	Laval University	De Serres, G (corresponding author), Quebec Natl Inst Publ Hlth, Quebec City, PQ G1E 7G9, Canada.	gaston.deserres@ssss.gouv.qc.ca						*CDC, 1999, PERC PERS AG 18 YEAR; Edmunds WJ, 2002, VACCINE, V20, P1316, DOI 10.1016/S0264-410X(01)00473-X; Forsyth KD, 2004, CLIN INFECT DIS, V39, P1802, DOI 10.1086/426020; Hethcote HW, 2004, VACCINE, V22, P2181, DOI 10.1016/j.vaccine.2003.11.053; Lugauer S, 2002, EUR J PEDIATR, V161, P142, DOI 10.1007/s00431-001-0893-5; Olin P, 2003, VACCINE, V21, P2015, DOI 10.1016/S0264-410X(02)00777-6; SALISBURY D M, 2004, VACCINES, P1387; Salmaso S, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.5.e81; Skowronski DM, 2004, VACCINE, V23, P353, DOI 10.1016/j.vaccine.2004.05.033; Van Rie A, 2004, VACCINE, V22, P3154, DOI 10.1016/j.vaccine.2004.01.067; Vitek CR, 2003, PEDIATR INFECT DIS J, V22, P628, DOI 10.1097/00006454-200307000-00012	11	9	9	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 19	2005	365	9464					1015	1016						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907QB	15781085				2022-12-24	WOS:000227731800010
J	Ortiz-Urda, S; Garcia, J; Green, CL; Chen, L; Lin, Q; Veitch, DP; Sakai, LY; Lee, H; Marinkovich, MP; Khavari, PA				Ortiz-Urda, S; Garcia, J; Green, CL; Chen, L; Lin, Q; Veitch, DP; Sakai, LY; Lee, H; Marinkovich, MP; Khavari, PA			Type VII collagen is required for Ras-driven human epidermal tumorigenesis	SCIENCE			English	Article							SQUAMOUS-CELL CARCINOMAS; EPIDERMOLYSIS-BULLOSA; ANCHORING FIBRILS; NC1 DOMAIN; LAMININ-5; BINDS; SKIN	Type VII collagen defects cause recessive dystrophic epidermolysis bullosa (RDEB), a blistering skin disorder often accompanied by epidermal cancers. To study the role of collagen VII in these cancers, we examined Ras-driven tumorigenesis in RDEB keratinocytes. Cells devoid of collagen VII did not form tumors in mice, whereas those retaining a specific collagen VII fragment (the amino-terminal noncollagenous domain NC1) were tumorigenic. Forced NC1 expression restored tumorigenicity to collagen VII-null epidermis in a non-cell-autonomous fashion. Fibronectin-like sequences within NC1 (FNC1) promoted tumor cell invasion in a laminin 5-dependent manner and were required for tumorigenesis. Tumor-stroma interactions mediated by collagen VII thus promote neoplasia, and retention of NC1 sequences in a subset of RDEB patients may contribute to their increased susceptibility to squamous cell carcinoma.	VA Palo Alto Healthcare Syst, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Oregon Health & Science University	Khavari, PA (corresponding author), VA Palo Alto Healthcare Syst, Palo Alto, CA 94304 USA.	khavari@cmgm.stanford.edu			NIAMS NIH HHS [AR43799, AR44012] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR043799, R01AR043799, P01AR044012] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Bruckner-Tuderman L, 1999, MATRIX BIOL, V18, P43, DOI 10.1016/S0945-053X(98)00007-9; Chen M, 1997, J BIOL CHEM, V272, P14516, DOI 10.1074/jbc.272.23.14516; Chen M, 1999, J INVEST DERMATOL, V112, P177, DOI 10.1046/j.1523-1747.1999.00491.x; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; HESSLE H, 1984, DIFFERENTIATION, V26, P49, DOI 10.1111/j.1432-0436.1984.tb01372.x; Kainulainen T, 1997, BRIT J DERMATOL, V136, P331, DOI 10.1046/j.1365-2133.1997.5581514.x; Lazarov M, 2002, NAT MED, V8, P1105, DOI 10.1038/nm779; Li J, 2003, EMBO J, V22, P2400, DOI 10.1093/emboj/cdg239; LUNSTRUM GP, 1986, J BIOL CHEM, V261, P9042; Mallipeddi R, 2002, CLIN EXP DERMATOL, V27, P616, DOI 10.1046/j.1365-2230.2002.01130.x; MARINKOVICH MP, 2003, DERMATOLOGY GEN MED, V1, P596; Ortiz-Urda S, 2003, J CLIN INVEST, V111, P251, DOI 10.1172/JCI200317193; Pulkkinen L, 1999, MATRIX BIOL, V18, P29, DOI 10.1016/S0945-053X(98)00005-5; Rousselle P, 1997, J CELL BIOL, V138, P719, DOI 10.1083/jcb.138.3.719; SAKAI LY, 1986, J CELL BIOL, V103, P1577, DOI 10.1083/jcb.103.4.1577; SAVOIA P, 1993, J INVEST DERMATOL, V101, P352, DOI 10.1111/1523-1747.ep12365531; WETZELS RHW, 1991, AM J PATHOL, V139, P451	18	101	104	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2005	307	5716					1773	1776		10.1126/science.1106209	http://dx.doi.org/10.1126/science.1106209			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774758				2022-12-24	WOS:000227883900044
J	Switzer, WM; Salemi, M; Shanmugam, V; Gao, F; Cong, ME; Kuiken, C; Bhullar, V; Beer, BE; Vallet, D; Gautier-Hion, A; Tooze, Z; Villinger, F; Holmes, EC; Heneine, W				Switzer, WM; Salemi, M; Shanmugam, V; Gao, F; Cong, ME; Kuiken, C; Bhullar, V; Beer, BE; Vallet, D; Gautier-Hion, A; Tooze, Z; Villinger, F; Holmes, EC; Heneine, W			Ancient co-speciation of simian foamy viruses and primates	NATURE			English	Article							MOLECULAR EVOLUTION; DIVERGENCE TIMES; ABSOLUTE RATES; DNA EVIDENCE; PHYLOGENY; SEQUENCES; GENE; HOSTS; COSPECIATION; COEVOLUTION	Although parasite - host co-speciation is a long-held hypothesis, convincing evidence for long-term co-speciation remains elusive, largely because of small numbers of hosts and parasites studied and uncertainty over rates of evolutionary change(1-5). Cospeciation is especially rare in RNA viruses, in which cross-species transfer is the dominant mode of evolution(6-9). Simian foamy viruses (SFVs) are ubiquitous, non-pathogenic retroviruses that infect all primates(10,11). Here we test the co-speciation hypothesis in SFVs and their primate hosts by comparing the phylogenies of SFV polymerase and mitochondrial cytochrome oxidase subunit II from African and Asian monkeys and apes. The phylogenetic trees were remarkably congruent in both branching order and divergence times, strongly supporting cospeciation. Molecular clock calibrations revealed an extremely low rate of SFV evolution, 1.7 x 10(-8) substitutions per site per year, making it the slowest-evolving RNA virus documented so far. These results indicate that SFVs might have co-speciated with Old World primates for at least 30 million years, making them the oldest known vertebrate RNA viruses.	Ctr Dis Control & Prevent, HIV & Retrovirol Branch, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA; Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA; Duke Univ, Human Vaccine Inst, Durham, NC 27710 USA; Los Alamos Natl Lab, Los Alamos, NM 87545 USA; So Res Inst, Frederick, MD 21701 USA; Univ Rennes 1, CNRS, Biol Stn, F-35380 Paimpont, France; Cercopan, Calabar, Cross River Sta, Nigeria; Emory Univ, Winship Canc Ctr, Dept Pathol, Atlanta, GA 30322 USA; Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Centers for Disease Control & Prevention - USA; State University System of Florida; University of Florida; Duke University; United States Department of Energy (DOE); Los Alamos National Laboratory; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; Emory University; University of Oxford	Switzer, WM (corresponding author), Ctr Dis Control & Prevent, HIV & Retrovirol Branch, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, 1600 Clifton Rd,MS G-19, Atlanta, GA 30333 USA.	bis3@cdc.gov	Holmes, Edward/GVR-9499-2022; Holmes, Edward/Y-2789-2019; VALLET, Dominique/L-2309-2018	Holmes, Edward/0000-0001-9596-3552; VALLET, Dominique/0000-0002-8551-6019				ADKINS RM, 1994, J MOL EVOL, V38, P215; BROOKS DR, 1987, INT J PARASITOL, V17, P291, DOI 10.1016/0020-7519(87)90052-X; Charleston MA, 2002, SYST BIOL, V51, P528, DOI 10.1080/10635150290069940; Charrel RN, 1999, J GEN VIROL, V80, P2329, DOI 10.1099/0022-1317-80-9-2329; DISOTELL TR, 1992, MOL BIOL EVOL, V9, P1; Gojobori T, 2000, AIDS REV, V2, P39; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; Groves CP, 2001, PRIMATE TAXONOMY; HAFNER MS, 1994, SCIENCE, V265, P1087, DOI 10.1126/science.8066445; Harris EE, 1998, MOL BIOL EVOL, V15, P892, DOI 10.1093/oxfordjournals.molbev.a025993; Holmes EC, 2003, J VIROL, V77, P3893, DOI 10.1128/JVI.77.7.3893-3897.2003; Hussain AI, 2003, VIROLOGY, V309, P248, DOI 10.1016/S0042-6822(03)00070-9; Jackson AP, 2004, MOL BIOL EVOL, V21, P45, DOI 10.1093/molbev/msg232; Johnson WE, 1999, P NATL ACAD SCI USA, V96, P10254, DOI 10.1073/pnas.96.18.10254; Lochelt M, 2003, CURR TOP MICROBIOL, V277, P27; McGeoch DJ, 2000, J VIROL, V74, P10401, DOI 10.1128/JVI.74.22.10401-10406.2000; Meiering CD, 2001, CLIN MICROBIOL REV, V14, P165, DOI 10.1128/CMR.14.1.165-176.2001; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; PAGE RDM, 1994, CLADISTICS, V10, P155, DOI 10.1111/j.1096-0031.1994.tb00170.x; PAGE RDM, 1990, SYST ZOOL, V39, P205, DOI 10.2307/2992182; Page SL, 2001, MOL PHYLOGENET EVOL, V18, P14, DOI 10.1006/mpev.2000.0895; Page SL, 1999, MOL PHYLOGENET EVOL, V13, P348, DOI 10.1006/mpev.1999.0653; RUVOLO M, 1993, MOL BIOL EVOL, V10, P1115; RUVOLO M, 1991, P NATL ACAD SCI USA, V88, P1570, DOI 10.1073/pnas.88.4.1570; Salemi M, 2003, J VIROL, V77, P7202, DOI 10.1128/JVI.77.13.7202-7213.2003; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; SHADAN FF, 1993, P NATL ACAD SCI USA, V90, P4117, DOI 10.1073/pnas.90.9.4117; VANDERKUYL AC, 1995, J MOL EVOL, V40, P173, DOI 10.1007/BF00167111; Woelk CH, 2002, MOL BIOL EVOL, V19, P2333, DOI 10.1093/oxfordjournals.molbev.a004059	30	211	226	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					376	380		10.1038/nature03341	http://dx.doi.org/10.1038/nature03341			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772660	Green Published			2022-12-24	WOS:000227715100050
J	Kiessling, AA				Kiessling, AA			Eggs alone - Human parthenotes: an ethical source of stem cells for therapies?	NATURE			English	Editorial Material									Harvard Inst Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Kiessling, AA (corresponding author), Harvard Inst Med, 4 Blackfan Circle, Boston, MA 02115 USA.							Cibelli JB, 2002, SCIENCE, V295, P819, DOI 10.1126/science.1065637; KIESSLING AA, 2003, HUMAN EMBRYONIC STEM; Kiessling Ann A, 2004, Conn Law Rev, V36, P1051; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402	4	18	19	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 10	2005	434	7030					145	145		10.1038/434145a	http://dx.doi.org/10.1038/434145a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15758976	Bronze			2022-12-24	WOS:000227494500022
J	de la Chica, RA; Ribas, I; Giraldo, J; Egozcue, J; Fuster, C				de la Chica, RA; Ribas, I; Giraldo, J; Egozcue, J; Fuster, C			Chromosomal instability in amniocytes from fetuses of mothers who smoke	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TOBACCO-SPECIFIC CARCINOGEN; SISTER-CHROMATID EXCHANGE; FRAGILE SITES; CIGARETTE-SMOKING; CHILDHOOD-CANCER; MATERNAL SMOKING; IN-UTERO; ABERRATION; WOMEN; REARRANGEMENTS	Context Tobacco increases the risk of systemic diseases, and it has adverse effects on pregnancy. However, only indirect data have been published on a possible genotoxic effect on pregnancy in humans. Objectives To determine whether maternal smoking has a genotoxic effect on amniotic cells, expressed as an increased chromosomal instability, and to analyze whether any chromosomal regions are especially affected by exposure to tobacco. Design, Setting, and Patients In this prospective study, amniocytes were obtained by routine amniocentesis for prenatal diagnosis from 25 controls and 25 women who smoke (greater than or equal to10 cigarettes/d for greater than or equal to10 years), who were asked to fill out a smoking questionnaire concerning their smoking habits. Chromosomal instability was analyzed in blinded fashion by 2 independent observers in routine chromosome spreads. Breakpoints implicated in chromosomal abnormalities were identified by G-banding. Main Outcome Measures Association between maternal smoking and increased chromosomal instability in amniotic fluid cells, expressed as chromosomal lesions (gaps and breaks) and structural chromosomal abnormalities. Results Comparison of cytogenetic data between smokers and nonsmokers (controls) showed important differences for the proportion of structural chromosomal abnormalities (smokers: 12.1 % [96/793]; controls: 3.5% [26/752]; P=.002) and to a lesser degree for the proportion of metaphases with chromosomal instability (smokers: 10.5% [262/2492]; controls: 8.0% [210/2637]; P=.04), and for the proportion of chromosomal lesions (smokers: 15.7% [391/2492]; controls: 10.1 % [267/2637]; P=.045). Statistical analysis of the 689 breakpoints detected showed that band 11q23, which is a band commonly implicated in hematopoietic malignancies, was the chromosomal region most affected by tobacco. Conclusions Our findings show that smoking 10 or more cigarettes per day for at least 10 years and during pregnancy is associated with increased chromosomal instability in amniocytes. Band 11q23, known to be involved in leukemogenesis, seems especially sensitive to genotoxic compounds contained in tobacco.	Univ Autonoma Barcelona, Dept Biol Cellular Fisiol & Immunol, Fac Med, E-08193 Barcelona, Spain; Ctr Patol Celular, Barcelona, Spain; Univ Autonoma Barcelona, Unitat Bioestadist, Bellaterra, Spain	Autonomous University of Barcelona; University of Barcelona; Autonomous University of Barcelona	Egozcue, J (corresponding author), Univ Autonoma Barcelona, Dept Biol Cellular Fisiol & Immunol, Fac Med, E-08193 Barcelona, Spain.	joselp.egozcue@uab.es	Giraldo, Jesus/F-9881-2011	Giraldo, Jesus/0000-0001-7082-4695				Anderson D, 1997, ENVIRON MOL MUTAGEN, V30, P95, DOI 10.1002/(SICI)1098-2280(1997)30:2<95::AID-EM1>3.0.CO;2-B; BAN S, 1995, MUTAT RES-ENVIR MUTA, V334, P197, DOI 10.1016/0165-1161(95)90011-X; BOHM U, 1995, HUM GENET, V95, P249, DOI 10.1007/BF00225189; CAPOROSSI D, 1995, HUM GENET, V96, P269; CHEN CS, 1993, BLOOD, V81, P2386; Cox MC, 2004, AM J CLIN PATHOL, V122, P298, DOI 10.1309/RX27R8GJQM330C22; FORD AM, 1993, NATURE, V363, P358, DOI 10.1038/363358a0; Glover TW, 1998, RECENT RES CANCER, V154, P185; Greenbaum IF, 1997, HUM GENET, V101, P109, DOI 10.1007/s004390050596; Hall GW, 2001, BEST PRACT RES CL HA, V14, P573, DOI 10.1053/beha.2001.0155; JAFFE ES, 2001, WHO CLASSIFICATION T, P86; Jalili T, 1998, CANCER RES, V58, P2633; Jauniaux E, 1999, OBSTET GYNECOL, V93, P25, DOI 10.1016/S0029-7844(98)00318-4; KERBER S, 1993, PRENATAL DIAG, V13, P21, DOI 10.1002/pd.1970130105; Kolialexi A, 1998, ANTICANCER RES, V18, P2359; Lackmann GM, 1999, J NATL CANCER I, V91, P459, DOI 10.1093/jnci/91.5.459; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; LITTLEFIELD LG, 1986, MUTAT RES, V170, P145, DOI 10.1016/0165-1218(86)90028-5; MIGUEZ L, 1991, EARLY HUM DEV, V26, P93, DOI 10.1016/0378-3782(91)90013-S; Milunsky A, 2000, PRENATAL DIAG, V20, P307, DOI 10.1002/(SICI)1097-0223(200004)20:4<307::AID-PD797>3.0.CO;2-M; Musthapa MS, 2004, ENVIRON MOL MUTAGEN, V43, P243, DOI 10.1002/em.20018; Norppa Hannu, 2004, IARC Sci Publ, P179; Pluth JM, 2000, MUTAT RES-GEN TOX EN, V465, P101, DOI 10.1016/S1383-5718(99)00217-X; PRICE PJ, 1988, KARYOGRAM, V14, P10; Richards RI, 2001, TRENDS GENET, V17, P339, DOI 10.1016/S0168-9525(01)02303-4; Rowland RE, 1999, HEREDITAS, V131, P143, DOI 10.1111/j.1601-5223.1999.00143.x; SALONEN K, 1993, MUTAT RES, V298, P285, DOI 10.1016/0165-1218(93)90008-2; Sasco AJ, 1999, HUM EXP TOXICOL, V18, P192, DOI 10.1191/096032799678839905; SHULMAN LP, 1991, AM J OBSTET GYNECOL, V165, P1877, DOI 10.1016/0002-9378(91)90049-W; SOLOMON E, 1991, CYTOGENET CELL GENET, V58, P1, DOI 10.1159/000133157; Spitz MR, 2003, CANCER EPIDEM BIOMAR, V12, P689; Stein CK, 2002, GENE CHROMOSOME CANC, V34, P333, DOI 10.1002/gcc.10061; Stokes ME, 2000, CATEGORICAL DATA ANA; Vogler GP, 2002, JAMA-J AM MED ASSOC, V287, P241, DOI 10.1001/jama.287.2.241	35	55	58	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2005	293	10					1212	1222		10.1001/jama.293.10.1212	http://dx.doi.org/10.1001/jama.293.10.1212			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904LB	15755944	Bronze			2022-12-24	WOS:000227498400022
J	Stephens, DS; Zughaier, SM; Whitney, CG; Baughman, WS; Barker, L; Gay, K; Jackson, D; Orenstein, WA; Arnold, K; Schuchat, A; Farley, MM				Stephens, DS; Zughaier, SM; Whitney, CG; Baughman, WS; Barker, L; Gay, K; Jackson, D; Orenstein, WA; Arnold, K; Schuchat, A; Farley, MM		Georgia Emerging Infections Progra	Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment	LANCET			English	Article							EFFLUX; PREVALENCE; MEF(A); GENES; MEFE	Background The prevalence of macrolide resistance in Streptococcus pneumoniae has risen in recent years after the introduction of new macrolides and their increased use. We assessed emergence of macrolide-resistant invasive S pneumoniae disease in Atlanta, CA, USA, before and after the licensing, in February 2000, of the heptavalent pneumococcal conjugate vaccine for young children. Methods Prospective population-based surveillance was used to obtain pneumococcal isolates and demographic data from patients with invasive pneumococcal disease. We calculated cumulative incidence rates for invasive pneumococcal disease for 1994-2002 using population estimates and census data from the US Census Bureau. Findings The incidence of invasive pneumococcal disease in Atlanta fell from 30.2 per 100 000 population (mean annual incidence 1994-99) to 13.1 per 100 000 in 2002 (p < 0.0001). Striking reductions were seen in children younger than 2 years (82% decrease) and in those 2-4 years (71% decrease), age-groups targeted to receive pneumococcal conjugate vaccine. Significant declines were also noted in adults aged 20-39 (54%), 40-64 (25%), and 65 years and older (39%). Macrolide resistance in invasive S pneumoniae disease in Atlanta, after increasing steadily from 4.5 per 100 000 in 1994 to 9.3 per 100 000 in 1999, fell to 2.9 per 100 000 by 2002. Reductions in disease caused by mefE-mediated and erm-mediated macrolide-resistant isolates of conjugate-vaccine serotypes 6B, 9V, 19F, and 23F, and the vaccine-associated serotype 6A were also recorded. Interpretation Vaccines can be a powerful strategy for reducing antibiotic resistance in a community.	Emory Univ, Sch Med, Dept Med, Atlanta, GA USA; VA Med Ctr, Res Serv, Atlanta, GA USA; Ctr Dis Control & Prevent, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA USA; Ctr Dis Control & Prevent, Natl Immunizat Program, Atlanta, GA USA; Georgia Dept Human Resources, Div Publ Hlth, Atlanta, GA USA	Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Stephens, DS (corresponding author), Emory Univ Hosp, Dept Med, 1364 Clifton Rd NE, Atlanta, GA 30322 USA.	dstep01@emory.edu	Zughaier, Susu/N-3185-2019; Zughaier, Susu/GLQ-9288-2022; Stephens, David S/A-8788-2012	Zughaier, Susu/0000-0001-7487-8770; 				Angot P, 2000, EUR J CLIN MICROBIOL, V19, P755, DOI 10.1007/PL00011229; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Arpin C, 1999, ANTIMICROB AGENTS CH, V43, P944, DOI 10.1128/AAC.43.4.944; *CDC, 2004, MMWR-MORBID MORTAL W, V53, P658; *CDC, 2001, MMWR-MORBID MORTAL W, V50, P1140; Centers for Disease Control and Prevention (CDC), 2003, MMWR MORB MORTAL WKL, V52, P987; Clancy J, 1996, MOL MICROBIOL, V22, P867, DOI 10.1046/j.1365-2958.1996.01521.x; Del Grosso M, 2002, J CLIN MICROBIOL, V40, P774, DOI 10.1128/JCM.40.3.774-778.2002; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Gay K, 2001, J INFECT DIS, V184, P56, DOI 10.1086/321001; Gay K, 2000, J INFECT DIS, V182, P1417, DOI 10.1086/315853; HOFMANN J, 1995, NEW ENGL J MED, V333, P481, DOI 10.1056/NEJM199508243330803; Huebner RE, 2000, Int J Infect Dis, V4, P214, DOI 10.1016/S1201-9712(00)90112-7; Hyde TB, 2001, JAMA-J AM MED ASSOC, V286, P1857, DOI 10.1001/jama.286.15.1857; Johnston NJ, 1998, ANTIMICROB AGENTS CH, V42, P2425, DOI 10.1128/AAC.42.9.2425; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; KLUGMAN KP, 2002, EUR RESPIR J, V36, P3; Lonks JR, 2002, CLIN INFECT DIS, V35, P556, DOI 10.1086/341978; McCaig LF, 2003, EMERG INFECT DIS, V9, P432; *NAT COMM CLIN LAB, 1998, M100SB NCCLS; Nuermberger E, 2004, CLIN INFECT DIS, V38, P99, DOI 10.1086/380126; Okamoto Hiroki, 2002, Journal of Infection and Chemotherapy, V8, P28; Santagati M, 2000, ANTIMICROB AGENTS CH, V44, P2585, DOI 10.1128/AAC.44.9.2585-2587.2000; Smith PJ, 2001, AM J PREV MED, V20, P17, DOI 10.1016/S0749-3797(01)00285-9; Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P1817, DOI 10.1128/AAC.40.8.1817; American Medical Association, 2004, MMWR Recomm Rep, V53, P1; Tait-Kamradt A, 2000, ANTIMICROB AGENTS CH, V44, P2118, DOI 10.1128/AAC.44.8.2118-2125.2000; TaitKamradt A, 1997, ANTIMICROB AGENTS CH, V41, P2251, DOI 10.1128/AAC.41.10.2251; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P577, DOI 10.1128/AAC.39.3.577; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	30	127	134	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2005	365	9462					855	863		10.1016/S0140-6736(05)71043-6	http://dx.doi.org/10.1016/S0140-6736(05)71043-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	903RZ	15752529				2022-12-24	WOS:000227444600027
J	Dommett, E; Coizet, W; Blaha, CD; Martindale, J; Lefebvre, W; Walton, N; Mayhew, JEW; Overton, PG; Redgrave, P				Dommett, E; Coizet, W; Blaha, CD; Martindale, J; Lefebvre, W; Walton, N; Mayhew, JEW; Overton, PG; Redgrave, P			How visual stimuli activate dopaminergic neurons at short latency	SCIENCE			English	Article							PRIMATE SUPERIOR COLLICULUS; MIDBRAIN DOPAMINE; SUBSTANTIA-NIGRA; RATS; INHIBITION; RECEPTORS; RESPONSES; RELEASE; EVENTS; SIGNAL	Unexpected, biologically salient stimuli elicit a short-latency, phasic response in midbrain dopaminergic (DA) neurons. Although this signal is, important for reinforcement learning the information it conveys to forebrain target structures remains uncertain. One way to decode the phasic DA signal would be to determine the perceptual properties of sensory inputs to DA neurons. After local disinhibition of the superior colliculus in anesthetized rats, DA neurons became visually responsive, whereas disinhibition of the visual cortex was ineffective. As the primary source of visual afferents, the limited processing capacities of the colliculus may constrain the visual information content of phasic DA responses.	Univ Sheffield, Dept Psychol, Sheffield S10 2TP, S Yorkshire, England; Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia	University of Sheffield; Macquarie University	Redgrave, P (corresponding author), Univ Sheffield, Dept Psychol, Sheffield S10 2TP, S Yorkshire, England.	P.Redgrave@sheffield.ac.uk	Coizet, Véronique/T-1601-2019	Coizet, Véronique/0000-0001-5192-6610; Overton, Paul/0000-0003-4334-261X; Dommett, Eleanor/0000-0002-6973-8762; Blaha, Charles/0000-0001-5155-1505				BINNS KE, 1995, VISUAL NEUROSCI, V12, P563, DOI 10.1017/S0952523800008452; Comoli E, 2003, NAT NEUROSCI, V6, P974, DOI 10.1038/nn1113; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Forster GL, 2003, EUR J NEUROSCI, V17, P751, DOI 10.1046/j.1460-9568.2003.02511.x; FREEMAN AS, 1985, LIFE SCI, V36, P1983, DOI 10.1016/0024-3205(85)90448-5; Garris PA, 1999, NATURE, V398, P67, DOI 10.1038/18019; GONON FG, 1988, NEUROSCIENCE, V24, P19, DOI 10.1016/0306-4522(88)90307-7; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Ikeda T, 2003, NEURON, V39, P693, DOI 10.1016/S0896-6273(03)00464-1; Katsuta H, 2003, NEUROSCI RES, V46, P73, DOI 10.1016/S0168-0102(03)00029-4; Michael DJ, 1999, J PHARMACEUT BIOMED, V19, P33, DOI 10.1016/S0731-7085(98)00145-9; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; REDGRAVE P, 1981, PSYCHOPHARMACOLOGY, V75, P198, DOI 10.1007/BF00432187; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Sefton Ann Jervie, 1995, P833; SPARKS DL, 1986, PHYSIOL REV, V66, P118, DOI 10.1152/physrev.1986.66.1.118; STEIN BE, 1991, ELECTROPHYSIOLOGY VI, P85; Takikawa Y, 2004, J NEUROPHYSIOL, V92, P2520, DOI 10.1152/jn.00238.2004; Thorpe SJ, 2001, SCIENCE, V291, P260, DOI 10.1126/science.1058249; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; WURTZ RH, 1980, ANNU REV NEUROSCI, V3, P189, DOI 10.1146/annurev.ne.03.030180.001201	26	214	224	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1476	1479		10.1126/science.1107026	http://dx.doi.org/10.1126/science.1107026			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746431				2022-12-24	WOS:000227503100050
J	Loog, M; Morgan, DO				Loog, M; Morgan, DO			Cyclin specificity in the phosphorylation of cyclin-dependent kinase substrates	NATURE			English	Article							B-TYPE CYCLINS; S-PHASE; SACCHAROMYCES-CEREVISIAE; RECOGNITION MOTIF; FISSION YEAST; BUDDING YEAST; CELL CYCLE; MITOSIS; REPLICATION; EXIT	Cell-cycle events are controlled by cyclin-dependent kinases (CDKs), whose periodic activation is driven by cyclins. Different cyclins promote distinct cell-cycle events, but the molecular basis for these differences remains unclear(1,2). Here we compare the specificity of two budding yeast cyclins, the S-phase cyclin Clb5 and the M-phase cyclin Clb2, in the phosphorylation of 150 Cdk1 (Cdc28) substrates. About 24% of these proteins were phosphorylated more efficiently by Clb5 - Cdk1 than Clb2 - Cdk1. The Clb5-specific targets include several proteins (Sld2, Cdc6, Orc6, Mcm3 and Cdh1) involved in early S-phase events. Clb5 specificity depended on an interaction between a hydrophobic patch in Clb5 and a short sequence in the substrate ( the RXL or Cy motif). Phosphorylation of Clb5-specific targets during S phase was reduced by replacing Clb5 with Clb2 or by mutating the substrate RXL motif, confirming the importance of Clb5 specificity in vivo. Although we did not identify any highly Clb2-specific substrates, we found that Clb2 - Cdk1 possessed higher intrinsic kinase activity than Clb5 - Cdk1, enabling efficient phosphorylation of a broad range of mitotic Cdk1 targets. Thus, Clb5 and Clb2 use distinct mechanisms to enhance the phosphorylation of S-phase and M-phase substrates.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Morgan, DO (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.	dmorgan@cgl.ucsf.edu		Morgan, David/0000-0001-8753-4416	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069901] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM069901] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 1996, MOL CELL BIOL, V16, P6623; Archambault V, 2004, MOL CELL, V14, P699, DOI 10.1016/j.molcel.2004.05.025; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Cross FR, 2000, MOL CELL BIOL, V20, P4782, DOI 10.1128/MCB.20.13.4782-4790.2000; Cross FR, 1999, MOL CELL, V4, P11, DOI 10.1016/S1097-2765(00)80183-5; Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Donaldson AD, 2000, EMBO REP, V1, P507; Fisher DL, 1996, EMBO J, V15, P850, DOI 10.1002/j.1460-2075.1996.tb00420.x; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Jacobson MD, 2000, MOL CELL BIOL, V20, P4483, DOI 10.1128/MCB.20.13.4483-4493.2000; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; Masumoto H, 2002, NATURE, V415, P651, DOI 10.1038/nature713; Miller ME, 2001, J CELL SCI, V114, P1811; Moore JD, 2003, SCIENCE, V300, P987, DOI 10.1126/science.1081418; PEEPER DS, 1993, EMBO J, V12, P1947, DOI 10.1002/j.1460-2075.1993.tb05844.x; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Roberts JM, 1999, CELL, V98, P129, DOI 10.1016/S0092-8674(00)81007-7; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; Stern B, 1996, TRENDS GENET, V12, P345; Takeda DY, 2001, J BIOL CHEM, V276, P1993, DOI 10.1074/jbc.M005719200; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; van Hemert MJ, 2002, P NATL ACAD SCI USA, V99, P5390, DOI 10.1073/pnas.072556099; Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856; Wilmes GM, 2004, GENE DEV, V18, P981, DOI 10.1101/gad.1202304; Yeong FM, 2000, MOL CELL, V5, P501, DOI 10.1016/S1097-2765(00)80444-X	29	286	288	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					104	108		10.1038/nature03329	http://dx.doi.org/10.1038/nature03329			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744308				2022-12-24	WOS:000227334600052
J	Kolaczinski, J; Graham, K; Fahim, A; Brooker, S; Rowland, M				Kolaczinski, J; Graham, K; Fahim, A; Brooker, S; Rowland, M			Malaria control in Afghanistan: progress and challenges	LANCET			English	Article							INSECTICIDE-TREATED NETS; PLASMODIUM-FALCIPARUM MALARIA; PROVIDES PERSONAL PROTECTION; ANOPHELES-CULICIFACIES; SOUTHWEST AFGHANISTAN; CATTLE OWNERSHIP; REFUGEE CAMP; TOP-SHEETS; PAKISTAN; RESISTANCE	From the 1950s until 1979 malaria control in Afghanistan was implemented through a vertical programme managed by the government, but little of the original programme remained functional by the early 1990s. Delivery of basic health care including malaria diagnosis and treatment was done by non-governmental organisations (NGOs) and UN agencies, which organised cross-border operations from Pakistan and Iran and placed much less emphasis on vertical programming. From 1992 the situation in the east of Afghanistan became stable enough to allow the establishment of a network of NGO-supported clinics and to introduce standardised training and monitoring of microscopists and clinical staff, coordinated by a lead agency specialising in malaria. After the collapse of the Taliban in 2001 and the subsequent establishment of an interim government, the first steps in health-system rehabilitation have been taken. The gradual integration of malaria control into routine health-care delivery is planned. This process should be guided by the knowledge and experience gained during the complex emergency and a focus on malaria should be maintained until the disease is brought under control.	Univ London London Sch Hyg & Trop Med, Dis Control & Vector Biol Unit, London WC1E 7HT, England; HealthNet Int, Peshawar, Pakistan; Minist Hlth, Dept Hlth Care & Promot, Kabul, Afghanistan	University of London; London School of Hygiene & Tropical Medicine	Kolaczinski, J (corresponding author), Univ London London Sch Hyg & Trop Med, Dis Control & Vector Biol Unit, Keppel St, London WC1E 7HT, England.	jan.kolaczinski@lshtm.ac.uk						Banatvala N, 2000, BMJ-BRIT MED J, V321, P101, DOI 10.1136/bmj.321.7253.101; Bhutta ZA, 2002, BMJ-BRIT MED J, V324, P349, DOI 10.1136/bmj.324.7333.349; BOUMA M, 1995, T ROY SOC TROP MED H, V89, P351, DOI 10.1016/0035-9203(95)90004-7; BOUMA MJ, 1995, T ROY SOC TROP MED H, V89, P62, DOI 10.1016/0035-9203(95)90661-4; Brentlinger PE, 2003, LANCET INFECT DIS, V3, P467, DOI 10.1016/s1473-3099(03)00717-5; Buck A.A., 1972, HLTH DIS RURAL AFGHA; DELFINI LF, 1989, T ROY SOC TROP MED H, V83, P316, DOI 10.1016/0035-9203(89)90486-0; Dhir S. L., 1957, Indian Journal of Malariology, V11, P73; DJELANTIK AAM, 1975, EMMAL169; DY F J, 1954, Bull World Health Organ, V11, P725; ESHGHY N, 1978, MOSQ NEWS, V38, P97; ESHGHY N, 1978, MOSQ NEWS, V38, P268; Hewitt S, 1999, TROP MED INT HEALTH, V4, P481, DOI 10.1046/j.1365-3156.1999.00433.x; HEWITT S, 1994, MED VET ENTOMOL, V8, P160, DOI 10.1111/j.1365-2915.1994.tb00156.x; Hewitt SE, 1996, ANN TROP MED PARASIT, V90, P337, DOI 10.1080/00034983.1996.11813059; Howard N, 2003, TROP MED INT HEALTH, V8, P1043, DOI 10.1046/j.1365-3156.2003.01163.x; JOHNSON C, 1998, AFGHANISTAN LAND SHA; Lengeler C, 2004, COCHRANE DB SYST REV, V2; LINDBERG K., 1949, RIV MALARIOL, V28, P1; Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8; POLEVOY NI, 1973, WHOMAL73795; Rab MA, 2001, ANN TROP MED PARASIT, V95, P41, DOI 10.1080/00034980020035906; RAMACHANDRA T, 1951, Bull World Health Organ, V3, P639; Reyburn H, 2000, T ROY SOC TROP MED H, V94, P361, DOI 10.1016/S0035-9203(00)90104-4; Rowland M, 1999, T ROY SOC TROP MED H, V93, P465, DOI 10.1016/S0035-9203(99)90341-3; Rowland M, 1997, TROP MED INT HEALTH, V2, P1049, DOI 10.1046/j.1365-3156.1997.d01-185.x; Rowland M, 2004, TROP MED INT HEALTH, V9, P343, DOI 10.1046/j.1365-3156.2003.01183.x; Rowland M, 2004, TROP MED INT HEALTH, V9, P335, DOI 10.1111/j.1365-3156.2004.01198.x; Rowland M, 2002, SOC SCI MED, V55, P2061, DOI 10.1016/S0277-9536(01)00341-0; Rowland M, 2002, TROP MED INT HEALTH, V7, P813, DOI 10.1046/j.1365-3156.2002.00940.x; Rowland M, 1996, T ROY SOC TROP MED H, V90, P357, DOI 10.1016/S0035-9203(96)90505-2; Rowland M, 1999, T ROY SOC TROP MED H, V93, P641, DOI 10.1016/S0035-9203(99)90081-0; Rowland M, 2001, LANCET, V357, P1837, DOI 10.1016/S0140-6736(00)04955-2; Rowland M, 2002, T ROY SOC TROP MED H, V96, P620, DOI 10.1016/S0035-9203(02)90331-7; Shah I, 1997, ANN TROP MED PARASIT, V91, P591, DOI 10.1080/00034989760680; Webster J, 2003, TROP MED INT HEALTH, V8, P196, DOI 10.1046/j.1365-3156.2003.01013.x; *WHO, 2003, WHOEMMAL289EG REG OF; *WHO, 2002, COUNTR UPD AFGH	38	42	45	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2005	365	9469					1506	1512		10.1016/S0140-6736(05)66423-9	http://dx.doi.org/10.1016/S0140-6736(05)66423-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850637				2022-12-24	WOS:000228651600031
J	Benes, CH; Wu, N; Elia, AEH; Dharia, T; Cantley, LC; Soltoff, SP				Benes, CH; Wu, N; Elia, AEH; Dharia, T; Cantley, LC; Soltoff, SP			The C2 domain of PKC delta is a phosphotyrosine binding domain	CELL			English	Article							PROTEIN-KINASE-C; HUMAN COLON-CANCER; TYROSINE PHOSPHORYLATION; CRYSTAL-STRUCTURE; SRC; CELLS; ACTIVATION; SALIVARY; RECEPTOR; REGION	In eukaryotic cells, the SH2 and PTB domains mediate protein-protein interactions by recognizing phosphotyrosine residues on target proteins. Here we make the unexpected finding that the C2 domain of PKC delta directly binds to phosphotyrosine peptides in a sequence-specific manner. We provide evidence that this domain mediates PKC delta interaction with a Src binding glycoprotein, CDCP1. The crystal structure of the PKC delta C2 domain in complex with an optimal phosphopeptide reveals a new mode of phosphotyrosine binding in which the phosphotyrosine moiety forms a ring-stacking interaction with a histidine residue of the C2 domain. This is also the first example of a protein Ser/Thr kinase containing a domain that binds phosphotyrosine.	Beth Israel Deaconess Med Ctr, Dept Med, Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Soltoff, SP (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Beth Israel Deaconess Med Ctr, Div Signal Transduct, New Res Bldg,Room1030 J 330 Brookline Ave, Boston, MA 02215 USA.	ssoltoff@bidmc.harvard.edu	Cantley, Lewis C/D-1800-2014	Cantley, Lewis C/0000-0002-1298-7653	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE014721, R01DE010877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE10877, DE14721] Funding Source: Medline; NIDDK NIH HHS [P30DK34854] Funding Source: Medline; NIGMS NIH HHS [GM56203, R01 GM056203] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Benes C, 2001, AM J PHYSIOL-CELL PH, V280, pC1498, DOI 10.1152/ajpcell.2001.280.6.C1498; Blake RA, 1999, CELL GROWTH DIFFER, V10, P231; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buhring HJ, 2004, STEM CELLS, V22, P334, DOI 10.1634/stemcells.22-3-334; Dekker LV, 1997, J BIOL CHEM, V272, P12747, DOI 10.1074/jbc.272.19.12747; DeMali KA, 1999, EXP CELL RES, V253, P271, DOI 10.1006/excr.1999.4669; Denning MF, 1996, J BIOL CHEM, V271, P5325, DOI 10.1074/jbc.271.10.5325; Eck MJ, 1996, CELL, V85, P695, DOI 10.1016/S0092-8674(00)81236-2; Gray MO, 1997, J BIOL CHEM, V272, P30945, DOI 10.1074/jbc.272.49.30945; Hanks SK, 2003, FRONT BIOSCI-LANDMRK, V8, pD982, DOI 10.2741/1114; Hooper JD, 2003, ONCOGENE, V22, P1783, DOI 10.1038/sj.onc.1206220; Irby R, 1997, CELL GROWTH DIFFER, V8, P1287; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Izumi Y, 1997, J BIOL CHEM, V272, P7381, DOI 10.1074/jbc.272.11.7381; Joseloff E, 2002, J BIOL CHEM, V277, P12318, DOI 10.1074/jbc.M111618200; Lopez-Lluch G, 2001, BIOCHEM J, V357, P39, DOI 10.1042/0264-6021:3570039; Malek RL, 2002, ONCOGENE, V21, P7256, DOI 10.1038/sj.onc.1205900; Mao WG, 1997, ONCOGENE, V15, P3083, DOI 10.1038/sj.onc.1201496; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Newton AC, 1998, BBA-REV BIOMEMBRANES, V1376, P155, DOI 10.1016/S0304-4157(98)00003-3; Otwinowski Z, 1997, PROCESSING XRAY DIFF, V276; Pappa H, 1998, STRUCT FOLD DES, V6, P885, DOI 10.1016/S0969-2126(98)00090-2; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Pepio AM, 2001, J BIOL CHEM, V276, P3846, DOI 10.1074/jbc.M006339200; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; RON D, 1995, J BIOL CHEM, V270, P24180, DOI 10.1074/jbc.270.41.24180; Scherl-Mostageer M, 2001, ONCOGENE, V20, P4402, DOI 10.1038/sj.onc.1204566; Shanmugam M, 1998, ONCOGENE, V16, P1649, DOI 10.1038/sj.onc.1201684; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; SOLTOFF SP, 1995, J BIOL CHEM, V270, P13490, DOI 10.1074/jbc.270.22.13490; Soltoff SP, 1998, ANN NY ACAD SCI, V842, P100, DOI 10.1111/j.1749-6632.1998.tb09637.x; Songyang Zhou, 1995, Trends in Biochemical Sciences, V20, P470, DOI 10.1016/S0968-0004(00)89103-3; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Storz P, 2004, MOL PHARMACOL, V66, P870, DOI 10.1124/mol.104.000687; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Zang Q, 1997, J BIOL CHEM, V272, P13275, DOI 10.1074/jbc.272.20.13275; ZHOU SY, 1995, METHOD ENZYMOL, V254, P523	40	213	229	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 22	2005	121	2					271	280		10.1016/j.cell.2005.02.019	http://dx.doi.org/10.1016/j.cell.2005.02.019			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851033	Bronze			2022-12-24	WOS:000228705000014
J	Ting, SB; Caddy, J; Hislop, N; Wilanowski, T; Auden, A; Zhao, LL; Ellis, S; Kaur, P; Uchida, Y; Holleran, WM; Elias, PM; Cunningham, JM; Jane, SM				Ting, SB; Caddy, J; Hislop, N; Wilanowski, T; Auden, A; Zhao, LL; Ellis, S; Kaur, P; Uchida, Y; Holleran, WM; Elias, PM; Cunningham, JM; Jane, SM			A homolog of Drosophila grainy head is essential for epidermal integrity in mice	SCIENCE			English	Article							DEVELOPMENTAL TRANSCRIPTION FACTORS; SKIN BARRIER FUNCTION; GENETIC-CONTROL; FAMILY; LACKING; TRANSGLUTAMINASE-1; IDENTIFICATION; MELANOGASTER; PROTEINS; FEATURES	The Drosophila cuticle is essential for maintaining the surface barrier defenses of the fly. Integral to cuticle resilience is the transcription factor grainy head, which regulates production of the enzyme required for covalent cross-linking of the cuticular structural components. We report that formation and maintenance of the epidermal barrier in mice are dependent on a mammalian homolog of grainy head, Grainy head-like 3. Mice tacking this factor display defective skin barrier function and deficient wound repair, accompanied by reduced expression of transglutaminase 1, the key enzyme involved in cross-linking the structural components of the superficial epidermis. These findings suggest that the functional mechanisms involving protein cross-linking that maintain the epidermal barrier and induce tissue repair are conserved across 700 million years of evolution.	Royal Melbourne Hosp PO, Rotary Bone Marrow Res Labs, Parkville, Vic 3050, Australia; Peter MacCallum Res Inst, Epithelial Stem cell Biol Lab, Microscopy Imaging Facil, Melbourne, Vic 3001, Australia; Univ Calif San Francisco, Dept Vet Affairs Med Ctr, Res Unit, San Francisco, CA 94121 USA; Univ Calif San Francisco, Dermatol Serv, San Francisco, CA 94121 USA; Univ Calif San Francisco, Sch Med, Dept Dermatol, San Francisco, CA 94121 USA; St Jude Childrens Res Hosp, Div Expt Hematol, Memphis, TN 38101 USA	Royal Melbourne Hospital; Peter Maccallum Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; St Jude Children's Research Hospital	Jane, SM (corresponding author), Royal Melbourne Hosp PO, Rotary Bone Marrow Res Labs, Grattan St, Parkville, Vic 3050, Australia.	jane@wehi.edu.au	Wilanowski, Tomasz/R-4077-2016; Jane, Stephen/D-6659-2011; Kaur, Pritinder/I-2605-2013	Wilanowski, Tomasz/0000-0003-4447-8164; Kelly, Nikki/0000-0003-1517-3249; Uchida, Yoshikazu/0000-0002-4980-3416; Jane, Stephen Marsden/0000-0002-1045-0481; Kaur, Pritinder/0000-0002-4994-2782; Ellis, Sarah/0000-0002-5772-6051	NCI NIH HHS [P30 CA 21765] Funding Source: Medline; NHLBI NIH HHS [P01 HL53749-03] Funding Source: Medline; NIAMS NIH HHS [P01-AR39448] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL053749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR039448] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BRAY SJ, 1989, GENE DEV, V3, P1130, DOI 10.1101/gad.3.8.1130; BRAY SJ, 1991, GENE DEV, V5, P1672, DOI 10.1101/gad.5.9.1672; Harden N, 2002, DIFFERENTIATION, V70, P181, DOI 10.1046/j.1432-0436.2002.700408.x; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Hemphala J, 2003, DEVELOPMENT, V130, P249, DOI 10.1242/dev.00218; Herrmann T, 2003, J CELL BIOL, V161, P1105, DOI 10.1083/jcb.200207080; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Inada R, 2000, AM J PATHOL, V157, P1875, DOI 10.1016/S0002-9440(10)64826-2; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; Kudryavtseva EI, 2003, DEV DYNAM, V226, P604, DOI 10.1002/dvdy.10255; Kuramoto N, 2002, J CLIN INVEST, V109, P243, DOI 10.1172/JCI200213563; Lee HY, 2004, MECH DEVELOP, V121, P37, DOI 10.1016/j.mod.2003.11.002; Mace KA, 2005, SCIENCE, V308, P381, DOI 10.1126/science.1107573; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Matsuki M, 1998, P NATL ACAD SCI USA, V95, P1044, DOI 10.1073/pnas.95.3.1044; MCCLUSKEY J, 1995, DEV BIOL, V170, P102, DOI 10.1006/dbio.1995.1199; Mlodzik M, 2002, TRENDS GENET, V18, P564, DOI 10.1016/S0168-9525(02)02770-1; Ostrowski S, 2002, GENETICS, V161, P171; Payre F, 2004, INT J DEV BIOL, V48, P207, DOI 10.1387/ijdb.15272387; Phillips Marjorie A, 2004, BMC Dermatol, V4, P2, DOI 10.1186/1471-5945-4-2; SCHAEFER J, 1987, SCIENCE, V235, P1200, DOI 10.1126/science.3823880; SCHOLNICK SB, 1986, SCIENCE, V234, P998, DOI 10.1126/science.3095924; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Takagi S, 2003, J CLIN INVEST, V112, P1372, DOI 10.1172/JCI200318513; Tarutani M, 1997, P NATL ACAD SCI USA, V94, P7400, DOI 10.1073/pnas.94.14.7400; Ting SB, 2003, NAT MED, V9, P1513, DOI 10.1038/nm961; Ting SB, 2003, BIOCHEM J, V370, P953, DOI 10.1042/BJ20021476; Venkatesan K, 2003, NUCLEIC ACIDS RES, V31, P4304, DOI 10.1093/nar/gkg644; Wilanowski T, 2002, MECH DEVELOP, V114, P37, DOI 10.1016/S0925-4773(02)00046-1; WRIGHT WE, 1991, MOL CELL BIOL, V11, P4104, DOI 10.1128/MCB.11.8.4104	31	228	229	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 15	2005	308	5720					411	413		10.1126/science.1107511	http://dx.doi.org/10.1126/science.1107511			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15831758				2022-12-24	WOS:000228492000052
J	Tanaka, M; Chien, P; Yonekura, K; Weissman, JS				Tanaka, M; Chien, P; Yonekura, K; Weissman, JS			Mechanism of cross-species prion transmission: An infectious conformation compatible with two highly divergent yeast prion proteins	CELL			English	Article							PROTEASE-RESISTANT FORMS; SINGLE AMINO-ACID; SACCHAROMYCES-CEREVISIAE; SUP35 PROTEIN; MOLECULAR-BASIS; IN-VITRO; MAMMALIAN PRIONS; STRUCTURAL BASIS; INCUBATION-TIME; PSI+ PRIONS	Efficiency of interspecies prion transmission decreases as the primary structures of the infectious proteins diverge. Yet, a single prion protein can misfold into multiple infectious conformations, and such differences in "strain conformation" also alter infection specificity. Here, we explored the relationship between prion strains and species barriers by creating distinct synthetic prion forms of the yeast prion protein Sup35. We identified a strain conformation of Sup35 that allows transmission from the S. cerevisiae (Sc) Sup35 to the highly divergent C. albicans (Ca) Sup35 both in vivo and in vitro. Remarkably, cross-species transmission leads to a novel Ca strain that in turn can infect the Sc protein. Structural studies reveal strain-specific conformational differences in regions of the prion domain that are involved in intermolecular contacts. Our findings support a model whereby strain conformation is the critical determinant of cross-species prion transmission while primary structure affects transmission specificity by altering the spectrum of preferred amyloid conformations.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, WM Keck Adv Microscopy Lab, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weissman, JS (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	weissman@cmp.ucsf.edu	YONEKURA, Koji/N-5060-2015; Tanaka, Motomasa/N-5064-2015	Tanaka, Motomasa/0000-0002-2994-7703; Yonekura, Koji/0000-0001-5520-4391; Weissman, Jonathan/0000-0003-2445-670X				Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Barron RM, 2001, EMBO J, V20, P5070, DOI 10.1093/emboj/20.18.5070; Baylis M, 2004, NATURE, V432, P810, DOI 10.1038/432810a; Bossers A, 1997, P NATL ACAD SCI USA, V94, P4931, DOI 10.1073/pnas.94.10.4931; Bradley ME, 2004, MOL MICROBIOL, V51, P1649, DOI 10.1111/j.1365-2958.2003.03955.x; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Chien P, 2003, NATURE, V424, P948, DOI 10.1038/nature01894; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derkatch IL, 2004, P NATL ACAD SCI USA, V101, P12934, DOI 10.1073/pnas.0404968101; Derkatch IL, 1996, GENETICS, V144, P1375; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; King CY, 1997, P NATL ACAD SCI USA, V94, P6618, DOI 10.1073/pnas.94.13.6618; King CY, 2001, J MOL BIOL, V307, P1247, DOI 10.1006/jmbi.2001.4542; Kochneva-Pervukhova NV, 2001, YEAST, V18, P489, DOI 10.1002/yea.700; KOCISKO DA, 1995, P NATL ACAD SCI USA, V92, P3923, DOI 10.1073/pnas.92.9.3923; Kushnirov VV, 2000, EMBO J, V19, P324, DOI 10.1093/emboj/19.3.324; Kushnirov VV, 2000, CURR BIOL, V10, P1443, DOI 10.1016/S0960-9822(00)00802-2; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Liu JJ, 2002, P NATL ACAD SCI USA, V99, P16446, DOI 10.1073/pnas.252652099; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; Manson JC, 1999, EMBO J, V18, P6855, DOI 10.1093/emboj/18.23.6855; Nakayashiki T, 2001, MOL CELL, V7, P1121, DOI 10.1016/S1097-2765(01)00259-3; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Serag AA, 2002, NAT STRUCT BIOL, V9, P734, DOI 10.1038/nsb838; Soto C, 2004, NAT MED, V10, pS63, DOI 10.1038/nm1069; Sparrer HE, 2000, SCIENCE, V289, P595, DOI 10.1126/science.289.5479.595; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; TERAVANESYAN MD, 1994, GENETICS, V137, P671; Tuite MF, 2003, NAT REV MOL CELL BIO, V4, P878, DOI 10.1038/nrm1247; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; Uptain SM, 2001, EMBO J, V20, P6236, DOI 10.1093/emboj/20.22.6236; Vanik DL, 2004, MOL CELL, V14, P139, DOI 10.1016/S1097-2765(04)00155-8; Wadsworth JDF, 2004, SCIENCE, V306, P1793, DOI 10.1126/science.1103932; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wille H, 1999, BIOPHYS J, V76, P1048, DOI 10.1016/S0006-3495(99)77270-X; Zhou P, 1999, EMBO J, V18, P1182, DOI 10.1093/emboj/18.5.1182	52	150	154	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 8	2005	121	1					49	62		10.1016/j.cell.2005.03.008	http://dx.doi.org/10.1016/j.cell.2005.03.008			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	915YU	15820678	Bronze			2022-12-24	WOS:000228348500009
J	Chapman, T				Chapman, T			Pure but not simple	NATURE			English	Article																			0	23	25	2	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 7	2005	434	7034					795	800		10.1038/434795a	http://dx.doi.org/10.1038/434795a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	913NU	15815637	Bronze			2022-12-24	WOS:000228160700049
J	Jaenicke, R				Jaenicke, R			Abundance of cellular material and proteins in the atmosphere	SCIENCE			English	Article							AEROSOLS		Univ Mainz, Inst Phys Atmosphare, D-55099 Mainz, Germany	Johannes Gutenberg University of Mainz	Jaenicke, R (corresponding author), Univ Mainz, Inst Phys Atmosphare, D-55099 Mainz, Germany.	jaenicke@uni-mainz.de	Jaenicke, Ruprecht/G-2296-2010					Andrews E, 2000, J AIR WASTE MANAGE, V50, P648, DOI 10.1080/10473289.2000.10464116; ARTAXO P, 1988, J GEOPHYS RES-ATMOS, V93, P1605, DOI 10.1029/JD093iD02p01605; BORODULIN AI, 2003, J AEROSOLS CI, V34, pS681; Graedel T. E., 1993, ATMOSPHERIC CHANGE E; Graham B, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD004049; Kenny C. M., 1998, J AEROSOL SCI, V29, pS779, DOI [DOI 10.1016/S0021-8502(98)90572-9, 10.1016/S0021-8502(98)90572-9]; O'Dowd CD, 2004, NATURE, V431, P676, DOI 10.1038/nature02959; Penner JE, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P289	8	373	400	6	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2005	308	5718					73	73		10.1126/science.1106335	http://dx.doi.org/10.1126/science.1106335			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914IQ	15802596				2022-12-24	WOS:000228221500034
J	Brixner, T; Stenger, J; Vaswani, HM; Cho, M; Blankenship, RE; Fleming, GR				Brixner, T; Stenger, J; Vaswani, HM; Cho, M; Blankenship, RE; Fleming, GR			Two-dimensional spectroscopy of electronic couplings in photosynthesis	NATURE			English	Article							PHOTON-ECHOES; FEMTOSECOND SPECTROSCOPY; INFRARED-SPECTROSCOPY; CHLOROBIUM-TEPIDUM; DIFFRACTIVE OPTICS; ANTENNA COMPLEXES; LINE-SHAPES; FMO COMPLEX; DYNAMICS; PROTEIN	Time-resolved optical spectroscopy is widely used to study vibrational and electronic dynamics by monitoring transient changes in excited state populations on a femtosecond timescale(1). Yet the fundamental cause of electronic and vibrational dynamics-the coupling between the different energy levels involved-is usually inferred only indirectly. Two-dimensional femtosecond infrared spectroscopy based on the heterodyne detection of three-pulse photon echoes(2-7) has recently allowed the direct mapping of vibrational couplings, yielding transient structural information. Here we extend the approach to the visible range(3,8) and directly measure electronic couplings in a molecular complex, the Fenna-Matthews-Olson photosynthetic light-harvesting protein(9,10). As in all photosynthetic systems, the conversion of light into chemical energy is driven by electronic couplings that ensure the efficient transport of energy from light-capturing antenna pigments to the reaction centre(11). We monitor this process as a function of time and frequency and show that excitation energy does not simply cascade stepwise down the energy ladder. We find instead distinct energy transport pathways that depend sensitively on the detailed spatial properties of the delocalized excited-state wavefunctions of the whole pigment-protein complex.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Inst Quantitat Biomed Res QB3, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Korea Univ, Dept Chem, Seoul 136701, South Korea; Korea Univ, Div Chem & Mol Engn, Ctr Multidimens Spect, Seoul 136701, South Korea; Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Korea University; Korea University; Arizona State University; Arizona State University-Tempe	Fleming, GR (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	grfleming@lbl.gov	Cho, Minhaeng/C-9983-2011; Brixner, Tobias/S-1451-2016	Cho, Minhaeng/0000-0003-1618-1056; Brixner, Tobias/0000-0002-6529-704X				[Anonymous], 2002, PHOTOSYNTHETICA; Asbury JB, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.237402; Asplund MC, 2000, P NATL ACAD SCI USA, V97, P8219, DOI 10.1073/pnas.140227997; BLANKENSHIP RE, 2003, LIGHT HARVESTING ANT, P195; Brixner T, 2004, J CHEM PHYS, V121, P4221, DOI 10.1063/1.1776112; Brixner T, 2004, OPT LETT, V29, P884, DOI 10.1364/OL.29.000884; Cervetto V, 2004, J CHEM PHYS, V121, P5935, DOI 10.1063/1.1778163; Cho MH, 2001, J CHEM PHYS, V115, P4424, DOI 10.1063/1.1389844; Cowan ML, 2004, CHEM PHYS LETT, V386, P184, DOI 10.1016/j.cplett.2004.01.027; FENNA RE, 1975, NATURE, V258, P573, DOI 10.1038/258573a0; Goodno GD, 1998, J OPT SOC AM B, V15, P1791, DOI 10.1364/JOSAB.15.001791; Jonas DM, 2003, ANNU REV PHYS CHEM, V54, P425, DOI 10.1146/annurev.physchem.54.011002.103907; Khalil M, 2003, J PHYS CHEM A, V107, P5258, DOI 10.1021/jp0219247; Kwac K, 2003, J PHYS CHEM A, V107, P5903, DOI 10.1021/jp034727w; Lepetit L, 1996, OPT LETT, V21, P564, DOI 10.1364/OL.21.000564; Li YF, 1997, J MOL BIOL, V271, P456, DOI 10.1006/jmbi.1997.1189; Maznev AA, 1998, OPT LETT, V23, P1319, DOI 10.1364/OL.23.001319; Mukamel S, 2000, ANNU REV PHYS CHEM, V51, P691, DOI 10.1146/annurev.physchem.51.1.691; Prall BS, 2004, J CHEM PHYS, V120, P2537, DOI 10.1063/1.1644794; Savikhin S, 1998, J PHYS CHEM B, V102, P5556, DOI 10.1021/jp981186f; Tian PF, 2003, SCIENCE, V300, P1553, DOI 10.1126/science.1083433; Tokmakoff A, 2000, J PHYS CHEM A, V104, P4247, DOI 10.1021/jp993207r; van Amerongen H., 2000, PHOTOSYNTHETIC EXCIT; Vulto SIE, 1998, J PHYS CHEM B, V102, P9577, DOI 10.1021/jp982095l; Vulto SIE, 1999, J PHYS CHEM B, V103, P8153, DOI 10.1021/jp984702a; Wendling M, 2002, PHOTOSYNTH RES, V71, P99, DOI 10.1023/A:1014947732165; Wright JC, 2002, INT REV PHYS CHEM, V21, P185, DOI 10.1080/01442350210124506; Yang M, 2003, BIOPHYS J, V85, P140, DOI 10.1016/S0006-3495(03)74461-0; ZEWAIL AH, 1994, FEMTOCHEMISTRY; Zhang WM, 1998, J CHEM PHYS, V108, P7763, DOI 10.1063/1.476212	30	977	993	9	391	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2005	434	7033					625	628		10.1038/nature03429	http://dx.doi.org/10.1038/nature03429			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911NN	15800619				2022-12-24	WOS:000228011000040
J	Eccles, SA; Paon, L				Eccles, SA; Paon, L			Breast cancer metastasis: when, where, how?	LANCET			English	Editorial Material									Inst Canc Res, Canc Res UK Ctr Canc Therapeut, McElwain Labs, Sutton SM2 5NG, Surrey, England	Cancer Research UK; University of London; Institute of Cancer Research - UK	Eccles, SA (corresponding author), Inst Canc Res, Canc Res UK Ctr Canc Therapeut, McElwain Labs, Sutton SM2 5NG, Surrey, England.	Sue.Eccles@icr.ac.uk						Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Brandt B, 1998, INT J CANCER, V76, P824, DOI 10.1002/(SICI)1097-0215(19980610)76:6<824::AID-IJC10>3.0.CO;2-2; EPSTEIN RJ, 2004, NAT REV CANCER, P1; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Zeelenberg IS, 2003, CANCER RES, V63, P3833	8	14	16	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 19	2005	365	9464					1006	1007		10.1016/S0140-6736(05)71116-8	http://dx.doi.org/10.1016/S0140-6736(05)71116-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907QB	15781080				2022-12-24	WOS:000227731800005
J	MacMahon, S; Neal, B; Rodgers, A				MacMahon, S; Neal, B; Rodgers, A			Hypertension - time to move on	LANCET			English	Editorial Material							BLOOD-PRESSURE; DISEASE		Univ Sydney, George Inst Int Hlth, Sydney, NSW 2006, Australia; Univ Auckland, Clin Trials Res Unit, Auckland 1, New Zealand	University of Sydney; University of Auckland	MacMahon, S (corresponding author), Royal Prince Alfred Hosp, George Inst Int Hlth, POB M201, Sydney, NSW 2050, Australia.	smacmahon@thegeorgeinstitute.org		MacMahon, Stephen/0000-0003-2064-7699; Rodgers, Anthony/0000-0003-1282-1896; Neal, Bruce/0000-0002-0490-7465				Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Fox KM, 2003, LANCET, V362, P782; HARINGTON M, 1959, BRIT MED J, V2, P969, DOI 10.1136/bmj.2.5158.969; Lawes CMM, 2003, J HYPERTENS, V21, P707, DOI 10.1097/01.hjh.0000052492.18130.07; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; MACMAHON S, 1994, HYPERTENS RES, V17, P23; Mancia G, 2003, J HYPERTENS, V21, P1011, DOI 10.1097/01.hjh.0000059051.65882.32; *NZ GUID GROUP, 2003, GUID DET MAN CARD DI; PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556; *REUT BUS INS HEAL, 2003, CARD MARK OUTL 2008; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Turnbull F, 2003, LANCET, V362, P1527; WHO, 2002, RED RISKS PROM HLTH; Williams B, 2004, BMJ-BRIT MED J, V328, P634, DOI 10.1136/bmj.328.7440.634; Yusuf S, 2000, NEW ENGL J MED, V342, P145	17	44	48	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2005	365	9464					1108	1109						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907QB	15781107				2022-12-24	WOS:000227731800036
J	Murray, JB; Muller, JP; Neukum, G; Werner, SC; van Gasselt, S; Hauber, E; Markiewicz, WJ; Head, JW; Foing, BH; Page, D; Mitchell, KL; Portyankina, G				Murray, JB; Muller, JP; Neukum, G; Werner, SC; van Gasselt, S; Hauber, E; Markiewicz, WJ; Head, JW; Foing, BH; Page, D; Mitchell, KL; Portyankina, G		HRSC Co-Investigator Team	Evidence from the Mars Express High Resolution Stereo Camera for a frozen sea close to Mars' equator	NATURE			English	Article							CERBERUS FOSSAE; WATER; PLAINS; FATE; GROUNDWATER; VOLCANISM; STABILITY; EVOLUTION; FLOODS; MODEL	It is thought that the Cerberus Fossae fissures on Mars were the source of both lava and water floods(1,2-4) two to ten million years ago(1,2,5). Evidence for the resulting lava plains has been identified in eastern Elysium(1,2,4,6 - 8), but seas and lakes from these fissures and previous water flooding events were presumed to have evaporated and sublimed away(9-11). Here we present High Resolution Stereo Camera images from the European Space Agency Mars Express spacecraft that indicate that such lakes may still exist. We infer that the evidence is consistent with a frozen body of water, with surface pack-ice, around 5 degrees north latitude and 150 degrees east longitude in southern Elysium. The frozen lake measures about 800 x 900 km in lateral extent and may be up to 45 metres deep - similar in size and depth to the North Sea. From crater counts, we determined its age to be 5 +/- 2 million years old. If our interpretation is confirmed, this is a place that might preserve evidence of primitive life, if it has ever developed on Mars.	Open Univ, Dept Earth Sci, Milton Keynes MK7 6AA, Bucks, England; UCL, Dept Geomat Engn, London WC1E 6BT, England; Free Univ Berlin, Inst Geosci, D-12249 Berlin, Germany; DLR, Inst Planetenforsch, D-12489 Berlin, Germany; Max Planck Inst Aeron, D-37191 Katlenburg Lindau, Germany; Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; European Space Agcy, Res & Sci Support Dept, ESTEC, SCISR, NL-2200 AG Noordwijk, Netherlands; Nat Hist Museum, Dept Mineral, London SW7 5PB, England; Univ Lancaster, Dept Environm Sci, Lancaster LA1 4YQ, England	Open University - UK; University of London; University College London; Free University of Berlin; Helmholtz Association; German Aerospace Centre (DLR); Max Planck Society; Brown University; European Space Agency; Natural History Museum London; Lancaster University	Murray, JB (corresponding author), Open Univ, Dept Earth Sci, Walton Hall, Milton Keynes MK7 6AA, Bucks, England.	J.B.Murray@open.ac.uk	Hauber, Ernst/U-2521-2018; Werner, Stephanie C/A-6438-2012; Mitchell, Karl Leon/AGL-9516-2022; Muller, Jan-Peter/Q-8886-2019; Mitchell, Karl Leon/AAG-3821-2020; van Gasselt, Stephan/L-9762-2013	Hauber, Ernst/0000-0002-1375-304X; Werner, Stephanie C/0000-0001-5704-0909; Muller, Jan-Peter/0000-0002-5077-3736; Mitchell, Karl Leon/0000-0003-1093-8441; van Gasselt, Stephan/0000-0003-2130-6343				Baker V.R., 1992, CHANNELS VALLEY NETW, P493; Berman DC, 2002, ICARUS, V159, P1, DOI 10.1006/icar.2002.6920; Burr DM, 2002, ICARUS, V159, P53, DOI 10.1006/icar.2002.6921; CARR MH, 1983, ICARUS, V56, P476, DOI 10.1016/0019-1035(83)90168-9; CARR MH, 1990, ICARUS, V87, P210, DOI 10.1016/0019-1035(90)90031-4; Carr MH, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001963; Clifford SM, 2001, ICARUS, V154, P40, DOI 10.1006/icar.2001.6671; CLIFFORD SM, 1993, J GEOPHYS RES-PLANET, V98, P10973, DOI 10.1029/93JE00225; Fuller ER, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2002JE001842; Garvin J.B., 2003, 6 INT C MARS; Greenberg R, 2000, J GEOPHYS RES-PLANET, V105, P17551, DOI 10.1029/1999JE001147; Haberle RA, 2003, ICARUS, V161, P66, DOI 10.1016/S0019-1035(02)00017-9; Hartmann WK, 2001, SPACE SCI REV, V96, P165, DOI 10.1023/A:1011945222010; Head JW, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017135; HUMPRHIS SE, 1995, AM GEOPHYS UNION MON, V91, P1; Keszthelyi L, 2000, J GEOPHYS RES-PLANET, V105, P15027, DOI 10.1029/1999JE001191; Kreslavsky MA, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001831; LANAGAN P, 2003, 6 INT C MARS; LASKAR J, 1993, NATURE, V361, P608, DOI 10.1038/361608a0; LASKAR J, 2004, LUNAR PLANET SCI, V35; Neukum G, 2004, NATURE, V432, P971, DOI 10.1038/nature03231; Patrick MR, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002537; Plescia JB, 2003, ICARUS, V164, P79, DOI 10.1016/S0019-1035(03)00139-8; RICE JW, 2002, LUNAR PLANET SCI, V33; Skinner B. J., 1966, GEOL SOC AM MEM, DOI [rg/10.1130/MEM97-p75, 10.1130/MEM97-p75]; Skorov YV, 2001, PLANET SPACE SCI, V49, P59, DOI 10.1016/S0032-0633(00)00121-5; WALLACE D, 1983, ICARUS, V39, P476; Werner SC, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002020	28	135	138	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2005	434	7031					352	356		10.1038/nature03379	http://dx.doi.org/10.1038/nature03379			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772653				2022-12-24	WOS:000227715100043
J	Herman, WH; Hoerger, TJ; Brandle, M; Hicks, K; Sorensen, S; Zhang, P; Hamman, RF; Ackermann, RT; Engelgau, MM; Ratner, RE				Herman, WH; Hoerger, TJ; Brandle, M; Hicks, K; Sorensen, S; Zhang, P; Hamman, RF; Ackermann, RT; Engelgau, MM; Ratner, RE		Diabetes Prevention Program Res Gr	The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance	ANNALS OF INTERNAL MEDICINE			English	Article							MELLITUS; RISK; DISEASE; NIDDM; PREVALENCE; INFARCTION; DIAGNOSIS; THERAPY; OBESITY; STROKE	Background: The Diabetes Prevention Program (DPP) demonstrated that interventions can delay or prevent the development of type 2 diabetes. Objective: To estimate the lifetime cost-utility of the DPP interventions. Design: Markov simulation model to estimate progression of disease, costs, and quality of life. Data Sources: The DPP and published reports. Target Population: Members of the DPP cohort 25 years of age or older with impaired glucose tolerance. Time Horizon: Lifetime. Perspectives: Health system and societal. Interventions: intensive lifestyle, metformin, and placebo interventions as implemented in the DPP. Outcome Measures: Cumulative incidence of diabetes, microvascular and neuropathic complications, cardiovascular complications, survival, direct medical and direct nonmedical costs, quality-adjusted life-years (QALYs), and cost per QALY. Results of Base-Case Analysis: Compared with the placebo intervention, the lifestyle and metformin interventions were estimated to delay the development of type 2 diabetes by 11 and 3 years, respectively, and to reduce the absolute incidence of diabetes by 20% and 8%, respectively. The cumulative incidence of microvascular, neuropathic, and cardiovascular complications were reduced and survival was improved by 0.5 and 0.2 years. Compared with the placebo intervention, the cost per QALY was approximately $1100 for the lifestyle intervention and $31300 for the metformin intervention. From a societal perspective, the interventions cost approximately $8800 and $29 900 per QALY, respectively. From both perspectives, the lifestyle intervention dominated the metformin intervention. Results of Sensitivity Analysis: Cost-effectiveness improved when the interventions were implemented as they might be in routine clinical practice. The lifestyle intervention was cost-effective in all age groups. The metformin intervention did not represent good use of resources for persons older than 65 years of age. Limitations: Simulation results depend on the accuracy of the underlying assumptions, including participant adherence. Conclusions: Health policy should promote diabetes prevention in high-risk individuals.	RTI Int, Res Triangle Pk, NC USA; Univ Michigan, Hlth Syst, Ann Arbor, MI USA; Ctr Dis Control & Prevent, Atlanta, GA USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA; Indiana Univ, Sch Med, Indianapolis, IN USA; Medstar Res Inst, Hyattsville, MD USA	Research Triangle Institute; University of Michigan System; University of Michigan; Centers for Disease Control & Prevention - USA; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Indiana University System; Indiana University-Purdue University Indianapolis	Herman, WH (corresponding author), George Washington Univ, Ctr Biostat, Diabet Prevent Program Coordinating Ctr, 6100 Execut Blvd,Suite 750, Rockville, MD 20852 USA.	dppmail@biostat.bsc.gwu.edu		Hicks, Katherine/0000-0002-1058-3401; Hoerger, Thomas/0000-0003-4154-7806	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK048489] Funding Source: NIH RePORTER; NIDDK NIH HHS [U01 DK048489, U01 DK048489-06] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adler AI, 2003, KIDNEY INT, V63, P225, DOI 10.1046/j.1523-1755.2003.00712.x; Barzilay JI, 2001, DIABETES CARE, V24, P1233, DOI 10.2337/diacare.24.7.1233; Brandle M, 2003, DIABETES CARE, V26, P2300, DOI 10.2337/diacare.26.8.2300; Bray GA, 1999, DIABETES CARE, V22, P623; Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Coffey JT, 2002, DIABETES CARE, V25, P2238, DOI 10.2337/diacare.25.12.2238; Diabet Prevention Program Res Grp, 2003, DIABETES CARE, V26, P2518, DOI 10.2337/diacare.26.9.2518; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Engelgau MM, 2004, ANN INTERN MED, V140, P945, DOI 10.7326/0003-4819-140-11-200406010-00035; Gold MR, 1996, COST EFFECTIVENESS H; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; Herman WH, 2003, DIABETES CARE, V26, P3182, DOI 10.2337/diacare.26.11.3182; Herman WH, 2003, DIABETES CARE, V26, P683, DOI 10.2337/diacare.26.3.683; Herman WH, 2003, DIABETES CARE, V26, P36; Herman WH, 1998, DIABETIC MED, V15, P1045, DOI 10.1002/(SICI)1096-9136(1998120)15:12<1045::AID-DIA696>3.0.CO;2-L; *HLTH CAR FIN ADM, 1998, 1999 MED CLIN DIAGN; Hoerger TJ, 2002, JAMA-J AM MED ASSOC, V287, P2542; KINGSLEY RG, 1977, J CONSULT CLIN PSYCH, V45, P288, DOI 10.1037/0022-006X.45.2.288; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kohner EM, 1998, ARCH OPHTHALMOL-CHIC, V116, P297, DOI 10.1001/archopht.116.3.297; Kothari V, 2002, STROKE, V33, P1776, DOI 10.1161/01.STR.0000020091.07144.C7; LAUPACIS A, 1992, CAN MED ASSOC J, V146, P473; MOSS SE, 1992, ARCH INTERN MED, V152, P610, DOI 10.1001/archinte.152.3.610; Nathan DM, 1996, JAMA-J AM MED ASSOC, V276, P1409; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Qureshi AI, 1998, STROKE, V29, P1329, DOI 10.1161/01.STR.29.7.1329; REIBER GE, 1995, NIH PUBLICATION, P409; Renjilian DA, 2001, J CONSULT CLIN PSYCH, V69, P717, DOI 10.1037//0022-006X.69.4.717; Rodby RA, 1996, DIABETES CARE, V19, P1051, DOI 10.2337/diacare.19.10.1051; SACCO RL, 1994, NEUROLOGY, V44, P626, DOI 10.1212/WNL.44.4.626; Saydah SH, 2001, DIABETES CARE, V24, P447, DOI 10.2337/diacare.24.3.447; SCHEFFLER RM, 1992, AM J PUBLIC HEALTH, V82, P168, DOI 10.2105/AJPH.82.2.168; Stearne MR, 1998, BMJ-BRIT MED J, V317, P720; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stevens RJ, 2001, CLIN SCI, V101, P671, DOI 10.1042/CS20000335; Thompson TJ, 1996, DIABETIC MED, V13, P337, DOI 10.1002/(SICI)1096-9136(199604)13:4<337::AID-DIA71>3.0.CO;2-A; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Ubel PA, 2003, ARCH INTERN MED, V163, P1637, DOI 10.1001/archinte.163.14.1637	41	477	487	0	65	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2005	142	5					323	332		10.7326/0003-4819-142-5-200503010-00007	http://dx.doi.org/10.7326/0003-4819-142-5-200503010-00007			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	902BB	15738451	Green Accepted			2022-12-24	WOS:000227325100002
J	Bellafiore, S; Barneche, F; Peltier, G; Rochaix, JD				Bellafiore, S; Barneche, F; Peltier, G; Rochaix, JD			State transitions and light adaptation require chloroplast thylakoid protein kinase STN7	NATURE			English	Article							COMPLEX-II LHCII; CHLAMYDOMONAS-REINHARDTII; PHOTOSYSTEM-II; ENERGY-DISTRIBUTION; PHOSPHORYLATION; PHOTOSYNTHESIS; XANTHOPHYLL; FLUORESCENCE; CHLOROPHYLL; MUTANTS	Photosynthetic organisms are able to adjust to changing light conditions through state transitions, a process that involves the redistribution of light excitation energy between photosystem II (PSII) and photosystem I (PSI)(1,2). Balancing of the light absorption capacity of these two photosystems is achieved through the reversible association of the major antenna complex (LHCII) between PSII and PSI (ref. 3). Excess stimulation of PSII relative to PSI leads to the reduction of the plastoquinone pool and the activation of a kinase(4,5); the phosphorylation of LHCII; and the displacement of LHCII from PSII to PSI ( state 2). Oxidation of the plastoquinone pool by excess stimulation of PSI reverses this process ( state 1). The Chlamydomonas thylakoid-associated Ser-Thr kinase Stt7, which is required for state transitions, has an orthologue named STN7 in Arabidopsis(6). Here we show that loss of STN7 blocks state transitions and LHCII phosphorylation. In stn7 mutant plants the plastoquinone pool is more reduced and growth is impaired under changing light conditions, indicating that STN7, and probably state transitions, have an important role in response to environmental changes.	Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; Univ Geneva, Dept Plant Biol, CH-1211 Geneva, Switzerland; CEA Cadarache, DSV,DEVM, Lab Ecophysiol Photosynth, UMR 6191,CNRS CEA, F-3108 St Paul Les Durance, France	University of Geneva; University of Geneva; CEA	Rochaix, JD (corresponding author), Univ Geneva, Dept Mol Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva, Switzerland.	jean-david.rochaix@molbio.unige.ch	Bellafiore, stephane/AFS-1835-2022; Rochaix, Jean-David/ABC-5243-2020; PELTIER, Gilles/ABD-4484-2021; BARNECHE, Fredy/AAB-5054-2019; Bellafiore, stephane/J-4756-2014; Barneche, Fredy/M-4228-2015	Bellafiore, stephane/0000-0002-4394-0866; BARNECHE, Fredy/0000-0002-7014-7097; Bellafiore, stephane/0000-0002-4394-0866; Barneche, Fredy/0000-0002-7014-7097; Peltier, Gilles/0000-0002-2226-3931				ALLEN JF, 1981, NATURE, V291, P25, DOI 10.1038/291025a0; ALLEN JF, 1992, BIOCHIM BIOPHYS ACTA, V1098, P275, DOI 10.1016/S0005-2728(09)91014-3; Baroli I, 2000, PHILOS T R SOC B, V355, P1385, DOI 10.1098/rstb.2000.0700; BASSI R, 1988, BIOCHIM BIOPHYS ACTA, V935, P152, DOI 10.1016/0005-2728(88)90212-5; BENNETT J, 1977, NATURE, V269, P344, DOI 10.1038/269344a0; BENNETT J, 1979, EUR J BIOCHEM, V99, P133, DOI 10.1111/j.1432-1033.1979.tb13239.x; BONAVENTURA C, 1969, BIOCHIM BIOPHYS ACTA, V189, P366, DOI 10.1016/0005-2728(69)90168-6; Delosme R, 1996, BBA-BIOENERGETICS, V1273, P150, DOI 10.1016/0005-2728(95)00143-3; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Havaux M, 2004, J BIOL CHEM, V279, P13878, DOI 10.1074/jbc.M311154200; Jensen PE, 2000, J BIOL CHEM, V275, P24701, DOI 10.1074/jbc.M000550200; Li XP, 2002, J BIOL CHEM, V277, P33590, DOI 10.1074/jbc.M204797200; Lunde C, 2000, NATURE, V408, P613, DOI 10.1038/35046121; Lunde C, 2003, PLANT CELL PHYSIOL, V44, P44, DOI 10.1093/pcp/pcg012; MURATA N, 1969, BIOCHIM BIOPHYS ACTA, V172, P242, DOI 10.1016/0005-2728(69)90067-X; Pfannschmidt T, 1999, NATURE, V397, P625, DOI 10.1038/17624; Race HL, 1996, BIOCHEMISTRY-US, V35, P13006, DOI 10.1021/bi961809k; Rintamaki E, 2000, P NATL ACAD SCI USA, V97, P11644, DOI 10.1073/pnas.180054297; ROBINSON HH, 1980, BIOCHIM BIOPHYS ACTA, V590, P97, DOI 10.1016/0005-2728(80)90149-8; Snyders S, 2001, J BIOL CHEM, V276, P32169, DOI 10.1074/jbc.M102539200; Snyders S, 1999, J BIOL CHEM, V274, P9137, DOI 10.1074/jbc.274.14.9137; SOKOLENKO A, 1995, FEBS LETT, V371, P176, DOI 10.1016/0014-5793(95)00892-D; Vener AV, 1997, P NATL ACAD SCI USA, V94, P1585, DOI 10.1073/pnas.94.4.1585; Vink M, 2004, BIOCHEMISTRY-US, V43, P7824, DOI 10.1021/bi030267l; WEIS E, 1985, PHOTOSYNTH RES, V6, P73, DOI 10.1007/BF00029047; WOLLMAN FA, 1984, J CELL BIOL, V98, P1, DOI 10.1083/jcb.98.1.1; WOLLMAN FA, 1988, BIOCHIM BIOPHYS ACTA, V933, P85, DOI 10.1016/0005-2728(88)90058-8; Zer H, 2003, BIOCHEMISTRY-US, V42, P728, DOI 10.1021/bi020451r; Zhang SP, 2004, J BIOL CHEM, V279, P3180, DOI 10.1074/jbc.M311640200; Zito F, 1999, EMBO J, V18, P2961, DOI 10.1093/emboj/18.11.2961	30	545	576	3	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2005	433	7028					892	895		10.1038/nature03286	http://dx.doi.org/10.1038/nature03286			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	899VT	15729347				2022-12-24	WOS:000227174600049
J	Lucas, MES; Deen, JL; von Seidlein, L; Wang, XY; Ampuero, J; Puri, M; Ali, M; Ansaruzzaman, M; Amos, J; Macuamule, A; Cavailler, P; Guerin, PJ; Mahoudeau, C; Kahozi-Sangwa, P; Chaignat, C; Barreto, A; Songane, FF; Clemens, JD				Lucas, MES; Deen, JL; von Seidlein, L; Wang, XY; Ampuero, J; Puri, M; Ali, M; Ansaruzzaman, M; Amos, J; Macuamule, A; Cavailler, P; Guerin, PJ; Mahoudeau, C; Kahozi-Sangwa, P; Chaignat, C; Barreto, A; Songane, FF; Clemens, JD			Effectiveness of mass oral cholera vaccination in Beira, Mozambique	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							B-SUBUNIT; FIELD TRIAL; VACCINES; EFFICACY; BANGLADESH; DIARRHEA	BACKGROUND: New-generation, orally administered cholera vaccines offer the promise of improved control of cholera in sub-Saharan Africa. However, the high prevalence of human immunodeficiency virus (HIV) infection in many cholera-affected African populations has raised doubts about the level of protection possible with vaccination. We evaluated a mass immunization program with recombinant cholera-toxin B subunit, killed whole-cell (rBS-WC) oral cholera vaccine in Beira, Mozambique, a city where the seroprevalence of HIV is 20 to 30 percent. METHODS: From December 2003 to January 2004, we undertook mass immunization of nonpregnant persons at least two years of age, using a two-dose regimen of rBS-WC vaccine in Esturro, Beira (population 21,818). We then assessed vaccine protection in a case-control study during an outbreak of El Tor Ogawa cholera in Beira between January and May 2004. To estimate the level of vaccine protection, antecedent rates of vaccination were compared between persons with culture-confirmed cholera severe enough to have prompted them to seek treatment and age- and sex-matched neighborhood controls without treated diarrhea. RESULTS: We assessed the effectiveness of the vaccine in 43 persons with cholera and 172 controls. Receipt of one or more doses of rBS-WC vaccine was associated with 78 percent protection (95 percent confidence interval, 39 to 92 percent; P=0.004). The vaccine was equally effective in children younger than five years of age and in older persons. A concurrently conducted case-control study designed to detect bias compared persons with treated, noncholeraic diarrhea and controls without diarrhea in the same population and found no protection associated with receipt of the rBS-WC vaccine. CONCLUSIONS: The rBS-WC vaccine was highly effective against clinically significant cholera in an urban sub-Saharan African population with a high prevalence of HIV infection.	Int Vaccine Inst, Seoul 151600, South Korea; Minist Hlth, Maputo, Mozambique; Ctr Hlth & Populat Res, Dhaka, Bangladesh; Epicentre, Paris, France; Med Sans Frontieres, Geneva, Switzerland; WHO, Maputo, Mozambique; NICHHD, Bethesda, MD 20892 USA	International Vaccine Institute; Doctors Without Borders; World Health Organization; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Deen, JL (corresponding author), Int Vaccine Inst, POB 14, Seoul 151600, South Korea.	jdeen@ivi.int	Ali, Mohammad/E-2365-2017; Cavailler, Philippe/G-4138-2017; Guerin, Philippe/AAH-8873-2021	Ali, Mohammad/0000-0003-1410-388X; Guerin, Philippe/0000-0002-6008-2963; Ampuero, Julia/0000-0001-5486-1656				Ansaruzzaman M, 2004, EMERG INFECT DIS, V10, P2057, DOI 10.3201/eid1011.040682; Clemens J, 1996, JAMA-J AM MED ASSOC, V275, P390, DOI 10.1001/jama.275.5.390; CLEMENS JD, 1986, LANCET, V2, P124; CLEMENS JD, 1990, LANCET, V335, P270, DOI 10.1016/0140-6736(90)90080-O; CLEMENS JD, 1990, AM J EPIDEMIOL, V131, P400, DOI 10.1093/oxfordjournals.aje.a115515; CLEMENS JD, 1988, J INFECT DIS, V158, P372, DOI 10.1093/infdis/158.2.372; Dorlencourt F, 1999, B WORLD HEALTH ORGAN, V77, P949; ERIKSSON K, 1993, AIDS, V7, P1087, DOI 10.1097/00002030-199308000-00010; HOLMGREN J, 2004, NEW GENERATION VACCI, P499; Legros D, 1999, B WORLD HEALTH ORGAN, V77, P837; LEWIS DJM, 1994, AIDS, V8, P779, DOI 10.1097/00002030-199406000-00009; MONSUR K. A., 1961, TRANS ROY SOC TROP MED AND HYG, V55, P440, DOI 10.1016/0035-9203(61)90090-6; ORENSTEIN WA, 1985, B WORLD HEALTH ORGAN, V63, P1055; Ortigao-deo-Sampaio MB, 1998, AIDS, V12, pF145, DOI 10.1097/00002030-199814000-00001; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; PELTOLA H, 1991, LANCET, V338, P1285, DOI 10.1016/0140-6736(91)92590-X; SANCHEZ JL, 1994, LANCET, V344, P1273, DOI 10.1016/S0140-6736(94)90755-2; Shapiro ED, 2004, PEDIATR INFECT DIS J, V23, P127, DOI 10.1097/01.inf.0000109248.32907.1d; Stolley PD, 1982, CASE CONTROL STUDIES, P69; *WHO, 1990, WHOCDDSER802; *WHO, MOZ SUMM COUNTR PROF; *WHO GLOB TASK FOR, 2003, REP CHOL CONTR PROGR; *WHO GLOB TASK FOR, 2004, WHOCDSCPEZFK20045 WH	23	186	199	1	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2005	352	8					757	767		10.1056/NEJMoa043323	http://dx.doi.org/10.1056/NEJMoa043323			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	899MC	15728808	Green Accepted			2022-12-24	WOS:000227147500005
J	Pasupathy, A; Miller, EK				Pasupathy, A; Miller, EK			Different time courses of learning-related activity in the prefrontal cortex and striatum	NATURE			English	Article							BASAL-GANGLIA; NEURONAL-ACTIVITY	To navigate our complex world, our brains have evolved a sophisticated ability to quickly learn arbitrary rules such as 'stop at red'. Studies in monkeys using a laboratory test of this capacity-conditional association learning-have revealed that frontal lobe structures ( including the prefrontal cortex) as well as subcortical nuclei of the basal ganglia are involved in such learning(1-5). Neural correlates of associative learning have been observed in both brain regions(6-14), but whether or not these regions have unique functions is unclear, as they have typically been studied separately using different tasks. Here we show that during associative learning in monkeys, neural activity in these areas changes at different rates: the striatum ( an input structure of the basal ganglia) showed rapid, almost bistable, changes compared with a slower trend in the prefrontal cortex that was more in accordance with slow improvements in behavioural performance. Also, pre-saccadic activity began progressively earlier in the striatum but not in the prefrontal cortex as learning took place. These results support the hypothesis that rewarded associations are first identified by the basal ganglia, the output of which 'trains' slower learning mechanisms in the frontal cortex(15).	MIT, Picower Ctr Learning & Memory, RIKEN MIT Neurosci Res Ctr, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); RIKEN; Massachusetts Institute of Technology (MIT)	Pasupathy, A (corresponding author), MIT, Picower Ctr Learning & Memory, RIKEN MIT Neurosci Res Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	anitha@mit.edu	Miller, Earl K./AAE-8187-2019	Miller, Earl K./0000-0002-0582-6958				Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Bar-Gad I, 2003, PROG NEUROBIOL, V71, P439, DOI 10.1016/j.pneurobio.2003.12.001; Brasted PJ, 2004, EUR J NEUROSCI, V19, P721, DOI 10.1111/j.0953-816X.2003.03181.x; DeLong M. R., 1981, HDB PHYSL NERVOUS SY, P1017; Fuster J. M., 1997, PREFRONTAL CORTEX; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; GRAYBIEL AM, 1990, REV NEUROL, V146, P570; Hadj-Bouziane F, 2003, EXP BRAIN RES, V153, P190, DOI 10.1007/s00221-003-1592-4; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Hoshi E, 2004, J NEUROPHYSIOL, V91, P2707, DOI 10.1152/jn.00904.2003; HOUK JC, 1995, CEREB CORTEX, V5, P95, DOI 10.1093/cercor/5.2.95; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Middleton FA, 2002, CEREB CORTEX, V12, P926, DOI 10.1093/cercor/12.9.926; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Murray EA, 2000, EXP BRAIN RES, V133, P114, DOI 10.1007/s002210000406; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; PASSINGHAM RE, 1995, FRONTAL LOEBS VOLUNT; PETRIDES M, 1994, HDB NEUROPSYCHOLOGY, P59; Reilly R. O., 2000, COMPUTATIONAL EXPLOR; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schumacher EH, 2003, J COGNITIVE NEUROSCI, V15, P1111, DOI 10.1162/089892903322598085; Toni I, 1999, EXP BRAIN RES, V127, P19, DOI 10.1007/s002210050770; Tremblay L, 1998, J NEUROPHYSIOL, V80, P964, DOI 10.1152/jn.1998.80.2.964; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740; Wilson CJ, 1996, J NEUROSCI, V16, P2397; Wirth S, 2003, SCIENCE, V300, P1578, DOI 10.1126/science.1084324; Wise SP, 1996, CRIT REV NEUROBIOL, V10, P317, DOI 10.1615/CritRevNeurobiol.v10.i3-4.30	30	528	536	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2005	433	7028					873	876		10.1038/nature03287	http://dx.doi.org/10.1038/nature03287			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	899VT	15729344				2022-12-24	WOS:000227174600044
J	Wainberg, MA				Wainberg, MA			Generic HIV drugs - Enlightened policy for global health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RESISTANCE		McGill Univ, Jewish Gen Hosp, AIDS Ctr, Montreal, PQ H3T 1E2, Canada	McGill University	Wainberg, MA (corresponding author), McGill Univ, Jewish Gen Hosp, AIDS Ctr, Montreal, PQ H3T 1E2, Canada.							*GLOB HIV AIDS PRO, 2004, AIDS S, V18, pS1; Kuritzkes DR, 1996, AIDS, V10, P975, DOI 10.1097/00002030-199610090-00007; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; *WHO, 2004, 3 AIDS MED REM PREQ	5	17	18	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2005	352	8					747	750		10.1056/NEJMp048356	http://dx.doi.org/10.1056/NEJMp048356			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	899MC	15728804				2022-12-24	WOS:000227147500001
J	Hendrix, SL; Cochrane, BB; Nygaard, IE; Handa, VL; Barnabei, VM; Iglesia, C; Aragaki, A; Naughton, MJ; Wallace, RB; McNeeley, SG				Hendrix, SL; Cochrane, BB; Nygaard, IE; Handa, VL; Barnabei, VM; Iglesia, C; Aragaki, A; Naughton, MJ; Wallace, RB; McNeeley, SG			Effects of estrogen with and without progestin on urinary incontinence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTMENOPAUSAL WOMEN; STRESS-INCONTINENCE; RISK-FACTORS; RECEPTORS; SYMPTOMS; PREVALENCE; MANAGEMENT; SUPPLEMENTATION; ESTRADIOL; HORMONES	Context Menopausal hormone therapy has long been credited with many benefits beyond the indications of relieving hot flashes, night sweats, and vaginal dryness, and it is often prescribed to treat urinary incontinence (UI). Objective To assess the effects of menopausal hormone therapy on the incidence and severity of symptoms of stress, urge, and mixed UI in healthy postmenopausal women. Design, Setting, and Participants Women's Health Initiative multicenter double-blind, placebo-controlled, randomized clinical trials of menopausal hormone therapy in 27347 postmenopausal women aged 50 to 79 years enrolled between 1993 and 1998, for whom UI symptoms were known in 23 296 participants at baseline and 1 year. Interventions Women were randomized based on hysterectomy status to active treatment or placebo in either the estrogen plus progestin (E + P) or estrogen alone trials. The E + P hormones were 0.625 mg/d of conjugated equine estrogen plus 2.5 mg/d of medroxyprogesterone acetate (CEE + MPA); estrogen alone consisted of 0.625 mg/d of conjugated equine estrogen (CEE). There were 8506 participants who received CEE + MPA (8102 who received placebo) and 5310 who received CEE alone (5429 who received placebo). Main Outcome Measures Incident UI at 1 year among women without UI at baseline and severity of UI at 1 year among women who had UI at baseline. Results Menopausal hormone therapy increased the incidence of all types of UI at 1 year among women who were continent at baseline. The risk was highest for stress UI (CEE + MPA: relative risk [RR], 1.87 [95% confidence interval {CI}, 1.61-2.18]; CEE alone: RR, 2.15 [95% CI, 1.77-2.62]), followed by mixed UI (CEE + MPA: RR, 1.49 [95% Cl, 1.10-2.01]; CEE alone: RR, 1.79 [95% Cl, 1.26-2.53]). The combination of CEE + MPA had no significant effect on developing urge UI (RR, 1.15; 95% Cl, 0.99-1.34), but CEE alone increased the risk (RR, 1.32; 95% Cl, 1.10-1.58). Among women experiencing UI at baseline, frequency worsened in both trials (CEE + MPA: RR, 1.38 [95% Cl, 1.28-1.49]; CEE alone: RR, 1.47 [95% Cl, 1.35-1.61]). Amount of UI worsened at 1 year in both trials (CEE + MPA: RR, 1.20 [95% Cl, 1.06-1.36]; CEE alone: RR, 1.59 [95% Cl, 1.39-1.82]). Women receiving menopausal hormone therapy were more likely to report that UI limited their daily activities (CEE + MPA: RR, 1.18 [95% Cl, 1.06-1.32]; CEE alone: RR, 1.29 [95% Cl, 1.15-1.45]) and bothered or disturbed them (CEE + MPA: RR, 1.22 [95% Cl, 1.13-1.32]; CEE alone: RR, 1.50 [95% Cl, 1.37-1.65]) at 1 year. Conclusions Conjugated equine estrogen alone and CEE + MPA increased the risk of UI among continent women and worsened the characteristics of UI among symptomatic women after 1 year. Conjugated equine estrogen with or without progestin should not be prescribed for the prevention or relief of UI.	Wayne State Univ, Sch Med, Hutzel Womens Hosp, Dept Obstet & Gynecol, Detroit, MI 48201 USA; Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; Univ Iowa, Carver Coll Med, Dept Obstet & Gynecol, Iowa City, IA USA; Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA USA; Johns Hopkins Univ, Sch Med, Dept Obstet & Gynecol, Baltimore, MD 21205 USA; Med Coll Wisconsin, Dept Obstet & Gynecol, Milwaukee, WI 53226 USA; Washington Hosp Ctr, Dept Obstet & Gynecol, Washington, DC 20010 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27103 USA	Wayne State University; Fred Hutchinson Cancer Center; University of Iowa; University of Iowa; Johns Hopkins University; Medical College of Wisconsin; MedStar Washington Hospital Center; Wake Forest University; Wake Forest Baptist Medical Center	Hendrix, SL (corresponding author), Wayne State Univ, Sch Med, Hutzel Womens Hosp, Dept Obstet & Gynecol, Detroit, MI 48201 USA.	shendrix@med.wayne.edu						*1 DATABANK INC, 2000, MDDB PROD LIN DOC MA; AHLSTROM K, 1990, GYNECOL OBSTET INVES, V30, P37, DOI 10.1159/000293211; *AM COLL OBST GYN, 2003, RESP WOM HLTH IN RES; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Andersson KE, 1999, BJU INT, V84, P923; BATRA SC, 1987, J UROLOGY, V138, P1301, DOI 10.1016/S0022-5347(17)43588-9; Brown JS, 1996, OBSTET GYNECOL, V87, P715, DOI 10.1016/0029-7844(96)00013-0; Brown JS, 1999, OBSTET GYNECOL, V94, P66, DOI 10.1016/S0029-7844(99)00263-X; Butler RN, 1999, GERIATRICS, V54, P31; Fantl JA, 1996, OBSTET GYNECOL, V88, P745; FANTL JA, 1994, OBSTET GYNECOL, V83, P12; Fornell EU, 2004, ACTA OBSTET GYN SCAN, V83, P383, DOI 10.1111/j.0001-6349.2004.00367.x; Grady D, 2001, OBSTET GYNECOL, V97, P116, DOI 10.1016/S0029-7844(00)01115-7; Griebling TL, 1997, ENDOCRIN METAB CLIN, V26, P347, DOI 10.1016/S0889-8529(05)70251-6; Grodstein F, 2003, AM J OBSTET GYNECOL, V189, P428, DOI 10.1067/S0002-9378(03)00361-2; Hays J, 2003, ANN EPIDEMIOL, V13, pS18, DOI 10.1016/S1047-2797(03)00042-5; Hunskaar S, 2003, UROLOGY, V62, P16, DOI 10.1016/S0090-4295(03)00755-6; IOSIF CS, 1981, AM J OBSTET GYNECOL, V141, P817, DOI 10.1016/0002-9378(81)90710-9; IOSIF CS, 1984, ACTA OBSTET GYN SCAN, V63, P257, DOI 10.3109/00016348409155509; Jackson S, 2002, BJOG-INT J OBSTET GY, V109, P339; Jackson S, 1999, BRIT J OBSTET GYNAEC, V106, P711, DOI 10.1111/j.1471-0528.1999.tb08372.x; JUDGE TG, 1969, GERONTOL CLIN, V11, P159, DOI 10.1159/000245230; Moehrer B, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001405; Muscatello DJ, 2001, INTERN MED J, V31, P151, DOI 10.1046/j.1445-5994.2001.00035.x; Novielli Karen D., 2003, International Urology and Nephrology, V35, P423, DOI 10.1023/B:UROL.0000022868.73066.9a; Patterson RE, 1999, ANN EPIDEMIOL, V9, P178, DOI 10.1016/S1047-2797(98)00055-6; RESNICK NM, 1994, J AM GERIATR SOC, V42, P202, DOI 10.1111/j.1532-5415.1994.tb04953.x; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rufford J, 2003, INT UROGYNECOL J, V14, P78, DOI 10.1007/s00192-003-1054-3; SAEZ S, 1981, J STEROID BIOCHEM, V15, P317, DOI 10.1016/0022-4731(81)90291-0; Sampselle CM, 2002, OBSTET GYNECOL, V100, P1230, DOI 10.1016/S0029-7844(02)02241-X; Sarkar PK, 2000, J CLIN PHARM THER, V25, P251; SCHREITER F, 1976, UROL INT, V31, P13, DOI 10.1159/000280026; Swithinbank LV, 1999, BRIT J GEN PRACT, V49, P897; Thom DH, 1998, J AM GERIATR SOC, V46, P1411; WILSON PD, 1987, BRIT J OBSTET GYNAEC, V94, P568, DOI 10.1111/j.1471-0528.1987.tb03152.x	37	330	336	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2005	293	8					935	948		10.1001/jama.293.8.935	http://dx.doi.org/10.1001/jama.293.8.935			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	899LR	15728164	Bronze			2022-12-24	WOS:000227146400015
J	Nojima, S; Schal, C; Webster, FX; Santangelo, RG; Roelofs, WL				Nojima, S; Schal, C; Webster, FX; Santangelo, RG; Roelofs, WL			Identification of the sex pheromone of the German cockroach, Blattella germanica	SCIENCE			English	Article							CALLING BEHAVIOR; LOW-INCOME; ALLERGEN; ABATEMENT; BLA-G-1	The sex pheromone of the German cockroach, Blattella germanica, has been characterized as gentisyl quinone isovalerate. This cockroach is a major cause of allergic disease and serves as a mechanical vector of pathogens, making it one of the most important residential and food-associated pests worldwide. The sex pheromone-producing gland in adult females was identified in 1993, but thermal instability of the pheromone made characterization difficult. Now, using a new preparative gas chromatography approach coupled with electro-, antennographic detection, we have isolated and characterized the pheromone, which we term btattellaquinone, and confirmed the identification by chemical synthesis. The synthetic pheromone was active in behavioral assays and highly effective in field trapping tests, which suggest that it may provide a new tool in cockroach population detection, monitoring, and control.	Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA; N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; SUNY Coll Environm Sci & Forestry, Dept Chem, Syracuse, NY 13210 USA	Cornell University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry	Roelofs, WL (corresponding author), Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA.	wlr1@cornell.edu	Schal, Coby/A-8717-2010	Schal, Coby/0000-0001-7195-6358				Arbes SJ, 2004, J ALLERGY CLIN IMMUN, V113, P109, DOI 10.1016/j.jaci.2003.10.042; Arbes SJ, 2003, J ALLERGY CLIN IMMUN, V112, P339, DOI 10.1067/mai.2003.1597; Brenner Richard J., 1995, P77; BROSSUT R, 1983, J CHEM ECOL, V9, P143, DOI 10.1007/BF00987778; Eisner T, 2004, J EXP BIOL, V207, P1313, DOI 10.1242/jeb.00849; LIANG D, 1993, EXPERIENTIA, V49, P324, DOI 10.1007/BF01923412; LIANG D, 1993, TISSUE CELL, V25, P763, DOI 10.1016/0040-8166(93)90057-R; LIANG DS, 1994, J INSECT PHYSIOL, V40, P251, DOI 10.1016/0022-1910(94)90048-5; LIANG DS, 1993, J INSECT BEHAV, V6, P603, DOI 10.1007/BF01048126; McConnell R, 2003, ANN ALLERG ASTHMA IM, V91, P546, DOI 10.1016/S1081-1206(10)61532-3; Nishida R., 1983, Memoirs of the College of Agriculture, Kyoto University, P1; Nojima S, 2004, J CHEM ECOL, V30, P2153, DOI 10.1023/B:JOEC.0000048780.26118.c0; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; SCHAL C, 1990, ANNU REV ENTOMOL, V35, P521, DOI 10.1146/annurev.en.35.010190.002513; Zurek L, 2004, VET MICROBIOL, V101, P263, DOI 10.1016/j.vetmic.2004.04.011	15	94	104	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2005	307	5712					1104	1106		10.1126/science.1107163	http://dx.doi.org/10.1126/science.1107163			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	900ED	15718472				2022-12-24	WOS:000227197300047
J	Opferman, JT; Iwasaki, H; Ong, CC; Suh, H; Mizuno, S; Akashi, K; Korsmeyer, SJ				Opferman, JT; Iwasaki, H; Ong, CC; Suh, H; Mizuno, S; Akashi, K; Korsmeyer, SJ			Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells	SCIENCE			English	Article							PROGENITORS; LINEAGES; DEATH; MICE; BAX; BCL-2	Apoptosis is important in controlling hematopoietic stem cell (HSC) numbers. However, the specific BCL-2 family member(s) that regulate HSC homeostasis are not precisely defined. We tested myeloid Leukemia-1 (MCL-1) as an attractive candidate that is highly expressed in HSCs and regulated by growth factor signals. Inducible deletion of Mcl-1 in mice resulted in ablation of bone marrow. This resulted in the Loss of early bone marrow progenitor populations, including HSCs. Moreover, growth factors including stem cell factor increased transcription of the Mcl-1 gene and required MCL-1 to augment survival of purified bone marrow progenitors. Deletion of Mcl-1 in other tissues, including liver, did not impair survival. Thus, MCL-1 is a critical and specific regulator essential for ensuring the homeostasis of early hematopoietic progenitors.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS Pathol & Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Akashi, K (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS Pathol & Med, 44 Binney St, Boston, MA 02115 USA.	Koichi_Akashi@dfci.harvard.edu; Stanley_Korsmeyer@dfci.harvard.edu	Opferman, Joseph T/M-5331-2018	Opferman, Joseph T/0000-0002-1147-5621	NCI NIH HHS [R37CA50239, CA072009] Funding Source: Medline; NIDDK NIH HHS [DK061320] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA072009, R37CA050239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061320] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Domen J, 2001, APOPTOSIS, V6, P239, DOI 10.1023/A:1011347623402; Huang HM, 2000, BLOOD, V96, P1764, DOI 10.1182/blood.V96.5.1764.h8001764_1764_1771; Iwasaki H, 2003, IMMUNITY, V19, P451, DOI 10.1016/S1074-7613(03)00242-5; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; MA A, 1995, P NATL ACAD SCI USA, V92, P4763, DOI 10.1073/pnas.92.11.4763; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Motoyama N, 1999, J EXP MED, V189, P1691, DOI 10.1084/jem.189.11.1691; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; OPFERMAN JT, UNPUB; Rinkenberger JL, 2000, GENE DEV, V14, P23; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Wagers AJ, 2002, GENE THER, V9, P606, DOI 10.1038/sj.gt.3301717; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108	20	440	461	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2005	307	5712					1101	1104		10.1126/science.1106114	http://dx.doi.org/10.1126/science.1106114			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ED	15718471				2022-12-24	WOS:000227197300046
J	Nimmerjahn, A; Kirchhoff, F; Helmchen, F				Nimmerjahn, A; Kirchhoff, F; Helmchen, F			Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo	SCIENCE			English	Article							ADULT CORTEX; ACTIVATION; CNS; NEOCORTEX; MOTILITY; PROTEIN; ACTIN	Microglial cells represent the immune system of the mammalian brain and therefore are critically involved in various injuries and diseases. Little is known about their role in the healthy brain and their immediate reaction to brain damage. By using in vivo two-photon imaging in neocortex, we found that microglial cells are highly active in their presumed resting state, continually surveying their microenvironment with extremely motile processes and protrusions. Furthermore, blood-brain barrier disruption provoked immediate and focal activation of microglia, switching their behavior from patroling to shielding of the injured site. Microglia thus are busy and vigilant housekeepers in the adult brain.	Max Planck Inst Med Res, Zellphysiol Abt, D-69120 Heidelberg, Germany; Max Planck Inst Expt Med, Abt Neurogenet, D-37075 Gottingen, Germany	Max Planck Society; Max Planck Society	Helmchen, F (corresponding author), Max Planck Inst Med Res, Zellphysiol Abt, Jahnstr 29, D-69120 Heidelberg, Germany.	fritjof@mpimf-heidelberg.mpg.de	Kirchhoff, Frank/B-9335-2008; Helmchen, Fritjof/A-6255-2008	Kirchhoff, Frank/0000-0002-2324-2761; Helmchen, Fritjof/0000-0002-8867-9569				Capani F, 2001, BRAIN RES, V923, P1, DOI 10.1016/S0006-8993(01)03189-4; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Hirrlinger J, 2004, EUR J NEUROSCI, V20, P2235, DOI 10.1111/j.1460-9568.2004.03689.x; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; LEHMENKUHLER A, 1993, NEUROSCIENCE, V55, P339, DOI 10.1016/0306-4522(93)90503-8; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Nolte C, 1996, NEUROSCIENCE, V73, P1091, DOI 10.1016/0306-4522(96)00106-6; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.3.CO;2-A; Stoll G, 1999, PROG NEUROBIOL, V58, P233, DOI 10.1016/S0301-0082(98)00083-5; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Streit WJ, 2004, J NEUROSCI RES, V77, P1, DOI 10.1002/jnr.20093; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; van Rossum D, 2004, METAB BRAIN DIS, V19, P393, DOI 10.1023/B:MEBR.0000043984.73063.d8; Vilhardt F, 2005, INT J BIOCHEM CELL B, V37, P17, DOI 10.1016/j.biocel.2004.06.010	17	3667	3779	14	306	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2005	308	5726					1314	1318		10.1126/science.1110647	http://dx.doi.org/10.1126/science.1110647			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931JT	15831717				2022-12-24	WOS:000229482300049
J	Crawford, ED				Crawford, ED			PSA testing: what is the use?	LANCET			English	Editorial Material							PROSTATE-SPECIFIC ANTIGEN; UNITED-STATES; CANCER; FINASTERIDE; MEN		Univ Colorado, Denver, CO 80262 USA	University of Colorado System; University of Colorado Denver	Crawford, ED (corresponding author), Univ Colorado, Denver, CO 80262 USA.	david.crawford@uchsc.edu						Andriole GL, 2005, JNCI-J NATL CANCER I, V97, P433, DOI 10.1093/jnci/dji065; Chu KC, 2003, CANCER-AM CANCER SOC, V97, P1507, DOI 10.1002/cncr.11212; Crawford ED, 1999, PROSTATE, V38, P296; Crawford ED, 2003, UROLOGY, V62, P3, DOI 10.1016/j.urology.2003.10.013; McConnell JD, 2003, NEW ENGL J MED, V349, P2387, DOI 10.1056/NEJMoa030656; Oottamasathien S, 2003, ARCH INTERN MED, V163, P661, DOI 10.1001/archinte.163.6.661; Raaijmakers R, 2004, UROLOGY, V63, P316, DOI 10.1016/j.urology.2003.09.028; Stamey TA, 2004, J UROLOGY, V172, P1297, DOI 10.1097/01.ju.0000139993.51181.5d; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Wilson SS, 2004, UROL CLIN N AM, V31, P219, DOI 10.1016/j.ucl.2004.01.002	11	16	18	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 23	2005	365	9469					1447	1449		10.1016/S0140-6736(05)66398-2	http://dx.doi.org/10.1016/S0140-6736(05)66398-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850617				2022-12-24	WOS:000228651600008
J	Heil, M; Rattke, J; Boland, W				Heil, M; Rattke, J; Boland, W			Postsecretory hydrolysis of nectar sucrose and specialization in ant/plant mutualism	SCIENCE			English	Article							IMPORTED FIRE ANT; DIGESTIVE ENZYMES; AMINO-ACIDS; HYMENOPTERA; SUGARS; FORMICIDAE; BEHAVIOR	Obligate Acacia ant plants house mutualistic ants as a defense mechanism and provide them with extrafloral nectar (EFN). Ant/plant mutualisms are widespread, but little is known about the biochemical basis of their species specificity. Despite its importance in these and other plant/animal interactions, little attention has been paid to the control of the chemical composition of nectar. We found high invertase (sucrose-cleaving) activity in Acacia EFN, which thus contained no sucrose. Sucrose, a disaccharide common in other EFNs, usually attracts nonsymbiotic ants. The EFN of the ant acacias was therefore unattractive to such ants. The Pseudomyrmex ants that are specialized to live on Acacia had almost no invertase activity in their digestive tracts and preferred sucrose-free EFN. Our results demonstrate postsecretory regulation of the carbohydrate composition of nectar.	Max Planck Inst Chem Ecol, Dept Bioorgan Chem, D-07745 Jena, Germany	Max Planck Society	Heil, M (corresponding author), Univ Duisburg Essen, FB Biogeoallgemeine Bot Pflanzenokol 9, Univ Str 5, D-45117 Essen, Germany.	Heil_Martin@web.de	Heil, Martin/I-1797-2012; Boland, Wilhelm/K-7762-2012; Heil, Martin/AAC-2730-2022; Heil, Martin/T-3960-2019	Boland, Wilhelm/0000-0001-6784-2534; Heil, Martin/0000-0001-8036-8697				AYRE GL, 1967, CAN ENTOMOL, V99, P408, DOI 10.4039/Ent99408-4; BAKER HG, 1973, NATURE, V241, P543, DOI 10.1038/241543b0; Baker HG., 1982, BIOCH ASPECTS EVOLUT, P131; BENTLEY B, 1983, BIOL NECTARIES; Bluthgen N, 2004, J ANIM ECOL, V73, P155, DOI 10.1111/j.1365-2656.2004.00789.x; Boeve JL, 2003, OECOLOGIA, V136, P508, DOI 10.1007/s00442-003-1249-9; Bronstein JL, 1998, BIOTROPICA, V30, P150, DOI 10.1111/j.1744-7429.1998.tb00050.x; BRONSTEIN JL, 1994, Q REV BIOL, V69, P31, DOI 10.1086/418432; Bronstein JL, 2001, ECOL LETT, V4, P277, DOI 10.1046/j.1461-0248.2001.00218.x; Brouat C, 2001, P ROY SOC B-BIOL SCI, V268, P2131, DOI 10.1098/rspb.2001.1763; Carter C, 2004, TRENDS PLANT SCI, V9, P320, DOI 10.1016/j.tplants.2004.05.008; Cornelius ML, 1996, ANZ SCHADLINGSKD PFL, V69, P41, DOI 10.1007/BF01907668; Elias T. S., 1983, The biology of nectaries, P174; Ghazoul J, 2001, ECOL LETT, V4, P295, DOI 10.1046/j.1461-0248.2001.00229.x; Heil M, 2004, J CHEM ECOL, V30, P1289, DOI 10.1023/B:JOEC.0000030299.59863.69; Heil M, 2004, NATURE, V430, P205, DOI 10.1038/nature02703; Heil M, 2004, J TROP ECOL, V20, P201, DOI 10.1017/S026646740300110X; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Hoeksema JD, 2000, OECOLOGIA, V125, P321, DOI 10.1007/s004420000496; JANZEN DH, 1975, SCIENCE, V188, P936, DOI 10.1126/science.188.4191.936; LANZA J, 1991, ECOL ENTOMOL, V16, P203, DOI 10.1111/j.1365-2311.1991.tb00210.x; LETOURNEAU DK, 1990, SCIENCE, V248, P215, DOI 10.1126/science.248.4952.215; Peumans WJ, 1997, PLANTA, V201, P298, DOI 10.1007/s004250050070; Raine NE, 2004, ECOL ENTOMOL, V29, P345, DOI 10.1111/j.0307-6946.2004.00608.x; Raine NE, 2002, ECOLOGY, V83, P3086, DOI 10.1890/0012-9658(2002)083[3086:SSAFAB]2.0.CO;2; RICKS BL, 1972, ENTOMOL EXP APPL, V15, P329, DOI 10.1007/BF00428298; Roshchina VV., 1993, EXCRETORY FUNCTION H, DOI [10.1007/978-3-642-78130-8, DOI 10.1007/978-3-642-78130-8]; Stanton ML, 2003, AM NAT, V162, pS10, DOI 10.1086/378646; Stapel JO, 1997, ENVIRON ENTOMOL, V26, P617, DOI 10.1093/ee/26.3.617; SVATOS A, UNPUB; Thornburg RW, 2003, PLANT SYST EVOL, V238, P211, DOI 10.1007/s00606-003-0282-9; VANDERMEER RK, 1995, FLA ENTOMOL, V78, P144, DOI 10.2307/3495679; Wilkinson DM, 2001, OIKOS, V92, P377, DOI 10.1034/j.1600-0706.2001.920222.x	33	122	129	4	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2005	308	5721					560	563		10.1126/science.1107536	http://dx.doi.org/10.1126/science.1107536			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15845855				2022-12-24	WOS:000228810500055
J	Louie, T				Louie, T			The pastor and the party of the century	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												tedlouie@msn.com							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2005	293	15					1835	1836		10.1001/jama.293.15.1835	http://dx.doi.org/10.1001/jama.293.15.1835			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QW	15840843				2022-12-24	WOS:000228401700001
J	Cabinum-Foeller, E; Frasier, L				Cabinum-Foeller, E; Frasier, L			Bruising in children	LANCET			English	Editorial Material									E Carolina Univ, Brody Sch Med, Greenville, NC 27834 USA; TEDI BEAR Childrens Advocacy Ctr, Greenville, NC USA; Univ Utah, Sch Med, Primary Childrens Med Ctr, Ctr Safe & Healthy Families, Salt Lake City, UT USA	University of North Carolina; East Carolina University; Utah System of Higher Education; University of Utah	Cabinum-Foeller, E (corresponding author), E Carolina Univ, Brody Sch Med, Greenville, NC 27834 USA.	cabinumfoellere@mail.ecu.edu						Bariciak ED, 2003, PEDIATRICS, V112, P804, DOI 10.1542/peds.112.4.804; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Jenny C., 2001, CHILD ABUSE MED DIAG, P23; Maguire S, 2005, ARCH DIS CHILD, V90, P182, DOI 10.1136/adc.2003.044065; Maguire S, 2005, ARCH DIS CHILD, V90, P187, DOI 10.1136/adc.2003.044073; Schwartz AJ, 1996, PEDIATRICS, V97, P254; Sirotnak AP, 2004, PEDIATR REV, V25, P264, DOI 10.1542/pir.25-8-264; Sugar NF, 1999, ARCH PEDIAT ADOL MED, V153, P399, DOI 10.1001/archpedi.153.4.399	8	3	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 16	2005	365	9468					1369	1370		10.1016/S0140-6736(05)66351-9	http://dx.doi.org/10.1016/S0140-6736(05)66351-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QY	15836871				2022-12-24	WOS:000228401900007
J	Koniaris, LG; Zimmers, TA; Lubarsky, DA; Sheldon, JP				Koniaris, LG; Zimmers, TA; Lubarsky, DA; Sheldon, JP			Inadequate anaesthesia in lethal injection for execution	LANCET			English	Article								Anaesthesia. during lethal injection is essential to minimise suffering and to maintain public acceptance of the practice. Lethal injection is usually done by sequential administration of thiopental, pancuronium, and potassium chloride. Protocol information from Texas and Virginia showed that executioners had no anaesthesia training, drugs were administered remotely with no monitoring for anaesthesia, data were not recorded and no peer-review was done. Toxicology reports from Arizona, Georgia, North Carolina, and South Carolina showed that post-mortem concentrations of thiopental in the blood were lower than that required for surgery in 43 of 49 executed inmates (88%); 21 (43%) inmates had concentrations consistent with awareness. Methods of lethal injection anaesthesia are flawed and some inmates might experience awareness and suffering during execution.	Univ Miami, Dewitt Daughtry Family Dept Surg, Miami, FL 33152 USA; Univ Miami, Dept Anaesthesiol Perioperat Med & Pain Managemen, Miami, FL 33152 USA; Univ Miami, Sch Business, Dept Management, Miami, FL 33152 USA; Law Off Jonathan P Sheldon, Arlington, VA USA	University of Miami; University of Miami; University of Miami	Koniaris, LG (corresponding author), Sylvester Comprehens Canc Ctr 3550 310T, 1475 NW 12th Ave, Miami, FL 33136 USA.	LKoniaris@med.miami.edu	Zimmers, Teresa/AAD-5461-2019	Zimmers, Teresa/0000-0001-7872-0540				Beaver BV, 2001, J AM VET MED ASSOC, V218, P669, DOI 10.2460/javma.2001.218.669; Denno, 2002, OHIO ST LJ, V63, P63; HUNG OR, 1992, ANESTHESIOLOGY, V77, P237, DOI 10.1097/00000542-199208000-00003; Khan A, 2002, J FORENSIC SCI, V47, P847; Martens-Lobenhoffer J, 1999, PHARMAZIE, V54, P597	5	47	47	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 16	2005	365	9468					1412	1414		10.1016/S0140-6736(05)66377-5	http://dx.doi.org/10.1016/S0140-6736(05)66377-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QY	15836890				2022-12-24	WOS:000228401900030
J	Sommer, C; Weishaupt, A; Brinkhoff, J; Biko, L; Wessig, C; Gold, R; Toyka, KV				Sommer, C; Weishaupt, A; Brinkhoff, J; Biko, L; Wessig, C; Gold, R; Toyka, KV			Paraneoplastic stiff-person syndrome: passive transfer to rats by means of IgG antibodies to amphiphysin	LANCET			English	Article							MOTOR-NERVE TERMINALS; MUSCLE HYPERALGESIA; MYASTHENIC SYNDROME; MOUSE; AUTOANTIBODIES; ENCEPHALOMYELITIS; ENDOCYTOSIS; THERAPY; NEURONS; GRAVIS	Background Stiff-person syndrome (SPS) with antibodies to amphiphysin is a paraneoplastic disorder of the central nervous system with a putative autoimmune pathogenesis. Proof of a causal role of the antibodies is still lacking for this and all other antibody-associated paraneoplastic syndromes of the central nervous system. Methods We obtained the plasma filtrate of a patient with breast cancer and SPS that responded to therapeutic plasmapheresis. The purified IgG fraction included high-titre antibodies to the synaptic protein amphiphysin. In a cotransfer design, this IgG fraction was injected intraperitoneally into female Lewis rats that had received encephalitogenic T-helper (Th) lymphocytes specific for myelin basic protein, to induce an immune-mediated leaky blood-brain barrier. The rats were followed up with behavioural tests, video photography, and electromyography. Findings The injection of the IgG fraction including antibodies to amphiphysin resulted in a dose-dependent stiffness with spasms resembling human SPS. Control IgG injected into rats that had received the same encephalitogenic Th cells had no effect. IgG binding was demonstrated in the central nervous system of rats that Showed signs of the disorder. Interpretation These experiments support the hypothesis of a pathogenetic role of antibodies to amphiphysin, thus adding paraneoplastic SPS to the group of antibody-mediated autoimmune disorders. Relevance to practice These findings provide a strong argument for a direct pathogenetic role of anti-amphiphysin in this type of SPS and support therapeutic attempts to eliminate these autoantibodies by plasmapheresis. The experimental approach used could help to elucidate the role of autoantibodies in other paraneoplastic syndromes, such as SPS with antibodies to glutamic acid decarboxylase, and others including anti-Hu-associated subacute cerebellar degeneration and limbic encephalitis.	Univ Wurzburg, Neurol Klin, Dept Neurol, D-97080 Wurzburg, Germany; Univ Gottingen, Inst MS Forsch, Bereich Humanmed, D-3400 Gottingen, Germany; Gemeinnutzige Hertie Stiftung, Gottingen, Germany	University of Wurzburg; University of Gottingen	Sommer, C (corresponding author), Univ Wurzburg, Neurol Klin, Dept Neurol, Josef Schneider Str 11, D-97080 Wurzburg, Germany.	sommer@mail.uni-wuemburg.de	Sommer, Claudia/A-9820-2010	Sommer, Claudia/0000-0002-7064-5002				BRASHEAR HR, 1991, NEUROLOGY, V41, P1588, DOI 10.1212/WNL.41.10.1588; Buchwald B, 1998, EUR J NEUROSCI, V10, P281, DOI 10.1046/j.1460-9568.1998.00053.x; Dropcho EJ, 1998, J NEUROL SCI, V153, P264, DOI 10.1016/S0022-510X(97)00296-7; FOLLI F, 1993, NEW ENGL J MED, V328, P546, DOI 10.1056/NEJM199302253280805; FUKUNAGA H, 1983, P NATL ACAD SCI-BIOL, V80, P7636, DOI 10.1073/pnas.80.24.7636; Kehl LJ, 2000, PAIN, V85, P333, DOI 10.1016/S0304-3959(99)00282-1; Kittler JT, 2000, J NEUROSCI, V20, P7972; KUNKELBAGDEN E, 1993, EXP NEUROL, V119, P153, DOI 10.1006/exnr.1993.1017; LANG B, 1983, J PHYSIOL-LONDON, V344, P335, DOI 10.1113/jphysiol.1983.sp014943; LININGTON C, 1988, AM J PATHOL, V130, P443; Meinck HM, 2002, MOVEMENT DISORD, V17, P853, DOI 10.1002/mds.10279; Meinck HM, 2001, CNS DRUGS, V15, P515, DOI 10.2165/00023210-200115070-00002; ROSE NR, 1993, IMMUNOL TODAY, V14, P426, DOI 10.1016/0167-5699(93)90244-F; Saiz A, 1999, J NEUROL NEUROSUR PS, V66, P214, DOI 10.1136/jnnp.66.2.214; Schafers M, 2003, PAIN, V104, P579, DOI 10.1016/S0304-3959(03)00115-5; Schmidt J, 2000, BRAIN, V123, P1431, DOI 10.1093/brain/123.7.1431; Schmierer K, 1998, NEUROLOGY, V51, P250, DOI 10.1212/WNL.51.1.250; TORO C, 1994, SEMIN NEUROL, V14, P154, DOI 10.1055/s-2008-1041073; TOYKA KV, 1980, J NEUROL NEUROSUR PS, V43, P836, DOI 10.1136/jnnp.43.9.836; TOYKA KV, 1975, SCIENCE, V190, P397, DOI 10.1126/science.1179220; Vasconcelos Olavo M., 2003, Curr Treat Options Neurol, V5, P79, DOI 10.1007/s11940-003-0024-x; Voltz R, 2002, LANCET NEUROL, V1, P294, DOI 10.1016/S1474-4422(02)00135-7; Wessig C, 2003, NEUROLOGY, V61, P195, DOI 10.1212/01.WNL.0000073143.53337.DD; Wigge P, 1998, TRENDS NEUROSCI, V21, P339, DOI 10.1016/S0166-2236(98)01264-8	24	146	154	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 16	2005	365	9468					1406	1411		10.1016/S0140-6736(05)66376-3	http://dx.doi.org/10.1016/S0140-6736(05)66376-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QY	15836889				2022-12-24	WOS:000228401900029
J	Edwards, AO; Ritter, R; Abel, KJ; Manning, A; Panhuysen, C; Farrer, LA				Edwards, AO; Ritter, R; Abel, KJ; Manning, A; Panhuysen, C; Farrer, LA			Complement factor H polymorphism and age-related macular degeneration	SCIENCE			English	Article							C-REACTIVE PROTEIN; GENOMEWIDE-SCAN; SUSCEPTIBILITY LOCI; EXTENDED FAMILIES; ASSOCIATION; MACULOPATHY; ACTIVATION; DISEASE; LINKAGE; GLOMERULONEPHRITIS	Age-related macular degeneration (AMD) is a common, late-onset, and complex trait with multiple risk factors. Concentrating on a region harboring a locus for AMD on 1q25-31, the ARMD1 locus, we tested single-nucleotide polymorphisms for association with AMD in two independent case-control populations. Significant association (P = 4.95 x 10(-10)) was identified within the regulation of complement activation locus and was centered over a tyrosine-402 --> histidine-402 protein polymorphism in the gene encoding complement factor H. Possession of at least one histidine at amino acid position 402 increased the risk of AMD 2.7-fold and may account for 50% of the attributable risk of AMD.	Univ Texas, SW Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Ophthalmol, Dallas, TX 75390 USA; Sequenom Inc, San Diego, CA 92121 USA; Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Med, Genet Program, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Genet & Genom, Boston, MA 02118 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Sequenom; Boston University; Boston University; Boston University; Boston University; Boston University	Edwards, AO (corresponding author), Inst Retina Res, 3215 Princess Lane, Dallas, TX 75229 USA.	albert-edwards@swbell.net	Farrer, Lindsay/AAS-1035-2020; Manning, Alisa Knodle/ABC-7711-2021; Mohammed, Imran/J-8271-2012	Mohammed, Imran/0000-0002-8412-0768; Farrer, Lindsay/0000-0001-5533-4225	NATIONAL EYE INSTITUTE [R01EY014467] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abecasis GR, 2004, AM J HUM GENET, V74, P482, DOI 10.1086/382786; Acosta J, 2004, CURR PHARM DESIGN, V10, P203, DOI 10.2174/1381612043453441; Backes JM, 2004, ANN PHARMACOTHER, V38, P110, DOI 10.1345/aph.1D203; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Dragon-Durey MA, 2004, J AM SOC NEPHROL, V15, P787, DOI 10.1097/01.ASN.0000115702.28859.A7; Esparza-Gordillo J, 2004, IMMUNOGENETICS, V56, P77, DOI 10.1007/s00251-004-0660-7; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Giannakis E, 2003, EUR J IMMUNOL, V33, P962, DOI 10.1002/eji.200323541; Greenfield JR, 2004, CIRCULATION, V109, P3022, DOI 10.1161/01.CIR.0000130640.77501.79; Iyengar SK, 2004, AM J HUM GENET, V74, P20, DOI 10.1086/380912; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Klein ML, 1998, ARCH OPHTHALMOL-CHIC, V116, P1082, DOI 10.1001/archopht.116.8.1082; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Klein R, 2002, OPHTHALMOLOGY, V109, P1767, DOI 10.1016/S0161-6420(02)01146-6; Majewski J, 2003, AM J HUM GENET, V73, P540, DOI 10.1086/377701; Mold C, 1999, IMMUNOPHARMACOLOGY, V42, P23, DOI 10.1016/S0162-3109(99)00007-7; Muller-Eberhard H J, 1980, Adv Immunol, V29, P1, DOI 10.1016/S0065-2776(08)60042-5; Mullins RF, 2001, EYE, V15, P390, DOI 10.1038/eye.2001.142; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schick JH, 2003, AM J HUM GENET, V72, P1412, DOI 10.1086/375500; Schultz DW, 2003, HUM MOL GENET, V12, P3315, DOI 10.1093/hmg/ddg348; Seddon JM, 2004, JAMA-J AM MED ASSOC, V291, P704, DOI 10.1001/jama.291.6.704; Seddon JM, 2003, AM J HUM GENET, V73, P780, DOI 10.1086/378505; Seddon JM, 2003, ARCH OPHTHALMOL-CHIC, V121, P785, DOI 10.1001/archopht.121.6.785; Weeks DE, 2004, AM J HUM GENET, V75, P174, DOI 10.1086/422476; Wener MH, 2000, J RHEUMATOL, V27, P2351; Zhao HY, 2003, PHARMACOGENOMICS, V4, P171, DOI 10.1517/phgs.4.2.171.22636	28	1890	2043	2	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 15	2005	308	5720					421	424		10.1126/science.1110189	http://dx.doi.org/10.1126/science.1110189			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15761121				2022-12-24	WOS:000228492000056
J	Baughman, RH				Baughman, RH			Playing nature's game with artificial muscles	SCIENCE			English	Editorial Material							TECHNOLOGY; ACTUATORS; STRAIN		Univ Texas, NanoTech Inst, Richardson, TX 75083 USA; Univ Texas, Dept Chem, Richardson, TX 75083 USA	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas	Baughman, RH (corresponding author), Univ Texas, NanoTech Inst, Richardson, TX 75083 USA.	ray.baughman@utdallas.edu	Baughman, Ray/A-8628-2018	Baughman, Ray/0000-0001-5845-5137				Baughman RH, 1996, SYNTHETIC MET, V78, P339, DOI 10.1016/0379-6779(96)80158-5; Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928; BAUGHMAN RH, 2003, Patent No. 6555945; EBRON VH, UNPUB; Hara S, 2004, J MATER CHEM, V14, P1516, DOI 10.1039/b404232h; HARA S, IN PRESS SYNTH METAL; Kaneko D, 2002, J MATER CHEM, V12, P2169, DOI 10.1039/b109981g; Lu W, 2002, SCIENCE, V297, P983, DOI 10.1126/science.1072651; Madden JDW, 2004, IEEE J OCEANIC ENG, V29, P706, DOI 10.1109/JOE.2004.833135; Nemat-Nasser S, 2003, J APPL PHYS, V93, P5255, DOI 10.1063/1.1563300; Pelrine R, 2000, SCIENCE, V287, P836, DOI 10.1126/science.287.5454.836; Schreyer HB, 2000, BIOMACROMOLECULES, V1, P642, DOI 10.1021/bm005557l; Smela E, 2003, ADV MATER, V15, P481, DOI 10.1002/adma.200390113; SMELA E, 1995, SCIENCE, V268, P1735, DOI 10.1126/science.268.5218.1735; Spinks GM, 2002, ADV MATER, V14, P1728, DOI 10.1002/1521-4095(20021203)14:23<1728::AID-ADMA1728>3.0.CO;2-8; Zhang M, 2004, SCIENCE, V306, P1358, DOI 10.1126/science.1104276; Zhang QM, 1998, SCIENCE, V280, P2101, DOI 10.1126/science.280.5372.2101	17	202	208	6	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2005	308	5718					63	65		10.1126/science.1099010	http://dx.doi.org/10.1126/science.1099010			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914IQ	15802593				2022-12-24	WOS:000228221500031
J	Pluta, RM; Dejam, A; Grimes, G; Gladwin, MT; Oldfield, EH				Pluta, RM; Dejam, A; Grimes, G; Gladwin, MT; Oldfield, EH			Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTRAVENTRICULAR SODIUM-NITROPRUSSIDE; OXIDE SYNTHASE ACTIVITY; CEREBROSPINAL-FLUID; BLOOD-FLOW; INTRAVENOUS NITROGLYCERIN; ENDOTHELIAL DYSFUNCTION; S-NITROSOHEMOGLOBIN; HYPOXIC CONDITIONS; GUANYLATE-CYCLASE; ANEURYSM-SURGERY	Context Delayed cerebral vasospasm causes permanent neurological deficits or death in at least 15% of patients following otherwise successful treatment for ruptured intracranial aneurysm. Decreased bioavailability of nitric oxide has been associated with the development of cerebral vasospasm. Objective To determine whether infusions of nitrite will prevent delayed cerebral vasospasm. Design, Setting, and Subjects A total of 14 anesthetized cynomolgus monkeys had an autologous blood clot placed around the right middle cerebral artery. Cerebral arteriography was performed before clot placement and on days 7 and 14 to assess vasospasm. The study was conducted from August 2003 to February 2004. Interventions A 90-mg sodium nitrite intravenous solution infused over 24 hours plus a 45-mg sodium nitrite bolus daily (n=31); a 180-mg sodium nitrite intravenous solution infused over 24 hours (n=3); or a control saline solution infusion (n=8). Each was infused continuously for 14 days. Main Outcome Measures Nitrite, S-nitrosothiol, and methemoglobin levels in blood and cerebrospinal fluid and degree of arteriographic vasospasm. Results In control monkeys, mean (SD) cerebrospinal fluid nitrite levels decreased from 3.1 (1.5) mu mol/L to 0.4 (0.1) mu mol/L at day 7 and to 0.4 (0.4) mu mol/L at day 14 (P=.03). All 8 control monkeys developed significant vasospasm of the right middle cerebral artery which was complicated by stroke and death in I animal. Sodium nitrite infusions increased the nitrite and methemoglobin levels (<2.1% of total hemoglobin) in the blood and cerebrospinal fluid without evoking systemic hypotension. Nitrite infusion prevented development of vasospasm (no animals developed significant vasospasm; mean [SD] reduction in right middle cerebral artery area on day 7 after subarachnoid hemorrhage of 8% [9%] in nitrite-treated monkeys vs 47% [5%] in saline-treated controls; P<.001). There was a negative correlation between the concentration of nitrite in cerebrospinal fluid and the degree of cerebral vasospasm (P<.001). Pharmacological effects of nitrite infusion were also associated with the formation of S-nitrosothiol in cerebrospinal fluid. There was no clinical or pathological evidence of nitrite toxicity. Conclusion Subacute sodium nitrite infusions prevented delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage.	NINDS, Surg Neurol Branch, Bethesda, MD 20892 USA; NIDDKD, Biol Chem Lab, Bethesda, MD 20892 USA; NHLBI, Dept Pharm, Ctr Clin, Vasc Therapeut Sect,Cardiovasc Branch, Bethesda, MD 20892 USA; NIH, Dept Crit Care Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA	Pluta, RM (corresponding author), NINDS, Surg Neurol Branch, 10 Ctr Dr,Room 5D37, Bethesda, MD 20892 USA.	rysiek@ninds.nih.gov			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002854] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AFSHAR JKB, 1995, J NEUROSURG, V83, P118, DOI 10.3171/jns.1995.83.1.0118; Asano T, 1999, CRIT REV NEUROSURG, V9, P303, DOI 10.1007/s003290050147; BAETMANN A, 1985, CEREBRAL VASCULAR SP, P209; BARKOVICH AJ, 1988, RADIOL CLIN N AM, V26, P801; BROWN FD, 1977, SURG NEUROL, V7, P67; Bryan NS, 2004, P NATL ACAD SCI USA, V101, P4308, DOI 10.1073/pnas.0306706101; BURNETT M, 2004, MANAGEMENT CEREBRAL, P127; Clark JF, 2002, J CEREBR BLOOD F MET, V22, P472, DOI 10.1097/00004647-200204000-00011; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Dejam A, 2004, BLOOD CELL MOL DIS, V32, P423, DOI 10.1016/j.bcmd.2004.02.002; Dietrich HH, 2000, NEUROSURGERY, V46, P517, DOI 10.1097/00006123-200003000-00001; DOYLE MP, 1981, J INORG BIOCHEM, V14, P351, DOI 10.1016/S0162-0134(00)80291-3; EGEMEN N, 1993, NEUROL RES, V15, P310; ESPINOSA F, 1984, J NEUROSURG, V60, P1167, DOI 10.3171/jns.1984.60.6.1167; FRAZEE JG, 1981, J NEUROSURG, V55, P865, DOI 10.3171/jns.1981.55.6.0865; Gabikian P, 2002, STROKE, V33, P2681, DOI 10.1161/01.STR.0000033931.62992.B1; Gladwin MT, 2003, NAT MED, V9, P496, DOI 10.1038/nm0503-496; Gladwin MT, 2002, J BIOL CHEM, V277, P27818, DOI 10.1074/jbc.M203236200; Gladwin MT, 2000, P NATL ACAD SCI USA, V97, P11482, DOI 10.1073/pnas.97.21.11482; Gladwin MT, 2004, FREE RADICAL BIO MED, V36, P707, DOI 10.1016/j.freeradbiomed.2003.11.032; GOMORI JM, 1985, RADIOLOGY, V157, P87, DOI 10.1148/radiology.157.1.4034983; HASHI K, 1972, J NEUROL SCI, V17, P1, DOI 10.1016/0022-510X(72)90016-0; Heros R C, 1976, Surg Neurol, V6, P227; HEROS RC, 1983, ANN NEUROL, V14, P599, DOI 10.1002/ana.410140602; Hino A, 1996, NEUROSURGERY, V39, P562, DOI 10.1097/00006123-199609000-00026; Hunter CJ, 2004, NAT MED, V10, P1122, DOI 10.1038/nm1109; IGNARRO LJ, 1980, BIOCHIM BIOPHYS ACTA, V631, P221, DOI 10.1016/0304-4165(80)90297-4; IGNARRO LJ, 1990, ANNU REV PHARMACOL, V30, P535, DOI 10.1146/annurev.pa.30.040190.002535; Ito Y, 2000, J CARDIOVASC PHARM, V35, P45, DOI 10.1097/00005344-200001000-00006; Iuliano BA, 2004, J NEUROSURG, V100, P287, DOI 10.3171/jns.2004.100.2.0287; Jung CS, 2004, J NEUROSURG, V101, P836, DOI 10.3171/jns.2004.101.5.0836; KASSELL NF, 1990, J NEUROSURG, V73, P18, DOI 10.3171/jns.1990.73.1.0018; KASSELL NF, 1984, STROKE, V15, P566, DOI 10.1161/01.STR.15.3.566; KASUYA H, 1995, J NEUROSURG, V82, P250, DOI 10.3171/jns.1995.82.2.0250; Khaldi A, 2001, NEUROSURGERY, V49, P33; KIM P, 1990, CEREBRAL VASOSPASM, P83; KISTLER JP, 1979, STROKE, V10, P26, DOI 10.1161/01.STR.10.1.26; Kranc KR, 2000, EUR J BIOCHEM, V267, P7094, DOI 10.1046/j.1432-1327.2000.01812.x; Lauer T, 2001, P NATL ACAD SCI USA, V98, P12814, DOI 10.1073/pnas.221381098; MACDONALD RL, 1991, STROKE, V22, P971, DOI 10.1161/01.STR.22.8.971; Macdonald RL, 2001, CEREBRAL VASOSPASM; Meyer F B, 1990, Neurosurg Clin N Am, V1, P367; Millar TM, 1998, FEBS LETT, V427, P225, DOI 10.1016/S0014-5793(98)00430-X; Nagababu E, 2003, J BIOL CHEM, V278, P46349, DOI 10.1074/jbc.M307572200; Nakao K, 1996, STROKE, V27, P1882, DOI 10.1161/01.STR.27.10.1882; Ng WH, 2001, NEUROSURGERY, V49, P622, DOI 10.1097/00006123-200109000-00016; NISHIZAWA S, 1995, STROKE, V26, P1916, DOI 10.1161/01.STR.26.10.1916; PAKARINEN S, 1967, ACTA NEUROL SCAND  S, V29, P1; Park KW, 2001, ANESTH ANALG, V92, P990; PAULSON OB, 1970, NEUROLOGY, V20, P63, DOI 10.1212/WNL.20.1.63; PLUTA R, 2004, VAS P 8 INT C NEW YO, P71; Pluta RM, 1998, J NEUROSURG, V88, P557, DOI 10.3171/jns.1998.88.3.0557; PLUTA RM, 1992, J NEUROSURG, V77, P740, DOI 10.3171/jns.1992.77.5.0740; Pluta RM, 1996, J NEUROSURG, V84, P648, DOI 10.3171/jns.1996.84.4.0648; Pluta RM, 2001, ACT NEUR S, V77, P67; Pluta RM, 1997, J NEUROSURG, V87, P746, DOI 10.3171/jns.1997.87.5.0746; Pluta RM, 2005, PHARMACOL THERAPEUT, V105, P23, DOI 10.1016/j.pharmthera.2004.10.002; Polin RS, 1998, NEUROSURGERY, V42, P1256, DOI 10.1097/00006123-199806000-00031; Raabe A, 2002, NEUROSURGERY, V50, P1006, DOI 10.1097/00006123-200205000-00013; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Sadamitsu D, 2001, CRIT CARE MED, V29, P77, DOI 10.1097/00003246-200101000-00018; Sakowitz OW, 2001, J CEREBR BLOOD F MET, V21, P1067, DOI 10.1097/00004647-200109000-00004; SAMBROOK MA, 1973, BRAIN, V96, P171, DOI 10.1093/brain/96.1.171; Schievink WI, 1997, NEW ENGL J MED, V336, P28, DOI 10.1056/NEJM199701023360106; Sercombe R, 2002, JPN J PHARMACOL, V88, P227, DOI 10.1254/jjp.88.227; SHIMODA M, 1993, J NEUROSURG, V78, P423, DOI 10.3171/jns.1993.78.3.0423; Suzuki M, 1999, NEUROSURG REV, V22, P96, DOI 10.1007/s101430050038; Thomas JE, 1999, NEUROSURGERY, V44, P48, DOI 10.1097/00006123-199901000-00026; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; TODA N, 1993, CIRC RES, V72, P206, DOI 10.1161/01.RES.72.1.206; Treggiari-Venzi MM, 2001, NEUROSURGERY, V48, P249, DOI 10.1097/00006123-200102000-00001; Wang XY, 2002, STROKE, V33, P1882, DOI 10.1161/01.STR.0000020121.41527.5D; WEIR B, 1978, J NEUROSURG, V48, P173, DOI 10.3171/jns.1978.48.2.0173; Weyerbrock A, 2003, J NEUROSURG, V99, P728, DOI 10.3171/jns.2003.99.4.0728; Woszczyk A, 2003, ACTA NEUROCHIR, V145, P257, DOI 10.1007/s00701-003-0004-7; Yamamoto S, 1997, BRAIN RES, V757, P1, DOI 10.1016/S0006-8993(96)01433-3; Yang BK, 2003, FREE RADICAL RES, V37, P1, DOI 10.1080/1071576021000033112; Zhang Z, 1998, BIOCHEM BIOPH RES CO, V249, P767, DOI 10.1006/bbrc.1998.9226; ZWEIER JL, 1995, NAT MED, V1, P804, DOI 10.1038/nm0895-804	79	211	219	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2005	293	12					1477	1484		10.1001/jama.293.12.1477	http://dx.doi.org/10.1001/jama.293.12.1477			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	908KA	15784871	Bronze			2022-12-24	WOS:000227784700027
J	Head, JW; Neukum, G; Jaumann, R; Hiesinger, H; Hauber, E; Carr, M; Masson, P; Foing, B; Hoffmann, H; Kreslavsky, M; Werner, S; Milkovich, S; van Gasselt, S				Head, JW; Neukum, G; Jaumann, R; Hiesinger, H; Hauber, E; Carr, M; Masson, P; Foing, B; Hoffmann, H; Kreslavsky, M; Werner, S; Milkovich, S; van Gasselt, S		HRSC Co-Investigator Team	Tropical to mid-latitude snow and ice accumulation, flow and glaciation on Mars	NATURE			English	Article							ROCK GLACIERS; EVOLUTION; FEATURES; DEBRIS	Images from the Mars Express HRSC (High-Resolution Stereo Camera) of debris aprons at the base of massifs in eastern Hellas reveal numerous concentrically ridged lobate and pitted features and related evidence of extremely ice-rich glacier-like viscous flow and sublimation. Together with new evidence for recent ice-rich rock glaciers at the base of the Olympus Mons scarp superposed on larger Late Amazonian debris-covered piedmont glaciers, we interpret these deposits as evidence for geologically recent and recurring glacial activity in tropical and mid-latitude regions of Mars during periods of increased spin-axis obliquity when polar ice was mobilized and redeposited in microenvironments at lower latitudes. The data indicate that abundant residual ice probably remains in these deposits and that these records of geologically recent climate changes are accessible to future automated and human surface exploration.	Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; Free Univ Berlin, Inst Geol Wissensch, D-12249 Berlin, Germany; DLR, Inst Planetenforsch, D-12489 Berlin, Germany; US Geol Survey, Menlo Pk, CA 94025 USA; Orsay Terre, F-91405 Orsay, France; ESTEC, SCISR, NL-2200 AG Noordwijk, Netherlands	Brown University; Free University of Berlin; Helmholtz Association; German Aerospace Centre (DLR); United States Department of the Interior; United States Geological Survey; European Space Agency	Head, JW (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.	james_head@brown.edu	Werner, Stephanie C/A-6438-2012; van Gasselt, Stephan/L-9762-2013; Hauber, Ernst/U-2521-2018; Kreslavsky, Mikhail/J-3425-2013; Jaumann, Ralf/N-1001-2018	Werner, Stephanie C/0000-0001-5704-0909; van Gasselt, Stephan/0000-0003-2130-6343; Hauber, Ernst/0000-0002-1375-304X; Jaumann, Ralf/0000-0002-9759-6597; Kreslavsky, Mikhail/0000-0002-1900-826X				BAKER VR, 1991, NATURE, V352, P589, DOI 10.1038/352589a0; Baratoux D, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013779; BENN DI, 1998, GLACIERS GLACIATION, P237; Boulton GS, 1971, TILL S, P41; Colaprete A, 1998, J GEOPHYS RES-PLANET, V103, P5897, DOI 10.1029/97JE03371; Eyles N., 1978, J GLACIOL, V20, P99, DOI [10.3189/S0022143000021249, DOI 10.1017/S0022143000021249]; Feldman WC, 2002, SCIENCE, V297, P75, DOI 10.1126/science.1073541; Grove JM, 1988, LITTLE ICE AGE; Haberle RA, 2003, ICARUS, V161, P66, DOI 10.1016/S0019-1035(02)00017-9; Hartmann WK, 2001, SPACE SCI REV, V96, P165, DOI 10.1023/A:1011945222010; HARTSHORN JH, 1952, GEOL SOC AM BULL, V63, P1259; Head JW, 2003, NATURE, V426, P797, DOI 10.1038/nature02114; Head JW, 2003, GEOLOGY, V31, P641, DOI 10.1130/0091-7613(2003)031<0641:CMGOMW>2.0.CO;2; HEAD JW, 2003, 3 MARS POL C; Ivanov BA, 2001, SPACE SCI REV, V96, P87, DOI 10.1023/A:1011941121102; JOHNSON PG, 1980, ARCTIC ALPINE RES, V12, P195, DOI 10.2307/1550516; KARGEL JS, 1992, GEOLOGY, V20, P3, DOI 10.1130/0091-7613(1992)020<0003:AGOM>2.3.CO;2; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; LUCCHITTA BK, 1981, ICARUS, V45, P264, DOI 10.1016/0019-1035(81)90035-X; Mangold N, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001885; Mangold N, 2002, PLANET SPACE SCI, V50, P385, DOI 10.1016/S0032-0633(02)00005-3; Mangold N, 2001, GEOPHYS RES LETT, V28, P407, DOI 10.1029/2000GL008491; Marchant DR, 2002, GEOL SOC AM BULL, V114, P718, DOI 10.1130/0016-7606(2002)114<0718:FOPGAS>2.0.CO;2; MARTIN HE, 1987, PROG PHYS GEOG, V11, P260; MELLON MT, 1995, J GEOPHYS RES-PLANET, V100, P11781, DOI 10.1029/95JE01027; MILKOVICH SM, 2003, 6 INT MARS C; Mischna MA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002051; MORRIS EC, 1994, MISC INV SER US GEOL; Neukum G, 2004, NATURE, V432, P971, DOI 10.1038/nature03231; Neukum G, 2001, SPACE SCI REV, V96, P55, DOI 10.1023/A:1011989004263; Neukum G., 2004, EUR SP AGENCY SPECIA, V1240, P17; Pierce TL, 2003, ICARUS, V163, P46, DOI 10.1016/S0019-1035(03)00046-0; POTTER N, 1984, J GEOL EDUC, V32, P226, DOI 10.5408/0022-1368-32.4.226; Richardson MI, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001536; SHEAN DE, 2004, LUNAR PLANET SCI, V35; Skorov YV, 2001, PLANET SPACE SCI, V49, P59, DOI 10.1016/S0032-0633(00)00121-5; SQUYRES SW, 1978, ICARUS, V34, P600, DOI 10.1016/0019-1035(78)90048-9; WARREN CR, 1995, GEOGR REV, V8, P2	38	253	256	2	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					346	351		10.1038/nature03359	http://dx.doi.org/10.1038/nature03359			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772652				2022-12-24	WOS:000227715100042
J	Kraemer, DJM; Macrae, CN; Green, AE; Kelley, WM				Kraemer, DJM; Macrae, CN; Green, AE; Kelley, WM			Musical imagery - Sound of silence activates auditory cortex	NATURE			English	Editorial Material							VISUAL-CORTEX; EVENT		Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; Univ Aberdeen, Sch Psychol, Aberdeen AB24 2UB, Scotland	Dartmouth College; University of Aberdeen	Kraemer, DJM (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA.	william.kelley@dartmouth.edu	Macrae, Neil/C-4761-2008					FLETCHER PC, 1995, NEUROIMAGE, V2, P195, DOI 10.1006/nimg.1995.1025; Halpern AR, 1999, CEREB CORTEX, V9, P697, DOI 10.1093/cercor/9.7.697; Hughes HC, 2001, NEUROIMAGE, V13, P1073, DOI 10.1006/nimg.2001.0766; Kosslyn SM, 2003, PSYCHOL BULL, V129, P723, DOI 10.1037/0033-2909.129.5.723; KOSSLYN SM, 1995, NATURE, V378, P496, DOI 10.1038/378496a0; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; Van Essen DC, 2001, VISION RES, V41, P1359, DOI 10.1016/S0042-6989(01)00045-1; Wheeler ME, 2000, P NATL ACAD SCI USA, V97, P11125, DOI 10.1073/pnas.97.20.11125; Yoo SS, 2001, NEUROREPORT, V12, P3045, DOI 10.1097/00001756-200110080-00013	9	179	182	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					158	158		10.1038/434158a	http://dx.doi.org/10.1038/434158a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15758989	Bronze			2022-12-24	WOS:000227494500033
J	Brown, JW; Braver, TS				Brown, JW; Braver, TS			Learned predictions of error likelihood in the anterior cingulate cortex	SCIENCE			English	Article							FRONTAL-CORTEX; COGNITIVE CONTROL; DOPAMINE NEURONS; REWARD; PERFORMANCE; BRAIN; GO	The anterior cingulate cortex (ACC) and the related medial wall play a critical role in recruiting cognitive control. Although ACC exhibits selective error and conflict responses, it has been unclear how these develop and become context-specific. With use of a modified stop-signal task, we show from integrated computational neural modeling and neuroimaging studies that ACC learns to predict error likelihood in a given context, even for trials in which there is no error or response conflict. These results support a more general error-likelihood theory of ACC function based on reinforcement learning, of which conflict and error detection are special cases.	Washington Univ, Dept Psychol, St Louis, MO 63130 USA	Washington University (WUSTL)	Brown, JW (corresponding author), Washington Univ, Dept Psychol, CB 1125, St Louis, MO 63130 USA.	jwbrown@artsci.wustl.edu	Brown, Joshua/G-2867-2011	Braver, Todd/0000-0002-2631-3393				Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; BERNSTEIN PS, 1995, J EXP PSYCHOL HUMAN, V21, P1312, DOI 10.1037/0096-1523.21.6.1312; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; BOUSSAOUD D, 1993, EXP BRAIN RES, V95, P28; Brown JW, 2004, NEURAL NETWORKS, V17, P471, DOI 10.1016/j.neunet.2003.08.006; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; GEHRING WJ, 1990, PSYCHOPHYSIOLOGY, V27, P34; HERMSTEIN RJ, 1961, J EXPT ANAL BEHAV, V4, P267; Hohnsbein J., 1989, J PSYCHOPHYSIOL, V3, P32; Holroyd CB, 2004, NAT NEUROSCI, V7, P497, DOI 10.1038/nn1238; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI [10.1037//0033-295X.109.4.679, 10.1037/0033-295X.109.4.679]; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Jones AD, 2002, COGN AFFECT BEHAV NE, V2, P300, DOI 10.3758/CABN.2.4.300; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rubia K, 2001, NEUROIMAGE, V13, P250, DOI 10.1006/nimg.2000.0685; Schall JD, 2002, NEURON, V36, P309, DOI 10.1016/S0896-6273(02)00964-9; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Stuphorn V, 2000, NATURE, V408, P857, DOI 10.1038/35048576; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765	26	649	657	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2005	307	5712					1118	1121		10.1126/science.1105783	http://dx.doi.org/10.1126/science.1105783			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ED	15718473				2022-12-24	WOS:000227197300051
J	DasGupta, R; Kaykas, A; Moon, RT; Perrimon, N				DasGupta, R; Kaykas, A; Moon, RT; Perrimon, N			Functional genomic analysis of the Wnt-Wingless signaling pathway	SCIENCE			English	Article							BETA-CATENIN; MORPHOGEN GRADIENT; WNT/BETA-CATENIN; DROSOPHILA; PROTEIN; CELL; TRANSDUCTION; REPRESSION; ARMADILLO; FAMILY	The Wnt-Wingless (Wg) pathway is one of a core set of evolutionarily conserved signaling pathways that regulates many aspects of metazoan development. Aberrant Writ signaling has been linked to human disease. In the present study, we used a genomewide RNA interference (RNAi) screen in Drosophila cells to screen for regulators of the Writ pathway. We identified 238 potential regulators, which include known pathway components, genes with functions not previously linked to this pathway, and genes with no previously assigned functions. Reciprocal-Best-Blast analyses reveal that 50% of the genes identified in the screen have human orthologs, of which similar to 18% are associated with human disease. Functional assays of selected genes from the cell-based screen in Drosophila, mammalian cells, and zebrafish embryos demonstrated that these genes have evolutionarily conserved functions in Writ signaling. High-throughput RNAi screens in cultured cells, followed by functional analyses in model organisms, prove to be a rapid means of identifying regulators of signaling pathways implicated in development and disease.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA; Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Pharmacol,Ctr Dev Biol, Seattle, WA 98195 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	DasGupta, R (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Res Bldg 339,77 Ave Louis Pasteur, Boston, MA 02115 USA.	rdasgupt@genetics.med.harvard.edu; rtmoon@u.washington.edu; perrimon@receptor.med.harvard.edu	Moon, Randall T/B-1743-2014; Moon, Randall/M-5605-2019	Moon, Randall T/0000-0002-9352-1408; Moon, Randall/0000-0002-9352-1408; Dasgupta, Ramanuj/0000-0001-9015-3729; Perrimon, Norbert/0000-0001-7542-472X				Adams MD, 2002, NAT REV GENET, V3, P189, DOI 10.1038/nrg752; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Baeg GH, 2004, DEV BIOL, V276, P89, DOI 10.1016/j.ydbio.2004.08.023; Bauer A, 2000, EMBO J, V19, P6121, DOI 10.1093/emboj/19.22.6121; Bauer A, 1998, P NATL ACAD SCI USA, V95, P14787, DOI 10.1073/pnas.95.25.14787; Benmerah A, 2004, CURR BIOL, V14, pR314, DOI 10.1016/j.cub.2004.03.053; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Dasgupta R, 2004, ONCOGENE, V23, P8359, DOI 10.1038/sj.onc.1208028; DASGUPTA R, UNPUB; Eggert US, 2004, PLOS BIOL, V2, P2135, DOI 10.1371/journal.pbio.0020379; Gonzallez-Gaitan M, 2003, NAT REV MOL CELL BIO, V4, P213, DOI 10.1038/nrm1053; Greaves S, 1999, GENETICS, V153, P1753; Hatzfeld M, 1999, INT REV CYTOL, V186, P179; Jung CY, 2004, CANCER RES, V64, P3046, DOI 10.1158/0008-5472.CAN-03-2614; KELLY GM, 1995, DEVELOPMENT, V121, P1787; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Korinek V, 1998, MOL CELL BIOL, V18, P1248, DOI 10.1128/MCB.18.3.1248; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; LOGAN CY, 2004, ANN REV CELL DEV BIO; Malbon CC, 2001, BIOCHEM BIOPH RES CO, V287, P589, DOI 10.1006/bbrc.2001.5630; Matsubayashi H, 2004, MOL CELL BIOL, V24, P2012, DOI 10.1128/MCB.24.5.2012-2024.2004; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Miller AS, 2000, IN VITRO CELL DEV-AN, V36, P180; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; MOON RT, UNPUB; MOON RT, 2005, SCI STKE         APR; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nusse R, 1999, TRENDS GENET, V15, P1, DOI 10.1016/S0168-9525(98)01634-5; PEEL DJ, 1990, TISSUE CELL, V22, P749, DOI 10.1016/0040-8166(90)90069-L; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; PERRIMON N, 2005, SCI STKE         APR; Polakis P, 2000, GENE DEV, V14, P1837; Ramel MC, 2004, DEVELOPMENT, V131, P3991, DOI 10.1242/dev.01277; Rosenfeld JL, 2002, RECEPTOR CHANNEL, V8, P87, DOI 10.1080/10606820212398; Rousset R, 2001, GENE DEV, V15, P658, DOI 10.1101/gad.869201; Schlesinger A, 2004, DEV CELL, V7, P535, DOI 10.1016/j.devcel.2004.09.001; Schweizer L, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-4; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Sinner D, 2004, DEVELOPMENT, V131, P3069, DOI 10.1242/dev.01176; Su MA, 2001, GENETICS, V157, P717; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tang AH, 2001, DEVELOPMENT, V128, P801; Venter JC, 1998, SCIENCE, V280, P1540, DOI 10.1126/science.280.5369.1540; Wharton KA, 2001, DEV BIOL, V234, P93, DOI 10.1006/dbio.2001.0238; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yanagawa S, 1998, J BIOL CHEM, V273, P32353, DOI 10.1074/jbc.273.48.32353; Yanagawa S, 2002, EMBO J, V21, P1733, DOI 10.1093/emboj/21.7.1733; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087	52	267	288	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2005	308	5723					826	833		10.1126/science.1109374	http://dx.doi.org/10.1126/science.1109374			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15817814	Green Submitted			2022-12-24	WOS:000228986500041
J	Blackstone, E; Morrison, M; Roth, MB				Blackstone, E; Morrison, M; Roth, MB			H2S induces a suspended animation-like state in mice	SCIENCE			English	Article							HIBERNATION		Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98105 USA; Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Roth, MB (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98105 USA.	mroth@fhcrc.org			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000057] Funding Source: NIH RePORTER; NIA NIH HHS [T32 AG00057] Funding Source: Medline; NIGMS NIH HHS [GM48435] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEAUCHAMP RO, 1984, CRC CR REV TOXICOL, V13, P25, DOI 10.3109/10408448409029321; BLACKSTONE E, UNPUB; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Drew KL, 2001, FREE RADICAL BIO MED, V31, P563, DOI 10.1016/S0891-5849(01)00628-1; Nystul TG, 2004, P NATL ACAD SCI USA, V101, P9133, DOI 10.1073/pnas.0403312101; Padilla PA, 2001, P NATL ACAD SCI USA, V98, P7331, DOI 10.1073/pnas.131213198; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; STOREY KB, 1990, Q REV BIOL, V65, P145, DOI 10.1086/416717	8	618	658	1	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2005	308	5721					518	518		10.1126/science.1108581	http://dx.doi.org/10.1126/science.1108581			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15845845				2022-12-24	WOS:000228810500043
J	Lecellier, CH; Dunoyer, P; Arar, K; Lehmann-Che, J; Eyquem, S; Himber, C; Saib, A; Voinnet, O				Lecellier, CH; Dunoyer, P; Arar, K; Lehmann-Che, J; Eyquem, S; Himber, C; Saib, A; Voinnet, O			A cellular MicroRNA mediates antiviral defense in human cells	SCIENCE			English	Article							SMALL INTERFERING RNA; VIRAL SUPPRESSOR; GENES; IDENTIFICATION; RECOGNITION; ANTISENSE	In eukaryotes, 21- to 24-nucteotide-long RNAs engage in sequence-specific interactions that inhibit gene expression by RNA silencing. This process has regulatory roles involving microRNAs and, in plants and insects, it also forms the basis of a defense mechanism directed by small interfering RNAs that derive from replicative or integrated viral genomes. We show that a cellular microRNA effectively restricts the accumulation of the retrovirus primate foamy virus type 1 (PFV-1) in human cells. PFV-1 also encodes a protein, Tas, that suppresses microRNA-directed functions in mammalian cells and displays cross-kingdom antisilencing activities. Therefore, through fortuitous recognition of foreign nucleic acids, cellular microRNAs have direct antiviral effects in addition to their regulatory functions.	CNRS, Inst Biol Mol Plantes, UPR 2357, F-67084 Strasbourg, France; Proligo, Paris, France; Hop St Louis, CNRS, UPR9051, Paris, France; Hop St Louis, INSERM, U462, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Lecellier, CH (corresponding author), CNRS, Inst Biol Mol Plantes, UPR 2357, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.	charles.lecellier@infobiogen.fr; olivier.voinnet@ibmp-ulp.u-strasbg.fr		Voinnet, Olivier/0000-0001-6982-9544; Lehmann-Che, jacqueline/0000-0001-6685-3354				Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BAUNACH G, 1993, J VIROL, V67, P5411, DOI 10.1128/JVI.67.9.5411-5418.1993; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Das AT, 2004, J VIROL, V78, P2601, DOI 10.1128/JVI.78.5.2601-2605.2004; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Heinkelein M, 2000, EMBO J, V19, P3436, DOI 10.1093/emboj/19.13.3436; Jepsen JS, 2004, OLIGONUCLEOTIDES, V14, P130, DOI 10.1089/1545457041526317; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100; Llave C, 2004, MOL PLANT PATHOL, V5, P361, DOI 10.1111/j.1364-3703.2004.00227.x; Lu SH, 2004, J VIROL, V78, P12868, DOI 10.1128/JVI.78.23.12868-12876.2004; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Schramke V, 2004, CURR OPIN GENET DEV, V14, P174, DOI 10.1016/j.gde.2004.02.006; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Vargason JM, 2003, CELL, V115, P799, DOI 10.1016/S0092-8674(03)00984-X; Ye KQ, 2003, NATURE, V426, P874, DOI 10.1038/nature02213	22	728	852	2	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2005	308	5721					557	560		10.1126/science.1108784	http://dx.doi.org/10.1126/science.1108784			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15845854				2022-12-24	WOS:000228810500054
J	Pocai, A; Lam, TKT; Gutierrez-Juarez, R; Obici, S; Schwartz, GJ; Bryan, J; Aguilar-Bryan, L; Rossetti, L				Pocai, A; Lam, TKT; Gutierrez-Juarez, R; Obici, S; Schwartz, GJ; Bryan, J; Aguilar-Bryan, L; Rossetti, L			Hypothalamic K-ATP channels control hepatic glucose production	NATURE			English	Article							SENSITIVE POTASSIUM CHANNELS; FOOD-INTAKE; BODY-WEIGHT; SULFONYLUREA RECEPTOR; INSULIN-SECRETION; ARCUATE NUCLEUS; MICE; INHIBITION; OBESITY; LEPTIN	Obesity is the driving force behind the worldwide increase in the prevalence of type 2 diabetes mellitus(1,2). Hyperglycaemia is a hallmark of diabetes and is largely due to increased hepatic gluconeogenesis(3). The medial hypothalamus is a major integrator of nutritional and hormonal signals(1,2,4), which play pivotal roles not only in the regulation of energy balance but also in the modulation of liver glucose output(5,6). Bidirectional changes in hypothalamic insulin signalling therefore result in parallel changes in both energy balance(7-10) and glucose metabolism(5). Here we show that activation of ATP-sensitive potassium (K-ATP) channels(11) in the mediobasal hypothalamus is sufficient to lower blood glucose levels through inhibition of hepatic gluconeogenesis. Finally, the infusion of a K-ATP blocker within the mediobasal hypothalamus, or the surgical resection of the hepatic branch of the vagus nerve, negates the effects of central insulin and halves the effects of systemic insulin on hepatic glucose production. Consistent with these results, mice lacking the SUR1 subunit of the K-ATP channel(12) are resistant to the inhibitory action of insulin on gluconeogenesis. These findings suggest that activation of hypothalamic K-ATP channels normally restrains hepatic gluconeogenesis, and that any alteration within this central nervous system/liver circuit can contribute to diabetic hyperglycaemia.	Albert Einstein Coll Med, Dept Med, Diabet Res Ctr, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Neurosci, Diabet Res Ctr, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Mol Pharmacol, Diabet Res Ctr, Bronx, NY 10461 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Baylor College of Medicine	Rossetti, L (corresponding author), Albert Einstein Coll Med, Dept Med, Diabet Res Ctr, Bronx, NY 10461 USA.	rossetti@aecom.yu.edu						Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Chutkow WA, 2001, P NATL ACAD SCI USA, V98, P11760, DOI 10.1073/pnas.201390398; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; Grill HJ, 2002, ENDOCRINOLOGY, V143, P239, DOI 10.1210/en.143.1.239; Karschin C, 1997, FEBS LETT, V401, P59, DOI 10.1016/S0014-5793(96)01438-X; la Fleur SE, 2003, DIABETES, V52, P2321, DOI 10.2337/diabetes.52.9.2321; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; Massillon D, 1995, AM J PHYSIOL-ENDOC M, V269, pE1037, DOI 10.1152/ajpendo.1995.269.6.E1037; Matsuhisa M, 2000, METABOLISM, V49, P11, DOI 10.1016/S0026-0495(00)90538-9; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Morton GJ, 2003, ENDOCRINOLOGY, V144, P2016, DOI 10.1210/en.2002-0115; Niswender KD, 2003, DIABETES, V52, P227, DOI 10.2337/diabetes.52.2.227; NORGREN R, 1988, J COMP NEUROL, V273, P207, DOI 10.1002/cne.902730206; Obici S, 2002, NAT NEUROSCI, V5, P566, DOI 10.1038/nn861; Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873; Obici S, 2002, DIABETES, V51, P271, DOI 10.2337/diabetes.51.2.271; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Pocai A, 2005, CELL METAB, V1, P53, DOI 10.1016/j.cmet.2004.11.001; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Seghers V, 2000, J BIOL CHEM, V275, P9270, DOI 10.1074/jbc.275.13.9270; Seino S, 2000, DIABETES, V49, P311, DOI 10.2337/diabetes.49.3.311; Seino S, 2003, PROG BIOPHYS MOL BIO, V81, P133, DOI 10.1016/S0079-6107(02)00053-6; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; Spanswick D, 2000, NAT NEUROSCI, V3, P757, DOI 10.1038/77660; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0	29	480	495	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					1026	1031		10.1038/nature03439	http://dx.doi.org/10.1038/nature03439			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846348				2022-12-24	WOS:000228524600040
J	Pizarro, JC; Vulliez-Le Normand, B; Chesne-Seck, ML; Coilins, CR; Withers-Martinez, C; Hackett, F; Blackman, MJ; Faber, BW; Remarque, EJ; Kocken, CHM; Thomas, AW; Bentley, GA				Pizarro, JC; Vulliez-Le Normand, B; Chesne-Seck, ML; Coilins, CR; Withers-Martinez, C; Hackett, F; Blackman, MJ; Faber, BW; Remarque, EJ; Kocken, CHM; Thomas, AW; Bentley, GA			Crystal structure of the malaria vaccine candidate apical membrane antigen 1	SCIENCE			English	Article							PLASMODIUM-KNOWLESI; ERYTHROCYTE INVASION; APPLE DOMAINS; PAN MODULE; PROTEIN; IMMUNIZATION; MEROZOITES; EXPRESSION; HOMOLOG; PROGRAM	Apical membrane antigen 1 from Plasmodium is a leading malaria vaccine candidate. The protein is essential for host-cell invasion, but its molecular function is unknown. The crystal structure of the three domains comprising the ectoplasmic region of the antigen from P. vivax, solved at 1.8 angstrom resolution, shows that domains I and II belong to the PAN motif, which defines a superfamily of protein folds implicated in receptor binding. We also mapped the epitope of an invasion-inhibitory monoclonal antibody specific for the P. falciparum ortholog and modeled this to the structure. The location of the epitope and current knowledge on structure-function correlations for PAN domains together suggest a receptor-binding role during invasion in which domain II plays a critical part. These results are likely to aid vaccine and drug design.	Inst Pasteur, CNRS, URA 2185, Unite Immunol Struct, F-75724 Paris, France; Natl Inst Med Res, Div Parasitol, London NW7 1AA, England; Biomed Primate Res Ctr, Dept Parasitol, NL-2280 GH Rijswijk, Netherlands	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; MRC National Institute for Medical Research	Bentley, GA (corresponding author), Inst Pasteur, CNRS, URA 2185, Unite Immunol Struct, 25 Rue Docteur Roux, F-75724 Paris, France.	bentley@pasteur.fr	Remarque, Edmond J/B-2217-2010; Remarque, Ed/AAE-8643-2020; Bentley, Graham/B-3623-2011	Marie-Laure, Chesne-Seck/0000-0002-0963-2181; Faber, Bart/0000-0001-6808-1204; Kocken, Clemens/0000-0002-4784-1734	Medical Research Council [MC_U117532063] Funding Source: Medline; MRC [MC_U117532063] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anders RF, 1998, VACCINE, V16, P240, DOI 10.1016/S0264-410X(97)88331-4; Brown PJ, 2001, FEBS LETT, V497, P31, DOI 10.1016/S0014-5793(01)02424-3; DEANS JA, 1988, PARASITE IMMUNOL, V10, P535, DOI 10.1111/j.1365-3024.1988.tb00241.x; Fraser TS, 2001, MOL BIOCHEM PARASIT, V117, P49, DOI 10.1016/S0166-6851(01)00326-7; Gaffar FR, 2004, INFECT IMMUN, V72, P2947, DOI 10.1128/IAI.72.5.2947-2955.2004; Healer J, 2002, INFECT IMMUN, V70, P5751, DOI 10.1128/IAI.70.10.5751-5758.2002; Hehl AB, 2000, INFECT IMMUN, V68, P7078, DOI 10.1128/IAI.68.12.7078-7086.2000; Hodder AN, 1996, J BIOL CHEM, V271, P29446, DOI 10.1074/jbc.271.46.29446; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huizinga EG, 2001, ACTA CRYSTALLOGR D, V57, P1071, DOI 10.1107/S0907444901007405; Kocken CHM, 1998, J BIOL CHEM, V273, P15119, DOI 10.1074/jbc.273.24.15119; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lietha D, 2001, EMBO J, V20, P5543, DOI 10.1093/emboj/20.20.5543; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mitchell GH, 2004, INFECT IMMUN, V72, P154, DOI 10.1128/IAI.72.1.154-158.2004; Nair M, 2002, J MOL BIOL, V322, P741, DOI 10.1016/S0022-2836(02)00806-9; Narum DL, 2000, INFECT IMMUN, V68, P2899, DOI 10.1128/IAI.68.5.2899-2906.2000; Stowers AW, 2002, INFECT IMMUN, V70, P6961, DOI 10.1128/IAI.70.12.6961-6967.2002; THOMAS AW, 1984, MOL BIOCHEM PARASIT, V13, P187, DOI 10.1016/0166-6851(84)90112-9; Thornton JM, 2000, NAT STRUCT BIOL, V7, P991, DOI 10.1038/80784; Tomley FM, 2001, TRENDS PARASITOL, V17, P81, DOI 10.1016/S1471-4922(00)01761-X; Tordai H, 1999, FEBS LETT, V461, P63, DOI 10.1016/S0014-5793(99)01416-7; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; Vulliez-Le Normand B, 2004, ACTA CRYSTALLOGR D, V60, P2040, DOI 10.1107/S090744490402116X; WATERS AP, 1990, J BIOL CHEM, V265, P17974	27	157	166	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2005	308	5720					408	411		10.1126/science.1107449	http://dx.doi.org/10.1126/science.1107449			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15731407				2022-12-24	WOS:000228492000051
J	Sonder, GJB; Regez, RM; Brinkman, K; Prins, JM; Mulder, JW; Spaargaren, J; Coutinho, RA; van den Hoek, A				Sonder, GJB; Regez, RM; Brinkman, K; Prins, JM; Mulder, JW; Spaargaren, J; Coutinho, RA; van den Hoek, A			Prophylaxis and follow-up after possible exposure to HIV, hepatitis B virus, and hepatitis C virus outside hospital: evaluation of policy 2000-3	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INJECTION-DRUG USE; POSTEXPOSURE PROPHYLAXIS	Problem Prophylactic treatment and follow-up after exposure to HIV, hepatitis B, and hepatitis C outside hospital needs to be improved. Background and setting Until January 2000, people in Amsterdam Could report exposure outside hospital to either a hospital or the municipal health service. If they reported to the municipal health service, they were then referred to hospitals for HIV prophylaxis, whereas the municipal health service handled treatment and follow-up related to hepatitis B and hepatitis C and traced sources. For cases reported to a hospital, hospital staff often did not trace HIV sources or follow up patients for hepatitis B and hepatitis C. Key measures for improvement Providing adequate treatment for HIV, hepatitis B and hepatitis C after exposure for all reported exposures outside hospital. Strategies for change On 1 January 2000, a new protocol was introduced in which three Amsterdam hospitals and the municipal health service collaborated in the treatment and follow-up of exposures outside hospital. Both municipal health service and hospitals can decide whether HIV prophylaxis is necessary and prescribe accordingly. All people exposed in the community who report to hospitals are subsequently referred to the municipal health service for further treatment and follow-up. Effects of change The protocol is effective in that most people comply with treatment and follow-up. When indicated, HIV prophylaxis is started soon after exposure. In nearly two thirds of cases the municipal health service traced and tested tire source. Lessons learnt Provision of treatment and follow-up in one place enables treatment, tracing and testing sources, and follow-tip, including counselling and registration of all reported exposures in Amsterdam, which allows for swift identification of emerging epidemiological trends. Since May 2004 all Amsterdam hospitals have participated in the protocol.	Dept Infect Dis, NL-1018 WT Amsterdam, Netherlands; Onze Lieve Vrouw Hosp, Dept Internal Med, Dept Clin Res, NL-1091 HA Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands; Slotervaart Hosp, Dept Internal Med, NL-1066 EC Amsterdam, Netherlands; Municipal Hlth Lab, Amsterdam, Netherlands; Municipal Hlth Serv Amsterdam, Amsterdam, Netherlands	Onze Lieve Vrouwe Gasthuis Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Slotervaart Hospital	Sonder, GJB (corresponding author), Dept Infect Dis, Nieuwe Achtergracht 100, NL-1018 WT Amsterdam, Netherlands.	gsonder@gggd.amsterdam.nl	Prins, Jan M./AAF-4945-2020					Almeda J, 2004, Euro Surveill, V9, P35; COLOMBO C, 2004, EUROSURVEILLANCE, V9, P40; Giele CM, 2002, SEX TRANSM INFECT, V78, P130, DOI 10.1136/sti.78.2.130; Kahn JO, 2001, J INFECT DIS, V183, P707, DOI 10.1086/318829; Katz MH, 1997, NEW ENGL J MED, V336, P1097, DOI 10.1056/NEJM199704103361512; Laporte A, 2002, AIDS, V16, P397, DOI 10.1097/00002030-200202150-00011; Tubiana Roland, 2004, Euro Surveill, V9, P3; van der Ende ME, 2002, INT J STD AIDS, V13, P30, DOI 10.1258/095646202762226137; VANSTEENBERGEN JE, 1999, LANDELIJKE COORDINAT	9	12	12	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2005	330	7495					825	829		10.1136/bmj.330.7495.825	http://dx.doi.org/10.1136/bmj.330.7495.825			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	915BZ	15817550	Green Published			2022-12-24	WOS:000228273900019
J	Freitas-Junior, LH; Hernandez-Rivas, R; Ralph, SA; Montiel-Condado, D; Ruvalcaba-Salazar, OK; Rojas-Meza, AP; Mancio-Silva, L; Leal-Silvestre, RJ; Gontijo, AM; Shorte, S; Scherf, A				Freitas-Junior, LH; Hernandez-Rivas, R; Ralph, SA; Montiel-Condado, D; Ruvalcaba-Salazar, OK; Rojas-Meza, AP; Mancio-Silva, L; Leal-Silvestre, RJ; Gontijo, AM; Shorte, S; Scherf, A			Telomeric heterochromatin propagation and histone acetylation control mutually exclusive expression of antigenic variation genes in malaria parasites	CELL			English	Article							PLASMODIUM-FALCIPARUM; GENOME SEQUENCE; VARIANT ANTIGEN; TRANSCRIPTION; RECOMBINATION; ERYTHROCYTES; PROTEINS; ORGANIZATION; COMPARTMENT; PHENOTYPES	Malaria parasites use antigenic variation to avoid immune clearance and increase the duration of infection in the human host. Variation at the surface of P. falciparurn-infected erythrocytes is mediated by the differential control of a family of surface antigens encoded by var genes. Switching of var gene expression occurs in situ, mostly from telomere-associated loci, without detectable DNA alterations, suggesting that it is controlled by chromatin structure. We have identified chromatin modifications at telomeres that spread far into telomere-proximal regions, including var gene loci (> 50 kb). One type of modification is mediated by a protein homologous to yeast Sir2 called PfSir2, which forms a chromosomal gradient of heterochromatin structure and histone hypoacetylation. Upon activation of a specific telomere-associated var gene, PfSir2 is removed from the promoter region and acetylation of histone occurs. Our data demonstrate that mutually exclusive transcription of var genes is linked to the dynamic remodeling of chromatin.	Inst Pasteur, Biol Host Parasite Interact Unit, CNRS, URA2581, F-75724 Paris, France; Dynam Imaging Platform, F-75724 Paris, France; IPN, Dept Mol Biomed, Ctr Invest & Estudios Avanzados, Mexico City 07360, DF, Mexico	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Scherf, A (corresponding author), Inst Pasteur, Biol Host Parasite Interact Unit, CNRS, URA2581, 25 Rue Dr Roux, F-75724 Paris, France.	ascherf@pasteur.fr	Silva, Liliana Mancio/AAB-2192-2020; Scherf, Artur/A-9674-2014; Gontijo, Alisson/G-6719-2011; Mancio-Silva, Liliana/F-9905-2013; Silvestre, Ricardo/C-7243-2011; Freitas-Junior, Lucio H/C-8677-2011; Ralph, Stuart/C-8590-2014	Silva, Liliana Mancio/0000-0002-5585-018X; Gontijo, Alisson/0000-0002-2530-3708; Mancio-Silva, Liliana/0000-0002-5585-018X; Silvestre, Ricardo/0000-0002-9270-2717; Freitas-Junior, Lucio H/0000-0002-8904-7897; Shorte, Spencer/0000-0002-2125-8663; MONTIEL CONDADO, DVORAK/0000-0003-0338-2764; Ralph, Stuart/0000-0003-0114-7808; Scherf, Artur/0000-0003-2411-3328				Al-Khedery B, 1999, MOL CELL, V3, P131, DOI 10.1016/S1097-2765(00)80304-4; Andrews KT, 2003, MOL MICROBIOL, V49, P655, DOI 10.1046/j.1365-2958.2003.03595.x; Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Borst P, 2002, CELL, V109, P5, DOI 10.1016/S0092-8674(02)00711-0; BOZDECH Z, 2003, PLOS BIOL, V109; Braunstein M, 1996, MOL CELL BIOL, V16, P4349; Buffet PA, 1999, P NATL ACAD SCI USA, V96, P12743, DOI 10.1073/pnas.96.22.12743; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; Deitsch KW, 1999, MOL BIOCHEM PARASIT, V101, P107, DOI 10.1016/S0166-6851(99)00062-6; Deitsch KW, 2001, NATURE, V412, P875, DOI 10.1038/35091146; del Portillo HA, 2001, NATURE, V410, P839, DOI 10.1038/35071118; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Fan Q, 2004, EUKARYOT CELL, V3, P264, DOI 10.1128/EC.3.2.264-276.2004; Figueiredo LM, 2000, MOL BIOCHEM PARASIT, V106, P169, DOI 10.1016/S0166-6851(99)00199-1; Figueiredo LM, 2005, NUCLEIC ACIDS RES, V33, P1111, DOI 10.1093/nar/gki260; Figueiredo LM, 2002, EMBO J, V21, P815, DOI 10.1093/emboj/21.4.815; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gotta M, 1997, EMBO J, V16, P3243, DOI 10.1093/emboj/16.11.3243; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Healer J, 2002, INFECT IMMUN, V70, P5751, DOI 10.1128/IAI.70.10.5751-5758.2002; Hediger F, 2002, NAT CELL BIOL, V4, pE53, DOI 10.1038/ncb0302-e53; Horrocks P, 2004, MOL BIOCHEM PARASIT, V134, P193, DOI 10.1016/j.molbiopara.2003.11.016; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kaviratne Mallika, 2003, P291, DOI 10.1016/B978-012194851-1/50039-1; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; Kyes S, 2001, ANNU REV MICROBIOL, V55, P673, DOI 10.1146/annurev.micro.55.1.673; LANZER M, 1992, NUCLEIC ACIDS RES, V20, P3051, DOI 10.1093/nar/20.12.3051; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Moazed D, 2001, MOL CELL, V8, P489, DOI 10.1016/S1097-2765(01)00340-9; Navarro M, 2001, NATURE, V414, P759, DOI 10.1038/414759a; PRENSIER G, 1986, J PARASITOL, V72, P731, DOI 10.2307/3281465; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Sambrook J, 1988, MOL CLONING LAB MANU; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; Scherf A, 2001, CURR OPIN MICROBIOL, V4, P409, DOI 10.1016/S1369-5274(00)00227-7; Shankaranarayana GD, 2003, CURR BIOL, V13, P1240, DOI 10.1016/S0960-9822(03)00489-5; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Taylor HM, 2000, MOL BIOCHEM PARASIT, V110, P391, DOI 10.1016/S0166-6851(00)00286-3; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Voss TS, 2003, MOL MICROBIOL, V48, P1593, DOI 10.1046/j.1365-2958.2003.03528.x; Voss TS, 2000, MOL BIOCHEM PARASIT, V107, P103, DOI 10.1016/S0166-6851(00)00176-6; Weiler KS, 1995, ANNU REV GENET, V29, P577, DOI 10.1146/annurev.ge.29.120195.003045	47	376	387	0	30	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 8	2005	121	1					25	36		10.1016/j.cell.2005.01.037	http://dx.doi.org/10.1016/j.cell.2005.01.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	915YU	15820676	Bronze			2022-12-24	WOS:000228348500007
J	Esashi, F; Christ, N; Gannon, J; Liu, YL; Hunt, T; Jasin, M; West, SC				Esashi, F; Christ, N; Gannon, J; Liu, YL; Hunt, T; Jasin, M; West, SC			CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair	NATURE			English	Article							HOMOLOGY-DIRECTED REPAIR; DOUBLE-STRAND BREAKS; CANCER SUSCEPTIBILITY; DNA-DAMAGE; RADIATION HYPERSENSITIVITY; CELL-CYCLE; RAD51; REPEATS; GENE; BINDING	Inherited mutations in BRCA2 are associated with a predisposition to early-onset breast cancers. The underlying basis of tumorigenesis is thought to be linked to defects in DNA double-strand break repair by homologous recombination. Here we show that the carboxy-terminal region of BRCA2, which interacts directly with the essential recombination protein RAD51, contains a site (serine 3291; S3291) that is phosphorylated by cyclin-dependent kinases. Phosphorylation of S3291 is low in S phase when recombination is active, but increases as cells progress towards mitosis. This modification blocks C-terminal interactions between BRCA2 and RAD51. However, DNA damage overcomes cell cycle regulation by decreasing S3291 phosphorylation and stimulating interactions with RAD51. These results indicate that S3291 phosphorylation might provide a molecular switch to regulate RAD51 recombination activity, providing new insight into why BRCA2 C-terminal deletions lead to radiation sensitivity and cancer predisposition.	Canc Res UK, London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Cancer Research UK; Memorial Sloan Kettering Cancer Center	West, SC (corresponding author), Canc Res UK, London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.	stephen.west@cancer.org.uk		West, Stephen/0000-0001-8848-9418; Esashi, Fumiko/0000-0003-0902-2364	Wellcome Trust [101009] Funding Source: Medline; Breast Cancer Now [2002:445] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission); Breast Cancer Now		Aylon Y, 2004, EMBO J, V23, P4868, DOI 10.1038/sj.emboj.7600469; Baumann P, 1997, MUTAT RES-DNA REPAIR, V384, P65, DOI 10.1016/S0921-8777(97)00028-1; Bertwistle D, 1997, CANCER RES, V57, P5485; Bignell G, 1997, HUM MOL GENET, V6, P53, DOI 10.1093/hmg/6.1.53; Bork P, 1996, NAT GENET, V13, P22, DOI 10.1038/ng0596-22; BROWN NR, 1995, STRUCTURE, V3, P1235, DOI 10.1016/S0969-2126(01)00259-3; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Chen CF, 1999, J BIOL CHEM, V274, P32931, DOI 10.1074/jbc.274.46.32931; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Chen PL, 1998, P NATL ACAD SCI USA, V95, P5287, DOI 10.1073/pnas.95.9.5287; Connor F, 1997, NAT GENET, V17, P423, DOI 10.1038/ng1297-423; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Donoho G, 2003, GENE CHROMOSOME CANC, V36, P317, DOI 10.1002/gcc.10148; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Godthelp BC, 2002, ONCOGENE, V21, P5002, DOI 10.1038/sj.onc.1205656; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; JINNO S, 1994, EMBO J, V13, P1549, DOI 10.1002/j.1460-2075.1994.tb06417.x; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Lee M, 2004, ONCOGENE, V23, P865, DOI 10.1038/sj.onc.1207223; Lomonosov M, 2003, GENE DEV, V17, P3017, DOI 10.1101/gad.279003; Marmorstein LY, 1998, P NATL ACAD SCI USA, V95, P13869, DOI 10.1073/pnas.95.23.13869; Mizuta R, 1997, P NATL ACAD SCI USA, V94, P6927, DOI 10.1073/pnas.94.13.6927; Moore JD, 2003, SCIENCE, V300, P987, DOI 10.1126/science.1081418; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Pellegrini L, 2004, TRENDS BIOCHEM SCI, V29, P310, DOI 10.1016/j.tibs.2004.04.009; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Petersen BO, 1999, EMBO J, V18, P396, DOI 10.1093/emboj/18.2.396; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Richardson C, 1998, GENE DEV, V12, P3831, DOI 10.1101/gad.12.24.3831; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Stark JM, 2002, J BIOL CHEM, V277, P20185, DOI 10.1074/jbc.M112132200; Tarsounas M, 2004, PHILOS T R SOC B, V359, P87, DOI 10.1098/rstb.2003.1368; Tarsounas M, 2003, ONCOGENE, V22, P1115, DOI 10.1038/sj.onc.1206263; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Tutt A, 1999, CURR BIOL, V9, P1107, DOI 10.1016/S0960-9822(99)80479-5; Tutt A, 2003, ONCOGENE, V22, P2926, DOI 10.1038/sj.onc.1206522; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Welcsh PL, 2001, HUM MOL GENET, V10, P705, DOI 10.1093/hmg/10.7.705; WEST SC, 2003, NATURE REV MOL CELL, V4, P1, DOI DOI 10.1038/NRM1127; Wohlschlegel JA, 2001, MOL CELL BIOL, V21, P4868, DOI 10.1128/MCB.21.15.4868-4874.2001; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Yu VPCC, 2000, GENE DEV, V14, P1400; Yuan SSF, 1999, CANCER RES, V59, P3547	48	336	346	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2005	434	7033					598	604		10.1038/nature03404	http://dx.doi.org/10.1038/nature03404			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911NN	15800615				2022-12-24	WOS:000228011000035
J	Goddard, MR; Godfray, HCJ; Burt, A				Goddard, MR; Godfray, HCJ; Burt, A			Sex increases the efficacy of natural selection in experimental yeast populations	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; MEIOSIS-I; RECOMBINATION; FITNESS; EVOLUTION; GENE; CHLAMYDOMONAS; PERSPECTIVE; ADAPTATION; MUTATIONS	Why sex evolved and persists is a problem for evolutionary biology, because sex disrupts favourable gene combinations and requires an expenditure of time and energy(1). Further, in organisms with unequal-sized gametes, the female transmits her genes at only half the rate of an asexual equivalent ( the twofold cost of sex)(2). Many modern theories that provide an explanation for the advantage of sex incorporate an idea originally proposed by Weismann more than 100 years ago: sex allows natural selection to proceed more effectively because it increases genetic variation(3-5). Here we test this hypothesis, which still lacks robust empirical support, with the use of experiments on yeast populations. Capitalizing on recent advances in the molecular biology of recombination in yeast, we produced by genetic manipulation strains that differed only in their capacity for sexual reproduction. We show that, as predicted by the theory, sex increases the rate of adaptation to a new harsh environment but has no measurable effect on fitness in a new benign environment where there is little selection.	Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Ascot SL5 7PY, Berks, England	Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); Imperial College London	Goddard, MR (corresponding author), Univ Auckland, Sch Biol Sci, Private Bag 92019, Auckland 1, New Zealand.	m.goddard@auckland.ac.nz	Goddard, Matthew/C-7462-2014	Burt, Austin/0000-0001-5146-9640; Goddard, Matthew/0000-0002-7482-4438				BAGANZ F, 1997, YEAST, V13, P1536; BARTON NH, 1995, GENET RES, V65, P123, DOI 10.1017/S0016672300033140; Barton NH, 1998, SCIENCE, V281, P1986, DOI 10.1126/science.281.5385.1986; Bell G., 1982, MASTERPIECE NATURE; BERRY DR, 1982, BIOL YEASTS; Birdsell J, 1996, P NATL ACAD SCI USA, V93, P908, DOI 10.1073/pnas.93.2.908; Bruggeman J, 2003, GENETICS, V164, P479; Burke D., 2000, METHODS YEAST GENETI; Burt A, 2000, EVOLUTION, V54, P337; BURT A, 1995, EVOLUTION, V49, P1, DOI 10.1111/j.1558-5646.1995.tb05954.x; Colegrave N, 2002, NATURE, V420, P664, DOI 10.1038/nature01191; Goho S, 2000, P ROY SOC B-BIOL SCI, V267, P123, DOI 10.1098/rspb.2000.0976; Greig D, 1998, P ROY SOC B-BIOL SCI, V265, P1017, DOI 10.1098/rspb.1998.0393; GREWAL NS, 1972, CAN J MICROBIOL, V18, P1897, DOI 10.1139/m72-295; Kaltz O, 2002, EVOLUTION, V56, P1743; KLAPHOLZ S, 1985, GENETICS, V110, P187; Marini A, 1999, CURR GENET, V35, P77, DOI 10.1007/s002940050435; Michod R. E., 1988, EVOLUTION SEX EXAMIN; Muller HJ, 1932, AM NAT, V66, P118, DOI 10.1086/280418; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Pinheiro Jose, 2000, MIXED EFFECTS MODELS; Rice WR, 2001, SCIENCE, V294, P555, DOI 10.1126/science.1061380; Rice WR, 2002, NAT REV GENET, V3, P241, DOI 10.1038/nrg760; Shonn MA, 2002, GENE DEV, V16, P1659, DOI 10.1101/gad.975802; STEELE DF, 1991, GENETICS, V127, P53; Wach A, 1998, METHOD MICROBIOL, V26, P67; WANG HT, 1987, MOL CELL BIOL, V7, P1425, DOI 10.1128/MCB.7.4.1425; WEISMANN A, 1904, EVOLUTION THEORY, V2; Zeyl C, 2001, GENETICS, V157, P53	29	312	320	0	271	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 31	2005	434	7033					636	640		10.1038/nature03405	http://dx.doi.org/10.1038/nature03405			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911NN	15800622				2022-12-24	WOS:000228011000043
J	Rappas, M; Schumacher, J; Beuron, F; Niwa, H; Bordes, P; Wigneshweraraj, S; Keetch, CA; Robinson, CV; Buck, M; Zhang, XD				Rappas, M; Schumacher, J; Beuron, F; Niwa, H; Bordes, P; Wigneshweraraj, S; Keetch, CA; Robinson, CV; Buck, M; Zhang, XD			Structural insights into the activity of enhancer-binding proteins	SCIENCE			English	Article							TRANSCRIPTIONAL ACTIVATION; ANGSTROM RESOLUTION; MOLECULAR MACHINE; ESCHERICHIA-COLI; CENTRAL DOMAIN; SIGMA(54); ATPASES; AAA(+); SIGMA-54; NTRC	Activators of bacterial sigma(54)-RNA polymerase holoenzyme are mechanochemical proteins that use adenosine triphosphate (ATP) hydrolysis to activate transcription. We have determined by cryogenic electron microscopy (cryo-EM) a 20 angstrom resolution structure of an activator, phage shock protein IF [PspF((1-275))], which is bound to an ATP transition state analog in complex with its basal factor, sigma(54). By fitting the crystal structure of PspF((1-275)) at 1.75 angstroms into the EM map, we identified two loops involved in binding sigma(54). Comparing enhancer-binding structures in different nucleotide states and mutational analysis led us to propose nucleotide-dependent conformational changes that free the loops for association with sigma(54)..	Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AZ, England; Univ London Imperial Coll Sci Technol & Med, Ctr Struct Biol, London SW7 2AZ, England; Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	Imperial College London; Imperial College London; University of London; Institute of Cancer Research - UK; University of Cambridge	Zhang, XD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AZ, England.	xiaodong.zhang@imperial.ac.uk		Bordes, Patricia/0000-0002-5746-0556; robinson, carol/0000-0001-7829-5505; Zhang, Xiaodong/0000-0001-9786-7038; Wigneshweraraj, Sivaramesh/0000-0002-1418-4029	Biotechnology and Biological Sciences Research Council [B17129] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Beuron F, 2003, J MOL BIOL, V327, P619, DOI 10.1016/S0022-2836(03)00178-5; Bordes P, 2003, P NATL ACAD SCI USA, V100, P2278, DOI 10.1073/pnas.0537525100; Bordes P, 2004, BIOCHEM J, V378, P735, DOI 10.1042/BJ20031464; Buck M, 2000, J BACTERIOL, V182, P4129, DOI 10.1128/JB.182.15.4129-4136.2000; Burrows PC, 2003, J BIOL CHEM, V278, P29728, DOI 10.1074/jbc.M303596200; Cannon W, 2003, J BIOL CHEM, V278, P19815, DOI 10.1074/jbc.M301296200; Cannon WV, 2000, NAT STRUCT BIOL, V7, P594; Chaney M, 2001, GENE DEV, V15, P2282, DOI 10.1101/gad.205501; Furst J, 2003, EMBO J, V22, P4365, DOI 10.1093/emboj/cdg420; Gonzalez V, 1998, MOL MICROBIOL, V28, P55, DOI 10.1046/j.1365-2958.1998.00772.x; Lee DerNan, 1997, Journal of the Chinese Society of Animal Science, V26, P373; Lee SY, 2003, GENE DEV, V17, P2552, DOI 10.1101/gad.1125603; Li JL, 1999, J BACTERIOL, V181, P5443, DOI 10.1128/JB.181.17.5443-5454.1999; Lupas AN, 2002, CURR OPIN STRUC BIOL, V12, P746, DOI 10.1016/S0959-440X(02)00388-3; MORETT E, 1993, J BACTERIOL, V175, P6067, DOI 10.1128/JB.175.19.6067-6074.1993; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Neuwald AF, 1999, GENOME RES, V9, P27; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; POPHAM DL, 1989, SCIENCE, V243, P629, DOI 10.1126/science.2563595; Rombel I, 1998, COLD SPRING HARB SYM, V63, P157, DOI 10.1101/sqb.1998.63.157; Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003; Svergun DI, 2000, J BIOL CHEM, V275, P4210, DOI 10.1074/jbc.275.6.4210; Wang J, 2001, STRUCTURE, V9, P1107, DOI 10.1016/S0969-2126(01)00670-0; Wang YK, 1997, J BACTERIOL, V179, P5812, DOI 10.1128/jb.179.18.5812-5819.1997; WEDEL A, 1995, GENE DEV, V9, P2042, DOI 10.1101/gad.9.16.2042; Xu H, 2001, CURR OPIN MICROBIOL, V4, P138, DOI 10.1016/S1369-5274(00)00179-X; Zhang X, 2002, MOL MICROBIOL, V45, P895, DOI 10.1046/j.1365-2958.2002.03065.x	27	135	139	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2005	307	5717					1972	1975		10.1126/science.1105932	http://dx.doi.org/10.1126/science.1105932			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910UI	15790859	Green Accepted			2022-12-24	WOS:000227957300060
J	Schweitzer, MH; Wittmeyer, JL; Horner, JR; Toporski, JK				Schweitzer, MH; Wittmeyer, JL; Horner, JR; Toporski, JK			Soft-tissue vessels and cellular preservation in Tyrannosaurus rex	SCIENCE			English	Article							DINOSAUR	Soft tissues are preserved within hindlimb elements of Tyrannosaurus rex (Museum of the Rockies specimen 1125). Removal of the mineral phase reveals transparent, flexible, hollow blood vessels containing small round microstructures that can be expressed from the vessels into solution. Some regions of the demineralized bone matrix are highly fibrous, and the matrix possesses elasticity and resilience. Three populations of microstructures have cell-like morphology. Thus, some dinosaurian soft tissues may retain some of their original flexibility, elasticity, and resilience.	N Carolina State Univ, Dept Marine Earth Atmospher Sci, Raleigh, NC 27695 USA; N Carolina State Museum Nat Sci, Raleigh, NC 27601 USA; Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA; Carnegie Inst Sci, Geophys Lab, Washington, DC 20018 USA	University of North Carolina; North Carolina State University; Montana State University System; Montana State University Bozeman; Carnegie Institution for Science	Schweitzer, MH (corresponding author), N Carolina State Univ, Dept Marine Earth Atmospher Sci, Raleigh, NC 27695 USA.	schweitzer@ncsu.edu	schweitzer, mary h/A-6756-2010; Schweitzer, Mary/V-8143-2019	schweitzer, mary h/0000-0002-0427-3829; 				Briggs DEG, 1997, J GEOL SOC LONDON, V154, P587, DOI 10.1144/gsjgs.154.4.0587; Chiappe LM, 1998, NATURE, V396, P258, DOI 10.1038/24370; Dal Sasso C, 1998, NATURE, V392, P383; Hedges REM, 2002, ARCHAEOMETRY, V44, P319, DOI 10.1111/1475-4754.00064; Higby Schweitzer Mary, 1999, Annales de Paleontologie, V85, P179, DOI 10.1016/S0753-3969(99)80013-5; Horner JR, 2004, P ROY SOC B-BIOL SCI, V271, P1875, DOI 10.1098/rspb.2004.2829; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Kellner AWA, 1996, NATURE, V379, P32, DOI 10.1038/379032a0; Martill David M., 1995, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V2, P118; MURPHY NL, 2002, J VERTEBR PALEONTOL, V33, pA91; MUYZER G, 1992, GEOLOGY, V20, P871, DOI 10.1130/0091-7613(1992)020<0871:POTBPO>2.3.CO;2; Pawlicki R, 1998, ANN ANAT, V180, P73, DOI 10.1016/S0940-9602(98)80140-4; PAWLICKI R, 1966, NATURE, V211, P655, DOI 10.1038/211655a0; SCHWEITZER M, UNPUB; Schweitzer MH, 1999, J EXP ZOOL, V285, P146; Schweitzer MH, 1997, P NATL ACAD SCI USA, V94, P6291, DOI 10.1073/pnas.94.12.6291; Sykes GA, 1995, ORG GEOCHEM, V23, P1059, DOI 10.1016/0146-6380(95)00086-0; WEINER S, 1989, APPL GEOCHEM, V4, P231; Wuttke M., 1988, Senckenberg-Buch, V64, P265; Xu X, 1999, NATURE, V401, P262, DOI 10.1038/45769	20	105	127	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2005	307	5717					1952	1955		10.1126/science.1108397	http://dx.doi.org/10.1126/science.1108397			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910UI	15790853				2022-12-24	WOS:000227957300054
J	Sonnenburg, JL; Xu, J; Leip, DD; Chen, CH; Westover, BP; Weatherford, J; Buhler, JD; Gordon, JI				Sonnenburg, JL; Xu, J; Leip, DD; Chen, CH; Westover, BP; Weatherford, J; Buhler, JD; Gordon, JI			Glycan foraging in vivo by an intestine-adapted bacterial symbiont	SCIENCE			English	Article							HOST-MICROBIAL INTERACTIONS; BACTEROIDES-THETAIOTAOMICRON; ECOSYSTEM; ENVIRONMENT; COMMENSAL; STARCH	Germ-free mice were maintained on polysaccharide-rich or simple-sugar diets and colonized for 10 days with an organism also found in human guts, Bacteroides thetaiotaomicron, followed by whole-genome transcriptional profiling of bacteria and mass spectrometry of cecal glycans. We found that these bacteria assembled on food particles and mucus, selectively induced outer-membrane polysaccharide-binding proteins and glycoside hydrolases, prioritized the consumption of liberated hexose sugars, and revealed a capacity to turn to host mucus glycans when polysaccharides were absent from the diet. This flexible foraging behavior should contribute to ecosystem stability and functional diversity.	Washington Univ, Ctr Genome Sci, St Louis, MO 63108 USA; Washington Univ, Dept Mol Biol & Pharmacol, St Louis, MO 63108 USA; Washington Univ, Dept Comp Sci & Engn, St Louis, MO 63108 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Gordon, JI (corresponding author), Washington Univ, Ctr Genome Sci, St Louis, MO 63108 USA.	jgordon@molecool.wustl.edu	Xu, Jian/A-6831-2008; Xu, Jian/G-8430-2012	Xu, Jian/0000-0002-0548-8477	NIDDK NIH HHS [DK052574, DK30292] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030292, P30DK052574, R37DK030292] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Cho KH, 2001, J BACTERIOL, V183, P7198, DOI 10.1128/JB.183.24.7198-7205.2001; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; MOORE WEC, 1974, APPL MICROBIOL, V27, P961, DOI 10.1128/AEM.27.5.961-979.1974; SALYERS AA, 1979, AM J CLIN NUTR, V32, P158, DOI 10.1093/ajcn/32.1.158; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Shipman JA, 2000, J BACTERIOL, V182, P5365, DOI 10.1128/JB.182.19.5365-5372.2000; Sonnenburg JL, 2004, NAT IMMUNOL, V5, P569, DOI 10.1038/ni1079; WESTOVER BP, 2004, BIOINFORMATICS  1111; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	16	778	815	8	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2005	307	5717					1955	1959		10.1126/science.1109051	http://dx.doi.org/10.1126/science.1109051			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910UI	15790854				2022-12-24	WOS:000227957300055
J	Elefteriou, F; Ahn, JD; Takeda, S; Starbuck, M; Yang, XL; Liu, XY; Kondo, H; Richards, WG; Bannon, TW; Noda, M; Clement, K; Vaisse, C; Karsenty, G				Elefteriou, F; Ahn, JD; Takeda, S; Starbuck, M; Yang, XL; Liu, XY; Kondo, H; Richards, WG; Bannon, TW; Noda, M; Clement, K; Vaisse, C; Karsenty, G			Leptin regulation of bone resorption by the sympathetic nervous system and CART	NATURE			English	Article							TARGETED DISRUPTION; MICE; ACTIVATION; ELEMENTS; OBESITY; CELLS; GENE	Bone remodelling, the mechanism by which vertebrates regulate bone mass, comprises two phases, namely resorption by osteoclasts and formation by osteoblasts; osteoblasts are multifunctional cells also controlling osteoclast differentiation. Sympathetic signalling via beta 2-adrenergic receptors (Adrb2) present on osteoblasts controls bone formation downstream of leptin(1). Here we show, by analysing Adrb2-deficient mice, that the sympathetic nervous system favours bone resorption by increasing expression in osteoblast progenitor cells of the osteoclast differentiation factor Rankl. This sympathetic function requires phosphorylation ( by protein kinase A) of ATF4, a cell-specific CREB-related transcription factor essential for osteoblast differentiation and function(2). That bone resorption cannot increase in gonadectomized Adrb2-deficient mice highlights the biological importance of this regulation, but also contrasts sharply with the increase in bone resorption characterizing another hypogonadic mouse with low sympathetic tone, the ob/ob mouse(3). This discrepancy is explained, in part, by the fact that CART ('cocaine amphetamine regulated transcript'), a neuropeptide whose expression is controlled by leptin and nearly abolished in ob/ob mice(4), inhibits bone resorption by modulating Rankl expression. Our study establishes that leptin-regulated neural pathways control both aspects of bone remodelling, and demonstrates that integrity of sympathetic signalling is necessary for the increase in bone resorption caused by gonadal failure.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Bone Dis Program Texas, Houston, TX 77030 USA; Baylor Coll Med, Childrens Nutr Res Ctr, Houston, TX 77030 USA; Tokyo Med & Dent Univ, Dept Orthoped, Tokyo 1010062, Japan; Tokyo Med & Dent Univ, Ctr Excellence Program Frontier Res Mol Destruct, Tokyo 1010062, Japan; Tokyo Med & Dent Univ, Dept Mol Pharmacol, Med Res Inst, Tokyo 1010062, Japan; Amgen Inc, Neurosci, Thousand Oaks, CA 91320 USA; CHRU Pitie Salpetriere, Hotel Dieu, Dept Nutr, F-75004 Paris, France; Univ Paris 06, INSERM, Avenir Team, EA3502, F-75004 Paris, France; Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Amgen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Karsenty, G (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	karsenty@bcm.tmc.edu	Clément, karine/R-1120-2017; Elefteriou, Florent/P-2586-2017; Vaisse, Christian/F-1067-2011; takeda, shu/B-5195-2012; Elefteriou, Florent/GMW-8429-2022	Elefteriou, Florent/0000-0002-2972-5633; Elefteriou, Florent/0000-0002-2972-5633; Elefteriou, Xiangli/0000-0002-2333-8747	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060540] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK060540] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Asnicar MA, 2001, ENDOCRINOLOGY, V142, P4394, DOI 10.1210/en.142.10.4394; BERKOWITZ LA, 1989, MOL CELL BIOL, V9, P4272, DOI 10.1128/MCB.9.10.4272; Chruscinski AJ, 1999, J BIOL CHEM, V274, P16694, DOI 10.1074/jbc.274.24.16694; Dominici M, 2004, P NATL ACAD SCI USA, V101, P11761, DOI 10.1073/pnas.0404626101; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; ORWOLL B, 2004, ORS AAOS PRESENTATIO; Rohrer DK, 1999, J BIOL CHEM, V274, P16701, DOI 10.1074/jbc.274.24.16701; Satoh N, 1999, DIABETES, V48, P1787, DOI 10.2337/diabetes.48.9.1787; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; THOMAS SA, 1995, NATURE, V374, P643, DOI 10.1038/374643a0; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7	18	890	959	3	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2005	434	7032					514	520		10.1038/nature03398	http://dx.doi.org/10.1038/nature03398			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909CH	15724149				2022-12-24	WOS:000227836000044
J	Lin, DY; Zhang, SZ; Block, E; Katz, LC				Lin, DY; Zhang, SZ; Block, E; Katz, LC			Encoding social signals in the mouse main olfactory bulb	NATURE			English	Article							GAS-CHROMATOGRAPHY; ODORANT RECEPTORS; HOUSE MOUSE; VOLATILE COMPOUNDS; MASS-SPECTROMETRY; FEMALE MICE; BODY ODORS; PHEROMONE; URINE; DISCRIMINATION	Mammalian urine releases complex mixtures of volatile compounds that are used in reproduction, territoriality and conspecific recognition. To understand how such complex mixtures are represented in the main olfactory bulb, we analysed the electrophysiological responses of individual mitral cells to volatile compounds in mouse urine. In both males and females, urine volatile compounds evoke robust responses in a small subset of mitral cells. Fractionation of the volatile compounds using gas chromatography showed that out of the hundreds of compounds present, mitral cells are activated by single compounds. One cohort of mitral cells responded exclusively to male urine; these neurons were activated by ( methylthio) methanethiol, a potent, previously unknown semiochemical present only in male urine. When added to urine, synthetic ( methylthio) methanethiol significantly enhances urine attractiveness to female mice. We conclude that mitral cells represent natural odorant stimuli by acting as selective feature detectors, and that their activation is largely independent of the presence of other components in the olfactory stimulus.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; SUNY Albany, Dept Chem, Albany, NY 12222 USA	Duke University; Howard Hughes Medical Institute; Duke University; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Lin, DY (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Box 3209, Durham, NC 27710 USA.	dayulin@neuro.duke.edu	Block, Eric/D-3989-2014	Block, Eric/0000-0002-4668-1687; Lin, Dayu/0000-0003-2006-0791				ANDREOLINI F, 1987, EXPERIENTIA, V43, P998, DOI 10.1007/BF01952217; Baek HH, 2004, FOOD SCI BIOTECHNOL, V13, P90; BALDWIN BA, 1974, ANIM BEHAV, V22, P220, DOI 10.1016/S0003-3472(74)80072-2; Belluscio L, 2002, NATURE, V419, P296, DOI 10.1038/nature01001; Bocchini P, 1999, RAPID COMMUN MASS SP, V13, P2133, DOI 10.1002/(SICI)1097-0231(19991115)13:21<2133::AID-RCM764>3.0.CO;2-J; Brennan PA, 2004, CURR BIOL, V14, pR81, DOI 10.1016/j.cub.2003.12.052; Brody CD, 2003, NEURON, V37, P843, DOI 10.1016/S0896-6273(03)00120-X; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Contarini G, 2002, J AGR FOOD CHEM, V50, P7350, DOI 10.1021/jf025713a; DOTY RL, 1982, HORM BEHAV, V16, P13, DOI 10.1016/0018-506X(82)90002-2; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Friedrich RW, 2004, NAT NEUROSCI, V7, P862, DOI 10.1038/nn1292; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Fu SG, 2002, J AGR FOOD CHEM, V50, P549, DOI 10.1021/jf010883t; GALEF BG, 1988, PHYSIOL BEHAV, V42, P119, DOI 10.1016/0031-9384(88)90285-5; HARVEY S, 1989, J CHEM ECOL, V15, P2061, DOI 10.1007/BF01207438; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; JEMIOLO B, 1991, J CHEM ECOL, V17, P353, DOI 10.1007/BF00994338; Kayali-Sayadi MN, 2003, J CHROMATOGR B, V796, P55, DOI 10.1016/j.jchromb.2003.08.001; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Lee SN, 2003, ANAL BIOANAL CHEM, V377, P749, DOI 10.1007/s00216-003-2163-z; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Lin WH, 2004, J NEUROSCI, V24, P3703, DOI 10.1523/JNEUROSCI.0188-04.2004; Lodovichi C, 2003, NEURON, V38, P265, DOI 10.1016/S0896-6273(03)00194-6; LOUCH D, 1992, ANAL CHEM, V64, P1187, DOI 10.1021/ac00034a020; MIYASHITA K, 1980, MECH AGEING DEV, V13, P177, DOI 10.1016/0047-6374(80)90060-3; MORI K, 1995, CURR OPIN NEUROBIOL, V5, P467, DOI 10.1016/0959-4388(95)80007-7; Motokizawa F, 1996, EXP BRAIN RES, V112, P24; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; NOVOTNY M, 1984, EXPERIENTIA, V40, P217, DOI 10.1007/BF01963608; NOVOTNY M, 1990, EXPERIENTIA, V46, P109, DOI 10.1007/BF01955433; Novotny MV, 1999, CHEM BIOL, V6, P377, DOI 10.1016/S1074-5521(99)80049-0; Schaal B, 2003, NATURE, V424, P68, DOI 10.1038/nature01739; Schaefer ML, 2001, J NEUROSCI, V21, P2481, DOI 10.1523/JNEUROSCI.21-07-02481.2001; Schaefer ML, 2002, J NEUROSCI, V22, P9513; SCHUTTE L, 1971, TETRAHEDRON LETT, P2321; SCHWENDE FJ, 1986, J CHEM ECOL, V12, P277, DOI 10.1007/BF01045611; SCOTT JW, 1970, PHYSIOL BEHAV, V5, P407, DOI 10.1016/0031-9384(70)90243-X; SHINODA K, 1989, J COMP NEUROL, V284, P362, DOI 10.1002/cne.902840304; SINGER AG, 1976, SCIENCE, V191, P948, DOI 10.1126/science.1251205; Stensmyr MC, 2003, J EXP BIOL, V206, P715, DOI 10.1242/jeb.00143; TANABE T, 1975, J NEUROPHYSIOL, V38, P1284, DOI 10.1152/jn.1975.38.5.1284; Torrens J, 2004, J CHROMATOGR SCI, V42, P310, DOI 10.1093/chromsci/42.6.310; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; WADHAMS LJ, 1982, Z NATURFORSCH C, V37, P947; WALLACE P, 1977, PHYSIOL BEHAV, V19, P577, DOI 10.1016/0031-9384(77)90238-4; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Weruaga E, 2001, CHEM SENSES, V26, P7, DOI 10.1093/chemse/26.1.7; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; YAMAGUCHI M, 1981, P NATL ACAD SCI-BIOL, V78, P5817, DOI 10.1073/pnas.78.9.5817	50	315	327	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2005	434	7032					470	477		10.1038/nature03414	http://dx.doi.org/10.1038/nature03414			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909CH	15724148				2022-12-24	WOS:000227836000033
J	Ho, LP; Urban, BC; Thickett, DR; Davies, RJO; McMichael, AJ				Ho, LP; Urban, BC; Thickett, DR; Davies, RJO; McMichael, AJ			Deficiency of a subset of T cells with immunoregulatory properties in sarcoidosis	LANCET			English	Article							NKT CELLS; AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; T(H)2 BIAS; EXPRESSION; ACTIVATION; PREVENTS; IL-12; LYMPHOCYTES	Background Sarcoidosis is a multisystem disorder that predominantly involves the lungs, characterised by a T-helper-1 (Th1) biased CD4-positive T-cell response and granuloma formation, for which the explanation is unknown. A newly identified subset of T cells with immunoregulatory functions, CD1d-restricted natural-killer T (NKT) cells, has been shown to protect against disorders with increased CD4-positive Th1 responses in animals. We explored whether abnormalities in these cells are implicated in the pathogenesis of sarcoidosis. Methods We generated fluorescence-labelled CD1d-tetrameric complexes and used them, with monoclonal antibodies to V alpha 24 and V beta 11 T-cell receptor, to assess the frequency of CD1d-restricted NKT cells in the peripheral blood of 60 patients with histologically proven sarcoidosis (16 with Lofgren's syndrome) and 60 healthy controls. Lung lymphocytes were also analysed in 16 of the patients with sarcoidosis. Findings CD1d-restricted NKT cells were absent or greatly reduced in peripheral blood from all patients with sarcoidosis, except those with Lofgren's syndrome (median proportion of lymphocytes 0.01% [IQR 0-0.03] vs 0.06% [0.03-0.12] in controls; p=0.0004). The deficiency was found in both acute and resolved disease and was unrelated to systemic corticosteroid therapy. There was no difference in the proportion of CD1d-restricted NKT cells between peripheral blood and lungs in patients, suggesting that the peripheral-blood deficiency is not due to sequestration of these cells in the lungs. The NKT cells were not observed in mediastinal lymph nodes or granulomatous lesions. CD1d expression on antigen-presenting cells of patients was normal, thus the deficiency of CD1d-restricted NKT cells is not explained by abnormal CD1d expression. Interpretation Loss of immunoregulation by CD1d-restricted NKT cells could explain the amplified and persistent T-cell activity that characterises sarcoidosis. Relevance to practice Our findings give new insight into the pathogenesis of sarcoidosis and draw attention to a potential target for therapeutic modulation in sarcoidosis.	John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 7DS, England; Churchill Hosp, Oxford Ctr Resp Med, Oxford OX3 7LJ, England; Univ Birmingham, Dept Med Sci, Lung Injury & Fibrosis Treatment Programme, Birmingham, W Midlands, England	University of Oxford; University of Oxford; University of Birmingham	Ho, LP (corresponding author), John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 7DS, England.		Urban, Britta/W-6087-2018; Ho, Ling-Pei/AAL-4776-2021; thickett, david/I-4770-2012	Urban, Britta/0000-0002-4197-8393; thickett, david/0000-0002-5456-6080; Ho, Ling Pei/0000-0001-8319-301X				Agostini C, 2002, CURR OPIN PULM MED, V8, P435, DOI 10.1097/00063198-200209000-00016; [Anonymous], 1999, Am J Respir Crit Care Med, V160, P736; Araki M, 2003, INT IMMUNOL, V15, P279, DOI 10.1093/intimm/dxg029; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Carnaud C, 1999, J IMMUNOL, V163, P4647; Galli G, 2003, J EXP MED, V197, P1051, DOI 10.1084/jem.20021616; Gansert JL, 2003, J IMMUNOL, V170, P3154, DOI 10.4049/jimmunol.170.6.3154; Gillessen S, 2003, P NATL ACAD SCI USA, V100, P8874, DOI 10.1073/pnas.1033098100; Ho LP, 2004, J IMMUNOL, V172, P7350, DOI 10.4049/jimmunol.172.12.7350; Ho LP, 2002, CHEST, V121, P1421, DOI 10.1378/chest.121.5.1421; Hong S, 2001, NAT MED, V7, P1052, DOI 10.1038/nm0901-1052; Hosoda Y, 1997, CLIN CHEST MED, V18, P681, DOI 10.1016/S0272-5231(05)70412-3; Illes Z, 2000, J IMMUNOL, V164, P4375, DOI 10.4049/jimmunol.164.8.4375; Karadimitris A, 2001, P NATL ACAD SCI USA, V98, P3294, DOI 10.1073/pnas.051604498; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; KONISHI K, 1988, J CLIN INVEST, V82, P775, DOI 10.1172/JCI113678; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Moller DR, 1996, J IMMUNOL, V156, P4952; Olivares-Villagomez D, 1998, J EXP MED, V188, P1883, DOI 10.1084/jem.188.10.1883; Park SH, 2001, J EXP MED, V193, P893, DOI 10.1084/jem.193.8.893; POWRIE F, 1995, IMMUNITY, V3, P171, DOI 10.1016/1074-7613(95)90086-1; Sharif S, 2001, NAT MED, V7, P1057, DOI 10.1038/nm0901-1057; Shigehara K, 2001, J IMMUNOL, V166, P642, DOI 10.4049/jimmunol.166.1.642; SILTZBACH LE, 1967, MED CLIN N AM, V51, P483, DOI 10.1016/S0025-7125(16)33069-3; Singh AK, 2001, J EXP MED, V194, P1801, DOI 10.1084/jem.194.12.1801; Spagnolo P, 2003, AM J RESP CRIT CARE, V168, P1162, DOI 10.1164/rccm.200303-456OC; Taha RA, 1999, AM J RESP CRIT CARE, V160, P1119, DOI 10.1164/ajrccm.160.4.9807120; Urban BC, 1999, NATURE, V400, P73, DOI 10.1038/21900; Van de Keere F, 1998, J EXP MED, V188, P1875, DOI 10.1084/jem.188.10.1875; Vincent MS, 2003, NAT IMMUNOL, V4, P517, DOI 10.1038/ni0603-517; Wilson SB, 1998, NATURE, V391, P177, DOI 10.1038/34419; Yang OO, 2000, J IMMUNOL, V165, P3756, DOI 10.4049/jimmunol.165.7.3756	34	68	70	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2005	365	9464					1062	1072		10.1016/S0140-6736(05)71143-0	http://dx.doi.org/10.1016/S0140-6736(05)71143-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907QB	15781102				2022-12-24	WOS:000227731800031
J	Liu, XG; Zhang, Y; Goswami, DK; Okasinski, JS; Salaita, K; Sun, P; Bedzyk, MJ; Mirkin, CA				Liu, XG; Zhang, Y; Goswami, DK; Okasinski, JS; Salaita, K; Sun, P; Bedzyk, MJ; Mirkin, CA			The controlled evolution of a polymer single crystal	SCIENCE			English	Article							DIP-PEN NANOLITHOGRAPHY; ATOMIC-FORCE MICROSCOPY; X-RAY-DIFFRACTION; ELECTROCHEMICAL NUCLEATION; GROWTH; MONOLAYERS; CRYSTALLIZATION; SURFACES; PARALLEL; PROBE	We present a method for controlling the initiation and kinetics of polymer crystal growth using dip-pen nanolithography and an atomic force microscope tip coated with poly-DL-lysine hydrobromide. Triangular prisms of the polymer epitaxially grow on freshly cleaved mica substrates, and their in-plane and out-of-plane growth rates can be controlled by raster scanning the coated tip across the substrate. Atomic force microscope images were concomitantly recorded, providing a set of photographic images of the process as it spans the nanometer-to micrometer-length scales as a function of environmental conditions.	Northwestern Univ, Dept Mat Sci & Engn, Inst Nanotechnol, Evanston, IL 60208 USA; Northwestern Univ, Nanoscale Sci & Engn Ctr, Evanston, IL 60208 USA; Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University	Mirkin, CA (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, Inst Nanotechnol, Evanston, IL 60208 USA.	camirkin@chem.northwestern.edu	Bedzyk, Michael J/K-6903-2013; LIU, XIAOGANG/A-8038-2011; salaita, khalid/C-4414-2008; Goswami, Dipak Kumar/AAR-4656-2021; Goswami, Dipak K/E-8186-2011; Bedzyk, Michael J/B-7503-2009; Mirkin, Chad A/E-3911-2010	LIU, XIAOGANG/0000-0003-2517-5790; Goswami, Dipak Kumar/0000-0002-5891-6172; Goswami, Dipak K/0000-0002-5891-6172; Mirkin, Chad/0000-0002-6634-7627	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062109] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62109-02] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwal G, 2003, J AM CHEM SOC, V125, P580, DOI 10.1021/ja020471g; Barsotti RJ, 2004, LANGMUIR, V20, P4795, DOI 10.1021/la049763g; Bullen D, 2004, APPL PHYS LETT, V84, P789, DOI 10.1063/1.1644317; Dzwolak W, 2004, J AM CHEM SOC, V126, P3762, DOI 10.1021/ja039138i; Empedocles SA, 1997, SCIENCE, V278, P2114, DOI 10.1126/science.278.5346.2114; Fransaer JL, 1999, J PHYS CHEM B, V103, P7643, DOI 10.1021/jp990622a; Ginger DS, 2004, ANGEW CHEM INT EDIT, V43, P30, DOI 10.1002/anie.200300608; HILLIER AC, 1994, SCIENCE, V263, P1261, DOI 10.1126/science.263.5151.1261; Hobbs JK, 2001, MACROMOLECULES, V34, P353, DOI 10.1021/ma001697b; Hong SH, 2000, SCIENCE, V288, P1808, DOI 10.1126/science.288.5472.1808; Hooks DE, 1998, J PHYS CHEM B, V102, P9958, DOI 10.1021/jp982851n; Horber JKH, 2003, SCIENCE, V302, P1002, DOI 10.1126/science.1067410; JACOBSON BS, 1977, SCIENCE, V195, P302, DOI 10.1126/science.831278; KERN R, 1989, NATO ADV SCI I B-PHY, P143; LAND TA, 1995, PHYS REV LETT, V75, P2774, DOI 10.1103/PhysRevLett.75.2774; LANDAU EM, 1985, NATURE, V318, P353, DOI 10.1038/318353a0; Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0; Maynor BW, 2004, J AM CHEM SOC, V126, P6409, DOI 10.1021/ja0317832; McCrone WC., 1965, PHYSICS CHEM ORGANIC, P726; Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661; Pluth JJ, 1997, P NATL ACAD SCI USA, V94, P12263, DOI 10.1073/pnas.94.23.12263; RATNER B, 1998, ACS S SERIES; Sanz N, 2004, LANGMUIR, V20, P5989, DOI 10.1021/la036385r; Teng HH, 1998, SCIENCE, V282, P724, DOI 10.1126/science.282.5389.724; Walko DA, 2004, AIP CONF PROC, V705, P1166, DOI 10.1063/1.1758007; Ward MD, 2001, CHEM REV, V101, P1697, DOI 10.1021/cr000020j; Yin YD, 2004, SCIENCE, V304, P711, DOI 10.1126/science.1096566	27	92	95	4	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2005	307	5716					1763	1766		10.1126/science.1109487	http://dx.doi.org/10.1126/science.1109487			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774755				2022-12-24	WOS:000227883900041
J	Jing, Q; Huang, S; Guth, S; Zarubin, T; Motoyama, A; Chen, JM; Di Padova, F; Lin, SC; Gram, H; Han, JH				Jing, Q; Huang, S; Guth, S; Zarubin, T; Motoyama, A; Chen, JM; Di Padova, F; Lin, SC; Gram, H; Han, JH			Involvement of MicroRNA in AU-rich element-mediated mRNA instability	CELL			English	Article							BINDING-PROTEIN; INTERFERENCE; SEQUENCE; CLONING; EXOSOME; HUR; TRISTETRAPROLIN; IDENTIFICATION; DEADENYLATION; TRANSLATION	AU-rich elements (AREs) in the 3' untranslated region (UTR) of unstable mRNAs dictate their degradation. An RNAi-based screen performed in Drosophila S2 cells has revealed that Dicer1, Argonaute1 (Ago1) and Ago2, components involved in microRNA (miRNA) processing and function, are required for the rapid decay of mRNA containing AREs of tumor necrosis factor-a. The requirement for Dicer in the instability of ARE-containing mRNA (ARE-RNA) was confirmed in HeLa cells. We further observed that miR16, a human miRNA containing an UAAAUAUU sequence that is complementary to the ARE sequence, is required for ARE-RNA turnover. The role of miR16 in ARE-RNA decay is sequence-specific and requires the ARE binding protein tristetraprolin (TTP). TTP does not directly bind to miR16 but interacts through association with Ago/eiF2C family members to complex with miR16 and assists in the targeting of ARE. miRNA targeting of ARE, therefore, appears to be an essential step in ARE-mediated mRNA degradation.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Novartis Inst Biomed Res, CH-4002 Basel, Switzerland; Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China	Scripps Research Institute; Novartis; Hong Kong University of Science & Technology	Han, JH (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jhan@scripps.edu	Motoyama, Andrea/AAB-9362-2019; Lin, SC/G-4666-2010; Han, J/G-4671-2010; Jing, Qing/F-6752-2016	Jing, Qing/0000-0001-9834-1214; Guth-Gundel, Sabine/0000-0001-9115-1397	NATIONAL CANCER INSTITUTE [R01CA093926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054796, R01AI041637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067101] Funding Source: NIH RePORTER; NCI NIH HHS [CA93926] Funding Source: Medline; NIAID NIH HHS [AI41637, AI054796] Funding Source: Medline; NIGMS NIH HHS [GM67101] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bakheet T, 2001, NUCLEIC ACIDS RES, V29, P246, DOI 10.1093/nar/29.1.246; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; CHEN CYA, 1994, MOL CELL BIOL, V14, P8471, DOI 10.1128/MCB.14.12.8471; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Doi N, 2003, CURR BIOL, V13, P41, DOI 10.1016/S0960-9822(02)01394-5; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Gueydan C, 1999, J BIOL CHEM, V274, P2322, DOI 10.1074/jbc.274.4.2322; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Michel SLJ, 2003, BIOCHEMISTRY-US, V42, P4626, DOI 10.1021/bi034073h; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Mukherjee D, 2002, EMBO J, V21, P165, DOI 10.1093/emboj/21.1.165; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Saxena S, 2003, J BIOL CHEM, V278, P44312, DOI 10.1074/jbc.M307089200; Sempere LF, 2002, DEV BIOL, V244, P170, DOI 10.1006/dbio.2002.0594; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Shyu AB, 2000, CELL, V102, P135, DOI 10.1016/S0092-8674(00)00018-0; Stoecklin G, 2002, EMBO J, V21, P4709, DOI 10.1093/emboj/cdf444; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Tran H, 2004, MOL CELL, V13, P101, DOI 10.1016/S1097-2765(03)00481-7; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652; Zhu W, 2001, AM J PHYSIOL-LUNG C, V281, pL499, DOI 10.1152/ajplung.2001.281.2.L499	45	673	740	4	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 11	2005	120	5					623	634		10.1016/j.cell.2004.12.038	http://dx.doi.org/10.1016/j.cell.2004.12.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766526	Bronze			2022-12-24	WOS:000227771400009
J	Su, H; Bidere, N; Zheng, LX; Cubre, A; Sakai, K; Dale, J; Salmena, L; Hakem, R; Straus, S; Lenardo, M				Su, H; Bidere, N; Zheng, LX; Cubre, A; Sakai, K; Dale, J; Salmena, L; Hakem, R; Straus, S; Lenardo, M			Requirement for caspase-8 in NF-kappa B activation by antigen receptor	SCIENCE			English	Article							MALT1; BCL10; THETA	Caspase-8, a proapoptotic protease, has an essential role in lymphocyte activation and protective immunity. We show that caspase-8 deficiency (CED) in humans and mice specifically abolishes activation of the transcription factor nuclear factor kappaB (NF-kappaB) after stimulation through antigen receptors, Fc receptors, or Toll-like receptor 4 in T, B, and natural killer cells. Caspase-8 also causes the up complex of the inhibitor of NF-kappaB kinase (IKK) to associate with the upstream Bcl10-MALT1 (mucosa-associated lymphatic tissue) adapter complex. Recruitment of the IKKalpha,beta complex, its activation, and the nuclear translocation of NF-kappaB require enzyme activity of full-length caspase-8. These findings thus explain the paradoxical association of defective apoptosis and combined immunodeficiency in human CED.	NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Toronto; University Toronto Affiliates; University Health Network Toronto	Lenardo, M (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	lenardo@nih.gov	Bidère, Nicolas/K-8887-2015; Su, Helen C/H-9541-2015; sakai, Keiko/F-5807-2013	Bidère, Nicolas/0000-0001-9177-0008; Su, Helen C/0000-0002-5582-9110; Hakem, Razqallah/0000-0001-5948-7931; Salmena, Leonardo/0000-0003-4023-658X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000769, Z01AI000732, Z01AI000565, ZIAAI000732, ZIAAI000565, ZIAAI000769] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Donepudi M, 2003, MOL CELL, V11, P543, DOI 10.1016/S1097-2765(03)00059-5; Falk M, 2004, J IMMUNOL, V173, P5077, DOI 10.4049/jimmunol.173.8.5077; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lin X, 2000, MOL CELL BIOL, V20, P2933, DOI 10.1128/MCB.20.8.2933-2940.2000; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Lucas PC, 2004, J CELL SCI, V117, P31, DOI 10.1242/jcs.00904; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Sneller MC, 1997, BLOOD, V89, P1341, DOI 10.1182/blood.V89.4.1341; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Yu L, 2003, SCIENCE, V302, P1515, DOI 10.1126/science.1092951; Zarnegar B, 2004, P NATL ACAD SCI USA, V101, P8108, DOI 10.1073/pnas.0402629101; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	21	338	363	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1465	1468		10.1126/science.1104765	http://dx.doi.org/10.1126/science.1104765			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746428	Green Published			2022-12-24	WOS:000227503100047
J	Veneti, Z; Bentley, JK; Koana, T; Braig, HR; Hurst, GDD				Veneti, Z; Bentley, JK; Koana, T; Braig, HR; Hurst, GDD			A functional dosage compensation complex required for male killing in Drosophila	SCIENCE			English	Article							SEX; MELANOGASTER; GENE; WILLISTONI	Bacteria that selectively kilt males ("male-killers") were first characterized more than 50 years ago in Drosophila and have proved to be common in insects. However, the mechanism by which sex specificity of virulence is achieved has remained unknown. We tested the ability of Spiroplasma poulsonii to kill Drosophila melanogaster mates carrying mutations in genes that encode the dosage compensation complex. The bacterium failed to kill mates lacking any of the five protein components of the complex.	UCL, Dept Biol, London NW1 2HE, England; Cent Res Inst Elect Power Ind, Low Dose Radiat Res Ctr, Tokyo 2018511, Japan; Univ Wales, Sch Biol Sci, Bangor LL57 2UW, Gwynedd, Wales	University of London; University College London; Central Research Institute of Electric Power Industry - Japan; Bangor University	Hurst, GDD (corresponding author), UCL, Dept Biol, Wolfson House,4 Stephenson Way, London NW1 2HE, England.	g.hurst@ucl.ac.uk	Hurst, Gregory D D/C-2723-2008; Braig, Henk/I-5477-2013	Hurst, Gregory D D/0000-0002-7163-7784; Braig, Henk/0000-0001-9592-1141				CLINE TW, 1984, GENETICS, V107, P231; COUNCE SJ, 1962, J EXP ZOOL, V151, P17, DOI 10.1002/jez.1401510103; Dyson EA, 2004, P NATL ACAD SCI USA, V101, P6520, DOI 10.1073/pnas.0304068101; Franke A, 1996, DEVELOPMENT, V122, P2751; Gilfillan GD, 2004, FEBS LETT, V567, P8, DOI 10.1016/j.febslet.2004.03.110; Hilfiker A, 1997, EMBO J, V16, P2054, DOI 10.1093/emboj/16.8.2054; Hurst GDD, 2000, EMERG INFECT DIS, V6, P329, DOI 10.3201/eid0604.000402; Hurst GDD, 2003, CONT T ENT, P177; Jiggins FM, 2000, P ROY SOC B-BIOL SCI, V267, P69, DOI 10.1098/rspb.2000.0968; MAGNI GE, 1953, NATURE, V172, P81, DOI 10.1038/172081a0; SAKAGUCHI B, 1963, GENETICS, V48, P841; SANCHEZ L, 1983, EMBO J, V2, P485, DOI 10.1002/j.1460-2075.1983.tb01451.x; ZHOU SB, 1995, EMBO J, V14, P2884, DOI 10.1002/j.1460-2075.1995.tb07288.x	13	74	75	3	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1461	1463		10.1126/science.1107182	http://dx.doi.org/10.1126/science.1107182			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746426				2022-12-24	WOS:000227503100045
J	Bertram, L; Hiltunen, M; Parkinson, M; Ingelsson, M; Lange, C; Ramasamy, K; Mullin, K; Menon, R; Sampson, AJ; Hsiao, MY; Elliott, KJ; Velicelebi, G; Moscarillo, T; Hyman, BT; Wagner, SL; Becker, KD; Blacker, D; Tanzi, RE				Bertram, L; Hiltunen, M; Parkinson, M; Ingelsson, M; Lange, C; Ramasamy, K; Mullin, K; Menon, R; Sampson, AJ; Hsiao, MY; Elliott, KJ; Velicelebi, G; Moscarillo, T; Hyman, BT; Wagner, SL; Becker, KD; Blacker, D; Tanzi, RE			Family-based association between Alzheimer's disease and variants in UBQLN1	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							APOLIPOPROTEIN-E; LINKAGE; PROTEIN; ALLELE; TESTS; ONSET; UBIQUILIN; AGE; UBIQUITINATION; ACCUMULATION	BACKGROUND Recent analyses suggest that the known Alzheimer's disease genes account for less than half the genetic variance in this disease. The gene encoding ubiquilin 1 (UBQLN1) is one of several candidate genes for Alzheimer's disease located near a well-established linkage peak on chromosome 9q22. METHODS We evaluated 19 single-nucleotide polymorphisms in three genes within the chromosome 9q linkage region in 437 multiplex families with Alzheimer's disease from the National Institute of Mental Health (NIMH) sample (1439 subjects). We then tested the single-nucleotide polymorphisms showing a positive result in an independently identified set of 217 sibships discordant for Alzheimer's disease (Consortium on Alzheimer's Genetics [CAG] sample; 489 subjects) and assessed the functional effect of an implicated single-nucleotide polymorphism in brain tissue from 25 patients with Alzheimer's disease and 17 controls. RESULTS In the NIMH sample, we observed a significant association between Alzheimer's disease and various single-nucleotide polymorphisms in UBQLN1. We confirmed these associations in the CAG sample. The risk-conferring haplotype in both samples was defined by a single intronic single-nucleotide polymorphism located downstream of exon 8. The risk allele was associated with a dose-dependent increase in an alternatively spliced UBQLN1 (lacking exon 8) transcript in RNA extracted from brain samples of patients with Alzheimer's disease. CONCLUSIONS Our findings suggest that genetic variants in UBQLN1 on chromosome 9q22 substantially increase the risk of Alzheimer's disease, possibly by influencing alternative splicing of this gene in the brain.	Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Genet & Aging Res Unit, Charlestown, MA USA; Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Alzheimer Dis Res Unit, Charlestown, MA USA; Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA; Massachusetts Gen Hosp, Dept Psychiat, Gerontol Res Unit, Charlestown, MA USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Neurogenetics, La Jolla, CA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Tanzi, RE (corresponding author), MGH E, MIND, Genet & Aging Res Unit, 114 16th St, Charlestown, MA 02129 USA.	tanzi@helix.mgh.harvard.edu	Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454; Elliott, Kathryn/0000-0002-4926-1215				Bedford FK, 2001, NAT NEUROSCI, V4, P908, DOI 10.1038/nn0901-908; Bertram L, 2004, HUM MOL GENET, V13, pR135, DOI 10.1093/hmg/ddh077; BLACKER D, 1994, ARCH NEUROL-CHICAGO, V51, P1198, DOI 10.1001/archneur.1994.00540240042014; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Daw EW, 2000, AM J HUM GENET, V66, P196, DOI 10.1086/302710; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Ingelsson M, 2004, NEUROLOGY, V62, P925, DOI 10.1212/01.WNL.0000115115.98960.37; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Ko HS, 2002, J BIOL CHEM, V277, P35386, DOI 10.1074/jbc.M203412200; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lake SL, 2000, AM J HUM GENET, V67, P1515, DOI 10.1086/316895; Li C, 2004, AM J HUM GENET, V74, P418, DOI 10.1086/381712; Mah AL, 2000, J CELL BIOL, V151, P847, DOI 10.1083/jcb.151.4.847; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; MARTIN ER, 2003, J BIOINFORM COMPUT B, V1, P1; Massey LK, 2004, J ALZHEIMERS DIS, V6, P79; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Pfeiffer RM, 2003, GENET EPIDEMIOL, V25, P136, DOI 10.1002/gepi.10245; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Tanzi RE, 1999, J CLIN INVEST, V104, P1175, DOI 10.1172/JCI8593; Witte JS, 1999, AM J EPIDEMIOL, V149, P693; Wollmer MA, 2003, NEUROBIOL AGING, V24, P421, DOI 10.1016/S0197-4580(02)00094-5; Wu AL, 1999, MOL CELL, V4, P619, DOI 10.1016/S1097-2765(00)80212-9; Wu SL, 2002, BBA-MOL CELL RES, V1542, P41, DOI 10.1016/S0167-4889(01)00164-1	30	196	204	1	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2005	352	9					884	894		10.1056/NEJMoa042765	http://dx.doi.org/10.1056/NEJMoa042765			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901VQ	15745979				2022-12-24	WOS:000227310700007
J	Horstmann, E; McCabe, MS; Grochow, L; Yamamoto, S; Rubinstein, L; Budd, T; Shoemaker, D; Emanuel, EJ; Grady, C				Horstmann, E; McCabe, MS; Grochow, L; Yamamoto, S; Rubinstein, L; Budd, T; Shoemaker, D; Emanuel, EJ; Grady, C			Risks and benefits of phase 1 oncology trials, 1991 through 2002	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NATIONAL-CANCER-INSTITUTE; CLINICAL-TRIALS; I TRIALS; THERAPEUTIC RESPONSE; PROGNOSTIC-FACTORS; ANTICANCER AGENTS; ETHICS; DESIGN; SURVIVAL; RATES	BACKGROUND Previous reviews of phase 1 oncology trials reported a rate of response to treatment of 4 to 6 percent and a toxicity-related death rate of 0.5 percent. These results may not reflect the rates in current phase 1 oncology trials. METHODS We reviewed all nonpediatric phase 1 oncology trials sponsored by the Cancer Therapy Evaluation Program at the National Cancer Institute between 1991 and 2002. We report the rates of response to treatment, of stable disease, of grade 4 toxic events, and of treatment-related deaths. RESULTS We analyzed 460 trials involving 11,935 participants, all of whom were assessed for toxicity and 10,402 of whom were assessed for a response to therapy. The overall response rate (i.e., for both complete and partial responses) was 10.6 percent, with considerable variation among trials. ``Classic'' phase 1 trials of single investigational chemotherapeutic agents represented only 20 percent of the trials and had a response rate of 4.4 percent. Studies that included at least one anticancer agent approved by the Food and Drug Administration constituted 46.3 percent of the trials and had a response rate of 17.8. An additional 34.1 percent of participants had stable disease or a less-than-partial response. The overall rate of death due to toxic events was 0.49 percent. Of 3465 participants for whom data on patient-specific grade 4 toxic events were available, 14.3 percent had had at least one episode of grade 4 toxic events. CONCLUSIONS Overall response rates among phase 1 oncology trials are higher than previously reported, although they have not changed for classic phase 1 trials, and toxicity-related death rates have remained stable. Rates of response and toxicity vary, however, among the various types of phase 1 oncology trials.	NIH, Dept Clin Bioeth, Warren G Magnuson Clin Ctr, Bethesda, MD 20892 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; NCI, Canc Therapy Evaluat Program, NIH, Rockville, MD USA; Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Tokyo 104, Japan	National Institutes of Health (NIH) - USA; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Cancer Center - Japan	Grady, C (corresponding author), NIH, Dept Clin Bioeth, Warren G Magnuson Clin Ctr, Bldg 10,Rm 1C118, Bethesda, MD 20892 USA.	cgrady@nih.gov		Rubinstein, Lawrence/0000-0002-9720-9737	CLINICAL CENTER [Z01CL010522] Funding Source: NIH RePORTER	CLINICAL CENTER		Agrawal M, 2003, JAMA-J AM MED ASSOC, V290, P1075, DOI 10.1001/jama.290.8.1075; Annas G J, 1992, Health Matrix Clevel, V2, P119; Ansher SS, 2001, ANN NY ACAD SCI, V949, P333; Bachelot T, 2000, ANN ONCOL, V11, P151, DOI 10.1023/A:1008368319526; *CANC THER EV PROG, 1999, COMM TOX CRIT CTC VE; Chen EX, 2004, JAMA-J AM MED ASSOC, V292, P2150, DOI 10.1001/jama.292.17.2150; Daugherty CK, 1997, ANN INTERN MED, V126, P892, DOI 10.7326/0003-4819-126-11-199706010-00008; DECOSTER G, 1990, ANN ONCOL, V1, P175, DOI 10.1093/oxfordjournals.annonc.a057716; Dent SF, 1996, ANN ONCOL, V7, P561; Eisenhauer EA, 2000, J CLIN ONCOL, V18, P684, DOI 10.1200/JCO.2000.18.3.684; EMANUEL EJ, 1995, J CLIN ONCOL, V13, P1049, DOI 10.1200/JCO.1995.13.5.1049; ESTEY E, 1986, CANCER TREAT REP, V70, P1105; Goldman DP, 2003, JAMA-J AM MED ASSOC, V289, P2970, DOI 10.1001/jama.289.22.2970; Han C, 2003, BRIT J CANCER, V89, P1166, DOI 10.1038/sj.bjc.6601218; ITOH K, 1994, CANCER CHEMOTH PHARM, V34, P451, DOI 10.1007/BF00685653; KODISH E, 1992, J CLIN ONCOL, V10, P1810, DOI 10.1200/JCO.1992.10.11.1810; LIPSETT MB, 1982, JAMA-J AM MED ASSOC, V248, P941, DOI 10.1001/jama.248.8.941; MARKMAN M, 1992, J CANCER RES CLIN, V119, P5, DOI 10.1007/BF01209482; Markman M, 2003, CLEV CLIN J MED, V70, P1008, DOI 10.3949/ccjm.70.12.1008; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Miller M, 2000, HASTINGS CENT REP, V30, P34, DOI 10.2307/3527646; Miller M, 2001, Int Anesthesiol Clin, V39, P13; Roberts TG, 2004, JAMA-J AM MED ASSOC, V292, P2130, DOI 10.1001/jama.292.17.2130; Sekine I, 2002, ANN ONCOL, V13, P1300, DOI 10.1093/annonc/mdf202; Shanafelt TD, 2004, J CLIN ONCOL, V22, P1966, DOI 10.1200/JCO.2004.08.176; Smith TL, 1996, J CLIN ONCOL, V14, P287, DOI 10.1200/JCO.1996.14.1.287; Takimoto CH, 2003, CANCER CHEMOTH PHARM, V52, pS29, DOI 10.1007/s00280-003-0623-y; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; VONHOFF DD, 1991, INVEST NEW DRUG, V9, P115, DOI 10.1007/BF00194562	29	332	340	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2005	352	9					895	904		10.1056/NEJMsa042220	http://dx.doi.org/10.1056/NEJMsa042220			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901VQ	15745980				2022-12-24	WOS:000227310700008
J	Yamagishi, K; Onuma, K; Suzuki, T; Okada, F; Tagami, J; Otsuki, M; Senawangse, P				Yamagishi, K; Onuma, K; Suzuki, T; Okada, F; Tagami, J; Otsuki, M; Senawangse, P			A synthetic enamel for rapid tooth repair	NATURE			English	Article							GROWTH		FAP Dent Inst, Meguro Ku, Tokyo 1520022, Japan; Natl Inst Adv Ind Sci & Technol, Inst Human Sci & Technol, Tsukuba, Ibaraki 3058566, Japan; Univ Yamanashi, Fac Engn, Dept Appl Chem & Biotechnol, Yamanashi 4008511, Japan; Tokyo Med & Dent Univ, Grad Sch, Dept Restorat Sci, Bunkyo Ku, Tokyo 1138549, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Yamanashi; Tokyo Medical & Dental University (TMDU)	Yamagishi, K (corresponding author), FAP Dent Inst, Meguro Ku, 3-2-1 Kakinokizaka,502, Tokyo 1520022, Japan.	FZT02705@nifty.com	Onuma, Kazuo/L-8736-2018					Banfield JF, 2000, SCIENCE, V289, P751, DOI 10.1126/science.289.5480.751; Carvalho RM, 1996, OPER DENT, V21, P17; Duschner H, 1997, EUR J ORAL SCI, V105, P466, DOI 10.1111/j.1600-0722.1997.tb00232.x; Elliot J. C., 1994, STRUCTURE CHEM APATI; FRANK RM, 1966, ARCH ORAL BIOL, V11, P883, DOI 10.1016/0003-9969(66)90080-X; GEROULD CH, 1945, J DENT RES, V24, P223, DOI 10.1177/00220345450240050201; Hilton TJ, 2002, AM J DENT, V15, P198; JOHNSON N. W., 1967, CARIES RES, V1, P356; Onuma K, 1998, CHEM MATER, V10, P3346, DOI 10.1021/cm980062c; Raskin A, 1999, J DENT, V27, P13, DOI 10.1016/S0300-5712(98)00026-8; Wilson NHF, 2000, J DENT, V28, P15, DOI 10.1016/S0300-5712(99)00055-X; YAMAGISHI K, 1995, ESTHETIC DENT, V7, P78	12	184	201	5	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2005	433	7028					819	819		10.1038/433819a	http://dx.doi.org/10.1038/433819a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	899VT	15729330				2022-12-24	WOS:000227174600030
J	Chandran, K; Sullivan, NJ; Felbor, U; Whelan, SP; Cunningham, JM				Chandran, K; Sullivan, NJ; Felbor, U; Whelan, SP; Cunningham, JM			Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection	SCIENCE			English	Article							ENVELOPE GLYCOPROTEIN; CATHEPSIN-B; INFLUENZA HEMAGGLUTININ; MEMBRANE-FUSION; INHIBITORS; CYSTEINE; ENTRY; PROTEINASES; CELLS; MICE	Ebola virus (EboV) causes rapidly fatal hemorrhagic fever in humans and there is currently no effective treatment. We found that the infection of African green monkey kidney (Vero) cells by vesicular stornatitis viruses bearing the EboV gtycoprotein (GP) requires the activity of endosomal cysteine proteases. Using selective protease inhibitors and protease-deficient cell lines, we identified an essential role for cathepsin B (CatB) and an accessory role for cathepsin L (CatL) in EboV GP-dependent entry. Biochemical studies demonstrate that CatB and CatL mediate entry by carrying out proteolysis of the EboV GP subunit GP1 and support a multistep mechanism that explains the relative contributions of these enzymes to infection. CatB and CatB/CatL inhibitors diminish the multiplication of infectious EboV-Zaire in cultured cells and may merit investigation as anti-EboV drugs.	Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; Biozentrum, Inst Human Genet, D-97074 Wurzburg, Germany; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Wurzburg; Harvard University; Harvard Medical School	Cunningham, JM (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	jcunningham@rics.bwh.harvard.edu		Whelan, Sean/0000-0003-1564-8590	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059371, Z01AI005079, Z01AI005081, Z01AI005082] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI059371, R01 AI059371-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BOULAY F, 1987, EMBO J, V6, P2643, DOI 10.1002/j.1460-2075.1987.tb02555.x; Chandran K, 2003, TRENDS MICROBIOL, V11, P374, DOI 10.1016/S0966-842X(03)00178-1; Deussing J, 1998, P NATL ACAD SCI USA, V95, P4516, DOI 10.1073/pnas.95.8.4516; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; Ebert DH, 2002, J BIOL CHEM, V277, P24609, DOI 10.1074/jbc.M201107200; Felbor U, 2002, P NATL ACAD SCI USA, V99, P7883, DOI 10.1073/pnas.112632299; Geisbert TW, 2004, NAT MED, V10, pS110, DOI 10.1038/nm1142; Ito H, 1999, J VIROL, V73, P8907, DOI 10.1128/JVI.73.10.8907-8912.1999; Jeffers SA, 2002, J VIROL, V76, P12463, DOI 10.1128/JVI.76.24.12463-12472.2002; Malashkevich VN, 1999, P NATL ACAD SCI USA, V96, P2662, DOI 10.1073/pnas.96.6.2662; Mothes W, 2000, CELL, V103, P679, DOI 10.1016/S0092-8674(00)00170-7; MURATA M, 1991, FEBS LETT, V280, P307, DOI 10.1016/0014-5793(91)80318-W; NIBERT ML, 1993, THESIS HARVARD U; Otto HH, 1997, CHEM REV, V97, P133, DOI 10.1021/cr950025u; Sanchez A, 1998, J VIROL, V72, P6442, DOI 10.1128/JVI.72.8.6442-6447.1998; SHAW E, 1994, METHOD ENZYMOL, V244, P649; Simmons G, 2003, J VIROL, V77, P13433, DOI 10.1128/JVI.77.24.13433-13438.2003; Simmons G, 2003, VIROLOGY, V305, P115, DOI 10.1006/viro.2002.1730; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Turk B, 1997, BIOL CHEM, V378, P141; Volchkov VE, 1999, CURR TOP MICROBIOL, V235, P35; Weissenhorn W, 1998, MOL CELL, V2, P605, DOI 10.1016/S1097-2765(00)80159-8; Wool-Lewis RJ, 1998, J VIROL, V72, P3155, DOI 10.1128/JVI.72.4.3155-3160.1998; Zhang T, 2000, IMMUNOLOGY, V100, P13, DOI 10.1046/j.1365-2567.2000.00000.x	25	629	670	1	194	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2005	308	5728					1643	1645		10.1126/science.1110656	http://dx.doi.org/10.1126/science.1110656			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	936BH	15831716	Green Accepted			2022-12-24	WOS:000229827000062
J	Koester, HJ; Johnston, D				Koester, HJ; Johnston, D			Target cell-dependent normalization of transmitter release at neocortical synapses	SCIENCE			English	Article							OPTICAL QUANTAL ANALYSIS; SYNAPTIC CONNECTIONS; PYRAMIDAL NEURONS; RAT NEOCORTEX; ACTION-POTENTIALS; CALCIUM DYNAMICS; NERVE-TERMINALS; NMDA RECEPTORS; DEPRESSION; HETEROGENEITY	The efficacy and short-term modification of neocortical synaptic connections vary with the type of target neuron. We investigated presynaptic Ca(2+) and release probability at single synaptic contacts between pairs of neurons in layer 2/3 of the rat neocortex. The amplitude of Ca(2+) signals in boutons of pyramids contacting bitufted or multipolar interneurons or other pyramids was dependent on the target cell type. Optical quantal analysis at single synaptic contacts suggested that release probabilities are also target cell-specific. Both the Ca(2+) signal and the release probability of different boutons of a pyramid contacting the same target cell varied little. We propose that the mechanisms that regulate the functional properties of boutons of a pyramid normalize the presynaptic Ca(2+) influx and release probability for all those boutons that innervate the same target cell.	Max Planck Inst Med Res, Zellphysiol Abt, D-69120 Heidelberg, Germany; Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Max Planck Society; Baylor College of Medicine	Koester, HJ (corresponding author), Univ Texas, Ctr Learning & Memory, Austin, TX 78712 USA.	HKoester@mail.utexas.edu			NIMH NIH HHS [MH44754, MH48432] Funding Source: Medline; NINDS NIH HHS [NNS37444] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH044754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS037444] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Buhl EH, 1997, J PHYSIOL-LONDON, V500, P689, DOI 10.1113/jphysiol.1997.sp022053; Cauli B, 2000, P NATL ACAD SCI USA, V97, P6144, DOI 10.1073/pnas.97.11.6144; Cook DL, 2003, NATURE, V421, P66, DOI 10.1038/nature01248; Cox CL, 2000, P NATL ACAD SCI USA, V97, P9724, DOI 10.1073/pnas.170278697; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Koester HJ, 2000, J PHYSIOL-LONDON, V529, P625, DOI 10.1111/j.1469-7793.2000.00625.x; KULLMANN DM, 1989, J NEUROSCI METH, V30, P231, DOI 10.1016/0165-0270(89)90134-9; Llano I, 1997, J PHYSIOL-LONDON, V502, P509, DOI 10.1111/j.1469-7793.1997.509bj.x; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Markram H, 1998, NEUROBIOL LEARN MEM, V70, P101, DOI 10.1006/nlme.1998.3841; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; STRICKER C, 1994, BIOPHYS J, V67, P532, DOI 10.1016/S0006-3495(94)80513-2; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; Yuste R, 1999, J NEUROSCI, V19, P1976; Zador A, 1998, J NEUROPHYSIOL, V79, P1219, DOI 10.1152/jn.1998.79.3.1219	28	160	162	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2005	308	5723					863	866		10.1126/science.1100815	http://dx.doi.org/10.1126/science.1100815			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15774725				2022-12-24	WOS:000228986500051
J	McQueen, A				McQueen, A			"I think she's just crazy"	LANCET			English	Editorial Material									Childrens Hosp Boston, Emergency Dept, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital	McQueen, A (corresponding author), Childrens Hosp Boston, Emergency Dept, Boston, MA 02115 USA.	Alisa.mcqueen@childrens.harvard.edu							0	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 23	2005	365	9469					1513	1513		10.1016/S0140-6736(05)66424-0	http://dx.doi.org/10.1016/S0140-6736(05)66424-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850638				2022-12-24	WOS:000228651600032
J	Vermot, J; Llamas, JG; Fraulob, V; Niederreither, K; Chambon, P; Dolle, P				Vermot, J; Llamas, JG; Fraulob, V; Niederreither, K; Chambon, P; Dolle, P			Retinoic acid controls the bilateral symmetry of somite formation in the mouse embryo	SCIENCE			English	Article							LEFT-RIGHT ASYMMETRY; SEGMENTATION CLOCK; BOUNDARY FORMATION; NODAL EXPRESSION; GENE-EXPRESSION; SOMITOGENESIS; FGF	A striking characteristic of vertebrate embryos is their bilaterally symmetric body plan, which is particularly obvious at the level of the somites and their derivatives such as the vertebra[ column. Segmentation of the presomitic mesoderm must therefore be tightly coordinated along the left and right embryonic sides. We show that mutant mice defective for retinoic acid synthesis exhibit delayed somite formation on the right side. Asymmetric somite formation correlates with a left-right desynchronization of the segmentation clock oscillations. These data implicate retinoic acid as an endogenous signal that maintains the bilateral synchrony of mesoderm segmentation, and therefore controls bilateral symmetry, in vertebrate embryos.	Coll France, ULP, INSERM, CNRS,Inst Genet & Biol Mol & Cellulaire, F-67404 Strasbourg, France; Baylor Coll Med, Ctr Cardiovasc Dev, Dept Med, Houston, TX 77030 USA; Baylor Coll Med, Ctr Cardiovasc Dev, Dept Mol Biol, Houston, TX 77030 USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Baylor College of Medicine; Baylor College of Medicine	Vermot, J (corresponding author), CALTECH, Beckman Inst, Pasadena, CA 91125 USA.	julien@igbmc.u-strasbg.fr; dolle@igbmc.u-strasbg.fr	Vermot, Julien/I-6568-2016; Dolle, Pascal/A-8037-2010	Dolle, Pascal/0000-0002-9294-9090; , Julien/0000-0002-8924-732X				Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Bessho Y, 2001, GENE DEV, V15, P2642, DOI 10.1101/gad.930601; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; CERFONTAINE P, 2006, ARCH BIOL, P22; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; Diez del Corral R, 2003, NEURON, V40, P65; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Forsberg H, 1998, CURR BIOL, V8, P1027, DOI 10.1016/S0960-9822(07)00424-1; Fujii H, 1997, EMBO J, V16, P4163, DOI 10.1093/emboj/16.14.4163; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; Krebs LT, 2003, GENE DEV, V17, P1207, DOI 10.1101/gad.1084703; Liu AM, 2003, DEVELOPMENT, V130, P6175, DOI 10.1242/dev.00845; Moreno TA, 2004, DEV CELL, V6, P205, DOI 10.1016/S1534-5807(04)00026-7; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Pourquie O, 2001, DEV CELL, V1, P619, DOI 10.1016/S1534-5807(01)00082-X; Raya A, 2003, GENE DEV, V17, P1213, DOI 10.1101/gad.1084403; Raya A, 2004, NATURE, V427, P121, DOI 10.1038/nature02190; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; Sawada A, 2001, DEVELOPMENT, V128, P4873; Takahashi Y, 2000, NAT GENET, V25, P390, DOI 10.1038/78062	22	167	175	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2005	308	5721					563	566		10.1126/science.1108363	http://dx.doi.org/10.1126/science.1108363			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15731404				2022-12-24	WOS:000228810500056
J	Huey, RB; Ward, PD				Huey, RB; Ward, PD			Hypoxia, global warming, and terrestrial Late Permian extinctions	SCIENCE			English	Article							TRIASSIC BOUNDARY; KAROO BASIN; OXYGEN; VERTEBRATES; DIVERSITY; CYCLE; MODEL	A catastrophic extinction occurred at the end of the Permian Period. However, baseline extinction rates appear to have been elevated even before the final catastrophe, suggesting sustained environmental degradation. For terrestrial vertebrates during the Late Permian, the combination of a drop in atmospheric oxygen plus climate warming would have induced hypoxic stress and consequently compressed altitudinal ranges to near sea level. Our simulations suggest that the magnitude of altitudinal compression would have forced extinctions by reducing habitat diversity, fragmenting and isolating populations, and inducing a species-area effect. It also might have delayed ecosystem recovery after the mass extinction.	Univ Washington, Dept Biol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Huey, RB (corresponding author), Univ Washington, Dept Biol, Box 351800, Seattle, WA 98195 USA.	hueyrb@u.washington.edu	Huey, Raymond/F-1597-2010	Huey, Raymond/0000-0002-4962-8670				ANGIELCZYK K, COMMUNICATION; BATTISTI D, COMMUNICATION; Benton MJ, 2004, NATURE, V432, P97, DOI 10.1038/nature02950; Benton MJ, 2003, TRENDS ECOL EVOL, V18, P358, DOI 10.1016/S0169-5347(03)00093-4; Bergman NM, 2004, AM J SCI, V304, P397, DOI 10.2475/ajs.304.5.397; Berner R.A., 2004, PHANEROZOIC CARBON C; Berner RA, 2001, AM J SCI, V301, P182, DOI 10.2475/ajs.301.2.182; Berner RA, 2003, ANNU REV EARTH PL SC, V31, P105, DOI 10.1146/annurev.earth.31.100901.141329; Berner RA, 2002, P NATL ACAD SCI USA, V99, P4172, DOI 10.1073/pnas.032095199; Berner RA, 2001, GEOCHIM COSMOCHIM AC, V65, P685, DOI 10.1016/S0016-7037(00)00572-X; BERNER RA, IN PRESS GEOCHIM COS; Bouverot P., 1985, ADAPTATION ALTITUDE; Bowring SA, 1999, P NATL ACAD SCI USA, V96, P8827, DOI 10.1073/pnas.96.16.8827; Erwin D. H, 1993, GREAT PALEOZOIC CRIS; Frazier MR, 2001, PHYSIOL BIOCHEM ZOOL, V74, P641, DOI 10.1086/322172; GASTON KJ, 2003, STRUCTURE DYNAMICS; GRAHAM JB, 1995, NATURE, V375, P117, DOI 10.1038/375117a0; Greenlee KJ, 2004, J EXP BIOL, V207, P497, DOI 10.1242/jeb.00767; Hallam A, 1999, EARTH-SCI REV, V48, P217, DOI 10.1016/S0012-8252(99)00055-0; Hanski I., 1999, METAPOPULATION ECOLO; Hillenius WJ, 2004, PHYSIOL BIOCHEM ZOOL, V77, P1019, DOI 10.1086/425185; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Kidder DL, 2004, PALAEOGEOGR PALAEOCL, V203, P207, DOI 10.1016/S0031-0182(03)00667-9; Knoll AH, 1996, SCIENCE, V273, P452, DOI 10.1126/science.273.5274.452; LABANDEIRA CC, 1993, SCIENCE, V261, P310, DOI 10.1126/science.11536548; Lasaga AC, 2002, GEOCHIM COSMOCHIM AC, V66, P361, DOI 10.1016/S0016-7037(01)00685-8; Rees PM, 2002, GEOLOGY, V30, P827; Retallack GJ, 2003, GEOL SOC AM BULL, V115, P1133, DOI 10.1130/B25215.1; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rowley DB, 2001, EARTH PLANET SC LETT, V188, P253, DOI 10.1016/S0012-821X(01)00324-7; Sheldon ND, 2002, GEOLOGY, V30, P919, DOI 10.1130/0091-7613(2002)030<0919:LOLIET>2.0.CO;2; SIDOR CA, IN PRESS NATURE; Ward PD, 2005, SCIENCE, V307, P709, DOI 10.1126/science.1107068; Wignall PB, 1999, J GEOL SOC LONDON, V156, P453, DOI 10.1144/gsjgs.156.3.0453	34	166	190	3	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2005	308	5720					398	401		10.1126/science.1108019	http://dx.doi.org/10.1126/science.1108019			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15831755				2022-12-24	WOS:000228492000048
J	Guber, C				Guber, C			Type 2 diabetes	LANCET			English	Editorial Material																		American Diabetes Association, 2003, AM DIAB ASS COMPL GU; [No title captured]	2	0	0	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 9	2005	365	9467					1347	1347		10.1016/S0140-6736(05)61033-1	http://dx.doi.org/10.1016/S0140-6736(05)61033-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	914HY	15823386				2022-12-24	WOS:000228219600031
J	Kloer, DP; Ruch, S; Al-Babili, S; Beyer, P; Schulz, GE				Kloer, DP; Ruch, S; Al-Babili, S; Beyer, P; Schulz, GE			The structure of a retinal-forming carotenoid oxygenase	SCIENCE			English	Article							BETA-CAROTENE; OXIDATIVE CLEAVAGE; SUBSTRATE-SPECIFICITY; DIOXYGENASE; ENZYME; IDENTIFICATION; BIOSYNTHESIS; ARABIDOPSIS; PROTEIN; 15,15'-DIOXYGENASE	Enzymes that produce retinal and related apocarotenoids constitute a sequence- and thus structure-related family, a member of which was analyzed by x-ray diffraction. This member is an oxygenase and contains an Fe2+-4-His arrangement at the axis of a seven-bladed beta-propeller chain fold covered by a dome formed by six large loops. The Fe2+ is accessible through a long nonpolar tunnel that holds a carotenoid derivative in one of the crystals. on binding, three consecutive double bonds of this carotenoid changed from a straight all-trans to a cranked cis-trans-cis conformation. The remaining trans bond is located at the dioxygen-ligated Fe2+ and cleaved by oxygen.	Univ Freiburg, Inst Organ Chem & Biochem, D-79104 Freiburg, Germany; Univ Freiburg, Inst Biol 2, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Schulz, GE (corresponding author), Univ Freiburg, Inst Organ Chem & Biochem, Albertstr 21, D-79104 Freiburg, Germany.	georg.schulz@ocbc.uni-freiburg.de		Al-Babili, Salim/0000-0003-4823-2882	NATIONAL EYE INSTITUTE [R01EY020551] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Barua AB, 2000, J NUTR, V130, P1996, DOI 10.1093/jn/130.8.1996; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Booker J, 2004, CURR BIOL, V14, P1232, DOI 10.1016/j.cub.2004.06.061; Bouvier F, 2003, SCIENCE, V300, P2089, DOI 10.1126/science.1085162; Bouvier F, 2003, PLANT CELL, V15, P47, DOI 10.1105/tpc.006536; Camara B, 2004, ARCH BIOCHEM BIOPHYS, V430, P16, DOI 10.1016/j.abb.2004.06.028; DellaPenna D, 1999, SCIENCE, V285, P375, DOI 10.1126/science.285.5426.375; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Gillmor SA, 1997, NAT STRUCT BIOL, V4, P1003, DOI 10.1038/nsb1297-1003; Giuliano G, 2003, TRENDS PLANT SCI, V8, P145, DOI 10.1016/S1360-1385(03)00053-0; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Jung KH, 2003, MOL MICROBIOL, V47, P1513, DOI 10.1046/j.1365-2958.2003.03395.x; Kajander T, 2002, STRUCTURE, V10, P483, DOI 10.1016/S0969-2126(02)00744-X; Kato T, 2003, J SURFACTANTS DETERG, V6, P331, DOI 10.1007/s11743-003-0278-x; Kiefer C, 2001, J BIOL CHEM, V276, P14110, DOI 10.1074/jbc.M011510200; Lancaster CRD, 1999, J MOL BIOL, V286, P883, DOI 10.1006/jmbi.1998.2532; Mata NL, 2004, J BIOL CHEM, V279, P635, DOI 10.1074/jbc.M310042200; MOLNAR P, 1997, J CHEM RES, V5, P120; Redmond TM, 2001, J BIOL CHEM, V276, P6560, DOI 10.1074/jbc.M009030200; Ruch S, 2005, MOL MICROBIOL, V55, P1015, DOI 10.1111/j.1365-2958.2004.04460.x; Scharff EI, 2001, STRUCTURE, V9, P493, DOI 10.1016/S0969-2126(01)00610-4; Schwartz SH, 2004, J BIOL CHEM, V279, P46940, DOI 10.1074/jbc.M409004200; Schwartz SH, 2001, J BIOL CHEM, V276, P25208, DOI 10.1074/jbc.M102146200; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; Tan BC, 2003, PLANT J, V35, P44, DOI 10.1046/j.1365-313X.2003.01786.x; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; Wendt KU, 1999, J MOL BIOL, V286, P175, DOI 10.1006/jmbi.1998.2470; Woggon WD, 2002, PURE APPL CHEM, V74, P1397, DOI 10.1351/pac200274081397; Wyss A, 2000, BIOCHEM BIOPH RES CO, V271, P334, DOI 10.1006/bbrc.2000.2619	32	208	217	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2005	308	5719					267	269		10.1126/science.1108965	http://dx.doi.org/10.1126/science.1108965			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915BX	15821095				2022-12-24	WOS:000228273700058
J	Chapman, T				Chapman, T			Small-scale separation	NATURE			English	Article																			0	23	25	2	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 7	2005	434	7034					795	795		10.1038/434795b	http://dx.doi.org/10.1038/434795b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	913NU	15815637	Bronze			2022-12-24	WOS:000228160700050
J	Kimball, AM; Thant, M				Kimball, AM; Thant, M			"What, me worry?" Businesses and AIDS at Davos	LANCET			English	Editorial Material									Univ Washington, Sch Publ Hlth, Hlth Serv, Seattle, WA 98195 USA; Asian Dev Bank, Manila, Philippines	University of Washington; University of Washington Seattle; Asian Development Bank	Kimball, AM (corresponding author), Univ Washington, Sch Publ Hlth, Hlth Serv, Seattle, WA 98195 USA.	akimball@u.washington.edu		Thant, Myo/0000-0002-3696-5977				Arora P, 2004, CAN MED ASSOC J, V171, P1337, DOI 10.1503/cmaj.045032; BLOOM D, 2005, WORLD EC FOR DAV; Brooks RA, 2004, AIDS CARE, V16, P756, DOI 10.1080/09540120412331269594; *GLOB BUS COAL HIV, 2005, MIN HLTH GLOB BUS CO; Kimball AM, 1996, LANCET, V347, P1670, DOI 10.1016/S0140-6736(96)91493-2; NAGELKERKE JD, 2002, B WORLD HEALTH ORGAN, V8, P89; Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147; *UNAIDS, 2004, FACT SHEET AS; 2004, LANCET, V364, P909	9	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 2	2005	365	9466					1213	1215		10.1016/S0140-6736(05)74792-9	http://dx.doi.org/10.1016/S0140-6736(05)74792-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	912VI	15811442	Green Published, Bronze			2022-12-24	WOS:000228107600009
J	Stanton, H; Rogerson, FM; East, CJ; Golub, SB; Lawlor, KE; Meeker, CT; Little, CB; Last, K; Farmer, PJ; Campbell, IK; Fourie, AM; Fosang, AJ				Stanton, H; Rogerson, FM; East, CJ; Golub, SB; Lawlor, KE; Meeker, CT; Little, CB; Last, K; Farmer, PJ; Campbell, IK; Fourie, AM; Fosang, AJ			ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro	NATURE			English	Article							ANTIGEN-INDUCED ARTHRITIS; EXPRESSION; GENE; METALLOPROTEINASE; INTERLEUKIN-1; CHONDROCYTES; PROTEIN; CLONING; FAMILY; MICE	Aggrecan is the major proteoglycan in cartilage, endowing this tissue with the unique capacity to bear load and resist compression. In arthritic cartilage, aggrecan is degraded by one or more 'aggrecanases' from the ADAMTS ( a disintegrin and metalloproteinase with thrombospondin motifs(1)) family of proteinases. ADAMTS1, 8 and 9 have weak aggrecan-degrading activity(2-5). However, they are not thought to be the primary aggrecanases because ADAMTS1 null mice are not protected from experimental arthritis(6), and cleavage by ADAMTS8 and 9 is highly inefficient. Although ADAMTS4 and 5 are expressed in joint tissues(7-13), and are known to be efficient aggrecanases in vitro, the exact contribution of these two enzymes to cartilage pathology is unknown. Here we show that ADAMTS5 is the major aggrecanase in mouse cartilage, both in vitro and in a mouse model of inflammatory arthritis. Our data suggest that ADAMTS5 may be a suitable target for the development of new drugs designed to inhibit cartilage destruction in arthritis, although further work will be required to determine whether ADAMTS5 is also the major aggrecanase in human arthritis.	Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; Royal Childrens Hosp, Murdoch Childrens Res Inst, Dept Surg, Parkville, Vic 3052, Australia; Univ Sydney, Royal N Shore Hosp, Raymond Purves Bone & Joint Res Labs, St Leonards, NSW 2065, Australia; Walter & Eliza Hall Inst Med Res, Reid Rheumatol Lab, Parkville, Vic 3052, Australia; Johnson & Johnson Pharmaceut Res & Dev, San Diego, CA 92121 USA	University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal North Shore Hospital; University of Sydney; Walter & Eliza Hall Institute; Johnson & Johnson; Johnson & Johnson USA	Fosang, AJ (corresponding author), Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia.	amanda.fosang@mcri.edu.au	Little, Christopher B/A-9280-2015	Little, Christopher B/0000-0002-0353-7634; Fosang, Amanda/0000-0002-5523-5427; STANTON, HEATHER/0000-0002-3427-5614; Last, Karena/0000-0002-4396-8404; Lawlor, Kate/0000-0003-0471-6842				Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; Bau B, 2002, ARTHRITIS RHEUM, V46, P2648, DOI 10.1002/art.10531; Collins-Racie LA, 2004, MATRIX BIOL, V23, P219, DOI 10.1016/j.matbio.2004.05.004; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; Glant TT, 2002, ARTHRITIS RHEUM-US, V46, P2207, DOI 10.1002/art.10555; Glasson SS, 2004, ARTHRITIS RHEUM-US, V50, P2547, DOI 10.1002/art.20558; Ilic MZ, 2000, MATRIX BIOL, V19, P257, DOI 10.1016/S0945-053X(00)00069-X; Kevorkian L, 2004, ARTHRITIS RHEUM-US, V50, P131, DOI 10.1002/art.11433; Koshy PJT, 2002, ARTHRITIS RHEUM, V46, P961, DOI 10.1002/art.10212; Kuno K, 1997, J BIOL CHEM, V272, P556, DOI 10.1074/jbc.272.1.556; Kuno K, 2000, FEBS LETT, V478, P241, DOI 10.1016/S0014-5793(00)01854-8; LITTLE CB, IN PRESS ARTHRITIS R; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Mould AW, 2003, ARTHRITIS RHEUM-US, V48, P2660, DOI 10.1002/art.11232; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RODRIGUEZMANZANEQU, 2002, BIOCHEM BIOPH RES CO, V293, P501; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Somerville RPT, 2003, J BIOL CHEM, V278, P9503, DOI 10.1074/jbc.M211009200; Tortorella MD, 2001, OSTEOARTHR CARTILAGE, V9, P539, DOI 10.1053/joca.2001.0427; van Meurs JBJ, 1998, ARTHRITIS RHEUM, V41, P647, DOI 10.1002/1529-0131(199804)41:4<647::AID-ART11>3.0.CO;2-T; van Meurs JBJ, 1999, ANN RHEUM DIS, V58, P350, DOI 10.1136/ard.58.6.350; van Meurs JBJ, 1999, ARTHRITIS RHEUM, V42, P1128, DOI 10.1002/1529-0131(199906)42:6<1128::AID-ANR9>3.0.CO;2-2; Vankemmelbeke MN, 2001, EUR J BIOCHEM, V268, P1259, DOI 10.1046/j.1432-1327.2001.01990.x; Yamanishi Y, 2002, J IMMUNOL, V168, P1405, DOI 10.4049/jimmunol.168.3.1405	24	702	740	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 31	2005	434	7033					648	652		10.1038/nature03417	http://dx.doi.org/10.1038/nature03417			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911NN	15800625				2022-12-24	WOS:000228011000046
J	Huffard, CL; Boneka, F; Full, RJ				Huffard, CL; Boneka, F; Full, RJ			Underwater bipedal locomotion by octopuses in disguise	SCIENCE			English	Article							PATTERNS		Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Sam Ratulangi, Dept Fisheries & Marine Sci, Manado, North Sulawesi, Indonesia	University of California System; University of California Berkeley; Universitas Sam Ratulangi	Huffard, CL (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	chuffard@berkeley.edu						Gutfreund Y, 1998, J NEUROSCI, V18, P5976; Hanlon RT, 1999, BIOL J LINN SOC, V66, P1; KIER WM, 1985, ZOOL J LINN SOC-LOND, V83, P307, DOI 10.1111/j.1096-3642.1985.tb01178.x; Mather JA, 1998, J COMP PSYCHOL, V112, P306, DOI 10.1037/0735-7036.112.3.306; PACKARD A, 1971, ANIM BEHAV, V19, P780, DOI 10.1016/S0003-3472(71)80181-1; Steinbeck J, 2000, CANNERY ROW; Sumbre G, 2001, SCIENCE, V293, P1845, DOI 10.1126/science.1060976; Vaughan CL, 2003, J BIOMECH, V36, P513, DOI 10.1016/S0021-9290(02)00419-0	8	62	64	2	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 25	2005	307	5717					1927	1927		10.1126/science.1109616	http://dx.doi.org/10.1126/science.1109616			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910UI	15790846				2022-12-24	WOS:000227957300047
J	Zhang, SMM; Buring, JE; Lee, IM; Cook, NR; Ridker, PM				Zhang, SMM; Buring, JE; Lee, IM; Cook, NR; Ridker, PM			C-reactive protein levels are not associated with increased risk for colorectal cancer in women	ANNALS OF INTERNAL MEDICINE			English	Article							HORMONE REPLACEMENT THERAPY; INFLAMMATORY-BOWEL-DISEASE; PHASE REACTANT PROTEINS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SERUM CARCINOEMBRYONIC ANTIGEN; POSTMENOPAUSAL WOMEN; INTERLEUKIN-6 LEVELS; TUMOR RECURRENCE; SURVIVAL; HEALTH	Background: Observations that risk for colorectal cancer is elevated in patients with inflammatory bowel disease and that longterm use of anti-inflammatory drugs may reduce colorectal cancer risk have raised the possibility that inflammation may play a role in the development of colorectal cancer. While a recent prospective study observed a positive association between C-reactive protein (CRP), a marker of inflammation, and risk for colon cancer, data testing this hypothesis are sparse. Objective: To evaluate whether plasma CRP levels predict colorectal cancer risk in women. Design: Prospective cohort study, with 97% morbidity follow-up and 100% mortality follow-up within the past 2 years. Setting: women's Health Study. Participants: 27 913 apparently healthy women age 45 years or older who had CRP measured at entry into a trial of low-dose aspirin and vitamin E. Maximum length of intervention and follow-up was 10.8 years. Measurements: self-reported incident colorectal adenocarcinoma confirmed by medical record review. Results: 169 women developed colorectal adenocarcinomas during follow-up. Baseline CRP levels were not significantly associated with colorectal cancer risk. The multivariate hazard ratios according to cutoff points for CRP proposed in clinical guidelines were 0.79 (95% CI, 0.53 to 1.17) for the category of 1 to 3 mg/L and 0.66 (CI, 0.43 to 1.03) for the category of greater than 3 mg/L (P for trend = 0.09), as compared with the category of less than 1 mg/L. High CRP levels were also not associated with increased risk in analyses done according to tumor location and stage at diagnosis, according to alternative cutoff points for CRP, or in any of the subgroups evaluated. Limitations: Despite multivariate analysis, residual confounding might still be present. Although this study was prospective, we cannot completely exclude undetected cancer at baseline. Measurements for CRP were available for only 71% of women in the cohort; however, the women who did and those who did not provide blood were mostly similar. Conclusions: Plasma CRP levels do not appear to predict an increased risk for developing colorectal cancer in apparently healthy women. Low-grade inflammation may not play an important role in increasing the risk for colorectal cancer.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Zhang, SMM (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med, 900 Commonwealth Ave E, Boston, MA 02115 USA.	shumin.zhang@channing.harvard.edu	Lee, I-Min/ABD-5409-2021		NCI NIH HHS [CA-47988, CA096619] Funding Source: Medline; NHLBI NIH HHS [HL-43851] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K07CA096619] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baron JA, 2003, PROG EXP TUMOR RES, V37, P1; Belluco C, 2000, ANN SURG ONCOL, V7, P133, DOI 10.1007/s10434-000-0133-7; Breen N, 2001, J NATL CANCER I, V93, P1704, DOI 10.1093/jnci/93.22.1704; Brown SL, 2002, ARTHRITIS RHEUM-US, V46, P3151, DOI 10.1002/art.10679; Chung YC, 2003, J SURG ONCOL, V83, P222, DOI 10.1002/jso.10269; Chung YC, 2003, EUR J GASTROEN HEPAT, V15, P369, DOI 10.1097/00042737-200304000-00006; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crespo CJ, 2002, DIABETES CARE, V25, P1675, DOI 10.2337/diacare.25.10.1675; Cushman M, 1999, CIRCULATION, V100, P717, DOI 10.1161/01.CIR.100.7.717; Demissie K, 2004, ANN EPIDEMIOL, V14, P215, DOI 10.1016/j.annepidem.2003.08.002; Du Clos TW, 2000, ANN MED, V32, P274, DOI 10.3109/07853890009011772; DURDEY P, 1984, BRIT J SURG, V71, P881, DOI 10.1002/bjs.1800711126; Erlinger TP, 2004, JAMA-J AM MED ASSOC, V291, P585, DOI 10.1001/jama.291.5.585; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Huls G, 2003, LANCET, V362, P230, DOI 10.1016/S0140-6736(03)13915-3; Kinoshita T, 1999, CANCER, V85, P2526, DOI 10.1002/(SICI)1097-0142(19990615)85:12<2526::AID-CNCR6>3.0.CO;2-3; Komoda H, 1998, WORLD J SURG, V22, P895, DOI 10.1007/s002689900489; MCMILLAN DC, 1995, AM J SURG, V170, P319, DOI 10.1016/S0002-9610(99)80296-7; McMillan DC, 2001, NUTR CANCER, V41, P64, DOI 10.1207/S15327914NC41-1&2_8; McMillan DC, 2003, BRIT J SURG, V90, P215, DOI 10.1002/bjs.4038; Meier-Ewert HK, 2001, CLIN CHEM, V47, P426; MERCER DW, 1985, CLIN CHEM, V31, P1824; Munkholm P, 2003, ALIMENT PHARM THER, V18, P1, DOI 10.1046/j.1365-2036.18.s2.2.x; Nielsen HJ, 2000, ANN SURG ONCOL, V7, P617, DOI 10.1007/BF02725342; Nozoe T, 1998, AM J SURG, V176, P335, DOI 10.1016/S0002-9610(98)00204-9; Ockene IS, 2001, CLIN CHEM, V47, P444; Panes J, 2001, ACTA PHYSIOL SCAND, V173, P159, DOI 10.1046/j.1365-201X.2001.00905.x; Pasche B, 2004, JAMA-J AM MED ASSOC, V291, P623, DOI 10.1001/jama.291.5.623; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Ridker PM, 1999, CIRCULATION, V100, P713, DOI 10.1161/01.CIR.100.7.713; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Ries L, 1975, SEER CANC STAT REV; Sesso HD, 2003, JAMA-J AM MED ASSOC, V290, P2945, DOI 10.1001/jama.290.22.2945; STAMATIADIS AP, 1990, CANCER, V65, P2055, DOI 10.1002/1097-0142(19900501)65:9<2055::AID-CNCR2820650927>3.0.CO;2-6; STAMATIADIS AP, 1992, EUR J SURG ONCOL, V18, P41; van Baal WM, 1999, THROMB HAEMOSTASIS, V81, P925, DOI 10.1055/s-0037-1614600; Vatay A, 2003, IMMUNOGENETICS, V55, P247, DOI 10.1007/s00251-003-0575-8; Wigmore SJ, 2001, BRIT J SURG, V88, P255, DOI 10.1046/j.1365-2168.2001.01669.x; Yuceyar S, 1996, INT SURG, V81, P136; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972	43	105	109	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2005	142	6					425	432		10.7326/0003-4819-142-6-200503150-00008	http://dx.doi.org/10.7326/0003-4819-142-6-200503150-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906DQ	15767620				2022-12-24	WOS:000227621100004
J	Paige, DA				Paige, DA			Ancient mars: Wet in many places	SCIENCE			English	Editorial Material								New results from the Mars Express Orbiter mission reveal multiple deposits of minerals formed in the presence of liquid water. They reinforce the conclusion that ancient Mars was warmer and wetter than it is today, and increase the number of promising localities to search for evidence of past life.	Univ Calif Los Angeles, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Paige, DA (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90095 USA.	dap@mars.ucla.edu						Arvidson RE, 2005, SCIENCE, V307, P1591, DOI 10.1126/science.1109509; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23873, DOI 10.1029/2000JE001415; Feldman WC, 2002, SCIENCE, V297, P75, DOI 10.1126/science.1073541; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; Kirkland LE, 2001, APPL OPTICS, V40, P4852, DOI 10.1364/AO.40.004852; Langevin Y, 2005, SCIENCE, V307, P1584, DOI 10.1126/science.1109091; Langevin Y, 2005, SCIENCE, V307, P1581, DOI 10.1126/science.1109438; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; Mustard JF, 2005, SCIENCE, V307, P1594, DOI 10.1126/science.1109098; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171	12	22	22	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2005	307	5715					1575	1576		10.1126/science.1110530	http://dx.doi.org/10.1126/science.1110530			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15761146				2022-12-24	WOS:000227622400033
J	Riley, J; Ross, JR				Riley, J; Ross, JR			Research into care at the end of life	LANCET			English	Editorial Material							PALLIATIVE CARE		Royal Marsden Hosp Fdn Trust, London SW3 6JJ, England	Royal Marsden NHS Foundation Trust	Riley, J (corresponding author), Royal Marsden Hosp Fdn Trust, London SW3 6JJ, England.	Julia.riley@rmh.nhs.uk						Acquaviva K, 2004, J PAIN SYMPTOM MANAG, V28, P488, DOI 10.1016/j.jpainsymman.2004.08.003; Casarett D, 2001, J Palliat Med, V4, P441, DOI 10.1089/109662101753381566; Casarett DJ, 2000, J PAIN SYMPTOM MANAG, V20, P130, DOI 10.1016/S0885-3924(00)00164-0; Grande GE, 2000, PALLIATIVE MED, V14, P69, DOI 10.1191/026921600677940614; *NIH, 2004, IN PRESS NIH STAT OF; Patrick D, 2004, J NATL CANC I MONOGR, V32, P9; Rees E, 2003, BRIT MED J, V327, P198, DOI 10.1136/bmj.327.7408.198	7	20	21	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB-MAR	2005	365	9461					735	737						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LZ	15733702				2022-12-24	WOS:000227285300007
J	Kim, JK; Gabel, HW; Kamath, RS; Tewari, M; Pasquinelli, A; Rual, JF; Kennedy, S; Dybbs, M; Bertin, N; Kaplan, JM; Vidal, M; Ruvkun, G				Kim, JK; Gabel, HW; Kamath, RS; Tewari, M; Pasquinelli, A; Rual, JF; Kennedy, S; Dybbs, M; Bertin, N; Kaplan, JM; Vidal, M; Ruvkun, G			Functional genomic analysis of RNA interference in C-elegans	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; GERMLINE; GENE; BETA; MAP	RNA interference (RNAi) of target genes is triggered by doubte-stranded RNAs (dsRNAs) processed by conserved nucleases and accessory factors. To identify the genetic components required for RNAi, we performed a genome-wide screen using an engineered RNAi sensor strain of Caenorhabditis elegans. The RNAi screen identified 90 genes. These included Piwi/PAZ proteins, DEAH helicases, RNA binding/processing factors, chromatin-associated factors, DNA recombination proteins, nuclear import/export factors, and 11 known components of the RNAi machinery. We demonstrate that some of these genes are also required for germline and somatic transgene silencing. Moreover, the physical interactions among these potential RNAi factors suggest links to other RNA-dependent gene regulatory pathways.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	ruvkun@molbio.mgh.harvard.edu	Bertin, Nicolas/O-9602-2019; Bertin, Nicolas/C-3025-2008	Rual, Jean-Francois/0000-0003-4465-8819; Bertin, Nicolas/0000-0002-9835-9606; Kennedy, Scott/0000-0002-7974-8155	NIA NIH HHS [K08-AG21613] Funding Source: Medline; NIGMS NIH HHS [GM44619] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG021613] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Chen CCG, 2005, CURR BIOL, V15, P378, DOI 10.1016/j.cub.2005.01.009; Domeier ME, 2000, SCIENCE, V289, P1928, DOI 10.1126/science.289.5486.1928; Dudley NR, 2002, P NATL ACAD SCI USA, V99, P4191, DOI 10.1073/pnas.062605199; Grishok A, 2002, ADV GENET, V46, P339; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kelly WG, 1997, GENETICS, V146, P227; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; MELLO CC, COMMUNICATION; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Pirrotta V, 2002, CELL, V110, P661, DOI 10.1016/S0092-8674(02)00967-4; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; Quimby BB, 2003, CURR OPIN CELL BIOL, V15, P338, DOI 10.1016/S0955-0674(03)00046-2; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Tijsterman M, 2004, CURR BIOL, V14, P111, DOI 10.1016/j.cub.2003.12.029; Vastenhouw NL, 2004, TRENDS GENET, V20, P314, DOI 10.1016/j.tig.2004.04.011; Yochem J, 1998, GENETICS, V149, P1323	26	227	283	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2005	308	5725					1164	1167		10.1126/science.1109267	http://dx.doi.org/10.1126/science.1109267			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TA	15790806				2022-12-24	WOS:000229293400042
J	Gollogly, S				Gollogly, S			Do as I say, not as I do	LANCET			English	Editorial Material																			0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 23	2005	365	9469					1499	1499		10.1016/S0140-6736(05)66421-5	http://dx.doi.org/10.1016/S0140-6736(05)66421-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850635				2022-12-24	WOS:000228651600029
J	Wu, T; Malinverni, J; Ruiz, N; Kim, S; Silhavy, TJ; Kahne, D				Wu, T; Malinverni, J; Ruiz, N; Kim, S; Silhavy, TJ; Kahne, D			Identification of a multicomponent complex required for outer membrane biogenesis in Escherichia coli	CELL			English	Article							CELL-SURFACE; PROTEINS; LIPOPROTEIN; LIPOPOLYSACCHARIDE; EXPORT; GENE; K-12; LOCALIZATION; PATHWAY; SYSTEM	Gram-negative bacteria have an outer membrane (OM) that functions as a barrier to protect the cell from toxic compounds such as antibiotics and detergents. The OM is a highly asymmetric bilayer composed of phospholipids, glycolipids, and proteins. Assembly of this essential organelle occurs outside the cytoplasm in an environment that lacks obvious energy sources such as ATP, and the mechanisms involved are poorly understood. We describe the identification of a multiprotein complex required for the assembly of proteins in the OM of Escherichia coli. We also demonstrate genetic interactions between genes encoding components of this protein assembly complex and imp, which encodes a protein involved in the assembly of lipopolysaccharides (LPS) in the OM. These genetic interactions suggest a role for YfgL, one of the lipoprotein components of the protein assembly complex, in a homeostatic control mechanism that coordinates the overall OM assembly process.	Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; Harvard Univ, Sch Med, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Princeton University; Harvard University; Princeton University; Harvard University; Harvard Medical School	Kahne, D (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	kahne@chemistry.harvard.edu	Kim, Seokhee/C-2303-2018; Wu, Tao/C-7533-2013	Kim, Seokhee/0000-0003-0806-583X; Silhavy, Thomas/0000-0001-7672-5153; Ruiz, Natividad/0000-0002-6369-2206	NIGMS NIH HHS [GM66174, GM34821] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066174, R37GM034821, R01GM034821] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAYER ME, 1968, J VIROL, V2, P346, DOI 10.1128/JVI.2.4.346-356.1968; Bos MP, 2004, P NATL ACAD SCI USA, V101, P9417, DOI 10.1073/pnas.0402340101; BOUVIER J, 1991, J BACTERIOL, V173, P5523, DOI 10.1128/jb.173.17.5523-5531.1991; Boyd D, 2000, J BACTERIOL, V182, P842, DOI 10.1128/JB.182.3.842-847.2000; Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Dartigalongue C, 2001, J BIOL CHEM, V276, P20866, DOI 10.1074/jbc.M100464200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Eggert US, 2001, SCIENCE, V294, P361, DOI 10.1126/science.1063611; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; FREUDL R, 1985, EMBO J, V4, P3593, DOI 10.1002/j.1460-2075.1985.tb04122.x; Fussenegger M, 1996, MOL MICROBIOL, V19, P1095, DOI 10.1046/j.1365-2958.1996.457984.x; Genevrois S, 2003, EMBO J, V22, P1780, DOI 10.1093/emboj/cdg174; GENNITY JM, 1991, J BIOL CHEM, V266, P16458; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; HALEGOUA S, 1979, J MOL BIOL, V130, P39, DOI 10.1016/0022-2836(79)90551-5; HALL MN, 1981, J MOL BIOL, V146, P23, DOI 10.1016/0022-2836(81)90364-8; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; KELLENBERGER E, 1990, MOL MICROBIOL, V4, P697, DOI 10.1111/j.1365-2958.1990.tb00640.x; Kloser A, 1998, MOL MICROBIOL, V27, P1003, DOI 10.1046/j.1365-2958.1998.00746.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; METCALFE M, 1980, FEMS MICROBIOL LETT, V7, P111, DOI 10.1111/j.1574-6941.1980.tb01587.x; MISRA R, 1991, J BIOL CHEM, V266, P13592; MUHLRADT PF, 1973, EUR J BIOCHEM, V35, P471, DOI 10.1111/j.1432-1033.1973.tb02861.x; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; OLIVER DB, 1981, CELL, V25, P765, DOI 10.1016/0092-8674(81)90184-7; ONUFRYK C, 2005, J BACTERIOL, V25, P765; PAGES JM, 1990, BIOCHIMIE, V72, P169, DOI 10.1016/0300-9084(90)90142-4; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; RIED G, 1990, J BACTERIOL, V172, P6048, DOI 10.1128/jb.172.10.6048-6053.1990; Rizzitello AE, 2001, J BACTERIOL, V183, P6794, DOI 10.1128/JB.183.23.6794-6800.2001; Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014; SAMPSON BA, 1989, GENETICS, V122, P491; SCHWEIZER M, 1978, EUR J BIOCHEM, V82, P211, DOI 10.1111/j.1432-1033.1978.tb12013.x; SCIDMORE MA, 1993, MOL BIOL CELL, V4, P1145, DOI 10.1091/mbc.4.11.1145; SILHAVY TJ, 1984, EXPT GENE FUSIONS PL; SMIT J, 1978, J BACTERIOL, V135, P687, DOI 10.1128/JB.135.2.687-702.1978; SNYDER WB, 1995, J BACTERIOL, V177, P4216, DOI 10.1128/jb.177.15.4216-4223.1995; Steeghs L, 1998, NATURE, V392, P449, DOI 10.1038/33046; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; YAMAGUCHI K, 1988, CELL, V53, P423, DOI 10.1016/0092-8674(88)90162-6; Yokota N, 1999, J BIOL CHEM, V274, P30995, DOI 10.1074/jbc.274.43.30995	43	550	561	0	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 22	2005	121	2					235	245		10.1016/j.cell.2005.02.015	http://dx.doi.org/10.1016/j.cell.2005.02.015			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851030	Bronze			2022-12-24	WOS:000228705000011
J	Dejean, A; Solano, PJ; Ayroles, J; Corbara, B; Orivel, J				Dejean, A; Solano, PJ; Ayroles, J; Corbara, B; Orivel, J			Insect behaviour: Arboreal ants build traps to capture prey	NATURE			English	Editorial Material									Univ Toulouse 3, Lab Evolut & Divers Biol, CNRS, UMR 5174, F-31062 Toulouse, France; Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; Univ Clermont Ferrand, Lab Psychol Sociale Cognit, CNRS, ESA 6024, F-63037 Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); University of Illinois System; University of Illinois Urbana-Champaign; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA)	Dejean, A (corresponding author), Univ Toulouse 3, Lab Evolut & Divers Biol, CNRS, UMR 5174, F-31062 Toulouse, France.	orivel@cict.fr	Orivel, Jerome/C-4034-2011	Orivel, Jerome/0000-0002-5636-3228; CORBARA, Bruno/0000-0003-4232-8234; Dejean, Alain/0000-0002-3561-2248				Benson WW, 1985, AMAZONIA, P239; Davidson DW, 1997, BIOL J LINN SOC, V61, P153, DOI 10.1006/bijl.1996.0128; Dejean A, 2003, ARTHROPODS OF TROPICAL FORESTS, P341; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Holldobler B., 1990, pi; MORAIS HC, 1994, INSECT SOC, V41, P339, DOI 10.1007/BF01242307; Offenberg J, 2001, BEHAV ECOL SOCIOBIOL, V49, P304, DOI 10.1007/s002650000303; van Borm S, 2002, P ROY SOC B-BIOL SCI, V269, P2023, DOI 10.1098/rspb.2002.2101	8	88	96	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					973	973		10.1038/434973a	http://dx.doi.org/10.1038/434973a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846335				2022-12-24	WOS:000228524600026
J	Coggon, DIW; Martyn, CN				Coggon, DIW; Martyn, CN			Time and chance: the stochastic nature of disease causation	LANCET			English	Article									Univ Southampton, Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England	University of Southampton	Martyn, CN (corresponding author), Univ Southampton, Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England.	cnm@mrc.soton.ac.uk						*BIBLE, KING JAMES, V11; Pepys Samuel, 1664, DIARY S PEPYS; WHEATLEY HB, PROJECT GUTENBERG RE	3	37	37	1	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 16	2005	365	9468					1434	1437		10.1016/S0140-6736(05)66380-5	http://dx.doi.org/10.1016/S0140-6736(05)66380-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QY	15836893				2022-12-24	WOS:000228401900033
J	Mayer, AL; Kauppi, PE; Angelstam, PK; Zhang, Y; Tikka, PM				Mayer, AL; Kauppi, PE; Angelstam, PK; Zhang, Y; Tikka, PM			Importing timber, exporting ecological impact	SCIENCE			English	Article							FOREST POLICY; CONSERVATION; MANAGEMENT		US EPA, Off Res & Dev, Natl Risk Management Res Lab, Cincinnati, OH 45268 USA; Univ Helsinki, Dept Biol & Environm Sci, FIN-00014 Helsinki, Finland; Swedish Univ Agr Sci, Fac Forest Sci, Sch Forest Engineers, S-75007 Uppsala, Sweden	United States Environmental Protection Agency; University of Helsinki; Swedish University of Agricultural Sciences	Mayer, AL (corresponding author), US EPA, Off Res & Dev, Natl Risk Management Res Lab, Cincinnati, OH 45268 USA.	mayer.audrey@epa.gov	Mayer, AL/AAO-3225-2020	Mayer, AL/0000-0003-3278-1182				Angelstam P, 2003, AMBIO, V32, P527, DOI 10.1639/0044-7447(2003)032[0527:TGAATF]2.0.CO;2; ANGELSTAM P, 2004, ECOL B, V51; BARBIER EB, 1999, WORLD FORESTS SOC EN, P106; Bergeron Y, 2004, FOREST CHRON, V80, P458, DOI 10.5558/tfc80458-4; BERLIK MM, 2002, 26 HARV U; Burnett C, 2003, CONSERV ECOL, V7; Burton PJ, 2003, TOWARDS SUSTAINABLE MANAGEMENT OF THE BOREAL FOREST, P1; Carlson A, 2000, FOREST ECOL MANAG, V131, P215, DOI 10.1016/S0378-1127(99)00215-7; Dekker-Robertson DL, 1998, BIOSCIENCE, V48, P471, DOI 10.2307/1313245; DUDAREV G, 2002, ETLA SERIES B, V195; FILIPTCHOUK AN, 2001, 18 UN EC COMM EUR; Flagstad O, 2003, MOL ECOL, V12, P869, DOI 10.1046/j.1365-294X.2003.01784.x; Hammett AL, 2001, J FOREST, V99, P4; Hanski I, 2000, ANN ZOOL FENN, V37, P271; Lehtonen E, 2003, ENVIRON SCI POLICY, V6, P195, DOI 10.1016/S1462-9011(03)00035-2; Linden H, 2000, WILDLIFE BIOL, V6, P179, DOI 10.2981/wlb.2000.007; Liski J, 2003, CLIMATIC CHANGE, V61, P89, DOI 10.1023/A:1026365005696; LUND HG, 1998, P INT WORKSH JOENS F; Moiseyev A., 1999, World forests, society and environment, P351; Sedjo RA, 2001, FOREST CHRON, V77, P221, DOI 10.5558/tfc77221-2; SEDJO RA, 1995, J FOREST, V93, P25; Sohngen B, 1999, AM J AGR ECON, V81, P1, DOI 10.2307/1244446; *US EMB BEIJ, 2000, FOR PEOPL PRC NAT FO; VEIJOLA P, COMMUNICATION; Wang S, 2004, FOREST POLICY ECON, V6, P71, DOI 10.1016/S1389-9341(02)00078-3; Wernick IK, 2000, J FOREST, V98, P8; Zhang PC, 2000, SCIENCE, V288, P2135, DOI 10.1126/science.288.5474.2135; 2003, XINHUA NEWS AGE 1201	28	128	135	5	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2005	308	5720					359	360		10.1126/science.1109476	http://dx.doi.org/10.1126/science.1109476			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15831743	Green Submitted			2022-12-24	WOS:000228492000034
J	Farmer, H; McCabe, N; Lord, CJ; Tutt, ANJ; Johnson, DA; Richardson, TB; Santarosa, M; Dillon, KJ; Hickson, I; Knights, C; Martin, NMB; Jackson, SP; Smith, GCM; Ashworth, A				Farmer, H; McCabe, N; Lord, CJ; Tutt, ANJ; Johnson, DA; Richardson, TB; Santarosa, M; Dillon, KJ; Hickson, I; Knights, C; Martin, NMB; Jackson, SP; Smith, GCM; Ashworth, A			Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy	NATURE			English	Article							HOMOLOGY-DIRECTED REPAIR; POLY(ADP-RIBOSE) POLYMERASE; REPLICATION FORKS; PROTEIN; CANCER; BREAKS; RECOMBINATION; PHOSPHORYLATION; INHIBITORS; PARP-1	BRCA1 and BRCA2 are important for DNA double-strand break repair by homologous recombination(1), and mutations in these genes predispose to breast and other cancers(2). Poly(ADP-ribose) polymerase ( PARP) is an enzyme involved in base excision repair, a key pathway in the repair of DNA single-strand breaks(3). We show here that BRCA1 or BRCA2 dysfunction unexpectedly and profoundly sensitizes cells to the inhibition of PARP enzymatic activity, resulting in chromosomal instability, cell cycle arrest and subsequent apoptosis. This seems to be because the inhibition of PARP leads to the persistence of DNA lesions normally repaired by homologous recombination. These results illustrate how different pathways cooperate to repair damage, and suggest that the targeted inhibition of particular DNA repair pathways may allow the design of specific and less toxic therapies for cancer.	Canc Res UK Gene Funct & Regulat Grp, London SW3 6JB, England; Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; Guys Hosp, London SE1 9RT, England; KuDOS Pharmaceut Ltd, Cambridge CB4 0WG, England; Univ Cambridge, Gurdon Inst Canc & Dev Biol, Wellcome Trust & Canc REs UK, Cambridge CB2 1QN, England; Univ Cambridge, Dept Zool, Cambridge CB2 1QN, England	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Guy's & St Thomas' NHS Foundation Trust; AstraZeneca; Cancer Research UK; University of Cambridge; University of Cambridge	Ashworth, A (corresponding author), Canc Res UK Gene Funct & Regulat Grp, Fulham Rd, London SW3 6JB, England.	gcmsmith@kudospharma.co.uk; alan.ashworth@icr.ac.uk	Lord, Christopher/AAX-7130-2021; Lord, Christopher J/B-3295-2012; Dry, Kate/I-2328-2014; Jackson, Stephen Philip/R-4548-2019; Santarosa, Manuela/A-7300-2013	Lord, Christopher J/0000-0002-3226-0515; Jackson, Stephen Philip/0000-0001-9317-7937; Santarosa, Manuela/0000-0001-7682-2578; Tutt, Andrew/0000-0001-8715-2901; Hickson, Ian/0000-0002-9167-0514	NCI NIH HHS [F31 CA260794] Funding Source: Medline; Breast Cancer Now [BREAST CANCER NOW RESEARCH CENTRE] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Now		Ame JC, 1999, J BIOL CHEM, V274, P17860, DOI 10.1074/jbc.274.25.17860; Arnaudeau C, 2001, J MOL BIOL, V307, P1235, DOI 10.1006/jmbi.2001.4564; Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Boulton S, 1999, CARCINOGENESIS, V20, P199, DOI 10.1093/carcin/20.2.199; Dantzer F, 1999, BIOCHIMIE, V81, P69, DOI 10.1016/S0300-9084(99)80040-6; Dillon KJ, 2003, J BIOMOL SCREEN, V8, P347, DOI 10.1177/1087057103008003013; Foray N, 2003, EMBO J, V22, P2860, DOI 10.1093/emboj/cdg274; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; Haber JE, 1999, TRENDS BIOCHEM SCI, V24, P271, DOI 10.1016/S0968-0004(99)01413-9; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Kickhoefer VA, 1999, J CELL BIOL, V146, P917, DOI 10.1083/jcb.146.5.917; Kraakman-van der Zwet M, 2002, MOL CELL BIOL, V22, P669, DOI 10.1128/MCB.22.2.669-679.2002; LOH VM, IN PRESS BIOINORG ME; Lomonosov M, 2003, GENE DEV, V17, P3017, DOI 10.1101/gad.279003; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Schultz N, 2003, NUCLEIC ACIDS RES, V31, P4959, DOI 10.1093/nar/gkg703; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Tutt A, 2002, TRENDS MOL MED, V8, P571, DOI 10.1016/S1471-4914(02)02434-6; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; Wang ZQ, 1997, GENE DEV, V11, P2347, DOI 10.1101/gad.11.18.2347; Wooster R, 2003, NEW ENGL J MED, V348, P2339, DOI 10.1056/NEJMra012284	22	4330	4496	29	687	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 14	2005	434	7035					917	921		10.1038/nature03445	http://dx.doi.org/10.1038/nature03445			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915SV	15829967				2022-12-24	WOS:000228327600045
J	Mehta, RH; Alexander, JH; Van de Werf, F; Armstrong, PW; Pieper, KS; Garg, J; Califf, RM; Granger, CB				Mehta, RH; Alexander, JH; Van de Werf, F; Armstrong, PW; Pieper, KS; Garg, J; Califf, RM; Granger, CB			Relationship of incorrect dosing of fibrinolytic therapy and clinical outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; MEDICATION ERRORS; THROMBOLYSIS; TRIAL; PREDICTORS; MORTALITY; ALTEPLASE; BENEFITS; STROKE; AGENTS	Context Incorrect dosing of alteplase has been associated with worse clinical outcomes in patients. However, patients at high risk of adverse events are more prone to dosing errors, thus confounding this relationship. Objective To determine if the association between incorrect dosing of alteplase and adverse outcomes is related to cause and effect or to confounding. Design, Setting, and Patients Observational analysis in May 2004 of a double-blind, double-dummy trial of 16949 patients with ST-segment elevation myocardial infarction who were enrolled in the Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) trial and were assigned to either a bolus of tenecteplase (with alteplase placebo bolus plus infusion) or a bolus of alteplase (with tenecteplase placebo plus infusion). Main Outcome Measures Thirty-day mortality, in-hospital stroke, and major bleeding associated with incorrect dosing of active alteplase compared with placebo alteplase. Results Incorrect dosing occurred in 4.9% of patients who received active alteplase and in 4.6% of patients who received alteplase placebo. Patients receiving incorrect doses of alteplase or alteplase placebo were more likely to be older, female, black, shorter, have lower body weight and systolic blood pressure, and have a higher Killip class at presentation. Thirty-day mortality was higher in patients who received an overdose (9.8%) or underdose (19.5%) of alteplase compared with those who received a correct dose (5.4%). The same pattern was present in patients who received an alteplase placebo (10.0% for overdose, 23.5% for underclose, and 5.4% for correct dose). Similar patterns were seen for in-hospital intracranial hemorrhage and major bleeding. The higher rates of adverse outcomes with incorrect dosing were largely accounted for by adjusting for baseline characteristics. Conclusions The relationship between incorrect dosing and patient outcome in ASSENT-2 is primarily due to confounding factors rather than incorrect dosing itself. These data highlight the need for caution when ascribing a causal relationship to associations between incorrect dosing and adverse outcomes.	Duke Univ, Med Ctr, Durham, NC 27710 USA; Duke Clin Res Inst, Durham, NC USA; Katholieke Univ Leuven Hosp, Dept Internal Med, Div Cardiol, Louvain, Belgium; Univ Alberta, Dept Internal Med, Div Cardiol, Edmonton, AB, Canada	Duke University; Duke University; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; University of Alberta	Granger, CB (corresponding author), Duke Univ, Med Ctr, Box 3409, Durham, NC 27710 USA.	grang001@mc.duke.edu	Alexander, John/GVS-7271-2022; Granger, Christopher B/D-3458-2014	Granger, Christopher B/0000-0002-0045-3291; Van de Werf, Frans/0000-0001-9479-7767; Armstrong, Paul/0000-0002-0460-3445; Alexander, John/0000-0002-1444-2462				Berkowitz SD, 1997, CIRCULATION, V95, P2508, DOI 10.1161/01.CIR.95.11.2508; Cannon CP, 2000, AM HEART J, V140, pS154, DOI 10.1067/mhj.2000.111605; Cannon CP, 2000, AM J CARDIOL, V85, p17C; COULTER SA, 2000, CIRCULATION S2, V102, P1590; Freedman JE, 2002, CIRCULATION, V106, P2623, DOI 10.1161/01.CIR.0000037748.19282.7D; GORE JM, 1995, CIRCULATION, V92, P2811, DOI 10.1161/01.CIR.92.10.2811; GRANGER CB, 1994, CIRCULATION S1, V90, P1324; Gurwitz JH, 1998, ANN INTERN MED, V129, P597, DOI 10.7326/0003-4819-129-8-199810150-00002; LEE KL, 1995, CIRCULATION, V91, P1659, DOI 10.1161/01.CIR.91.6.1659; Phillips DP, 1998, LANCET, V351, P643, DOI 10.1016/S0140-6736(98)24009-8; SMALLING RW, 1995, CIRCULATION, V91, P2725, DOI 10.1161/01.CIR.91.11.2725; Van de Werf F, 1999, LANCET, V354, P716, DOI 10.1016/S0140-6736(99)07403-6; VORCHHEIMER DA, 1997, CIRCULATION S1, V96, P1535	13	13	14	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2005	293	14					1746	1750		10.1001/jama.293.14.1746	http://dx.doi.org/10.1001/jama.293.14.1746			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	915JS	15827313	Bronze			2022-12-24	WOS:000228301100028
J	Crombie, C; Fraser, A				Crombie, C; Fraser, A			Treating genetic disease through RNA interference	LANCET			English	Editorial Material							CELLS		Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Wellcome Trust Sanger Institute	Fraser, A (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	agf@sanger.ac.uk		Fraser, Andrew/0000-0001-9939-6014				Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Reich S, 2003, MOL VIS, V9, P210; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121	7	4	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2005	365	9467					1288	1290		10.1016/S0140-6736(05)61006-9	http://dx.doi.org/10.1016/S0140-6736(05)61006-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	914HY	15823365				2022-12-24	WOS:000228219600007
J	Huber, D; Veinante, P; Stoop, R				Huber, D; Veinante, P; Stoop, R			Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala	SCIENCE			English	Article							EXTENDED AMYGDALA; BINDING SITES; IN-VITRO; RAT; BEHAVIOR; BRAIN; RELEASE; NUCLEUS; ANTAGONIST; EXPRESSION	Vasopressin and oxytocin strongly modulate autonomic fear responses, through mechanisms that are still unclear. We describe how these neuro-peptides excite distinct neuronal populations in the central amygdala, which provides the major output of the amygdaloid complex to the autonomic nervous system. We identified these two neuronal. populations as part of an inhibitory network, through which vasopressin and oxytocin modulate the integration of excitatory information from the basolateral amygdala and cerebral cortex in opposite manners. Through this network, the expression and endogenous activation of vasopressin and oxytocin receptors may regulate the autonomic expression of fear.	Univ Lausanne, Ctr Hosp Univ Vaudois, Dept Cellular Biol & Morphol, CH-1015 Lausanne, Switzerland; Univ Lausanne, Ctr Hosp Univ Vaudois, Dept Psychiat, Ctr Psychiat Neurosci, CH-1015 Lausanne, Switzerland; Univ Strasbourg 1, CNRS, UMR 7519, Strasbourg, France	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Stoop, R (corresponding author), Univ Lausanne, Ctr Hosp Univ Vaudois, Dept Cellular Biol & Morphol, CH-1015 Lausanne, Switzerland.	rstoop@unil.ch	Huber, Daniel/C-2932-2013	Huber, Daniel/0000-0002-0744-7679; Veinante, Pierre/0000-0002-6608-8960				Bale TL, 2001, J NEUROSCI, V21, P2546, DOI 10.1523/JNEUROSCI.21-07-02546.2001; Bielsky IF, 2004, NEUROPSYCHOPHARMACOL, V29, P483, DOI 10.1038/sj.npp.1300360; Cassell MD, 1999, ANN NY ACAD SCI, V877, P217, DOI 10.1111/j.1749-6632.1999.tb09270.x; Champagne F, 2001, P NATL ACAD SCI USA, V98, P12736, DOI 10.1073/pnas.221224598; CONDESLARA M, 1994, BRAIN RES, V637, P277, DOI 10.1016/0006-8993(94)91245-9; DEVRIES GJ, 1983, BRAIN RES, V273, P307, DOI 10.1016/0006-8993(83)90855-7; Ebner K, 2005, NEUROPSYCHOPHARMACOL, V30, P223, DOI 10.1038/sj.npp.1300607; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Francis DD, 2002, J NEUROENDOCRINOL, V14, P349, DOI 10.1046/j.0007-1331.2002.00776.x; Griebel G, 2002, P NATL ACAD SCI USA, V99, P6370, DOI 10.1073/pnas.092012099; Kang-Park MH, 2004, NEUROPHARMACOLOGY, V46, P1, DOI 10.1016/S0028-3908(03)00340-X; Koob GF, 2003, EUR NEUROPSYCHOPHARM, V13, P442, DOI 10.1016/j.euroneuro.2003.08.005; KOVACS GL, 1994, PHARMACOL REV, V46, P269; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lu YF, 1997, BRAIN RES, V768, P266, DOI 10.1016/S0006-8993(97)00655-0; Lubin DA, 2003, BEHAV NEUROSCI, V117, P195, DOI 10.1037/0735-7044.117.2.195; McDonald AJ, 1999, ANN NY ACAD SCI, V877, P309, DOI 10.1111/j.1749-6632.1999.tb09275.x; Nie ZG, 2004, SCIENCE, V303, P1512, DOI 10.1126/science.1092550; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Raggenbass M, 2001, PROG NEUROBIOL, V64, P307, DOI 10.1016/S0301-0082(00)00064-2; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Savander V, 1996, J COMP NEUROL, V374, P291, DOI 10.1002/(SICI)1096-9861(19961014)374:2<291::AID-CNE10>3.0.CO;2-Y; SOFRONIEW MV, 1983, TRENDS NEUROSCI, V6, P467, DOI 10.1016/0166-2236(83)90221-7; Veinante P, 1997, J COMP NEUROL, V383, P305; Windle RJ, 1997, ENDOCRINOLOGY, V138, P2829, DOI 10.1210/en.138.7.2829	27	601	623	1	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2005	308	5719					245	248		10.1126/science.1105636	http://dx.doi.org/10.1126/science.1105636			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915BX	15821089				2022-12-24	WOS:000228273700051
J	Bricelj, VM; Connell, L; Konoki, K; MacQuarrie, SP; Scheuer, T; Catterall, WA; Trainer, VL				Bricelj, VM; Connell, L; Konoki, K; MacQuarrie, SP; Scheuer, T; Catterall, WA; Trainer, VL			Sodium channel mutation leading to saxitoxin resistance in clams increases risk of PSP	NATURE			English	Article							SITE-DIRECTED MUTAGENESIS; TETRODOTOXIN; INSENSITIVITY; ADAPTATION; MECHANISMS; BINDING; TOXINS; REGION; GENE	Bivalve molluscs, the primary vectors of paralytic shellfish poisoning (PSP) in humans, show marked inter-species variation in their capacity to accumulate PSP toxins (PSTs)(1) which has a neural basis(2,3). PSTs cause human fatalities by blocking sodium conductance in nerve fibres(4,5). Here we identify a molecular basis for inter-population variation in PSP resistance within a species, consistent with genetic adaptation to PSTs. Softshell clams (Mya arenaria) from areas exposed to 'red tides' are more resistant to PSTs, as demonstrated by whole-nerve assays, and accumulate toxins at greater rates than sensitive clams from unexposed areas. PSTs lead to selective mortality of sensitive clams. Resistance is caused by natural mutation of a single amino acid residue, which causes a 1,000-fold decrease in affinity at the saxitoxin-binding site in the sodium channel pore of resistant, but not sensitive, clams. Thus PSTs might act as potent natural selection agents, leading to greater toxin resistance in clam populations and increased risk of PSP in humans. Furthermore, global expansion of PSP to previously unaffected coastal areas(6) might result in long-term changes to communities and ecosystems.	Natl Res Council Canada, Inst Marine Biosci, Halifax, NS B3H 3Z1, Canada; Univ Maine, Sch Marine Sci, Orono, ME 04469 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; NOAA Fisheries, NW Fisheries Sci Ctr, Seattle, WA 98112 USA	International Business Machines (IBM); National Research Council Canada; University of Maine System; University of Maine Orono; University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA	Bricelj, VM (corresponding author), Natl Res Council Canada, Inst Marine Biosci, Halifax, NS B3H 3Z1, Canada.	monica.bricelj@nrc-cnrc.gc.ca	Trainer, Vera/AAE-9306-2022; KONOKI, Keiichi/U-2249-2019					AULD VJ, 1990, P NATL ACAD SCI USA, V87, P323, DOI 10.1073/pnas.87.1.323; Bricelj V, 1996, HARMFUL TOXIC ALGAL, P405; Bricelj V. Monica, 1998, Reviews in Fisheries Science, V6, P315, DOI 10.1080/10641269891314294; BRICELJ VM, 1991, MAR ECOL PROG SER, V74, P33, DOI 10.3354/meps074033; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Fozzard HA, 1996, PHYSIOL REV, V76, P887, DOI 10.1152/physrev.1996.76.3.887; Geffeney S, 2002, SCIENCE, V297, P1336, DOI 10.1126/science.1074310; Hallegraeff G. M., 2003, MANUAL HARMFUL MARIN, P25; He HQ, 1999, BIOCHEM BIOPH RES CO, V261, P558, DOI 10.1006/bbrc.1999.1076; HILLE B, 1968, J GEN PHYSIOL, V51, P199, DOI 10.1085/jgp.51.2.199; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; KONTIS KJ, 1993, MOL PHARMACOL, V43, P635; KVITEK RG, 1991, MAR ECOL PROG SER, V69, P47, DOI 10.3354/meps069047; Linford NJ, 1998, P NATL ACAD SCI USA, V95, P13947, DOI 10.1073/pnas.95.23.13947; LIPKIND GM, 1994, BIOPHYS J, V66, P1, DOI 10.1016/S0006-3495(94)80746-5; Liu MY, 1998, ARCH INSECT BIOCHEM, V37, P73, DOI 10.1002/(SICI)1520-6327(1998)37:1&lt;73::AID-ARCH9&gt;3.0.CO;2-W; MACQUARRIE S. P., 2002, THESIS DALHOUSIE U; Martin JL., 1996, HARMFUL TOXIC ALGAL, P3; NARAHASHI T, 1968, J GEN PHYSIOL, V51, pS93; Oshima Y, 1995, MANUAL HARMFUL MARIN, P81; SATIN J, 1992, SCIENCE, V256, P1202, DOI 10.1126/science.256.5060.1202; Sivilotti L, 1997, FEBS LETT, V409, P49, DOI 10.1016/S0014-5793(97)00479-1; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; TERLAU H, 1991, FEBS LETT, V293, P93, DOI 10.1016/0014-5793(91)81159-6; TWAROG BM, 1972, TOXICON, V10, P273, DOI 10.1016/0041-0101(72)90012-8; Twarog BM, 1974, P 2 INT COR REEF S, P505; Yamane M, 2003, INST GLOB ENVIRONM S, V3, P3	27	237	251	5	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2005	434	7034					763	767		10.1038/nature03415	http://dx.doi.org/10.1038/nature03415			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	913NU	15815630				2022-12-24	WOS:000228160700041
J	Strom, BL				Strom, BL			Statins and over-the counter availibility	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Strom, BL (corresponding author), Univ Penn, Sch Med, Philadelphia, PA 19104 USA.								0	18	18	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 7	2005	352	14					1403	1405		10.1056/NEJMp058025	http://dx.doi.org/10.1056/NEJMp058025			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	913IP	15814874				2022-12-24	WOS:000228145200001
J	Jenner, L; Romby, P; Rees, B; Schulze-Briese, C; Springer, M; Ehresmann, C; Ehresmann, B; Moras, D; Yusupova, G; Yusupov, M				Jenner, L; Romby, P; Rees, B; Schulze-Briese, C; Springer, M; Ehresmann, C; Ehresmann, B; Moras, D; Yusupova, G; Yusupov, M			Translational operator of mRNA on the ribosome: How repressor proteins exclude ribosome binding	SCIENCE			English	Article							RAY CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; ANGSTROM RESOLUTION; SYNTHETASE GENE; SUBUNIT; SITE; EXPRESSION; S1	The ribosome of Thermus thermophilus was cocrystallized with initiator transfer RNA (tRNA) and a structured messenger RNA (mRNA) carrying a translational operator. The path of the mRNA was defined at 5.5 angstroms resolution by comparing it with either the crystal structure of the same ribosomal complex lacking mRNA or with an unstructured mRNA. A precise ribosomal environment positions the operator stem-loop structure perpendicular to the surface of the ribosome on the platform of the 30S subunit. The binding of the operator and of the initiator tRNA occurs on the ribosome with an unoccupied tRNA exit site, which is expected for an initiation complex. The positioning of the regulatory domain of the operator relative to the ribosome elucidates the molecular mechanism by which the bound repressor switches off translation. Our data suggest a general way in which mRNA control elements must be placed on the ribosome to perform their regulatory task.	Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France; Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France; Paul Scherrer Inst, Swiss Light Source, CH-8048 Zurich, Switzerland; Inst Biol Physicochim, F-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Yusupov, M (corresponding author), Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France.	marat@titus.u-strasbg.fr	ROMBY, Pascale/AGP-3328-2022; Yusupov, Marat/I-6126-2013; Yusupova, Gulnara/E-1877-2014; Jenner, Lasse/H-1584-2017	Yusupov, Marat/0000-0001-5544-0597; Jenner, Lasse/0000-0003-3917-8853				Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Blaha G, 2001, COLD SPRING HARB SYM, V66, P135, DOI 10.1101/sqb.2001.66.135; Caillet J, 2003, MOL MICROBIOL, V47, P961, DOI 10.1046/j.1365-2958.2003.03364.x; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Dallas A, 2001, MOL CELL, V8, P855, DOI 10.1016/S1097-2765(01)00356-2; GRAFFE M, 1992, SCIENCE, V255, P994, DOI 10.1126/science.1372129; Gromadski KB, 2004, MOL CELL, V13, P191, DOI 10.1016/S1097-2765(04)00005-X; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; KEITH GM, UNPUB; Komarova AV, 2002, RNA, V8, P1137, DOI 10.1017/S1355838202029990; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; Nogueira T, 2001, J MOL BIOL, V310, P709, DOI 10.1006/jmbi.2001.4796; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Romby P, 2003, TRENDS GENET, V19, P155, DOI 10.1016/S0168-9525(03)00020-9; Sacerdot C, 1998, MOL MICROBIOL, V29, P1077, DOI 10.1046/j.1365-2958.1998.00995.x; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Schlax PJ, 2003, MOL MICROBIOL, V48, P1157, DOI 10.1046/j.1365-2958.2003.03517.x; Sengupta J, 2001, P NATL ACAD SCI USA, V98, P11991, DOI 10.1073/pnas.211266898; SPIRIN A, 1998, METHOD ENZYMOL, V164, P631; Torres-Larios A, 2002, NAT STRUCT BIOL, V9, P343, DOI 10.1038/nsb789; Vila-Sanjurjo A, 2003, P NATL ACAD SCI USA, V100, P8682, DOI 10.1073/pnas.1133380100; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	25	76	83	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2005	308	5718					120	123		10.1126/science.1105639	http://dx.doi.org/10.1126/science.1105639			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914IQ	15802605				2022-12-24	WOS:000228221500047
J	Kinjo, Y; Wu, D; Kim, GS; Xing, GW; Poles, MA; Ho, DD; Tsuji, M; Kawahara, K; Wong, CH; Kronenberg, M				Kinjo, Y; Wu, D; Kim, GS; Xing, GW; Poles, MA; Ho, DD; Tsuji, M; Kawahara, K; Wong, CH; Kronenberg, M			Recognition of bacterial glycosphingolipids by natural killer T cells	NATURE			English	Article							NKT CELLS; ALPHA-GALACTOSYLCERAMIDE; CUTTING EDGE; ACTIVATION	Natural killer T (NKT) cells constitute a highly conserved T lymphocyte subpopulation that has the potential to regulate many types of immune responses through the rapid secretion of cytokines(1,2). NKT cells recognize glycolipids presented by CD1d, a class I-like antigen- presenting molecule. They have an invariant T-cell antigen receptor (TCR) alpha-chain, but whether this invariant TCR recognizes microbial antigens is still controversial. Here we show that most mouse and human NKT cells recognize glycosphingolipids from Sphingomonas, Gram-negative bacteria that do not contain lipopolysaccharide(3-5). NKT cells are activated in vivo after exposure to these bacterial antigens or bacteria, and mice that lack NKT cells have a marked defect in the clearance of Sphingomonas from the liver. These data suggest that NKT cells are T lymphocytes that provide an innate-type immune response to certain microorganisms through recognition by their antigen receptor, and that they might be useful in providing protection from bacteria that cannot be detected by pattern recognition receptors such as Toll-like receptor 4.	La Jolla Inst Allergy & Immunol, Div Dev Immunol, San Diego, CA 92121 USA; Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; NYU, Sch Med, Dept Med, Div Gastroenterol, New York, NY 10016 USA; Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA; NYU, Sch Med, Dept Med & Mol Parasitol, New York, NY 10010 USA; Kitasato Inst, Minato Ku, Tokyo 1088642, Japan	La Jolla Institute for Immunology; Scripps Research Institute; Scripps Research Institute; New York University; Rockefeller University; New York University	Kronenberg, M (corresponding author), La Jolla Inst Allergy & Immunol, Div Dev Immunol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.	mitch@liai.org	Tsuji, Moriya/B-1471-2008	Poles, Michael/0000-0002-7993-6156; Tsuji, Moriya/0000-0001-8587-277X				Amprey JL, 2004, J EXP MED, V200, P895, DOI 10.1084/jem.20040704; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; Brossay L, 1998, J IMMUNOL, V161, P5124; Cheroutre H, 2004, ANNU REV IMMUNOL, V22, P217, DOI 10.1146/annurev.immunol.22.012703.104522; FISCHER B, 1985, FERTILITAT, V1, P101; Fujii S, 2002, NAT IMMUNOL, V3, P867, DOI 10.1038/ni827; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Gonzalez-Aseguinolaza G, 2002, J EXP MED, V195, P617, DOI 10.1084/jem.20011889; Kawahara K, 2002, FEMS MICROBIOL LETT, V214, P289; KAWAHARA K, 1991, FEBS LETT, V292, P107, DOI 10.1016/0014-5793(91)80845-T; Kawahara K, 2000, EUR J BIOCHEM, V267, P1837, DOI 10.1046/j.1432-1327.2000.01189.x; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kobayashi E, 1995, ONCOL RES, V7, P529; Lehuen A, 1998, J EXP MED, V188, P1831, DOI 10.1084/jem.188.10.1831; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Matsuda JL, 2003, P NATL ACAD SCI USA, V100, P8395, DOI 10.1073/pnas.1332805100; Matsuda JL, 2001, P NATL ACAD SCI USA, V98, P12636, DOI 10.1073/pnas.221445298; Mempel M, 2002, J IMMUNOL, V168, P365, DOI 10.4049/jimmunol.168.1.365; Neef A, 1999, J IND MICROBIOL BIOT, V23, P261, DOI 10.1038/sj.jim.2900768; Park SH, 2000, EUR J IMMUNOL, V30, P620, DOI 10.1002/1521-4141(200002)30:2<620::AID-IMMU620>3.0.CO;2-4; Schumann J, 2003, J IMMUNOL, V170, P5815, DOI 10.4049/jimmunol.170.12.5815; Shaw PX, 2003, J IMMUNOL, V170, P6151, DOI 10.4049/jimmunol.170.12.6151; Sidobre S, 2004, P NATL ACAD SCI USA, V101, P12254, DOI 10.1073/pnas.0404632101; Skold M, 2003, INFECT IMMUN, V71, P5447, DOI 10.1128/IAI.71.10.5447-5455.2003; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Vincent MS, 2003, NAT IMMUNOL, V4, P517, DOI 10.1038/ni0603-517; Wu DY, 2003, J EXP MED, V198, P173, DOI 10.1084/jem.20030446; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	30	741	772	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2005	434	7032					520	525		10.1038/nature03407	http://dx.doi.org/10.1038/nature03407			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909CH	15791257				2022-12-24	WOS:000227836000045
J	Stukel, TA; Lucas, FL; Wennberg, DE				Stukel, TA; Lucas, FL; Wennberg, DE			Long-term outcomes of regional variations in intensity of invasive vs medical management of medicare patients with acute myocardial infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LIPID-LOWERING THERAPY; ELDERLY-PATIENTS; CORONARY-ANGIOGRAPHY; CARDIAC PROCEDURES; UNSTABLE ANGINA; UNITED-STATES; THROMBOLYTIC THERAPY; GEOGRAPHIC-VARIATION; PRIMARY ANGIOPLASTY; QUALITY	Context The health and policy implications of the marked regional variations in intensity of invasive compared with medical management of patients with acute myocardial infarction (AMI) are unknown. Objectives To evaluate patient clinical characteristics associated with receiving more intensive treatment; and to assess whether AMI patients residing in regions with more intensive invasive treatment and management strategies have better long-term survival than those residing in regions with more intensive medical management strategies. Design, Setting, and Patients National cohort study of 158 831 elderly Medicare patients hospitalized with first episode of confirmed AMI in 1994-1995, followed up for 7 years (mean, 3.6 years), according to the intensity of invasive management (performance of cardiac catheterization within 30 days) and medical management (prescription of beta-blockers to appropriate patients at discharge) in their region of residence. Baseline chart reviews were drawn from the Cooperative Cardiovascular Project and linked to Medicare health administrative data. Main Outcome Measure Long-term survival over 7 years of follow-up. Results Patient baseline AMI severity was similar across regions. In all regions, younger and healthier patients were more likely than older high-risk patients to receive invasive treatment and medical therapy. Regions with more invasive treatment practice styles had more cardiac catheterization laboratory capacity; patients in these regions were more likely to receive interventional treatment, regardless of age, clinical indication, or risk profile. The absolute unadjusted difference in 7-year survival between regions providing the highest rates of both invasive and medical management strategies and those providing the lowest rates of both was 6.2%. For both ST- and non-ST-segment elevation AMI patients, survival improved with regional intensity of both invasive and medical management. In areas with higher rates of medical management, there appeared to be little or no improvement in survival associated with increased invasive treatment. Conclusions In elderly Medicare patients with AMI, more intensive medical treatment provides population survival benefits. However, routine use of more costly and invasive treatment strategies may not be associated with an overall population benefit beyond that seen with excellent medical management. Efforts should focus on directing invasive clinical resources to patients with the greatest expected benefit.	Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; Dartmouth Coll Sch Med, Ctr Evaluat Clin Sci, Hanover, NH USA; Univ Toronto, Fac Med, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; Maine Med Ctr, Ctr Outcomes Res & Evaluat, Portland, ME 04102 USA	University of Toronto; Dartmouth College; University of Toronto; Maine Medical Center	Stukel, TA (corresponding author), Inst Clin Evaluat Sci, G106-2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	stukel@ices.on.ca		Stukel, Therese/0000-0002-2951-1360	NIA NIH HHS [P01 AG019783, 1PO1-AG19783-01] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alter DA, 2001, JAMA-J AM MED ASSOC, V285, P2101, DOI 10.1001/jama.285.16.2101; Aronow HD, 2003, ARCH INTERN MED, V163, P2576, DOI 10.1001/archinte.163.21.2576; Bach RG, 2004, ANN INTERN MED, V141, P186, DOI 10.7326/0003-4819-141-3-200408030-00007; BLUSTEIN J, 1993, JAMA-J AM MED ASSOC, V270, P344, DOI 10.1001/jama.270.3.344; Boden WE, 1998, NEW ENGL J MED, V338, P1785, DOI 10.1056/NEJM199806183382501; Braunwald E, 2003, CIRCULATION, V108, P28; Brophy JM, 2004, ANN INTERN MED, V141, P292, DOI 10.7326/0003-4819-141-4-200408170-00009; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Cox D. R., 1984, ANAL SURVIVAL DATA; COX DR, 1968, J ROY STAT SOC B, V30, P248, DOI 10.1111/j.2517-6161.1968.tb00724.x; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fonarow GC, 2001, AM J CARDIOL, V87, P819, DOI 10.1016/S0002-9149(00)01519-8; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Gattis WA, 2004, J AM COLL CARDIOL, V43, P1534, DOI 10.1016/j.jacc.2003.12.040; Guadagnoli E, 2000, NEW ENGL J MED, V343, P1460, DOI 10.1056/NEJM200011163432006; GUADAGNOLI E, 1995, NEW ENGL J MED, V333, P573, DOI 10.1056/NEJM199508313330908; Guadagnoli E, 2001, MED CARE, V39, P446, DOI 10.1097/00005650-200105000-00005; Henderson RA, 2003, J AM COLL CARDIOL, V42, P1161, DOI 10.1016/S0735-1097(03)00951-3; Hlatky MA, 2004, NEW ENGL J MED, V350, P2126, DOI 10.1056/NEJMp048071; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P305, DOI 10.1001/jama.289.3.305; Jencks SF, 2000, JAMA-J AM MED ASSOC, V284, P1670, DOI 10.1001/jama.284.13.1670; Kaul P, 2004, CIRCULATION, V110, P1754, DOI 10.1161/01.CIR.0000142671.06167.91; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Keeley EC, 2004, ANN INTERN MED, V141, P298, DOI 10.7326/0003-4819-141-4-200408170-00010; Ko DT, 2004, JAMA-J AM MED ASSOC, V291, P1864, DOI 10.1001/jama.291.15.1864; Krumholz HM, 1999, ANN INTERN MED, V131, P648, DOI 10.7326/0003-4819-131-9-199911020-00003; Krumholz HM, 1997, JAMA-J AM MED ASSOC, V277, P1683, DOI 10.1001/jama.277.21.1683; Krumholz HM, 2003, AM HEART J, V146, P242, DOI 10.1016/S0002-8703(03)00237-0; Krumholz HM, 1998, JAMA-J AM MED ASSOC, V280, P623, DOI 10.1001/jama.280.7.623; Krumholz HM, 1998, CIRCULATION, V98, P2010, DOI 10.1161/01.CIR.98.19.2010; Lagerqvist B, 2002, J AM COLL CARDIOL, V40, P1902, DOI 10.1016/S0735-1097(02)02572-X; LIN DY, 1994, STAT MED, V13, P2233, DOI 10.1002/sim.4780132105; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; MARK DB, 1994, NEW ENGL J MED, V331, P1130, DOI 10.1056/NEJM199410273311706; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; Newhouse JP, 1998, ANNU REV PUBL HEALTH, V19, P17, DOI 10.1146/annurev.publhealth.19.1.17; O'Connor GT, 1999, JAMA-J AM MED ASSOC, V281, P627, DOI 10.1001/jama.281.7.627; Petersen LA, 2003, NEW ENGL J MED, V348, P2209, DOI 10.1056/NEJMsa021725; Petersen LA, 2001, CIRCULATION, V104, P2898, DOI 10.1161/hc4901.100524; Pilote L, 1996, NEW ENGL J MED, V335, P1198, DOI 10.1056/NEJM199610173351606; PILOTE L, 1995, NEW ENGL J MED, V333, P565, DOI 10.1056/NEJM199508313330907; Rosenbaum P. R., 2002, OBSERVATIONAL STUDIE; Ryan TJ, 1999, J AM COLL CARDIOL, V34, P890, DOI 10.1016/S0735-1097(99)00351-4; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Selby JV, 1996, NEW ENGL J MED, V335, P1888, DOI 10.1056/NEJM199612193352506; Solomon DH, 2001, J AM COLL CARDIOL, V38, P969, DOI 10.1016/S0735-1097(01)01503-0; Tu JV, 1997, NEW ENGL J MED, V336, P1500, DOI 10.1056/NEJM199705223362106; Wennberg D.E, 1999, DARTMOUTH ATLAS CARD; Wennberg DE, 1996, JAMA-J AM MED ASSOC, V275, P1161, DOI 10.1001/jama.275.15.1161; Wennberg DE, 2004, JAMA-J AM MED ASSOC, V292, P1961, DOI 10.1001/jama.292.16.1961; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1	52	109	125	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2005	293	11					1329	1337		10.1001/jama.293.11.1329	http://dx.doi.org/10.1001/jama.293.11.1329			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907EP	15769966	Green Accepted			2022-12-24	WOS:000227698600021
J	Cowan, ML; Bruner, BD; Huse, N; Dwyer, JR; Chugh, B; Nibbering, ETJ; Elsaesser, T; Miller, RJD				Cowan, ML; Bruner, BD; Huse, N; Dwyer, JR; Chugh, B; Nibbering, ETJ; Elsaesser, T; Miller, RJD			Ultrafast memory loss and energy redistribution in the hydrogen bond network of liquid H2O	NATURE			English	Article							INFRARED-SPECTROSCOPY; VIBRATIONAL-RELAXATION; ICE IH; WATER; DYNAMICS; SPECTRA	Many of the unusual properties of liquid water are attributed to its unique structure, comprised of a random and fluctuating three-dimensional network of hydrogen bonds that link the highly polar water molecules(1,2). One of the most direct probes of the dynamics of this network is the infrared spectrum of the OH stretching vibration(3-11), which reflects the distribution of hydrogen-bonded structures and the intermolecular forces controlling the structural dynamics of the liquid. Indeed, water dynamics has been studied in detail(5-14), most recently using multi-dimensional nonlinear infrared spectroscopy(15,16) for acquiring structural and dynamical information on femtosecond timescales. But owing to technical difficulties, only OH stretching vibrations in D2O or OD vibrations in H2O could be monitored. Here we show that using a specially designed, ultrathin sample cell allows us to observe OH stretching vibrations in H2O. Under these fully resonant conditions, we observe hydrogen bond network dynamics more than one order of magnitude faster than seen in earlier studies that include an extremely fast sweep in the OH frequencies on a 50-fs timescale and an equally fast disappearance of the initial inhomogeneous distribution of sites. Our results highlight the efficiency of energy redistribution within the hydrogen-bonded network, and that liquid water essentially loses the memory of persistent correlations in its structure within 50 fs.	Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; Univ Toronto, Dept Phys, Toronto, ON M5S 3H6, Canada; Max Born Inst Nichtlineare Opt & Kurzzeitspektros, D-12489 Berlin, Germany	University of Toronto; University of Toronto; Max Born Institute for Nonlinear Optics & Short Term Spectroscopy	Miller, RJD (corresponding author), Univ Toronto, Dept Chem, 80 St George St, Toronto, ON M5S 3H6, Canada.	rjdmiller@lphys.chem.utoronto.ca	Elsaesser, Thomas/P-7608-2014; Huse, Nils/A-5712-2017	Elsaesser, Thomas/0000-0003-3056-6665; Huse, Nils/0000-0002-3281-7600; Dwyer, Jason/0000-0002-2938-2888; Bruner, Barry/0000-0003-3915-6304				Asbury JB, 2004, J PHYS CHEM A, V108, P1107, DOI 10.1021/jp036266k; Asplund MC, 2000, P NATL ACAD SCI USA, V97, P8219, DOI 10.1073/pnas.140227997; CASTNER EW, 1995, J CHEM PHYS, V102, P653, DOI 10.1063/1.469177; Cowan ML, 2004, CHEM PHYS LETT, V386, P184, DOI 10.1016/j.cplett.2004.01.027; Eisenberg D. S., 2005, STRUCTURE PROPERTIES; Fecko CJ, 2003, SCIENCE, V301, P1698, DOI 10.1126/science.1087251; Franks F., 1972, WATER COMPREHENSIVE; Gale GM, 1999, PHYS REV LETT, V82, P1068, DOI 10.1103/PhysRevLett.82.1068; GRAENER H, 1991, PHYS REV LETT, V66, P2092, DOI 10.1103/PhysRevLett.66.2092; Hybl JD, 1998, CHEM PHYS LETT, V297, P307, DOI 10.1016/S0009-2614(98)01140-3; JIMENEZ R, 1994, NATURE, V369, P471, DOI 10.1038/369471a0; Lawrence CP, 2002, J CHEM PHYS, V117, P8847, DOI 10.1063/1.1514652; Lepetit L, 1995, J OPT SOC AM B, V12, P2467, DOI 10.1364/JOSAB.12.002467; Lock AJ, 2002, J CHEM PHYS, V117, P1708, DOI 10.1063/1.1485966; Luzar A, 1996, NATURE, V379, P55, DOI 10.1038/379055a0; Marx D, 1999, NATURE, V397, P601, DOI 10.1038/17579; Moller KB, 2004, J PHYS CHEM A, V108, P1275, DOI 10.1021/jp035935r; Mukamel S, 2000, ANNU REV PHYS CHEM, V51, P691, DOI 10.1146/annurev.physchem.51.1.691; Pakoulev A, 2003, CHEM PHYS LETT, V371, P594, DOI 10.1016/S0009-2614(03)00314-2; POHORILLE A, 1987, J CHEM PHYS, V87, P6070, DOI 10.1063/1.453481; Poulsen JA, 2003, J PHYS CHEM A, V107, P8420, DOI 10.1021/jp0225469; RICE SA, 1983, J PHYS CHEM-US, V87, P4295, DOI 10.1021/j100244a061; Saito S, 1997, J CHEM PHYS, V106, P4889, DOI 10.1063/1.473538; Stenger J, 2002, J PHYS CHEM A, V106, P2341, DOI 10.1021/jp013104k; Stenger J, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.027401; Torre R, 2004, NATURE, V428, P296, DOI 10.1038/nature02409; WOJCIK MJ, 1993, J CHEM PHYS, V99, P2332, DOI 10.1063/1.465248; Woutersen S, 1999, NATURE, V402, P507, DOI 10.1038/990058	28	601	611	4	234	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					199	202		10.1038/nature03383	http://dx.doi.org/10.1038/nature03383			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15758995				2022-12-24	WOS:000227494500040
J	Enriquez-Sarano, M; Avierinos, JF; Messika-Zeitoun, D; Detaint, D; Capps, M; Nkomo, V; Scott, C; Schaff, HV; Tajik, AJ				Enriquez-Sarano, M; Avierinos, JF; Messika-Zeitoun, D; Detaint, D; Capps, M; Nkomo, V; Scott, C; Schaff, HV; Tajik, AJ			Quantitative determinants of the outcome of asymptomatic mitral regurgitation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOPPLER ASSESSMENT; NATURAL-HISTORY; ORIFICE AREA; VALVULAR REGURGITATION; AORTIC REGURGITATION; VALVE PROLAPSE; ECHOCARDIOGRAPHY; DISEASE; CARDIOLOGY; SEVERITY	BACKGROUND The clinical outcome of asymptomatic mitral regurgitation is poorly defined, and the treatment is uncertain. We studied the effect on the outcome of quantifying mitral regurgitation according to recent guidelines. METHODS We prospectively enrolled 456 patients (mean [+/-SD] age, 63+/-14 years; 63 percent men; ejection fraction, 70+/-8 percent) with asymptomatic organic mitral regurgitation, quantified according to current recommendations (regurgitant volume, 66+/-40 ml per beat; effective regurgitant orifice, 40+/-27 mm(sup 2)). RESULTS The estimated five-year rates (+/-SE) of death from any cause, death from cardiac causes, and cardiac events (death from cardiac causes, heart failure, or new atrial fibrillation) with medical management were 22+/-3 percent, 14+/-3 percent, and 33+/-3 percent, respectively. Independent determinants of survival were increasing age, the presence of diabetes, and increasing effective regurgitant orifice (adjusted risk ratio per 10-mm(sup 2) increment, 1.18; 95 percent confidence interval, 1.06 to 1.30; P<0.01), the predictive power of which superseded all other qualitative and quantitative measures of regurgitation. Patients with an effective regurgitant orifice of at least 40 mm(sup 2) had a five-year survival rate that was lower than expected on the basis of U.S. Census data (58+/-9 percent vs. 78 percent, P=0.03). As compared with patients with a regurgitant orifice of less than 20 mm(sup 2), those with an orifice of at least 40 mm(sup 2) had an increased risk of death from any cause (adjusted risk ratio, 2.90; 95 percent confidence interval, 1.33 to 6.32; P<0.01), death from cardiac causes (adjusted risk ratio, 5.21; 95 percent confidence interval, 1.98 to 14.40; P<0.01), and cardiac events (adjusted risk ratio, 5.66; 95 percent confidence interval, 3.07 to 10.56; P<0.01). Cardiac surgery was ultimately performed in 232 patients and was independently associated with improved survival (adjusted risk ratio, 0.28; 95 percent confidence interval, 0.14 to 0.55; P<0.01). CONCLUSIONS Quantitative grading of mitral regurgitation is a powerful predictor of the clinical outcome of asymptomatic mitral regurgitation. Patients with an effective regurgitant orifice of at least 40 mm(sup 2) should promptly be considered for cardiac surgery.	Mayo Clin, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA; Mayo Clin, Div Cardiac Surg, Rochester, MN 55905 USA; Mayo Clin, Biostat Sect, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Enriquez-Sarano, M (corresponding author), Mayo Clin, Div Cardiovasc Dis & Internal Med, 200 1st St SW, Rochester, MN 55905 USA.	sarano.maurice@mayo.edu		Schaff, Hartzell/0000-0003-0994-027X; Scott, Christopher/0000-0003-1340-0647	NHLBI NIH HHS [HL 64928] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064928] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Avierinos JF, 2002, CIRCULATION, V106, P1355, DOI 10.1161/01.CIR.0000028933.34260.09; BLUMLEIN S, 1986, CIRCULATION, V74, P306, DOI 10.1161/01.CIR.74.2.306; Bonow RO, 1998, CIRCULATION, V98, P1949, DOI 10.1161/01.CIR.98.18.1949; Borer JS, 2003, CIRCULATION, V108, P2432, DOI 10.1161/01.CIR.0000096400.00562.A3; BRAUNWALD E, 1963, CIRCULATION, V27, P29, DOI 10.1161/01.CIR.27.1.29; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; DELAHAYE JP, 1991, EUR HEART J, V12, P5, DOI 10.1093/eurheartj/12.suppl_B.5; Dujardin KS, 1997, CIRCULATION, V96, P3409; Enriquez-Sarano M, 1999, J AM COLL CARDIOL, V34, P1137, DOI 10.1016/S0735-1097(99)00313-7; Enriquez-Sarano R, 1999, J AM COLL CARDIOL, V34, P1129, DOI 10.1016/S0735-1097(99)00314-9; ENRIQUEZSARANO M, 1995, CIRCULATION, V91, P1022, DOI 10.1161/01.CIR.91.4.1022; EnriquezSarano M, 1997, MAYO CLIN PROC, V72, P1034, DOI 10.4065/72.11.1034; ENRIQUEZSARANO M, 1995, J AM COLL CARDIOL, V25, P703, DOI 10.1016/0735-1097(94)00434-R; ENRIQUEZSARANO M, 1994, J AM COLL CARDIOL, V24, P1536, DOI 10.1016/0735-1097(94)90151-1; ENRIQUEZSARANO M, 1993, J AM COLL CARDIOL, V21, P1211, DOI 10.1016/0735-1097(93)90248-Y; ENRIQUEZSARANO M, 1993, J AM COLL CARDIOL, V22, P342; ENRIQUEZSARANO M, 1993, CIRCULATION, V87, P841, DOI 10.1161/01.CIR.87.3.841; ENRIQUEZSARANO M, 1994, J AM COLL CARDIOL, V23, P443, DOI 10.1016/0735-1097(94)90432-4; Gillinov AM, 1998, J THORAC CARDIOV SUR, V116, P734, DOI 10.1016/S0022-5223(98)00450-4; Grigioni F, 2001, CIRCULATION, V103, P1759, DOI 10.1161/01.CIR.103.13.1759; HELMCKE F, 1987, CIRCULATION, V75, P175, DOI 10.1161/01.CIR.75.1.175; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; Ling LH, 1996, NEW ENGL J MED, V335, P1417, DOI 10.1056/NEJM199611073351902; Ling LH, 1997, CIRCULATION, V96, P1819, DOI 10.1161/01.CIR.96.6.1819; MACISAAC AI, 1992, AUST NZ J MED, V22, P532, DOI 10.1111/j.1445-5994.1992.tb00473.x; MOHTY D, 2001, CIRCULATION S1, V104, P1, DOI 10.1161/hc37t1.094903; OTT DA, 1995, CIRCULATION, V91, P1264, DOI 10.1161/01.CIR.91.4.1264; REN JF, 1983, J AM COLL CARDIOL, V2, P729, DOI 10.1016/S0735-1097(83)80313-1; ROKEY R, 1986, J AM COLL CARDIOL, V7, P1273, DOI 10.1016/S0735-1097(86)80146-2; ROSEN SE, 1994, AM J CARDIOL, V74, P374, DOI 10.1016/0002-9149(94)90406-5; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; SELLERS RD, 1964, AM J CARDIOL, V14, P437, DOI 10.1016/0002-9149(64)90027-X; SELZER A, 1972, MEDICINE, V51, P337, DOI 10.1097/00005792-197209000-00001; Singh JP, 1999, AM J CARDIOL, V83, P897, DOI 10.1016/S0002-9149(98)01064-9; Singh JP, 1999, AM J CARDIOL, V84, P1143; SPAIN MG, 1989, J AM COLL CARDIOL, V13, P585, DOI 10.1016/0735-1097(89)90597-4; Tribouilloy CM, 1999, CIRCULATION, V99, P400, DOI 10.1161/01.CIR.99.3.400; VANDERVOORT PM, 1993, CIRCULATION, V88, P1150, DOI 10.1161/01.CIR.88.3.1150; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	39	738	771	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2005	352	9					875	883		10.1056/NEJMoa041451	http://dx.doi.org/10.1056/NEJMoa041451			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901VQ	15745978				2022-12-24	WOS:000227310700006
J	Berkley, JA; Maitland, K; Mwangi, I; Ngetsa, C; Mwarumba, S; Lowe, BS; Newton, CRJC; Marsh, K; Scott, JAG; English, M				Berkley, JA; Maitland, K; Mwangi, I; Ngetsa, C; Mwarumba, S; Lowe, BS; Newton, CRJC; Marsh, K; Scott, JAG; English, M			Use of clinical syndromes to target antibiotic prescribing in seriously ill children in malaria endemic area: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE BACTERIAL-MENINGITIS; CEREBRAL MALARIA; PROGNOSTIC INDICATORS; GAMBIAN CHILDREN; MANAGEMENT; PNEUMONIA; OVERLAP; DIAGNOSIS; TANZANIA; FEATURES	Objectives To determine how well antibiotic treatment is targeted by simple clinical syndromes and to what extent drug resistance threatens affordable antibiotics. Design Observational study involving a priori definition of a hierarchy of syndromic indications for antibiotic therapy derived from World Health Organization integrated management of childhood illness and inpatient guidelines and application of these rules to a prospectively collected dataset. Setting Kilifi District Hospital, Kenya. Participants 11 847 acute paediatric admissions. Main outcome measures Presence of invasive bacterial infection (bacteraemia or meningitis) or Plasmodium falciparum parasitaemia; antimicrobial sensitivities of isolated bacteria. Results 6254 (53%) admissions met criteria for syndromes requiring antibiotics (sick young infants; meningitis/encephalopathy; severe malnutrition; very severe, severe, or mild pneumonia; skin or soft tissue infection): 672 (11%) had an invasive bacterial infection (80% of all invasive bacterial infections identified), and 753 (12%) (lied (93%) of all inpatient deaths). Among P falciparum infected children with a syndromic indication for parenteral antibiotics, an invasive bacterial infection was detected in 4.0-8.8%. For the syndrome of meningitis/encephalopathy, 96/123 (76%) isolates were fully sensitive in vitro to penicillin or chloramphenicol. Conclusions Simple clinical syndromes effectively target children admitted with invasive bacterial infection and those at risk of death. Malaria parasitaemia does not justify withholding empirical parenteral antibiotics. Lumbar puncture is critical to the rational use of antibiotics.	Ctr Geog Med Res Coast, Kilifi, Kenya		Berkley, JA (corresponding author), Ctr Geog Med Res Coast, POB 230, Kilifi, Kenya.	jberkley@kilifi.mimcom.net	Newton, Charles RJC/B-7578-2014; Newton, Charles/V-7872-2019	Newton, Charles RJC/0000-0002-6999-5507; Newton, Charles/0000-0002-6999-5507; English, Michael/0000-0002-7427-0826; Maitland, Kathryn/0000-0002-0007-0645; Berkley, James/0000-0002-1236-849X	Wellcome Trust [061089, 081835] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Berkley J, 1999, T ROY SOC TROP MED H, V93, P283, DOI 10.1016/S0035-9203(99)90024-X; Berkley JA, 2004, PEDIATRICS, V114, pE713, DOI 10.1542/peds.2004-0007; Berkley JA, 2003, BRIT MED J, V326, P361, DOI 10.1136/bmj.326.7385.361; Berkley JA, 1999, QJM-INT J MED, V92, P151, DOI 10.1093/qjmed/92.3.151; Berkley JA, 2001, LANCET, V357, P1753, DOI 10.1016/S0140-6736(00)04897-2; BERKLEY JA, 2002, NEW ENGL J MED, V352, P39; Duke T, 2003, ARCH DIS CHILD, V88, P536, DOI 10.1136/adc.88.6.536; English M, 1996, T ROY SOC TROP MED H, V90, P658, DOI 10.1016/S0035-9203(96)90423-X; English M, 2003, B WORLD HEALTH ORGAN, V81, P166; Evans JA, 2004, QJM-INT J MED, V97, P591, DOI 10.1093/qjmed/hch093; Falade AG, 1997, ANN TROP PAEDIATR, V17, P315, DOI 10.1080/02724936.1997.11747904; Falade AG, 2001, ANN TROP PAEDIATR, V21, P293, DOI 10.1080/07430170120093472; Kallander K, 2004, ACTA TROP, V90, P211, DOI 10.1016/j.actatropica.2003.11.013; Makani J, 2003, QJM-INT J MED, V96, P355, DOI 10.1093/qjmed/hcg059; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; MOLYNEUX ME, 1989, Q J MED, V71, P441; *NAT COMM CLIN LAB, 1997, M100S7 NCCLS; ODEMPSEY TJD, 1993, T ROY SOC TROP MED H, V87, P662, DOI 10.1016/0035-9203(93)90279-Y; Perkins BA, 1997, B WORLD HEALTH ORGAN, V75, P33; PRADA J, 1993, LANCET, V342, P1114, DOI 10.1016/0140-6736(93)92096-C; *REP KEN MIN HLTH, 2001, AIDS KEN; *REP KENY MINST HL, 2001, AIDS KEN; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Robertson MA, 2001, ARCH DIS CHILD, V85, P214, DOI 10.1136/adc.85.3.214; Tamburlini G, 1999, ARCH DIS CHILD, V81, P478, DOI 10.1136/adc.81.6.478; Tulloch J., 1999, Lancet (British edition), V354, P16, DOI 10.1016/S0140-6736(99)90252-0; *WHO, 2000, T ROYAL SOC TROP S1, V94; World Health Organization, 2000, MAN CHILD SER INF SE; 1993, ADV PAED LIFE SUPPOR	30	112	114	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2005	330	7498					995	999		10.1136/bmj.38408.471991.8F	http://dx.doi.org/10.1136/bmj.38408.471991.8F			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UP	15797893	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000228935100019
J	Kim, JH; Kim, B; Cai, L; Choi, HJ; Ohgi, KA; Tran, C; Chen, C; Chung, CH; Huber, O; Rose, DW; Sawyers, CL; Rosenfeld, MG; Baek, SH				Kim, JH; Kim, B; Cai, L; Choi, HJ; Ohgi, KA; Tran, C; Chen, C; Chung, CH; Huber, O; Rose, DW; Sawyers, CL; Rosenfeld, MG; Baek, SH			Transcriptional regulation of a metastasis suppressor gene by Tip60 and beta-catenin complexes	NATURE			English	Article							NF-KAPPA-B; PROSTATE-CANCER; RNA INTERFERENCE; TARGET; CELLS; TRANSFORMATION; PONTIN52; PROTEIN; GROWTH; COLON	Defining the molecular strategies that integrate diverse signalling pathways in the expression of specific gene programmes that are critical in homeostasis and disease remains a central issue in biology. This is particularly pertinent in cancer biology because downregulation of tumour metastasis suppressor genes is a common occurrence(1,2), and the underlying molecular mechanisms are not well established. Here we report that the downregulation of a metastasis suppressor gene, KAI1, in prostate cancer cells involves the inhibitory actions of beta-catenin, along with a reptin chromatin remodelling complex. This inhibitory function of beta-catenin - reptin requires both increased beta-catenin expression and recruitment of histone deacetylase activity. The coordinated actions of beta- catenin - reptin components that mediate the repressive state serve to antagonize a Tip60 coactivator complex(3-8) that is required for activation; the balance of these opposing complexes controls the expression of KAI1 and metastatic potential. The molecular mechanisms underlying the antagonistic regulation of b- catenin - reptin and the Tip60 coactivator complexes for the metastasis suppressor gene, KAI1, are likely to be prototypic of a selective downregulation strategy for many genes, including a subset of NF-kappa B target genes.	Seoul Natl Univ, Coll Nat Sci, Dept Sci Biol, Seoul 151742, South Korea; Univ Calif San Diego, Howard Hughes Med Inst, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Med, Los Angeles, CA 90095 USA; Charite, Inst Clin Chem & Pathobiochem, D-12200 Berlin, Germany; Univ Calif San Diego, Sch Med, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA	Seoul National University (SNU); Howard Hughes Medical Institute; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of California System; University of California San Diego	Baek, SH (corresponding author), Seoul Natl Univ, Coll Nat Sci, Dept Sci Biol, Seoul 151742, South Korea.	mrosenfeld@ucsd.edu; sbaek@snu.ac.kr	Huber, Otmar/AAA-4548-2021; Tran, Canh-Dung/D-4442-2011; Sawyers, Charles/G-5327-2016	Huber, Otmar/0000-0003-4359-1747; Tran, Canh-Dung/0000-0002-1011-4226; 				Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; ALBINI A, 1987, CANCER RES, V47, P3239; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Bauer A, 2000, EMBO J, V19, P6121, DOI 10.1093/emboj/19.22.6121; Bauer A, 1998, P NATL ACAD SCI USA, V95, P14787, DOI 10.1073/pnas.95.25.14787; Chesire DR, 2003, ENDOCR-RELAT CANCER, V10, P537, DOI 10.1677/erc.0.0100537; Chesire DR, 2002, ONCOGENE, V21, P2679, DOI 10.1038/sj.onc.1205352; Clevers H, 2004, CANCER CELL, V5, P5, DOI 10.1016/S1535-6108(03)00339-8; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; DONG JT, 1995, SCIENCE, V268, P884, DOI 10.1126/science.7754374; Dong JT, 1996, CANCER RES, V56, P4387; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Feng Y, 2003, CANCER RES, V63, P8726; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; KOBAYASHI H, 1992, CANCER RES, V52, P3610; Li J, 2001, J BIOL CHEM, V276, P18579, DOI 10.1074/jbc.M100846200; Madrid Lee V, 2003, Methods Mol Biol, V223, P523; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; PETRYLAK DP, 1995, NAT MED, V1, P739, DOI 10.1038/nm0895-739; Rottbauer W, 2002, CELL, V111, P661, DOI 10.1016/S0092-8674(02)01112-1; Shevde LA, 2003, CANCER LETT, V198, P1, DOI 10.1016/S0304-3835(03)00304-5; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; Wood MA, 2000, MOL CELL, V5, P321, DOI 10.1016/S1097-2765(00)80427-X	25	255	268	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 14	2005	434	7035					921	926		10.1038/nature03452	http://dx.doi.org/10.1038/nature03452			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915SV	15829968				2022-12-24	WOS:000228327600046
J	Sekijima, Y; Wiseman, RL; Matteson, J; Hammarstrom, P; Miller, SR; Sawkar, AR; Balch, WE; Kelly, JW				Sekijima, Y; Wiseman, RL; Matteson, J; Hammarstrom, P; Miller, SR; Sawkar, AR; Balch, WE; Kelly, JW			The biological and chemical basis for tissue-selective amyloid disease	CELL			English	Article							ENDOPLASMIC-RETICULUM; SECRETION EFFICIENCY; FIBRIL FORMATION; QUALITY-CONTROL; HUMAN LYSOZYME; HUNGARIAN-TYPE; TRANSTHYRETIN; PROTEIN; POLYNEUROPATHY; PLASMA	Factors controlling the onset and progression of extracellular amyloid diseases remain largely unknown. Central to disease etiology is the efficiency of the endoplasmic reticulum (ER) machinery that targets destabilized mutant proteins for degradation and the enhanced tendency of these variants to aggregate if secreted. We demonstrate that mammalian cells secrete numerous transthyretin (TTR) disease-assock ated variants with wild-type efficiency in spite of compromised folding energetics. Only the most highly destabilized TTR variants are subjected to ER-associated degradation (ERAD) and then only in certain tissues, providing insight into tissue selective amyloidosis. Rather than a "quality control" standard based on wild-type stability, we find that ER-assisted folding (ERAF), based on global protein energetics, determines the extent of export. We propose that ERAF (influenced by the energetics of the protein fold, chaperone enzyme distributions, and metabolite chaperones) in competition with ERAD defines the unique secretory aptitude of each tissue.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol & Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Balch, WE (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd,BCC506, La Jolla, CA 92037 USA.	webalch@scripps.edu; jkelly@scripps.edu		Hammarstrom, Per/0000-0001-5827-3587; Wiseman, Luke/0000-0001-9287-6840	NCRR NIH HHS [M01 RR00833] Funding Source: Medline; NIGMS NIH HHS [GM 43226] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ANDO Y, 1995, BIOCHEM BIOPH RES CO, V211, P354, DOI 10.1006/bbrc.1995.1820; Benson MD, 1996, AM J PATHOL, V148, P351; Bernier V, 2004, TRENDS ENDOCRIN MET, V15, P222, DOI 10.1016/j.tem.2004.05.003; BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; COPELAND CS, 1986, J CELL BIOL, V103, P1179, DOI 10.1083/jcb.103.4.1179; DICKSON PW, 1987, J BIOL CHEM, V262, P13907; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; DWULET FE, 1983, BIOCHEM BIOPH RES CO, V114, P657, DOI 10.1016/0006-291X(83)90831-8; DWULET FE, 1984, P NATL ACAD SCI-BIOL, V81, P694, DOI 10.1073/pnas.81.3.694; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Fan JQ, 2003, TRENDS PHARMACOL SCI, V24, P355, DOI 10.1016/S0165-6147(03)00158-5; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Garzuly F, 1996, NEUROLOGY, V47, P1562, DOI 10.1212/WNL.47.6.1562; Garzuly Ferenc, 1996, Orvosi Hetilap, V137, P2393; Gelman Marina S, 2003, Methods Mol Biol, V232, P27; Green NS, 2003, J AM CHEM SOC, V125, P13404, DOI 10.1021/ja030294z; Hamilton JA, 2001, CELL MOL LIFE SCI, V58, P1491, DOI 10.1007/PL00000791; Hammarstrom P, 2003, BIOCHEMISTRY-US, V42, P6656, DOI 10.1021/bi027319b; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; Hammarstrom P, 2002, P NATL ACAD SCI USA, V99, P16427, DOI 10.1073/pnas.202495199; Harkany T, 2002, BRIT J DERMATOL, V146, P674, DOI 10.1046/j.1365-2133.2002.04594.x; HOLMGREN G, 1993, LANCET, V341, P1113, DOI 10.1016/0140-6736(93)93127-M; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Ikeda S, 2002, CLIN CHEM LAB MED, V40, P1257, DOI 10.1515/CCLM.2002.217; JACOBSON DR, 1992, HUM GENET, V89, P353; Jiang X, 2001, BIOCHEMISTRY-US, V40, P11442, DOI 10.1021/bi011194d; Kelly JW, 1996, CURR OPIN STRUC BIOL, V6, P11, DOI 10.1016/S0959-440X(96)80089-3; Kowalski JM, 1998, BIOCHEMISTRY-US, V37, P1264, DOI 10.1021/bi9722397; Kowalski JM, 1998, J BIOL CHEM, V273, P19453, DOI 10.1074/jbc.273.31.19453; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; LaPointe P, 2004, MOL CELL, V14, P413, DOI 10.1016/S1097-2765(04)00267-9; Lashuel HA, 1999, BIOCHEMISTRY-US, V38, P13560, DOI 10.1021/bi991021c; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; MUSIL LS, 1993, CELL, V74, P1065, DOI 10.1016/0092-8674(93)90728-9; OMURA F, 1991, EUR J BIOCHEM, V198, P477, DOI 10.1111/j.1432-1033.1991.tb16038.x; Plante-Bordeneuve V, 1998, NEUROLOGY, V51, P708, DOI 10.1212/WNL.51.3.708; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; Sekijima Y, 2003, LAB INVEST, V83, P409, DOI 10.1097/01.LAB.0000059937.11023.1F; Shusta EV, 1999, J MOL BIOL, V292, P949, DOI 10.1006/jmbi.1999.3130; Spagnoli FM, 1998, J CELL BIOL, V143, P1101, DOI 10.1083/jcb.143.4.1101; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Suhr OB, 2002, LIVER TRANSPLANT, V8, P787, DOI 10.1053/jlts.2002.34386; TANIYAMA Y, 1992, J BIOL CHEM, V267, P4619; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; WALLACE MR, 1986, J CLIN INVEST, V78, P6, DOI 10.1172/JCI112573; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Zheng W, 2002, BRAIN RES, V958, P371, DOI 10.1016/S0006-8993(02)03683-1	54	347	353	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 8	2005	121	1					73	85		10.1016/j.cell.2005.01.018	http://dx.doi.org/10.1016/j.cell.2005.01.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	915YU	15820680	Bronze			2022-12-24	WOS:000228348500011
J	Venegas, JG; Winkler, T; Musch, G; Melo, MFV; Layfield, D; Tgavalekos, N; Fischman, AJ; Callahan, RJ; Bellani, G; Harris, RS				Venegas, JG; Winkler, T; Musch, G; Melo, MFV; Layfield, D; Tgavalekos, N; Fischman, AJ; Callahan, RJ; Bellani, G; Harris, RS			Self-organized patchiness in asthma as a prelude to catastrophic shifts	NATURE			English	Article							AIRWAY SMOOTH-MUSCLE; VENTILATION; LUNG; PET; HYPERRESPONSIVENESS; METHACHOLINE; PERFUSION; VOLUME; TREE	Asthma is a common disease affecting an increasing number of children throughout the world. In asthma, pulmonary airways narrow in response to contraction of surrounding smooth muscle. The precise nature of functional changes during an acute asthma attack is unclear. The tree structure of the pulmonary airways has been linked to complex behaviour in sudden airway narrowing(1,2) and avalanche-like reopening(3,4). Here we present experimental evidence that bronchoconstriction leads to patchiness in lung ventilation, as well as a computational model that provides interpretation of the experimental data. Using positron emission tomography, we observe that bronchoconstricted asthmatics develop regions of poorly ventilated lung. Using the computational model we show that, even for uniform smooth muscle activation of a symmetric bronchial tree, the presence of minimal heterogeneity breaks the symmetry and leads to large clusters of poorly ventilated lung units. These clusters are generated by interaction of short- and long-range feedback mechanisms, which lead to catastrophic shifts similar to those linked to self-organized patchiness in nature(5,6). This work might have implications for the treatment of asthma, and might provide a model for studying diseases of other distributed organs.	Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med, Pulm & Crit Care Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Boston Univ, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Boston University	Venegas, JG (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, 55 Fruit St, Boston, MA 02114 USA.	jvenegas@vqpet.mgh.harvard.edu	Melo, Marcos Vidal/AAN-7219-2020; Melo, Marcos F Vidal/C-3452-2013; Winkler, Tilo/B-5337-2009; Bellani, Giacomo/D-2379-2010	Winkler, Tilo/0000-0002-7276-5550; Bellani, Giacomo/0000-0002-3089-205X				Alencar AM, 2002, NATURE, V417, P809, DOI 10.1038/417809b; Altemeier WA, 2000, J APPL PHYSIOL, V88, P1551, DOI 10.1152/jappl.2000.88.5.1551; Anafi RC, 2003, J APPL PHYSIOL, V94, P1003, DOI 10.1152/japplphysiol.00569.2002; Anafi RC, 2001, J APPL PHYSIOL, V91, P1185, DOI 10.1152/jappl.2001.91.3.1185; BATES JH, 1995, COMMENTS THEOR BIOL, V3, P397; Beigelman-Aubry C, 2002, RADIOLOGY, V223, P181, DOI 10.1148/radiol.2231010779; Cox PG, 2004, EUR RESPIR J, V24, P659, DOI 10.1183/09031936.04.00054604; Danek CJ, 2004, J APPL PHYSIOL, V97, P1946, DOI 10.1152/japplphysiol.01282.2003; Fredberg JJ, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-2; GUNST SJ, 1988, J APPL PHYSIOL, V64, P2522, DOI 10.1152/jappl.1988.64.6.2522; Judd SL, 2000, PHYSICA D, V136, P45, DOI 10.1016/S0167-2789(99)00154-2; Klarreich E, 2003, NATURE, V424, P873, DOI 10.1038/424873a; Latourelle J, 2002, J APPL PHYSIOL, V92, P771, DOI 10.1152/japplphysiol.01090.2000; Laurent F, 2000, EUR RADIOL, V10, P1404, DOI 10.1007/s003300000504; LAUWERIER H, 1991, FRACTALS ENDLESSLY R, P71; Lutchen KR, 2001, AM J RESP CRIT CARE, V164, P207, DOI 10.1164/ajrccm.164.2.2008119; Mauroy B, 2004, NATURE, V427, P633, DOI 10.1038/nature02287; Melo MFV, 2003, J NUCL MED, V44, P1982; Musch G, 2002, J APPL PHYSIOL, V93, P1841, DOI 10.1152/japplphysiol.00223.2002; NEWMAN KB, 1994, CHEST, V106, P105, DOI 10.1378/chest.106.1.105; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Samee S, 2003, J ALLERGY CLIN IMMUN, V111, P1205, DOI 10.1067/mai.2003.1544; SKLOOT G, 1995, J CLIN INVEST, V96, P2393, DOI 10.1172/JCI118296; Smith D, 2003, ANN EMERG MED, V41, P706, DOI 10.1067/mem.2003.144; SMITH JC, 1984, J APPL PHYSIOL, V57, P1422, DOI 10.1152/jappl.1984.57.5.1422; Suki B, 2003, J APPL PHYSIOL, V95, P2122, DOI 10.1152/japplphysiol.00636.2003; SUKI B, 1994, NATURE, V368, P615, DOI 10.1038/368615a0; Venegas JG, 2000, J APPL PHYSIOL, V88, P1365, DOI 10.1152/jappl.2000.88.4.1365; Wagers S, 2003, J ALLERGY CLIN IMMUN, V111, P1201, DOI 10.1067/mai.2003.1545; Weibel ER, 1963, MORPHOMETRY HUMAN LU, P115	30	391	403	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 7	2005	434	7034					777	782		10.1038/nature03490	http://dx.doi.org/10.1038/nature03490			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	913NU	15772676				2022-12-24	WOS:000228160700044
J	Koster, DA; Croquette, V; Dekker, C; Shuman, S; Dekker, NH				Koster, DA; Croquette, V; Dekker, C; Shuman, S; Dekker, NH			Friction and torque govern the relaxation of DNA supercoils by eukaryotic topoisomerase IB	NATURE			English	Article							VACCINIA TOPOISOMERASE; DUPLEX DNA; ESCHERICHIA-COLI; MECHANISM; MOLECULE; PROTEIN; ELASTICITY; COVALENT; ROTATION; GYRASE	Topoisomerases relieve the torsional strain in DNA that is built up during replication and transcription. They are vital for cell proliferation(1-3) and are a target for poisoning by anti-cancer drugs(4,5). Type IB topoisomerase (TopIB) forms a protein clamp around the DNA duplex(6-8) and creates a transient nick that permits removal of supercoils. Using real-time single-molecule observation, we show that TopIB releases supercoils by a swivel mechanism that involves friction between the rotating DNA and the enzyme cavity: that is, the DNA does not freely rotate. Unlike a nicking enzyme, TopIB does not release all the supercoils at once, but it typically does so in multiple steps. The number of supercoils removed per step follows an exponential distribution. The enzyme is found to be torque-sensitive, as the mean number of supercoils per step increases with the torque stored in the DNA. We propose a model for topoisomerization in which the torque drives the DNA rotation over a rugged periodic energy landscape in which the topoisomerase has a small but quantifiable probability to religate the DNA once per turn.	Delft Univ Technol, Fac Sci Appl, Kavli Inst Nanosci, NL-2628 CJ Delft, Netherlands; Ecole Normale Super, Lab Phys Stat, F-75005 Paris, France; Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA	Delft University of Technology; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite; Memorial Sloan Kettering Cancer Center	Dekker, NH (corresponding author), Delft Univ Technol, Fac Sci Appl, Kavli Inst Nanosci, Lorentzweg 1, NL-2628 CJ Delft, Netherlands.	nynke.dekker@mb.tn.tudelft.nl		Croquette, Vincent/0000-0003-1400-0039; Dekker, Cees/0000-0001-6273-071X; Dekker, Nynke/0000-0003-4029-0973				BROWN PO, 1981, P NATL ACAD SCI-BIOL, V78, P843, DOI 10.1073/pnas.78.2.843; BROWN PO, 1979, P NATL ACAD SCI USA, V76, P6110, DOI 10.1073/pnas.76.12.6110; BROWN PO, 1979, SCIENCE, V206, P1081, DOI 10.1126/science.227059; Bustamante C, 2003, NATURE, V421, P423, DOI 10.1038/nature01405; Carey JF, 2003, P NATL ACAD SCI USA, V100, P5640, DOI 10.1073/pnas.1031537100; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Cheng CH, 1998, CELL, V92, P841, DOI 10.1016/S0092-8674(00)81411-7; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; Dekker NH, 2002, P NATL ACAD SCI USA, V99, P12126, DOI 10.1073/pnas.132378799; KIM RA, 1989, J MOL BIOL, V208, P257, DOI 10.1016/0022-2836(89)90387-2; Krogh BO, 2000, BIOCHEMISTRY-US, V39, P6422, DOI 10.1021/bi000184u; LIU LF, 1980, CELL, V19, P697, DOI 10.1016/S0092-8674(80)80046-8; Liu LF, 2000, ANN NY ACAD SCI, V922, P1; MIZUUCHI K, 1980, P NATL ACAD SCI-BIOL, V77, P1847, DOI 10.1073/pnas.77.4.1847; Moroz JD, 1997, P NATL ACAD SCI USA, V94, P14418, DOI 10.1073/pnas.94.26.14418; Pommier Y, 1998, BBA-GENE STRUCT EXPR, V1400, P83, DOI 10.1016/S0167-4781(98)00129-8; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; RICE JA, 1988, MATH STAT DATA ANAL, P31; SEKIGUCHI J, 1994, NUCLEIC ACIDS RES, V22, P5360, DOI 10.1093/nar/22.24.5360; Sekiguchi J, 1996, EMBO J, V15, P3448, DOI 10.1002/j.1460-2075.1996.tb00711.x; SEKIGUCHI J, 1994, J BIOL CHEM, V269, P31731; Shuman S, 1997, EMBO J, V16, P6584, DOI 10.1093/emboj/16.21.6584; SHUMAN S, 1988, J BIOL CHEM, V263, P16401; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Stivers JT, 1997, BIOCHEMISTRY-US, V36, P5212, DOI 10.1021/bi962880t; Strick TR, 2000, NATURE, V404, P901, DOI 10.1038/35009144; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Woo MH, 2003, P NATL ACAD SCI USA, V100, P13767, DOI 10.1073/pnas.2235886100	29	245	253	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 31	2005	434	7033					671	674		10.1038/nature03395	http://dx.doi.org/10.1038/nature03395			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911NN	15800630				2022-12-24	WOS:000228011000051
J	Muratani, M; Kung, C; Shokat, KM; Tansey, WR				Muratani, M; Kung, C; Shokat, KM; Tansey, WR			The F box protein Dsg1/Mdm30 is a transcriptional coactivator that stimulates Gal4 turnover and cotranscriptional mRNA processing	CELL			English	Article							UBIQUITIN-DEPENDENT PROTEOLYSIS; POLYMERASE-II TRANSCRIPTION; CARBOXY-TERMINAL DOMAIN; SACCHAROMYCES-CEREVISIAE; ACTIVATE TRANSCRIPTION; PHOSPHORYLATED FORMS; CAPPING ENZYME; ELONGATION; KINASE; YEAST	We report here that the prototypical yeast transcription factor Gal4 undergoes two distinct modes of ubiquitin-mediated proteolysis: one that occurs independent of transcription and restricts Gal4 function, and another that is transcription coupled and essential for productive activation of Gal4 target genes. Destruction of transcriptionally active Gal4 depends on an F box protein called Dsgl/Mdm30. In the absence of Dsg1, Gal4 is stable, nonubiquitylated, and unable to productively stimulate transcription. Analysis of the phenotype of dsgl-nuil yeast reveals a striking disconnect between GAL gene RNA and protein levels; in the absence of Dsgl, Gal4 target genes are transcribed, but the resulting RNAs are not translated. The translational defects of these RNAs are related to defects in phosphorylation of the RNA polymerase 11 carboxy-terminal domain, which in turn affects recruitment of RNA processing machinery. We propose that Gal4 ubiquitylation and destruction are required for initiation-competent transcription complexes to transition to fully mature elongating complexes capable of appropriate mRNA processing.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	Cold Spring Harbor Laboratory; University of California System; University of California San Francisco	Tansey, WR (corresponding author), Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA.	tansey@cshl.edu	Muratani, Masafumi/A-6379-2011		NCI NIH HHS [CA13106] Funding Source: Medline; NIAID NIH HHS [AI044009] Funding Source: Medline; NIGMS NIH HHS [GM067728] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067728] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; BAILEY RB, 1984, MOL GEN GENET, V193, P507, DOI 10.1007/BF00382091; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; Dower K, 2002, RNA, V8, P686, DOI 10.1017/S1355838202024068; Du YCN, 2002, CELL, V109, P835, DOI 10.1016/S0092-8674(02)00773-0; Fritz S, 2003, MOL BIOL CELL, V14, P2303, DOI 10.1091/mbc.E02-12-0831; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hengartner CJ, 1998, MOL CELL, V2, P43, DOI 10.1016/S1097-2765(00)80112-4; Hirst M, 1999, MOL CELL, V3, P673, DOI 10.1016/S1097-2765(00)80360-3; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; Keogh MC, 2003, MOL CELL BIOL, V23, P7005, DOI 10.1128/MCB.23.19.7005-7018.2003; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Kobor MS, 2002, BBA-GENE STRUCT EXPR, V1577, P261, DOI 10.1016/S0167-4781(02)00457-8; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; Lipford JR, 2003, NAT CELL BIOL, V5, P845, DOI 10.1038/ncb1003-845; Liu Y, 2004, MOL CELL BIOL, V24, P1721, DOI 10.1128/MCB.24.4.1721-1735.2004; LU H, 1992, NATURE, V358, P641, DOI 10.1038/358641a0; Lutfiyya LL, 1998, GENETICS, V150, P1377; MA J, 1987, CELL, V50, P137, DOI 10.1016/0092-8674(87)90670-2; Mandal SS, 2004, P NATL ACAD SCI USA, V101, P7572, DOI 10.1073/pnas.0401493101; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; McCracken S, 1997, GENE DEV, V11, P3306, DOI 10.1101/gad.11.24.3306; Molinari E, 1999, EMBO J, V18, P6439, DOI 10.1093/emboj/18.22.6439; Morillon A, 2003, CELL, V115, P425, DOI 10.1016/S0092-8674(03)00880-8; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Murray S, 2001, MOL CELL BIOL, V21, P4089, DOI 10.1128/MCB.21.13.4089-4096.2001; MYLIN LM, 1990, MOL CELL BIOL, V10, P4623, DOI 10.1128/MCB.10.9.4623; Ostendorff HP, 2002, NATURE, V416, P99, DOI 10.1038/416099a; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Pei Y, 2003, J BIOL CHEM, V278, P7180, DOI 10.1074/jbc.M211713200; Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150; Russell SJ, 1999, MOL CELL, V3, P687, DOI 10.1016/S1097-2765(01)80001-0; SADOWSKI I, 1991, P NATL ACAD SCI USA, V88, P10510, DOI 10.1073/pnas.88.23.10510; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Wu YB, 1996, EMBO J, V15, P3951, DOI 10.1002/j.1460-2075.1996.tb00769.x; YAGLOM J, 1995, MOL CELL BIOL, V15, P731	45	139	142	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 25	2005	120	6					887	899		10.1016/j.cell.2004.12.025	http://dx.doi.org/10.1016/j.cell.2004.12.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	912HF	15797387	Bronze			2022-12-24	WOS:000228067500016
J	Hao, SZ; Sharp, JW; Ross-Inta, CM; McDaniel, BJ; Anthony, TG; Wek, RC; Cavener, DR; McGrath, BC; Rudell, JB; Koehnle, TJ; Gietzen, DW				Hao, SZ; Sharp, JW; Ross-Inta, CM; McDaniel, BJ; Anthony, TG; Wek, RC; Cavener, DR; McGrath, BC; Rudell, JB; Koehnle, TJ; Gietzen, DW			Uncharged tRNA and sensing of amino acid deficiency in mammalian piriform cortex	SCIENCE			English	Article							EUKARYOTIC INITIATION FACTOR-2-ALPHA; FOOD-INTAKE; PREPYRIFORM CORTEX; PROTEIN-SYNTHESIS; DIETS DEFICIENT; KINASE GCN2; RATS; THREONINE; PHOSPHORYLATION; DEPRIVATION	Recognizing a deficiency of indispensable amino acids (IAAs) for protein synthesis is vital for dietary selection in metazoans, including humans. Celts in the brain's anterior piriform cortex (APC) are sensitive to IAA deficiency, Signaling diet rejection and foraging for complementary IAA sources, but the mechanism is unknown. Here we report that the mechanism for recognizing IAA-deficient foods follows the conserved general control (GC) system, wherein uncharged transfer RNA induces phosphorylation of eukaryotic initiation factor 2 (elF2) via the GC nonderepressing 2 (GCN2) kinase. Thus, a basic mechanism of nutritional stress management functions in mammalian brain to guide food selection for survival.	Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA; Indiana Univ Sch Med, Dept Biochem & Mol Biol, Evansville, IN 47712 USA; Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; Penn State Univ, Dept Biol, University Pk, PA 16802 USA; Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA	University of California System; University of California Davis; Indiana University System; Indiana University System; Indiana University-Purdue University Indianapolis; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gietzen, DW (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA.	dwgietzen@ucdavis.edu	Anthony, Tracy/K-7951-2017; Cavener, Douglas R/E-3524-2010	Anthony, Tracy/0000-0002-8586-5884; 	NIGMS NIH HHS [GM49164] Funding Source: Medline; NINDS NIH HHS [NS33347, NS043231] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049164, R29GM049164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033347, R21NS043231] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200; BEVERLY JL, 1990, AM J PHYSIOL, V259, pR709, DOI 10.1152/ajpregu.1990.259.4.R709; Blevins JE, 2000, BRAIN RES, V879, P65, DOI 10.1016/S0006-8993(00)02734-7; Carpenter KJ, 2003, J NUTR, V133, P638, DOI 10.1093/jn/133.3.638; DELANEY K, 1986, J COMP PHYSIOL A, V159, P281, DOI 10.1007/BF00603975; FIRMAN JD, 1988, BRAIN RES BULL, V21, P637, DOI 10.1016/0361-9230(88)90203-1; Gietzen DW, 2004, J NUTR, V134, P717, DOI 10.1093/jn/134.4.717; GIETZEN DW, 1986, PHYSIOL BEHAV, V36, P1071, DOI 10.1016/0031-9384(86)90482-8; GIETZEN DW, 2000, NEURAL METABOLIC CON, pCH23; HABERLY LB, 1978, J COMP NEUROL, V178, P711, DOI 10.1002/cne.901780408; HANSEN BS, 1972, J BIOL CHEM, V247, P3854; Kimball SR, 2001, BIOCHEM BIOPH RES CO, V280, P293, DOI 10.1006/bbrc.2000.4103; KIMBALL SR, 1991, J BIOL CHEM, V266, P1969; Koehnle TJ, 2004, J NUTR, V134, P2365, DOI 10.1093/jn/134.9.2365; Koehnle TJ, 2003, J NUTR, V133, P2331, DOI 10.1093/jn/133.7.2331; LEUNG PMB, 1971, AM J PHYSIOL, V221, P929, DOI 10.1152/ajplegacy.1971.221.3.929; LEUNG PMB, 1972, PHYSIOL BEHAV, V9, P553, DOI 10.1016/0031-9384(72)90011-X; Markison S, 1999, J NUTR, V129, P1604, DOI 10.1093/jn/129.8.1604; Milton K, 2003, J NUTR, V133, p3886S, DOI 10.1093/jn/133.11.3886S; Monda M, 1997, AM J PHYSIOL-REG I, V273, pR554, DOI 10.1152/ajpregu.1997.273.2.R554; MURPHY ME, 1993, PHYSIOL BEHAV, V53, P689, DOI 10.1016/0031-9384(93)90175-F; PANKSEPP J, 1971, NATURE, V233, P341, DOI 10.1038/233341a0; Russell MC, 2003, NUTR NEUROSCI, V6, P247, DOI 10.1080/1028415031000151567; Sharp JW, 2004, NEUROSCIENCE, V126, P1053, DOI 10.1016/j.neuroscience.2004.03.066; Sharp JW, 2002, MOL BRAIN RES, V105, P11, DOI 10.1016/S0169-328X(02)00380-7; Sood R, 2000, GENETICS, V154, P787; WASHBURN BS, 1994, AM J PHYSIOL, V266, pR1922, DOI 10.1152/ajpregu.1994.266.6.R1922; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002	29	252	268	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2005	307	5716					1776	1778		10.1126/science.1104882	http://dx.doi.org/10.1126/science.1104882			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774759				2022-12-24	WOS:000227883900045
J	Langevin, Y; Poulet, F; Bibring, JP; Schmitt, B; Doute, S; Gondet, B				Langevin, Y; Poulet, F; Bibring, JP; Schmitt, B; Doute, S; Gondet, B			Summer evolution of the north polar cap of Mars as observed by OMEGA/Mars express	SCIENCE			English	Article							ORBITER CAMERA; WATER ICE; MODEL; SURFACES	The Observatoire pour la Mineralogie, l'Eau, les Gtaces, et l'Activite (OMEGA) visible-infrared imaging spectrometer extensively observed regions of Mars with latitudes above 70degreesN in late 2004 (heliocentric longitude from L-s 93degrees to L-s 127degrees). The extent of water ice at the surface and the size of ice grains were monitored as a function of time. Bright, small-grained frost, which initially covered a large fraction of the polar cap, waned in favor of large-grained ice. In outlying regions, dominated by large-grained ice, the albedo increased over the period. Evaluating the dust content was mode[ dependent. However, contamination of ice by dust was low.	Univ Paris 11, CNRS, Inst Astrophys Spatiale, F-91405 Orsay, France; Univ Grenoble 1, CNRS, Lab Planetol Grenoble, F-38400 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Langevin, Y (corresponding author), Univ Paris 11, CNRS, Inst Astrophys Spatiale, F-91405 Orsay, France.	yves.langevin@ias.u-psud.fr	Schmitt, Bernard/A-1064-2009	Schmitt, Bernard/0000-0002-1230-6627				Bass DS, 2000, ICARUS, V144, P382, DOI 10.1006/icar.1999.6300; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; CALVIN WM, 2004, LUNAR PLANET SCI, V35, P1455; Doute S, 1998, J GEOPHYS RES-PLANET, V103, P31367, DOI 10.1029/98JE01894; Grundy WM, 1998, J GEOPHYS RES-PLANET, V103, P25809, DOI 10.1029/98JE00738; HALE AS, 2003, LUNAR PLANET SCI, V34, P1422; James PB, 2001, ICARUS, V154, P131, DOI 10.1006/icar.2001.6653; KIEFFER HH, 1976, SCIENCE, V194, P1341, DOI 10.1126/science.194.4271.1341; KIEFFER HH, 1990, J GEOPHYS RES-SOLID, V95, P1481, DOI 10.1029/JB095iB02p01481; Kieffer HH, 2001, ICARUS, V154, P162, DOI 10.1006/icar.2001.6670; Levrard B, 2004, NATURE, V431, P1072, DOI 10.1038/nature03055; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; Mischna MA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002051; Nolin AW, 1998, J GEOPHYS RES-PLANET, V103, P25851, DOI 10.1029/98JE02082; Poulet F, 2002, ICARUS, V160, P313, DOI 10.1006/icar.2002.6970; Shkuratov Y, 1999, ICARUS, V137, P235, DOI 10.1006/icar.1998.6035	16	117	123	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2005	307	5715					1581	1584		10.1126/science.1109438	http://dx.doi.org/10.1126/science.1109438			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15718426				2022-12-24	WOS:000227622400035
J	Mustard, JF; Poulet, F; Gendrin, A; Bibring, JP; Langevin, Y; Gondet, B; Mangold, N; Bellucci, G; Altieri, F				Mustard, JF; Poulet, F; Gendrin, A; Bibring, JP; Langevin, Y; Gondet, B; Mangold, N; Bellucci, G; Altieri, F			Olivine and pyroxene, diversity in the crust of Mars	SCIENCE			English	Article							BASALTIC ROCKS; MGS-TES; SPECTRA; SPECTROSCOPY; REFLECTANCE; METEORITES	Data from the Observatoire pour la Mineralogie, l'Eau, les Glaces, et l'Activite (OMEGA) on the Mars Express spacecraft identify the distinct mafic, rock-forming minerals olivine, low-calcium pyroxene (LCP), and high-calcium pyroxene (HCP) on the surface of Mars. Olivine- and HCP-rich regions are found in deposits that span the age range of geologic units. However, LCP-rich regions are found only in the ancient Noachian-aged units, which suggests that melts for these deposits were derived from a mantle depleted in aluminum and calcium. Extended dark regions in the northern plains exhibit no evidence of strong mafic absorptions or absorptions due to hydrated materials.	Brown Univ, Providence, RI 02912 USA; Inst Astrophys Spatiale, F-91405 Orsay, France; IDES, F-91405 Orsay, France; IFSI INAF, Rome, Italy	Brown University; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Istituto Nazionale Astrofisica (INAF)	Mustard, JF (corresponding author), Brown Univ, Providence, RI 02912 USA.	john_mustard@brown.edu	Bellucci, Giancarlo/ABA-9201-2020	Bellucci, Giancarlo/0000-0003-0867-8679; Altieri, Francesca/0000-0002-6338-8300				ADAMS JB, 1974, J GEOPHYS RES, V79, P4829, DOI 10.1029/JB079i032p04829; Arvidson RE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001982; Bandfield JL, 2000, SCIENCE, V287, P1626, DOI 10.1126/science.287.5458.1626; Bibring J.-P., 2004, EUR SPACE AGENCY SPE, V1240, P37; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; BIBRING JP, 1989, NATURE, V341, P591, DOI 10.1038/341591a0; Burns R.G., 1970, MINERALOGIC APPL CRY; CLOUTIS EA, 1991, J GEOPHYS RES-PLANET, V96, P22809, DOI 10.1029/91JE02512; Hamilton VE, 2003, METEORIT PLANET SCI, V38, P871, DOI 10.1111/j.1945-5100.2003.tb00284.x; Hamilton VE, 2001, J GEOPHYS RES-PLANET, V106, P14733, DOI 10.1029/2000JE001353; HESS PC, 2002, WORKSH UNM SNCS LUN; Hoefen TM, 2003, SCIENCE, V302, P627, DOI 10.1126/science.1089647; KING TVV, 1987, J GEOPHYS RES-SOLID, V92, P11457, DOI 10.1029/JB092iB11p11457; Kraft MD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018848; McSween HY, 2002, METEORIT PLANET SCI, V37, P7, DOI 10.1111/j.1945-5100.2002.tb00793.x; McSween HY, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002175; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.3050842; MINITTI ME, 2002, J GEOPHYS RES, V107, pE5, DOI DOI 10.1029/2001JE001518; MITTLEFEHLDT D, 1994, METEORITICS, V29, P900, DOI 10.1111/j.1945-5100.1994.tb01106.x; MORRIS RV, 2003, 6 INT C MARS PAS CA; MUSTARD JF, 1995, SCIENCE, V267, P1623, DOI 10.1126/science.7886449; Mustard JF, 1997, J GEOPHYS RES-PLANET, V102, P25605, DOI 10.1029/97JE02354; SUNSHINE JM, 1993, J GEOPHYS RES-PLANET, V98, P9075, DOI 10.1029/93JE00677; SUNSHINE JM, 1990, J GEOPHYS RES-SOLID, V95, P6955, DOI 10.1029/JB095iB05p06955; Wyatt MB, 2002, NATURE, V417, P263, DOI 10.1038/417263a	25	311	313	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2005	307	5715					1594	1597		10.1126/science.1109098	http://dx.doi.org/10.1126/science.1109098			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15718427				2022-12-24	WOS:000227622400039
J	Verhagen, E; Sauer, PJJ				Verhagen, E; Sauer, PJJ			The Groningen protocol - Euthanasia in severely ill newborn	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LIFE		Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands	University of Groningen	Verhagen, E (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands.		Verhagen, Eduard/F-9784-2013	Verhagen, Eduard/0000-0001-9555-6922				Sauer PJJ, 2001, EUR J PEDIATR, V160, P364, DOI 10.1007/s004310100735; vanderHeide A, 1997, LANCET, V350, P251, DOI 10.1016/S0140-6736(97)02315-5; Verhagen A A E, 2005, Ned Tijdschr Geneeskd, V149, P183	3	218	224	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2005	352	10					959	962		10.1056/NEJMp058026	http://dx.doi.org/10.1056/NEJMp058026			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904JC	15758003				2022-12-24	WOS:000227491200001
J	Relaix, F; Rocancourt, D; Mansouri, A; Buckingham, M				Relaix, F; Rocancourt, D; Mansouri, A; Buckingham, M			A Pax3/Pax7-dependent population of skeletal muscle progenitor cells	NATURE			English	Article							PAX-3 EXPRESSION; SATELLITE CELLS; MYF-5; SPECIFICATION; DERMOMYOTOME; MIGRATION	During vertebrate development, successive phases of embryonic and fetal myogenesis lead to the formation and growth of skeletal muscles(1). Although the origin and molecular regulation of the earliest embryonic muscle cells is well understood(2), less is known about later stages of myogenesis. We have identified a new cell population that expresses the transcription factors Pax3 and Pax7 (paired box proteins 3 and 7) but no skeletal-muscle-specific markers. These cells are maintained as a proliferating population in embryonic and fetal muscles of the trunk and limbs throughout development. Using a stable green fluorescent protein (GFP) reporter targeted to Pax3, we demonstrate that they constitute resident muscle progenitor cells that subsequently become myogenic and form skeletal muscle. Late in fetal development, these cells adopt a satellite cell position characteristic of progenitor cells in postnatal muscle. In the absence of both Pax3 and Pax7, further muscle development is arrested and only the early embryonic muscle of the myotome forms. Cells failing to express Pax3 or Pax7 die or assume a non-myogenic fate. We conclude that this resident Pax3/Pax7-dependent progenitor cell population constitutes a source of myogenic cells of prime importance for skeletal muscle formation, a finding also of potential value in the context of cell therapy for muscle disease.	Inst Pasteur, CNRS, URA 2578, Dept Dev Biol, F-75724 Paris, France; Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Max Planck Society	Relaix, F (corresponding author), Inst Pasteur, CNRS, URA 2578, Dept Dev Biol, F-75724 Paris, France.	frelaix@pasteur.fr; margab@pasteur.fr		Relaix, Frederic/0000-0003-1270-1472				ARMAND O, 1983, ARCH ANAT MICROSC MO, V72, P163; Ben-Yair R, 2005, DEVELOPMENT, V132, P689, DOI 10.1242/dev.01617; BOBER E, 1994, DEVELOPMENT, V120, P603; Borycki AG, 1999, DEVELOPMENT, V126, P1665; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; COSSU G, 2001, ADV DEV BIOL BIOCH, P127; GOULDING M, 1994, DEVELOPMENT, V120, P957; GROS J, 2005, NATURE          0420, DOI DOI 10.1038/NATURE03572; JOSTES B, 1990, MECH DEVELOP, V33, P27, DOI 10.1016/0925-4773(90)90132-6; Kardon G, 2003, DEV CELL, V5, P937, DOI 10.1016/S1534-5807(03)00360-5; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Mansouri A, 1996, DEVELOPMENT, V122, P831; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Relaix F, 2004, GENE DEV, V18, P1088, DOI 10.1101/gad.301004; Relaix F, 2003, GENE DEV, V17, P2950, DOI 10.1101/gad.281203; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Schubert FR, 2001, DEV DYNAM, V222, P506, DOI 10.1002/dvdy.1211; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Tajbakhsh S, 2000, CURR TOP DEV BIOL, V48, P225; Tajbakhsh S, 1996, NATURE, V384, P266, DOI 10.1038/384266a0; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; Tremblay P, 1998, DEV BIOL, V203, P49, DOI 10.1006/dbio.1998.9041; WILLIAMS BA, 1994, DEVELOPMENT, V120, P785	25	772	801	0	53	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 16	2005	435	7044					948	953		10.1038/nature03594	http://dx.doi.org/10.1038/nature03594			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935RN	15843801	Green Published			2022-12-24	WOS:000229799700048
J	Eckburg, PB; Bik, EM; Bernstein, CN; Purdom, E; Dethlefsen, L; Sargent, M; Gill, SR; Nelson, KE; Relman, DA				Eckburg, PB; Bik, EM; Bernstein, CN; Purdom, E; Dethlefsen, L; Sargent, M; Gill, SR; Nelson, KE; Relman, DA			Diversity of the human intestinal microbial flora	SCIENCE			English	Article							GUT MICROBIOTA; COMMUNITIES; SEQUENCE; BACTERIA; MUCOSA	The human endogenous intestinal microflora is an essential "organ" in providing nourishment, regulating epithelial. development, and instructing innate immunity; yet, surprisingly, basic features remain poorly described. We examined 13,355 prokaryotic ribosomal RNA gene sequences from multiple colonic mucosal sites and feces of healthy subjects to improve our understanding of gut microbial diversity. A majority of the bacterial sequences corresponded to uncultivated species and novel microorganisms. We discovered significant intersubject variability and differences between stool and mucosa community composition. Characterization of this immensely diverse ecosystem is the first step in elucidating its role in health and disease.	Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA; Dept Microbiol & Immunol, Stanford, CA 94305 USA; Univ Manitoba, Dept Med, Gastroenterol Sect, Winnipeg, MB R3A 1R9, Canada; Stanford Univ, Dept Stat, Stanford, CA 94305 USA; Inst Genom Res, Rockville, MD 20850 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	Stanford University; University of Manitoba; Stanford University; J. Craig Venter Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Eckburg, PB (corresponding author), Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Room S-169,300 Pasteur Dr, Stanford, CA 94305 USA.	eckburg1@stanford.edu; relman@stanford.edu	Dethlefsen, Les/R-2220-2018; Bik, Elisabeth M/A-1204-2007	Dethlefsen, Les/0000-0001-9622-1630; Bik, Elisabeth M/0000-0001-5477-0324; Relman, David A./0000-0001-8331-1354	NIAID NIH HHS [AI51259, R01 AI051259] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051259] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000; Colwell R. K., 2004, ESTIMATES VERSION 7; Curtis TP, 2004, CURR OPIN MICROBIOL, V7, P221, DOI 10.1016/j.mib.2004.04.010; Fargione J, 2003, P NATL ACAD SCI USA, V100, P8916, DOI 10.1073/pnas.1033107100; Hayashi H, 2002, MICROBIOL IMMUNOL, V46, P535, DOI 10.1111/j.1348-0421.2002.tb02731.x; Hold GL, 2002, FEMS MICROBIOL ECOL, V39, P33, DOI 10.1111/j.1574-6941.2002.tb00904.x; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Horner-Devine MC, 2004, P ROY SOC B-BIOL SCI, V271, P113, DOI 10.1098/rspb.2003.2549; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pavoine S, 2004, J THEOR BIOL, V228, P523, DOI 10.1016/j.jtbi.2004.02.014; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Relman DA, 2001, TRENDS MICROBIOL, V9, P206, DOI 10.1016/S0966-842X(01)02041-8; Schloss PD, 2004, APPL ENVIRON MICROB, V70, P5485, DOI 10.1128/AEM.70.9.5485-5492.2004; Sonnenburg JL, 2004, NAT IMMUNOL, V5, P569, DOI 10.1038/ni1079; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Wang X, 2003, J APPL MICROBIOL, V95, P508, DOI 10.1046/j.1365-2672.2003.02005.x; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	22	5073	5559	77	1756	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2005	308	5728					1635	1638		10.1126/science.1110591	http://dx.doi.org/10.1126/science.1110591			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	936BH	15831718	Green Accepted, Green Submitted			2022-12-24	WOS:000229827000059
J	Calin, GA; Trapasso, F; Shimizu, M; Dumitru, CD; Yendamuri, S; Godwin, AK; Ferracin, M; Bernardi, G; Chatterjee, D; Baldassarre, G; Rattan, S; Alder, H; Mabuchi, H; Shiraishi, T; Hansen, LL; Overgaard, J; Herlea, V; Mauro, FR; Dighiero, G; Movsas, B; Rassenti, L; Kipps, T; Baffa, R; Fusco, A; Mori, M; Russo, G; Liu, CG; Neuberg, D; Bullrich, F; Negrini, M; Croce, CM				Calin, GA; Trapasso, F; Shimizu, M; Dumitru, CD; Yendamuri, S; Godwin, AK; Ferracin, M; Bernardi, G; Chatterjee, D; Baldassarre, G; Rattan, S; Alder, H; Mabuchi, H; Shiraishi, T; Hansen, LL; Overgaard, J; Herlea, V; Mauro, FR; Dighiero, G; Movsas, B; Rassenti, L; Kipps, T; Baffa, R; Fusco, A; Mori, M; Russo, G; Liu, CG; Neuberg, D; Bullrich, F; Negrini, M; Croce, CM			Familial cancer associated with a polymorphism in ARLTS1	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; TUMOR-SUPPRESSOR LOCUS; DOWN-REGULATION; 13Q14; GENE; SEQUENCE; REGION; IDENTIFICATION; EXPRESSION; DELETIONS	BACKGROUND: The finding of hemizygous or homozygous deletions at band 14 on chromosome 13 in a variety of neoplasms suggests the presence of a tumor-suppressor locus telomeric to the RB1 gene. METHODS: We studied samples from 216 patients with various types of sporadic tumors or idiopathic pancytopenia, peripheral-blood samples from 109 patients with familial cancer or multiple cancers, and control blood samples from 475 healthy people or patients with diseases other than cancer. We performed functional studies of cell lines lacking ARLTS1 expression with the use of both the full-length ARLTS1 gene and a truncated variant. RESULTS: We found a gene at 13q14, ARLTS1, a member of the ADP-ribosylation factor family, with properties of a tumor-suppressor gene. We analyzed 800 DNA samples from tumors and blood cells from patients with sporadic or familial cancer and controls and found that the frequency of a nonsense polymorphism, G446A (Trp149Stop), was similar in controls and patients with sporadic tumors but was significantly more common among patients with familial cancer than among those in the other two groups (P=0.02; odds ratio, 5.7; 95 percent confidence interval, 1.3 to 24.8). ARLTS1 was down-regulated by promoter methylation in 25 percent of the primary tumors we analyzed. Transfection of wild-type ARLTS1 into A549 lung-cancer cells suppressed tumor formation in immunodeficient mice and induced apoptosis, whereas transfection of truncated ARLTS1 had a limited effect on apoptosis and tumor suppression. Microarray analysis revealed that the wild-type and Trp149Stop-transfected clones had different expression profiles. CONCLUSIONS: A genetic variant of ARLTS1 predisposes patients to familial cancer.	Thomas Jefferson Univ, Philadelphia, PA 19107 USA; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; Univ Ferrara, I-44100 Ferrara, Italy; Natl Canc Inst, Aviano, Italy; Aarhus Univ, Aarhus, Denmark; Fundeni Clin Hosp, Bucharest, Romania; Univ Roma La Sapienza, Rome, Italy; Inst Pasteur, Paris, France; Univ Calif San Diego, La Jolla, CA 92093 USA; Univ Catanzaro, Catanzaro, Italy; Kyushu Univ, Beppu, Oita, Japan; Ist Ricovero & Cura Carattere Sci, Rome, Italy; Dana Farber Canc Inst, Boston, MA 02115 USA	Jefferson University; Fox Chase Cancer Center; University of Ferrara; Aarhus University; Institutul Clinic Fundeni; Sapienza University Rome; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of California System; University of California San Diego; Magna Graecia University of Catanzaro; Kyushu University; Harvard University; Dana-Farber Cancer Institute	Croce, CM (corresponding author), Ohio State Univ, Ctr Comprehens Canc, 385K Wiseman Hall,400 W 12th Ave, Columbus, OH 43210 USA.	carlo.croce@osumc.edu	Hansen, Lise Lotte/I-3377-2016; Baldassarre, Gustavo/K-1350-2016; Young, Richard A/F-6495-2012; herlea, vlad/AAT-3967-2021; Ferracin, Manuela/K-2097-2016; Negrini, Massimo/J-2377-2016; Russo, Giandomenico/K-9566-2016; Calin, George/E-9390-2011	Hansen, Lise Lotte/0000-0001-7915-2506; Baldassarre, Gustavo/0000-0002-9750-8825; Young, Richard A/0000-0001-8855-8647; Ferracin, Manuela/0000-0002-1595-6887; Negrini, Massimo/0000-0002-0007-1920; Russo, Giandomenico/0000-0002-7718-9687; Fusco, Alfredo/0000-0003-3332-5197; Mauro, Francesca Romana/0000-0003-2425-9474; Calin, George/0000-0001-6704-5615; Yendamuri, Sai/0000-0001-6654-3487	NCI NIH HHS [P01CA81534, P30CA56036, P01CA76259] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA081534, P30CA056036, P01CA076259] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abudugupur A, 2002, CELL DEATH DIFFER, V9, P158, DOI 10.1038/sj.cdd.4400942; BROWN AG, 1993, NAT GENET, V3, P67, DOI 10.1038/ng0193-67; Bullrich F, 1996, BLOOD, V88, P3109, DOI 10.1182/blood.V88.8.3109.bloodjournal8883109; Bullrich F, 2001, CANCER RES, V61, P6640; Bullrich F, 2001, CHRONIC LYMPHOCYTIC, P9; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Dahlen A, 2003, INT J CANCER, V103, P616, DOI 10.1002/ijc.10864; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Ghosh K, 1999, BIOCHEM CELL BIOL, V77, P165; Goggins M, 1996, CANCER RES, V56, P5360; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; He H, 2002, GENE EXPRESSION, V10, P231, DOI 10.3727/000000002783992406; Houlston RS, 2003, LEUKEMIA RES, V27, P871, DOI 10.1016/S0145-2126(03)00023-7; KAHN RA, 1992, FASEB J, V6, P2512, DOI 10.1096/fasebj.6.8.1592203; La Starza R, 1998, BLOOD, V91, P231, DOI 10.1182/blood.V91.1.231.231_231_237; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Mabuchi H, 2001, CANCER RES, V61, P2870; Mazoyer S, 1996, NAT GENET, V14, P253, DOI 10.1038/ng1196-253; Mertens D, 2002, BLOOD, V99, P4116, DOI 10.1182/blood.V99.11.4116; Migliazza A, 2001, BLOOD, V97, P2098, DOI 10.1182/blood.V97.7.2098; Moss J, 1998, J BIOL CHEM, V273, P21431, DOI 10.1074/jbc.273.34.21431; Ramakrishnan R, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.7.e30; Roest Crollius H, 2000, NAT GENET, V25, P235, DOI 10.1038/76118; Rondeau Gaelle, 2001, Mutation Research, V458, P55, DOI 10.1016/S0027-5107(01)00219-6; Sambrook JFE, 1989, MOL CLONING LAB MANU; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001; Venter JC, 2001, SCIENCE, V292, P1838; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Yin ZN, 1999, ONCOGENE, V18, P7576, DOI 10.1038/sj.onc.1203203	30	104	113	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 21	2005	352	16					1667	1676		10.1056/NEJMoa042280	http://dx.doi.org/10.1056/NEJMoa042280			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	918CE	15843669				2022-12-24	WOS:000228515200008
J	Provoost, V; Cools, F; Mortier, F; Bilsen, J; Ramet, J; Vandenplas, Y; Deliens, L				Provoost, V; Cools, F; Mortier, F; Bilsen, J; Ramet, J; Vandenplas, Y; Deliens, L		Neonatal Intensive Care Consortium	Medical end-of-life decisions in neonates and infants in Flanders	LANCET			English	Article							SELF-REPORTED PRACTICES; INTENSIVE-CARE; ATTITUDES; EUTHANASIA; NEWBORNS	Background Paediatricians are increasingly confronted with end-of-life decisions in critically ill neonates and infants. little is known about the frequency and characteristics of end-of-life decisions in this population, nor about the relation with clinical and patients' characteristics. Methods A death-certificate study was done for all deaths of neonates and infants in the whole of Flanders over a 12-month period (August, 1999, to July, 2000). We sent an anonymous questionnaire by mail to the attending physician for each of the 292 children who died under the age of 1 year. Information on patients was obtained from national registers. An attitude study was done for all physicians who attended at least one death during the study period. Findings 253 (87%) of the 292 questionnaires were returned, and 121 (69%) of the 175 physicians involved completed the attitude questions. An end-of-life decision was possible in 194 (77%; 95% CI 70.4-82.4) of the 253 deaths studied, and such a decision was made in 143 cases (57%; 48.9-64.0). Lethal drugs were administered in 15 cases among 117 early neonatal deaths and in two cases among 77 later deaths (13% vs 3%; p=0.018). The attitude study showed that 95 (79%; 70.1-85.5) of the 121 physicians thought that their professional duty sometimes includes the prevention of unnecessary suffering by hastening death and 69 (58%; 48.1-66.5) of 120 supported legalisation of life termination in some cases. Interpretation Death of neonates and infants is commonly preceded by an end-of-life decision. The type of decision varied substantially according to the age of the child. Most physicians favour legalisation of the use of lethal drugs in some cases.	Free Univ Brussels, End Life Care Res Grp, B-1090 Brussels, Belgium; Free Univ Brussels, Univ Hosp, Dept Paediat, Brussels, Belgium; Univ Ghent, Ctr Bioeth, B-9000 Ghent, Belgium; Vrije Univ Amsterdam Med Ctr, Dept Publ & Occupat Hlth, Inst Res Extramural Med, Amsterdam, Netherlands	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Ghent University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Deliens, L (corresponding author), Free Univ Brussels, End Life Care Res Grp, Laarbeeklaan 103, B-1090 Brussels, Belgium.	luc.deliens@vub.ac.be	Provoost, Veerle/H-4214-2011	Mortier, Freddy/0000-0002-5390-3508; Cools, Filip/0000-0002-6581-7009; Deliens, Luc/0000-0002-8158-2422				*BRIT MED ASS, 1999, WITHH WITHDR LIF PRO; Cantagrel S, 2000, ARCH PEDIATRIE, V7, P725, DOI 10.1016/S0929-693X(00)80152-9; Cook L A, 1996, J Perinatol, V16, P133; Cuttini M, 2000, LANCET, V355, P2112, DOI 10.1016/S0140-6736(00)02378-3; de Leeuw R, 2000, J PEDIATR-US, V137, P608, DOI 10.1067/mpd.2000.109144; Deliens L, 2000, LANCET, V356, P1806, DOI 10.1016/S0140-6736(00)03233-5; DILLMAN DA, 1991, ANNU REV SOCIOL, V17, P225, DOI 10.1146/annurev.so.17.080191.001301; Doron MW, 1998, PEDIATRICS, V102, P574, DOI 10.1542/peds.102.3.574; DUFF RS, 1973, NEW ENGL J MED, V289, P890, DOI 10.1056/NEJM197310252891705; *EUR WORK GROUP, 2001, 7 SCI PUBL HLTH EUR; Garel M, 1997, ARCH PEDIATRIE, V4, P662, DOI 10.1016/S0929-693X(97)83370-2; HARRIS J, 1985, VALUE LIFE INTRO MED, P34; Kollee LAA, 1999, SEMIN PERINATOL, V23, P234, DOI 10.1016/S0146-0005(99)80068-8; McCallum DE, 2000, J PAIN SYMPTOM MANAG, V20, P417, DOI 10.1016/S0885-3924(00)00212-8; McHaffie HE, 1999, J MED ETHICS, V25, P440, DOI 10.1136/jme.25.6.440; McHugh-Strong CM, 2000, AM J PERINAT, V17, P27, DOI 10.1055/s-2000-7291; Norup M, 1998, ACTA PAEDIATR, V87, P896, DOI 10.1080/080352598750013707; Norup M, 1999, ACTA PAEDIATR, V88, P438, DOI 10.1080/08035259950169846; POWDERLY KE, 1999, ETHICS CRITICAL CARE, P475; Rebagliato M, 2000, JAMA-J AM MED ASSOC, V284, P2451, DOI 10.1001/jama.284.19.2451; Sklansky M, 2001, J MED ETHICS, V27, P5, DOI 10.1136/jme.27.1.5; van der Maas PJ, 1991, LANCET, V338, P669, DOI 10.1016/0140-6736(91)91241-L; van der Maas PJ, 1996, NEW ENGL J MED, V335, P1699, DOI 10.1056/NEJM199611283352227; vanderHeide A, 1997, LANCET, V350, P251, DOI 10.1016/S0140-6736(97)02315-5	24	47	47	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2005	365	9467					1315	1320		10.1016/S0140-6736(05)61028-8	http://dx.doi.org/10.1016/S0140-6736(05)61028-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	914HY	15823381				2022-12-24	WOS:000228219600026
J	Falk, D; Hildebolt, C; Smith, K; Morwood, MJ; Sutikna, T; Brown, P; Jatmiko; Saptomo, EW; Brunsden, B; Prior, F				Falk, D; Hildebolt, C; Smith, K; Morwood, MJ; Sutikna, T; Brown, P; Jatmiko; Saptomo, EW; Brunsden, B; Prior, F			The brain of LB1, Homo floresiensis	SCIENCE			English	Article							INDONESIA; EVOLUTION; HOMININ; APES	The brain of Homo floresiensis was assessed by comparing a virtual endocast from the type specimen (LB1) with endocasts from great apes, Homo erectus, Homo sapiens, a human pygmy, a human microcephalic, specimen number Sts 5 (Australopithecus africanus), and specimen number WT 17000 (Paranthropus aethiopicus). Morphometric, allometric, and shape data indicate that LB1 is not a microcephalic or pygmy. LB1's brain/body size ratio scales like that of an australopithecine, but its endocast shape resembles that of Homo erectus. LB1 has derived frontal and temporal lobes and a lunate sulcus in a derived position, which are consistent with capabilities for higher cognitive processing.	Florida State Univ, Dept Anthropol, Tallahassee, FL 32306 USA; Washington Univ, Sch Med, Edward Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; Univ New England, Armidale, NSW 2351, Australia; Indonesian Ctr Archaeol, Jakarta 12001, Indonesia	State University System of Florida; Florida State University; Washington University (WUSTL); University of New England	Falk, D (corresponding author), Florida State Univ, Dept Anthropol, Tallahassee, FL 32306 USA.	dfalk@fsu.edu	Brown, Peter/C-8763-2018; Falk, Dean/C-6400-2019; Sutikna, Thomas/C-4709-2018	Falk, Dean/0000-0003-1654-0469; Sutikna, Thomas/0000-0002-9742-4226				Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; CAVALLISFORZA LL, 1986, AFRICAN PYGMIES, P81; Connolly CJ, 1950, EXTERNAL MORPHOLOGY; Conroy G.C., 1985, P419; CONROY GC, 1990, SCIENCE, V247, P838, DOI 10.1126/science.2305255; Conroy GC, 1998, SCIENCE, V280, P1730, DOI 10.1126/science.280.5370.1730; Diamond J, 2004, SCIENCE, V306, P2047, DOI 10.1126/science.1107565; FALK D, 1983, SCIENCE, V221, P1072, DOI 10.1126/science.221.4615.1072; Falk D, 2000, J HUM EVOL, V38, P695, DOI 10.1006/jhev.1999.0378; FALK D, 1993, AM J PHYS ANTHROPOL, V92, P81, DOI 10.1002/ajpa.1330920107; FLOWER WH, 1889, J ANTHR I, V18, P3; GROVES C, 2004, BEFORE FARMING, V4; HENNEBERG M, 2004, BEFORE FARMING, V4; Holloway R. L., 2004, HUMAN FOSSIL RECORD, V3; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Kumar A, 2002, J BIOSCIENCES, V27, P629, DOI 10.1007/BF02708369; LEMAY M, 1992, AM J NEURORADIOL, V13, P493; Morwood MJ, 2004, NATURE, V431, P1087, DOI 10.1038/nature02956; PASSINGHAM R, 1975, NEW SCI, V27, P510; Rilling JK, 2002, J HUM EVOL, V42, P505, DOI 10.1006/jhev.2001.0537; Schultz A.H., 1956, PRIMATOLOGIA, P887; Semendeferi K, 2001, EVOLUTIONARY ANATOMY OF THE PRIMATE CEREBRAL CORTEX, P257; Semendeferi K, 2000, J HUM EVOL, V38, P317, DOI 10.1006/jhev.1999.0381; Semendeferi K, 2001, AM J PHYS ANTHROPOL, V114, P224, DOI 10.1002/1096-8644(200103)114:3<224::AID-AJPA1022>3.0.CO;2-I; Shea BT, 1996, AM J PHYS ANTHROPOL, V100, P311; Spoor F, 2000, J ANAT, V197, P61, DOI 10.1046/j.1469-7580.2000.19710061.x; VERLOES A, 2004, ORPHANET ENCY; WEIDENREICH FRANZ, 1938, PALEONTOL SINICA SER D, V3, P1	28	172	182	5	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2005	308	5719					242	245		10.1126/science.1109727	http://dx.doi.org/10.1126/science.1109727			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915BX	15749690	Green Submitted			2022-12-24	WOS:000228273700050
J	Dejardin, J; Rappailles, A; Cuvier, O; Grimaud, C; Decoville, M; Locker, D; Cavalli, G				Dejardin, J; Rappailles, A; Cuvier, O; Grimaud, C; Decoville, M; Locker, D; Cavalli, G			Recruitment of Drosophila Polycomb group proteins to chromatin by DSP1	NATURE			English	Article							HMG-LIKE PROTEIN; RESPONSE ELEMENT; HOMEOTIC GENE; BITHORAX COMPLEX; ENGRAILED GENE; DNA; MELANOGASTER; REPRESSION; REGION; GAGA	Polycomb and trithorax group (PcG and trxG) proteins maintain silent and active transcriptional states, respectively, throughout development(1). In Drosophila, PcG and trxG proteins associate with DNA regions named Polycomb and trithorax response elements (PRE and TRE), but the mechanisms of recruitment are unknown. We previously characterized a minimal element from the regulatory region of the Abdominal-B gene, termed Ab-Fab. Ab-Fab contains a PRE and a TRE and is able to maintain repressed or active chromatin states during development(2). Here we show that the Dorsal switch protein 1 (DSP1), a Drosophila HMGB2 homologue, binds to a sequence present within Ab-Fab and in other characterized PREs. Addition of this motif to an artificial sequence containing Pleiohomeotic and GAGA factor consensus sites is sufficient for PcG protein recruitment in vivo. Mutations that abolish DSP1 binding to Ab-Fab and to a PRE from the engrailed locus lead to loss of PcG protein binding, loss of silencing, and switching of these PREs into constitutive TREs. The binding of DSP1 to PREs is therefore important for the recruitment of PcG proteins.	CNRS, Inst Human Genet, F-34396 Montpellier, France; Univ Orleans, CNRS, Ctr Biophys Mol, F-45071 Orleans, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans	Cavalli, G (corresponding author), CNRS, Inst Human Genet, 141 Rue Cardonille, F-34396 Montpellier, France.	giacomo.cavalli@igh.cnrs.fr	Cuvier, Olivier/ADO-0657-2022; cavalli, giacomo/Z-2754-2019; CUVIER, Olivier/AAC-4693-2019; Cavalli, Giacomo/A-7958-2008; grimaud, charlotte/Y-6689-2019	cavalli, giacomo/0000-0003-3709-3469; CUVIER, Olivier/0000-0003-0644-2734; Cavalli, Giacomo/0000-0003-3709-3469; grimaud, charlotte/0000-0001-7944-5931; DEJARDIN, Jerome/0000-0003-0151-1104				Americo J, 2002, GENETICS, V160, P1561; Brickman JM, 1999, P NATL ACAD SCI USA, V96, P10679, DOI 10.1073/pnas.96.19.10679; Brown JL, 2003, DEVELOPMENT, V130, P285, DOI 10.1242/dev.00204; BROWN KL, 1998, RRD INORG CHEM, V1, P1; Busturia A, 2001, DEVELOPMENT, V128, P2163; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; CHAN CS, 1994, EMBO J, V13, P2553, DOI 10.1002/j.1460-2075.1994.tb06545.x; Decoville M, 2001, GENETICS, V157, P237; Dejardin J, 2004, EMBO J, V23, P857, DOI 10.1038/sj.emboj.7600108; Duncan IW, 2002, ANNU REV GENET, V36, P521, DOI 10.1146/annurev.genet.36.060402.100441; FAUVARQUE MO, 1993, GENE DEV, V7, P1508, DOI 10.1101/gad.7.8.1508; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; FRANKE A, 1992, EMBO J, V11, P2941, DOI 10.1002/j.1460-2075.1992.tb05364.x; Fritsch C, 1999, DEVELOPMENT, V126, P3905; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Hagstrom K, 1997, GENETICS, V146, P1365; Kassis JA, 2002, ADV GENET, V46, P421; KASSIS JA, 1994, GENETICS, V136, P1025; LEHMING N, 1994, NATURE, V371, P175, DOI 10.1038/371175a0; MARTIN CH, 1995, P NATL ACAD SCI USA, V92, P8398, DOI 10.1073/pnas.92.18.8398; Mishra RK, 2001, MOL CELL BIOL, V21, P1311, DOI 10.1128/MCB.21.4.1311-1318.2001; Mohd-Sarip A, 2002, MOL CELL BIOL, V22, P7473, DOI 10.1128/MCB.22.21.7473-7483.2002; Mosrin-Huaman C, 1998, DEV GENET, V23, P324; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Ringrose L, 2003, DEV CELL, V5, P759, DOI 10.1016/S1534-5807(03)00337-X; Shimell MJ, 2000, DEV BIOL, V218, P38, DOI 10.1006/dbio.1999.9576; Thomas JO, 2001, BIOCHEM SOC T, V29, P395, DOI 10.1042/BST0290395; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; ZINK D, 1995, EMBO J, V14, P5660, DOI 10.1002/j.1460-2075.1995.tb00253.x	29	121	124	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2005	434	7032					533	538		10.1038/nature03386	http://dx.doi.org/10.1038/nature03386			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909CH	15791260				2022-12-24	WOS:000227836000048
J	Harris, TG; Burk, RD; Palefsky, JM; Massad, LS; Bang, JY; Anastos, K; Minkoff, H; Hall, CB; Bacon, MC; Levine, AM; Watts, DH; Silverberg, MJ; Xue, XN; Melnick, SL; Strickler, HD				Harris, TG; Burk, RD; Palefsky, JM; Massad, LS; Bang, JY; Anastos, K; Minkoff, H; Hall, CB; Bacon, MC; Levine, AM; Watts, DH; Silverberg, MJ; Xue, XN; Melnick, SL; Strickler, HD			Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	8th International Conference on Malignancies in AIDS and Other Immunodeficiencies	APR 29-30, 2004	Bethesda, MD				HIGH-RISK HPV; CYTOLOGY; WOMEN; NEOPLASIA; CANCER; ABNORMALITIES; SMEARS	Context Recent cervical cancer screening guidelines state that the interval between screenings can be safely extended to 3 years in healthy women 30 years or older who have normal cytology results and have negative test results for oncogenic human papillomavirus (HPV) DNA. Objective To determine the incidence of squamous intraepithelial lesions (SILs) in HIV-seropositive women with normal cytology results, by baseline HPV DNA results. Design, Setting, and Patients Participants were HIV-seropositive (n=855; mean age, 36 years) and HIV-seronegative (n=343; mean age, 34 years) US women with normal baseline cervical cytology who were enrolled in the Women's Interagency HIV Study (WIHS), a large, multi-institutional prospective cohort study. Since their recruitment during 1994-1995, WIHS participants have been followed up semi-annually with repeated Pap smears for a median of 7 years. Main Outcome Measure The cumulative incidence of any SIL and high-grade SIL or cancer (HSIL+) was estimated according to baseline HPV DNA results, stratified by HIV serostatus and CD4 T-cell count. Results Development of any SIL in women with negative HPV results (both oncogenic and nononcogenic) at 2 years was as follows: in HIV-seropositive women with CD4 counts less than 200/mu L, 9% (95% Cl, 1%-18%); with CD4 counts between 200/mu L and 500/mu L, 9% (95% Cl, 4%-13%); and with CD4 counts greater than 500/ mu L, 4% (95% Cl, 1%-7%). The Cis for these estimates overlapped with those for HIV-seronegative women with normal baseline cytology who were HPV-negative (3%; 95% Cl, 1%-5%), indicating that at 2 years, there were no large absolute differences in the cumulative incidence of any SIL between groups. Furthermore, no HPV-negative participants in any group developed HSIL+ lesions within 3 years. Multivariate Cox models showed that on a relative scale, the incidence of any SIL among HIV-seropositive women with CD4 counts greater than 500/mu L (hazard ratio [HR], 1.2; 95% Cl, 0.5-3.0), but not those with CD4 counts less than or equal to 500/mu L (HR, 2.9; 95% C1, 1.2-7.1), was similar to that in HIV-seronegative women. Conclusion The similar low cumulative incidence of any SIL among HIV-seronegative and HIV-seropositive women with CD4 counts greater than 500/mu L and who had normal cervical cytology and HPV-negative test results suggests that similar cervical cancer screening practices may be applicable to both groups, although this strategy warrants evaluation in an appropriate clinical trial.	Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; So Illinois Univ, Sch Med, Springfield, IL USA; Maimonides Hosp, Brooklyn, NY 11219 USA; Georgetown Univ, Med Ctr, Washington, DC 20007 USA; Univ So Calif, Los Angeles, CA USA; NICHHD, Bethesda, MD 20892 USA; Johns Hopkins Univ, Baltimore, MD USA; NCI, Bethesda, MD 20892 USA	Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Francisco; Southern Illinois University System; Southern Illinois University; Maimonides Medical Center; Georgetown University; University of Southern California; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Harris, TG (corresponding author), Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, 1300 Morris Pk Ave,Belfer 1308A, Bronx, NY 10461 USA.	tharris@aecom.yu.edu	Hall, Charles B./AAX-8216-2020	Hall, Charles/0000-0001-9982-8120; Harris, Tiffany/0000-0003-2212-0874	NCI NIH HHS [R01-CA-085178] Funding Source: Medline; NCRR NIH HHS [M01-RR-00079, M01-RR-0007, M01-RR-00083] Funding Source: Medline; NIAID NIH HHS [U01-AI-31834, U01-AI-42590, U01-AI-35004, U01-AI-34994, U01-AI-34993, U01-AI-34989] Funding Source: Medline; OID CDC HHS [U01-CH-32632] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA085178] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000083, M01RR000079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI042590, U01AI034989, U01AI031834, U01AI034994, U01AI034993, U01AI035004] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OID CDC HHS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		*2 NAT CANC I WORK, 1993, ACTA CYTOL, V37, P115; ACOG Comm Obstet Practice, 2003, OBSTET GYNECOL, V102, P415; [Anonymous], 1995, Clin Infect Dis, V21 Suppl 1, pS32; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Clavel C, 2004, BRIT J CANCER, V90, P1803, DOI 10.1038/sj.bjc.6601726; COX DR, 1972, J R STAT SOC B, V34, P187; Delmas MC, 2000, AIDS, V14, P1775, DOI 10.1097/00002030-200008180-00013; Ellerbrock TV, 2000, JAMA-J AM MED ASSOC, V283, P1031, DOI 10.1001/jama.283.8.1031; Goldie SJ, 2001, AM J MED, V111, P140, DOI 10.1016/S0002-9343(01)00780-X; Kaplan Jonathan E, 2002, MMWR Recomm Rep, V51, P1; Kinney WK, 1998, OBSTET GYNECOL, V91, P973, DOI 10.1016/S0029-7844(98)00080-5; Kulasingam SL, 2002, JAMA-J AM MED ASSOC, V288, P1749, DOI 10.1001/jama.288.14.1749; Lawless J.F, 1982, STAT MODELS METHODS; LONKY NM, 1995, OBSTET GYNECOL, V85, P716, DOI 10.1016/0029-7844(95)00041-O; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; Palefsky JM, 1999, JNCI-J NATL CANCER I, V91, P226, DOI 10.1093/jnci/91.3.226; Ratnam S, 2000, CANCER EPIDEM BIOMAR, V9, P945; Rozendaal L, 2000, J CLIN PATHOL, V53, P606, DOI 10.1136/jcp.53.8.606; Schneider A, 2000, INT J CANCER, V89, P529, DOI 10.1002/1097-0215(20001120)89:6&lt;529::AID-IJC11&gt;3.0.CO;2-G; Sherman ME, 2003, JNCI-J NATL CANCER I, V95, P46, DOI 10.1093/jnci/95.1.46; Solomon D, 2003, AM J OBSTET GYNECOL, V188, P1393, DOI 10.1067/mob.2003.462; Strickler HD, 2003, JNCI-J NATL CANCER I, V95, P1062, DOI 10.1093/jnci/95.14.1062; Wright TC, 2004, OBSTET GYNECOL, V103, P304, DOI 10.1097/01.AOG.0000109426.82624.f8; WRIGHT TC, 1995, OBSTET GYNECOL, V85, P202, DOI 10.1016/0029-7844(94)00373-L	24	134	135	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2005	293	12					1471	1476		10.1001/jama.293.12.1471	http://dx.doi.org/10.1001/jama.293.12.1471			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	908KA	15784870				2022-12-24	WOS:000227784700026
J	Gibson, MC; Perrimon, N				Gibson, MC; Perrimon, N			Extrusion and death of DPP/BMP-compromised epithelial cells in the developing Drosophila wing	SCIENCE			English	Article							DPP MORPHOGEN GRADIENT; JUVENILE POLYPOSIS; THICK VEINS; I RECEPTORS; APOPTOSIS; MUTATIONS; JNK; MECHANISMS; SURVIVAL; KINASE	During animal development, epithelial cell fates are specified according to spatial position by extracellular signaling pathways. Among these, the transforming growth factor beta/bone morphogenetic protein (TGF-beta/BMP) pathways are evolutionarily conserved and play crucial roles in the development and homeostasis of a wide range of multicellular tissues. Here we show that in the developing Drosophila wing imaginal epithelium, cell clones deprived of the BMP-like ligand Decapentaplegic (DPP) do not die as previously thought but rather extrude from the cell layer as viable cysts exhibiting marked abnormalities in cell shape and cytoskeletal organization. We propose that in addition to assigning cell fates, a crucial developmental function of DPP/BMP signaling is the position-specific control of epithelial. architecture.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Perrimon, N (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	perrimon@receptor.med.harvard.edu		Gibson, Matthew/0000-0001-5588-8842; Perrimon, Norbert/0000-0001-7542-472X				Adachi-Yamada T, 2004, J BIOCHEM, V136, P13, DOI 10.1093/jb/mvh099; Adachi-Yamada T, 2002, DEV BIOL, V251, P74, DOI 10.1006/dbio.2002.0821; Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; AFFOLTER M, 1994, DEVELOPMENT, V120, P3105; Auerbach C., 1936, Transactions of the Royal Society of Edinburgh, V58, P787; BRUMMEL TJ, 1994, CELL, V78, P251, DOI 10.1016/0092-8674(94)90295-X; Burke R, 1996, DEVELOPMENT, V122, P2261; Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5; COHEN SM, 1993, DEV DROSOPHILA MELAN, V2, P74; Duffy JB, 1998, DEVELOPMENT, V125, P2263; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; Gelbart W, 2003, NUCLEIC ACIDS RES, V31, P172, DOI 10.1093/nar/gkg094; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; Ingram AJ, 2000, KIDNEY INT, V58, P1431, DOI 10.1046/j.1523-1755.2000.00305.x; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Martin-Blanco E, 2000, P NATL ACAD SCI USA, V97, P7888, DOI 10.1073/pnas.97.14.7888; Milan M, 2002, DEV CELL, V2, P797, DOI 10.1016/S1534-5807(02)00169-7; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; NELLEN D, 1994, CELL, V78, P225, DOI 10.1016/0092-8674(94)90293-3; PENTON A, 1994, CELL, V78, P239, DOI 10.1016/0092-8674(94)90294-1; Ramet M, 2002, DEV BIOL, V241, P145, DOI 10.1006/dbio.2001.0502; Ricos MG, 1999, J CELL SCI, V112, P1225; Rosenblatt J, 2001, CURR BIOL, V11, P1847, DOI 10.1016/S0960-9822(01)00587-5; RUBERTE E, 1995, CELL, V80, P889, DOI 10.1016/0092-8674(95)90292-9; Sayed MG, 2002, ANN SURG ONCOL, V9, P901, DOI 10.1007/BF02557528; Singer MA, 1997, DEVELOPMENT, V124, P79	29	148	150	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2005	307	5716					1785	1789		10.1126/science.1104751	http://dx.doi.org/10.1126/science.1104751			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774762				2022-12-24	WOS:000227883900048
J	Najemnik, J; Geisler, WS				Najemnik, J; Geisler, WS			Optimal eye movement strategies in visual search	NATURE			English	Article							SIGNAL-DETECTION; MODEL	To performvisual search, humans, like many mammals, encode a large field of view with retinas having variable spatial resolution, and then use high-speed eye movements to direct the highest-resolution region, the fovea, towards potential target locations(1,2). Good search performance is essential for survival, and hence mammals may have evolved efficient strategies for selecting fixation locations. Here we address two questions: what are the optimal eye movement strategies for a foveated visual system faced with the problem of finding a target in a cluttered environment, and do humans employ optimal eye movement strategies during a search? We derive the ideal bayesian observer(3-6) for search tasks in which a target is embedded at an unknown location within a random background that has the spectral characteristics of natural scenes(7). Our ideal searcher uses precise knowledge about the statistics of the scenes in which the target is embedded, and about its own visual system, to make eye movements that gain the most information about target location. We find that humans achieve nearly optimal search performance, even though humans integrate information poorly across fixations(8-10). Analysis of the ideal searcher reveals that there is little benefit from perfect integration across fixations - much more important is efficient processing of information on each fixation. Apparently, evolution has exploited this fact to achieve efficient eye movement strategies with minimal neural resources devoted to memory.	Univ Texas, Ctr Perceptual Syst, Austin, TX 78712 USA; Univ Texas, Dept Psychol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Geisler, WS (corresponding author), Univ Texas, Ctr Perceptual Syst, Austin, TX 78712 USA.	geisler@psy.utexas.edu		Geisler, Wilson/0000-0003-4630-6614				Blake A., 1992, ACTIVE VISION; BURGESS AE, 1981, SCIENCE, V214, P93, DOI 10.1126/science.7280685; BURGESS AE, 1984, J OPT SOC AM A, V1, P906, DOI 10.1364/JOSAA.1.000906; Carpenter RHS, 1991, EYE MOVEMENTS; Eckstein MP, 2001, PERCEPTION, V30, P1389, DOI 10.1068/p3128; Eckstein MP, 2000, PERCEPT PSYCHOPHYS, V62, P425, DOI 10.3758/BF03212096; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; FINDLAY JM, 1982, VISION RES, V22, P1033, DOI 10.1016/0042-6989(82)90040-2; Geisler WS, 2003, COGNITIVE SCI, V27, P379, DOI 10.1016/S0364-0213(03)00009-0; Geman D, 1996, IEEE T PATTERN ANAL, V18, P1, DOI 10.1109/34.476006; Green DM, 1966, SIGNAL DETECTION THE; Hayhoe MM, 1998, VISION RES, V38, P125, DOI 10.1016/S0042-6989(97)00116-8; IRWIN DE, 1991, COGNITIVE PSYCHOL, V23, P420, DOI 10.1016/0010-0285(91)90015-G; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Legge GE, 2002, VISION RES, V42, P2219, DOI 10.1016/S0042-6989(02)00131-1; Liversedge SP, 2000, TRENDS COGN SCI, V4, P6, DOI 10.1016/S1364-6613(99)01418-7; Lu ZL, 1999, J OPT SOC AM A, V16, P764, DOI 10.1364/JOSAA.16.000764; Palmer J, 2000, VISION RES, V40, P1227, DOI 10.1016/S0042-6989(99)00244-8; Pelli DG, 1999, J OPT SOC AM A, V16, P647, DOI 10.1364/JOSAA.16.000647; Rajashekar U., 2002, Proceedings ETRA 2002. Eye Tracking Research and Applications Symposium, P119, DOI 10.1145/507072.507096; Rao RPN, 2002, VISION RES, V42, P1447, DOI 10.1016/S0042-6989(02)00040-8; Rensink RA, 2002, ANNU REV PSYCHOL, V53, P245, DOI 10.1146/annurev.psych.53.100901.135125; Schall J. D., 2004, VISUAL NEUROSCIENCES, P1369; Wolfe Jeremy M, 2010, Curr Biol, V20, pR346, DOI 10.1016/j.cub.2010.02.016; Zelinsky GJ, 1997, PSYCHOL SCI, V8, P448, DOI 10.1111/j.1467-9280.1997.tb00459.x	26	547	565	1	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					387	391		10.1038/nature03390	http://dx.doi.org/10.1038/nature03390			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772663				2022-12-24	WOS:000227715100053
J	Peiter, E; Maathuis, FJM; Mills, LN; Knight, H; Pelloux, J; Hetherington, AM; Sanders, D				Peiter, E; Maathuis, FJM; Mills, LN; Knight, H; Pelloux, J; Hetherington, AM; Sanders, D			The vacuolar Ca2+-activated channel TPC1 regulates germination and stomatal movement	NATURE			English	Article							INDUCED CALCIUM-RELEASE; GUARD-CELL VACUOLES; ION CHANNELS; ARABIDOPSIS; PROTEIN; IDENTIFICATION; TRANSFORMATION; OSCILLATIONS; SODIUM; SYSTEM	Cytosolic free calcium ([Ca2+](cyt)) is a ubiquitous signalling component in plant cells(1). Numerous stimuli trigger sustained or transient elevations of [Ca2+](cyt) that evoke downstream stimulus-specific responses. Generation of [Ca2+](cyt) signals is effected through stimulus-induced opening of Ca2+-permeable ion channels that catalyse a flux of Ca2+ into the cytosol from extracellular or intracellular stores. Many classes of Ca2+ current have been characterized electrophysiologically in plant membranes(2). However, the identity of the ion channels that underlie these currents has until now remained obscure. Here we show that the TPC1 ('two-pore channel 1') gene of Arabidopsis thaliana encodes a class of Ca2+-dependent Ca2+-release channel that is known from numerous electrophysiological studies as the slow vacuolar channel(3-5). Slow vacuolar channels are ubiquitous in plant vacuoles, where they form the dominant conductance at micromolar [Ca2+](cyt). We show that a tpc1 knockout mutant lacks functional slow vacuolar channel activity and is defective in both abscisic acid-induced repression of germination and in the response of stomata to extracellular calcium. These studies unequivocally demonstrate a critical role of intracellular Ca2+-release channels in the physiological processes of plants.	Univ York, Dept Biol, Area 9, York YO10 5YW, N Yorkshire, England; Univ Lancaster, Dept Biol, Lancaster Environm Ctr, Lancaster LA1 4YQ, England; Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England	University of York - UK; Lancaster University; University of Oxford	Sanders, D (corresponding author), Univ York, Dept Biol, Area 9, POB 373, York YO10 5YW, N Yorkshire, England.	ds10@york.ac.uk	Peiter, Edgar/C-2577-2013	Peiter, Edgar/0000-0002-9104-3238; Hetherington, Alistair/0000-0001-6060-9203; Pelloux, Jerome/0000-0002-9371-1711; Knight, Heather/0000-0003-2047-6084	Biotechnology and Biological Sciences Research Council [P18580] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ABEL S, 1994, PLANT J, V5, P421, DOI 10.1111/j.1365-313X.1994.00421.x; Allen GJ, 1997, ADV BOT RES, V25, P217, DOI 10.1016/S0065-2296(08)60154-8; Allen GJ, 1996, PLANT J, V10, P1055, DOI 10.1046/j.1365-313X.1996.10061055.x; Allen GJ, 2000, SCIENCE, V289, P2338, DOI 10.1126/science.289.5488.2338; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bewell MA, 1999, FEBS LETT, V458, P41, DOI 10.1016/S0014-5793(99)01109-6; Carter C, 2004, PLANT CELL, V16, P3285, DOI 10.1105/tpc.104.027078; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Furuichi T, 2001, PLANT CELL PHYSIOL, V42, P900, DOI 10.1093/pcp/pce145; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Hashimoto K, 2004, PLANT CELL PHYSIOL, V45, P496, DOI 10.1093/pcp/pch053; HEDRICH R, 1987, NATURE, V329, P833, DOI 10.1038/329833a0; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; HOFTE H, 1991, PLANTA, V184, P431, DOI 10.1007/BF00197889; Ishibashi K, 2000, BIOCHEM BIOPH RES CO, V270, P370, DOI 10.1006/bbrc.2000.2435; Kadota Y, 2004, BIOCHEM BIOPH RES CO, V317, P823, DOI 10.1016/j.bbrc.2004.03.114; Kurusu T, 2004, PLANT CELL PHYSIOL, V45, P693, DOI 10.1093/pcp/pch082; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; Maathuis FJM, 1995, METHOD CELL BIOL, V49, P293, DOI 10.1016/S0091-679X(08)61461-2; Maathuis FJM, 2001, PLANT PHYSIOL, V127, P1617, DOI 10.1104/pp.010502; MCAINSH MR, 1995, PLANT CELL, V7, P1207, DOI 10.1105/tpc.7.8.1207; Muir SR, 1997, PLANT PHYSIOL, V114, P1511, DOI 10.1104/pp.114.4.1511; Pottosin II, 2001, J MEMBRANE BIOL, V181, P55, DOI 10.1007/s0023200100073; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Schonknecht G, 2002, FEBS LETT, V511, P28, DOI 10.1016/S0014-5793(01)03273-2; Schroeder JI, 2001, ANNU REV PLANT PHYS, V52, P627, DOI 10.1146/annurev.arplant.52.1.627; Szponarski W, 2004, PROTEOMICS, V4, P397, DOI 10.1002/pmic.200300607; WARD JM, 1994, PLANT CELL, V6, P669; White PJ, 2000, BBA-BIOMEMBRANES, V1465, P171, DOI 10.1016/S0005-2736(00)00137-1	30	378	401	1	101	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					404	408		10.1038/nature03381	http://dx.doi.org/10.1038/nature03381			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772667				2022-12-24	WOS:000227715100057
J	Beman, JM; Arrigo, KR; Matson, PA				Beman, JM; Arrigo, KR; Matson, PA			Agricultural runoff fuels large phytoplankton blooms in vulnerable areas of the ocean	NATURE			English	Article							GULF-OF-CALIFORNIA; NITROGEN-FIXATION; DENITRIFICATION; VARIABILITY; PHOSPHORUS; PATTERNS; NITRATE; WATERS; SEA; BAY	Biological productivity in most of the world's oceans is controlled by the supply of nutrients to surface waters. The relative balance between supply and removal of nutrients - including nitrogen, iron and phosphorus - determines which nutrient limits phytoplankton growth. Although nitrogen limits productivity in much of the ocean(1,2), large portions of the tropics and subtropics are defined by extreme nitrogen depletion. In these regions, microbial denitrification removes biologically available forms of nitrogen from the water column, producing substantial deficits relative to other nutrients(3-5). Here we demonstrate that nitrogen-deficient areas of the tropical and subtropical oceans are acutely vulnerable to nitrogen pollution. Despite naturally high nutrient concentrations and productivity(6-8), nitrogen-rich agricultural runoff fuels large (54 - 577 km(2)) phytoplankton blooms in the Gulf of California. Runoff exerts a strong and consistent influence on biological processes, in 80% of cases stimulating blooms within days of fertilization and irrigation of agricultural fields. We project that by the year 2050, 27 - 59% of all nitrogen fertilizer will be applied in developing regions located upstream of nitrogen-deficient marine ecosystems. Our findings highlight the present and future vulnerability of these ecosystems to agricultural runoff.	Stanford Univ, Dept Geog & Environm Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Geophys, Stanford, CA 94305 USA; Stanford Univ, Sch Earth Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Beman, JM (corresponding author), Stanford Univ, Dept Geog & Environm Sci, Stanford, CA 94305 USA.	beman@stanford.edu		Arrigo, Kevin/0000-0002-7364-876X				Alvarez-Borrego S., 1978, CIENC MAR, V5, P53, DOI [10.7773/cm.v5i2.322, DOI 10.7773/CM.V5I2.322]; Alvarez-Borrego Saul, 2002, P41; Beron-Vera FJ, 2000, J GEOPHYS RES-OCEANS, V105, P11441, DOI 10.1029/2000JC900038; Chen YLL, 2004, CONT SHELF RES, V24, P527, DOI 10.1016/j.csr.2003.12.006; Corredor JE, 1999, BIOGEOCHEMISTRY, V46, P163; Deutsch C, 2001, GLOBAL BIOGEOCHEM CY, V15, P483, DOI 10.1029/2000GB001291; Galloway JN, 2003, BIOSCIENCE, V53, P341, DOI 10.1641/0006-3568(2003)053[0341:TNC]2.0.CO;2; Gaxiola-Castro G, 1999, J PLANKTON RES, V21, P231, DOI 10.1093/plankt/21.2.231; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Harrison J, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001991; Harrison J.A., 2003, THESIS STANFORD U; Howell EA, 1997, GEOPHYS RES LETT, V24, P2549, DOI 10.1029/97GL01538; Kahru M, 2004, DEEP-SEA RES PT II, V51, P139, DOI 10.1016/j.dsr2.2003.04.001; Matson PA, 1998, SCIENCE, V280, P112, DOI 10.1126/science.280.5360.112; MCCULLAGH P., 1991, GEN LINEAR MODELS; Mills MM, 2004, NATURE, V429, P292, DOI 10.1038/nature02550; NAYLOR RL, 2001, 0101 CIMMYT; Pegau WS, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014076; Riley WJ, 2001, NUTR CYCL AGROECOSYS, V61, P223, DOI 10.1023/A:1013758116346; Sala E, 2004, FISHERIES, V29, P19, DOI 10.1577/1548-8446(2004)29[19:FDCFWI]2.0.CO;2; Switzer AC, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2000JC000444; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941; Tyrrell T, 1998, NATURE, V393, P318, DOI 10.1038/30632; Tyrrell T, 2002, CONT SHELF RES, V22, P2497, DOI 10.1016/S0278-4343(02)00077-8; VALSARAJ CP, 1994, HYDROBIOLOGIA, V286, P139, DOI 10.1007/BF00006245; ZEITZSCHEL B, 1969, MAR BIOL, V3, P201, DOI 10.1007/BF00360952	28	365	389	17	201	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					211	214		10.1038/nature03370	http://dx.doi.org/10.1038/nature03370			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15758999				2022-12-24	WOS:000227494500044
J	Kelley, DS; Karson, JA; Fruh-Green, GL; Yoerger, DR; Shank, TM; Butterfield, DA; Hayes, JM; Schrenk, MO; Olson, EJ; Proskurowski, G; Jakuba, M; Bradley, A; Larson, B; Ludwig, K; Glickson, D; Buckman, K; Bradley, AS; Brazelton, WJ; Roe, K; Elend, MJ; Delacour, A; Bernasconi, SM; Lilley, MD; Baross, JA; Summons, RT; Sylva, SP				Kelley, DS; Karson, JA; Fruh-Green, GL; Yoerger, DR; Shank, TM; Butterfield, DA; Hayes, JM; Schrenk, MO; Olson, EJ; Proskurowski, G; Jakuba, M; Bradley, A; Larson, B; Ludwig, K; Glickson, D; Buckman, K; Bradley, AS; Brazelton, WJ; Roe, K; Elend, MJ; Delacour, A; Bernasconi, SM; Lilley, MD; Baross, JA; Summons, RT; Sylva, SP			A serpentinite-hosted ecosystem: The lost city hydrothermal field	SCIENCE			English	Article							MID-ATLANTIC RIDGE; PERIDOTITE; REDUCTION; FLUIDS; ROCKS; EARTH; CH4; CO2	The serpentinite-hosted Lost City hydrothermal field is a remarkable submarine ecosystem in which geological, chemical, and biological processes are intimately interlinked. Reactions between seawater and upper mantle peridotite produce methane- and hydrogen-rich fluids, with temperatures ranging from <40 degrees to 90 degrees C at pH 9 to 11, and carbonate chimneys 30 to 60 meters tall. A low diversity of microorganisms related to methane-cycling Archaea thrive in the warm porous interiors of the edifices. Macrofaunal communities show a degree of species diversity at least as high as that of black smoker vent sites along the Mid-Atlantic Ridge, but they lack the high biomasses of chemosynthetic organisms that are typical of volcanically driven systems.	Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; Duke Univ, Div Earth & Ocean Sci, Durham, NC 27708 USA; ETH Zentrum, Dept Earth Sci, Zurich, Switzerland; Univ Washington, Joint Inst Study Atmosphere & Oceans, Seattle, WA 98115 USA; NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; Woods Hole Oceanog Inst, MIT WHOI Joint Program, Woods Hole, MA 02543 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	University of Washington; University of Washington Seattle; Duke University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; Massachusetts Institute of Technology (MIT); Woods Hole Oceanographic Institution; Massachusetts Institute of Technology (MIT)	Kelley, DS (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	kelley@ocean.washington.edu	Proskurowski, Giora/B-3862-2013; Bernasconi, Stefano M/E-5394-2010; Summons, Roger Everett/AAL-3789-2020; Delacour, Adélie/B-8639-2012; Matthew, Schrenk/AAH-5682-2020; Butterfield, David/H-3815-2016; Sylva, Sean/D-4400-2014; Bradley, Alexander/A-9391-2009; Larson, Benjamin/K-4859-2016	Bernasconi, Stefano M/0000-0001-7672-8856; Butterfield, David/0000-0002-1595-9279; Sylva, Sean/0000-0002-4727-440X; Bradley, Alexander/0000-0002-4044-2802; Larson, Benjamin/0000-0002-1007-1684; Schrenk, Matthew/0000-0002-5623-8558; Ludwig, Kristin/0000-0002-0935-9410				ABRAJANO TA, 1988, CHEM GEOL, V71, P211, DOI 10.1016/0009-2541(88)90116-7; Bach W, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000279; Berndt ME, 1996, GEOLOGY, V24, P351, DOI 10.1130/0091-7613(1996)024<0351:ROCDSO>2.3.CO;2; Blackman DK, 2002, MAR GEOPHYS RES, V23, P443, DOI 10.1023/B:MARI.0000018232.14085.75; BONATTI E, 1989, EARTH PLANET SC LETT, V91, P297, DOI 10.1016/0012-821X(89)90005-8; Charlou JL, 2002, CHEM GEOL, V191, P345, DOI 10.1016/S0009-2541(02)00134-1; Dick HJB, 2003, NATURE, V426, P405, DOI 10.1038/nature02128; Edmonds HN, 2003, NATURE, V421, P252, DOI 10.1038/nature01351; Fritz P., 1992, P 7 INT S WAT ROCK I, V7, P793; Fruh-Green GL, 2003, SCIENCE, V301, P495, DOI 10.1126/science.1085582; Fryer P, 1999, GEOLOGY, V27, P103, DOI 10.1130/0091-7613(1999)027<0103:MBMVIF>2.3.CO;2; Gebruk AV, 1997, ADV MAR BIOL, V32, P93; Gracia E, 2000, EARTH PLANET SC LETT, V177, P89, DOI 10.1016/S0012-821X(00)00034-0; Grove TL, 2004, EARTH PLANET SC LETT, V219, P173, DOI 10.1016/S0012-821X(04)00002-0; Hayes JM, 2001, REV MINERAL GEOCHEM, V43, P225, DOI 10.2138/gsrmg.43.1.225; Hinrichs KU, 2000, ORG GEOCHEM, V31, P1685, DOI 10.1016/S0146-6380(00)00106-6; JANECKY DR, 1986, GEOCHIM COSMOCHIM AC, V50, P1357, DOI 10.1016/0016-7037(86)90311-X; Karson JA, 1998, GEOPH MONOG SERIES, V106, P177; Kelley DS, 2004, GEOPHYS MONOGR SER, V144, P167, DOI 10.1029/144GM11; Kelley DS, 2002, ANNU REV EARTH PL SC, V30, P385, DOI 10.1146/annurev.earth.30.091201.141331; Kelley DS, 2001, NATURE, V412, P145, DOI 10.1038/35084000; Lagabrielle Y, 1998, GEOPH MONOG SERIES, V106, P153; LILLEY MD, 1993, NATURE, V364, P45, DOI 10.1038/364045a0; Lilley MD, 2003, NATURE, V422, P878, DOI 10.1038/nature01569; LOWELL RP, 2002, GEOPHYS RES LETT, V29, DOI DOI 10.1029/2001GL01411; McCollom TM, 2001, GEOCHIM COSMOCHIM AC, V65, P3769, DOI 10.1016/S0016-7037(01)00655-X; Michael P, 2002, NATURE, V419, P445, DOI 10.1038/419445a; Mottl MJ, 2003, GEOCHEM GEOPHY GEOSY, V4, P11; NEAL C, 1983, EARTH PLANET SC LETT, V66, P315, DOI 10.1016/0012-821X(83)90144-9; Orphan VJ, 2002, P NATL ACAD SCI USA, V99, P7663, DOI 10.1073/pnas.072210299; Reston TJ, 2001, GEOLOGY, V29, P587, DOI 10.1130/0091-7613(2001)029<0587:DFMSAS>2.0.CO;2; Reysenbach A.-L., 2002, BIODIVERSITY MICROBI, P345; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schrenk MO, 2004, ENVIRON MICROBIOL, V6, P1086, DOI 10.1111/j.1462-2920.2004.00650.x; Schroeder T, 2002, GEOLOGY, V30, P367, DOI 10.1130/0091-7613(2002)030<0367:GIOSCT>2.0.CO;2; Shock EL, 1998, J GEOPHYS RES-PLANET, V103, P28513, DOI 10.1029/98JE02142; SPIESS FN, 1980, SCIENCE, V207, P1421, DOI 10.1126/science.207.4438.1421; Surour AA, 1997, J AFR EARTH SCI, V24, P315, DOI 10.1016/S0899-5362(97)00046-8; Treves B, 1994, OFIOLITI, V19, P435; Tunnicliffe V, 1996, NATURE, V379, P531, DOI 10.1038/379531a0; WELHAN J, 1979, EOS, V60, P863; Welhan JA, 1983, HYDROTHERMAL PROCESS, P391, DOI [DOI 10.1007/978-1-4899-0402-7_17, 10.1007/978-1-4899-0402-7_17]; Wetzel LR, 2000, J GEOPHYS RES-SOL EA, V105, P8319, DOI 10.1029/1999JB900382; WILCOCK WW, 2004, GEOPHYSICAL MONOGRAP, V144	44	802	840	9	352	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1428	1434		10.1126/science.1102556	http://dx.doi.org/10.1126/science.1102556			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746419				2022-12-24	WOS:000227503100036
J	Alverson, K				Alverson, K			Watching over the world's oceans	NATURE			English	Editorial Material									UNESCO, Global Ocean Observing Syst Intergovt Oceanog Com, F-75732 Paris 15, France		Alverson, K (corresponding author), UNESCO, Global Ocean Observing Syst Intergovt Oceanog Com, 1 Rue Miollis, F-75732 Paris 15, France.								0	9	9	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 3	2005	434	7029					19	20		10.1038/434019a	http://dx.doi.org/10.1038/434019a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744274				2022-12-24	WOS:000227334600021
J	Rodgers, JT; Lerin, C; Haas, W; Gygi, SP; Spiegelman, BM; Puigserver, P				Rodgers, JT; Lerin, C; Haas, W; Gygi, SP; Spiegelman, BM; Puigserver, P			Nutrient control of glucose homeostasis through a complex of PGC-1 alpha and SIRT1	NATURE			English	Article							HEPATIC GLUCONEOGENESIS; LIFE-SPAN; METABOLISM; P53	Homeostatic mechanisms in mammals respond to hormones and nutrients to maintain blood glucose levels within a narrow range. Caloric restriction causes many changes in glucose metabolism and extends lifespan; however, how this metabolism is connected to the ageing process is largely unknown. We show here that the Sir2 homologue, SIRT1 - which modulates ageing in several species(1-3) - controls the gluconeogenic/glycolytic pathways in liver in response to fasting signals through the transcriptional coactivator PGC-1alpha. A nutrient signalling response that is mediated by pyruvate induces SIRT1 protein in liver during fasting. We find that once SIRT1 is induced, it interacts with and deacetylates PGC-1alpha at specific lysine residues in an NAD(+)-dependent manner. SIRT1 induces gluconeogenic genes and hepatic glucose output through PGC-1alpha, but does not regulate the effects of PGC-1alpha on mitochondrial genes. In addition, SIRT1 modulates the effects of PGC-1alpha repression of glycolytic genes in response to fasting and pyruvate. Thus, we have identified a molecular mechanism whereby SIRT1 functions in glucose homeostasis as a modulator of PGC-1alpha. These findings have strong implications for the basic pathways of energy homeostasis, diabetes and lifespan.	Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Johns Hopkins University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Puigserver, P (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA.	ppuigse1@bs.jhmi.edu	Lerin, Carles/AAP-9916-2020	Lerin, Carles/0000-0003-0950-4363; Rodgers, Joseph/0000-0002-6598-5520				Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Dhahbi JM, 1999, AM J PHYSIOL-ENDOC M, V277, pE352, DOI 10.1152/ajpendo.1999.277.2.E352; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Hagopian K, 2003, EXP GERONTOL, V38, P267, DOI 10.1016/S0531-5565(02)00202-4; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SS, 2001, J BIOL CHEM, V276, P36000, DOI 10.1074/jbc.M103509200; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; MACDONALD M, 1976, AM J PHYSIOL, V231, P619, DOI 10.1152/ajplegacy.1976.231.2.619; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Timchenko NA, 1999, MOL CELL BIOL, V19, P2936; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang QH, 2000, P NATL ACAD SCI USA, V97, P14323, DOI 10.1073/pnas.011283598	22	2422	2530	5	273	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					113	118		10.1038/nature03354	http://dx.doi.org/10.1038/nature03354			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744310				2022-12-24	WOS:000227334600054
J	Rubin, EJ				Rubin, EJ			Clinical implications of basic research: Toward a new therapy for tuberculosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Rubin, EJ (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.			Rubin, Eric/0000-0001-5120-962X				Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753	1	11	12	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2005	352	9					933	934		10.1056/NEJMcibr044438	http://dx.doi.org/10.1056/NEJMcibr044438			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901VQ	15745987				2022-12-24	WOS:000227310700016
J	Jagasia, R; Grote, P; Westermann, B; Conradt, B				Jagasia, R; Grote, P; Westermann, B; Conradt, B			DRP-1-mediated mitochondrial fragmentation during EGL-1-induced cell death in C-elegans	NATURE			English	Article							PROTEIN; APOPTOSIS; FISSION; CED-9; DYNAMICS; NEMATODE; EGL-1	Genetic analyses in Caenorhabditis elegans have been instrumental in the elucidation of the central cell-death machinery, which is conserved from C. elegans to mammals(1,2). One possible difference that has emerged is the role of mitochondria. By releasing cytochrome c, mitochondria are involved in the activation of caspases in mammals(3,4). However, there has previously been no evidence that mitochondria are involved in caspase activation in C. elegans. Here we show that mitochondria fragment in cells that normally undergo programmed cell death during C. elegans development. Mitochondrial fragmentation is induced by the BH3-only protein EGL-1 and can be blocked by mutations in the bcl-2-like gene ced-9, indicating that members of the Bcl-2 family might function in the regulation of mitochondrial fragmentation in apoptotic cells. Mitochondrial fragmentation is independent of CED-4/Apaf-1 and CED-3/caspase, indicating that it occurs before or simultaneously with their activation. Furthermore, DRP-1/dynamin-related protein, a key component of the mitochondrial fission machinery, is required and sufficient to induce mitochondrial fragmentation and programmed cell death during C. elegans development. These results assign an important role to mitochondria in the cell-death pathway in C. elegans.	Dartmouth Coll, Sch Med, Dept Genet, Hanover, NH 03755 USA; Univ Bayreuth, D-95440 Bayreuth, Germany; Univ Munich, Inst Physiol Chem, D-81377 Munich, Germany; Max Planck Inst Neurobiol, D-82152 Planegg Martinsried, Germany	Dartmouth College; University of Bayreuth; University of Munich; Max Planck Society	Conradt, B (corresponding author), Dartmouth Coll, Sch Med, Dept Genet, 7400 Remsen, Hanover, NH 03755 USA.	barbara.conradt@dartmouth.edu	Westermann, Benedikt/H-7766-2013; Conradt, Barbara/K-2665-2014; Grote, Phillip/AAG-9188-2020	Westermann, Benedikt/0000-0002-2991-1604; Grote, Phillip/0000-0002-9254-1458; Conradt, Barbara/0000-0002-3731-4308				Aspock G, 2003, DEVELOPMENT, V130, P3369, DOI 10.1242/dev.00551; Bloom L, 1997, P NATL ACAD SCI USA, V94, P3414, DOI 10.1073/pnas.94.7.3414; Bloss TA, 2003, NATURE, V424, P1066, DOI 10.1038/nature01920; Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; Breckenridge DG, 2003, J CELL BIOL, V160, P1115, DOI 10.1083/jcb.200212059; Chen FL, 2000, SCIENCE, V287, P1485, DOI 10.1126/science.287.5457.1485; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; Conradt B, 1999, CELL, V98, P317, DOI 10.1016/S0092-8674(00)81961-3; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; FRANCIS B, 2001, SEX ED, V1, P1; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; HENGARTNER MO, 1994, NATURE, V369, P318, DOI 10.1038/369318a0; HENGARTNER MO, 1992, NATURE, V356, P494, DOI 10.1038/356494a0; Horvitz HR, 1999, CANCER RES, V59, p1701S; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Mello C, 1995, METHOD CELL BIOL, V48, P451; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Parrish J, 2000, P NATL ACAD SCI USA, V97, P11916, DOI 10.1073/pnas.210391597; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; Riddle DL, 1997, C ELEGANS, P739; Shaw JM, 2002, TRENDS CELL BIOL, V12, P178, DOI 10.1016/S0962-8924(01)02246-2; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; van der Bliek AM, 1999, TRENDS CELL BIOL, V9, P96, DOI 10.1016/S0962-8924(98)01490-1; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194	30	264	276	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2005	433	7027					754	760		10.1038/nature03316	http://dx.doi.org/10.1038/nature03316			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897XH	15716954				2022-12-24	WOS:000227039200042
J	Allen, E; Xie, ZX; Gustafson, AM; Carrington, JC				Allen, E; Xie, ZX; Gustafson, AM; Carrington, JC			microRNA-directed phasing during trans-acting siRNA biogenesis in plants	CELL			English	Article							DEPENDENT RNA-POLYMERASE; DSRNA-BINDING-PROTEIN; ARABIDOPSIS-THALIANA; NUCLEAR EXPORT; CAENORHABDITIS-ELEGANS; MESSENGER-RNAS; LEAF POLARITY; GENES; INITIATION; MIRNA	Plants and animals use small RNAs (microRNAs [miRNAs] and siRNAs) as guides for posttranscriptional and epigenetic regulation. In plants, miRNAs and trans-acting (ta) siRNAs form through distinct biogenesis pathways, although they both interact with target transcripts and guide cleavage. An integrated approach to identify targets of Arabidopsis thaliana miRNAs and ta-siRNAs revealed several new classes of small RNA-regulated genes, including conventional genes such as Argonaute2 and an E2-ubiquitin conjugating enzyme. Surprisingly, five tasiRNA-generating transcripts were identified as targets of miR173 or miR390. Rather than functioning as negative regulators, miR173- and miR390-guided cleavage was shown to set the 21-nucleotide phase for ta-siRNA precursor processing. These data support a model in which miRNA-guided formation of a 5' or 3' terminus within pre-ta-siRNA transcripts, followed by RDR6-dependent formation of dsRNA and Dicer-like processing, yields phased ta-siRNAs that negatively regulate other genes.	Oregon State Univ, Ctr Gene Res & Biotechnol, Corvallis, OR 97331 USA; Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Carrington, JC (corresponding author), Oregon State Univ, Ctr Gene Res & Biotechnol, Corvallis, OR 97331 USA.	carrington@cgrb.oregonstate.edu	; Carrington, James/A-4656-2012	Allen, Edwards/0000-0002-8318-6319; Carrington, James/0000-0003-3572-129X; Xie, Zhixin/0000-0002-6191-5170	NIAID NIH HHS [AI43288] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI043288, R01AI043288, R37AI043288] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Bollman KM, 2003, DEVELOPMENT, V130, P1493, DOI 10.1242/dev.00362; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Gazzani S, 2004, SCIENCE, V306, P1046, DOI 10.1126/science.1101092; Guan HC, 2000, P NATL ACAD SCI USA, V97, P12451, DOI 10.1073/pnas.97.23.12451; Gustafson AM, 2005, NUCLEIC ACIDS RES, V33, pD637, DOI 10.1093/nar/gki127; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Juarez MT, 2004, NATURE, V428, P84, DOI 10.1038/nature02363; Kao CC, 2001, VIROLOGY, V287, P251, DOI 10.1006/viro.2001.1039; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kidner CA, 2004, NATURE, V428, P81, DOI 10.1038/nature02366; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Lappartient AG, 1999, PLANT J, V18, P89, DOI 10.1046/j.1365-313X.1999.00416.x; Laufs P, 2004, DEVELOPMENT, V131, P4311, DOI 10.1242/dev.01320; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Nemhauser JL, 2000, DEVELOPMENT, V127, P3877; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804; Park MY, 2005, P NATL ACAD SCI USA, V102, P3691, DOI 10.1073/pnas.0405570102; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; RAO ALN, 1989, P NATL ACAD SCI USA, V86, P5335, DOI 10.1073/pnas.86.14.5335; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Remington DL, 2004, PLANT PHYSIOL, V135, P1738, DOI 10.1104/pp.104.039669; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schauer SE, 2002, TRENDS PLANT SCI, V7, P487, DOI 10.1016/S1360-1385(02)02355-5; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Sessions A, 1997, DEVELOPMENT, V124, P4481; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Yu DQ, 2003, MOL PLANT MICROBE IN, V16, P206, DOI 10.1094/MPMI.2003.16.3.206; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	66	1648	1827	8	252	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 22	2005	121	2					207	221		10.1016/j.cell.2005.04.004	http://dx.doi.org/10.1016/j.cell.2005.04.004			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851028	Bronze			2022-12-24	WOS:000228705000009
J	Annas, GJ				Annas, GJ			"Culture of life'' politics at the bedside - The case of Terri Schiavo	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				ANNAS GJ, 1991, NEW ENGL J MED, V324, P1210, DOI 10.1056/NEJM199104253241711; ANNAS GJ, 1975, RIGHTS HOSP PATIENTS, P81; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; EISENBERG D, 2005, TIME            0404, P23; GOODNOUGH A, 2005, NY TIMES        0427, pA1; Kirkpatrick David D, 2005, N Y Times Web, pA18; *MULT TASK FORC PV, 1995, NEW ENGL J MED, V333, P130; Shannon TA, 2004, HASTINGS CENT REP, V34, P18, DOI 10.2307/3528689	8	95	97	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 21	2005	352	16					1710	1715		10.1056/NEJMlim050643	http://dx.doi.org/10.1056/NEJMlim050643			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	918CE	15784657	Green Published			2022-12-24	WOS:000228515200015
J	Kwiterovich, PO; Cockrill, SL; Virgil, DG; Garrett, ES; Otvos, J; Knight-Gibson, C; Alaupovic, P; Forte, T; Zhang, L; Farwig, ZN; Macfarlane, RD				Kwiterovich, PO; Cockrill, SL; Virgil, DG; Garrett, ES; Otvos, J; Knight-Gibson, C; Alaupovic, P; Forte, T; Zhang, L; Farwig, ZN; Macfarlane, RD			A large high-density lipoprotein enriched in apolipoprotein C-I - A novel biochemical marker in infants of lower birth weight and younger gestational age	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTRAUTERINE GROWTH RESTRICTION; ESTER TRANSFER PROTEIN; HUMAN CORD BLOOD; TRIGLYCERIDE-RICH LIPOPROTEINS; CHOLESTEROL ACYLTRANSFERASE; SUBCLASS DISTRIBUTION; PLACENTAL APOPTOSIS; MASS-SPECTROMETRY; HEPATIC LIPASE; HUMAN-PLASMA	Context Low birth weight is associated with increased cardiovascular disease in adulthood, and differences in the molecular weight, composition, and quantity of lipoprotein subclasses are associated with coronary artery disease. Objective To determine if there are novel patterns of lipoprotein heterogeneity in low-birth-weight infants. Design, Setting, and Participants Prospective study at a US medical center of a representative sample of infants (n = 163; 70 white and 93 black) born at 28 or more weeks of gestational age between January 3, 2000, and September 27, 2000. This sample constituted 20% of all infants born during the study period at this site. Main Outcome Measures Plasma levels and particle sizes of lipoprotein subclasses and plasma concentrations of lipids, lipoproteins (high-density lipoprotein [HDL] and low-density lipoprotein [LDL]), and apolipoproteins. Results An elevated lipoprotein peak of a particle with density between 1.062 and 1.072 g/mL was identified using physical-chemical methods. This subclass of large HDL was enriched in apolipoprotein C-I (apo C-I). Based on the amount of the apo C-I-enriched HDL peak, 156 infants were assigned to 1 of 4 groups: 0 (none detected), 17%; 1 (possibly present), 41%; 2 (probably present), 22%; 3 (elevated), 19%. Infants in group 3, compared with those in the other 3 groups, had significantly (P < .001) lower mean birth weight (2683.7 vs 3307.1 g) and younger mean gestational age (36.2 vs 39.3 wk). After correction for age, infants in group 3 had significantly higher levels of total and large HDL cholesterol and of total and large LDL cholesterol and LDL particle number. However, infants in group 3 had lower levels of small HDL, very low-density lipoproteins, and triglycerides than infants in the other 3 groups. This lipoprotein profile differed from that in infants born small for gestational age, who had significantly higher triglyceride (P < .001) and apo B (P = .04) levels, but lower levels of total and large HDL cholesterol (P < .001) and apo A-I (P < .001). Conclusions Because apo C-l-enriched HDL, and purified apo C-I alone, promotes apoptosis in vitro, increased amounts of this particle may have physiological significance and identify a novel group of low-birth-weight infants apparently distinct from traditionally classified small-for-gestational-age infants.	Johns Hopkins Med Inst, Baltimore, MD 21205 USA; Texas A&M Univ, Lab Cardiovasc Chem, College Stn, TX USA; LipoSci Inc, Raleigh, NC USA; Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; Univ Calif Berkeley, Donner Lab, Berkeley, CA 94720 USA	Johns Hopkins University; Johns Hopkins Medicine; Texas A&M University System; Texas A&M University College Station; LipoScience, Inc; Oklahoma Medical Research Foundation; University of California System; University of California Berkeley	Kwiterovich, PO (corresponding author), 550 N Broadway,Suite 308, Baltimore, MD 21205 USA.	pkwitero@jhmi.edu		Garrett-Mayer, Elizabeth/0000-0003-4709-0333	NCRR NIH HHS [M01-RR-00052] Funding Source: Medline; NHLBI NIH HHS [HL 68794, HL 18574, HL 54566] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068794, P01HL018574, R01HL054566] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aban M, 2004, TOHOKU J EXP MED, V204, P195, DOI 10.1620/tjem.204.195; ALBERS JJ, 1979, ARTERY, V5, P61; Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; Bjorkegren J, 2002, ARTERIOSCL THROM VAS, V22, P1470, DOI 10.1161/01.ATV.0000029972.42487.42; Bjorkegren J, 2000, CIRCULATION, V101, P227, DOI 10.1161/01.CIR.101.3.227; BLUM CB, 1985, J LIPID RES, V26, P755; Clausson B, 2000, BRIT J OBSTET GYNAEC, V107, P375, DOI 10.1111/j.1471-0528.2000.tb13234.x; Conde-Knape K, 2002, J LIPID RES, V43, P2136, DOI 10.1194/jlr.M200210-JLR200; Crocker IP, 2004, J PATHOL, V204, P11, DOI 10.1002/path.1610; CURRY MD, 1981, CLIN CHEM, V27, P543; DAVIS PA, 1983, BIOCHIM BIOPHYS ACTA, V753, P186, DOI 10.1016/0005-2760(83)90006-1; DAVIS PA, 1983, ARTERIOSCLEROSIS, V3, P357, DOI 10.1161/01.ATV.3.4.357; DIAZ M, 1989, METABOLISM, V38, P435, DOI 10.1016/0026-0495(89)90194-7; Farwig ZN, 2003, ANAL CHEM, V75, P3823, DOI 10.1021/ac026273p; Gautier T, 2000, J BIOL CHEM, V275, P37504, DOI 10.1074/jbc.M007210200; GENZELBOROVICZENY O, 1988, PEDIATR RES, V23, P543, DOI 10.1203/00006450-198806000-00001; GENZELBOROVICZENY O, 1986, PEDIATR RES, V20, P487, DOI 10.1203/00006450-198606000-00001; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; Kaser S, 2001, METABOLISM, V50, P723, DOI 10.1053/meta.2001.23307; KHERKEULIDZE P, 1991, ACTA PAEDIATR SCAND, V80, P770, DOI 10.1111/j.1651-2227.1991.tb11947.x; KLIMOV AN, 1979, PEDIATR RES, V13, P208, DOI 10.1203/00006450-197903000-00018; Kolmakova A, 2004, ARTERIOSCL THROM VAS, V24, P264, DOI 10.1161/01.ATV.0000112036.72200.ac; Kwiterovich PO, 2004, ETHNIC DIS, V14, P351; Kwiterovich PO, 2002, AM J CARDIOL, V90, p1I, DOI 10.1016/S0002-9149(02)02796-0; LACKO AG, 1972, LIPIDS, V7, P426, DOI 10.1007/BF02531515; Macfarlane RD, 1997, ELECTROPHORESIS, V18, P1796, DOI 10.1002/elps.1150181014; Mayhew TM, 2004, PLACENTA, V25, P829, DOI 10.1016/j.placenta.2004.04.011; Merzouk H, 1997, ACTA PAEDIATR, V86, P528, DOI 10.1111/j.1651-2227.1997.tb08925.x; Nagasaka H, 2002, ATHEROSCLEROSIS, V161, P215, DOI 10.1016/S0021-9150(01)00663-3; Navab M, 2001, J LIPID RES, V42, P1308; NICHOLS AV, 1991, BIOCHIM BIOPHYS ACTA, V1085, P306, DOI 10.1016/0005-2760(91)90134-4; OTVOS JD, 2000, HDB LIPOPROTEIN TEST, P609; Radunovic N, 2000, J CLIN ENDOCR METAB, V85, P85, DOI 10.1210/jc.85.1.85; ROSSENEU M, 1983, PEDIATR RES, V17, P788, DOI 10.1203/00006450-198310000-00004; SEHAYEK E, 1991, J BIOL CHEM, V266, P18259; Shachter NS, 2001, CURR OPIN LIPIDOL, V12, P297, DOI 10.1097/00041433-200106000-00009; Smith SC, 1997, AM J OBSTET GYNECOL, V177, P1395, DOI 10.1016/S0002-9378(97)70081-4; WEISGRABER KH, 1990, J BIOL CHEM, V265, P22453; WINDLER E, 1985, J LIPID RES, V26, P556; WINDLER EET, 1980, J BIOL CHEM, V255, P464; Xu Y, 1999, J LIPID RES, V40, P50; Zambon A, 2003, CURR OPIN LIPIDOL, V14, P179, DOI 10.1097/00041433-200304000-00010; Zhong SB, 1996, J CLIN INVEST, V97, P2917, DOI 10.1172/JCI118751	43	18	21	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2005	293	15					1891	1899		10.1001/jama.293.15.1891	http://dx.doi.org/10.1001/jama.293.15.1891			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QW	15840864	Bronze			2022-12-24	WOS:000228401700028
J	Charest, MG; Lerner, CD; Brubaker, JD; Siege, DR; Myers, AG				Charest, MG; Lerner, CD; Brubaker, JD; Siege, DR; Myers, AG			A convergent enantioselective route to structurally diverse 6-deoxytetracycline antibiotics	SCIENCE			English	Article							RIBOSOMAL-SUBUNIT; BENZOIC-ACID; TETRACYCLINES; DERIVATIVES; CHEMISTRY; ALCOHOLS	Complex antibiotics based on natural products are almost invariably prepared by semisynthesis, or chemical transformation of the isolated natural products. This approach greatly limits the range of accessible structures that might be studied as new antibiotic candidates. Here we report a short and enantioselective synthetic route to a diverse range of 6-deoxytetracycline antibiotics. The common feature of this class is a scaffold of four linearly fused rings, labeled A through D. We targeted not a single compound but a group of structures with the D ring as a site of structural variability. A late-stage, diastereoselective C-ring construction was used to couple structurally varied D-ring precursors with an AB precursor containing much of the essential functionality for binding to the bacterial ribosome. Five derivatives were synthesized from benzoic acid in yields ranging from 5 to 7% over 14 to 15 steps, and a sixth, (-)-doxycycline, was synthesized in 8.3% yield over 18 steps.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University	Myers, AG (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	myers@chemistry.harvard.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048825] Funding Source: NIH RePORTER; NIAID NIH HHS [AI48825] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMYYES SGB, 2001, MAGIC BULLETS LOST H; BERK SC, 1990, ORGANOMETALLICS, V9, P3053, DOI 10.1021/om00162a016; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; Bush K, 2004, CURR OPIN MICROBIOL, V7, P466, DOI 10.1016/j.mib.2004.08.013; Cane DE, 1998, SCIENCE, V282, P63, DOI 10.1126/science.282.5386.63; COREY EJ, 1981, TETRAHEDRON LETT, V22, P3455, DOI 10.1016/S0040-4039(01)81930-4; DAVIS FA, 1992, J ORG CHEM, V57, P7274, DOI 10.1021/jo00052a050; Dodd J.H., 1979, TETRAHEDRON LETT, V20, P3593; FRIGERIO M, 1994, TETRAHEDRON LETT, V35, P8019, DOI 10.1016/0040-4039(94)80038-3; GUREVICH AI, 1967, TETRAHEDRON LETT, V8, P131; HAUSER FM, 1980, SYNTHESIS-STUTTGART, P72; HAUSER FM, 1978, J ORG CHEM, V43, P178, DOI 10.1021/jo00395a048; Ho T.-L., 1992, TANDEM ORGANIC REACT; Katz L, 1997, CHEM REV, V97, P2557, DOI 10.1021/cr960025+; KORST JJ, 1968, J AM CHEM SOC, V90, P439, DOI 10.1021/ja01004a041; Leeb M, 2004, NATURE, V431, P892, DOI 10.1038/431892a; LEEPER FJ, 1978, J CHEM SOC CHEM COMM, P406, DOI 10.1039/c39780000406; MUXFELDT H, 1979, J AM CHEM SOC, V101, P689, DOI 10.1021/ja00497a035; Myers AG, 2001, ORG LETT, V3, P2923, DOI 10.1021/ol010151m; Myers AG, 1996, TETRAHEDRON LETT, V37, P4841, DOI 10.1016/0040-4039(96)00965-3; NELSON M, 2001, TETRACYCLINES BIOL C; PARHAM WE, 1976, J ORG CHEM, V41, P1184, DOI 10.1021/jo00869a022; PEVARELLO P, 1992, SYNTHETIC COMMUN, V22, P1939, DOI 10.1080/00397919208021324; Pine SH., 1970, ORG REACTIONS, V18, P403; Pioletti M, 2001, EMBO J, V20, P1829, DOI 10.1093/emboj/20.8.1829; Prilezhaeva E. N., 2001, RUSS CHEM REV, V70, P897; REINER AM, 1971, BIOCHEMISTRY-US, V10, P2530, DOI 10.1021/bi00789a017; ROGALSKI W, 1985, HDB EXPT PHARM, V78, pCH5; STEPHENS CR, 1963, J AM CHEM SOC, V85, P2643, DOI 10.1021/ja00900a027; Stork G, 1996, J AM CHEM SOC, V118, P5304, DOI 10.1021/ja960434n; STORK G, 1978, J AM CHEM SOC, V100, P3609, DOI 10.1021/ja00479a060; Strohl WR, 2001, METAB ENG, V3, P4, DOI 10.1006/mben.2000.0172; Sum PE, 1999, BIOORG MED CHEM LETT, V9, P1459, DOI 10.1016/S0960-894X(99)00216-4; Tatsuta K, 2000, CHEM LETT, P646, DOI 10.1246/cl.2000.646; VYAS DM, 1984, TETRAHEDRON LETT, V25, P487, DOI 10.1016/S0040-4039(00)99918-0; Walsh C., 2003, ANTIBIOTICS ACTIONS; WHITE JD, 1986, J ORG CHEM, V51, P1150, DOI 10.1021/jo00357a047	37	231	248	2	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2005	308	5720					395	398		10.1126/science.1109755	http://dx.doi.org/10.1126/science.1109755			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	917TL	15831754				2022-12-24	WOS:000228492000047
J	Berry, RJ; Kihlberg, R; Devine, O				Berry, RJ; Kihlberg, R; Devine, O			Impact of misclassification of in vitro fertilisation in studies of folic acid and twinning: modelling using population based Swedish vital records	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SUPPLEMENTATION; FORTIFICATION; RATES; BORN; RISK	Objective To determine whether failure to adequately adjust for a reported 40% misclassification of use of in vitro fertilisation (IVF) as reported in a Swedish study could have led to a false finding that folic acid increases dizygotic twinning. Design Modelling with population based data. Setting Swedish vital records for 1995-9. Main outcome measures Rates of twinning calculated according to whether women used AT to become pregnant. Estimated unadjusted and adjusted odds ratios of the association between use of folic acid and twinning by use of IVF. Results In 1995-9, Swedish women who used IVF had almost 20 times the chance of having twins than women who did not use IVF (rate ratio 19.7, 95% confidence interval 18.7 to 20.6). In the absence of true effect of folic acid, the use of a 40% misclassified surrogate variable to adjust for use of IVF would have resulted in a false finding that folic acid was associated with a more than twofold increase in twinning. Conclusion Use of IVF is a strong confounder because it is associated with both use of folic acid and twinning. Even when misclassification of IVF was reduced to 5%, this bias persisted in the adjusted model. Using a 40% misclassified surrogate to adjust for IVF, as reported in the Swedish study, probably led to a false finding that folic acid increased dizygotic twinning.	Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Dept Hlth & Human Serv, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Berry, RJ (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Dept Hlth & Human Serv, 1600 Clifton Rd,MS E-86, Atlanta, GA 30333 USA.	RJBerry@cdc.gov		Berry, Robert/0000-0002-7162-5046				Bergh T, 1999, LANCET, V354, P1579, DOI 10.1016/S0140-6736(99)04345-7; Cornel MC, 1997, TERATOLOGY, V55, P134; Czeizel A. E., 1994, Acta Geneticae Medicae et Gemellologiae, V43, P175; Czeizel AE, 2004, AM J OBSTET GYNECOL, V191, P790, DOI 10.1016/j.ajog.2004.02.018; Ericson A, 2002, HUM REPROD, V17, P929, DOI 10.1093/humrep/17.4.929; Ericson A, 2001, Twin Res, V4, P63, DOI 10.1375/twin.4.2.63; George L, 2002, JAMA-J AM MED ASSOC, V288, P1867, DOI 10.1001/jama.288.15.1867; Kallen B, 2002, OBSTET GYNECOL, V100, P414, DOI 10.1016/S0029-7844(02)02069-0; Kallen B, 2004, EARLY HUM DEV, V80, P143, DOI 10.1016/j.earlhumdev.2004.06.002; KIHLBERG R, 2002, DAGENS MED, V41, P38; Kinzler WL, 2000, J SOC GYNECOL INVEST, V7, P321, DOI 10.1016/S1071-5576(00)00084-8; Kucik J, 2004, J REPROD MED, V49, P707; Li Z, 2003, LANCET, V361, P380, DOI 10.1016/S0140-6736(03)12390-2; Lumley J, 2001, BRIT J OBSTET GYNAEC, V108, P937, DOI 10.1111/j.1471-0528.2001.00228.x; Marshall JR, 2003, J NUTR, V133, p881S, DOI 10.1093/jn/133.3.881S; *NAT BOARD HLTH WE, 2004, ASS BEFR 2001; *NAT BOARD HLTH WE, 2000, BARN FODD SVER PROV; National Board of Health and Welfare Centre for Epidemiology, 2003, SWED MED BIRTH REG S; National Board of Health and Welfare Centre for Epidemiology, 2002, FAKT MAMM FORL NYF B; Shaw GM, 2003, AM J MED GENET A, V119A, P137, DOI 10.1002/ajmg.a.20145; Waller DK, 2003, PAEDIATR PERINAT EP, V17, P378, DOI 10.1046/j.1365-3016.2003.00511.x	21	16	17	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2005	330	7495					815	818		10.1136/bmj.38369.437789.82	http://dx.doi.org/10.1136/bmj.38369.437789.82			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	915BZ	15722370	Bronze, Green Published			2022-12-24	WOS:000228273900015
J	Condon, D; Zhu, MY; Bowring, S; Wang, W; Yang, AH; Jin, YG				Condon, D; Zhu, MY; Bowring, S; Wang, W; Yang, AH; Jin, YG			U-Pb ages from the neoproterozoic Doushantuo Formation, China	SCIENCE			English	Article							SNOWBALL EARTH HYPOTHESIS; SOUTH CHINA; MARINOAN GLACIATION; METAZOAN EVOLUTION; CONSTRAINTS; FOSSILS; NAMIBIA; OMAN; CARBONATES; AUSTRALIA	U-Pb zircon dates from volcanic ash beds within the Doushantuo Formation (China) indicate that its deposition occurred between 635 and 551 million years ago. The base records termination of the global-scale Marinoan glaciation and is coeval with similar dated rocks from Namibia, indicating synchronous deglaciation. Carbon isotopic and sequence-stratigraphic data imply that the spectacular animal fossils of the Doushantuo Formation are for the most part younger than 580 million years old. The uppermost Doushantuo Formation contains a pronounced negative carbonate carbon isotopic excursion, which we interpret as a global event at circa 551 million years ago.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Chinese Acad Sci, Nanjing Inst Geol & Paleontol, Nanjing 210008, Peoples R China	Massachusetts Institute of Technology (MIT); Chinese Academy of Sciences; Nanjing Institute of Geology & Paleontology, CAS	Condon, D (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	dcondon@mit.edu	Condon, Daniel/A-4249-2008; Zhu, Maoyan/K-1124-2014	Condon, Daniel/0000-0002-9082-3283; Zhu, Maoyan/0000-0001-7327-9856				Allen P.A., 2002, 16 INT SED C VOL JOA, P7; Amthor JE, 2003, GEOLOGY, V31, P431, DOI 10.1130/0091-7613(2003)031<0431:EOCANA>2.0.CO;2; Barfod GH, 2002, EARTH PLANET SC LETT, V201, P203, DOI 10.1016/S0012-821X(02)00687-8; Bowring SA, 2003, GEOPH RES ABSTR, V5, P13219; BURNS SJ, 1993, ECLOGAE GEOL HELV, V86, P595; Calver CR, 2000, PRECAMBRIAN RES, V100, P121, DOI 10.1016/S0301-9268(99)00072-8; Chen DF, 2004, PRECAMBRIAN RES, V132, P123, DOI 10.1016/j.precamres.2004.02.005; Chen JY, 2004, SCIENCE, V305, P218, DOI 10.1126/science.1099213; Corsetti FA, 2003, GEOL SOC AM BULL, V115, P916, DOI 10.1130/B25066.1; Cozzi A, 2004, GEOL SOC AM BULL, V116, P1367, DOI 10.1130/B25387.1; Fedonkin MA, 1997, NATURE, V388, P868, DOI 10.1038/42242; Grazhdankin D, 2004, PALEOBIOLOGY, V30, P203, DOI 10.1666/0094-8373(2004)030<0203:PODITE>2.0.CO;2; GROTZINGER JP, 1995, SCIENCE, V270, P598, DOI 10.1126/science.270.5236.598; HALVERSON GP, IN PRESS GEOL SOC AM; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; Hoffman PF, 2002, TERRA NOVA, V14, P129, DOI 10.1046/j.1365-3121.2002.00408.x; Hoffmann KH, 2004, GEOLOGY, V32, P817, DOI 10.1130/G20519.1; Jenkins RJF, 2002, J GEOL SOC LONDON, V159, P645, DOI 10.1144/0016-764901-127; Jiang GQ, 2003, GEOLOGY, V31, P917, DOI 10.1130/G19790.1; Jiang GQ, 2003, NATURE, V426, P822, DOI 10.1038/nature02201; LOGAN GA, 1995, NATURE, V376, P53, DOI 10.1038/376053a0; Macouin M, 2004, EARTH PLANET SC LETT, V224, P387, DOI 10.1016/j.epsl.2004.05.015; Martin MW, 2000, SCIENCE, V288, P841, DOI 10.1126/science.288.5467.841; Myrow PM, 1999, J SEDIMENT RES, V69, P784, DOI 10.2110/jsr.69.784; Narbonne GM, 2003, GEOLOGY, V31, P27, DOI 10.1130/0091-7613(2003)031<0027:LASTOC>2.0.CO;2; Rothman DH, 2003, P NATL ACAD SCI USA, V100, P8124, DOI 10.1073/pnas.0832439100; Saylor BZ, 1998, J SEDIMENT RES, V68, P1223, DOI 10.2110/jsr.68.1223; [王伟 Wang Wei], 2002, [微体古生物学报, Acta Micropalaeontologica Sinica], V19, P382; Wood RA, 2002, SCIENCE, V296, P2383, DOI 10.1126/science.1071599; Xiao SH, 1998, NATURE, V391, P553, DOI 10.1038/35318; Xiao SH, 2004, PRECAMBRIAN RES, V130, P1, DOI 10.1016/j.precamres.2003.10.013; Xiao SH, 2002, J PALEONTOL, V76, P347, DOI 10.1666/0022-3360(2002)076<0347:MCCIAT>2.0.CO;2; Yang JD, 1999, PRECAMBRIAN RES, V93, P215; Zhou CM, 2004, GEOLOGY, V32, P437, DOI 10.1130/G20286.1; Zhu MY, 2003, PROG NAT SCI-MATER, V13, P951, DOI 10.1080/10020070312331344710	35	974	1157	11	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2005	308	5718					95	98		10.1126/science.1107765	http://dx.doi.org/10.1126/science.1107765			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914IQ	15731406				2022-12-24	WOS:000228221500040
J	Kohfeld, KE; Le Quere, C; Harrison, SP; Anderson, RF				Kohfeld, KE; Le Quere, C; Harrison, SP; Anderson, RF			Role of marine biology in glacial-interglacial CO2 cycles	SCIENCE			English	Article							SOUTHERN-OCEAN; ATMOSPHERIC CO2; PHYTOPLANKTON BLOOM; IRON ENRICHMENT; CARBON-CYCLE; BOX MODELS; RECORDS; PACIFIC; PUMP; REPRESENTATION	It has been hypothesized that changes in the marine biological pump caused a major portion of the glacial reduction of atmospheric carbon dioxide by 80 to 100 parts per million through increased iron fertilization of marine plankton, increased ocean nutrient content or utilization, or shifts in dominant plankton types. We analyze sedimentary records of marine productivity at the peak and the middle of the last glacial cycle and show that neither changes in nutrient utilization in the Southern Ocean nor shifts in plankton dominance explain the CO2 drawdown. Iron fertilization and associated mechanisms can be responsible for no more than half the observed drawdown.	Max Planck Inst Biogeochem, Jena, Germany; Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; Columbia Univ, Dept Earth & Environm Sci, Palisades, NY 10964 USA	Max Planck Society; Columbia University; Columbia University	Kohfeld, KE (corresponding author), CUNY Queens Coll, Sch Earth & Environm Sci, Flushing, NY 11367 USA.	office@kohfeld.com	Le Quere, Corinne/C-2631-2017	Le Quere, Corinne/0000-0003-2319-0452; Anderson, Robert/0000-0002-8472-2494; Harrison, Sandy/0000-0001-5687-1903; Kohfeld, Karen/0000-0001-7241-1624				Anderson DM, 2002, NATURE, V416, P70, DOI 10.1038/416070a; Anderson RF, 2002, DEEP-SEA RES PT II, V49, P1909, DOI 10.1016/S0967-0645(02)00018-8; Archer D, 2000, REV GEOPHYS, V38, P159, DOI 10.1029/1999RG000066; ARCHER D, 1994, NATURE, V367, P260, DOI 10.1038/367260a0; Archer DE, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000760; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI [10.1175/1520-0469(1978)035<2362:LTVODI>2.0.CO;2, 10.1016/0033-5894(78)90064-9]; Bijma J, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2002GC000388; Bopp L, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001445; Bopp L, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000810; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Broecker W, 1999, GLOBAL BIOGEOCHEM CY, V13, P817, DOI 10.1029/1999GB900050; BROECKER WS, 1982, GEOCHIM COSMOCHIM AC, V46, P1689, DOI 10.1016/0016-7037(82)90110-7; Brzezinski MA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014349; Budziak D, 2000, PALEOCEANOGRAPHY, V15, P307, DOI 10.1029/1999PA000433; Calvo E, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000992; Catubig NR, 1998, PALEOCEANOGRAPHY, V13, P298, DOI 10.1029/98PA00609; Clemens SC, 1990, PALEOCEANOGRAPHY, V5, P109, DOI 10.1029/PA005i002p00109; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; Coale KH, 2004, SCIENCE, V304, P408, DOI 10.1126/science.1089778; CONKRIGHT ME, 2002, 46 NOAA NESDIS, V5; De La Rocha CL, 1998, NATURE, V395, P680, DOI 10.1038/27174; Elderfield H, 2000, NATURE, V405, P305, DOI 10.1038/35012507; Francois R, 1997, NATURE, V389, P929, DOI 10.1038/40073; HESSE PP, 1994, QUATERNARY SCI REV, V13, P257, DOI 10.1016/0277-3791(94)90029-9; Hutchins DA, 1998, NATURE, V393, P561, DOI 10.1038/31203; Ikehara M, 2000, PALEOCEANOGRAPHY, V15, P170, DOI 10.1029/1999PA000425; Kaplan JO, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013366; Kawahata H, 2000, QUATERNARY SCI REV, V19, P1279, DOI 10.1016/S0277-3791(99)00096-7; Kawahata H., 1999, J OCEANOGR, V55, P747; Kohfeld KE, 2001, EARTH-SCI REV, V54, P81, DOI 10.1016/S0012-8252(01)00042-3; Levitus S, 2001, SCIENCE, V292, P267, DOI 10.1126/science.1058154; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Martinez P, 1996, ORG GEOCHEM, V24, P411, DOI 10.1016/0146-6380(96)00044-7; Matsumoto K, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001442; MCELROY MB, 1983, NATURE, V302, P328, DOI 10.1038/302328a0; Muller PJ, 1997, PALAEOGEOGR PALAEOCL, V135, P71, DOI 10.1016/S0031-0182(97)00018-7; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Robinson RS, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000996; Rosenthal Y, 2000, PALEOCEANOGRAPHY, V15, P65, DOI 10.1029/1999PA000369; SANYAL A, 1995, NATURE, V373, P234, DOI 10.1038/373234a0; SCHNEIDER S, 2002, BER FACHBER GEOWISS, V187, P134; Sicre MA, 2000, ORG GEOCHEM, V31, P577, DOI 10.1016/S0146-6380(00)00021-8; Sigman DM, 1999, PALEOCEANOGRAPHY, V14, P118, DOI 10.1029/1998PA900018; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; Stephens BB, 2000, NATURE, V404, P171, DOI 10.1038/35004556; TIEDEMANN R, 1994, PALEOCEANOGRAPHY, V9, P619, DOI 10.1029/94PA00208; Toggweiler JR, 1999, PALEOCEANOGRAPHY, V14, P571, DOI 10.1029/1999PA900033; Toggweiler JR, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001841; Toggweiler JR, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001401; Tsuda A, 2003, SCIENCE, V300, P958, DOI 10.1126/science.1082000; Watson AJ, 2000, NATURE, V407, P730, DOI 10.1038/35037561; XIE LS, 1995, FISH OCEANOGR, V4, P52, DOI 10.1111/j.1365-2419.1995.tb00060.x	53	289	297	3	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2005	308	5718					74	78		10.1126/science.1105375	http://dx.doi.org/10.1126/science.1105375			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914IQ	15802597				2022-12-24	WOS:000228221500035
J	Okie, S				Okie, S			Perspective: Raising the safety bar - the FDA's coxib meeting.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Harris G., 2005, NY TIMES 0225, pA1; Nussmeier NA, 2005, NEW ENGL J MED, V352, P1081, DOI 10.1056/NEJMoa050330; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405	4	43	43	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2005	352	13					1283	1285		10.1056/NEJMp058055	http://dx.doi.org/10.1056/NEJMp058055			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	911JL	15800221				2022-12-24	WOS:000227998300001
J	Stanulla, M; Schaeffeler, E; Flohr, T; Cario, G; Schrauder, A; Zimmermann, M; Welte, K; Ludwig, WD; Bartram, CR; Zanger, UM; Eichelbaum, M; Schrappe, M; Schwab, M				Stanulla, M; Schaeffeler, E; Flohr, T; Cario, G; Schrauder, A; Zimmermann, M; Welte, K; Ludwig, WD; Bartram, CR; Zanger, UM; Eichelbaum, M; Schrappe, M; Schwab, M			Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MINIMAL RESIDUAL DISEASE; S-METHYLTRANSFERASE; PROGNOSTIC VALUE; POPULATION; 6-MERCAPTOPURINE; QUANTIFICATION; IDENTIFICATION; POLYMORPHISM; PHENOTYPE; ALLELES	Context Early response to multiagent chemotherapy, including mercaptopurine, as measured by minimal residual disease is an important prognostic factor for children with acute lymphoblastic leukemia (ALL). Thiopurine m ethyltransfe rase (TPMT) is involved in the metabolism of mercaptopurine and subject to genetic polymorphism, with heterozygous individuals having intermediate and homozygous mutant individuals having very low TPMT activity. Objective To assess the association of TPMT genotype with minimal residual disease load before and after treatment with mercaptopurine in the early treatment course of childhood ALL. Design, Setting, and Patients TPMT genotyping of childhood ALL patients (n=814) in Germany consecutively enrolled in the ALL-BFM (Berlin-Frankfurt-MOnster) 2000 study from October 1999 to September 2002. Minimal residual disease was analyzed on treatment days 33 and 78 for risk-adapted treatment stratification. A 4-week cycle of mercaptopurine was administered between these 2 minimal residual disease measurements. Patients (n =4) homozygous for a mutant TPMT allele, and consequently deficient in TPMT activity, were treated with reduced doses of mercaptopurine and, therefore, not included in the analyses. Main Outcome Measures Minimal residual disease load before (day 33) and after (day 78) mercaptopurine treatment. Loads smaller than 10(-4) were defined as negative. Results Patients (n =55) heterozygous for allelic variants of TPMT conferring lower enzyme activity had a significantly lower rate of minimal residual disease positivity (9.1%) compared with patients (n=755) with homozygous wild-type alleles (22.8%) on day 78 (P=.02). This translated into a 2.9-fold reduction in risk for patients with wild-type heterozygous alleles (relative risk, 0.34; 95% confidence interval, 0.13-0.86). Conclusions TPMT genotype has a substantial impact on minimal residual disease after administration of mercaptopurine in the early course of childhood ALL, most likely through modulation of mercaptopurine dose intensity. Our findings support a role for minimal residual disease analyses in the assessment of genotype-phenotype associations in multiagent chemotherapeutic trials.	Hannover Med Sch, Dept Pediat Hematol & Oncol, D-30625 Hannover, Germany; Heidelberg Univ, Inst Human Genet, Heidelberg, Germany; Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-7000 Stuttgart, Germany; HELIOS Clin Berlin, Dept Hematol Oncol & Tumor Immunol, Robert Rossle Clin, Berlin, Germany; Univ Childrens Hosp, Kiel, Germany	Hannover Medical School; Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Kiel; Schleswig Holstein University Hospital	Stanulla, M (corresponding author), Hannover Med Sch, Dept Pediat Hematol & Oncol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	Stanulla.Martin@MH-Hannover.de	Schrappe, Martin/ABA-6144-2020; Cario, Gunnar/D-2535-2010; Stanulla, Martin/N-4674-2017; Schrappe, Martin/A-8109-2010; Zanger, Ulrich M./A-9364-2012; Stanulla, Martin/D-2528-2010; Schwab, Matthias/ABH-7449-2020	Stanulla, Martin/0000-0002-3834-0727; Zanger, Ulrich M./0000-0002-5276-2002; 				BRISCO MJ, 1994, LANCET, V343, P196, DOI 10.1016/S0140-6736(94)90988-1; BURCHENAL JH, 1953, BLOOD, V8, P965, DOI 10.1182/blood.V8.11.965.965; Cave H, 1998, NEW ENGL J MED, V339, P591, DOI 10.1056/NEJM199808273390904; Ciudad J, 1998, J CLIN ONCOL, V16, P3774, DOI 10.1200/JCO.1998.16.12.3774; Coustan-Smith E, 2000, BLOOD, V96, P2691, DOI 10.1182/blood.V96.8.2691; Dworzak MN, 2002, BLOOD, V99, P1952, DOI 10.1182/blood.V99.6.1952; ELION GB, 1952, J AM CHEM SOC, V74, P411, DOI 10.1021/ja01122a037; Ganiere-Monteil C, 2004, EUR J CLIN PHARMACOL, V60, P89, DOI 10.1007/s00228-004-0732-5; Indjova D, 2003, THER DRUG MONIT, V25, P631, DOI 10.1097/00007691-200310000-00013; Kurzawski M, 2004, THER DRUG MONIT, V26, P541, DOI 10.1097/00007691-200410000-00013; LENNARD L, 1990, LANCET, V336, P225, DOI 10.1016/0140-6736(90)91745-V; McLeod HL, 2000, LEUKEMIA, V14, P567, DOI 10.1038/sj.leu.2401723; McLeod HL, 1999, BRIT J HAEMATOL, V105, P696, DOI 10.1046/j.1365-2141.1999.01416.x; *NAT CANC I, 1999, COMM TOX CRIT MAN VE; Nyvold C, 2002, BLOOD, V99, P1253, DOI 10.1182/blood.V99.4.1253; Pui CH, 2001, LANCET ONCOL, V2, P597, DOI 10.1016/S1470-2045(01)00516-2; Relling MV, 1999, BLOOD, V93, P2817; Relling MV, 1999, JNCI-J NATL CANCER I, V91, P2001, DOI 10.1093/jnci/91.23.2001; Schaeffeler E, 2004, PHARMACOGENETICS, V14, P407, DOI 10.1097/01.fpc.0000114745.08559.db; Schaeffeler E, 2001, CLIN CHEM, V47, P548; Schrappe M, 2000, LEUKEMIA, V14, P2205, DOI 10.1038/sj.leu.2401973; Silverman LB, 2003, CURR OPIN HEMATOL, V10, P290, DOI 10.1097/00062752-200307000-00007; van der Velden VHJ, 2003, LEUKEMIA, V17, P1013, DOI 10.1038/sj.leu.2402922; van Dongen JJM, 1998, LANCET, V352, P1731, DOI 10.1016/S0140-6736(98)04058-6	24	214	237	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2005	293	12					1485	1489		10.1001/jama.293.12.1485	http://dx.doi.org/10.1001/jama.293.12.1485			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	908KA	15784872				2022-12-24	WOS:000227784700028
J	Battersby, MW				Battersby, MW		SA HlthPlus Team	Health reform through coordinated care: SA HealthPlus	BRITISH MEDICAL JOURNAL			English	Article								How can care for chronic illness best be coordinated? An Australian study sought to move towards collaborative and patient centred planned care.	Flinders Univ S Australia, Flinders Human Behav & Hlth Res Unit, Adelaide, SA 5001, Australia	Flinders University South Australia	Battersby, MW (corresponding author), Flinders Univ S Australia, Flinders Human Behav & Hlth Res Unit, GPO Box 2100, Adelaide, SA 5001, Australia.	malcolm.battersby@flinders.edu.au		Battersby, Malcolm/0000-0001-7306-5591				Australian Government Department of Health and Ageing, AUSTR PRIM CAR COLL; Badamgarav E, 2003, AM J PSYCHIAT, V160, P2080, DOI 10.1176/appi.ajp.160.12.2080; Battersby M, 2002, AUSTR COORDINATED CA, P201; Battersby MW., 2003, AUSTR J PRIM HLTH, V9, P41, DOI [10.1071/PY03022, DOI 10.1071/PY03022]; Chen A., 2000, BEST PRACTICES COORD; *COMM DEP HLTH AG, 2004, LOOK OUR PEOPL INF H; *COMM DEP HLTH AG, 2001, 2911 COMM DEP HLTH A; *COMM DEP HLTH AG, 1999, EXPR INT PRIM CAR I; Commonwealth Department of Health and Aged Care, 1999, AUSTR COORD CAR TRIA; GAMBLE C, 2000, WORKING SERIOUS MENT; Harvey P, 2000, AUST NZ J PUBL HEAL, V24, P217, DOI 10.1111/j.1467-842X.2000.tb00149.x; HARVEY PW, 2001, AUST J RURAL HEALTH, V9, P70, DOI DOI 10.1046/J.1440-1584.2001.00319.X; HARVEY PW, 2001, THESIS U W AUSTR PER; HEARD A, 2002, AUST J PRIM HEALTH, V8, P52; Henning JH, 2002, BRIT MED J, V325, P1; Marks I, 1986, BEHAV PSYCHOTHERAPY; Marks IM, 1977, NURSING BEHAV PSYCHO; Murray C. J. L., 1996, GLOBAL BURDEN DIS; *S AUSTR DEP HUM S, 2003, FIN REP GEN HLTH REV; Smith BJ, 2002, MED J AUSTRALIA, V177, P481, DOI 10.5694/j.1326-5377.2002.tb04915.x; Wagner E H, 1999, Manag Care Q, V7, P56; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	23	69	71	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 19	2005	330	7492					662	665		10.1136/bmj.330.7492.662	http://dx.doi.org/10.1136/bmj.330.7492.662			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	909LP	15775001	Green Published, Green Submitted			2022-12-24	WOS:000227861700034
J	Fialova, D; Topinkova, E; Gambassi, G; Finne-Soveri, H; Jonsson, PV; Carpenter, I; Schroll, M; Onder, G; Sorbye, LW; Wagner, C; Reissigova, J; Bernabei, R				Fialova, D; Topinkova, E; Gambassi, G; Finne-Soveri, H; Jonsson, PV; Carpenter, I; Schroll, M; Onder, G; Sorbye, LW; Wagner, C; Reissigova, J; Bernabei, R		AdHOC Project Res Grp	Potentially inappropriate among elderly home medication use care patients in Europe	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MINIMUM DATA SET; OLDER-ADULTS; EXPLICIT CRITERIA; CONSENSUS PANEL; COMMUNITY; POPULATION; RESIDENTS; POLYPHARMACY; INPATIENTS; PEOPLE	Context Criteria for potentially inappropriate medication use among elderly patients have been used in the past decade in large US epidemiological surveys to identify populations at risk and specifically target risk-management strategies. In contrast, in Europe little information is available about potentially inappropriate medication use and is based on small studies with uncertain generalizability. Objective To estimate the prevalence and associated factors of potentially inappropriate medication use among elderly home care patients in European countries. Design, Setting, and Participants Retrospective cross-sectional study of 2707 elderly patients receiving home care (mean [SDI age, 82.2 [7.2] years) representatively enrolled in metropolitan areas of the Czech Republic, Denmark, Finland, Iceland, Italy, the Netherlands, Norway, and the United Kingdom. Patients were prospectively assessed between September 2001 and January 2002 using the Minimum Data Set in Home Care instrument. Main Outcome Measures Prevalence of potentially inappropriate medication use was documented using all expert panels criteria for community-living elderly persons (Beers and McLeod). Patient-related characteristics independently associated with inappropriate medication use were identified with a multiple logistic regression model. Results Combining all 3 sets of criteria, we found that 19.8% of patients in the total sample used at least 1 inappropriate medication; using older 1997 criteria it was 9.8% to 10.9%. Substantial differences were documented between Eastern Europe (41.1% in the Czech Republic) and Western Europe (mean 15.8%, ranging from 5.8% in Denmark to 26.5% in Italy). Potentially inappropriate medication use was associated with patient's poor economic situation (adjusted relative risk [RR], 1.96; 95% confidence interval [CI], 1.58-2.36), polypharmacy (RR, 1.91; 95% Cl, 1.62-2.22), anxiolytic drug use (RR, 1.82; 95% Cl, 1.51-2.15), and depression (RR, 1.29; 95% Cl, 1.06-1.55). Negatively associated factors were age 85 years and older (RR, 0.78; 95% Cl, 0.65-0.92) and living alone (RR, 0.76; 95% Cl, 0.64-0.89). The odds of potentially inappropriate medication use significantly increased with the number of associated factors (P<.001). Conclusions Substantial differences in potentially inappropriate medication use exist between European countries and might be a consequence of different regulatory measures, clinical practices, or inequalities in socioeconomic background. Since financial resources and selected patient-related characteristics are associated with such prescribing, specific educational strategies and regulations should reflect these factors to improve prescribing quality in elderly individuals in Europe.	Charles Univ Prague, Dept Geriatr & Gerontol, Fac Med 1, Prague 12000 2, Czech Republic; Charles Univ Prague, Fac Pharm, Dept Social & Clin Pharm, CS-50165 Hradec Kralove, Czech Republic; Univ Cattolica Sacro Cuore, Ctr Med Invecchiamento, Rome, Italy; Natl Res & Dev Ctr Social Welf & Hlth, STATES CHESS, Helsinki, Finland; Univ Iceland, Landspitali Univ Hosp, Dept Geriatr, Reykjavik, Iceland; Univ Kent, Ctr Hlth Serv Studies, Canterbury, Kent, England; E Kent Hosp NHS Trust, Canterbury, Kent, England; Bispebjerg Hosp, DK-2400 Copenhagen, Denmark; Decon Coll, Oslo, Norway; Netherlands Inst Hlth Serv Res, NIVEL, Utrecht, Netherlands; AS CR, Inst Comp Sci, EuroMISE Ctr, Prague, Czech Republic	Charles University Prague; Charles University Prague; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Landspitali National University Hospital; University of Iceland; University of Kent; University of Copenhagen; Bispebjerg Hospital; Netherlands Institute for Health Services Research; Czech Academy of Sciences; Institute of Computer Science of the Czech Academy of Sciences	Fialova, D (corresponding author), Charles Univ Prague, Dept Geriatr & Gerontol, Fac Med 1, Londynska 15, Prague 12000 2, Czech Republic.	fickova@faf.cuni.cz	Topinkova, Eva/A-5076-2019; Reissigova, Jindra/B-3201-2014; Bernabei, Roberto/AAB-2704-2019	Topinkova, Eva/0000-0002-6786-4116; Bernabei, Roberto/0000-0002-9197-004X				ADAMS SR, 2002, 48325 HCFAOBRA MEDPA; Balogun SA, 2003, J AM GERIATR SOC, V51, pS103; BEERS MH, 1991, ARCH INTERN MED, V151, P1825; Beers MH, 1997, ARCH INTERN MED, V157, P1531, DOI 10.1001/archinte.157.14.1531; *BRIT MED ASS ROYA, 2004, BRIT NAT FORM; Burrows AB, 2000, AGE AGEING, V29, P165, DOI 10.1093/ageing/29.2.165; Carpenter I, 2004, AGING CLIN EXP RES, V16, P259; Chutka DS, 2004, MAYO CLIN PROC, V79, P122, DOI 10.4065/79.1.122; Cohen JS, 2000, GERIATRICS-US, V55, P54; Curtis LH, 2004, ARCH INTERN MED, V164, P1621, DOI 10.1001/archinte.164.15.1621; *CZECH NAT FORM, 2003, PHARM BREV; Fick D, 2001, J MANAGE CARE PHARM, V7, P407, DOI [10.18553/jmcp.2001.7.5.407, DOI 10.18553/JMCP.2001.7.5.407]; Fick DM, 2003, ARCH INTERN MED, V163, P2716, DOI 10.1001/archinte.163.22.2716; Giron MST, 2001, J AM GERIATR SOC, V49, P277, DOI 10.1046/j.1532-5415.2001.4930277.x; Goulding MR, 2004, ARCH INTERN MED, V164, P305, DOI 10.1001/archinte.164.3.305; Gray SL, 2003, ANN PHARMACOTHER, V37, P988, DOI 10.1345/aph.1C365; Hanlon JT, 2001, J AM GERIATR SOC, V49, P200, DOI 10.1046/j.1532-5415.2001.49042.x; Hanlon JT, 2004, ANN PHARMACOTHER, V38, P9, DOI 10.1345/aph.1D313; *IC NAT FORM, 2003, SERL 2002 2003; Landi F, 2000, MED CARE, V38, P1184, DOI 10.1097/00005650-200012000-00005; Lane CJ, 2004, J AM GERIATR SOC, V52, P861, DOI 10.1111/j.1532-5415.2004.52250.x; Lau DT, 2005, ARCH INTERN MED, V165, P68, DOI 10.1001/archinte.165.1.68; Linjakumpu T, 2002, INT J GERIATR PSYCH, V17, P874, DOI 10.1002/gps.712; Malik AB, 2003, J AM GERIATR SOC, V51, pS123; McLeod PJ, 1997, CAN MED ASSOC J, V156, P385; MCNUTT LA, 1994, J CLIN EPIDEMIOL, V47, P613, DOI 10.1016/0895-4356(94)90209-7; Morris JN, 1997, J AM GERIATR SOC, V45, P1017, DOI 10.1111/j.1532-5415.1997.tb02975.x; Morris JN, 1999, J GERONTOL A-BIOL, V54, pM546, DOI 10.1093/gerona/54.11.M546; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; *NORW MED AG, NORW PHARM PROD COMP; Onder G, 2003, EUR J CLIN PHARMACOL, V59, P157, DOI 10.1007/s00228-003-0600-8; ONDER G, IN PRESS EUR J CLIN; Pitkala KH, 2002, ARCH INTERN MED, V162, P1707, DOI 10.1001/archinte.162.15.1707; Schmader KE, 2004, AM J MED, V116, P394, DOI 10.1016/j.amjmed.2003.10.031; STEWART RB, 1994, DRUG AGING, V4, P449, DOI 10.2165/00002512-199404060-00002; STUCK AE, 1994, ARCH INTERN MED, V154, P2195; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; Tamblyn R, 2003, CAN MED ASSOC J, V169, P549; Thirstrup S, 2001, LANCET, V358, P1734, DOI 10.1016/S0140-6736(01)06760-5; Zhan Chunliu, 2001, JAMA (Journal of the American Medical Association), V286, P2823; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	41	482	503	5	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2005	293	11					1348	1358		10.1001/jama.293.11.1348	http://dx.doi.org/10.1001/jama.293.11.1348			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	907EP	15769968	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000227698600023
J	Arvidson, RE; Poulet, F; Bibring, JP; Wolff, M; Gendrin, A; Morris, RV; Freeman, JJ; Langevin, Y; Mangold, N; Bellucci, G				Arvidson, RE; Poulet, F; Bibring, JP; Wolff, M; Gendrin, A; Morris, RV; Freeman, JJ; Langevin, Y; Mangold, N; Bellucci, G			Spectral reflectance and morphologic correlations in eastern Terra Meridiani, Mars	SCIENCE			English	Article							OPPORTUNITY ROVER; PLANUM; SPECTROMETER; WATER	The Mars Express Observatoire pour la Mineralogie, l'Eau, les Glaces, et l'Activite (OMEGA) hyperspectral image data covering eastern Terra Meridiani indicate the ubiquitous presence of molecular water in etched terrain materials that disconformabty overlie heavily cratered terrains and underlie the hematite-bearing plains explored by the Opportunity rover. Identification of crystalline water in kieserite (MgSO4.H2O) is linked to materials exposed in a valley and plateau to the north of hematite-bearing plains. The mineralogical similarities between the etched terrain deposits examined with OMEGA data and the layered rocks examined by Opportunity imply that the ancient aqueous environments inferred from analyses of the rover data extend over regional scales.	Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Inst Astrophys Spatiale, F-91405 Orsay, France; Space Sci Inst, Boulder, CO 80301 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Ist Fis Spazio Interplanetario, Ist Nazl Astrofis, I-00133 Rome, Italy	Washington University (WUSTL); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Istituto Nazionale Astrofisica (INAF)	Arvidson, RE (corresponding author), Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA.	arvidson@wunder.wustl.edu	Bellucci, Giancarlo/ABA-9201-2020	Bellucci, Giancarlo/0000-0003-0867-8679				Arvidson RE, 2004, SCIENCE, V306, P1730, DOI 10.1126/science.1104211; Arvidson RE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001982; Baldridge AM, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002066; Bell JF, 2004, SCIENCE, V306, P1703, DOI 10.1126/science.1105245; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; BISHOP JL, UNPUB; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9623, DOI 10.1029/1999JE001093; Christensen PR, 2004, SCIENCE, V306, P1733, DOI 10.1126/science.1104909; Crowley JK., 2003, GEOCHEM-EXPLOR ENV A, V3, P219, DOI DOI 10.1144/1467-7873/03-001; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; GREEN AA, 1988, IEEE T GEOSCI REMOTE, V26, P65, DOI 10.1109/36.3001; Herzberg G, 1945, MOL SPECTRA MOL STRU; Hynek BM, 2004, NATURE, V431, P156, DOI 10.1038/nature02902; Hynek BM, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2002JE001891; Hynek BM, 2001, GEOLOGY, V29, P407, DOI 10.1130/0091-7613(2001)029<0407:EFEDOT>2.0.CO;2; Langevin Y, 2005, SCIENCE, V307, P1584, DOI 10.1126/science.1109091; MORRIS RV, 1985, J GEOPHYS RES-SOLID, V90, P3126, DOI 10.1029/JB090iB04p03126; Murchie S, 2000, ICARUS, V147, P444, DOI 10.1006/icar.2000.6446; Mustard JF, 2005, SCIENCE, V307, P1594, DOI 10.1126/science.1109098; MUSTARD JF, 1994, GEOPHYS RES LETT, V21, P353, DOI 10.1029/94GL00198; Smith DE, 2001, J GEOPHYS RES-PLANET, V106, P23689, DOI 10.1029/2000JE001364; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; STAMNES K, 1988, APPL OPTICS, V27, P2502, DOI 10.1364/AO.27.002502; Yen AS, 1998, J GEOPHYS RES-PLANET, V103, P11125, DOI 10.1029/98JE00739	24	150	154	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2005	307	5715					1591	1594		10.1126/science.1109509	http://dx.doi.org/10.1126/science.1109509			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15718425				2022-12-24	WOS:000227622400038
J	Froemke, RC; Poo, MM; Dan, Y				Froemke, RC; Poo, MM; Dan, Y			Spike-timing-dependent synaptic plasticity depends on dendritic location	NATURE			English	Article							ACTION-POTENTIALS; NMDA RECEPTORS; CALCIUM; MECHANISM; INPUTS; COINCIDENCE; SUMMATION; CHANNELS; NEURONS; CELLS	In the neocortex, each neuron receives thousands of synaptic inputs distributed across an extensive dendritic tree. Although postsynaptic processing of each input is known to depend on its dendritic location(1-8), it is unclear whether activity-dependent synaptic modification is also location-dependent. Here we report that both the magnitude and the temporal specificity of spike-timing-dependent synaptic modification(9-17) vary along the apical dendrite of rat cortical layer 2/3 pyramidal neurons. At the distal dendrite, the magnitude of long-termpotentiation is smaller, and the window of pre-/postsynaptic spike interval for long-term depression (LTD) is broader. The spike-timing window for LTD correlates with the window of action potential-induced suppression of NMDA (N-methyl-D-aspartate) receptors; this correlation applies to both their dendritic location-dependence and pharmacological properties. Presynaptic stimulation with partial blockade of NMDA receptors induced LTD and occluded further induction of spike-timing-dependent LTD, suggesting that NMDA receptor suppression underlies LTD induction. Computer simulation studies showed that the dendritic inhomogeneity of spike-timing-dependent synaptic modification leads to differential input selection at distal and proximal dendrites according to the temporal characteristics of presynaptic spike trains. Such location-dependent tuning of inputs, together with the dendritic heterogeneity of postsynaptic processing, could enhance the computational capacity of cortical pyramidal neurons.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Dan, Y (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	ydan@berkeley.edu		Froemke, Robert/0000-0002-1230-6811; Dan, Yang/0000-0002-3818-877X				Archie KA, 2000, NAT NEUROSCI, V3, P54, DOI 10.1038/71125; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Hausser M, 2003, CURR OPIN NEUROBIOL, V13, P372, DOI 10.1016/S0959-4388(03)00075-8; Hausser M, 2001, SCIENCE, V291, P138, DOI 10.1126/science.291.5501.138; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Nevian T, 2004, J NEUROSCI, V24, P1689, DOI 10.1523/JNEUROSCI.3332-03.2004; ROSENMUND C, 1995, J NEUROPHYSIOL, V73, P427, DOI 10.1152/jn.1995.73.1.427; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Sourdet V, 1999, LEARN MEMORY, V6, P422, DOI 10.1101/lm.6.5.422; Stuart G, 1998, J NEUROSCI, V18, P3501; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Tamas G, 2002, J NEUROSCI, V22, P740, DOI 10.1523/JNEUROSCI.22-03-00740.2002; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; Umemiya M, 2001, J NEUROSCI, V21, P1, DOI 10.1523/JNEUROSCI.21-01-00001.2001; Watanabe S, 2002, P NATL ACAD SCI USA, V99, P8366, DOI 10.1073/pnas.122210599; Waters J, 2003, J NEUROSCI, V23, P8558; Zilberter Y, 1999, NEURON, V24, P979, DOI 10.1016/S0896-6273(00)81044-2; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	30	266	270	4	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					221	225		10.1038/nature03366	http://dx.doi.org/10.1038/nature03366			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15759002				2022-12-24	WOS:000227494500047
J	Buddha, S				Buddha, S			Complication of urethral catheterisation	LANCET			English	Editorial Material									Prince Charles Hosp, Merthyr Tydfil CF47 9DT, M Glam, Wales		Buddha, S (corresponding author), Prince Charles Hosp, Merthyr Tydfil CF47 9DT, M Glam, Wales.								0	11	12	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 5	2005	365	9462					909	909		10.1016/S0140-6736(05)71051-5	http://dx.doi.org/10.1016/S0140-6736(05)71051-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	903RZ	15752537				2022-12-24	WOS:000227444600035
J	Avery, AA; Prakash, CS; McHughen, A; Trewavas, AR; DeGregori, TR				Avery, AA; Prakash, CS; McHughen, A; Trewavas, AR; DeGregori, TR			What kind of farming works best?	SCIENCE			English	Letter									Ctr Global Food Issues, Hudson Inst, Churchville, VA 24421 USA; Tuskegee Univ, Ctr Plant Biotechnol Res, Tuskegee, AL 36088 USA; Univ Calif Riverside, Riverside, CA 92521 USA; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland; Univ Houston, Dept Econ, Houston, TX 77204 USA	Tuskegee University; University of California System; University of California Riverside; University of Edinburgh; University of Houston System; University of Houston	Avery, AA (corresponding author), Ctr Global Food Issues, Hudson Inst, POB 202, Churchville, VA 24421 USA.	aavery@cgfi.org	McHughen, Alan/AAM-9215-2021; McHughen, Alan/HII-3301-2022					Dobbs TL, 1996, J SUSTAIN AGR, V9, P63, DOI 10.1300/J064v09n01_06; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; SHEPARD M, 2003, ASSESSMENT ENV IMPAC; SMIL V, COMMUNICATION; *SOIL WAT CONS SOC, 1995, FARM BETT ENV	5	1	1	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1410	1410						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15751124				2022-12-24	WOS:000227503100022
J	Ali, Y				Ali, Y			Always trust your gut feeling	LANCET			English	Editorial Material									Brown Univ, Dept Med, Providence, RI 02906 USA	Brown University	Ali, Y (corresponding author), Brown Univ, Dept Med, 49 Seekonk St, Providence, RI 02906 USA.	yali@lifespan.org							0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR-APR	2005	365	9465					1201	1201		10.1016/S0140-6736(05)71884-5	http://dx.doi.org/10.1016/S0140-6736(05)71884-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	910DD	15794976				2022-12-24	WOS:000227909500034
J	Mota, LJ; Journet, L; Sorg, I; Agrain, C; Cornelis, GR				Mota, LJ; Journet, L; Sorg, I; Agrain, C; Cornelis, GR			Bacterial injectisomes: Needle length does matter	SCIENCE			English	Article									Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of Basel	Cornelis, GR (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.	guy.cornelis@unibas.ch	Mota, Luis/B-9497-2008	Mota, Luis/0000-0002-5592-8397; Journet, Laure/0000-0002-5847-2962				Cornelis GR, 2002, NAT REV MOL CELL BIO, V3, P742, DOI 10.1038/nrm932; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291; Hoiczyk E, 2000, EMBO J, V19, P5989, DOI 10.1093/emboj/19.22.5989; Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610	6	111	117	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1278	1278		10.1126/science.1107679	http://dx.doi.org/10.1126/science.1107679			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731447				2022-12-24	WOS:000227313200049
J	West, NP; Sansonetti, P; Mounier, J; Exley, RM; Parsot, C; Guadagnini, S; Prevost, MC; Prochnicka-Chalufour, A; Delepierre, M; Tanguy, M; Tang, CM				West, NP; Sansonetti, P; Mounier, J; Exley, RM; Parsot, C; Guadagnini, S; Prevost, MC; Prochnicka-Chalufour, A; Delepierre, M; Tanguy, M; Tang, CM			Optimization of virulence functions through glucosylation of Shigella LPS	SCIENCE			English	Article							O-ANTIGEN MODIFICATION; IPAB PROTEIN; PLASMID; INVASION; GENES	Shigella, the leading cause of bacillary dysentery, uses a type III secretion system (TTSS) to inject proteins into human cells, leading to bacterial invasion and a vigorous inflammatory response. The bacterium is protected against the response by the O antigen of lipopolysaccha ride (LPS) on its surface. We show that bacteriophage-encoded glucosylation of Shigella O antigen, the basis of different serotypes, shortens the LPS molecule by around half. This enhances TTSS function without compromising the protective properties of the LPS. Thus, LPS glucosylation promotes bacterial invasion and evasion of innate immunity, which may have contributed to the emergence of serotype diversity in Shigella.	Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis, Ctr Mol Microbiol & Infect, London SW7 2AZ, England; Inst Pasteur, INSERM, U389, Unite Pathogenie Microbienne, F-75724 Paris 15, France; Inst Pasteur, Plate Forme Microscopie Elect, F-75724 Paris 15, France; Inst Pasteur, CNRS, URA 2185, Unite Resonance Magnet Nucl Biomol, F-75724 Paris 15, France	Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Tang, CM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis, Ctr Mol Microbiol & Infect, Flowers Bldg, London SW7 2AZ, England.	c.tang@imperial.ac.uk	West, Nicholas P/C-3119-2008	West, Nicholas P/0000-0003-0955-9890				Allison GE, 2000, TRENDS MICROBIOL, V8, P17, DOI 10.1016/S0966-842X(99)01646-7; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; BOCK K, 1982, J CHEM SOC PERK T 2, P59, DOI 10.1039/p29820000059; Buchrieser C, 2000, MOL MICROBIOL, V38, P760, DOI 10.1046/j.1365-2958.2000.02179.x; Clement MJ, 2003, J BIOL CHEM, V278, P47928, DOI 10.1074/jbc.M308259200; Cunliffe RN, 2004, J LEUKOCYTE BIOL, V75, P49, DOI 10.1189/jlb.0503249; Finlay BB, 1997, SCIENCE, V276, P718, DOI 10.1126/science.276.5313.718; Guan S, 1999, MICROBIOL-UK, V145, P1263, DOI 10.1099/13500872-145-5-1263; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Hong M, 1997, MOL MICROBIOL, V24, P779, DOI 10.1046/j.1365-2958.1997.3731744.x; Huan PT, 1997, GENE, V195, P217, DOI 10.1016/S0378-1119(97)00143-1; ITO K, 1991, MICROBIOL IMMUNOL, V35, P335, DOI 10.1111/j.1348-0421.1991.tb01563.x; KENNE L, 1978, EUR J BIOCHEM, V91, P279, DOI 10.1111/j.1432-1033.1978.tb20963.x; MAURELLI AT, 1985, INFECT IMMUN, V49, P164, DOI 10.1128/IAI.49.1.164-171.1985; SANSONETTI PJ, 1982, INFECT IMMUN, V35, P852, DOI 10.1128/IAI.35.3.852-860.1982; SANSONETTI PJ, 1995, J CLIN INVEST, V96, P884, DOI 10.1172/JCI118135; SIMMONS DAR, 1990, BIOCHEM SOC T, V18, P1271, DOI 10.1042/bst0181271; Skoudy A, 2000, CELL MICROBIOL, V2, P19, DOI 10.1046/j.1462-5822.2000.00028.x; VENKATESAN MM, 1992, J BACTERIOL, V174, P1990, DOI 10.1128/jb.174.6.1990-2001.1992; WEST NP, UNPUB	20	231	249	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1313	1317		10.1126/science.1108472	http://dx.doi.org/10.1126/science.1108472			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731456				2022-12-24	WOS:000227313200060
J	Lasmezas, CI; Comoy, E; Hawkins, S; Herzog, C; Mouthon, F; Konold, T; Auvre, F; Correia, E; Lescoutra-Etchegaray, N; Sales, N; Wells, G; Brown, P; Deslys, JP				Lasmezas, CI; Comoy, E; Hawkins, S; Herzog, C; Mouthon, F; Konold, T; Auvre, F; Correia, E; Lescoutra-Etchegaray, N; Sales, N; Wells, G; Brown, P; Deslys, JP			Risk of oral infection with bovine spongiform encephalopathy agent in primates	LANCET			English	Article							BSE; TRANSMISSION; HEALTH; TISSUE; CATTLE	The uncertain extent of human exposure to bovine spongiform encephalopathy (BSE)-which can lead to variant Creutzfeldt-jakob disease (vCJD)-is compounded by incomplete knowledge about the efficiency of oral infection and the magnitude of any bovine-to-human biological barrier to transmission. We therefore investigated oral transmission of BSE to non-human primates. We gave two macaques a 5 g oral dose of brain homogenate from a BSE-infected cow. One macaque developed vCjD-Iike neurological disease 60 months after exposure, whereas the other remained free of disease at 76 months. On the basis of these findings and data from other studies, we made a preliminary estimate of the food exposure risk for man, which provides additional assurance that existing public health measures can prevent transmission of BSE to man.	Commissariat Energie Atom, Direct Sci Vivant, Dept Rech Med, F-92265 Fontenay Aux Roses, France; Vet Labs Agcy, Addlestone, Surrey, England	CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Veterinary Laboratories Agency	Deslys, JP (corresponding author), Commissariat Energie Atom, Direct Sci Vivant, Dept Rech Med, 18 Route Panorama, F-92265 Fontenay Aux Roses, France.	jpdeslys@cea.fr	Konold, Timm/C-6498-2011; Hawkins, Stephen/F-1136-2011					Anderson RM, 1996, NATURE, V382, P779, DOI 10.1038/382779a0; Deslys JP, 2001, NATURE, V409, P476, DOI 10.1038/35054134; *EUR COMM, OP SCI STEER COMM HU; Grassi J, 2001, VET REC, V149, P577, DOI 10.1136/vr.149.19.577; Herzog C, 2004, LANCET, V363, P422, DOI 10.1016/S0140-6736(04)15487-1; KLITZMAN R L, 1984, Neuroepidemiology, V3, P3, DOI 10.1159/000110837; Lasmezas CI, 1996, NATURE, V381, P743, DOI 10.1038/381743a0; Lasmezas CI, 2001, P NATL ACAD SCI USA, V98, P4142, DOI 10.1073/pnas.041490898; Moynagh J, 1999, NATURE, V400, P105, DOI 10.1038/21981	9	73	74	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2005	365	9461					781	783		10.1016/S0140-6736(05)17985-9	http://dx.doi.org/10.1016/S0140-6736(05)17985-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LZ	15733719				2022-12-24	WOS:000227285300025
J	Giraldez, AJ; Cinalli, RM; Glasner, ME; Enright, AJ; Thomson, JM; Baskerville, S; Hammond, SM; Bartel, DP; Schier, AF				Giraldez, AJ; Cinalli, RM; Glasner, ME; Enright, AJ; Thomson, JM; Baskerville, S; Hammond, SM; Bartel, DP; Schier, AF			MicroRNAs regulate brain morphogenesis in zebrafish	SCIENCE			English	Article							RNA-INTERFERENCE; GENE-EXPRESSION; MESSENGER-RNAS; DICER; DROSOPHILA; CELLS; INITIATION; TARGETS; DIFFERENTIATION; MECHANISMS	MicroRNAs (miRNAs) are small RNAs that regulate gene expression posttranscriptionally. To block all miRNA formation in zebrafish, we generated maternal-zygotic dicer (MZdicer) mutants that disrupt the Dicer ribonuclease III and double-stranded RNA-binding domains. Mutant embryos do not process precursor miRNAs into mature miRNAs, but injection of preprocessed miRNAs restores gene silencing, indicating that the disrupted domains are dispensable for later steps in silencing. MZdicer mutants undergo axis formation and differentiate multiple cell types but display abnormal morphogenesis during gastrulation, brain formation, somitogenesis, and heart development. Injection of miR-430 miRNAs rescues the brain defects in MZdicer mutants, revealing essential roles for miRNAs during morphogenesis.	NYU, Sch Med, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA	New York University; New York University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Wellcome Trust Sanger Institute; University of North Carolina; University of North Carolina Chapel Hill	Giraldez, AJ (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA.	giraldez@saturn.med.nyu.edu; schier@saturn.med.nyu.edu	Enright, Anton/F-3094-2011	Enright, Anton/0000-0002-6090-3100; Schier, Alexander Franz/0000-0001-7645-5325; Glasner, Margaret/0000-0003-1818-1965; Giraldez, Antonio/0000-0002-6823-137X				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Ciruna B, 2002, P NATL ACAD SCI USA, V99, P14919, DOI 10.1073/pnas.222459999; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doi N, 2003, CURR BIOL, V13, P41, DOI 10.1016/S0960-9822(02)01394-5; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; GLASNER ME, UNPUB; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kloosterman WP, 2004, NUCLEIC ACIDS RES, V32, P6284, DOI 10.1093/nar/gkh968; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Lowery LA, 2004, MECH DEVELOP, V121, P1189, DOI 10.1016/j.mod.2004.04.022; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Schier AF, 2001, CURR OPIN GENET DEV, V11, P393, DOI 10.1016/S0959-437X(00)00209-4; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Wienholds E, 2003, NAT GENET, V35, P217, DOI 10.1038/ng1251; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	40	996	1144	6	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2005	308	5723					833	838		10.1126/science.1109020	http://dx.doi.org/10.1126/science.1109020			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15774722				2022-12-24	WOS:000228986500042
J	Chamberlain, P				Chamberlain, P			Death after withdrawal of nutrition and hydration	LANCET			English	Editorial Material							RIGHT-TO-DIE		John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England	University of Oxford	Chamberlain, P (corresponding author), John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England.	paul.chamberlain@obs-gyn.ox.ac.uk						GOVE M, 2005, TIMES LONDON    0329, P18; *IR MED COUNC, 1995, IR MED COUNC STAT; JENNETT B, 2002, VEGETATIVE STATE MED; MURDOCH A, 1995, BRIT MED J, V311, P405; SHERWELL P, 2005, SUNDAY TELEGRAP 0327, P17; WALL M, 1995, LANCET, V346, P368, DOI 10.1016/S0140-6736(95)92243-1	6	9	9	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 23	2005	365	9469					1446	1447		10.1016/S0140-6736(05)66397-0	http://dx.doi.org/10.1016/S0140-6736(05)66397-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850616				2022-12-24	WOS:000228651600007
J	Macleod, J; Salisbury, C; Low, N; McCarthy, A; Sterne, JAC; Holloway, A; Patel, R; Sanford, E; Morcom, A; Horner, P; Smith, GD; Skidmore, S; Herring, A; Caul, O; Hobbs, FDR; Egger, M				Macleod, J; Salisbury, C; Low, N; McCarthy, A; Sterne, JAC; Holloway, A; Patel, R; Sanford, E; Morcom, A; Horner, P; Smith, GD; Skidmore, S; Herring, A; Caul, O; Hobbs, FDR; Egger, M			Coverage and uptake of systematic postal screening for genital Chlamydia trachomatis and prevalence of infection in the United Kingdom general population: cross sectional study	BRITISH MEDICAL JOURNAL			English	Article								Objective To measure the coverage and uptake of systematic postal screening for genital Chlamydia trachomatis and the prevalence of infection in the general population in the United Kingdom. To investigate factors associated with these measures. Design Cross sectional survey of people randomly selected from general practice registers. Invitation to provide a specimen collected at home. Setting England. Participants 19 773 men and women aged 16-39 years invited to participate in screening. Main outcome measures Coverage and uptake of screening; prevalence of chlamydia. Results Coverage of chlamydia screening was 73% and was lower in areas with a higher proportion of non-white residents. Uptake in 16-24 year olds was 31.5% and was lower in men, younger adults, and practices in disadvantaged areas. Overall prevalence of chlamydia was 2.8% (95% confidence interval 2.2% to 3.4%) in men and 3.6% (3. 1 % to 4.9%) in women, but it was higher in people younger than 25 years (men 5. 1 %; 4.0% to 6.3%; women 6.2%; 5.2% to 7.8%). Prevalence was higher in the subgroup of younger women who were harder to engage in screening. The strongest determinant of chlamydial infection was having one or more new sexual partners in the past year. Conclusions Postal chlamydia screening was feasible, but coverage was incomplete and uptake was modest. Lower coverage of postal screening in areas with more non-white residents along with poorer uptake in more deprived areas and among women at higher risk of infection could mean that screening leads to wider inequalities in sexual health.	Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England; Univ Bristol, Dept Community Based Med, Bristol BS6 6JL, Avon, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Univ Bern, Dept Social & Prevent Med, CH-3012 Bern, Switzerland; United Bristol Healthcare Trust, Milne Ctr, Bristol BS21 7LR, Avon, England; Publ Hlth Lab Serv, Birmingham B9 5SS, W Midlands, England; Publ Hlth Lab Serv, Genitourinary Infect Reference Lab, Bristol BS2 8EL, Avon, England	University of Birmingham; University of Bristol; University of Bristol; University of Bern	Macleod, J (corresponding author), Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England.	j.a.macleod@bham.ac.uk	Low, Nicola/H-4718-2019; Sterne, Jonathan/Z-3106-2019; Davey Smith, George/A-7407-2013; Salisbury, Chris/C-6724-2008; Fazli, Ghazal/AAE-8320-2022	Low, Nicola/0000-0003-4817-8986; Sterne, Jonathan/0000-0001-8496-6053; Davey Smith, George/0000-0002-1407-8314; Salisbury, Chris/0000-0002-4378-3960; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Egger, Matthias/0000-0001-7462-5132; s, hema/0000-0002-3440-9475; Macleod, John/0000-0001-8202-1144; hobbs, richard/0000-0001-7976-7172; Holloway, Aisha/0000-0003-3070-3703; Horner, Paddy/0000-0003-0411-8332				Andersen B, 2002, J INFECT DIS, V185, P252, DOI 10.1086/338268; *DEP HLTH, 2001, CHOOS HLTH MAK HLTH; Fenton KA, 2001, LANCET, V358, P1851, DOI 10.1016/S0140-6736(01)06886-6; Low N, 2003, LANCET, V362, P1157, DOI 10.1016/S0140-6736(03)14480-7; Low N, 2002, INT J EPIDEMIOL, V31, P891, DOI 10.1093/ije/31.5.891; Low N, 2001, SEX TRANSM INFECT, V77, P15, DOI 10.1136/sti.77.1.15; Low N, 2004, SEX TRANSM INFECT, V80, P342, DOI 10.1136/sti.2003.006197; Macleod J, 1999, BRIT J GEN PRACT, V49, P455; OSTERGAARD L, 2002, SCREENING KLAMYDIA M; SALISBURY C, 2005, IN PRESS BRIT J GEN	10	97	98	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 23	2005	330	7497					940	942		10.1136/bmj.38413.663137.8F	http://dx.doi.org/10.1136/bmj.38413.663137.8F			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920UP	15809231	Bronze, Green Published, Green Submitted			2022-12-24	WOS:000228715900021
J	Dean, RA; Talbot, NJ; Ebbole, DJ; Farman, ML; Mitchell, TK; Orbach, MJ; Thon, M; Kulkarni, R; Xu, JR; Pan, HQ; Read, ND; Lee, YH; Carbone, I; Brown, D; Oh, YY; Donofrio, N; Jeong, JS; Soanes, DM; Djonovic, S; Kolomiets, E; Rehmeyer, C; Li, WX; Harding, M; Kim, S; Lebrun, MH; Bohnert, H; Coughlan, S; Butler, J; Calvo, S; Ma, LJ; Nicol, R; Purcell, S; Nusbaum, C; Galagan, JE; Birren, BW				Dean, RA; Talbot, NJ; Ebbole, DJ; Farman, ML; Mitchell, TK; Orbach, MJ; Thon, M; Kulkarni, R; Xu, JR; Pan, HQ; Read, ND; Lee, YH; Carbone, I; Brown, D; Oh, YY; Donofrio, N; Jeong, JS; Soanes, DM; Djonovic, S; Kolomiets, E; Rehmeyer, C; Li, WX; Harding, M; Kim, S; Lebrun, MH; Bohnert, H; Coughlan, S; Butler, J; Calvo, S; Ma, LJ; Nicol, R; Purcell, S; Nusbaum, C; Galagan, JE; Birren, BW			The genome sequence of the rice blast fungus Magnaporthe grisea	NATURE			English	Article							INDUCED POINT MUTATION; GENE-EXPRESSION; DRAFT SEQUENCE; PHYSICAL MAP; RESISTANCE; INFECTION; KINASE; ORGANIZATION; SPECIFICITY; CONTAINS	Magnaporthe grisea is the most destructive pathogen of rice worldwide and the principal model organism for elucidating the molecular basis of fungal disease of plants. Here, we report the draft sequence of the M. grisea genome. Analysis of the gene set provides an insight into the adaptations required by a fungus to cause disease. The genome encodes a large and diverse set of secreted proteins, including those defined by unusual carbohydrate-binding domains. This fungus also possesses an expanded family of G-protein-coupled receptors, several new virulence-associated genes and large suites of enzymes involved in secondary metabolism. Consistent with a role in fungal pathogenesis, the expression of several of these genes is upregulated during the early stages of infection-related development. The M. grisea genome has been subject to invasion and proliferation of active transposable elements, reflecting the clonal nature of this fungus imposed by widespread rice cultivation.	N Carolina State Univ, Ctr Integrated Fungal Res, Raleigh, NC 27695 USA; Univ Exeter, Sch Biol & Chem Sci, Washington Singer Labs, Exeter EX4 4QG, Devon, England; Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; Univ Kentucky, Dept Plant Pathol, Lexington, KY 40546 USA; Univ Arizona, Dept Plant Pathol, Tucson, AZ 85721 USA; Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JH, Midlothian, Scotland; Seoul Natl Univ, Sch Agr Biotechnol, Seoul 151742, South Korea; Bayer Cropsci, CNRS Bayer, FRE2579, F-69263 Lyon, France; Agilent Technol, Wilmington, DE 19808 USA; MIT, Broad Inst, Cambridge, MA 02141 USA; Harvard Univ, Broad Inst, Cambridge, MA 02141 USA	University of North Carolina; North Carolina State University; University of Exeter; Texas A&M University System; Texas A&M University College Station; University of Kentucky; University of Arizona; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Edinburgh; Seoul National University (SNU); Bayer AG; Bayer CropScience; Agilent Technologies; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Dean, RA (corresponding author), N Carolina State Univ, Ctr Integrated Fungal Res, Raleigh, NC 27695 USA.	Ralph_Dean@ncsu.edu	Talbot, Nicholas J/I-9584-2014; Harding, Michael/R-4098-2019; Thon, Michael/M-9463-2014; Talbot, Nicholas J/I-5618-2019; Ma, Li-Jun/AAG-2359-2020	Talbot, Nicholas J/0000-0001-6434-7757; Harding, Michael/0000-0002-9322-1894; Thon, Michael/0000-0002-7225-7003; Talbot, Nicholas J/0000-0001-6434-7757; Galagan, James/0000-0003-0542-3291; Read, Nick/0000-0002-2286-2862; Rehmeyer Caudill, Cathryn/0000-0001-8267-8795; Bohnert, Heidi/0000-0002-0887-5026; Nicol, Robert/0000-0003-1932-1392; Pan, Huaqin/0000-0002-7166-108X; Ma, Li-Jun/0000-0002-2733-3708; LEBRUN, marc-henri/0000-0003-1562-1902; Oh, Yeonyee/0000-0002-5571-3687				Bohnert HU, 2004, PLANT CELL, V16, P2499, DOI 10.1105/tpc.104.022715; Bolker M, 1998, FUNGAL GENET BIOL, V25, P143, DOI 10.1006/fgbi.1998.1102; BONMAN JM, 1992, EUPHYTICA, V63, P115, DOI 10.1007/BF00023917; CHAO CCT, 1991, CAN J BOT, V69, P2130, DOI 10.1139/b91-267; Dean RA, 1997, ANNU REV PHYTOPATHOL, V35, P211, DOI 10.1146/annurev.phyto.35.1.211; deJong JC, 1997, NATURE, V389, P244, DOI 10.1038/38418; DeZwaan TM, 1999, PLANT CELL, V11, P2013, DOI 10.1105/tpc.11.10.2013; Ebbole DJ, 2004, MOL PLANT MICROBE IN, V17, P1337, DOI 10.1094/MPMI.2004.17.12.1337; Farman ML, 2002, GENETICS, V160, P137; Farman ML, 2002, MOL PLANT MICROBE IN, V15, P6, DOI 10.1094/MPMI.2002.15.1.6; Fellbrich G, 2002, PLANT J, V32, P375, DOI 10.1046/j.1365-313X.2002.01454.x; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Freitag M, 2002, P NATL ACAD SCI USA, V99, P8802, DOI 10.1073/pnas.132212899; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; HAMER JE, 1988, SCIENCE, V239, P288, DOI 10.1126/science.239.4837.288; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Idnurm A, 2001, MOL PLANT PATHOL, V2, P241, DOI 10.1046/j.1464-6722.2001.00070.x; Ikeda K, 2002, MOL MICROBIOL, V45, P1355, DOI 10.1046/j.1365-2958.2002.03101.x; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; JOOSTEN MHAJ, 1994, NATURE, V367, P384, DOI 10.1038/367384a0; Kang S, 2001, MOL PLANT MICROBE IN, V14, P671, DOI 10.1094/MPMI.2001.14.5.671; Kang SC, 1995, MOL PLANT MICROBE IN, V8, P939, DOI 10.1094/MPMI-8-0939; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Kulkarni RD, 2003, TRENDS BIOCHEM SCI, V28, P118, DOI 10.1016/S0968-0004(03)00025-2; MITCHELL TK, 1995, PLANT CELL, V7, P1869, DOI 10.1105/tpc.7.11.1869; MOSS J, 1993, J BIOL CHEM, V268, P6383; Nakayashiki H, 2001, NUCLEIC ACIDS RES, V29, P4106, DOI 10.1093/nar/29.20.4106; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; Nitta N, 1997, THEOR APPL GENET, V95, P20, DOI 10.1007/s001220050528; Ptashne M, 2003, SCIENCE, V299, P1025, DOI 10.1126/science.1081519; Schmidt R, 2000, CURR OPIN PLANT BIOL, V3, P97, DOI 10.1016/S1369-5266(99)00048-5; Sesma A, 2004, NATURE, V431, P582, DOI 10.1038/nature02880; Steiner-Lange S, 2003, MOL PLANT MICROBE IN, V16, P893, DOI 10.1094/MPMI.2003.16.10.893; SWEIGARD JA, 1992, MOL GEN GENET, V232, P183, DOI 10.1007/BF00279995; SWEIGARD JA, 1993, GENETIC MAPS; Takano Y, 2003, MOL PLANT PATHOL, V4, P337, DOI [10.1046/j.1364-3703.2003.00182.x, 10.1046/J.1364-3703.2003.00182.X]; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; THIERINGER R, 1991, J BIOL CHEM, V266, P13110; Thines E, 2000, PLANT CELL, V12, P1703, DOI 10.1105/tpc.12.9.1703; Thon MR, 2004, FUNGAL GENET BIOL, V41, P657, DOI 10.1016/j.fgb.2004.02.003; VALENT B, 1991, ANNU REV PHYTOPATHOL, V29, P443, DOI 10.1146/annurev.py.29.090191.002303; van den Burg HA, 2003, J BIOL CHEM, V278, P27340, DOI 10.1074/jbc.M212196200; Weiland J., 1997, FUNGAL GENET NEWSL, V44, P60, DOI DOI 10.4148/1941-4765.1290; Wolpert TJ, 2002, ANNU REV PHYTOPATHOL, V40, P251, DOI 10.1146/annurev.phyto.40.011402.114210; Xu JR, 1996, GENE DEV, V10, P2696, DOI 10.1101/gad.10.21.2696; Xu JR, 2000, FUNGAL GENET BIOL, V31, P137, DOI 10.1006/fgbi.2000.1237; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; ZEIGELR RS, 1994, RICE BLAST DIS; Zhu H, 1999, GENOME RES, V9, P739	50	1117	1648	13	243	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					980	986		10.1038/nature03449	http://dx.doi.org/10.1038/nature03449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846337	hybrid			2022-12-24	WOS:000228524600029
J	Tanaka, K; Mukae, N; Dewar, H; van Breugel, M; James, EK; Prescott, AR; Antony, C; Tanaka, TU				Tanaka, K; Mukae, N; Dewar, H; van Breugel, M; James, EK; Prescott, AR; Antony, C; Tanaka, TU			Molecular mechanisms of kinetochore capture by spindle microtubules	NATURE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; NEWT LUNG-CELLS; BUDDING YEAST; MITOTIC-SPINDLE; CHROMOSOME ATTACHMENT; PRECOCIOUS SEPARATION; SISTER CHROMATIDS; BI-ORIENTATION; DASH COMPLEX; DYNAMICS	For high-fidelity chromosome segregation, kinetochores must be properly captured by spindle microtubules, but the mechanisms underlying initial kinetochore capture have remained elusive. Here we visualized individual kinetochore-microtubule interactions in Saccharomyces cerevisiae by regulating the activity of a centromere. Kinetochores are captured by the side of microtubules extending from spindle poles, and are subsequently transported poleward along them. The microtubule extension from spindle poles requires microtubule plus-end-tracking proteins and the Ran GDP/GTP exchange factor. Distinct kinetochore components are used for kinetochore capture by microtubules and for ensuring subsequent sister kinetochore bi-orientation on the spindle. Kar3, a kinesin-14 family member, is one of the regulators that promote transport of captured kinetochores along microtubules. During such transport, kinetochores ensure that they do not slide off their associated microtubules by facilitating the conversion of microtubule dynamics from shrinkage to growth at the plus ends. This conversion is promoted by the transport of Stu2 from the captured kinetochores to the plus ends of microtubules.	Univ Dundee, Sch Life Sci, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; European Mol Biol Lab, D-69117 Heidelberg, Germany	University of Dundee; Max Planck Society; European Molecular Biology Laboratory (EMBL)	Tanaka, K (corresponding author), Univ Dundee, Sch Life Sci, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland.	t.tanaka@dundee.ac.uk	antony, claude/K-5342-2013; Tanaka, Tomoyuki U/A-4775-2008; James, Euan K/K-1135-2012; Prescott, Alan/Y-5956-2018; Tanaka, Kozo/Y-6566-2018	James, Euan K/0000-0001-7969-6570; Prescott, Alan/0000-0002-0747-7317; Tanaka, Tomoyuki/0000-0002-9886-5947; Tanaka, Kozo/0000-0001-6086-2858				Adams IR, 2000, TRENDS CELL BIOL, V10, P329, DOI 10.1016/S0962-8924(00)01798-0; Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; ALEXANDER SP, 1991, J CELL BIOL, V113, P805, DOI 10.1083/jcb.113.4.805; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Carazo-Salas RE, 2003, CURR BIOL, V13, P1728, DOI 10.1016/j.cub.2003.09.006; Carazo-Salas RE, 2001, NAT CELL BIOL, V3, P228, DOI 10.1038/35060009; Carvalho P, 2004, DEV CELL, V6, P815, DOI 10.1016/j.devcel.2004.05.001; Cheeseman IM, 2001, J CELL BIOL, V152, P197, DOI 10.1083/jcb.152.1.197; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Corbett AH, 1997, MICROBIOL MOL BIOL R, V61, P193, DOI 10.1128/.61.2.193-211.1997; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; Dewar H, 2004, NATURE, V428, P93, DOI 10.1038/nature02328; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; Gupta ML, 2002, MOL BIOL CELL, V13, P2919, DOI 10.1091/mbc.E02-01-0003; HAYDEN JH, 1990, J CELL BIOL, V111, P1039, DOI 10.1083/jcb.111.3.1039; He XW, 2000, CELL, V101, P763, DOI 10.1016/S0092-8674(00)80888-0; He XW, 2001, CELL, V106, P195, DOI 10.1016/S0092-8674(01)00438-X; Hetzer M, 2002, NAT CELL BIOL, V4, pE177, DOI 10.1038/ncb0702-e177; Hildebrandt ER, 2000, BBA-MOL CELL RES, V1496, P99, DOI 10.1016/S0167-4889(00)00012-4; HILL A, 1987, MOL CELL BIOL, V7, P2397, DOI 10.1128/MCB.7.7.2397; Janke C, 2002, EMBO J, V21, P181, DOI 10.1093/emboj/21.1.181; King JM, 2000, J CELL BIOL, V151, P739, DOI 10.1083/jcb.151.4.739; Li YM, 2002, GENE DEV, V16, P183, DOI 10.1101/gad.959402; Lin HJ, 2001, J CELL BIOL, V155, P1173, DOI 10.1083/jcb.200108119; Maddox PS, 2003, CURR BIOL, V13, P1423, DOI 10.1016/S0960-9822(03)00547-5; Maddox PS, 2000, NAT CELL BIOL, V2, P36, DOI 10.1038/71357; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; McIntosh JR, 2002, ANNU REV CELL DEV BI, V18, P193, DOI 10.1146/annurev.cellbio.18.032002.132412; MELUH PB, 1990, CELL, V60, P1029, DOI 10.1016/0092-8674(90)90351-E; MERDES A, 1990, EUR J CELL BIOL, V53, P313; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; Muller-Reichert T, 2003, CHROMOSOMA, V111, P417, DOI 10.1007/s00412-002-0220-6; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Nekrasov VS, 2003, MOL BIOL CELL, V14, P4931, DOI 10.1091/mbc.E03-06-0419; O'Toole ET, 1999, MOL BIOL CELL, V10, P2017, DOI 10.1091/mbc.10.6.2017; Pearson CG, 2001, J CELL BIOL, V152, P1255, DOI 10.1083/jcb.152.6.1255; PICKETTHEAPS J, 1991, INT REV CYTOL, V128, P63; Quimby BB, 2003, CURR OPIN CELL BIOL, V15, P338, DOI 10.1016/S0955-0674(03)00046-2; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; SAUNDERS WS, 1995, J CELL BIOL, V128, P617, DOI 10.1083/jcb.128.4.617; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tanaka TU, 2005, PHILOS T R SOC B, V360, P581, DOI 10.1098/rstb.2004.1612; Tirnauer JS, 1999, J CELL BIOL, V145, P993, DOI 10.1083/jcb.145.5.993; van Breugel M, 2003, J CELL BIOL, V161, P359, DOI 10.1083/jcb.200211097; Westermann S, 2003, J CELL BIOL, V163, P215, DOI 10.1083/jcb.200305100; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000; Winey M, 2001, NAT CELL BIOL, V3, pE23, DOI 10.1038/35050663	50	216	219	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					987	994		10.1038/nature03483	http://dx.doi.org/10.1038/nature03483			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846338				2022-12-24	WOS:000228524600030
J	Klein, RJ; Zeiss, C; Chew, EY; Tsai, JY; Sackler, RS; Haynes, C; Henning, AK; SanGiovanni, JP; Mane, SM; Mayne, ST; Bracken, MB; Ferris, FL; Ott, J; Barnstable, C; Hoh, J				Klein, RJ; Zeiss, C; Chew, EY; Tsai, JY; Sackler, RS; Haynes, C; Henning, AK; SanGiovanni, JP; Mane, SM; Mayne, ST; Bracken, MB; Ferris, FL; Ott, J; Barnstable, C; Hoh, J			Complement factor H polymorphism in age-related macular degeneration	SCIENCE			English	Article							GENOMEWIDE-SCAN; SUSCEPTIBILITY LOCI; EXTENDED FAMILIES; DISEASE; DRUSEN; ASSOCIATIONS; ACTIVATION; REGIONS; PROJECT; PROTEIN	Age-related macular degeneration (AMD) is a major cause of blindness in the elderly. We report a genome-wide screen of 96 cases and 50 controls for polymorphisms associated with AMD. Among 116,204 single-nucleotide polymorphisms genotyped, an intronic and common variant in the complement factor H gene (CFH) is strongly associated with AMD (nominal P value <10(-7)). in individuals homozygous for the risk allele, the likelihood of AMD is increased by a factor of 7.4 (95% confidence interval 2.9 to 19). Resequencing revealed a polymorphism in linkage disequilibrium with the Ask allele representing a tyrosine-histidine change at amino acid 402. This polymorphism is in a region of CFH that binds heparin and C-reactive protein. The CFH gene is located on chromosome 1 in a region repeatedly linked to AMD in family-based studies.	Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA; Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06520 USA; NEI, Bethesda, MD 20892 USA; EMMES Corp, Rockville, MD 20850 USA; Yale Univ, WM Keck Facil, New Haven, CT 06511 USA	Yale University; Rockefeller University; Yale University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Emmes Corporation; Yale University	Hoh, J (corresponding author), Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, 60 Coll St, New Haven, CT 06520 USA.	josephine.hoh@yale.edu	SanGiovanni, John Paul/AAU-3895-2020; Barnstable, Colin/GLU-9219-2022; Mohammed, Imran/J-8271-2012; Klein, Robert/K-1888-2013; SanGiovanni, John Paul/A-7605-2008; Barnstable, Colin/ABB-4822-2021	Mohammed, Imran/0000-0002-8412-0768; Klein, Robert/0000-0003-3539-5391; SanGiovanni, John Paul/0000-0001-7199-7053; Ferris, Frederick/0000-0002-4933-0639; Barnstable, Colin/0000-0002-7011-4068	NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR016090] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [Z01EY000394, R01EY015771] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K25HG000060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH044292] Funding Source: NIH RePORTER	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abecasis GR, 2004, AM J HUM GENET, V74, P482, DOI 10.1086/382786; Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Anand R, 2000, OPHTHALMOLOGY, V107, P2224; Blom AM, 2003, ARCH BIOCHEM BIOPHYS, V418, P108, DOI 10.1016/j.abb.2003.08.018; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; de Cordoba SR, 2004, MOL IMMUNOL, V41, P355, DOI 10.1016/j.molimm.2004.02.005; Devlin B, 2004, NAT GENET, V36, P1129, DOI 10.1038/ng1104-1129; Esparza-Gordillo J, 2004, IMMUNOGENETICS, V56, P77, DOI 10.1007/s00251-004-0660-7; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hayashi M, 2004, Ophthalmic Genet, V25, P111; Iyengar SK, 2004, AM J HUM GENET, V74, P20, DOI 10.1086/380912; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Majewski J, 2003, AM J HUM GENET, V73, P540, DOI 10.1086/377701; McIntyre LM, 2000, GENET EPIDEMIOL, V19, P18, DOI 10.1002/1098-2272(200007)19:1<18::AID-GEPI2>3.0.CO;2-Y; McKay GJ, 2004, MOL VIS, V10, P682; Mullins RF, 2001, EYE, V15, P390, DOI 10.1038/eye.2001.142; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Schultz DW, 2003, HUM MOL GENET, V12, P3315, DOI 10.1093/hmg/ddg348; Seddon JM, 2004, JAMA-J AM MED ASSOC, V291, P704, DOI 10.1001/jama.291.6.704; Seddon JM, 2003, AM J HUM GENET, V73, P780, DOI 10.1086/378505; TEMPLETON AR, 1987, GENETICS, V117, P343; Tuo JS, 2004, PROG RETIN EYE RES, V23, P229, DOI 10.1016/j.preteyeres.2004.02.001; Weeks DE, 2004, AM J HUM GENET, V75, P174, DOI 10.1086/422476; Wistow G, 2002, MOL VIS, V8, P205	30	3158	3470	7	343	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 15	2005	308	5720					385	389		10.1126/science.1109557	http://dx.doi.org/10.1126/science.1109557			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15761122	Green Accepted			2022-12-24	WOS:000228492000044
J	Jamrozik, K				Jamrozik, K			Estimate of deaths attributable to passive smoking among UK adults: database analysis	BRITISH MEDICAL JOURNAL			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; LUNG-CANCER; OCCUPATIONAL-EXPOSURE; CIGARETTE-SMOKING; ISCHEMIC-STROKE; HEART-DISEASE; RISK	Objective To estimate deaths from passive smoking in employees of the hospitality industry as well as in the general workforce and general population of the United Kingdom. Design Calculation, using the formula for population attributable proportion, of deaths likely to have been caused by passive smoking at home and at work in the UK according to occupation. Sensitivity analyses to examine impact of varying assumptions regarding prevalence and risks of exposure. Setting National UK databases of causes of death, employment, structure of households, and prevalences of active and passive smoking. Main outcome measures Estimates of deaths due to passive smoking according to age group (< 65 or >= 65) and site of exposure (domestic or workplace). Results Across the United Kingdom as a whole, passive smoking at work is likely to be responsible for the deaths of more than two employed people per working day (617 deaths per year), including 54 deaths in the hospitality industry each year. Each year passive smoking at home might account for another 2700 deaths in persons aged 20-64 years and 8000 deaths among people aged >= 65. Conclusion Exposure at work might contribute up to one fifth of all deaths from passive smoking in the general population aged 20-64 years, and up to half of such deaths among employees of the hospitality industry. Adoption of smoke free policies in all workplaces and reductions in the general prevalence of active smoking would lead to substantial reductions in these avoidable deaths.	Univ Queensland, Sch Populat Hlth, Herston, Qld 4006, Australia	University of Queensland	Jamrozik, K (corresponding author), Univ Queensland, Sch Populat Hlth, Herston, Qld 4006, Australia.	k.jamrozik@sph.uq.edu.au						*BMRB INT, 2002, COMP UK LAB FORC STA; Bonita R, 1999, TOB CONTROL, V8, P156, DOI 10.1136/tc.8.2.156; DONNAN GA, 1989, LANCET, V2, P643; Glantz SA, 2000, TOB CONTROL, V9, P111; HIRAYAMA T, 1981, BRIT MED J, V282, P183, DOI 10.1136/bmj.282.6259.183; Iribarren C, 2004, NEUROEPIDEMIOLOGY, V23, P38, DOI 10.1159/000073973; Jarvis MJ, 2000, BRIT MED J, V321, P343, DOI 10.1136/bmj.321.7257.343; JARVIS MJ, 2001, QUANTITATIVE SURVEY; Johnsson T, 2003, AM J IND MED, V43, P523, DOI 10.1002/ajim.10207; KAWACHI I, 1989, NEW ZEAL MED J, V102, P337; Kurukulaaratchy RJ, 2004, PEDIATRICS, V113, P345, DOI 10.1542/peds.113.2.345; Law MR, 1996, BRIT MED BULL, V52, P22, DOI 10.1093/oxfordjournals.bmb.a011528; LEE PN, 1986, BRIT J CANCER, V54, P97, DOI 10.1038/bjc.1986.157; MCDONNELL S, 1991, AUSTRALIAN      0613, P3; MOLGAARD C A, 1986, Neuroepidemiology, V5, P88, DOI 10.1159/000110818; *NAT HLTH MED RES, 1997, HLTH EFF PASS SMOK S; Nurminen MM, 2001, J OCCUP ENVIRON MED, V43, P687, DOI 10.1097/00043764-200108000-00006; *OFF NAT STAT, EMPL WORKF JOBS IND; *OFF NAT STAT, GEN HOUS SURV LIV BR; *OFF NAT STAT, 2004, MID 2002 POP EST UK; *OFF NAT STAT, EMPL WORKF JOS IND; *OFF NAT STAT, MID 2002 POP EST UK; *OFF NAT STAT, DEATHS AG SEX UND CA; *SECT SKILLS DEV A, 2002, MARK ASS HOSP LEIS T; Stead LF, 2006, REP SCI COMM TOB HLT, DOI 10.1002/14651858.CD002850.pub2; The Office of Environmental Health Hazard Assessment, 1997, HLTH EFF EXP ENV TOB; TRICHOPOULOS D, 1981, INT J CANCER, V27, P1, DOI 10.1002/ijc.2910270102; Wakefield M, 2002, AUST NZ J PUBL HEAL, V26, P375, DOI 10.1111/j.1467-842X.2002.tb00190.x; Whincup PH, 2004, BRIT MED J, V329, P200, DOI 10.1136/bmj.38146.427188.55; White V, 2003, TOB CONTROL, V12, P67, DOI 10.1136/tc.12.suppl_2.ii67; WOODWARD A, 2000, DEATHS NZ ATTRIBUTAB; You RX, 1999, AM J PUBLIC HEALTH, V89, P572, DOI 10.2105/AJPH.89.4.572	32	81	83	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 9	2005	330	7495					812	+		10.1136/bmj.38370.496632.8F	http://dx.doi.org/10.1136/bmj.38370.496632.8F			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	915BZ	15741188	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000228273900014
J	Fridkin, SK; Hageman, JC; Morrison, M; Sanza, LT; Como-Sabetti, K; Jernigan, JA; Harriman, K; Harrison, LH; Lynfield, R; Farley, MM				Fridkin, SK; Hageman, JC; Morrison, M; Sanza, LT; Como-Sabetti, K; Jernigan, JA; Harriman, K; Harrison, LH; Lynfield, R; Farley, MM		Active Bacterial Core Surveillance	Methicillin-resistant staphylococcus aureus disease in three communities	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CLINDAMYCIN TREATMENT; UNITED-STATES; INFECTIONS; CHILDREN; SKIN; EPIDEMIOLOGY; BACTEREMIA; ADULTS	BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) infection has emerged in patients who do not have the established risk factors. The national burden and clinical effect of this novel presentation of MRSA disease are unclear. METHODS: We evaluated MRSA infections in patients identified from population-based surveillance in Baltimore and Atlanta and from hospital-laboratory-based sentinel surveillance of 12 hospitals in Minnesota. Information was obtained by interviewing patients and by reviewing their medical records. Infections were classified as community-acquired MRSA disease if no established risk factors were identified. RESULTS: From 2001 through 2002, 1647 cases of community-acquired MRSA infection were reported, representing between 8 and 20 percent of all MRSA isolates. The annual disease incidence varied according to site (25.7 cases per 100,000 population in Atlanta vs. 18.0 per 100,000 in Baltimore) and was significantly higher among persons less than two years old than among those who were two years of age or older (relative risk, 1.51; 95 percent confidence interval, 1.19 to 1.92) and among blacks than among whites in Atlanta (age-adjusted relative risk, 2.74; 95 percent confidence interval, 2.44 to 3.07). Six percent of cases were invasive, and 77 percent involved skin and soft tissue. The infecting strain of MRSA was often (73 percent) resistant to prescribed antimicrobial agents. Among patients with skin or soft-tissue infections, therapy to which the infecting strain was resistant did not appear to be associated with adverse patient-reported outcomes. Overall, 23 percent of patients were hospitalized for the MRSA infection. CONCLUSIONS: Community-associated MRSA infections are now a common and serious problem. These infections usually involve the skin, especially among children, and hospitalization is common.	Ctr Dis Control & Prevent, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA USA; Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Natl Ctr Infect Dis, Atlanta, GA USA; Emory Univ, Sch Med, Atlanta, GA USA; Vet Affairs Med Ctr, Atlanta, GA 30033 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; Minnesota Dept Hlth, Minneapolis, MN USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Minnesota Department of Health (MHD)	Fridkin, SK (corresponding author), CDC, NCID, DBMD, MDB, MS C-09,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	skf0@cdc.gov		Jernigan, John/0000-0001-8163-925X				Albanese BA, 2002, CLIN INFECT DIS, V34, P15, DOI 10.1086/323674; [Anonymous], 1999, JAMA, V282, P1123; Archer GL, 1998, CLIN INFECT DIS, V26, P1179, DOI 10.1086/520289; Baggett HC, 2003, INFECT CONT HOSP EP, V24, P397, DOI 10.1086/502221; BRUMFITT W, 1989, NEW ENGL J MED, V320, P1188, DOI 10.1056/NEJM198905043201806; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P919; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P88; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Culpepper R, 2002, JAMA-J AM MED ASSOC, V287, P181; Daum RS, 2001, CRIT CARE MED, V29, pN92, DOI 10.1097/00003246-200104001-00007; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Flannery B, 2004, JAMA-J AM MED ASSOC, V291, P2197, DOI 10.1001/jama.291.18.2197; Frank AL, 2002, PEDIATR INFECT DIS J, V21, P530, DOI 10.1097/00006454-200206000-00010; Fridkin SK, 2003, CLIN INFECT DIS, V36, P429, DOI 10.1086/346207; Gorak EJ, 1999, CLIN INFECT DIS, V29, P797, DOI 10.1086/520437; Groom AV, 2001, JAMA-J AM MED ASSOC, V286, P1201, DOI 10.1001/jama.286.10.1201; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Iyer S, 2004, J AM ACAD DERMATOL, V50, P854, DOI 10.1016/j.jaad.2003.12.043; JORGENSEN JH, 1986, EUR J CLIN MICROBIOL, V5, P693, DOI 10.1007/BF02013307; Lee MC, 2004, PEDIATR INFECT DIS J, V23, P123, DOI 10.1097/01.inf.0000109288.06912.21; Lorenz E, 2000, INFECT IMMUN, V68, P6398, DOI 10.1128/IAI.68.11.6398-6401.2000; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Marcinak JF, 2003, CURR OPIN INFECT DIS, V16, P265, DOI 10.1097/00001432-200306000-00014; Martinez-Aguilar G, 2003, PEDIATR INFECT DIS J, V22, P593, DOI 10.1097/00006454-200307000-00006; Morin CA, 2001, J INFECT DIS, V184, P1029, DOI 10.1086/323459; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; NNIS System, 2002, AM J INFECT CONTROL, V30, P458, DOI 10.1067/mic.2002.130032; Raney PM, 2002, DIAGN MICR INFEC DIS, V43, P135, DOI 10.1016/S0732-8893(02)00378-4; Robinson KA, 2001, JAMA-J AM MED ASSOC, V285, P1729, DOI 10.1001/jama.285.13.1729; Sattler CA, 2002, PEDIATR INFECT DIS J, V21, P910, DOI 10.1097/00006454-200210000-00005; Taylor G, 1990, Can J Infect Dis, V1, P121; Watt JP, 2004, CLIN INFECT DIS, V38, P496, DOI 10.1086/381198; 2003, MMWR MORB MORTAL WKL, V52, P793; 2003, MMWR MORB MORTAL WKL, V52, P992; 2003, JAMA, V289, P1377; 2004, MMWR MORB MORTAL WKL, V53, P767	38	1114	1183	0	83	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 7	2005	352	14					1436	1444		10.1056/NEJMoa043252	http://dx.doi.org/10.1056/NEJMoa043252			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	913IP	15814879				2022-12-24	WOS:000228145200007
J	DeRiemer, K; Garcia-Garcia, L; Bobadilla-del-Valle, M; Palacios-Martinez, M; Martinez-Gamboa, A; Small, PM; Sifuentes-Osornio, J; Ponce-de-Leon, A				DeRiemer, K; Garcia-Garcia, L; Bobadilla-del-Valle, M; Palacios-Martinez, M; Martinez-Gamboa, A; Small, PM; Sifuentes-Osornio, J; Ponce-de-Leon, A			Does DOTS work in populations with drug-resistant tuberculosis?	LANCET			English	Article							EPIDEMIOLOGY; STANDARD	Background Directly observed therapy (DOTS) is the main strategy for prevention and control of tuberculosis worldwide. However, its effect on tuberculosis transmission in populations with moderate rates of drug-resistant disease is not known. Methods This population-based prospective study in southern Mexico between March, 1995, and February, 2000, was based on passive case finding and detection of acid-fast bacilli in sputum samples to diagnose pulmonary tuberculosis. We also used cultures, drug-susceptibility testing, bacterial genotyping, and monitoring of treatment outcomes. Findings We enrolled 436 patients; the HIV seroprevalence rate was 2%. We used three indicators to monitor continuing tuberculosis transmission: the incidence rate of pulmonary tuberculosis, which decreased by 54.4% between 1995 and 2000, from 42.1 to 19.2 per 10(5) population (p=0.00048); the percentage of clustered pulmonary tuberculosis cases, which decreased by 62.6% from 22% to 8% (p=0.02); and the rate of primary drug resistance, which decreased by 84.0% from 9.4 to 1.5 per 10(5) population (p=0.004). Rates of multidrug-resistant (MDR) tuberculosis also decreased (p<0.0001). The case-fatality ratio was 12% for MDR tuberculosis (five of 41), 7% for strains resistant to at least one drug after exclusion of MDR (four of 55), and 3% for pansusceptible strains (nine of 272). There were 13 treatment failures (11%) in 1995 and one (2%) in 2000 (p=0.012). Interpretation Even in settings with moderate rates of MDR tuberculosis, DOTS can rapidly reduce the transmission and incidence of both drug-susceptible and drug-resistant tuberculosis. However, further interventions, such as drug-susceptibility testing and standardised or individualised treatment regimens, are needed to reduce mortality rates for MDR tuberculosis.	Inst Nacl Salud Publ, TB Unit, Cuernavaca 62508, Morelos, Mexico; Stanford Univ, Med Ctr, Div Infect Dis & Geog Med, Stanford, CA 94305 USA; Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Infect Dis, Mexico City, DF, Mexico; Bill & Melinda Gates Fdn, Seattle, WA USA; Univ Panamericana, Sch Med, Mexico City, DF, Mexico	Instituto Nacional de Salud Publica; Stanford University; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Bill & Melinda Gates Foundation; Universidad Panamericana - Ciudad de Mexico	Garcia-Garcia, L (corresponding author), Inst Nacl Salud Publ, TB Unit, Ave Univ 655,Colonia Sta Maria Ahuacatitlan, Cuernavaca 62508, Morelos, Mexico.	garcigar@correo.insp.mx	García, Maria de Lourdes/I-2724-2019; Bobadilla-del-Valle, Miriam/AAD-6418-2020	García, Maria de Lourdes/0000-0001-5262-1157; Ponce-de-Leon, Alfredo/0000-0003-2640-2916; Sifuentes-Osornio, Jose/0000-0001-9584-1360; BOBADILLA-DEL VALLE, MIRIAM/0000-0003-1184-827X; DeRiemer, Kathryn/0000-0002-8375-7505	FOGARTY INTERNATIONAL CENTER [K01TW000001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035969] Funding Source: NIH RePORTER; FIC NIH HHS [K01 TW000001-06, K01 TW000001] Funding Source: Medline; NIAID NIH HHS [AI 35969] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Burgos M, 2003, J INFECT DIS, V188, P1878, DOI 10.1086/379895; Dye C, 2002, SCIENCE, V295, P2042, DOI 10.1126/science.1063814; Elzinga G, 2004, LANCET, V363, P814, DOI 10.1016/S0140-6736(04)15698-5; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Garcia-Garcia MD, 2000, ARCH INTERN MED, V160, P630, DOI 10.1001/archinte.160.5.630; Garcia-Garcia MD, 1999, INT J EPIDEMIOL, V28, P135, DOI 10.1093/ije/28.1.135; Garcia-Garcia MD, 2000, INT J TUBERC LUNG D, V4, P12; Geng E, 2002, NEW ENGL J MED, V346, P1453, DOI 10.1056/NEJMoa012972; *I NAC EST GEOGR I, 1995, AN EST EST VER MEX T; Jasmer RM, 1999, ANN INTERN MED, V130, P971, DOI 10.7326/0003-4819-130-12-199906150-00004; Kim JY, 2003, TUBERCULOSIS, V83, P59, DOI 10.1016/S1472-9792(02)00078-1; Lie RK, 2004, J MED ETHICS, V30, P190, DOI 10.1136/jme.2003.006031; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Murray M, 2002, AM J EPIDEMIOL, V155, P565, DOI 10.1093/aje/155.6.565; Nachega JB, 2003, CLIN INFECT DIS, V36, pS24, DOI 10.1086/344657; Pablos-Mendez A, 2002, B WORLD HEALTH ORGAN, V80, P489; Pan AmericanHealthOrganization, 1998, B EPIDEMIOL, P1; Park SK, 2002, INT J TUBERC LUNG D, V6, P143; Pio A, 1997, B WORLD HEALTH ORGAN, V75, P569; Raviglione M, 2001, INT J TUBERC LUNG D, V5, P213; Richardson HS, 2004, HASTINGS CENT REP, V34, P25, DOI 10.2307/3528248; ROSNER B, 2000, FUNDAMENTALS BIOSTAT, P707; *SECR SAL, 2000, NOM006SSA2 NORM OF M; Secretaria de Salud, 1995, NOM006SSA2 SECR SAL, P20; Suarez PG, 2002, LANCET, V359, P1980, DOI 10.1016/S0140-6736(02)08830-X; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; *WHO IUATLD, 2000, WHOCDCTB2000278; World Health Organization, 2002, WHOCDSTB2002297; YANEZVELASCO LB, 1997, INT J TUBERC LUNG D, V1, pS68; Yang ZH, 2000, J CLIN MICROBIOL, V38, P3572, DOI 10.1128/JCM.38.10.3572-3576.2000	30	64	67	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2005	365	9466					1239	1245		10.1016/S0140-6736(05)74812-1	http://dx.doi.org/10.1016/S0140-6736(05)74812-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	912VI	15811457				2022-12-24	WOS:000228107600027
J	Schoffelen, JM; Oostenveld, R; Fries, P				Schoffelen, JM; Oostenveld, R; Fries, P			Neuronal coherence as a mechanism of effective corticospinal interaction	SCIENCE			English	Article							CAT VISUAL-CORTEX; CORTICAL-NEURONS; COINCIDENCE DETECTION; MOTOR CORTEX; HUMAN BRAIN; IN-VIVO; SYNCHRONIZATION; OSCILLATIONS; MODULATION; MUSCLE	Neuronal groups can interact with each other even if they are widely separated. One group might modulate its firing rate or its internal oscillatory synchronization to influence another group. We propose that coherence between two neuronal groups is a mechanism of efficient interaction, because it renders mutual input optimally timed and thereby maximally effective. Modulations of subjects' readiness to respond in a simple reaction-time task were closely correlated with the strength of gamma-band (40 to 70 hertz) coherence between motor cortex and spinal cord neurons. This coherence may contribute to an effective corticospinal interaction and shortened reaction times.	Radboud Univ Nijmegen, FC Donders Ctr Cognit Neuroimaging, NL-6525 EK Nijmegen, Netherlands; Radboud Univ Nijmegen, Dept Biophys, NL-6525 EZ Nijmegen, Netherlands; Aalborg Univ, Ctr Sensory Motor Interact, DK-9220 Aalborg, Denmark	Radboud University Nijmegen; Radboud University Nijmegen; Aalborg University	Schoffelen, JM (corresponding author), Radboud Univ Nijmegen, FC Donders Ctr Cognit Neuroimaging, NL-6525 EK Nijmegen, Netherlands.	jan.schoffelen@fcdonders.ru.nl	Fries, Pascal/E-3196-2010; Schoffelen, Jan-Mathijs/D-3716-2009; Oostenveld, Robert/D-3259-2009	Fries, Pascal/0000-0002-4270-1468; Schoffelen, Jan-Mathijs/0000-0003-0923-6610; Oostenveld, Robert/0000-0002-1974-1293				Andino SLG, 2005, HUM BRAIN MAPP, V24, P50, DOI 10.1002/hbm.20056; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; Baker SN, 1997, J PHYSIOL-LONDON, V501, P225, DOI 10.1111/j.1469-7793.1997.225bo.x; Brown P, 2000, PROG NEUROBIOL, V60, P97, DOI 10.1016/S0301-0082(99)00029-5; Conway BA, 1995, J PHYSIOL-LONDON, V489, P917, DOI 10.1113/jphysiol.1995.sp021104; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P6048, DOI 10.1073/pnas.88.14.6048; ENGEL AK, 1991, SCIENCE, V252, P1177, DOI 10.1126/science.252.5009.1177; FRIEN A, 1994, NEUROREPORT, V5, P2273, DOI 10.1097/00001756-199411000-00017; Fries P, 2002, J NEUROSCI, V22, P3739; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; Kilner JM, 2000, J NEUROSCI, V20, P8838; KONIG P, 1995, P NATL ACAD SCI USA, V92, P290, DOI 10.1073/pnas.92.1.290; Livingstone MS, 1996, J NEUROPHYSIOL, V75, P2467, DOI 10.1152/jn.1996.75.6.2467; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Pinto DJ, 2003, J COMPUT NEUROSCI, V15, P283, DOI 10.1023/A:1025825102620; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; Schreiber S, 2004, J NEUROPHYSIOL, V91, P194, DOI 10.1152/jn.00556.2003; Tiesinga PHE, 2004, NEURAL COMPUT, V16, P251, DOI 10.1162/089976604322742029; Trillenberg P, 2000, CLIN NEUROPHYSIOL, V111, P1216, DOI 10.1016/S1388-2457(00)00274-1; van Rossum MCW, 2002, J NEUROSCI, V22, P1956, DOI 10.1523/JNEUROSCI.22-05-01956.2002; Volgushev M, 1998, NEUROSCIENCE, V83, P15, DOI 10.1016/S0306-4522(97)00380-1	26	371	377	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2005	308	5718					111	113		10.1126/science.1107027	http://dx.doi.org/10.1126/science.1107027			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914IQ	15802603	Green Published			2022-12-24	WOS:000228221500044
J	Croll, DA; Maron, JL; Estes, JA; Danner, EM; Byrd, GV				Croll, DA; Maron, JL; Estes, JA; Danner, EM; Byrd, GV			Introduced predators transform subarctic islands from grassland to tundra	SCIENCE			English	Article							TROPHIC CASCADES; FOOD WEBS; COMMUNITIES; ECOLOGY; MARINE	Top predators often have powerful direct effects on prey populations, but whether these direct effects propagate to the base of terrestrial food webs is debated. There are few examples of trophic cascades strong enough to alter the abundance and composition of entire plant communities. We show that the introduction of arctic foxes (Alopex lagopus) to the Aleutian archipelago induced strong shifts in plant productivity and community structure via a previously unknown pathway. By preying on seabirds, foxes reduced nutrient transport from ocean to land, affecting soil fertility and transforming grasslands to dwarf shrub/forb-dominated ecosystems.	Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95060 USA; Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; US Geol Survey, Western Ecol Res Ctr, Santa Cruz, CA 95060 USA; US Fish & Wildlife Serv, Homer, AK 99603 USA	University of California System; University of California Santa Cruz; University of Montana System; University of Montana; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service	Croll, DA (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95060 USA.	croll@biology.ucsc.edu	Bond, Alexander L/A-3786-2010	Danner, Eric/0000-0003-0860-2869; Byrd, George Vernon/0000-0003-1108-541X				BYRD GV, 1994, T N AM WILDL NAT RES, P317; Carpenter S. R., 1993, Bulletin of the Ecological Society of America, V74, P186; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; COUNCIL NR, 1996, BERING SEA ECOSYSTEM; Dawson TE, 2002, ANNU REV ECOL SYST, V33, P507, DOI 10.1146/annurev.ecolsys.33.020602.095451; Erskine PD, 1998, OECOLOGIA, V117, P187, DOI 10.1007/s004420050647; FRETWELL SD, 1987, OIKOS, V50, P291, DOI 10.2307/3565489; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; Halaj J, 2002, ECOLOGY, V83, P3141, DOI 10.1890/0012-9658(2002)083[3141:IOADSO]2.0.CO;2; Kitchell JF, 1999, LIMNOL OCEANOGR, V44, P828, DOI 10.4319/lo.1999.44.3_part_2.0828; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; PAINE RT, 1980, J ANIM ECOL, V49, P667; Paine RT, 2000, J MAMMAL, V81, P637, DOI 10.1644/1545-1542(2000)081<0637:PFTMMR>2.3.CO;2; Polis G.A., 2004, FOOD WEBS LANDSCAPE; Polis GA, 2000, TRENDS ECOL EVOL, V15, P473, DOI 10.1016/S0169-5347(00)01971-6; Polis GA, 1996, AM NAT, V147, P396, DOI 10.1086/285858; Schmitz OJ, 2000, AM NAT, V155, P141, DOI 10.1086/303311; SCHNEIDER DE, 2004, FOOD WEBS LANDSCAPE, P12; SHAVER GR, 1986, ARCTIC ALPINE RES, V18, P261, DOI 10.2307/1550883; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; *US FISH WILDL SER, 2004, BER SEAB COL CAT COM; Williamson M. H., 1981, ISLAND POPULATIONS; [No title captured]	23	352	368	4	276	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 25	2005	307	5717					1959	1961		10.1126/science.1108485	http://dx.doi.org/10.1126/science.1108485			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910UI	15790855				2022-12-24	WOS:000227957300056
J	Stainier, DYR				Stainier, DYR			No organ left behind: Tales of gut development and evolution	SCIENCE			English	Editorial Material							SONIC HEDGEHOG; GENES; REGIONALIZATION; ORGANOGENESIS; MORPHOGENESIS; EXPRESSION	The function of an organ is dependent on its cellular constituents as well as on their assembly into a cohesive unit. The developing gut faces unique challenges as one of the longest and largest organs in the body and also because it is constantly interfacing with external factors through the diet. Its location deep within the body has until recently hampered investigation into its formation. The patterning of the gut along its longitudinal, dorsoventral, left-right, and radial axes is one of the fascinating issues that pertain to the development, function, and homeostasis of this understudied organ.	Univ Calif San Francisco, Dept Biochem & Biophys, Program Dev Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Genet Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Program Human Genet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Stainier, DYR (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Program Dev Biol, San Francisco, CA 94143 USA.	didier_stainier@biochem.ucsf.edu		Stainier, Didier/0000-0002-0382-0026				Ao W, 2004, SCIENCE, V305, P1743, DOI 10.1126/science.1102216; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Barbara PD, 2002, AM J MED GENET, V115, P221, DOI 10.1002/ajmg.10978; Beck F, 2000, BIOESSAYS, V22, P431, DOI 10.1002/(SICI)1521-1878(200005)22:5<431::AID-BIES5>3.0.CO;2-X; BIENZ M, 1994, TRENDS GENET, V10, P22, DOI 10.1016/0168-9525(94)90015-9; Brittan M, 2004, CELL PROLIFERAT, V37, P35, DOI 10.1111/j.1365-2184.2004.00299.x; Clements D, 2001, INT REV CYTOL, V203, P383; DOLLE P, 1991, MECH DEVELOP, V36, P3, DOI 10.1016/0925-4773(91)90067-G; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Fukuda K, 2002, J GASTROENTEROL, V37, P239, DOI 10.1007/s005350200030; Grapin-Botton A, 2000, TRENDS GENET, V16, P124, DOI 10.1016/S0168-9525(99)01957-5; Horne-Badovinac S, 2003, SCIENCE, V302, P662, DOI 10.1126/science.1085397; Huang D, 1998, DEVELOPMENT, V125, P3235; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kiefer JC, 2003, DEV DYNAM, V228, P287, DOI 10.1002/dvdy.10382; Kondo T, 1996, DEVELOPMENT, V122, P2651; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Matsumoto A, 2002, ANAT EMBRYOL, V205, P53, DOI 10.1007/s00429-001-0226-5; Pacha J, 2000, PHYSIOL REV, V80, P1633, DOI 10.1152/physrev.2000.80.4.1633; Parisi MA, 2000, CURR OPIN PEDIATR, V12, P610, DOI 10.1097/00008480-200012000-00017; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Roberts DJ, 1998, DEVELOPMENT, V125, P2791; ROBERTS DJ, 1995, DEVELOPMENT, V121, P3163; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Sancho E, 2003, CURR OPIN CELL BIOL, V15, P763, DOI 10.1016/j.ceb.2003.10.012; Schubert M, 2005, DEVELOPMENT, V132, P61, DOI 10.1242/dev.01554; Stainier DYR, 2002, GENE DEV, V16, P893, DOI 10.1101/gad.974902; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393; Yelon D, 2002, CURR BIOL, V12, pR707, DOI 10.1016/S0960-9822(02)01213-7; YOKOUCHI Y, 1995, DEV BIOL, V169, P76, DOI 10.1006/dbio.1995.1128	31	75	76	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2005	307	5717					1902	1904		10.1126/science.1108709	http://dx.doi.org/10.1126/science.1108709			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910UI	15790841				2022-12-24	WOS:000227957300042
J	Izawa, D; Goto, M; Yamashita, A; Yamano, H; Yamamoto, M				Izawa, D; Goto, M; Yamashita, A; Yamano, H; Yamamoto, M			Fission yeast Mes1p ensures the onset of meiosis II by blocking degradation of cyclin Cdc13p	NATURE			English	Article							ANAPHASE-PROMOTING COMPLEX; CYTOSTATIC FACTOR ARREST; SCHIZOSACCHAROMYCES-POMBE; GENETICALLY INTERACTS; SPINDLE CHECKPOINT; PROTEIN-KINASE; DIRECT BINDING; CELL-CYCLE; MITOSIS; APC	Meiosis is a special form of nuclear division to generate eggs, spermand spores in eukaryotes. Meiosis consists of the first (MI) and the second (MII) meiotic divisions, which occur consecutively. MI is reductional, in which homologous chromosomes derived from parents segregate. MI is supported by an elaborate mechanism involving meiosis-specific cohesin and its protector(1). MII is equational, in which replicated sister-chromatids separate as in mitosis. MII is generally considered to mimic mitosis in mechanism. However, fission yeastMes1p is essential for MII but dispensable for mitosis. The mes1-B44 mutant arrests before MII2. Transcription of mes1 is low in vegetative cells and boosted in a narrow window between late MI and late MII3. The mes1 mRNA undergoes meiosis-specific splicing(4). Here we show that Mes1p is a factor that suppresses the degradation of cyclin Cdc13p at anaphase I. Mes1p binds to Slp1p, an activator of APC/C ( anaphase promoting complex/cyclosome), and counteracts its function to engage Cdc13p in proteolysis. Inhibition of APC/C-dependent degradation of Cdc13p by Mes1p was reproduced in a Xenopus egg extract. We therefore propose that Mes1p has a key function in saving a sufficient level of MPF ( M-phase-promoting factor) activity required for the execution of MII.	Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan; Univ Tokyo, Mol Genet Res Lab, Tokyo 1130033, Japan; Natl Inst Basic Biol, Dept Cell Proliferat, Okazaki, Aichi 4440867, Japan; Marie Curie Res Inst, Cell Cycle Control Grp, Surrey RH8 0TL, England	University of Tokyo; University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Yamamoto, M (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan.	myamamot@ims.u-tokyo.ac.jp	Yamashita, Akira/A-5278-2015	Yamashita, Akira/0000-0002-1805-1434				Blanco MA, 2001, J CELL SCI, V114, P2135; Borgne A, 2002, MOL BIOL CELL, V13, P2080, DOI 10.1091/mbc.01-10-0507; BUENO A, 1993, MOL CELL BIOL, V13, P2286, DOI 10.1128/MCB.13.4.2286; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; Decottignies A, 2001, J CELL SCI, V114, P2627; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; He XW, 1997, P NATL ACAD SCI USA, V94, P7965, DOI 10.1073/pnas.94.15.7965; Iwabuchi M, 2000, EMBO J, V19, P4513, DOI 10.1093/emboj/19.17.4513; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; KISHIDA M, 1994, CURR GENET, V25, P497, DOI 10.1007/BF00351668; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Matsumoto T, 1997, MOL CELL BIOL, V17, P742, DOI 10.1128/MCB.17.2.742; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MORENO S, 1989, CELL, V58, P361, DOI 10.1016/0092-8674(89)90850-7; Nakajo N, 2000, GENE DEV, V14, P328; Ohsumi K, 2004, P NATL ACAD SCI USA, V101, P12531, DOI 10.1073/pnas.0405300101; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Reimann JDR, 2002, NATURE, V416, P850, DOI 10.1038/416850a; Reimann JDR, 2001, GENE DEV, V15, P3278, DOI 10.1101/gad.945701; Shah JV, 2000, CELL, V103, P997, DOI 10.1016/S0092-8674(00)00202-6; SHIMODA C, 1985, MOL GEN GENET, V200, P252, DOI 10.1007/BF00425432; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Watanabe Y, 2004, J CELL SCI, V117, P4017, DOI 10.1242/jcs.01352; Yamada HY, 2000, J CELL SCI, V113, P3989; Yamano H, 2004, MOL CELL, V13, P137, DOI 10.1016/S1097-2765(03)00480-5; Yamano H, 2000, MOL CELL, V6, P1377, DOI 10.1016/S1097-2765(00)00135-0	30	61	65	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2005	434	7032					529	533		10.1038/nature03406	http://dx.doi.org/10.1038/nature03406			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909CH	15791259				2022-12-24	WOS:000227836000047
J	Macq, J				Macq, J			Commentary: Trials should inform structures and processes needed for tailoring interventions	BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE; DESIGN		Free Univ Brussels, Sch Publ Hlth, Dept Hlth Syst & Policies, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel	Macq, J (corresponding author), Free Univ Brussels, Sch Publ Hlth, Dept Hlth Syst & Policies, CP 597,808 Route Lennik, B-1070 Brussels, Belgium.	jmacq@ulb.ac.be						Battersby MW, 2005, BRIT MED J, V330, P662, DOI 10.1136/bmj.330.7492.662; Cretin S, 2004, EVALUATION REV, V28, P28, DOI 10.1177/0193841X03256298; Kumpers S, 2002, PUBLIC ADMIN, V80, P339, DOI 10.1111/1467-9299.00307; Segal L, 2004, HEALTH POLICY, V69, P215, DOI 10.1016/j.healthpol.2004.02.001; Singh D, 2005, TRANSFORMING CHRONIC	5	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 19	2005	330	7492					665	666		10.1136/bmj.330.7492.665	http://dx.doi.org/10.1136/bmj.330.7492.665			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	909LP	15775002	Green Published			2022-12-24	WOS:000227861700035
J	MacFadden, BJ				MacFadden, BJ			Fossil horses - Evidence for evolution	SCIENCE			English	Editorial Material									Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	MacFadden, BJ (corresponding author), Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA.	bmacfadd@flmnh.uft.edu						Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Froehlich DJ, 2002, ZOOL J LINN SOC-LOND, V134, P141, DOI 10.1046/j.1096-3642.2002.00005.x; Janis CM, 2000, P NATL ACAD SCI USA, V97, P7899, DOI 10.1073/pnas.97.14.7899; Kelly Thomas S., 1995, Contributions in Science (Los Angeles), V455, P1; MacFadden B.J., 1992, FOSSIL HORSES SYSTEM; MacFadden BJ, 1999, SCIENCE, V283, P824, DOI 10.1126/science.283.5403.824; Nowak R. M., 1997, WALKERS MAMMALS WORL; Oakenfull E. Ann, 2000, Conservation Genetics, V1, P341, DOI 10.1023/A:1011559200897; SCHUCHERT C, 1940, MARSH PIONEER PALEON; Simpson GG, 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764	10	86	91	0	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2005	307	5716					1728	1730		10.1126/science.1105458	http://dx.doi.org/10.1126/science.1105458			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774746				2022-12-24	WOS:000227883900030
J	Johnson, SM; Grosshans, H; Shingara, J; Byrom, M; Jarvis, R; Cheng, A; Labourier, E; Reinert, KL; Brown, D; Slack, FJ				Johnson, SM; Grosshans, H; Shingara, J; Byrom, M; Jarvis, R; Cheng, A; Labourier, E; Reinert, KL; Brown, D; Slack, FJ			RAS is regulated by the let-7 MicroRNA family	CELL			English	Article							C-ELEGANS; PATTERN-FORMATION; CELL FATES; SMALL RNAS; GENE; ENCODES; VULVAR; IDENTIFICATION; ACTIVATION; INHIBITION	MicroRNAs (miRNAs) are regulatory RNAs found in multicellular eukaryotes, including humans, where they are implicated in cancer. The let-7 miRNA times seam cell terminal differentiation in C. elegans. Here we show that the let-7 family negatively regulates let-60/RAS. Loss of let-60/RAS suppresses let-7, and the let-60/RAS 3'UTR contains multiple let-7 complementary sites (LCSs), restricting reporter gene expression in a let-7-dependent manner. mir-84, a let-7 family member, is largely absent in vulval precursor cell P6.p at the time that let-60/RAS specifies the 1 degrees vulval fate in that cell, and mir-84 overexpression suppresses the multivulva phenotype of activating let-60/ RAS mutations. The 3'UTRs of the human RAS genes contain multiple LCSs, allowing let-7 to regulate RAS expression. let-7 expression is lower in lung tumors than in normal lung tissue, while RAS protein is significantly higher in lung tumors, providing a possible mechanism for let-7 in cancer.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Ambion Inc, Austin, TX 78744 USA	Yale University	Slack, FJ (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.	frank.slack@yale.edu	Ferrua, Camila/F-5439-2015; Jackson, Benjamin L/C-4297-2012; Grosshans, Helge/W-8931-2019; Vickers, Michael M/E-4095-2010; Johnson, Steven M/B-3940-2013	Ferrua, Camila/0000-0001-8071-377X; Grosshans, Helge/0000-0002-8169-6905; Johnson, Steven/0000-0002-7399-8153; Slack, Frank/0000-0001-8263-0409; Labourier, Emmanuel/0000-0001-8010-0674	NIGMS NIH HHS [R01 GM062594, GM62594] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062594] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrahante JE, 2003, DEV CELL, V4, P625, DOI 10.1016/S1534-5807(03)00127-8; Ahrendt SA, 2001, CANCER, V92, P1525, DOI 10.1002/1097-0142(20010915)92:6<1525::AID-CNCR1478>3.0.CO;2-H; Ambros V, 1999, DEVELOPMENT, V126, P1947; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BEITEL GJ, 1990, NATURE, V348, P503, DOI 10.1038/348503a0; Berset T, 2001, SCIENCE, V291, P1055, DOI 10.1126/science.1055642; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Ceol CJ, 2004, DEV CELL, V6, P563, DOI 10.1016/S1534-5807(04)00065-6; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Dent JA, 1998, MECH DEVELOP, V72, P179, DOI 10.1016/S0925-4773(98)00026-4; Eisenmann DM, 1997, GENETICS, V146, P553; GAUWERKY CE, 1989, P NATL ACAD SCI USA, V86, P8867, DOI 10.1073/pnas.86.22.8867; Grosshans H, 2005, DEV CELL, V8, P321, DOI 10.1016/j.devcel.2004.12.019; HAN M, 1990, GENETICS, V126, P899; HAN M, 1990, CELL, V63, P921, DOI 10.1016/0092-8674(90)90495-Z; Hopper NA, 2000, MOL CELL, V6, P65, DOI 10.1016/S1097-2765(00)00008-3; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Johnson SM, 2003, DEV BIOL, V259, P364, DOI 10.1016/S0012-1606(03)00202-1; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; KATZ WS, 1995, CELL, V82, P297, DOI 10.1016/0092-8674(95)90317-8; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LEE JH, 1994, GENE DEV, V8, P60, DOI 10.1101/gad.8.1.60; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lin SY, 2003, DEV CELL, V4, P639, DOI 10.1016/S1534-5807(03)00124-2; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; MCKAY IA, 1986, EMBO J, V5, P2617, DOI 10.1002/j.1460-2075.1986.tb04542.x; McManus MT, 2003, SEMIN CANCER BIOL, V13, P253, DOI 10.1016/S1044-579X(03)00038-5; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Michael MZ, 2003, MOL CANCER RES, V1, P882; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; PULCIANI S, 1985, MOL CELL BIOL, V5, P2836, DOI 10.1128/MCB.5.10.2836; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; STERNBERG PW, 1988, NATURE, V335, P551, DOI 10.1038/335551a0; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tam W, 2002, J VIROL, V76, P4275, DOI 10.1128/JVI.76.9.4275-4286.2002; Tam W, 2001, GENE, V274, P157, DOI 10.1016/S0378-1119(01)00612-6; Tan PB, 1998, CELL, V93, P569, DOI 10.1016/S0092-8674(00)81186-1; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Wang MQ, 2001, CURR TOP DEV BIOL, V51, P189, DOI 10.1016/S0070-2153(01)51006-6; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yoo AS, 2004, SCIENCE, V303, P663, DOI 10.1126/science.1091639; YOON CH, 1995, SCIENCE, V269, P1102, DOI 10.1126/science.7652556	56	2818	3146	6	295	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 11	2005	120	5					635	647		10.1016/j.cell.2005.01.014	http://dx.doi.org/10.1016/j.cell.2005.01.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766527	Bronze			2022-12-24	WOS:000227771400010
J	Vergani, P; Lockless, SW; Nairn, AC; Gadsby, DC				Vergani, P; Lockless, SW; Nairn, AC; Gadsby, DC			CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains	NATURE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; MULTIDRUG-RESISTANCE PROTEIN; ABC TRANSPORTER; HYDROLYSIS; SUBUNIT; CYCLE; DIMER	ABC (ATP-binding cassette) proteins constitute a large family of membrane proteins that actively transport a broad range of substrates. Cystic fibrosis transmembrane conductance regulator ( CFTR), the protein dysfunctional in cystic fibrosis, is unique among ABC proteins in that its transmembrane domains comprise an ion channel. Opening and closing of the pore have been linked to ATP binding and hydrolysis at CFTR's two nucleotide-binding domains, NBD1 and NBD2 (see, for example, refs 1, 2). Isolated NBDs of prokaryotic ABC proteins dimerize upon binding ATP, and hydrolysis of the ATP causes dimer dissociation(3-5). Here, using single-channel recording methods on intact CFTR molecules, we directly follow opening and closing of the channel gates, and relate these occurrences to ATP-mediated events in the NBDs. We find that energetic coupling(6) between two CFTR residues, expected to lie on opposite sides of its predicted NBD1-NBD2 dimer interface, changes in concert with channel gating status. The two monitored side chains are independent of each other in closed channels but become coupled as the channels open. The results directly link ATP-driven tight dimerization of CFTR's cytoplasmic nucleotide-binding domains to opening of the ion channel in the transmembrane domains. This establishes a molecular mechanism, involving dynamic restructuring of the NBD dimer interface, that is probably common to all members of the ABC protein superfamily.	Rockefeller Univ, Lab Cardiac Membrane Physiol, New York, NY 10021 USA; Rockefeller Univ, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA; Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; Yale Univ, Dept Psychiat, New Haven, CT 06519 USA	Rockefeller University; Rockefeller University; Rockefeller University; Yale University	Gadsby, DC (corresponding author), Rockefeller Univ, Lab Cardiac Membrane Physiol, 1230 York Ave, New York, NY 10021 USA.	paola.vergani@rockefeller.edu; gadsby@rockefeller.edu	Vergani, Paola/C-2019-2008	Vergani, Paola/0000-0002-5422-4662; Nairn, Angus/0000-0002-7075-0195	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051767] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK051767, R01 DK051767-09] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Austermuhle MI, 2004, J BIOL CHEM, V279, P28243, DOI 10.1074/jbc.M403508200; Bakos E, 1997, BIOCHEM J, V323, P777, DOI 10.1042/bj3230777; Basso C, 2003, J GEN PHYSIOL, V122, P333, DOI 10.1085/jgp.200308798; CARSON MR, 1995, J BIOL CHEM, V270, P1711, DOI 10.1074/jbc.270.4.1711; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Csanady L, 2000, BIOPHYS J, V78, P785, DOI 10.1016/S0006-3495(00)76636-7; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Fersht A. R., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; GUNDERSON KL, 1995, CELL, V82, P231, DOI 10.1016/0092-8674(95)90310-0; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2003, CURR OPIN STRUC BIOL, V13, P249, DOI 10.1016/S0959-440X(03)00037-X; Horn C, 2003, J MOL BIOL, V334, P403, DOI 10.1016/j.jmb.2003.09.079; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Janas E, 2003, J BIOL CHEM, V278, P26862, DOI 10.1074/jbc.M301227200; KNOWLES JR, 1980, ANNU REV BIOCHEM, V49, P877, DOI 10.1146/annurev.bi.49.070180.004305; Lerner-Marmarosh N, 1999, J BIOL CHEM, V274, P34711, DOI 10.1074/jbc.274.49.34711; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Qian YM, 2001, J BIOL CHEM, V276, P38636, DOI 10.1074/jbc.M107025200; SERRANO L, 1990, BIOCHEMISTRY-US, V29, P9343, DOI 10.1021/bi00492a006; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Tombline G, 2004, J BIOL CHEM, V279, P31212, DOI 10.1074/jbc.M404689200; Verdon G, 2003, J MOL BIOL, V330, P343, DOI 10.1016/S0022-2836(03)00575-8; Verdon G, 2003, J MOL BIOL, V334, P255, DOI 10.1016/j.jmb.2003.08.065; Vergani P, 2003, J GEN PHYSIOL, V121, P17, DOI 10.1085/jgp.20028673	28	326	332	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2005	433	7028					876	880		10.1038/nature03313	http://dx.doi.org/10.1038/nature03313			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	899VT	15729345	Green Accepted, Green Published			2022-12-24	WOS:000227174600045
J	Duster, T				Duster, T			Medicine - Race and reification in science	SCIENCE			English	Article							DNA; BLACKS		NYU, Inst Hist Prod Knowledge, New York, NY 10003 USA	New York University	Duster, T (corresponding author), NYU, Inst Hist Prod Knowledge, 269 Mercer St, New York, NY 10003 USA.	troy.duster@nyu.edu						Cooper RS, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-2; Cooper RS, 1998, HYPERTENSION, V32, P813, DOI 10.1161/01.HYP.32.5.813; Donohue JJ, 2001, J LAW ECON, V44, P367, DOI 10.1086/322810; Duster T., 2004, DNA CRIMINAL JUSTICE, P315; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; GRIFFITH V, 2001, FINANCIAL TIMES 0309, P13; HACKER A, 1992, 2 NATIONS BLACK WHIT, P197; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Jobling MA, 2004, NAT REV GENET, V5, P739, DOI 10.1038/nrg1455; Kahn J., COMMUNICATION; Kahn Jonathan, 2004, Yale J Health Policy Law Ethics, V4, P1; KLAG MJ, 1991, JAMA-J AM MED ASSOC, V265, P599, DOI 10.1001/jama.265.5.599; Knowles J, 2001, J POLIT ECON, V109, P203, DOI 10.1086/318603; LAZER D, 2004, DNA CRIMINAL JUSTICE, P1; Lowe AL, 2001, FORENSIC SCI INT, V119, P17, DOI 10.1016/S0379-0738(00)00387-X; Mauer M., 1999, RACE INCARCERATE; *NITROMED INC, 2005, PR NEWSWIRE US  0111; Shriver MD, 1997, AM J HUM GENET, V60, P957; Simonov VI, 2003, NATO SCI SER II-MATH, V126, P1; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934; Whitehead AN., 1929, PROCESS REALITY, P11	21	234	238	3	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2005	307	5712					1050	1051		10.1126/science.1110303	http://dx.doi.org/10.1126/science.1110303			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ED	15718453				2022-12-24	WOS:000227197300028
J	Dacey, DM; Liao, HW; Peterson, BB; Robinson, FR; Smith, VC; Pokorny, J; Yau, KW; Gamlin, PD				Dacey, DM; Liao, HW; Peterson, BB; Robinson, FR; Smith, VC; Pokorny, J; Yau, KW; Gamlin, PD			Melanopsin-expressing ganglion cells in primate retina signal colour and irradiance and project to the LGN	NATURE			English	Article							ACTION SPECTRUM; S-CONE; BRIGHTNESS; RESPONSES; ADAPTATION; PATHWAY; HUMANS; SYSTEM; MIDGET	Human vision starts with the activation of rod photoreceptors in dim light and short (S)-, medium (M)-, and long (L)-wavelength-sensitive cone photoreceptors in daylight. Recently a parallel, non-rod, non-cone photoreceptive pathway, arising from a population of retinal ganglion cells, was discovered in nocturnal rodents(1). These ganglion cells express the putative photopigment melanopsin and by signalling gross changes in light intensity serve the subconscious, 'non-image-forming' functions of circadian photoentrainment and pupil constriction(1-7). Here we show an anatomically distinct population of 'giant', melanopsin-expressing ganglion cells in the primate retina that, in addition to being intrinsically photosensitive, are strongly activated by rods and cones, and display a rare, S-Off, ( L + M)-On type of colour-opponent receptive field. The intrinsic, rod and (L + M) cone-derived light responses combine in these giant cells to signal irradiance over the full dynamic range of human vision. In accordance with cone-based colour opponency, the giant cells project to the lateral geniculate nucleus, the thalamic relay to primary visual cortex. Thus, in the diurnal trichromatic primate, 'non-image-forming' and conventional 'image-forming' retinal pathways are merged, and the melanopsin-based signal might contribute to conscious visual perception.	Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; Washington Natl Primate Res Ctr, Seattle, WA 98195 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; Univ Chicago, Vis Sci Labs, Chicago, IL 60637 USA; Univ Alabama Birmingham, Vis Sci Res Ctr, Birmingham, AL 35294 USA	University of Washington; University of Washington Seattle; Johns Hopkins University; Johns Hopkins University; University of Chicago; University of Alabama System; University of Alabama Birmingham	Dacey, DM (corresponding author), Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.	dmd@u.washington.edu	Gamlin, Paul/W-2169-2019	Gamlin, Paul/0000-0002-2966-4762; Dacey, Dennis/0000-0001-8476-5585; Robinson, Farrel/0000-0002-3903-8327	NATIONAL EYE INSTITUTE [R01EY014596, R37EY006837, R01EY006837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006904] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY006837-17, R01 EY014596-01, R37 EY006837, R37 EY006837-15S1, R01 EY006837-16A1, R37 EY006837-15, R01 EY006837, R01 EY014596, R01 EY006837-18] Funding Source: Medline; NIDCD NIH HHS [R01 DC006904, R01 DC006904-01] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BARLOW HB, 1969, J PHYSIOL-LONDON, V202, P699, DOI 10.1113/jphysiol.1969.sp008836; BARLOW RB, 1976, VISION RES, V16, P1291, DOI 10.1016/0042-6989(76)90056-0; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Brainard GC, 2001, J NEUROSCI, V21, P6405; Cottaris NP, 1998, NATURE, V395, P896, DOI 10.1038/27666; DACEY DM, 1994, NATURE, V367, P731, DOI 10.1038/367731a0; Dacey DM, 2003, NEURON, V37, P15, DOI 10.1016/S0896-6273(02)01143-1; Diller L, 2004, J NEUROSCI, V24, P1079, DOI 10.1523/JNEUROSCI.3828-03.2004; ENROTHCUGELL C, 1983, J PHYSIOL-LONDON, V341, P279, DOI 10.1113/jphysiol.1983.sp014806; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; Hankins MW, 2002, CURR BIOL, V12, P191, DOI 10.1016/S0960-9822(02)00659-0; Hannibal J, 2004, INVEST OPHTH VIS SCI, V45, P4202, DOI 10.1167/iovs.04-0313; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Kaufman L, 1986, HDB PERCEPTION HUMAN, Vfirst, P1; KAYAMA Y, 1979, J NEUROPHYSIOL, V42, P1495, DOI 10.1152/jn.1979.42.6.1495; Kinoshita M, 2001, J NEUROPHYSIOL, V86, P2559, DOI 10.1152/jn.2001.86.5.2559; Klug K, 2003, J NEUROSCI, V23, P9881; KRAUSKOPF J, 1982, VISION RES, V22, P1123, DOI 10.1016/0042-6989(82)90077-3; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; MARROCCO RT, 1975, BRAIN RES, V86, P128, DOI 10.1016/0006-8993(75)90644-7; MOLLON JD, 1989, DIE FARBE, V35, P139; Packer O, 2001, VISION RES, V41, P427, DOI 10.1016/S0042-6989(00)00271-6; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; TAKAHASHI JS, 1984, NATURE, V308, P186, DOI 10.1038/308186a0; Thapan K, 2001, J PHYSIOL-LONDON, V535, P261, DOI 10.1111/j.1469-7793.2001.t01-1-00261.x; VALBERG A, 1986, VISION RES, V26, P1061, DOI 10.1016/0042-6989(86)90040-4	30	900	930	3	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2005	433	7027					749	754		10.1038/nature03387	http://dx.doi.org/10.1038/nature03387			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897XH	15716953				2022-12-24	WOS:000227039200041
J	Garne, D; Watson, M; Chapman, S; Byrne, F				Garne, D; Watson, M; Chapman, S; Byrne, F			Environmental tobacco smoke research published in the journal Indoor and Built Environment and associations with the tobacco industry	LANCET			English	Article							SECONDHAND SMOKE; 2ND-HAND SMOKE; DOCUMENTS; RISK	In the late 1980s, the international tobacco industry assisted in the establishment of the International Society of the Built Environment, which published the journal Indoor and Built Environment. Using evidence from tobacco industry documents, we examine the industry associations of the Society's executive, the journal's editor and board, and the extent to which the journal publishes papers on environmental tobacco smoke that would be deemed favourable by the tobacco industry. The society's executive has been dominated by paid consultants to the tobacco industry: all six members in 1992 and seven of eight members in 2002 had financial associations through industry lawyers. 67% of the editorial board in 1992 and 66% in 2002 had histories of financial associations with the tobacco industry. 61% (40/66) of papers related to environmental tobacco smoke published in Indoor and Built Environment in the study period reached conclusions that could be judged to be industry-positive. Of these, 90% (36/40) had at least one author with a history of association with the tobacco industry. The executive of the International Society of the Built Environment and the editorial board of Indoor and Built Environment are in large part consisted of people with histories of consultancies to the tobacco industry. On the basis of the evidence presented in this paper, there is a serious concern the tobacco industry may have been unduly influential on the content of the journal.	Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia	University of Sydney	Chapman, S (corresponding author), Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia.	simonchapman@health.usyd.edu.au	Chapman, Simon/D-4114-2009		NATIONAL CANCER INSTITUTE [R01CA087110] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA87110-01A1] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aguinaga Bialous S., 2002, PROFITS PEOPLE TOBAC; Assunta M, 2004, Tob Control, V13 Suppl 2, pii4, DOI 10.1136/tc.2003.005199; Barnes D E, 1997, Tob Control, V6, P19; Barnes DE, 1996, J HEALTH POLIT POLIC, V21, P515, DOI 10.1215/03616878-21-3-515; Barnes DE, 1998, JAMA-J AM MED ASSOC, V279, P1566, DOI 10.1001/jama.279.19.1566; Barnoya J, 2002, TOB CONTROL, V11, P305, DOI 10.1136/tc.11.4.305; BERO L, 1995, JAMA-J AM MED ASSOC, V274, P241, DOI 10.1001/jama.274.3.241; BRIGGS D, 1987, TI M WASH MARCH 18 1; Centers for Disease Control (CDC), 1986, MMWR Morb Mortal Wkly Rep, V35, P769; Drope J, 2004, TOB CONTROL, V13, P41, DOI 10.1136/tc.2003.004101; Drope J, 2001, J EPIDEMIOL COMMUN H, V55, P588, DOI 10.1136/jech.55.8.588; Glantz S.A., 1996, CIGARETTE PAPERS; GREEN C, 1987, JOINT TAC VDC JTI TI; GREEN C, COMMUNICATION   0406; HIRAYAMA T, 1981, BRIT MED J, V282, P183, DOI 10.1136/bmj.282.6259.183; Hirschhorn N, 2001, TOB CONTROL, V10, P375, DOI 10.1136/tc.10.4.375; Hong MK, 2002, BRIT MED J, V325, P1413, DOI 10.1136/bmj.325.7377.1413; International Committee of Medical Journal Editors, UN REQ MAN SUBM BIOM; Lee K, 2004, ADDICTION, V99, P394, DOI 10.1111/j.1360-0443.2004.00718.x; Liberman J, 2002, TOB CONTROL, V11, P271, DOI 10.1136/tc.11.3.271; Muggli ME, 2003, NICOTINE TOB RES, V5, P303, DOI 10.1080/1462220031000094169; Ong EK, 2000, LANCET, V355, P1253, DOI 10.1016/S0140-6736(00)02098-5; *SAG PUBL, IND BUILT ENV	23	28	29	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2005	365	9461					804	809		10.1016/S0140-6736(05)17990-2	http://dx.doi.org/10.1016/S0140-6736(05)17990-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LZ	15733724				2022-12-24	WOS:000227285300030
J	Lee, JH; Paull, TT				Lee, JH; Paull, TT			ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex	SCIENCE			English	Article							DAMAGE; NBS1; AUTOPHOSPHORYLATION; PHOSPHORYLATION; REQUIREMENT; MRE11/RAD50; CHECKPOINT; BINDING; REPAIR; SMC1	The ataxia-tetangiectasia mutated (ATM) kinase signals the presence of DNA double-strand breaks in mammalian cells by phosphorylating proteins that initiate cell-cycle arrest, apoptosis, and DNA repair. We show that the Mre11-Rad50-Nbs1 (MRN) complex acts as a double-strand break sensor for ATM and recruits ATM to broken DNA molecules. Inactive ATM dimers were activated in vitro with DNA in the presence of MRN, leading to phosphorylation of the downstream cellular targets p53 and Chk2. ATM autophosphorylation was not required for monomerization of ATM by MRN. The unwinding of DNA ends by MRN was essential for ATM stimulation, which is consistent with the central role of single-stranded DNA as an evolutionarily conserved signal for DNA damage.	Univ Texas, Inst Mol & Cellular Biol, Dept Mol Genet & Microbiol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Paull, TT (corresponding author), Univ Texas, Inst Mol & Cellular Biol, Dept Mol Genet & Microbiol, 1 Univ Stn,A4800, Austin, TX 78712 USA.	tpaull@icmb.utexas.edu	Lee, Jihoon/AAK-3497-2021	Lee, Jihoon/0000-0001-7387-935X; Paull, Tanya/0000-0002-2991-651X	NCI NIH HHS [CA094008] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA094008] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ali A, 2004, GENE DEV, V18, P249, DOI 10.1101/gad.1176004; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Buscemi G, 2001, MOL CELL BIOL, V21, P5214, DOI 10.1128/MCB.21.15.5214-5222.2001; Girard PM, 2002, ONCOGENE, V21, P4191, DOI 10.1038/sj.onc.1205596; Goodarzi AA, 2004, EMBO J, V23, P4451, DOI 10.1038/sj.emboj.7600455; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Lee JH, 2003, J BIOL CHEM, V278, P45171, DOI 10.1074/jbc.M308705200; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2003, MOL CANCER RES, V1, P674; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Moncalian G, 2004, J MOL BIOL, V335, P937, DOI 10.1016/j.jmb.2003.11.026; Nakada D, 2003, GENE DEV, V17, P1957, DOI 10.1101/gad.1099003; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702	18	1021	1061	1	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2005	308	5721					551	554		10.1126/science.1108297	http://dx.doi.org/10.1126/science.1108297			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15790808				2022-12-24	WOS:000228810500052
J	Schmittner, A				Schmittner, A			Decline of the marine ecosystem caused by a reduction in the Atlantic overturning circulation	NATURE			English	Article							NORTH-ATLANTIC; CLIMATE; PRODUCTIVITY; MODEL; SCALE; CO2	Reorganizations of the Atlantic meridional overturning circulation were associated with large and abrupt climatic changes in the North Atlantic region during the last glacial period(1-4). Projections with climate models suggest that similar reorganizations may also occur in response to anthropogenic global warming(5-7). Here I use ensemble simulations with a coupled climate-ecosytem model of intermediate complexity to investigate the possible consequences of such disturbances to the marine ecosystem. In the simulations, a disruption of the Atlantic meridional overturning circulation leads to a collapse of the North Atlantic plankton stocks to less than half of their initial biomass, owing to rapid shoaling of winter mixed layers and their associated separation from the deep ocean nutrient reservoir. Globally integrated export production declines by more than 20 per cent owing to reduced upwelling of nutrient-rich deep water and gradual depletion of upper ocean nutrient concentrations. These model results are consistent with the available high-resolution palaeorecord, and suggest that global ocean productivity is sensitive to changes in the Atlantic meridional overturning circulation.	Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA	Oregon State University	Schmittner, A (corresponding author), Oregon State Univ, Coll Ocean & Atmospher Sci, 104 COAS Adm Bldg, Corvallis, OR 97331 USA.	aschmittner@coas.oregonstae.edu	Schmittner, Andreas/A-3101-2008; Schmittner, Andreas/O-9647-2015	Schmittner, Andreas/0000-0002-8376-0843				Antoine D, 1996, GLOBAL BIOGEOCHEM CY, V10, P57, DOI 10.1029/95GB02832; Aumont O, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001745; Bopp L, 2001, GLOBAL BIOGEOCHEM CY, V15, P81, DOI 10.1029/1999GB001256; Clark PU, 2002, NATURE, V415, P863, DOI 10.1038/415863a; Conkright M., 2002, NOAA ATLAS NESDIS42; Cubasch U., 2001, PROJECTIONS FUTURE C, P525; Dokken TM, 1999, NATURE, V401, P458, DOI 10.1038/46753; Gregg WW, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016889; Hendy IL, 2003, QUATERNARY SCI REV, V22, P673, DOI 10.1016/S0277-3791(02)00186-5; KIEFER T, 1998, 90 U KIEL GEOL PAL I; Lebreiro SM, 1997, PALEOCEANOGRAPHY, V12, P718, DOI 10.1029/97PA01748; MANABE S, 1993, NATURE, V364, P215, DOI 10.1038/364215a0; Ortiz JD, 2004, GEOLOGY, V32, P521, DOI 10.1130/G20234.1; Rasmussen TL, 2003, MAR MICROPALEONTOL, V47, P143, DOI 10.1016/S0377-8398(02)00115-9; Sarmiento JL, 2004, NATURE, V427, P56, DOI 10.1038/nature02127; SARTHEIN M, 2001, NO N ATLANTIC, P45; Schartau M, 2003, J MAR RES, V61, P765, DOI 10.1357/002224003322981147; Schmittner A, 2003, QUATERNARY SCI REV, V22, P659, DOI 10.1016/S0277-3791(02)00184-1; SCHMITTNER A, IN PRESS GLOB BIOGEO; Schulte S, 2001, GEO-MAR LETT, V21, P168, DOI 10.1007/s003670100080; Simmons HL, 2004, OCEAN MODEL, V6, P245, DOI 10.1016/S1463-5003(03)00011-8; Six KD, 1996, GLOBAL BIOGEOCHEM CY, V10, P559, DOI 10.1029/96GB02561; Stocker TF, 1997, NATURE, V388, P862, DOI 10.1038/42224; THOMAS E, 1995, PALEOCEANOGRAPHY, V10, P545, DOI 10.1029/94PA03056; Vink A, 2001, PALEOCEANOGRAPHY, V16, P479, DOI 10.1029/2000PA000582; Weaver AJ, 2001, ATMOS OCEAN, V39, P361, DOI 10.1080/07055900.2001.9649686; Weinelt M., 2003, Z DTSCH GEOL GES, V154, P47, DOI DOI 10.1127/ZDGG/154/2003/47; Willamowski C, 2000, PALEOCEANOGRAPHY, V15, P515, DOI 10.1029/1999PA000467	28	212	216	3	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2005	434	7033					628	633		10.1038/nature03476	http://dx.doi.org/10.1038/nature03476			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911NN	15800620				2022-12-24	WOS:000228011000041
J	Colosimo, PF; Hosemann, KE; Balabhadra, S; Villarreal, G; Dickson, M; Grimwood, J; Schmutz, J; Myers, RM; Schluter, D; Kingsley, DM				Colosimo, PF; Hosemann, KE; Balabhadra, S; Villarreal, G; Dickson, M; Grimwood, J; Schmutz, J; Myers, RM; Schluter, D; Kingsley, DM			Widespread parallel evolution in sticklebacks by repeated fixation of ectodysplasin alleles	SCIENCE			English	Article							HYPOHIDROTIC ECTODERMAL DYSPLASIA; THREESPINE STICKLEBACKS; GASTEROSTEUS-ACULEATUS; GENETIC ARCHITECTURE; SELECTIVE PREDATION; MITOCHONDRIAL-DNA; LATERAL PLATES; REDUCTION; POPULATIONS; MUTATIONS	Major phenotypic changes evolve in parallel in nature by molecular mechanisms that are largely unknown. Here, we use positional cloning methods to identify the major chromosome locus controlling armor plate patterning in wild threespine sticklebacks. Mapping, sequencing, and transgenic studies show that the Ectodysplasin (EDA) signaling pathway plays a key role in evolutionary change in natural populations and that parallel evolution. of stickleback low-plated phenotypes at most freshwater locations around the world has occurred by repeated selection of Eda alleles derived from an ancestral low-plated haplotype that first appeared more than two million years ago. Members of this clade of tow-plated alleles are present at tow frequencies in marine fish, which suggests that standing genetic variation can provide a molecular basis for rapid, parallel evolution of dramatic phenotypic change in nature.	Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Stanford Human Genome Ctr, Stanford, CA 94305 USA; Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; University of British Columbia; University of British Columbia	Colosimo, PF (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.		Grimwood, Jane/ABD-5737-2021; Schmutz, Jeremy/N-3173-2013	Schmutz, Jeremy/0000-0001-8062-9172; Schluter, Dolph/0000-0003-1683-7836	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002568] Funding Source: NIH RePORTER; NHGRI NIH HHS [1P50HG02568] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AVISE JC, 1976, GENET RES, V27, P33, DOI 10.1017/S0016672300016219; Bayes M, 1998, HUM MOL GENET, V7, P1661, DOI 10.1093/hmg/7.11.1661; Bell M.A., 1994, EVOLUTIONARY BIOL TH; Bergstrom CA, 2002, CAN J ZOOL, V80, P207, DOI 10.1139/Z01-226; Colosimo PF, 2004, PLOS BIOL, V2, P635, DOI 10.1371/journal.pbio.0020109; Cresko WA, 2004, P NATL ACAD SCI USA, V101, P6050, DOI 10.1073/pnas.0308479101; CUVIER G, 1829, HIST NATURELLE POISS; Deagle BE, 1996, CAN J ZOOL, V74, P1045, DOI 10.1139/z96-116; Futuyma DJ., 1998, EVOL BIOL; GILES N, 1983, J ZOOL, V199, P535; HAGEN DW, 1967, J FISH RES BOARD CAN, V24, P1637, DOI 10.1139/f67-138; HAGEN DW, 1972, EVOLUTION, V26, P32, DOI 10.1111/j.1558-5646.1972.tb00172.x; HAGEN DW, 1973, HEREDITY, V30, P273, DOI 10.1038/hdy.1973.38; HEUTS MJ, 1947, EVOLUTION, V1, P89, DOI 10.2307/2405407; Higuchi M, 1996, ENVIRON BIOL FISH, V47, P1, DOI 10.1007/BF00002375; Hosemann KE, 2004, BEHAVIOUR, V141, P1345, DOI 10.1163/1568539042948097; Kangas AT, 2004, NATURE, V432, P211, DOI 10.1038/nature02927; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Kingsley DM, 2004, BEHAVIOUR, V141, P1331, DOI 10.1163/1568539042948150; Kondo S, 2001, CURR BIOL, V11, P1202, DOI 10.1016/S0960-9822(01)00324-4; LANDER ES, 1986, COLD SPRING HARB SYM, V51, P49, DOI 10.1101/SQB.1986.051.01.007; LINDSEY CC, 1962, CAN J ZOOLOG, V40, P271, DOI 10.1139/z62-028; MACLEAN J, 1980, CAN J ZOOL, V58, P2026, DOI 10.1139/z80-279; Mikkola ML, 1999, MECH DEVELOP, V88, P133, DOI 10.1016/S0925-4773(99)00180-X; MOODIE GEE, 1973, BEHAVIOUR, V47, P95, DOI 10.1163/156853973X00292; ORTI G, 1994, EVOLUTION, V48, P608, DOI 10.1111/j.1558-5646.1994.tb01348.x; Paakkonen K, 2001, Hum Mutat, V17, P349, DOI 10.1002/humu.33; Peichel CL, 2001, NATURE, V414, P901, DOI 10.1038/414901a; Ransom DG, 1999, METHOD CELL BIOL, V60, P195; Reimchen TE, 2000, BEHAVIOUR, V137, P1081, DOI 10.1163/156853900502448; REIMCHEN TE, 1992, EVOLUTION, V46, P1224, DOI 10.1111/j.1558-5646.1992.tb00631.x; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schluter D, 2004, AM NAT, V163, P809, DOI 10.1086/383621; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Sire JY, 2003, BIOL REV, V78, P219, DOI 10.1017/S1464793102006073; Srivastava AK, 2001, HUM MOL GENET, V10, P2973, DOI 10.1093/hmg/10.26.2973; Taylor EB, 1999, BIOL J LINN SOC, V66, P271, DOI 10.1111/j.1095-8312.1999.tb01891.x; TAYLOR EB, 1986, CAN J ZOOL, V64, P416, DOI 10.1139/z86-064; THESLEFF I, 2002, SCI STKE, V131; Vincent MC, 2001, EUR J HUM GENET, V9, P355, DOI 10.1038/sj.ejhg.5200635; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; Williams-Blangero S, 2002, P NATL ACAD SCI USA, V99, P5533, DOI 10.1073/pnas.082115999; Yan MH, 2000, SCIENCE, V290, P523, DOI 10.1126/science.290.5491.523	43	1069	1094	9	361	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 25	2005	307	5717					1928	1933		10.1126/science.1107239	http://dx.doi.org/10.1126/science.1107239			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910UI	15790847				2022-12-24	WOS:000227957300048
J	Dunavan, CP				Dunavan, CP			Jambo, Jahi	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												cpanosian@mednet.ucla.edu							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2005	293	12					1430	1431						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	908KA	15784849				2022-12-24	WOS:000227784700001
J	Janssen, EM; Droin, NM; Lemmens, EE; Pinkoski, MJ; Bensinger, SJ; Ehst, BD; Griffith, TS; Green, DR; Schoenberger, SP				Janssen, EM; Droin, NM; Lemmens, EE; Pinkoski, MJ; Bensinger, SJ; Ehst, BD; Griffith, TS; Green, DR; Schoenberger, SP			CD4(+) T-cell help controls CD8(+) T-cell memory via TRAIL-mediated activation-induced cell death	NATURE			English	Article							TUMOR-NECROSIS-FACTOR; CD8-T-CELL MEMORY; CD4-T-CELL HELP; ACUTE INFECTION; LIGAND TRAIL; FAS-LIGAND; APOPTOSIS; EXPRESSION; RECEPTOR; FAMILY	The 'help' provided by CD4(+) T lymphocytes during the priming of CD8(+) T lymphocytes confers a key feature of immune memory: the capacity for autonomous secondary expansion following re-encounter with antigen(1-4). Once primed in the presence of CD4(+) T cells, 'helped' CD8(+) T cells acquire the ability to undergo a second round of clonal expansion upon restimulation in the absence of T-cell help. 'Helpless' CD8(+) T cells that are primed in the absence of CD4(+) T cells, in contrast, can mediate effector functions such as cytotoxicity and cytokine secretion upon restimulation, but do not undergo a second round of clonal expansion. These disparate responses have features of being 'programmed', that is, guided by signals that are transmitted to naive CD8(+) T cells during priming, which encode specific fates for their clonal progeny. Here we explore the instructional programme that governs the secondary response of CD8(+) T cells and find that helpless cells undergo death by activation-induced cell death upon secondary stimulation. This death is mediated by tumour-necrosis factor (TNF)- related apoptosis-inducing ligand ( TRAIL). Regulation of Trail expression can therefore account for the role of CD4(+) T cells in the generation of CD8(+) T cell memory and represents a novel mechanism for controlling adaptive immune responses.	La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA; Univ Minnesota, Sch Med, Ctr Immunol, Dept Microbiol, Minneapolis, MN 55455 USA; Univ Iowa, Dept Urol, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA	La Jolla Institute for Immunology; University of Minnesota System; University of Minnesota Twin Cities; University of Iowa	Schoenberger, SP (corresponding author), La Jolla Inst Allergy & Immunol, Div Cellular Immunol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.	doug@liai.org; sps@liai.org	Griffith, Thomas/ABF-8225-2020; Droin, Nathalie M/Y-5506-2018; Green, Douglas R/N-8083-2018	Droin, Nathalie M/0000-0002-6099-5324; Green, Douglas R/0000-0002-7332-1417				Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Bhardwaj A, 2003, J CLIN IMMUNOL, V23, P317, DOI 10.1023/A:1025319031417; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Cretney E, 2002, J IMMUNOL, V168, P1356, DOI 10.4049/jimmunol.168.3.1356; DIALYNAS DP, 1983, J IMMUNOL, V131, P2445; Droin NM, 2003, MOL CELL BIOL, V23, P7638, DOI 10.1128/MCB.23.21.7638-7647.2003; Ehst BD, 2003, AM J TRANSPLANT, V3, P1355, DOI 10.1046/j.1600-6135.2003.00246.x; GRILLOT DAM, 1995, J EXP MED, V182, P1973, DOI 10.1084/jem.182.6.1973; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MacFarlane M, 1997, J BIOL CHEM, V272, P25417, DOI 10.1074/jbc.272.41.25417; Martinez-Lorenzo MJ, 1998, EUR J IMMUNOL, V28, P2714, DOI 10.1002/(SICI)1521-4141(199809)28:09<2714::AID-IMMU2714>3.0.CO;2-9; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pascolo S, 1997, J EXP MED, V185, P2043, DOI 10.1084/jem.185.12.2043; Pinkoski MJ, 2002, J BIOL CHEM, V277, P42380, DOI 10.1074/jbc.M208167200; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Schoenberger SP, 1998, J IMMUNOL, V161, P3808; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Smyth MJ, 2003, IMMUNITY, V18, P1, DOI 10.1016/S1074-7613(02)00502-2; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Zhang XR, 2003, CELL DEATH DIFFER, V10, P203, DOI 10.1038/sj.cdd.4401138	26	478	500	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					88	93		10.1038/nature03337	http://dx.doi.org/10.1038/nature03337			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744305				2022-12-24	WOS:000227334600049
J	Griesinger, CB; Richards, CD; Ashmore, JF				Griesinger, CB; Richards, CD; Ashmore, JF			Fast vesicle replenishment allows indefatigable signalling at the first auditory synapse	NATURE			English	Article							INNER HAIR-CELLS; RELEASABLE POOL; RIBBON SYNAPSE; EFFERENT SYNAPSES; AFFERENT SYNAPSE; ACTIVE ZONES; GUINEA-PIG; EXOCYTOSIS; ENDOCYTOSIS; COCHLEA	Ribbon-type synapses in inner hair cells of the mammalian cochlea encode the complexity of auditory signals by fast and tonic release through fusion of neurotransmitter-containing vesicles. At any instant, only about 100 vesicles are tethered to the synaptic ribbon, and about 14 of these are docked to the plasma membrane(1,2), constituting the readily releasable pool(3). Although this pool contains about the same number of vesicles as that of conventional synapses(4,5), ribbon release sites operate at rates of about two orders of magnitude higher(3,6,7) and with submillisecond precision(8-11). How these sites replenish their vesicles so efficiently remains unclear(3,12,13). We show here, using two-photon imaging of single release sites in the intact cochlea, that preformed vesicles derived from cytoplasmic vesicle-generating compartments(14) participate in fast release and replenishment. Vesicles were released at a maximal initial rate of 3 per millisecond during a depolarizing pulse, and were replenished at a rate of 1.9 per millisecond. We propose that such rapid resupply of vesicles enables temporally precise and sustained release rates. This may explain how the first auditory synapse can encode with indefatigable precision without having to rely on the slow, local endocytic vesicle cycle(7).	UCL, Dept Physiol, London WC1E 6BT, England; UCL, UCL Ear Inst, London WC1E 6BT, England; Univ Freiburg, Inst Physiol 2, D-79104 Freiburg, Germany	University of London; University College London; University of London; University College London; University of Freiburg	Griesinger, CB (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.	claudius.griesinger@physiologie.uni-freiburg.de; j.ashmore@ucl.ac.uk						Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Edmonds BW, 2004, J PHYSIOL-LONDON, V560, P439, DOI 10.1113/jphysiol.2004.066035; Eisen MD, 2004, J NEUROPHYSIOL, V91, P2422, DOI 10.1152/jn.01130.2003; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Glowatzki E, 2002, NAT NEUROSCI, V5, P147, DOI 10.1038/nn796; Griesinger CB, 2002, J NEUROSCI, V22, P3939, DOI 10.1523/JNEUROSCI.22-10-03939.2002; Heidelberger R, 2002, J NEUROPHYSIOL, V88, P98, DOI 10.1152/jn.2002.88.1.98; Holt M, 2004, CURR BIOL, V14, P173, DOI 10.1016/j.cub.2003.12.053; JOHNSON DH, 1980, J ACOUST SOC AM, V68, P1115, DOI 10.1121/1.384982; KIANG NYS, 1965, ACTA OTOLARYNG STOCK, V59, P186, DOI DOI 10.3109/00016486509124552; Lenzi D, 2002, NEURON, V36, P649, DOI 10.1016/S0896-6273(02)01025-5; LIBERMAN MC, 1980, HEARING RES, V3, P189, DOI 10.1016/0378-5955(80)90046-5; MAMMANO F, 1993, NATURE, V365, P838, DOI 10.1038/365838a0; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; Neves G, 1999, J PHYSIOL-LONDON, V515, P181, DOI 10.1111/j.1469-7793.1999.181ad.x; PALMER AR, 1986, HEARING RES, V24, P1, DOI 10.1016/0378-5955(86)90002-X; Parsons TD, 2003, NEURON, V37, P379, DOI 10.1016/S0896-6273(03)00062-X; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; SAITO K, 1980, J ULTRA MOL STRUCT R, V71, P222, DOI 10.1016/S0022-5320(80)90108-2; Schikorski T, 1997, J NEUROSCI, V17, P5858; SEWELL WF, 1996, SPR HDB AUD, V8, P503; SIEGEL JH, 1981, BRAIN RES, V220, P188, DOI 10.1016/0006-8993(81)90224-9; Slepecky NB, 2000, HEARING RES, V144, P124, DOI 10.1016/S0378-5955(00)00055-1; Smith CB, 1996, NATURE, V380, P531, DOI 10.1038/380531a0; Spicer SS, 1999, J COMP NEUROL, V409, P424; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500	30	97	99	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2005	435	7039					212	215		10.1038/nature03567	http://dx.doi.org/10.1038/nature03567			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15829919				2022-12-24	WOS:000229021100042
J	Patel, RR; Murphy, DJ; Peters, TJ				Patel, RR; Murphy, DJ; Peters, TJ		ALSPAC	Operative delivery and postnatal depression: a cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK; CHILDREN; IMPACT	Objectives To assess the association between elective caesarean section and postnatal depression compared with planned vaginal delivery and whether emergency caesarean section or assisted vaginal delivery is associated with postnatal depression compared with spontaneous vaginal delivery. Design Prospective population based cohort study. Setting ALSPAC (the Avon longitudinal study of parents and children). Participants 14 663 women recruited antenatally with a due date between I April 1991 and 31 December 1992. Main outcome measure Edinburgh postnatal depression scale score >= 13 at eight weeks postnatal on self completed questionnaire. Results Albeit with wide confidence intervals, there was no evidence that elective caesarean section altered the odds of postnatal depression compared with planned vaginal delivery (adjusted odds ratio 1.06, 95% confidence interval 0.66 to 1.70, P = 0.80). Among planned vaginal deliveries there was similarly little evidence of a difference between women who have emergency caesarean section or assisted vaginal delivery and those who have spontaneous vaginal delivery (1.17, 0.77 to 1.79, P = 0.46, and 0.89, 0.68 to 1.18, P = 0.42, respectively). Conclusions There is no reason for women at risk of postnatal depression to be managed differently with regard to mode of delivery. Elective caesarean section does not protect against postnatal depression. Women who plan vaginal delivery and require emergency caesarean section or assisted vaginal delivery can be reassured that there is no reason to believe that they are at increased risk of postnatal depression.	Univ Bristol, St Michaels Hosp, Div Obstet & Gynaecol, Bristol BS2 8EG, Avon, England; Univ Dundee, Ninewells Hosp & Med Sch, Div Maternal & Child Hlth Sci, Dundee DD1 9SY, Scotland; Univ Bristol, Dept Community Based Med, Acad Unit Primary Hlth Care, Bristol BS8 1AU, Avon, England	University of Bristol; University of Dundee; University of Bristol	Patel, RR (corresponding author), Univ Bristol, St Michaels Hosp, Div Obstet & Gynaecol, Level D, Bristol BS2 8EG, Avon, England.	roshni.patel@bristol.ac.uk		Peters, Tim/0000-0003-2881-4180; Patel, Roshni/0000-0002-1399-3131; Murphy, Deirdre/0000-0001-6074-6718				BOYCE PM, 1992, MED J AUSTRALIA, V157, P172, DOI 10.5694/j.1326-5377.1992.tb137080.x; COGILL SR, 1986, BMJ-BRIT MED J, V292, P1165, DOI 10.1136/bmj.292.6529.1165; Cooper PJ, 1998, BMJ-BRIT MED J, V316, P1884; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Forman DN, 2000, BRIT J OBSTET GYNAEC, V107, P1210; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Hay DF, 2001, J CHILD PSYCHOL PSYC, V42, P871, DOI 10.1111/1469-7610.00784; Johnstone SJ, 2001, AUST NZ J PSYCHIAT, V35, P69, DOI 10.1046/j.1440-1614.2001.00862.x; Koo V, 2003, J OBSTET GYNAECOL RE, V29, P246, DOI 10.1046/j.1341-8076.2003.00104.x; Lydon-Rochelle MT, 2001, PAEDIATR PERINAT EP, V15, P232, DOI 10.1046/j.1365-3016.2001.00345.x; MURRAY L, 1990, BRIT J PSYCHIAT, V157, P288, DOI 10.1192/bjp.157.2.288; *NAT COLL CTR WOM, 2004, CAESAREAN SECTION CL; National Collaborating Centre for Women's and Children's Health, 2004, CAES SECT CLIN GUID; O'Connor TG, 2002, J AM ACAD CHILD PSY, V41, P1470, DOI 10.1097/00004583-200212000-00019; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; ONEILL T, 1990, IRISH MED J, V83, P17; PATEL RR, 2004, IN PRESS INT J EPIDE; Saisto T, 2001, ACTA OBSTET GYN SCAN, V80, P39, DOI 10.1080/791201832; Sharp D, 1995, J CHILD PSYCHOL PSYC, V36, P1315, DOI 10.1111/j.1469-7610.1995.tb01666.x; Singleton N., 2001, PSYCHIAT MORBIDITY A; Thompson JF, 2002, BIRTH-ISS PERINAT C, V29, P83, DOI 10.1046/j.1523-536X.2002.00167.x; Verdoux H, 2002, ACTA PSYCHIAT SCAND, V106, P212, DOI 10.1034/j.1600-0447.2002.02398.x; WRATE RM, 1985, BRIT J PSYCHIAT, V146, P622, DOI 10.1192/bjp.146.6.622; 2003, AVON LONGITUDINAL ST	24	53	56	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2005	330	7496					879	881		10.1136/bmj.38376.603426.D3	http://dx.doi.org/10.1136/bmj.38376.603426.D3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	917UA	15734748	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000228493500018
J	Zhou, FQ; Snider, WD				Zhou, FQ; Snider, WD			GSK-3 beta and microtubule assembly in axons	SCIENCE			English	Editorial Material							GSK3-BETA PHOSPHORYLATION; NEURONAL POLARITY; GROWTH; GUIDANCE; PROTEIN; KINASE; MULTITASKING; MECHANISMS; UPSTREAM; BINDING		Univ N Carolina, Sch Med, Ctr Neurosci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Zhou, FQ (corresponding author), Univ N Carolina, Sch Med, Ctr Neurosci, Chapel Hill, NC 27599 USA.	wsnider@med.unc.edu						Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Atwal JK, 2003, J NEUROSCI, V23, P7602; Bienz M, 2002, NAT REV MOL CELL BIO, V3, P328, DOI 10.1038/nrm806; Del Rio JA, 2004, CURR BIOL, V14, P840, DOI 10.1016/j.cub.2004.04.046; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Eickholt BJ, 2002, J CELL BIOL, V157, P211, DOI 10.1083/jcb.200201098; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Goold RG, 2005, MOL CELL NEUROSCI, V28, P524, DOI 10.1016/j.mcn.2004.11.005; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Salie R, 2005, NEURON, V45, P189, DOI 10.1016/j.neuron.2005.01.002; Trivedi N, 2005, J CELL SCI, V118, P993, DOI 10.1242/jcs.01697; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; ZHOU F, UNPUB; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	20	132	135	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2005	308	5719					211	+		10.1126/science.1110301	http://dx.doi.org/10.1126/science.1110301			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915BX	15825222				2022-12-24	WOS:000228273700038
J	Falck, J; Coates, J; Jackson, SP				Falck, J; Coates, J; Jackson, SP			Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage	NATURE			English	Article							DEPENDENT PROTEIN-KINASE; DOUBLE-STRAND BREAKS; CATALYTIC SUBUNIT; S-PHASE; IONIZING-RADIATION; MRE11 COMPLEX; IN-VITRO; CHECKPOINT; ACTIVATION; REPAIR	Ataxia-telangiectasia mutated (ATM), ataxia-telangiectasia and Rad3-related (ATR) and DNA-dependent protein kinase catalytic subunit (DNA-PKcs) are members of the phosphoinositide-3-kinase-related protein kinase (PIKK) family, and are rapidly activated in response to DNA damage. ATM and DNA-PKcs respond mainly to DNA double-strand breaks, whereas ATR is activated by single-stranded DNA and stalled DNA replication forks. In all cases, activation involves their recruitment to the sites of damage. Here we identify related, conserved carboxy-terminal motifs in human Nbs1, ATRIP and Ku80 proteins that are required for their interaction with ATM, ATR and DNA-PKcs, respectively. These motifs are essential not only for efficient recruitment of ATM, ATR and DNA-PKcs to sites of damage, but are also critical for ATM-, ATR- and DNA-PKcs-mediated signalling events that trigger cell cycle checkpoints and DNA repair. Our findings reveal that recruitment of these PIKKs to DNA lesions occurs by common mechanisms through an evolutionarily conserved motif, and provide direct evidence that PIKK recruitment is required for PIKK-dependent DNA-damage signalling.	Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; Univ Cambridge, Dept Zool, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	Jackson, SP (corresponding author), Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	s.jackson@gurdon.cam.ac.uk	Jackson, Stephen Philip/R-4548-2019; Dry, Kate/I-2328-2014	Jackson, Stephen Philip/0000-0001-9317-7937; 				Andegeko Y, 2001, J BIOL CHEM, V276, P38224; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Brewerton SC, 2004, J STRUCT BIOL, V145, P295, DOI 10.1016/j.jsb.2003.11.024; Brodsky MH, 2000, GENE DEV, V14, P666; Carson CT, 2003, EMBO J, V22, P6610, DOI 10.1093/emboj/cdg630; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Costanzo V, 2004, PLOS BIOL, V2, P600, DOI 10.1371/journal.pbio.0020110; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Douglas P, 2002, BIOCHEM J, V368, P243, DOI 10.1042/BJ20020973; DVIR A, 1992, P NATL ACAD SCI USA, V89, P11920, DOI 10.1073/pnas.89.24.11920; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Gell D, 1999, NUCLEIC ACIDS RES, V27, P3494, DOI 10.1093/nar/27.17.3494; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Hammarsten O, 2000, J BIOL CHEM, V275, P1541, DOI 10.1074/jbc.275.3.1541; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Horejsi Z, 2004, ONCOGENE, V23, P3122, DOI 10.1038/sj.onc.1207447; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Meek K, 2004, IMMUNOL REV, V200, P132, DOI 10.1111/j.0105-2896.2004.00162.x; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Nakada D, 2003, GENE DEV, V17, P1957, DOI 10.1101/gad.1099003; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Rouse J, 2002, MOL CELL, V9, P857, DOI 10.1016/S1097-2765(02)00507-5; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Singleton BK, 1999, MOL CELL BIOL, V19, P3267; Smith GCM, 1999, P NATL ACAD SCI USA, V96, P11134, DOI 10.1073/pnas.96.20.11134; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Tsao CC, 2004, EMBO J, V23, P4660, DOI 10.1038/sj.emboj.7600463; Unsal-Kacmaz K, 2004, MOL CELL BIOL, V24, P1292, DOI 10.1128/MCB.24.3.1292-1300.2003; Unsal-Kacmaz K, 2002, P NATL ACAD SCI USA, V99, P6673, DOI 10.1073/pnas.102167799; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Veuger SJ, 2004, ONCOGENE, V23, P7322, DOI 10.1038/sj.onc.1207984; Wakayama T, 2001, MOL CELL BIOL, V21, P755, DOI 10.1128/MCB.21.3.755-764.2001; Wolkow TD, 2002, MOL BIOL CELL, V13, P480, DOI 10.1091/mbc.01-03-0104; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	42	948	1004	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 31	2005	434	7033					605	611		10.1038/nature03442	http://dx.doi.org/10.1038/nature03442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911NN	15758953				2022-12-24	WOS:000228011000036
J	Shimmi, O; Umulis, D; Othmer, H; O'Connor, MB				Shimmi, O; Umulis, D; Othmer, H; O'Connor, MB			Facilitated transport of a Dpp/Scw heterodimer by Sog/Tsg leads to robust patterning of the Drosophila blastoderm embryo	CELL			English	Article							SHORT GASTRULATION GENE; DORSAL-VENTRAL PATTERN; TWISTED GASTRULATION; ACTIVITY GRADIENT; GROWTH-FACTOR; BETA FAMILY; MORPHOGEN GRADIENT; I RECEPTORS; DPP; SOG	Patterning the dorsal surface of the Drosophila blastoderm embryo requires Decapentaplegic (Dpp) and Screw (Scw), two BMP family members. Signaling by these ligands is regulated at the extracellular level by the BMP binding proteins Sog and Tsg. We demonstrate that Tsg and Sog play essential roles in transporting Dpp to the dorsal-most cells. Furthermore, we provide biochemical and genetic evidence that a heterodimer of Dpp and Scw, but not the Dpp homodimer, is the primary transported ligand and that the heterodimer signals synergistically through the two type I BMP receptors Tkv and Sax. We propose that the use of broadly distributed Dpp homodimers and spatially restricted Dpp/Scw heterodimers produces the biphasic signal that is responsible for specifying the two dorsal tissue types. Finally, we demonstrate mathematically that heterodimer levels can be less sensitive to changes in gene dosage than homodimers, thereby providing further selective advantage for using heterodimers as morphogens.	Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; Univ Minnesota, Howard Hughes Med Inst, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Math, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; Howard Hughes Medical Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	O'Connor, MB (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	moconnor@mail.med.umn.edu	O'Connor, Michael B/C-9977-2014; Umulis, David/AAB-1312-2021; , 0000-0001-6341-9130/P-9094-2018	O'Connor, Michael B/0000-0002-3067-5506; , 0000-0001-6341-9130/0000-0001-6341-9130	NIGMS NIH HHS [GM29123, R01 GM029123] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029123] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARORA K, 1994, GENE DEV, V8, P2588, DOI 10.1101/gad.8.21.2588; Ashe HL, 2000, DEVELOPMENT, V127, P3305; Biehs B, 1996, GENE DEV, V10, P2922, DOI 10.1101/gad.10.22.2922; Decotto E, 2001, DEVELOPMENT, V128, P3831; Dorfman R, 2001, DEVELOPMENT, V128, P965; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; FERGUSON EL, 1992, DEVELOPMENT, V114, P583; FERGUSON EL, 1992, CELL, V71, P451, DOI 10.1016/0092-8674(92)90514-D; FRANCOIS V, 1994, GENE DEV, V8, P2602, DOI 10.1101/gad.8.21.2602; GRAY AM, 1990, SCIENCE, V247, P1328, DOI 10.1126/science.2315700; Haerry TE, 1998, DEVELOPMENT, V125, P3977; Holley SA, 1997, BIOESSAYS, V19, P281, DOI 10.1002/bies.950190404; Holley SA, 1996, CELL, V86, P607, DOI 10.1016/S0092-8674(00)80134-8; LETSOU A, 1995, CELL, V80, P899, DOI 10.1016/0092-8674(95)90293-7; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; MASON ED, 1994, GENE DEV, V8, P1489, DOI 10.1101/gad.8.13.1489; Massague J, 2000, GENE DEV, V14, P627; Neul JL, 1998, CELL, V95, P483, DOI 10.1016/S0092-8674(00)81616-5; Nguyen M, 1998, CELL, V95, P495, DOI 10.1016/S0092-8674(00)81617-7; Oelgeschlager M, 2000, NATURE, V405, P757, DOI 10.1038/35015500; PADGETT RW, 1987, NATURE, V325, P81, DOI 10.1038/325081a0; Raftery LA, 2003, TRENDS GENET, V19, P701, DOI 10.1016/j.tig.2003.10.009; RAY RP, 1991, DEVELOPMENT, V113, P35; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; RUBERTE E, 1995, CELL, V80, P889, DOI 10.1016/0092-8674(95)90292-9; Rushlow C, 2001, GENE DEV, V15, P340, DOI 10.1101/gad.861401; Schier AF, 2001, CURR OPIN GENET DEV, V11, P393, DOI 10.1016/S0959-437X(00)00209-4; Schmid B, 2000, DEVELOPMENT, V127, P957; SHIMELL MJ, 1991, CELL, V67, P469, DOI 10.1016/0092-8674(91)90522-Z; Shimmi O, 2003, DEVELOPMENT, V130, P4673, DOI 10.1242/dev.00684; Srinivasan S, 2002, DEV CELL, V2, P91, DOI 10.1016/S1534-5807(01)00097-1; WHARTON KA, 1993, DEVELOPMENT, V117, P807	33	230	237	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 25	2005	120	6					873	886		10.1016/j.cell.2005.02.009	http://dx.doi.org/10.1016/j.cell.2005.02.009			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	912HF	15797386	Bronze, Green Accepted			2022-12-24	WOS:000228067500015
J	Lazarov, O; Robinson, J; Tang, YP; Hairston, IS; Korade-Mirnics, Z; Lee, VMY; Hersh, LB; Sapolsky, RM; Mirnics, K; Sisodia, SS				Lazarov, O; Robinson, J; Tang, YP; Hairston, IS; Korade-Mirnics, Z; Lee, VMY; Hersh, LB; Sapolsky, RM; Mirnics, K; Sisodia, SS			Environmental enrichment reduces A beta levels and amyloid deposition in transgenic mice	CELL			English	Article							ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; MOUSE MODEL; DENTATE GYRUS; IN-VIVO; MEMORY CONSOLIDATION; SYNAPTIC PLASTICITY; PHYSICAL-ACTIVITY; GENE-EXPRESSION; AGING BRAIN	Cerebral deposition of beta-amyloid (A beta) peptides is an invariant pathological hallmark in brains of patients with Alzheimer's disease (AD) and transgenic mice coexpressing familial AD-linked APP and PS1 variants. We now report that exposure of transgenic mice to an "enriched environment" results in pronounced reductions in cerebral A beta levels and amyloid deposits, compared to animals raised under "standard housing" conditions. The enzymatic activity of an A beta-degrading endopeptidase, neprilysin, is elevated in the brains of "enriched" mice and inversely correlated with amyloid burden. Moreover, DNA microarray analysis revealed selective upregulation in levels of transcripts encoded by genes associated with learning and memory, vasculogenesis, neurogenesis, cell survival pathways, A beta sequestration, and prostaglandin synthesis. These studies provide evidence that environmental enrichment leads to reductions in steady-state levels of cerebral A beta peptides and amyloid deposition and selective upregulation in levels of specific transcripts in brains of transgenic mice.	Univ Pittsburgh, Dept Psychiat, Dept Neurobiol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15261 USA; Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; Univ Chicago, Dept Psychiat, Chicago, IL 60637 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Chicago; University of Chicago; Stanford University; Stanford University; University of Pennsylvania; Pennsylvania Medicine; University of Kentucky	Mirnics, K (corresponding author), Univ Pittsburgh, Dept Psychiat, Dept Neurobiol, Pittsburgh, PA 15261 USA.	karoly+@pitt.edu; ssisodia@drugs.bsd.uchicago.edu	Hairston, Ilana/AAT-7442-2021; Mirnics, Karoly/E-6730-2010; Lazarov, Orly/F-9406-2015; Tang, Ya-Ping/A-1035-2011	Mirnics, Karoly/0000-0002-5521-0254; Korade, Zeljka/0000-0002-8690-4507; Tang, Ya-Ping/0000-0002-0445-4072; Lazarov, Orly/0000-0002-5887-948X	NIA NIH HHS [AG021494, AG11542, AG19323] Funding Source: Medline; NIDA NIH HHS [DA02243] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG019323, R01AG021494, P01AG011542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002243] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Abe Mayumi, 2001, Angiogenesis, V4, P289, DOI 10.1023/A:1016018617152; Arendash GW, 2004, NEUROREPORT, V15, P1751, DOI 10.1097/01.wnr.0000137183.68847.4e; BENZING WC, 1993, BRAIN RES, V625, P125, DOI 10.1016/0006-8993(93)90145-D; BLACK JE, 1990, P NATL ACAD SCI USA, V87, P5568, DOI 10.1073/pnas.87.14.5568; Blanchard RJ, 2003, HORM BEHAV, V44, P161, DOI 10.1016/S0018-506X(03)00127-2; Braun N, 2000, EUR J NEUROSCI, V12, P4357, DOI 10.1046/j.1460-9568.2000.01342.x; Califano A, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P75; Churchill JD, 2002, NEUROBIOL AGING, V23, P941, DOI 10.1016/S0197-4580(02)00028-3; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; DeMattos RB, 2002, J NEUROCHEM, V81, P229, DOI 10.1046/j.1471-4159.2002.00889.x; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; Dickey CA, 2004, J NEUROCHEM, V88, P434, DOI 10.1046/j.1471-4159.2003.02185.x; Dickey CA, 2003, J NEUROSCI, V23, P5219; el-Ghissassi F, 2002, ONCOGENE, V21, P6772, DOI 10.1038/sj.onc.1205888; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Farmer J, 2004, NEUROSCIENCE, V124, P71, DOI 10.1016/j.neuroscience.2003.09.029; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; FORDYCE DE, 1993, BRAIN RES, V619, P111, DOI 10.1016/0006-8993(93)91602-O; HILBICH C, 1993, J BIOL CHEM, V268, P26571; Iacopetti P, 1999, P NATL ACAD SCI USA, V96, P4639, DOI 10.1073/pnas.96.8.4639; ISAACS KR, 1992, J CEREBR BLOOD F MET, V12, P110, DOI 10.1038/jcbfm.1992.14; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; Jankowsky JL, 2003, J NEUROPATH EXP NEUR, V62, P1220, DOI 10.1093/jnen/62.12.1220; Ji Y, 2001, J ALZHEIMERS DIS, V3, P23, DOI 10.3233/JAD-2001-3105; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kim SH, 2001, J BIOL CHEM, V276, P43343, DOI 10.1074/jbc.M108245200; Kramer AF, 2002, J MOL NEUROSCI, V19, P227, DOI 10.1007/s12031-002-0038-y; Lazarov O, 2002, J NEUROSCI, V22, P9785; Lee EHY, 2003, EUR J NEUROSCI, V18, P2842, DOI 10.1111/j.1460-9568.2003.03032.x; LI CW, 1995, METHOD ENZYMOL, V248, P253; Marr RA, 2003, J NEUROSCI, V23, P1992; Mattson MP, 2001, MECH AGEING DEV, V122, P757, DOI 10.1016/S0047-6374(01)00226-3; Mattson MP, 2000, BRAIN RES, V886, P47, DOI 10.1016/S0006-8993(00)02790-6; Mechtcheriakova D, 1999, BLOOD, V93, P3811, DOI 10.1182/blood.V93.11.3811.411k40_3811_3823; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; NITSCH RM, 1993, P NATL ACAD SCI USA, V90, P5191, DOI 10.1073/pnas.90.11.5191; Pinsky DJ, 2002, J CLIN INVEST, V109, P1031, DOI 10.1172/JCI200210649; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Sapolsky RM., 1993, PRIMATE SOCIAL CONFL, P171; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Seo J, 2004, BIOINFORMATICS, V20, P2534, DOI 10.1093/bioinformatics/bth280; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Silverman ES, 1999, AM J PATHOL, V154, P665, DOI 10.1016/S0002-9440(10)65312-6; SISODIA SS, 1993, J NEUROSCI, V13, P3136; Song ES, 2003, J BIOL CHEM, V278, P49789, DOI 10.1074/jbc.M308983200; Stein TD, 2002, J NEUROSCI, V22, P7380; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Swain RA, 2003, NEUROSCIENCE, V117, P1037, DOI 10.1016/S0306-4522(02)00664-4; Tong LQ, 2001, NEUROBIOL DIS, V8, P1046, DOI 10.1006/nbdi.2001.0427; Tsai KJ, 2002, P NATL ACAD SCI USA, V99, P3990, DOI 10.1073/pnas.062405399; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Turner RS, 1996, J BIOL CHEM, V271, P8966, DOI 10.1074/jbc.271.15.8966; Urade Y, 2000, BBA-PROTEIN STRUCT M, V1482, P259, DOI 10.1016/S0167-4838(00)00161-8; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Wang J, 2003, NEUROBIOL DIS, V14, P318, DOI 10.1016/j.nbd.2003.08.009; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Yasojima K, 2001, NEUROSCI LETT, V297, P97, DOI 10.1016/S0304-3940(00)01675-X; Yasojima K, 2001, BRAIN RES, V919, P115, DOI 10.1016/S0006-8993(01)03008-6	63	681	706	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 11	2005	120	5					701	713		10.1016/j.cell.2005.01.015	http://dx.doi.org/10.1016/j.cell.2005.01.015			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766532	Bronze			2022-12-24	WOS:000227771400015
J	van Rossum, DB; Patterson, RL; Sharma, S; Barrow, RK; Kornberg, M; Gill, DL; Snyder, SH				van Rossum, DB; Patterson, RL; Sharma, S; Barrow, RK; Kornberg, M; Gill, DL; Snyder, SH			Phospholipase C gamma 1 controls surface expression of TRPC3 through an intermolecular PH domain	NATURE			English	Article							CHANNELS; RECEPTOR; DATABASE; FOLD	Many ion channels are regulated by lipids(1-3), but prominent motifs for lipid binding have not been identified in most ion channels. Recently, we reported that phospholipase Cgamma1 (PLC-gamma1) binds to and regulates TRPC3 channels(4), components of agonist-induced Ca2+ entry into cells. This interaction requires a domain in PLC-gamma1 that includes a partial pleckstrin homology (PH)domain - a consensus lipid-binding and protein-binding sequence(5,6). We have developed a gestalt algorithm to detect hitherto 'invisible' PH and PH-like domains, and now report that the partial PH domain of PLC-gamma1 interacts with a complementary partial PH-like domain in TRPC3 to elicit lipid binding and cell-surface expression of TRPC3. Our findings imply a far greater abundance of PH domains than previously appreciated, and suggest that intermolecular PH-like domains represent a widespread signalling mode.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; Penn State Univ, Dept Biol, University Pk, PA 16802 USA; Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Maryland; University of Maryland Baltimore	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu	Kornberg, Michael Davin/K-3329-2019	Kornberg, Michael Davin/0000-0003-2588-7325; van Rossum, Damian/0000-0003-1011-2586				Baranano DE, 2000, J BIOL CHEM, V275, P15166, DOI 10.1074/jbc.275.20.15166; DINITTO JP, 2003, SCI STKE; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; Gervais V, 2004, NAT STRUCT MOL BIOL, V11, P616, DOI 10.1038/nsmb782; Jogl G, 2002, EMBO J, V21, P4785, DOI 10.1093/emboj/cdf502; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Marchler-Bauer A, 2003, NUCLEIC ACIDS RES, V31, P383, DOI 10.1093/nar/gkg087; Patterson RL, 2002, CELL, V111, P529, DOI 10.1016/S0092-8674(02)01045-0; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Rebecchi MJ, 1998, ANNU REV BIOPH BIOM, V27, P503, DOI 10.1146/annurev.biophys.27.1.503; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969	15	151	159	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 3	2005	434	7029					99	104		10.1038/nature03340	http://dx.doi.org/10.1038/nature03340			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744307				2022-12-24	WOS:000227334600051
J	Laurberg, P				Laurberg, P			Global or Gaelic epidemic of hypothyroidism?	LANCET			English	Editorial Material							IODINE INTAKE; THYROID-DISEASE; POPULATION; HYPERTHYROIDISM; HEALTH		Aarhus Univ Hosp, Aalborg Hosp, Dept Endocrinol & Med, DK-9000 Aalborg, Denmark	Aalborg University; Aalborg University Hospital; Aarhus University	Laurberg, P (corresponding author), Aarhus Univ Hosp, Aalborg Hosp, Dept Endocrinol & Med, DK-9000 Aalborg, Denmark.	laurberg@aas.nja.dk						Flynn RWV, 2004, J CLIN ENDOCR METAB, V89, P3879, DOI 10.1210/jc.2003-032089; HALL R, 1987, BRIT MED J, V294, P721, DOI 10.1136/bmj.294.6574.721; Hetzel B.S., 2004, GLOBAL ELIMINATION B; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Laurberg P, 1999, THYROID, V9, P33, DOI 10.1089/thy.1999.9.33; Laurberg P, 2001, THYROID, V11, P457, DOI 10.1089/105072501300176417; LAURBERG P, 2003, IDD NEWSLETTER   NOV, P55; Pedersen IB, 2002, J CLIN ENDOCR METAB, V87, P4462, DOI 10.1210/jc.2002-020750; Phillips DIW, 1997, J EPIDEMIOL COMMUN H, V51, P391, DOI 10.1136/jech.51.4.391; *UN CHILDREN FUND, 2001, ASS IOD DEF DIS MON; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; Wittig Holger, 2003, Leg Med (Tokyo), V5 Suppl 1, pS173, DOI 10.1016/S1344-6223(02)00103-7	12	18	18	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB-MAR	2005	365	9461					738	740						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LZ	15733704				2022-12-24	WOS:000227285300009
J	Rooney, HCE; van 't Klooster, JW; van der Hoorn, RAL; Joosten, MHAJ; Jones, JDG; de Wit, PJGM				Rooney, HCE; van 't Klooster, JW; van der Hoorn, RAL; Joosten, MHAJ; Jones, JDG; de Wit, PJGM			Cladosporium Avr2 inhibits tomato Rcr3 protease required for Cf-2-dependent disease resistance	SCIENCE			English	Article							FOR-GENE CONCEPT; III EFFECTOR; CYSTEINE PROTEASE; AVIRULENCE GENE; PROTEINS; FULVUM; ARABIDOPSIS; PLANTS; RIN4; AVRRPT2	How plants recognize pathogens and activate defense is still mysterious. Direct interaction between pathogen avirulence (Avr) proteins and plant disease resistance proteins is the exception rather than the rule. During infection, Cladosporium fulvum secretes Avr2 protein into the apoplast of tomato leaves and, in the presence of the extracellular leucine-rich repeat receptor-like Cf-2 protein, triggers a hypersensitive response (HR) that also requires the extracellular tomato cysteine protease Rcr3. We show here that Avr2 binds and inhibits Rcr3 and propose that the Rcr3-Avr2 complex enables the Cf-2 protein to activate an HR.	Univ Wageningen & Res Ctr, Phytopathol Lab, NL-6709 PD Wageningen, Netherlands; John Innes Ctr, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	Wageningen University & Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	de Wit, PJGM (corresponding author), Univ Wageningen & Res Ctr, Phytopathol Lab, Binnenhaven 5, NL-6709 PD Wageningen, Netherlands.	pierre.dewit@wur.nl	Joosten, Matthieu/AAB-5150-2022; van der Hoorn, Renier/AAU-1005-2020; van der Hoorn, Renier/E-5346-2011; de Wit, Pierre J. G.M./CAI-9966-2022; Joosten, Matthieu/AAB-5131-2022; de Wit, Pierre/A-1998-2013; Jones, Jonathan DG/J-5129-2012	van der Hoorn, Renier/0000-0002-3692-7487; Joosten, Matthieu/0000-0002-6243-4547; de Wit, Pierre/0000-0002-4208-288X; Jones, Jonathan DG/0000-0002-4953-261X				Axtell MJ, 2003, MOL MICROBIOL, V49, P1537, DOI 10.1046/j.1365-2958.2003.03666.x; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Chang JH, 2004, CURR OPIN MICROBIOL, V7, P11, DOI 10.1016/j.mib.2003.12.006; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; DEWIT P, UNPUB; Dixon MS, 1996, CELL, V84, P451, DOI 10.1016/S0092-8674(00)81290-8; Dixon MS, 2000, P NATL ACAD SCI USA, V97, P8807, DOI 10.1073/pnas.97.16.8807; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; GRIGNON C, 1991, ANNU REV PLANT PHYS, V42, P103, DOI 10.1146/annurev.pp.42.060191.000535; JOOSTEN MHAJ, 1994, NATURE, V367, P384, DOI 10.1038/367384a0; Joosten MHAJ, 1999, ANNU REV PHYTOPATHOL, V37, P335, DOI 10.1146/annurev.phyto.37.1.335; Kocks C, 2003, MOL CELL PROTEOMICS, V2, P1188, DOI 10.1074/mcp.M300067-MCP200; Kruger J, 2002, SCIENCE, V296, P744, DOI 10.1126/science.1069288; Lauge R, 2000, PLANT J, V23, P735, DOI 10.1046/j.1365-313x.2000.00843.x; LAZAROVITS G, 1976, CAN J BOT, V54, P224, DOI 10.1139/b76-022; Luderer R, 2002, MOL MICROBIOL, V45, P875, DOI 10.1046/j.1365-2958.2002.03060.x; Luderer R, 2001, MOL PLANT MICROBE IN, V14, P867, DOI 10.1094/MPMI.2001.14.7.867; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Ron M, 2004, PLANT CELL, V16, P1604, DOI 10.1105/tpc.022475; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; Tian MY, 2004, J BIOL CHEM, V279, P26370, DOI 10.1074/jbc.M400941200; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; Van der Hoorn RAL, 2002, TRENDS PLANT SCI, V7, P67, DOI 10.1016/S1360-1385(01)02188-4; van der Hoorn RAL, 2004, PLANT PHYSIOL, V135, P1170, DOI 10.1104/pp.104.041467; VANKAN JAL, 1992, PLANT MOL BIOL, V20, P513, DOI 10.1007/BF00040610; Wit P. J. G. M. de, 1977, Netherlands Journal of Plant Pathology, V83, P109, DOI 10.1007/BF01981556	28	328	345	1	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 17	2005	308	5729					1783	1786		10.1126/science.1111404	http://dx.doi.org/10.1126/science.1111404			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937LY	15845874				2022-12-24	WOS:000229926800053
J	Hundley, HA; Walter, W; Bairstow, S; Craig, EA				Hundley, HA; Walter, W; Bairstow, S; Craig, EA			Human Mpp11 J protein: Ribosome-tethered molecular chaperones are ubiquitous	SCIENCE			English	Article							NEWLY SYNTHESIZED PROTEINS; SACCHAROMYCES-CEREVISIAE; ATPASE ACTIVITY; NASCENT CHAIN; HSP70; COMPLEX; DNAJ; SSB; TRANSLOCATION; BINDING	The existence of specialized molecular chaperones that interact directly with ribosomes is well established in microorganisms. Such proteins bind polypeptides exiting the ribosomal tunnel and provide a physical link between translation and protein folding. We report that ribosome-associated molecular chaperones have been maintained throughout eukaryotic evolution, as illustrated by Mpp11, the human ortholog of the yeast ribosome-associated J protein Zuo. When expressed in yeast, Mpp11 partially substituted for Zuo by partnering with the multipurpose Hsp70 Ssa, the homolog of mammalian Hsc70. We propose that in metazoans, ribosome-associated Mpp11 recruits the multifunctional soluble Hsc70 to nascent polypeptide chains as they exit the ribosome.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, Grad Program Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Craig, EA (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	ecraig@wisc.edu	Hundley, Heather/AAV-2808-2020		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031107] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM031107] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albanese V, 2002, NAT STRUCT BIOL, V9, P716, DOI 10.1038/nsb1002-716; Barouch W, 1997, BIOCHEMISTRY-US, V36, P4303, DOI 10.1021/bi962727z; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; BRODSKY JL, 1993, J CELL BIOL, V123, P1355, DOI 10.1083/jcb.123.6.1355; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Craig EA, 2003, CURR OPIN MICROBIOL, V6, P157, DOI 10.1016/S1369-5274(03)00030-4; D'Silva PD, 2003, P NATL ACAD SCI USA, V100, P13839, DOI 10.1073/pnas.1936150100; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Gautschi M, 2002, P NATL ACAD SCI USA, V99, P4209, DOI 10.1073/pnas.062048599; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Horwich A, 2004, NATURE, V431, P520, DOI 10.1038/431520a; Hundley H, 2002, P NATL ACAD SCI USA, V99, P4203, DOI 10.1073/pnas.062048399; Kim SY, 2005, EUKARYOT CELL, V4, P82, DOI 10.1128/EC.4.1.82-89.2005; MatsumotoTaniura N, 1996, MOL BIOL CELL, V7, P1455, DOI 10.1091/mbc.7.9.1455; Pfund C, 1998, EMBO J, V17, P3981, DOI 10.1093/emboj/17.14.3981; Pfund C, 2001, MOL BIOL CELL, V12, P3773, DOI 10.1091/mbc.12.12.3773; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; WALL D, 1994, J BIOL CHEM, V269, P5446; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; WERNERWASHBURNE M, 1987, MOL CELL BIOL, V7, P2568, DOI 10.1128/MCB.7.7.2568; Yan W, 1998, EMBO J, V17, P4809, DOI 10.1093/emboj/17.16.4809	24	85	89	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2005	308	5724					1032	1034		10.1126/science.1109247	http://dx.doi.org/10.1126/science.1109247			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15802566				2022-12-24	WOS:000229190700049
J	Lam, RTS; Belenguer, A; Roberts, SL; Naumann, C; Jarrosson, T; Otto, S; Sanders, JKM				Lam, RTS; Belenguer, A; Roberts, SL; Naumann, C; Jarrosson, T; Otto, S; Sanders, JKM			Amplification of acetylcholine-binding catenanes from dynamic combinatorial libraries	SCIENCE			English	Article							SELECTION; CHEMISTRY; RECEPTORS; HOSTS	Directed chemical synthesis can produce a vast range of molecular structures, but the intended product must be known at the outset. In contrast, evolution in nature can lead to efficient receptors and catalysts whose structures defy prediction. To access such unpredictable structures, we prepared dynamic combinatorial libraries in which reversibly binding building blocks assemble around a receptor target. We selected for an acetylcholine receptor by adding the neurotransmitter to solutions of dipeptide hydrazones [proline-phenylalanine or proline-(cyclohexyl)alanine], which reversibly combine through hydrazone linkages. At thermodynamic equilibrium, the dominant receptor structure was an elaborate [2]-catenane consisting of two interlocked macrocyclic trimers. This complex receptor with a 100 nM affinity for acetylcholine could be isolated on a preparative scale in 67% yield.	Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge	Sanders, JKM (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	jkms@cam.ac.uk	Naumann, Christoph/A-4552-2010; Jarrosson, Thibaut/K-8730-2018; Otto, Sijbren/E-9568-2014	Jarrosson, Thibaut/0000-0002-2673-4198; Otto, Sijbren/0000-0003-0259-5637; Sanders, Jeremy Keith Morris/0000-0002-5143-5210	Engineering and Physical Sciences Research Council [GR/S76892/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		BRADY PA, 1996, CHEM COMMUN, V35, P2143; Brisig B, 2003, ANGEW CHEM INT EDIT, V42, P1270, DOI 10.1002/anie.200390326; Corbett PT, 2004, CHEM-EUR J, V10, P3139, DOI 10.1002/chem.200400300; Cousins GRL, 2001, ANGEW CHEM INT EDIT, V40, P423, DOI 10.1002/1521-3773(20010119)40:2<423::AID-ANIE423>3.0.CO;2-6; Dietrich-Buchecker C, 1999, CHEM COMMUN, P615, DOI 10.1039/a809885i; Godt A, 2004, EUR J ORG CHEM, V2004, P1639, DOI 10.1002/ejoc.200300503; HUNTER CA, 1992, J AM CHEM SOC, V114, P5303, DOI 10.1021/ja00039a047; Lehn JM, 2001, SCIENCE, V291, P2331, DOI 10.1126/science.1060066; Otto S, 2002, SCIENCE, V297, P590, DOI 10.1126/science.1072361; Otto S, 2003, J AM CHEM SOC, V125, P7804, DOI 10.1021/ja0351589; Otto S, 2003, CURR OPIN DRUG DISC, V6, P509; Raehm L, 2002, SYNLETT, P1743; Ramstrom O, 2002, NAT REV DRUG DISCOV, V1, P26, DOI 10.1038/nrd704; Roberts SL, 2003, ORG BIOMOL CHEM, V1, P1625, DOI 10.1039/b300956d; Rowan SJ, 2002, ANGEW CHEM INT EDIT, V41, P898, DOI 10.1002/1521-3773(20020315)41:6<898::AID-ANIE898>3.0.CO;2-E; Sarri P, 2004, J ORG CHEM, V69, P3654, DOI 10.1021/jo049899j; Vignon SA, 2004, ORG LETT, V6, P1095, DOI 10.1021/ol0364881	17	242	242	0	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2005	308	5722					667	669		10.1126/science.1109999	http://dx.doi.org/10.1126/science.1109999			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15761119				2022-12-24	WOS:000228810900041
J	Wang, YX; Botvinick, EL; Zhao, YH; Berns, MW; Usami, S; Tsien, RY; Chien, S				Wang, YX; Botvinick, EL; Zhao, YH; Berns, MW; Usami, S; Tsien, RY; Chien, S			Visualizing the mechanical activation of Src	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; FOCAL ADHESIONS; FAMILY KINASES; LIVING CELLS; V-SRC; CYTOSKELETON; DOMAIN; SPECIFICITY; P130(CAS); MEMBRANE	The mechanical environment crucially influences many cell functions(1). However, it remains largely mysterious how mechanical stimuli are transmitted into biochemical signals. Src is known to regulate the integrin-cytoskeleton interaction(2), which is essential for the transduction of mechanical stimuli(3-5). Using fluorescent resonance energy transfer (FRET), here we develop a genetically encoded Src reporter that enables the imaging and quantification of spatio-temporal activation of Src in live cells. We introduced a local mechanical stimulation to human umbilical vein endothelial cells (HUVECs) by applying laser-tweezer traction on fibronectin-coated beads adhering to the cells. Using the Src reporter, we observed a rapid distal Src activation and a slower directional wave propagation of Src activation along the plasma membrane. This wave propagated away from the stimulation site with a speed (mean +/- s.e.m.) of 18.1 +/- 1.7 nm s(-1). This force-induced directional and long-range activation of Src was abolished by the disruption of actin filaments or microtubules. Our reporter has thus made it possible to monitor mechanotransduction in live cells with spatio-temporal characterization. We find that the transmission of mechanically induced Src activation is a dynamic process that directs signals via the cytoskeleton to spatial destinations.	Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; Univ Calif San Diego, Whitaker Inst Biomed Engn, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA; Univ Calif Irvine, Beckman Laser Inst, Irvine, CA 92697 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Irvine; University of California System; University of California Irvine	Chien, S (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	schien@bioeng.ucsd.edu		Berns, Michael/0000-0002-9640-2885				ALENGHAT FJ, 2002, SCI STKE, pE6; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Bradshaw JM, 1999, BIOCHEMISTRY-US, V38, P5147, DOI 10.1021/bi982974y; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Chicurel ME, 1998, NATURE, V392, P730, DOI 10.1038/33719; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; Felsenfeld DP, 1999, NAT CELL BIOL, V1, P200, DOI 10.1038/12021; Fincham VJ, 2000, MOL CELL BIOL, V20, P6518, DOI 10.1128/MCB.20.17.6518-6536.2000; Hamasaki K, 1996, BIOCHEM BIOPH RES CO, V222, P338, DOI 10.1006/bbrc.1996.0745; Heidemann SR, 1999, J CELL BIOL, V145, P109, DOI 10.1083/jcb.145.1.109; Hu SH, 2003, AM J PHYSIOL-CELL PH, V285, pC1082, DOI 10.1152/ajpcell.00159.2003; Ingber DE, 2003, J CELL SCI, V116, P1397, DOI 10.1242/jcs.00360; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Kaplan G, 1996, EMBO J, V15, P4282, DOI 10.1002/j.1460-2075.1996.tb00803.x; Mack PJ, 2004, AM J PHYSIOL-CELL PH, V287, pC954, DOI 10.1152/ajpcell.00567.2003; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Timpson P, 2001, CURR BIOL, V11, P1836, DOI 10.1016/S0960-9822(01)00583-8; Ting AY, 2001, P NATL ACAD SCI USA, V98, P15003, DOI 10.1073/pnas.211564598; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vuori K, 1996, MOL CELL BIOL, V16, P2606; WAKSMAN G, 1992, NATURE, V358, P646, DOI 10.1038/358646a0; Yang F, 1999, ANAL BIOCHEM, V266, P167, DOI 10.1006/abio.1998.2885; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	30	525	557	6	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					1040	1045		10.1038/nature03469	http://dx.doi.org/10.1038/nature03469			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846350	Green Published			2022-12-24	WOS:000228524600043
J	Syvitski, JPM; Vorosmarty, CJ; Kettner, AJ; Green, P				Syvitski, JPM; Vorosmarty, CJ; Kettner, AJ; Green, P			Impact of humans on the flux of terrestrial sediment to the global coastal ocean	SCIENCE			English	Article							CLIMATE-CHANGE; RIVERS; VARIABILITY; CALIFORNIA; DISCHARGE	Here we provide global estimates of the seasonal flux of sediment, on a river-by-river basis, under modern and prehuman conditions. Humans have simultaneously increased the sediment transport by global rivers through soil erosion (by 2.3 +/- 0.6 billion metric tons per year), yet reduced the flux of sediment reaching the world's coasts (by 1.4 +/- 0.3 billion metric tons per year) because of retention within reservoirs. Over 100 billion metric tons of sediment and 1 to 3 billion metric tons of carbon are now sequestered in reservoirs constructed largely within the past So years. African and Asian rivers carry a greatly reduced sediment load; Indonesian rivers deliver much more sediment to coastal areas.	Univ Colorado, Inst Arctic & Alpine Res, Environm Computat & Imaging Facil, Boulder, CO 80309 USA; Univ New Hampshire, Inst Study Earth Oceans & Space, Water Syst Anal Grp, Durham, NH 03824 USA; Delft Univ Technol, Delft, Netherlands	University of Colorado System; University of Colorado Boulder; University System Of New Hampshire; University of New Hampshire; Delft University of Technology	Syvitski, JPM (corresponding author), Univ Colorado, Inst Arctic & Alpine Res, Environm Computat & Imaging Facil, Boulder, CO 80309 USA.	james.syvitski@colorado.edu	Syvitski, James P M/L-2008-2013; Kettner, Albert/ABI-7635-2020	Kettner, Albert/0000-0002-7191-6521; Syvitski, Jaia/0000-0003-3116-6997				Dearing JA, 2003, GLOBAL PLANET CHANGE, V39, P147, DOI 10.1016/S0921-8181(03)00022-5; Douglas I., 1993, EARTH TRANSFORMED HU, P215; Fekete B M, 1999, 22 GRDC; Hagemann S, 1998, CLIM DYNAM, V14, P17, DOI 10.1007/s003820050205; Hu D, 2001, IGBP PUBLICATION SER, V3, P245; Inman DL, 1999, J GEOL, V107, P251, DOI 10.1086/314346; Liquete C., 2004, OCEANOGRAPHY, V17, P70, DOI [10.5670/oceanog.2004.05, DOI 10.5670/OCEANOG.2004.05]; Marmulla G., 2001, 419 FAO; McLaughlin CJ, 2003, GLOBAL PLANET CHANGE, V39, P191, DOI 10.1016/S0921-8181(03)00024-9; Milliman J.D., 1992, J GEOL, V100, P25; Morehead MD, 2003, GLOBAL PLANET CHANGE, V39, P95, DOI 10.1016/S0921-8181(03)00019-5; Morehead MK, 2001, GLOBAL PLANET CHANGE, V28, P107, DOI 10.1016/S0921-8181(00)00068-0; Pasternack GB, 2001, EARTH SURF PROC LAND, V26, P409, DOI 10.1002/esp.189; RESTROPO JD, IN PRESS GLOBAL PLAN; Smith SV, 2001, GLOBAL BIOGEOCHEM CY, V15, P697, DOI 10.1029/2000GB001341; Syvitski J.P.M., 1987, FJORDS PROCESSES PRO; Syvitski JP, 1999, MAR GEOL, V154, P13, DOI 10.1016/S0025-3227(98)00100-5; Syvitski JPM, 2004, SEDIMENT GEOL, V164, P345, DOI 10.1016/j.sedgeo.2003.11.001; Syvitski JPM, 2003, SEDIMENT GEOL, V162, P5, DOI 10.1016/S0037-0738(03)00232-X; Syvitski JPM, 2003, GLOBAL PLANET CHANGE, V39, P1, DOI 10.1016/S0921-8181(03)00008-0; Syvitski JPM, 2002, POLAR RES, V21, P323, DOI 10.1111/j.1751-8369.2002.tb00087.x; SYVITSKI JPM, IN PRESS J COASTAL R; SYVITSKI JPM, IN PRESS MAR GEOL; SYVITSKI JPM, IN PRESS LOICZ COAST; Vorosmarty CJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P599, DOI 10.1029/1999GB900092; Vorosmarty CJ, 2003, GLOBAL PLANET CHANGE, V39, P169, DOI 10.1016/S0921-8181(03)00023-7; Vorosmarty CJ, 2000, BIOSCIENCE, V50, P753, DOI 10.1641/0006-3568(2000)050[0753:ADOTTW]2.0.CO;2; Walling DE, 2003, GLOBAL PLANET CHANGE, V39, P111, DOI 10.1016/S0921-8181(03)00020-1; Wolanski E, 2000, REG ENVIRON CHANGE, V1, P152, DOI 10.1007/s101130000014; [No title captured], DOI DOI 10.1126/SCIENCE.278.5341.1209C	30	1765	1887	40	687	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 15	2005	308	5720					376	380		10.1126/science.1109454	http://dx.doi.org/10.1126/science.1109454			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15831750				2022-12-24	WOS:000228492000042
J	Banerjee, A; Yang, W; Karplus, M; Verdine, GL				Banerjee, A; Yang, W; Karplus, M; Verdine, GL			Structure of a repair enzyme interrogating undamaged DNA elucidates recognition of damaged DNA	NATURE			English	Article							FREE-ENERGY SIMULATIONS; CRYSTAL-STRUCTURE; SUBSTRATE RECOGNITION; REVERSE-TRANSCRIPTASE; PROTEIN; GLYCOSYLASE; 8-OXOGUANINE; CATALYSIS; COMPLEX; BASES	How DNA repair proteins distinguish between the rare sites of damage and the vast expanse of normal DNA is poorly understood. Recognizing the mutagenic lesion 8-oxoguanine (oxoG) represents an especially formidable challenge, because this oxidized nucleobase differs by only two atoms from its normal counterpart, guanine (G). Here we report the use of a covalent trapping strategy to capture a human oxoG repair protein, 8-oxogunanine DNA glycosylase I (hOGG1), in the act of interrogating normal DNA. The X-ray structure of the trapped complex features a target G nucleobase extruded from the DNA helix but denied insertion into the lesion recognition pocket of the enzyme. Free energy difference calculations show that both attractive and repulsive interactions have an important role in the preferential binding of oxoG compared with G to the active site. The structure reveals a remarkably effective gate-keeping strategy for lesion discrimination and suggests a mechanism for oxoG insertion into the hOGG1 active site.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Univ Strasbourg 1, ISIS, F-67000 Strasbourg, France	Harvard University; Harvard University; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Karplus, M (corresponding author), Harvard Univ, Dept Chem & Biol Chem, 12 Oxford St, Cambridge, MA 02138 USA.	marci@tammy.harvard.edu; verdine@chemistry.harvard.edu	Yang, Wei/H-5428-2011; Banerjee, Anirban/AAC-4286-2020	Banerjee, Anirban/0000-0002-9314-2862; banerjee, anirban/0000-0003-1494-6801	NATIONAL CANCER INSTITUTE [R01CA100742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044853] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA100742] Funding Source: Medline; NIGMS NIH HHS [R01 GM044853] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BASH PA, 1991, BIOCHEMISTRY-US, V30, P5826, DOI 10.1021/bi00238a003; Berdal KG, 1998, EMBO J, V17, P363, DOI 10.1093/emboj/17.2.363; Bjoras M, 2002, J MOL BIOL, V317, P171, DOI 10.1006/jmbi.2002.5400; BROOKS CL, 1988, ADV CHEM PHYS, V71; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Cappelli E, 2001, CARCINOGENESIS, V22, P387, DOI 10.1093/carcin/22.3.387; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P379; CERVI AR, 1993, NUCLEIC ACIDS RES, V21, P5623, DOI 10.1093/nar/21.24.5623; Cui Q, 2001, J PHYS CHEM B, V105, P569, DOI 10.1021/jp0029109; Dinner AR, 2001, NATURE, V413, P752, DOI 10.1038/35099587; Fromme JC, 2004, NATURE, V427, P652, DOI 10.1038/nature02306; Fromme JC, 2003, NAT STRUCT BIOL, V10, P204, DOI 10.1038/nsb902; Gao YG, 1998, NAT STRUCT BIOL, V5, P782, DOI 10.1038/1822; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Huang HF, 2000, CHEM BIOL, V7, P355, DOI 10.1016/S1074-5521(00)00113-7; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MACMILLAN AM, 1991, TETRAHEDRON, V47, P2603, DOI 10.1016/S0040-4020(01)81793-2; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; Norman DPG, 2003, BIOCHEMISTRY-US, V42, P1564, DOI 10.1021/bi026823d; Norman DPG, 2001, J AM CHEM SOC, V123, P359, DOI 10.1021/ja003144m; O'Brien PJ, 2004, J BIOL CHEM, V279, P26876, DOI 10.1074/jbc.M403860200; Robinson H, 1998, NATURE, V392, P202, DOI 10.1038/32455; Schaefer M, 1997, J PHYS CHEM B, V101, P1663, DOI 10.1021/jp962972s; Simonson T, 2002, ACCOUNTS CHEM RES, V35, P430, DOI 10.1021/ar010030m; SIMONSON T, 1997, J PHYS CHEM-US, V41, P8347; Verdine GL, 2003, ANNU REV BIOCHEM, V72, P337, DOI 10.1146/annurev.biochem.72.121801.161447; Verdine GL, 1997, CHEM BIOL, V4, P329, DOI 10.1016/S1074-5521(97)90123-X; Viadiu H, 2000, MOL CELL, V5, P889, DOI 10.1016/S1097-2765(00)80329-9; Yang W, 2004, J CHEM PHYS, V120, P9450, DOI 10.1063/1.1738106	31	290	319	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2005	434	7033					612	618		10.1038/nature03458	http://dx.doi.org/10.1038/nature03458			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911NN	15800616				2022-12-24	WOS:000228011000037
J	Penkner, AM; Prinz, S; Ferscha, S; Klein, F				Penkner, AM; Prinz, S; Ferscha, S; Klein, F			Mnd2, an essential antagonist of the anaphase-promoting complex during meiotic prophase	CELL			English	Article							MEIOSIS-I DEPENDS; CHROMOSOME SEGREGATION; MITOTIC EXIT; SACCHAROMYCES-CEREVISIAE; SPORE FORMATION; PROTEIN; SEPARASE; SUBUNITS; CDC20; DEGRADATION	Melotic cohesin serves in sister chromatid linkage and DNA repair until its subunit Rec8 is cleaved by separase. Separase is activated when its inhibitor, securin, is polyubiquitinated by the Cdc20 regulated anaphase-promoting complex (ApC(Cdc20)) and consequently degraded. Differently regulated APCs (ApC(Cdh1), ApC(Ama1)) have not been implicated in securin degradation at meiosis 1. We show that Mnd2, a factor known to associate with APC components, prevents premature securin degradation in meiosis by ApC(Ama1). mnd2 Delta cells lack linear chromosome axes and exhibit precocious sister chromatid separation, but deletion of AMA1 suppresses these defects. Besides securin, Sgo1, a protein essential for protection of centromeric cohesion during anaphase 1, is also destabilized in mnd2 Delta cells. Mnd2 ' s disappearance prior to anaphase 11 may activate ApC(Ama1). Human oocytes may spend many years in meiotic prophase before maturation. Inhibitors of meiotic APC variants could prevent loss of chiasmata also in these cells, thereby guarding against aberrant chromosome segregation.	Vienna Bioctr 2, Max Perutz Labs, Dept Chromosome Biol, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Klein, F (corresponding author), Vienna Bioctr 2, Max Perutz Labs, Dept Chromosome Biol, Dr Bohr Gasse 1, A-1030 Vienna, Austria.	franz.klein@univie.ac.at		Klein, Franz/0000-0001-7204-1432				Asakawa H, 2001, MOL GENET GENOMICS, V265, P424, DOI 10.1007/s004380000429; Blanco MA, 2001, J CELL SCI, V114, P2135; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Buonomo SBC, 2003, DEV CELL, V4, P727, DOI 10.1016/S1534-5807(03)00129-1; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Cooper KF, 1997, EMBO J, V16, P4665, DOI 10.1093/emboj/16.15.4665; Cooper KF, 2000, P NATL ACAD SCI USA, V97, P14548, DOI 10.1073/pnas.250351297; Davis ES, 2002, GENETICS, V160, P805; Dong XZ, 1997, GENE DEV, V11, P94, DOI 10.1101/gad.11.1.94; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Golden A, 2000, J CELL BIOL, V151, P1469, DOI 10.1083/jcb.151.7.1469; GOLDWAY M, 1993, GENETICS, V133, P159; Grosskortenhaus R, 2002, DEV CELL, V2, P29, DOI 10.1016/S1534-5807(01)00104-6; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Hall MC, 2003, J BIOL CHEM, V278, P16698, DOI 10.1074/jbc.M213109200; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Kamieniecki RJ, 2000, CURR BIOL, V10, P1182, DOI 10.1016/S0960-9822(00)00723-5; KANE SM, 1974, J BACTERIOL, V118, P8, DOI 10.1128/JB.118.1.8-14.1974; Katis VL, 2004, CURR BIOL, V14, P560, DOI 10.1016/j.cub.2004.03.001; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Loidl J, 1998, METHOD CELL BIOL, V53, P257; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Nairz K, 1997, GENE DEV, V11, P2272, DOI 10.1101/gad.11.17.2272; Passmore LA, 2003, EMBO J, V22, P786, DOI 10.1093/emboj/cdg084; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Peters JM, 1999, EXP CELL RES, V248, P339, DOI 10.1006/excr.1999.4443; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Piatti S, 1996, GENE DEV, V10, P1516, DOI 10.1101/gad.10.12.1516; PRIELER S, 2005, GENE DEV, V19, P1516; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; Rabitsch KP, 2004, CURR BIOL, V14, P287, DOI 10.1016/j.cub.2004.01.051; Rabitsch KP, 2001, CURR BIOL, V11, P1001, DOI 10.1016/S0960-9822(01)00274-3; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Salah SM, 2000, CHROMOSOMA, V109, P27, DOI 10.1007/s004120050409; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Schwickart M, 2004, MOL CELL BIOL, V24, P3562, DOI 10.1128/MCB.24.8.3562-3576.2004; Siomos MF, 2001, CURR BIOL, V11, P1825, DOI 10.1016/S0960-9822(01)00588-7; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Sullivan M, 2001, NAT CELL BIOL, V3, P771, DOI 10.1038/ncb0901-771; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; SYM M, 1995, J CELL BIOL, V128, P455, DOI 10.1083/jcb.128.4.455; Taieb FE, 2001, CURR BIOL, V11, P508, DOI 10.1016/S0960-9822(01)00145-2; Tinker-Kulberg RL, 1999, GENE DEV, V13, P1936, DOI 10.1101/gad.13.15.1936; Varshavsky A, 1997, GENES CELLS, V2, P13, DOI 10.1046/j.1365-2443.1997.1020301.x; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Yoon HJ, 2002, CURR BIOL, V12, P2048, DOI 10.1016/S0960-9822(02)01331-3; Zachariae W, 1996, SCIENCE, V274, P1201, DOI 10.1126/science.274.5290.1201; Zeng XM, 1999, J CELL BIOL, V146, P415, DOI 10.1083/jcb.146.2.415	55	51	56	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 25	2005	120	6					789	801		10.1016/j.cell.2005.01.017	http://dx.doi.org/10.1016/j.cell.2005.01.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	912HF	15797380	Bronze			2022-12-24	WOS:000228067500009
J	Lolle, SJ; Victor, JL; Young, JM; Pruitt, RE				Lolle, SJ; Victor, JL; Young, JM; Pruitt, RE			Genome-wide non-mendelian inheritance of extra-genomic information in Arabidopsis	NATURE			English	Article							CHIMERIC RNA/DNA OLIGONUCLEOTIDES; DEPENDENT RNA-POLYMERASE; DOUBLE-STRANDED-RNA; ORGAN FUSION; GENE; METHYLATION; MUTATION; TRANSGENE; NEUROSPORA; EVOLUTION	A fundamental tenet of classical mendelian genetics is that allelic information is stably inherited from one generation to the next, resulting in predictable segregation patterns of differing alleles(1). Although several exceptions to this principle are known, all represent specialized cases that are mechanistically restricted to either a limited set of specific genes ( for example mating type conversion in yeast(2)) or specific types of alleles ( for example alleles containing transposons(3) or repeated sequences(4)). Here we show that Arabidopsis plants homozygous for recessive mutant alleles of the organ fusion gene HOTHEAD(5) (HTH) can inherit allele-specific DNA sequence information that was not present in the chromosomal genome of their parents but was present in previous generations. This previously undescribed process is shown to occur at all DNA sequence polymorphisms examined and therefore seems to be a general mechanism for extragenomic inheritance of DNA sequence information. We postulate that these genetic restoration events are the result of a template-directed process that makes use of an ancestral RNA-sequence cache.	Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Pruitt, RE (corresponding author), Purdue Univ, Dept Bot & Plant Pathol, 915 W State St, W Lafayette, IN 47907 USA.	pruittr@purdue.edu		Pruitt, Robert E/0000-0003-4817-5806				AUERBACH C, 1971, ANNU REV GENET, V5, P163, DOI 10.1146/annurev.ge.05.120171.001115; Bao N, 2004, DEV CELL, V7, P653, DOI 10.1016/j.devcel.2004.10.003; Beetham PR, 1999, P NATL ACAD SCI USA, V96, P8774, DOI 10.1073/pnas.96.15.8774; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Cogoni C, 1996, EMBO J, V15, P3153, DOI 10.1002/j.1460-2075.1996.tb00678.x; ColeStrauss A, 1996, SCIENCE, V273, P1386, DOI 10.1126/science.273.5280.1386; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FOSTER PL, 1992, GENETICS, V131, P783; Galitski T, 1996, GENETICS, V143, P645; GONDO Y, 1993, P NATL ACAD SCI USA, V90, P297, DOI 10.1073/pnas.90.1.297; HALL BG, 1990, GENETICS, V126, P5; KLAR AJS, 1979, GENETICS, V92, P777; Kovalchuk I, 2003, NATURE, V423, P760, DOI 10.1038/nature01683; Krolikowski KA, 2003, PLANT J, V35, P501, DOI 10.1046/j.1365-313X.2003.01824.x; Lolle SJ, 1998, GENETICS, V149, P607; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; Mendel G., 1866, VERHAND NATURF VER B, V4, P3, DOI DOI 10.5962/BHL.TITLE.61004; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; Pruitt RE, 2000, P NATL ACAD SCI USA, V97, P1311, DOI 10.1073/pnas.97.3.1311; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Ries G, 2000, NATURE, V406, P98, DOI 10.1038/35017595; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; Taller J, 1998, THEOR APPL GENET, V97, P705, DOI 10.1007/s001220050946; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; Zhu T, 1999, P NATL ACAD SCI USA, V96, P8768, DOI 10.1073/pnas.96.15.8768	30	142	152	0	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2005	434	7032					505	509		10.1038/nature03380	http://dx.doi.org/10.1038/nature03380			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909CH	15785770				2022-12-24	WOS:000227836000042
J	Sonnichsen, B; Koski, LB; Walsh, A; Marschall, P; Neumann, B; Brehm, M; Alleaume, AM; Artelt, J; Bettencourt, P; Cassin, E; Hewitson, M; Holz, C; Khan, M; Lazik, S; Martin, C; Nitzsche, B; Ruer, M; Stamford, J; Winzi, M; Heinkel, R; Roder, M; Finell, J; Hantsch, H; Jones, SJM; Jones, M; Piano, F; Gunsalus, KC; Oegema, K; Gonczy, P; Coulson, A; Hyman, AA; Echeverri, CJ				Sonnichsen, B; Koski, LB; Walsh, A; Marschall, P; Neumann, B; Brehm, M; Alleaume, AM; Artelt, J; Bettencourt, P; Cassin, E; Hewitson, M; Holz, C; Khan, M; Lazik, S; Martin, C; Nitzsche, B; Ruer, M; Stamford, J; Winzi, M; Heinkel, R; Roder, M; Finell, J; Hantsch, H; Jones, SJM; Jones, M; Piano, F; Gunsalus, KC; Oegema, K; Gonczy, P; Coulson, A; Hyman, AA; Echeverri, CJ			Full-genome RNAi profiling of early embryogenesis in Caenorhabditis elegans	NATURE			English	Article							DOUBLE-STRANDED-RNA; C-ELEGANS; CELL-DIVISION; INTERFERENCE; GENES; GENERATION; EMBRYOS	A key challenge of functional genomics today is to generate well-annotated data sets that can be interpreted across different platforms and technologies. Large-scale functional genomics data often fail to connect to standard experimental approaches of gene characterization in individual laboratories. Furthermore, a lack of universal annotation standards for phenotypic data sets makes it difficult to compare different screening approaches. Here we address this problem in a screen designed to identify all genes required for the first two rounds of cell division in the Caenorhabditis elegans embryo. We used RNA-mediated interference to target 98% of all genes predicted in the C. elegans genome in combination with differential interference contrast time-lapse microscopy. Through systematic annotation of the resulting movies, we developed a phenotypic profiling system, which shows high correlation with cellular processes and biochemical pathways, thus enabling us to predict new functions for previously uncharacterized genes.	Cenix Biosci GmbH, D-01307 Dresden, Germany; Max Planck Inst Cell Biol & Genet, D-01307 Dresden, Germany; British Columbia Canc Res Ctr, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; NYU, Dept Biol, Ctr Comparat Funct Genom, New York, NY 10003 USA	Max Planck Society; British Columbia Cancer Agency; Wellcome Trust Sanger Institute; New York University	Sonnichsen, B (corresponding author), Cenix Biosci GmbH, Tatzberg 47-51, D-01307 Dresden, Germany.	soennichsen@cenix.bioscience.com	Jones, Steven J/C-3621-2009; Hyman, Tony/F-1923-2011; Hyman, Anthony A/B-3917-2017; Bettencourt, Paulo/V-5793-2017	Jones, Steven J/0000-0003-3394-2208; Hyman, Anthony A/0000-0003-3664-154X; Bettencourt, Paulo/0000-0002-4884-5470; Gonczy, Pierre/0000-0002-6305-6883; Neumann, Beate/0000-0002-6899-502X; Nitzsche, Bjorn/0000-0002-4759-0760; Alleaume, Anne-Marie/0000-0001-7881-1880				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Askjaer P, 2002, MOL BIOL CELL, V13, P4355, DOI 10.1091/mbc.E02-06-0346; BRENNER S, 1974, GENETICS, V77, P71; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Davy A, 2001, EMBO REP, V2, P821, DOI 10.1093/embo-reports/kve184; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Gonczy P, 1999, J CELL BIOL, V144, P927, DOI 10.1083/jcb.144.5.927; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; KIGER A, 2003, J BIOL, V2; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Piano F, 2002, CURR BIOL, V12, P1959, DOI 10.1016/S0960-9822(02)01301-5; Schneider SQ, 2003, ANNU REV GENET, V37, P221, DOI 10.1146/annurev.genet.37.110801.142443; STROME S, 1983, CELL, V35, P15, DOI 10.1016/0092-8674(83)90203-9; Walhout AJM, 2002, CURR BIOL, V12, P1952, DOI 10.1016/S0960-9822(02)01279-4; Zipperlen P, 2001, EMBO J, V20, P3984, DOI 10.1093/emboj/20.15.3984	21	682	704	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2005	434	7032					462	469		10.1038/nature03353	http://dx.doi.org/10.1038/nature03353			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909CH	15791247				2022-12-24	WOS:000227836000032
J	Turek, FW; Joshu, C; Kohsaka, A; Lin, E; Ivanova, G; McDearmon, E; Laposky, A; Losee-Olson, S; Easton, A; Jensen, DR; Eckel, RH; Takahashi, JS; Bass, J				Turek, FW; Joshu, C; Kohsaka, A; Lin, E; Ivanova, G; McDearmon, E; Laposky, A; Losee-Olson, S; Easton, A; Jensen, DR; Eckel, RH; Takahashi, JS; Bass, J			Obesity and metabolic syndrome in circadian Clock mutant mice	SCIENCE			English	Article							SUPRACHIASMATIC NUCLEUS; ENERGY HOMEOSTASIS; GENE-EXPRESSION; MOUSE; GHRELIN; SLEEP; LIVER; IDENTIFICATION; REPRODUCTION; PATHWAYS	The CLOCK transcription factor is a key component of the molecular circadian clock within pacemaker neurons of the hypothalamic suprachiasmatic nucleus. We found that homozygous Clock mutant mice have a greatly attenuated diurnal feeding rhythm, are hyperphagic and obese, and develop a metabolic syndrome of hyperleptinemia, hyperlipidemia, hepatic steatosis, hyperglycemia, and hypoinsulinemia. Expression of transcripts encoding selected hypothalamic peptides associated with energy balance was attenuated in the Clock mutant mice. These results suggest that the circadian clock gene network plays an important rote in mammalian energy balance.	Northwestern Univ, Feinberg Sch Med, Dept Med, Evanston, IL 60208 USA; Northwestern Univ, Feinberg Sch Med, Dept Neurol, Evanston, IL 60208 USA; Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Evanston NW Healthcare Res Inst, Evanston, IL 60208 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA; Hlth Sci Ctr, Aurora, CO 80045 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Howard Hughes Medical Institute; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Bass, J (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Evanston, IL 60208 USA.	j-bass@northwestern.edu	Jansen, Heiko T./A-5770-2008; Takahashi, Joseph S./Y-2781-2019; Takahashi, Joseph S/E-8482-2012	Jansen, Heiko T./0000-0003-0178-396X; Takahashi, Joseph S./0000-0003-0384-8878; Takahashi, Joseph S/0000-0003-0384-8878	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059598, R01HL075029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002675, R01DK026356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018200, P01AG011412] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [R01 HL075029, HL75029, R01 HL059598, HL59598] Funding Source: Medline; NIA NIH HHS [R01 AG018200, AG18200, AG11412, P01 AG011412] Funding Source: Medline; NIDDK NIH HHS [R01 DK026356, K08 DK002675, DK26356, DK02675] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bodosi B, 2004, AM J PHYSIOL-REG I, V287, pR1071, DOI 10.1152/ajpregu.00294.2004; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Kanamoto N, 2004, ENDOCRINOLOGY, V145, P4144, DOI 10.1210/en.2003-1718; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kitamura Y, 2004, REV ENDOCR METAB DIS, V5, P143, DOI 10.1023/B:REMD.0000021436.91347.93; la Fleur SE, 2001, DIABETES, V50, P1237, DOI 10.2337/diabetes.50.6.1237; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Taheri S, 2002, ANNU REV NEUROSCI, V25, P283, DOI 10.1146/annurev.neuro.25.112701.142826; TAKAHASHI JS, 2001, HDB BEHAV NEUROBIOLO, V12, P770; VANCAUTER E, 2000, HDB PHYSL 7, P313; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Willie JT, 2001, ANNU REV NEUROSCI, V24, P429, DOI 10.1146/annurev.neuro.24.1.429; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yamada K, 2002, INT J OBESITY, V26, P132, DOI 10.1038/sj.ijo.0801848; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	27	1734	1806	12	238	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2005	308	5724					1043	1045		10.1126/science.1108750	http://dx.doi.org/10.1126/science.1108750			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15845877	Green Accepted			2022-12-24	WOS:000229190700053
J	Indovina, I; Maffei, V; Bosco, G; Zago, M; Macaluso, E; Lacquaniti, F				Indovina, I; Maffei, V; Bosco, G; Zago, M; Macaluso, E; Lacquaniti, F			Representation of visual gravitational motion in the human vestibular cortex	SCIENCE			English	Article							INTERNAL-MODELS; EYE-MOVEMENTS; PERCEPTION; GRAVITY; ACCELERATION; INTERCEPTION; RESPONSES; BRAIN; LAWS; STIMULATION	How do we perceive the visual motion of objects that. are accelerated by gravity? We propose that, because vision is poorly sensitive to accelerations, an internal model that calculates the effects of gravity is derived from graviceptive information, is stored in the vestibular cortex, and is activated by visual motion that appears to be coherent with natural gravity. The acceleration of visual targets was manipulated while brain activity was measured using functional magnetic resonance imaging. In agreement with the internal model hypothesis, we found that the vestibular network was selectively engaged when acceleration was consistent with natural gravity. These findings demonstrate that predictive mechanisms of physical laws of motion are represented in the human brain.	Sci Inst Fdn Santa Lucia, Dept Neuromotor Physiol, I-00179 Rome, Italy; Sci Inst Fdn Santa Lucia, Dept Neuroimaging, I-00179 Rome, Italy; Univ Roma Tor Vergata, Dept Neurosci, I-00133 Rome, Italy; Univ Roma Tor Vergata, Ctr Space Biomed, I-00173 Rome, Italy	IRCCS Santa Lucia; IRCCS Santa Lucia; University of Rome Tor Vergata; University of Rome Tor Vergata	Lacquaniti, F (corresponding author), Sci Inst Fdn Santa Lucia, Dept Neuromotor Physiol, Via Ardeatina 306, I-00179 Rome, Italy.	lacquaniti@caspur.it	Indovina, Iole/Z-2978-2019; Macaluso, Emiliano/H-3139-2017; Bosco, Gianfranco/AAA-1548-2019; Lacquaniti, Francesco/J-9842-2016; Zago, Myrka/B-3669-2012; Macaluso, Emiliano/AAE-9185-2019	Indovina, Iole/0000-0002-1183-0013; Macaluso, Emiliano/0000-0002-1919-5288; Bosco, Gianfranco/0000-0002-7080-0674; Lacquaniti, Francesco/0000-0003-0896-7315; Zago, Myrka/0000-0001-7100-7582; Macaluso, Emiliano/0000-0002-1919-5288; maffei, vincenzo/0000-0003-0957-6615				Angelaki DE, 2004, NATURE, V430, P560, DOI 10.1038/nature02754; Bense S, 2001, J NEUROPHYSIOL, V85, P886, DOI 10.1152/jn.2001.85.2.886; Blanke O, 2002, NATURE, V419, P269, DOI 10.1038/419269a; BOTTINI G, 1994, EXP BRAIN RES, V99, P164; BRANDT T, 1994, ANN NEUROL, V35, P403, DOI 10.1002/ana.410350406; Brouwer AM, 2002, PERCEPT PSYCHOPHYS, V64, P1160, DOI 10.3758/BF03194764; GRUSSER OJ, 1990, J PHYSIOL-LONDON, V430, P537; Guldin WO, 1998, TRENDS NEUROSCI, V21, P254, DOI 10.1016/S0166-2236(97)01211-3; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; Jokisch D, 2003, J VISION, V3, P252, DOI 10.1167/3.4.1; KIM IK, 1992, J EXP PSYCHOL HUMAN, V18, P385, DOI 10.1037/0096-1523.18.2.385; LACQUANITI F, 1989, J NEUROSCI, V9, P134, DOI 10.1523/JNEUROSCI.09-01-00134.1989; Lacquaniti F., 1993, MULTISENSORY CONTROL, P379, DOI [10.1093/acprof:oso/9780198547853.003.0190, DOI 10.1093/ACPROF:OSO/9780198547853.003.0190]; LEE DN, 1981, NATURE, V293, P293, DOI 10.1038/293293a0; Lisberger SG, 1999, J NEUROSCI, V19, P2224; MCBEATH MK, 1995, SCIENCE, V268, P569, DOI 10.1126/science.7725104; McIntyre J, 2001, NAT NEUROSCI, V4, P693, DOI 10.1038/89477; Merchant H, 2004, CEREB CORTEX, V14, P314, DOI 10.1093/cercor/bhg130; Merfeld DM, 1999, NATURE, V398, P615, DOI 10.1038/19303; Orban GA, 2003, NEUROPSYCHOLOGIA, V41, P1757, DOI 10.1016/S0028-3932(03)00177-5; Peterka RJ, 2004, J NEUROPHYSIOL, V92, P2333, DOI 10.1152/jn.00174.2004; Port NL, 1997, EXP BRAIN RES, V116, P406, DOI 10.1007/PL00005769; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; SHEPARD RN, 1984, PSYCHOL REV, V91, P417, DOI 10.1037/0033-295X.91.4.417; Smetacek V, 2002, NATURE, V415, P481, DOI 10.1038/415481a; Todd J T, 1981, J Exp Psychol Hum Percept Perform, V7, P975; Twardy CR, 2002, PERCEPT PSYCHOPHYS, V64, P956, DOI 10.3758/BF03196799; WATSON JS, 1992, PERCEPTION, V21, P69, DOI 10.1068/p210069; WERKHOVEN P, 1992, VISION RES, V32, P2313, DOI 10.1016/0042-6989(92)90095-Z; Zago M, 2004, J NEUROPHYSIOL, V91, P1620, DOI 10.1152/jn.00862.2003; Zupan LH, 2002, BIOL CYBERN, V86, P209, DOI 10.1007/s00422-001-0290-1	31	233	235	3	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2005	308	5720					416	419		10.1126/science.1107961	http://dx.doi.org/10.1126/science.1107961			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15831760	Green Published			2022-12-24	WOS:000228492000054
J	Wootton, SK; Halbert, CL; Miller, AD				Wootton, SK; Halbert, CL; Miller, AD			Sheep retrovirus structural protein induces lung tumours	NATURE			English	Article							RODENT FIBROBLASTS; JAAGSIEKTE; TRANSFORMATION; RECEPTOR; VECTORS; TRANSDUCTION; CELLS; HYAL2; GENE; BRONCHIOLOALVEOLAR	Jaagsiekte sheep retrovirus ( JSRV) causes a contagious lung cancer in sheep and goats, with significant animal health and economic consequences(1). The host range of JSRV is in part limited by species-specific differences in the virus entry receptor, hyaluronidase 2 (Hyal2), which is not functional as a receptor in mice but is functional in humans(2). Sheep are immunotolerant of JSRV because of the expression of closely related endogenous retroviruses(3,4), which are not present in humans and most other species, and this may facilitate oncogenesis. Here we show that expression of the JSRV envelope (Env) protein alone in lungs of mice, by using a replication-incompetent adeno-associated virus vector, results in tumours with a bronchiolo-alveolar localization like those seen in sheep. Whereas lethal disease was observed in immunodeficient mice, tumour development was almost entirely blocked in immunocompetent mice. Our results provide a rare example of an oncogenic viral structural protein, show that interaction of the viral Env protein with the virus entry receptor Hyal2 is not required for tumorigenesis, and indicate that immune recognition of Env can protect against JSRV tumorigenesis.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Miller, AD (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N, Seattle, WA 98109 USA.	dmiller@fhcrc.org		Miller, Dusty/0000-0002-3736-3660	NIDDK NIH HHS [P30 DK047754] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL054881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK047754] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allen JM, 2000, MOL THER, V1, P88, DOI 10.1006/mthe.1999.0010; Allen TE, 2002, J GEN VIROL, V83, P2733, DOI 10.1099/0022-1317-83-11-2733; Danilkovitch-Miagkova A, 2003, P NATL ACAD SCI USA, V100, P4580, DOI 10.1073/pnas.0837136100; De las Heras M, 2000, EUR RESPIR J, V16, P330, DOI 10.1034/j.1399-3003.2000.16b23.x; FAN H, 2003, JAAGSIEKTE SHEEP RET; Fisher GH, 1999, ONCOGENE, V18, P5253, DOI 10.1038/sj.onc.1203087; Halbert CL, 2002, NAT BIOTECHNOL, V20, P697, DOI 10.1038/nbt0702-697; Halbert CL, 1997, J VIROL, V71, P5932, DOI 10.1128/JVI.71.8.5932-5941.1997; Halbert CL, 2001, J VIROL, V75, P6615, DOI 10.1128/JVI.75.14.6615-6624.2001; Hiatt KM, 2002, HUM PATHOL, V33, P680, DOI 10.1053/hupa.2002.125776; Liu SL, 2005, J VIROL, V79, P927, DOI 10.1128/JVI.79.2.927-933.2005; Liu SL, 2003, J VIROL, V77, P7924, DOI 10.1128/JVI.77.14.7924-7935.2003; Liu SL, 2003, J VIROL, V77, P2850, DOI 10.1128/JVI.77.5.2850-2858.2003; Maeda N, 2001, P NATL ACAD SCI USA, V98, P4449, DOI 10.1073/pnas.071547598; MALKINSON AM, 1989, TOXICOLOGY, V54, P241, DOI 10.1016/0300-483X(89)90062-0; Miller AD, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-64; Palmarini M, 2001, J VIROL, V75, P11002, DOI 10.1128/JVI.75.22.11002-11009.2001; Platt JA, 2002, VET PATHOL, V39, P341, DOI 10.1354/vp.39-3-341; Rai SK, 2000, J VIROL, V74, P4698, DOI 10.1128/JVI.74.10.4698-4704.2000; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; SHARP JM, 1983, ARCH VIROL, V78, P89, DOI 10.1007/BF01310861; Spencer TE, 2003, J VIROL, V77, P749, DOI 10.1128/JVI.77.1.749-753.2003; Summers C, 2002, J GEN VIROL, V83, P1753, DOI 10.1099/0022-1317-83-7-1753; Yousem SA, 2001, HUM PATHOL, V32, P1039, DOI 10.1053/hupa.2001.28249	24	115	126	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2005	434	7035					904	907		10.1038/nature03492	http://dx.doi.org/10.1038/nature03492			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915SV	15829964	Green Accepted			2022-12-24	WOS:000228327600042
J	Hughes, AL; Todd, BL; Espenshade, PJ				Hughes, AL; Todd, BL; Espenshade, PJ			SREBP pathway responds to sterols and functions as an oxygen sensor in fission yeast	CELL			English	Article							CLEAVAGE-ACTIVATING PROTEIN; ELEMENT-BINDING PROTEINS; SACCHAROMYCES-CEREVISIAE; REGULATORY ELEMENT; SCHIZOSACCHAROMYCES-POMBE; CHOLESTEROL HOMEOSTASIS; SITE-1 PROTEASE; LIPID-SYNTHESIS; SCAP; GENES	Cholesterol and fatty acid synthesis in mammals are controlled by SREBPs, a family of membrane bound transcription factors. Our studies identified homologs of SREBP, its binding partner SCAP, and the ER retention protein Insig in Schizosaccharomyces pombe, named sre1(+), scp1(+), and ins1(+). Like SREBP, Sre1 is cleaved and activated in response to sterol depletion in a Scp1-dependent manner. Microarray analysis revealed that Sre1 activates sterol biosynthetic enzymes as in mammals, and, surprisingly, Sre1 also stimulates transcription of genes required for adaptation to hypoxia. Furthermore, Sre1 rapidly activates these target genes in response to low oxygen and is itself required for anaerobic growth. Based on these findings, we propose and test a model in which Sre1 and Scp1 monitor oxygen-dependent sterol synthesis as an indirect measure of oxygen supply and mediate a hypoxic response in fission yeast.	Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Espenshade, PJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA.	peter.espenshade@jhmi.edu		Hughes, Adam/0000-0002-7095-3793	NHLBI NIH HHS [HL-077588, R01 HL077588-01, R01 HL077588] Funding Source: Medline; NIGMS NIH HHS [GM007445] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077588] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alfa C, 1993, EXPT FISSION YEAST L; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BROWN MS, 1978, J BIOL CHEM, V253, P1121; BURKE JD, 1994, MOL GEN GENET, V242, P169, DOI 10.1007/BF00391010; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Espenshade PJ, 1999, J BIOL CHEM, V274, P22795, DOI 10.1074/jbc.274.32.22795; Feramisco JD, 2004, J BIOL CHEM, V279, P8487, DOI 10.1074/jbc.M312623200; Gardner RG, 2001, J BIOL CHEM, V276, P8681, DOI 10.1074/jbc.M007888200; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; KORNITZER D, 1994, EMBO J, V13, P6021, DOI 10.1002/j.1460-2075.1994.tb06948.x; Kwast KE, 2002, J BACTERIOL, V184, P250, DOI 10.1128/JB.184.1.250-265.2002; Kwast KE, 1998, J EXP BIOL, V201, P1177; Loewen CJR, 2002, CURR BIOL, V12, pR779, DOI 10.1016/S0960-9822(02)01292-7; LORENZ RT, 1991, LIPIDS, V26, P598, DOI 10.1007/BF02536423; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; McKay RM, 2003, DEV CELL, V4, P131, DOI 10.1016/S1534-5807(02)00411-2; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Parraga A, 1998, STRUCT FOLD DES, V6, P661, DOI 10.1016/S0969-2126(98)00067-7; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Rawson RB, 2003, NAT REV MOL CELL BIO, V4, P631, DOI 10.1038/nrm1174; Rosenfeld E, 2003, YEAST, V20, P1115, DOI 10.1002/yea.1026; Sambrook J., 2001, MOL CLONING LAB MANU; Seegmiller AC, 2002, DEV CELL, V2, P229, DOI 10.1016/S1534-5807(01)00119-8; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Vik A, 2001, MOL CELL BIOL, V21, P6395, DOI 10.1128/MCB.21.19.6395-6405.2001; Wang H, 2001, J NEUROCHEM, V77, P53; Wilcox LJ, 2002, J BIOL CHEM, V277, P32466, DOI 10.1074/jbc.M204707200; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Yabe D, 2002, P NATL ACAD SCI USA, V99, P16672, DOI 10.1073/pnas.262669399; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Ye J, 2000, P NATL ACAD SCI USA, V97, P5123, DOI 10.1073/pnas.97.10.5123	36	254	256	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 25	2005	120	6					831	842		10.1016/j.cell.2005.01.012	http://dx.doi.org/10.1016/j.cell.2005.01.012			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	912HF	15797383	Bronze			2022-12-24	WOS:000228067500012
J	Rosenfeld, N; Young, JW; Alon, U; Swain, PS; Elowitz, MB				Rosenfeld, N; Young, JW; Alon, U; Swain, PS; Elowitz, MB			Gene regulation at the single-cell level	SCIENCE			English	Article							BACTERIOPHAGE-LAMBDA; ESCHERICHIA-COLI; EXPRESSION; NETWORKS; STOCHASTICITY; REPRESSOR; NOISE; TRANSCRIPTION; FEEDBACK; OPERATOR	The quantitative relation between transcription factor concentrations and the rate of protein production from downstream genes is central to the function of genetic networks. Here we show that this relation, which we call the gene regulation function (GRF), fluctuates dynamically in individual living cells, thereby limiting the accuracy with which transcriptional genetic circuits can transfer signals. Using fluorescent reporter genes and fusion proteins, we characterized the bacteriophage lambda promoter P-R in Escherichia coli. A novel technique based on binomial errors in protein partitioning enabled calibration of in vivo biochemical parameters in molecular units. We found that protein production rates fluctuate over a time scale of about one cell cycle, while intrinsic noise decays rapidly. Thus, biochemical parameters, noise, and slowly varying cellular states together determine the effective single-cell GRF. These results can form a basis for quantitative modeling of natural gene circuits and for design of synthetic ones.	CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; Weizmann Inst Sci, Dept Mol Cell Biol & Phys Complex Syst, IL-76100 Rehovot, Israel; McGill Univ, Dept Physiol, Ctr Nonlinear Dynam, Montreal, PQ H3G 1Y6, Canada	California Institute of Technology; California Institute of Technology; Weizmann Institute of Science; McGill University	Elowitz, MB (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	melowitz@caltech.edu	Swain, Peter S/AAW-3265-2020	Swain, Peter/0000-0001-7489-8587				Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Darling PJ, 2000, J MOL BIOL, V302, P625, DOI 10.1006/jmbi.2000.4050; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Dodd IB, 2004, GENE DEV, V18, P344, DOI 10.1101/gad.1167904; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; KOBLAN KS, 1992, BIOCHEMISTRY-US, V31, P57, DOI 10.1021/bi00116a010; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; MCADAMS HH, 1995, SCIENCE, V269, P650, DOI 10.1126/science.7624793; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; MEYER BJ, 1980, J MOL BIOL, V139, P163, DOI 10.1016/0022-2836(80)90303-4; Mirasoli M, 2002, ANAL CHEM, V74, P5948, DOI 10.1021/ac0259008; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Ptashne M, 1992, GENETIC SWITCH PHAGE; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; SAVAGEAU MA, 1976, BIOCH SYSTEMS ANAL; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Swain PS, 2004, J MOL BIOL, V344, P965, DOI 10.1016/j.jmb.2004.09.073	29	788	809	3	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2005	307	5717					1962	1965		10.1126/science.1106914	http://dx.doi.org/10.1126/science.1106914			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910UI	15790856				2022-12-24	WOS:000227957300057
J	McCoy, CB; Rodriguez, F				McCoy, CB; Rodriguez, F			Global overview of injecting drug use and HIV infection	LANCET			English	Editorial Material									Univ Miami, Miller Sch Med, Dept Epidemiol & Publ Hlth, Miami, FL 33176 USA; Univ Costa Rica, Inst Hlth Res, San Jose, Costa Rica	University of Miami; Universidad Costa Rica	McCoy, CB (corresponding author), Univ Miami, Miller Sch Med, Dept Epidemiol & Publ Hlth, Miami, FL 33176 USA.	cmccoy@med.miami.edu						Aceijas C, 2004, AIDS, V18, P2295, DOI 10.1097/00002030-200411190-00010; [Anonymous], 1992, AIDS WORLD; Ball A L, 1998, Public Health Rep, V113 Suppl 1, P170; DESJARLAIS DC, 1992, AIDS, V6, P1053, DOI 10.1097/00002030-199210000-00001; McCoy CB, 2004, ANN EPIDEMIOL, V14, P535, DOI 10.1016/j.annepidem.2003.10.001; Pisani E., 2003, ESTIMATING SIZE POPU; Stimson G. V., 1993, Bulletin on Narcotics, V45, P3; *UNAIDS, 2003, FOLL UP 2001 UN GEN	8	11	11	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 19	2005	365	9464					1008	1009						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907QB	15781081				2022-12-24	WOS:000227731800006
J	Carrel, L; Willard, HF				Carrel, L; Willard, HF			X-inactivation profile reveals extensive variability in X-linked gene expression in females	NATURE			English	Article							CHROMOSOME INACTIVATION; MAMMALIAN X; FACULTATIVE HETEROCHROMATIN; REPEAT HYPOTHESIS; METHYLATION; REGION	In female mammals, most genes on one X chromosome are silenced as a result of X-chromosome inactivation(1,2). However, some genes escape X-inactivation and are expressed from both the active and inactive X chromosome. Such genes are potential contributors to sexually dimorphic traits, to phenotypic variability among females heterozygous for X-linked conditions, and to clinical abnormalities in patients with abnormal X chromosomes(3). Here, we present a comprehensive X-inactivation profile of the human X chromosome, representing an estimated 95% of assayable genes in fibroblast-based test systems(4,5). In total, about 15% of X-linked genes escape inactivation to some degree, and the proportion of genes escaping inactivation differs dramatically between different regions of the X chromosome, reflecting the evolutionary history of the sex chromosomes. An additional 10% of X-linked genes show variable patterns of inactivation and are expressed to different extents from some inactive X chromosomes. This suggests a remarkable and previously unsuspected degree of expression heterogeneity among females.	Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Duke University	Carrel, L (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA.	lcarrel@psu.edu						Bailey JA, 2000, P NATL ACAD SCI USA, V97, P6634, DOI 10.1073/pnas.97.12.6634; Brown CJ, 2003, TRENDS GENET, V19, P432, DOI 10.1016/S0168-9525(03)00177-X; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; Carrel L, 1999, P NATL ACAD SCI USA, V96, P14440, DOI 10.1073/pnas.96.25.14440; Carrel L, 1999, P NATL ACAD SCI USA, V96, P7364, DOI 10.1073/pnas.96.13.7364; Chadwick BP, 2004, P NATL ACAD SCI USA, V101, P17450, DOI 10.1073/pnas.0408021101; Chadwick BP, 2003, SEMIN CELL DEV BIOL, V14, P359, DOI 10.1016/j.semcdb.2003.09.016; Esposito T, 1997, GENOMICS, V43, P183, DOI 10.1006/geno.1997.4797; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; Graves JAM, 1996, ANNU REV GENET, V30, P233, DOI 10.1146/annurev.genet.30.1.233; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Jegalian K, 1998, NATURE, V394, P776, DOI 10.1038/29522; Ke X, 2003, ANN HUM GENET, V67, P242, DOI 10.1046/j.1469-1809.2003.00038.x; Kohn M, 2004, TRENDS GENET, V20, P598, DOI 10.1016/j.tig.2004.09.008; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; LYON MF, 1962, AM J HUM GENET, V14, P135; Lyon MF, 1998, CYTOGENET CELL GENET, V80, P133, DOI 10.1159/000014969; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Miller AP, 1998, P NATL ACAD SCI USA, V95, P8709, DOI 10.1073/pnas.95.15.8709; MOHANDAS T, 1981, SCIENCE, V211, P393, DOI 10.1126/science.6164095; Ohno S., 1967, SEX CHROMOSOMES SEX; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Rougeulle C, 2004, MOL CELL BIOL, V24, P5475, DOI 10.1128/MCB.24.12.5475-5484.2004; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Willard HF, 2000, METABOLIC MOL BASES, P1191; Wizemann T. M., 2001, EXPLORING BIOL CONTR	28	1427	1471	1	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2005	434	7031					400	404		10.1038/nature03479	http://dx.doi.org/10.1038/nature03479			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772666				2022-12-24	WOS:000227715100056
J	High, K				High, K			Anemia and gene therapy - A matter of control	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Univ Penn, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania	High, K (corresponding author), Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.							Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Kirn D, 2002, TRENDS MOL MED, V8, pS68, DOI 10.1016/S1471-4914(02)02318-3; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Takacs K, 2004, P NATL ACAD SCI USA, V101, P16298, DOI 10.1073/pnas.0405271101	5	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2005	352	11					1146	1147		10.1056/NEJMcibr044437	http://dx.doi.org/10.1056/NEJMcibr044437			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906PU	15784669				2022-12-24	WOS:000227655000016
J	Zatorre, R; McGill, J				Zatorre, R; McGill, J			Music, the food of neuroscience?	NATURE			English	Article							ABSOLUTE PITCH; LANGUAGE; BRAIN		Montreal Neurol Inst, Montreal, PQ, Canada	McGill University	Zatorre, R (corresponding author), Montreal Neurol Inst, Montreal, PQ, Canada.							Ayotte J, 2000, BRAIN, V123, P1926, DOI 10.1093/brain/123.9.1926; Baharloo S, 2000, AM J HUM GENET, V67, P755, DOI 10.1086/303057; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Drayna D, 2001, SCIENCE, V291, P1969, DOI 10.1126/science.291.5510.1969; Luria A R, 1965, J Neurol Sci, V2, P288, DOI 10.1016/0022-510X(65)90113-9; Meyer L. B., 1956, EMOTION MEANING MUSI; PANTEV C, 2003, COGNITIVE NEUROSCIEN, P382; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; Peretz I, 2002, NEURON, V33, P185, DOI 10.1016/S0896-6273(01)00580-3; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Saffran J.R., 2003, COGNITIVE NEUROSCIEN, P32; SCHLAUG G, 2003, COGNITIVE NEUROSCIEN, P366; Sloboda J.A., 2001, SERIES AFFECTIVE SCI; Trehub SE, 2003, NAT NEUROSCI, V6, P669, DOI 10.1038/nn1084; Zatorre RJ, 2003, NAT NEUROSCI, V6, P692, DOI 10.1038/nn1085; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	16	183	189	3	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2005	434	7031					312	315		10.1038/434312a	http://dx.doi.org/10.1038/434312a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	907KG	15772648				2022-12-24	WOS:000227715100037
J	Busby, A; Abramsky, L; Dolk, H; Armstrong, B				Busby, A; Abramsky, L; Dolk, H; Armstrong, B		Eurocat Folic Acid Working Grp	Preventing neural tube defects in Europe: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Northwick Pk Hosp & Clin Res Ctr, N Thames W Congenital Malformat Register, Harrow HA1 3UJ, Middx, England; Univ Ulster, EUROCAT Cent Registry, Newtownabbey BT37 0QB, Antrim, North Ireland	University of London; London School of Hygiene & Tropical Medicine; Imperial College London; Ulster University	Busby, A (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	araceli.busby@lshtm.ac.uk		Relton, Caroline/0000-0003-2052-4840; armstrong, benedict/0000-0003-4407-0409				[Anonymous], 1991, Lancet, V338, P131, DOI 10.1016/0140-6736(91)90133-A; BUSBY A, 2005, EUROCAT SPECIAL REPO; CLARK NAC, 1994, BRIT J OBSTET GYNAEC, V101, P709, DOI 10.1111/j.1471-0528.1994.tb13190.x; DOLK H, 1991, J EPIDEMIOL COMMUN H, V45, P52, DOI 10.1136/jech.45.1.52; *EUR FOL AC WORK G, 2003, EUR SPEC REP PREV NE; Honein MA, 2001, JAMA-J AM MED ASSOC, V285, P2981, DOI 10.1001/jama.285.23.2981; Persad VL, 2002, CAN MED ASSOC J, V167, P241	7	86	98	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2005	330	7491					574	575		10.1136/bmj.330.7491.574	http://dx.doi.org/10.1136/bmj.330.7491.574			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906EC	15760997	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000227622300018
J	Lee, TT; Agarwalla, S; Stroud, RM				Lee, TT; Agarwalla, S; Stroud, RM			A unique RNA fold in the RumA-RNA-Cofactor ternary complex contributes to substrate selectivity and enzymatic function	CELL			English	Article							IRON-SULFUR CLUSTER; CRYSTAL-STRUCTURE; PSEUDOURIDINE SYNTHASE; ESCHERICHIA-COLI; METHYLTRANSFERASE; MECHANISM; RECOGNITION; BASE; NUCLEOSIDES; M(5)U1939	A single base (U1939) within E. coli 23S ribosomal RNA is methylated by its dedicated enzyme, RumA. The structure of RumA/RNA/S-adenosylhomocysteine uncovers the mechanism for achieving unique selectivity. The single-stranded substrate is "refolded" on the enzyme into a compact conformation with six key intra-RNA interactions. The RNA substrate contributes directly to catalysis. In addition to the target base, a second base is "flipped out" from the core loop to stack against the adenine of the cofactor S-adenosylhomocysteine. Nucleotides in permuted sequence order are stacked into the site vacated by the everted target U1939 and compensate for the energetic penalty of base eversion. The 3' hairpin segment of the RNA binds distal to the active site and provides binding energy that contributes to enhanced catalytic efficiency. Active collaboration of RNA in catalysis leads us to conclude that RumA and its substrate RNA may reflect features from the earliest RNA-protein era.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Stroud, RM (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	stroud@msg.ucsf.edu	Stroud, Rhonda/GQZ-0151-2022	Stroud, Rhonda/0000-0001-5242-8015	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051232] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM51232] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwalla S, 2004, J BIOL CHEM, V279, P34123, DOI 10.1074/jbc.M405702200; Agarwalla S, 2002, J BIOL CHEM, V277, P8835, DOI 10.1074/jbc.M111825200; Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; Antson AA, 2000, CURR OPIN STRUC BIOL, V10, P87, DOI 10.1016/S0959-440X(99)00054-8; Arcus V, 2002, CURR OPIN STRUC BIOL, V12, P794, DOI 10.1016/S0959-440X(02)00392-5; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bashan A, 2003, MOL CELL, V11, P91, DOI 10.1016/S1097-2765(03)00009-1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cheng XD, 2002, STRUCTURE, V10, P127, DOI 10.1016/S0969-2126(02)00710-4; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Eiler S, 1999, EMBO J, V18, P6532, DOI 10.1093/emboj/18.22.6532; Fersht A. R., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Freeland SJ, 1999, SCIENCE, V286, P690, DOI 10.1126/science.286.5440.690; Fromme JC, 2003, EMBO J, V22, P3461, DOI 10.1093/emboj/cdg311; Gimenez JAM, 1998, J THEOR BIOL, V194, P485, DOI 10.1006/jtbi.1998.0770; GU XG, 1992, BIOCHEMISTRY-US, V31, P10295, DOI 10.1021/bi00157a017; HARTLEY BS, 1954, BIOCHEM J, V56, P288, DOI 10.1042/bj0560288; Hoang C, 2001, CELL, V107, P929, DOI 10.1016/S0092-8674(01)00618-3; HOFFMAN JL, 1986, BIOCHEMISTRY-US, V25, P4444, DOI 10.1021/bi00363a041; Ishitani R, 2003, CELL, V113, P383, DOI 10.1016/S0092-8674(03)00280-0; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KEALEY JT, 1994, BIOCHIMIE, V76, P1133, DOI 10.1016/0300-9084(94)90042-6; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee TT, 2004, STRUCTURE, V12, P397, DOI 10.1016/j.str.2004.02.009; Lei M, 2003, NATURE, V426, P198, DOI 10.1038/nature02092; LIU L, 1992, BIOCHEMISTRY-US, V31, P5100, DOI 10.1021/bi00137a002; Madsen CT, 2003, NUCLEIC ACIDS RES, V31, P4738, DOI 10.1093/nar/gkg657; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; OGara M, 1996, J MOL BIOL, V261, P634, DOI 10.1006/jmbi.1996.0489; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan H, 2003, P NATL ACAD SCI USA, V100, P12648, DOI 10.1073/pnas.2135585100; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PERRY KM, 1990, PROTEINS, V8, P315, DOI 10.1002/prot.340080406; Roberts RJ, 1998, ANNU REV BIOCHEM, V67, P181, DOI 10.1146/annurev.biochem.67.1.181; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; SOLIE TN, 1968, J MOL BIOL, V33, P61, DOI 10.1016/0022-2836(68)90281-7; Suck D, 1997, NAT STRUCT BIOL, V4, P161, DOI 10.1038/nsb0397-161; Valle M, 2003, SCIENCE, V300, P127, DOI 10.1126/science.1081798; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu J C, 1985, Prog Clin Biol Res, V198, P119; Xiong Y, 2004, NATURE, V430, P640, DOI 10.1038/nature02711; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	49	91	93	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 11	2005	120	5					599	611		10.1016/j.cell.2004.12.037	http://dx.doi.org/10.1016/j.cell.2004.12.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766524	Bronze			2022-12-24	WOS:000227771400007
J	Bradshaw, GA; Schore, AN; Brown, JL; Poole, JH; Moss, CJ				Bradshaw, GA; Schore, AN; Brown, JL; Poole, JH; Moss, CJ			Elephant breakdown	NATURE			English	Article									Oregon State Univ, Environm Sci Grad Programme, Corvallis, OR 97331 USA; Oregon State Univ, Dept Forest Sci, Corvallis, OR 97331 USA; Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA USA; Smithsonian Natl Zool Pk, Washington, DC USA; Amboseli Elephant Res Project, Nairobi, Kenya	Oregon State University; Oregon State University; University of California System; University of California Los Angeles; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Bradshaw, GA (corresponding author), Oregon State Univ, Environm Sci Grad Programme, Corvallis, OR 97331 USA.							CLUBB R, 2002, REV WELFARE ELEPHANT; Schore A.N., 2003, AFFECT DYSREGULATION; Slotow R, 2000, NATURE, V408, P425, DOI 10.1038/35044191	3	106	108	3	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2005	433	7028					807	807		10.1038/433807a	http://dx.doi.org/10.1038/433807a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	899VT	15729320	Bronze			2022-12-24	WOS:000227174600022
J	Krentz, AJ; Wheeler, DC				Krentz, AJ; Wheeler, DC			New-onset diabetes after transplantation: a threat to graft and patient survival	LANCET			English	Editorial Material							IMMUNOSUPPRESSIVE AGENTS; CALCINEURIN INHIBITORS; KIDNEY-TRANSPLANTATION; MELLITUS; DISEASE; OBESITY		Univ Calif San Diego, Dept Family & Prevent Med, Div Epidemiol, La Jolla, CA 92093 USA; UCL Royal Free & Univ Coll Med Sch, Ctr Nephrol, London, England	University of California System; University of California San Diego; University of London; University College London; UCL Medical School	Krentz, AJ (corresponding author), Univ Calif San Diego, Dept Family & Prevent Med, Div Epidemiol, La Jolla, CA 92093 USA.	akrentz@ucsd.edu	Krentz, Andrew/AAD-2493-2019					Beckebaum S, 2004, TRANSPL P, V36, p574S, DOI 10.1016/j.transproceed.2004.01.044; Boots JMM, 2004, DRUGS, V64, P2047, DOI 10.2165/00003495-200464180-00004; Bostom AD, 2002, AM J TRANSPLANT, V2, P491, DOI 10.1034/j.1600-6143.2002.20602.x; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Heisel O, 2004, AM J TRANSPLANT, V4, P583, DOI 10.1046/j.1600-6143.2003.00372.x; Jindal RM, 2000, TRANSPLANTATION, V70, pSS58; John PR, 2002, LIVER TRANSPLANT, V8, P708, DOI 10.1053/jlts.2002.34638; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Kasiske BL, 2003, AM J TRANSPLANT, V3, P178, DOI 10.1034/j.1600-6143.2003.00010.x; KRENTZ AJ, 1995, CLIN IMMUNOTHER, V4, P103, DOI 10.1007/BF03259076; Markell M, 2004, AM J KIDNEY DIS, V43, P953, DOI 10.1053/j.ajkd.2004.03.020; Montori VM, 2002, DIABETES CARE, V25, P583, DOI 10.2337/diacare.25.3.583; Morris PJ, 2004, NEW ENGL J MED, V351, P2678, DOI 10.1056/NEJMp048256; Pischon T, 2001, NEPHROL DIAL TRANSPL, V16, P14, DOI 10.1093/ndt/16.1.14; Schulak JA, 2004, J SURG RES, V117, P154, DOI 10.1016/j.jss.2003.11.005; Sims RJA, 2003, BRIT MED J, V327, P463, DOI 10.1136/bmj.327.7413.463; Tanabe K, 2003, DRUGS, V63, P1535, DOI 10.2165/00003495-200363150-00002; Valantine H, 2004, J HEART LUNG TRANSPL, V23, pS187, DOI 10.1016/j.healun.2004.03.009; Wilkinson A, 2003, TRANSPLANTATION, V75, pSS1, DOI 10.1097/00007890-200305271-00001; Woodward RS, 2003, AM J TRANSPLANT, V3, P590, DOI 10.1034/j.1600-6143.2003.00082.x	20	32	33	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 19	2005	365	9460					640	642						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	898SP	15721460				2022-12-24	WOS:000227096800008
J	Sato, T; Cheng, YN; Wu, XC; Zelenitsky, DK; Hsiao, YF				Sato, T; Cheng, YN; Wu, XC; Zelenitsky, DK; Hsiao, YF			A pair of shelled eggs inside a female dinosaur	SCIENCE			English	Article							CHINA; NEST		Canadian Museum Nat, Ottawa, ON K1P 6P4, Canada; Natl Museum Nat Hist, Taichung, Taiwan; Univ Calgary, Dept Geol & Geophys, Calgary, AB T2N 1N4, Canada; Paleowonders Fossil & Mineral Museum, Taipei, Taiwan	University of Calgary	Sato, T (corresponding author), Canadian Museum Nat, POB 3443,Stn D, Ottawa, ON K1P 6P4, Canada.	tsato@mus-nature.ca; xcwu@mus-nature.ca						Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; Clark James M., 1999, American Museum Novitates, V3265, P1; Dong ZM, 1996, CAN J EARTH SCI, V33, P631, DOI 10.1139/e96-046; NORELL MA, 1995, NATURE, V378, P774, DOI 10.1038/378774a0; Varricchio DJ, 1997, NATURE, V385, P247, DOI 10.1038/385247a0; Varricchio DJ, 2004, LIFE O PAST, P215	6	95	102	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2005	308	5720					375	375		10.1126/science.1110578	http://dx.doi.org/10.1126/science.1110578			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15831749	Green Submitted			2022-12-24	WOS:000228492000041
J	Bartkova, J; Horejsi, Z; Koed, K; Kramer, A; Tort, F; Zieger, K; Guldberg, P; Sehested, M; Nesland, JM; Lukas, C; Orntoft, T; Lukas, J; Bartek, J				Bartkova, J; Horejsi, Z; Koed, K; Kramer, A; Tort, F; Zieger, K; Guldberg, P; Sehested, M; Nesland, JM; Lukas, C; Orntoft, T; Lukas, J; Bartek, J			DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis	NATURE			English	Article							CELL-CYCLE CONTROL; CHROMOSOME INSTABILITY; GENOMIC INSTABILITY; BREAST-CANCER; HISTONE H2AX; PHOSPHORYLATION; REPLICATION; PROTEIN; ATM; P53	During the evolution of cancer, the incipient tumour experiences 'oncogenic stress', which evokes a counter- response to eliminate such hazardous cells. However, the nature of this stress remains elusive, as does the inducible anti-cancer barrier that elicits growth arrest or cell death. Here we show that in clinical specimens from different stages of human tumours of the urinary bladder, breast, lung and colon, the early precursor lesions ( but not normal tissues) commonly express markers of an activated DNA damage response. These include phosphorylated kinases ATM and Chk2, and phosphorylated histone H2AX and p53. Similar checkpoint responses were induced in cultured cells upon expression of different oncogenes that deregulate DNA replication. Together with genetic analyses, including a genome-wide assessment of allelic imbalances, our data indicate that early in tumorigenesis ( before genomic instability and malignant conversion), human cells activate an ATR/ATM- regulated DNA damage response network that delays or prevents cancer. Mutations compromising this checkpoint, including defects in the ATM - Chk2 p53 pathway, might allow cell proliferation, survival, increased genomic instability and tumour progression.	Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark; Danish Canc Soc, Ctr Genotox Stress Res, DK-2100 Copenhagen, Denmark; Aarhus Univ Hosp, Dept Clin Biochem, DK-8200 Aarhus, Denmark; Univ Copenhagen Hosp, Dept Pathol, DK-2100 Copenhagen, Denmark; Univ Oslo, Norwegian Radium Hosp, Dept Pathol, N-0310 Oslo, Norway; Acad Sci Czech Republ, Inst Genet Mol, CZ-16637 Prague, Czech Republic	Danish Cancer Society; Danish Cancer Society; Aarhus University; University of Copenhagen; University of Oslo; Czech Academy of Sciences	Bartek, J (corresponding author), Danish Canc Soc, Inst Canc Biol, Strandblvd 49, DK-2100 Copenhagen, Denmark.	jb@cancer.dk	Bartek, Jiri/G-5870-2014	Lukas, Claudia/0000-0001-7169-6883; Licenikova Horejsi, Zuzana/0000-0002-9943-1649; Tort, Frederic/0000-0003-2733-1603; Lukas, Jiri/0000-0001-9087-506X				Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bao SD, 2001, NATURE, V411, P969, DOI 10.1038/35082110; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bartek J, 1997, EXP CELL RES, V237, P1, DOI 10.1006/excr.1997.3776; Binz SK, 2004, DNA REPAIR, V3, P1015, DOI 10.1016/j.dnarep.2004.03.028; Cangi MG, 2000, J CLIN INVEST, V106, P753, DOI 10.1172/JCI9174; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; Gatei M, 2003, J BIOL CHEM, V278, P14806, DOI 10.1074/jbc.M210862200; GRAEBER TG, 1994, MOL CELL BIOL, V14, P6264, DOI 10.1128/MCB.14.9.6264; Hart KC, 2000, ONCOGENE, V19, P3309, DOI 10.1038/sj.onc.1203650; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; Lew DJ, 1996, CURR OPIN CELL BIOL, V8, P795, DOI 10.1016/S0955-0674(96)80080-9; Lindblad-Toh K, 2000, NAT BIOTECHNOL, V18, P1001, DOI 10.1038/79269; Lindstrom MS, 2003, ONCOGENE, V22, P4993, DOI 10.1038/sj.onc.1206659; Lomonosov M, 2003, GENE DEV, V17, P3017, DOI 10.1101/gad.279003; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Meeker AK, 2004, CLIN CANCER RES, V10, P3317, DOI 10.1158/1078-0432.CCR-0984-03; Merrick CJ, 2004, J BIOL CHEM, V279, P20067, DOI 10.1074/jbc.M400022200; Minella AC, 2002, CURR BIOL, V12, P1817, DOI 10.1016/S0960-9822(02)01225-3; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Reed SE, 2004, CANCER RES, V64, P795, DOI 10.1158/0008-5472.CAN-03-3417; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rogoff HA, 2004, MOL CELL BIOL, V24, P2968, DOI 10.1128/MCB.24.7.2968-2977.2004; Santoni-Rugiu E, 2000, MOL CELL BIOL, V20, P3497, DOI 10.1128/MCB.20.10.3497-3509.2000; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tanaka S, 2002, GENE DEV, V16, P2639, DOI 10.1101/gad.1011002; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zindy F, 2003, P NATL ACAD SCI USA, V100, P15930, DOI 10.1073/pnas.2536808100; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	49	2123	2201	7	210	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2005	434	7035					864	870		10.1038/nature03482	http://dx.doi.org/10.1038/nature03482			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915SV	15829956				2022-12-24	WOS:000228327600032
J	Caballero, B				Caballero, B			A nutrition paradox - Uderweight and obesity in developing countries	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRANSITION; BURDEN		Johns Hopkins Univ, Ctr Human Nutr, Baltimore, MD 21218 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Caballero, B (corresponding author), Johns Hopkins Univ, Ctr Human Nutr, Baltimore, MD 21218 USA.							Doak CM, 2005, INT J OBESITY, V29, P129, DOI 10.1038/sj.ijo.0802824; Monteiro C, 2004, INT J OBESITY, V28, P1181, DOI 10.1038/sj.ijo.0802716; Monteiro CA, 2004, AM J PUBLIC HEALTH, V94, P433, DOI 10.2105/AJPH.94.3.433; Ruel M. T., 2001, Nutrition and health in developing countries, P465; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20	5	234	248	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 14	2005	352	15					1514	1516		10.1056/NEJMp048310	http://dx.doi.org/10.1056/NEJMp048310			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	915SH	15829531				2022-12-24	WOS:000228324200002
J	Burton, MJ; Holland, MJ; Makalo, P; Aryee, EAN; Alexander, NDE; Sillah, A; Faal, H; West, SK; Foster, A; Johnson, GJ; Mabey, DCW; Bailey, RL				Burton, MJ; Holland, MJ; Makalo, P; Aryee, EAN; Alexander, NDE; Sillah, A; Faal, H; West, SK; Foster, A; Johnson, GJ; Mabey, DCW; Bailey, RL			Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study	LANCET			English	Article							RANDOMIZED CONTROLLED-TRIAL; AZITHROMYCIN; DIAGNOSIS; CHILDREN; AREA	Background Community-wide mass antibiotic treatment is a central component of trachoma control. The optimum frequency and duration of treatment are unknown. We measured the effect of mass treatment on the conjunctival burden of Chlamydia trachomatis in a Gambian community with low to medium trachoma prevalence and investigated the rate, route, and determinants of re-emergent infection. Methods 14 trachoma-endemic villages in rural Gambia were examined and conjunctival swabs obtained at baseline, 2, 6, 12, and 17 months. Mass antibiotic treatment with azithromycin was given to the community at baseline. C trachomatis was detected by qualitative PCR and individual infection load then estimated by real-time quantitative PCR. Findings C trachomatis was detected in 95 (7%) of 1319 individuals at baseline. Treatment coverage was 83% of the population (1328 of 1595 people). The effect of mass treatment was heterogeneous. In 12 villages all baseline infections (34 [3%] of 1062 individuals) resolved, and prevalence (three [0.3%]) and infection load remained low throughout the study. Two villages (baseline infection: 61 [24%] of 257 individuals) had increased infection 2 months after treatment (74 [30%]), after extensive contact with other untreated communities. Subsequently, this value reduced to less than half of that before treatment (25 [11%]). Interpretation Mass antibiotic treatment generally results in effective, longlasting control of C trachomatis in this environment. For low prevalence regions, one treatment episode might be sufficient. Infection can be reintroduced through contact with untreated populations. Communities need to be monitored for treatment failure and control measures implemented over wide geographical areas.	Univ London London Sch Hyg & Trop Med, Int Ctr Eye Hlth, London WC1E 7HT, England; MRC Labs, Fajara, Gambia; Natl Eye Care Programme, Banjul, Gambia; Johns Hopkins Univ, Dana Ctr Prevent Ophthalmol, Baltimore, MD USA; Inst Ophthalmol, Div Epidemiol & Int Eye Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine; MRC Laboratory Molecular Biology; Johns Hopkins University; University of London; University College London	Burton, MJ (corresponding author), Univ London London Sch Hyg & Trop Med, Int Ctr Eye Hlth, Keppel St, London WC1E 7HT, England.	matthew.burton@lshtm.ac.uk	Holland, Martin J/K-6502-2012	Holland, Martin J/0000-0002-5828-6318; Mabey, David/0000-0002-0031-8276; Foster, Allen/0000-0003-2368-4436; Burton, Matthew/0000-0003-1872-9169	MRC [MC_U190081961] Funding Source: UKRI; Medical Research Council [MC_U190081961] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bailey R, 1999, EPIDEMIOL INFECT, V123, P479, DOI 10.1017/S0950268899003076; BAILEY RL, 1993, LANCET, V342, P453, DOI 10.1016/0140-6736(93)91591-9; Baral K, 1999, B WORLD HEALTH ORGAN, V77, P461; Bird M, 2003, J INFECT DIS, V187, P1669, DOI 10.1086/374743; Burton MJ, 2003, INVEST OPHTH VIS SCI, V44, P4215, DOI 10.1167/iovs.03-0107; Dawson CR, 1981, GUIDE TRACHOMA CONTR; Dolin PJ, 1998, BRIT J OPHTHALMOL, V82, P930, DOI 10.1136/bjo.82.8.930; Emerson PM, 2004, LANCET, V363, P1093, DOI 10.1016/S0140-6736(04)15891-1; Emerson PM, 2000, TROP MED INT HEALTH, V5, P515, DOI 10.1046/j.1365-3156.2000.00603.x; Emerson PM, 1999, LANCET, V353, P1401, DOI 10.1016/S0140-6736(98)09158-2; Fraser-Hurt N, 2001, B WORLD HEALTH ORGAN, V79, P632; Lietman T, 1999, NAT MED, V5, P572, DOI 10.1038/8451; Moalic E, 2000, PEDIATR INFECT DIS J, V19, P979, DOI 10.1097/00006454-200010000-00008; Munoz B, 2003, INVEST OPHTH VIS SCI, V44, P1464, DOI 10.1167/iovs.02-0234; Schachter J, 1999, LANCET, V354, P630, DOI 10.1016/S0140-6736(98)12387-5; Smith A, 2001, Ophthalmic Epidemiol, V8, P127, DOI 10.1076/opep.8.2.127.4164; Solomon AW, 2003, LANCET, V362, P198, DOI 10.1016/S0140-6736(03)13909-8; Sterne J., 1988, ESSENTIAL MED STAT; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; THYLEFORS B, 1995, B WORLD HEALTH ORGAN, V73, P115; WARD M, 1990, SCAND J INFECT DIS, P137; WEST S, 1993, INVEST OPHTH VIS SCI, V34, P3194; WEST S, 1995, LANCET, V345, P155, DOI 10.1016/S0140-6736(95)90167-1; *WHO, 1997, WHOPBL9656; *WHO, 2001, 6 M WHO ALL GLOB EL	25	110	110	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2005	365	9467					1321	1328		10.1016/S0140-6736(05)61029-X	http://dx.doi.org/10.1016/S0140-6736(05)61029-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	914HY	15823382				2022-12-24	WOS:000228219600027
J	Dupont, S; Zacchigna, L; Cordenonsi, M; Soligo, S; Adorno, M; Rugge, M; Piccolo, S				Dupont, S; Zacchigna, L; Cordenonsi, M; Soligo, S; Adorno, M; Rugge, M; Piccolo, S			Germ-layer specification and control of cell growth by ectodermin, a Smad4 ubiquitin ligase	CELL			English	Article							TGF-BETA; COLORECTAL-CANCER; SPEMANNS ORGANIZER; TUMOR SUPPRESSORS; XENOPUS; MUTATIONS; INDUCTION; PATHWAY; GENE; BMP	TGF-beta signaling is essential for development and proliferative homeostasis. During embryogenesis, maternal determinants act in concert with TGF-beta signals to form mesoderm and endoderm. In contrast, ectoderm specification requires the TGF-beta response to be attenuated, although the mechanisms by which this is achieved remain unknown. In a functional screen for ectoderm determinants, we have identified Ecto-dermin (Ecto). In Xenopus embryos, Ecto is essential for the specification of the ectoderm and acts by restricting the mesoderm-inducing activity of TGF-beta signals to the mesoderm and favoring neural induction. Ecto is a RING-type ubiquitin ligase for Smad4, a TGF-beta signal transducer. Depletion of Ecto in human cells enforces TGF-beta-induced cytostasis and, moreover, plays a causal role in limiting the antimitogenic effects of Smad4 in tumor cells. We propose that Ectodermin is a key switch in the control of TGF-beta gene responses during early embryonic development and cell proliferation.	Univ Padua, Dept Histol Microbiol & Med Biotechnol, Sect Histol & Embryol, I-35121 Padua, Italy; Univ Padua, Dept Oncol & Surg Sci, Pathol Sect, I-35121 Padua, Italy	University of Padua; IRCCS Istituto Oncologico Veneto (IOV); University of Padua	Piccolo, S (corresponding author), Univ Padua, Dept Histol Microbiol & Med Biotechnol, Sect Histol & Embryol, I-35121 Padua, Italy.	piccolo@civ.bio.unipd.it	Cordenonsi, Michelangelo/K-7692-2016; Dupont, Sirio/AAP-8133-2021; Rugge, Massimo/K-7525-2016	Cordenonsi, Michelangelo/0000-0002-8253-5724; PICCOLO, STEFANO/0000-0002-2037-0004; Dupont, Sirio/0000-0002-6869-1966	Telethon [GGP04030] Funding Source: Medline	Telethon(Fondazione Telethon)		Bell E, 2003, DEVELOPMENT, V130, P1381, DOI 10.1242/dev.00344; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Chen CR, 2001, P NATL ACAD SCI USA, V98, P992, DOI 10.1073/pnas.98.3.992; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Howell M, 1999, DEV BIOL, V214, P354, DOI 10.1006/dbio.1999.9430; LeSueur JA, 2002, DEV CELL, V2, P771, DOI 10.1016/S1534-5807(02)00172-7; Lin X, 2003, J BIOL CHEM, V278, P18714, DOI 10.1074/jbc.M302243200; Mizuseki K, 1998, DEVELOPMENT, V125, P579; Moren A, 2000, ONCOGENE, V19, P4396, DOI 10.1038/sj.onc.1203798; Nicolas FJ, 2003, ONCOGENE, V22, P3698, DOI 10.1038/sj.onc.1206420; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Schmidt JE, 1996, DEVELOPMENT, V122, P1711; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; SNAPE A, 1987, DEV BIOL, V119, P503, DOI 10.1016/0012-1606(87)90053-4; Takaku K, 1999, CANCER RES, V59, P6113; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Venturini L, 1999, ONCOGENE, V18, P1209, DOI 10.1038/sj.onc.1202655; Wessely O, 2000, DEVELOPMENT, V127, P2053; Whitman M, 2001, DEV CELL, V1, P605, DOI 10.1016/S1534-5807(01)00076-4; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Woodford-Richens KL, 2001, P NATL ACAD SCI USA, V98, P9719, DOI 10.1073/pnas.171321498; Xu J, 2000, P NATL ACAD SCI USA, V97, P4820, DOI 10.1073/pnas.97.9.4820; Zhang J, 1998, CELL, V94, P515, DOI 10.1016/S0092-8674(00)81592-5; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	32	257	277	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 8	2005	121	1					87	99		10.1016/j.cell.2005.01.033	http://dx.doi.org/10.1016/j.cell.2005.01.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	915YU	15820681	Bronze			2022-12-24	WOS:000228348500012
J	King-Casas, B; Tomlin, D; Anen, C; Camerer, CF; Quartz, SR; Montague, PR				King-Casas, B; Tomlin, D; Anen, C; Camerer, CF; Quartz, SR; Montague, PR			Getting to know you: Reputation and trust in a two-person economic exchange	SCIENCE			English	Article							TEMPORAL DIFFERENCE MODELS; NEURAL BASIS; FMRI; COOPERATION; PREDICTION; EVOLUTION; STRIATUM; ERRORS; ROLES; BRAIN	Using a multiround version of an economic exchange (trust game), we report that reciprocity expressed by one player strongly predicts future trust expressed by their partner - a behavioral finding mirrored by neural responses in the dorsal striatum. Here, analyses within and between brains revealed two signals - one encoded by response magnitude, and the other by response timing. Response magnitude correlated with the "intention to trust" on the next play of the game, and the peak of these "intention to trust" responses shifted its time of occurrence by 14 seconds as player reputations developed. This temporal transfer resembles a similar shift of reward prediction errors common to reinforcement learning models, but in the context of a social exchange. These data extend previous model-based functional magnetic resonance imaging, studies into the social domain and broaden our view of the spectrum of functions implemented by the dorsal striatum.	Baylor Coll Med, Dept Neurosci, Human Neuroimaging Lab, Houston, TX 77030 USA; Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA; CALTECH, Div Humanities & Social Sci 228 77, Social Cognit Neurosci Lab, Pasadena, CA 91125 USA	Baylor College of Medicine; Baylor College of Medicine; California Institute of Technology	Montague, PR (corresponding author), Baylor Coll Med, Dept Neurosci, Human Neuroimaging Lab, 1 Baylor Plaza, Houston, TX 77030 USA.	read@bcm.tmc.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA014883, R01DA011723] Funding Source: NIH RePORTER; NIDA NIH HHS [DA14883, DA11723] Funding Source: Medline; NIMH NIH HHS [MH52797] Funding Source: Medline; NINDS NIH HHS [NS045790] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Berridge KC, 2001, PSYCHOL LEARN MOTIV, V40, P223, DOI 10.1016/s0079-7421(00)80022-5; CAMERER C, 1988, ECONOMETRICA, V56, P1, DOI 10.2307/1911840; CAMERER CF, 2003, BEHAV GAME THEORY EX, P60; Coleman James S., 1990, FDN SOCIAL THEORY, P177; Dayan P., 2001, THEORETICAL NEUROSCI; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Decety J, 2004, NEUROIMAGE, V23, P744, DOI 10.1016/j.neuroimage.2004.05.025; DICKINSON A, 2002, STEVENS HDB EXPT PSY, V3, P26; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; FEHR E, 1993, Q J ECON, V108, P437, DOI 10.2307/2118338; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Hill EL, 2003, PHILOS T R SOC B, V358, P281, DOI 10.1098/rstb.2002.1209; Johnson PA, 2003, J NEUROPSYCH CLIN N, V15, P397, DOI 10.1176/appi.neuropsych.15.4.397; Lee KH, 2004, PSYCHOL MED, V34, P391, DOI 10.1017/S0033291703001284; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; Montague PR, 2002, NEUROIMAGE, V16, P1159, DOI 10.1006/nimg.2002.1150; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; OREILLY RC, 1999, WMODELS WORKING MEMO, P375; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; Rachlin H, 2002, BEHAV BRAIN SCI, V25, P239, DOI 10.1017/S0140525X02000055; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755	32	799	829	16	239	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2005	308	5718					78	83		10.1126/science.1108062	http://dx.doi.org/10.1126/science.1108062			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	914IQ	15802598	Green Published			2022-12-24	WOS:000228221500036
J	Poole, JH; Tyack, PL; Stoeger-Horwath, AS; Watwood, S				Poole, JH; Tyack, PL; Stoeger-Horwath, AS; Watwood, S			Elephants are capable of vocal learning	NATURE			English	Editorial Material							AFRICAN ELEPHANTS		Amboseli Trust Elephants, ElephantVoices, Nairobi, Kenya; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; Univ Vienna, Inst Zool, A-1090 Vienna, Austria	Woods Hole Oceanographic Institution; University of Vienna	Poole, JH (corresponding author), Amboseli Trust Elephants, ElephantVoices, POB 15135,Langata 00509, Nairobi, Kenya.	ptyack@whoi.edu	Watwood, Stephanie/AAE-7191-2019; Tyack, Peter/AAC-4513-2019; Tyack, Peter L/D-6209-2013	Tyack, Peter/0000-0002-8409-4790; Tyack, Peter L/0000-0002-8409-4790; Stoeger, Angela S/0000-0002-6714-8291				GARSTANG M, 1995, J EXP BIOL, V198, P939; Janik VM, 1997, ADV STUD BEHAV, V26, P59, DOI 10.1016/S0065-3454(08)60377-0; McComb K, 2000, ANIM BEHAV, V59, P1103, DOI 10.1006/anbe.2000.1406; McKay G.M., 1973, Smithsonian Contributions to Zoology, VNo. 125, P1; Moss CJ, 1983, PRIMATE SOCIAL RELAT, P315; POOLE JH, 1988, BEHAV ECOL SOCIOBIOL, V22, P385, DOI 10.1007/BF00294975; Tyack PL, 2003, ANIMAL SOCIAL COMPLEXITY, P342	7	171	175	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2005	434	7032					455	456		10.1038/434455a	http://dx.doi.org/10.1038/434455a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909CH	15791244				2022-12-24	WOS:000227836000029
J	Ross, MT; Grafham, DV; Coffey, AJ; Scherer, S; McLay, K; Muzny, D; Platzer, M; Howell, GR; Burrows, C; Bird, CP; Frankish, A; Lovell, FL; Howe, KL; Ashurst, JL; Fulton, RS; Sudbrak, R; Wen, GP; Jones, MC; Hurles, ME; Andrews, TD; Scott, CE; Searle, S; Ramser, J; Whittaker, A; Deadman, R; Carter, NP; Hunt, SE; Chen, R; Cree, A; Gunaratne, P; Havlak, P; Hodgson, A; Metzker, ML; Richards, S; Scott, G; Steffen, D; Sodergren, E; Wheeler, DA; Worley, KC; Ainscough, R; Ambrose, KD; Ansari-Lari, MA; Aradhya, S; Ashwell, RIS; Babbage, AK; Bagguley, CL; Ballabio, A; Banerjee, R; Barker, GE; Barlow, KF; Barrett, IP; Bates, KN; Beare, DM; Beasley, H; Beasley, O; Beck, A; Bethel, G; Blechschmidt, K; Brady, N; Bray-Allen, S; Bridgeman, AM; Brown, AJ; Brown, MJ; Bonnin, D; Bruford, EA; Buhay, C; Burch, P; Burford, D; Burgess, J; Burrill, W; Burton, J; Bye, JM; Carder, C; Carrel, L; Chako, J; Chapman, JC; Chavez, D; Chen, E; Chen, G; Chen, Y; Chen, ZJ; Chinault, C; Ciccodicola, A; Clark, SY; Clarke, G; Clee, CM; Clegg, S; Clerc-Blankenburg, K; Clifford, K; Cobley, V; Cole, CG; Conquer, JS; Corby, N; Connor, RE; David, R; Davies, J; Davis, C; Davis, J; Delgado, O; DeShazo, D; Dhami, P; Ding, Y; Dinh, H; Dodsworth, S; Draper, H; Dugan-Rocha, S; Dunham, A; Dunn, M; Durbin, KJ; Dutta, I; Eades, T; Ellwood, M; Emery-Cohen, A; Errington, H; Evans, KL; Faulkner, L; Francis, F; Frankland, J; Fraser, AE; Galgoczy, P; Gilbert, J; Gill, R; Glockner, G; Gregory, SG; Gribble, S; Griffiths, C; Grocock, R; Gu, YH; Gwilliam, R; Hamilton, C; Hart, EA; Hawes, A; Heath, PD; Heitmann, K; Hennig, S; Hernandez, J; Hinzmann, B; Ho, S; Hoffs, M; Howden, PJ; Huckle, EJ; Hume, J; Hunt, PJ; Hunt, AR; Isherwood, J; Jacob, L; Johnson, D; Jones, S; de Jong, PJ; Joseph, SS; Keenan, S; Kelly, S; Kershaw, JK; Khan, Z; Kioschis, P; Klages, S; Knights, AJ; Kosiura, A; Kovar-Smith, C; Laird, GK; Langford, C; Lawlor, S; Leversha, M; Lewis, L; Liu, W; Lloyd, C; Lloyd, DM; Loulseged, H; Loveland, JE; Lovell, JD; Lozado, R; Lu, J; Lyne, R; Ma, J; Maheshwari, M; Matthews, LH; McDowall, J; McLaren, S; McMurray, A; Meidl, P; Meitinger, T; Milne, S; Miner, G; Mistry, SL; Morgan, M; Morris, S; Muller, I; Mullikin, JC; Nguyen, N; Nordsiek, G; Nyakatura, G; O'Dell, CN; Okwuonu, G; Palmer, S; Pandian, R; Parker, D; Parrish, J; Pasternak, S; Patel, D; Pearce, AV; Pearson, DM; Pelan, SE; Perez, L; Porter, KM; Ramsey, Y; Reichwald, K; Rhodes, S; Ridler, KA; Schlessinger, D; Schueler, MG; Sehra, HK; Shaw-Smith, C; Shen, H; Sheridan, EM; Shownkeen, R; Skuce, CD; Smith, ML; Sotheran, EC; Steingruber, HE; Steward, CA; Storey, R; Swann, RM; Swarbreck, D; Tabor, PE; Taudien, S; Taylor, T; Teague, B; Thomas, K; Thorpe, A; Timms, K; Tracey, A; Trevanion, S; Tromans, AC; d'Urso, M; Verduzco, D; Villasana, D; Waldron, L; Wall, M; Wang, QY; Warren, J; Warry, GL; Wei, XH; West, A; Whitehead, SL; Whiteley, MN; Wilkinson, JE; Willey, DL; Williams, G; Williams, L; Williamson, A; Williamson, H; Wilming, L; Woodmansey, RL; Wray, PW; Yen, J; Zhang, JK; Zhou, JL; Zoghbi, H; Zorilla, S; Buck, D; Reinhardt, R; Poustka, A; Rosenthal, A; Lehrach, H; Meindl, A; Minx, PJ; Hillier, LW; Willard, HF; Wilson, RK; Waterston, RH; Rice, CM; Vaudin, M; Coulson, A; Nelson, DL; Weinstock, G; Sulston, JE; Durbin, R; Hubbard, T; Gibbs, RA; Beck, S; Rogers, J; Bentley, DR				Ross, MT; Grafham, DV; Coffey, AJ; Scherer, S; McLay, K; Muzny, D; Platzer, M; Howell, GR; Burrows, C; Bird, CP; Frankish, A; Lovell, FL; Howe, KL; Ashurst, JL; Fulton, RS; Sudbrak, R; Wen, GP; Jones, MC; Hurles, ME; Andrews, TD; Scott, CE; Searle, S; Ramser, J; Whittaker, A; Deadman, R; Carter, NP; Hunt, SE; Chen, R; Cree, A; Gunaratne, P; Havlak, P; Hodgson, A; Metzker, ML; Richards, S; Scott, G; Steffen, D; Sodergren, E; Wheeler, DA; Worley, KC; Ainscough, R; Ambrose, KD; Ansari-Lari, MA; Aradhya, S; Ashwell, RIS; Babbage, AK; Bagguley, CL; Ballabio, A; Banerjee, R; Barker, GE; Barlow, KF; Barrett, IP; Bates, KN; Beare, DM; Beasley, H; Beasley, O; Beck, A; Bethel, G; Blechschmidt, K; Brady, N; Bray-Allen, S; Bridgeman, AM; Brown, AJ; Brown, MJ; Bonnin, D; Bruford, EA; Buhay, C; Burch, P; Burford, D; Burgess, J; Burrill, W; Burton, J; Bye, JM; Carder, C; Carrel, L; Chako, J; Chapman, JC; Chavez, D; Chen, E; Chen, G; Chen, Y; Chen, ZJ; Chinault, C; Ciccodicola, A; Clark, SY; Clarke, G; Clee, CM; Clegg, S; Clerc-Blankenburg, K; Clifford, K; Cobley, V; Cole, CG; Conquer, JS; Corby, N; Connor, RE; David, R; Davies, J; Davis, C; Davis, J; Delgado, O; DeShazo, D; Dhami, P; Ding, Y; Dinh, H; Dodsworth, S; Draper, H; Dugan-Rocha, S; Dunham, A; Dunn, M; Durbin, KJ; Dutta, I; Eades, T; Ellwood, M; Emery-Cohen, A; Errington, H; Evans, KL; Faulkner, L; Francis, F; Frankland, J; Fraser, AE; Galgoczy, P; Gilbert, J; Gill, R; Glockner, G; Gregory, SG; Gribble, S; Griffiths, C; Grocock, R; Gu, YH; Gwilliam, R; Hamilton, C; Hart, EA; Hawes, A; Heath, PD; Heitmann, K; Hennig, S; Hernandez, J; Hinzmann, B; Ho, S; Hoffs, M; Howden, PJ; Huckle, EJ; Hume, J; Hunt, PJ; Hunt, AR; Isherwood, J; Jacob, L; Johnson, D; Jones, S; de Jong, PJ; Joseph, SS; Keenan, S; Kelly, S; Kershaw, JK; Khan, Z; Kioschis, P; Klages, S; Knights, AJ; Kosiura, A; Kovar-Smith, C; Laird, GK; Langford, C; Lawlor, S; Leversha, M; Lewis, L; Liu, W; Lloyd, C; Lloyd, DM; Loulseged, H; Loveland, JE; Lovell, JD; Lozado, R; Lu, J; Lyne, R; Ma, J; Maheshwari, M; Matthews, LH; McDowall, J; McLaren, S; McMurray, A; Meidl, P; Meitinger, T; Milne, S; Miner, G; Mistry, SL; Morgan, M; Morris, S; Muller, I; Mullikin, JC; Nguyen, N; Nordsiek, G; Nyakatura, G; O'Dell, CN; Okwuonu, G; Palmer, S; Pandian, R; Parker, D; Parrish, J; Pasternak, S; Patel, D; Pearce, AV; Pearson, DM; Pelan, SE; Perez, L; Porter, KM; Ramsey, Y; Reichwald, K; Rhodes, S; Ridler, KA; Schlessinger, D; Schueler, MG; Sehra, HK; Shaw-Smith, C; Shen, H; Sheridan, EM; Shownkeen, R; Skuce, CD; Smith, ML; Sotheran, EC; Steingruber, HE; Steward, CA; Storey, R; Swann, RM; Swarbreck, D; Tabor, PE; Taudien, S; Taylor, T; Teague, B; Thomas, K; Thorpe, A; Timms, K; Tracey, A; Trevanion, S; Tromans, AC; d'Urso, M; Verduzco, D; Villasana, D; Waldron, L; Wall, M; Wang, QY; Warren, J; Warry, GL; Wei, XH; West, A; Whitehead, SL; Whiteley, MN; Wilkinson, JE; Willey, DL; Williams, G; Williams, L; Williamson, A; Williamson, H; Wilming, L; Woodmansey, RL; Wray, PW; Yen, J; Zhang, JK; Zhou, JL; Zoghbi, H; Zorilla, S; Buck, D; Reinhardt, R; Poustka, A; Rosenthal, A; Lehrach, H; Meindl, A; Minx, PJ; Hillier, LW; Willard, HF; Wilson, RK; Waterston, RH; Rice, CM; Vaudin, M; Coulson, A; Nelson, DL; Weinstock, G; Sulston, JE; Durbin, R; Hubbard, T; Gibbs, RA; Beck, S; Rogers, J; Bentley, DR			The DNA sequence of the human X chromosome	NATURE			English	Article							LINKED MENTAL-RETARDATION; MAMMALIAN Y-CHROMOSOME; HUMAN GENOME SEQUENCE; INACTIVATION CENTER; REPEAT HYPOTHESIS; GENE FAMILY; EVOLUTION; MUTATIONS; REGION; RNA	The human X chromosome has a unique biology that was shaped by its evolution as the sex chromosome shared by males and females. We have determined 99.3% of the euchromatic sequence of the X chromosome. Our analysis illustrates the autosomal origin of the mammalian sex chromosomes, the stepwise process that led to the progressive loss of recombination between X and Y, and the extent of subsequent degradation of the Y chromosome. LINE1 repeat elements cover one-third of the X chromosome, with a distribution that is consistent with their proposed role as way stations in the process of X-chromosome inactivation. We found 1,098 genes in the sequence, of which 99 encode proteins expressed in testis and in various tumour types. A disproportionately high number of mendelian diseases are documented for the X chromosome. Of this number, 168 have been explained by mutations in 113 X-linked genes, which in many cases were characterized with the aid of the DNA sequence.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Baylor Coll Med, Human Genome Sequencing Ctr, Dept Mol & Human Genet, Houston, TX 77030 USA; Inst Mol Biotechnol, D-07745 Jena, Germany; Washington Univ, Genome Sequencing Ctr, St Louis, MO 63108 USA; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; Univ Munich, D-80336 Munich, Germany; UCL, Galton Lab, HUGO Gen Nomenclature Comm, Dept Biol, London NW1 2HE, England; Penn State Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; PE Appl Biosyst, Adv Ctr Genet Technol, Foster City, CA 94404 USA; European Bioinformat Inst, Cambridge CB10 1SD, England; Inst Genet & Biophys, I-80100 Naples, Italy; Univ Edinburgh, Western Gen Hosp, Med Genet Sect, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Paris 05, INSERM, U567,Inst Cochin, Lab Genet & Physiopathol Retards Mentaux, F-75014 Paris, France; Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany; GSF, Natl Res Ctr Environm Hlth, Inst Human Genet, D-85764 Neuherberg, Germany; RZPD Resource Ctr Genome Res, D-14059 Berlin, Germany; NHGRI, NIH, Bethesda, MD 20892 USA; NIA, Genet Lab, Baltimore, MD 21224 USA; Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA	Wellcome Trust Sanger Institute; Baylor College of Medicine; Washington University (WUSTL); Max Planck Society; University of Kiel; University of Munich; University of London; University College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Thermo Fisher Scientific; Applied Biosystems; European Molecular Biology Laboratory (EMBL); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Edinburgh; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Duke University	Ross, MT (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	mtr@sanger.ac.uk	Driemeier, David/H-3461-2012; Weinstock, George M/C-6314-2013; Andrews, Dan/ABG-4815-2020; Bruford, Elspeth/AAU-4961-2020; Sudbrak, Ralf/HHZ-8821-2022; Hubbard, Tim J.P./AAT-4571-2020; Norouzi, Neil/H-2530-2012; Wilson, Richard K./AAF-4139-2019; Lyne, Rachel/AAE-2189-2020; Durbin, Richard/AAE-7178-2019; Francis, Fiona/B-5854-2016; Frankish, Adam/G-6545-2011; Wheeler, David A/M-9740-2018; Evans, Kathryn KL/I-5910-2012; Glöckner, Gernot/A-7800-2010; Hubbard, Tim J/C-2567-2008; BALLABIO, Andrea/AAL-2672-2020; Johnson, David/A-3907-2011; Meitinger, Thomas/O-1318-2015	Driemeier, David/0000-0003-3766-0654; Weinstock, George M/0000-0002-2997-4592; Bruford, Elspeth/0000-0002-8380-5247; Hubbard, Tim J.P./0000-0002-1767-9318; Wilson, Richard K./0000-0002-1992-1358; Lyne, Rachel/0000-0001-8050-402X; Durbin, Richard/0000-0002-9130-1006; Wheeler, David A/0000-0002-9056-6299; Glöckner, Gernot/0000-0002-9061-1061; Hubbard, Tim J/0000-0002-1767-9318; BALLABIO, Andrea/0000-0003-1381-4604; Johnson, David/0000-0003-0887-3343; Bridgeman, Anne/0000-0002-9478-6125; Davidson, Claire/0000-0002-4910-8202; Steward, Charles/0000-0001-8829-5349; Delgado, Oliver/0000-0003-2547-5857; Keenan, Stephen/0000-0002-9141-7690; Wass, Elizabeth/0000-0002-8605-9921; Francis, Fiona/0000-0001-8542-7537; Wilming, Laurens/0000-0002-4154-7358; Evans, Kathryn/0000-0002-7884-5877; Swarbreck, David/0000-0002-5453-1013; Zoghbi, Huda/0000-0002-0700-3349; ARADHYA, SWAROOP/0000-0001-6219-2931; Trevanion, Stephen/0000-0002-4862-3333; Howe, Kevin/0000-0002-1751-9226; /0000-0002-9833-2817; Ciccodicola, Alfredo/0000-0002-9924-1482; Reinhardt, Richard/0000-0001-9376-2132; Gilbert, James/0000-0001-8079-3159; Frankish, Adam/0000-0002-4333-628X; Hunt, Sarah/0000-0002-8350-1235; Storey, Roy/0000-0003-1375-7136; Meitinger, Thomas/0000-0002-8838-8403; Hunt, Adrienne/0000-0002-1227-0310; Fosker, Christine/0000-0002-3799-9474; Gregory, Simon/0000-0002-7805-1743; Worley, Kim/0000-0002-0282-1000; Loveland, Jane/0000-0002-7669-2934; Andrews, Dan/0000-0003-3922-6376	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, Z01HG200330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000647] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Bailey JA, 2000, P NATL ACAD SCI USA, V97, P6634, DOI 10.1073/pnas.97.12.6634; Bentley DR, 2001, NATURE, V409, P942, DOI 10.1038/35057165; Bourque G, 2002, GENOME RES, V12, P26; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; Chomez P, 2001, CANCER RES, V61, P5544; Chow JC, 2003, GENOMICS, V82, P309, DOI 10.1016/S0888-7543(03)00170-8; Chureau C, 2002, GENOME RES, V12, P894, DOI 10.1101/gr.152902; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; Delbridge ML, 2004, CHROMOSOME RES, V12, P345, DOI 10.1023/B:CHRO.0000034134.91243.1c; Deloukas P, 2004, NATURE, V429, P375, DOI 10.1038/nature02462; Dunham A, 2004, NATURE, V428, P522, DOI 10.1038/nature02379; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; FRANCKE U, 1994, CYTOGENET CELL GENET, V65, P206, DOI 10.1159/000133633; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; FREIJE D, 1992, SCIENCE, V258, P1784, DOI 10.1126/science.1465614; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; GRAVES JAM, 1995, BIOESSAYS, V17, P311, DOI 10.1002/bies.950170407; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Humphray SJ, 2004, NATURE, V429, P369, DOI 10.1038/nature02465; Hurst LD, 2001, NATURE, V411, P149, DOI 10.1038/35075697; Iwase M, 2003, P NATL ACAD SCI USA, V100, P5258, DOI 10.1073/pnas.0635848100; *J HOPK U NAT CTR, 2000, OMIM ONL MEND INH MA; Jegalian K, 1998, NATURE, V394, P776, DOI 10.1038/29522; Ke X, 2003, ANN HUM GENET, V67, P242, DOI 10.1046/j.1469-1809.2003.00038.x; Kohn M, 2004, TRENDS GENET, V20, P598, DOI 10.1016/j.tig.2004.09.008; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lahn BT, 2000, HUM MOL GENET, V9, P311, DOI 10.1093/hmg/9.2.311; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lyon MF, 1998, CYTOGENET CELL GENET, V80, P133, DOI 10.1159/000014969; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Mahtani MM, 1998, GENOME RES, V8, P100, DOI 10.1101/gr.8.2.100; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Migeon BR, 2001, AM J HUM GENET, V69, P951, DOI 10.1086/324022; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; Mungall AJ, 2003, NATURE, V425, P805, DOI 10.1038/nature02055; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Ohno S., 1967, SEX CHROMOSOMES SEX; Orrico A, 2000, FEBS LETT, V481, P285, DOI 10.1016/S0014-5793(00)01994-3; PAGE DC, 1984, NATURE, V311, P119, DOI 10.1038/311119a0; Pegoraro E, 1997, AM J HUM GENET, V61, P160, DOI 10.1086/513901; Pruitt KD, 2000, TRENDS GENET, V16, P44, DOI 10.1016/S0168-9525(99)01882-X; Ropers HH, 2003, TRENDS GENET, V19, P316, DOI 10.1016/S0168-9525(03)00113-6; ROYERPOKORA B, 1986, NATURE, V322, P32, DOI 10.1038/322032a0; Rudd MK, 2004, TRENDS GENET, V20, P529, DOI 10.1016/j.tig.2004.08.008; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sargent CA, 1996, GENOMICS, V32, P200, DOI 10.1006/geno.1996.0106; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Schmid M, 2000, CYTOGENET CELL GENET, V90, P169, DOI 10.1159/000056772; Schmutz J, 2004, NATURE, V429, P365, DOI 10.1038/nature02390; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; She XW, 2004, NATURE, V430, P857, DOI 10.1038/nature02806; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; SMIT AFA, 1995, J MOL BIOL, V246, P401, DOI 10.1006/jmbi.1994.0095; Spence JM, 2002, EMBO J, V21, P5269, DOI 10.1093/emboj/cdf511; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Toder R, 2000, CYTOGENET CELL GENET, V91, P285, DOI 10.1159/000056858	67	762	1543	2	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2005	434	7031					325	337		10.1038/nature03440	http://dx.doi.org/10.1038/nature03440			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772651	Green Accepted, Bronze			2022-12-24	WOS:000227715100040
J	Rathore, SS; Epstein, AJ; Volpp, KGM; Krumholz, HM				Rathore, SS; Epstein, AJ; Volpp, KGM; Krumholz, HM			Regionalization of care for acute coronary syndromes - More evidence is needed	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; PRIMARY ANGIOPLASTY; IMMEDIATE THROMBOLYSIS; FIBRINOLYTIC THERAPY; RANDOMIZED-TRIAL; ELDERLY-PATIENTS; VOLUME; MORTALITY; INTERVENTION; SPECIALTY		Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Internal Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06510 USA; Yale New Haven Med Ctr, Ctr Outcomes Res & EValuat, New Haven, CT 06504 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Vet Affairs Ctr Hlth Equity Res & Promot, Philadelphia, PA USA	Yale University; Yale University; Yale University; Yale University; University of Pennsylvania	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Sect Cardiovasc Med, Room I-456 SHM,333 Cedar St,POB 208088, New Haven, CT 06520 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020	Epstein, Andrew/0000-0001-5078-6564; Volpp, Kevin/0000-0003-1423-4599	NIGMS NIH HHS [T32 GM007205, T32 GM007205-35, GM07205] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersen HR, 2003, NEW ENGL J MED, V349, P733, DOI 10.1056/NEJMoa025142; Armstrong PW, 2003, NEW ENGL J MED, V349, P2168; Ayanian JZ, 2002, NEW ENGL J MED, V347, P1678, DOI 10.1056/NEJMsa020080; Bogaty P, 2003, LANCET, V361, P1813, DOI 10.1016/S0140-6736(03)13407-1; Califf RM, 2003, CIRCULATION, V107, P1467, DOI 10.1161/01.CIR.0000065160.19016.26; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Canto JG, 2000, NEW ENGL J MED, V342, P1573, DOI 10.1056/NEJM200005253422106; Chen J, 1999, NEW ENGL J MED, V340, P286, DOI 10.1056/NEJM199901283400407; Dalby M, 2003, CIRCULATION, V108, P1809, DOI 10.1161/01.CIR.0000091088.63921.8C; DEVERS KJ, 2003, SPECIALTY HOSP FOCUS; Eagle KA, 2002, LANCET, V359, P373, DOI 10.1016/S0140-6736(02)07595-5; Epstein AJ, 2004, J AM COLL CARDIOL, V43, P1755, DOI 10.1016/j.jacc.2003.09.070; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Frances CD, 1999, ARCH INTERN MED, V159, P1429, DOI 10.1001/archinte.159.13.1429; *GEN ACC OFF, 2003, PUBL GEN ACC OFF; Gibson CM, 2004, EUR HEART J, V25, P1001, DOI 10.1016/j.ehj.2004.04.029; Go AS, 2000, AM J MED, V108, P216, DOI 10.1016/S0002-9343(99)00430-1; Grines CL, 2002, J AM COLL CARDIOL, V39, P1713, DOI 10.1016/S0735-1097(02)01870-3; Healthcare Cost and Utilization Project, HEALTHC COST UT PROJ; Ho V, 2000, CIRCULATION, V101, P1806, DOI 10.1161/01.CIR.101.15.1806; Ho V, 2002, J HEALTH ECON, V21, P873, DOI 10.1016/S0167-6296(02)00057-7; Jollis JG, 1996, NEW ENGL J MED, V335, P1880, DOI 10.1056/NEJM199612193352505; Kansagra SM, 2004, JAMA-J AM MED ASSOC, V292, P1717, DOI 10.1001/jama.292.14.1717; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Keeley EC, 2004, ANN INTERN MED, V141, P298, DOI 10.7326/0003-4819-141-4-200408170-00010; Kent DM, 2002, J GEN INTERN MED, V17, P887, DOI 10.1046/j.1525-1497.2002.11232.x; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; Nallamothu BK, 2003, AM J CARDIOL, V92, P824, DOI 10.1016/S0002-9149(03)00891-9; NALLAMOTHU BK, IN PRESS CIRCULATION; *NAT HEART ATT AL, 1998, J THROMB THROMBOLYS, V6, P19; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; Shahian DM, 2003, ANN THORAC SURG, V75, P1048, DOI 10.1016/S0003-4975(02)04308-4; Steg PG, 2003, CIRCULATION, V108, P2851, DOI 10.1161/01.CIR.0000103122.10021.F2; Stukel TA, 2005, JAMA-J AM MED ASSOC, V293, P1329, DOI 10.1001/jama.293.11.1329; Thiemann DR, 1999, NEW ENGL J MED, V340, P1640, DOI 10.1056/NEJM199905273402106; Topol EJ, 2003, CIRCULATION, V107, P1463, DOI 10.1161/01.CIR.0000063680.45780.A0; Vermeer F, 1999, HEART, V82, P426, DOI 10.1136/hrt.82.4.426; Widimsky P, 2000, EUR HEART J, V21, P823, DOI 10.1053/euhj.1999.1993; Widimsky P, 2003, EUR HEART J, V24, P94, DOI 10.1016/S0195-668X(02)00468-2; Williams DO, 2004, CIRCULATION, V109, P1806, DOI 10.1161/01.CIR.0000126892.17646.83	40	31	31	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2005	293	11					1383	1387		10.1001/jama.293.11.1383	http://dx.doi.org/10.1001/jama.293.11.1383			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907EP	15769973	Green Accepted			2022-12-24	WOS:000227698600028
J	Bibring, JP; Langevin, Y; Gendrin, A; Gondet, B; Poulet, F; Berthe, M; Soufflot, A; Arvidson, R; Mangold, N; Mustard, J; Drossart, P				Bibring, JP; Langevin, Y; Gendrin, A; Gondet, B; Poulet, F; Berthe, M; Soufflot, A; Arvidson, R; Mangold, N; Mustard, J; Drossart, P		OMEGA Team	Mars surface diversity as revealed by the OMEGA/Mars Express observations	SCIENCE			English	Article							MGS-TES; CAP; WATER; SOIL	The Observatoire pour [a Mineralogie, l'Eau, les Glaces, et I'Activite (OMEGA) investigation, on board the European Space Agency Mars Express mission, is mapping the surface composition of Mars at a 0.3- to 5-kilometer resolution by means of visible-near-infrared hyperspectral reflectance imagery. The data acquired during, the first 9 months of the mission already reveal a diverse and complex surface mineralogy, offering key insights into the evolution of Mars. OMEGA has identified and mapped mafic iron-bearing silicates of both the northern and southern crust, localized concentrations of hydrated phyllosilicates and sulfates but nocarbonates, and ices and frosts with a water-ice composition of the north polar perennial cap, as for the south cap, covered by a thin carbon dioxide-ice veneer.	Inst Astrophys Spatiale, F-91405 Orsay, France; Washington Univ, St Louis, MO 63130 USA; IDES, F-91405 Orsay, France; Brown Univ, Providence, RI 02912 USA; Observ Paris, LESIA, F-92195 Meudon, France	UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Washington University (WUSTL); Brown University; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris	Bibring, JP (corresponding author), Inst Astrophys Spatiale, Batiment 121,Orsay Campus, F-91405 Orsay, France.	bibring@ias.u-psud.fr	Drossart, Pierre/H-8670-2013; Schmitt, Bernard/A-1064-2009; Bellucci, Giancarlo/ABA-9201-2020; Fouchet, Thierry/C-6374-2017	Schmitt, Bernard/0000-0002-1230-6627; Bellucci, Giancarlo/0000-0003-0867-8679; Erard, Stephane/0000-0002-9099-8366; Fouchet, Thierry/0000-0001-9040-8285; Altieri, Francesca/0000-0002-6338-8300; Capaccioni, Fabrizio/0000-0003-1631-4314; Cerroni, Priscilla/0000-0003-0239-2741; Ignatiev, Nikolay/0000-0002-6358-7094				Arvidson RE, 2005, SCIENCE, V307, P1591, DOI 10.1126/science.1109509; Arvidson RE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001982; Bandfield JL, 2000, SCIENCE, V287, P1626, DOI 10.1126/science.287.5458.1626; Bandfield JL, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2000JE001469; Banin A, 1997, J GEOPHYS RES-PLANET, V102, P13341, DOI 10.1029/97JE01160; Bibring J.-P., 2004, EUR SPACE AGENCY SPE, V1240, P37; Bibring JP, 2004, NATURE, V428, P627, DOI 10.1038/nature02461; Bibring JP, 2001, SPACE SCI REV, V96, P293, DOI 10.1023/A:1011909708806; Byrne S, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017597; CHICARRO A, 2004, ESA SPEC PUBL, V1240, P00003; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; Hamilton VE, 2003, METEORIT PLANET SCI, V38, P871, DOI 10.1111/j.1945-5100.2003.tb00284.x; Hoefen TM, 2003, SCIENCE, V302, P627, DOI 10.1126/science.1089647; Kieffer HH, 2001, ICARUS, V154, P162, DOI 10.1006/icar.2001.6670; Langevin Y, 2005, SCIENCE, V307, P1584, DOI 10.1126/science.1109091; Langevin Y, 2005, SCIENCE, V307, P1581, DOI 10.1126/science.1109438; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; MILLIKEN MS, 2003, LUNAR PLANET SCI C, V34, P1345; MINITTI ME, 2002, J GEOPHYS RES, V107, pE5, DOI DOI 10.1029/2001JE001518; Mustard JF, 2005, SCIENCE, V307, P1594, DOI 10.1126/science.1109098; Mustard JF, 1997, J GEOPHYS RES-PLANET, V102, P25605, DOI 10.1029/97JE02354; Poulet F, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002179; Ruff SW, 2001, J GEOPHYS RES-PLANET, V106, P23921, DOI 10.1029/2000JE001329; Schultz PH, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2002JE002025; SETTLE M, 1979, J GEOPHYS RES, V84, P8343, DOI 10.1029/JB084iB14p08343; Tosca NJ, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002218; Vaniman DT, 2004, NATURE, V431, P663, DOI 10.1038/nature02973; Wyatt MB, 2002, NATURE, V417, P263, DOI 10.1038/417263a; Yen AS, 2000, SCIENCE, V289, P1909, DOI 10.1126/science.289.5486.1909	29	741	752	5	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2005	307	5715					1576	1581		10.1126/science.1108806	http://dx.doi.org/10.1126/science.1108806			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15718430				2022-12-24	WOS:000227622400034
J	Delamarre, L; Pack, M; Chang, H; Mellman, I; Trombetta, ES				Delamarre, L; Pack, M; Chang, H; Mellman, I; Trombetta, ES			Differential lysosomal proteolysis in antigen-presenting CeRs determines antigen fate	SCIENCE			English	Article							CLASS-II COMPLEXES; DENDRITIC CELLS; PROTEIN ANTIGENS; TRANSPORT; IMMUNITY; HIV	Antigen-presenting cells (APCs) internalize antigens and present antigen-derived peptides to T cells. Although APCs have been thought to exhibit a well-developed capacity for lysosomal proteolysis, here we found that they can exhibit two distinct strategies upon antigen encounter. Whereas macrophages contained high levels of lysosomal proteases and rapidly degraded internalized proteins, dendritic cells (DCs) and B lymphocytes were protease-poor, resulting in a limited capacity for lysosomal degradation. Consistent with these findings, DCs in vivo degraded internalized antigens slowly and thus retained antigen in lymphoid organs for extended periods. Limited lysosomal proteolysis also favored antigen presentation. These results help explain why DCs are able to efficiently accumulate, process, and disseminate antigens and microbes systemically for purposes of tolerance and immunity.	Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Immunobiol, New Haven, CT 06520 USA	Yale University; Ludwig Institute for Cancer Research; Yale University	Mellman, I (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St,POB 208002, New Haven, CT 06520 USA.	ira.mellman@yale.edu; sergio.trombetta@yale.edu	Mellman, Ira/ABG-5896-2020		NIAID NIH HHS [R37-AI34098] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034098] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amara A, 2003, J CELL BIOL, V162, P371, DOI 10.1083/jcb.200307062; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Hartmann S, 2003, INT J PARASITOL, V33, P1291, DOI 10.1016/S0020-7519(03)00163-2; INABA K, 1990, J EXP MED, V172, P631, DOI 10.1084/jem.172.2.631; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; KIM EE, 1992, BIOCHEMISTRY-US, V31, P12304, DOI 10.1021/bi00164a004; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Mellman I, 1998, TRENDS CELL BIOL, V8, P231, DOI 10.1016/S0962-8924(98)01276-8; Niedergang F, 2004, TRENDS MICROBIOL, V12, P79, DOI 10.1016/j.tim.2003.12.011; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; RICHARDS FM, 1971, BOVINE PANCREATIC RI, V4; ROMANI N, 1989, J EXP MED, V169, P1169, DOI 10.1084/jem.169.3.1169; Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991; Stebbing J, 2004, NEW ENGL J MED, V350, P1872, DOI 10.1056/NEJMra032395; Steinman RM, 2003, CURR TOP MICROBIOL, V276, P1; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; TROMBETTA ES, UNPUB; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522	21	542	564	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2005	307	5715					1630	1634		10.1126/science.1108003	http://dx.doi.org/10.1126/science.1108003			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15761154				2022-12-24	WOS:000227622400049
J	Matsuo, Y; Imagawa, H; Nishizawa, M; Shizuri, Y				Matsuo, Y; Imagawa, H; Nishizawa, M; Shizuri, Y			Isolation of an algal morphogenesis inducer from a marine bacterium	SCIENCE			English	Article							AXENIC CULTURE; MONOSTROMA-OXYSPERMUM; ULVA; CHLOROPHYCEAE		Marine Biotechnol Inst Co Ltd, Kamaishi, Iwate 0260001, Japan; Tokushima Bunri Univ, Fac Pharmaceut Sci, Yamashiro, Tokushima 7708514, Japan	Japanese Society of Marine Biotechnology; Tokushima Bunri University	Matsuo, Y (corresponding author), Marine Biotechnol Inst Co Ltd, 3-75-1 Heita, Kamaishi, Iwate 0260001, Japan.	yoshihide.matsuo@mbio.jp						BONNEAU ER, 1977, J PHYCOL, V13, P133, DOI 10.1111/j.1529-8817.1977.tb00569.x; FRIES L, 1975, BOT MAR, V18, P251, DOI 10.1515/botm.1975.18.4.251; Matsuo Y, 2003, ENVIRON MICROBIOL, V5, P25, DOI 10.1046/j.1462-2920.2003.00382.x; MATSUO Y, UNPUB; Nakanishi K, 1996, J PHYCOL, V32, P479, DOI 10.1111/j.0022-3646.1996.00479.x; PROVASOLI L, 1958, BIOL BULL, V114, P375, DOI 10.2307/1538992; PROVASOLI L, 1980, J PHYCOL, V16, P196, DOI 10.1111/j.1529-8817.1980.tb03019.x; PROVASOLI L, 1963, P INT SEAWEED S, V4, P1; TATEWAKI M, 1983, J PHYCOL, V19, P409, DOI 10.1111/j.0022-3646.1983.00409.x	9	161	167	7	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2005	307	5715					1598	1598		10.1126/science.1105486	http://dx.doi.org/10.1126/science.1105486			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	906ED	15761147				2022-12-24	WOS:000227622400040
J	Inoue, N; Ikawa, M; Isotani, A; Okabe, M				Inoue, N; Ikawa, M; Isotani, A; Okabe, M			The immunoglobulin superfamily protein Izumo is required for sperm to fuse with eggs	NATURE			English	Article							PLASMA-MEMBRANE; CD9-DEFICIENT MICE; ACROSOME REACTION; HUMAN-SPERMATOZOA; GAMETE FUSION; FERTILIN-BETA; MOUSE; BINDING; RECEPTORS; CALMEGIN	Representing the 60 trillion cells that build a human body, a sperm and an egg meet, recognize each other, and fuse to form a new generation of life. The factors involved in this important membrane fusion event, fertilization, have been sought for a long time(1). Recently, CD9 on the egg membrane was found to be essential for fusion(2-4), but sperm-related fusion factors remain unknown. Here, by using a fusion-inhibiting monoclonal antibody(5) and gene cloning, we identify a mouse sperm fusion-related antigen and show that the antigen is a novel immunoglobulin superfamily protein. We have termed the gene Izumo and produced a gene-disrupted mouse line. Izumo(-/-) mice were healthy but males were sterile. They produced normal-looking sperm that bound to and penetrated the zona pellucida but were incapable of fusing with eggs. Human sperm also contain Izumo and addition of the antibody against human Izumo left the sperm unable to fuse with zona-free hamster eggs.	Osaka Univ, Genome Informat Res Ctr, Suita, Osaka 5650871, Japan; Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; Osaka Univ, Fac Pharmaceut Sci, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University	Okabe, M (corresponding author), Osaka Univ, Genome Informat Res Ctr, Yamadaoka 3-1, Suita, Osaka 5650871, Japan.	okabe@gen-info.osaka-u.ac.jp	Inoue, Naokazu/A-9911-2009; Isotani, Ayako/A-9929-2009; Isotani, Ayako/D-4564-2017; ikawa, masahito/A-5315-2009; Okabe, Masaru/B-6917-2015	Isotani, Ayako/0000-0002-4720-2318; Isotani, Ayako/0000-0002-4720-2318; ikawa, masahito/0000-0001-9859-6217; Inoue, Naokazu/0000-0002-6187-8293; Okabe, Masaru/0000-0002-0803-9044				ANDERSON DJ, 1993, P NATL ACAD SCI USA, V90, P10051, DOI 10.1073/pnas.90.21.10051; BLOBEL CP, 1992, NATURE, V356, P248, DOI 10.1038/356248a0; BOOKBINDER LH, 1995, SCIENCE, V269, P86, DOI 10.1126/science.7604284; Cho CH, 1998, SCIENCE, V281, P1857, DOI 10.1126/science.281.5384.1857; Ellerman DA, 2003, MOL BIOL CELL, V14, P5098, DOI 10.1091/mbc.E03-04-0244; Hagaman JR, 1998, P NATL ACAD SCI USA, V95, P2552, DOI 10.1073/pnas.95.5.2552; Hao ZL, 2002, BIOL REPROD, V66, P735, DOI 10.1095/biolreprod66.3.735; He ZY, 2003, DEV BIOL, V254, P226, DOI 10.1016/S0012-1606(02)00043-X; Ikawa M, 2001, DEV BIOL, V240, P254, DOI 10.1006/dbio.2001.0462; Ilayperuma I, 2002, J EXP ZOOL, V293, P617, DOI 10.1002/jez.10182; Inoue N, 2003, MOL CELL BIOL, V23, P2614, DOI 10.1128/MCB.23.7.2614-2622.2003; Inoue N, 2001, J IMMUNOL, V166, P424, DOI 10.4049/jimmunol.166.1.424; Kaji K, 2000, NAT GENET, V24, P279, DOI 10.1038/73502; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; Le Naour F, 2000, SCIENCE, V287, P319, DOI 10.1126/science.287.5451.319; Manandhar G, 2001, BIOL REPROD, V65, P1425, DOI 10.1095/biolreprod65.5.1425; Miyado K, 2000, SCIENCE, V287, P321, DOI 10.1126/science.287.5451.321; Nakanishi T, 1999, FEBS LETT, V449, P277, DOI 10.1016/S0014-5793(99)00433-0; Nishimura H, 2004, J BIOL CHEM, V279, P34957, DOI 10.1074/jbc.M314249200; Nishimura H, 2001, DEV BIOL, V233, P204, DOI 10.1006/dbio.2001.0166; OKABE M, 1990, FERTIL STERIL, V54, P1121; OKABE M, 1987, J REPROD IMMUNOL, V11, P91, DOI 10.1016/0165-0378(87)90014-3; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; OVERSTREET JW, 1980, FERTIL STERIL, V33, P534; ROCHWERGER L, 1992, DEV BIOL, V153, P83, DOI 10.1016/0012-1606(92)90093-V; Saxena DK, 2002, REPRODUCTION, V123, P435, DOI 10.1530/rep.0.1230435; Stein KK, 2004, J CELL SCI, V117, P6269, DOI 10.1242/jcs.01598; Yamagata K, 2002, DEV BIOL, V250, P348, DOI 10.1006/dbio.2002.0803; YANAGIMACHI R, 1976, BIOL REPROD, V15, P471, DOI 10.1095/biolreprod15.4.471; Yanagimachi R, 1994, MAMMALIAN FERTILIZAT; Yoda Y., 1971, JAPANESE J ANIM REPR, V16, P147, DOI [DOI 10.1262/JRD1955.16.147, 10.1262/jrd1955.16.147]	31	528	572	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					234	238		10.1038/nature03362	http://dx.doi.org/10.1038/nature03362			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15759005				2022-12-24	WOS:000227494500050
J	Andersen, JB; Rourke, BC; Caiozzo, VJ; Bennett, AF; Hicks, JW				Andersen, JB; Rourke, BC; Caiozzo, VJ; Bennett, AF; Hicks, JW			Postprandial cardiac hypertrophy in pythons	NATURE			English	Editorial Material							HEART; MODEL		Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Orthopaed, Irvine, CA 92697 USA; Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; California State University System; California State University Long Beach	Andersen, JB (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA.	jhicks@uci.edu						COOPER G, 1987, ANNU REV PHYSIOL, V49, P501, DOI 10.1146/annurev.ph.49.030187.002441; MORGAN HE, 1987, ANNU REV PHYSIOL, V49, P533; Quinn KE, 1998, BIOPHYS J, V74, pA355; Richey PA, 1998, J SPORT SCI, V16, P129; Secor SM, 1997, AM J PHYSIOL-REG I, V272, pR902, DOI 10.1152/ajpregu.1997.272.3.R902; Secor SM, 2000, J EXP BIOL, V203, P2447; Secor SM, 1998, NATURE, V395, P659, DOI 10.1038/27131; Starck JM, 2001, J EXP BIOL, V204, P325; VLIEGEN HW, 1990, COMP BIOCHEM PHYS A, V95, P109, DOI 10.1016/0300-9629(90)90017-M	9	84	88	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 3	2005	434	7029					37	38		10.1038/434037a	http://dx.doi.org/10.1038/434037a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744290				2022-12-24	WOS:000227334600034
J	Boxma, B; de Graaf, RM; van der Staay, GWM; van Alen, TA; Ricard, G; Gabaldon, T; van Hoek, AHAM; Moon-van der Staay, SY; Koopman, WJH; van Hellemond, JJ; Tielens, AGM; Friedrich, T; Veenhuis, M; Huynen, MA; Hackstein, JHP				Boxma, B; de Graaf, RM; van der Staay, GWM; van Alen, TA; Ricard, G; Gabaldon, T; van Hoek, AHAM; Moon-van der Staay, SY; Koopman, WJH; van Hellemond, JJ; Tielens, AGM; Friedrich, T; Veenhuis, M; Huynen, MA; Hackstein, JHP			An anaerobic mitochondrion that produces hydrogen	NATURE			English	Article							CHYTRID NEOCALLIMASTIX SP; PYRUVATE-FORMATE-LYASE; COMPLEX-I; ORGANELLES; GENOME; EVOLUTION; EUKARYOTE; MEMBRANE; SEQUENCE; ORIGINS	Hydrogenosomes are organelles that produce ATP and hydrogen(1), and are found in various unrelated eukaryotes, such as anaerobic flagellates, chytridiomycete fungi and ciliates(2). Although all of these organelles generate hydrogen, the hydrogenosomes from these organisms are structurally and metabolically quite different, just like mitochondria where large differences also exist(3). These differences have led to a continuing debate about the evolutionary origin of hydrogenosomes(4,5). Here we show that the hydrogenosomes of the anaerobic ciliate Nyctotherus ovalis, which thrives in the hindgut of cockroaches, have retained a rudimentary genome encoding components of a mitochondrial electron transport chain. Phylogenetic analyses reveal that those proteins cluster with their homologues from aerobic ciliates. In addition, several nucleus-encoded components of the mitochondrial proteome, such as pyruvate dehydrogenase and complex II, were identified. The N. ovalis hydrogenosome is sensitive to inhibitors of mitochondrial complex I and produces succinate as a major metabolic end product - biochemical traits typical of anaerobic mitochondria(3). The production of hydrogen, together with the presence of a genome encoding respiratory chain components, and biochemical features characteristic of anaerobic mitochondria, identify the N. ovalis organelle as a missing link between mitochondria and hydrogenosomes.	Radboud Univ Nijmegen, Fac Sci, Dept Evolutionary Microbiol, NL-6525 ED Nijmegen, Netherlands; Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6500 HB Nijmegen, Netherlands; Radboud Univ Nijmegen, Med Ctr, NCMLS, Microscop Imaging Ctr, NL-6500 HB Nijmegen, Netherlands; Radboud Univ Nijmegen, Med Ctr, NCMLS, Dept Biochem, NL-6500 HB Nijmegen, Netherlands; Univ Utrecht, Fac Vet Med, Dept Biochem & Cell Biol, NL-3508 TD Utrecht, Netherlands; Univ Freiburg, Inst Organ Chem & Biochem, D-79104 Freiburg, Germany; Univ Groningen, Dept Eukaryot Microbiol, NL-9750 AA Haren, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; University of Freiburg; University of Groningen	Hackstein, JHP (corresponding author), Radboud Univ Nijmegen, Fac Sci, Dept Evolutionary Microbiol, Toernooiveld 1, NL-6525 ED Nijmegen, Netherlands.	j.hackstein@science.ru.nl	de Graaf, Rob/E-7665-2012; Koopman, Werner J.H./D-3592-2009; van Hellemond, Jaap/T-7555-2019; Koopman, Werner J.H./AAC-9668-2020; Huijnen, M.A./H-8051-2014; Gabaldón, Toni/A-7336-2008; Huynen, Martijn A/A-1530-2014	Koopman, Werner J.H./0000-0002-5340-6747; van Hellemond, Jaap/0000-0003-4862-7796; Koopman, Werner J.H./0000-0002-5340-6747; Gabaldón, Toni/0000-0003-0019-1735; Huynen, Martijn A/0000-0001-6189-5491; de Graaf, Rob/0000-0001-9143-8961				Akhmanova A, 1999, MOL MICROBIOL, V32, P1103, DOI 10.1046/j.1365-2958.1999.01434.x; Akhmanova A, 1998, NATURE, V396, P527, DOI 10.1038/25023; Boxma B, 2004, MOL MICROBIOL, V51, P1389, DOI 10.1046/j.1365-2958.2003.03912.x; Brunk CF, 2003, NUCLEIC ACIDS RES, V31, P1673, DOI 10.1093/nar/gkg270; Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012; Clemens DL, 2000, MOL BIOCHEM PARASIT, V106, P307, DOI 10.1016/S0166-6851(99)00220-0; Cotter D, 2004, NUCLEIC ACIDS RES, V32, pD463, DOI 10.1093/nar/gkh048; Curtis EA, 1999, ANN NY ACAD SCI, V870, P349, DOI 10.1111/j.1749-6632.1999.tb08900.x; Dyall SD, 2004, NATURE, V431, P1103, DOI 10.1038/nature02990; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Embley TM, 2003, IUBMB LIFE, V55, P387, DOI 10.1080/15216540310001592834; Embley TM, 1997, TRENDS ECOL EVOL, V12, P437, DOI 10.1016/S0169-5347(97)01208-1; Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2; Fenchel T., 1995, ECOLOGY EVOLUTION AN; Hrdy I, 2004, NATURE, V432, P618, DOI 10.1038/nature03149; Koopman WJH, 2001, BIOPHYS J, V81, P57, DOI 10.1016/S0006-3495(01)75679-2; Leon-Avila G, 2004, MICROBIOL-SGM, V150, P1245, DOI 10.1099/mic.0.26923-0; Martin W, 2001, BIOL CHEM, V382, P1521, DOI 10.1515/BC.2001.187; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; MULLER M, 1993, J GEN MICROBIOL, V139, P2879, DOI 10.1099/00221287-139-12-2879; Roger AJ, 1999, AM NAT, V154, pS146, DOI 10.1086/303290; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Tielens AGM, 2002, TRENDS BIOCHEM SCI, V27, P564, DOI 10.1016/S0968-0004(02)02193-X; van der Giezen M, 2002, EMBO J, V21, P572, DOI 10.1093/emboj/21.4.572; Van Hoek AHAM, 1999, J EUKARYOT MICROBIOL, V46, P427, DOI 10.1111/j.1550-7408.1999.tb04623.x; van Hoek AHAM, 2000, MOL BIOL EVOL, V17, P251, DOI 10.1093/oxfordjournals.molbev.a026304; vanderGiezen M, 1997, FEBS LETT, V408, P147, DOI 10.1016/S0014-5793(97)00409-2; VanHellemond JJ, 1995, J BIOL CHEM, V270, P31065, DOI 10.1074/jbc.270.52.31065; Voncken F, 2002, MOL MICROBIOL, V44, P1441, DOI 10.1046/j.1365-2958.2002.02959.x; Voncken FGJ, 2002, GENE, V284, P103, DOI 10.1016/S0378-1119(02)00388-8	30	156	166	4	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					74	79		10.1038/nature03343	http://dx.doi.org/10.1038/nature03343			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744302	Green Submitted, Green Published			2022-12-24	WOS:000227334600046
J	Duan, NH				Duan, NH			Listening to consumers and HIV vaccine preparedness	LANCET			English	Editorial Material							DEVELOPING-COUNTRIES; TRIAL; AIDS; SWITZERLAND; RISK; IF		Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Duan, NH (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA.	naihua@mednet.ucla.edu		Duan, Naihua/0000-0001-9411-2924				Andreasen AlanR., 1995, MARKETING SOCIAL CHA; Buchbinder SP, 2004, JAIDS-J ACQ IMM DEF, V36, P604, DOI 10.1097/00126334-200405010-00009; CELENTANO DD, 1995, AIDS, V9, P1079, DOI 10.1097/00002030-199509000-00015; Chang ML, 2003, AIDS, V17, pW1, DOI [10.1097/01.aids.0000076356.20434.a0, 10.1097/00002030-200310170-00025]; Dubois-Arber F, 1999, AIDS, V13, P2571, DOI 10.1097/00002030-199912240-00011; DUBOIS-ARBER F, 1988, World Health Forum, V9, P376; DuboisArber F, 1997, AM J PUBLIC HEALTH, V87, P558, DOI 10.2105/AJPH.87.4.558; Esparza J, 2002, VACCINE, V20, P1897, DOI 10.1016/S0264-410X(02)00062-2; Francis DP, 2003, AIDS, V17, P147, DOI 10.1097/00002030-200301240-00003; Mills E, 2004, AIDS, V18, P2235, DOI 10.1097/00002030-200411190-00003; Newman PA, 2004, AIDS PATIENT CARE ST, V18, P691, DOI 10.1089/apc.2004.18.691; Newman PA, 2004, JAIDS-J ACQ IMM DEF, V37, P1393, DOI 10.1097/01.qai.0000127064.84325.ad; Streefland PH, 2003, VACCINE, V21, P1304, DOI 10.1016/S0264-410X(02)00685-0; Tucker T, 2003, LANCET, V362, P995, DOI 10.1016/S0140-6736(03)14374-7; Urban GL, 1993, DESIGN MARKETING NEW; WOODS DR, 1991, PUBLIC HEALTH REP, V106, P616; Zimet GD, 1999, J PEDIATR PSYCHOL, V24, P67, DOI 10.1093/jpepsy/24.1.67; [No title captured]	18	11	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2005	365	9465					1119	1121		10.1016/S0140-6736(05)71857-2	http://dx.doi.org/10.1016/S0140-6736(05)71857-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	910DD	15794955				2022-12-24	WOS:000227909500008
J	Carreira, S; Goodall, J; Aksan, I; La Rocca, SA; Galibert, MD; Denat, L; Larue, L; Goding, CR				Carreira, S; Goodall, J; Aksan, I; La Rocca, SA; Galibert, MD; Denat, L; Larue, L; Goding, CR			Mitf cooperates with Rb1 and activates p21(Cip1) expression to regulate cell cycle progression	NATURE			English	Article							MICROPHTHALMIA GENE-PRODUCT; DEPENDENT KINASE INHIBITOR; TRANSCRIPTION FACTOR; MELANOCYTE DEVELOPMENT; FACTOR TBX2; IN-VITRO; S PHASE; PROMOTER; TARGET; DIFFERENTIATION	The controls that enable melanoblasts and melanoma cells to proliferate are likely to be related, but so far no key regulator of cell cycle progression specific to the melanocyte lineage has been identified. The microphthalmia-associated transcription factor Mitf has a crucial but poorly defined role in melanoblast and melanocyte survival and in differentiation(1). Here we show that Mitf can act as a novel anti-proliferative transcription factor able to induce a G1 cell-cycle arrest that is dependent on Mitf-mediated activation of the p21(Cip1) (CDKN1A) cyclin-dependent kinase inhibitor gene. Moreover, cooperation between Mitf and the retinoblastoma protein Rb1 potentiates the ability of Mitf to activate transcription. The results indicate that Mitf-mediated activation of p21(Cip1) expression and consequent hypophosphorylation of Rb1 will contribute to cell cycle exit and activation of the differentiation programme. The mutation of genes associated with melanoma, such as INK4a or BRAF that would affect either Mitf cooperation with Rb1 or Mitf stability respectively, would impair Mitf-mediated cell cycle control.	Inst Curie, CNRS, UMR146, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Goding, CR (corresponding author), Marie Curie Res Inst, Signalling & Dev Lab, The Chart, Oxted RH8 OTL, Surrey, England.	c.goding@mcri.ac.uk	KURNAZ, ISIL/GXG-5616-2022; Larue, Lionel/F-7355-2013; la rocca, severina anna/D-8028-2011; Larue, Lionel/I-6532-2016; Carreira, Suzanne/C-8445-2012	Carreira, Suzanne/0000-0002-5077-5379; Goding, Colin/0000-0002-1614-3909				Aksan I, 1998, MOL CELL BIOL, V18, P6930, DOI 10.1128/MCB.18.12.6930; Allan LA, 2000, MOL CELL BIOL, V20, P1291, DOI 10.1128/MCB.20.4.1291-1298.2000; BENTLEY NJ, 1994, MOL CELL BIOL, V14, P7996, DOI 10.1128/MCB.14.12.7996; Bertolotto C, 1998, J CELL BIOL, V142, P827, DOI 10.1083/jcb.142.3.827; Carreira S, 2000, J BIOL CHEM, V275, P21920, DOI 10.1074/jbc.M000035200; Carreira S, 1998, MOL CELL BIOL, V18, P5099, DOI 10.1128/MCB.18.9.5099; Chew YP, 1998, ONCOGENE, V17, P2177, DOI 10.1038/sj.onc.1202443; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Galibert MD, 2001, EMBO J, V20, P5022, DOI 10.1093/emboj/20.17.5022; Halaban R, 1998, ONCOGENE, V16, P2489, DOI 10.1038/sj.onc.1201773; HIRST K, 1994, EMBO J, V13, P5410, DOI 10.1002/j.1460-2075.1994.tb06876.x; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Hornyak TJ, 2001, MECH DEVELOP, V101, P47, DOI 10.1016/S0925-4773(00)00569-4; Jacobs JJL, 2000, NAT GENET, V26, P291, DOI 10.1038/81583; JIANG HP, 1995, ONCOGENE, V10, P1855; KONYUKHOV BV, 1966, FOLIA BIOL-PRAGUE, V12, P116; LERNER AB, 1986, J INVEST DERMATOL, V87, P299, DOI 10.1111/1523-1747.ep12524353; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; OKURA M, 1995, J INVEST DERMATOL, V105, P322, DOI 10.1111/1523-1747.ep12319939; Prince S, 2004, CANCER RES, V64, P1669, DOI 10.1158/0008-5472.CAN-03-3286; QUELLE DE, 1995, CELL, V83, P993; QUELLE DE, 1995, ONCOGENE, V11, P635; Takahashi Y, 2000, GENE DEV, V14, P804; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; Vance KW, 2004, PIGM CELL RES, V17, P318, DOI 10.1111/j.1600-0749.2004.00164.x; Vigo E, 1999, MOL CELL BIOL, V19, P6379; YAVUZER U, 1995, ONCOGENE, V10, P123; Yu BD, 2003, P NATL ACAD SCI USA, V100, P14881, DOI 10.1073/pnas.2431391100	30	299	308	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2005	433	7027					764	769		10.1038/nature03269	http://dx.doi.org/10.1038/nature03269			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897XH	15716956				2022-12-24	WOS:000227039200044
J	Gros, J; Manceau, M; Thome, V; Marcelle, C				Gros, J; Manceau, M; Thome, V; Marcelle, C			A common somitic origin for embryonic muscle progenitors and satellite cells	NATURE			English	Article							MYOGENIC PROGENITORS; SKELETAL-MUSCLE; CHICK; REGENERATION; MYOTOME	In the embryo and in the adult, skeletal muscle growth is dependent on the proliferation and the differentiation of muscle progenitors present within muscle masses. Despite the importance of these progenitors, their embryonic origin is unclear(1,2). Here we use electroporation of green fluorescent protein in chick somites(3), video confocal microscopy analysis of cell movements, and quail-chick grafting experiments to show that the dorsal compartment of the somite, the dermomyotome, is the origin of a population of muscle progenitors that contribute to the growth of trunk muscles during embryonic and fetal life. Furthermore, long-term lineage analyses indicate that satellite cells, which are known progenitors of adult skeletal muscles(4), derive from the same dermomyotome cell population. We conclude that embryonic muscle progenitors and satellite cells share a common origin that can be traced back to the dermomyotome.	Univ Mediterranee, CNRS,UMR 6545, Dev Biol Inst Marseille, Lab Genet & Physiol Dev, F-13288 Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Marcelle, C (corresponding author), Univ Mediterranee, CNRS,UMR 6545, Dev Biol Inst Marseille, Lab Genet & Physiol Dev, Campus Luminy,Case 907, F-13288 Marseille, France.	marcelle@ibdm.univ-mrs.fr		Gros, Jerome/0000-0002-2264-2851				ARMAND O, 1983, ARCH ANAT MICROSC MO, V72, P163; Bischoff R., 1994, MYOLOGY, VVolume 1, P97; CHRIST B, 1995, ANAT EMBRYOL, V191, P381, DOI 10.1007/BF00304424; De Angelis L, 1999, J CELL BIOL, V147, P869, DOI 10.1083/jcb.147.4.869; FELDMAN JL, 1992, DEV BIOL, V153, P217, DOI 10.1016/0012-1606(92)90107-R; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Gros J, 2004, DEV CELL, V6, P875, DOI 10.1016/j.devcel.2004.05.006; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; HARTLEY RS, 1992, DEV BIOL, V153, P206, DOI 10.1016/0012-1606(92)90106-Q; HAUSCHKA SD, 1994, MYOLOGY, P3; Huang RJ, 2000, ANAT EMBRYOL, V202, P369, DOI 10.1007/s004290000130; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Morgan JE, 2003, INT J BIOCHEM CELL B, V35, P1151, DOI 10.1016/S1357-2725(03)00042-6; Olivera-Martinez I, 2000, DEVELOPMENT, V127, P4611; Parker MH, 2003, NAT REV GENET, V4, P497, DOI 10.1038/nrg1109; Scaal M, 2004, ANAT EMBRYOL, V208, P411, DOI 10.1007/s00429-004-0417-y; Scaal M, 2004, DEV DYNAM, V229, P643, DOI 10.1002/dvdy.10433; Seale P, 2001, DEV CELL, V1, P333, DOI 10.1016/S1534-5807(01)00049-1; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; TOSNEY KW, 1994, DEV BIOL, V163, P389, DOI 10.1006/dbio.1994.1157	20	417	458	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2005	435	7044					954	958		10.1038/nature03572	http://dx.doi.org/10.1038/nature03572			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935RN	15843802				2022-12-24	WOS:000229799700049
J	Ware, DM; Thomson, RE				Ware, DM; Thomson, RE			Bottom-up ecosystem trophic dynamics determine fish production in the northeast Pacific	SCIENCE			English	Article							WEST-COAST; WATERS	We addressed the question of bottom-up versus top-down control of marine ecosystem trophic interactions by using annual fish catch data and satellite-derived (SeaWiFS) chlorophyll a measurements for the continental margin of western North America. Findings reveal a marked alongshore variation in retained primary production that is highly correlated with the alongshore variation in resident fish yield. The highest productivity occurs off, the coasts of Washington and southern British Columbia. Zooplankton data for coastal British Columbia confirm strong bottom-up trophic linkages between phytoplankton, zooplankton, and resident fish, extending to regional areas as small as 10,000 square kilometers.	Fisheries Oceans Canada Inst Ocean Sci, Sidney, BC V8L 4B2, Canada; Aquat Ecosyst Associates, Nanaimo, BC V9T 1M2, Canada; Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V5Z 1M9, Canada; Simon Fraser Univ, Sch Resource & Environm Management, Burnaby, BC V5A 1S6, Canada; Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC, Canada	Fisheries & Oceans Canada; University of British Columbia; Simon Fraser University; University of Victoria	Thomson, RE (corresponding author), Fisheries Oceans Canada Inst Ocean Sci, 9860 W Saanich Rd, Sidney, BC V8L 4B2, Canada.	thomsonr@pac.dfo-mpo.gc.ca						DORMAN CE, 1995, J GEOPHYS RES-OCEANS, V100, P16029, DOI 10.1029/95JC00964; Gregg WW, 2004, REMOTE SENS ENVIRON, V93, P463, DOI 10.1016/j.rse.2003.12.012; *I OC SCI, UNPUB; IVERSON RL, 1990, LIMNOL OCEANOGR, V35, P1593, DOI 10.4319/lo.1990.35.7.1593; Logerwell EA, 2003, FISH OCEANOGR, V12, P554, DOI 10.1046/j.1365-2419.2003.00238.x; LYNDE MVH, 1986, NMFSNWC103 NOAA; McGowan JA, 1998, SCIENCE, V281, P210, DOI 10.1126/science.281.5374.210; Perry M. J., 1989, COASTAL OCEANOGRAPHY, P117, DOI DOI 10.1016/S0422-9894(08)70347-7; Richardson AJ, 2004, SCIENCE, V305, P1609, DOI 10.1126/science.1100958; ROYER TC, 1982, J GEOPHYS RES-OCEANS, V87, P2017, DOI 10.1029/JC087iC03p02017; Ruddick KG, 2000, APPL OPTICS, V39, P897, DOI 10.1364/AO.39.000897; Scheffer M, 2000, CAN J FISH AQUAT SCI, V57, P1208, DOI 10.1139/cjfas-57-6-1208; Stabeno PJ, 2004, CONT SHELF RES, V24, P859, DOI 10.1016/j.csr.2004.02.007; STRUB PT, 1991, J GEOPHYS RES-OCEANS, V96, P14743, DOI 10.1029/91JC01024; TANASICHUK RW, 1991, CAN J FISH AQUAT SCI, V48, P2118, DOI 10.1139/f91-251; TASSAN S, 1994, APPL OPTICS, V33, P2369, DOI 10.1364/AO.33.002369; Ware D.M., 1989, CAN SPEC PUBL FISH A, V108, P359	17	509	535	8	199	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2005	308	5726					1280	1284		10.1126/science.1109049	http://dx.doi.org/10.1126/science.1109049			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931JT	15845876				2022-12-24	WOS:000229482300038
J	Law, M; Morris, JK; Wald, N; Luczynska, C; Burney, P				Law, M; Morris, JK; Wald, N; Luczynska, C; Burney, P			Changes in atopy over a quarter of a century, based on cross sectional data at three time periods	BRITISH MEDICAL JOURNAL			English	Article							POPULATION		Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, Ctr Environm & Prevent Med, London EC1M 6BQ, England; Guys Hosp, Guys Kings & St Thomas Sch Med, Dept Publ Hlth Sci, Div Primary Care & Publ Hlth Sci, London SE1 3QD, England	University of London; Queen Mary University London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Law, M (corresponding author), Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, Ctr Environm & Prevent Med, London EC1M 6BQ, England.	m.r.law@qmul.ac.uk	Wald, Nicholas/AAY-8924-2021; Morris, Joan/AAT-9211-2020	Morris, Joan/0000-0002-7164-612X; Burney, Peter/0000-0001-8635-5678				Kosunen TU, 2002, CLIN EXP ALLERGY, V32, P373, DOI 10.1046/j.1365-2222.2002.01330.x; Krause TG, 2002, LANCET, V360, P691, DOI 10.1016/S0140-6736(02)09841-0; Linneberg A, 2000, J ALLERGY CLIN IMMUN, V106, P247, DOI 10.1067/mai.2000.108312; NAKAGOMI T, 1994, LANCET, V343, P121, DOI 10.1016/S0140-6736(94)90854-0; POTTS J, 2002, EUR RESP J S38, V20, pS120	5	79	82	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 21	2005	330	7501					1187	1188		10.1136/bmj.38435.582975.AE	http://dx.doi.org/10.1136/bmj.38435.582975.AE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	929CU	15833748	Bronze, Green Published			2022-12-24	WOS:000229320500020
J	Cheng, J; Kapranov, P; Drenkow, J; Dike, S; Brubaker, S; Patel, S; Long, J; Stern, D; Tammana, H; Helt, G; Sementchenko, V; Piccolboni, A; Bekiranov, S; Bailey, DK; Ganesh, M; Ghosh, S; Bell, I; Gerhard, DS; Gingeras, TR				Cheng, J; Kapranov, P; Drenkow, J; Dike, S; Brubaker, S; Patel, S; Long, J; Stern, D; Tammana, H; Helt, G; Sementchenko, V; Piccolboni, A; Bekiranov, S; Bailey, DK; Ganesh, M; Ghosh, S; Bell, I; Gerhard, DS; Gingeras, TR			Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution	SCIENCE			English	Article							TRANS-ACTING SIRNAS; HUMAN GENOME; BINDING SITES; CDNA; ANNOTATION; HUMAN-CHROMOSOME-21; BROWSER; GENES; RNAS	Sites of transcription of polyadenylated and nonpolyadenylated RNAs for 10 human chromosomes were mapped at 5-base pair resolution in eight cell lines. Unannotated, nonpotyadenylated transcripts comprise the major proportion of the transcriptional output of the human genome. Of all transcribed sequences, 19.4, 43.7, and 36.9% were observed to be polyadenytated, nonpolyadenylated, and bimorphic, respectively. Half of all transcribed sequences are found only in the nucleus and for the most part are unannotated. Overall, the transcribed portions of the human genome are predominantly composed of interlaced networks of both poly A+ and poly A- annotated transcripts and unannotated transcripts of unknown function. This organization has important implications for interpreting genotype-phenotype associations, regulation of gene expression, and the definition of a gene.	Affymetrix Inc, Santa Clara, CA 95051 USA; NCI, Off Canc Genom, Bethesda, MD 20892 USA	Affymetrix; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG)	Gingeras, TR (corresponding author), Affymetrix Inc, Santa Clara, CA 95051 USA.	tom_gingeras@affymetrix.com		Gingeras, Thomas/0000-0001-9106-3573; Kapranov, Philipp/0000-0003-2647-4856				Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; BIRNSTIEL ML, 1985, CELL, V41, P349, DOI 10.1016/S0092-8674(85)80007-6; Bono H, 2003, GENOME RES, V13, P1318, DOI 10.1101/gr.1075103; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chen JJ, 2002, P NATL ACAD SCI USA, V99, P12257, DOI 10.1073/pnas.192436499; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; EDMONDS M, 1969, J BIOL CHEM, V244, P1314; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; GEOGHEGAN TE, 1978, BIOCHEMISTRY-US, V17, P4200, DOI 10.1021/bi00613a014; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Imanishi T, 2004, PLOS BIOL, V2, P856, DOI 10.1371/journal.pbio.0020162; INHORN RC, 1986, BIOCHEM BIOPH RES CO, V137, P431, DOI 10.1016/0006-291X(86)91228-3; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; KATINAKIS PK, 1980, FEBS LETT, V116, P1, DOI 10.1016/0014-5793(80)80515-1; Kawabe Y, 2001, J BIOL CHEM, V276, P20364, DOI 10.1074/jbc.C100035200; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Martone R, 2003, P NATL ACAD SCI USA, V100, P12247, DOI 10.1073/pnas.2135255100; MILCAREK C, 1974, CELL, V3, P1, DOI 10.1016/0092-8674(74)90030-0; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; SALDITTGEORGIEFF M, 1981, MOL CELL BIOL, V1, P179, DOI 10.1128/MCB.1.2.179; Seki M, 2004, J EXP BOT, V55, P213, DOI 10.1093/jxb/erh007; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; SNIDER BJ, 1992, BRAIN RES REV, V17, P263, DOI 10.1016/0165-0173(92)90019-I; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808	35	878	988	3	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2005	308	5725					1149	1154		10.1126/science.1108625	http://dx.doi.org/10.1126/science.1108625			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TA	15790807				2022-12-24	WOS:000229293400038
J	Renehan, AG				Renehan, AG			Preventing cancer, cardiovascular disease, and diabetes	LANCET			English	Editorial Material							BREAST-CANCER; RISK; MECHANISMS; SERUM		Christie Hosp NHS Trust, Dept Surg, Manchester M20 4BX, Lancs, England; Christie Hosp NHS Trust, Canc Res UK Dept Med Oncol, Manchester M20 4BX, Lancs, England	Christie NHS Foundation Trust; Christie Hospital; Cancer Research UK; Christie NHS Foundation Trust; Christie Hospital	Renehan, AG (corresponding author), Christie Hosp NHS Trust, Dept Surg, Manchester M20 4BX, Lancs, England.	arenehan@picr.man.ac.uk	; Renehan, Andrew/K-5992-2015	Howell, Anthony/0000-0002-6233-719X; Renehan, Andrew/0000-0003-4309-4396				*AM CANC SOC, CANC FACTS FIG 2005; American Diabetes Association, DIAB STAT; American Stroke Association American Heart Association, HEART DIS STROK STAT; Amir E, 2003, J MED GENET, V40, P807, DOI 10.1136/jmg.40.11.807; ANDERSON RM, 2002, NATL VITAL STAT REPO, V53; *BHF, BHF COR HEART DIS ST; *BHF, EC COSTS CHD; Bianchini F, 2002, WEIGHT CONTROL PHYS; Bosanquet N, 2004, LANCET ONCOL, V5, P568, DOI 10.1016/S1470-2045(04)01569-4; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; *CANC RES UK, 2004, CANCERSTATS INC UK; *DIAB UK, 3 DIAB UK; *DIAB UK, GETS DIAB WHAT CAUS; Doll R, 1998, Stat Methods Med Res, V7, P87, DOI 10.1191/096228098668199908; Dowsett M, 2002, NAT MED, V8, P1341, DOI 10.1038/nm1202-1341; Erlinger TP, 2004, JAMA-J AM MED ASSOC, V291, P585, DOI 10.1001/jama.291.5.585; Eyre H, 2004, CA-CANCER J CLIN, V54, P190, DOI 10.3322/canjclin.54.4.190; Juul A, 2002, CIRCULATION, V106, P939, DOI 10.1161/01.CIR.0000027563.44593.CC; Kreeger Karen, 2003, Nature, V424, P1090, DOI 10.1038/nj6952-1090a; McTiernan A, 1998, CANCER CAUSE CONTROL, V9, P487, DOI 10.1023/A:1008853601471; *NAT CANC RES I, 2002, STRAT AN OV CANC RES; *NAT CANC RES I, 2004, PREV RISK RES UK REP; *OFF NAT STAT, 2003, MORT STAT CAUS DH2, V30; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616	26	29	30	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 23	2005	365	9469					1449	1451		10.1016/S0140-6736(05)66399-4	http://dx.doi.org/10.1016/S0140-6736(05)66399-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850618				2022-12-24	WOS:000228651600009
J	Skilton, MR; Evans, N; Griffiths, KA; Harmer, JA; Celermajer, DS				Skilton, MR; Evans, N; Griffiths, KA; Harmer, JA; Celermajer, DS			Aortic wall thickness in newborns with intrauterine growth restriction	LANCET			English	Article							MEDIA THICKNESS; HEART-DISEASE; RISK-FACTORS; ATHEROSCLEROSIS; CHILDREN; WEIGHT; INTIMA; ADULTS; ARTERY	Much epidemiological evidence has linked low birthweight with late cardiovascular risk. We measured aortic wall thickness (a marker of early atherosclerosis) by ultrasonography in 25 newborn babies with intrauterine growth restriction and 25 with normal birthweight. Maximum aortic thicknesses were significantly higher in the babies with intrauterine growth restriction (810 mu m [SD 113]) than in those without (743 mu m [76], p=0.02), more so after adjustment for birthweight (300 mu m/kg [45] vs 199 mu m/kg [29], p<0.0001). Newborn babies with growth restriction have significant aortic thickening, suggesting that prenatal events might predispose to later cardiovascular risk.	Univ Sydney, Dept Med, Sydney, NSW 2006, Australia; Royal Prince Alfred Hosp, Dept Newborn Care, Sydney, NSW, Australia; Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of Sydney	Celermajer, DS (corresponding author), Univ Sydney, Dept Med, Sydney, NSW 2006, Australia.	david.celermajer@email.cs.nsw.gov.au		Skilton, Michael/0000-0003-2793-2388				BARKER DJP, 1989, LANCET, V2, P577; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Jarvisalo MJ, 2001, CIRCULATION, V104, P2943, DOI 10.1161/hc4901.100522; Leeson CPM, 2001, CIRCULATION, V103, P1264; McGill HC, 2000, ARTERIOSCL THROM VAS, V20, P836, DOI 10.1161/01.ATV.20.3.836; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103	6	217	228	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2005	365	9469					1484	1486		10.1016/S0140-6736(05)66419-7	http://dx.doi.org/10.1016/S0140-6736(05)66419-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850633				2022-12-24	WOS:000228651600027
J	Bichot, NP; Rossi, AF; Desimone, R				Bichot, NP; Rossi, AF; Desimone, R			Parallel and serial neural mechanisms for visual search in macaque area V4	SCIENCE			English	Article							SELECTIVE ATTENTION; PREFRONTAL CORTEX; WORKING-MEMORY; RESPONSES; SYNCHRONIZATION; SPACE; V2	To find a target object in a crowded scene, a face in a crowd for example, the visual system might turn the neural representation of each object on and off in a serial fashion, testing each representation against a template of the target item. Alternatively, it might allow the processing of all objects in parallel but bias activity in favor of those neurons that represent critical features of the target, until the target emerges from the background. To test these possibilities, we recorded neurons in area V4 of monkeys freely scanning a complex array to find a target defined by color, shape, or both. Throughout the period of searching, neurons gave enhanced responses and synchronized their activity in the gamma range whenever a preferred stimulus in their receptive field matched a feature of the target, as predicted by parallel models. Neurons also gave enhanced responses to candidate targets that were selected for saccades, or foveation, reflecting a serial component of visual search. Thus, serial and parallel mechanisms of response enhancement and neural synchrony work together to identify objects in a scene.	NIMH, Neuropsychol Lab, NIH, Bethesda, MD 20892 USA; NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA; Vanderbilt Univ, Dept Psychol, Nashville, TN 37203 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Vanderbilt University; Massachusetts Institute of Technology (MIT)	Bichot, NP (corresponding author), NIMH, Neuropsychol Lab, NIH, Bldg 9, Bethesda, MD 20892 USA.	bichotn@mail.nih.gov	Desimone, Robert/G-1121-2018		NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002036] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Bichot NP, 1999, NAT NEUROSCI, V2, P549, DOI 10.1038/9205; BUFFALO EA, UNPUB; Cave Kyle R., 2005, P547, DOI 10.1016/B978-012375731-9/50094-X; Chelazzi L, 2001, CEREB CORTEX, V11, P761, DOI 10.1093/cercor/11.8.761; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; HAENNY PE, 1988, EXP BRAIN RES, V69, P245, DOI 10.1007/BF00247570; Hamker FH, 2005, CEREB CORTEX, V15, P431, DOI 10.1093/cercor/bhh146; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; Liversedge SP, 2000, TRENDS COGN SCI, V4, P6, DOI 10.1016/S1364-6613(99)01418-7; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Mazer JA, 2003, NEURON, V40, P1241, DOI 10.1016/S0896-6273(03)00764-5; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; Miller EK, 1996, J NEUROSCI, V16, P5154; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1994, J NEUROSCI, V14, P2178; Ogawa T, 2004, J NEUROSCI, V24, P6371, DOI 10.1523/JNEUROSCI.0569-04.2004; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; Seidemann E, 1999, J NEUROPHYSIOL, V81, P1783, DOI 10.1152/jn.1999.81.4.1783; Thompson KG, 2005, PROG BRAIN RES, V147, P251, DOI 10.1016/S0079-6123(04)47019-8; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419	27	463	468	2	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2005	308	5721					529	534		10.1126/science.1109676	http://dx.doi.org/10.1126/science.1109676			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15845848				2022-12-24	WOS:000228810500046
J	Coaker, G; Falick, A; Staskawicz, B				Coaker, G; Falick, A; Staskawicz, B			Activation of a phytopathogenic bacterial effector protein by a eukaryotic cyclophilin	SCIENCE			English	Article							III EFFECTOR; SACCHAROMYCES-CEREVISIAE; DISEASE RESISTANCE; INNATE IMMUNITY; AVRRPT2; ARABIDOPSIS; RIN4; SECRETION; CLEAVAGE; PROTEASES	Innate immunity in higher plants invokes a sophisticated surveillance system capable of recognizing bacterial effector proteins. In Arabidopsis, resistance to infection by strains of Pseudomonas syringae expressing the effector AvrRpt2 requires the plant resistance protein RPS2. AvrRpt2 was identified as a putative cysteine protease that results in the elimination of the Arabidopsis protein RIN4. RIN4 cleavage serves as a signal to activate RP52-mediated resistance. AvrRpt2 is delivered into the plant cell, where it is activated by a eukaryotic factor that we identify as cyclophilin. This activation of AvrRpt2 is necessary for protease activity. Active AvrRpt2 can then directly cleave RIN4.	Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Mass Spectrometry Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Staskawicz, B (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	stask@nature.berkeley.edu			PHS HHS [R01-FM069680-01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Arevalo-Rodriguez M, 2005, EUKARYOT CELL, V4, P17, DOI 10.1128/EC.4.1.17-29.2005; Axtell MJ, 2003, MOL MICROBIOL, V49, P1537, DOI 10.1046/j.1365-2958.2003.03666.x; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Chisholm ST, 2005, P NATL ACAD SCI USA, V102, P2087, DOI 10.1073/pnas.0409468102; COAKER, UNPUB; CORCORAN ML, 1995, ADV EXP MED BIOL, V385, P151; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Day B, 2005, PLANT CELL, V17, P1292, DOI 10.1105/tpc.104.030163; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Dolinski K, 1997, P NATL ACAD SCI USA, V94, P13093, DOI 10.1073/pnas.94.24.13093; FLOR HH, 1955, PHYTOPATHOLOGY, V45, P680; Hotson A, 2004, CURR OPIN PLANT BIOL, V7, P384, DOI 10.1016/j.pbi.2004.05.003; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jin P, 2003, PLANT PHYSIOL, V133, P1072, DOI 10.1104/pp.103.025999; Jones DA, 2004, CURR OPIN IMMUNOL, V16, P48, DOI 10.1016/j.coi.2003.11.016; KIEFHABER T, 1990, BIOCHEMISTRY-US, V29, P3061, DOI 10.1021/bi00464a024; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Mudgett MB, 1999, MOL MICROBIOL, V32, P927, DOI 10.1046/j.1365-2958.1999.01403.x; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; WANDERSMAN C, 1989, MOL MICROBIOL, V3, P1825, DOI 10.1111/j.1365-2958.1989.tb00169.x	22	185	198	3	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2005	308	5721					548	550		10.1126/science.1108633	http://dx.doi.org/10.1126/science.1108633			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15746386				2022-12-24	WOS:000228810500051
J	Tu, D; Blaha, G; Moore, PB; Steitz, TA				Tu, D; Blaha, G; Moore, PB; Steitz, TA			Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance	CELL			English	Article							PEPTIDYL TRANSFERASE CENTER; ESCHERICHIA-COLI RIBOSOMES; ERYTHROMYCIN RESISTANCE; BACTERIAL-RIBOSOMES; MACROLIDE ANTIBIOTICS; BOND FORMATION; BINDING-SITE; RNA; MUTANTS; VIRGINIAMYCIN	Crystal structures of H. marismortui large ribosomal subunits containing the mutation G2099A (A2058 in E. coli) with erythromycin, azithromycin, clindamycin, virginiamycin S, and telithromycin bound explain why eubacterial ribosomes containing the mutation A2058G are resistant to them. Azithromycin binds almost identically to both G2099A and wild-type subunits, but the erythromycin affinity increases by more than 10(4)-fold, implying that desolvation of the N2 of 62099 accounts for the low wild-type affinity for macrolides. All macrolides bind similarly to the H. marismortui subunit, but their binding differs significantly from what has been reported in the D. radioidurans subunit. The synergy in the binding of streptogramins A and B appears to result from a reorientation of the base of A2103 (A2062, E. coli) that stacks between them. The structure of large subunit containing a three residue deletion mutant of L22 shows a change in the L22 structure and exit tunnel shape that illuminates its macrolide resistance phenotype.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Chem, New Haven, CT 06520 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	eatherton@csb.yale.edu	Steitz, Thomas A./C-6559-2009		NIGMS NIH HHS [GM022778] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agouridas C, 1998, J MED CHEM, V41, P4080, DOI 10.1021/jm980240d; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bashan A, 2003, MOL CELL, V11, P91, DOI 10.1016/S1097-2765(03)00009-1; Berisio R, 2003, J BACTERIOL, V185, P4276, DOI 10.1128/JB.185.14.4276-4279.2003; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; CHITTUM HS, 1994, J BACTERIOL, V176, P6192, DOI 10.1128/jb.176.20.6192-6198.1994; Clark C, 2002, ANTIMICROB AGENTS CH, V46, P2956, DOI 10.1128/AAC.46.9.2956-2962.2002; COCITO C, 1978, MOL GEN GENET, V166, P53, DOI 10.1007/BF00379729; COCITO C, 1979, MICROBIOL REV, V43, P145, DOI 10.1128/MMBR.43.2.145-192.1979; Das K, 1996, J MOL BIOL, V264, P1085, DOI 10.1006/jmbi.1996.0698; DECLERCQ JP, 1978, ACTA CRYSTALLOGR B, V34, P3644, DOI 10.1107/S0567740878011796; DOUTHWAITE S, 1993, J MOL BIOL, V232, P725, DOI 10.1006/jmbi.1993.1426; ENNIS HL, 1971, BIOCHEMISTRY-US, V10, P1265, DOI 10.1021/bi00783a025; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Gabashvili IS, 2001, MOL CELL, V8, P181, DOI 10.1016/S1097-2765(01)00293-3; Garza-Ramos G, 2001, J BACTERIOL, V183, P6898, DOI 10.1128/JB.183.23.6898-6907.2001; Gregory ST, 1999, J MOL BIOL, V289, P827, DOI 10.1006/jmbi.1999.2839; Hansen JL, 2002, P NATL ACAD SCI USA, V99, P11670, DOI 10.1073/pnas.172404099; Hansen JL, 2002, MOL CELL, V10, P117, DOI 10.1016/S1097-2765(02)00570-1; Hansen JL, 2003, J MOL BIOL, V330, P1061, DOI 10.1016/S0022-2836(03)00668-5; Hansen LH, 1999, MOL MICROBIOL, V31, P623, DOI 10.1046/j.1365-2958.1999.01202.x; Harms JM, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-4; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KARLE IL, 1990, ACTA CRYSTALLOGR C, V46, P303, DOI 10.1107/S0108270189006906; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; Kosutic-Hulita N, 2001, CROAT CHEM ACTA, V74, P327; KREBS MP, 1993, P NATL ACAD SCI USA, V90, P1987, DOI 10.1073/pnas.90.5.1987; LEBAN I, 1994, ACTA CHIM SLOV, V0041; Malbruny B, 2002, ANTIMICROB AGENTS CH, V46, P2200, DOI 10.1128/AAC.46.7.2200-2207.2002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARFAIT R, 1978, MOL GEN GENET, V166, P45, DOI 10.1007/BF00379728; PESTKA S, 1974, ANTIMICROB AGENTS CH, V6, P474, DOI 10.1128/AAC.6.4.474; SANZ JL, 1993, CAN J MICROBIOL, V39, P311, DOI 10.1139/m93-044; Schlunzen F, 2001, NATURE, V413, P814, DOI 10.1038/35101544; Spahn CMT, 1996, J MOL MED, V74, P423, DOI 10.1007/s001090050044; Stephenson GA, 1997, J PHARM SCI, V86, P1239, DOI 10.1021/js9701667; Tenson T, 2003, J MOL BIOL, V330, P1005, DOI 10.1016/S0022-2836(03)00662-4; VANNUFFEL P, 1992, J BIOL CHEM, V267, P16114; Vester B, 2001, ANTIMICROB AGENTS CH, V45, P1, DOI 10.1128/AAC.45.1.1-12.2001; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P577, DOI 10.1128/AAC.39.3.577; WITTMANN HG, 1973, MOL GEN GENET, V127, P175, DOI 10.1007/BF00333665; Xiong LQ, 1999, MOL MICROBIOL, V31, P633, DOI 10.1046/j.1365-2958.1999.01203.x	44	335	347	2	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 22	2005	121	2					257	270		10.1016/j.cell.2005.02.005	http://dx.doi.org/10.1016/j.cell.2005.02.005			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851032	Bronze			2022-12-24	WOS:000228705000013
J	Quill, TE				Quill, TE			Terri Schiavo - A tragedy compounded	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Rochester, Med Ctr, Ctr Palliat Care & Clin Eth, Rochester, NY 14642 USA	University of Rochester	Quill, TE (corresponding author), Univ Rochester, Med Ctr, Ctr Palliat Care & Clin Eth, Rochester, NY 14642 USA.							ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Ganzini L, 2003, NEW ENGL J MED, V349, P359, DOI 10.1056/NEJMsa035086; Gostin L, 1991, Law Med Health Care, V19, P9; JENNETT B, 2002, VEGETATIVE STATE MED; *MULT TASK FORC PV, 1995, NEW ENGL J MED, V333, P130	5	77	80	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 21	2005	352	16					1630	+		10.1056/NEJMp058062	http://dx.doi.org/10.1056/NEJMp058062			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	918CE	15784658				2022-12-24	WOS:000228515200002
J	Rosvold, EA; Tyssen, R				Rosvold, EA; Tyssen, R			Should physicians' self-prescribing be restricted by law?	LANCET			English	Editorial Material							MENTAL-HEALTH PROBLEMS; DOCTORS; CARE		Univ Oslo, Fac Med, Inst Gen Practice & Community Med, N-0318 Oslo, Norway; Univ Oslo, Fac Med, Dept Behav Sci Med, Inst Basic Med Sci, N-0318 Oslo, Norway	University of Oslo; University of Oslo	Rosvold, EA (corresponding author), Univ Oslo, Fac Med, Inst Gen Practice & Community Med, N-0318 Oslo, Norway.	e.o.rosvold@medisin.uio.no						Forsythe M, 1999, BRIT MED J, V319, P605, DOI 10.1136/bmj.319.7210.605; Fromme E, 2003, JAMA-J AM MED ASSOC, V290, P2048, DOI 10.1001/jama.290.15.2048; Garfinkel PE, 1997, CAN J PSYCHIAT, V42, P764, DOI 10.1177/070674379704200710; HUGHES PH, 1992, JAMA-J AM MED ASSOC, V267, P2333, DOI 10.1001/jama.267.17.2333; Ingstad B., 2001, ANTHROPOL MED, V8, P201, DOI [DOI 10.HTTP://DX.D0I.0RG/10.1080/13648470120101372, 10.1080/13648470120101372, DOI 10.1080/13648470120101372]; Kay Margaret, 2005, Aust Fam Physician, V34, P94; LOTT DA, 2001, PSYCHIAT TIMES, V18; ROSVOLD EO, 2002, THESIS U OSLO OSLO N; Schneck SA, 1998, JAMA-J AM MED ASSOC, V280, P2039, DOI 10.1001/jama.280.23.2039; STOUDEMIRE A, 1983, ANN INTERN MED, V98, P654, DOI 10.7326/0003-4819-98-5-654; Toyry S, 2000, ARCH FAM MED, V9, P1079, DOI 10.1001/archfami.9.10.1079; Tyssen R, 2004, SOC PSYCH PSYCH EPID, V39, P989, DOI 10.1007/s00127-004-0831-8; Tyssen R, 2002, HARVARD REV PSYCHIAT, V10, P154, DOI 10.1080/10673220216218	13	15	15	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 16	2005	365	9468					1372	1374		10.1016/S0140-6736(05)66353-2	http://dx.doi.org/10.1016/S0140-6736(05)66353-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	916QY	15836873				2022-12-24	WOS:000228401900009
J	Rosenberg, GA				Rosenberg, GA			Matrix metalloproteinases biomarkers in multiple sclerosis	LANCET			English	Editorial Material							MATRIX-METALLOPROTEINASE-9; GELATINASE; TIMP-1; INTERFERON-BETA-1A; MMP-9; BETA; MRI		Univ New Mexico, Hlth Sci Ctr, Dept Neurol, Albuquerque, NM 87131 USA; Univ New Mexico, Hlth Sci Ctr, Dept Neurosci, Albuquerque, NM 87131 USA; Univ New Mexico, Hlth Sci Ctr, Dept Cell Biol, Albuquerque, NM 87131 USA; Univ New Mexico, Hlth Sci Ctr, Dept Physiol, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center	Rosenberg, GA (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Neurol, Albuquerque, NM 87131 USA.	grosenberg@salud.unm.edu						Dubois B, 2003, J NEUROL, V250, P1037, DOI 10.1007/s00415-003-0110-8; GIJBELS K, 1992, J NEUROIMMUNOL, V41, P29, DOI 10.1016/0165-5728(92)90192-N; Karabudak R, 2004, J NEUROL, V251, P279, DOI 10.1007/s00415-004-0285-7; Lee MA, 1999, BRAIN, V122, P191, DOI 10.1093/brain/122.2.191; LEPPERT D, 1995, J IMMUNOL, V154, P4379; Liuzzi GM, 2002, MULT SCLER, V8, P222, DOI 10.1191/1352458502ms800oa; Rosenberg GA, 1996, NEUROLOGY, V46, P1626, DOI 10.1212/WNL.46.6.1626; Rosenberg GA, 2002, NEUROSCIENTIST, V8, P586, DOI 10.1177/1073858402238517; Waubant E, 1999, NEUROLOGY, V53, P1397, DOI 10.1212/WNL.53.7.1397; Waubant E, 2003, NEUROLOGY, V60, P52, DOI 10.1212/WNL.60.1.52; Yong VW, 1998, NEUROLOGY, V51, P682; Yushchenko M, 2003, J NEUROL, V250, P1224, DOI 10.1007/s00415-003-0191-4	12	29	32	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 9	2005	365	9467					1291	1293		10.1016/S0140-6736(05)61008-2	http://dx.doi.org/10.1016/S0140-6736(05)61008-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	914HY	15823367				2022-12-24	WOS:000228219600009
J	Rumpel, S; LeDoux, J; Zador, A; Malinow, R				Rumpel, S; LeDoux, J; Zador, A; Malinow, R			Postsynaptic receptor trafficking underlying a form of associative learning	SCIENCE			English	Article							LONG-TERM POTENTIATION; DRIVING AMPA RECEPTORS; SYNAPTIC PLASTICITY; SPATIAL MEMORY; FEAR; LTP; HIPPOCAMPUS; EXPRESSION; SYNAPSES; AMYGDALA	To elucidate molecular, cellular, and circuit changes that occur in the brain during learning, we investigated the rote of a glutamate receptor subtype in fear conditioning. In this form of learning, animals associate two stimuli, such as a tone and a shock. Here we report that fear conditioning drives AMPA-type glutamate receptors into the synapse of a large fraction of postsynaptic neurons in the lateral amygdala, a brain structure essential for this learning process. Furthermore, memory was reduced if AMPA receptor synaptic incorporation was blocked in as few as 10 to 20% of lateral amygdala neurons. Thus, the encoding of memories in the lateral amygdala is mediated by AMPA receptor trafficking, is widely distributed, and displays little redundancy.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; NYU, New York, NY 10003 USA	Cold Spring Harbor Laboratory; New York University	Malinow, R (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	malinow@cshl.edu		Zador, Anthony/0000-0002-8431-9136				Andersen P, 2003, PHILOS T R SOC B, V358, P613, DOI 10.1098/rstb.2002.1232; ANDERSEN P, 1977, NATURE, V266, P736, DOI 10.1038/266736a0; ANDERSEN P, 1995, J NEUROBIOL, V26, P396, DOI 10.1002/neu.480260311; Bahi A, 2004, EUR J NEUROSCI, V19, P1621, DOI 10.1111/j.1460-9568.2004.03260.x; Bellgowan PSF, 1996, BEHAV NEUROSCI, V110, P727; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; Carlezon WA, 1997, SCIENCE, V277, P812, DOI 10.1126/science.277.5327.812; Choi S, 2003, PHILOS T ROY SOC B, V358, P695, DOI 10.1098/rstb.2002.1249; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Dong ZZ, 2003, P NATL ACAD SCI USA, V100, P12438, DOI 10.1073/pnas.2132992100; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Faber ESL, 2001, J NEUROPHYSIOL, V85, P714, DOI 10.1152/jn.2001.85.2.714; FREUD S, 1895, ORIGINS PSYCHOANALYS, P356; GOOD MA, 2004, ANN M SOC NEUR SAN D; Goosens KA, 2001, LEARN MEMORY, V8, P148, DOI 10.1101/lm.37601; Goss James R, 2004, Methods Mol Biol, V246, P309; Harris KM, 2003, PHILOS T R SOC B, V358, P745, DOI 10.1098/rstb.2002.1254; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hebb D.O., 1949, ORG BEHAV; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lisman J, 2003, PHILOS T ROY SOC B, V358, P829, DOI 10.1098/rstb.2002.1242; Lynch G, 2003, PHILOS T ROY SOC B, V358, P625, DOI 10.1098/rstb.2002.1253; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Malinow R, 2003, PHILOS T ROY SOC B, V358, P707, DOI 10.1098/rstb.2002.1233; Maren S, 2000, EUR J NEUROSCI, V12, P4047, DOI 10.1046/j.1460-9568.2000.00281.x; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McNaughton BL, 2003, PHILOS T ROY SOC B, V358, P629, DOI 10.1098/rstb.2002.1231; Morris RGM, 2003, PHILOS T ROY SOC B, V358, P643, DOI 10.1098/rstb.2002.1230; Moser MB, 1998, J NEUROSCI, V18, P7535; MOSER MB, 1995, P NATL ACAD SCI USA, V92, P9697, DOI 10.1073/pnas.92.21.9697; Neve R L, 1999, Adv Neurol, V79, P1027; Nicoll RA, 2003, PHILOS T R SOC B, V358, P721, DOI 10.1098/rstb.2002.1228; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Pittenger C, 2003, PHILOS T ROY SOC B, V358, P757, DOI 10.1098/rstb.2002.1247; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; SANANES CB, 1992, BEHAV NEUROSCI, V106, P72, DOI 10.1037/0735-7044.106.1.72; Sandler VM, 2002, J NEUROSCI METH, V121, P211, DOI 10.1016/S0165-0270(02)00262-5; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Snowdon DA, 2003, ANN INTERN MED, V139, P450, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00014; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Stevens CF, 1998, NEURON, V20, P1, DOI 10.1016/S0896-6273(00)80426-2; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Tonegawa S, 2003, PHILOS T R SOC B, V358, P787, DOI 10.1098/rstb.2002.1243; Watt AJ, 2004, NAT NEUROSCI, V7, P518, DOI 10.1038/nn1220; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805	52	546	560	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2005	308	5718					83	88		10.1126/science.1103944	http://dx.doi.org/10.1126/science.1103944			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914IQ	15746389	Bronze			2022-12-24	WOS:000228221500037
J	Ong, BN; Evans, D; Bartlam, A				Ong, BN; Evans, D; Bartlam, A			A patient's journey with myalgic encephalomyelitis	BRITISH MEDICAL JOURNAL			English	Review							CHRONIC ILLNESS; CHRONIC PAIN		Keele Univ, Primary Care Sci Res Ctr, Keele ST5 5BG, Staffs, England; Light Oaks, Stoke On Trent ST2 7DE, Staffs, England; Keele Med Sch, Keele ST5 5BG, Staffs, England	Keele University; Keele University	Ong, BN (corresponding author), Keele Univ, Primary Care Sci Res Ctr, Keele ST5 5BG, Staffs, England.	b.n.ong@kcele.ac.uk						Barry CA, 2001, SOC SCI MED, V53, P487, DOI 10.1016/S0277-9536(00)00351-8; BENDELOW GA, 1995, SOCIOL HEALTH ILL, V17, P139, DOI 10.1111/1467-9566.ep10933376; COMAROFF J, 1981, SOC SCI MED-MED ANTH, V15, P115, DOI 10.1016/0160-7987(81)90034-X; HUTCHINSON A, 2002, REPORT CHIEF MED OFF; Hyden LC, 2002, HEALTH, V6, P325, DOI 10.1177/136345930200600305; May C, 2004, SOCIOL HEALTH ILL, V26, P135, DOI 10.1111/j.1467-9566.2004.00384.x; POLANYI M, 1997, MEANING; Risdon A, 2003, SOC SCI MED, V56, P375, DOI 10.1016/S0277-9536(02)00043-6; Smith M., 1998, PERSPECTIVES PAIN MA, P26; Werner A, 2004, SOC SCI MED, V59, P1035, DOI 10.1016/j.socscimed.2003.12.001; Williams SJ, 2000, SOCIOL HEALTH ILL, V22, P40, DOI 10.1111/1467-9566.00191	11	6	6	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 19	2005	330	7492					648	650		10.1136/bmj.330.7492.648	http://dx.doi.org/10.1136/bmj.330.7492.648			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	909LP	15774997	Green Published			2022-12-24	WOS:000227861700027
J	Hauber, E; van Gasselt, S; Ivanov, B; Werner, S; Head, JW; Neukum, G; Jaumann, R; Greeley, R; Mitchell, KL; Muller, P				Hauber, E; van Gasselt, S; Ivanov, B; Werner, S; Head, JW; Neukum, G; Jaumann, R; Greeley, R; Mitchell, KL; Muller, P		HRSC Co-Investigator Team	Discovery of a flank caldera and very young glacial activity at Hecates Tholus, Mars	NATURE			English	Article							GROUND ICE; SUBLIMATION; VOLCANISM; EVOLUTION; WATER; DEPOSITS	The majority of volcanic products on Mars are thought to be mafic and effusive(1,2). Explosive eruptions of basic to ultrabasic chemistry are expected to be common(3,4), but evidence for them is rare and mostly confined to very old surface features(5). Here we present new image and topographic data from the High Resolution Stereo Camera that reveal previously unknown traces of an explosive eruption at 30 degrees N and 149 degrees E on the northwestern flank of the shield volcano Hecates Tholus. The eruption created a large, 10-km-diameter caldera similar to 350 million years ago. We interpret these observations to mean that large-scale explosive volcanism on Mars was not confined to the planet's early evolution. We also show that glacial deposits partly fill the caldera and an adjacent depression. Their age, derived from crater counts, is about 5 to 24 million years. Climate models predict that near-surface ice is not stable at mid-latitudes today(6), assuming a thermo-dynamic steady state. Therefore, the discovery of very young glacial features at Hecates Tholus suggests recent climate changes. We show that the absolute ages of these very recent glacial deposits correspond very well to a period of increased obliquity of the planet's rotational axis(7).	DLR, German Aerosp Ctr, Inst Planetary Res, D-12489 Berlin, Germany; FU Berlin, Inst Geosci, D-12249 Berlin, Germany; Russian Acad Sci, Inst Dynam Geospheres, Moscow 117334, Russia; Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Univ Lancaster, Dept Environm Sci, Lancaster LA1 4YQ, England; UCL, Dept Geomat Engn, London WC1E 6BT, England	Helmholtz Association; German Aerospace Centre (DLR); Free University of Berlin; Russian Academy of Sciences; Sadovsky Institute of Geosphere Dynamics of the Russian Academy of Sciences; Brown University; Arizona State University; Arizona State University-Tempe; Lancaster University; University of London; University College London	Hauber, E (corresponding author), DLR, German Aerosp Ctr, Inst Planetary Res, D-12489 Berlin, Germany.	Ernst.Hauber@dlr.de	Hauber, Ernst/U-2521-2018; Werner, Stephanie C/A-6438-2012; Mitchell, Karl Leon/AGL-9516-2022; Muller, Jan-Peter/Q-8886-2019; Jaumann, Ralf/N-1001-2018; van Gasselt, Stephan/L-9762-2013; Mitchell, Karl Leon/AAG-3821-2020	Hauber, Ernst/0000-0002-1375-304X; Werner, Stephanie C/0000-0001-5704-0909; Muller, Jan-Peter/0000-0002-5077-3736; Jaumann, Ralf/0000-0002-9759-6597; van Gasselt, Stephan/0000-0003-2130-6343; Mitchell, Karl Leon/0000-0003-1093-8441				Baker VR, 2001, NATURE, V412, P228, DOI 10.1038/35084172; FELDMAN WC, 2004, J GEOPHYS RES-PLANET, V109, DOI DOI 10.1029/2003JE002160; FRANCIS PW, 1982, J GEOPHYS RES, V87, P9881, DOI 10.1029/JB087iB12p09881; GREELEY R, 1990, J GEOPHYS RES-SOLID, V95, P7133, DOI 10.1029/JB095iB05p07133; GREELEY R, 1981, REV GEOPHYS, V19, P13, DOI 10.1029/RG019i001p00013; GULICK VC, 1990, J GEOPHYS RES-SOLID, V95, P14325, DOI 10.1029/JB095iB09p14325; Haberle RA, 2003, ICARUS, V161, P66, DOI 10.1016/S0019-1035(02)00017-9; Hartmann WK, 2001, SPACE SCI REV, V96, P165, DOI 10.1023/A:1011945222010; Head JW, 2003, NATURE, V426, P797, DOI 10.1038/nature02114; Head JW, 2003, GEOLOGY, V31, P641, DOI 10.1130/0091-7613(2003)031<0641:CMGOMW>2.0.CO;2; HELBERT J, 2003, 6 INT C MARS LUN PLA; JAKOSKY BM, 1995, J GEOPHYS RES-PLANET, V100, P1579, DOI 10.1029/94JE02801; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; Levrard B, 2004, NATURE, V431, P1072, DOI 10.1038/nature03055; Mangold N, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001885; Marchant DR, 2002, GEOL SOC AM BULL, V114, P718, DOI 10.1130/0016-7606(2002)114<0718:FOPGAS>2.0.CO;2; MELLON MT, 1995, J GEOPHYS RES-PLANET, V100, P11781, DOI 10.1029/95JE01027; Mellon MT, 1997, J GEOPHYS RES-PLANET, V102, P19357, DOI 10.1029/97JE01346; Mischna MA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002051; Mitrofanov I, 2002, SCIENCE, V297, P78, DOI 10.1126/science.1073616; Mouginis-Mark P.J., 1992, MARS PP, P424; MOUGINISMARK PJ, 1982, J GEOPHYS RES, V87, P9890, DOI 10.1029/JB087iB12p09890; Neukum G, 2004, NATURE, V432, P971, DOI 10.1038/nature03231; Neukum G., 2004, EUR SP AGENCY SPECIA, V1240, P17; Skorov YV, 2001, PLANET SPACE SCI, V49, P59, DOI 10.1016/S0032-0633(00)00121-5; SQUYRES SW, 1978, ICARUS, V34, P600, DOI 10.1016/0019-1035(78)90048-9; WALL SD, 1981, ICARUS, V47, P173, DOI 10.1016/0019-1035(81)90165-2; WERNER SC, 2004, LUNAR PLANET SCI, V35; Wewel F., 2000, Canadian Journal of Remote Sensing, V26, P466; WILSON L, 1994, REV GEOPHYS, V32, P221, DOI 10.1029/94RG01113	30	66	66	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					356	361		10.1038/nature03423	http://dx.doi.org/10.1038/nature03423			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772654				2022-12-24	WOS:000227715100044
J	Anderson, BL; Winawer, J				Anderson, BL; Winawer, J			Image segmentation and lightness perception	NATURE			English	Article							ILLUMINATION; ORGANIZATION; DEPENDS	The perception of surface albedo ( lightness) is one of the most basic aspects of visual awareness. It is well known that the apparent lightness of a target depends on the context in which it is embedded(1-6), but there is extensive debate about the computations and representations underlying perceived lightness. One view asserts that the visual system explicitly separates surface reflectance from the prevailing illumination and atmospheric conditions in which it is embedded(7-10), generating layered image representations. Some recent theory has challenged this view and asserted that the human visual system derives surface lightness without explicitly segmenting images into multiple layers(11,12). Here we present new lightness illusions - the largest reported to date - that unequivocally demonstrate the effect that layered image representations can have in lightness perception. We show that the computations that underlie the decomposition of luminance into multiple layers under conditions of transparency can induce dramatic lightness illusions, causing identical texture patches to appear either black or white. These results indicate that mechanisms involved in decomposing images into layered representations can play a decisive role in the perception of surface lightness.	Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia; MIT, Cambridge, MA 02139 USA	University of New South Wales Sydney; Massachusetts Institute of Technology (MIT)	Anderson, BL (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	bart.a@unsw.edu.au	Winawer, Jonathan/AFQ-2476-2022	Winawer, Jonathan/0000-0001-7475-5586; Anderson, Barton/0000-0003-0313-4285				ADELSON EH, 1993, SCIENCE, V262, P2042, DOI 10.1126/science.8266102; ADELSON EH, 1999, NEW COGNITIVE NEUROS, P339; Anderson BL, 1997, PERCEPTION, V26, P419, DOI 10.1068/p260419; Anderson BL, 2003, PSYCHOL REV, V110, P785, DOI 10.1037/0033-295X.110.4.785; Anderson BL, 2003, PERCEPTION, V32, P269, DOI 10.1068/p3216; Anderson BL, 1999, NEURON, V24, P919, DOI 10.1016/S0896-6273(00)81039-9; Barrow H., 1978, COMPUT VIS SYST, V2, P2; BERGSTROM SS, 1977, SCAND J PSYCHOL, V18, P180, DOI 10.1111/j.1467-9450.1977.tb00275.x; Boyaci H, 2003, J VISION, V3, P541, DOI 10.1167/3.8.2; Eagleman DM, 2004, NATURE, V428, P854, DOI 10.1038/nature02467; Gilchrist A, 1999, PSYCHOL REV, V106, P795, DOI 10.1037/0033-295X.106.4.795; GILCHRIST AL, 1980, PERCEPT PSYCHOPHYS, V28, P527, DOI 10.3758/BF03198821; GILCHRIST AL, 1979, SCI AM, V240, P112, DOI 10.1038/scientificamerican0379-112; GILCHRIST AL, 1977, SCIENCE, V195, P185, DOI 10.1126/science.831266; KNILL DC, 1991, NATURE, V351, P228, DOI 10.1038/351228a0; Koffka K., 1935, PRINCIPLES GESTALT P; Rutherford MD, 2002, PSYCHOL SCI, V13, P142, DOI 10.1111/1467-9280.00426; Singh M, 2002, PSYCHOL REV, V109, P492, DOI 10.1037//0033-295X.109.3.492	18	115	117	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					79	83		10.1038/nature03271	http://dx.doi.org/10.1038/nature03271			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744303				2022-12-24	WOS:000227334600047
J	Krakauer, AH				Krakauer, AH			Kin selection and cooperative courtship in wild turkeys	NATURE			English	Article							MELEAGRIS-GALLOPAVO; NATURAL-POPULATIONS; LEK; EVOLUTION; ORNAMENTATION; RELATEDNESS; VERTEBRATES; PATERNITY; MARKERS; MALES	In the few species of birds in which males form display partnerships to attract females, one male secures most or all of the copulations(1,2). This leads to the question of why subordinate males help in the absence of observable reproductive benefits. Hamilton's concept of kin selection(3), whereby individuals can benefit indirectly by helping a relative, was a crucial breakthrough for understanding apparently altruistic systems. However in the only direct test of kin selection in coordinated display partnerships, partners were unrelated(1), discounting kin selection as an explanation for the evolution of cooperation. Here I show, using genetic measures of relatedness and reproductive success, that kin selection can explain the evolution of cooperative courtship in wild turkeys. Subordinate ( helper) males do not themselves reproduce, but their indirect fitness as calculated by Hamilton's rule(3,4) more than offsets the cost of helping. This result confirms a textbook example of kin selection(2) that until now has been controversial(5) and also extends recent findings(6-8) of male relatedness on avian leks by quantifying the kin-selected benefits gained by non-reproducing males.	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Krakauer, AH (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	krakauer@berkeley.edu		Krakauer, Alan/0000-0001-9177-7963				BALPH DF, 1980, AUK, V97, P854; Blouin MS, 2003, TRENDS ECOL EVOL, V18, P503, DOI 10.1016/S0169-5347(03)00225-8; Brown J.L., 1987, HELPING COMMUNAL BRE; Buchholz R, 1997, J AVIAN BIOL, V28, P223, DOI 10.2307/3676973; BUCHHOLZ R, 1995, ANIM BEHAV, V50, P929, DOI 10.1016/0003-3472(95)80095-6; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Donoghue AM, 1999, BIOL REPROD, V61, P422, DOI 10.1095/biolreprod61.2.422; EMLEN ST, 1994, TRENDS ECOL EVOL, V9, P282, DOI 10.1016/0169-5347(94)90030-2; GOODENOUGH J, 2001, PERSPECTIVES ANIMAL; Griffin AS, 2003, SCIENCE, V302, P634, DOI 10.1126/science.1089402; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Healy W., 1992, WILD TURKEY BIOL MAN, P46; Hoglund J, 1999, P ROY SOC B-BIOL SCI, V266, P813; Hoglund J, 2003, ANN ZOOL FENN, V40, P249; Kokko H, 1996, P ROY SOC B-BIOL SCI, V263, P919, DOI 10.1098/rspb.1996.0136; Lank DB, 2002, BEHAV ECOL, V13, P209, DOI 10.1093/beheco/13.2.209; Lucas JR, 1996, ANIM BEHAV, V51, P225, DOI 10.1006/anbe.1996.0019; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; MCDONALD DB, 1994, SCIENCE, V266, P1030, DOI 10.1126/science.7973654; Mock KE, 2002, MOL ECOL, V11, P643, DOI 10.1046/j.1365-294X.2002.01467.x; Petrie M, 1999, NATURE, V401, P155, DOI 10.1038/43651; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reed KM, 2000, ANIM GENET, V31, P140, DOI 10.1046/j.1365-2052.2000.00571.x; Shorey L, 2000, NATURE, V408, P352, DOI 10.1038/35042562; WATTS CR, 1971, SCI AM, V224, P112; Wilson E.O., 1975, P1	27	138	140	4	235	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					69	72		10.1038/nature03325	http://dx.doi.org/10.1038/nature03325			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744300				2022-12-24	WOS:000227334600044
J	Hinds, DA; Stuve, LL; Nilsen, GB; Halperin, E; Eskin, E; Ballinger, DG; Frazer, KA; Cox, DR				Hinds, DA; Stuve, LL; Nilsen, GB; Halperin, E; Eskin, E; Ballinger, DG; Frazer, KA; Cox, DR			Whole-genome patterns of common DNA variation in three human populations	SCIENCE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; LINKAGE-DISEQUILIBRIUM; HAPLOTYPE; ASSOCIATION; DISEASE; ADMIXTURE; SELECTION; MAP; SUSCEPTIBILITY; DIVERSITY	Individual differences in DNA sequence are the genetic basis of human variability. We have characterized whole-genome patterns of common human DNA variation by genotyping 1,586,383 single-nucleotide polymorphisms (SNPs) in 71 Americans of European, African, and Asian ancestry. Our results indicate that these SNPs capture most common genetic variation as a result of linkage disequilibrium, the correlation among common SNP alleles. We observe a strong correlation between extended regions of linkage disequilibrium and functional genomic elements. Our data provide a toot for exploring many questions that remain regarding the causal role of common human DNA variation in complex human traits and for investigating the nature of genetic variation within and between human populations.	Perlegen Sci Inc, Mountain View, CA 94043 USA; Int Comp Sci Inst, Berkeley, CA 94704 USA; Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Cox, DR (corresponding author), Perlegen Sci Inc, 2021 Stierlin Court, Mountain View, CA 94043 USA.	david_cox@perlegen.com	Eskin, Eleazar/J-9187-2012	Eskin, Eleazar/0000-0003-1149-4758; Hinds, David/0000-0002-4911-803X; Frazer, Kelly/0000-0002-6060-8902				Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Bader JS, 2001, PHARMACOGENOMICS, V2, P11, DOI 10.1517/14622416.2.1.11; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; Carlson CS, 2003, NAT GENET, V33, P518, DOI 10.1038/ng1128; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Dawson E, 2002, NATURE, V418, P544, DOI 10.1038/nature00864; De Kloet ER, 2004, ANN NY ACAD SCI, V1018, P1, DOI 10.1196/annals.1296.001; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Duggal P, 2003, GENES IMMUN, V4, P245, DOI 10.1038/sj.gene.6363950; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Halperin E, 2004, BIOINFORMATICS, V20, P1842, DOI 10.1093/bioinformatics/bth149; Hinds DA, 2004, AM J HUM GENET, V74, P317, DOI 10.1086/381716; Hinds David A., 2004, Human Genomics, V1, P421; Hosking L, 2004, EUR J HUM GENET, V12, P395, DOI 10.1038/sj.ejhg.5201164; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Huttley GA, 1999, GENETICS, V152, P1711; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Nakayama K, 2002, J HUM GENET, V47, P92, DOI 10.1007/s100380200007; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Pittman AM, 2004, HUM MOL GENET, V13, P1267, DOI 10.1093/hmg/ddh138; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Romualdi C, 2002, GENOME RES, V12, P602, DOI 10.1101/gr.214902; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Roses AD, 1997, NEUROGENETICS, V1, P3, DOI 10.1007/s100480050001; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Serre D, 2004, GENOME RES, V14, P1679, DOI 10.1101/gr.2529604; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; *U WASH FRED HUTCH, SEATTLESNPS; Van Gassen G, 2003, NEUROSCIENTIST, V9, P117, DOI 10.1177/1073858403252227; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Xiao Q, 1996, J CLIN INVEST, V98, P2027, DOI 10.1172/JCI119007	38	890	958	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2005	307	5712					1072	1079		10.1126/science.1105436	http://dx.doi.org/10.1126/science.1105436			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ED	15718463				2022-12-24	WOS:000227197300038
J	Sarbassov, DD; Guertin, DA; Ali, SM; Sabatini, DM				Sarbassov, DD; Guertin, DA; Ali, SM; Sabatini, DM			Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex	SCIENCE			English	Article							PROTEIN-KINASE-B; INTEGRIN-LINKED KINASE; INSULIN-RESISTANCE; BINDING PARTNER; S6 KINASE; DNA-PK; RAPAMYCIN; ACTIVATION; MECHANISM; GROWTH	Deregulation of Akt/protein kinase B (PKB) is implicated in the pathogenesis of cancer and diabetes. Akt/PKB activation requires the phosphorylation of Thr(308) in the activation loop by the phosphoinositide-dependent kinase 1 (PDK1) and Ser(473) within the carboxyl-terminal hydrophobic motif by an unknown kinase. We show that in Drosophila and human cells the target of rapamycin (TOR) kinase and its associated protein rictor are necessary for Ser(473) phosphorylation and that a reduction in rictor or mammalian TOR (mTOR) expression inhibited an Akt/PKB effector. The rictor-mTOR complex directly phosphorylated Akt/PKB on Ser(473) in vitro and facilitated Thr(308) phosphorylation by PDK1. Rictor-mTOR may serve as a drug target in tumors that have lost the expression of PTEN, a tumor suppressor that opposes Akt/PKB activation.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Broad Inst, Cambridge, MA 02141 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Sabatini, DM (corresponding author), MIT, Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu	Ali, Siraj/AAE-2958-2019; Sarbassov, Dos/AAS-4950-2020	Sarbassov, Dos/0000-0002-6848-1133; /0000-0002-1446-7256	NIAID NIH HHS [R01 AI47389] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047389] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Dore AS, 2004, DNA REPAIR, V3, P33, DOI 10.1016/j.dnarep.2003.09.003; Edinger AL, 2003, CANCER RES, V63, P8451; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hill MM, 2001, J BIOL CHEM, V276, P25643, DOI 10.1074/jbc.C100174200; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Lynch DK, 1999, ONCOGENE, V18, P8024, DOI 10.1038/sj.onc.1203258; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Radimerski T, 2002, GENE DEV, V16, P2627, DOI 10.1101/gad.239102; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Taccioli GE, 1998, IMMUNITY, V9, P355, DOI 10.1016/S1074-7613(00)80618-4; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6	29	5005	5224	17	610	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2005	307	5712					1098	1101		10.1126/science.1106148	http://dx.doi.org/10.1126/science.1106148			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ED	15718470				2022-12-24	WOS:000227197300045
J	Hua, JY; Smear, MC; Baier, H; Smith, SJ				Hua, JY; Smear, MC; Baier, H; Smith, SJ			Regulation of axon growth in vivo by activity-based competition	NATURE			English	Article							VISUAL-CORTEX; SYNAPTIC COMPETITION; OCULAR DOMINANCE; BRANCH DYNAMICS; NEURAL ACTIVITY; ZEBRAFISH; SYSTEM; REVEALS; ARBORS; BRAIN	The formation of functional neural networks requires precise regulation of the growth and branching of the terminal arbors of axons, processes known to be influenced by early network electrical activity(1-3). Here we show that a rule of activity-based competition between neighbouring axons appears to govern the growth and branching of retinal ganglion cell (RGC) axon arbors in the developing optic tectum of zebrafish. Mosaic expression of an exogenous potassium channel or a dominant-negative SNARE protein was used to suppress electrical or neurosecretory activity in subsets of RGC axons. Imaging in vivo showed that these forms of activity suppression strongly inhibit both net growth and the formation of new branches by individually transfected RGC axon arbors. The inhibition is relieved when the activity of nearby 'competing' RGC axons is also suppressed. These results therefore identify a new form of activity-based competition rule that might be a key regulator of axon growth and branch initiation.	Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; Univ Calif San Francisco, Dept Physiol, Program Neurosci, San Francisco, CA 94143 USA	Stanford University; Stanford University; University of California System; University of California San Francisco	Hua, JY (corresponding author), Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.	huayy@stanford.edu		Smith, Stephen/0000-0002-2290-8701				ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Cogen J, 2000, J NEUROBIOL, V45, P120, DOI 10.1002/1097-4695(20001105)45:2<120::AID-NEU6>3.0.CO;2-6; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Drapeau P, 2002, PROG NEUROBIOL, V68, P85, DOI 10.1016/S0301-0082(02)00075-8; Gnuegge L, 2001, J NEUROSCI, V21, P3542, DOI 10.1523/JNEUROSCI.21-10-03542.2001; Haas K, 2002, DIFFERENTIATION, V70, P148, DOI 10.1046/j.1432-0436.2002.700404.x; Hua JYY, 2004, NAT NEUROSCI, V7, P327, DOI 10.1038/nn1218; Johnson FA, 1999, J COMP NEUROL, V406, P548, DOI 10.1002/(SICI)1096-9861(19990419)406:4<548::AID-CNE8>3.0.CO;2-3; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Koster RW, 2001, DEV BIOL, V233, P329, DOI 10.1006/dbio.2001.0242; Li WY, 2003, J NEUROSCI, V23, P10467; LICHTMAN JW, 1990, J NEUROBIOL, V21, P99, DOI 10.1002/neu.480210107; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Scales SJ, 2000, NEURON, V26, P457, DOI 10.1016/S0896-6273(00)81177-0; Schmidt JT, 2004, J NEUROBIOL, V58, P328, DOI 10.1002/neu.10286; Schmidt JT, 2000, J NEUROBIOL, V42, P303, DOI 10.1002/(SICI)1097-4695(20000215)42:3<303::AID-NEU2>3.3.CO;2-1; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Sorensen JB, 2002, P NATL ACAD SCI USA, V99, P1627, DOI 10.1073/pnas.251673298; STRYKER MP, 1986, J NEUROSCI, V6, P2117; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8	25	172	173	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 21	2005	434	7036					1022	1026		10.1038/nature03409	http://dx.doi.org/10.1038/nature03409			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846347				2022-12-24	WOS:000228524600039
J	Palleroni, A; Miller, CT; Hauser, M; Marler, P				Palleroni, A; Miller, CT; Hauser, M; Marler, P			Predation - Prey plumage adaptation against falcon attack	NATURE			English	Editorial Material							BIRDS		Harvard Univ, Dept Psychol, Primate Cognit Neurosci Lab, Cambridge, MA 02138 USA; Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Lab Auditory Neurophysiol, Baltimore, MD 21205 USA; Univ Calif Davis, Anim Commun Lab, Davis, CA 95616 USA	Harvard University; Johns Hopkins University; University of California System; University of California Davis	Palleroni, A (corresponding author), Harvard Univ, Dept Psychol, Primate Cognit Neurosci Lab, 33 Kirkland St, Cambridge, MA 02138 USA.	aliparti@wjh.harvard.edu						Bond AB, 1999, ANIM LEARN BEHAV, V27, P461, DOI 10.3758/BF03209981; Brooke MD, 1998, FUNCT ECOL, V12, P339; Cade T. J., 1982, FALCONS WORLD; Cade TJ, 1988, PEREGRINE FALCON POP; Goodwin D., 1970, PIGEONS DOVES WORLD; Helfman G., 2009, DIVERSITY FISHES; Johnston RF, 1995, FERAL PIGEONS; LIMA SL, 1993, WILSON BULL, V105, P1; Tinbergen, 1951, STUDY INSTINCT; Tucker VA, 1998, J EXP BIOL, V201, P403	10	29	30	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					973	974		10.1038/434973b	http://dx.doi.org/10.1038/434973b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846334				2022-12-24	WOS:000228524600027
J	Wang, GX; Poo, MM				Wang, GX; Poo, MM			Requirement of TRPC channels in netrin-1-induced chemotropic turning of nerve growth cones	NATURE			English	Article							CATION CHANNEL; CA2+ CHANNELS; CALCIUM; XENOPUS; BRAIN; CELLS; MODULATION; ACTIVATION; GUIDANCE; CURRENTS	Ion channels formed by the TRP ( transient receptor potential) superfamily of proteins act as sensors for temperature, osmolarity, mechanical stress and taste(1,2). The growth cones of developing axons are responsible for sensing extracellular guidance factors, many of which trigger Ca2+ influx at the growth cone(3,4); however, the identity of the ion channels involved remains to be clarified. Here, we report that TRP-like channel activity exists in the growth cones of cultured Xenopus neurons and can be modulated by exposure to netrin-1 and brain-derived neurotrophic factor, two chemoattractants for axon guidance. Whole-cell recording from growth cones showed that netrin-1 induced a membrane depolarization, part of which remained after all major voltage-dependent channels were blocked. Furthermore, the membrane depolarization was sensitive to blockers of TRP channels. Pharmacological blockade of putative TRP currents or downregulation of Xenopus TRP-1 (xTRPC1) expression with a specific morpholino oligonucleotide abolished the growth-cone turning and Ca2+ elevation induced by a netrin-1 gradient. Thus, TRPC currents reflect early events in the growth cone's detection of some extracellular guidance signals, resulting in membrane depolarization and cytoplasmic Ca2+ elevation that mediates the turning of growth cones.	Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Poo, MM (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.	mpoo@berkeley.edu		Wang, Gordon/0000-0002-2707-7118				Amiri H, 2003, CELL CALCIUM, V33, P463, DOI 10.1016/S0143-4160(03)00061-7; Bobanovic LK, 1999, BIOCHEM J, V340, P593, DOI 10.1042/0264-6021:3400593; Brereton HM, 2000, MOL CELL BIOCHEM, V214, P63, DOI 10.1023/A:1007193720930; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; GU X, 1993, J NEUROSCI, V13, P4936; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Lintschinger B, 2000, J BIOL CHEM, V275, P27799; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Schaefer M, 2002, J BIOL CHEM, V277, P3752, DOI 10.1074/jbc.M109850200; SCHWARZ G, 1994, CELL CALCIUM, V15, P45, DOI 10.1016/0143-4160(94)90103-1; SCHWEITZ H, 1994, P NATL ACAD SCI USA, V91, P878, DOI 10.1073/pnas.91.3.878; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Strubing C, 2003, J BIOL CHEM, V278, P39014, DOI 10.1074/jbc.M306705200; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Xu XZS, 1997, CELL, V89, P1155, DOI 10.1016/S0092-8674(00)80302-5; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133	29	251	261	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2005	434	7035					898	904		10.1038/nature03478	http://dx.doi.org/10.1038/nature03478			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915SV	15758951				2022-12-24	WOS:000228327600041
J	Krosnar, K				Krosnar, K			Cross-border trade in medicines causes concern in the EU	LANCET			English	Editorial Material																			0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 9	2005	365	9467					1297	1298		10.1016/S0140-6736(05)61011-2	http://dx.doi.org/10.1016/S0140-6736(05)61011-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	914HY	15828082				2022-12-24	WOS:000228219600012
J	Coyne, MJ; Reinap, B; Lee, MM; Comstock, LE				Coyne, MJ; Reinap, B; Lee, MM; Comstock, LE			Human symbionts use a host-like pathway for surface fucosylation	SCIENCE			English	Article							CAPSULAR POLYSACCHARIDES; EPITHELIAL-CELLS; SIALIC-ACID; BLOOD-GROUP; FUCOSE; COMMENSAL; BIOSYNTHESIS; ARABIDOPSIS; INTESTINE; ECOSYSTEM	The mammalian intestine harbors a beneficial microbiota numbering approximately 10(12) organisms per gram of colonic content. The host tolerates this tremendous bacterial. load while maintaining the ability to efficiently respond to pathogenic organisms. In this study, we show that the Bacteroides use a mammalian-like pathway to decorate numerous surface capsular polysaccharides and glycoproteins with L-fucose, an abundant surface molecule of intestinal epithelial cells, resulting in the coordinated expression of this surface molecule by host and symbiont. A Bacteroides mutant deficient in the ability to cover its surface with L-fucose is defective in colonizing the mammalian intestine under competitive conditions.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Channing Lab, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Comstock, LE (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Channing Lab, Boston, MA 02115 USA.	lcomstock@channing.harvard.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI044193, R01AI053694, R01AI044193] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI053694-03, R01 AI044193-07, R01 AI053694, R01 AI044193, AI44193, AI53694] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andrianopoulos K, 1998, J BACTERIOL, V180, P998, DOI 10.1128/JB.180.4.998-1001.1998; BAUMANN H, 1992, BIOCHEMISTRY-US, V31, P4081, DOI 10.1021/bi00131a026; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; BERG RD, 1975, INFECT IMMUN, V11, P320, DOI 10.1128/IAI.11.2.320-329.1975; BJORK S, 1987, J BIOL CHEM, V262, P6758; Bonin CP, 1997, P NATL ACAD SCI USA, V94, P2085, DOI 10.1073/pnas.94.5.2085; Bouchet V, 2003, P NATL ACAD SCI USA, V100, P8898, DOI 10.1073/pnas.1432026100; Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380; Coyne MJ, 2000, INFECT IMMUN, V68, P6176, DOI 10.1128/IAI.68.11.6176-6181.2000; Coyne MJ, 2003, P NATL ACAD SCI USA, V100, P10446, DOI 10.1073/pnas.1832655100; FINNE J, 1989, J BIOL CHEM, V264, P5720; FOO MC, 1974, INFECT IMMUN, V9, P1066, DOI 10.1128/IAI.9.6.1066-1069.1974; Freshour G, 2003, PLANT PHYSIOL, V131, P1602, DOI 10.1104/pp.102.016444; Gaskins H. R., 1997, GASTROINTESTINAL MIC, V2, P537, DOI [10.1007/978-1-4757-0322-1_14, DOI 10.1007/978-1-4757-0322-1_14]; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; Krinos CM, 2001, NATURE, V414, P555, DOI 10.1038/35107092; PREVIATO JO, 1985, MOL BIOCHEM PARASIT, V16, P85, DOI 10.1016/0166-6851(85)90051-9	17	203	227	4	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2005	307	5716					1778	1781		10.1126/science.1106469	http://dx.doi.org/10.1126/science.1106469			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774760				2022-12-24	WOS:000227883900046
J	Olshansky, SJ; Passaro, DJ; Hershow, RC; Layden, J; Carnes, BA; Brody, J; Hayflick, L; Butler, RN; Allison, DB; Ludwig, DS				Olshansky, SJ; Passaro, DJ; Hershow, RC; Layden, J; Carnes, BA; Brody, J; Hayflick, L; Butler, RN; Allison, DB; Ludwig, DS			A potential decline in life expectancy in the United States in the 21st century	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VANCOMYCIN-RESISTANT ENTEROCOCCI; BODY-MASS INDEX; YOUNG ADULTHOOD; HUMAN LONGEVITY; US ADULTS; FOLLOW-UP; OBESITY; MORTALITY; OVERWEIGHT; DISEASE	Forecasts of life expectancy are an important component of public policy that influence age-based entitlement programs such as Social Security and Medicare. Although the Social Security Administration recently raised its estimates of how long Americans are going to live in the 21st century, current trends in obesity in the United States suggest that these estimates may not be accurate. From our analysis of the effect of obesity on longevity, we conclude that the steady rise in life expectancy during the past two centuries may soon come to an end.	Univ Illinois, Chicago, IL 60612 USA; Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Int Longev Ctr, New York, NY USA; Univ Alabama Birmingham, Birmingham, AL USA; Childrens Hosp, Boston, MA 02115 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of California System; University of California San Francisco; University of Alabama System; University of Alabama Birmingham; Harvard University; Boston Children's Hospital	Olshansky, SJ (corresponding author), Univ Illinois, 1603 W Taylor St,Rm 885, Chicago, IL 60612 USA.	sjayo@uic.edu	Hayflick, Leonard/AAW-2460-2020	Allison, David/0000-0003-3566-9399; Ludwig, David/0000-0003-3307-8544	NIA NIH HHS [AG00979-05, K02 AG00785-05] Funding Source: Medline; NIDDK NIH HHS [1R01DK59240] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K02AG000785] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; Allison DB, 1999, AM J PUBLIC HEALTH, V89, P1194, DOI 10.2105/AJPH.89.8.1194; ANDERSON RN, 1999, DHHS PUBLICATION; ANDRES R, 1985, ANN INTERN MED, V103, P1030, DOI 10.7326/0003-4819-103-6-1030; ARIAS E, 2000, DHHS PUBLICATION; Armstrong GL, 1999, JAMA-J AM MED ASSOC, V281, P61, DOI 10.1001/jama.281.1.61; BAYO F, 1974, 72 SOC SEC ADM; BAYO F, 1966, 62 SOC SEC ADM; BELL FC, 2002, 116 SOC SEC ADM; Bender R, 1999, JAMA-J AM MED ASSOC, V281, P1498, DOI 10.1001/jama.281.16.1498; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Carnethon MR, 2003, JAMA-J AM MED ASSOC, V290, P3092, DOI 10.1001/jama.290.23.3092; Centers for Disease Control and Prevention, 1999, JAMA-J AM MED ASSOC, V282, P724, DOI DOI 10.1001/JAMA.282.8.724; CHENG AW, 2004, SSA PUBLICATION; Daviglus ML, 2004, JAMA-J AM MED ASSOC, V292, P2743, DOI 10.1001/jama.292.22.2743; De Grey ADNJ, 2002, ANN NY ACAD SCI, V959, P452, DOI 10.1111/j.1749-6632.2002.tb02115.x; Dean H, 2002, DIABETES, V51, pA24; *DEP EC SOC AFF, 2004, STESASERA236 DEP EC; Diekema DJ, 2003, J CLIN MICROBIOL, V41, P3655, DOI 10.1128/JCM.41.8.3655-3660.2003; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; *EC SOC AFF POP DI, 2004, STESASERA229 POP DIV; FABER JF, 1982, SSA PUBLICATION; FABER JF, 1981, SSA PUBLICATION; Fagot-Campagna A, 2000, J PEDIATR-US, V136, P664, DOI 10.1067/mpd.2000.105141; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Karon JM, 2001, AM J PUBLIC HEALTH, V91, P1060, DOI 10.2105/AJPH.91.7.1060; Koplan J., 2005, PREVENTING CHILDHOOD; Lakdawalla DN, 2004, HEALTH AFFAIR, V23, P168, DOI 10.1377/hlthaff.23.1.168; Ludwig DS, 2001, JAMA-J AM MED ASSOC, V286, P1427, DOI 10.1001/jama.286.12.1427; MacDonell WR, 1913, BIOMETRIKA, V9, P366, DOI 10.1093/biomet/9.3-4.366; Manuel DG, 2004, DIABETES CARE, V27, P407, DOI 10.2337/diacare.27.2.407; McDonald LC, 1997, EMERG INFECT DIS, V3, P311, DOI 10.3201/eid0303.970307; McNeill W.H., 1976, PLAGUES PEOPLES, V1st ed.; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; MYERS RJ, 1952, 33 SOC SEC ADM; NHLBI Obesity Education Initiative, 2000, NIH PUBL; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Olshansky S.J., 1996, HLTH MORTALITY ELDER, P39; OLSHANSKY SJ, 1990, SCIENCE, V250, P634, DOI 10.1126/science.2237414; Olshansky SJ, 1997, POPUL BULL, V52, P2; Olshansky SJ, 2001, SCIENCE, V291, P1491, DOI 10.1126/science.291.5508.1491; Osmon S, 2003, CHEST, V124, P1021, DOI 10.1378/chest.124.3.1021; Peeters A, 2003, JAMA-J AM MED ASSOC, V289, P2941, DOI 10.1001/jama.289.22.2941-a; Pietrobelli A, 2002, J ENDOCRINOL INVEST, V25, P884, DOI 10.1007/BF03344052; *PRES COUNC BIOETH, 2004, THER BIOT PURS HAPP; *SOC SEC ADM, 2003 OASDI TRUST REP; *SOC SEC ADM, 1995, ANN REP BOARD TRUST; Strauss RS, 2001, JAMA-J AM MED ASSOC, V286, P2845, DOI 10.1001/jama.286.22.2845; *TECHN PAN ASS MET, 2003, 2003 REP SOC SEC ADV; Todoriki H., 2004, OKINAWAN J AM STUDIE, V1, P55; Tuljapurkar S, 2000, NATURE, V405, P789, DOI 10.1038/35015561; *U AL SCH PUBL HLT, RES TABL; UTTLEY AHC, 1988, LANCET, V1, P57; WADE A, 1986, SSA PUBLICATION; WADE JF, 1984, SSA PUBLICATION; Wilmoth JR, 2000, SCIENCE, V289, P2366, DOI 10.1126/science.289.5488.2366; Wolf AM, 1998, OBES RES, V6, P97, DOI 10.1002/j.1550-8528.1998.tb00322.x; World Health Organization (WHO), 1999, INFL PAND PLAN ROL W	65	1728	1769	2	199	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2005	352	11					1138	1145		10.1056/NEJMsr043743	http://dx.doi.org/10.1056/NEJMsr043743			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906PU	15784668				2022-12-24	WOS:000227655000015
J	Fu, Y; Gu, Y; Zheng, ZL; Wasteneys, G; Yang, ZB				Fu, Y; Gu, Y; Zheng, ZL; Wasteneys, G; Yang, ZB			Arabidopsis interdigitating cell growth requires two antagonistic pathways with opposing action on cell morphogenesis	CELL			English	Article							F-ACTIN; MICROTUBULE; SHAPE; POLLEN; PROTEINS; DYNAMICS; GTPASES; ARP2/3; PLANTS; GENE	Coordinating growth and communication between adjacent cells is a critical yet poorly understood aspect of tissue development and organ morphogenesis. We report a Rho GTPase signaling network underlying the jigsaw puzzle appearance of Arabidopsis leaf pavement cells, in which localized outgrowth in one cell is coordinated with localized inhibition of outgrowth of the adjacent cell to form interdigitating lobes and indentations. Locally activated ROP2, a Rho-related GTPase from plants, activates RIC4 to promote the assembly of cortical actin microfilaments required for localized outgrowth. Meanwhile, ROP2 inactivates another target RIC1, whose activity promotes well-ordered cortical microtubules. RIC1-dependent microtubule organization not only locally inhibits outgrowth but in turn suppresses ROP2 activation in the indentation zones. Thus, outgrowth-promoting ROP2 and outgrowth-inhibiting RIC1 pathways antagonize each other. We propose that the counteractivity of these two pathways demarcates outgrowing and indenting cortical domains, coordinating a process that gives rise to interdigitations between adjacent pavement cells.	Univ Calif Riverside, Ctr Plant Cell Biol, Inst Integrat Genome Biol, Riverside, CA 92521 USA; Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; Univ British Columbia, Dept Bot, Vancouver, BC V5Z 1M9, Canada	University of California System; University of California Riverside; University of California System; University of California Riverside; University of British Columbia	Yang, ZB (corresponding author), Univ Calif Riverside, Ctr Plant Cell Biol, Inst Integrat Genome Biol, Riverside, CA 92521 USA.	zhenbiao.yang@ucr.edu	Wasteneys, Geoffrey/AGQ-5388-2022	Wasteneys, Geoffrey/0000-0002-8746-7994; Gu, Ying/0000-0001-8415-4768				Cau J, 2001, J CELL BIOL, V155, P1029, DOI 10.1083/jcb.200104123; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Deeks MJ, 2003, CURR OPIN PLANT BIOL, V6, P561, DOI 10.1016/j.pbi.2003.09.013; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Frank MJ, 2002, CURR BIOL, V12, P849, DOI 10.1016/S0960-9822(02)00819-9; Franz CM, 2004, J BIOL CHEM, V279, P6588, DOI 10.1074/jbc.M312812200; Fu Y, 2001, J CELL BIOL, V152, P1019, DOI 10.1083/jcb.152.5.1019; Fu Y, 2002, PLANT CELL, V14, P777, DOI 10.1105/tpc.001537; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Himmelspach R, 2003, PLANT J, V36, P565, DOI 10.1046/j.1365-313X.2003.01906.x; Kodama A, 2004, J CELL BIOL, V167, P203, DOI 10.1083/jcb.200408047; Le J, 2003, CURR BIOL, V13, P1341, DOI 10.1016/S0960-9822(03)00493-7; Lew DJ, 2003, CURR OPIN CELL BIOL, V15, P648, DOI 10.1016/j.ceb.2003.09.001; Li H, 2001, PLANT PHYSIOL, V126, P670, DOI 10.1104/pp.126.2.670; Li H, 1998, PLANT PHYSIOL, V118, P407, DOI 10.1104/pp.118.2.407; Li SD, 2003, PLANT PHYSIOL, V132, P2034, DOI 10.1104/pp.103.028563; Lin YK, 1997, PLANT CELL, V9, P1647, DOI 10.1105/tpc.9.9.1647; Lloyd C, 2001, NAT REV MOL CELL BIO, V2, P40, DOI 10.1038/35048005; Mathur J, 2003, PLANT CELL, V15, P1632, DOI 10.1105/tpc.011676; Qiu JL, 2002, PLANT CELL, V14, P101, DOI 10.1105/tpc.010346; Smith LG, 2003, CURR OPIN PLANT BIOL, V6, P63, DOI 10.1016/S1369-5266(02)00012-2; Ueda K, 1999, PROTOPLASMA, V206, P201, DOI 10.1007/BF01279267; Wasteneys GO, 1997, J MICROSC-OXFORD, V188, P51, DOI 10.1046/j.1365-2818.1977.2390796.x; Wasteneys GO, 2003, ANNU REV PLANT BIOL, V54, P691, DOI 10.1146/annurev.arplant.54.031902.134818; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Whittington AT, 2001, NATURE, V411, P610, DOI 10.1038/35079128; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082; Wu G, 2001, PLANT CELL, V13, P2841, DOI 10.1105/tpc.13.12.2841; Yang ZB, 2002, PLANT CELL, V14, pS375, DOI 10.1105/tpc.001065	29	401	430	0	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 11	2005	120	5					687	700		10.1016/j.cell.2004.12.026	http://dx.doi.org/10.1016/j.cell.2004.12.026			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766531	Bronze			2022-12-24	WOS:000227771400014
J	Kempf, S; Srama, R; Postberg, F; Burton, M; Green, SF; Helfert, S; Hillier, JK; McBride, N; McDonnell, JAM; Moragas-Klostermeyer, G; Roy, M; Grun, E				Kempf, S; Srama, R; Postberg, F; Burton, M; Green, SF; Helfert, S; Hillier, JK; McBride, N; McDonnell, JAM; Moragas-Klostermeyer, G; Roy, M; Grun, E			Composition of saturnian stream particles	SCIENCE			English	Article							DUST; JUPITER	During Cassini's approach to Saturn, the Cosmic Dust Analyser (CDA) discovered streams of tiny (less than 20 nanometers) high-velocity (similar to100 kilometers per second) dust particles escaping from the saturnian system. A fraction of these impactors originated from the outskirts of Saturn's dense A ring. The CDA time-of-flight mass spectrometer recorded 584 mass spectra from the stream particles. The particles consist predominantly of oxygen, silicon, and iron, with some evidence of water ice, ammonium, and perhaps carbon. The stream particles primarily consist, of silicate materials, and this implies that the particles are impurities from the icy ring material rather than the ice particles themselves.	Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Open Univ, Planetary & Space Sci Res Inst, Milton Keynes MK7 6AA, Bucks, England; Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA	Max Planck Society; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Open University - UK; University of Hawaii System	Kempf, S (corresponding author), Max Planck Inst Kernphys, Saupfercheckweg 1, D-69117 Heidelberg, Germany.	Sascha.Kempf@mpi-hd.mpg.de	Green, Simon F/C-7408-2009; Postberg, Frank/AAE-6295-2019	Green, Simon F/0000-0002-9153-9786; Postberg, Frank/0000-0002-5862-4276; KEMPF, SASCHA/0000-0001-5236-3004				Ahrens TJ, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001912; [Anonymous], 1984, SATURN; Auer S, 2001, ASTR AST LI, P385; GUERNSEY C, COMMUNICATION; HAMILTON DP, 1993, NATURE, V364, P695, DOI 10.1038/364695a0; Horanyi M, 2000, PHYS PLASMAS, V7, P3847, DOI 10.1063/1.1288909; HORANYI M, 1993, J GEOPHYS RES-SPACE, V98, P21245, DOI 10.1029/93JA02588; JESSBERGER EK, 1991, ASTROPHYS SPACE SC L, V167, P1075, DOI 10.1017/S0252921100012823; Kempf S, 2005, NATURE, V433, P289, DOI 10.1038/nature03218; KNABE W, 1983, THESIS U HEIDELBERG; MOCKER A, UNPUB; Srama R, 2004, SPACE SCI REV, V114, P465, DOI 10.1007/s11214-004-1435-z; STUBIG M, 2002, THESIS U HEIDELBERG; TIMMERMANN T, 1991, ORIGIN EVOLUTION INT, P387	14	67	67	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1274	1276		10.1126/science.1106218	http://dx.doi.org/10.1126/science.1106218			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731446				2022-12-24	WOS:000227313200048
J	Thompson, JR; Pacocha, S; Pharino, C; Klepac-Ceraj, V; Hunt, DE; Benoit, J; Sarma-Rupavtarm, R; Distel, DL; Polz, MF				Thompson, JR; Pacocha, S; Pharino, C; Klepac-Ceraj, V; Hunt, DE; Benoit, J; Sarma-Rupavtarm, R; Distel, DL; Polz, MF			Genotypic diversity within a natural coastal bacterioplankton population	SCIENCE			English	Article							LATERAL GENE-TRANSFER; SULFATE-REDUCING BACTERIA; ESCHERICHIA-COLI; EVOLUTION; SEQUENCE; GENOME; PATHOGENICITY; COMMUNITY; DYNAMICS	The genomic diversity and relative importance of distinct genotypes within natural bacterial populations have remained largely unknown. Here, we analyze the diversity and annual dynamics of a group of coastal bacterioplankton (greater than 99% 16S ribosomal RNA identity to Vibrio splendidus). We show that this group consists of at least a thousand distinct genotypes, each occurring at extremely low environmental concentrations (on average less than one cell per milliliter). Overall, the genomes show extensive allelic diversity and size variation. Individual genotypes rarely recurred in samples, and allelic distribution did not show spatial or temporal substructure. Ecological considerations suggest that much genotypic and possibly phenotypic variation within natural populations should be considered neutral.	MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; New England Biolabs Inc, Ocean Genome Legacy, Beverly, MA 01915 USA	Massachusetts Institute of Technology (MIT); Woods Hole Oceanographic Institution	Polz, MF (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mpolz@mit.edu	Distel, Daniel/A-8047-2017; Polz, Martin/ABE-7199-2020; Preheim, Sarah P/B-3432-2010; Thompson, Janelle/AAJ-8225-2020; Hunt, Dana/A-2051-2012	Distel, Daniel/0000-0002-3860-194X; Preheim, Sarah P/0000-0001-7365-2382; Thompson, Janelle/0000-0003-0445-3720; Hunt, Dana/0000-0002-8801-9624; Klepac-Ceraj, Vanja/0000-0001-5387-5706; /0000-0001-9296-3733; Polz, Martin/0000-0002-4975-2946				Acinas SG, 2004, NATURE, V430, P551, DOI 10.1038/nature02649; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Berg OG, 2002, MOL BIOL EVOL, V19, P2265, DOI 10.1093/oxfordjournals.molbev.a004050; Bergthorsson U, 1998, MOL BIOL EVOL, V15, P6, DOI 10.1093/oxfordjournals.molbev.a025847; Blackburn N, 1999, MAR ECOL PROG SER, V189, P1, DOI 10.3354/meps189001; Boucher Y, 2003, ANNU REV GENET, V37, P283, DOI 10.1146/annurev.genet.37.050503.084247; DeLong EF, 2002, CURR OPIN MICROBIOL, V5, P520, DOI 10.1016/S1369-5274(02)00353-3; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; Hacker J, 2001, EMBO REP, V2, P376, DOI 10.1093/embo-reports/kve097; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Jaspers E, 2004, APPL ENVIRON MICROB, V70, P4831, DOI 10.1128/AEM.70.8.4831-4839.2004; Joyce EA, 2002, NAT REV GENET, V3, P462, DOI 10.1038/nrg820; Klepac-Ceraj V, 2004, ENVIRON MICROBIOL, V6, P686, DOI 10.1111/j.1462-2920.2004.00600.x; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Lawrence JG, 2002, TRENDS MICROBIOL, V10, P1, DOI 10.1016/S0966-842X(01)02282-X; Lindsay JA, 2004, TRENDS MICROBIOL, V12, P378, DOI 10.1016/j.tim.2004.06.004; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Palys T, 1997, INT J SYST BACTERIOL, V47, P1145, DOI 10.1099/00207713-47-4-1145; Perna NT, 1998, INFECT IMMUN, V66, P3810, DOI 10.1128/IAI.66.8.3810-3817.1998; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Reid SD, 2000, NATURE, V406, P64, DOI 10.1038/35017546; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Sass H, 1998, ARCH MICROBIOL, V170, P243, DOI 10.1007/s002030050639; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; Thompson J. O. F., UNPUB; Thompson JR, 2004, APPL ENVIRON MICROB, V70, P4103, DOI 10.1128/AEM.70.7.4103-4110.2004; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799	30	289	297	0	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1311	1313		10.1126/science.1106028	http://dx.doi.org/10.1126/science.1106028			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731455	Green Submitted			2022-12-24	WOS:000227313200059
J	Martinez, C; Rietbrock, S; Wise, L; Ashby, D; Chick, J; Moseley, J; Evans, S; Gunnell, D				Martinez, C; Rietbrock, S; Wise, L; Ashby, D; Chick, J; Moseley, J; Evans, S; Gunnell, D			Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study	BRITISH MEDICAL JOURNAL			English	Article							SEROTONIN REUPTAKE INHIBITORS; SUICIDE; PREVENTION; OXFORD	Objective To compare the risk of non-fatal self harm and suicide in patients taking selective serotonin reuptake inhibitors (SSRIs) with that of patients taking tricyclic antidepressants, as well as between different SSRIs and different tricyclic antidepressants. Design Nested case-control study. Setting Primary care in the United Kingdom. Participants 146 095 individuals with a first prescription of an antidepressant for depression. Main outcome measures Suicide and non-fatal self harm. Results 1968 cases of non-fatal self harm and 69 suicides occurred. The overall adjusted odds ratio of non-fatal self harm was 0.99 (95% confidence interval 0.86 to 1.14) and that of suicide 0.57 (0.26 to 1.25) in people prescribed SSRIs compared with those prescribed tricyclic antidepressants. We found little evidence that associations differed over time since starting or stopping treatment. We found some evidence that risks of non-fatal self harm in people prescribed SSRIs compared with those prescribed tricyclic antidepressants differed by age group (interaction P = 0.02). The adjusted odds ratio of non-fatal self harm for people prescribed SSRIs compared with users of tricylic antidepressants for those aged 18 or younger was 1.59 (1.01 to 2.50), but no association was apparent in other age groups. No suicides occur-red in those aged 18 or younger currently or recently prescribed tricyclic antidepressants or SSRIs. Conclusion We found no evidence that the risk of suicide or non-fatal self harm in adults prescribed SSRIs was greater than in those prescribed tricyclic antidepressants. We found some weak evidence of air increased risk of non-fatal self harm for current SSRI use among those aged 18 or younger. However, preferential prescribing of SSRIs to patients at higher risk of suicidal behaviour cannot be ruled out.	Med & Healthcare Prod Regulatory Agcy, Gen Practice Res Database Div, London SW8 5NQ, England; Med & Healthcare Prod Regulatory Agcy, Post Licensing Div, London SW8 5NQ, England; Univ London, Queen Mary, Wolfson Inst Prevent Med, London WC1E 7HU, England; Univ Edinburgh, Dept Psychiat, Edinburgh EH8 9YL, Midlothian, Scotland; London Sch Hyg & Trop Med, Med Stat Unit, London, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	The Medicines & Healthcare Products Regulatory Agency; The Medicines & Healthcare Products Regulatory Agency; University of London; Queen Mary University London; University of Edinburgh; University of London; London School of Hygiene & Tropical Medicine; University of Bristol	Martinez, C (corresponding author), Med & Healthcare Prod Regulatory Agcy, Gen Practice Res Database Div, London SW8 5NQ, England.	carlos.martinez@gprd.de	Gunnell, David/ABE-6653-2020; anand, amit/A-7222-2009	Gunnell, David/0000-0002-0829-6470; Martinez, Carlos/0000-0001-6498-6428; Evans, Stephen/0000-0002-1474-2596				Breslow NE., 1987, STAT METHODS CANC RE, P81; Brock A, 2003, HLTH STAT Q, V20, P7; Buckley NA, 2002, BRIT MED J, V325, P1332, DOI 10.1136/bmj.325.7376.1332; Gunnell D, 2004, BRIT MED J, V329, P34, DOI 10.1136/bmj.329.7456.34; GUNNELL D, 1994, BMJ-BRIT MED J, V308, P1227, DOI 10.1136/bmj.308.6938.1227; Hawton K, 2003, PSYCHOL MED, V33, P987, DOI 10.1017/S0033291703007943; Hawton K, 1997, BRIT J PSYCHIAT, V171, P556, DOI 10.1192/bjp.171.6.556; Healy D, 2003, PSYCHOTHER PSYCHOSOM, V72, P71, DOI 10.1159/000068691; International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 2005, ICH HARM TRIP GUID C; Jick H, 2004, JAMA-J AM MED ASSOC, V292, P338, DOI 10.1001/jama.292.3.338; JICK SS, 1995, BRIT MED J, V310, P215, DOI 10.1136/bmj.310.6974.215; Medawar C, 1997, Int J Risk Saf Med, V10, P75, DOI 10.3233/JRS-1997-10203; Medawar C, 2002, INT J RISK SAFETY ME, V15, P161; *NAT STAT ONL, CENS 2001; *NAT STAT ONL, TRENDS SUIC METH ENG, P7; *NAT STAT ONL, TRENDS SUIC METH ENG; Vandenbroucke JP, 2004, LANCET, V363, P1728, DOI 10.1016/S0140-6736(04)16261-2; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1; Wood L, 2004, DRUG SAFETY, V27, P871, DOI 10.2165/00002018-200427120-00004; Zahl DL, 2004, BRIT J PSYCHIAT, V185, P70, DOI 10.1192/bjp.185.1.70; 2003, CURR PROBL PHARMACOV, V29, P4	21	179	183	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 19	2005	330	7488					389	393		10.1136/bmj.330.7488.389	http://dx.doi.org/10.1136/bmj.330.7488.389			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	900NA	15718538	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000227220400017
J	Asher, RJ; Meng, J; Wible, JR; McKenna, MC; Rougier, GW; Dashzeveg, D; Novacek, MJ				Asher, RJ; Meng, J; Wible, JR; McKenna, MC; Rougier, GW; Dashzeveg, D; Novacek, MJ			Stem lagomorpha and the antiquity of Glires	SCIENCE			English	Article							RODENTS; SYSTEMATICS; TIMESCALE; RADIATION; RELATIVES; MAMMALIA; RABBITS	We describe several fossils referable to Gomphos elkema from deposits close to the Paleocene-Eocene boundary at Tsagan Khushu, Mongolia. Gomphos shares a suite of cranioskeletal characters with extant rabbits, hares, and pikas but retains a primitive dentition and jaw compared to its modern relatives. Phylogenetic analysis supports the position of Gomphos as a stem lagomorph and excludes Cretaceous taxa from the crown radiation of placental mammals. Our results support the hypothesis that rodents and lagomorphs radiated during the Cenozoic and diverged from other placental mammals close to the Cretaceous-Tertiary boundary.	Humboldt Univ, Museum Nat, D-10115 Berlin, Germany; Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; Carnegie Museum Nat Hist, Sect Mammals, Pittsburgh, PA 15206 USA; Univ Wyoming, Dept Geol & Geophys, Laramie, WY 82071 USA; Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA; Mongolian Acad Sci, Geol Ctr, Ulaanbaatar, Mongolia	Humboldt University of Berlin; American Museum of Natural History (AMNH); University of Wyoming; University of Louisville; Mongolian Academy of Sciences	Asher, RJ (corresponding author), Humboldt Univ, Museum Nat, Invalidenstr 43, D-10115 Berlin, Germany.	robert.asher@museum.hu-berlin.de						Adkins RM, 2003, MOL PHYLOGENET EVOL, V26, P409, DOI 10.1016/S1055-7903(02)00304-4; Archibald JD, 2001, NATURE, V414, P62, DOI 10.1038/35102048; Bowen GJ, 2002, SCIENCE, V295, P2062, DOI 10.1126/science.1068700; DASHZEVEG D, 1987, P K NED AKAD B PHYS, V90, P133; Douzery EJP, 2003, J MOL EVOL, V57, pS201, DOI 10.1007/s00239-003-0028-x; GOLOBOFF P, NONA VERS 1 9; Hartenberger JL, 1998, CR ACAD SCI II A, V326, P439, DOI 10.1016/S1251-8050(98)80068-2; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Huchon D, 2002, MOL BIOL EVOL, V19, P1053, DOI 10.1093/oxfordjournals.molbev.a004164; KIELANJAWOROWSK.Z, 1978, PALAEONTOL POL, V37, P32; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lee MSY, 2000, SYST BIOL, V49, P829, DOI 10.1080/106351500750049879; Li C., 1985, EVOLUTIONARY RELATIO, P35; Luckett W.P., 1985, EVOLUTIONARY RELATIO; Matthee CA, 2004, SYST BIOL, V53, P433, DOI 10.1080/10635150490445715; MCKENNA MC, 1994, NAT HIST, V103, P56; McKenna MC, 2001, J VERTEBR PALEONTOL, V21, P565, DOI 10.1671/0272-4634(2001)021[0565:APRORF]2.0.CO;2; McKenna MC, 1997, CLASSIFICATION MAMMA; Meng J, 2004, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2004)425<0001:GEGMFT>2.0.CO;2; Meng J, 2003, B AM MUS NAT HIST, P1; Montgelard C, 2002, MOL PHYLOGENET EVOL, V22, P220, DOI 10.1006/mpev.2001.1056; Nilsson MA, 2003, J MOL EVOL, V57, pS3, DOI 10.1007/s00239-003-0001-8; NIXON KC, WINCLADA BETA VER 0; Rohlf F.J., 1995, STAT TABLES; SHEVYREVA NS, 1975, B GEORGIAN ACAD SCI, V77, P225; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Swofford DL, 2002, PHYLOGENETIC ANAL US; VANVALEN L, 1964, EVOLUTION, V18, P484, DOI 10.1111/j.1558-5646.1964.tb01624.x; Wible JR, 2004, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2004)281<0001:NDOTSA>2.0.CO;2; Wyss AR, 1996, SYST BIOL, V45, P559, DOI 10.2307/2413531; ZHEGALLO VI, 1976, JT SOV MONG PALEONTO, V3, P269	31	142	157	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2005	307	5712					1091	1094		10.1126/science.1107808	http://dx.doi.org/10.1126/science.1107808			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ED	15718468				2022-12-24	WOS:000227197300043
J	Malsam, J; Satoh, A; Pelletier, L; Warren, G				Malsam, J; Satoh, A; Pelletier, L; Warren, G			Goigin tethers define subpopulations of COPI vesicles	SCIENCE			English	Article							GOLGI; TRANSPORT; PROTEIN; ARCHITECTURE; RECRUITMENT; CONTAINS; REVEALS; COMPLEX; P115	Coiled-coil proteins of the golgin family have been implicated in intra-Golgi transport through tethering coat protein complex I (COPI) vesicles. The p115-golgin tether is the best studied, and here we characterize the golgin-84-CASP tether. The vesicles bound by this tether were strikingly different from those bound by the p115-golgin tether in that they lacked members of the p24 family of putative cargo receptors and contained enzymes instead of anterograde cargo. Microinjected golgin-84 or CASP also inhibited Golgi-enzyme transport to the endoplasmic reticulum, further implicating this tether in retrograde transport. These and other golgins may modulate the flow patterns within the Golgi stack.	Yale Univ, Sch Med, Dept Cell Biol, Ludwig Inst Canc Res, New Haven, CT 06520 USA	Ludwig Institute for Cancer Research; Yale University	Warren, G (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, Ludwig Inst Canc Res, 333 Cedar St, New Haven, CT 06520 USA.	graham.warren@yale.edu	Satoh, Ayano/B-2423-2011; Pelletier, Laurence/F-8858-2013	Satoh, Ayano/0000-0003-3736-1283; 				Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Axelsson MAB, 2004, MOL BIOL CELL, V15, P1843, DOI 10.1091/mbc.E03-07-0459; Diao A, 2003, J CELL BIOL, V160, P201, DOI 10.1083/jcb.200207045; Dominguez M, 1998, J CELL BIOL, V140, P751, DOI 10.1083/jcb.140.4.751; Gillingham AK, 2003, BBA-MOL CELL RES, V1641, P71, DOI 10.1016/S0167-4889(03)00088-0; Gillingham AK, 2002, MOL BIOL CELL, V13, P3761, DOI 10.1091/mbc.E02-06-0349; Girod A, 1999, NAT CELL BIOL, V1, P423, DOI 10.1038/15658; Glick BS, 1998, CELL, V95, P883, DOI 10.1016/S0092-8674(00)81713-4; ITIN C, 1995, J CELL BIOL, V131, P57, DOI 10.1083/jcb.131.1.57; Lanoix J, 2001, J CELL BIOL, V155, P1199, DOI 10.1083/jcb.200108017; Malsam J, 1999, FEBS LETT, V462, P267, DOI 10.1016/S0014-5793(99)01543-4; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Nelson DS, 1998, J CELL BIOL, V143, P319, DOI 10.1083/jcb.143.2.319; Nickel W, 2002, J CELL SCI, V115, P3235; OSTERMANN J, 1993, CELL, V75, P1015, DOI 10.1016/0092-8674(93)90545-2; Pelham HRB, 2000, CELL, V102, P713, DOI 10.1016/S0092-8674(00)00060-X; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; Puthenveedu MA, 2004, P NATL ACAD SCI USA, V101, P1253, DOI 10.1073/pnas.0306373101; Rojo M, 1997, J CELL BIOL, V139, P1119, DOI 10.1083/jcb.139.5.1119; Satoh A, 2003, TRAFFIC, V4, P153, DOI 10.1034/j.1600-0854.2003.00103.x; Seemann J, 2000, NATURE, V407, P1022, DOI 10.1038/35039538; Seemann J, 2000, MOL BIOL CELL, V11, P635, DOI 10.1091/mbc.11.2.635; Shorter J, 2002, ANNU REV CELL DEV BI, V18, P379, DOI 10.1146/annurev.cellbio.18.030602.133733; Sonnichsen B, 1998, J CELL BIOL, V140, P1013, DOI 10.1083/jcb.140.5.1013; Storrie B, 1998, J CELL BIOL, V143, P1505, DOI 10.1083/jcb.143.6.1505; Trucco A, 2004, NAT CELL BIOL, V6, P1071, DOI 10.1038/ncb1180; VELASCO A, 1993, J CELL BIOL, V122, P39, DOI 10.1083/jcb.122.1.39; Whyte JRC, 2002, J CELL SCI, V115, P2627	28	150	161	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2005	307	5712					1095	1098		10.1126/science.1108061	http://dx.doi.org/10.1126/science.1108061			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ED	15718469				2022-12-24	WOS:000227197300044
J	Schellenberg, D; Menendez, C; Aponte, JJ; Kahigwa, E; Tanner, M; Mshinda, H; Alonso, P				Schellenberg, D; Menendez, C; Aponte, JJ; Kahigwa, E; Tanner, M; Mshinda, H; Alonso, P			Intermittent preventive antimalarial treatment for Tanzanian infants: follow-up to age 2 years of a randomised, placebo-controlled trial	LANCET			English	Article							MALARIA	Stopping antimalarial chemoprophylaxis can be followed by increased risk of malaria, suggesting that it interferes with the development of antimalarial immunity. We report analysis of extended follow-up until age 2 years of a randomised, placebo-controlled double-blind trial of intermittent preventive antimalarial treatment in infants. The rate of clinical malaria (events per person-year at risk, starting 1 month after final dose of intermittent treatment) was 0.28 in the sulfadoxine-pyrimethamine group and 0.43 in the placebo group (protective effect 36%, 95% Cl 11-53). Intermittent treatment produced a sustained reduction in the risk of clinical malaria extending well beyond the duration of the pharmacological effects of the drugs, excluding a so-called rebound effect and suggesting that such treatment could facilitate development of immunity against Plasmodium falciparum.	Hosp Clin Barcelona, IDIBAPS, Ctr Int Hlth, Barcelona, Spain; Ifakara Hlth Res & Dev Ctr, Kilombero, Tanzania; London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; Swiss Trop Inst, CH-4002 Basel, Switzerland	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Ifakara Health Institute; University of London; London School of Hygiene & Tropical Medicine; University of Basel; Swiss Tropical & Public Health Institute	Schellenberg, D (corresponding author), IHRDC, POB 78373, Dar Es Salaam, Tanzania.	dmschellenberg@aol.com	Alonso, Pedro L/AAZ-3645-2020; Menéndez, Clara/Q-3446-2016	Alonso, Pedro L/0000-0003-3292-3443; Menéndez, Clara/0000-0002-2641-6907; Schellenberg, David/0000-0001-8222-0186				Belnoue E, 2004, J IMMUNOL, V172, P2487, DOI 10.4049/jimmunol.172.4.2487; Drakeley C, 2003, TROP MED INT HEALTH, V8, P767, DOI 10.1046/j.1365-3156.2003.01100.x; Geerligs PDP, 2003, B WORLD HEALTH ORGAN, V81, P205; Schellenberg D, 2002, AM J TROP MED HYG, V67, P17, DOI 10.4269/ajtmh.2002.67.17; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; Schellenberg DM, 2003, T ROY SOC TROP MED H, V97, P647, DOI 10.1016/S0035-9203(03)80096-2; 1999, COMPENDIUM DATA SHEE	7	122	124	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2005	365	9469					1481	1483		10.1016/S0140-6736(05)66418-5	http://dx.doi.org/10.1016/S0140-6736(05)66418-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850632				2022-12-24	WOS:000228651600026
J	Almond, CSD; Shin, AY; Fortescue, EB; Mannix, RC; Wypij, D; Binstadt, BA; Duncan, CN; Olson, DP; Salerno, AE; Newburger, JW; Greenes, DS				Almond, CSD; Shin, AY; Fortescue, EB; Mannix, RC; Wypij, D; Binstadt, BA; Duncan, CN; Olson, DP; Salerno, AE; Newburger, JW; Greenes, DS			Hyponatremia among runners in the Boston Marathon	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PULMONARY-EDEMA; EXERCISE; ILLNESS	Background Hyponatremia has emerged as an important cause of race-related death and life-threatening illness among marathon runners. We studied a cohort of marathon runners to estimate the incidence of hyponatremia and to identify the principal risk factors. Methods Participants in the 2002 Boston Marathon were recruited one or two days before the race. Subjects completed a survey describing demographic information and training history. After the race, runners provided a blood sample and completed a questionnaire detailing their fluid consumption and urine output during the race. Prerace and postrace weights were recorded. Multivariate regression analyses were performed to identify risk factors associated with hyponatremia. Results Of 766 runners enrolled, 488 runners (64 percent) provided a usable blood sample at the finish line. Thirteen percent had hyponatremia (a serum sodium concentration of 135 mmol per liter or less); 0.6 percent had critical hyponatremia (120 mmol per liter or less). On univariate analyses, hyponatremia was associated with substantial weight gain, consumption of more than 3 liters of fluids during the race, consumption of fluids every mile, a racing time of >4:00 hours, female sex, and low body-mass index. On multivariate analysis, hyponatremia was associated with weight gain (odds ratio, 4.2; 95 percent confidence interval, 2.2 to 8.2), a racing time of >4:00 hours (odds ratio for the comparison with a time of <3:30 hours, 7.4; 95 percent confidence interval, 2.9 to 23.1), and body-mass-index extremes. Conclusions Hyponatremia occurs in a substantial fraction of nonelite marathon runners and can be severe. Considerable weight gain while running, a long racing time, and body-mass-index extremes were associated with hyponatremia, whereas female sex, composition of fluids ingested, and use of nonsteroidal antiinflammatory drugs were not.	Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; Childrens Hosp, Dept Med, Boston, MA 02115 USA; Childrens Hosp, Clin Res Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Almond, CSD (corresponding author), Childrens Hosp, Dept Cardiol, Bader 2,300 Longwood Ave, Boston, MA 02115 USA.	christopher.almond@childrens.harvard.edu	Binstadt, Bryce/N-1305-2013; Hug, Balthasar L./G-1568-2010; Mannix, Rebekah/AAD-8702-2020	Binstadt, Bryce/0000-0003-3127-3856; Mannix, Rebekah/0000-0003-3608-2792; Wypij, David/0000-0001-8367-8711	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002172] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-02172] Funding Source: Medline; NHLBI NIH HHS [T32 HL007572] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ayus JC, 2000, ANN INTERN MED, V132, P711, DOI 10.7326/0003-4819-132-9-200005020-00005; Backer HD, 1999, AM J EMERG MED, V17, P532, DOI 10.1016/S0735-6757(99)90191-2; CASA DJ, 2003, PROPER HYDRATION DIS; Davis DP, 2001, J EMERG MED, V21, P47, DOI 10.1016/S0736-4679(01)00320-1; FRIZZELL RT, 1986, JAMA-J AM MED ASSOC, V255, P772, DOI 10.1001/jama.255.6.772; Garigan TP, 1999, MIL MED, V164, P234, DOI 10.1093/milmed/164.3.234; Hastie TJ., 1990, GEN ADDITIVE MODELS; Hew TD, 2003, CLIN J SPORT MED, V13, P41, DOI 10.1097/00042752-200301000-00008; HILLMAN M, CLOSE CALL HYPONATRE; Hsieh M, 2002, MED SCI SPORT EXER, V34, P185, DOI 10.1097/00005768-200202000-00001; IRVING RA, 1991, J APPL PHYSIOL, V70, P342, DOI 10.1152/jappl.1991.70.1.342; NEARMAN S, 2002, WASHINGTON TIME 1030; Noakes T, 2003, CLIN J SPORT MED, V13, P309, DOI 10.1097/00042752-200309000-00007; NOAKES TD, 1990, MED SCI SPORT EXER, V22, P165; Noakes TD, 2003, BRIT MED J, V327, P113, DOI 10.1136/bmj.327.7407.113; NOALES TD, 2004, BRIT J SPORT MED, V38, pE16; O'Brien KK, 2001, MIL MED, V166, P405, DOI 10.1093/milmed/166.5.405; Roberts WO, 2000, MED SCI SPORT EXER, V32, P1549; SMITH S, 2002, NY TIMES        0813; Speedy D B, 2001, Emerg Med (Fremantle), V13, P17, DOI 10.1046/j.1442-2026.2001.00173.x; Speedy DB, 1999, MED SCI SPORT EXER, V31, P809, DOI 10.1097/00005768-199906000-00008; Steinberg D., 2003, WASH POST, pA1; *TRACK FIELD RUNN, RUNN US; YOUNG M, 1987, AM REV RESPIR DIS, V136, P737, DOI 10.1164/ajrccm/136.3.737	24	350	358	0	67	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 14	2005	352	15					1550	1556		10.1056/NEJMoa043901	http://dx.doi.org/10.1056/NEJMoa043901			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	915SH	15829535				2022-12-24	WOS:000228324200007
J	Robinson, DA; Kearns, AM; Holmes, A; Morrison, D; Grundmann, H; Edwards, G; O'Brien, FG; Tenover, FC; McDougal, LK; Monk, AB; Enright, MC				Robinson, DA; Kearns, AM; Holmes, A; Morrison, D; Grundmann, H; Edwards, G; O'Brien, FG; Tenover, FC; McDougal, LK; Monk, AB; Enright, MC			Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone	LANCET			English	Article							PANTON-VALENTINE LEUKOCIDIN; EMERGENCE; STRAINS	During the 1950s, the notorious penicillin-resistant clone of Staphylococcus aureus known as phage type 80/81 emerged and caused serious hospital-acquired and community-acquired infections worldwide. This clone was largely eliminated in the 1960s, concurrent with the widespread use of penicillinase-resistant beta lactams. We investigated whether early 80/81 isolates had the genes for Panton-Valentine leucocidin, a toxin associated with virulence in healthy young people. Multilocus sequence analysis suggested that descendants of 80/81 have acquired meticillin resistance, are re-emerging as a community-acquired meticillin-resistant S aureus (MRSA) clone, and represent a sister lineage to pandemic hospital-acquired MRSA.	Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; Hlth Protect Agcy, Lab Healthcare Associated Infect, Specialist & Reference Microbiol Div, London, England; Stobhill Hosp, Dept Microbiol, Scottish MRSA Reference Lab, Glasgow, Lanark, Scotland; Natl Inst Publ Hlth & Environm, RIVM, Dept Infect Dis Epidemiol, NL-3720 BA Bilthoven, Netherlands; Curtin Univ Technol, Sch Biomed Sci, Perth, WA 6001, Australia; Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA USA	University of Bath; Health Protection Agency; Netherlands National Institute for Public Health & the Environment; Curtin University; Centers for Disease Control & Prevention - USA	Enright, MC (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	m.c.enright@bath.ac.uk		Enright, Mark/0000-0001-5273-8750				DONAHUE JA, 1966, J INFECT DIS, V116, P324, DOI 10.1093/infdis/116.3.324; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Robinson DA, 2003, ANTIMICROB AGENTS CH, V47, P3926, DOI 10.1128/AAC.47.12.3926-3934.2003; ROUNTREE Phyllis M., 1958, Medical Journal of Australia, V2, P789; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978	5	199	206	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2005	365	9466					1256	1258		10.1016/S0140-6736(05)74814-5	http://dx.doi.org/10.1016/S0140-6736(05)74814-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	912VI	15811459				2022-12-24	WOS:000228107600029
J	Gami, AS; Howard, DE; Olson, EJ; Somers, VK				Gami, AS; Howard, DE; Olson, EJ; Somers, VK			Day-night pattern of sudden death in obstructive sleep apnea	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; CERTIFICATE DIAGNOSIS; CARDIAC DEATH; ATRIOVENTRICULAR-CONDUCTION; MYOCARDIAL-INFARCTION; BREATHING DISORDERS; QT INTERVAL; VALIDATION; POPULATION; DISTURBANCES	BACKGROUND: The risk of sudden death from cardiac causes in the general population peaks from 6 a.m. to noon and has a nadir from midnight to 6 a.m. Obstructive sleep apnea is highly prevalent and associated with neurohormonal and electrophysiological abnormalities that may increase the risk of sudden death from cardiac causes, especially during sleep. METHODS: We reviewed polysomnograms and the death certificates of 112 Minnesota residents who had undergone polysomnography and had died suddenly from cardiac causes between July 1987 and July 2003. For four intervals of the day, we compared the rates of sudden death from cardiac causes among people with obstructive sleep apnea and the following: the rates among people without obstructive sleep apnea, the rates in the general population, and the expectations according to chance. For each interval, we assessed the median apnea-hypopnea index and the relative risk of sudden death from cardiac causes. We similarly analyzed sudden death from cardiac causes during three time intervals that correlate with usual sleep-wake cycles. RESULTS: From midnight to 6 a.m., sudden death from cardiac causes occurred in 46 percent of people with obstructive sleep apnea, as compared with 21 percent of people without obstructive sleep apnea (P=0.01), 16 percent of the general population (P<0.001), and the 25 percent expected by chance (P<0.001). People with sudden death from cardiac causes from midnight to 6 a.m. had a significantly higher apnea-hypopnea index than those with sudden death from cardiac causes during other intervals, and the apnea-hypopnea index correlated directly with the relative risk of sudden death from cardiac causes from midnight to 6 a.m. For people with obstructive sleep apnea, the relative risk of sudden death from cardiac causes from midnight to 6 a.m. was 2.57 (95 percent confidence interval, 1.87 to 3.52). The analysis of usual sleep-wake cycles showed similar results. CONCLUSIONS: People with obstructive sleep apnea have a peak in sudden death from cardiac causes during the sleeping hours, which contrasts strikingly with the nadir of sudden death from cardiac causes during this period in people without obstructive sleep apnea and in the general population.	Mayo Clin & Mayo Fdn, Coll Med, Div Cardiovasc Dis, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Coll Med, Div Pulm & Crit Care Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Coll Med, Div Hypertens, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Coll Med, Dept Internal Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Somers, VK (corresponding author), Mayo Clin & Mayo Fdn, Coll Med, Div Cardiovasc Dis, 200 1st St SW, Rochester, MN 55905 USA.	somers.virend@mayo.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065176, R01HL061560, R01HL073211] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDREOTTI F, 1988, AM J CARDIOL, V62, P635, DOI 10.1016/0002-9149(88)90669-8; BECKER H, 1995, AM J RESP CRIT CARE, V151, P215, DOI 10.1164/ajrccm.151.1.7812557; BEXTON RS, 1986, BRIT HEART J, V55, P253; CLARKE JM, 1976, LANCET, V2, P508, DOI 10.1016/S0140-6736(76)90801-1; Coady SA, 2001, J CLIN EPIDEMIOL, V54, P40, DOI 10.1016/S0895-4356(00)00272-9; Cohen MC, 1997, AM J CARDIOL, V79, P1512, DOI 10.1016/S0002-9149(97)00181-1; Fichter J, 2002, CHEST, V122, P558, DOI 10.1378/chest.122.2.558; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; FOLSOM AR, 1987, AM J EPIDEMIOL, V125, P1012, DOI 10.1093/oxfordjournals.aje.a114617; Fox CS, 2004, CIRCULATION, V110, P522, DOI 10.1161/01.CIR.0000136993.34344.41; Fries R, 1999, PACE, V22, P223, DOI 10.1111/j.1540-8159.1999.tb00337.x; GILLIS AM, 1991, SLEEP, V14, P346, DOI 10.1093/sleep/14.4.346; GONZALEZROTHI RJ, 1988, CHEST, V94, P531, DOI 10.1378/chest.94.3.531; Goraya TY, 2000, MAYO CLIN PROC, V75, P681; Goraya TY, 2003, AM J EPIDEMIOL, V157, P763, DOI 10.1093/aje/kwg057; Grimm W, 1996, AM J CARDIOL, V77, P1310, DOI 10.1016/S0002-9149(96)00197-X; GUILLEMINAULT C, 1983, AM J CARDIOL, V52, P490, DOI 10.1016/0002-9149(83)90013-9; Harbison J, 2000, CHEST, V118, P591, DOI 10.1378/chest.118.3.591; HUIKURI HV, 1994, CIRCULATION, V90, P121, DOI 10.1161/01.CIR.90.1.121; HUIKURI HV, 1995, PACE, V18, P1362, DOI 10.1111/j.1540-8159.1995.tb02597.x; Iribarren C, 1998, AM J CARDIOL, V82, P50, DOI 10.1016/S0002-9149(98)00240-9; Koehler U, 1998, EUR RESPIR J, V11, P434, DOI 10.1183/09031936.98.11020434; Legramante JM, 2003, J HYPERTENS, V21, P1555, DOI 10.1097/00004872-200308000-00021; MOSER DK, 1994, J AM COLL CARDIOL, V24, P963, DOI 10.1016/0735-1097(94)90856-7; MULLER JE, 1987, CIRCULATION, V75, P131, DOI 10.1161/01.CIR.75.1.131; Narkiewicz K, 1999, CIRCULATION, V99, P1183, DOI 10.1161/01.CIR.99.9.1183; Narkiewicz K, 1998, CIRCULATION, V98, P1071, DOI 10.1161/01.CIR.98.11.1071; Priori SG, 2002, EUR HEART J, V23, P257; Sanner BM, 2000, EUR RESPIR J, V16, P648, DOI 10.1034/j.1399-3003.2000.16d14.x; Schafer H, 1997, CHEST, V111, P387, DOI 10.1378/chest.111.2.387; SEPPALA T, 1991, J INTERN MED, V229, P23, DOI 10.1111/j.1365-2796.1991.tb00301.x; Shamsuzzaman ASM, 2003, JAMA-J AM MED ASSOC, V290, P1906, DOI 10.1001/jama.290.14.1906; SHEPARD JW, 1985, CHEST, V88, P335, DOI 10.1378/chest.88.3.335; SOMERS VK, 1995, J CLIN INVEST, V96, P1897, DOI 10.1172/JCI118235; SOMERS VK, 1993, NEW ENGL J MED, V328, P303, DOI 10.1056/NEJM199302043280502; TILKIAN AG, 1977, AM J MED, V63, P348, DOI 10.1016/0002-9343(77)90272-8; VIROLAINEN J, 1995, J APPL PHYSIOL, V79, P455, DOI 10.1152/jappl.1995.79.2.455; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Young T, 1997, SLEEP, V20, P705, DOI 10.1093/sleep/20.9.705; ZWILLICH C, 1982, J CLIN INVEST, V69, P1286, DOI 10.1172/JCI110568; [No title captured]	41	640	688	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2005	352	12					1206	1214		10.1056/NEJMoa041832	http://dx.doi.org/10.1056/NEJMoa041832			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	909AW	15788497				2022-12-24	WOS:000227832300007
J	Garcia, CM; Ramirez, E				Garcia, CM; Ramirez, E			Evidence that sensory traps can evolve into honest signals	NATURE			English	Article							SEXUAL SELECTION; FEMALE CHOICE; MATING PREFERENCES; MATE CHOICE; CAROTENOIDS; EVOLUTION; BIASES; MALES	Conventional models(1-4) explaining extreme sexual ornaments propose that these reflect male genetic quality(2-4) or are arbitrary results of genetic linkage between female preference and the ornament(1). The chase-away model(5) emphasizes sexual conflict: male signals attract females because they exploit receiver biases(6-9). As males gain control of mating decisions, females may experience fitness costs through suboptimal mating rates or post-copulatory exploitation. Elaboration of male signals is expected if females increase their response threshold to resist such exploitation. If ornaments target otherwise adaptive biases such as feeding responses(8-10), selection on females might eventually separate sexual and non-sexual responses to the signal. Here we show that the terminal yellow band (TYB) of several Goodeinae species evokes both feeding and sexual responses; sexual responsiveness phylogenetically pre-dates the expression of the TYB in males and is comparable across taxa, yet feeding responsiveness decreases in species with more elaborated TYBs. Displaying a TYB is costly, and thus provides an example where a trait arose as a sensory trap but has evolved into an honest signal.	Univ Nacl Autonoma Mexico, Dept Ecol Evolut, Inst Ecol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Garcia, CM (corresponding author), Univ Nacl Autonoma Mexico, Dept Ecol Evolut, Inst Ecol, AP 70-275, Mexico City 04510, DF, Mexico.	maciasg@servidor.unam.mx	Garcia, Constantino Macias/S-1948-2019; Garcia, Constantino Macías/A-9399-2010	Garcia, Constantino Macías/0000-0003-3242-4214; Ramirez-Carrillo, Elvia/0000-0001-8447-0971				ANDERSSON M, 1986, EVOLUTION, V40, P804, DOI 10.1111/j.1558-5646.1986.tb00540.x; Basolo AL, 2002, BEHAV ECOL, V13, P832, DOI 10.1093/beheco/13.6.832; Basolo AL, 1998, P ROY SOC B-BIOL SCI, V265, P2223, DOI 10.1098/rspb.1998.0563; Burton BG, 2003, J EXP BIOL, V206, P3963, DOI 10.1242/jeb.00600; Cordero C, 2003, J EVOLUTION BIOL, V16, P1, DOI 10.1046/j.1420-9101.2003.00506.x; Cordoba-Aguilar A, 2002, AM NAT, V160, P594, DOI 10.1086/342819; Dawkins MS, 1996, AM NAT, V148, P937, DOI 10.1086/285964; Endler JA, 1998, TRENDS ECOL EVOL, V13, P415, DOI 10.1016/S0169-5347(98)01471-2; FISHER RA, 1958, GENETICAL THEORY NAT, P146; Grether GF, 2002, SCIENCE, V296, P847; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; Holland B, 1999, P NATL ACAD SCI USA, V96, P5083, DOI 10.1073/pnas.96.9.5083; Jayasooriya AP, 2002, SCIENCE, V296, P847; KODRICBROWN A, 1989, BEHAV ECOL SOCIOBIOL, V25, P393, DOI 10.1007/BF00300185; Kokko H, 2002, P ROY SOC B-BIOL SCI, V269, P1331, DOI 10.1098/rspb.2002.2020; Kokko H, 2003, P ROY SOC B-BIOL SCI, V270, P653, DOI 10.1098/rspb.2002.2235; LeBas NR, 2003, P ROY SOC B-BIOL SCI, V270, P2159, DOI 10.1098/rspb.2003.2482; MILINSKI M, 1990, NATURE, V344, P330, DOI 10.1038/344330a0; Olson VA, 1998, TRENDS ECOL EVOL, V13, P510, DOI 10.1016/S0169-5347(98)01484-0; Partridge L, 1999, EVOLUTION OF BIOLOGICAL DIVERSITY, P130; Rodd FH, 2002, P ROY SOC B-BIOL SCI, V269, P475, DOI 10.1098/rspb.2001.1891; Ryan M.J., 1990, Oxford Surveys in Evolutionary Biology, V7, P157; RYAN MJ, 1987, SCIENCE, V236, P595, DOI 10.1126/science.236.4801.595; Webb SA, 2004, MOL PHYLOGENET EVOL, V30, P527, DOI 10.1016/S1055-7903(03)00257-4; [No title captured], DOI DOI 10.1086/285303)	26	111	114	0	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2005	434	7032					501	505		10.1038/nature03363	http://dx.doi.org/10.1038/nature03363			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909CH	15791255				2022-12-24	WOS:000227836000041
J	Riskin, DK; Hermanson, JW				Riskin, DK; Hermanson, JW			Biomechanics - Independent evolution of running in vampire bats	NATURE			English	Editorial Material							BODY SIZE; LOCOMOTION; MECHANICS; SPEED		Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA	Cornell University	Riskin, DK (corresponding author), Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA.	dkr8@cornell.edu		Riskin, Daniel K./0000-0001-8742-8509				ALTENBACH JS, 1979, SPEC PUBL ANN SOC MA, V6, P137; Gambaryan PP, 2002, ZH OBSHCH BIOL, V63, P426; Greenhall A. M., 1988, NATURAL HIST VAMPIRE; HEGLUND NC, 1988, J EXP BIOL, V138, P301; Hildebrand M., 1985, P38; Parchman AJ, 2003, J EXP BIOL, V206, P1379, DOI 10.1242/jeb.00267; RISKIN DK, IN PRESS J EXP BIOL; Schutt WA, 1997, J EXP BIOL, V200, P3003; TAYLOR CR, 1982, J EXP BIOL, V97, P1; VAUGHAN TERRY A., 1959, UNIV KANSAS PUBL MUS NAT HIST, V12, P1	11	32	32	5	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2005	434	7031					292	292		10.1038/434292a	http://dx.doi.org/10.1038/434292a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772640	Bronze			2022-12-24	WOS:000227715100029
J	Back, AL; Arnold, RM				Back, AL; Arnold, RM			Dealing with conflict in caring for the seriously ill - "It was just out of the question"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTENSIVE-CARE-UNIT; DOCTOR-NURSE GAME; INTERPERSONAL CONFLICTS; PROLONGED STAY; CRITICALLY-ILL; FOLLOW-UP; COMMUNICATION; LIFE; PHYSICIANS; END	Physicians often assume that conflict is undesirable and destructive, yet conflict handled Well can be productive, and the clarity that results can lead to clearer decision making and greater family, patient, and clinician satisfaction. We review the course of Mrs B, an 84-year-old woman with advanced dementia and an advance directive stating no artificial hydration or nutrition. Over the course of her illness, her family and physicians had conflicting opinions about the use of short-term tube feeding and intravenous hydration in her care. We describe the conflicts that arose between her physicians and family and a typology of conflicts common in care of patients who are seriously ill (family vs team, team member vs team member). Drawing from the business, psychology, and mediation literature, we describe useful communication tools and common pitfalls. We outline a step-wise approach that physicians can use to deal with conflicts and the use of treatment trials as a strategy to address conflicts about the use of life-sustaining medical interventions.	Univ Washington, Dept Med, Seattle, WA USA; Univ Pittsburgh, Dept Med, Pittsburgh, PA USA	University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Back, AL (corresponding author), Seattle Canc Care Alliance, 825 Eastlake Ave E,POB 19023, Seattle, WA 98109 USA.	tonyback@u.washington.edu			PHS HHS [R25 92055] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		*AM MED ASS, 2004, END PAT PHYS REL; Andrew L B, 1999, Physician Exec, V25, P38; Aschenbrener C A, 1999, Physician Exec, V25, P44; Aulisio MP, 2004, CRIT CARE CLIN, V20, P505, DOI 10.1016/j.ccc.2004.03.006; Azoulay E, 2000, CRIT CARE MED, V28, P3044, DOI 10.1097/00003246-200008000-00061; Bowman KW, 2000, J PALLIATIVE CARE, V16, pS17, DOI 10.1177/082585970001601S05; Breen CM, 2001, J GEN INTERN MED, V16, P283, DOI 10.1046/j.1525-1497.2001.00419.x; Brett AS, 2003, ARCH INTERN MED, V163, P1645, DOI 10.1001/archinte.163.14.1645; Burns JP, 2003, CRIT CARE MED, V31, P2107, DOI 10.1097/01.CCM.0000069732.65524.72; Charon R, 2001, JAMA-J AM MED ASSOC, V286, P1897, DOI 10.1001/jama.286.15.1897; Dowdy MD, 1998, CRIT CARE MED, V26, P252, DOI 10.1097/00003246-199802000-00020; DUBLER N, 2003, BIOETHICS MED GUIDE; Emanuel EJ, 1999, NEW ENGL J MED, V341, P956, DOI 10.1056/NEJM199909233411306; FARBER NJ, 1990, ACAD MED, V65, P713, DOI 10.1097/00001888-199011000-00019; Fetters MD, 2001, CRIT CARE MED, V29, P921, DOI 10.1097/00003246-200105000-00001; Finucane TE, 1999, JAMA-J AM MED ASSOC, V282, P1365, DOI 10.1001/jama.282.14.1365; Fisher R., 1991, GETTING YES NEGOTIAT; Frederich Michael E, 2002, J Palliat Med, V5, P155; GABBARD GO, 1985, JAMA-J AM MED ASSOC, V254, P2926, DOI 10.1001/jama.254.20.2926; Goleman D., 2002, PRIMAL LEADERSHIP RE; Goold SD, 2000, JAMA-J AM MED ASSOC, V283, P909, DOI 10.1001/jama.283.7.909; Green P, 2004, AM J DRUG ALCOHOL AB, V30, P489, DOI 10.1081/ADA-120037390; GROSS JJ, 1993, J PERS SOC PSYCHOL, V64, P970, DOI 10.1037/0022-3514.64.6.970; Jain A, 1999, BRIT MED J, V318, P1596, DOI 10.1136/bmj.318.7198.1596; Jameson JK, 2003, J HEALTH COMMUN, V8, P563, DOI 10.1080/716100415; Kalisch B J, 1977, J Nurs Adm, V7, P50, DOI 10.1097/00005110-197701000-00014; Kressel Kenneth, 2002, J Health Care Law Policy, V5, P364; Kristjanson LJ, 1997, J PALLIATIVE CARE, V13, P5; LEVENSON RW, 1994, J PERS SOC PSYCHOL, V67, P56, DOI 10.1037/0022-3514.67.1.56; Levine C, 1999, Trustee, V52, P24; Levine C, 2004, CLIN MED, V4, P244, DOI 10.7861/clinmedicine.4-3-244; Levinson W, 1999, JAMA-J AM MED ASSOC, V282, P1477, DOI 10.1001/jama.282.15.1477; Levinson W, 1997, JAMA-J AM MED ASSOC, V277, P553, DOI 10.1001/jama.277.7.553; Lilly CM, 2000, AM J MED, V109, P469, DOI 10.1016/S0002-9343(00)00524-6; Lilly CM, 2003, CRIT CARE MED, V31, pS394, DOI 10.1097/01.CCM.0000065279.77449.B4; McDonagh JR, 2004, CRIT CARE MED, V32, P1484, DOI 10.1097/01.CCM.0000127262.16690.65; Meier DE, 2001, JAMA-J AM MED ASSOC, V286, P3007, DOI 10.1001/jama.286.23.3007; Orr Robert D., 2001, American Journal of Bioethics, V1, P45, DOI 10.1162/152651601317139397; PORTER S, 1991, J ADV NURS, V16, P728, DOI 10.1111/j.1365-2648.1991.tb01731.x; Prendergast TJ, 2000, JAMA-J AM MED ASSOC, V283, P3200; PRESCOTT PA, 1985, ANN INTERN MED, V103, P127, DOI 10.7326/0003-4819-103-1-127; Rabeneck L, 1997, LANCET, V349, P496, DOI 10.1016/S0140-6736(96)07369-2; Rosenbaum JR, 2004, AM J MED, V116, P402, DOI 10.1016/j.amjmed.2003.09.044; Rosenstein AH, 2002, AM J NURS, V102, P26, DOI 10.1097/00000446-200206000-00040; Roter DL, 2004, ANNU REV PUBL HEALTH, V25, P497, DOI 10.1146/annurev.publhealth.25.101802.123134; Schneiderman LJ, 2003, JAMA-J AM MED ASSOC, V290, P1166, DOI 10.1001/jama.290.9.1166; Schnohr P, 2001, EUR HEART J SUPPL, V3, pH1; STEIN LI, 1967, ARCH GEN PSYCHIAT, V16, P699; STEIN LI, 1990, NEW ENGL J MED, V322, P546, DOI 10.1056/NEJM199002223220810; Stone D., 1999, DIFFICULT CONVERSATI; Studdert DM, 2003, INTENS CARE MED, V29, P1489, DOI 10.1007/s00134-003-1853-5; Studdert DM, 2003, PEDIATRICS, V112, P553, DOI 10.1542/peds.112.3.553; TANNEN D, 2000, YOU JUST DONT UNDERS; Taylor SR, 2004, BMJ-BRIT MED J, V329, P233, DOI 10.1136/bmj.329.7459.233; The AM, 2002, BRIT MED J, V325, P1326, DOI 10.1136/bmj.325.7376.1326; Thomas EJ, 2003, CRIT CARE MED, V31, P956, DOI 10.1097/01.CCM.0000056183.89175.76; TOMLINSON T, 1990, GERONTOLOGIST, V30, P54, DOI 10.1093/geront/30.1.54; Ury W., 1991, GETTING PAST NO NEGO; VAILLANT GE, 1972, NEW ENGL J MED, V287, P372, DOI 10.1056/NEJM197208242870802; Valdimarsdottir U, 2004, PALLIATIVE MED, V18, P432, DOI 10.1191/0269216304pm891oa; Weitzman PF, 2003, CLIN PSYCHOL REV, V23, P523, DOI 10.1016/S0272-7358(02)00209-X; Weitzman PF, 2001, INT J AGING HUM DEV, V52, P281, DOI 10.2190/H3LH-59KQ-8WJP-ULM5	62	84	86	1	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2005	293	11					1374	1381		10.1001/jama.293.11.1374	http://dx.doi.org/10.1001/jama.293.11.1374			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	907EP	15769971				2022-12-24	WOS:000227698600026
J	Lemoine, FJ; Degtyareva, NP; Lobachev, K; Petes, TD				Lemoine, FJ; Degtyareva, NP; Lobachev, K; Petes, TD			Chromosomal translocations in yeast induced by low levels of DNA polymerase: A model for chromosome fragile sites	CELL			English	Article							DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; GENOMIC INSTABILITY; GENETIC INSTABILITY; REARRANGEMENTS; RECOMBINATION; COMMON; REPLICATION; REPAIR; PALINDROMES	In the yeast Saccharomyces cerevisiae, reduced levels of the replicative a DNA polymerase result in greatly elevated frequencies of chromosome translocations and chromosome loss. We selected translocations in a small region of chromosome III and found that they involve homologous recombination events between yeast retrotransposons (Ty elements) on chromosome III and retrotransposons located on other chromosomes. One of the two preferred sites of these translocations on chromosome III involve two Ty elements arrayed head-to-head; disruption of this site substantially reduces the rate of translocations. We demonstrate that this pair of T elements constitutes a preferred site for double-strand DNA breaks when DNA replication is compromised, analogous to the fragile sites observed in mammalian chromosomes.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; Georgia Inst Technol, Sch Biol, Inst Bioengn & Biosci, Atlanta, GA 30322 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University System of Georgia; Georgia Institute of Technology	Petes, TD (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	tompetes@duke.edu	Degtyareva, Natalya/AAI-5500-2021	Degtyareva, Natalya/0000-0002-7141-6308	NCI NIH HHS [CA09156] Funding Source: Medline; NIGMS NIH HHS [GM52319] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; Arlt MF, 2003, CYTOGENET GENOME RES, V100, P92, DOI 10.1159/000072843; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Fischer G, 2000, NATURE, V405, P451, DOI 10.1038/35013058; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; GLOVER TW, 1988, AM J HUM GENET, V43, P265; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; GORDENIN DA, 1993, MOL CELL BIOL, V13, P5315, DOI 10.1128/MCB.13.9.5315; GORDENIN DA, 1991, YEAST, V7, P37, DOI 10.1002/yea.320070105; Gotter AL, 2004, HUM MOL GENET, V13, P103, DOI 10.1093/hmg/ddh004; Guthrie C, 1991, GUIDE YEAST GENETICS; HAWTHORNE DC, 1963, GENETICS, V48, P1721; Kim JM, 1998, GENOME RES, V8, P464, DOI 10.1101/gr.8.5.464; Kokoska RJ, 2000, MOL CELL BIOL, V20, P7490, DOI 10.1128/MCB.20.20.7490-7504.2000; Kurahashi H, 2001, HUM MOL GENET, V10, P2605, DOI 10.1093/hmg/10.23.2605; Le Beau MM, 1998, HUM MOL GENET, V7, P755, DOI 10.1093/hmg/7.4.755; LEACH DRF, 1994, BIOESSAYS, V16, P893, DOI 10.1002/bies.950161207; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lobachev KS, 1998, GENETICS, V148, P1507; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; Malkova A, 2001, GENE DEV, V15, P1055, DOI 10.1101/gad.875901; MCCUSKER JH, 1981, GENETICS, V99, P383; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; ROEDER GS, 1980, CELL, V21, P239, DOI 10.1016/0092-8674(80)90131-2; RUSKIN B, 1993, GENETICS, V134, P43; STRATHERN J, 1981, J MOL BIOL, V147, P357, DOI 10.1016/0022-2836(81)90488-5; Umezu K, 2002, GENETICS, V160, P97; Wang L, 1997, GENOMICS, V41, P485, DOI 10.1006/geno.1997.4690; WICKSTEED BL, 1994, YEAST, V10, P39, DOI 10.1002/yea.320100105; Zlotorynski E, 2003, MOL CELL BIOL, V23, P7143, DOI 10.1128/MCB.23.20.7143-7151.2003	33	247	251	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 11	2005	120	5					587	598		10.1016/j.cell.2004.12.039	http://dx.doi.org/10.1016/j.cell.2004.12.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766523	Bronze			2022-12-24	WOS:000227771400006
J	Onodera, Y; Haag, JR; Ream, T; Nunes, PC; Pontes, O; Pikaard, CS				Onodera, Y; Haag, JR; Ream, T; Nunes, PC; Pontes, O; Pikaard, CS			Plant nuclear RNA polymerase IV mediates siRNA and DNA methylation-dependent heterochromatin formation	CELL			English	Article							ARABIDOPSIS-THALIANA; TRANSCRIPTION; METHYLTRANSFERASES; PURIFICATION; CHROMOSOMES; ARGONAUTE4; HOLOENZYME; RESOLUTION; GENES; DRM	All eukaryotes have three nuclear DNA-dependent RNA polymerases, namely, Pol I, II, and III. Interestingly, plants have catalytic subunits for a fourth nuclear polymerase, Pol IV. Genetic and biochemical evidence indicates that Pol IV does not functionally overlap with Pol I, II, or III and is nonessential for viability. However, disruption of the Pol IV catalytic subunit genes NRPD1 or NRPD2 inhibits heterochromatin association into chromocenters, coincident with losses in cytosine methylation at pericentromeric 5S gene clusters and AtSN1 retroelements. Loss of CG, CNG, and CNN methylation in Pol IV mutants implicates a partnership between Pol IV and the methyltransferase responsible for RNA-directed de novo methylation. Consistent with this hypothesis, 5S gene and AtSN1 siRNAs are essentially eliminated in Pol IV mutants. The data suggest that Pol IV helps produce siRNAs that target de novo cytosine methylation events required for facultative heterochromatin formation and higher-order heterochromatin associations.	Washington Univ, Dept Biol, St Louis, MO 63130 USA; Hokkaido Univ, Fac Agr, Grad Sch Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan; Inst Super Agron, Ctr Bot & Engn Biol, Seccao Genet, P-1349017 Lisbon, Portugal	Washington University (WUSTL); Hokkaido University; Universidade de Lisboa	Pikaard, CS (corresponding author), Washington Univ, Dept Biol, 1 Brookings Dr, St Louis, MO 63130 USA.	pikaard@biology.wustl.edu	Pontes, Olga MF/F-9768-2011; Pikaard, Craig S/K-8772-2012	Pontes, Olga MF/0000-0003-3316-1145; Pikaard, Craig S/0000-0001-8204-7459	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060380] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM60380] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARCHAMBAULT J, 1993, MICROBIOL REV, V57, P703, DOI 10.1128/MMBR.57.3.703-724.1993; Aufsatz W, 2002, P NATL ACAD SCI USA, V99, P16499, DOI 10.1073/pnas.162371499; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bender J, 2004, CURR OPIN PLANT BIOL, V7, P521, DOI 10.1016/j.pbi.2004.07.003; CAMPELL BR, 1992, GENE, V112, P225, DOI 10.1016/0378-1119(92)90380-8; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Chen ZJ, 1998, P NATL ACAD SCI USA, V95, P14891, DOI 10.1073/pnas.95.25.14891; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Fransz P, 2002, P NATL ACAD SCI USA, V99, P14584, DOI 10.1073/pnas.212325299; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; HERR A, 2005, IN PRESS SCIENC 0203, DOI DOI 10.1126/SCIENCE.1106910; Houben A, 1996, CHROMOSOME RES, V4, P191, DOI 10.1007/BF02254958; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Larkin RM, 1999, GENE, V231, P41, DOI 10.1016/S0378-1119(99)00090-6; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; MCCLELLAND M, 1994, NUCLEIC ACIDS RES, V22, P3640, DOI 10.1093/nar/22.17.3640; Pontes O, 2004, P NATL ACAD SCI USA, V101, P18240, DOI 10.1073/pnas.0407258102; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Rountree MR, 1997, GENE DEV, V11, P2383, DOI 10.1101/gad.11.18.2383; Saez-Vasquez J, 2000, J BIOL CHEM, V275, P37173, DOI 10.1074/jbc.M006057200; SaezVasquez J, 1997, P NATL ACAD SCI USA, V94, P11869, DOI 10.1073/pnas.94.22.11869; Sambrook J, 2001, MOL CLONING LAB MANU, V3rd; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; SCHWARTZ LB, 1974, J BIOL CHEM, V249, P5898; Schwarzacher HG, 2000, CYTOGENET CELL GENET, V91, P243, DOI 10.1159/000056853; Soppe WJJ, 2002, EMBO J, V21, P6549, DOI 10.1093/emboj/cdf657; Wassenegger M, 2000, PLANT MOL BIOL, V43, P203, DOI 10.1023/A:1006479327881; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055	36	485	510	6	58	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 11	2005	120	5					613	622		10.1016/j.cell.2005.02.007	http://dx.doi.org/10.1016/j.cell.2005.02.007			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766525	Bronze			2022-12-24	WOS:000227771400008
J	Cerdeno-Tarraga, AM; Patrick, S; Crossman, LC; Blakely, G; Abratt, V; Lennard, N; Poxton, I; Duerden, B; Harris, B; Quail, MA; Barron, A; Clark, L; Corton, C; Doggett, J; Holden, MTG; Larke, N; Line, A; Lord, A; Norbertczak, H; Ormond, D; Price, C; Rabbinowitsch, E; Woodward, J; Barrell, B; Parkhill, J				Cerdeno-Tarraga, AM; Patrick, S; Crossman, LC; Blakely, G; Abratt, V; Lennard, N; Poxton, I; Duerden, B; Harris, B; Quail, MA; Barron, A; Clark, L; Corton, C; Doggett, J; Holden, MTG; Larke, N; Line, A; Lord, A; Norbertczak, H; Ormond, D; Price, C; Rabbinowitsch, E; Woodward, J; Barrell, B; Parkhill, J			Extensive DNA inversions in the B. fragilis genome control variable gene expression	SCIENCE			English	Article							BACTEROIDES-FRAGILIS; ANTIGENIC VARIATION; POLYSACCHARIDES; SALMONELLA	The obligately anaerobic bacterium Bacteroides fragilis, an opportunistic pathogen and inhabitant,of the normal human colonic microbiota, exhibits considerable within-strain phase and antigenic variation of surface components. The complete genome sequence has revealed an unusual breadth (in number and in effect) of DNA inversion events that potentially control expression of man different components, including surface and secreted components, regulatory molecules, and restriction-modification proteins. Invertible promoters of two different types (12 group 1 and 11 group 2) were identified. One group has inversion crossover (fix) sites similar to the hix sites of Salmonella typhimurium. There are also four independent intergenic shufflons that potentially alter the expression and function of varied genes. The composition of the 10 different polysaccharide biosynthesis gene clusters identified (7 with associated invertible promoters) suggests a mechanism of synthesis similar to the O-antigen capsules of Escherichia coli.	Queens Univ Belfast, Sch Med, Dept Microbiol & Immunobiol, Belfast BT12 6BN, Antrim, North Ireland; Sanger Inst, Cambridge CB10 1SA, England; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland; Univ Cape Town, Dept Mol & Cell Biol, ZA-7701 Rondebosch, South Africa; Univ Edinburgh, Sch Med, Div Med Microbiol, Edinburgh EH8 9AG, Midlothian, Scotland; Univ Wales Coll Med, Dept Med Microbiol, Cardiff CF14 4XN, S Glam, Wales	Queens University Belfast; Wellcome Trust Sanger Institute; University of Edinburgh; University of Cape Town; University of Edinburgh; Cardiff University	Patrick, S (corresponding author), Queens Univ Belfast, Sch Med, Dept Microbiol & Immunobiol, Grosvenor Rd, Belfast BT12 6BN, Antrim, North Ireland.	s.patrick@qub.ac.uk; parkhill@sanger.ac.uk	Quail, michael/ABE-6131-2020; Holden, Matthew TG/K-6449-2014; Parkhill, Julian/G-4703-2011	Holden, Matthew TG/0000-0002-4958-2166; Parkhill, Julian/0000-0002-7069-5958; Cerdeno-Tarraga, Ana M./0000-0001-6635-3237; Crossman, Lisa/0000-0003-2390-4750				Chambaud I, 2001, NUCLEIC ACIDS RES, V29, P2145, DOI 10.1093/nar/29.10.2145; Coyne MJ, 2003, P NATL ACAD SCI USA, V100, P10446, DOI 10.1073/pnas.1832655100; Erridge C, 2004, J MED MICROBIOL, V53, P735, DOI 10.1099/jmm.0.45598-0; Gyohda A, 2004, ADV BIOPHYS, V38, P183, DOI 10.1016/S0065-227X(04)80166-7; Horino A, 2003, J BACTERIOL, V185, P231, DOI 10.1128/JB.185.1.231-242.2003; Krinos CM, 2001, NATURE, V414, P555, DOI 10.1038/35107092; Kuwahara T, 2004, P NATL ACAD SCI USA, V101, P14919, DOI 10.1073/pnas.0404172101; LINDBERG AA, 1990, REV INFECT DIS, V12, P133; LUTTON DA, 1991, J MED MICROBIOL, V35, P229, DOI 10.1099/00222615-35-4-229; Patrick S., 2002, Molecular medical microbiology: Volumes 1-3, P1921; Patrick S, 1999, INFECT IMMUN, V67, P4346, DOI 10.1128/IAI.67.9.4346-4351.1999; PATRICK S, 1986, J GEN MICROBIOL, V132, P1099; Patrick S, 2003, MICROBIOL-SGM, V149, P915, DOI 10.1099/mic.0.26166-0; POXTON IR, 1986, J GEN MICROBIOL, V132, P2475; SILVERMAN M, 1979, P NATL ACAD SCI USA, V76, P391, DOI 10.1073/pnas.76.1.391; TZIANABOS AO, 1993, SCIENCE, V262, P416, DOI 10.1126/science.8211161; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029	18	205	530	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1463	1465		10.1126/science.1107008	http://dx.doi.org/10.1126/science.1107008			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746427	Green Submitted			2022-12-24	WOS:000227503100046
J	Gombosi, TI; Hansen, KC				Gombosi, TI; Hansen, KC			Viewpoint - Saturn's variabie magnetosphere	SCIENCE			English	Editorial Material								Since the Cassini spacecraft reached Saturn's orbit in 2004, its instruments have been sending back a wealth of data on the planet's magnetosphere (the region dominated by the magnetic field of the planet). In this Viewpoint, we discuss some of these results, which are reported in a collection of reports in this issue. The magnetosphere is shown to be highly variable and influenced by the planet's rotation, sources of plasma within the planetary system, and the solar wind. New insights are also gained into the chemical composition of the magnetosphere, with surprising results. These early results from Cassini's first orbit around Saturn bode well for the future as the spacecraft continues to orbit the planet.	Univ Michigan, Dept Atmospher Ocean & Space Sci, Ctr Space Environm Modeling, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Gombosi, TI (corresponding author), Univ Michigan, Dept Atmospher Ocean & Space Sci, Ctr Space Environm Modeling, Ann Arbor, MI 48109 USA.	tamas@umich.edu; kenhan@umich.edu	Hansen, Kenneth C/F-3693-2011; Gombosi, Tamas I/G-4238-2011	Hansen, Kenneth C/0000-0002-8502-1980; Gombosi, Tamas I/0000-0001-9360-4951				Blanc M, 2002, SPACE SCI REV, V104, P253, DOI 10.1023/A:1023605110711; Dougherty MK, 2005, SCIENCE, V307, P1266, DOI 10.1126/science.1106098; Esposito LW, 2005, SCIENCE, V307, P1251, DOI 10.1126/science.1105606; Gurnett DA, 2005, SCIENCE, V307, P1255, DOI 10.1126/science.1105356; JURAC S, IN PRESS J GEOPHYS R; Krimigis SM, 2005, SCIENCE, V307, P1270, DOI 10.1126/science.1105978; Powell KG, 1999, J COMPUT PHYS, V154, P284, DOI 10.1006/jcph.1999.6299; Sanchez-Lavega A, 2005, SCIENCE, V307, P1223, DOI 10.1126/science.1104956; Waite JH, 2005, SCIENCE, V307, P1260, DOI 10.1126/science.1105734; Young DT, 2005, SCIENCE, V307, P1262, DOI 10.1126/science.1106151	10	10	10	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1224	1226		10.1126/science.1108226	http://dx.doi.org/10.1126/science.1108226			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731438				2022-12-24	WOS:000227313200037
J	Evans, JMM; Donnelly, LA; Emslie-Smith, AM; Alessi, DR; Morris, AD				Evans, JMM; Donnelly, LA; Emslie-Smith, AM; Alessi, DR; Morris, AD			Metformin and reduced risk of cancer in diabetic patients	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RECORD LINKAGE		Univ Dundee, Div Community Hlth Sci, Sect Publ Hlth, Dundee DD2 4BF, Scotland; Univ Dundee, Sch Life Sci, Dundee, Scotland; Univ Dundee, Div Med, Dundee, Scotland	University of Dundee; University of Dundee; University of Dundee	Evans, JMM (corresponding author), Univ Dundee, Div Community Hlth Sci, Sect Publ Hlth, Dundee DD2 4BF, Scotland.	j.m.mstansfield@dundee.ac.uk	Morris, Andrew D/C-2837-2009	Alessi, Dario/0000-0002-2140-9185	MRC [MC_U127070193] Funding Source: UKRI; Medical Research Council [MC_U127070193] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		EVANS JMM, 1995, BMJ-BRIT MED J, V311, P22, DOI 10.1136/bmj.311.6996.22; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Merom D, 2004, J SCI MED SPORT, V7, P32, DOI 10.1016/S1440-2440(04)80041-0; Morris AD, 1997, BMJ-BRIT MED J, V315, P524, DOI 10.1136/bmj.315.7107.524	5	1704	1817	4	169	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 4	2005	330	7503					1304	1305		10.1136/bmj.38415.708634.F7	http://dx.doi.org/10.1136/bmj.38415.708634.F7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933TL	15849206	Bronze, Green Published, Green Submitted			2022-12-24	WOS:000229655700023
J	Latvala, J; von Hertzen, L; Lindholm, H; Haahtela, T				Latvala, J; von Hertzen, L; Lindholm, H; Haahtela, T			Trends in prevalence of asthma and allergy in Finnish young men: nationwide study, 1966-2003	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RHINITIS		Finnish Inst Occupat Hlth, Res Inst Mil Med, Oulu 90220, Finland; Univ Helsinki, Cent Hosp, Skin & Allergy Hosp, Helsinki 00029, Finland; Finnish Inst Occupat Hlth, Helsinki 00250, Finland	Finnish Institute of Occupational Health; University of Helsinki; Helsinki University Central Hospital; Finnish Institute of Occupational Health	Latvala, J (corresponding author), Finnish Inst Occupat Hlth, Res Inst Mil Med, Aapistie 1, Oulu 90220, Finland.	jari.latvala@ttl.fi						Braback L, 2004, CLIN EXP ALLERGY, V34, P38, DOI 10.1111/j.1365-2222.2004.01841.x; Braun-Fahrlander C, 2004, EUR RESPIR J, V23, P407, DOI 10.1183/09031936.04.00074004; HAAHTELA T, 1990, BRIT MED J, V301, P266, DOI 10.1136/bmj.301.6746.266; Haahtela T, 2001, THORAX, V56, P806, DOI 10.1136/thorax.56.10.806; Verlato G, 2003, J ALLERGY CLIN IMMUN, V111, P1232, DOI 10.1067/mai.2003.1484	5	82	86	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2005	330	7501					1186	1187		10.1136/bmj.38448.603924.AE	http://dx.doi.org/10.1136/bmj.38448.603924.AE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	929CU	15849204	Green Published, Bronze			2022-12-24	WOS:000229320500019
J	Hollinghurst, S; Kessler, D; Peters, TJ; Gunnell, D				Hollinghurst, S; Kessler, D; Peters, TJ; Gunnell, D			Opportunity cost of antidepressant prescribing in England: analysis of routine data	BRITISH MEDICAL JOURNAL			English	Article									Univ Bristol, Dept Community Based Med, Acad Unit Primary Hlth Care, Bristol BS6 6JL, Avon, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	University of Bristol; University of Bristol	Hollinghurst, S (corresponding author), Univ Bristol, Dept Community Based Med, Acad Unit Primary Hlth Care, Bristol BS6 6JL, Avon, England.	s.p.hollinghurst@bristol.ac.uk	Kessler, david/ABB-6489-2021; Gunnell, David/ABE-6653-2020	Gunnell, David/0000-0002-0829-6470; Peters, Tim/0000-0003-2881-4180				[Anonymous], 2004, MAN DEPR PRIM SEC CA; Curtis, 2003, UNIT COSTS HLTH SOCI; Gunnell D, 2004, BRIT MED J, V329, P34, DOI 10.1136/bmj.329.7456.34; Lawrenson RA, 2000, J AFFECT DISORDERS, V59, P149, DOI 10.1016/S0165-0327(99)00147-0; *OFF NAT STAT, 2001, PSYCH MORT AD LIV PR	5	27	27	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 30	2005	330	7498					999	1000		10.1136/bmj.38377.715799.F7	http://dx.doi.org/10.1136/bmj.38377.715799.F7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	923UP	15778232	Bronze, Green Published, Green Submitted			2022-12-24	WOS:000228935100020
J	Kiernan, AE; Pelling, AL; Leung, KKH; Tang, ASP; Bell, DM; Tease, C; Lovell-Badge, R; Steel, KP; Cheah, KSE				Kiernan, AE; Pelling, AL; Leung, KKH; Tang, ASP; Bell, DM; Tease, C; Lovell-Badge, R; Steel, KP; Cheah, KSE			Sox2 is required for sensory organ development in the mammalian inner ear	NATURE			English	Article							HAIR-CELLS; STEM-CELLS; EXPRESSION; DROSOPHILA; MATH1; GENERATION; CHICKEN; GENES; DIFFERENTIATION; EPITHELIUM	Sensory hair cells and their associated non-sensory supporting cells in the inner ear are fundamental for hearing and balance. They arise from a common progenitor(1), but little is known about the molecular events specifying this cell lineage. We recently identified two allelic mouse mutants, light coat and circling (Lcc) and yellow submarine (Ysb), that show hearing and balance impairment(2). Lcc/Lcc mice are completely deaf, whereas Ysb/Ysb mice are severely hearing impaired(2). We report here that inner ears of Lcc/Lcc mice fail to establish a prosensory domain and neither hair cells nor supporting cells differentiate, resulting in a severe inner ear malformation, whereas the sensory epithelium of Ysb/Ysb mice shows abnormal development with disorganized and fewer hair cells. These phenotypes are due to the absence (in Lcc mutants) or reduced expression (in Ysb mutants) of the transcription factor SOX2, specifically within the developing inner ear. SOX2 continues to be expressed in the inner ears of mice lacking Math1 (also known as Atoh1 and HATH1), a gene essential for hair cell differentiation, whereas Math1 expression is absent in Lcc mutants, suggesting that Sox2 acts upstream of Math1.	Univ Hong Kong, Dept Biochem, Pokfulam, Hong Kong, Peoples R China; Univ Nottingham, MRC, Inst Hearing Res, Nottingham NG7 2RD, England; Natl Inst Med Res, MRC, Div Dev Genet, London NW7 1AA, England; MRC, Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England	University of Hong Kong; University of Nottingham; MRC National Institute for Medical Research; MRC Harwell	Cheah, KSE (corresponding author), Univ Hong Kong, Dept Biochem, Fac Med Bldg,21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	hrmbdkc@hkusua.hku.hk	Cheah, Kathryn/C-4222-2009; Leung, Keith/C-4491-2009	Bell, Donald/0000-0002-3788-1580; Lovell-Badge, Robin/0000-0001-9364-4179	MRC [MC_U117562207] Funding Source: UKRI; Medical Research Council [MC_U117562207] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Buescher M, 2002, DEVELOPMENT, V129, P4193; Cai JL, 2002, DEV BIOL, V251, P221, DOI 10.1006/dbio.2002.0828; Chang W, 2004, DEVELOPMENT, V131, P4201, DOI 10.1242/dev.01292; CHEAH KSE, 1995, J CELL BIOL, V128, P223, DOI 10.1083/jcb.128.1.223; Chen P, 2002, DEVELOPMENT, V129, P2495; Chen P, 1999, DEVELOPMENT, V126, P1581; Cole LK, 2000, J COMP NEUROL, V424, P509, DOI 10.1002/1096-9861(20000828)424:3<509::AID-CNE8>3.0.CO;2-Q; Dong S, 2002, GENOMICS, V79, P777, DOI 10.1006/geno.2002.6783; Eddison M, 2000, P NATL ACAD SCI USA, V97, P11692, DOI 10.1073/pnas.97.22.11692; Fekete DM, 1998, J NEUROSCI, V18, P7811; Jan Yuh Nung, 1994, Current Opinion in Neurobiology, V4, P8, DOI 10.1016/0959-4388(94)90025-6; Kiernan AE, 2001, P NATL ACAD SCI USA, V98, P3873, DOI 10.1073/pnas.071496998; Kishi M, 2000, DEVELOPMENT, V127, P791; KNOWLTON VY, 1967, J MORPHOL, V121, P179, DOI 10.1002/jmor.1051210302; Li HW, 2003, P NATL ACAD SCI USA, V100, P13495, DOI 10.1073/pnas.2334503100; Li HW, 2003, NAT MED, V9, P1293, DOI 10.1038/nm925; LYON MF, 1979, MUTAT RES, V63, P161, DOI 10.1016/0027-5107(79)90113-1; Morsli H, 1998, J NEUROSCI, V18, P3327; Overton PM, 2002, DEVELOPMENT, V129, P4219; Pauley S, 2003, DEV DYNAM, V227, P203, DOI 10.1002/dvdy.10297; Pirvola U, 2002, NEURON, V35, P671, DOI 10.1016/S0896-6273(02)00824-3; Tsai H, 2001, HUM MOL GENET, V10, P507, DOI 10.1093/hmg/10.5.507; Uchikawa M, 1999, MECH DEVELOP, V84, P103, DOI 10.1016/S0925-4773(99)00083-0; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; Woods C, 2004, NAT NEUROSCI, V7, P1310, DOI 10.1038/nn1349; Zappone MV, 2000, DEVELOPMENT, V127, P2367; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753	30	396	415	4	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					1031	1035		10.1038/nature03487	http://dx.doi.org/10.1038/nature03487			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846349				2022-12-24	WOS:000228524600041
J	Lin, XR; Hull, CM; Heitman, J				Lin, XR; Hull, CM; Heitman, J			Sexual reproduction between partners of the same mating type in Cryptococcus neoformans	NATURE			English	Article							PNEUMOCYSTIS-CARINII; FILOBASIDIELLA-NEOFORMANS; SACCHAROMYCES-CEREVISIAE; ALPHA; YEAST; GENE; ASSOCIATION; TOXOPLASMA; ACTIVATION; EVOLUTION	Cryptococcus neoformans is a globally distributed human fungal pathogen that causes life-threatening meningoencephalitis in immunocompromised patients(1). It has a defined sexual cycle involving haploid cells of a and a mating types(2), yet the vast majority of environmental and clinical isolates are a (ref. 3). Sexual recombination is normally expected to occur between isolates of opposite mating type in organisms with two mating types (or sexes). How sexual reproductive potential can be maintained in an organism with a largely unisexual, nearly clonal population genetic structure is unknown. One clue, however, is that a strains undergo fruiting, a process that resembles sexual mating(4) but is thought to be strictly mitotic and asexual. We report here that hallmarks of mating occur during fruiting, including diploidization and meiosis. Pheromone response pathway elements and the key meiotic regulator Dmc1 are required for efficient fruiting. Furthermore, fusion and meiosis can occur between non-isogenic a strains, enabling genetic exchange. These studies reveal how sexual reproduction can occur between partners of the same mating type. These findings have implications for the evolution of microbial pathogens, as well as for parthenogenesis, cell fusion events and transitions between self-fertilizing and outcrossing modes of reproduction observed in both fungi and other kingdoms.	Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Duke University	Lin, XR (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	xrlin@duke.edu; heitm001@duke.edu	Lin, Xiaorong/ABC-4163-2021; Heitman, Joseph/ABC-6006-2021	Lin, Xiaorong/0000-0002-3390-8387; 				Anderson JB, 2004, GENETICS, V168, P1915, DOI 10.1534/genetics.104.033266; Casadevall A., 1998, CRYPTOCOCCUS NEOFORM, DOI [10.1128/9781555818241, DOI 10.1128/9781555818241]; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; Grigg ME, 2001, SCIENCE, V294, P161, DOI 10.1126/science.1061888; Hull CM, 2002, GENE DEV, V16, P3046, DOI 10.1101/gad.1041402; Hull CM, 2002, ANNU REV GENET, V36, P557, DOI 10.1146/annurev.genet.36.052402.152652; Johnson A, 2003, NAT REV MICROBIOL, V1, P106, DOI 10.1038/nrmicro752; KWONCHUNG KJ, 1978, AM J EPIDEMIOL, V108, P337, DOI 10.1093/oxfordjournals.aje.a112628; KWONCHUNG KJ, 1976, MYCOLOGIA, V68, P821, DOI 10.2307/3758800; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P602, DOI 10.1128/IAI.60.2.602-605.1992; Marra RE, 2004, GENETICS, V167, P619, DOI 10.1534/genetics.103.023408; MATSUMOTO Y, 1984, J PROTOZOOL, V31, P420, DOI 10.1111/j.1550-7408.1984.tb02989.x; McClelland CM, 2004, TRENDS MICROBIOL, V12, P208, DOI 10.1016/j.tim.2004.03.003; MITCHELL AP, 1986, NATURE, V319, P738, DOI 10.1038/319738a0; ROSE MD, 1986, MOL CELL BIOL, V6, P3490, DOI 10.1128/MCB.6.10.3490; Sauvageau S, 2004, BIOESSAYS, V26, P1151, DOI 10.1002/bies.20150; Shen WC, 2002, EUKARYOT CELL, V1, P366, DOI 10.1128/EC.1.3.366-377.2002; Shimizu KK, 2004, SCIENCE, V306, P2081, DOI 10.1126/science.1103776; Sia RA, 2000, FUNGAL GENET BIOL, V29, P153, DOI 10.1006/fgbi.2000.1192; Smulian AG, 2001, GENETICS, V157, P991; Su C, 2003, SCIENCE, V299, P414, DOI 10.1126/science.1078035; Thomas CF, 2004, NEW ENGL J MED, V350, P2487, DOI 10.1056/NEJMra032588; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Wang P, 2000, MOL CELL BIOL, V20, P352, DOI 10.1128/MCB.20.1.352-362.2000; Wickes BL, 1996, P NATL ACAD SCI USA, V93, P7327, DOI 10.1073/pnas.93.14.7327; Wyder MA, 1998, J EUKARYOT MICROBIOL, V45, P233, DOI 10.1111/j.1550-7408.1998.tb04531.x; Zeyl C, 2004, FEMS MICROBIOL LETT, V233, P187, DOI 10.1016/j.femsle.2004.02.007; Zeyl C, 2003, SCIENCE, V299, P555, DOI 10.1126/science.1078417	30	293	307	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					1017	1021		10.1038/nature03448	http://dx.doi.org/10.1038/nature03448			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846346				2022-12-24	WOS:000228524600038
J	Thompson, WG; Goldstein, SL				Thompson, WG; Goldstein, SL			Open-system coral ages reveal persistent suborbital sea-level cycles	SCIENCE			English	Article							LAST INTERGLACIAL PERIOD; HUON PENINSULA; NORTH-ATLANTIC; REEF TERRACES; CLIMATE; TEMPERATURE; STALAGMITE; FLUCTUATIONS; OSCILLATIONS; CHRONOLOGY	Sea level is a sensitive index of global climate that has been linked to Earth's orbital variations, with a minimum periodicity of about 21,000 years. Although there is ample evidence for climate oscillations that are too frequent to be explained by orbital forcing, suborbital-frequency sea-level change has been difficult to resolve, primarily because of problems with uranium/thorium coral dating. Here we use a new approach that corrects coral ages for the frequently observed open-system behavior of uranium-series nuclides, substantially improving the resolution of sea-level reconstruction. This curve reveals persistent sea-level oscillations that are too frequent to be explained exclusively by orbital forcing.	Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; Columbia Univ, Dept Earth & Environm Sci, Palisades, NY 10964 USA	Columbia University; Columbia University	Thompson, WG (corresponding author), Woods Hole Oceanog Inst, Dept Geol & Geophys, Clark Lab 118, Mail Stop 23, Woods Hole, MA 02543 USA.	wthompson@whoi.edu	Thompson, William/H-2407-2011					Abegg C, 2002, BIOL J LINN SOC, V75, P555, DOI 10.1046/j.1095-8312.2002.00045.x; [Anonymous], [No title captured]; Bard E, 2002, EARTH PLANET SC LETT, V196, P135, DOI 10.1016/S0012-821X(01)00600-8; BROECKER WS, 1963, J GEOPHYS RES, V68, P2817, DOI 10.1029/JZ068i009p02817; Chappell J, 2002, QUATERNARY SCI REV, V21, P1229, DOI 10.1016/S0277-3791(01)00141-X; CHEN JH, 1991, GEOL SOC AM BULL, V103, P82, DOI 10.1130/0016-7606(1991)103<0082:PCOTLI>2.3.CO;2; Cutler KB, 2003, EARTH PLANET SC LETT, V206, P253, DOI 10.1016/S0012-821X(02)01107-X; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Esat TM, 1999, SCIENCE, V283, P197, DOI 10.1126/science.283.5399.197; Fruijtier C, 2000, GEOL SOC AM BULL, V112, P267, DOI 10.1130/0016-7606(2000)112<0267:MSUTAF>2.3.CO;2; GALLUP CD, 1994, SCIENCE, V263, P796, DOI 10.1126/science.263.5148.796; Gallup CD, 2002, SCIENCE, V295, P310, DOI 10.1126/science.1065494; Genty D, 2003, NATURE, V421, P833, DOI 10.1038/nature01391; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Henderson GM, 2000, NATURE, V404, P61, DOI 10.1038/35003541; Holgate SJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019626; Lea DW, 2002, QUATERNARY SCI REV, V21, P283, DOI 10.1016/S0277-3791(01)00081-6; LI WX, 1989, NATURE, V339, P534, DOI 10.1038/339534a0; LUNDBERG J, 1994, QUATERNARY SCI REV, V13, P1, DOI 10.1016/0277-3791(94)90121-X; MARTINSON DG, 1987, QUATERNARY RES, V27, P1, DOI 10.1016/0033-5894(87)90046-9; MESOLELL.KJ, 1969, J GEOL, V77, P250, DOI 10.1086/627434; Oppo DW, 2001, PALEOCEANOGRAPHY, V16, P280, DOI 10.1029/2000PA000527; Oppo DW, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2001GC000260; PLANGES V, 2002, EARTH PLANET SC LETT, V201, P87; Potter EK, 2004, EARTH PLANET SC LETT, V225, P191, DOI 10.1016/j.epsl.2004.05.034; Potter EK, 2004, EARTH PLANET SC LETT, V217, P171, DOI 10.1016/S0012-821X(03)00587-9; Richards DA, 2003, REV MINERAL GEOCHEM, V52, P407, DOI 10.2113/0520407; RICHARDS DA, 1994, NATURE, V367, P357, DOI 10.1038/367357a0; Sasaki K, 2004, QUATERN INT, V120, P51, DOI 10.1016/j.quaint.2004.01.006; Schellmann G, 2004, EARTH-SCI REV, V64, P157, DOI 10.1016/S0012-8252(03)00043-6; Schmidt MW, 2004, NATURE, V428, P160, DOI 10.1038/nature02346; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; Siddall M, 2003, NATURE, V423, P853, DOI 10.1038/nature01690; Smart P. L., 1998, CAVE KARST SCI, V25, P67; Speed RC, 2004, GEOL SOC AM BULL, V116, P219, DOI 10.1130/B25167.1; Spotl C, 2002, GEOLOGY, V30, P815, DOI 10.1130/0091-7613(2002)030<0815:SOTLIP>2.0.CO;2; STEIN M, 1993, GEOCHIM COSMOCHIM AC, V57, P2541, DOI 10.1016/0016-7037(93)90416-T; STIRLING CH, 1995, EARTH PLANET SC LETT, V135, P115, DOI 10.1016/0012-821X(95)00152-3; Stirling CH, 2001, SCIENCE, V291, P290, DOI 10.1126/science.291.5502.290; STIRLING CH, 1998, EARTH PLANET SC LETT, V160, P115; Thompson WG, 2003, EARTH PLANET SC LETT, V210, P365, DOI 10.1016/S0012-821X(03)00121-3; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; Wang XF, 2004, NATURE, V432, P740, DOI 10.1038/nature03067; Yokoyama Y, 2001, EARTH PLANET SC LETT, V193, P579, DOI 10.1016/S0012-821X(01)00515-5; Zhao JX, 2001, EARTH PLANET SC LETT, V184, P635, DOI 10.1016/S0012-821X(00)00353-8	45	199	205	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2005	308	5720					401	404		10.1126/science.1104035	http://dx.doi.org/10.1126/science.1104035			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15831756				2022-12-24	WOS:000228492000049
J	Bryant, HE; Schultz, N; Thomas, HD; Parker, KM; Flower, D; Lopez, E; Kyle, S; Meuth, M; Curtin, NJ; Helleday, T				Bryant, HE; Schultz, N; Thomas, HD; Parker, KM; Flower, D; Lopez, E; Kyle, S; Meuth, M; Curtin, NJ; Helleday, T			Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase	NATURE			English	Article							DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS; DNA-DAMAGE; REPLICATION FORKS; NUCLEAR FOCI; REPAIR; PARP-1; STABILITY; REQUIREMENT	Poly( ADP-ribose) polymerase (PARP1) facilitates DNA repair by binding to DNA breaks and attracting DNA repair proteins to the site of damage(1-3). Nevertheless, PARP1(-/-) mice are viable, fertile and do not develop early onset tumours(4). Here, we show that PARP inhibitors trigger gamma-H2AX and RAD51 foci formation. We propose that, in the absence of PARP1, spontaneous single-strand breaks collapse replication forks and trigger homologous recombination for repair. Furthermore, we show that BRCA2-deficient cells, as a result of their deficiency in homologous recombination, are acutely sensitive to PARP inhibitors, presumably because resultant collapsed replication forks are no longer repaired. Thus, PARP1 activity is essential in homologous recombination-deficient BRCA2 mutant cells. We exploit this requirement in order to kill BRCA2-deficient tumours by PARP inhibition alone. Treatment with PARP inhibitors is likely to be highly tumour specific, because only the tumours ( which are BRCA2(-/-)) in BRCA2(+/-) patients are defective in homologous recombination. The use of an inhibitor of a DNA repair enzyme alone to selectively kill a tumour, in the absence of an exogenous DNA-damaging agent, represents a new concept in cancer treatment.	Univ Sheffield, Sch Med, Inst Canc Studies, Sheffield S10 2RX, S Yorkshire, England; Stockholm Univ, Arrhenius Lab, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden; Newcastle Univ, Sch Med, No Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	University of Sheffield; Stockholm University; Newcastle University - UK	Helleday, T (corresponding author), Univ Sheffield, Sch Med, Inst Canc Studies, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England.	t.helleday@sheffield.ac.uk	Helleday, Thomas/D-5224-2013; bryant, helen/AHB-1139-2022; Schultz, Niklas/AFQ-8244-2022	bryant, helen/0000-0003-2720-7020; Curtin, Nicola/0000-0003-1369-1843; Helleday, Thomas/0000-0002-7384-092X; Lopez Knowles, Elena/0000-0002-0893-3361	NCI NIH HHS [F31 CA260794] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arnaudeau C, 2001, J MOL BIOL, V307, P1235, DOI 10.1006/jmbi.2001.4564; Bowman KJ, 2001, BRIT J CANCER, V84, P106, DOI 10.1054/bjoc.2000.1555; Calabrese CR, 2004, J NATL CANCER I, V96, P56, DOI 10.1093/jnci/djh005; CALDECOTT KW, 1992, NUCLEIC ACIDS RES, V20, P4575, DOI 10.1093/nar/20.17.4575; Conde C, 2001, EMBO J, V20, P3535, DOI 10.1093/emboj/20.13.3535; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; deMurcia JM, 1997, P NATL ACAD SCI USA, V94, P7303, DOI 10.1073/pnas.94.14.7303; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Griffin CS, 2000, NAT CELL BIOL, V2, P757, DOI 10.1038/35036399; GRUBE K, 1991, ANAL BIOCHEM, V193, P236, DOI 10.1016/0003-2697(91)90015-L; HALLDORSSON H, 1978, FEBS LETT, V85, P349, DOI 10.1016/0014-5793(78)80489-X; Kraakman-van der Zwet M, 2002, MOL CELL BIOL, V22, P669, DOI 10.1128/MCB.22.2.669-679.2002; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LINDAHL T, 1995, TRENDS BIOCHEM SCI, V20, P405, DOI 10.1016/S0968-0004(00)89089-1; Lundin C, 2003, J MOL BIOL, V328, P521, DOI 10.1016/S0022-2836(03)00313-9; Mohindra A, 2002, HUM MOL GENET, V11, P2189, DOI 10.1093/hmg/11.18.2189; MOLINETE M, 1993, EMBO J, V12, P2109, DOI 10.1002/j.1460-2075.1993.tb05859.x; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Schultz N, 2003, NUCLEIC ACIDS RES, V31, P4959, DOI 10.1093/nar/gkg703; Skalitzky DJ, 2003, J MED CHEM, V46, P210, DOI 10.1021/jm0255769; TEBBS RS, 1995, P NATL ACAD SCI USA, V92, P6354, DOI 10.1073/pnas.92.14.6354; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang ZQ, 1997, GENE DEV, V11, P2347, DOI 10.1101/gad.11.18.2347; Yang YG, 2004, ONCOGENE, V23, P3872, DOI 10.1038/sj.onc.1207491	25	3387	3510	17	308	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 14	2005	434	7035					913	917		10.1038/nature03443	http://dx.doi.org/10.1038/nature03443			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915SV	15829966				2022-12-24	WOS:000228327600044
J	Riedl, SJ; Li, WY; Chao, Y; Schwarzenbacher, R; Shi, YG				Riedl, SJ; Li, WY; Chao, Y; Schwarzenbacher, R; Shi, YG			Structure of the apoptotic protease-activating factor 1 bound to ADP	NATURE			English	Article							CYTOCHROME-C; CASPASE-9 ACTIVATION; PROCASPASE-9; APAF-1; OLIGOMERIZATION; ASSOCIATION; MECHANISMS; APOPTOSOME; BINDING; PROGRAM	Apoptosis is executed by caspases, which undergo proteolytic activation in response to cell death stimuli(1). The apoptotic protease-activating factor 1 (Apaf-1) controls caspase activation downstream of mitochondria(2). During apoptosis, Apaf-1 binds to cytochrome c and in the presence of ATP/dATP forms an apoptosome, leading to the recruitment and activation of the initiator caspase, caspase-9 ( ref. 2). The mechanisms underlying Apaf-1 function are largely unknown. Here we report the 2.2-angstrom crystal structure of an ADP-bound, WD40-deleted Apaf-1, which reveals the molecular mechanism by which Apaf-1 exists in an inactive state before ATP binding. The amino-terminal caspase recruitment domain packs against a three-layered alpha/beta fold, a short helical motif and a winged-helix domain, resulting in the burial of the caspase-9-binding interface. The deeply buried ADP molecule serves as an organizing centre to strengthen interactions between these four adjoining domains, thus locking Apaf-1 in an inactive conformation. Apaf-1 binds to and hydrolyses ATP/dATP and their analogues. The binding and hydrolysis of nucleotides seem to drive conformational changes that are essential for the formation of the apoptosome and the activation of caspase-9.	Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA; Univ Calif San Diego, Joint Ctr Struct Genom, La Jolla, CA 92093 USA	Princeton University; University of California System; University of California San Diego	Shi, YG (corresponding author), Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Washington Rd, Princeton, NJ 08544 USA.	yshi@molbio.princeton.edu		Shi, Yigong/0000-0003-2030-168X				Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Cain K, 1999, J BIOL CHEM, V274, P22686, DOI 10.1074/jbc.274.32.22686; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Genini D, 2000, J BIOL CHEM, V275, P29, DOI 10.1074/jbc.275.1.29; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hu YM, 1998, J BIOL CHEM, V273, P33489, DOI 10.1074/jbc.273.50.33489; Hu YM, 1999, EMBO J, V18, P3586, DOI 10.1093/emboj/18.13.3586; Inohara N, 2001, ONCOGENE, V20, P6473, DOI 10.1038/sj.onc.1204787; Jaroszewski L, 2000, PROTEINS, V39, P197, DOI 10.1002/(SICI)1097-0134(20000515)39:3<197::AID-PROT10>3.0.CO;2-V; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Leoni LM, 1998, P NATL ACAD SCI USA, V95, P9567, DOI 10.1073/pnas.95.16.9567; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lupas AN, 2002, CURR OPIN STRUC BIOL, V12, P746, DOI 10.1016/S0959-440X(02)00388-3; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Saleh A, 1999, J BIOL CHEM, V274, P17941, DOI 10.1074/jbc.274.25.17941; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wang XD, 2001, GENE DEV, V15, P2922; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	30	261	274	5	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2005	434	7035					926	933		10.1038/nature03465	http://dx.doi.org/10.1038/nature03465			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915SV	15829969				2022-12-24	WOS:000228327600047
J	Kistorp, C; Raymond, I; Pedersen, F; Gustafsson, F; Faber, J; Hildebrandt, P				Kistorp, C; Raymond, I; Pedersen, F; Gustafsson, F; Faber, J; Hildebrandt, P			N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; VENTRICULAR SYSTOLIC FUNCTION; ACUTE MYOCARDIAL-INFARCTION; GENERAL-POPULATION; RISK PREDICTION; LARGE-SAMPLE; PLASMA; DYSFUNCTION; FAILURE; MARKERS	Context B-type natriuretic peptides have been shown to predict cardiovascular disease in apparently healthy individuals but their predictive ability for mortality and future cardiovascular events compared with C-reactive protein (CRP) and urinary albumin/creatinine ratio is unknown. Objective To assess the prognostic value of the N-amino terminal fragment of the prohormone brain natriuretic peptide (NT-proBNP) vs CRP and urinary albumin/creatinine ratio in an older adult population. Design, Setting, and Participants A population-based prospective study of 764 participants aged 50 to 89 years from a community in Copenhagen, Denmark, in which 658 participants provided blood and urinary samples and were examined between September 1, 1998, and January 24, 2000. Of these participants, 626 without heart or renal failure were enrolled. A subgroup of 537 had no history of cardiovascular disease at baseline. During 5 years of follow-up (to December 31, 2003), 94 participants died and 65 developed a first major cardiovascular event. Main Outcome Measures Risk of mortality and first major cardiovascular event by baseline levels of NT-proBNP, CRP, and urinary albumin/creatinine ratio levels. Results After adjustment for the cardiovascular risk factors of age, sex, smoking, diabetes mellitus, hypertension or ischemic heart disease, total cholesterol, and serum creatinine, the hazard ratio (HR) of mortality for values above the 80th percentile of NT-proBNP was 1.96 (95% confidence interval [CI], 1.21-3.19); for CRP, 1.46 (95% CI, 0.89-2.24); and for urinary albumin/creatinine ratio, 1.88 (95% CI, 1.18-2.98). Additional adjustment for left ventricular systolic dysfunction did not markedly attenuate the predictive value of NT-proBNP (HR, 1.82; 95% CI, 1.11-2.98). The absolute unadjusted increase in mortality risk for participants with values above the 80th percentile vs equal to or below the 80th percentile was 24.5% for NT-proBNP, 7.8% for CRP, and 19.5% for urinary albumin/creatinine ratio. The NT-proBNP levels were associated with first major cardiovascular events (nonfatal myocardial infarction, fatal coronary heart disease, unstable angina, heart failure, stroke, and transient ischemic attack) with an adjusted HR of 3.24 (95% CI, 1.80-5.79) vs 1.02 (95% CI, 0.56-1.85) for CRP and 2.32 (95% CI, 1.33-4.05) for urinary albumin/creatinine ratio when comparing participants with values above the 80th percentile with those with values equal to or below the 80th percentile. Conclusions Measurements of NT-proBNP provide prognostic information of mortality and first major cardiovascular events beyond traditional risk factors. NT-proBNP was a stronger risk biomarker for cardiovascular disease and death than CRP was in nonhospitalized individuals aged 50 to 89 years.	Frederiksberg Univ Hosp, Dept Cardiol & Endocrinol, DK-2000 Copenhagen, Denmark; Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark; Herlev Univ Hosp, Dept Endocrinol, DK-2730 Herlev, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital	Kistorp, C (corresponding author), Frederiksberg Univ Hosp, Dept Cardiol & Endocrinol, 57 Nordre Fasanvej, DK-2000 Copenhagen, Denmark.	cnkistorp@dadlnet.dk		Gustafsson, Finn/0000-0003-2144-341X; Kistorp, Caroline/0000-0002-3019-6775				Andersen TF, 1999, DAN MED BULL, V46, P263; Berger R, 2002, CIRCULATION, V105, P2392, DOI 10.1161/01.CIR.0000016642.15031.34; Blake GJ, 2002, J INTERN MED, V252, P283, DOI 10.1046/j.1365-2796.2002.01019.x; Borch-Johnsen K, 1999, ARTERIOSCL THROM VAS, V19, P1992, DOI 10.1161/01.ATV.19.8.1992; DAMSGAARD EM, 1990, BRIT MED J, V300, P297, DOI 10.1136/bmj.300.6720.297; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; de Lemos JA, 2001, NEW ENGL J MED, V345, P1014, DOI 10.1056/NEJMoa011053; Eda S, 1998, J CLIN LAB ANAL, V12, P137, DOI 10.1002/(SICI)1098-2825(1998)12:3<137::AID-JCLA2>3.0.CO;2-6; Folsom AR, 2002, AM HEART J, V144, P233, DOI 10.1067/mhj.2002.124054; Goetze JP, 2004, EUR HEART J, V25, P759, DOI 10.1016/j.ehj.2004.02.009; Groenning BA, 2004, HEART, V90, P297, DOI 10.1136/hrt.2003.026021; Gustafsson Finn, 2003, HeartDrug, V3, P141, DOI 10.1159/000073839; HAMA N, 1995, CIRCULATION, V92, P1558, DOI 10.1161/01.CIR.92.6.1558; Haverkate F, 1997, LANCET, V349, P462, DOI 10.1016/S0140-6736(96)07591-5; HUNT PJ, 1995, BIOCHEM BIOPH RES CO, V214, P1175, DOI 10.1006/bbrc.1995.2410; Karl J, 1999, SCAND J CLIN LAB INV, V59, P177; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Lubien E, 2002, CIRCULATION, V105, P595, DOI 10.1161/hc0502.103010; McClure SJ, 1998, BRIT MED J, V317, P516; McDonagh TA, 2001, HEART, V86, P21, DOI 10.1136/heart.86.1.21; Mendall MA, 2000, EUR HEART J, V21, P1584, DOI 10.1053/euhj.1999.1982; Mizuno Y, 2000, AM J CARDIOL, V86, P1036, DOI 10.1016/S0002-9149(00)01147-4; Omland T, 2002, CIRCULATION, V106, P2913, DOI 10.1161/01.CIR.0000041661.63285.AE; Omland T, 1996, CIRCULATION, V93, P1963, DOI 10.1161/01.CIR.93.11.1963; Omland T, 1996, HEART, V76, P232, DOI 10.1136/hrt.76.3.232; Pearson TA, 2003, CIRCULATION, V107, P645, DOI 10.1161/01.CIR.0000054482.38437.13; Pradhan AD, 2002, JAMA-J AM MED ASSOC, V288, P980, DOI 10.1001/jama.288.8.980; Raymond I, 2003, HEART, V89, P745, DOI 10.1136/heart.89.7.745; Raymond Ilan, 2002, HeartDrug, V2, P167, DOI 10.1159/000065944; Richards AM, 2003, CIRCULATION, V107, P2786, DOI 10.1161/01.CIR.0000070953.76250.B9; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rossing P, 1996, BRIT MED J, V313, P779; Rubattu S, 2004, STROKE, V35, P814, DOI 10.1161/01.STR.0000119381.52589.AB; Tateishi J, 2000, CLIN CARDIOL, V23, P776, DOI 10.1002/clc.4960231016; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P1121, DOI 10.1161/01.ATV.17.6.1121; Troughton RW, 2004, J AM COLL CARDIOL, V43, P416, DOI 10.1016/j.jacc.2003.08.046; Tsutamoto T, 1997, CIRCULATION, V96, P509; van der Meer IM, 2003, ARCH INTERN MED, V163, P1323, DOI 10.1001/archinte.163.11.1323; Vasan RS, 2003, CIRCULATION, V107, P1486, DOI 10.1161/01.CIR.0000057810.48709.F6; Vasan RS, 2002, JAMA-J AM MED ASSOC, V288, P1252, DOI 10.1001/jama.288.10.1252; Wallen T, 1997, HEART, V77, P264, DOI 10.1136/hrt.77.3.264; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; Wiese S, 2000, CIRCULATION, V102, P3074	44	426	441	1	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2005	293	13					1609	1616		10.1001/jama.293.13.1609	http://dx.doi.org/10.1001/jama.293.13.1609			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	913EV	15811980	Bronze			2022-12-24	WOS:000228135300023
J	Gardner, RG; Nelson, ZW; Gottschling, DE				Gardner, RG; Nelson, ZW; Gottschling, DE			Degradation-mediated protein quality control in the nucleus	CELL			English	Article							OCULOPHARYNGEAL MUSCULAR-DYSTROPHY; UBIQUITIN-CONJUGATING ENZYMES; ER-ASSOCIATED DEGRADATION; YEAST SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; INTRACELLULAR-LOCALIZATION; MOLECULAR CHAPERONES; PROTEASOME PATHWAY; BINDING-PROTEIN; BUDDING YEAST	Protein quality control degradation systems rid the cell of aberrant proteins, preventing detrimental effects on normal cellular function. Although such systems have been identified in most subcellular compartments, none have been found in the nucleus. Here, we report the discovery of such a system in Saccharomyces cerevisiae. It is defined by San1p, a ubiquitin-protein ligase that, in conjunction with the ubiquitin-conjugating enzymes Cdc34p and Ubc1p, targets four distinct mutant nuclear proteins for ubiquitination and destruction by the proteasome. San1p has exquisite specificity for aberrant proteins and does not target the wild-type versions of its mutant substrates. San1p is nuclear localized and requires nuclear localization for function. Loss of SAN1 results in a chronic stress response, underscoring its role of protein quality control in the cell. We propose that San1p-mediated degradation acts as the last line of proteolytic defense against the deleterious accumulation of aberrant proteins in the nucleus and that analogous systems exist in other eukaryotes.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Gottschling, DE (corresponding author), Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98109 USA.	dgottsch@fhcrc.org		Gardner, Richard/0000-0003-2162-6275	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043893] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM043893-14, GM43893] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abu-Baker A, 2003, HUM MOL GENET, V12, P2609, DOI 10.1093/hmg/ddg293; APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Arnold I, 2002, BBA-MOL CELL RES, V1592, P89, DOI 10.1016/S0167-4889(02)00267-7; BANERJEE A, 1995, J BIOL CHEM, V270, P26209, DOI 10.1074/jbc.270.44.26209; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Betting J, 1996, J BIOL CHEM, V271, P25790, DOI 10.1074/jbc.271.42.25790; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Blondel M, 2000, EMBO J, V19, P6085, DOI 10.1093/emboj/19.22.6085; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Brais B, 2003, CYTOGENET GENOME RES, V100, P252, DOI 10.1159/000072861; Brewster NK, 2001, MOL CELL BIOL, V21, P3491, DOI 10.1128/MCB.21.10.3491-3502.2001; Burchett SA, 2002, J BIOL CHEM, V277, P22156, DOI 10.1074/jbc.M202254200; Calado A, 2000, HUM MOL GENET, V9, P2321, DOI 10.1093/oxfordjournals.hmg.a018924; Cameroni E, 2004, CELL CYCLE, V3, P462; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Chernova TA, 2003, J BIOL CHEM, V278, P52102, DOI 10.1074/jbc.M310283200; Chughtai ZS, 2001, J BIOL CHEM, V276, P20261, DOI 10.1074/jbc.M100364200; Cullen PJ, 2004, GENE DEV, V18, P1695, DOI 10.1101/gad.1178604; Dasgupta A, 2004, J BIOL CHEM, V279, P26830, DOI 10.1074/jbc.M400894200; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Evans DRH, 1998, GENETICS, V150, P1393; Fazzio TG, 2001, MOL CELL BIOL, V21, P6450, DOI 10.1128/MCB.21.19.6450-6460.2001; Formosa T, 2001, EMBO J, V20, P3506, DOI 10.1093/emboj/20.13.3506; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Gardner RG, 1999, EMBO J, V18, P5994, DOI 10.1093/emboj/18.21.5994; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Grandin N, 2001, MOL GENET GENOMICS, V265, P126, DOI 10.1007/s004380000398; Grant CM, 2000, BBA-GENE STRUCT EXPR, V1490, P33, DOI 10.1016/S0167-4781(99)00234-1; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Jana NR, 2003, J CHEM NEUROANAT, V26, P95, DOI 10.1016/S0891-0618(03)00029-2; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kahana A, 1999, MOL CELL BIOL, V19, P6608; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Kawai R, 1999, CELL STRESS CHAPERON, V4, P46, DOI 10.1054/csac.1999.0076; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; Lagorce A, 2003, J BIOL CHEM, V278, P20345, DOI 10.1074/jbc.M211604200; LIU Y, 1995, MOL CELL BIOL, V15, P5635; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; MADURA K, 1993, J BIOL CHEM, V268, P12046; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Moazed D, 1997, P NATL ACAD SCI USA, V94, P2186, DOI 10.1073/pnas.94.6.2186; Moskvina E, 1998, YEAST, V14, P1041, DOI 10.1002/(SICI)1097-0061(199808)14:11<1041::AID-YEA296>3.0.CO;2-4; PALLADINO F, 1993, CELL, V75, P543, DOI 10.1016/0092-8674(93)90388-7; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Ptak C, 2001, MOL CELL BIOL, V21, P6537, DOI 10.1128/MCB.21.19.6537-6548.2001; Qi HY, 2000, GENE DEV, V14, P1777; RINE J, 1987, GENETICS, V116, P9; ROSSI JM, 1989, J CELL BIOL, V108, P425, DOI 10.1083/jcb.108.2.425; ROWLEY A, 1991, MOL CELL BIOL, V11, P5718, DOI 10.1128/MCB.11.11.5718; SCHNELL R, 1989, GENETICS, V122, P29; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Shastry BS, 2003, NEUROCHEM INT, V43, P1, DOI 10.1016/S0197-0186(02)00196-1; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Stirling PC, 2003, EMBO REP, V4, P565, DOI 10.1038/sj.embor.embor869; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wojcik C, 2003, INT J BIOCHEM CELL B, V35, P579, DOI 10.1016/S1357-2725(02)00380-1; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; XU QL, 1995, MOL CELL BIOL, V15, P6025; XU QL, 1993, MOL CELL BIOL, V13, P7553, DOI 10.1128/MCB.13.12.7553	72	207	209	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 25	2005	120	6					803	815		10.1016/j.cell.2005.01.016	http://dx.doi.org/10.1016/j.cell.2005.01.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	912HF	15797381	Bronze			2022-12-24	WOS:000228067500010
J	Cavanagh, P				Cavanagh, P			The artist as neuroscientist	NATURE			English	Article							PERCEPTION; FACES; RECOGNITION		Harvard Univ, Dept Psychol, Vis Sci Lab, Cambridge, MA 02138 USA	Harvard University	Cavanagh, P (corresponding author), Harvard Univ, Dept Psychol, Vis Sci Lab, 33 Kirkland St, Cambridge, MA 02138 USA.							Bovet D, 2000, BEHAV BRAIN RES, V109, P143, DOI 10.1016/S0166-4328(00)00146-7; Bruno VJ, 1977, FORM COLOUR GREEK PA; BUSEY TA, 1990, PERCEPT PSYCHOPHYS, V48, P1, DOI 10.3758/BF03205006; CASATI R, 2004, SHADOW CLUB; Cavanagh P, 2004, 2ND INTERNATIONAL SYMPOSIUM ON 3D DATA PROCESSING, VISUALIZATION, AND TRANSMISSION, PROCEEDINGS, P35, DOI 10.1109/TDPVT.2004.1335139; CAVANAGH P, 1989, J EXP PSYCHOL HUMAN, V15, P3, DOI 10.1037/0096-1523.15.1.3; Croucher CJ, 2002, J EXP PSYCHOL HUMAN, V28, P546, DOI 10.1037//0096-1523.28.3.546; Fleming RW, 2003, J VISION, V3, P347, DOI 10.1167/3.5.3; GOMBRICH EH, 1995, SHADOWS; Hills Paul, 1987, LIGHT EARLY ITALIAN; ITAKURA S, 1994, J GEN PSYCHOL, V121, P189, DOI 10.1080/00221309.1994.9921195; KENNEDY JM, 1974, PERCEPTION, V3, P313, DOI 10.1068/p030313; KENNEDY JM, 1975, PERCEPTION, V4, P391, DOI 10.1068/p040391; Koenderink JJ, 2003, LOOKING INTO PICTURES, P239; METELLI F, 1974, SCI AM, V230, P91, DOI 10.1038/scientificamerican0474-90; MILLER J, 1998, REFLECTION; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; OSTROVSKY Y, IN PRESS PERCEPTION; Pegna AJ, 2005, NAT NEUROSCI, V8, P24, DOI 10.1038/nn1364; SAVARESE S., 2004, P 1 S APPL PERC GRAP, P115, DOI DOI 10.1145/1012551.1012571; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; WASSERSTEIN J, 1987, BRAIN COGNITION, V6, P1, DOI 10.1016/0278-2626(87)90042-X; YONAS A, 1978, SCIENCE, V200, P77, DOI 10.1126/science.635576; YONAS A, 1994, PERCEPTION, V23, P1427, DOI 10.1068/p231427	24	146	148	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					301	307		10.1038/434301a	http://dx.doi.org/10.1038/434301a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772645				2022-12-24	WOS:000227715100034
J	Langevin, Y; Poulet, F; Bibring, JP; Gondet, B				Langevin, Y; Poulet, F; Bibring, JP; Gondet, B			Sulfates in the north polar region of Mars detected by OMEGA/Mars express	SCIENCE			English	Article							EVOLUTION; DEPOSITS	The Observatoire pour la Mineralogie, l'Eau, les Glaces, et l'Activite (OMEGA) imaging spectrometer observed the northern circumpolar regions of Mars at a resolution of a few kilometers. An extended region at 240degreesE, 85degreesN, with an area of 60 kilometers by 200 kilometers, exhibits absorptions at wavelengths of 1.45, 1.75, 1.94, 2.22, 2.26, and 2.48 micrometers. These signatures can be unambiguously attributed to calcium-rich sulfates, most likely gypsum. This region corresponds to the dark longitudinal dunes of Olympia Planitia. These observations reveal that Water alteration played a major role in the formation of the constituting minerals of northern circumpolar terrains.	Inst Astrophys Spatiale, F-91405 Orsay, France	UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay	Langevin, Y (corresponding author), Inst Astrophys Spatiale, Batiment 121, F-91405 Orsay, France.	yves.langevin@ias.u-psud.fr						Baker V.R., 1992, CHANNELS VALLEY NETW, P493; Bibring J.-P., 2004, EUR SPACE AGENCY SPE, V1240, P37; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; BISHOP JL, IN PRESS INT J ASTRO; BURNS RG, 1990, J GEOPHYS RES-SOLID, V95, P14415, DOI 10.1029/JB095iB09p14415; Byrne S, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001615; Clifford SM, 2000, ICARUS, V144, P210, DOI 10.1006/icar.1999.6290; CLIFFORD SM, 1999, LUNAR PLANET SCI, V30, P1619; Fishbaugh KE, 2000, J GEOPHYS RES-PLANET, V105, P22455, DOI 10.1029/1999JE001230; FISHBAUGH KE, 2004, LUN PLAN SCI C, V25, P1156; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; Herkenhoff KE, 1999, J GEOPHYS RES-PLANET, V104, P16487, DOI 10.1029/1998JE000589; IVANOV S, 2003, 6 INT C MARS PAS CA; Langevin Y, 2005, SCIENCE, V307, P1581, DOI 10.1126/science.1109438; Mischna MA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002051; PAIGE DA, 1994, J GEOPHYS RES-PLANET, V99, P25959, DOI 10.1029/93JE03428; PARKER TJ, 1989, ICARUS, V82, P111, DOI 10.1016/0019-1035(89)90027-4; PATHARE AV, 1998, 1 INT C MARS POL SCI; Wyatt M. B., 2003, 3 INT C MARS POL SCI	19	387	398	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2005	307	5715					1584	1586		10.1126/science.1109091	http://dx.doi.org/10.1126/science.1109091			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15718428				2022-12-24	WOS:000227622400036
J	Krogsgaard, M; Li, QJ; Sumen, C; Huppa, JB; Huse, M; Davis, MM				Krogsgaard, M; Li, QJ; Sumen, C; Huppa, JB; Huse, M; Davis, MM			Agonist/endogenous peptide-MHC heterodimers drive T cell activation and sensitivity	NATURE			English	Article							IMMUNOLOGICAL SYNAPSE FORMATION; HLA-DR MOLECULES; CLASS-II; LIGAND RECOGNITION; FOREIGN ANTIGEN; BINDING-SITE; CD8; PROLIFERATION; EXPRESSION; CONTRIBUTE	alphabeta T lymphocytes are able to detect even a single peptide - major histocompatibility complex (MHC) on the surface of an antigen-presenting cell(1,2). This is despite clear evidence, at least with CD4(+) T cells, that monomeric ligands are not stimulatory(3,4). In an effort to understand how this remarkable sensitivity is achieved, we constructed soluble peptide - MHC heterodimers in which one peptide is an agonist and the other is one of the large number of endogenous peptide - MHCs displayed by presenting cells. We found that some specific combinations of these heterodimers can stimulate specific T cells in a CD4-dependent manner. This activation is severely impaired if the CD4-binding site on the agonist ligand is ablated, but the same mutation on an endogenous ligand has no effect. These data correlate well with analyses of lipid bilayers and cells presenting these ligands, and indicate that the basic unit of helper T cell activation is a heterodimer of agonist peptide - and endogenous peptide MHC complexes, stabilized by CD4.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Davis, MM (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	mdavis@cmgm.stanford.edu		Davis, Mark/0000-0001-6868-657X; Huppa, Johannes/0000-0003-2634-8198				Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; CAMMAROTA G, 1992, NATURE, V356, P799, DOI 10.1038/356799a0; Cochran JR, 2000, IMMUNITY, V12, P241, DOI 10.1016/S1074-7613(00)80177-6; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Delon J, 1998, IMMUNITY, V9, P467, DOI 10.1016/S1074-7613(00)80630-5; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; Ge Q, 2002, P NATL ACAD SCI USA, V99, P13729, DOI 10.1073/pnas.212515299; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; KONIG R, 1992, NATURE, V356, P796, DOI 10.1038/356796a0; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Lee SJE, 2002, TRENDS IMMUNOL, V23, P492, DOI 10.1016/S1471-4906(02)02285-8; Li QJ, 2004, NAT IMMUNOL, V5, P791, DOI 10.1038/ni1095; MARRACK P, 1993, J EXP MED, V178, P2173, DOI 10.1084/jem.178.6.2173; MICELI MC, 1993, ADV IMMUNOL, V53, P59, DOI 10.1016/S0065-2776(08)60498-8; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; SCHILD H, 1994, CELL, V76, P29, DOI 10.1016/0092-8674(94)90170-8; Schild H, 1995, INT IMMUNOL, V7, P1957, DOI 10.1093/intimm/7.12.1957; Sporri R, 2002, EUR J IMMUNOL, V32, P3161, DOI 10.1002/1521-4141(200211)32:11<3161::AID-IMMU3161>3.0.CO;2-6; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Sumen C, 2004, J CELL BIOL, V166, P579, DOI 10.1083/jcb.200404059; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; TSIEN RY, 1989, ANNU REV NEUROSCI, V12, P227, DOI 10.1146/annurev.ne.12.030189.001303; WETTSTEIN DA, 1991, J EXP MED, V174, P219, DOI 10.1084/jem.174.1.219; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741	30	266	271	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					238	243		10.1038/nature03391	http://dx.doi.org/10.1038/nature03391			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15724150				2022-12-24	WOS:000227494500051
J	Kumarevel, T; Mizuno, H; Kumar, PKR				Kumarevel, T; Mizuno, H; Kumar, PKR			Structural basis of HutP-mediated anti-termination and roles of the Mg2+ ion and L-histidine ligand	NATURE			English	Article							RNA-BINDING PROTEIN; X-RAY-DIFFRACTION; BACILLUS-SUBTILIS; TRANSCRIPTIONAL ANTITERMINATION; GENOME SEQUENCE; MESSENGER-RNA; ATTENUATION PROTEIN; CRYSTAL-STRUCTURE; IN-VITRO; OPERON	HutP regulates the expression of the hut structural genes of Bacillus subtilis by an anti-termination mechanism and requires two components, Mg2+ ions and L-histidine. HutP recognizes three UAG triplet units, separated by four non-conserved nucleotides on the terminator region. Here we report the 1.60-Angstrom resolution crystal structure of the quaternary complex ( HutP - L- histidine - Mg2+ 21-base single-stranded RNA). In the complex, the RNA adopts a novel triangular fold on the hexameric surface of HutP, without any base-pairing, and binds to the protein mostly by specific protein - base interactions. The structure explains how the HutP and RNA interactions are regulated critically by the L- histidine and Mg2+ ion through the structural rearrangement. To gain insights into these structural rearrangements, we solved two additional crystal structures ( uncomplexed HutP and HutP - L- histidine - Mg2+) that revealed the intermediate structures of HutP ( before forming an active structure) and the importance of the Mg2+ ion interactions in the complexes.	Natl Inst Adv Ind Sci & Technol, Inst Biol Resources & Funct, Funct Nucl Acids Grp, Tsukuba, Ibaraki 3058566, Japan; Natl Inst Agrobiol Sci, Dept Biochem, Tsukuba, Ibaraki 3058602, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Agrobiological Sciences - Japan	Kumar, PKR (corresponding author), Natl Inst Adv Ind Sci & Technol, Inst Biol Resources & Funct, Funct Nucl Acids Grp, Cent 6,1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	pkr-kumar@aist.go.jp	Penmetcha, Kumar/K-8834-2017; Kumarevel, Thirumananseri/C-6275-2012	Penmetcha, Kumar/0000-0002-3512-704X; Kumarevel, Thirumananseri/0000-0001-9326-6585				Alpert CA, 1997, J BACTERIOL, V179, P1555, DOI 10.1128/jb.179.5.1555-1562.1997; Antson AA, 1999, NATURE, V401, P235, DOI 10.1038/45730; Arnaud M, 1996, J BIOL CHEM, V271, P18966, DOI 10.1074/jbc.271.31.18966; AYMERICH S, 1992, P NATL ACAD SCI USA, V89, P10410, DOI 10.1073/pnas.89.21.10410; BABITZKE P, 1993, P NATL ACAD SCI USA, V90, P133, DOI 10.1073/pnas.90.1.133; Bogden CE, 1999, MOL CELL, V3, P487, DOI 10.1016/S1097-2765(00)80476-1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; CHASIN LA, 1968, J BIOL CHEM, V243, P5165; Deo RC, 1999, CELL, V98, P835, DOI 10.1016/S0092-8674(00)81517-2; Glatz E, 1996, MOL MICROBIOL, V19, P319, DOI 10.1046/j.1365-2958.1996.376903.x; Gollnick P, 2002, BBA-GENE STRUCT EXPR, V1577, P240, DOI 10.1016/S0167-4781(02)00455-4; Handa N, 1999, NATURE, V398, P579, DOI 10.1038/19242; HOUMAN F, 1990, CELL, V62, P1153, DOI 10.1016/0092-8674(90)90392-R; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Kimmhi Y., 1970, J BIOL CHEM, V245, P3545; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kumarevel T, 2004, STRUCTURE, V12, P1269, DOI 10.1016/j.str.2004.05.005; Kumarevel TS, 2004, NUCLEIC ACIDS RES, V32, P3904, DOI 10.1093/nar/gkh725; Kumarevel TS, 2002, J STRUCT BIOL, V138, P237, DOI 10.1016/S1047-8477(02)00024-2; KUMAREVEL TS, 2003, NUCL ACIDS RES S, V3, P199; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Liu ZH, 2001, SCIENCE, V294, P1098, DOI 10.1126/science.1064719; Lu Y, 1996, P NATL ACAD SCI USA, V93, P14462, DOI 10.1073/pnas.93.25.14462; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; NAGAI K, 1990, NATURE, V348, P515, DOI 10.1038/348515a0; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; ODA M, 1988, J BACTERIOL, V170, P3199, DOI 10.1128/jb.170.7.3199-3205.1988; Oda M, 2000, MOL MICROBIOL, V35, P1244, DOI 10.1046/j.1365-2958.2000.01795.x; Oldfield TJ, 2001, ACTA CRYSTALLOGR D, V57, P82, DOI 10.1107/S0907444900014098; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Stulke J, 2002, ARCH MICROBIOL, V177, P433, DOI 10.1007/s00203-002-0407-5; Takami H, 2000, NUCLEIC ACIDS RES, V28, P4317, DOI 10.1093/nar/28.21.4317; Thore S, 2003, J BIOL CHEM, V278, P1239, DOI 10.1074/jbc.M207685200; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; WRAY LV, 1994, J BACTERIOL, V176, P5466, DOI 10.1128/JB.176.17.5466-5473.1994; Yang YS, 2002, EMBO J, V21, P1987, DOI 10.1093/emboj/21.8.1987; Yanofsky C, 2001, ANNU REV BIOCHEM, V70, P1, DOI 10.1146/annurev.biochem.70.1.1	39	38	39	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					183	191		10.1038/nature03355	http://dx.doi.org/10.1038/nature03355			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15758992				2022-12-24	WOS:000227494500037
J	Neijssen, J; Herberts, C; Drijfhout, JW; Reits, E; Janssen, L; Neefjes, J				Neijssen, J; Herberts, C; Drijfhout, JW; Reits, E; Janssen, L; Neefjes, J			Cross-presentation by intercellular peptide transfer through gap junctions	NATURE			English	Article							MHC CLASS-I; CD8(+) T-CELLS; ANTIGEN PRESENTATION; COMMUNICATION; PROTEIN; DEGRADATION; GROWTH; VITRO	Major histocompatibility complex (MHC) class I molecules present peptides that are derived from endogenous proteins1. These antigens can also be transferred to professional antigen-presenting cells in a process called cross-presentation, which precedes initiation of a proper T-cell response(2,3); but exactly how they do this is unclear. We tested whether peptides can be transferred directly from the cytoplasm of one cell into the cytoplasm of its neighbour through gap junctions. Here we show that peptides with a relative molecular mass of up to,1,800 diffuse intercellularly through gap junctions unless a three-dimensional structure is imposed. This intercellular peptide transfer causes cytotoxic T-cell recognition of adjacent, innocent bystander cells as well as activated monocytes. Gap-junction-mediated peptide transfer is restricted to a few coupling cells owing to the high cytosolic peptidase activity. We present a mechanism of antigen acquisition for cross-presentation that couples the antigen presentation system of two adjacent cells and is lost in most tumours: gap-junction-mediated intercellular peptide coupling for presentation by bystander MHC class I molecules and transfer to professional antigen presenting cells for cross-priming.	Netherlands Canc Inst, Div Tumor Biol, NL-1066 CX Amsterdam, Netherlands; Univ Med Ctr, Dept Immunohematol & Blood Transfus Leiden, NL-2333 RC Leiden, Netherlands	Netherlands Cancer Institute	Neijssen, J (corresponding author), Netherlands Canc Inst, Div Tumor Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	J.Neefjes@nki.nl	Neefjes, Jacques J.C./H-8780-2017; Drijfhout, Jan Wouter/ABA-6318-2021	Neefjes, Jacques J.C./0000-0001-6763-2211; Drijfhout, Jan Wouter/0000-0003-4808-5296; Janssen, Lennert/0000-0001-9705-0204; Neijssen, Joost/0000-0001-6697-4324				Ackerman AL, 2004, NAT IMMUNOL, V5, P678, DOI 10.1038/ni1082; ESINDUY CB, 1995, CARCINOGENESIS, V16, P915, DOI 10.1093/carcin/16.4.915; Eugenin EA, 2003, J IMMUNOL, V170, P1320, DOI 10.4049/jimmunol.170.3.1320; Fischer NO, 2001, J VIROL METHODS, V91, P157, DOI 10.1016/S0166-0934(00)00260-3; Giepmans BNG, 2001, J BIOL CHEM, V276, P8544, DOI 10.1074/jbc.M005847200; Gil-Torregrosa BC, 2004, EUR J IMMUNOL, V34, P398, DOI 10.1002/eji.200324508; GOLDBERG GS, 1993, BIOCHEM J, V295, P735, DOI 10.1042/bj2950735; Goldberg GS, 2004, BBA-BIOMEMBRANES, V1662, P96, DOI 10.1016/j.bbamem.2003.11.022; Gromme M, 1999, P NATL ACAD SCI USA, V96, P10326, DOI 10.1073/pnas.96.18.10326; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Harks EGA, 2003, FASEB J, V17, P941, DOI 10.1096/fj.02-0786fje; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Kurts C, 1998, CIBA F SYMP, V215, P172; Li ZH, 2002, CURR OPIN IMMUNOL, V14, P45, DOI 10.1016/S0952-7915(01)00297-7; Mesnil M, 2000, CANCER RES, V60, P3989; Norbury CC, 2004, SCIENCE, V304, P1318, DOI 10.1126/science.1096378; OELZE L, 1995, J VIROL, V69, P4489; Oviedo-Orta E, 2004, BBA-BIOMEMBRANES, V1662, P102, DOI 10.1016/j.bbamem.2003.10.021; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Rock KL, 2003, NAT IMMUNOL, V4, P941, DOI 10.1038/ni1003-941; Savinov AY, 2003, J EXP MED, V197, P643, DOI 10.1084/jem.20021378; Segretain D, 2004, BBA-BIOMEMBRANES, V1662, P3, DOI 10.1016/j.bbamem.2004.01.007; Serna A, 2003, J IMMUNOL, V171, P5668, DOI 10.4049/jimmunol.171.11.5668; Shen LJ, 2004, P NATL ACAD SCI USA, V101, P3035, DOI 10.1073/pnas.0308345101; Verra NCV, 2004, CANCER RES, V64, P2153, DOI 10.1158/0008-5472.CAN-03-1339; Warn-Cramer BJ, 2004, BBA-BIOMEMBRANES, V1662, P81, DOI 10.1016/j.bbamem.2003.10.018; Wolkers MC, 2004, SCIENCE, V304, P1314, DOI 10.1126/science.1096268; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250	30	327	340	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					83	88		10.1038/nature03290	http://dx.doi.org/10.1038/nature03290			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744304				2022-12-24	WOS:000227334600048
J	Porco, CC; Baker, E; Barbara, J; Beurle, K; Brahic, A; Burns, JA; Charnoz, S; Cooper, N; Dawson, DD; Del Genio, AD; Denk, T; Dones, L; Dyudina, U; Evans, MW; Giese, B; Grazier, K; Heifenstein, P; Ingersoll, AP; Jacobson, RA; Johnson, TV; McEwen, A; Murray, CD; Neukum, G; Owen, WM; Perry, J; Roatsch, T; Spitale, J; Squyres, S; Thornas, P; Tiscareno, M; Turtle, E; Vasavada, AR; Veverka, J; Wagner, R; West, R				Porco, CC; Baker, E; Barbara, J; Beurle, K; Brahic, A; Burns, JA; Charnoz, S; Cooper, N; Dawson, DD; Del Genio, AD; Denk, T; Dones, L; Dyudina, U; Evans, MW; Giese, B; Grazier, K; Heifenstein, P; Ingersoll, AP; Jacobson, RA; Johnson, TV; McEwen, A; Murray, CD; Neukum, G; Owen, WM; Perry, J; Roatsch, T; Spitale, J; Squyres, S; Thornas, P; Tiscareno, M; Turtle, E; Vasavada, AR; Veverka, J; Wagner, R; West, R			Cassini Imaging Science: Initial results on Saturn's atmosphere	SCIENCE			English	Article							ZONAL WINDS; ELECTROSTATIC DISCHARGES; JUPITERS ATMOSPHERE; CLOUD LEVEL; MORPHOLOGY; MOTIONS	The Cassini Imaging Science Subsystem (ISS) began observing Saturn in early February 2004. From analysis of cloud motions through early October 2004, we report vertical wind shear in Saturn's equatorial jet and a maximum wind speed of similar to375 meters per second, a value that differs from both Hubble Space Telescope and Voyager values. We also report a particularly active narrow southern mid-latitude region in which dark ovals are observed both to merge with each other and to arise from the eruptions of large, bright storms. Bright storm eruptions are correlated with Saturn's electrostatic discharges, which are thought to originate from lightning.	Space Sci Inst, Cassini Imaging Cent Lab Operat, Boulder, CO 80301 USA; NASA, Goddard Inst Space Studies, New York, NY 10025 USA; Univ London, Queen Mary, Astron Unit, London E1 4NS, England; Univ Paris 07, Ctr Etud Saclay, F-91191 Gif Sur Yvette, France; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA; Free Univ Berlin, Inst Geol Wissensch, D-12249 Berlin, Germany; SW Res Inst, Dept Space Sci, Boulder, CO 80302 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; German Aerosp Ctr, Inst Planetary Res, D-12489 Berlin, Germany; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of London; Queen Mary University London; UDICE-French Research Universities; Universite Paris Cite; Cornell University; University of Arizona; Free University of Berlin; California Institute of Technology; Helmholtz Association; German Aerospace Centre (DLR); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Porco, CC (corresponding author), Space Sci Inst, Cassini Imaging Cent Lab Operat, 4750 Walnut St,Suite 205, Boulder, CO 80301 USA.	carolyn@ciclops.org	Tiscareno, Matthew/D-6963-2011; Evans, Michael W/AAG-4117-2020; Turtle, Elizabeth/K-8673-2012; Del Genio, Anthony/D-4663-2012	Turtle, Elizabeth/0000-0003-1423-5751; Del Genio, Anthony/0000-0001-7450-1359; Barbara, John/0000-0002-2190-4290				BARNET CD, 1992, ICARUS, V100, P499, DOI 10.1016/0019-1035(92)90113-L; BEZARD B, 1984, ICARUS, V60, P274, DOI 10.1016/0019-1035(84)90189-1; BURNS JA, 1983, ICARUS, V54, P280, DOI 10.1016/0019-1035(83)90198-7; Flasar FM, 2005, SCIENCE, V307, P1247, DOI 10.1126/science.1105806; Galopeau PHM, 2000, J GEOPHYS RES-SPACE, V105, P13089, DOI 10.1029/1999JA005089; Gurnett DA, 2005, SCIENCE, V307, P1255, DOI 10.1126/science.1105356; Ingersoll AP, 2000, NATURE, V403, P630, DOI 10.1038/35001021; INGERSOLL AP, 1984, SATURN, P195; Kaiser M. L., 1984, SATURN, P378; KAISER ML, 1983, NATURE, V303, P50, DOI 10.1038/303050a0; Porco CC, 2004, SPACE SCI REV, V115, P363, DOI 10.1007/s11214-004-1456-7; Porco CC, 2003, SCIENCE, V299, P1541, DOI 10.1126/science.1079462; Sanchez-Lavega A, 2000, ICARUS, V147, P405, DOI 10.1006/icar.2000.6449; Sanchez-Lavega A, 2004, ICARUS, V170, P519, DOI 10.1016/j.icarus.2004.05.002; Sanchez-Lavega A, 2003, NATURE, V423, P623, DOI 10.1038/nature01653; SanchezLavega A, 1996, SCIENCE, V271, P631, DOI 10.1126/science.271.5249.631; SANCHEZLAVEGA A, 1991, NATURE, V353, P397, DOI 10.1038/353397a0; SROMOVSKY LA, 1983, J GEOPHYS RES-SPACE, V88, P8650, DOI 10.1029/JA088iA11p08650; TEMMA T, IN PRESS ICARUS; WEST RA, 1982, ICARUS, V51, P51, DOI 10.1016/0019-1035(82)90029-X	20	93	93	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1243	1247		10.1126/science.1107691	http://dx.doi.org/10.1126/science.1107691			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731441				2022-12-24	WOS:000227313200040
J	Yoshimura, Y; Dantzker, JLM; Callaway, EM				Yoshimura, Y; Dantzker, JLM; Callaway, EM			Excitatory cortical neurons form fine-scale functional networks	NATURE			English	Article							PRIMARY VISUAL-CORTEX; ORIENTATION SELECTIVITY; INHIBITORY NEURONS; RECEPTIVE-FIELDS; PYRAMIDAL CELLS; RAT; CONNECTIONS; CIRCUITS; LAYERS; INTERNEURONS	The specificity of cortical neuron connections creates columns of functionally similar neurons spanning from the pia to the white matter(1-6). Here we investigate whether there is an additional, finer level of specificity that creates subnetworks of excitatory neurons within functional columns. We tested for fine-scale specificity of connections to cortical layer 2/3 pyramidal neurons in rat visual cortex by using cross-correlation analyses of synaptic currents evoked by photostimulation. Recording simultaneously from adjacent layer 2/3 pyramidal cells, we find that when they are connected to each other (20% of all recorded pairs) they share common input from layer 4 and within layer 2/3. When adjacent layer 2/3 neurons are not connected to each other, they share very little ( if any) common excitatory input from layers 4 and 2/3. In contrast, all layer 2/3 neurons share common excitatory input from layer 5 and inhibitory input from layers 2/3 and 4, regardless of whether they are connected to each other. Thus, excitatory connections from layer 4 to layer 2/3 and within layer 2/3 form fine-scale assemblies of selectively interconnected neurons; inhibitory connections and excitatory connections from layer 5 link neurons across these fine-scale subnetworks. Relatively independent subnetworks of excitatory neurons are therefore embedded within the larger-scale functional architecture; this allows neighbouring neurons to convey information more independently than suggested by previous descriptions of cortical circuitry.	Salk Inst Biol Studies, Syst Neurobiol Labs, La Jolla, CA 92037 USA	Salk Institute	Callaway, EM (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	callaway@salk.edu	Callaway, Edward/D-4336-2011	Callaway, Edward/0000-0002-6366-5267; Yoshimura, Yumiko/0000-0002-7526-4153	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063912] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH063912] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; AGMON A, 1992, J NEUROSCI, V12, P319; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Braitenberg V, 1991, ANATOMY CORTEX; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Girman SV, 1999, J NEUROPHYSIOL, V82, P301, DOI 10.1152/jn.1999.82.1.301; Gonchar Y, 2003, J NEUROSCI, V23, P10904; Gonchar Y, 1999, CEREB CORTEX, V9, P683, DOI 10.1093/cercor/9.7.683; Hebb D.O., 1949, ORG BEHAV; HELLWIG B, 1994, BIOL CYBERN, V71, P1, DOI 10.1007/BF00198906; Hellwig B, 2000, BIOL CYBERN, V82, P111, DOI 10.1007/PL00007964; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kawaguchi Y, 2002, J NEUROCYTOL, V31, P277, DOI 10.1023/A:1024126110356; Meskenaite V, 1997, J COMP NEUROL, V379, P113; Mooser F, 2004, NAT NEUROSCI, V7, P872, DOI 10.1038/nn1287; Mountcastle VB, 2003, CEREB CORTEX, V13, P2, DOI 10.1093/cercor/13.1.2; Sawatari A, 2000, NEURON, V25, P459, DOI 10.1016/S0896-6273(00)80908-3; Schubert D, 2003, J NEUROSCI, V23, P2961; Staiger JF, 2002, EUR J NEUROSCI, V16, P11, DOI 10.1046/j.1460-9568.2002.02048.x; Sur M, 2002, CURR BIOL, V12, pR168, DOI 10.1016/S0960-9822(02)00733-9; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Thomson AM, 2002, J NEUROCYTOL, V31, P239, DOI 10.1023/A:1024117908539; Yoshimura Y, 2003, J NEUROSCI, V23, P6557	30	425	465	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2005	433	7028					868	873		10.1038/nature03252	http://dx.doi.org/10.1038/nature03252			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	899VT	15729343				2022-12-24	WOS:000227174600043
J	Tian, F; Toon, OB; Pavlov, AA; De Sterck, H				Tian, F; Toon, OB; Pavlov, AA; De Sterck, H			A hydrogen-rich early Earth atmosphere	SCIENCE			English	Article							NONTHERMAL ESCAPE; PHOTOCHEMISTRY; FORMALDEHYDE; OXIDATION; ORIGIN; WATER; LIFE; SUN; HCN; CO2	We show that the escape of hydrogen from early Earth's atmosphere likely occurred at rates slower by two orders of magnitude than previously thought. The balance between slow hydrogen escape and volcanic outgassing could have maintained a hydrogen. mixing ratio of more than 30%. The production of prebiotic organic compounds in such an atmosphere would have been more efficient than either exogenous delivery or synthesis in hydrothermal systems. The organic soup in the oceans and ponds on early Earth would have been a more favorable place for the origin of life than previously thought.	Univ Colorado, Astrophys & Planetary Sci Dept, Boulder, CO 80309 USA; Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA; Univ Colorado, Program Atmospher & Ocean Sci, Boulder, CO 80309 USA; Univ Waterloo, Dept Appl Math, Waterloo, ON N2L 3G1, Canada	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Waterloo	Tian, F (corresponding author), Univ Colorado, Astrophys & Planetary Sci Dept, Boulder, CO 80309 USA.	tian@colorado.edu	Tian, Feng/C-1344-2015; Pavlov, Alexander A./F-3779-2012	Tian, Feng/0000-0002-9607-560X; Pavlov, Alexander A./0000-0001-8771-1646; De Sterck, Hans/0000-0002-1641-932X				ABELSON PH, 1966, P NATL ACAD SCI USA, V55, P1365, DOI 10.1073/pnas.55.6.1365; Anbar AD, 2001, J GEOPHYS RES-PLANET, V106, P3219, DOI 10.1029/2000JE001272; CANUTO VM, 1983, NATURE, V305, P281, DOI 10.1038/305281a0; CHYBA C, 1991, ORIGINS LIFE EVOL B, V21, P3, DOI 10.1007/BF01809509; CHYBA CF, 1997, COMETS ORIGIN EVOLUT, P00147, DOI DOI 10.1002/2017JE005406; de Pater I, 2001, PLANETARY SCI, P66; Delano JW, 2001, ORIGINS LIFE EVOL B, V31, P311, DOI 10.1023/A:1011895600380; Dobson CM, 2000, P NATL ACAD SCI USA, V97, P11864, DOI 10.1073/pnas.200366897; DORREN JD, 1994, ASTROPHYS J, V428, P805, DOI 10.1086/174289; Ehrenfreund P, 2002, REP PROG PHYS, V65, P1427, DOI 10.1088/0034-4885/65/10/202; Holland HD, 2002, GEOCHIM COSMOCHIM AC, V66, P3811, DOI 10.1016/S0016-7037(02)00950-X; HUNTEN DM, 1982, PLANET SPACE SCI, V30, P773, DOI 10.1016/0032-0633(82)90110-6; KASTING JF, 1993, SCIENCE, V259, P920, DOI 10.1126/science.11536547; KUMAR S, 1983, ICARUS, V55, P369, DOI 10.1016/0019-1035(83)90109-4; Lammer H, 2003, ICARUS, V165, P9, DOI 10.1016/S0019-1035(03)00170-2; LOVE SG, 1993, SCIENCE, V262, P550, DOI 10.1126/science.262.5133.550; McCollom TM, 2001, GEOCHIM COSMOCHIM AC, V65, P3769, DOI 10.1016/S0016-7037(01)00655-X; MILLER SL, 1953, SCIENCE, V117, P528, DOI 10.1126/science.117.3046.528; Pavlov AA, 2001, GEOLOGY, V29, P1003, DOI 10.1130/0091-7613(2001)029<1003:OHIESE>2.0.CO;2; Pierazzo E, 1999, METEORIT PLANET SCI, V34, P909, DOI 10.1111/j.1945-5100.1999.tb01409.x; PINTO JP, 1980, SCIENCE, V210, P183, DOI 10.1126/science.210.4466.183; Ryder G, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001583; SCHLESINGER G, 1983, J MOL EVOL, V19, P376, DOI 10.1007/BF02101642; STRIBLING R, 1987, ORIGINS LIFE EVOL B, V17, P261, DOI 10.1007/BF02386466; TURCOTTE DL, 1980, EARTH PLANET SC LETT, V48, P53, DOI 10.1016/0012-821X(80)90169-7; Walker, 1977, EVOLUTION ATMOSPHERE, V32, P71; WALKER JCG, 1985, ORIGINS LIFE EVOL B, V16, P117, DOI 10.1007/BF01809466; ZAHNLE KJ, 1986, J GEOPHYS RES-ATMOS, V91, P2819, DOI 10.1029/JD091iD02p02819; ZUILEN MA, 2002, NATURE, V418, P627	29	279	296	5	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2005	308	5724					1014	1017		10.1126/science.1106983	http://dx.doi.org/10.1126/science.1106983			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15817816				2022-12-24	WOS:000229190700044
J	James, C; Ugo, V; Le Couedic, JP; Staerk, J; Delhommeau, F; Lacout, C; Garcon, L; Raslova, H; Berger, R; Bennaceur-Griscelli, A; Villeval, JL; Constantinescu, SN; Casadevall, N; Vainchenker, W				James, C; Ugo, V; Le Couedic, JP; Staerk, J; Delhommeau, F; Lacout, C; Garcon, L; Raslova, H; Berger, R; Bennaceur-Griscelli, A; Villeval, JL; Constantinescu, SN; Casadevall, N; Vainchenker, W			A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera	NATURE			English	Article							ERYTHROID PROGENITORS; PSEUDOKINASE DOMAIN; TYROSINE KINASE; T-CELL; ERYTHROPOIETIN; EXPRESSION; LEUKEMIA; JANUS-KINASE-2; INTERFERON; RESPONSES	Myeloproliferative disorders are clonal haematopoietic stem cell malignancies characterized by independency or hypersensitivity of haematopoietic progenitors to numerous cytokines(1,2). The molecular basis of most myeloproliferative disorders is unknown. On the basis of the model of chronic myeloid leukaemia, it is expected that a constitutive tyrosine kinase activity could be at the origin of these diseases. Polycythaemia vera is an acquired myeloproliferative disorder, characterized by the presence of polycythaemia diversely associated with thrombocytosis, leukocytosis and splenomegaly(3). Polycythaemia vera progenitors are hypersensitive to erythropoietin and other cytokines(4,5). Here, we describe a clonal and recurrent mutation in the JH2 pseudo-kinase domain of the Janus kinase 2 (JAK2) gene in most (>80%) polycythaemia vera patients. The mutation, a valine-to-phenylalanine substitution at amino acid position 617, leads to constitutive tyrosine phosphorylation activity that promotes cytokine hypersensitivity and induces erythrocytosis in a mouse model. As this mutation is also found in other myeloproliferative disorders, this unique mutation will permit a new molecular classification of these disorders and novel therapeutical approaches.	Univ Paris 11, Inst Gustave Roussy, INSERM, U362, F-94805 Villejuif, France; CHU Brest, Hematol Lab, F-29609 Brest, France; Hop Hotel Dieu, Hematol Lab, F-75181 Paris, France; Catholic Univ Louvain, Ludwig Inst Canc Res, B-1200 Brussels, Belgium; Catholic Univ Louvain, Christian de Duve Inst Cellular Pathol, B-1200 Brussels, Belgium; Catholic Univ Louvain, MEXP Unit, B-1200 Brussels, Belgium; Hop Necker Enfants Malad, INSERM, E0210, F-75743 Paris, France; Inst Gustave Roussy, Hematol Lab, F-94805 Villejuif, France; Hop St Louis, Polyclin Hematol, F-75475 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; CHU Brest; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Vainchenker, W (corresponding author), Univ Paris 11, Inst Gustave Roussy, INSERM, U362, PR1,39 Rue Camille Desmoulins, F-94805 Villejuif, France.	verpre@igr.fr	james, chloe/A-2015-2012; Raslova, Hana/N-3562-2018; Constantinescu, Stefan N/E-5277-2012	Raslova, Hana/0000-0001-8846-5299; Vainchenker, William/0000-0003-4705-202X; Ugo, Valerie/0000-0002-4678-2138; Delhommeau, Francois/0000-0002-4915-0734; Staerk, Judith/0000-0001-8698-6998; Villeval, Jean-Luc/0000-0002-0562-925X; bennaceur griscelli, annelise/0000-0002-3557-4499; James, Chloe/0000-0001-9553-2701; Constantinescu, Stefan N./0000-0002-8599-2699				Argetsinger LS, 2004, MOL CELL BIOL, V24, P4955, DOI 10.1128/MCB.24.11.4955-4967.2004; Bernabei P, 2001, J LEUKOCYTE BIOL, V70, P950; CASADEVALL N, 1982, BLOOD, V59, P447; Chagraoui C, 2003, BLOOD, V101, P2983, DOI 10.1182/blood-2002-09-2839; Cools J, 1999, CYTOGENET CELL GENET, V85, P260, DOI 10.1159/000015308; Dorsch M, 2002, BLOOD, V100, P2046, DOI 10.1182/blood.V100.6.2046.h81802002046_2046_2055; Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697; Feener EP, 2004, MOL CELL BIOL, V24, P4968, DOI 10.1128/MCB.24.11.4968-4978.2004; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Kohlhuber F, 1997, MOL CELL BIOL, V17, P695, DOI 10.1128/MCB.17.2.695; Kralovics R, 2003, BLOOD, V102, P3793, DOI 10.1182/blood-2003-03-0885; Kralovics R, 2002, EXP HEMATOL, V30, P229, DOI 10.1016/S0301-472X(01)00789-5; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; LECONIAT M, 1995, GENE CHROMOSOME CANC, V14, P204; Lindauer K, 2001, PROTEIN ENG, V14, P27, DOI 10.1093/protein/14.1.27; Luo H, 1997, MOL CELL BIOL, V17, P1562, DOI 10.1128/MCB.17.3.1562; Najfeld V, 2002, BRIT J HAEMATOL, V119, P558, DOI 10.1046/j.1365-2141.2002.03763.x; Pearson TC, 1996, LEUKEMIA LYMPHOMA, V22, P87; PRCHAL JF, 1974, NEW ENGL J MED, V290, P1382; Prchal JT, 2005, CURR OPIN HEMATOL, V12, P112, DOI 10.1097/01.moh.0000154029.05396.d2; Saharinen P, 2000, MOL CELL BIOL, V20, P3387, DOI 10.1128/MCB.20.10.3387-3395.2000; Saharinen P, 2003, MOL BIOL CELL, V14, P1448, DOI 10.1091/mbc.E02-06-0342; Spivak JL, 2004, SEMIN HEMATOL, V41, P1, DOI 10.1053/j.seminhematol.2004.02.011; Spivak JL, 2002, BLOOD, V100, P4272, DOI 10.1182/blood-2001-12-0349; Ugo V, 2004, EXP HEMATOL, V32, P179, DOI 10.1016/j.exphem.2003.11.003; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; Zhao SM, 2002, EMBO J, V21, P2159, DOI 10.1093/emboj/21.9.2159	27	2627	2888	0	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2005	434	7037					1144	1148		10.1038/nature03546	http://dx.doi.org/10.1038/nature03546			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15793561				2022-12-24	WOS:000228693300046
J	Tilley, SJ; Orlova, EV; Gilbert, RJC; Andrew, PW; Saibil, HR				Tilley, SJ; Orlova, EV; Gilbert, RJC; Andrew, PW; Saibil, HR			Structural basis of pore formation by the bacterial toxin pneumolysin	CELL			English	Article							CHOLESTEROL-DEPENDENT CYTOLYSIN; PERFRINGOLYSIN-O; CLOSTRIDIUM-PERFRINGENS; THETA-TOXIN; TRYPTOPHAN RESIDUES; MEMBRANE INSERTION; PREPORE COMPLEX; STREPTOLYSIN-O; FORMING TOXIN; BINDING	The bacterial toxin pneumolysin is released as a soluble monomer that kills target cells by assembling into large oligomeric rings and forming pores in cholesterol-containing membranes. Using cryo-EM and image processing, we have determined the structures of membrane-surface bound (prepore) and inserted-pore oligomer forms, providing a direct observation of the conformational transition into the pore form of a cholesterol-dependent cytolysin. In the pore structure, the domains of the monomer separate and double over into an arch, forming a wall sealing the bilayer around the pore. This transformation is accomplished by substantial refolding of two of the four protein domains along with deformation of the membrane. Extension of protein density into the bilayer supports earlier predictions that the protein inserts beta hairpins into the membrane. With an oligomer size of up to 44 subunits in the pore, this assembly creates a transmembrane channel 260 angstrom in diameter lined by 176 beta strands.	Univ London Birkbeck Coll, Sch Crystallog, London WC1E 7HX, England; Univ London Birkbeck Coll, Inst Struct Mol Biol, London WC1E 7HX, England; Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Oxford, Ctr Mol Sci, Cent Chem Lab, Oxford OX1 3QU, England; Univ Leicester, Dept Infect Immun & Inflammat, Leicester LE1 9HN, Leics, England	University of London; Birkbeck University London; University of London; Birkbeck University London; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Leicester	Saibil, HR (corresponding author), Univ London Birkbeck Coll, Sch Crystallog, Malet St, London WC1E 7HX, England.	h.saibil@mail.cryst.bbk.ac.uk	Andrew, Peter W/G-7526-2012; Orlova, Elena/CAF-8290-2022	Orlova, Elena/0000-0003-3371-415X	Biotechnology and Biological Sciences Research Council [B13531] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alexander JE, 1998, MICROB PATHOGENESIS, V24, P167, DOI 10.1006/mpat.1997.0185; Alouf JE, 2000, INT J MED MICROBIOL, V290, P351; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERRY AM, 1989, INFECT IMMUN, V57, P2037, DOI 10.1128/IAI.57.7.2037-2042.1989; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; Czajkowsky DM, 2004, EMBO J, V23, P3206, DOI 10.1038/sj.emboj.7600350; Giddings KS, 2003, P NATL ACAD SCI USA, V100, P11315, DOI 10.1073/pnas.2033520100; Gilbert RJC, 1998, J MOL BIOL, V284, P1223, DOI 10.1006/jmbi.1998.2258; Gilbert RJC, 1999, CELL, V97, P647, DOI 10.1016/S0092-8674(00)80775-8; Gilbert RJC, 2002, CELL MOL LIFE SCI, V59, P832, DOI 10.1007/s00018-002-8471-1; Heuck AP, 2000, MOL CELL, V6, P1233, DOI 10.1016/S1097-2765(00)00119-2; Heuck AP, 2003, J BIOL CHEM, V278, P31218, DOI 10.1074/jbc.M303151200; HILL J, 1994, INFECT IMMUN, V62, P757, DOI 10.1128/IAI.62.2.757-758.1994; Hotze EM, 2002, J BIOL CHEM, V277, P11597, DOI 10.1074/jbc.M111039200; Hotze EM, 2001, J BIOL CHEM, V276, P8261, DOI 10.1074/jbc.M009865200; Jacobs T, 1998, MOL MICROBIOL, V28, P1081, DOI 10.1046/j.1365-2958.1998.00858.x; Korchev YE, 1998, BIOCHEM J, V329, P571; MITCHELL TJ, 1991, MOL MICROBIOL, V5, P1883, DOI 10.1111/j.1365-2958.1991.tb00812.x; MITCHELL TJ, 1992, ZBL BAKT, V23, P429; MORGAN PJ, 1995, FEBS LETT, V371, P77, DOI 10.1016/0014-5793(95)00887-F; NAKAMURA M, 1995, BIOCHEMISTRY-US, V34, P6513, DOI 10.1021/bi00019a032; Nakamura M, 1998, J BIOCHEM, V123, P1145; Nollmann M, 2004, BIOPHYS J, V86, P3141, DOI 10.1016/S0006-3495(04)74362-3; OHNOIWASHITA Y, 1988, EUR J BIOCHEM, V176, P95, DOI 10.1111/j.1432-1033.1988.tb14255.x; OLOFSSON A, 1993, FEBS LETT, V319, P125, DOI 10.1016/0014-5793(93)80050-5; Palmer M, 1998, EMBO J, V17, P1598, DOI 10.1093/emboj/17.6.1598; Palmer M, 2001, TOXICON, V39, P1681, DOI 10.1016/S0041-0101(01)00155-6; PATON JC, 1984, INFECT IMMUN, V43, P1085, DOI 10.1128/IAI.43.3.1085-1087.1984; Ramachandran R, 2004, NAT STRUCT MOL BIOL, V11, P697, DOI 10.1038/nsmb793; Ramachandran R, 2002, NAT STRUCT BIOL, V9, P823, DOI 10.1038/nsb855; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; SekinoSuzuki N, 1996, EUR J BIOCHEM, V241, P941, DOI 10.1111/j.1432-1033.1996.00941.x; SEKIYA K, 1993, J BACTERIOL, V175, P5953, DOI 10.1128/JB.175.18.5953-5961.1993; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Shepard LA, 2000, BIOCHEMISTRY-US, V39, P10284, DOI 10.1021/bi000436r; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Smith JM, 1999, J STRUCT BIOL, V125, P223, DOI 10.1006/jsbi.1998.4073; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; White HE, 2004, J MOL BIOL, V336, P453, DOI 10.1016/j.jmb.2003.12.015	40	316	326	1	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 22	2005	121	2					247	256		10.1016/j.cell.2005.02.033	http://dx.doi.org/10.1016/j.cell.2005.02.033			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851031	Bronze			2022-12-24	WOS:000228705000012
J	Duraisingh, MT; Voss, TS; Marty, AJ; Duffy, MF; Good, RT; Thompson, JK; Freitas-Junior, LH; Scherf, A; Crabb, BS; Cowman, AF				Duraisingh, MT; Voss, TS; Marty, AJ; Duffy, MF; Good, RT; Thompson, JK; Freitas-Junior, LH; Scherf, A; Crabb, BS; Cowman, AF			Heterochromatin silencing and locus repositioning linked to regulation of virulence genes in Plasmodium faiciparum	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; ANTIGENIC VARIATION; HUMAN ERYTHROCYTES; FALCIPARUM; EXPRESSION; MALARIA; ORGANIZATION; PROTEINS; RECOMBINATION; TRANSCRIPTION	The malaria parasite Plasmodium falciparum undergoes antigenic variation to evade host immune responses through switching expression of variant surface proteins encoded by the var gene family. We demonstrate that both a subtelomeric transgene and var genes are subject to reversible gene silencing. Var gene silencing involves the SIR complex as gene disruption of PfSIR2 results in activation of this gene family. We also demonstrate that perinuclear gene activation involves chromatin alterations and repositioning into a location that may be permissive for transcription. Together, this implies that locus repositioning and heterochromatic silencing play important roles in the epigenetic regulation of virulence genes in P. falciparum.	Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; Inst Pasteur, Paris, France; Univ Melbourne, Dept Med, Melbourne, Vic, Australia	Walter & Eliza Hall Institute; Monash University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Melbourne	Cowman, AF (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.	crabb@wehi.edu.au	Duffy, Michael/A-8618-2012; Scherf, Artur/A-9674-2014; Cowman, Alan F/C-7642-2013; Jackson, Allison/D-6528-2012; Crabb, Brendan/F-5287-2013; Freitas-Junior, Lucio H/C-8677-2011	Duffy, Michael/0000-0001-5635-4033; Cowman, Alan F/0000-0001-5145-9004; Jackson, Allison/0000-0002-9614-6471; Freitas-Junior, Lucio H/0000-0002-8904-7897; Scherf, Artur/0000-0003-2411-3328				Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; ASLUND L, 1985, J MOL BIOL, V185, P509, DOI 10.1016/0022-2836(85)90067-1; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Crabb BS, 1996, P NATL ACAD SCI USA, V93, P7289, DOI 10.1073/pnas.93.14.7289; Deitsch KW, 2001, NATURE, V412, P875, DOI 10.1038/35091146; Duffy MF, 2002, MOL MICROBIOL, V43, P1285, DOI 10.1046/j.1365-2958.2002.02822.x; DUFFY MF, 2005, IN PRESS MOL MICROB; Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096; Ersfeld K, 1998, CHROMOSOMA, V107, P237, DOI 10.1007/s004120050302; Feuerbach F, 2002, NAT CELL BIOL, V4, P214, DOI 10.1038/ncb756; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Figueiredo LM, 2000, MOL BIOCHEM PARASIT, V106, P169, DOI 10.1016/S0166-6851(99)00199-1; Francastel C, 2000, NAT REV MOL CELL BIO, V1, P137, DOI 10.1038/35040083; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7; Gasser SM, 2001, CELL, V104, P639, DOI 10.1016/S0092-8674(01)00259-8; GOTTSCHLING DE, 1992, P NATL ACAD SCI USA, V89, P4062, DOI 10.1073/pnas.89.9.4062; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Grewal SIS, 2000, J CELL PHYSIOL, V184, P311, DOI 10.1002/1097-4652(200009)184:3<311::AID-JCP4>3.0.CO;2-D; Henikoff S., 2000, BIOCHIM BIOPHYS ACTA, V1470, P01; Hsieh J, 2000, ANNU REV GENET, V34, P187, DOI 10.1146/annurev.genet.34.1.187; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lusic M, 2003, EMBO J, V22, P6550, DOI 10.1093/emboj/cdg631; Lustig AJ, 1998, CURR OPIN GENET DEV, V8, P233, DOI 10.1016/S0959-437X(98)80146-9; Moazed D, 2001, MOL CELL, V8, P489, DOI 10.1016/S1097-2765(01)00340-9; Navarro M, 2001, NATURE, V414, P759, DOI 10.1038/414759a; O'Donnell RA, 2002, EMBO J, V21, P1231, DOI 10.1093/emboj/21.5.1231; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; Skok JA, 2001, NAT IMMUNOL, V2, P848, DOI 10.1038/ni0901-848; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; TELFORD DJ, 1989, INT J BIOCHEM, V21, P127, DOI 10.1016/0020-711X(89)90100-6; Voss TS, 2003, MOL MICROBIOL, V48, P1593, DOI 10.1046/j.1365-2958.2003.03528.x	38	361	369	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 8	2005	121	1					13	24		10.1016/j.cell.2005.01.036	http://dx.doi.org/10.1016/j.cell.2005.01.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	915YU	15820675	Bronze			2022-12-24	WOS:000228348500006
J	Marquardt, T; Shirasaki, R; Ghosh, S; Andrews, SE; Carter, N; Hunter, T; Pfaff, SL				Marquardt, T; Shirasaki, R; Ghosh, S; Andrews, SE; Carter, N; Hunter, T; Pfaff, SL			Coexpressed EphA receptors and ephrin-A ligands mediate opposing actions on growth cone navigation from distinct membrane domains	CELL			English	Article							MOTOR-NEURONS; AXON GUIDANCE; LIPID RAFTS; INTERMEDIATE TARGET; TYROSINE KINASES; FAMILY; MECHANISMS; MORPHOGENESIS; EXPRESSION; REQUIRES	Contact-dependent signaling between membrane-linked ligands and receptors such as the ephrins and Eph receptor tyrosine kinases controls a wide range of developmental and pathological processes. Paradoxically, many cell types coexpress both ligands and receptors, raising the question of how specific signaling readouts are achieved under these conditions. Here, we studied the signaling activities exerted by coexpressed EphA receptors and GPI-linked ephrin-A ligands in spinal motor neuron growth cones. We demonstrate that coexpressed Eph and ephrin proteins segregate laterally into distinct membrane domains from which they signal opposing effects on the growth cone: EphAs direct growth cone collapse/repulsion and ephrin-As signal motor axon growth/attraction. This subcellular arrangement of Eph-ephrin proteins enables axons to discriminate between cis- versus trans-configurations of ligand/receptor proteins, thereby allowing the utilization of both Ephs and ephrins as functional guidance receptors within the same neuronal growth cone.	Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA	Salk Institute; Salk Institute	Pfaff, SL (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pfaff@salk.edu		Ghosh, Sourav/0000-0001-5990-8708	NATIONAL CANCER INSTITUTE [R01CA082683] Funding Source: NIH RePORTER; NCI NIH HHS [CA82683] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams RH, 2001, CELL, V104, P57, DOI 10.1016/S0092-8674(01)00191-X; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; Carter N, 2002, NAT CELL BIOL, V4, P565, DOI 10.1038/ncb823; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; Dravis C, 2004, DEV BIOL, V271, P272, DOI 10.1016/j.ydbio.2004.03.027; Drescher U, 1997, CURR OPIN NEUROBIOL, V7, P75, DOI 10.1016/S0959-4388(97)80123-7; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; Eberhart J, 2002, DEV BIOL, V247, P89, DOI 10.1006/dbio.2002.0695; Feng GP, 2000, NEURON, V25, P295, DOI 10.1016/S0896-6273(00)80895-8; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gerety SS, 2002, DEVELOPMENT, V129, P1397; Godenschwege TA, 2002, NAT NEUROSCI, V5, P1294, DOI 10.1038/nn976; Guirland C, 2004, NEURON, V42, P51, DOI 10.1016/S0896-6273(04)00157-6; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Helmbacher F, 2000, DEVELOPMENT, V127, P3313; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Iwamasa H, 1999, DEV GROWTH DIFFER, V41, P685; Kamiguchi H, 2000, CURR OPIN CELL BIOL, V12, P598, DOI 10.1016/S0955-0674(00)00138-1; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Knoll B, 2001, DEVELOPMENT, V128, P895; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Lemke G, 1997, MOL CELL NEUROSCI, V9, P331, DOI 10.1006/mcne.1997.0630; Manes S, 2003, TRENDS IMMUNOL, V24, P320, DOI 10.1016/S1471-4906(03)00137-6; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Thaler JP, 2002, CELL, V110, P237, DOI 10.1016/S0092-8674(02)00823-1; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; Wang XM, 1999, MOL CELL, V4, P903, DOI 10.1016/S1097-2765(00)80220-8; Yin Y, 2004, NEUROSCI RES, V48, P285, DOI 10.1016/j.neures.2003.11.009; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045	44	195	199	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 8	2005	121	1					127	139		10.1016/j.cell.2005.01.020	http://dx.doi.org/10.1016/j.cell.2005.01.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	915YU	15820684	Bronze			2022-12-24	WOS:000228348500015
J	Goldenberg, NA; Jacobson, L; Manco-Johnson, MJ				Goldenberg, NA; Jacobson, L; Manco-Johnson, MJ			Brief communication: Duration of platelet dysfunction after a 1-day course of ibuprofen	ANNALS OF INTERNAL MEDICINE			English	Article							FUNCTION ANALYZER; BLEEDING-TIME; BLOOD-LOSS; ASPIRIN; PFA-100(TM); VOLUNTEERS; DRUGS	Background: Despite a paucity of evidence, clinicians routinely advise that patients discontinue using nonsteroidal anti-inflammatory drugs (NSAIDs), including ibuprofen, at least 1 week before most surgical procedures. Objective: To define the duration of ibuprofen-induced platelet dysfunction. Design: Prospective cohort study. Setting: Denver/Aurora, Colorado. Participants: 11 healthy adult volunteers. Measurements: individuals were tested at baseline and serially after completion of a 7-day course of ibuprofen (600 mg orally every 8 hours). The platelet function analyzer (PFA-100, Dade Behring, Newark, Delaware, a test that has replaced the bleeding time in many clinical settings, was used. Results: All participants exhibited normal platelet function before starting ibuprofen. Platelet dysfunction was apparent after completion of the ibuprofen course in 7 of the 11 participants and normalized by 24 hours after the last ibuprofen dose. Limitations: The sample size in this study was small, and no participants had a major illness. Correlation between PFA-100 results and clinical bleeding has not been established. Conclusions: Platelet function seems to normalize within 24 hours after cessation of regular ibuprofen use in healthy individuals. Further studies are warranted to provide a rational basis for timing of NSAID withdrawal in a range of patients undergoing surgery.	Univ Colorado, Hlth Sci Ctr, Mt States Hemophilia & Thrombosis Ctr, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Goldenberg, NA (corresponding author), Univ Colorado, Hlth Sci Ctr, Mt States Hemophilia & Thrombosis Ctr, POB 6507,Mail Stop F416, Aurora, CO 80045 USA.	neil.goidenberg@uchsc.edu						FERRARIS VA, 1983, SURG GYNECOL OBSTET, V156, P439; FERRARIS VA, 1988, ANN THORAC SURG, V45, P71, DOI 10.1016/S0003-4975(10)62401-0; Fressinaud E, 1998, BLOOD, V91, P1325, DOI 10.1182/blood.V91.4.1325; *I CLIN SYST IMPR, 2003, HLTH CAR GUID PREOP; Kadakia SC, 1996, GASTROINTEST ENDOSC, V44, P309, DOI 10.1016/S0016-5107(96)70170-0; Knijff-Dutmer EAJ, 2003, QJM-INT J MED, V96, P513, DOI 10.1093/qjmed/hcg090; KUNDU SK, 1995, SEMIN THROMB HEMOST, V21, P106; Leese PT, 2000, J CLIN PHARMACOL, V40, P124, DOI 10.1177/00912700022008766; Leese PT, 2002, AM J EMERG MED, V20, P275, DOI 10.1053/ajem.2002.32635; Mammen EF, 1998, SEMIN THROMB HEMOST, V24, P195, DOI 10.1055/s-2007-995840; Munsterhjelm E, 2003, BRIT J ANAESTH, V91, P357, DOI 10.1093/bja/aeg195; NADELL J, 1974, J CLIN PHARMACOL, V14, P176, DOI 10.1002/j.1552-4604.1974.tb01395.x; Peterson P, 1998, ARCH SURG-CHICAGO, V133, P134, DOI 10.1001/archsurg.133.2.134; Schafer AI, 2003, CIRCULATION, V108, P910, DOI 10.1161/01.CIR.0000088843.52678.8A; Sonksen JR, 1999, BRIT J ANAESTH, V82, P360, DOI 10.1093/bja/82.3.360; Spell NO, 2001, MED CLIN N AM, V85, P1117, DOI 10.1016/S0025-7125(05)70367-9; TOROSIAN M, 1978, ANN INTERN MED, V89, P325, DOI 10.7326/0003-4819-89-3-325; Wuillemin WA, 2002, SWISS MED WKLY, V132, P443	18	56	59	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 5	2005	142	7					506	509		10.7326/0003-4819-142-7-200504050-00009	http://dx.doi.org/10.7326/0003-4819-142-7-200504050-00009			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	913QL	15809462				2022-12-24	WOS:000228167800004
J	Fenton, KA; Mercer, CH; McManus, S; Erens, B; Wellings, K; Macdowall, W; Byron, CL; Copas, AJ; Nanchahal, K; Field, J; Johnson, AM				Fenton, KA; Mercer, CH; McManus, S; Erens, B; Wellings, K; Macdowall, W; Byron, CL; Copas, AJ; Nanchahal, K; Field, J; Johnson, AM			Ethnic variations in sexual behaviour in Great Britain and risk of sexually transmitted infections: a probability survey	LANCET			English	Article							HIV TRANSMISSION; GONORRHEA; LONDON; RACE; EPIDEMIOLOGY; PARTNERSHIPS; CHLAMYDIA; EDUCATION; PATTERNS; HEALTH	Background Ethnic variations in the rate of diagnosed sexually transmitted infections (STIs) have been reported in many developed countries. We used data from the second British National Survey of Sexual Attitudes and Lifestyles (Natsal 2000) to investigate the frequency of high-risk sexual behaviours and, adverse sexual health outcomes in five ethnic groups in Great Britain. Methods We did a stratified probability sample survey of 11161 men and women aged 16-44 years, resident in Great Britain, using computer-assisted interviews. Additional sampling enabled us to do more detailed analyses for 949 black Caribbean, black African, Indian, and Pakistani respondents. We used logistic regression to assess reporting of STI diagnoses in the past 5 years, after controlling for demographic and behavioural variables. Findings We rioted striking variations in number of sexual partnerships by ethnic group and between men and women. Reported numbers of sexual partnerships in a lifetime were highest in black Caribbean (median 9 [IQR 4-20]) and black African (9 [3-20]) men, and in white (5 [2-9]) and black Caribbean (4 [2-7]) women. Indian and Pakistani men and women reported fewer sexual partnerships, later first intercourse, and substantially lower prevalence of diagnosed STIs than did other groups. We recorded a significant association between ethnic origin and reported STIs in the past 5 years with increased risk in sexually active black Caribbean (OR 2.74 [95% CI 1.22-6.15]) and black African (2.95 [1.45-5.99]) men compared with white men, and black Caribbean (2.41 [1.35-4.28]) women compared with white women. odds ratios changed little after controlling for age, number of sexual partnerships, homosexual and overseas partnerships, and condom use at last sexual intercourse. Interpretation Individual sexual behaviour is a key determinant of STI transmission risk, but alone does not explain the varying risk across ethnic groups. Our findings suggest a need for targeted and culturally competent prevention interventions.	UCL, Ctr Sexual Hlth & HIV Res, Dept Primary Care & Populat Sci, London, England; Hlth Protect Agcy, Ctr Communicable Dis Surveillance, HIV & STI Dept, London, England; Natl Ctr Social Res, London, England; London Sch Hyg & Trop Med, Ctr Sexual & Reprod Hlth Res, London WC1, England	University of London; University College London; Health Protection Agency; University of London; London School of Hygiene & Tropical Medicine	Fenton, KA (corresponding author), Hlth Protect Agcy, Ctr Communicable Dis Surveillance, HIV & Sexually Transmitted Infect Dept, London NW9 5EQ, England.	Kevin.fenton@hpa.org.uk	McManus, Sally/S-4697-2019; McManus, Sally/HGD-4860-2022	McManus, Sally/0000-0003-2711-0819; Mercer, Catherine/0000-0002-4220-5034; Nanchahal, Kiran/0000-0001-8812-7628; Copas, Andrew/0000-0001-8968-5963; Erens, Robert/0000-0002-3054-504X; Johnson, Anne/0000-0003-1330-7100; Erens, Bob/0000-0002-4430-954X; Macdowall, Wendy/0000-0001-5868-8336				Aral SO, 2000, SEX TRANSM INFECT, V76, P415, DOI 10.1136/sti.76.6.415; Buzi RS, 1998, ADOLESCENCE, V33, P313; CHINOUYA M, 2000, SEXUAL ATTITUDES LIF; Choi KH, 2003, AIDS EDUC PREV, V15, P53, DOI 10.1521/aeap.15.1.5.53.23609; Cliffe S, 1999, Ethn Health, V4, P5; Copas AJ, 1997, AIDS, V11, P783, DOI 10.1097/00002030-199706000-00011; Department of Health, 2001, NAT STRAT SEX HLTH H, P1; Dodds JP, 2004, SEX TRANSM INFECT, V80, P236, DOI 10.1136/sti.2003.007286; Elam G., 1999, EXPLORING ETHNICITY, P1; Erens B, 2001, NATL SURVEY SEXUAL A; Fenton K, 1997, BRIT MED J, V314, P1703, DOI 10.1136/bmj.314.7096.1703; Fenton KA, 2001, SEX TRANSM INFECT, V77, P84, DOI 10.1136/sti.77.2.84; Fenton KA, 2001, AIDS, V15, P1442, DOI 10.1097/00002030-200107270-00017; Fenton KA, 2001, LANCET, V358, P1851, DOI 10.1016/S0140-6736(01)06886-6; Ghani AC, 1997, SEX TRANSM DIS, V24, P45, DOI 10.1097/00007435-199701000-00009; HOLMES KK, 1984, UROL CLIN N AM, V11, P3; HOOYKAAS C, 1991, GENITOURIN MED, V67, P378; Hughes G, 2001, SEX TRANSM DIS, V28, P379, DOI 10.1097/00007435-200107000-00004; *ISD SCIEH HLTH PR, 2003, REN FOC HIV OTH SEX; JAMES NJ, 1991, AIDS, V5, P333, DOI 10.1097/00002030-199103000-00016; Johnson AM, 2001, LANCET, V358, P1835, DOI 10.1016/S0140-6736(01)06883-0; JOHNSON AM, 1994, SEXUAL ATTITUDES LIF; Jonsson M, 1997, INT J STD AIDS, V8, P501, DOI 10.1258/0956462971920659; Lacey CJN, 1997, BRIT MED J, V314, P1715, DOI 10.1136/bmj.314.7096.1715; LAUMANN EO, 2000, SEX TRANSM DIS, V26, P264; Low N, 2001, SEX TRANSM INFECT, V77, P15, DOI 10.1136/sti.77.1.15; Low N, 1997, BRIT MED J, V314, P1719, DOI 10.1136/bmj.314.7096.1719; MAY RM, 1987, NATURE, V326, P137, DOI 10.1038/326137a0; McFarlane M, 1999, J ADOLESCENT HEALTH, V25, P199, DOI 10.1016/S1054-139X(98)00156-6; *OFF NAT STAT, 2000, POP EST 1999; Rogstad KE, 2004, BRIT MED J, V329, P214, DOI 10.1136/bmj.329.7459.214; Ross MW, 1998, SEX TRANSM INFECT, V74, P2; Santelli JS, 2000, AM J PUBLIC HEALTH, V90, P1582, DOI 10.2105/AJPH.90.10.1582; Sinka K, 2003, AIDS, V17, P1683, DOI 10.1097/00002030-200307250-00013; STATA, 2001, STAT STAT SOFTW REL; Stephenson JM, 2003, CONTROL CLIN TRIALS, V24, P643, DOI 10.1016/S0197-2456(03)00070-9; THOMAS JC, 2000, SOC SCI MED, V49, P1084; Wellings F, 2001, LANCET, V358, P1843, DOI 10.1016/S0140-6736(01)06885-4; Wight D, 2002, BMJ-BRIT MED J, V324, P1430, DOI 10.1136/bmj.324.7351.1430; Williams DR, 2002, AM J PUBLIC HEALTH, V92, P588, DOI 10.2105/AJPH.92.4.588	40	122	122	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2005	365	9466					1246	1255		10.1016/S0140-6736(05)74813-3	http://dx.doi.org/10.1016/S0140-6736(05)74813-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	912VI	15811458				2022-12-24	WOS:000228107600028
J	Baines, CP; Kaiser, RA; Purcell, NH; Blair, NS; Osinska, H; Hambleton, MA; Brunskill, EW; Sayen, MR; Gottlieb, RA; Dorn, GW; Robbins, J; Molkentin, JD				Baines, CP; Kaiser, RA; Purcell, NH; Blair, NS; Osinska, H; Hambleton, MA; Brunskill, EW; Sayen, MR; Gottlieb, RA; Dorn, GW; Robbins, J; Molkentin, JD			Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death	NATURE			English	Article							CYTOCHROME-C RELEASE; CYCLOSPORINE-A; LETHAL INJURY; PORE COMPLEX; BAX; APOPTOSIS; ISCHEMIA; TRANSLOCATOR; HEPATOCYTES; ACTIVATION	Mitochondria play a critical role in mediating both apoptotic and necrotic cell death. The mitochondrial permeability transition (mPT) leads to mitochondrial swelling, outer membrane rupture and the release of apoptotic mediators. The mPT pore is thought to consist of the adenine nucleotide translocator, a voltage-dependent anion channel, and cyclophilin D (the Ppif gene product), a prolyl isomerase located within the mitochondrial matrix(1,2). Here we generated mice lacking Ppif and mice overexpressing cyclophilin D in the heart. Ppif null mice are protected from ischaemia/reperfusion-induced cell death in vivo, whereas cyclophilin D-overexpressing mice show mitochondrial swelling and spontaneous cell death. Mitochondria isolated from the livers, hearts and brains of Ppif null mice are resistant to mitochondrial swelling and permeability transition in vitro. Moreover, primary hepatocytes and fibroblasts isolated from Ppif null mice are largely protected from Ca2+-overload and oxidative stress-induced cell death. However, Bcl-2 family member-induced cell death does not depend on cyclophilin D, and Ppif null fibroblasts are not protected from staurosporine or tumour-necrosis factor-alpha-induced death. Thus, cyclophilin D and the mitochondrial permeability transition are required for mediating Ca2+-and oxidative damage-induced cell death, but not Bcl-2 family member-regulated death.	Univ Cincinnati, Childrens Hosp, Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; Univ Cincinnati, Childrens Hosp, Med Ctr, Dept Mol Genet, Cincinnati, OH 45229 USA; Univ Cincinnati, Childrens Hosp, Med Ctr, Dept Med, Cincinnati, OH 45229 USA; Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Scripps Research Institute	Molkentin, JD (corresponding author), Univ Cincinnati, Childrens Hosp, Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA.	jeff.molkentin@cchmc.org		Baines, Christopher/0000-0002-4473-3869; Molkentin, Jeffery/0000-0002-3558-6529; Gottlieb, Roberta/0000-0002-1432-006X				Adams JW, 2000, CIRC RES, V87, P1180, DOI 10.1161/01.RES.87.12.1180; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Clarke SJ, 2002, J BIOL CHEM, V277, P34793, DOI 10.1074/jbc.M202191200; Crompton M, 2003, CURR MED CHEM, V10, P1473, DOI 10.2174/0929867033457197; Eskes R, 1998, J CELL BIOL, V143, P217, DOI 10.1083/jcb.143.1.217; GRIFFITHS EJ, 1993, J MOL CELL CARDIOL, V25, P1461, DOI 10.1006/jmcc.1993.1162; GRIFFITHS EJ, 1995, BIOCHEM J, V307, P93, DOI 10.1042/bj3070093; Halestrap A, 2005, NATURE, V434, P578, DOI 10.1038/434578a; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; He LH, 2002, FEBS LETT, V512, P1, DOI 10.1016/S0014-5793(01)03314-2; IMBERTI R, 1993, J PHARMACOL EXP THER, V265, P392; Kagawa S, 2000, GENE THER, V7, P75, DOI 10.1038/sj.gt.3301048; Kaiser RA, 2004, J BIOL CHEM, V279, P15524, DOI 10.1074/jbc.M313717200; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Li YM, 2004, BIOCHEM J, V383, P101, DOI 10.1042/BJ20040669; Lin DT, 2002, J BIOL CHEM, V277, P31134, DOI 10.1074/jbc.M112035200; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; NIEMINEN AL, 1995, BIOCHEM J, V307, P99, DOI 10.1042/bj3070099; Pallotti F, 2001, METHOD CELL BIOL, V65, P1, DOI 10.1016/S0091-679X(01)65002-7; Pastorino JG, 1998, J BIOL CHEM, V273, P7770, DOI 10.1074/jbc.273.13.7770; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; Qian T, 1997, AM J PHYSIOL-CELL PH, V273, pC1783, DOI 10.1152/ajpcell.1997.273.6.C1783; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; von Ahsen O, 2000, J CELL BIOL, V150, P1027, DOI 10.1083/jcb.150.5.1027; Zamzami N, 2000, ONCOGENE, V19, P6342, DOI 10.1038/sj.onc.1204030	27	1736	1797	8	172	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2005	434	7033					658	662		10.1038/nature03434	http://dx.doi.org/10.1038/nature03434			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911NN	15800627				2022-12-24	WOS:000228011000048
J	Oelschlaegel, T; Schwickart, M; Matos, J; Bogdanova, A; Camasses, A; Havlis, J; Shevchenko, A; Zachariae, W				Oelschlaegel, T; Schwickart, M; Matos, J; Bogdanova, A; Camasses, A; Havlis, J; Shevchenko, A; Zachariae, W			The yeast APC/C subunit Mnd2 prevents premature sister chromatid separation triggered by the meiosis-specific APC/C-Ama1	CELL			English	Article							ANAPHASE-PROMOTING COMPLEX; CHROMOSOME SEGREGATION; FISSION YEAST; CENTROMERIC COHESION; SPORE FORMATION; PROTEIN FAMILY; KINASE CDC5; CLEAVAGE; MITOSIS; PROTEOLYSIS	Cohesion established between sister chromatids during pre-meiotic DNA replication mediates two rounds of chromosome segregation. The first division is preceded by an extended prophase wherein homologous chromosomes undergo recombination. The persistence of cohesion during prophase is essential for recombination and both meiotic divisions. Here we show that Mnd2, a subunit of the anaphase-promoting complex (APC/C) from budding yeast, is essential to prevent premature destruction of cohesion in meiosis. During S- and prophase, Mnd2 prevents activation of the APC/C by a melosis-specific activator called Ama1. In cells lacking Mnd2 the APC/C-Ama1 enzyme triggers degradation of Pds1, which causes premature sister chromatid separation due to unrestrained separase activity. In vitro, Mnd2 inhibits ubiquitination of Pds1 by APC/C-Ama1 but not by other APC/C holo-enzymes. We conclude that chromosome segregation in meiosis depends on the selective inhibition of a meiosis-specific form of the APC/C.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Zachariae, W (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	Zachariae@mpi-cbg.de; Zachariae@mpi-cbg.de	Matos, Joao/C-1488-2014; Havlis, Jan/AAC-9525-2019; Havliš, Jan/D-9508-2012	Matos, Joao/0000-0002-3754-3709; Havlis, Jan/0000-0001-7822-2023; Havliš, Jan/0000-0001-7822-2023				Alexandru G, 1999, EMBO J, V18, P2707, DOI 10.1093/emboj/18.10.2707; Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Asakawa H, 2001, MOL GENET GENOMICS, V265, P424, DOI 10.1007/s004380000429; Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Blanco MA, 2001, J CELL SCI, V114, P2135; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Camasses A, 2003, MOL CELL, V12, P87, DOI 10.1016/S1097-2765(03)00244-2; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; Chu T, 2001, GENESIS, V29, P141, DOI 10.1002/gene.1017; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; Clyne RK, 2003, NAT CELL BIOL, V5, P480, DOI 10.1038/ncb977; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Cooper KF, 2000, P NATL ACAD SCI USA, V97, P14548, DOI 10.1073/pnas.250351297; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; Grosskortenhaus R, 2002, DEV CELL, V2, P29, DOI 10.1016/S1534-5807(01)00104-6; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Indjeian VB, 2005, SCIENCE, V307, P130, DOI 10.1126/science.1101366; Jacobs HW, 2002, CURR BIOL, V12, P1435, DOI 10.1016/S0960-9822(02)01074-6; Katis VL, 2004, CURR BIOL, V14, P560, DOI 10.1016/j.cub.2004.03.001; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kitajima TS, 2003, EMBO J, V22, P5643, DOI 10.1093/emboj/cdg527; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; KLAPHOLZ S, 1985, GENETICS, V110, P187; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Loidl J, 1998, METHOD CELL BIOL, V53, P257; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Pfleger CM, 2001, GENE DEV, V15, P1759, DOI 10.1101/gad.897901; Rabitsch KP, 2001, CURR BIOL, V11, P1001, DOI 10.1016/S0960-9822(01)00274-3; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Reimann JDR, 2001, GENE DEV, V15, P3278, DOI 10.1101/gad.945701; Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1; Salah SM, 2000, CHROMOSOMA, V109, P27, DOI 10.1007/s004120050409; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Schwickart M, 2004, MOL CELL BIOL, V24, P3562, DOI 10.1128/MCB.24.8.3562-3576.2004; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Watanabe Y, 2004, J CELL SCI, V117, P4017, DOI 10.1242/jcs.01352; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; Yoon HJ, 2002, CURR BIOL, V12, P2048, DOI 10.1016/S0960-9822(02)01331-3; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	51	69	73	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 25	2005	120	6					773	788		10.1016/j.cell.2005.01.032	http://dx.doi.org/10.1016/j.cell.2005.01.032			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	912HF	15797379	Bronze			2022-12-24	WOS:000228067500008
J	Mahadevan, L; Rica, S				Mahadevan, L; Rica, S			Self-organized origami	SCIENCE			English	Article							CONVECTION		Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Univ Chile, Dept Fis, Santiago, Chile	Harvard University; Harvard University; Universidad de Chile	Mahadevan, L (corresponding author), Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA.	lm@deas.harvard.edu	Rica, Sergio/G-9865-2011					Bowden N, 1998, NATURE, V393, P146, DOI 10.1038/30193; Haas F, 1996, P ROY SOC B-BIOL SCI, V263, P1651, DOI 10.1098/rspb.1996.0241; Kobayashi H, 1998, P ROY SOC B-BIOL SCI, V265, P147, DOI 10.1098/rspb.1998.0276; Kresling Biruta, 1995, Biomimetics, V3, P105; Miura K., 1980, P 31 C INT ASTRONAUT, P1; NEWELL AC, 1969, J FLUID MECH, V38, P279, DOI 10.1017/S0022112069000176; RIZZIERI R, COMMUNICATION; SEGEL LA, 1969, J FLUID MECH, V38, P203, DOI 10.1017/S0022112069000127	8	173	177	9	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2005	307	5716					1740	1740		10.1126/science.1105169	http://dx.doi.org/10.1126/science.1105169			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774751				2022-12-24	WOS:000227883900035
J	Shen, J; Dahmann, C				Shen, J; Dahmann, C			Extrusion of cells with inappropriate Dpp signaling from Drosophila wing disc epithelia	SCIENCE			English	Article							TGF-BETA; APOPTOSIS; MORPHOGENESIS; SURVIVAL; ROLES; JNK	Decapentaplegic (Dpp) is a signaling molecule that controls growth and patterning of the developing Drosophila wing. Mutant cells lacking Dpp signal transduction have been shown to activate c-Jun amino-terminal kinase (JNK)-dependent apoptosis and to be lost from the wing disc epithelium. These observations have led to the hypothesis that Dpp promotes cell survival by preventing apoptosis. Here, we show that in the absence of JNK-dependent apoptosis, mutant cells tacking Dpp signal transduction can survive; however, they are still lost from the wing disc epithelium. This loss correlates with extensive cytoskeletal changes followed by basal epithelial extrusion. We propose that Dpp promotes cell survival within disc epithelia by affecting cytoskeletal organization.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Dahmann, C (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	dahmann@mpi-cbg.de	Dahmann, Christian/B-5841-2017; shen, jie/W-9807-2019; shen, jie/H-9087-2016	shen, jie/0000-0002-6021-7151; 				Adachi-Yamada T, 2002, DEV BIOL, V251, P74, DOI 10.1006/dbio.2002.0821; Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; Azpiazu N, 2000, DEVELOPMENT, V127, P2685; BRYANT PJ, 1988, DEV BIOL, V128, P386, DOI 10.1016/0012-1606(88)90300-4; Eaton S, 1996, J CELL BIOL, V135, P1277, DOI 10.1083/jcb.135.5.1277; Martin-Blanco E, 2000, P NATL ACAD SCI USA, V97, P7888, DOI 10.1073/pnas.97.14.7888; Milan M, 2002, DEV CELL, V2, P797, DOI 10.1016/S1534-5807(02)00169-7; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Ricos MG, 1999, J CELL SCI, V112, P1225; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208	13	127	130	2	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2005	307	5716					1789	1790		10.1126/science.1104784	http://dx.doi.org/10.1126/science.1104784			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774763				2022-12-24	WOS:000227883900049
J	Boccaccio, C; Sabatino, G; Medico, E; Girolami, F; Follenzi, A; Reato, G; Sottile, A; Naldini, L; Comoglio, PM				Boccaccio, C; Sabatino, G; Medico, E; Girolami, F; Follenzi, A; Reato, G; Sottile, A; Naldini, L; Comoglio, PM			The MET oncogene drives a genetic programme linking cancer to haemostasis	NATURE			English	Article							LENTIVIRAL VECTORS; EXPRESSION; GROWTH; RECEPTORS; CYCLOOXYGENASE-2; MOUSE; CELLS	The close relationship between activation of blood coagulation and cancer is an old enigma. In 1865, migrans trombophlebitis ('a condition of the blood that predisposes it to spontaneous coagulation') was described as a forewarning of occult malignancy ( Trousseau's sign(1)). This pioneering observation emphasized the existence of haemostasis disorders associated with cancer onset; this phenomenon has since been extensively reported in clinical and epidemiological studies(2-4), but has so far resisted a mechanistic explanation. Here we report a mouse model of sporadic tumorigenesis based on genetic manipulation of somatic cells. Targeting the activated, human MET oncogene to adult liver caused slowly progressing hepatocarcinogenesis. This was preceded and accompanied by a syndrome manifesting first with blood hypercoagulation ( venous thromboses), and then evolving towards fatal internal haemorrhages. The pathogenesis of this syndrome is driven by the transcriptional response to the oncogene, including prominent upregulation of plasminogen activator inhibitor type 1 (PAI-1) and cyclooxygenase-2 (COX-2) genes. In vivo analysis showed that both proteins support the thrombohaemorrhagic phenotype, thus providing direct genetic evidence for the long-sought-after link between oncogene activation and haemostasis.	Univ Turin, Sch Med, Inst Canc Res & Treatment, Div Mol Oncol, I-10060 Turin, Italy	University of Turin	Boccaccio, C (corresponding author), Univ Turin, Sch Med, Inst Canc Res & Treatment, Div Mol Oncol, Str Prov 142, I-10060 Turin, Italy.	carla.boccaccio@ircc.it	Boccaccio, Carla/AHE-7875-2022; Girolami, Flavia/K-6304-2013; Medico, Enzo/AAC-3185-2021; Naldini, Luigi/E-9083-2012	Boccaccio, Carla/0000-0003-2620-9083; Girolami, Flavia/0000-0001-9005-5301; Medico, Enzo/0000-0002-3917-2438; REATO, GIGLIOLA/0000-0003-3463-2930; sottile, antonino/0000-0003-4252-3240; NALDINI, Luigi/0000-0002-7835-527X; Follenzi, Antonia/0000-0001-9780-300X; Comoglio, Paolo/0000-0002-7056-5328	Telethon [TGT06S01, TGT03D03] Funding Source: Medline	Telethon(Fondazione Telethon)		Baron JA, 1998, LANCET, V351, P1077, DOI 10.1016/S0140-6736(97)10018-6; Collen D, 1999, THROMB HAEMOSTASIS, V82, P259; DIRENZO MF, 1991, ONCOGENE, V6, P1997; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; FitzGerald G, 2003, NAT REV DRUG DISCOV, V2, P879, DOI 10.1038/nrd1225; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Follenzi A, 2002, HUM GENE THER, V13, P243, DOI 10.1089/10430340252769770; Friederich PW, 1997, CIRCULATION, V96, P916; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Lee AYY, 2003, CIRCULATION, V107, pI17, DOI 10.1161/01.CIR.0000078466.72504.AC; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Medico E, 1996, MOL BIOL CELL, V7, P495, DOI 10.1091/mbc.7.4.495; Muller-Berghaus G, 1999, THROMB HAEMOSTASIS, V82, P706; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; Oshima M, 2001, CANCER RES, V61, P1733; PARK M, 1986, CELL, V45, P895, DOI 10.1016/0092-8674(86)90564-7; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Pfeifer A, 2001, MOL THER, V3, P319, DOI 10.1006/mthe.2001.0276; PONDER KP, 1991, P NATL ACAD SCI USA, V88, P1217, DOI 10.1073/pnas.88.4.1217; Rickles FR, 2001, ACTA HAEMATOL-BASEL, V106, P6, DOI 10.1159/000046583; Rickles FR, 2000, HEMOSTASIS THROMBOSI, P1132; Schmidt L, 1997, NAT GENET, V16, P68, DOI 10.1038/ng0597-68; Sidenius N, 2003, CANCER METAST REV, V22, P205, DOI 10.1023/A:1023099415940; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Trousseau A, 1865, CLIN MED HOTEL DIEU, P654; Trusolino L, 1998, FASEB J, V12, P1267, DOI 10.1096/fasebj.12.13.1267; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Vigna E, 2000, J GENE MED, V2, P308; Zeng QH, 2002, J BIOL CHEM, V277, P50137, DOI 10.1074/jbc.M208952200	30	200	219	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					396	400		10.1038/nature03357	http://dx.doi.org/10.1038/nature03357			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772665				2022-12-24	WOS:000227715100055
J	Reynolds, R				Reynolds, R			The evolution of sensibility	NATURE			English	Article									Univ Calif San Diego, Dept Mus, La Jolla, CA 92037 USA	University of California System; University of California San Diego	Reynolds, R (corresponding author), Univ Calif San Diego, Dept Mus, La Jolla, CA 92037 USA.							Levitin DJ, 2004, MUSIC PERCEPT, V22, P167, DOI 10.1525/mp.2004.22.2.167; MCADAMS S, IN PRESS PERCEPTION	2	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2005	434	7031					316	319		10.1038/434316a	http://dx.doi.org/10.1038/434316a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772649				2022-12-24	WOS:000227715100038
J	Sellal, F; Stoll-Keller, F				Sellal, F; Stoll-Keller, F			Rabies: ancient yet contemporary cause of encephalitis	LANCET			English	Editorial Material									Hop Univ Strasbourg, Dept Neurol, F-67091 Strasbourg, France; Hop Univ Strasbourg, Inst Virol, F-67091 Strasbourg, France	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Sellal, F (corresponding author), Hop Univ Strasbourg, Dept Neurol, F-67091 Strasbourg, France.	Francois.Sellal@chru-strasbourg.fr						Badrane H, 2001, J VIROL, V75, P8096, DOI 10.1128/JVI.75.17.8096-8104.2001; Coleman PG, 2004, EMERG INFECT DIS, V10, P140, DOI 10.3201/eid1001.020744; Dietzschold B, 2004, LANCET, V364, P648, DOI 10.1016/S0140-6736(04)16912-2; Galperine T, 2004, PRESSE MED, V33, P791, DOI 10.1016/S0755-4982(04)98745-3; Hemachudha T, 2004, CLIN INFECT DIS, V39, P1085, DOI 10.1086/423813; Hemachudha T, 2002, LANCET NEUROL, V1, P101, DOI 10.1016/S1474-4422(02)00041-8; Laothamatas J, 2003, AM J NEURORADIOL, V24, P1102; Morimoto K, 1996, P NATL ACAD SCI USA, V93, P5653, DOI 10.1073/pnas.93.11.5653; Nathwani D, 2003, CLIN INFECT DIS, V37, P598, DOI 10.1086/376641; RAY NB, 1995, J VIROL, V69, P764, DOI 10.1128/JVI.69.2.764-772.1995; Schankin CJ, 2005, LANCET, V365, P358; Warrell MJ, 2004, LANCET, V363, P959, DOI 10.1016/S0140-6736(04)15792-9	12	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 12	2005	365	9463					921	923		10.1016/S0140-6736(05)71060-6	http://dx.doi.org/10.1016/S0140-6736(05)71060-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	905HS	15766980	Green Published, Bronze			2022-12-24	WOS:000227559800008
J	Kamata, H; Honda, S; Maeda, S; Chang, LF; Hirata, H; Karin, M				Kamata, H; Honda, S; Maeda, S; Chang, LF; Hirata, H; Karin, M			Reactive oxygen species promote TNF alpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases	CELL			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; NECROTIC CELL-DEATH; INDUCED APOPTOSIS; REDOX REGULATION; CYTOCHROME-C; LIVER-REGENERATION; FACTOR RECEPTOR; IKK-BETA; PROTEIN	TNF alpha is a pleiotropic cytokine that induces either cell proliferation or cell death. Inhibition of NF-kappa B activation increases susceptibility to TNF alpha-induced death, concurrent with sustained JNK activation, an important contributor to the death response. Sustained JNK activation in NF-kappa B-deficient cells was suggested to depend on reactive oxygen species (ROS), but how RIDS affect JNK activation was unclear. We now show that TNF alpha-induced ROS, whose accumulation is suppressed by mitochondrial superoxide dismutase, cause oxidation and inhibition of JNK-inactivating phosphatases by converting their catalytic cysteine to sulfenic acid. This results in sustained JNK activation, which is required for cytochrome c release and caspase 3 cleavage, as well as necrotic cell death. Treatment of cells or experimental animals with an antioxidant prevents H(2)O(2) accumulation, JNK phosphatase oxidation, sustained JNK activity, and both forms of cell death. Antioxidant treatment also prevents TNF alpha-mediated fulminant liver failure without affecting liver regeneration.	Univ Calif San Diego, Sch Med, Lab Gene Regulat, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Hyogo	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Lab Gene Regulat, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Kamata, Hideaki/N-3907-2017		NIAID NIH HHS [AI43477] Funding Source: Medline; NIEHS NIH HHS [ES04151, ES06376, 5P42 ES10337] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337, R01ES004151, R37ES004151, R01ES006376] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Amanullah A, 2003, NATURE, V424, P741, DOI 10.1038/424741b; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; BRENNER DA, 1989, NATURE, V337, P661, DOI 10.1038/337661a0; Cai JY, 1998, J BIOL CHEM, V273, P11401, DOI 10.1074/jbc.273.19.11401; Cauwels A, 2003, NAT IMMUNOL, V4, P387, DOI 10.1038/ni914; Cavigelli M, 1996, EMBO J, V15, P6269, DOI 10.1002/j.1460-2075.1996.tb01017.x; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Georgiou G, 2003, SCIENCE, V300, P592, DOI 10.1126/science.1084976; GOOSSENS V, 1995, P NATL ACAD SCI USA, V92, P8115, DOI 10.1073/pnas.92.18.8115; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Holmgren A, 2000, ANTIOXID REDOX SIGN, V2, P811, DOI 10.1089/ars.2000.2.4-811; Iverson SL, 2004, ARCH BIOCHEM BIOPHYS, V423, P37, DOI 10.1016/j.abb.2003.12.002; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li X, 2002, J BIOL CHEM, V277, P45129, DOI 10.1074/jbc.M205165200; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; Masuda K, 2001, J BIOL CHEM, V276, P39002, DOI 10.1074/jbc.M104600200; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Nomura K, 2000, BIOCHEM J, V351, P183, DOI 10.1042/0264-6021:3510183; Park JM, 2004, GENE DEV, V18, P584, DOI 10.1101/gad.1168104; Perfettini JL, 2003, NAT IMMUNOL, V4, P308, DOI 10.1038/ni0403-308; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Sanchez-Perez I, 2000, ONCOGENE, V19, P5142, DOI 10.1038/sj.onc.1203887; Savitsky PA, 2002, J BIOL CHEM, V277, P20535, DOI 10.1074/jbc.M201589200; Schwabe RF, 2003, HEPATOLOGY, V37, P824, DOI 10.1053/jhep.2003.50135; Smith ML, 1996, ONCOGENE, V13, P2255; Takeda K, 2003, CELL STRUCT FUNCT, V28, P23; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Tanoue T, 2001, J BIOL CHEM, V276, P26629, DOI 10.1074/jbc.M101981200; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Vanden Berghe T, 2004, J BIOL CHEM, V279, P7925, DOI 10.1074/jbc.M307807200; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; WONG GHW, 1989, CELL, V58, P923, DOI 10.1016/0092-8674(89)90944-6; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441	52	1421	1474	3	145	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 11	2005	120	5					649	661		10.1016/j.cell.2004.12.041	http://dx.doi.org/10.1016/j.cell.2004.12.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766528	Bronze			2022-12-24	WOS:000227771400011
J	Tobler, PN; Fiorillo, CD; Schultz, W				Tobler, PN; Fiorillo, CD; Schultz, W			Adaptive coding of reward value by dopamine neurons	SCIENCE			English	Article							NEURAL BASIS; PREDICTION; MOTIVATION; MECHANISMS; CONTRAST	It is important for animals to estimate the value of rewards as accurately as, possible. Because the number of potential reward values is very large, it is necessary that the brain's limited resources be allocated so as to discriminate! better among more likely reward outcomes at the expense of less likely outcomes. We found that midbrain dopamine neurons rapidly adapted to the information provided by reward-predicting stimuli. Responses shifted relative to the expected reward value, and the gain adjusted to the variance of reward value. In this way, dopamine neurons maintained their reward sensitivity over a large range of reward values.	Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England; Univ Fribourg, Inst Physiol, CH-1700 Fribourg, Switzerland	University of Cambridge; University of Fribourg	Schultz, W (corresponding author), Univ Cambridge, Dept Anat, Downing St, Cambridge CB2 3DY, England.	ws234@cam.ac.uk	Fiorillo, Christopher Dante/C-1718-2011; schultz, wolfram/H-8958-2016	Tobler, Philippe/0000-0002-4915-9448; Fiorillo, Christopher/0000-0002-7232-9505; schultz, wolfram/0000-0002-8530-4518	Wellcome Trust [095495] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Arnauld A., 1662, LOGIQUE LHRT PENSER; Barlow HB, 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Glimcher PW, 2003, BRADFORD BOOKS, P1; Kawakami D, 2004, COMP EXPTL METHODS, V10, P13; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Leon MI, 1998, J EXP PSYCHOL ANIM B, V24, P265, DOI 10.1037/0097-7403.24.3.265; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; OHZAWA I, 1982, NATURE, V298, P266, DOI 10.1038/298266a0; Pavlov IP, 1927, CONDITIONAL REFLEXES; Rescorla RA, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Shizgal P, 1997, CURR OPIN NEUROBIOL, V7, P198, DOI 10.1016/S0959-4388(97)80008-6; Smirnakis SM, 1997, NATURE, V386, P69, DOI 10.1038/386069a0; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; Thorndike EL., 1911, ANIMAL INTELLIGENCE, DOI DOI 10.4324/9781351321044; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; WISE RA, 1992, SYNAPSE, V10, P247, DOI 10.1002/syn.890100307; [No title captured]	25	839	850	1	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2005	307	5715					1642	1645		10.1126/science.1105370	http://dx.doi.org/10.1126/science.1105370			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15761155	Green Submitted			2022-12-24	WOS:000227622400052
J	Cranmer, HH				Cranmer, HH			The public health emergency in Indonesia - One patient at a time	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brigham & Womens Hosp, Dept Emergency Med, Div Int Hlth & Humanitarian Programs, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Cranmer, HH (corresponding author), Brigham & Womens Hosp, Dept Emergency Med, Div Int Hlth & Humanitarian Programs, 75 Francis St, Boston, MA 02115 USA.							TOOLE M J, 1989, Bulletin of the World Health Organization, V67, P381	1	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2005	352	10					965	965		10.1056/NEJMp058045	http://dx.doi.org/10.1056/NEJMp058045			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	904JC	15758005				2022-12-24	WOS:000227491200003
J	Waite, JH; Cravens, TE; Ip, WH; Kasprzak, WT; Luhmann, JG; McNutt, RL; Niemann, HB; Yelle, RV; Mueller-Wodarg, I; Ledvina, SA; Scherer, S				Waite, JH; Cravens, TE; Ip, WH; Kasprzak, WT; Luhmann, JG; McNutt, RL; Niemann, HB; Yelle, RV; Mueller-Wodarg, I; Ledvina, SA; Scherer, S			Oxygen ions observed near Saturn's A ring	SCIENCE			English	Article								Ions were detected in the vicinity of Saturn's A ring by the Ion and Neutral Mass Spectrometer (INMS) instrument onboard the Cassini Orbiter during the spacecraft's passage over the rings. The INMS saw signatures of molecular and atomic oxygen ions and of protons, thus demonstrating the existence of an ionosphere associated with the A ring. A likely explanation for these ions is photoionization by solar ultraviolet radiation of neutral O-2 molecules associated with a tenuous ring atmosphere. INMS neutral measurements made during the ring encounter are dominated by a background signal.	Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA; Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; Natl Cent Univ, Inst Astron, Chungli 32054, Taiwan; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ London Imperial Coll Sci Technol & Med, Space & Atmospher Phys Grp, London SW7 2BW, England	University of Kansas; University of Michigan System; University of Michigan; National Central University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of California System; University of California Berkeley; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Arizona; Imperial College London	Cravens, TE (corresponding author), Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA.	cravens@ku.edu	McNutt, Ralph L/E-8006-2010; Mueller-Wodarg, Ingo C. F./M-9945-2014	McNutt, Ralph L/0000-0002-4722-9166; Mueller-Wodarg, Ingo C. F./0000-0001-6308-7826				[Anonymous], 1984, SATURN; COATES AJ, 1991, GEOPHYS MONOGR SER, V61, P301; CONNERNEY JEP, 1984, SATURN, P354; Gurnett DA, 2005, SCIENCE, V307, P1255, DOI 10.1126/science.1105356; HUEBNER WF, 1980, ASTROPHYS J, V238, P753, DOI 10.1086/158033; IP WH, 1995, ICARUS, V115, P295, DOI 10.1006/icar.1995.1098; IP WH, 1983, NATURE, V302, P599, DOI 10.1038/302599a0; Johnson R.E., 1990, ENERGETIC CHARGED PA, DOI [10.1007/978-3-642-48375-2, DOI 10.1007/978-3-642-48375-2]; Johnson RE, 2003, ASTROBIOLOGY, V3, P823, DOI 10.1089/153110703322736123; Kasprzak W, 1996, P SOC PHOTO-OPT INS, V2803, P129, DOI 10.1117/12.253413; Kliore AJ, 1997, SCIENCE, V277, P355, DOI 10.1126/science.277.5324.355; Krimigis SM, 2005, SCIENCE, V307, P1270, DOI 10.1126/science.1105978; LUHMANN JG, 1991, GEOPHYS MONOGR, V61, P5; WAITE JH, IN PRESS SPACE SCI R; WILSON GR, 1989, J GEOPHYS RES, P17287; Young DT, 2005, SCIENCE, V307, P1262, DOI 10.1126/science.1106151	16	54	54	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1260	1262		10.1126/science.1105734	http://dx.doi.org/10.1126/science.1105734			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731442				2022-12-24	WOS:000227313200044
J	Emerson, BC; Kolm, N				Emerson, BC; Kolm, N			Species diversity can drive speciation	NATURE			English	Article							ADAPTIVE RADIATION; ISLANDS; AREA; ENDEMISM	A fundamental question in evolutionary ecology and conservation biology is: why do some areas contain greater species diversity than others? Island biogeographic theory has identified the roles of immigration and extinction in relation to area size and proximity to source areas(1,2), and the role of speciation is also recognized as an important factor(3-6). However, one as yet unexplored possibility is that species diversity itself might help to promote speciation, and indeed the central tenets of island biogeographic theory support such a prediction. Here we use data for plants and arthropods of the volcanic archipelagos of the Canary and Hawaiian Islands to address whether there is a positive relationship between species diversity and rate of diversification. Our index of diversification for each island is the proportion of species that are endemic, and we test our prediction that this increases with increasing species number. We show that even after controlling for several important physical features of islands, diversification is strongly related to species number.	Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Emerson, BC (corresponding author), Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England.	b.emerson@uea.ac.uk		Kolm, Niclas/0000-0001-5791-336X; Emerson, Brent/0000-0003-4067-9858				Buckling A, 2000, NATURE, V408, P961, DOI 10.1038/35050080; Carson Hampton L., 1995, P14; DRAPER NR, 1979, COMMUN STAT A-THEOR, V8, P99, DOI 10.1080/03610927908827741; Gillespie R, 2004, SCIENCE, V303, P356, DOI 10.1126/science.1091875; GINOVES JRA, IN PRESS LISTA ESPEC; Heaney LR, 2000, GLOBAL ECOL BIOGEOGR, V9, P59, DOI 10.1046/j.1365-2699.2000.00163.x; Hobohm C, 2000, FLORA, V195, P9; Hubbell Stephen P., 2001, V32, pi; Kassen R, 2000, NATURE, V406, P508, DOI 10.1038/35020060; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; MAC ARTHUR ROBERT H., 1967; MACARTHUR RH, 1963, EVOLUTION, V17, P373, DOI 10.2307/2407089; Nishida G. M., 2002, BISHOP MUSEUM HAWAII; OROMI P, IN PRESS LISTA ESPEC; Price Jonathan Paul, 2004, Pacific Science, V58, P27, DOI 10.1353/psc.2004.0008; Price JP, 2004, J BIOGEOGR, V31, P487, DOI 10.1046/j.0305-0270.2003.00990.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Roos MC, 2004, J BIOGEOGR, V31, P1893, DOI 10.1111/j.1365-2699.2004.01154.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Tokeshi M, 1999, SPECIES COEXISTENCE	21	224	235	0	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					1015	1017		10.1038/nature03450	http://dx.doi.org/10.1038/nature03450			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846345				2022-12-24	WOS:000228524600037
J	Gu, DF; Reynolds, K; Wu, XG; Chen, F; Duan, XF; Reynolds, RF; Whelton, PK; He, J				Gu, DF; Reynolds, K; Wu, XG; Chen, F; Duan, XF; Reynolds, RF; Whelton, PK; He, J		InterASIA Collaborative Grp	Prevalence of the metabolic syndrome and overweight among adults in China	LANCET			English	Article							REPUBLIC-OF-CHINA; CARDIOVASCULAR-DISEASES; BLOOD-PRESSURE; GLOBAL BURDEN; RISK-FACTORS; LIPOPROTEIN CHOLESTEROL; GEOGRAPHIC VARIATIONS; DIABETES-MELLITUS; NATIONAL-HEALTH; PART I	Background The metabolic syndrome and obesity are major risk factors for cardiovascular disease. Little information exists on the prevalence of the metabolic syndrome in China. We aimed to provide up-to-date estimates of the prevalence of the metabolic syndrome and overweight in the general adult population in China. Methods We did a cross-sectional survey in a nationally representative sample of 15 540 Chinese adults aged 35-74 years in 2000-01. Metabolic syndrome was defined according to guidelines from the US National Cholesterol Education Program. Overweight was defined as body-mass index of 25.0 kg/m(2) or greater. Findings The age-standardised prevalence of metabolic syndrome was 9.8% (95% CI 9.0-10.6) in men and 17.8% (16.6-19.0) in women. The age-standardised prevalence of overweight was 26.9% (25.7-28.1) in men and 31.1% (29.7-32.5) in women. The prevalence of the metabolic syndrome and overweight was higher in northern than in southern China, and higher in urban than rural residents. Interpretation Our results indicate that a large proportion of Chinese adults have the metabolic syndrome and that overweight has become an important public health problem in China. These findings emphasise the urgent need to develop national strategies for the prevention, detection, and treatment of overweight and the metabolic syndrome, to reduce the societal burden of cardiovascular disease in China.	Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA; Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA; Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100037, Peoples R China; Chinese Acad Med Sci, Fuwai Hosp, Beijing 100037, Peoples R China; Peking Union Med Coll, Beijing, Peoples R China; Pfizer Inc, New York, NY USA	Tulane University; Tulane University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Pfizer	He, J (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, 1430 Tulane Ave SL18, New Orleans, LA 70112 USA.	jhe@tulane.edu	He, Jiang/AAF-5303-2020; Reynolds, Kristi/AAN-1434-2021	He, Jiang/0000-0002-8286-9652; Reynolds, Kristi/0000-0001-7619-1649				*3 NAT HLTH NUTR E, 1994, VITAL HLTH STAT, V32, P1; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; ALLAIN CC, 1974, CLIN CHEM, V20, P470; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Chuang SY, 2002, ACTA CARDIOL SIN, V18, P16; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Ford ES, 2003, DIABETES CARE, V26, P575, DOI 10.2337/diacare.26.3.575; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Further Study Of Risk Factors For Stroke And Coronary Heart Disease group, 2002, Zhonghua Yu Fang Yi Xue Za Zhi, V36, P298; Gu D, 2003, DIABETOLOGIA, V46, P1190, DOI 10.1007/s00125-003-1167-8; Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5; HAFFNER SM, 1992, DIABETES, V41, P715, DOI 10.2337/diabetes.41.6.715; He J, 2004, CIRCULATION, V110, P405, DOI 10.1161/01.CIR.0000136583.52681.0D; HE J, 1995, STROKE, V26, P2222, DOI 10.1161/01.STR.26.12.2222; HUANG ZD, 1994, J HYPERTENS, V12, P1103; Ismail M N, 2002, Obes Rev, V3, P203, DOI 10.1046/j.1467-789X.2002.00074.x; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Krauss R M, 1998, Circulation, V98, P1472; Laaksonen DE, 2002, AM J EPIDEMIOL, V156, P1070, DOI 10.1093/aje/kwf145; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Liese AD, 1998, EPIDEMIOL REV, V20, P157, DOI 10.1093/oxfordjournals.epirev.a017978; Lopez Alan D., 1993, World Health Statistics Quarterly, V46, P91; Meigs JB, 2002, AM J MANAG CARE, V8, pS283; MOON OR, 2002, OBES REV, V3, P191, DOI DOI 10.1046/J.1467-789X.2002.00073.X; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; MYERS GL, 1989, CLIN LAB MED, V9, P105, DOI 10.1016/S0272-2712(18)30645-0; *NIH, 1997, OBES RES S2, V6, pS51; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460; Popkin BM, 2001, NUTR REV, V59, P379, DOI 10.1111/j.1753-4887.2001.tb06967.x; Popkin BM, 1998, NUTR REV, V56, P106; POPKIN BM, 1993, EUR J CLIN NUTR, V47, P333; POPKIN BM, 1995, AM J PUBLIC HEALTH, V85, P690, DOI 10.2105/AJPH.85.5.690; Reynolds K, 2003, J HYPERTENS, V21, P1273, DOI 10.1097/00004872-200307000-00014; Saw S. M., 1997, Annals Academy of Medicine Singapore, V26, P489; Tan CE, 1999, DIABETES CARE, V22, P241, DOI 10.2337/diacare.22.2.241; TAO SQ, 1995, CHINESE MED J-PEKING, V108, P483; Trevisan M, 1998, AM J EPIDEMIOL, V148, P958; *WHO W PAC REG INT, 2000, AS PAC PERSP RED OB; World Health Organization, DEF DIAGN CLASS DI 1; Wu XG, 1996, J HYPERTENS, V14, P1267, DOI 10.1097/00004872-199611000-00003; Wu ZS, 2001, CIRCULATION, V103, P462; Yao C, 1993, World Health Stat Q, V46, P113; Yoshiike N, 2002, Obes Rev, V3, P183, DOI 10.1046/j.1467-789X.2002.00070.x; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; ZHOU BF, 1995, INT J EPIDEMIOL, V24, P528, DOI 10.1093/ije/24.3.528; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P245; 2000, ARCH INTERN MED, V160, P898	52	735	889	2	95	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 16	2005	365	9468					1398	1405		10.1016/S0140-6736(05)66375-1	http://dx.doi.org/10.1016/S0140-6736(05)66375-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QY	15836888				2022-12-24	WOS:000228401900028
J	Haines, JL; Hauser, MA; Schmidt, S; Scott, WK; Olson, LM; Gallins, P; Spencer, KL; Kwan, SY; Noureddine, M; Gilbert, JR; Schnetz-Boutaud, N; Agarwal, A; Postel, EA; Pericak-Vance, MA				Haines, JL; Hauser, MA; Schmidt, S; Scott, WK; Olson, LM; Gallins, P; Spencer, KL; Kwan, SY; Noureddine, M; Gilbert, JR; Schnetz-Boutaud, N; Agarwal, A; Postel, EA; Pericak-Vance, MA			Complement factor H variant increases the risk of age-related macular degeneration	SCIENCE			English	Article							C-REACTIVE PROTEIN; SUSCEPTIBILITY LOCI; GENOMEWIDE-SCAN; MACULOPATHY; DISEASE; ASSOCIATION; ACTIVATION; MEMBRANE; PATHWAY; COMMON	Age-related macular degeneration (AMD) is a leading cause of visual impairment and blindness in the elderly whose etiology remains largely unknown. Previous studies identified chromosome 1q32 as harboring a susceptibility locus for AMD. We used single-nucleotide polymorphisms to interrogate this region and identified a strongly associated haplotype in two independent data sets. DNA resequencing of the complement factor H gene within this haplotype revealed a common coding variant, Y402H, that significantly increases the risk for AMD with odds ratios between 2.45 and 5.57. This common variant likely explains similar to 43% of AMD in older adults.	Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Vanderbilt Eye Inst, Nashville, TN 37232 USA; Duke Univ, Med Ctr, Duke Univ Eye Ctr, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA	Duke University; Duke University; Vanderbilt University; Vanderbilt University; Duke University; Duke University	Pericak-Vance, MA (corresponding author), Duke Univ, Med Ctr, Ctr Human Genet, DUMC Box 3445,595 LaSalle St, Durham, NC 27710 USA.	mpv@chg.duhs.duke.edu	Scott, William/A-7593-2009; Haines, Jonathan/C-3374-2012; Mohammed, Imran/J-8271-2012	Haines, Jonathan/0000-0002-4351-4728; Mohammed, Imran/0000-0002-8412-0768; Scott, William/0000-0001-9336-6404	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000095] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R03EY015216, U10EY012118, R01EY012118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P60AG011268] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR-00095] Funding Source: Medline; NEI NIH HHS [EY015216, EY12118] Funding Source: Medline; NIA NIH HHS [AG11268] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abecasis GR, 2004, AM J HUM GENET, V74, P482, DOI 10.1086/382786; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Blackmore TK, 1998, INFECT IMMUN, V66, P1427, DOI 10.1128/IAI.66.4.1427-1431.1998; CDC (Cent. Dis. Control Prev.), 2004, MMWR-MORBID MORTAL W, V53, P1069; de Cordoba SR, 2004, MOL IMMUNOL, V41, P355, DOI 10.1016/j.molimm.2004.02.005; Esparza-Gordillo J, 2004, IMMUNOGENETICS, V56, P77, DOI 10.1007/s00251-004-0660-7; FEARON DT, 1978, P NATL ACAD SCI USA, V75, P1971, DOI 10.1073/pnas.75.4.1971; Giannakis E, 2003, EUR J IMMUNOL, V33, P962, DOI 10.1002/eji.200323541; GURNE DH, 1991, OPHTHALMOLOGY, V98, P602; Hammond CJ, 2002, OPHTHALMOLOGY, V109, P730, DOI 10.1016/S0161-6420(01)01049-1; HEIBA IM, 1994, GENET EPIDEMIOL, V11, P51, DOI 10.1002/gepi.1370110106; Iyengar SK, 2004, AM J HUM GENET, V74, P20, DOI 10.1086/380912; KILLINGSWORTH MC, 1990, EYE, V4, P613, DOI 10.1038/eye.1990.86; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1646, DOI 10.1001/archopht.116.12.1646; MOLD C, 1984, J IMMUNOL, V133, P882; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Oksjoki R, 2003, ARTERIOSCL THROM VAS, V23, P630, DOI 10.1161/01.ATV.0000057808.91263.A4; Schmidt Silke, 2002, Ophthalmic Genet, V23, P209, DOI 10.1076/opge.23.4.209.13883; Schultz DW, 2003, HUM MOL GENET, V12, P3315, DOI 10.1093/hmg/ddg348; Seddon JM, 2004, JAMA-J AM MED ASSOC, V291, P704, DOI 10.1001/jama.291.6.704; Stone EM, 1998, NAT GENET, V20, P328, DOI 10.1038/3798; Weeks DE, 2004, AM J HUM GENET, V75, P174, DOI 10.1086/422476	22	1863	2017	2	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2005	308	5720					419	421		10.1126/science.1110359	http://dx.doi.org/10.1126/science.1110359			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15761120				2022-12-24	WOS:000228492000055
J	Ma, JB; Yuan, YR; Meister, G; Pei, Y; Tuschl, T; Patel, DJ				Ma, JB; Yuan, YR; Meister, G; Pei, Y; Tuschl, T; Patel, DJ			Structural basis for 5 '-end-specific recognition of guide RNA by the A-fulgidus Piwi protein	NATURE			English	Article							CRYSTAL-STRUCTURE; ARGONAUTE2; MICRORNA; BINDING; INTERFERENCE; MECHANISMS; CLEAVAGE	RNA interference (RNAi) is a conserved sequence-specific gene regulatory mechanism(1-3) mediated by the RNA-induced silencing complex ( RISC), which is composed of a single-stranded guide RNA and an Argonaute protein. The PIWI domain, a highly conserved motif within Argonaute, has been shown to adopt an RNase H fold(4,5) critical for the endonuclease cleavage activity of RISC4-6. Here we report the crystal structure of Archaeoglobus fulgidus Piwi protein bound to double-stranded RNA, thereby identifying the binding pocket for guide-strand 5 '-end recognition and providing insight into guide-strand-mediated messenger RNA target recognition. The phosphorylated 5 ' end of the guide RNA is anchored within a highly conserved basic pocket, supplemented by the carboxy-terminal carboxylate and a bound divalent cation. The first nucleotide from the 5 ' end of the guide RNA is unpaired and stacks over a conserved tyrosine residue, whereas successive nucleotides form a four-base-pair RNA duplex. Mutation of the corresponding amino acids that contact the 5 ' phosphate in human Ago2 resulted in attenuated mRNA cleavage activity. Our structure of the Piwi-RNA complex, and that determined elsewhere(7), provide direct support for the 5 ' region of the guide RNA serving as a nucleation site for pairing with target mRNA and for a fixed distance separating the RISC-mediated mRNA cleavage site from the anchored 5 ' end of the guide RNA.	Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA; Rockefeller Univ, Lab RNA Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Rockefeller University	Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10021 USA.	pateld@mskcc.org	Pei, Yi/D-8998-2011	Pei, Yi/0000-0002-3466-760X	NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068776] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748] Funding Source: Medline; NIAID NIH HHS [R01 AI068776] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Chiu YL, 2003, RNA, V9, P1034, DOI 10.1261/rna.5103703; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Rand TA, 2004, P NATL ACAD SCI USA, V101, P14385, DOI 10.1073/pnas.0405913101; Sagar MB, 2004, RNA, V10, P772, DOI 10.1261/rna.5266504; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; YANG W, 1995, STRUCTURE, V3, P131, DOI 10.1016/S0969-2126(01)00142-3	29	468	511	4	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2005	434	7033					666	670		10.1038/nature03514	http://dx.doi.org/10.1038/nature03514			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911NN	15800629	Green Accepted			2022-12-24	WOS:000228011000050
J	Harrison, CJ; Corley, SB; Moylan, EC; Alexander, DL; Scotland, RW; Langdale, JA				Harrison, CJ; Corley, SB; Moylan, EC; Alexander, DL; Scotland, RW; Langdale, JA			Independent recruitment of a conserved developmental mechanism during leaf evolution	NATURE			English	Article							KNOTTED1-LIKE HOMEOBOX GENE; COMPOUND LEAF; ROUGH-SHEATH2 GENE; KNOX GENES; EXPRESSION; LEAVES; TOMATO; ARABIDOPSIS; PLANTS; PRIMORDIA	Vascular plants evolved in the Middle to Late Silurian period, about 420 million years ago(1). The fossil record indicates that these primitive plants had branched stems with sporangia but no leaves. Leaf-like lateral outgrowths subsequently evolved on at least two independent occasions(2-4). In extant plants, these events are represented by microphyllous leaves in lycophytes (clubmosses, spikemosses and quillworts) and megaphyllous leaves in euphyllophytes ( ferns, gymnosperms and angiosperms). Our current understanding of how leaves develop is restricted to processes that operate during megaphyll formation. Because microphylls and megaphylls evolved independently, different mechanisms might be required for leaf formation. Here we show that this is not so. Gene expression data from a microphyllous lycophyte, phylogenetic analyses, and a cross-species complementation experiment all show that a common developmental mechanism can underpin both microphyll and megaphyll formation. We propose that this mechanism might have operated originally in the context of primitive plant apices to facilitate bifurcation. Recruitment of this pathway to formleaves occurred independently and in parallel in different plant lineages.	Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England	University of Oxford	Langdale, JA (corresponding author), Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford OX1 3RB, England.	jane.langdale@plants.ox.ac.uk	Moylan, Elizabeth C/J-5611-2019; Langdale, Jane A./AAE-8343-2019	Langdale, Jane/0000-0001-7648-3924; Harrison, Jill/0000-0002-5228-600X	Biotechnology and Biological Sciences Research Council [G19201] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Bharathan G, 2002, SCIENCE, V296, P1858, DOI 10.1126/science.1070343; BIERHORST DW, 1977, AM J BOT, V64, P125, DOI 10.2307/2442101; Boyce CK, 2002, PALEOBIOLOGY, V28, P70, DOI 10.1666/0094-8373(2002)028&lt;0070:EODPAT&gt;2.0.CO;2; Byrne ME, 2000, NATURE, V408, P967, DOI 10.1038/35050091; EDWARDS D, 1983, BOT J LINN SOC, V86, P19, DOI 10.1111/j.1095-8339.1983.tb00715.x; Gifford EM, 1989, MORPHOLOGY EVOLUTION; Golz JF, 2002, CURR BIOL, V12, P515, DOI 10.1016/S0960-9822(02)00721-2; Hareven D, 1996, CELL, V84, P735, DOI 10.1016/S0092-8674(00)81051-X; Hofer J, 2001, PLANT MOL BIOL, V45, P387, DOI 10.1023/A:1010739812836; JACKSON D, 1994, DEVELOPMENT, V120, P405; Janssen BJ, 1998, PLANT PHYSIOL, V117, P771, DOI 10.1104/pp.117.3.771; Kenrick P, 1997, ORIGIN EARLY DIVERSI; Kim M, 2003, DEVELOPMENT, V130, P4405, DOI 10.1242/dev.00655; Kim M, 2003, NATURE, V424, P438, DOI 10.1038/nature01820; LINCOLN C, 1994, PLANT CELL, V6, P1859, DOI 10.1105/tpc.6.12.1859; Long JA, 1996, NATURE, V379, P66, DOI 10.1038/379066a0; McHale NA, 2004, PLANT CELL, V16, P1251, DOI 10.1105/tpc.019307; Muller J, 2001, PLANT J, V27, P13, DOI 10.1046/j.1365-313x.2001.01064.x; Nishimura A, 1999, PLANT J, V18, P337, DOI 10.1046/j.1365-313X.1999.00457.x; Parnis A, 1997, PLANT CELL, V9, P2143, DOI 10.1105/tpc.9.12.2143; Pautot W, 2001, PLANT CELL, V13, P1719, DOI 10.1105/tpc.13.8.1719; Schneeberger R, 1998, DEVELOPMENT, V125, P2857; Sentoku N, 1999, PLANT CELL, V11, P1651, DOI 10.1105/tpc.11.9.1651; SMITH LG, 1992, DEVELOPMENT, V116, P21; STEEVES TA, 1957, AM J BOT, V44, P665, DOI 10.2307/2438631; Theodoris G, 2003, P NATL ACAD SCI USA, V100, P6837, DOI 10.1073/pnas.1132113100; Timmermans MCP, 1999, SCIENCE, V284, P151, DOI 10.1126/science.284.5411.151; Tsiantis M, 2003, NAT REV GENET, V4, P169, DOI 10.1038/nrg1002; Tsiantis M, 1999, SCIENCE, V284, P154, DOI 10.1126/science.284.5411.154; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782	30	153	160	2	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2005	434	7032					509	514		10.1038/nature03410	http://dx.doi.org/10.1038/nature03410			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909CH	15791256				2022-12-24	WOS:000227836000043
J	Sharrock, NE; Finerty, E				Sharrock, NE; Finerty, E			Hip replacement, hip seeding, and epidural anaesthesia	LANCET			English	Editorial Material							BLADDER MANAGEMENT; ARTHROPLASTY; MORTALITY		Hosp Special Surg, Dept Anesthesiol, New York, NY 10021 USA; Hosp Special Surg, Dept Nursing, Infect Control & Occupat Hlth Serv, New York, NY 10021 USA		Sharrock, NE (corresponding author), Hosp Special Surg, Dept Anesthesiol, 535 E 70th St, New York, NY 10021 USA.	sharrockn@hss.edu						Gedney JA, 1998, ANAESTHESIA, V53, P1148, DOI 10.1046/j.1365-2044.1998.00636.x; Knight RM, 1996, J ARTHROPLASTY, V11, P882, DOI 10.1016/S0883-5403(96)80127-6; Macdowell AD, 2004, J BONE JOINT SURG BR, V86B, P1115, DOI 10.1302/0301-620X.86B8.14240; MICHELSON JD, 1988, NEW ENGL J MED, V319, P321; Rodgers A, 2000, BMJ-BRIT MED J, V321, P1493, DOI 10.1136/bmj.321.7275.1493; Salvati EA, 2000, J BONE JOINT SURG AM, V82A, P252; SHARROCK NE, 1995, ANESTH ANALG, V80, P242, DOI 10.1097/00000539-199502000-00008; Sharrock NE, 2005, REGION ANESTH PAIN M, V30, P123, DOI 10.1016/j.rapm.2004.12.005; Tambyah PA, 2002, INFECT CONT HOSP EP, V23, P27, DOI 10.1086/501964; Williams A, 1995, J ROY SOC MED, V88, pP699; Wong ES., 1981, GUIDELINE PREVENTION; WROBLEWSKI BM, 1980, CLIN ORTHOP RELAT R, P209	12	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 19	2005	365	9464					1011	1012						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907QB	15781083				2022-12-24	WOS:000227731800008
J	Wang, PY; Weng, F; Anderson, RGW				Wang, PY; Weng, F; Anderson, RGW			OSBP is a cholesterol-regrulated scaffolding protein in control of ERK1/2 activation	SCIENCE			English	Article							OXYSTEROL-BINDING-PROTEIN; GOLGI LOCALIZATION; CELLS; PHOSPHORYLATION; EXPRESSION; MOTIF; VAP	Oxysterol-binding protein (OSBP) is the founding member of a family of sterol-binding proteins implicated in vesicle transport, lipid metabolism, and signal transduction. Here, OSBP was found to function as a cholesterol-binding scaffolding protein coordinating the activity of two phosphatases to control the extracellular signal-regulated kinase (ERK) signaling pathway. Cytosolic OSBP formed a similar to440-kilodalton oligomer with a member of the PTPPBS family of tyrosine phosphatases, the serine/threonine phosphatase PP2A, and cholesterol. This oligomer had dual specific phosphatase activity for phosphorylated ERK (pERK). When cell cholesterol was lowered, the oligomer disassembled and the level of pERK rose. The oligomer also disassembled when exposed to oxysterols. Increasing the amount of OSBP oligomer rendered cells resistant to the effects of cholesterol depletion and decreased the basal level of pERK. Thus, cholesterol functions through its interaction with OSBP outside of membranes to regulate the assembly of an oligomeric phosphatase that controls a key signaling pathway in the cell.	Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Anderson, RGW (corresponding author), Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA.	richard.anderson@utsouthwestern.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052016] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 20948] Funding Source: Medline; NIGMS NIH HHS [GM 52016] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ares MPS, 2000, ATHEROSCLEROSIS, V153, P23, DOI 10.1016/S0021-9150(00)00380-4; Augustine KA, 2000, ANAT REC, V258, P221, DOI 10.1002/(SICI)1097-0185(20000301)258:3<221::AID-AR1>3.0.CO;2-W; Furuchi T, 1998, J BIOL CHEM, V273, P21099, DOI 10.1074/jbc.273.33.21099; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Mohammadi A, 2001, J LIPID RES, V42, P1062; Munro S, 2003, NATURE, V426, P775, DOI 10.1038/426775a; Pulido R, 1998, EMBO J, V17, P7337, DOI 10.1093/emboj/17.24.7337; RIDGWAY ND, 1992, J CELL BIOL, V116, P307, DOI 10.1083/jcb.116.2.307; Storey MK, 1998, BIOCHEM J, V336, P247, DOI 10.1042/bj3360247; Wang PY, 2003, EMBO J, V22, P2658, DOI 10.1093/emboj/cdg255; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Yoon JH, 2004, HEPATOLOGY, V39, P732, DOI 10.1002/hep.20125	13	222	236	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1472	1476		10.1126/science.1107710	http://dx.doi.org/10.1126/science.1107710			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746430				2022-12-24	WOS:000227503100049
J	Krimigis, SM; Mitchell, DG; Hamilton, DC; Krupp, N; Livi, S; Roelof, EC; Dandouras, J; Armstrong, TP; Mauk, BH; Paranicas, C; Brandt, PC; Bolton, S; Cheng, AF; Choo, T; Gloeckler, G; Hayes, J; Hsieh, KC; Ip, WH; Jaskulek, S; Keath, EP; Kirsch, E; Kusterer, M; Lagg, A; Lanzerotti, LJ; LaVallee, D; Manweiler, J; McEntire, RW; Rasmuss, W; Saur, J; Turner, FS; Williams, DJ; Woch, J				Krimigis, SM; Mitchell, DG; Hamilton, DC; Krupp, N; Livi, S; Roelof, EC; Dandouras, J; Armstrong, TP; Mauk, BH; Paranicas, C; Brandt, PC; Bolton, S; Cheng, AF; Choo, T; Gloeckler, G; Hayes, J; Hsieh, KC; Ip, WH; Jaskulek, S; Keath, EP; Kirsch, E; Kusterer, M; Lagg, A; Lanzerotti, LJ; LaVallee, D; Manweiler, J; McEntire, RW; Rasmuss, W; Saur, J; Turner, FS; Williams, DJ; Woch, J			Dynamics of Saturn's magnetosphere from MIMI during Cassini's orbital insertion	SCIENCE			English	Article							NITROGEN TORI; HOT PLASMA; PARTICLES; INNER; GAS	The Magnetospheric Imaging Instrument (MIMI) onboard the Cassini spacecraft observed the saturnian magnetosphere from January 2004 until Saturn orbit insertion (Sol) on 1 July 2004. The MIMI sensors observed frequent energetic particle activity in interplanetary space for several months before Sol. When the imaging sensor was switched to its energetic neutral atom (ENA) operating mode on 20 February 2004, at similar to10(3) times Saturn's radius R-s (0.43 astronomical units), a weak but persistent signal was observed from the magnetosphere. About 10 days before Sol, the magnetosphere exhibited a day-night asymmetry that varied with an similar to 11-hour periodicity. Once Cassini entered the magnetosphere, in situ measurements showed high concentrations of H+, H-2(+), O+, OH+, and H2O+ and low concentrations of N+. The radial dependence of ion intensity profiles implies neutral gas densities sufficient to produce high loss rates of trapped ions from the middle and inner magnetosphere. ENA imaging has revealed a radiation belt that resides inward of the D ring and is probably the result of double charge exchange between the main radiation belt and the upper layers of Saturn's exosphere.	Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; Univ Maryland, Dept Phys, College Pk, MD 20742 USA; Max Planck Inst Sonnensyst Forsch, D-37191 Lindau, Germany; Ctr Etud Spatiale Rayonnements, F-31028 Toulouse, France; Fundamental Technol Inc, Lawrence, KS 66049 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Arizona, Dept Phys, Tucson, AZ 85721 USA; Natl Cent Univ, Grad Inst Astron, Jhongli City, Peoples R China; Bell Labs, Murray Hill, NJ 07974 USA; New Jersey Inst Technol, Newark, NJ 07102 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University System of Maryland; University of Maryland College Park; Max Planck Society; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Arizona; AT&T; New Jersey Institute of Technology	Krimigis, SM (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA.	tom.krimigis@jhuapl.edu	Dandouras, Iannis/V-2709-2017; Mitchell, Donald G/H-4601-2016; Brandt, Pontus C/N-1218-2016; Saur, Joachim/V-6780-2019; Mauk, Barry H/E-8420-2017; Korpi-Lagg, Andreas/W-8166-2019; Paranicas, Christopher/B-1470-2016; Krimigis, Stamatios/G-4591-2019; Roelof, Edmond/G-6654-2019; Kusterer, Martha/AAE-5505-2021; Bolton, Scott/M-4392-2019	Dandouras, Iannis/0000-0002-7121-1118; Mitchell, Donald G/0000-0003-1960-2119; Brandt, Pontus C/0000-0002-4644-0306; Saur, Joachim/0000-0003-1413-1231; Mauk, Barry H/0000-0001-9789-3797; Korpi-Lagg, Andreas/0000-0003-1459-7074; Paranicas, Christopher/0000-0002-4391-8255; Krimigis, Stamatios/0000-0003-2781-2386; Roelof, Edmond/0000-0002-2270-0652; bolton, scott/0000-0002-9115-0789; Turner, Franklin/0000-0002-7935-7621; Kusterer, Martha/0000-0002-7943-1852; Manweiler, Jerry/0000-0002-8800-2128; Hamilton, Douglas/0000-0001-6103-8019				CHENG AF, 1989, OUTSTANDING PROBLEMS, P253; Dougherty MK, 2005, SCIENCE, V307, P1266, DOI 10.1126/science.1106098; Esposito LW, 2005, SCIENCE, V307, P1251, DOI 10.1126/science.1105606; EVIATAR A, 1983, J GEOPHYS RES-SPACE, V88, P833, DOI 10.1029/JA088iA02p00833; FILLIUS W, 1980, SCIENCE, V207, P425, DOI 10.1126/science.207.4429.425; GLOECKLER G, 2001, S-P B ASTROPHYS, P287; IP WH, 1992, ADV SPACE RES-SERIES, V12, P73, DOI 10.1016/0273-1177(92)90379-C; KIRSCH E, 1981, NATURE, V292, P718, DOI 10.1038/292718a0; Krimigis SM, 2004, SPACE SCI REV, V114, P233, DOI 10.1007/s11214-004-1410-8; KRIMIGIS SM, 1982, SCIENCE, V215, P571, DOI 10.1126/science.215.4532.571; KRIMIGIS SM, 1981, SCIENCE, V212, P225, DOI 10.1126/science.212.4491.225; KRIMIGIS SM, 1983, J GEOPHYS RES-SPACE, V88, P8871, DOI 10.1029/JA088iA11p08871; KRIMIGIS SM, 2004, 36 DIV PLAN SCI M LO; Mauk BH, 1999, J GEOPHYS RES-SPACE, V104, P22759, DOI 10.1029/1999JA900097; Mitchell DG, 2001, GEOPHYS RES LETT, V28, P1151, DOI 10.1029/2000GL012395; Moritz J., 1972, Zeitschrift fur Geophysik, V38, P701; Richardson JD, 1998, REV GEOPHYS, V36, P501, DOI 10.1029/98RG01691; ROELOF EC, 1985, J GEOPHYS RES-SPACE, V90, P991, DOI 10.1029/JA090iA11p10991; Smith HT, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020580; VANALLEN JA, 1980, SCIENCE, V207, P415, DOI 10.1126/science.207.4429.415	20	154	154	3	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1270	1273		10.1126/science.1105978	http://dx.doi.org/10.1126/science.1105978			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731445				2022-12-24	WOS:000227313200047
J	Richardson, CJ; Reiss, P; Hussain, NA; Alwash, AJ; Pool, DJ				Richardson, CJ; Reiss, P; Hussain, NA; Alwash, AJ; Pool, DJ			The restoration potential of the Mesopotamian marshes of Iraq	SCIENCE			English	Article							SELENIUM; ENVIRONMENT; RIVER	Uncontrolled releases of Tigris and Euphrates River waters after the 2003 war have partially restored some former marsh areas in southern Iraq, but restoration is failing in others because of high soil and water salinities. Nearly 20% of the original 15,000-square-kilometer marsh area was reflooded by March 2004, but the extent of marsh restoration is unknown. High-quality water, nonsaline soils, and the densest native vegetation were found in the only remaining natural marsh, the Al-Hawizeh, located on the Iranian border. Although substantially reduced in area and under current threat of an Iranian dike, it has the potential to be a native repopulation center for the region. Rapid reestablishment, high productivity, and reproduction of native flora and fauna in reflooded former marsh areas indicate a high probability for successful restoration, provided the restored wetlands are hydraulically designed to allow sufficient flow of noncontaminated water and flushing of salts through the ecosystem.	Duke Univ, Nicholas Sch Environm & Earth sci, Duke Univ Wetland Ctr, Res Triangle Pk, NC 27709 USA; Dev Alternat, Bethesda, MD 20895 USA; Univ Basra, Coll Sci, Basra, Iraq; Iraq Fdn, Washington, DC 20005 USA; Int Resources Grp, Washington, DC 20036 USA	Duke University; University of Basrah	Richardson, CJ (corresponding author), Duke Univ, Nicholas Sch Environm & Earth sci, Duke Univ Wetland Ctr, Box 80333, Res Triangle Pk, NC 27709 USA.	curtr@duke.edu	Richardson, Curt/P-5905-2019; Richardson, Curtis J/A-8202-2009					Al-Mousawi AHA, 1983, ARAB GULF J SCI RES, V1, P237; ALHILLI MR, 1977, THESIS U CAIRO; BANAT KM, IN PRESS J ARID ENV; BRASINGTON J, 2002, IRAQI MARSHLANDS HUM, P151; Buringh P., 1960, SOILS SOIL CONDITION; DOUABUL AA, 1988, ARCH ENVIRON CON TOX, V17, P405, DOI 10.1007/BF01055178; ELDEMERDASH MA, 1994, VEGETATIO, V112, P141, DOI 10.1007/BF00044688; EVANS MI, 2002, IRAQI MARSHLANDS HUM, P201; Farber E, 2004, GEOCHIM COSMOCHIM AC, V68, P1989, DOI 10.1016/j.gca.2003.09.021; HUSSAIN NA, 1992, AHWAR IRAQ ENV APPRO; *IR FDN, 2003, ED AG INT TECHN ADV; Lemly AD, 1999, HUM ECOL RISK ASSESS, V5, P1139, DOI 10.1080/10807039.1999.10518883; LEMLY AD, 1993, ENVIRON MONIT ASSESS, V28, P83, DOI 10.1007/BF00547213; LEMLY AD, 1985, ECOTOX ENVIRON SAFE, V10, P314; MAAS E V, 1986, Applied Agricultural Research, V1, P12; Maas E. V., 1999, Agricultural drainage., P55; Maltby E, 1994, DRAFT CONSULTIVE B; MAULOOD BK, 1981, HYDROBIOLOGIA, V80, P269, DOI 10.1007/BF00018367; Meyerson L. A., 2000, Wetlands Ecology and Management, V8, P89, DOI 10.1023/A:1008432200133; Nicholson E., 2003, IRAQI MARSHLANDS HUM; PARTOW H, 2001, UNEP PUBLICATION; RICHARDS LA, 1954, AGR HDB USDA, V60; Saeed T, 1999, WATER SCI TECHNOL, V40, P89, DOI 10.2166/wst.1999.0335; Salim S.M., 1962, MARSH DWELLERS EUPHR; Serag MS, 2001, ENVIRONMETRICS, V12, P219, DOI 10.1002/env.458; Thesinger W, 1964, MARSH ARABS; UNEP, 2003, ENV IR UNEP PROGR RE; YOUNG G, 1977, RETURN MARSHES LIFE	28	92	106	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1307	1311		10.1126/science.1105750	http://dx.doi.org/10.1126/science.1105750			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731454				2022-12-24	WOS:000227313200058
J	Kuhl, M; Chen, M; Ralph, PJ; Schreiber, U; Larkum, AWD				Kuhl, M; Chen, M; Ralph, PJ; Schreiber, U; Larkum, AWD			A niche for cyanobacteria containing chlorophyll d	NATURE			English	Article							OXYGENIC PHOTOSYNTHETIC PROKARYOTE; ACARYOCHLORIS-MARINA; MAJOR PIGMENT		Univ Copenhagen, Marine Biol Lab, Inst Biol, DK-3000 Helsingor, Denmark; Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; Univ Technol Sydney, Inst Water & Environm Resource Management, Gore Hill, NSW 2065, Australia; Univ Wurzburg, Julius von Sachs Inst Biowissensch, D-97082 Wurzburg, Germany	University of Copenhagen; University of Sydney; University of Technology Sydney; University of Wurzburg	Kuhl, M (corresponding author), Univ Copenhagen, Marine Biol Lab, Inst Biol, Strandpromenaden 5, DK-3000 Helsingor, Denmark.	mkuhl@bi.ku.dk	Ralph, Peter J/C-5029-2009; Kühl, Michael/A-1977-2009; Ralph, Peter/L-1527-2019	Ralph, Peter J/0000-0002-3103-7346; Kühl, Michael/0000-0002-1792-4790; Ralph, Peter/0000-0002-3103-7346; Chen, Min/0000-0001-8070-3248				Boichenko VA, 2000, PHOTOSYNTH RES, V65, P269, DOI 10.1023/A:1010637631417; Chen M, 2005, MOL BIOL EVOL, V22, P21, DOI 10.1093/molbev/msh250; Kuhl M, 2000, MICROBIAL ECOL, V40, P94; KUHL M, 2002, SYMBIOSIS MECH MODEL, P273; Miller SR, 2005, P NATL ACAD SCI USA, V102, P850, DOI 10.1073/pnas.0405667102; Miyashita H, 2003, J PHYCOL, V39, P1247, DOI 10.1111/j.0022-3646.2003.03-158.x; Miyashita H, 1997, PLANT CELL PHYSIOL, V38, P274, DOI 10.1093/oxfordjournals.pcp.a029163; Miyashita H, 1996, NATURE, V383, P402, DOI 10.1038/383402a0; Murakami A, 2004, SCIENCE, V303, P1633, DOI 10.1126/science.1095459; Schiller H, 1997, FEBS LETT, V410, P433, DOI 10.1016/S0014-5793(97)00620-0	10	150	172	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2005	433	7028					820	820		10.1038/433820a	http://dx.doi.org/10.1038/433820a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	899VT	15729331	Bronze			2022-12-24	WOS:000227174600031
J	Zerr, DM; Meier, AS; Selke, SS; Frenkel, LM; Huang, M; Wald, A; Rhoads, MP; Nguy, L; Bornemann, R; Morrow, RA; Corey, L				Zerr, DM; Meier, AS; Selke, SS; Frenkel, LM; Huang, M; Wald, A; Rhoads, MP; Nguy, L; Bornemann, R; Morrow, RA; Corey, L			A population-based study of primary human herpesvirus 6 infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN HERPESVIRUS-6 INFECTION; CHILDREN; REACTIVATION; DNA	BACKGROUND: Serologic studies indicate that human herpesvirus 6 (HHV-6) infects 90 percent of children by two years of age. Little is known about the acquisition, virologic course, and clinical manifestations of HHV-6 infection. METHODS: We prospectively studied a cohort of 277 children from birth through the first two years of life to define the pattern of acquisition of HHV-6. The children's saliva was tested weekly for HHV-6 DNA with the use of the polymerase chain reaction. Parents maintained a daily log of signs and symptoms of illness in their children. RESULTS: Primary HHV-6 infection occurred in 130 children, with cumulative percentages of 40 percent by the age of 12 months and 77 percent by the age of 24 months. The peak age of acquisition was between 9 and 21 months. The acquisition of HHV-6 was associated with female sex (adjusted hazard ratio, 1.7; 95 percent confidence interval, 1.2 to 2.4) and having older siblings (adjusted hazard ratio, 2.1; 95 percent confidence interval, 1.4 to 2.9). Among 81 children with a well-defined time of acquisition of HHV-6, 93 percent had symptoms, and 38 percent were seen by a physician. None had seizures. As compared with children who had other illnesses, those with primary HHV-6 infection were more likely to have fever (P=0.003), fussiness (P=0.02), diarrhea (P=0.03), rash (P=0.003), and roseola (P=0.002) and were more likely to visit a physician (P=0.003). CONCLUSIONS: The acquisition of HHV-6 in infancy is usually symptomatic and often results in medical evaluation. Roseola occurs in a minority of patients, and febrile seizures are infrequently associated with primary HHV-6 infection. Older siblings appear to serve as a source of HHV-6 transmission.	Childrens Hosp, Seattle, WA 98105 USA; Univ Washington, Dept Pediat, Seattle, WA 98195 USA; Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Program Biostat, Seattle, WA 98104 USA; Fred Hutchinson Canc Res Ctr, Program Infect Dis, Seattle, WA 98104 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Zerr, DM (corresponding author), Childrens Hosp, 8G-1,4800 Sand Point Way NE, Seattle, WA 98105 USA.	zerr@u.washington.edu	Wald, Anna/B-6272-2012	Wald, Anna/0000-0003-3486-6438	NIAID NIH HHS [AI001679, AI-30731] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI030731, K23AI001679] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Black JB, 1996, CLIN DIAGN LAB IMMUN, V3, P79, DOI 10.1128/CDLI.3.1.79-83.1996; CHERRY JD, 1998, TXB PEDIAT INFECT DI, V1, P738; DALESSIO J, 1992, J CLIN MICROBIOL, V30, P1005, DOI 10.1128/JCM.30.4.1005-1007.1992; HALL CB, 1994, NEW ENGL J MED, V331, P432, DOI 10.1056/NEJM199408183310703; Ljungman P, 2000, BRIT J HAEMATOL, V111, P774, DOI 10.1046/j.1365-2141.2000.02422.x; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; OKUNO T, 1989, J CLIN MICROBIOL, V27, P651, DOI 10.1128/JCM.27.4.651-653.1989; PRUKSANANONDA P, 1992, NEW ENGL J MED, V326, P1445, DOI 10.1056/NEJM199205283262201; Ryncarz AJ, 1999, J CLIN MICROBIOL, V37, P1941, DOI 10.1128/JCM.37.6.1941-1947.1999; YAMAMOTO M, 1990, J CLIN MICROBIOL, V28, P1957, DOI 10.1128/JCM.28.9.1957-1962.1990; Zerr DM, 2000, J CLIN MICROBIOL, V38, P1981, DOI 10.1128/JCM.38.5.1981-1983.2000; Zerr DM, 2002, CLIN INFECT DIS, V34, P309, DOI 10.1086/338044; Zerr DM, 2001, CLIN INFECT DIS, V33, P763, DOI 10.1086/322642	13	282	298	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2005	352	8					768	776		10.1056/NEJMoa042207	http://dx.doi.org/10.1056/NEJMoa042207			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	899MC	15728809				2022-12-24	WOS:000227147500006
J	Deahl, M				Deahl, M			Smoke, mirrors, and Gulf War illness	LANCET			English	Editorial Material							MORTALITY; VETERANS		256 City London Field Hosp V, London SE17 3RF, England		Deahl, M (corresponding author), 256 City London Field Hosp V, 71 Braganza St, London SE17 3RF, England.	martindeahl@fsmail.net						Barrett DH, 2002, EPIDEMIOL REV, V24, P218, DOI 10.1093/epirev/mxf003; DANDEKER C, IN PRESS ARMED FORCE; Davis LE, 2004, NEUROLOGY, V63, P1070, DOI 10.1212/01.WNL.0000138426.88460.CB; Haley RW, 2003, LANCET NEUROL, V2, P272, DOI 10.1016/S1474-4422(03)00376-4; INST. OF MED, 2000, GULF WAR HLTH; IVERSEN A, IN PRESS BR J PSYCHI; Kang HK, 2002, OCCUP ENVIRON MED, V59, P794, DOI 10.1136/oem.59.12.794; Macfarlane GJ, 2000, LANCET, V356, P17, DOI 10.1016/S0140-6736(00)02428-4; *RES ADV COMM GULF, 2004, 2004 REP REC; SHANE S, 2004, NY TIMES        1116, P6; TURNER MA, IN PRESS BR J PSYCHI; 2004, TIMES LOND      1207, P18	12	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 19	2005	365	9460					635	638						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	898SP	15721458				2022-12-24	WOS:000227096800006
J	Domergue, R; Castano, I; De las Penas, A; Zupancic, M; Lockatell, V; Hebel, JR; Johnson, D; Cormack, BP				Domergue, R; Castano, I; De las Penas, A; Zupancic, M; Lockatell, V; Hebel, JR; Johnson, D; Cormack, BP			Nicotinic acid limitation regulates silecing of Candida adhesins during UTI	SCIENCE			English	Article							ESCHERICHIA-COLI; GENE FAMILY; GLABRATA; DEACETYLASE; METABOLISM; EVOLUTION; CHROMATIN	The adherence of Candida glabrata to host cells is mediated, at least in part, by the EPA genes, a family of adhesins encoded at subtelomeric loci, where they are subject to transcriptional silencing. We show that normally silent EPA genes are expressed during murine urinary tract infection (UTI) and that the inducing signal is the limitation of nicotinic acid (NA), a precursor of nicotinamide adenine dinucleotide (NAD(+)). C. glabrata is an NA auxotroph, and NA-induced EPA expression is likely the result of a reduction in NAD(+) availability for the NAD(+)-dependent histone deacetylase Sir2p. The adaptation of C. glabrata to the host, therefore, involves a loss of metabolic capacity and exploitation of the resulting auxotrophy to signal a particular host environment.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Univ Maryland, Sch Med, Div Infect Dis, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA; Dept Vet Affairs, Res Serv, Baltimore, MD 21201 USA	Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Cormack, BP (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	bcormack@jhmi.edu	De Las Penas, Alejandro/M-7719-2013	De Las Penas, Alejandro/0000-0002-2933-2856; Castano, Irene/0000-0002-5968-2101	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK049720] Funding Source: NIH RePORTER; NIAID NIH HHS [R01AI46223] Funding Source: Medline; NIDDK NIH HHS [2PO1DK49720] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bedalov A, 2003, MOL CELL BIOL, V23, P7044, DOI 10.1128/MCB.23.19.7044-7054.2003; Castano I, 2005, MOL MICROBIOL, V55, P1246, DOI 10.1111/j.1365-2958.2004.04465.x; Cormack BP, 1999, SCIENCE, V285, P578, DOI 10.1126/science.285.5427.578; DAI J, UNPUB; De las Penas A, 2003, GENE DEV, V17, P2245, DOI 10.1101/gad.1121003; Di Martino P, 2003, CAN J MICROBIOL, V49, P443, DOI 10.1139/W03-056; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Fukuwatari T, 2004, BIOSCI BIOTECH BIOCH, V68, P44, DOI 10.1271/bbb.68.44; Guarente L, 2000, GENE DEV, V14, P1021; HAGBERG L, 1983, INFECT IMMUN, V40, P273, DOI 10.1128/IAI.40.1.273-283.1983; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; Iraqui I, 2005, MOL MICROBIOL, V55, P1259, DOI 10.1111/j.1365-2958.2004.04475.x; KUNIN CM, 1993, J CLIN MICROBIOL, V31, P47, DOI 10.1128/JCM.31.1.47-49.1993; LIDIA Do CARMO-SOUSA, 1969, The yeasts. Vol. I. Biology of yeasts., P79; Llorente B, 2000, FEBS LETT, V475, P237, DOI 10.1016/S0014-5793(00)01698-7; Lundstrom T, 2001, CLIN INFECT DIS, V32, P1602, DOI 10.1086/320531; MAHAN MJ, 1993, SCIENCE, V259, P686, DOI 10.1126/science.8430319; Panozzo C, 2002, FEBS LETT, V517, P97, DOI 10.1016/S0014-5793(02)02585-1; Perrod S, 2001, EMBO J, V20, P197, DOI 10.1093/emboj/20.1.197; ROBESON JP, 1980, NATURE, V283, P104, DOI 10.1038/283104a0; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Sandmeier JJ, 2002, GENETICS, V160, P877; Staib P, 1999, MOL MICROBIOL, V32, P533, DOI 10.1046/j.1365-2958.1999.01367.x; Sundstrom P, 2002, CELL MICROBIOL, V4, P461, DOI 10.1046/j.1462-5822.2002.00206.x; Trick WE, 2002, CLIN INFECT DIS, V35, P627, DOI 10.1086/342300; VANPILSUN J, 1974, BIOL DATA BOOK, P1496; Vazquez JA, 1999, CLIN INFECT DIS, V28, P1025, DOI 10.1086/514746	27	204	219	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2005	308	5723					866	870		10.1126/science.1108640	http://dx.doi.org/10.1126/science.1108640			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15774723				2022-12-24	WOS:000228986500052
J	Li, QS; Duan, LJ; Estes, JD; Ma, ZM; Rourke, T; Wang, YC; Reilly, C; Carlis, J; Miller, CJ; Haase, AT				Li, QS; Duan, LJ; Estes, JD; Ma, ZM; Rourke, T; Wang, YC; Reilly, C; Carlis, J; Miller, CJ; Haase, AT			Peak SIV replication in resting memory CD4(+) T cells depletes gut lamina propria CD4(+) T cells	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; GASTROINTESTINAL-TRACT; HIV-1 INFECTION; RHESUS MACAQUES; LYMPHOCYTES; TRANSMISSION; FAS; EXPRESSION; APOPTOSIS; LEU-23	In early simian immunodeficiency virus (SIV) and human immunodeficiency virus-1 (HIV-1) infections, gut-associated lymphatic tissue (GALT), the largest component of the lymphoid organ system(1), is a principal site of both virus production and depletion of primarily lamina propria memory CD4(+) T cells; that is, CD4-expressing T cells that previously encountered antigens and microbes and homed to the lamina propria of GALT(2-9). Here, we show that peak virus production in gut tissues of SIV-infected rhesus macaques coincides with peak numbers of infected memory CD4(+) T cells. Surprisingly, most of the initially infected memory cells were not, as expected(10,11), activated but were instead immunophenotypically 'resting' cells that, unlike truly resting cells, but like the first cells mainly infected at other mucosal sites and peripheral lymph nodes(12,13), are capable of supporting virus production. In addition to inducing immune activation and thereby providing activated CD4(+) T-cell targets to sustain infection, virus production also triggered(14) an immunopathologically limiting Fas-Fas-ligand-mediated apoptotic pathway(15,16) in lamina propria CD4(+) T cells, resulting in their preferential ablation. Thus, SIV exploits a large, resident population of resting memory CD4(+) T cells in GALT to produce peak levels of virus that directly (through lytic infection) and indirectly ( through apoptosis of infected and uninfected cells) deplete CD4(+) T cells in the effector arm of GALT. The scale of this CD4(+) T-cell depletion has adverse effects on the immune system of the host, underscoring the importance of developing countermeasures to SIV that are effective before infection of GALT.	Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; Univ Minnesota, Inst Technol, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA; Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; Univ Calif Davis, Sch Med, Div Infect Dis, Davis, CA 95616 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Haase, AT (corresponding author), Univ Minnesota, Sch Med, Dept Microbiol, MMC 196,420 Delaware St SE, Minneapolis, MN 55455 USA.	haase001@umn.edu						Boirivant M, 1996, J CLIN INVEST, V98, P2616, DOI 10.1172/JCI119082; Boirivant M, 1998, J CLIN IMMUNOL, V18, P39, DOI 10.1023/A:1023235803948; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Clayton F, 1997, CLIN EXP IMMUNOL, V107, P288, DOI 10.1111/j.1365-2249.1997.236-ce1111.x; DeMaria R, 1996, J CLIN INVEST, V97, P316, DOI 10.1172/JCI118418; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Kewenig S, 1999, GASTROENTEROLOGY, V116, P1115, DOI 10.1016/S0016-5085(99)70014-4; LIM SG, 1993, CLIN EXP IMMUNOL, V92, P448, DOI 10.1111/j.1365-2249.1993.tb03419.x; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; MILLER CJ, 1994, J VIROL, V68, P6391, DOI 10.1128/JVI.68.10.6391-6400.1994; MILLER CJ, UNPUB J VIROL; Mothe BR, 2002, J VIROL, V76, P875, DOI 10.1128/JVI.76.2.875-884.2002; Mowat AM, 1997, IMMUNOL REV, V156, P145, DOI 10.1111/j.1600-065X.1997.tb00966.x; Phillips AN, 1996, SCIENCE, V271, P497, DOI 10.1126/science.271.5248.497; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; POPPEMA S, 1991, AM J PATHOL, V139, P725; Reilly C, 2002, J AM STAT ASSOC, V97, P943, DOI 10.1198/016214502388618735; REYNOLDS MR, IN PRESS J VIROL; SCHNEIDER T, 1995, GUT, V37, P524, DOI 10.1136/gut.37.4.524; TESTI R, 1989, J IMMUNOL, V142, P1854; TESTI R, 1988, J IMMUNOL, V141, P2557; Veazey Ronald, 2003, AIDS Rev, V5, P245; Veazey RS, 2000, J VIROL, V74, P57, DOI 10.1128/JVI.74.1.57-64.2000; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P5640, DOI 10.1073/pnas.0308425101	26	755	788	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2005	434	7037					1148	1152		10.1038/nature03513	http://dx.doi.org/10.1038/nature03513			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15793562				2022-12-24	WOS:000228693300047
J	Goes, JI; Thoppil, PG; Gomes, HD; Fasullo, JT				Goes, JI; Thoppil, PG; Gomes, HD; Fasullo, JT			Warming of the Eurasian landmass is making the Arabian Sea more productive	SCIENCE			English	Article							INDIAN-SUMMER MONSOON; DIPOLE MODE; SNOW COVER; OCEAN; OCEANOGRAPHY; VARIABILITY; CIRCULATION; MECHANISMS; DYNAMICS; SURFACE	The recent trend of declining winter and spring snow cover over Eurasia is causing a land-ocean thermal gradient that is particularly favorable to stronger southwest (summer) monsoon winds. Since 1997, sea surface winds have been strengthening over the western Arabian Sea. This escalation in the intensity of summer monsoon winds, accompanied by enhanced upwelling and an increase of more than 350% in average summertime phytoplankton biomass along the coast and over 300% offshore, raises the possibility that the current warming trend of the Eurasian landmass is making the Arabian Sea more productive.	Bigelow Lab Ocean Sci, W Boothbay Harbor, ME 04575 USA; USN, Dept Oceanog, Postgrad Sch, Monterey, CA 93943 USA; Univ Colorado, Program Atmospher & Ocean Sci, Boulder, CO 80309 USA	Bigelow Laboratory for Ocean Sciences; United States Department of Defense; United States Navy; Naval Postgraduate School; University of Colorado System; University of Colorado Boulder	Goes, JI (corresponding author), Bigelow Lab Ocean Sci, W Boothbay Harbor, ME 04575 USA.	jgoes@bigelow.org	Fasullo, John/H-4552-2019	Fasullo, John/0000-0003-1216-892X; Thoppil, Prasad/0000-0003-2240-9782; DO ROSARIO GOMES, MARIA HELGA/0000-0002-6287-354X; Goes, Joaquim/0000-0002-9785-6985				Bamzai AS, 1999, J CLIMATE, V12, P3117, DOI 10.1175/1520-0442(1999)012<3117:RBESCS>2.0.CO;2; Banse K, 2000, DEEP-SEA RES PT II, V47, P1623, DOI 10.1016/S0967-0645(99)00157-5; BARNETT TP, 1989, J ATMOS SCI, V46, P661, DOI 10.1175/1520-0469(1989)046<0661:TEOESC>2.0.CO;2; Blanford HF., 1884, P R SOC LOND, V37, P3, DOI DOI 10.1098/RSPL.1884.0003; CLEMENS S, 1991, NATURE, V353, P720, DOI 10.1038/353720a0; Fasham MJR, 2001, AMBIO, P4; FINDLATER J, 1969, Q J ROY METEOR SOC, V95, P362, DOI 10.1002/qj.49709540409; Hitchcock GL, 2000, DEEP-SEA RES PT II, V47, P1605, DOI 10.1016/S0967-0645(99)00156-3; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kumar KK, 1999, SCIENCE, V284, P2156, DOI 10.1126/science.284.5423.2156; Lee CM, 2000, DEEP-SEA RES PT II, V47, P1177, DOI 10.1016/S0967-0645(99)00141-1; MEEHL GA, 1994, J CLIMATE, V7, P1033, DOI 10.1175/1520-0442(1994)007<1033:IOTLSI>2.0.CO;2; MEEHL GA, 1994, SCIENCE, V266, P263, DOI 10.1126/science.266.5183.263; Morrison JM, 1999, DEEP-SEA RES PT II, V46, P1903, DOI 10.1016/S0967-0645(99)00048-X; Murtugudde R, 2000, J GEOPHYS RES-OCEANS, V105, P3295, DOI 10.1029/1999JC900294; Naqvi SWA, 2000, NATURE, V408, P346, DOI 10.1038/35042551; Overland JE, 2001, FISH OCEANOGR, V10, P69, DOI 10.1046/j.1365-2419.2001.00154.x; Parthasarathy B, 1995, Advances in Atmospheric Sciences, V12, P143, DOI 10.1007/BF02656828; Prasad TG, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001872; Prasad TG, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002000; REYNOLDS RW, 1994, J CLIMATE, V7, P929, DOI 10.1175/1520-0442(1994)007<0929:IGSSTA>2.0.CO;2; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43854; SCHOTT F, 1983, PROG OCEANOGR, V12, P357, DOI 10.1016/0079-6611(83)90014-9; Schott FA, 2001, PROG OCEANOGR, V51, P1, DOI 10.1016/S0079-6611(01)00083-0; Schott FA, 2002, PROG OCEANOGR, V53, P57, DOI 10.1016/S0079-6611(02)00039-3; SENGUPTA R, 1984, DEEP-SEA RES, V31, P671; SHINODA TM, 2004, J CLIMATOL, V7, P929; Slingo JM, 2000, MON WEATHER REV, V128, P1778, DOI 10.1175/1520-0493(2000)128<1778:TENOOT>2.0.CO;2; Smith SL, 1998, DEEP-SEA RES PT II, V45, P1905, DOI 10.1016/S0967-0645(98)00058-7; SWALLOW JC, 1984, DEEP-SEA RES, V31, P639, DOI 10.1016/0198-0149(84)90032-3; Webster PJ, 1999, NATURE, V401, P356, DOI 10.1038/43848; Webster PJ, 1998, J GEOPHYS RES-OCEANS, V103, P14451, DOI 10.1029/97JC02719; WHITE WB, 1988, EOS, V69, P122; Wiggert JD, 2002, DEEP-SEA RES PT II, V49, P2319, DOI 10.1016/S0967-0645(02)00039-5	34	169	175	4	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2005	308	5721					545	547		10.1126/science.1106610	http://dx.doi.org/10.1126/science.1106610			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15845852				2022-12-24	WOS:000228810500050
J	Okada, Y; Feng, Q; Lin, YH; Jiang, Q; Li, YQ; Coffield, VM; Su, LS; Xu, GL; Zhang, Y				Okada, Y; Feng, Q; Lin, YH; Jiang, Q; Li, YQ; Coffield, VM; Su, LS; Xu, GL; Zhang, Y			hDOT1L links histone methylation to leukemogenesis	CELL			English	Article							PROTO-ONCOPROTEIN MLL; HOX GENE-EXPRESSION; BONE-MARROW-CELLS; HOMEOBOX GENES; SET DOMAIN; METHYLTRANSFERASE COMPLEX; MYELOID PROGENITORS; LYSINE METHYLATION; LEUCINE-ZIPPER; FAMILY	Epigenetic modifications play an important role in human cancer. One such modification, histone methylation, contributes to human cancer through deregulation of cancer-relevant genes. The yeast Dot1 and its human counterpart, hDOT1L, methylate lysine 79 located within the globular domain of histone H3. Here we report that hDOT1L interacts with AF10, an MLL (mixed lineage leukemia) fusion partner involved in acute myeloid leukemia, through the OM-LZ region of AF10 required for MLL-AF10-mediated leukemogenesis. We demonstrate that direct fusion of hDOT1L to MLL results in leukemic transformation in an hDOT1L methyltransferase activity-dependent manner. Transformation by MLL-hDOT1L and MLL-AF10 results in upregulation of a number of leukemia-relevant genes, such as Hoxa9, concomitant with hypermethylation of H3-K79. Our studies thus establish that mistargeting of hDOT1L to Hoxa9 plays an important role in MLLAF10-mediated leukemogenesis and suggests that the enzymatic activity of hDOT1L may provide a potential target for therapeutic intervention.	Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Zhang, Y (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu		Zhang, Yi/0000-0002-2789-0811	NATIONAL CANCER INSTITUTE [R01CA119133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI053804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068804] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA119133-01A1] Funding Source: Medline; NIAID NIH HHS [AI5380402, AI04840704] Funding Source: Medline; NIGMS NIH HHS [GM68804, GM63076] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Buske C, 2000, INT J HEMATOL, V71, P301; Caslini C, 2000, LEUKEMIA, V14, P1898, DOI 10.1038/sj.leu.2401933; CHAPLIN T, 1995, BLOOD, V86, P2073, DOI 10.1182/blood.V86.6.2073.bloodjournal8662073; Coffield VM, 2003, NAT BIOTECHNOL, V21, P1321, DOI 10.1038/nbt889; Daser A, 2004, GENE DEV, V18, P965, DOI 10.1101/gad.1195504; DiMartino JF, 1999, BRIT J HAEMATOL, V106, P614, DOI 10.1046/j.1365-2141.1999.01439.x; DiMartino JF, 2002, BLOOD, V99, P3780, DOI 10.1182/blood.V99.10.3780; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Nakamura T, 1996, ONCOGENE, V13, P2235; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; So CW, 2003, BLOOD, V101, P633, DOI 10.1182/blood-2002-06-1785; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yokoyama A, 2002, BLOOD, V100, P3710, DOI 10.1182/blood-2002-04-1015; Zhang WZ, 2004, BIOCHEM J, V377, P641, DOI 10.1042/BJ20030839; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	35	612	634	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 22	2005	121	2					167	178		10.1016/j.cell.2005.02.020	http://dx.doi.org/10.1016/j.cell.2005.02.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851025	Bronze, Green Published			2022-12-24	WOS:000228705000006
J	Sachs, K; Perez, O; Pe'er, D; Lauffenburger, DA; Nolan, GP				Sachs, K; Perez, O; Pe'er, D; Lauffenburger, DA; Nolan, GP			Causal protein-signaling networks derived from multiparameter single-cell data	SCIENCE			English	Article							FLOW-CYTOMETRY; RAF-1; ACTIVATION; EXPRESSION	Machine learning was applied for the automated derivation of causal influences in cellular signaling networks. This derivation relied on the simultaneous measurement of multiple phosphorylated protein and phospholipid components in thousands of individual primary human immune system cells. Perturbing these cells with molecular interventions drove the ordering of connections between pathway components, wherein Bayesian network computational methods automatically elucidated most of the traditionally reported signaling relationships and predicted novel interpathway network causalities, which we verified experimentally. Reconstruction of network models from physiologically relevant primary single cells might be applied to understanding native-state tissue signaling biology, complex drug actions, and dysfunctional signaling in diseased cells.	MIT, Biol Engn Div, Cambridge, MA 02139 USA; Stanford Univ, Sch Med, Baxter Lab Genet Pharmacol, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Stanford University; Harvard University; Harvard Medical School	Lauffenburger, DA (corresponding author), MIT, Biol Engn Div, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lauffen@mit.edu; gnotan@stanford.edu	Califano, Andrea/F-7239-2012; Nolan, Garry/AAE-7903-2019	Nolan, Garry/0000-0002-8862-9043	NIAID NIH HHS [P01-AI39646, AI35304] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035304, P01AI039646] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CARROLL MP, 1994, J BIOL CHEM, V269, P1249; FRIEDMAN KMN, 1998, P 14 ANN C UNC ART I; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Fukuda R, 2003, CANCER RES, V63, P2330; Hartemink A J, 2001, Pac Symp Biocomput, P422; Heckerman D, 1998, NATO ADV SCI I D-BEH, V89, P301; Herzenberg LA, 2002, CLIN CHEM, V48, P1819; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; IRENE JDG, 2002, BIOINFORMATICS, V18, pS241; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Kelley BP, 2004, NUCLEIC ACIDS RES, V32, pW83, DOI 10.1093/nar/gkh411; Marais R, 1998, SCIENCE, V280, P109, DOI 10.1126/science.280.5360.109; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; Pe'er D, 2001, Bioinformatics, V17 Suppl 1, pS215; Pearl J., 1988, PROBABILISTIC REASON, DOI [10.1016/C2009-0-27609-4, DOI 10.1016/C2009-0-27609-4, 10.1016/B978-0-08-051489-5.50008-4]; Pearl J., 2000, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; PEER D, 2005, SCI STKE 2005; Perez OD, 2002, NAT BIOTECHNOL, V20, P155, DOI 10.1038/nbt0202-155; Perez OD, 2003, NAT IMMUNOL, V4, P1083, DOI 10.1038/ni984; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Roederer M, 2004, CLIN IMMUNOL, V110, P199, DOI 10.1016/j.clim.2003.11.015; Sachs Karen, 2002, Sci STKE, V2002, ppe38, DOI 10.1126/stke.2002.148.pe38; Steffen M, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-34; Woolf PJ, 2005, BIOINFORMATICS, V21, P741, DOI 10.1093/bioinformatics/bti056; Zhang WM, 1998, AM J PHYSIOL-CELL PH, V274, pC82, DOI 10.1152/ajpcell.1998.274.1.C82	26	963	1008	7	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2005	308	5721					523	529		10.1126/science.1105809	http://dx.doi.org/10.1126/science.1105809			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15845847				2022-12-24	WOS:000228810500045
J	Honda, K; Ohba, Y; Yanai, H; Negishi, H; Mizutani, T; Takaoka, A; Taya, C; Taniguchi, T				Honda, K; Ohba, Y; Yanai, H; Negishi, H; Mizutani, T; Takaoka, A; Taya, C; Taniguchi, T			Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction	NATURE			English	Article							CPG-DNA; BACTERIAL-DNA; CELLS; ACTIVATION; RECOGNITION; ENDOCYTOSIS; ALPHA/BETA; EXPRESSION; MOTIFS; MYD88	Robust type-I interferon (IFN-alpha/beta) induction in plasmacytoid dendritic cells, through the activation of Toll-like receptor 9 (TLR9), constitutes a critical aspect of immunity(1-6). It is absolutely dependent on the transcription factor IRF-7, which interacts with and is activated by the adaptor MyD88 (ref. 7). How plasmacytoid dendritic cells, but not other cell types (such as conventional dendritic cells), are able to activate the MyD88 IRF-7-dependent IFN induction pathway remains unknown. Here we show that the spatiotemporal regulation of MyD88 IRF-7 signalling is critical for a high-level IFN induction in response to TLR9 activation. The IFN-inducing TLR9 ligand, A/D-type CpG oligodeoxynucleotide (CpG-A)(3,4,8-11), is retained for long periods in the endosomal vesicles of plasmacytoid dendritic cells, together with the MyD88-IRF-7 complex. However, in conventional dendritic cells, CpG-A is rapidly transferred to lysosomal vesicles. We further show that conventional dendritic cells can also mount a robust IFN induction if CpG-A is manipulated for endosomal retention using a cationic lipid. This strategy also allows us to demonstrate endosomal activation of the IFN pathway by the otherwise inactive TLR9 ligand B/K-type oligodeoxynucleotide (CpG-B)(3,4,8-12). Thus, our study offers insights into the regulation of TLR9 signalling in space, potentially suggesting a new avenue for therapeutic intervention.	Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan; JST, PRESTO, Informat & Cell Funct, Kawaguchi, Saitama 3320012, Japan; Tokyo Metropolitan Inst Med Sci, Dept Lab Anim Sci, Bunkyo Ku, Tokyo 1138613, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Tokyo Metropolitan Institute of Medical Science	Taniguchi, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	tada@m.u-tokyo.ac.jp	Mizutani, Tatsuaki/AAA-5044-2021; Yanai, Hideyuki/AGK-5933-2022; Serei, Virian D/B-4616-2015; Honda, Kenya/N-5297-2015; Ohba, Yusuke/E-7944-2011	Mizutani, Tatsuaki/0000-0002-4323-4347; Yanai, Hideyuki/0000-0002-0115-9000; Honda, Kenya/0000-0001-8937-9835				Asselin-Paturel C, 2003, J IMMUNOL, V171, P6466, DOI 10.4049/jimmunol.171.12.6466; Brunetti CR, 1998, J VIROL, V72, P3330, DOI 10.1128/JVI.72.4.3330-3339.1998; Coccia EM, 2004, EUR J IMMUNOL, V34, P796, DOI 10.1002/eji.200324610; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; DURRER P, 1995, J BIOL CHEM, V270, P17575, DOI 10.1074/jbc.270.29.17575; Hacker H, 2000, J EXP MED, V192, P595, DOI 10.1084/jem.192.4.595; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2003, J IMMUNOL, V170, P3059, DOI 10.4049/jimmunol.170.6.3059; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; HONDA K, 2005, NATURE          0330, DOI DOI 10.1038/NATURE03464; Izaguirre A, 2003, J LEUKOCYTE BIOL, V74, P1125, DOI 10.1189/jlb.0603255; Kerkmann M, 2003, J IMMUNOL, V170, P4465, DOI 10.4049/jimmunol.170.9.4465; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Koltover I, 1998, SCIENCE, V281, P78, DOI 10.1126/science.281.5373.78; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Radler JO, 1997, SCIENCE, V275, P810, DOI 10.1126/science.275.5301.810; Ronnblom L, 2003, ARTHRITIS RES THER, V5, P68, DOI 10.1186/ar625; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Verthelyi D, 2001, J IMMUNOL, V166, P2372, DOI 10.4049/jimmunol.166.4.2372; Wagner H, 2004, TRENDS IMMUNOL, V25, P381, DOI 10.1016/j.it.2004.04.011; ZABNER J, 1995, J BIOL CHEM, V270, P18997, DOI 10.1074/jbc.270.32.18997	30	695	731	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					1035	1040		10.1038/nature03547	http://dx.doi.org/10.1038/nature03547			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15815647				2022-12-24	WOS:000228524600042
J	Frevert, U; Nardin, E				Frevert, U; Nardin, E			Arrest in the liver - A genetically defined malaria vaccine?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NYU, Sch Med, Dept Med & Mol Parasitol, New York, NY 10003 USA	New York University	Frevert, U (corresponding author), NYU, Sch Med, Dept Med & Mol Parasitol, New York, NY 10003 USA.			Frevert, Ute/0000-0001-9556-7330				CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; Frevert U, 2004, TRENDS PARASITOL, V20, P417, DOI 10.1016/j.pt.2004.07.007; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; Matuschewski K, 2002, J BIOL CHEM, V277, P41948, DOI 10.1074/jbc.M207315200; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188	5	7	8	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 14	2005	352	15					1600	1602		10.1056/NEJMcibr050521	http://dx.doi.org/10.1056/NEJMcibr050521			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	915SH	15829544				2022-12-24	WOS:000228324200017
J	Leliveld, J; Lechtenbolumer, S; Assonov, SS; Brenninkmeijer, CAM; Dienst, C; Fischedick, M; Hanke, T				Leliveld, J; Lechtenbolumer, S; Assonov, SS; Brenninkmeijer, CAM; Dienst, C; Fischedick, M; Hanke, T			Greenhouse gases: Low methane leakage from gas pipelines	NATURE			English	Editorial Material									Max Planck Inst Chem, D-55128 Mainz, Germany; Wuppertal Inst Climate Environm & Energy, D-42103 Wuppertal, Germany	Max Planck Society	Leliveld, J (corresponding author), Max Planck Inst Chem, D-55128 Mainz, Germany.	leliveld@mpch-mainz.mpg.de	Lelieveld, Jos/A-1986-2013; Lechtenböhmer, Stefan/H-4940-2019; Brenninkmeijer, Carl/B-6860-2013	Lelieveld, Jos/0000-0001-6307-3846; Lechtenböhmer, Stefan/0000-0001-5987-5416; Fischedick, Manfred/0000-0003-2893-5003; Assonov, Sergey/0000-0001-9096-4150				*BRIT PETR, 2004, STAT REV WORLD EN 20; Dedikov JV, 1999, ATMOS ENVIRON, V33, P3291, DOI 10.1016/S1352-2310(98)00388-4; Dlugokencky EJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018126; Fiore AM, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015601; International Energy Agency, 2004, NAT GAS INF 2004; LELIEVELD J, 1992, NATURE, V355, P339, DOI 10.1038/355339a0; Ramaswamy V., CLIMATE CHANGE 2001, P349; Reshetnikov AI, 2000, J GEOPHYS RES-ATMOS, V105, P3517, DOI 10.1029/1999JD900761; *US EPA, 2004, INV US GREENH GAS SO; *US EPA, 1996, EPA600R96080 US; Wang JS, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002180	11	71	72	4	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 14	2005	434	7035					841	842		10.1038/434841a	http://dx.doi.org/10.1038/434841a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915SV	15829951				2022-12-24	WOS:000228327600027
J	Malausa, T; Bethenod, MT; Bontemps, A; Bourguet, D; Cornuet, JM; Ponsard, S				Malausa, T; Bethenod, MT; Bontemps, A; Bourguet, D; Cornuet, JM; Ponsard, S			Assortative mating in sympatric host races of the European corn borer	SCIENCE			English	Article							OSTRINIA-NUBILALIS HUBNER; REPRODUCTIVE ISOLATION; GENETIC ISOLATION; LARCH BUDMOTH; PLANT RACES; SPECIATION; POPULATIONS; SPECIALIZATION; LEPIDOPTERA; PYRALIDAE	Although a growing body of work supports the plausibility of sympatric speciation in animals, the practical difficulties of directly quantifying reproductive isolation between diverging taxa remain an obstacle to analyzing this process. We used a combination of genetic and biogeochemical markers to produce a direct field estimate of assortative mating in phytophagous insect populations. We show that individuals of the same insect species, the European corn borer Ostrinia nubilalis, that develop on different host plants can display almost absolute reproductive isolation-the proportion of assortative mating was >95%-even in the absence of temporal or spatial isolation.	Univ Toulouse 3, Lab Dynam Biodivers, CNRS, UMR 5172, F-31062 Toulouse, France; Inst Natl Rech Agron, CBGP, F-34988 Montferrier Sur Lez, France; Inst Natl Rech Agron, Unite Genet Microbienne & Environm, F-78285 Guyancourt, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; INRAE; Institut de Recherche pour le Developpement (IRD); INRAE	Malausa, T (corresponding author), Univ Toulouse 3, Lab Dynam Biodivers, CNRS, UMR 5172, F-31062 Toulouse, France.	malausa@cict.fr	Malausa, Thibaut/X-1614-2018	Malausa, Thibaut/0000-0003-1681-7958; Bourguet, Denis/0000-0002-2109-5323				Berlocher SH, 2002, ANNU REV ENTOMOL, V47, P773, DOI 10.1146/annurev.ento.47.091201.145312; Bethenod MT, 2005, HEREDITY, V94, P264, DOI 10.1038/sj.hdy.6800611; Bontemps A, 2004, P ROY SOC B-BIOL SCI, V271, P2179, DOI 10.1098/rspb.2004.2851; Craig TP, 1997, EVOLUTION, V51, P1552, DOI 10.1111/j.1558-5646.1997.tb01478.x; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Dres M, 2002, PHILOS T R SOC B, V357, P471, DOI 10.1098/rstb.2002.1059; Emelianov I, 2003, J EVOLUTION BIOL, V16, P208, DOI 10.1046/j.1420-9101.2003.00524.x; Emelianov I, 2001, EVOLUTION, V55, P2002, DOI 10.1111/j.0014-3820.2001.tb01317.x; FEDER JL, 1994, P NATL ACAD SCI USA, V91, P7990, DOI 10.1073/pnas.91.17.7990; FEDER JL, 1993, ENTOMOL EXP APPL, V69, P117, DOI 10.1007/BF02380639; KLUN JA, 1975, ENVIRON ENTOMOL, V4, P891, DOI 10.1093/ee/4.6.891; Kondrashov AS, 1998, P ROY SOC B-BIOL SCI, V265, P2273, DOI 10.1098/rspb.1998.0570; Martel C, 2003, HEREDITY, V90, P141, DOI 10.1038/sj.hdy.6800186; Noor MAF, 1999, HEREDITY, V83, P503, DOI 10.1038/sj.hdy.6886320; Parker PG, 1998, ECOLOGY, V79, P361, DOI 10.1890/0012-9658(1998)079[0361:WMCTUA]2.0.CO;2; Pelozuelo L, 2004, J CHEM ECOL, V30, P335, DOI 10.1023/B:JOEC.0000017981.03762.ed; Rice WR, 1987, EVOL ECOL, V1, P301, DOI 10.1007/BF02071555; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; SHOWERS WB, 1976, ENVIRON ENTOMOL, V5, P1099, DOI 10.1093/ee/5.6.1099; Thomas Y, 2003, EVOLUTION, V57, P261; Via S, 2001, TRENDS ECOL EVOL, V16, P381, DOI 10.1016/S0169-5347(01)02188-7; Via S, 1999, EVOLUTION, V53, P1446, DOI [10.1111/j.1558-5646.1999.tb05409.x, 10.2307/2640891]	22	123	130	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2005	308	5719					258	260		10.1126/science.1107577	http://dx.doi.org/10.1126/science.1107577			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915BX	15821092				2022-12-24	WOS:000228273700055
J	Mooney, H; Cropper, A; Reid, W				Mooney, H; Cropper, A; Reid, W			Confronting the human dilemma	NATURE			English	Editorial Material									Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Millennium Ecosyst Assessment, Oakland, CA 94611 USA; Cropper Fdn, Port Of Spain, Trinidad Tobago	Stanford University	Mooney, H (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.							2002, NATURE, V417, P112	1	93	102	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2005	434	7033					561	562		10.1038/434561a	http://dx.doi.org/10.1038/434561a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911NN	15800597				2022-12-24	WOS:000228011000019
J	Coulibaly, F; Chevalier, C; Gutsche, I; Pous, J; Navaza, J; Bressanelli, S; Delmas, B; Rey, FA				Coulibaly, F; Chevalier, C; Gutsche, I; Pous, J; Navaza, J; Bressanelli, S; Delmas, B; Rey, FA			The birnavirus crystal structure reveals structural relationships among icosahedral viruses	CELL			English	Article							INFECTIOUS BURSAL DISEASE; DOUBLE-STRANDED-RNA; PANCREATIC NECROSIS VIRUS; MAJOR CAPSID PROTEIN; L-A VIRUS; ATOMIC-STRUCTURE; ANGSTROM RESOLUTION; POLYMERASE-ACTIVITY; MATURATION PROCESS; AMINO-ACIDS	Double-stranded RNA virions are transcriptionally competent icosahedral particles that must translocate across a lipid bilayer to function within the cytoplasm of the target cell. Birnaviruses are unique among dsRNA viruses as they have a single T = 13 icosahedral shell, lacking the characteristic inner capsid observed in the others. We determined the crystal structures of the T = 1 subviral particle (260 A in diameter) and of the T = 13 intact virus particle (700 A in diameter) of an avian birnavirus to 3 A and 7 A resolution, respectively. Our results show that VP2, the only component of the virus icosahedral capsid, is homologous both to the capsid protein of positive-strand RNA viruses, like the T = 3 nodaviruses, and to the T = 13 capsid protein of members of the Reoviridae family of dsRNA viruses. Together, these results provide important insights into the multiple functions of the birnavirus capsid and reveal unexpected structural relationships among icosahedral viruses.	INRA, Unite Virol & Immunol Mol, Domaine Vilvert, F-78350 Jouy En Josas, France; CNRS, INRA, UMR 2472 1157, Lab Virol Mol & Struct, F-91198 Gif Sur Yvette, France; IFR 115, F-91198 Gif Sur Yvette, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); INRAE; Universite Paris Saclay	Delmas, B (corresponding author), INRA, Unite Virol & Immunol Mol, Domaine Vilvert, F-78350 Jouy En Josas, France.	delmas@jouy.inra.fr	Chevalier, Christophe/AAK-4461-2020; Chevalier, Christophe/AAW-5560-2020; Rey, Felix/B-6497-2012; Chevalier, Christophe/C-2575-2009	Chevalier, Christophe/0000-0003-3231-9027; Coulibaly, Fasseli/0000-0003-3380-2117; Rey, Felix/0000-0002-9953-7988; Bressanelli, Stephane/0000-0002-0921-6727				Bamford DH, 2002, THEOR POPUL BIOL, V61, P461, DOI 10.1006/tpbi.2002.1591; Birghan C, 2000, EMBO J, V19, P114, DOI 10.1093/emboj/19.1.114; Bottcher B, 1997, J VIROL, V71, P325; Bourgeois D, 1999, ACTA CRYSTALLOGR D, V55, P1733, DOI 10.1107/S0907444999008355; Brandt M, 2001, J VIROL, V75, P11974, DOI 10.1128/JVI.75.24.11974-11982.2001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Butcher SJ, 1997, EMBO J, V16, P4477, DOI 10.1093/emboj/16.14.4477; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Caston JR, 1997, J CELL BIOL, V138, P975, DOI 10.1083/jcb.138.5.975; Caston JR, 2001, J VIROL, V75, P10815, DOI 10.1128/JVI.75.22.10815-10828.2001; Chevalier C, 2004, J VIROL, V78, P3296, DOI 10.1128/JVI.78.7.3296-3303.2004; Chevalier C, 2002, J VIROL, V76, P2384, DOI 10.1128/JVI.76.5.2384-2392.2002; COHEN J, 1975, BIOCHEM BIOPH RES CO, V62, P689, DOI 10.1016/0006-291X(75)90454-4; Da Costa B, 2002, J VIROL, V76, P2393, DOI 10.1128/JVI.76.5.2393-2402.2002; DeFilippis VR, 2001, FIELDS VIROLOGY, P353; Delmas B, 2004, VIRUS TAXONOMY, P561; Diprose JM, 2001, EMBO J, V20, P7229, DOI 10.1093/emboj/20.24.7229; DOBOS P, 1979, J VIROL, V32, P593, DOI 10.1128/JVI.32.2.593-605.1979; Dryden KA, 1998, VIROLOGY, V245, P33, DOI 10.1006/viro.1998.9146; Estes M.K., 2001, FIELDS VIROLOGY, V2., P1747; FLORES TP, 1994, PROTEIN ENG, V7, P31, DOI 10.1093/protein/7.1.31; Gorbalenya AE, 2002, J MOL BIOL, V324, P47, DOI 10.1016/S0022-2836(02)01033-1; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Gouet P, 1999, CELL, V97, P481, DOI 10.1016/S0092-8674(00)80758-8; GRIMES J, 1995, NATURE, V373, P167, DOI 10.1038/373167a0; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; Hanzlik TN, 1997, ADV VIRUS RES, V48, P101, DOI 10.1016/S0065-3527(08)60287-0; Harrison SC, 2001, CURR OPIN STRUC BIOL, V11, P195, DOI 10.1016/S0959-440X(00)00189-5; Helgstrand C, 2004, VIROLOGY, V318, P192, DOI 10.1016/j.virol.2003.08.045; Hjalmarsson A, 1999, J VIROL, V73, P3484, DOI 10.1128/JVI.73.4.3484-3490.1999; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Johnson JE, 1997, J MOL BIOL, V269, P665, DOI 10.1006/jmbi.1997.1068; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; JONES TA, 1992, MOL REPLACEMENT, P91; Lawton JA, 1997, NAT STRUCT BIOL, V4, P118, DOI 10.1038/nsb0297-118; Liemann S, 2002, CELL, V108, P283, DOI 10.1016/S0092-8674(02)00612-8; Lim BL, 1999, J VIROL, V73, P2854, DOI 10.1128/JVI.73.4.2854-2862.1999; Mathieu M, 2001, EMBO J, V20, P1485, DOI 10.1093/emboj/20.7.1485; Mertens PPC, 1996, VIROLOGY, V217, P582, DOI 10.1006/viro.1996.0153; Muller H, 2003, VET MICROBIOL, V97, P153, DOI 10.1016/j.vetmic.2003.08.005; Mundt E, 1999, J GEN VIROL, V80, P2067, DOI 10.1099/0022-1317-80-8-2067; Munshi S, 1996, J MOL BIOL, V261, P1, DOI 10.1006/jmbi.1996.0437; Naitow H, 2002, NAT STRUCT BIOL, V9, P725, DOI 10.1038/nsb844; Nakagawa A, 2003, STRUCTURE, V11, P1227, DOI 10.1016/j.str.2003.08.012; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Nibert ML., 2001, FIELDS VIROLOGY, P1679; Ona A, 2004, VIROLOGY, V322, P135, DOI 10.1016/j.virol.2004.01.025; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OZEL M, 1985, ARCH VIROL, V84, P149, DOI 10.1007/BF01378968; Paul AV, 1998, NATURE, V393, P280, DOI 10.1038/30529; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; ROSSMANN MG, 1989, ANNU REV BIOCHEM, V58, P533, DOI 10.1146/annurev.bi.58.070189.002533; Schneemann A, 1998, ADV VIRUS RES, V50, P381, DOI 10.1016/S0065-3527(08)60812-X; SCHNITZLER D, 1993, J GEN VIROL, V74, P1563, DOI 10.1099/0022-1317-74-8-1563; SPIES U, 1987, VIRUS RES, V8, P127, DOI 10.1016/0168-1702(87)90024-4; Tan BH, 2001, J VIROL, V75, P3937, DOI 10.1128/JVI.75.8.3937-3947.2001; Tang L, 2002, J VIROL, V76, P6370, DOI 10.1128/JVI.76.12.6370-6375.2002; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1755, DOI 10.1107/S0907444901013737; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; van Loon AAWM, 2002, J GEN VIROL, V83, P121, DOI 10.1099/0022-1317-83-1-121; [No title captured]	64	243	262	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 25	2005	120	6					761	772		10.1016/j.cell.2005.01.009	http://dx.doi.org/10.1016/j.cell.2005.01.009			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	912HF	15797378	Bronze			2022-12-24	WOS:000228067500007
J	Ihrie, RA; Marques, MR; Nguyen, BT; Horner, JS; Papazoglu, C; Bronson, RT; Mills, AA; Attardi, LD				Ihrie, RA; Marques, MR; Nguyen, BT; Horner, JS; Papazoglu, C; Bronson, RT; Mills, AA; Attardi, LD			Perp is a p63-regulated gene essential for epithelial integrity	CELL			English	Article							P53-DEPENDENT APOPTOSIS; EPIDERMAL MORPHOGENESIS; P53 HOMOLOG; P63; CELL; PLAKOPHILIN-1; TARGET; DESMOPLAKIN; DESMOSOMES; COMPLEX	p63 is a master regulator of stratified epithelial development that is both necessary and sufficient for specitying this multifaceted program. We show here that Perp, a tetraspan membrane protein originally identified as an apoptosis-associated target of the p53 tumor suppressor, is the first direct target of p63 clearly involved in mediating this developmental program in vivo. During embryogenesis, Perp is expressed in an epithelial pattern, and its expression depends on p63. Perp(-/-) mice die postnatally, with dramatic blistering in stratified epithelia symptomatic of compromised adhesion. Perp localizes specifically to desmosomes, adhesion junctions important for tissue integrity, and numerous structural defects in desmosomes are observed in Perp-deficient skin, suggesting a role for Perp in promoting the stable assembly of desmosomal adhesive complexes. These findings demonstrate that Perp is a key effector in the p63 developmental program, playing an essential role in an adhesion subprogram central to epithelial integrity and homeostasis.	Stanford Univ, Sch Med, Div Radiat & Canc Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Stanford University; Stanford University; Stanford University; Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Harvard University; Harvard Medical School	Attardi, LD (corresponding author), Stanford Univ, Sch Med, Div Radiat & Canc Biol, Stanford, CA 94305 USA.	attardi@stanford.edu		Ihrie, Rebecca/0000-0003-0439-0141	NCI NIH HHS [CA09302, CA93665-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA093665] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Attardi LD, 2000, GENE DEV, V14, P704; Attardi LD, 1999, CELL MOL LIFE SCI, V55, P48, DOI 10.1007/s000180050269; Bornslaeger EA, 2001, J CELL SCI, V114, P727; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Garrod DR, 2002, CURR OPIN CELL BIOL, V14, P537, DOI 10.1016/S0955-0674(02)00366-6; Getsios S, 2004, NAT REV MOL CELL BIO, V5, P271, DOI 10.1038/nrm1356; Green KJ, 2000, NAT REV MOL CELL BIO, V1, P208, DOI 10.1038/35043032; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Ihrie RA, 2003, CURR BIOL, V13, P1985, DOI 10.1016/j.cub.2003.10.055; Jetten AM, 2000, PROG NUCLEIC ACID RE, V64, P97, DOI 10.1016/S0079-6603(00)64003-5; Koch PJ, 1997, J CELL BIOL, V137, P1091, DOI 10.1083/jcb.137.5.1091; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Kurata S, 2004, J BIOL CHEM, V279, P50069, DOI 10.1074/jbc.M406322200; McKeon F, 2004, GENE DEV, V18, P465, DOI 10.1101/gad.1190504; McMillan JR, 2003, J INVEST DERMATOL, V121, P96, DOI 10.1046/j.1523-1747.2003.12324.x; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Reczek EE, 2003, MOL CANCER RES, V1, P1048; South AP, 2003, J CELL SCI, V116, P3303, DOI 10.1242/jcs.00636; Tsukita S, 2002, CURR OPIN CELL BIOL, V14, P531, DOI 10.1016/S0955-0674(02)00362-9; Vasioukhin V, 2001, NAT CELL BIOL, V3, P1076, DOI 10.1038/ncb1201-1076; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wong P, 2000, J CELL BIOL, V150, P921, DOI 10.1083/jcb.150.4.921; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yeaman C, 2004, J CELL SCI, V117, P559, DOI 10.1242/jcs.00893	31	247	255	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 25	2005	120	6					843	856		10.1016/j.cell.2005.01.008	http://dx.doi.org/10.1016/j.cell.2005.01.008			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	912HF	15797384	Bronze			2022-12-24	WOS:000228067500013
J	Tao, QH; Yokota, C; Puck, H; Kofron, M; Birsoy, B; Yan, D; Asashima, M; Wylie, CC; Lin, XH; Heasman, J				Tao, QH; Yokota, C; Puck, H; Kofron, M; Birsoy, B; Yan, D; Asashima, M; Wylie, CC; Lin, XH; Heasman, J			Maternal Wnt11 activates the canonical wnt signaling pathway required for axis formation in Xenopus embryos	CELL			English	Article							CONVERGENT EXTENSION MOVEMENTS; HEPARAN-SULFATE PROTEOGLYCANS; DORSAL-VENTRAL AXIS; BETA-CATENIN; CORTICAL ROTATION; ZEBRAFISH GASTRULATION; MIDBLASTULA TRANSITION; VERTEBRATE DEVELOPMENT; MESODERM INDUCTION; KIDNEY DEVELOPMENT	Wnt signaling pathways play essential roles in patterning and proliferation of embryonic and adult tissues. In many organisms, this signaling pathway directs axis formation. Although the importance of intracellular components of the pathway, including P-catenin and Tcf3, has been established, the mechanism of their activation is uncertain. In Xenopus, the initiating signal that localizes p-catenin to dorsal nuclei has been suggested to be intracellular and Wnt independent. Here, we provide three lines of evidence that the pathway specifying the dorsal axis is activated extracellularly in Xenopus embryos. First, we identify Wnt11 as the initiating signal. Second, we show that activation requires the glycosyl transferase X.EXT1. Third, we find that the EGF-CFC protein, FRL1, is also essential and interacts with Wnt11 to activate canonical Wnt signaling.	Cincinnati Childrens Res Fdn, Div Dev Biol, Cincinnati, OH 45229 USA; Univ Tokyo, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University of Tokyo	Heasman, J (corresponding author), Cincinnati Childrens Res Fdn, Div Dev Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	heabq9@chmcc.org		Kofron, Matthew/0000-0001-6427-4148; Birsoy, Bilge/0000-0003-4337-4582	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD033002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063891] Funding Source: NIH RePORTER; NICHD NIH HHS [HD33002] Funding Source: Medline; NIGMS NIH HHS [GM-63891] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adamson ED, 2002, J CELL PHYSIOL, V190, P267, DOI 10.1002/jcp.10072; AHN J, 1995, NAT GENET, V11, P137, DOI 10.1038/ng1095-137; BRANDT R, 1994, J BIOL CHEM, V269, P17320; Branford WW, 2002, CURR BIOL, V12, P2136, DOI 10.1016/S0960-9822(02)01360-X; Chang CB, 2000, MECH DEVELOP, V90, P227, DOI 10.1016/S0925-4773(99)00257-9; Chen CH, 2004, CURR BIOL, V14, P618, DOI 10.1016/j.cub.2004.02.042; Cheng SK, 2003, GENE DEV, V17, P31, DOI 10.1101/gad.1041203; Chi LJ, 2004, DEVELOPMENT, V131, P3345, DOI 10.1242/dev.01200; Christiansen JH, 1996, ONCOGENE, V12, P2705; CUI YZ, 1995, DEVELOPMENT, V121, P2177; Desbordes SC, 2003, DEVELOPMENT, V130, P6245, DOI 10.1242/dev.00874; Ding XY, 1998, MECH DEVELOP, V70, P15, DOI 10.1016/S0925-4773(97)00163-9; Djiane A, 2000, DEVELOPMENT, V127, P3091; Dominguez I, 2000, DEVELOPMENT, V127, P861; DU SJ, 1995, MOL CELL BIOL, V15, P2625; Eisenberg CA, 1999, DEV DYNAM, V216, P45, DOI 10.1002/(SICI)1097-0177(199909)216:1<45::AID-DVDY7>3.0.CO;2-L; ELINSON RP, 1988, DEV BIOL, V128, P185, DOI 10.1016/0012-1606(88)90281-3; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Gawantka V, 1995, EMBO J, V14, P6268, DOI 10.1002/j.1460-2075.1995.tb00317.x; GIMLICH RL, 1984, DEV BIOL, V104, P117, DOI 10.1016/0012-1606(84)90042-3; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Hacker U, 1997, DEVELOPMENT, V124, P3565; Han C, 2004, DEVELOPMENT, V131, P1563, DOI 10.1242/dev.01051; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Heasman J, 2000, DEV BIOL, V222, P124, DOI 10.1006/dbio.2000.9720; HEASMAN J, 1994, CELL, V79, P791, DOI 10.1016/0092-8674(94)90069-8; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; HOULISTON E, 1991, J CELL BIOL, V114, P1017, DOI 10.1083/jcb.114.5.1017; Houston DW, 2002, DEVELOPMENT, V129, P4015; Katada T, 2002, DEV GENES EVOL, V212, P248, DOI 10.1007/s00427-002-0237-0; Kelly C, 2000, DEVELOPMENT, V127, P3899; Kilian B, 2003, MECH DEVELOP, V120, P467, DOI 10.1016/S0925-4773(03)00004-2; KINOSHITA N, 1995, CELL, V83, P621, DOI 10.1016/0092-8674(95)90102-7; Kirikoshi H, 2001, INT J MOL MED, V8, P651; Kofron M, 2004, DEVELOPMENT, V131, P5065, DOI 10.1242/dev.01396; Kofron M, 2001, DEV BIOL, V237, P183, DOI 10.1006/dbio.2001.0371; KU M, 1993, DEVELOPMENT, V119, P1161; Kuhl M, 2002, SEMIN CELL DEV BIOL, V13, P243, DOI 10.1016/S1084-9521(02)00050-2; Lako M, 1998, GENE, V219, P101, DOI 10.1016/S0378-1119(98)00393-X; Larabell CA, 1997, J CELL BIOL, V136, P1123, DOI 10.1083/jcb.136.5.1123; Larabell CA, 1996, DEVELOPMENT, V122, P1281; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Lopez SL, 2003, DEVELOPMENT, V130, P2225, DOI 10.1242/dev.00443; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Merrill BJ, 2004, DEVELOPMENT, V131, P263, DOI 10.1242/dev.00935; Miller JR, 1999, J CELL BIOL, V146, P427, DOI 10.1083/jcb.146.2.427; MOON RT, 1993, DEVELOPMENT, V119, P97; Morkel M, 2003, DEVELOPMENT, V130, P6283, DOI 10.1242/dev.00859; Nasevicius A, 1998, DEVELOPMENT, V125, P4283; Nojima H, 2004, MECH DEVELOP, V121, P371, DOI 10.1016/j.mod.2004.02.003; Ohkawara B, 2003, DEVELOPMENT, V130, P2129, DOI 10.1242/dev.00435; Ouko L, 2004, J BIOL CHEM, V279, P26707, DOI 10.1074/jbc.M402877200; Perrimon N, 2004, DEVELOPMENT, V131, P2509, DOI 10.1242/dev.01225; Quaas J, 2002, DEV BIOL, V243, P272, DOI 10.1006/dbio.2001.0564; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Rowning BA, 1997, P NATL ACAD SCI USA, V94, P1224, DOI 10.1073/pnas.94.4.1224; RUPP RAW, 1991, CELL, V65, P927, DOI 10.1016/0092-8674(91)90545-A; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; Schohl A, 2002, DEVELOPMENT, V129, P37; Schroeder KE, 1999, DEV BIOL, V214, P288, DOI 10.1006/dbio.1999.9426; Shen MM, 2000, TRENDS GENET, V16, P303, DOI 10.1016/S0168-9525(00)02006-0; Stickens D, 1996, NAT GENET, V14, P25, DOI 10.1038/ng0996-25; Sumanas S, 2000, DEVELOPMENT, V127, P1981; Sun BI, 1999, DEVELOPMENT, V126, P1467; Tanegashima K, 2004, INT J DEV BIOL, V48, P275, DOI 10.1387/ijdb.041805kt; Teel AL, 1996, MECH DEVELOP, V59, P115, DOI 10.1016/0925-4773(96)00584-9; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Ulrich F, 2003, DEVELOPMENT, V130, P5375, DOI 10.1242/dev.00758; VINCENT JP, 1986, DEV BIOL, V113, P484, DOI 10.1016/0012-1606(86)90184-3; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Westfall TA, 2003, J CELL BIOL, V162, P889, DOI 10.1083/jcb.200303107; Wikramanayake AH, 2003, NATURE, V426, P446, DOI 10.1038/nature02113; Xanthos JB, 2002, DEVELOPMENT, V129, P4027; Xanthos JB, 2001, DEVELOPMENT, V128, P167; Yabe SI, 2003, DEVELOPMENT, V130, P2071, DOI 10.1242/dev.00430; Yan YT, 2002, MOL CELL BIOL, V22, P4439, DOI 10.1128/MCB.22.13.4439-4449.2002; Yang J, 2002, DEVELOPMENT, V129, P5743, DOI 10.1242/dev.00150; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0; Yokota C, 2003, DEVELOPMENT, V130, P2199, DOI 10.1242/dev.00434; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zhang J, 1998, CELL, V94, P515, DOI 10.1016/S0092-8674(00)81592-5; Zuck M. V., 1998, COMP METHODS APPROAC, P341	85	384	404	0	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 25	2005	120	6					857	871		10.1016/j.cell.2005.01.013	http://dx.doi.org/10.1016/j.cell.2005.01.013			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	912HF	15797385	Bronze			2022-12-24	WOS:000228067500014
J	Grandesso, F; Sanderson, F; Kruijt, J; Koene, T; Brown, V				Grandesso, F; Sanderson, F; Kruijt, J; Koene, T; Brown, V			Mortality and malnutrition among populations living in South Darfur, Sudan - Results of 3 surveys, September 2004	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context Mass violence against civilians in the west of Sudan has resulted in the displacement of more than 1.5 million people (25% of the population of the Darfur region). Most of these people are camped in 142 settlements. There has been increasing international concern about the health status of the displaced population. Objective To perform rapid epidemiological assessments of mortality and nutritional status at 3 sites in South Darfur for relief efforts. Design, Setting, and Participants In August and September 2004, mortality surveys were conducted among 137000 internally displaced persons (IDPs) in 3 sites in South Darfur (Kass [n = 900 households], Kalma [n = 893 households], and Muhajiria [n = 900 households]). A nutritional survey was performed concomitantly among children aged 6 to 59 months using weight for height as an index of acute malnutrition (Kass [n = 894], Kalma [n = 8881, and Muhajiria [n = 8961). A questionnaire detailing access to food and basic services was administered to a subset of households (n = 210 in each site). Main Outcome Measures Crude and under 5-year mortality rates and nutritional status of IDPs in Kass, Kalma, and Muhajiria, South Darfur. Results Crude mortality rates, expressed as deaths per 10000 per day, were 3.2 (95% confidence interval [CI], 2.2-4.1) in Kass, 2.0 (95% Cl, 1.3-2.7) in Kalma, and 2.3 (95% Cl, 1.2-3.4) in Muhajiria. Under 5-year mortality rates were 5.9 (95% Cl, 3.8-8.0) in Kass, 3.5 (95% Cl, 1.5-5.7) in Kalma, and 1.0 (95% Cl, 0.03-1.9) in Muhajiria. During the period of displacement covered by our survey in Muhajiria, violence was reported to be responsible for 72% of deaths, mainly among young men. Diarrheal disease was reported to cause between 25% and 47% of deaths in camp residents and mainly affected the youngest and oldest age groups. Acute malnutrition was common, affecting 14.1% of the target population in Kass, 23.6% in Kalma, and 10.7% in Muhajiria. Conclusion This study provides epidemiological evidence of the high rates of mortality and malnutrition among the displaced population in South Darfur and reinforces the need to mount appropriate and timely humanitarian responses.	Charing Cross Hosp, Dept Infect, London W6 8RF, England; Epictr, Paris, France; Med Sans Frontieres, Amsterdam, Netherlands	Imperial College London; Doctors Without Borders	Sanderson, F (corresponding author), Charing Cross Hosp, Dept Infect, London W6 8RF, England.	frances.sanderson@imperial.ac.uk						*CEDAT BRIEF DARF, 2004, AN MORT NUTR SURV N; Depoortere E, 2004, LANCET, V364, P1315, DOI 10.1016/S0140-6736(04)17187-0; HENDERSON RH, 1982, B WORLD HEALTH ORGAN, V60, P253; *MED FRONT, 1995, NUTR GUID; Spiegel PB, 2004, JAMA-J AM MED ASSOC, V292, P613, DOI 10.1001/jama.292.5.613; The Sphere Project, 1998, HUM CHART MIN STAND; UN. High Commission for Refugees, 1999, HDB EM; WOODRUFF BA, 2002, FIELD EXCHANGE, V17, P16; *WORLD MED ASS, DECL HELS 2004	9	33	33	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2005	293	12					1490	1494		10.1001/jama.293.12.1490	http://dx.doi.org/10.1001/jama.293.12.1490			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	908KA	15784873				2022-12-24	WOS:000227784700029
J	Berenbrink, M; Koldkjaer, P; Kepp, O; Cossins, AR				Berenbrink, M; Koldkjaer, P; Kepp, O; Cossins, AR			Evolution of oxygen secretion in fishes and the emergence of a complex physiological system	SCIENCE			English	Article							STRUCTURAL BASIS; MEMBRANE-TRANSPORT; HEMOGLOBIN; ERYTHROCYTES; AFFINITY; MECHANISM; TELEOST; BLOOD; EYE	We have reconstructed the events that led to the evolution of a key physiological innovation underpinning the large adaptive radiation of fishes, namely their unique ability to secrete molecular oxygen (O-2). We show that O-2 secretion into the swimbladder evolved some 100 million years after another O-2-secreting system in the eye. We unravel the likely sequence in which the functional components of both systems evolved. These components include ocular and swimbladder countercurrent exchangers, the Bohr and Root effects, the buffering power and surface histidine content of hemoglobins, and red blood cell Na+/H+ exchange activity. Our synthesis reveals the dynamics of gains and losses of these multiple traits over time, accounting for part of the huge diversity of form and function in living fishes.	Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; Humboldt Univ, Dept Anim Physiol, D-10115 Berlin, Germany	University of Liverpool; Humboldt University of Berlin	Berenbrink, M (corresponding author), Univ Liverpool, Sch Biol Sci, Crown St, Liverpool L69 7ZB, Merseyside, England.	michaelb@liv.ac.uk	Berenbrink, Michael/W-7519-2019; Kepp, Oliver/N-2763-2017; Kepp, Oliver/GPX-8627-2022	Kepp, Oliver/0000-0002-6081-9558; Cossins, Andrew/0000-0002-0813-5212				ALEXANDER RM, 1966, BIOL REV, V41, P141, DOI 10.1111/j.1469-185X.1966.tb01542.x; Berenbrink M, 2000, J PHYSIOL-LONDON, V526, P69, DOI 10.1111/j.1469-7793.2000.t01-1-00069.x; Bohr C, 1894, J Physiol, V15, P494; BORGESE F, 1992, P NATL ACAD SCI USA, V89, P6765, DOI 10.1073/pnas.89.15.6765; FAIRBANKS MB, 1974, J GEN PHYSIOL, V64, P263, DOI 10.1085/jgp.64.3.263; Fang TY, 1999, BIOCHEMISTRY-US, V38, P13423, DOI 10.1021/bi9911379; FARMER M, 1979, COMP BIOCHEM PHYS A, V62, P109, DOI 10.1016/S0300-9629(79)80004-3; FONNER DB, 1973, COMP BIOCHEM PHYSIOL, V46, P559, DOI 10.1016/0300-9629(73)90107-2; GILLEN RG, 1977, ARCH BIOCHEM BIOPHYS, V183, P678, DOI 10.1016/0003-9861(77)90401-5; Heaslet HA, 1999, STRUCT FOLD DES, V7, P517, DOI 10.1016/S0969-2126(99)80068-9; Heisler N., 1986, P397; Inoue JG, 2003, MOL PHYLOGENET EVOL, V26, P110, DOI 10.1016/S1055-7903(02)00331-7; ITO N, 1995, J MOL BIOL, V250, P648, DOI 10.1006/jmbi.1995.0405; JENSEN FB, 1989, J EXP BIOL, V143, P225; KILLMARTIN JV, 1976, BR MED B, V32, P209; LAUDER G V, 1983, Bulletin of the Museum of Comparative Zoology, V150, P95; MOTAIS R, 1987, J GEN PHYSIOL, V90, P197, DOI 10.1085/jgp.90.2.197; Nikinmaa M, 1997, J EXP BIOL, V200, P369; NIKINMAA M, 1992, PHYSIOL REV, V72, P301, DOI 10.1152/physrev.1992.72.2.301; Pelster B, 1998, FISH RESP, P113; Perutz MF, 1996, NAT STRUCT BIOL, V3, P211, DOI 10.1038/nsb0396-211; PERUTZ MF, 1982, NATURE, V299, P421, DOI 10.1038/299421a0; Qiu Y, 2000, J BIOL CHEM, V275, P13517, DOI 10.1074/jbc.275.18.13517; Root RW, 1931, BIOL BULL-US, V61, P427, DOI 10.2307/1536959; Venkatesh B, 2001, P NATL ACAD SCI USA, V98, P11382, DOI 10.1073/pnas.201415598; WITTENBERG JB, 1974, BIOL BULL-US, V146, P116, DOI 10.2307/1540402; WITTENBERG JB, 1962, NATURE, V194, P106, DOI 10.1038/194106a0; Yokoyama T, 2004, J BIOL CHEM, V279, P28632, DOI 10.1074/jbc.M401740200	28	170	176	2	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2005	307	5716					1752	1757		10.1126/science.1107793	http://dx.doi.org/10.1126/science.1107793			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774753				2022-12-24	WOS:000227883900038
J	Srinivasan, A; Burton, EC; Kuehnert, MJ; Rupprecht, C; Sutker, WL; Ksiazek, TG; Paddock, CD; Guarner, J; Shieh, WJ; Goldsmith, C; Hanlon, CA; Zoretic, J; Fischbach, B; Niezgoda, M; El-Feky, WH; Orciari, L; Sanchez, EQ; Likos, A; Klintmalm, GB; Cardo, D; LeDuc, J; Chamberland, ME; Jernigan, DB; Zaki, SR				Srinivasan, A; Burton, EC; Kuehnert, MJ; Rupprecht, C; Sutker, WL; Ksiazek, TG; Paddock, CD; Guarner, J; Shieh, WJ; Goldsmith, C; Hanlon, CA; Zoretic, J; Fischbach, B; Niezgoda, M; El-Feky, WH; Orciari, L; Sanchez, EQ; Likos, A; Klintmalm, GB; Cardo, D; LeDuc, J; Chamberland, ME; Jernigan, DB; Zaki, SR		Rabies Transplant Recipients Inves	Transmission of rabies virus from an organ donor to four transplant recipients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ORTHOTOPIC LIVER-TRANSPLANTATION; ARTERIAL REVASCULARIZATION; UNITED-STATES; EPIDEMIOLOGY; PREVENTION; CONDUITS; DEATHS; GRAFTS	BACKGROUND: In 2004, four recipients of kidneys, a liver, and an arterial segment from a common organ donor died of encephalitis of an unknown cause. METHODS: We reviewed the medical records of the organ donor and the recipients. Blood, cerebrospinal fluid, and tissues from the recipients were tested with a variety of assays and pathological stains for numerous causes of encephalitis. Samples from the recipients were also inoculated into mice. RESULTS: The organ donor had been healthy before having a subarachnoid hemorrhage that led to his death. Encephalitis developed in all four recipients within 30 days after transplantation and was accompanied by rapid neurologic deterioration characterized by agitated delirium, seizures, respiratory failure, and coma. They died an average of 13 days after the onset of neurologic symptoms. Mice inoculated with samples from the affected patients became ill seven to eight days later, and electron microscopy of central nervous system (CNS) tissue demonstrated rhabdovirus particles. Rabies-specific immunohistochemical and direct fluorescence antibody staining demonstrated rabies virus in multiple tissues from all recipients. Cytoplasmic inclusions consistent with Negri bodies were seen in CNS tissue from all recipients. Antibodies against rabies virus were present in three of the four recipients and the donor. The donor had told others of being bitten by a bat. CONCLUSIONS: This report documenting the transmission of rabies virus from an organ donor to multiple recipients underscores the challenges of preventing and detecting transmission of unusual pathogens through transplantation.	Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv Branch, Div Appl Publ Hlth Training, Epidemiol Program Off, Atlanta, GA USA; Baylor Univ, Med Ctr, Dallas, TX USA; Texas Dept State Hlth Serv, Austin, TX USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Baylor University; Baylor University Medical Center; Texas Department of State Health Services	Srinivasan, A (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Natl Ctr Infect Dis, Atlanta, GA 30333 USA.		Rupprecht, Charles/AAI-1544-2020; Guarner, Jeannette/B-8273-2013	Guarner, Jeannette/0000-0001-5610-3541				ANDERSON LJ, 1984, ANN INTERN MED, V100, P728, DOI 10.7326/0003-4819-100-5-728; Awasthi M, 2001, AM J NEURORADIOL, V22, P677; BLECK TP, 2000, PRINCIPLES PRACTICE, P1811; DOE J, 2000, MMWR RECOMM REP, V49, P737; DOE J, 1999, MMWR RECOMM REP, V48, P16; DOE J, 1999, MMWR RECOMM REP, V48, P1; ESIRI MM, 1992, GREENFIELDS NEUROPAT, P335; GODE GR, 1988, LANCET, V2, P791; GOLDSTEIN RM, 1990, SURGERY, V107, P540; HOUFF SA, 1979, NEW ENGL J MED, V300, P603, DOI 10.1056/NEJM197903153001105; Human death associated with bat rabies-California, 2003, MMWR MORB MORTAL WKL, V53, P33; Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987; *JOINT COMM ACCR H, PROP TISS STOR ISS S; Mani J, 2003, POSTGRAD MED J, V79, P352, DOI 10.1136/pmj.79.932.352; Muiesan P, 1998, LIVER TRANSPLANT SUR, V4, P232, DOI 10.1002/lt.500040314; Muralidharan V, 2004, TRANSPL INT, V17, P163, DOI 10.1007/s00147-004-0701-z; Noah DL, 1998, ANN INTERN MED, V128, P922, DOI 10.7326/0003-4819-128-11-199806010-00012; *ORG PROC TRANSPL, MIN PROC STAND ORG P; Organ Procurement and Transplantation Network, ORG PROC TRANSPL NET; Pinna AD, 1996, TRANSPLANTATION, V62, P1584, DOI 10.1097/00007890-199612150-00010; Sellers MT, 2002, AM J TRANSPLANT, V2, P471, DOI 10.1034/j.1600-6143.2002.20513.x; Shames BD, 2003, ANN SURG, V237, P116, DOI 10.1097/00000658-200301000-00016; SUREAU P, 1981, CR ACAD SCI III-VIE, V293, P689; ZAKI SR, 1995, AM J PATHOL, V146, P552; Zamboni F, 2002, DIGEST LIVER DIS, V34, P122, DOI 10.1016/S1590-8658(02)80241-9; 2004, MMWR MORB MORTAL WKL, V53, P1171; 1981, MMWR MORB MORTAL WKL, V30, P473; PROTOCOL POSTMORTEM; 2003, MMWR MORB MORTAL WKL, V52, P1102; 1980, MMWR MORB MORTAL WKL, V29, P25; CASES RABIES HUMAN B	32	278	303	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2005	352	11					1103	1111		10.1056/NEJMoa043018	http://dx.doi.org/10.1056/NEJMoa043018			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906PU	15784663				2022-12-24	WOS:000227655000007
J	Wang, YC; Ferguson, EL				Wang, YC; Ferguson, EL			Spatial bistability of Dpp-receptor interactions during Drosophila dorsal-ventral patterning	NATURE			English	Article							TWISTED GASTRULATION; SIGNAL-TRANSDUCTION; ACTIVITY GRADIENT; BMP ACTIVITY; I RECEPTORS; EMBRYO; GENE; SOG; IDENTIFICATION; ACTIVATION	In many developmental contexts, a locally produced morphogen specifies positional information by forming a concentration gradient over a field of cells(1). However, during embryonic dorsal - ventral patterning in Drosophila, two members of the bone morphogenetic protein (BMP) family, Decapentaplegic (Dpp) and Screw (Scw), are broadly transcribed but promote receptor-mediated signalling in a restricted subset of expressing cells(2-4). Here we use a novel immunostaining protocol to visualize receptor-bound BMPs and show that both proteins become localized to a sharp stripe of dorsal cells. We demonstrate that proper BMP localization involves two distinct processes. First, Dpp undergoes directed, long-range extracellular transport. Scw also undergoes long-range movement, but can do so independently of Dpp transport. Second, an intracellular positive feedback circuit promotes future ligand binding as a function of previous signalling strength. These data elicit a model in which extracellular Dpp transport initially creates a shallow gradient of BMP binding that is acted on by positive intracellular feedback to produce two stable states of BMP - receptor interactions, a spatial bistability in which BMP binding and signalling capabilities are high in dorsal-most cells and low in lateral cells.	Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Ferguson, EL (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA.	elfergus@midway.uchicago.edu	Wang, Yu-Chiun/N-6541-2015	Wang, Yu-Chiun/0000-0002-3797-4138; Ferguson, Edwin/0000-0003-4125-4253				ARORA K, 1994, GENE DEV, V8, P2588, DOI 10.1101/gad.8.21.2588; Ashe HL, 1999, NATURE, V398, P427, DOI 10.1038/18892; BRUMMEL TJ, 1994, CELL, V78, P251, DOI 10.1016/0092-8674(94)90295-X; Decotto E, 2001, DEVELOPMENT, V128, P3831; Dorfman R, 2001, DEVELOPMENT, V128, P965; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; FERGUSON EL, 1992, CELL, V71, P451, DOI 10.1016/0092-8674(92)90514-D; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Holley SA, 1996, CELL, V86, P607, DOI 10.1016/S0092-8674(00)80134-8; IRISH VF, 1987, GENE DEV, V1, P868, DOI 10.1101/gad.1.8.868; Kosman D, 1997, DEVELOPMENT, V124, P1343; Lai K, 2004, BIOPHYS J, V86, P2748, DOI 10.1016/S0006-3495(04)74328-3; LETSOU A, 1995, CELL, V80, P899, DOI 10.1016/0092-8674(95)90293-7; Little SC, 2004, DEVELOPMENT, V131, P5825, DOI 10.1242/dev.01464; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; Mason ED, 1997, MECH DEVELOP, V64, P61, DOI 10.1016/S0925-4773(97)00049-X; Neul JL, 1998, CELL, V95, P483, DOI 10.1016/S0092-8674(00)81616-5; Nguyen M, 1998, CELL, V95, P495, DOI 10.1016/S0092-8674(00)81617-7; Oelgeschlager M, 2003, DEVELOPMENT, V130, P4047, DOI 10.1242/dev.00633; PENTON A, 1994, CELL, V78, P239, DOI 10.1016/0092-8674(94)90294-1; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; RUSHLOW C, 1987, GENE DEV, V1, P1268, DOI 10.1101/gad.1.10.1268; Rushlow C, 2001, GENE DEV, V15, P340, DOI 10.1101/gad.861401; Shimmi O, 2003, DEVELOPMENT, V130, P4673, DOI 10.1242/dev.00684; SHIMMI O, IN PRESS CELL; STEIN D, 1991, CELL, V65, P725, DOI 10.1016/0092-8674(91)90381-8; STJOHNSTON RD, 1987, EMBO J, V6, P2785, DOI 10.1002/j.1460-2075.1987.tb02574.x; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Wisotzkey RG, 1998, DEVELOPMENT, V125, P1433; Xie J, 2005, DEVELOPMENT, V132, P383, DOI 10.1242/dev.01577	31	165	169	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					229	234		10.1038/nature03318	http://dx.doi.org/10.1038/nature03318			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15759004				2022-12-24	WOS:000227494500049
J	Hayward, R				Hayward, R			Historical keywords - Development	LANCET			English	Editorial Material									UCL, Wellcome Trust Ctr Hist Med, London, England	University of London; University College London	Hayward, R (corresponding author), UCL, Wellcome Trust Ctr Hist Med, London, England.	Rhodri.Hayward@ucl.ac.uk							0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 5	2005	365	9462					839	839		10.1016/S0140-6736(05)71028-X	http://dx.doi.org/10.1016/S0140-6736(05)71028-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	903RZ	15752517	Bronze			2022-12-24	WOS:000227444600012
J	Du, C; Falini, G; Fermani, S; Abbott, C; Moradian-Oldak, J				Du, C; Falini, G; Fermani, S; Abbott, C; Moradian-Oldak, J			Supramolecular assembly of amelogenin nanospheres into birefringent microribbons	SCIENCE			English	Article							EMBRYONIC BOVINE ENAMEL; NEUTRAL-SOLUBLE PROTEINS; DYNAMIC LIGHT-SCATTERING; TOOTH ENAMEL; ORGANIC MATRIX; RAT; MATURATION; CRYSTALS; APATITE; GROWTH	Although both tooth enamel and bone are composed of organized assemblies of carbonated apatite crystals, enamel is unusual in that it does not contain collagen nor does it remodel. Self-assembly of amelogenin protein into nanospheres has been recognized. as a key factor in controlling the oriented and elongated growth of carbonated apatite crystals during dental enamel biomineralization. We report the in vitro formation of birefringent microribbon structures that were generated through the supramolecular assembly of amelogenin nanospheres. These microribbons have diffraction patterns that indicate a periodic structure of crystalline units along the long axis. The growth of apatite crystals orientated along the c axis and parallel to the long axes of the microribbons was observed in vitro. The linear arrays (chains) of nanospheres observed as intermediate states before the microribbon formation give an important indication as to the function of amelogenin in controlling the oriented growth of apatite crystals during enamel mineralization.	Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA; Univ Bologna, Dipartimento Chim G Ciamician, I-40126 Bologna, Italy	University of Southern California; University of Bologna	Moradian-Oldak, J (corresponding author), Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, 2250 Alcazar St,CSA 103, Los Angeles, CA 90033 USA.	joldak@usc.edu	Du, Chang/H-4200-2012	Du, Chang/0000-0002-6460-0764	NIDCR NIH HHS [R01-DE-13414, R01 DE013414, R21-DE-15332] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE015332] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BETKE U, 1995, DISCRETE COMPUT GEOM, V13, P297, DOI 10.1007/BF02574046; BONAR LC, 1965, J ULTRA MOL STRUCT R, V13, P308, DOI 10.1016/S0022-5320(65)80079-X; Bouropoulos N, 2004, J DENT RES, V83, P278, DOI 10.1177/154405910408300402; DACULSI G, 1978, J ULTRA MOL STRUCT R, V65, P163, DOI 10.1016/S0022-5320(78)90053-9; EASTOE JE, 1960, NATURE, V187, P411, DOI 10.1038/187411b0; FINCHAM AG, 1995, J STRUCT BIOL, V115, P50, DOI 10.1006/jsbi.1995.1029; Fincham AG, 1999, J STRUCT BIOL, V126, P270, DOI 10.1006/jsbi.1999.4130; Iijima M, 2004, J MATER CHEM, V14, P2189, DOI 10.1039/b401961j; Manoharan VN, 2003, SCIENCE, V301, P483, DOI 10.1126/science.1086189; MECHANIC GL, 1967, BIOCHIM BIOPHYS ACTA, V133, P97, DOI 10.1016/0005-2795(67)90042-6; Moradian-Oldak J, 1998, J STRUCT BIOL, V122, P320, DOI 10.1006/jsbi.1998.4008; MORADIANOLDAK J, 1994, BIOPOLYMERS, V34, P1339, DOI 10.1002/bip.360341006; NIKIFORUK G, 1965, J DENT RES, V44, P1119, DOI 10.1177/00220345650440061101; Paine ML, 2001, MATRIX BIOL, V20, P273, DOI 10.1016/S0945-053X(01)00153-6; REITH EJ, 1961, J BIOPHYS BIOCHEM CY, V9, P825, DOI 10.1083/jcb.9.4.825; RENUGOPALAKRISHNAN V, 1989, BIOPOLYMERS, V28, P297, DOI 10.1002/bip.360280130; RENUGOPALAKRISHNAN V, 1986, BIOCHEMISTRY-US, V25, P4879, DOI 10.1021/bi00365a023; ROBINSON C, 1981, J CRYST GROWTH, V53, P160, DOI 10.1016/0022-0248(81)90062-2; ROBINSON C, 1981, CALCIFIED TISSUE INT, V33, P513, DOI 10.1007/BF02409483; ROBINSON C, 1978, CARIES RES, V12, P1, DOI 10.1159/000260309; Shaw WJ, 2004, J BIOL CHEM, V279, P40263, DOI 10.1074/jbc.C400322200; SMALES FC, 1975, NATURE, V258, P772, DOI 10.1038/258772a0; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; Toyosawa S, 1998, P NATL ACAD SCI USA, V95, P13056, DOI 10.1073/pnas.95.22.13056; TRAVIS DF, 1964, J CELL BIOL, V23, P447, DOI 10.1083/jcb.23.3.447; WATSON ML, 1960, J BIOPHYS BIOCHEM CY, V7, P489, DOI 10.1083/jcb.7.3.489; Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j; WEINER S, 1986, CALCIFIED TISSUE INT, V39, P365, DOI 10.1007/BF02555173; ZHENG SD, 1987, BIOPOLYMERS, V26, P1809, DOI 10.1002/bip.360261012	29	279	292	14	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1450	1454		10.1126/science.1105675	http://dx.doi.org/10.1126/science.1105675			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746422				2022-12-24	WOS:000227503100041
J	Cuthill, IC; Stevens, M; Sheppard, J; Maddocks, T; Parraga, CA; Troscianko, TS				Cuthill, IC; Stevens, M; Sheppard, J; Maddocks, T; Parraga, CA; Troscianko, TS			Disruptive coloration and background pattern matching	NATURE			English	Article								Effective camouflage renders a target indistinguishable from irrelevant background objects. Two interrelated but logically distinct mechanisms for this are background pattern matching (crypsis(1,2)) and disruptive coloration: in the former, the animal's colours are a random sample of the background(1,2); in the latter, bold contrasting colours on the animal's periphery break up its outline. The latter has long been proposed as an explanation for some apparently conspicuous coloration in animals(3,4), and is standard textbook material. Surprisingly, only one quantitative test(5) of the theory exists, and one experimental test of its effectiveness against non-human predators(6). Here we test two key predictions: that patterns on the body's outline should be particularly effective in promoting concealment and that highly contrasting colours should enhance this disruptive effect. Artificial moth-like targets were exposed to bird predation in the field, with the experimental colour patterns on the 'wings' and a dead mealworm as the edible 'body'. Survival analysis supported the predictions, indicating that disruptive coloration is an effective means of camouflage, above and beyond background pattern matching.	Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England; Univ Bristol, Dept Expt Psychol, Bristol BS8 1TN, Avon, England	University of Bristol; University of Bristol	Cuthill, IC (corresponding author), Univ Bristol, Sch Biol Sci, Woodland Rd, Bristol BS8 1UG, Avon, England.	i.cuthill@bristol.ac.uk	; Parraga, C. Alejandro/D-2329-2011	Stevens, Martin/0000-0001-7768-3426; Parraga, C. Alejandro/0000-0002-3809-241X	Biotechnology and Biological Sciences Research Council [S18903] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Behrens RR., 2002, FALSE COLORS ART DES; BENNETT ATD, 1994, AM NAT, V144, P848, DOI 10.1086/285711; Cott H.B., 1940, ADAPTIVE COLORATION; COX DR, 1972, J R STAT SOC B, V34, P187; Cuthill IC, 2000, ADV STUD BEHAV, V29, P159, DOI 10.1016/S0065-3454(08)60105-9; Cuthill Innes C., 2000, Acta Ethologica, V3, P29, DOI 10.1007/s102110000027; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; ENDLER JA, 1981, BIOL J LINN SOC, V16, P25, DOI 10.1111/j.1095-8312.1981.tb01840.x; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; ENDLER JA, 1984, BIOL J LINN SOC, V22, P187, DOI 10.1111/j.1095-8312.1984.tb01677.x; Hart NS, 2000, J COMP PHYSIOL A, V186, P375, DOI 10.1007/s003590050437; KILTIE RA, 1988, TRENDS ECOL EVOL, V3, P21, DOI 10.1016/0169-5347(88)90079-1; Maddocks SA, 2001, J EXP BIOL, V204, P2509; Majerus MEN, 2000, J EVOLUTION BIOL, V13, P155, DOI 10.1046/j.1420-9101.2000.00170.x; Merilaita S, 1998, P ROY SOC B-BIOL SCI, V265, P1059, DOI 10.1098/rspb.1998.0399; Merilaita S, 1999, BIOL J LINN SOC, V67, P151, DOI 10.1006/bijl.1998.0298; Parraga CA, 2002, CURR BIOL, V12, P483, DOI 10.1016/S0960-9822(02)00718-2; Rasband W., 2003, IMAGEJ; Ruxton GD, 2004, ANIM BEHAV, V68, P445, DOI 10.1016/j.anbehav.2003.12.009; SILBERGLIED RE, 1980, SCIENCE, V209, P617, DOI 10.1126/science.209.4456.617; *SPSS INC, 2003, SPSS WIND REL 9 0; THAYER AH, 1896, AUK, V13, P124; Thayer GH, 1909, CONCEALING COLORATIO; WALDBAUER GP, 1983, EVOLUTION, V37, P1085, DOI 10.1111/j.1558-5646.1983.tb05635.x	24	381	388	25	377	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					72	74		10.1038/nature03312	http://dx.doi.org/10.1038/nature03312			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744301				2022-12-24	WOS:000227334600045
J	Zaidi, AKM; Huskins, WC; Thaver, D; Bhutta, ZA; Abbas, Z; Goldmann, DA				Zaidi, AKM; Huskins, WC; Thaver, D; Bhutta, ZA; Abbas, Z; Goldmann, DA			Hospital-acquired neonatal infections in developing countries	LANCET			English	Review							INTENSIVE-CARE-UNIT; SPECTRUM BETA-LACTAMASE; LOW-BIRTH-WEIGHT; LATE-ONSET INFECTION; KLEBSIELLA-PNEUMONIAE; NOSOCOMIAL INFECTIONS; MOLECULAR EPIDEMIOLOGY; BACTERIAL-MENINGITIS; PEDIATRIC CARE; RISK-FACTORS	Hospital-born babies in developing countries are at increased risk of neonatal infections because of poor intraparturn and postnatal infection-control practices. We reviewed data from developing countries on rates of neonatal infections among hospital-born babies, range of pathogens, antimicrobial resistance, and infection-control interventions. Reported rates of neonatal infections were 3-20 times higher than those reported for hospital-born babies in industrialised countries. Klebsiella pneumoniae, other gram-negative rods (Escherichia coli, Pseudomonas spp, Acinetobacter spp), and Staphylococcus aureus were the major pathogens among 11471 bloodstream isolates reported. These infections can often present soon after birth. About 70% would not be covered by an empiric regimen of ampicillin and gentamicin, and many might be untreatable in resource-constrained environments. The associated morbidity, mortality, costs, and adverse effect on future health-seeking behaviour by communities pose barriers to improvement of neonatal outcomes in developing countries. Low-cost, "bundled" interventions using systems quality improvement approaches for improved infection control are possible, but should be supported by evidence in developing country settings.	Aga Khan Univ, Dept Paediat & Child Hlth, Karachi 74800, Pakistan; Mayo Clin, Dept Pediat & Adolescent Med, Div Pediat Infect Dis, Rochester, MN USA; Mayo Clin, Coll Med, Rochester, MN USA; Harvard Univ, Childrens Hosp Boston, Sch Med, Boston, MA 02115 USA; Inst Healthcare Improvement, Cambridge, MA USA	Aga Khan University; Mayo Clinic; Mayo Clinic; Harvard University; Boston Children's Hospital; Harvard Medical School; Institute for Healthcare Improvement	Zaidi, AKM (corresponding author), Aga Khan Univ, Dept Paediat & Child Hlth, Stadium Rd,POB 3500, Karachi 74800, Pakistan.	anita.zaidi@aku.edu		Huskins, W. Charles/0000-0002-9989-175X				Adejuyigbe E A, 2001, East Afr Med J, V78, P540; ADHIKARI M, 1995, J TROP PEDIATRICS, V41, P81, DOI 10.1093/tropej/41.2.81; ADLERBERTH I, 1991, ACTA PAEDIATR SCAND, V80, P602, DOI 10.1111/j.1651-2227.1991.tb11917.x; Ahmed A S M Nawshad Uddin, 2002, Indian Pediatr, V39, P1034; AIREDE AI, 1993, DEV MED CHILD NEUROL, V35, P424; AIREDE AI, 1992, J TROP PEDIATRICS, V38, P189, DOI 10.1093/tropej/38.4.189; Aktas E, 2002, J INT MED RES, V30, P445, DOI 10.1177/147323000203000414; Al-Harthi AA, 2000, SAUDI MED J, V21, P550; Ali Z, 2004, ANN TROP PAEDIATR, V24, P41, DOI 10.1179/027249304225013367; [Anonymous], HAZ AN CRIT CONTR PO; [Anonymous], 1980, EXPLORATIONS QUALITY; ANTIAOBONG OE, 1992, CENT AFR J MED, V38, P161; Anwer S K, 2000, J Pak Med Assoc, V50, P91; Anyebuno M, 1995, E AFR MED J, V72, P805; Arif MA, 1999, J TROP PEDIATRICS, V45, P278, DOI 10.1093/tropej/45.5.278; Aurangzeb Brekhna, 2003, J Coll Physicians Surg Pak, V13, P629; Ayan M, 2003, INFECT CONT HOSP EP, V24, P495, DOI 10.1086/502245; AYENGAR V, 1991, Indian Journal of Pediatrics, V58, P661, DOI 10.1007/BF02820186; Bakr AF, 2003, J TROP PEDIATRICS, V49, P295, DOI 10.1093/tropej/49.5.295; Baltimore Robert S, 2003, Paediatr Drugs, V5, P723, DOI 10.2165/00148581-200305110-00002; Baltimore RS, 1998, SEMIN PERINATOL, V22, P25, DOI 10.1016/S0146-0005(98)80005-0; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Barroso-Aguirre J, 1992, Bol Med Hosp Infant Mex, V49, P666; Becerra-Posada F, 2004, LANCET, V364, P997, DOI 10.1016/S0140-6736(04)17026-8; Ben-Hamouda T, 2003, J MED MICROBIOL, V52, P427, DOI 10.1099/jmm.0.04981-0; BERG DE, 1995, CLIN INFECT DIS, V21, P588, DOI 10.1093/clinids/21.3.588; Bhutta ZA, 2004, BRIT MED J, V329, P1151, DOI 10.1136/bmj.329.7475.1151; Bhutta ZA, 1997, AM J PERINAT, V14, P577, DOI 10.1055/s-2007-994338; Bhutta ZA, 2000, IMPROVING NEWBORN INFANT HEALTH IN DEVELOPING COUNTRIES, P289, DOI 10.1142/9781848160705_0016; BHUTTA ZA, 1991, ACTA PAEDIATR SCAND, V80, P596, DOI 10.1111/j.1651-2227.1991.tb11916.x; BOO NY, 1994, J PAEDIATR CHILD H, V30, P23, DOI 10.1111/j.1440-1754.1994.tb00560.x; Boukadida J, 2002, ARCH PEDIATRIE, V9, P463, DOI 10.1016/S0929-693X(01)00827-2; Brown SM, 2003, INFECT CONT HOSP EP, V24, P172, DOI 10.1086/502186; BUETOW KC, 1965, AM J DIS CHILD, V110, P29, DOI 10.1001/archpedi.1965.02090030035005; Chandrashekar M R, 1997, J Indian Med Assoc, V95, P72; Cisse C T, 2001, Gynecol Obstet Fertil, V29, P433, DOI 10.1016/S1297-9589(01)00157-6; CISSE MF, 1992, PRESSE MED, V21, P413; Clark Reese, 2004, J Perinatol, V24, P382, DOI 10.1038/sj.jp.7211120; CONDEAGUDELO A, 2003, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD002771.PUB2]; CONNER JM, 2003, COCHRANE DB SYST REV, V4; Cotton MF, 2000, J HOSP INFECT, V44, P13, DOI 10.1053/jhin.1999.0650; CRAIG WS, 1962, CARE NEWLY BORN INFA; Daoud AS, 1996, J TROP PEDIATRICS, V42, P267, DOI 10.1093/tropej/42.5.267; DAOUD AS, 1995, ANN TROP PAEDIATR, V15, P93, DOI 10.1080/02724936.1995.11747755; Darmstadt GL, 2004, PEDIATR INFECT DIS J, V23, P719, DOI 10.1097/01.inf.0000133047.50836.6f; Darmstadt GL, 2003, B WORLD HEALTH ORGAN, V81, P224; Dawodu A, 1997, J TROP PEDIATRICS, V43, P84, DOI 10.1093/tropej/43.2.84; DEALMEIDA SH, 2003, BRAZ J INFECT DIS, V7, P381; Desinor OY, 2004, J TROP PEDIATRICS, V50, P48, DOI 10.1093/tropej/50.1.48; DREWS MB, 1995, J HOSP INFECT, V30, P65, DOI 10.1016/0195-6701(95)90250-3; Edwards MS., 2015, INFECT DIS FETUS NEW, V8th ed., P1091; EICKHOFF TC, 1964, NEW ENGL J MED, V271, P1221, DOI 10.1056/NEJM196412102712401; English M, 2004, LANCET, V364, P1622, DOI 10.1016/S0140-6736(04)17318-2; English M, 2004, LANCET, V363, P1948, DOI 10.1016/S0140-6736(04)16408-8; Ferguson JK, 1996, J PAEDIATR CHILD H, V32, P525, DOI 10.1111/j.1440-1754.1996.tb00967.x; Fernandez A, 1993, J Postgrad Med, V39, P57; Fernandez Armida, 2003, Indian Pediatr, V40, P1161; FIKREE FF, 2001, STATE WORLDS NEWBORN; Gebremariam A, 1998, ANN TROP PAEDIATR, V18, P279, DOI 10.1080/02724936.1998.11747960; Ghiorghis B, 1997, ETHIOPIAN MED J, V35, P169; GHIORGIS B, 1991, ETHIOPIAN MED J, V29, P167; GLUCK L, 1966, PEDIATR CLIN N AM, V13, P1131; Goldmann DA, 1997, CLIN INFECT DIS, V24, pS139, DOI 10.1093/clinids/24.Supplement_1.S139; Gonzalez-Vertiz A, 2001, INFECT CONT HOSP EP, V22, P723, DOI 10.1086/501854; GUPTA AK, 1993, J TROP PEDIATRICS, V39, P32, DOI 10.1093/tropej/39.1.32; Gupta P, 1997, Indian Pediatr, V34, P144; Gupta Piyush, 1993, Indian Journal of Pediatrics, V60, P565, DOI 10.1007/BF02751435; Halder D, 1999, Med J Malaysia, V54, P52; HALEY RW, 1995, J INFECT DIS, V171, P614, DOI 10.1093/infdis/171.3.614; HAQUE KN, 1990, J TROP PEDIATRICS, V36, P20, DOI 10.1093/tropej/36.1.20; Harris JS, 2001, INFECT DIS FETUS NEW, P1371; Ho JJ, 2001, PEDIATR INFECT DIS J, V20, P557, DOI 10.1097/00006454-200106000-00002; Hyder AA, 2003, BJOG-INT J OBSTET GY, V110, P894, DOI 10.1111/j.1471-0528.2003.02446.x; Isturiz RE, 2000, INFECT CONT HOSP EP, V21, P394, DOI 10.1086/501780; Jain A, 2003, J MED MICROBIOL, V52, P421, DOI 10.1099/jmm.0.04966-0; Jain S, 2004, J TROP PEDIATRICS, V50, P170, DOI 10.1093/tropej/50.3.170; Joshi S. G., 2000, Indian Journal of Pediatrics, V67, P27; KARPUCH J, 1983, ISRAEL J MED SCI, V19, P963; Karthikeyan G., 2001, Indian Journal of Pediatrics, V68, P715, DOI 10.1007/BF02752407; Karunasekera K. A. W., 1999, Ceylon Medical Journal, V44, P81; Kaushik Shayam L., 1998, Journal of Communicable Diseases, V30, P147; Kilani R A, 2000, J Med Liban, V48, P77; Klein O.J., 2001, INFECT DIS FETUS NEW, P943; Klingenberg C, 2003, ANN TROP PAEDIATR, V23, P293, DOI 10.1179/027249303225007806; Koksal Nilgun, 2001, Indian Journal of Pediatrics, V68, P15, DOI 10.1007/BF02728850; KONAI AK, 1999, J TROP PEDIATRICS, V45, P146; Kumar M, 2002, J TROP PEDIATRICS, V48, P43, DOI 10.1093/tropej/48.1.43; Kumhar GD, 2002, J HEALTH POPUL NUTR, V20, P343; Kurlat I, 1998, J HOSP INFECT, V40, P149, DOI 10.1016/S0195-6701(98)90094-9; Kuruvilla K A, 1998, Indian Pediatr, V35, P851; Langley G.J., 1996, IMPROVEMENT GUIDE PR; Lawn JE, 2004, LANCET, V364, P399, DOI 10.1016/S0140-6736(04)16783-4; Lim N L, 1995, Med J Malaysia, V50, P59; Luby SP, 2004, JAMA-J AM MED ASSOC, V291, P2547, DOI 10.1001/jama.291.21.2547; LUMBIGANON P, 2004, COCHRANE DB SYST REV, V4; Mahmood A, 2002, J Pak Med Assoc, V52, P348; Malik A S, 1994, Med J Malaysia, V49, P17; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; MANTARING JB, 2004, REDUCTION NEONATAL B, P80; Martinez-Aguilar G, 2001, INFECT CONT HOSP EP, V22, P725, DOI 10.1086/501855; Mas-Munoz R L, 1992, Bol Med Hosp Infant Mex, V49, P839; MASSOUD R, MODERN PARADIGM IMPR; MATHUR N B, 1991, Indian Pediatrics, V28, P1259; MCCRACKEN GH, 1966, AM J DIS CHILD, V112, P33, DOI 10.1001/archpedi.1966.02090100069006; Misallati A, 2000, East Mediterr Health J, V6, P483; Mishra A, 1998, Indian Pediatr, V35, P27; MOFFET HL, 1967, AM J DIS CHILD, V114, P13, DOI 10.1001/archpedi.1967.02090220019003; Mokuolu A O, 2002, Afr J Med Med Sci, V31, P127; MONDAL G P, 1991, Indian Journal of Pediatrics, V58, P529, DOI 10.1007/BF02750936; MORENO MT, 1994, PEDIATR INFECT DIS J, V13, P516, DOI 10.1097/00006454-199406000-00010; Moss William, 2002, J Perinatol, V22, P484; Mullany LC, 2003, PEDIATR INFECT DIS J, V22, P996, DOI 10.1097/01.inf.0000095429.97172.48; Musoke RN, 2000, J TROP PEDIATRICS, V46, P86, DOI 10.1093/tropej/46.2.86; Mussi-Pinhata MM, 2004, J TROP PEDIATRICS, V50, P6, DOI 10.1093/tropej/50.1.6; Nagata E, 2002, AM J INFECT CONTROL, V30, P26, DOI 10.1067/mic.2002.119823; *NAT NEON FOR, 2000, NAT NEON PER DAT REP; NATHOO KJ, 1990, CENT AFR J MED, V36, P150; NATHOO KJ, 1993, PEDIATR INFECT DIS J, V12, P840, DOI 10.1097/00006454-199310000-00009; NATHOO KJ, 1991, ANN TROP PAEDIATR, V11, P11, DOI 10.1080/02724936.1991.11747472; Nejjari Noureddine, 2003, Tunis Med, V81, P121; Nel E, 2000, J TROP PEDIATRICS, V46, P237, DOI 10.1093/tropej/46.4.237; Newman Mercy J, 2002, West Afr J Med, V21, P310; Ng PC, 2004, ARCH DIS CHILD-FETAL, V89, pF336, DOI 10.1136/adc.2003.031104; Nolan T, 2001, LANCET, V357, P106, DOI 10.1016/S0140-6736(00)03542-X; NTIAOBONG OE, 1991, TROP DOCT, V21, P169; Nuland SB, 2003, DOCTORS PLAGUE GERMS; Orrett FA, 1998, INFECT CONT HOSP EP, V19, P136; Orrett FA, 2001, ANN TROP PAEDIATR, V21, P20, DOI 10.1080/02724930020028867; Palmer A, 1999, J TROP PEDIATRICS, V45, P51, DOI 10.1093/tropej/45.1.51; PANNUTI CS, 1995, INFECT CONT HOSP EP, V16, P170; Pearse J, 1997, Afr Health, V19, P10; PEGUES DA, 1994, AM J INFECT CONTROL, V22, P163, DOI 10.1016/0196-6553(94)90005-1; Pengsaa Krisana, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P102; Pessoa-Silva CL, 2004, INFECT CONT HOSP EP, V25, P772, DOI 10.1086/502475; Pessoa-Silva CL, 2003, J HOSP INFECT, V53, P198, DOI 10.1053/jhin.2002.1373; Petdachai Witaya, 2000, Journal of the Medical Association of Thailand, V83, P392; Peterson S, 2004, LANCET, V363, P1955, DOI 10.1016/S0140-6736(04)16411-8; Pillay T, 1998, AM J PERINAT, V15, P47, DOI 10.1055/s-2007-993898; Pittet D, 2004, J HOSP INFECT, V58, P1, DOI 10.1016/j.jhin.2004.06.002; PONCEDELEON S, 1991, J HOSP INFECT, V18, P376, DOI 10.1016/0195-6701(91)90044-9; PRASERTSOM W, 1990, Journal of the Medical Association of Thailand, V73, P106; RAGHAVAN M, 1992, Indian Journal of Pediatrics, V59, P335, DOI 10.1007/BF02821801; Rahman S, 2002, ARCH DIS CHILD-FETAL, V87, pF52, DOI 10.1136/fn.87.1.F52; RAJAB A, 1990, ANN TROP PAEDIATR, V10, P39, DOI 10.1080/02724936.1990.11747407; RAO PS, 1993, J TROP PEDIATRICS, V39, P230, DOI 10.1093/tropej/39.4.230; Raza MW, 2004, J HOSP INFECT, V57, P294, DOI 10.1016/j.jhin.2004.03.019; RHINEHART E, 1991, AM J MED, V91, pS213, DOI 10.1016/0002-9343(91)90371-4; Richards C, 2004, INFECT CONT HOSP EP, V25, P221, DOI 10.1086/502382; Saez-Llorens X, 2000, PEDIATR INFECT DIS J, V19, P200, DOI 10.1097/00006454-200003000-00005; Sanghvi KP, 1996, J PAEDIATR CHILD H, V32, P333, DOI 10.1111/j.1440-1754.1996.tb02565.x; SENSES D A, 1991, Mikrobiyoloji Bulteni, V25, P238; SHINEFIELD HR, 2001, INFECT DIS FETUS NEW, P1217; Silva J, 2001, J CLIN MICROBIOL, V39, P3193, DOI 10.1128/JCM.39.9.3193-3196.2001; Singh D, 2000, IMPROVING NEWBORN INFANT HEALTH IN DEVELOPING COUNTRIES, P503, DOI 10.1142/9781848160705_0030; Sjahrodji A M, 1990, Paediatr Indones, V30, P191; SOBAYO EI, 1991, J HOSP INFECT, V18, P388, DOI 10.1016/0195-6701(91)90046-B; Stoll BJ, 2002, NEW ENGL J MED, V347, P240, DOI 10.1056/NEJMoa012657; Stoll BJ, 2001, J PEDIATR-US, V139, P729, DOI 10.1067/mpd.2001.118881; Stoll BJ, 2001, INFECT DIS FETUS NEW, P139; Szabo D, 1999, J CLIN MICROBIOL, V37, P4167; Tallur Shashikala S., 2000, Indian Journal of Pediatrics, V67, P169, DOI 10.1007/BF02723654; Taskin E, 2004, J TROP PEDIATRICS, V50, P124, DOI 10.1093/tropej/50.2.124; Tietjen L, 2003, INFECT PREVENTION GU; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; Ursprung R, 2004, PEDIATR RES, V55, p435A; VAIDYA U, 1991, Indian Pediatrics, V28, P1265; Vargas P E, 1990, Rev Med Panama, V15, P127; Velazco E, 2002, ENFERM INFEC MICR CL, V20, P321, DOI 10.1016/S0213-005X(02)72808-5; Waheed Maryam, 2003, J Coll Physicians Surg Pak, V13, P449; Webster J, 2003, Cochrane Database Syst Rev, pCD003670; Weinberg M, 2001, ARCH INTERN MED, V161, P2357, DOI 10.1001/archinte.161.19.2357; WHEELER WE, 1967, AM J DIS CHILD, V101, P273; *WHO, 1993, MOTH BAB PACK ROAD M; *WHO, APPR RAP SCAL UP US; *WHO DEP REPR HLTH, 2001, INT MAN PREGN CHILD; *WHO UNICEF, 2000, WHOFCHCAH0012000; Yalcin Ata Nevzat, 2003, Indian J Med Sci, V57, P450; Yu J. L., 2001, SMJ Singapore Medical Journal, V42, P107; ZAIDI AK, 2002, EXPLORE SIMPLIFIED A; ZAIDI M, 1995, J HOSP INFECT, V31, P25, DOI 10.1016/0195-6701(95)90080-2; ZAIDI-JACOBSON M, 1991, Boletin Medico del Hospital Infantil de Mexico, V48, P538; Zupan J, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/1465-1858.CD001057; 1999, MARTINDALE COMPLETE, P1108; 2001, SAVING NEWBORN LIVES	184	433	448	1	35	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2005	365	9465					1175	1188		10.1016/S0140-6736(05)71881-X	http://dx.doi.org/10.1016/S0140-6736(05)71881-X			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	910DD	15794973				2022-12-24	WOS:000227909500031
J	Roosild, TP; Greenwald, J; Vega, M; Castronovo, S; Riek, R; Choe, S				Roosild, TP; Greenwald, J; Vega, M; Castronovo, S; Riek, R; Choe, S			NMR structure of Mistic, a membrane-integrating protein for membrane protein expression	SCIENCE			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; RESONANCE; CHANNEL; SPECTROSCOPY; SENSITIVITY	Although structure determination of soluble proteins has become routine, our understanding of membrane proteins has been limited by experimental bottlenecks in obtaining both sufficient yields of protein and ordered crystals. Mistic is an unusual Bacillus subtilis integral membrane protein that folds autonomously into the membrane, bypassing the cellular translocon machinery. Using paramagnetic probes, we determined by nuclear magnetic resonance (NMR) spectroscopy that the protein forms a helical bundle with a surprisingly polar lipid-facing surface. Additional experiments suggest that Mistic can be used for high-level production of other membrane proteins in their native conformations, including many eukaryotic proteins that have previously been intractable to bacterial. expression.	Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Riek, R (corresponding author), Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA.	riek@salk.edu; choe@salk.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056653] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM056653] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arora A, 2001, NAT STRUCT BIOL, V8, P334, DOI 10.1038/86214; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; CHOE S, 1992, NATURE, V357, P216, DOI 10.1038/357216a0; Clore GM, 1997, NAT STRUCT BIOL, V4, P849; Fernandez C, 2004, J MOL BIOL, V336, P1211, DOI 10.1016/j.jmb.2003.09.014; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hilty C, 2004, CHEMBIOCHEM, V5, P467, DOI 10.1002/cbic.200300815; Hwang PM, 2002, P NATL ACAD SCI USA, V99, P13560, DOI 10.1073/pnas.212344499; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Kiefer H, 2000, RECEPTOR CHANNEL, V7, P109; KOSEN PA, 1989, METHOD ENZYMOL, V177, P86; Laage R, 2001, TRAFFIC, V2, P99, DOI 10.1034/j.1600-0854.2001.020204.x; Littler DR, 2004, J BIOL CHEM, V279, P9298, DOI 10.1074/jbc.M308444200; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Ramamurthy V, 1997, J BIOL CHEM, V272, P23239, DOI 10.1074/jbc.272.37.23239; Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224; Ritter C, 2004, J BIOMOL NMR, V28, P289, DOI 10.1023/B:JNMR.0000013698.89582.dc; Salzmann M, 1999, J BIOMOL NMR, V15, P181, DOI 10.1023/A:1008358030477; Tate CG, 2001, FEBS LETT, V504, P94, DOI 10.1016/S0014-5793(01)02711-9; Tucker J, 1996, BIOCHEM J, V317, P891, DOI 10.1042/bj3170891; Wimley WC, 2000, BIOCHEMISTRY-US, V39, P4432, DOI 10.1021/bi992746j; Wuthrich K, 1998, NAT STRUCT BIOL, V5, P492, DOI 10.1038/728; Zhang W, 2003, J BIOL CHEM, V278, P50128, DOI 10.1074/jbc.M309840200	25	214	229	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1317	1321		10.1126/science.1106392	http://dx.doi.org/10.1126/science.1106392			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731457				2022-12-24	WOS:000227313200061
J	Rondelez, Y; Tresset, G; Nakashima, T; Kato-Yamada, Y; Fujita, H; Takeuchi, S; Noji, H				Rondelez, Y; Tresset, G; Nakashima, T; Kato-Yamada, Y; Fujita, H; Takeuchi, S; Noji, H			Highly coupled ATP synthesis by F-1-ATPase single molecules	NATURE			English	Article							EPSILON-SUBUNIT; ESCHERICHIA-COLI; THERMOPHILIC F1-ATPASE; F0F1-ATP SYNTHASE; ROTATION; RESOLUTION; CATALYSIS; ENZYME; MOTOR	F-1-ATPase is the smallest known rotary motor, and it rotates in an anticlockwise direction as it hydrolyses ATP(1-5). Single-molecule experiments(6-9) point towards three catalytic events per turn, in agreement with the molecular structure of the complex(10). The physiological function of F-1 is ATP synthesis. In the ubiquitous F0F1 complex, this energetically uphill reaction is driven by F-0, the partner motor of F-1, which forces the backward ( clockwise) rotation of F-1, leading to ATP synthesis(11-13). Here, we have devised an experiment combining single- molecule manipulation and microfabrication techniques to measure the yield of this mechanochemical transformation. Single F-1 molecules were enclosed in femtolitre-sized hermetic chambers and rotated in a clockwise direction using magnetic tweezers. When the magnetic field was switched off, the F-1 molecule underwent anticlockwise rotation at a speed proportional to the amount of synthesized ATP. At 10 Hz, the mechanochemical coupling efficiency was low for the alpha(3)beta(3)gamma subcomplex (F-1(-epsilon)), but reached up to 77% after reconstitution with the epsilon-subunit (F-1(+epsilon)). We provide here direct evidence that F-1 is designed to tightly couple its catalytic reactions with the mechanical rotation. Our results suggest that the epsilon-subunit has an essential function during ATP synthesis.	Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan; Univ Tokyo, CNRS IIS, LIMMS, Tokyo 1538505, Japan; Rikkyo St Pauls Univ, Coll Sci, Dept Life Sci, Tokyo 1718501, Japan; Univ Tokyo, Inst Ind Sci, CIRMM, Tokyo 1538505, Japan	University of Tokyo; University of Tokyo; Rikkyo University; University of Tokyo	Noji, H (corresponding author), Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan.	hnoji@iis.u-tokyo.ac.jp	Takeuchi, Shoji/J-5349-2019; Rondelez, Yannick/F-3315-2014; Tresset, Guillaume/B-9009-2008	Rondelez, Yannick/0000-0002-2565-476X; Takeuchi, Shoji/0000-0001-6946-0409				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2003, METHOD ENZYMOL, V361, P211; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Bulygin VV, 2004, J BIOL CHEM, V279, P35616, DOI 10.1074/jbc.M405012200; Diez M, 2004, NAT STRUCT MOL BIOL, V11, P135, DOI 10.1038/nsmb718; DUNN SD, 1987, BIOCHEMISTRY-US, V26, P4488, DOI 10.1021/bi00388a047; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; HIRONOHARA Y, IN PRESS P NATL ACAD; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Kato Y, 1997, J BIOL CHEM, V272, P24906, DOI 10.1074/jbc.272.40.24906; Kato-Yamada Y, 1998, J BIOL CHEM, V273, P19375, DOI 10.1074/jbc.273.31.19375; Kinosita K Jr, 2000, Essays Biochem, V35, P3; LAGET PP, 1979, ARCH BIOCHEM BIOPHYS, V197, P83, DOI 10.1016/0003-9861(79)90222-4; Leslie AGW, 2000, PHILOS T ROY SOC B, V355, P465, DOI 10.1098/rstb.2000.0588; MATSUI T, 1995, BBA-BIOENERGETICS, V1231, P139, DOI 10.1016/0005-2728(95)00070-Y; McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Noji H, 2001, J BIOL CHEM, V276, P25480, DOI 10.1074/jbc.M102200200; Nowak KF, 2002, BIOCHEMISTRY-US, V41, P15130, DOI 10.1021/bi026594v; RONDELEZ Y, IN PRESS NATURE BIOT; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P6560, DOI 10.1073/pnas.111128098; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; Zhou YT, 1997, P NATL ACAD SCI USA, V94, P10583, DOI 10.1073/pnas.94.20.10583	30	264	281	3	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2005	433	7027					773	777		10.1038/nature03277	http://dx.doi.org/10.1038/nature03277			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897XH	15716957	Bronze			2022-12-24	WOS:000227039200046
J	Murata, T; Yamato, I; Kakinuma, Y; Leslie, AGW; Walker, JE				Murata, T; Yamato, I; Kakinuma, Y; Leslie, AGW; Walker, JE			Structure of the rotor of the V-type Na+-ATPase from Enterococcus hirae	SCIENCE			English	Article							SUBUNIT-C; MOLECULAR ARCHITECTURE; ROTARY MOTOR; F1F0; SYNTHASE; BINDING; RING; SYMMETRY; SINGLE	The membrane rotor ring from the vacuolar-type (V-type) sodium ion-pumping adenosine triphosphatase (Na+-ATPase) from Enterococcus hirae consists of 10 NtpK subunits, which are homologs of the 16-kilodalton and 8-kilodalton proteotipids found in other V-ATPases and in F1F0- or F-ATPases, respectively. Each NtpK subunit has four transmembrane a helices, with a sodium ion bound between helices 2 and 4 at a site buried deeply in the membrane that includes the essential residue glutamate-139. This site is probably connected to the membrane surface by two half-channels in subunit Ntpl, against which the ring rotates. Symmetry mismatch between the rotor and catalytic domains appears to be an intrinsic feature of both V- and F-ATPases.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England; Tokyo Univ Sci, Dept Biol Sci & Technol, Chiba 2788510, Japan; Ehime Univ, Fac Agr, Matsuyama, Ehime 7908566, Japan	MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; Tokyo University of Science; Ehime University	Leslie, AGW (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	andrew@mrc-tmb.cam.ac.uk; watker@mrc-dunn.cam.ac.uk	Murata, Takeshi/J-6181-2017; Murata, Takeshi/F-6114-2011	Murata, Takeshi/0000-0002-5748-4670; Walker, John/0000-0001-7929-2162				ARAI H, 1988, J BIOL CHEM, V263, P8796; Girvin ME, 1998, BIOCHEMISTRY-US, V37, P8817, DOI 10.1021/bi980511m; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; HENDRIX RW, 1978, P NATL ACAD SCI USA, V75, P4779, DOI 10.1073/pnas.75.10.4779; HERMOLIN J, 1989, J BIOL CHEM, V264, P3896; Hirata R, 1997, J BIOL CHEM, V272, P4795, DOI 10.1074/jbc.272.8.4795; HOLZENBURG A, 1993, EUR J BIOCHEM, V213, P21, DOI 10.1111/j.1432-1033.1993.tb17730.x; IBBOTT FA, 1964, BIOCHEMISTRY-US, V3, P2008, DOI 10.1021/bi00900a039; Iwata M, 2004, P NATL ACAD SCI USA, V101, P59, DOI 10.1073/pnas.0305165101; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; Junge W, 1997, TRENDS BIOCHEM SCI, V22, P420, DOI 10.1016/S0968-0004(97)01129-8; Kaim G, 1998, EMBO J, V17, P5887, DOI 10.1093/emboj/17.20.5887; Kaim G, 1998, EMBO J, V17, P688, DOI 10.1093/emboj/17.3.688; Kaim G, 1997, BIOCHEMISTRY-US, V36, P9185, DOI 10.1021/bi970831q; Kawano M, 2002, J BIOL CHEM, V277, P24405, DOI 10.1074/jbc.M200973200; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Mitome N, 2004, P NATL ACAD SCI USA, V101, P12159, DOI 10.1073/pnas.0403545101; Murata T, 2000, J BIOL CHEM, V275, P13415, DOI 10.1074/jbc.275.18.13415; Murata T, 2003, J BIOL CHEM, V278, P21162, DOI 10.1074/jbc.M301620200; Murata T, 2001, BBA-BIOENERGETICS, V1505, P75, DOI 10.1016/S0005-2728(00)00278-4; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Nishi T, 2003, J BIOL CHEM, V278, P5821, DOI 10.1074/jbc.M209875200; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Seelert H, 2000, NATURE, V405, P418, DOI 10.1038/35013148; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Thomas DR, 1999, P NATL ACAD SCI USA, V96, P10134, DOI 10.1073/pnas.96.18.10134; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; von Ballmoos C, 2002, EUR J BIOCHEM, V269, P5581, DOI 10.1046/j.1432-1033.2002.03264.x; von Ballmoos C, 2002, J BIOL CHEM, V277, P3504, DOI 10.1074/jbc.M110301200; Vonck J, 2002, J MOL BIOL, V321, P307, DOI 10.1016/S0022-2836(02)00597-1; Walker JE, 1998, ANGEW CHEM INT EDIT, V37, P2309, DOI 10.1002/(SICI)1521-3773(19980918)37:17<2308::AID-ANIE2308>3.0.CO;2-W	31	308	316	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2005	308	5722					654	659		10.1126/science.1110064	http://dx.doi.org/10.1126/science.1110064			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15802565				2022-12-24	WOS:000228810900038
J	Barratt, A; Howard, K; Irwig, L; Salkeld, G; Houssami, N				Barratt, A; Howard, K; Irwig, L; Salkeld, G; Houssami, N			Model of outcomes of screening mammography: information to support informed choices	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARCINOMA IN-SITU; BREAST-CANCER; WOMEN; METAANALYSIS	Objective To provide easy to use estimates of the benefits and harms of biennial screening mammography for women aged 40, 50, 60, and 70 years. Design Markov process model, with data from BreastScreen Australia, the Australian Institute of Health and Welfare, and the Australian Bureau of Statistics. Main outcome measure Age specific outcomes expressed per 1000 women over 10 years. Results For every 1000 women screened over 10 years, 167-251 (depending on age) receive an abnormal result; 56-64 of these women undergo at least one biopsy, 9-26 have an invasive cancer detected by screening, and 3-6 have ductal carcinoma in situ (DCIS) detected by screening. More breast cancers (both invasive and DCIS) are diagnosed among screened than unscreened women. For example, among 1000 women aged 50 who have five biennial screens, 33 breast cancers are diagnosed: 28 invasive cancers (18 detected at screening and 10 interval cancers) and five DCTS (all detected at screening). By comparison, among 1000 women aged 50 who decline screening, 20 cancers are diagnosed over 10 years. There are about 0.5, 2, 3, and 2 fewer deaths from breast cancer over 10 years per 1000 women aged 40, 50, 60, and 70, respectively, who choose to be screened compared with women who decline screening at times determined by relevant policy. Conclusion Benefits and harms of screening mammography are relatively finely balanced. Quantitative estimates such as these can be used to support individual informed choices about screening.	Univ Sydney, Sch Publ Hlth, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia	University of Sydney	Barratt, A (corresponding author), Univ Sydney, Sch Publ Hlth, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia.	alexb@usyd.edu.au	Houssami, Nehmat/ABC-1103-2020; Barratt, Alexandra/A-7349-2011	Houssami, Nehmat/0000-0002-3641-952X; Barratt, Alexandra/0000-0002-2561-3319; Howard, Kirsten/0000-0002-0918-7540				Anttila A, 2002, J MED SCREEN, V9, P153, DOI 10.1136/jms.9.4.153; *AUSTR I HLH WELF, 2000, CANC SER AUSTR I HLT, V13; *AUSTR I HLTH WELF, 2003, BREASTSCREEN AUSTR M; *AUSTR I HLTH WELF, 2000, CANC SER AUSTR I HLT, V13; Barratt A, 2004, BMJ-BRIT MED J, V329, P507, DOI 10.1136/bmj.329.7464.507; *BREASTSCREEN AUST, WHO SHOULD HAV MAMM; *BREASTSCREEN SA, 2003, BREASTSCREEN SA STAT; *BREASTSCREEN VICT, 2002, BREASTSCREEN VICT 20; Chen H H, 1995, J Med Screen, V2, P10; Drossaert CHC, 2001, J MED SCREEN, V8, P204, DOI 10.1136/jms.8.4.204; Ernster VL, 2002, J NATL CANCER I, V94, P1546; *GEN MED COUNC, SEEK PAT CONS ETH CO; GLASZIOU PP, 1992, J CLIN EPIDEMIOL, V45, P1251, DOI 10.1016/0895-4356(92)90166-K; IRWIG I, 1997, REV EVIDENCE VALUE M; Irwig L., 1997, REV EVIDENCE VALUE M; KERLIKOWSKE K, 1995, JAMA-J AM MED ASSOC, V273, P149, DOI 10.1001/jama.273.2.149; Paci E, 2004, J MED SCREEN, V11, P23, DOI 10.1258/096914104772950718; *QUEENSL HLTH, 2001, BREASTSCREEN QUEENSL; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; Taylor R, 2001, J MED SCREEN, V8, P73, DOI 10.1136/jms.8.2.73; Thornton H, 2003, BMJ-BRIT MED J, V327, P101, DOI 10.1136/bmj.327.7406.101; U.S. Preventive Services Task Force, 2011, SCREEN BREAST CANC; *UK NAT SCREEN COM, 2 UK NAT SCREEN COMM; Van Zee KJ, 1999, CANCER-AM CANCER SOC, V86, P1757, DOI 10.1002/(SICI)1097-0142(19991101)86:9<1757::AID-CNCR18>3.0.CO;2-V; Welch HG, 1996, ANN INTERN MED, V124, P577, DOI 10.7326/0003-4819-124-6-199603150-00007; Zahl PH, 2004, BMJ-BRIT MED J, V328, P921, DOI 10.1136/bmj.38044.666157.63	26	94	95	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2005	330	7497					936	938		10.1136/bmj.38398.469479.8F	http://dx.doi.org/10.1136/bmj.38398.469479.8F			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920UP	15755755	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000228715900019
J	Rajan, S; Plant, LD; Rabin, ML; Butler, MH; Goldstein, SAN				Rajan, S; Plant, LD; Rabin, ML; Butler, MH; Goldstein, SAN			Sumoylation silences the plasma membrane leak K+ channel K2P1	CELL			English	Article							CEREBELLAR GRANULE NEURONS; DOMAIN POTASSIUM CHANNELS; CONJUGATING ENZYME MUBC9; 2 PORE DOMAINS; SUMO CONJUGATION; UBIQUITIN; EXPRESSION; TASK-1; LOCALIZATION; PROTEINS	Reversible, covalent modification with small ubiquitin-related modifier proteins (SUMOs) is known to mediate nuclear import/export and activity of transcription factors. Here, the SUMO pathway is shown to operate at the plasma membrane to control ion channel function. SUMO-conjugating enzyme is seen to be resident in plasma membrane, to assemble with K2P1, and to modify K2P1 lysine 274. K2P1 had not previously shown function despite mRNA expression in heart, brain, and kidney and sequence features like other two-P loop K+ leak (K2P) pores that control activity of excitable cells. Removal of the peptide adduct by SUMO protease reveals K2P1 to be a K+-selective, pH-sensitive, openly rectifying channel regulated by reversible peptide linkage.	Univ Chicago, Pritzker Sch Med, Dept Pediat, Chicago, IL 60637 USA	University of Chicago	Goldstein, SAN (corresponding author), Univ Chicago, Pritzker Sch Med, Dept Pediat, 5721 S Maryland Ave, Chicago, IL 60637 USA.	sangoldstein@uchicago.edu	Goldstein, Steven A./E-9817-2015	Goldstein, Steven A./0000-0001-5207-5061				Bailey D, 2004, J BIOL CHEM, V279, P692, DOI 10.1074/jbc.M306195200; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bockenhauer D, 2001, NAT NEUROSCI, V4, P486, DOI 10.1038/87434; Bockenhauer D, 2000, GENE, V261, P365, DOI 10.1016/S0378-1119(00)00492-3; Colquhoun David, 1995, P483; Giorgino F, 2000, P NATL ACAD SCI USA, V97, P1125, DOI 10.1073/pnas.97.3.1125; Goldman DE, 1943, J GEN PHYSIOL, V27, P37, DOI 10.1085/jgp.27.1.37; Goldstein SAN, 1998, J MOL MED-JMM, V76, P13, DOI 10.1007/s109-1998-8100-0; Goldstein SAN, 1996, P NATL ACAD SCI USA, V93, P13256, DOI 10.1073/pnas.93.23.13256; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; GOLDSTEIN SAN, 2002, IUPHAR COMPENDIUM VO, P173; Gong LM, 1999, FEBS LETT, V448, P185, DOI 10.1016/S0014-5793(99)00367-1; Gong LM, 2000, J BIOL CHEM, V275, P3355, DOI 10.1074/jbc.275.5.3355; Han J, 2002, J PHYSIOL-LONDON, V542, P431, DOI 10.1113/jphysiol.2002.017590; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Ilan N, 2001, BIOPHYS J, V80, P241, DOI 10.1016/S0006-3495(01)76010-9; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; KETCHUM KA, 1995, NATURE, V376, P690, DOI 10.1038/376690a0; Kim LA, 2004, NEURON, V41, P513, DOI 10.1016/S0896-6273(04)00050-9; Kim Y, 1999, AM J PHYSIOL-HEART C, V277, pH1669, DOI 10.1152/ajpheart.1999.277.5.H1669; Kuryshev YA, 2000, AM J PHYSIOL-CELL PH, V278, pC931, DOI 10.1152/ajpcell.2000.278.5.C931; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; Levy DI, 2004, KIDNEY INT, V65, P918, DOI 10.1111/j.1523-1755.2004.00458.x; Li SJ, 2003, J CELL BIOL, V160, P1069, DOI 10.1083/jcb.200212052; Lopes CMB, 2000, J BIOL CHEM, V275, P16969, DOI 10.1074/jbc.M001948200; Machon O, 2000, MECH DEVELOP, V97, P3, DOI 10.1016/S0925-4773(00)00402-0; Mahajan R, 1998, J CELL BIOL, V140, P259, DOI 10.1083/jcb.140.2.259; Malbert-Colas L, 2003, CR BIOL, V326, P615, DOI 10.1016/S1631-0691(03)00154-9; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Nishida T, 2001, J BIOL CHEM, V276, P39060, DOI 10.1074/jbc.M103955200; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Orias M, 1997, AM J PHYSIOL-RENAL, V273, pF663, DOI 10.1152/ajprenal.1997.273.4.F663; Plant LD, 2002, STROKE, V33, P2324, DOI 10.1161/01.STR.0000027440.68031.B0; Rajan S, 2001, J BIOL CHEM, V276, P7302, DOI 10.1074/jbc.M008985200; Rajan S, 2000, J BIOL CHEM, V275, P16650, DOI 10.1074/jbc.M000030200; Rajan S, 2002, J PHYSIOL-LONDON, V545, P13, DOI 10.1113/jphysiol.2002.027052; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Saitoh H, 1998, CURR BIOL, V8, P121, DOI 10.1016/S0960-9822(98)70044-2; Salinas M, 1999, J BIOL CHEM, V274, P11751, DOI 10.1074/jbc.274.17.11751; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; Ubbels GA, 1997, CELL MOL LIFE SCI, V53, P382, DOI 10.1007/PL00000613; Wang ZG, 1998, CIRCULATION, V98, P2422, DOI 10.1161/01.CIR.98.22.2422; Washburn CP, 2002, J NEUROSCI, V22, P1256, DOI 10.1523/JNEUROSCI.22-04-01256.2002; Zilberberg N, 2000, J GEN PHYSIOL, V116, P721, DOI 10.1085/jgp.116.5.721; Zilberberg N, 2001, NEURON, V32, P635, DOI 10.1016/S0896-6273(01)00503-7	51	206	212	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 8	2005	121	1					37	47		10.1016/j.cell.2005.01.019	http://dx.doi.org/10.1016/j.cell.2005.01.019			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	915YU	15820677	Bronze, Green Published, Green Submitted			2022-12-24	WOS:000228348500008
J	Shin, S; El-Diwany, R; Schaffert, S; Adams, EJ; Garcia, KC; Pereira, P; Chien, YH				Shin, S; El-Diwany, R; Schaffert, S; Adams, EJ; Garcia, KC; Pereira, P; Chien, YH			Antigen recognition determinants of gamma delta T cell receptors	SCIENCE			English	Article							REPERTOIRE; SELECTION; SPECIFICITY; LYMPHOCYTES; POPULATION; REGION; MICE	The molecular basis of gamma delta T cell receptor (TCR) recognition is poorly understood. Here, we analyze the TCR sequences of a natural gamma delta T cell population specific for the major histocompatibility complex class Ib molecule T22. We find that T22 recognition correlates strongly with a somatically recombined TCR delta complementarity-determining region 3 (CDR3) motif derived from germ line-encoded residues. Sequence diversity around these residues modulates TCR ligand-binding affinities, whereas V gene usage correlates mainly with tissue origin. These results show how an antigen-specific gamma delta TCR repertoire can be generated at a high frequency and suggest that gamma delta T cells recognize a limited number of antigens.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA; Inst Pasteur, Unite Dev Lymphocytes, CNRS, URA 1961, F-75724 Paris, France	Stanford University; Stanford University; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Chien, YH (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	chien@stanford.edu	Pereira, Pablo/M-7224-2014	El-Diwany, Ramy/0000-0002-3224-6414; Pereira, Pablo/0000-0003-1784-2776; Schaffert, Steven/0000-0001-8842-0218	NIAID NIH HHS [AI33431] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033431] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams EJ, 2005, SCIENCE, V308, P227, DOI 10.1126/science.1106885; ASARNOW DM, 1989, NATURE, V341, P60, DOI 10.1038/341060a0; Azuara V, 1998, EUR J IMMUNOL, V28, P3456, DOI 10.1002/(SICI)1521-4141(199811)28:11&lt;3456::AID-IMMU3456&gt;3.0.CO;2-F; BLUESTONE JA, 1988, J EXP MED, V168, P1899, DOI 10.1084/jem.168.5.1899; BONNEVILLE M, 1989, P NATL ACAD SCI USA, V86, P5928, DOI 10.1073/pnas.86.15.5928; Bousso P, 1998, IMMUNITY, V9, P169, DOI 10.1016/S1074-7613(00)80599-3; CANDEIAS S, 1991, J EXP MED, V174, P989, DOI 10.1084/jem.174.5.989; Chien YH, 1996, ANNU REV IMMUNOL, V14, P511, DOI 10.1146/annurev.immunol.14.1.511; Crowley MP, 2000, SCIENCE, V287, P314, DOI 10.1126/science.287.5451.314; DAVIS MM, 2003, FUNDAMENTAL IMMUNOLO; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; JANEWAY CA, 1988, IMMUNOL TODAY, V9, P73, DOI 10.1016/0167-5699(88)91267-4; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; OHASHI PS, 1985, NATURE, V316, P606, DOI 10.1038/316606a0; PEREIRA P, 1995, J EXP MED, V182, P1921, DOI 10.1084/jem.182.6.1921; Pereira P, 2004, J IMMUNOL, V173, P3261, DOI 10.4049/jimmunol.173.5.3261; Pereira P, 2000, EUR J IMMUNOL, V30, P1988, DOI 10.1002/1521-4141(200007)30:7<1988::AID-IMMU1988>3.0.CO;2-W; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; SHIN S, UNPUB; Spada FM, 2000, J EXP MED, V191, P937, DOI 10.1084/jem.191.6.937; SPERLING AI, 1992, J IMMUNOL, V149, P3200; Wu J, 2002, J IMMUNOL, V169, P1236, DOI 10.4049/jimmunol.169.3.1236; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6	25	138	141	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2005	308	5719					252	255		10.1126/science.1106480	http://dx.doi.org/10.1126/science.1106480			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915BX	15821090				2022-12-24	WOS:000228273700053
J	Simpson, SD; Meekan, M; Montgomery, J; McCauley, R; Jeffs, A				Simpson, SD; Meekan, M; Montgomery, J; McCauley, R; Jeffs, A			Homeward sound	SCIENCE			English	Article							CORAL-REEF FISHES; RECRUITMENT; POPULATION		Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JT, Midlothian, Scotland; Australian Inst Marine Sci, Darwin, NT, Australia; Univ Auckland, Leigh Marine Lab, Auckland 1, New Zealand; Curtin Univ, Ctr Marine Sci & Technol, Perth, WA 6845, Australia; Natl Inst Water & Atmospher Res Ltd, Auckland, New Zealand	University of Edinburgh; Australian Institute of Marine Science; University of Auckland; Curtin University; National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Simpson, SD (corresponding author), Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JT, Midlothian, Scotland.	s.simpson@ed.ac.uk	Jeffs, Andrew G/D-9474-2012; Montgomery, John C/D-4310-2009	Montgomery, John C/0000-0002-7451-3541; Simpson, Stephen/0000-0002-4856-6164; Meekan, Mark/0000-0002-3067-9427; Jeffs, Andrew/0000-0002-8504-1949	Natural Environment Research Council [NE/B501720/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Ackerman JL, 2000, MAR ECOL PROG SER, V206, P227, DOI 10.3354/meps206227; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; McCauley RD, 2000, PHILOS T ROY SOC B, V355, P1289, DOI 10.1098/rstb.2000.0686; Simpson SD, 2004, MAR ECOL PROG SER, V276, P263, DOI 10.3354/meps276263; Stobutzki IC, 1997, MAR ECOL PROG SER, V149, P35, DOI 10.3354/meps149035; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533	6	245	249	0	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2005	308	5719					221	221		10.1126/science.1107406	http://dx.doi.org/10.1126/science.1107406			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915BX	15821083				2022-12-24	WOS:000228273700043
J	Wang, MC; Bohmann, D; Jasper, H				Wang, MC; Bohmann, D; Jasper, H			JNK extends life span and limits growth by antagonizing cellular and organism-wide responses to insulin signaling	CELL			English	Article							TRANSCRIPTION FACTOR FOXO3A; N-TERMINAL KINASE; OXIDATIVE STRESS; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; FAT-BODY; DROSOPHILA; RECEPTOR; DAF-16; PATHWAY	Aging of a eukaryotic organism is affected by its nutrition state and by its ability to prevent or repair oxidative damage. Consequently, signal transduction systems that control metabolism and oxidative stress responses influence life span. When nutrients are abundant, the insulin/IGF signaling (IIS) pathway promotes growth and energy storage but shortens life span. The transcription factor Foxo, which is inhibited by IIS, extends life span in conditions of low IIS activity. Life span can also be increased by activating the stress-responsive Jun-N-terminal kinase (JNK) pathway. Here we show that JNK requires Foxo to extend life span in Drosophila. JNK antagonizes IIS, causing nuclear localization of Foxo and inducing its targets, including growth control and stress defense genes. JNK and Foxo also restrict IIS activity systemically by repressing IIS ligand expression in neuroendocrine cells. The convergence of JNK signaling and IIS on Foxo provides a model to explain the effects of stress and nutrition on longevity.	Univ Rochester, Med Ctr, Dept Biomed Genet, Aab Inst Biomed Sci, Rochester, NY 14642 USA	University of Rochester	Bohmann, D (corresponding author), Univ Rochester, Med Ctr, Dept Biomed Genet, Aab Inst Biomed Sci, 601 Elmwood Ave,Box 633, Rochester, NY 14642 USA.	dirk_bohmann@urmc.rochester.edu; henri_jasper@urmc.rochester.edu	Gimenez, Luis E Diaz/D-9291-2011; Wang, Meng/F-2951-2019	Wang, Meng/0000-0002-5898-6007				Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Arrigo AP, 1998, BIOL CHEM, V379, P19; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Clancy DJ, 2002, SCIENCE, V296, P319, DOI 10.1126/science.1069366; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Goberdhan DCI, 2003, DIFFERENTIATION, V71, P375, DOI 10.1046/j.1432-0436.2003.7107001.x; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Hekimi S, 2003, SCIENCE, V299, P1351, DOI 10.1126/science.1082358; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Jasper H, 2001, DEV CELL, V1, P579, DOI 10.1016/S1534-5807(01)00045-4; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kaneto H, 2002, J BIOL CHEM, V277, P30010, DOI 10.1074/jbc.M202066200; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; Kockel L, 2001, ONCOGENE, V20, P2347, DOI 10.1038/sj.onc.1204300; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; Lee YH, 2003, J BIOL CHEM, V278, P2896, DOI 10.1074/jbc.M208359200; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Miron M, 2001, NAT CELL BIOL, V3, P596, DOI 10.1038/35078571; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oldham S, 2002, DEVELOPMENT, V129, P4103; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Stronach BE, 1999, ONCOGENE, V18, P6172, DOI 10.1038/sj.onc.1203125; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Tatar M, 2001, EXP GERONTOL, V36, P723, DOI 10.1016/S0531-5565(00)00238-2; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Tu MP, 2002, AGING CELL, V1, P75, DOI 10.1046/j.1474-9728.2002.00010.x; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Weber U, 2000, DEVELOPMENT, V127, P3619; Welsh MJ, 1998, ANN NY ACAD SCI, V851, P28, DOI 10.1111/j.1749-6632.1998.tb08973.x; WESSELL RJ, 2004, GENET, V36, P1275; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Zeitlinger J, 1999, DEVELOPMENT, V126, P3947; Zhang B, 2003, DIABETES, V52, P2720, DOI 10.2337/diabetes.52.11.2720	59	420	439	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 8	2005	121	1					115	125		10.1016/j.cell.2005.02.030	http://dx.doi.org/10.1016/j.cell.2005.02.030			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	915YU	15820683	Bronze			2022-12-24	WOS:000228348500014
J	Yamashita, M; Ying, SX; Zhang, GM; Li, CL; Cheng, SY; Deng, CX; Zhang, YE				Yamashita, M; Ying, SX; Zhang, GM; Li, CL; Cheng, SY; Deng, CX; Zhang, YE			Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation	CELL			English	Article							ACTIVATED PROTEIN-KINASE; TGF-BETA RECEPTOR; C-JUN; TRANSCRIPTIONAL ACTIVATION; I RECEPTOR; SMAD; DIFFERENTIATION; EXPRESSION; PROMOTER; ELEMENTS	Bone is constantly resorbed and formed throughout life by coordinated actions of osteoclasts and osteoblasts. Here we show that Smurf1, a HECT domain ubiquitin ligase, has a specific physiological role in suppressing the osteogenic activity of osteoblasts. Smurf1-deficient mice are born normal but exhibit an age-dependent increase of bone mass. The cause of this increase can be traced to enhanced activities of osteoblasts, which become sensitized to bone morphogenesis protein (BMP) in the absence of Smurf1. However, loss of Smurf1 does not affect the canonical Smad-mediated intracellular TGF beta or BMP signaling; instead, it leads to accumulation of phosphorylated MEKK2 and activation of the downstream JNK signaling cascade. We demonstrate that Smurf1 physically interacts with MEKK2 and promotes the ubiquitination and turnover of MEKK2. These results indicate that Smurf1 negatively regulates osteoblast activity and response to BMP through controlling MEKK2 degradation.	NCI, Cellular & Mol Biol Lab, Ctr Canc Res, Bethesda, MD 20892 USA; NCI, Lab Anim Sci Program, Frederick, MD 21702 USA; NIDDKD, Mammalian Genet Sect, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Zhang, YE (corresponding author), NCI, Cellular & Mol Biol Lab, Ctr Canc Res, Bldg 37, Bethesda, MD 20892 USA.	yingz@helix.nih.gov	Zhang, Ying E/G-3657-2015; deng, chuxia/N-6713-2016	Zhang, Ying E/0000-0003-2753-7601; 	Intramural NIH HHS [ZIA BC011168-01, Z01 BC010419-08] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC010419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK056001] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Bakin AV, 2002, J CELL SCI, V115, P3193; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; BHARGAVA U, 1988, BONE, V9, P155, DOI 10.1016/8756-3282(88)90005-1; Brown JD, 1999, J BIOL CHEM, V274, P8797, DOI 10.1074/jbc.274.13.8797; Cheng JK, 2000, MOL CELL BIOL, V20, P2334, DOI 10.1128/MCB.20.7.2334-2342.2000; D'Alonzo RC, 2002, J BIOL CHEM, V277, P816, DOI 10.1074/jbc.M107082200; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Eferl R, 2004, EMBO J, V23, P2789, DOI 10.1038/sj.emboj.7600282; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; FRACESCHI RT, 2003, J CELL BIOCHEM, V88, P446; Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060; Hess J, 2001, J BIOL CHEM, V276, P20029, DOI 10.1074/jbc.M010601200; HOGAN B, 1994, MANUPULATING MOUSE E; Ito Y, 2003, CURR OPIN GENET DEV, V13, P43, DOI 10.1016/S0959-437X(03)00007-8; Itoh S, 2003, J BIOL CHEM, V278, P3751, DOI 10.1074/jbc.M208258200; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kenner L, 2004, J CELL BIOL, V164, P613, DOI 10.1083/jcb.200308155; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Liberati NT, 1999, P NATL ACAD SCI USA, V96, P4844, DOI 10.1073/pnas.96.9.4844; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Maeda S, 2004, EMBO J, V23, P552, DOI 10.1038/sj.emboj.7600067; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Murakami G, 2003, MOL BIOL CELL, V14, P2809, DOI 10.1091/mbc.E02-07-0441; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Sano Y, 1999, J BIOL CHEM, V274, P8949, DOI 10.1074/jbc.274.13.8949; Su B, 2001, J BIOL CHEM, V276, P14784, DOI 10.1074/jbc.M010134200; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wong C, 1999, MOL CELL BIOL, V19, P1821; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Wu XB, 2003, J CLIN INVEST, V112, P924, DOI 10.1172/JCI200315543; Yamaguchi K, 1999, EMBO J, V18, P179, DOI 10.1093/emboj/18.1.179; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Ying SX, 2003, J BIOL CHEM, V278, P39029, DOI 10.1074/jbc.M301193200; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zhao M, 2004, J BIOL CHEM, V279, P12854, DOI 10.1074/jbc.M313294200; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200; Zhao M, 2002, J CELL BIOL, V157, P1049, DOI 10.1083/jcb.200109012; Zheng CJ, 1999, J BIOL CHEM, V274, P28966, DOI 10.1074/jbc.274.41.28966; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	51	270	287	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 8	2005	121	1					101	113		10.1016/j.cell.2005.01.035	http://dx.doi.org/10.1016/j.cell.2005.01.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	915YU	15820682	Green Accepted, Bronze			2022-12-24	WOS:000228348500013
J	Wright, JT; Dunn, JK; Cutler, JA; Davis, BR; Cushman, WC; Ford, CE; Haywood, LJ; Leenen, FHH; Margolis, KL; Papademetriou, V; Probstfield, JL; Whelton, PK; Habib, GB				Wright, JT; Dunn, JK; Cutler, JA; Davis, BR; Cushman, WC; Ford, CE; Haywood, LJ; Leenen, FHH; Margolis, KL; Papademetriou, V; Probstfield, JL; Whelton, PK; Habib, GB		ALLHAT Collaborative Res Grp	Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONVERTING-ENZYME-INHIBITOR; LIPID-LOWERING TREATMENT; CALCIUM-CHANNEL BLOCKER; HEART-FAILURE EVENTS; ATTACK TRIAL ALLHAT; BLOOD-PRESSURE; COMBINATION THERAPY; CARDIOVASCULAR MORBIDITY; RANDOMIZED-TRIAL; MORTALITY	Context Few cardiovascular outcome data are available for blacks with hypertension treated with angiotensin-converting enzyme (ACE) inhibitors or calcium channel blockers (CCBs). Objective To determine whether an ACE inhibitor or CCB is superior to a thiazide-type diuretic in reducing cardiovascular disease (CVD) incidence in racial subgroups. Design, Setting, and Participants Prespecified subgroup analysis of ALLHAT, a randomized, double-blind, active-controlled, clinical outcome trial conducted between February 1994 and March 2002 in 33 357 hypertensive US and Canadian patients aged 55 years or older (35% black) with at least 1 other cardiovascular risk factor. Interventions Anti hypertensive regimens initiated with a CCB (amlodipine) or an ACE inhibitor (lisinopril) vs a thiazide-type diuretic (chlorthalidone). Other medications were added to achieve goal blood pressures (BPs) less than 140/90 mm Hg. Main Outcome Measures The primary outcome was combined fatal coronary heart disease (CHD) or nonfatal myocardial infarction (MI), analyzed by intention-to-treat. Secondary outcomes included all-cause mortality, stroke, combined CVD (CND death, nonfatal MI, stroke, angina, coronary revascularization, heart failure [HF], or peripheral vascular disease), and end-stage renal disease. Results No significant difference was found between treatment groups for the primary CHD outcome in either racial subgroup. For amlodipine vs chlorthalidone only, HF was the only prespecified clinical outcome that differed significantly (overall: relative risk [RR], 1.37; 95% confidence interval [Cl], 1.24-1.51; blacks: RR, 1.46; 95% CI, 1.24-1.73; nonblacks: RR, 1.32; 95% CI, 1.17-1.49; P<.001 for each comparison) with no difference in treatment effects by race (P=.38 for interaction). For lisinopril vs chlorthalidone, results differed by race for systolic BP (greater decrease in blacks with chlorthalidone), stroke, and combined CVD outcomes (P<.001, P=.01, and P=.04, respectively, for interactions). In blacks and nonblacks, respectively, the RRs for stroke were 1.40 (95% CI, 1.17-1.68) and 1.00 (95% CI, 0.85-1.17) and for combined CVD were 1.19 (95% CI, 1.09-1.30) and 1.06(95% CI, 1.00-1.13). For HF, the RRs were 1.30 (95% CI, 1.10-1.54) and 1.13 (95% CI, 1.00-1.28), with no significant interaction by race. Time-dependent BP adjustment did not significantly alter differences in outcome for lisinopril vs chlorthalidone in blacks. Conclusions In blacks and nonblack subgroups, rates were not lower in the amlodipine or lisinopril groups than in the chlorthalidone group for either the primary CHD or any other prespecified clinical outcome, and diuretic-based treatment resulted in the lowest risk of heart failure. While the improved outcomes with chlorthalidone were more pronounced for some outcomes in blacks than in nonblacks, thiazide-type diuretics remain the drugs of choice for initial therapy of hypertension in both black and nonblack hypertensive patients.	Case Western Reserve Univ, Gen Clin Res Ctr, Cleveland, OH 44106 USA; Univ Texas, Hlth Sci Ctr, Sch Publ Hlth, Houston, TX USA; NHLBI, Div Epidemiol & Clin Applicat, Bethesda, MD 20892 USA; Memphis Vet Affairs Med Ctr, Memphis, TN USA; Univ So Calif, Los Angeles Cty Med Ctr, Los Angeles, CA 90033 USA; Univ Ottawa, Inst Heart, Ottawa, ON, Canada; Berman Ctr Outcomes & Clin Res, Minneapolis, MN USA; Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA; Vet Affairs Med Ctr, Washington, DC 20422 USA; Univ Washington, Seattle, WA 98195 USA; Tulane Univ, Hlth Sci Ctr, New Orleans, LA 70118 USA; Houston Vet Affairs Med Ctr, Houston, TX USA	Case Western Reserve University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of Southern California; University of Ottawa; University of Ottawa Heart Institute; Hennepin County Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Washington; University of Washington Seattle; Tulane University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center	Wright, JT (corresponding author), Case Western Reserve Univ, Gen Clin Res Ctr, 11000 Euclid Ave,Bowell Bldg,5th Floor, Cleveland, OH 44106 USA.	jackson.wright@case.edu		Margolis, Karen/0000-0003-1862-7402; Papademetriou, Vasilios/0000-0002-2882-2757	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC035130] Funding Source: NIH RePORTER	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Alderman MH, 2003, HYPERTENSION, V42, P239, DOI 10.1161/01.HYP.0000086521.95630.5A; [Anonymous], 2006, SURVIVAL ANAL TECHNI; Black HR, 2003, JAMA-J AM MED ASSOC, V289, P2073, DOI 10.1001/jama.289.16.2073; BOLZANO K, 1987, J CARDIOVASC PHARM, V9, pS43, DOI 10.1097/00005344-198700003-00011; Brown MJ, 2000, LANCET, V356, P366, DOI 10.1016/S0140-6736(00)02527-7; Brown NJ, 1996, CLIN PHARMACOL THER, V60, P8, DOI 10.1016/S0009-9236(96)90161-7; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cushman WC, 2000, ARCH INTERN MED, V160, P825, DOI 10.1001/archinte.160.6.825; Davis BR, 1996, AM J HYPERTENS, V9, P342, DOI 10.1016/0895-7061(96)00037-4; Davis BR, 2002, ANN INTERN MED, V137, P313, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00006; Douglas JG, 2003, ARCH INTERN MED, V163, P525, DOI 10.1001/archinte.163.5.525; Dries DL, 2002, J AM COLL CARDIOL, V40, P311, DOI 10.1016/S0735-1097(02)01943-5; Einhorn P, 2003, CIRCULATION, V108, P399; Exner DV, 2001, NEW ENGL J MED, V344, P1351, DOI 10.1056/NEJM200105033441802; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; GILLUM RF, 1991, CARDIOVASCULAR DIS B, P3; Grimm RH, 2001, HYPERTENSION, V37, P19, DOI 10.1161/01.HYP.37.1.19; Hansson L, 2000, LANCET, V356, P359, DOI 10.1016/S0140-6736(00)02526-5; Hansson L, 1999, LANCET, V353, P611, DOI 10.1016/S0140-6736(98)05012-0; Hansson L, 1999, LANCET, V354, P1751, DOI 10.1016/S0140-6736(99)10327-1; JOHNSON E, 2005, HYPERTENSION, P587; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Kalbfleisch J. D., 2002, STAT ANAL FAILURE TI; Khan NA, 2004, CAN J CARDIOL, V20, P41; Kostis JB, 1997, JAMA-J AM MED ASSOC, V278, P212; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; LUTHER RR, 1986, AM J MED, V80, P73, DOI 10.1016/0002-9343(86)90856-9; MACGREGOR GA, 1985, J CARDIOVASC PHARM, V7, pS82, DOI 10.1097/00005344-198507001-00016; MANDER A, 2000, HOTDECK IMPUTATION, P196; Materson BJ, 1996, AM J HYPERTENS, V9, pS187, DOI 10.1016/S0895-7061(96)90100-4; MATERSON BJ, 1993, NEW ENGL J MED, V328, P914, DOI 10.1056/NEJM199304013281303; Messerli FH, 2000, AM J CARDIOL, V86, P1182, DOI 10.1016/S0002-9149(00)01199-1; Packer M, 1996, NEW ENGL J MED, V335, P1107, DOI 10.1056/NEJM199610103351504; Piller LB, 2002, CURR CONTR TRIALS C, V3, DOI 10.1186/1468-6708-3-10; PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; Rahman M, 1997, ENDOCRIN METAB CLIN, V26, P125, DOI 10.1016/S0889-8529(05)70237-1; RAHMAN M, IN PRESS ARCH INTERN; Roca-Cusachs A, 2001, J CARDIOVASC PHARM, V38, P840, DOI 10.1097/00005344-200112000-00005; SAUNDERS E, 1990, ARCH INTERN MED, V150, P1707, DOI 10.1001/archinte.150.8.1707; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Turnbull F, 2003, LANCET, V362, P1527; WHO, 2002, RED RISKS PROM HLTH; Williams B, 2004, BMJ-BRIT MED J, V328, P634, DOI 10.1136/bmj.328.7440.634; WILLIAMS GH, 1988, NEW ENGL J MED, V319, P1517; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; Yusuf S, 2000, NEW ENGL J MED, V342, P145	51	304	311	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2005	293	13					1595	1607		10.1001/jama.293.13.1595	http://dx.doi.org/10.1001/jama.293.13.1595			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	913EV	15811979				2022-12-24	WOS:000228135300022
J	Pedraza, JM; van Oudenaarden, A				Pedraza, JM; van Oudenaarden, A			Noise propagation in gene networks	SCIENCE			English	Article							STOCHASTICITY; EXPRESSION	Accurately predicting noise propagation in gene networks is crucial for understanding signal fidelity in natural networks and designing noise-tolerant gene circuits. To quantify how noise propagates through gene networks, we measured expression correlations between genes in single cells. We found that noise in a gene was determined by its intrinsic fluctuations, transmitted noise from upstream genes, and global noise affecting all genes. A model was developed that explains the complex behavior exhibited by the correlations and reveals the dominant noise sources. The model successfully predicts the correlations as the network is systematically perturbed. This approach provides a step toward understanding and manipulating noise propagation in more complex gene networks.	MIT, Dept Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	van Oudenaarden, A (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	avano@mit.edu	van Oudenaarden, Alexander/AAA-1705-2019	Pedraza, Juan/0000-0002-1802-3337	NIGMS NIH HHS [R01-GM068957] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068957] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; CHOCK PB, 1977, P NATL ACAD SCI USA, V74, P2766, DOI 10.1073/pnas.74.7.2766; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2001, Q REV BIOPHYS, V34, P1, DOI 10.1017/S0033583501003663; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; SAVAGEAU MA, 1976, BIOCH SYSTEMS ANAL; Thattai M, 2002, BIOPHYS J, V82, P2943, DOI 10.1016/S0006-3495(02)75635-X; van Kampen N.G., 1981, STOCHASTIC PROCESSES	18	588	601	1	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2005	307	5717					1965	1969		10.1126/science.1109090	http://dx.doi.org/10.1126/science.1109090			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910UI	15790857				2022-12-24	WOS:000227957300058
J	Mattner, J; DeBord, KL; Ismail, N; Goff, RD; Cantu, C; Zhou, DP; Saint-Mezard, P; Wang, V; Gao, Y; Yin, N; Hoebe, K; Schneewind, O; Walker, D; Beutler, B; Teyton, L; Savage, PB; Bendelac, A				Mattner, J; DeBord, KL; Ismail, N; Goff, RD; Cantu, C; Zhou, DP; Saint-Mezard, P; Wang, V; Gao, Y; Yin, N; Hoebe, K; Schneewind, O; Walker, D; Beutler, B; Teyton, L; Savage, PB; Bendelac, A			Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections	NATURE			English	Article							KILLER T-CELLS; ANAPLASMA-PHAGOCYTOPHILUM; GLYCOSPHINGOLIPIDS; IDENTIFICATION; BACTERIUM; SYNTHASE; INNATE	CD1d-restricted natural killer T ( NKT) cells are innate-like lymphocytes that express a conserved T-cell receptor and contribute to host defence against various microbial pathogens(1,2). However, their target lipid antigens have remained elusive. Here we report evidence for microbial, antigen-specific activation of NKT cells against Gram-negative, lipopolysaccharide (LPS)negative alpha-Proteobacteria such as Ehrlichia muris and Sphingomonas capsulata. We have identified glycosylceramides from the cell wall of Sphingomonas that serve as direct targets for mouse and human NKT cells, controlling both septic shock reaction and bacterial clearance in infected mice. In contrast, Gram-negative, LPS-positive Salmonella typhimurium activates NKT cells through the recognition of an endogenous lysosomal glycosphingolipid, iGb3, presented by LPS-activated dendritic cells. These findings identify two novel antigenic targets of NKT cells in antimicrobial defence, and show that glycosylceramides are an alternative to LPS for innate recognition of the Gram-negative, LPS-negative bacterial cell wall.	Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; Univ Chicago, Comm Microbiol, Chicago, IL 60637 USA; Univ Texas, Med Branch, Dept Pathol, Galveston, TX 77555 USA; Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	University of Chicago; University of Chicago; University of Texas System; University of Texas Medical Branch Galveston; Brigham Young University; Scripps Research Institute	Savage, PB (corresponding author), Univ Chicago, Comm Immunol, Chicago, IL 60637 USA.	paul_savage@byu.edu; abendela@bsd.uchicago.edu	Zhou, Dapeng/A-6446-2019; zhou, dapeng/GXG-9715-2022; Savage, Paul B/HGB-3414-2022; Mattner, Jochen/AAT-7866-2021; Savage, Paul B/E-1448-2011; Yin, NIng/C-8991-2011	Zhou, Dapeng/0000-0003-1347-3811; Savage, Paul B/0000-0002-4642-6109; Savage, Paul B/0000-0002-4642-6109; Hoebe, Kasper/0000-0002-3626-8098				AMANO K, 1987, INFECT IMMUN, V55, P2290, DOI 10.1128/IAI.55.9.2290-2292.1987; Bendelac A, 1996, J EXP MED, V184, P1285, DOI 10.1084/jem.184.4.1285; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Fischer K, 2004, P NATL ACAD SCI USA, V101, P10685, DOI 10.1073/pnas.0403787101; Fujii SI, 2004, J EXP MED, V199, P1607, DOI 10.1084/jem.20040317; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Hsueh PR, 1998, CLIN INFECT DIS, V26, P676, DOI 10.1086/514595; Ismail N, 2004, J IMMUNOL, V172, P1786, DOI 10.4049/jimmunol.172.3.1786; Kawahara K, 2000, EUR J BIOCHEM, V267, P1837, DOI 10.1046/j.1432-1327.2000.01189.x; Kawakami K, 2003, EUR J IMMUNOL, V33, P3322, DOI 10.1002/eji.200324254; Keusch JJ, 2000, J BIOL CHEM, V275, P25308, DOI 10.1074/jbc.M002629200; Kita H, 2002, GASTROENTEROLOGY, V123, P1031, DOI 10.1053/gast.2002.36020; Lee PT, 2002, J EXP MED, V195, P637, DOI 10.1084/jem.20011908; Lin MQ, 2003, INFECT IMMUN, V71, P5324, DOI 10.1128/IAI.71.9.5324-5331.2003; Nieuwenhuis EES, 2002, NAT MED, V8, P588, DOI 10.1038/nm0602-588; Olano JP, 2002, MED CLIN N AM, V86, P375, DOI 10.1016/S0025-7125(03)00093-2; Park SH, 2000, NATURE, V406, P788, DOI 10.1038/35021233; Proia RL, 2003, PHILOS T R SOC B, V358, P879, DOI 10.1098/rstb.2003.1268; Selmi C, 2003, HEPATOLOGY, V38, P1250, DOI 10.1053/jhep.2003.50446; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; von Loewenich FD, 2004, EUR J IMMUNOL, V34, P1789, DOI 10.1002/eji.200425250; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	24	890	933	3	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2005	434	7032					525	529		10.1038/nature03408	http://dx.doi.org/10.1038/nature03408			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909CH	15791258				2022-12-24	WOS:000227836000046
J	Baxter, EJ; Scott, LM; Campbell, PJ; East, C; Fourouclas, N; Swanton, S; Vassiliou, GS; Bench, AJ; Boyd, EM; Curtin, N; Scott, MA; Erber, WN; Green, AR				Baxter, EJ; Scott, LM; Campbell, PJ; East, C; Fourouclas, N; Swanton, S; Vassiliou, GS; Bench, AJ; Boyd, EM; Curtin, N; Scott, MA; Erber, WN; Green, AR		Canc Genome Project	Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders	LANCET			English	Article							POLYCYTHEMIA-VERA; DIAGNOSTIC-CRITERIA; ESSENTIAL THROMBOCYTHEMIA; PROGENITOR CELLS; STEM-CELL; BCL-X; EXPRESSION; RECEPTOR; HYPERSENSITIVITY; MYELOFIBROSIS	Background Human myeloproliferative disorders form a range of clonal haematological malignant diseases, the main members of which are polycythaemia vera, essential thrombocythaemia, and idiopathic myelofibrosis. The molecular pathogenesis of these disorders is unknown, but tyrosine kinases have been implicated in several related disorders. We investigated the role of the cytoplasmic tyrosine kinase JAK2 in patients with a myeloproliferative disorder. Methods We obtained DNA samples from patients with polycythaemia vera, essential thrombocythaemia, or idiopathic myelofibrosis. The coding exons of JAK2 were bidirectionally sequenced from peripheral-blood granulocytes, T cells, or both. Allele-specific PCR, molecular cytogenetic studies, microsatellite PCR, Affymetrix single nucleotide polymorphism array analyses, and colony assays were undertaken on subgroups of patients. Findings A single point mutation (Val617Phe) was identified in JAK2 in 71 (97%) of 73 patients with polycythaemia vera, 29 (57%) of 51 with essential thrombocythaemia, and eight (50%) of 16 with idiopathic myelofibrosis. The mutation is acquired, is present in a variable proportion of granulocytes, alters a highly conserved valine present in the negative regulatory JH2 domain, and is predicted to dysregulate kinase activity. It was heterozygous in most patients, homozygous in a subset as a result of mitotic recombination, and arose in a multipotent progenitor capable of giving rise to erythroid and myeloid cells. The mutation was present in all erythropoietin-independent erythroid colonies. Interpretation A single acquired mutation of JAK2 was noted in more than half of patients with a myeloproliferative disorder. Its presence in all erythropoietin-independent erythroid colonies demonstrates a link with growth factor hypersensitivity, a key biological feature of these disorders. Relevance to practice Identification of the Val617Phe JAK2 mutation lays the foundation for new approaches to the diagnosis, classification, and treatment of myeloproliferative disorders.	Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 2XY, England; Addenbrookes NHS Trust, Dept Haematol, Cambridge, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital	Green, AR (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Hills Rd, Cambridge CB2 2XY, England.	arg1000@cam.ac.uk	Scott, Linda/D-9777-2012; Erber, Wendy/A-1955-2012	Scott, Linda/0000-0003-0334-1479; Vassiliou, George/0000-0003-4337-8022; Erber, Wendy/0000-0002-1028-9376; Raine, Keiran/0000-0002-5634-1539; Green, Anthony/0000-0002-9795-0218; Baxter, Elizabeth Joanna/0000-0002-5946-5238	Wellcome Trust [088340] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ADAMSON JW, 1976, NEW ENGL J MED, V295, P913, DOI 10.1056/NEJM197610212951702; Axelrad AA, 2000, BLOOD, V96, P3310; Barosi G, 1999, BRIT J HAEMATOL, V104, P730, DOI 10.1046/j.1365-2141.1999.01262.x; Bench AJ, 2000, ONCOGENE, V19, P3902, DOI 10.1038/sj.onc.1203728; DAI CH, 1992, BLOOD, V80, P891; DAMESHEK W, 1951, BLOOD, V6, P372, DOI 10.1182/blood.V6.4.372.372; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; FIALKOW PJ, 1981, BLOOD, V58, P916; Gesbert F, 2000, BLOOD, V96, P2269, DOI 10.1182/blood.V96.6.2269.h8002269_2269_2276; Green AR, 2004, HEMATOL J, V5, pS126, DOI 10.1038/sj.thj.6200438; Griesshammer M, 2004, ANN HEMATOL, V83, P364, DOI 10.1007/s00277-004-0864-9; Harrison CN, 2003, HEMATOL ONCOL CLIN N, V17, P1175, DOI 10.1016/S0889-8588(03)00082-0; Hinshelwood S, 1997, BLOOD REV, V11, P224, DOI 10.1016/S0268-960X(97)90021-7; Klippel S, 2003, BLOOD, V102, P3569, DOI 10.1182/blood-2003-03-0919; KOBAYASHI S, 1993, BRIT J HAEMATOL, V83, P539, DOI 10.1111/j.1365-2141.1993.tb04688.x; Komura E, 2003, EXP HEMATOL, V31, P622, DOI 10.1016/S0301-472X(03)00085-7; Kralovics R, 2005, BLOOD REV, V19, P1, DOI 10.1016/j.blre.2004.02.002; Kralovics R, 2002, EXP HEMATOL, V30, P229, DOI 10.1016/S0301-472X(01)00789-5; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Landolfi R, 2004, NEW ENGL J MED, V350, P114, DOI 10.1056/NEJMoa035572; LI Y, 1994, BRIT J HAEMATOL, V87, P471, DOI 10.1111/j.1365-2141.1994.tb08300.x; Lindauer K, 2001, PROTEIN ENG, V14, P27, DOI 10.1093/protein/14.1.27; Luo H, 1997, MOL CELL BIOL, V17, P1562, DOI 10.1128/MCB.17.3.1562; Moliterno AR, 1998, NEW ENGL J MED, V338, P572, DOI 10.1056/NEJM199802263380903; Murphy S, 1997, SEMIN HEMATOL, V34, P29; Pearson TC, 2001, SEMIN HEMATOL, V38, P21, DOI 10.1053/shem.2001.23043; Peeters P, 1997, BLOOD, V90, P2535, DOI 10.1182/blood.V90.7.2535.2535_2535_2540; PRCHAL JF, 1974, NEW ENGL J MED, V290, P1382; Reilly JT, 2003, BLOOD REV, V17, P241, DOI 10.1016/S0268-960X(03)00024-9; Saharinen P, 2000, MOL CELL BIOL, V20, P3387, DOI 10.1128/MCB.20.10.3387-3395.2000; Saharinen P, 2002, J BIOL CHEM, V277, P47954, DOI 10.1074/jbc.M205156200; Silva M, 1998, NEW ENGL J MED, V338, P564, DOI 10.1056/NEJM199802263380902; Skoda RC, 2004, HEMATOL J, V5, pS122, DOI 10.1038/sj.thj.6200437; Spivak Jerry L, 2003, Hematology Am Soc Hematol Educ Program, P200; Ugo V, 2004, EXP HEMATOL, V32, P179, DOI 10.1016/j.exphem.2003.11.003; Wadleigh M, 2005, BLOOD, V105, P22, DOI 10.1182/blood-2003-11-3896	36	2641	2896	1	93	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2005	365	9464					1054	1061		10.1016/S0140-6736(05)71142-9	http://dx.doi.org/10.1016/S0140-6736(05)71142-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	907QB	15781101				2022-12-24	WOS:000227731800030
J	Holland, ND; Clague, DA; Gordon, DP; Gebruk, A; Pawson, DL; Vecchione, M				Holland, ND; Clague, DA; Gordon, DP; Gebruk, A; Pawson, DL; Vecchione, M			Lophenteropneust' hypothesis refuted by collection and photos of new deep-sea hemichordates	NATURE			English	Article							PACIFIC	The deep ocean is home to a group of broad-collared hemichordates - the so-called 'lophenteropneusts' - that have been photographed gliding on the sea floor(1-8) but have not previously been collected. It has been claimed that these worms have collar tentacles and blend morphological features of the two main hemichordate body plans, namely the tentacle-less enteropneusts and the tentacle-bearing pterobranchs. Consequently, lophenteropneusts have been invoked as missing links to suggest that the former evolved into the latter(5). The most significant aspect of the lophenteropneust hypothesis is its prediction that the fundamental body plan within a basal phylum of deuterostomes was enteropneust-like. The assumption of such an ancestral state influences ideas about the evolution of the vertebrates from the invertebrates(9-14). Here we report on the first collected specimen of a broad-collared, deep-sea enteropneust and describe it as a new family, genus and species. The collar, although disproportionately broad, lacks tentacles. In addition, we find no evidence of tentacles in the available deep-sea photographs ( published and unpublished) of broad-collared enteropneusts, including those formerly designated as lophenteropneusts. Thus, the lophenteropneust hypothesis was based on misinterpretation of deep-sea photographs of low quality and should no longer be used to support the idea that the enteropneust body plan is basal within the phylum Hemichordata.	Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA; Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; Natl Inst Water & Atmospher Res, Wellington, New Zealand; Russian Acad Sci, PP Shirshov Oceanol Inst, Moscow 117851, Russia; Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20013 USA; Natl Museum Nat Hist, NOAA, Natl Systemat Lab, Washington, DC 20013 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Monterey Bay Aquarium Research Institute; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Russian Academy of Sciences; Shirshov Institute of Oceanology; Smithsonian Institution; Smithsonian National Museum of Natural History; National Oceanic Atmospheric Admin (NOAA) - USA; Smithsonian Institution; Smithsonian National Museum of Natural History	Holland, ND (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA.	nholland@ucsd.edu	Gebruk, Andrey/A-9041-2016					Bateson W, 1886, Q J MICROSC SCI, V26, P535; Bett BJ, 2001, CONT SHELF RES, V21, P917, DOI 10.1016/S0278-4343(00)00119-9; BOURNE DW, 1965, SCIENCE, V150, P60, DOI 10.1126/science.150.3692.60; Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; Dilly P.N., 1975, Symposia Zool Soc Lond, VNo. 36, P1; Ewing M., 1967, DEEP SEA PHOTOGRAPHY, P259; FOELL EJ, 1986, OHIO J SCI, V86, P61; Gage JD, 1991, DEEP SEA BIOL NATURA; GAILLARD C, 1991, Palaios, V6, P302, DOI 10.2307/3514910; Heezen B.C., 1971, FACE DEEP; JACOBS SS, 1970, HYDROGRAPHIC STATION, P32; Jefferies RPS, 2001, SYST ASSOC SPEC VOL, V61, P40; JOLLIE M, 1973, ACTA ZOOLOGICA, V54, P81; LEMCHE H, 1976, VINDENSK MEDDR DANSK, V139, P262; Lowe CJ, 2003, CELL, V113, P853, DOI 10.1016/S0092-8674(03)00469-0; Menzies R.J., 1973, ABYSSAL ENV ECOLOGY; PAWSON D, 2003, DEEP SEA NEWSL, V32, P6; SPENGEL JW, 1893, MONOGRAPH, V18; Tendal Ole Secher, 1998, Deep-Sea Newsletter, V27, P21; TENDAL OS, 1999, DEEP SEA NEWSL, V28, P8; Thiel H., 1979, Ambio Special Report, P25; THORNDIKE EM, 1982, OCEAN FLOOR, P255; WOODWICK KH, 1985, P BIOL SOC WASH, V98, P351; WOODWICK KH, 1993, TAXONOMIC ATLAS BENT, V14, P251; Young CM, 2003, ECOSY WORLD, V28, P381	25	39	42	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					374	376		10.1038/nature03382	http://dx.doi.org/10.1038/nature03382			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772659				2022-12-24	WOS:000227715100049
J	Ozdamar, B; Bose, R; Barrios-Rodiles, M; Wang, HR; Zhang, Y; Wrana, JL				Ozdamar, B; Bose, R; Barrios-Rodiles, M; Wang, HR; Zhang, Y; Wrana, JL			Regulation of the polarity protein Par6 by TGF beta receptors controls epithelial cell plasticity	SCIENCE			English	Article							MESENCHYMAL TRANSITION; TIGHT JUNCTIONS; KINASE-C; TRANSDIFFERENTIATION; MECHANISMS; PATHWAYS; COMPLEX; GROWTH; SIGNAL; RHO	The transition of cells from an epithelia[ to a mesenchymal phenotype is a critical event during morphogenesis in multicellular organisms and underlies the pathology of many diseases, including the invasive phenotype associated with metastatic carcinomas. Transforming growth factor beta (TGFbeta) is a key regulator of epithetial-to-mesenchymal transition (EMT). However, the molecular mechanisms that control the dissolution of tight junctions, an early event in EMT, remain elusive. We demonstrate that Par6, a regulator of epithelia[ cell polarity and tight-junction assembly, interacts with TGFbeta receptors and is a substrate of the type II receptor, TbetaRII Phosphorylation of Par6 is required for TGFbeta-dependent EMT in mammary gland epithelia[ cells and controls the interaction of Par6 with the E3 ubiquitin ligase Smurf1. Smurf1, in turn, targets the guanosine triphosphatase RhoA for degradation, thereby leading to a loss of tight junctions. These studies define how an extracellular cue signals to the polarity machinery to control epithelia[ cell morphology.	Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Wrana, JL (corresponding author), Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON, Canada.	wrana@mshri.on.ca	Bose, Rohit/O-9825-2018; Wrana, Jeffrey/F-8857-2013	Bose, Rohit/0000-0002-6785-0697; Wang, Hong-Rui/0000-0002-2916-8849				Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bakin AV, 2002, J CELL SCI, V115, P3193; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chen ML, 2002, J BIOL CHEM, V277, P4247, DOI 10.1074/jbc.M109254200; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Ehrlich M, 2001, J CELL SCI, V114, P1777; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Feng XH, 1996, J BIOL CHEM, V271, P13123, DOI 10.1074/jbc.271.22.13123; Fujita H, 2000, BIOCHEM J, V346, P617, DOI 10.1042/0264-6021:3460617; Gao C, 2002, MOL CANCER RES, V1, P12; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Johansson AS, 2000, J CELL SCI, V113, P3267; Kaartinen V, 2002, INT J MOL MED, V9, P563; Lemmers C, 2004, MOL BIOL CELL, V15, P1324, DOI 10.1091/mbc.E03-04-0235; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Moustakas A, 2001, J CELL SCI, V114, P4359; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; Nam SC, 2003, DEVELOPMENT, V130, P4363, DOI 10.1242/dev.00648; Noda Y, 2003, J BIOL CHEM, V278, P43516, DOI 10.1074/jbc.M306330200; Oft M, 1998, CURR BIOL, V8, P1243, DOI 10.1016/S0960-9822(07)00533-7; OZDAMAR B, UNPUB; Pagan R, 1996, EXP CELL RES, V222, P333, DOI 10.1006/excr.1996.0043; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Plant PJ, 2003, NAT CELL BIOL, V5, P301, DOI 10.1038/ncb948; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P3717, DOI 10.1091/mbc.12.12.3717; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shook D, 2003, MECH DEVELOP, V120, P1351, DOI 10.1016/j.mod.2003.06.005; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Suzuki C, 2002, J BIOL CHEM, V277, P39919, DOI 10.1074/jbc.M201901200; Tian YC, 2003, AM J PHYSIOL-RENAL, V285, pF130, DOI 10.1152/ajprenal.00408.2002; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Watts JL, 1996, DEVELOPMENT, V122, P3133; WILLOTT E, 1993, P NATL ACAD SCI USA, V90, P7834, DOI 10.1073/pnas.90.16.7834; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366	48	683	725	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2005	307	5715					1603	1609		10.1126/science.1105718	http://dx.doi.org/10.1126/science.1105718			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15761148				2022-12-24	WOS:000227622400042
J	Paradise, J; Andrews, L; Holbrook, T				Paradise, J; Andrews, L; Holbrook, T			Patents on human genes: An analysis of scope and claims	SCIENCE			English	Editorial Material							INTELLECTUAL PROPERTY-RIGHTS; POLICY		Chicago Kent Coll Law, IIT, Chicago, IL 60661 USA	Illinois Institute of Technology	Paradise, J (corresponding author), Chicago Kent Coll Law, IIT, 565 W Adams, Chicago, IL 60661 USA.	jparadise@kent-law.edu						Andrews LB, 2002, NAT REV GENET, V3, P803, DOI 10.1038/nrg909; Barton JH, 2000, SCIENCE, V287, P1933, DOI 10.1126/science.287.5460.1933; BLANTON K, 2002, BOSTON GLOBE    0224, P10; Campbell EG, 2002, JAMA-J AM MED ASSOC, V287, P473, DOI 10.1001/jama.287.4.473; Cho M. K., 1998, PREPARING MILLENNIUM, P47; Gad S, 2001, J MED GENET, V38, P388, DOI 10.1136/jmg.38.6.388; Lemley MA, 2001, NORTHWEST U LAW REV, V95, P1495; MERGES RP, 1999, BERKELEY TECH L J, V14, P577; Merz JF, 2002, NATURE, V415, P577, DOI 10.1038/415577a	9	41	43	2	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2005	307	5715					1566	1567		10.1126/science.1105162	http://dx.doi.org/10.1126/science.1105162			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15761140	Green Submitted			2022-12-24	WOS:000227622400027
J	El-Khamisy, SF; Saifi, GM; Weinfeld, M; Johansson, F; Helleday, T; Lupski, JR; Caldecott, KW				El-Khamisy, SF; Saifi, GM; Weinfeld, M; Johansson, F; Helleday, T; Lupski, JR; Caldecott, KW			Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1	NATURE			English	Article							I COVALENT COMPLEXES; TOPOISOMERASE-I; BASE DAMAGES; PHOSPHODIESTERASE; XRCC1; MUTATION; TDP1; ELONGATION; PATHWAYS; ABSENCE	Spinocerebellar ataxia with axonal neuropathy- 1 (SCAN1) is a neurodegenerative disease that results from mutation of tyrosyl phosphodiesterase 1 (TDP1)(1). In lower eukaryotes, Tdp1 removes topoisomerase 1 (top1) peptide from DNA termini during the repair of double-strand breaks created by collision of replication forks with top1 cleavage complexes in proliferating cells(2-4). Although TDP1 most probably fulfils a similar function in human cells, this role is unlikely to account for the clinical phenotype of SCAN1, which is associated with progressive degeneration of post-mitotic neurons. In addition, this role is redundant in lower eukaryotes, and Tdp1 mutations alone confer little phenotype(4-7). Moreover, defects in processing or preventing double-strand breaks during DNA replication are most probably associated with increased genetic instability and cancer, phenotypes not observed in SCAN1 ( ref. 8). Here we show that in human cells TDP1 is required for repair of chromosomal singlestrand breaks arising independently of DNA replication from abortive top1 activity or oxidative stress. We report that TDP1 is sequestered into multi-protein single-strand break repair (SSBR) complexes by direct interaction with DNA ligase IIIalpha and that these complexes are catalytically inactive in SCAN1 cells. These data identify a defect in SSBR in a neurodegenerative disease, and implicate this process in the maintenance of genetic integrity in post-mitotic neurons.	Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; Univ Stockholm, Arrhenius Lab, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden; Univ Sheffield, Sch Med, Inst Canc Studies, Sheffield S10 2RX, S Yorkshire, England	University of Sussex; Baylor College of Medicine; University of Alberta; Stockholm University; University of Sheffield	Caldecott, KW (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Sci Pk Rd, Brighton BN1 9RQ, E Sussex, England.	k.w.caldecott@sussex.ac.uk	Caldecott, Keith/S-4245-2019; Helleday, Thomas/D-5224-2013	, Sherif/0000-0003-2721-7763; Caldecott, Keith/0000-0003-4255-9016; Helleday, Thomas/0000-0002-7384-092X	Medical Research Council [G0001259] Funding Source: Medline; MRC [G0001259] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BENDIXEN C, 1990, BIOCHEMISTRY-US, V29, P5613, DOI 10.1021/bi00475a028; BRADLEY MO, 1979, NUCLEIC ACIDS RES, V7, P793, DOI 10.1093/nar/7.3.793; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; Caldecott KW, 1995, NUCLEIC ACIDS RES, V23, P4836, DOI 10.1093/nar/23.23.4836; FAIRBAIRN DW, 1995, MUTAT RES-REV GENET, V339, P37, DOI 10.1016/0165-1110(94)00013-3; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Inamdar KV, 2002, J BIOL CHEM, V277, P27162, DOI 10.1074/jbc.M204688200; Kathe SD, 2004, J BIOL CHEM, V279, P18511, DOI 10.1074/jbc.M313598200; Lambert S, 2001, ONCOGENE, V20, P6627, DOI 10.1038/sj.onc.1204813; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Liu CY, 2002, P NATL ACAD SCI USA, V99, P14970, DOI 10.1073/pnas.182557199; Liu JK, 2004, CHEM BIODIVERS, V1, P601, DOI 10.1002/cbdv.200490050; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; Moore DJ, 2000, P NATL ACAD SCI USA, V97, P13649, DOI 10.1073/pnas.250477597; O'Driscoll M, 2001, MOL CELL, V8, P1175, DOI 10.1016/S1097-2765(01)00408-7; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; Plo I, 2003, DNA REPAIR, V2, P1087, DOI 10.1016/S1568-7864(03)00116-2; Pommier Y, 2003, MUTAT RES-FUND MOL M, V532, P173, DOI 10.1016/j.mrfmmm.2003.08.016; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; Pouliot JJ, 2001, GENES CELLS, V6, P677, DOI 10.1046/j.1365-2443.2001.00452.x; Pourquier P, 1999, J BIOL CHEM, V274, P8516, DOI 10.1074/jbc.274.13.8516; Rasouli-Nia A, 2004, P NATL ACAD SCI USA, V101, P6905, DOI 10.1073/pnas.0400099101; Shivji MKK, 2004, DNA REPAIR, V3, P835, DOI 10.1016/j.dnarep.2004.03.008; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Taylor RM, 2000, MOL CELL BIOL, V20, P735, DOI 10.1128/MCB.20.2.735-740.2000; Vance JR, 2002, P NATL ACAD SCI USA, V99, P13669, DOI 10.1073/pnas.202242599; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wu JX, 1997, NUCLEIC ACIDS RES, V25, P4181, DOI 10.1093/nar/25.21.4181; ZHOU W, 1994, BIOCHEMISTRY-US, V33, P14926, DOI 10.1021/bi00253a032	30	337	340	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					108	113		10.1038/nature03314	http://dx.doi.org/10.1038/nature03314			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744309				2022-12-24	WOS:000227334600053
J	Guimera, R; Amaral, LAN				Guimera, R; Amaral, LAN			Functional cartography of complex metabolic networks	NATURE			English	Article							SMALL-WORLD; ORGANIZATION; MODULARITY	High-throughput techniques are leading to an explosive growth in the size of biological databases and creating the opportunity to revolutionize our understanding of life and disease. Interpretation of these data remains, however, a major scientific challenge. Here, we propose a methodology that enables us to extract and display information contained in complex networks(1-3). Specifically, we demonstrate that we can find functional modules(4,5) in complex networks, and classify nodes into universal roles according to their pattern of intra- and inter-module connections. The method thus yields a 'cartographic representation' of complex networks. Metabolic networks(6-8) are among the most challenging biological networks and, arguably, the ones with most potential for immediate applicability(9). We use our method to analyse the metabolic networks of twelve organisms from three different superkingdoms. We find that, typically, 80% of the nodes are only connected to other nodes within their respective modules, and that nodes with different roles are affected by different evolutionary constraints and pressures. Remarkably, we find that metabolites that participate in only a few reactions but that connect different modules are more conserved than hubs whose links are mostly within a single module.	Northwestern Univ, NICO, Evanston, IL 60208 USA; Northwestern Univ, Dept Biol & Chem Engn, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Amaral, LAN (corresponding author), Northwestern Univ, NICO, Evanston, IL 60208 USA.	amaral@northwestern.edu	Guimera, Roger/C-1727-2008; Amaral, Luis N./C-5485-2009; Guimera, Roger/M-9808-2019; Amaral, LAN/A-4980-2008	Guimera, Roger/0000-0002-3597-4310; Guimera, Roger/0000-0002-3597-4310; Amaral, LAN/0000-0002-3762-789X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K25GM069546] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Amaral LAN, 2004, EUR PHYS J B, V38, P147, DOI 10.1140/epjb/e2004-00110-5; Arenas A, 2004, EUR PHYS J B, V38, P373, DOI 10.1140/epjb/e2004-00130-1; Donetti L, 2004, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2004/10/P10012; Eriksen KA, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.148701; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimera R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.025101; Guimera R, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/02/P02001; Guimera R, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.065103; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hatzimanikatis V, 2004, CURR OPIN STRUC BIOL, V14, P300, DOI 10.1016/j.sbi.2004.04.004; Holme P, 2003, BIOINFORMATICS, V19, P532, DOI 10.1093/bioinformatics/btg033; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Krause AE, 2003, NATURE, V426, P282, DOI 10.1038/nature02115; Ma HW, 2003, BIOINFORMATICS, V19, P270, DOI 10.1093/bioinformatics/19.2.270; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Papin JA, 2004, TRENDS BIOCHEM SCI, V29, P641, DOI 10.1016/j.tibs.2004.10.001; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786; Schuster S, 2002, BIOINFORMATICS, V18, P351, DOI 10.1093/bioinformatics/18.2.351; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; WASSERMAN S, 1994, SOCIAL NETWORK ANAL, pCH12	29	2228	2376	40	438	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 24	2005	433	7028					895	900		10.1038/nature03288	http://dx.doi.org/10.1038/nature03288			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	899VT	15729348	Green Accepted, Green Submitted			2022-12-24	WOS:000227174600050
J	Raimondo, G; Pollicino, T; Squadrito, G				Raimondo, G; Pollicino, T; Squadrito, G			What is the clinical impact of occult hepatitis B virus infection?	LANCET			English	Editorial Material							ANTIGEN		Univ Messina, Dept Internal Med, Unit Clin & Mol Hepatol, I-98124 Messina, Italy	University of Messina	Raimondo, G (corresponding author), Univ Messina, Dept Internal Med, Unit Clin & Mol Hepatol, I-98124 Messina, Italy.	raimondo@unime.it	Pollicino, Teresa/HDN-3708-2022; Pollicino, Teresa/K-5790-2016	Pollicino, Teresa/0000-0001-6602-3035				Allain JP, 2004, VOX SANG, V86, P83, DOI 10.1111/j.0042-9007.2004.00406.x; Brechot C, 2001, HEPATOLOGY, V34, P194, DOI 10.1053/jhep.2001.25172; Brechot C, 2000, SEMIN CANCER BIOL, V10, P211, DOI 10.1006/scbi.2000.0321; Cacciola I, 1999, NEW ENGL J MED, V341, P22, DOI 10.1056/NEJM199907013410104; CARMAN W, 1993, LANCET, V341, P349, DOI 10.1016/0140-6736(93)90146-8; CHAZOUILLERES O, 1994, LANCET, V343, P142, DOI 10.1016/S0140-6736(94)90934-2; Chemin I, 2001, J HEPATOL, V34, P447, DOI 10.1016/S0168-8278(00)00100-8; GRUMAYER ER, 1989, J HEPATOL, V8, P232, DOI 10.1016/0168-8278(89)90012-3; Marusawa H, 2000, HEPATOLOGY, V31, P488, DOI 10.1002/hep.510310232; Minuk GY, 2004, HEPATOLOGY, V40, P1072, DOI 10.1002/hep.20435; Pollicino T, 2004, GASTROENTEROLOGY, V126, P102, DOI 10.1053/j.gastro.2003.10.048; Raimondo C, 2001, J HEPATOL, V34, P471, DOI 10.1016/S0168-8278(01)00016-2; Torbenson M, 2002, LANCET INFECT DIS, V2, P479, DOI 10.1016/S1473-3099(02)00345-6; WAITE J, 1988, AIDS, V2, P443, DOI 10.1097/00002030-198812000-00006; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Wieland SF, 2004, P NATL ACAD SCI USA, V101, P2129, DOI 10.1073/pnas.0308478100	16	46	53	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 19	2005	365	9460					638	640						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	898SP	15721459				2022-12-24	WOS:000227096800007
J	Snir, Y; Kamien, RD				Snir, Y; Kamien, RD			Entropically driven helix formation	SCIENCE			English	Article							SHAPES		Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA	University of Pennsylvania	Kamien, RD (corresponding author), Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA.	kamien@physics.upenn.edu						ASAKURA S, 1954, J CHEM PHYS, V22, P1255, DOI 10.1063/1.1740347; Banavar JR, 2003, REV MOD PHYS, V75, P23, DOI 10.1103/RevModPhys.75.23; BELLO J, 1993, BIOPOLYMERS, V33, P491, DOI 10.1002/bip.360330315; DELATOUR EB, 1988, CELL, V55, P937, DOI 10.1016/0092-8674(88)90239-5; Gellman SH, 1998, ACCOUNTS CHEM RES, V31, P173, DOI 10.1021/ar960298r; Gonzalez O, 1999, P NATL ACAD SCI USA, V96, P4769, DOI 10.1073/pnas.96.9.4769; LAU KF, 1989, MACROMOLECULES, V22, P3986, DOI 10.1021/ma00200a030; Maritan A, 2000, NATURE, V406, P287, DOI 10.1038/35018538; Pickett GT, 2000, PHYS REV LETT, V85, P3652, DOI 10.1103/PhysRevLett.85.3652	9	217	223	4	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2005	307	5712					1067	1067		10.1126/science.1106243	http://dx.doi.org/10.1126/science.1106243			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ED	15718461	Green Submitted			2022-12-24	WOS:000227197300036
J	Kural, C; Kim, H; Syed, S; Goshima, G; Gelfand, VI; Selvin, PR				Kural, C; Kim, H; Syed, S; Goshima, G; Gelfand, VI; Selvin, PR			Kinesin and dynein move a peroxisome in vivo: A tug-of-war or coordinated movement?	SCIENCE			English	Article							HAND-OVER-HAND; CYTOPLASMIC DYNEIN; ORGANELLE TRANSPORT; MOLECULAR MOTORS; PROTEINS; NEURONS; LOAD	We used fluorescence imaging with one nanometer accuracy (FIONA) to analyze organelle movement by conventional kinesin and cytoplasmic dynein in a cell. We located a green fluorescence protein (GFP)-tagged peroxisome in cultured Drosophila S2 cells to within 1.5 nanometers in 1.1 milliseconds, a 400-fold improvement in temporal resolution, sufficient to, determine the average step size to be similar to 8 nanometers for both dynein and kinesin. Furthermore, we found that dynein and kinesin do not work against each other in vivo during peroxisome transport. Rather, multiple kinesins or multiple dyneins work together, producing up to 10 times the in vitro speed.	Univ Illinois, Loomis Lab Phys, Ctr Biophys, Urbana, IL 61801 USA; Univ Illinois, Dept Phys, Urbana, IL 61801 USA; Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94107 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California San Francisco	Selvin, PR (corresponding author), Univ Illinois, Loomis Lab Phys, Ctr Biophys, 1110 W Green St, Urbana, IL 61801 USA.	selvin@uiuc.edu	Gelfand, Vladimir I/D-2545-2013; Gelfand, Vladimir/M-1974-2019	Gelfand, Vladimir I/0000-0002-6361-2798; Gelfand, Vladimir/0000-0002-6361-2798; Kural, Comert/0000-0002-9065-6542	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR044420, R01AR044420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM052111, R01GM052111, R01GM068625] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR44420] Funding Source: Medline; NIGMS NIH HHS [GM52111, GM 068625] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASHKIN A, 1990, NATURE, V348, P346, DOI 10.1038/348346a0; BRADY ST, 1982, SCIENCE, V218, P1129, DOI 10.1126/science.6183745; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; GRAFSTEIN B, 1980, PHYSIOL REV, V60, P1167, DOI 10.1152/physrev.1980.60.4.1167; Gross SP, 2000, J CELL BIOL, V148, P945, DOI 10.1083/jcb.148.5.945; Gross SP, 2002, J CELL BIOL, V156, P855, DOI 10.1083/jcb.200105055; Hill DB, 2004, EUR BIOPHYS J BIOPHY, V33, P623, DOI 10.1007/s00249-004-0403-6; HUNT AJ, 1994, BIOPHYS J, V67, P766, DOI 10.1016/S0006-3495(94)80537-5; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Ma YT, 2004, CURR BIOL, V14, P725, DOI 10.1016/j.cub.2004.03.061; Mallik R, 2004, CURR BIOL, V14, pR971, DOI 10.1016/j.cub.2004.10.046; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Nishiura M, 2004, J BIOL CHEM, V279, P22799, DOI 10.1074/jbc.M313362200; Rogers SL, 2000, CURR OPIN CELL BIOL, V12, P57, DOI 10.1016/S0955-0674(99)00057-5; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	23	465	481	1	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2005	308	5727					1469	1472		10.1126/science.1108408	http://dx.doi.org/10.1126/science.1108408			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933HK	15817813				2022-12-24	WOS:000229619300054
J	Urnov, FD; Miller, JC; Lee, YL; Beausejour, CM; Rock, JM; Augustus, S; Jamieson, AC; Porteus, MH; Gregory, PD; Holmes, MC				Urnov, FD; Miller, JC; Lee, YL; Beausejour, CM; Rock, JM; Augustus, S; Jamieson, AC; Porteus, MH; Gregory, PD; Holmes, MC			Highly efficient endogenous human gene correction using designed zinc-finger nucleases	NATURE			English	Article							DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; DNA RECOGNITION; SITE; CLEAVAGE; SPECIFICITY; ACTIVATION; PROTEINS; THERAPY; REPAIR	Permanent modification of the human genome in vivo is impractical owing to the low frequency of homologous recombination in human cells, a fact that hampers biomedical research and progress towards safe and effective gene therapy. Here we report a general solution using two fundamental biological processes: DNA recognition by C2H2 zinc-finger proteins and homology-directed repair of DNA double-strand breaks. Zinc-finger proteins engineered to recognize a unique chromosomal site can be fused to a nuclease domain, and a double-strand break induced by the resulting zinc-finger nuclease can create specific sequence alterations by stimulating homologous recombination between the chromosome and an extrachromosomal DNA donor. We show that zinc-finger nucleases designed against an X-linked severe combined immune deficiency ( SCID) mutation in the IL2R gamma gene yielded more than 18% gene-modified human cells without selection. Remarkably, about 7% of the cells acquired the desired genetic modification on both X chromosomes, with cell genotype accurately reflected at the messenger RNA and protein levels. We observe comparably high frequencies in human T cells, raising the possibility of strategies based on zinc-finger nucleases for the treatment of disease.	Sangamo BioSci Inc, Richmond, CA 94804 USA; Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	Sangamo Therapeutics, Inc.; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Holmes, MC (corresponding author), Sangamo BioSci Inc, Pt Richmond Tech Ctr 501,Canal Blvd,Suite A100, Richmond, CA 94804 USA.	matthew.porteus@UTSouthwestern.edu; mholmes@sangamo.com	Wilson, Matthew H/K-3193-2013	Rock, Jeremy/0000-0002-9310-951X; Urnov, Fyodor/0000-0001-7542-4084; Gregory, Philip/0000-0001-9249-2468				Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Bibikova M, 2002, GENETICS, V161, P1169; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Buckley RH, 2000, NEW ENGL J MED, V343, P1313, DOI 10.1056/NEJM200011023431806; Bunz F, 2002, CANCER RES, V62, P1129; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Choo Y, 1997, CURR OPIN STRUC BIOL, V7, P117, DOI 10.1016/S0959-440X(97)80015-2; CHOO Y, 1994, NATURE, V372, P642, DOI 10.1038/372642a0; Choo Y, 2000, CURR OPIN STRUC BIOL, V10, P411, DOI 10.1016/S0959-440X(00)00107-X; CHOULIKA A, 1995, MOL CELL BIOL, V15, P1968; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93; Isalan M, 2001, METHOD ENZYMOL, V340, P593; Isalan M, 2001, NAT BIOTECHNOL, V19, P656, DOI 10.1038/90264; Jamieson AC, 2003, NAT REV DRUG DISCOV, V2, P361, DOI 10.1038/nrd1087; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; KLUG A, 1993, GENE, V135, P83, DOI 10.1016/0378-1119(93)90052-5; Kohn DB, 2003, NAT REV CANCER, V3, P477, DOI 10.1038/nrc1122; Liu PQ, 2001, J BIOL CHEM, V276, P11323, DOI 10.1074/jbc.M011172200; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Moore M, 2001, P NATL ACAD SCI USA, V98, P1437, DOI 10.1073/pnas.98.4.1437; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Persons Derek A, 2003, Curr Hematol Rep, V2, P348; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; Sargent RG, 1997, MOL CELL BIOL, V17, P267, DOI 10.1128/MCB.17.1.267; Schell T, 2002, GENOME BIOL, V3; SEDIVY JM, 1992, GENE TARGETING; Smith J, 1999, NUCLEIC ACIDS RES, V27, P674, DOI 10.1093/nar/27.2.674; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Tan SY, 2003, P NATL ACAD SCI USA, V100, P11997, DOI 10.1073/pnas.2035056100; THOMAS KR, 1986, CELL, V44, P419, DOI 10.1016/0092-8674(86)90463-0; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wilson JH, 2003, NAT BIOTECHNOL, V21, P759, DOI 10.1038/nbt0703-759; Yanez RJ, 1998, GENE THER, V5, P149, DOI 10.1038/sj.gt.3300601; Zhang L, 2000, J BIOL CHEM, V275, P33850, DOI 10.1074/jbc.M005341200	39	1177	1517	5	203	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2005	435	7042					646	651		10.1038/nature03556	http://dx.doi.org/10.1038/nature03556			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931HK	15806097				2022-12-24	WOS:000229476200043
J	Ma, L; Chen, ZB; Erdjument-Bromage, H; Tempst, P; Pandolfi, PP				Ma, L; Chen, ZB; Erdjument-Bromage, H; Tempst, P; Pandolfi, PP			Phosphorylation and functional inactivation of TSC2 by Erk: Implications for tuberous sclerosis and cancer pathogenesis	CELL			English	Article							INITIATION-FACTOR 4E; P70 S6 KINASE; TUMOR-SUPPRESSOR PROTEINS; CELL-GROWTH; MAP KINASE; GENE-PRODUCTS; IN-VIVO; TRANSLATIONAL CONTROL; 3-KINASE/AKT PATHWAY; SIGNALING PATHWAY	Tuberous sclerosis (TSC) is a tumor syndrome caused by mutation in TSC1 or TSC2genes. TSC tumorigenesis is not always accompanied by loss of heterozygosity (LOH). Recently, extracellular signal-regulated kinase (Erk) has been found activated in TSC lesions lacking TSC1 or TSC2 LOH. Here, we show that Erk may play a critical role in TSC progression through posttranslational inactivation of TSC2. Erk-dependent phosphorylation leads to TSC1-TSC2 dissociation and markedly impairs TSC2 ability to inhibit mTOR signaling, cell proliferation, and oncogenic transformation. Importantly, expression of an Erk nonphosphorylatable TSC2 mutant in TSC2(+/-) tumor cells where Erk is constitutively activated blocks tumori-genecity in vivo, while wild-type TSC2 is ineffective. Our findings position the Ras/MAPK pathway upstream of the TSC complex and suggest that Erk may modulate mTOR signaling and contribute to disease progression through phosphorylation and inactivation of TSC2.	Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Grad Program Physiol Biophys & Syst Biol, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY 10021 USA.	p-pandolfi@ski.mskcc.org	Ma, Li/GQR-1313-2022	Ma, Li/0000-0001-9965-989X; Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594	NCI NIH HHS [U01 CA-84292, P30 CA08748] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA084292, P30CA008748] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Ballif BA, 2005, P NATL ACAD SCI USA, V102, P667, DOI 10.1073/pnas.0409143102; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Cheadle JP, 2000, HUM GENET, V107, P97, DOI 10.1007/s004390000348; Clemens MJ, 1999, INT J BIOCHEM CELL B, V31, P1, DOI 10.1016/S1357-2725(98)00127-7; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gomez M. R., 1999, TUBEROUS SCLEROSIS C; Gomez MR, 1988, TUBEROUS SCLEROSIS; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Govindarajan B, 2003, CLIN CANCER RES, V9, P3469; GREEN AJ, 1994, NAT GENET, V6, P193, DOI 10.1038/ng0294-193; Han S, 2004, CANCER RES, V64, P812, DOI 10.1158/0008-5472.CAN-03-3277; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Henske EP, 1996, AM J HUM GENET, V59, P400; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Ito N, 1999, CELL, V96, P529, DOI 10.1016/S0092-8674(00)80657-1; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kobayashi T, 1999, CANCER RES, V59, P1206; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Li Y, 2004, TRENDS BIOCHEM SCI, V29, P32, DOI 10.1016/j.tibs.2003.11.007; Maheshwar MM, 1997, HUM MOL GENET, V6, P1991, DOI 10.1093/hmg/6.11.1991; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Niida Y, 2001, AM J HUM GENET, V69, P493, DOI 10.1086/321972; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Plank TL, 1998, CANCER RES, V58, P4766; Posewitz MC, 1999, ANAL CHEM, V71, P2883, DOI 10.1021/ac981409y; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Scheper GC, 2001, MOL CELL BIOL, V21, P743, DOI 10.1128/MCB.21.3.743-754.2001; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shah OJ, 2002, BIOCHEM J, V366, P57, DOI 10.1042/BJ20020198; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; van Slegtenhorst M, 1998, HUM MOL GENET, V7, P1053, DOI 10.1093/hmg/7.6.1053; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; WIENECKE R, 1995, J BIOL CHEM, V270, P16409, DOI 10.1074/jbc.270.27.16409; Winkler GS, 2002, METHODS, V26, P260, DOI 10.1016/S1046-2023(02)00030-0; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	60	978	1013	3	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 22	2005	121	2					179	193		10.1016/j.cell.2005.02.031	http://dx.doi.org/10.1016/j.cell.2005.02.031			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851026	Bronze			2022-12-24	WOS:000228705000007
J	Okie, S				Okie, S			Physician-assisted suicide - Oregon and beyond	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		COLBURN D, 2005, OREGONIAN       0304, pA1; Ganzini L, 2001, JAMA-J AM MED ASSOC, V285, P2363, DOI 10.1001/jama.285.18.2363; Tolle SW, 2004, J CLIN ETHIC, V15, P111	3	23	23	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 21	2005	352	16					1627	1630		10.1056/NEJMp058004	http://dx.doi.org/10.1056/NEJMp058004			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	918CE	15843663				2022-12-24	WOS:000228515200001
J	Weil, M; Bressler, J; Parsons, P; Bolla, K; Glass, T; Schwartz, B				Weil, M; Bressler, J; Parsons, P; Bolla, K; Glass, T; Schwartz, B			Blood mercury levels and neurobehavioral function	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTORS; ALZHEIMERS-DISEASE; COGNITIVE DECLINE; FATTY-ACIDS; METHYLMERCURY; POPULATION; PERFORMANCE; PRESSURE; EXPOSURE; HEALTH	Context Due to its cardiovascular benefits, fish consumption is widely encouraged among older Americans. However, this fast-growing population is at increased risk of cognitive impairment and may be particularly sensitive to methylmercury, a neurotoxicant found in fish. Objective To describe associations of blood mercury levels with neurobehavioral test scores in an urban adult population. Design, Setting, and Participants Cross-sectional analysis to determine the effect of mercury levels on neurobehavior in 474 randomly selected participants in the Baltimore Memory Study, a longitudinal study of cognitive decline involving 1140 Baltimore residents aged 50 to 70 years. We measured total mercury in whole blood samples and used multiple linear regression to examine its associations with neurobehavioral test scores. First-visit data were obtained in 2001-2002. Main Outcome Measures Twenty scores from 12 neurobehavioral tests. Results The median blood mercury level was 2.1 mu g/L (range, 0-16 mu g/L). After adjustment for covariates, increasing blood mercury was associated with worse performance on Rey complex figure delayed recall, a test of visual memory (beta, -0.224; 95% confidence interval, -0.402 to -0.047). However, increasing blood mercury levels were associated with better performance on finger tapping, a test of manual dexterity (beta for dominant hand, 0.351; 95% confidence interval, 0.017-0.686). Conclusion Overall, the data do not provide strong evidence that blood mercury levels are associated with worse neurobehavioral performance in this population of older urban adults.	Johns Hopkins Med Inst, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; Kennedy Krieger Inst, Baltimore, MD USA; New York State Dept Hlth, Wadsworth Ctr, Trace Met Lab, Albany, NY USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Kennedy Krieger Institute; State University of New York (SUNY) System; Wadsworth Center	Weil, M (corresponding author), Assoc State & Terr Hlth Officials, 1275 K St NW,Suite 800, Washington, DC 20005 USA.	mweil@jhsph.edu	Parsons, Patrick/ABE-2655-2020; Parsons, Patrick J/I-2985-2015	Parsons, Patrick/0000-0001-9133-875X; Parsons, Patrick J/0000-0001-9133-875X; Glass, Thomas/0000-0003-4399-612X	NATIONAL INSTITUTE ON AGING [R01AG019604] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG19604] Funding Source: Medline; NIEHS NIH HHS [ES-07141] Funding Source: Medline; ODCDC CDC HHS [T42/CCT310419] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ODCDC CDC HHS		Agency for Toxic Substances and Disease Registry, 1999, TOX PROF MERC UPD; Ahlqwist M, 1999, ACTA ODONTOL SCAND, V57, P168; *AM DIAB ASS, SPEC TYP FAT; Bannon DI, 2001, CLIN CHEM, V47, P1703; Barbosa F, 2004, J ANAL ATOM SPECTROM, V19, P1000, DOI 10.1039/b400315b; Beuter A, 1998, NEUROTOXICOL TERATOL, V20, P581, DOI 10.1016/S0892-0362(98)00021-X; BLOCK G, 1986, AM J EPIDEMIOL, V124, P453, DOI 10.1093/oxfordjournals.aje.a114416; Block G, 1998, REVISION BLOCK DIETA; *BMDP STAT SOFTW I, 1991, POW AN SOLO; Breteler MMB, 1998, HAEMOSTASIS, V28, P167; CALNE DB, 1986, LANCET, V2, P1067, DOI 10.1016/S0140-6736(86)90469-1; *CDCP, 2003, 2 NAT CTR ENV HLTH; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Dolbec J, 2000, INT ARCH OCC ENV HEA, V73, P195, DOI 10.1007/s004200050027; Eto K, 2000, NEUROPATHOLOGY, V20, pS14; Ferraro FR, 2002, BRAIN COGNITION, V50, P139; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; GORMAN J, 2003, NY TIMES F      0729, P5; Guallar E, 2002, NEW ENGL J MED, V347, P1747, DOI 10.1056/NEJMoa020157; Haan MN, 1999, JAMA-J AM MED ASSOC, V282, P40, DOI 10.1001/jama.282.1.40; Halstead WC, 1985, HALSTEADREITAN NEURO; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Hightower JM, 2003, ENVIRON HEALTH PERSP, V111, P604, DOI 10.1289/ehp.5837; Johansson N, 2002, BIOMETALS, V15, P189, DOI 10.1023/A:1015202301127; JONES DP, 1992, NUTR CANCER, V17, P57, DOI 10.1080/01635589209514173; Kales SN, 2002, J OCCUP ENVIRON MED, V44, P143, DOI 10.1097/00043764-200202000-00009; Kaplan E, 2001, BOSTON NAMING TEST; KAPUR N, 1977, J STUD ALCOHOL, V38, P2025, DOI 10.15288/jsa.1977.38.2025; KERSHAW TG, 1980, ARCH ENVIRON HEALTH, V35, P28; Kleinbaum DG, 1998, APPL REGRESSION ANAL; *LAF INSTR CO, 1999, 32020 LAF INSTR CO; Lebel J, 1996, NEUROTOXICOLOGY, V17, P157; Lebel J, 1998, ENVIRON RES, V79, P20, DOI 10.1006/enrs.1998.3846; Lopez OL, 2003, ARCH NEUROL-CHICAGO, V60, P1394, DOI 10.1001/archneur.60.10.1394; MacKay AJ, 2002, J INT NEUROPSYCH SOC, V8, P764, DOI 10.1017/S1355617702860040; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940; National Academy of Sciences, 2000, TOX EFF METH; PHELPS RW, 1980, ARCH ENVIRON HEALTH, V35, P161, DOI 10.1080/00039896.1980.10667486; PLAISIER MK, 2005, COMMUNICATION   0131; RAINES B, 2003, HEALTH, P120; Raven J. C., 1965, COLOURED PROGR MATRI; RAVEN JC, 1965, MANUAL RAVENS COLOUR; Rice DC, 2003, RISK ANAL, V23, P107, DOI 10.1111/1539-6924.00294; Rice DC, 1996, NEUROTOXICOLOGY, V17, P583; Sadowski M, 2004, NEUROCHEM RES, V29, P1257, DOI 10.1023/B:NERE.0000023612.66691.e6; Schafer JH, 2005, J AM GERIATR SOC, V53, P381, DOI 10.1111/j.1532-5415.2005.53153.x; Schmidt M., 1996, W PSYCHOL SERVICES; Schober SE, 2003, JAMA-J AM MED ASSOC, V289, P1667, DOI 10.1001/jama.289.13.1667; Schwartz BS, 2004, ENVIRON HEALTH PERSP, V112, P314, DOI 10.1289/ehp.6727; SIMON JA, 1995, AM J EPIDEMIOL, V142, P469, DOI 10.1093/oxfordjournals.aje.a117662; Skoog I, 1997, BIOMED PHARMACOTHER, V51, P367, DOI 10.1016/S0753-3322(97)89428-0; Starr JM, 1999, CURR OPIN NEPHROL HY, V8, P347, DOI 10.1097/00041552-199905000-00012; UCHINO M, 1995, J ENVIRON SCI HEAL B, V30, P699, DOI 10.1080/03601239509372961; *US EPA, 2003, MERC FREQ ASK QUEST; *US EPA, NAT LIST FISH ADV FA; US FDA, 2001, RAT ISS REV ADV METH; Uttl B, 1997, J CLIN EXP NEUROPSYC, V19, P405, DOI 10.1080/01688639708403869; VALCIUKAS JA, 1980, ENVIRON RES, V21, P275, DOI 10.1016/0013-9351(80)90029-8; WEAVER V, 2003, J HOPK BLOOMB SCH PU; Weiss B, 2002, ENVIRON HEALTH PERSP, V110, P851, DOI 10.1289/ehp.02110s5851; Weiss B, 1996, NEUROTOXICOLOGY, V17, P257; WHO, 1990, METH; WILKINSON RT, 1982, HUM FACTORS, V24, P487, DOI 10.1177/001872088202400409; Yokoo Edna M, 2003, Environ Health, V2, P8, DOI 10.1186/1476-069X-2-8	64	69	76	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2005	293	15					1875	1882		10.1001/jama.293.15.1875	http://dx.doi.org/10.1001/jama.293.15.1875			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	916QW	15840862	Bronze			2022-12-24	WOS:000228401700026
J	Li, Y; Jia, YC; Cui, K; Li, N; Zheng, ZY; Wang, YZ; Yuan, XB				Li, Y; Jia, YC; Cui, K; Li, N; Zheng, ZY; Wang, YZ; Yuan, XB			Essential role of TRPC channels in the guidance of nerve growth cones by brain-derived neurotrophic factor	NATURE			English	Article							PHOSPHOLIPASE-C; CATION CHANNELS; AXON GUIDANCE; CELLS; RECEPTORS; ACTIVATION; INHIBITOR; CURRENTS; FAMILY; BDNF	Brain-derived neurotrophic factor ( BDNF) is known to promote neuronal survival and differentiation(1) and to guide axon extension both in vitro(2,3) and in vivo(4). The BDNF-induced chemoattraction of axonal growth cones requires Ca2+ signalling(3), but how Ca2+ is regulated by BDNF at the growth cone remains largely unclear. Extracellular application of BDNF triggers membrane currents resembling those through TRPC ( transient receptor potential canonical) channels in rat pontine neurons(5) and in Xenopus spinal neurons(6). Here, we report that in cultured cerebellar granule cells, TRPC channels contribute to the BDNF-induced elevation of Ca2+ at the growth cone and are required for BDNF-induced chemo-attractive turning. Several members of the TRPC family are highly expressed in these neurons, and both Ca2+ elevation and growth-cone turning induced by BDNF are abolished by pharmacological inhibition of TRPC channels, overexpression of a dominant-negative form of TRPC3 or TRPC6, or downregulation of TRPC3 expression via short interfering RNA. Thus, TRPC channel activity is essential for nerve-growth-cone guidance by BDNF.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Yuan, XB (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China.	yzwang@ion.ac.cn; yuanxb@ion.ac.cn		Yuan, Xiaobing/0000-0002-1632-8460; Jia, Yichang/0000-0002-7767-5714				Blum R, 2002, NATURE, V419, P687, DOI 10.1038/nature01085; Borghesani PR, 2002, DEVELOPMENT, V129, P1435; BURGESS GM, 1984, NATURE, V309, P63, DOI 10.1038/309063a0; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Groschner K, 1998, FEBS LETT, V437, P101, DOI 10.1016/S0014-5793(98)01212-5; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; LOHOF AM, 1992, J NEUROSCI, V12, P1253; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; PRENTKI M, 1984, NATURE, V309, P562, DOI 10.1038/309562a0; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; TAPLEY P, 1992, ONCOGENE, V7, P371; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Trebak M, 2003, CELL CALCIUM, V33, P451, DOI 10.1016/S0143-4160(03)00056-3; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; Yamada H, 2000, NEUROSCI LETT, V285, P111, DOI 10.1016/S0304-3940(00)01033-8; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895; Zitt C, 1997, J CELL BIOL, V138, P1333, DOI 10.1083/jcb.138.6.1333	29	352	379	2	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 14	2005	434	7035					894	898		10.1038/nature03477	http://dx.doi.org/10.1038/nature03477			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915SV	15758952				2022-12-24	WOS:000228327600040
J	Mistry, AR; Felix, CA; Whitmarsh, RJ; Mason, A; Reiter, A; Cassinat, B; Parry, A; Walz, C; Wiemels, JL; Segal, MR; Ades, L; Blair, IA; Osheroff, N; Peniket, AJ; Lafage-Pochitaloff, M; Cross, NCP; Chomienne, C; Solomon, E; Fenaux, P; Grimwade, D				Mistry, AR; Felix, CA; Whitmarsh, RJ; Mason, A; Reiter, A; Cassinat, B; Parry, A; Walz, C; Wiemels, JL; Segal, MR; Ades, L; Blair, IA; Osheroff, N; Peniket, AJ; Lafage-Pochitaloff, M; Cross, NCP; Chomienne, C; Solomon, E; Fenaux, P; Grimwade, D			DNA topoisomerase II in therapy-related acute promyelocytic leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BREAKPOINT CLUSTER REGION; BALANCED CHROMOSOME-ABERRATIONS; ACUTE MYELOID-LEUKEMIA; MYELODYSPLASTIC SYNDROMES; INTERNATIONAL WORKSHOP; TRANSLOCATION BREAKPOINTS; SECONDARY LEUKEMIA; CLEAVAGE; MLL; INHIBITORS	Background Chromosomal translocations leading to chimeric oncoproteins are important in leukemogenesis, but how they form is unclear. We studied acute promyelocytic leukemia (APL) with the t(15;17) translocation that developed after treatment of breast or laryngeal cancer with chemotherapeutic agents that poison topoisomerase II. Methods We used long-range polymerase chain reaction and sequence analysis to characterize t(15;17) genomic breakpoints in therapy-related APL. To determine whether topoisomerase II was directly involved in mediating breaks of double-stranded DNA at the observed translocation breakpoints, we used a functional in vitro assay to examine topoisomerase II-mediated cleavage in the normal homologues of the PML and RARA breakpoints. Results Translocation breakpoints in APL that developed after exposure to mitoxantrone, a topoisomerase II poison, were tightly clustered in an 8-bp region within PML intron 6. In functional assays, this ``hot spot'' and the corresponding RARA breakpoints were common sites of mitoxantrone-induced cleavage by topoisomerase II. Etoposide and doxorubicin also induced cleavage by topoisomerase II at the translocation breakpoints in APL arising after exposure to these agents. Short, homologous sequences in PML and RARA suggested the occurrence of DNA repair by means of the nonhomologous end-joining pathway. Conclusions Drug-induced cleavage of DNA by topoisomerase II mediates the formation of chromosomal translocation breakpoints in mitoxantrone-related APL and in APL that occurs after therapy with other topoisomerase II poisons.	Guys Kings & St Thomas Sch Med, Dept Med & Mol Genet, London, England; Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Univ Heidelberg, Fak Klin Med Mannheim, D-6800 Mannheim, Germany; Hop St Louis, Nucl Med Serv, Unite Biol Cellulaire, Paris, France; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Paris 13, Hop Avicenne, Bobigny, France; Univ Penn, Ctr Canc Pharmacol, Philadelphia, PA 19104 USA; Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; John Radcliffe Hosp, Dept Haematol, Oxford OX3 9DU, England; Inst J Paoli I Calmettes, INSERM, UMR 599, F-13009 Marseille, France; Univ Aix Marseille 2, Marseille, France; Wessex Reg Genet Lab, Salisbury, Wilts, England; UCL Hosp, Dept Haematol, London, England	University of London; King's College London; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Ruprecht Karls University Heidelberg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California San Francisco; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; University of Pennsylvania; Pennsylvania Medicine; Vanderbilt University; Vanderbilt University; University of Oxford; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; University College London Hospitals NHS Foundation Trust; University of London; University College London	Mistry, AR (corresponding author), Guys Hosp, Dept Med & Mol Genet, Canc Genet Lab, 8th Fl,Guys Tower, London SE1 9RT, England.	david.grimwade@genetics.kcl.ac.uk	CASSINAT, BRUNO/N-2752-2017; Cross, Nicholas/B-4817-2009; Blair, Ian A/B-3320-2010; Ades, lionel/T-6882-2019	CASSINAT, BRUNO/0000-0002-6514-3905; Cross, Nicholas/0000-0001-5481-2555; CHOMIENNE, Christine/0000-0001-5513-5752	NATIONAL CANCER INSTITUTE [R01CA080175, R01CA077683, R01CA089032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033944] Funding Source: NIH RePORTER; NCI NIH HHS [CA89032, R01 CA77683, R01 CA80175] Funding Source: Medline; NIGMS NIH HHS [GM33944] Funding Source: Medline; PHS HHS [R0185469] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ahuja HG, 2000, GENE CHROMOSOME CANC, V29, P96, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1013>3.0.CO;2-T; Andersen MK, 2002, GENE CHROMOSOME CANC, V33, P395, DOI 10.1002/gcc.10043; Aplan PD, 1996, BLOOD, V87, P2649, DOI 10.1182/blood.V87.7.2649.bloodjournal8772649; Beaumont M, 2003, J CLIN ONCOL, V21, P2123, DOI 10.1200/JCO.2003.09.072; Betti CJ, 2003, CANCER RES, V63, P1377; Betti CJ, 2001, CANCER RES, V61, P4550; Bloomfield CD, 2002, GENE CHROMOSOME CANC, V33, P362, DOI 10.1002/gcc.10046; Carli PM, 2000, LEUKEMIA, V14, P1014, DOI 10.1038/sj.leu.2401787; DOMER PH, 1995, LEUKEMIA, V9, P1305; DONG S, 1993, GENE CHROMOSOME CANC, V6, P133, DOI 10.1002/gcc.2870060302; Eguchi-Ishimae M, 2001, BLOOD, V97, P737, DOI 10.1182/blood.V97.3.737; Felix CA, 2001, MED PEDIATR ONCOL, V36, P525, DOI 10.1002/mpo.1125; Fortune JM, 2000, PROG NUCLEIC ACID RE, V64, P221, DOI 10.1016/S0079-6603(00)64006-0; GLAZ J, 1991, ADV APPL PROBAB, V23, P751; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Grimwade D, 2001, BEST PRACT RES CL HA, V14, P497, DOI 10.1053/beha.2001.0152; Grimwade D, 1996, BRIT J HAEMATOL, V94, P557; Kudo K, 1998, LEUKEMIA, V12, P1171, DOI 10.1038/sj.leu.2401089; Lovett BD, 2001, BIOCHEMISTRY-US, V40, P1159, DOI 10.1021/bi002361x; Lovett BD, 2001, P NATL ACAD SCI USA, V98, P9802, DOI 10.1073/pnas.171309898; Megonigal MD, 2000, P NATL ACAD SCI USA, V97, P2814, DOI 10.1073/pnas.050397097; Mistry AR, 2003, BLOOD REV, V17, P71, DOI 10.1016/S0268-960X(02)00075-9; NEGRINI M, 1993, CANCER RES, V53, P4489; PEDERSENBJERGAARD, 2002, BLOOD, V99, P1909; PEDERSENBJERGAARD, 1994, BLOOD, V83, P2780; Piazza F, 2001, ONCOGENE, V20, P7216, DOI 10.1038/sj.onc.1204855; Pulsoni A, 2002, BLOOD, V100, P1972, DOI 10.1182/blood-2001-12-0312; Reiter A, 2003, GENE CHROMOSOME CANC, V36, P175, DOI 10.1002/gcc.10154; Rowley JD, 2001, NAT REV CANCER, V1, P245, DOI 10.1038/35106108; Rowley JD, 2002, GENE CHROMOSOME CANC, V33, P331, DOI 10.1002/gcc.10040; Segal MR, 2002, J AM STAT ASSOC, V97, P66, DOI 10.1198/016214502753479239; Smith MA, 1999, J CLIN ONCOL, V17, P569, DOI 10.1200/JCO.1999.17.2.569; Smith SM, 2003, BLOOD, V102, P43, DOI 10.1182/blood-2002-11-3343; Stanulla M, 1997, MOL CELL BIOL, V17, P4070, DOI 10.1128/MCB.17.7.4070; Strissel PL, 1998, BLOOD, V92, P3793, DOI 10.1182/blood.V92.10.3793.422a24_3793_3803; Whitmarsh RJ, 2003, ONCOGENE, V22, P8448, DOI 10.1038/sj.onc.1207052; Zhang YM, 2002, P NATL ACAD SCI USA, V99, P3070, DOI 10.1073/pnas.042702899	38	215	220	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 14	2005	352	15					1529	1538		10.1056/NEJMoa042715	http://dx.doi.org/10.1056/NEJMoa042715			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	915SH	15829534				2022-12-24	WOS:000228324200005
J	Lima, SQ; Miesenbock, G				Lima, SQ; Miesenbock, G			Remote control of behavior through genetically targeted photostimulation of neurons	CELL			English	Article							DROSOPHILA NERVOUS-SYSTEM; ION CHANNELS; GIANT-FIBER; CAPSAICIN RECEPTOR; IDENTIFIED NEURONS; MAMMALIAN NEURONS; EXPRESSION; MELANOGASTER; DOPAMINE; MUTATIONS	Optically gated ion channels were expressed in circumscribed groups of neurons in the Drosophila CNS so that broad illumination of flies evoked action potentials only in genetically designated target cells. Flies harboring the "phototriggers" in different sets of neurons responded to laser light with behaviors specific to the sites of phototrigger expression. Photostimulation of neurons in the giant fiber system elicited the characteristic escape behaviors of jumping, wing beating, and flight; photostimulation of dopaminergic neurons caused changes in locomotor activity and locomotor patterns. These responses reflected the direct optical activation of central neuronal targets rather than confounding visual input, as they persisted unabated in carriers of a mutation that eliminates phototransduction. Encodable phototriggers provide noninvasive control interfaces for studying the connectivity and dynamics of neural circuits, for assigning behavioral content to neurons and their activity patterns, and, potentially, for restoring information corrupted by injury or disease.	Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Yale University	Miesenbock, G (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA.	gero.miesenboeck@yale.edu		Miesenboeck, Gero/0000-0003-2940-3228; Lima, Susana/0000-0003-2446-9869				Allen MJ, 1999, J NEUROSCI, V19, P9374; ARBUTHNOTT GW, 1975, EXP NEUROL, V47, P162, DOI 10.1016/0014-4886(75)90244-7; Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; BROADIE KS, 2000, DROSOPHILA PROTOCOLS, P273; Broughton SJ, 2004, CURR BIOL, V14, pR290, DOI 10.1016/j.cub.2004.03.037; BUCHNER E, 1991, J NEUROGENET, V7, P153, DOI 10.3109/01677069109167432; BUDNIK V, 1988, J COMP NEUROL, V268, P400, DOI 10.1002/cne.902680309; Burrows M., 1996, NEUROBIOLOGY INSECT; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Carlson SD, 2000, ANNU REV ENTOMOL, V45, P151, DOI 10.1146/annurev.ento.45.1.151; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; FARBER IC, 1983, SCIENCE, V222, P1025, DOI 10.1126/science.6648515; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; FORK RL, 1971, SCIENCE, V171, P907, DOI 10.1126/science.171.3974.907; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; GALVANI L, 1791, DEVIRIBUS ELECT MOTU; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hoang B, 2001, DEV BIOL, V229, P55, DOI 10.1006/dbio.2000.9983; HOTTA Y, 1970, P NATL ACAD SCI USA, V67, P1156, DOI 10.1073/pnas.67.3.1156; Jacobs K, 2000, DEVELOPMENT, V127, P5203; Johns DC, 1999, J NEUROSCI, V19, P1691; Kaczmarek LK, 1987, NEUROMODULATION BIOC; KAPLAN JH, 1978, BIOCHEMISTRY-US, V17, P1929, DOI 10.1021/bi00603a020; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; KOTO M, 1981, BRAIN RES, V221, P213, DOI 10.1016/0006-8993(81)90772-1; KUPFERMANN I, 1978, BEHAV BRAIN SCI, V1, P3, DOI 10.1017/S0140525X00059057; Kupfermann I, 2001, CURR OPIN NEUROBIOL, V11, P673, DOI 10.1016/S0959-4388(01)00267-7; Lechner HAE, 2002, J NEUROSCI, V22, P5287; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; Liu L, 1999, NATURE, V400, P753, DOI 10.1038/23456; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.3.CO;2-O; McClung C, 1998, CURR BIOL, V8, P109, DOI 10.1016/S0960-9822(98)70041-7; MCCRAY JA, 1989, ANNU REV BIOPHYS BIO, V18, P239, DOI 10.1146/annurev.biophys.18.1.239; MCKENNA M, 1989, P NATL ACAD SCI USA, V86, P8118, DOI 10.1073/pnas.86.20.8118; Miesenbock G, 2004, CURR OPIN NEUROBIOL, V14, P395, DOI 10.1016/j.conb.2004.05.004; Nakayama S, 1997, MOL GEN GENET, V254, P449, DOI 10.1007/s004380050438; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; PAK WL, 1970, NATURE, V227, P518, DOI 10.1038/227518b0; QUINN WG, 1984, ANNU REV NEUROSCI, V7, P67, DOI 10.1146/annurev.ne.07.030184.000435; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; SELVERSTON AI, 1985, ANNU REV PHYSIOL, V47, P29; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Slimko EM, 2002, J NEUROSCI, V22, P7373; Sun BH, 1999, P NATL ACAD SCI USA, V96, P10438, DOI 10.1073/pnas.96.18.10438; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; TANOUYE MA, 1980, J NEUROPHYSIOL, V44, P405, DOI 10.1152/jn.1980.44.2.405; TEMPEL BL, 1984, P NATL ACAD SCI-BIOL, V81, P3577, DOI 10.1073/pnas.81.11.3577; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; THOMAS JB, 1982, NATURE, V298, P650, DOI 10.1038/298650a0; THOMAS JB, 1984, J NEUROSCI, V4, P530; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Trimarchi JR, 1999, INT REV NEUROBIOL, V43, P241, DOI 10.1016/S0074-7742(08)60548-6; TRIMARCHI JR, 1995, J COMP PHYSIOL A, V176, P355, DOI 10.1007/BF00219061; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; WIERSMA CAG, 1964, COMP BIOCHEM PHYSIOL, V12, P509, DOI 10.1016/0010-406X(64)90153-7; Wyman R.J., 1984, P133; Yasuyama K, 1999, MICROSC RES TECHNIQ, V45, P65, DOI 10.1002/(SICI)1097-0029(19990415)45:2<65::AID-JEMT2>3.0.CO;2-0; Yellman C, 1997, P NATL ACAD SCI USA, V94, P4131, DOI 10.1073/pnas.94.8.4131; Zemelman BV, 2003, P NATL ACAD SCI USA, V100, P1352, DOI 10.1073/pnas.242738899; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zemelman BV, 2001, CURR OPIN NEUROBIOL, V11, P409, DOI 10.1016/S0959-4388(00)00227-0	69	384	427	1	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 8	2005	121	1					141	152		10.1016/j.cell.2005.02.004	http://dx.doi.org/10.1016/j.cell.2005.02.004			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	915YU	15820685	Bronze			2022-12-24	WOS:000228348500016
J	Pan, H; Yan, BS; Rojas, M; Shebzukhov, YV; Zhou, HW; Kobzik, L; Higgins, DE; Daly, MJ; Bloom, BR; Kramnik, I				Pan, H; Yan, BS; Rojas, M; Shebzukhov, YV; Zhou, HW; Kobzik, L; Higgins, DE; Daly, MJ; Bloom, BR; Kramnik, I			Ipr1 gene mediates innate immunity to tuberculosis	NATURE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; RECEPTOR; MICE; INFECTION; PROTEIN; SUSCEPTIBILITY; SUBSTRAINS; EXPRESSION; RESISTANCE; EVOLUTION	An estimated eight million people are infected each year with the pathogen Mycobacterium tuberculosis, and more than two million die annually(1). Yet only about 10% of those infected develop tuberculosis. Genetic variation within host populations is known to be significant in humans and animals(2,3), but the nature of genetic control of host resistance to tuberculosis remains poorly understood. Previously we mapped a new genetic locus on mouse chromosome 1, designated sst1 (for supersusceptibility to tuberculosis 1)(4). Here we show that this locus mediates innate immunity in sst1 congenic mouse strains and identify a candidate gene, Intracellular pathogen resistance 1 (Ipr1), within the sst1 locus. The Ipr1 gene is upregulated in the sst1 resistant macrophages after activation and infection, but it is not expressed in the sst1 susceptible macrophages. Expression of the Ipr1 transgene in the sst1 susceptible macrophages limits the multiplication not only of M. tuberculosis but also of Listeria monocytogenes and switches a cell death pathway of the infected macrophages from necrosis to apoptosis. Our data indicate that the Ipr1 gene product might have a previously undocumented function in integrating signals generated by intracellular pathogens with mechanisms controlling innate immunity, cell death and pathogenesis.	Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Physiol Program, Boston, MA 02115 USA; Univ Antioquia, Fac Med, Grp Inmunol Celular & Inmunogenet, Medellin, Colombia; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Universidad de Antioquia; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute	Kramnik, I (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 667 Huntington Ave, Boston, MA 02115 USA.	ikramnik@hsph.harvard.edu	Daly, Mark J/B-2453-2017; Rojas Lopez, Mauricio/P-4924-2018	Daly, Mark J/0000-0002-0949-8752; Kramnik, Igor/0000-0001-6511-9246; Yan, Bo-Shiun/0000-0002-9613-4788; Rojas Lopez, Mauricio/0000-0002-7791-9328	NIAID NIH HHS [R01 AI049421] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049421] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AGULNIK S, 1993, MAMM GENOME, V4, P704, DOI 10.1007/BF00357793; Bellamy R, 2000, P NATL ACAD SCI USA, V97, P8005, DOI 10.1073/pnas.140201897; Bleed D, 2000, Curr Opin Pulm Med, V6, P174, DOI 10.1097/00063198-200005000-00002; Bloch DB, 2000, MOL CELL BIOL, V20, P6138, DOI 10.1128/MCB.20.16.6138-6146.2000; Bloom BR, 2002, NEW ENGL J MED, V346, P1434, DOI 10.1056/NEJM200205093461902; Bottomley MJ, 2001, NAT STRUCT BIOL, V8, P626, DOI 10.1038/89675; Boyartchuk V, 2004, J IMMUNOL, V173, P5112, DOI 10.4049/jimmunol.173.8.5112; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Castrillo A, 2004, ANNU REV CELL DEV BI, V20, P455, DOI 10.1146/annurev.cellbio.20.012103.134432; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Cosma CL, 2003, ANNU REV MICROBIOL, V57, P641, DOI 10.1146/annurev.micro.57.030502.091033; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Hofmann TG, 2003, CELL DEATH DIFFER, V10, P1290, DOI 10.1038/sj.cdd.4401313; HORVAI A, 1995, P NATL ACAD SCI USA, V92, P5391, DOI 10.1073/pnas.92.12.5391; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; KADEREIT S, 1993, J BIOL CHEM, V268, P24432; Kamath AB, 2003, INFECT IMMUN, V71, P4112, DOI 10.1128/IAI.71.7.4112-4118.2003; Kramnik I, 1998, NOVART FDN SYMP, V217, P120, DOI 10.1002/0470846526.ch9; Kramnik I, 2000, P NATL ACAD SCI USA, V97, P8560, DOI 10.1073/pnas.150227197; KROG HH, 1978, J HERED, V69, P66, DOI 10.1093/oxfordjournals.jhered.a108905; Lo Surdo P, 2003, MOL ENDOCRINOL, V17, P1283, DOI 10.1210/me.2002-0409; Nicewonger J, 2004, J VIROL, V78, P9412, DOI 10.1128/JVI.78.17.9412-9422.2004; Raviglione MC, 2003, TUBERCULOSIS, V83, P4, DOI 10.1016/S1472-9792(02)00071-9; Saito T, 2004, BIOCHEM BIOPH RES CO, V317, P335, DOI 10.1016/j.bbrc.2004.03.056; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; Taylor JL, 2003, INFECT IMMUN, V71, P2192, DOI 10.1128/IAI.71.4.2192-2198.2003; Traut W, 2001, CHROMOSOMA, V110, P247, DOI 10.1007/s004120100152; Wasylyk C, 2002, MOL CELL BIOL, V22, P2687, DOI 10.1128/MCB.22.8.2687-2702.2002; Watashi K, 2003, MOL CELL BIOL, V23, P7498, DOI 10.1128/MCB.23.21.7498-7509.2003; Weichenhan D, 2001, MAMM GENOME, V12, P590, DOI 10.1007/s00335-001-3015-9	30	324	351	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2005	434	7034					767	772		10.1038/nature03419	http://dx.doi.org/10.1038/nature03419			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	913NU	15815631	Green Accepted			2022-12-24	WOS:000228160700042
J	Luo, ZX; Wible, JR				Luo, ZX; Wible, JR			A Late Jurassic digging mammal and early mammalian diversification	SCIENCE			English	Article							EVOLUTION; CHINA	A fossil mammal from the Late Jurassic Morrison Formation, Colorado, has highly specialized teeth similar to those of xenarthran and tubulidentate placental mammals and different from the generalized insectivorous or omnivorous dentitions of other Jurassic mammals. It has many forelimb features specialized for digging, and its lumbar vertebrae show xenarthrous articulations. Parsimony analysis suggests that this fossil represents a separate basal mammalian lineage with some dental and vertebral convergences to those of modern xenarthran placentals, and reveals a previously unknown ecomorph of early mammals.	Carnegie Museum Nat Hist, Pittsburgh, PA 15213 USA		Luo, ZX (corresponding author), Carnegie Museum Nat Hist, Pittsburgh, PA 15213 USA.	luoz@carnegiemnh.org	Luo, Zhe-XI/AAU-2263-2021					Gaudin Timothy J., 1999, Fieldiana Geology, V41, P1; GAUDIN TJ, 1992, J MORPHOL, V214, P63, DOI 10.1002/jmor.1052140105; Gow C. E., 2001, Palaeontologia Africana, V37, P93; Hildebrand M., 1985, P89; Hu Yaoming, 1998, Vertebrata Palasiatica, V36, P102; Hu YM, 1997, NATURE, V390, P137, DOI 10.1038/36505; JENKINS FA, 1976, PHILOS T ROY SOC B, V273, P387, DOI 10.1098/rstb.1976.0022; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; Ji Q, 1999, NATURE, V398, P326; Kielan-Jaworowska Z., 2005, MAMMALS AGE DINOSAUR; Kielan-Jaworowska Zofia, 1994, Fossils and Strata, V36, P1; KRAUSE D W, 1983, Bulletin of the Museum of Comparative Zoology, V150, P199; Krebs B., 1991, Berliner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V133, P1; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Luo ZX, 2003, SCIENCE, V302, P1934, DOI 10.1126/science.1090718; Luo ZX, 2002, ACTA PALAEONTOL POL, V47, P1; Luo ZX, 2001, SCIENCE, V292, P1535, DOI 10.1126/science.1058476; LUO ZX, IN PRESS J MAMM EVOL; Martin T, 2000, GUIMAROTA JURASSIC E; McKenna MC, 1997, CLASSIFICATION MAMMA; MCLEOD N, 1993, AM J SCI, V293, P300; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Novacek MJ, 1997, NATURE, V389, P483, DOI 10.1038/39020; Nowak R.M., 1983, WALKERS MAMMALS WORL; Prothero DR, 1981, B AM MUS NAT HIST, V167, P277; ROSE KD, 1993, MAMMAL PHYLOGENY : PLACENTALS, P81; ROSE KD, 1999, ENCY PALEONTOLOGY, V1, P220; Rougier GW, 2003, ACTA GEOL SIN-ENGL, V77, P7; Rougier GW, 1998, NATURE, V396, P459, DOI 10.1038/24856; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; SIMPSON GEORGE GAYLORD, 1929, MEM PEABODY MUS YALE UNIV, V3, P1; SUES HD, 1983, THESIS HARVARD U; Swofford D. L., 2000, PAUP PHYLOGENETIC AN; Szalay F.S., 1994, EVOLUTIONARY HIST MA; Weil A, 2002, NATURE, V416, P798, DOI 10.1038/416798a	35	146	161	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2005	308	5718					103	107		10.1126/science.1108875	http://dx.doi.org/10.1126/science.1108875			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914IQ	15802602				2022-12-24	WOS:000228221500042
J	Zatz, M				Zatz, M			When science is not enough: Fighting genetic disease in Brazil	SCIENCE			English	Editorial Material									Univ Sao Paulo, Biosci Inst, BR-05508090 Sao Paulo, Brazil	Universidade de Sao Paulo	Zatz, M (corresponding author), Univ Sao Paulo, Biosci Inst, Rua Matao 277,Sala 211, BR-05508090 Sao Paulo, Brazil.		Zatz, Mayana/M-5338-2015	Zatz, Mayana/0000-0003-3970-8025					0	5	5	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2005	308	5718					55	57		10.1126/science.1111730	http://dx.doi.org/10.1126/science.1111730			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914IQ	15802588				2022-12-24	WOS:000228221500026
J	Parker, JS; Roe, SM; Barford, D				Parker, JS; Roe, SM; Barford, D			Structural insights into mRNA recognition from a PIWI domain-siRNA guide complex	NATURE			English	Article							CRYSTAL-STRUCTURE; MICRORNA; ARGONAUTE2; INTERFERENCE; MECHANISMS; CLEAVAGE	RNA interference and related RNA silencing phenomena use short antisense guide RNA molecules to repress the expression of target genes(1,2). Argonaute proteins(3), containing amino-terminal PAZ (for PIWI/Argonaute/Zwille) domains and carboxy-terminal PIWI domains, are core components of these mechanisms. Here we show the crystal structure of a Piwi protein from Archaeoglobus fulgidus (AfPiwi) in complex with a small interfering RNA (siRNA)-like duplex, which mimics the 5 ' end of a guide RNA strand bound to an overhanging target messenger RNA. The structure contains a highly conserved metal-binding site that anchors the 5 ' nucleotide of the guide RNA. The first base pair of the duplex is unwound, separating the 5 ' nucleotide of the guide from the complementary nucleotide on the target strand, which exits with the 3 ' overhang through a short channel. The remaining base-paired nucleotides assume an A-form helix, accommodated within a channel in the PIWI domain, which can be extended to place the scissile phosphate of the target strand adjacent to the putative slicer catalytic site. This study provides insights into mechanisms of target mRNA recognition and cleavage by an Argonaute-siRNA guide complex.	Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Barford, D (corresponding author), Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, 237 Fulham Rd, London SW3 6JB, England.	david.barford@icr.ac.uk		Roe, Mark/0000-0002-7371-9855	Wellcome Trust [074543] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chiu YL, 2002, MOL CELL, V10, P549, DOI 10.1016/S1097-2765(02)00652-4; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Sontheimer EJ, 2005, NAT REV MOL CELL BIO, V6, P127, DOI 10.1038/nrm1568; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129	30	371	408	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2005	434	7033					663	666		10.1038/nature03462	http://dx.doi.org/10.1038/nature03462			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911NN	15800628	Green Accepted			2022-12-24	WOS:000228011000049
J	Beuvink, I; Boulay, A; Fumagalli, S; Zilbermann, F; Ruetz, S; O'Reilly, T; Natt, F; Hall, J; Lane, HA; Thomas, G				Beuvink, I; Boulay, A; Fumagalli, S; Zilbermann, F; Ruetz, S; O'Reilly, T; Natt, F; Hall, J; Lane, HA; Thomas, G			The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation	CELL			English	Article							INDUCED G(1) ARREST; P53 GENE-MUTATIONS; CDK INHIBITOR; GROWTH ARREST; CANCER; ACTIVATION; CISPLATIN; KINASE; TARGET; MYC	Although DNA damaging agents have revolutionized chemotherapy against solid tumors, a narrow therapeutic window combined with severe side effects has limited their broader use. Here we show that RAD001 (everolimus), a rapamycin derivative, dramatically enhances cisplatin-induced apoptosis in wild-type p53, but not mutant p53 tumor cells. The use of isogenic tumor cell lines expressing either wild-type mTOR cDNA or a mutant that does not bind RAD001 demonstrates that the effects of RAD001 are through inhibition of mTOR function. We further show that RAD001 sensitizes cells to cisplatin by inhibiting p53-induced p21 expression. Unexpectedly, this effect is attributed to a small but significant inhibition of p2l translation combined with its short half-life. These findings provide the molecular rationale for combining DNA damaging agents with RAD001, showing that a general effect on a major anabolic process may dramatically enhance the efficacy of an established drug protocol in the treatment of cancer patients with solid tumors.	Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; Novartis Pharma AG, Novartis Inst Biomed Res, CH-4002 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Novartis	Lane, HA (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66,POB 2543, CH-4058 Basel, Switzerland.	heidi.lane@pharma.novartis.com; gthomas@fmi.ch	FUMAGALLI, Stefano/C-2914-2019; Thomas, George/K-9235-2014	Thomas, George/0000-0003-3518-8149; Hall, Jonathan/0000-0003-4160-7135; Fumagalli, Stefano/0000-0001-5832-8680				Bartek J, 2001, FEBS LETT, V490, P117, DOI 10.1016/S0014-5793(01)02114-7; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; Boulay A, 2004, CANCER RES, V64, P252, DOI 10.1158/0008-5472.CAN-3554-2; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Decker T, 2003, BLOOD, V101, P278, DOI 10.1182/blood-2002-01-0189; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Dutcher Janice P, 2004, Curr Oncol Rep, V6, P111, DOI 10.1007/s11912-004-0022-5; El-Deiry WS, 2003, ONCOGENE, V22, P7486, DOI 10.1038/sj.onc.1206949; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fan SJ, 1997, ONCOGENE, V14, P2127, DOI 10.1038/sj.onc.1201052; FAN SJ, 1994, CANCER RES, V54, P5824; Fumagalli S, 2000, COLD SPRING HARBOR M, V39, P695; Gaben AM, 2004, INT J CANCER, V108, P200, DOI 10.1002/ijc.11521; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gartel AL, 2002, MOL CANCER THER, V1, P639; Gervais JLM, 1998, J BIOL CHEM, V273, P19207, DOI 10.1074/jbc.273.30.19207; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Huang S, 2003, MOL CELL, V11, P1491, DOI 10.1016/S1097-2765(03)00180-1; Huang S, 2003, CURR OPIN PHARMACOL, V3, P371, DOI 10.1016/S1471-4892(03)00071-7; Huang SL, 2003, CANCER BIOL THER, V2, P222, DOI 10.4161/cbt.2.3.360; Huang SL, 2001, CANCER RES, V61, P3373; Jaeschke A, 2003, CURR TOP MICROBIOL, V279, P283; Jaeschke A, 2002, J CELL BIOL, V159, P217, DOI 10.1083/jcb.jcb.200206108; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kralj M, 2003, CANCER GENE THER, V10, P457, DOI 10.1038/sj.cgt.7700588; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; LI R, 1994, NATURE, V371, P534, DOI 10.1038/371534a0; Liu ZM, 2004, ONCOGENE, V23, P503, DOI 10.1038/sj.onc.1207173; Luan FL, 2002, TRANSPLANTATION, V73, P1565, DOI 10.1097/00007890-200205270-00008; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Marygold SJ, 2002, CURR BIOL, V12, pR785, DOI 10.1016/S0960-9822(02)01294-0; McCormick F, 2004, NATURE, V428, P267, DOI 10.1038/428267a; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; Owa T, 2001, CURR MED CHEM, V8, P1487, DOI 10.2174/0929867013371996; Panwalkar A, 2004, CANCER-AM CANCER SOC, V100, P657, DOI 10.1002/cncr.20026; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Prendergast GC, 2003, CANCER CELL, V4, P244, DOI 10.1016/S1535-6108(03)00247-2; Proud CG, 2003, CURR TOP MICROBIOL, V279, P215; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Segal-Bendirdjian E, 1998, CELL DEATH DIFFER, V5, P390, DOI 10.1038/sj.cdd.4400357; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; SHI YF, 1995, CANCER RES, V55, P1982; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Soussi T, 2000, HUM MUTAT, V15, P105, DOI 10.1002/(SICI)1098-1004(200001)15:1<105::AID-HUMU19>3.0.CO;2-G; Suzuki A, 1998, ONCOGENE, V17, P931, DOI 10.1038/sj.onc.1202021; Tian H, 2000, CANCER RES, V60, P679; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Vousden KH, 2002, CANCER CELL, V2, P351, DOI 10.1016/S1535-6108(02)00186-1; Weiss RH, 2003, CANCER CELL, V4, P425, DOI 10.1016/S1535-6108(03)00308-8; Weiss RH, 2003, CANCER LETT, V189, P39, DOI 10.1016/S0304-3835(02)00495-0; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Woods DB, 2001, EXP CELL RES, V264, P56, DOI 10.1006/excr.2000.5141; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zhang YK, 1999, ONCOGENE, V18, P1131, DOI 10.1038/sj.onc.1202426	57	423	437	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 25	2005	120	6					747	759		10.1016/j.cell.2004.12.040	http://dx.doi.org/10.1016/j.cell.2004.12.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	912HF	15797377	Bronze			2022-12-24	WOS:000228067500006
J	Dong, XH; Li, H; Derdowski, A; Ding, LM; Burnett, A; Chen, XM; Peters, TR; Dermody, TS; Woodruff, E; Wang, JJ; Spearman, P				Dong, XH; Li, H; Derdowski, A; Ding, LM; Burnett, A; Chen, XM; Peters, TR; Dermody, TS; Woodruff, E; Wang, JJ; Spearman, P			AP-3 directs the intracellular trafficking of HIV-1 Gag and plays a key role in particle assembly	CELL			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HERMANSKY-PUDLAK-SYNDROME; ENVELOPE GLYCOPROTEIN; PATHWAY REQUIRES; PLASMA-MEMBRANE; PROTEIN COMPLEX; DOMAIN; TRANSPORT; BINDING; TSG101	Gag proteins direct the process of retroviral particle assembly and form the major protein constituents of the viral core. The matrix region of the HIV-1 Gag polyprotein plays a critical role in the transport of Gag to the plasma membrane assembly site. Recent evidence indicates that Gag trafficking to late endosomal compartments, including multivesicular bodies, occurs prior to viral particle budding from the plasma membrane. Here we demonstrate that the matrix region of HIV-1 Gag interacts directly with the 6 subunit of the AP-3 complex, and that this interaction plays an important functional role in particle assembly. Disruption of this interaction eliminated Gag trafficking to multivesicular bodies and diminished HIV particle formation. These studies illuminate an early step in retroviral particle assembly and provide evidence that the trafficking of Gag to late endosomes is part of a productive particle assembly pathway.	Vanderbilt Univ, Dept Pediat, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; Fu Jen Catholic Univ, Dept Cell Biol, Taipei, Taiwan	Vanderbilt University; Vanderbilt University; Fu Jen Catholic University	Spearman, P (corresponding author), Vanderbilt Univ, Dept Pediat, 221 Kirkland Hall, Nashville, TN 37232 USA.	paul.spearman@vanderbilt.edu		Burnett, Atuhani/0000-0003-3276-3697	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040338, R01AI032539, R21AI055441, P30AI054999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, P30DK058404] Funding Source: NIH RePORTER; NCI NIH HHS [CA68485] Funding Source: Medline; NIAID NIH HHS [P30 AI054999, R21 AI055441, R01 AI40338, R01 AI32539] Funding Source: Medline; NICHD NIH HHS [HD15052] Funding Source: Medline; NIDDK NIH HHS [DK58404, DK20593] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Berlioz-Torrent C, 1999, J VIROL, V73, P1350, DOI 10.1128/JVI.73.2.1350-1361.1999; Boehm M, 2002, GENE, V286, P175, DOI 10.1016/S0378-1119(02)00422-5; Boge M, 1998, J BIOL CHEM, V273, P15773, DOI 10.1074/jbc.273.25.15773; Clark RH, 2003, NAT IMMUNOL, V4, P1111, DOI 10.1038/ni1000; Darsow T, 2001, MOL BIOL CELL, V12, P37, DOI 10.1091/mbc.12.1.37; Dell'Angelica EC, 2000, J BIOL CHEM, V275, P1300, DOI 10.1074/jbc.275.2.1300; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; Derdowski A, 2004, J VIROL, V78, P1230, DOI 10.1128/JVI.78.3.1230-1242.2004; FACKE M, 1993, J VIROL, V67, P4972; FRANKE EK, 1994, NATURE, V372, P359, DOI 10.1038/372359a0; Freedman BI, 1998, AM J HYPERTENS, V11, P251, DOI 10.1016/S0895-7061(97)00481-0; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Gould SJ, 2003, P NATL ACAD SCI USA, V100, P10592, DOI 10.1073/pnas.1831413100; Huang Y, 2001, J VIROL, V75, P4947, DOI 10.1128/JVI.75.10.4947-4951.2001; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Le Borgne R, 1998, J BIOL CHEM, V273, P29451, DOI 10.1074/jbc.273.45.29451; Lindwasser OW, 2004, J VIROL, V78, P6013, DOI 10.1128/JVI.78.11.6013-6023.2004; Luban J, 2001, NAT MED, V7, P1278, DOI 10.1038/nm1201-1278; Martin-Serrano J, 2003, J VIROL, V77, P4794, DOI 10.1128/JVI.77.8.4794-4804.2003; Nakatsu F, 2003, CELL STRUCT FUNCT, V28, P419, DOI 10.1247/csf.28.419; Nguyen DG, 2003, J BIOL CHEM, V278, P52347, DOI 10.1074/jbc.M309009200; Nydegger S, 2003, TRAFFIC, V4, P902, DOI 10.1046/j.1600-0854.2003.00145.x; Ohno H, 1997, VIROLOGY, V238, P305, DOI 10.1006/viro.1997.8839; Ono A, 2004, J VIROL, V78, P1552, DOI 10.1128/JVI.78.3.1552-1563.2004; Ono A, 1999, J VIROL, V73, P4136, DOI 10.1128/JVI.73.5.4136-4144.1999; Ono A, 1997, J VIROL, V71, P4409, DOI 10.1128/JVI.71.6.4409-4418.1997; Ono A, 2000, J VIROL, V74, P2855, DOI 10.1128/JVI.74.6.2855-2866.2000; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; PEVSNER J, 1994, GENE, V146, P279, DOI 10.1016/0378-1119(94)90306-9; Pornillos O, 2003, J CELL BIOL, V162, P425, DOI 10.1083/jcb.200302138; Raposo G, 2002, TRAFFIC, V3, P718, DOI 10.1034/j.1600-0854.2002.31004.x; Rehling P, 1999, NAT CELL BIOL, V1, P346, DOI 10.1038/14037; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Rous BA, 2002, MOL BIOL CELL, V13, P1071, DOI 10.1091/mbc.01-08-0409; Sandefur S, 2000, J VIROL, V74, P7238, DOI 10.1128/JVI.74.16.7238-7249.2000; Schneider S, 1996, BIOTECHNIQUES, V20, P960; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Simpson F, 1996, J CELL BIOL, V133, P749, DOI 10.1083/jcb.133.4.749; Simpson F, 1997, J CELL BIOL, V137, P835, DOI 10.1083/jcb.137.4.835; SPEARMAN P, 1994, J VIROL, V68, P3232, DOI 10.1128/JVI.68.5.3232-3242.1994; Starcevic M, 2002, SEMIN CELL DEV BIOL, V13, P271, DOI 10.1016/S1084952102000563; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Varthakavi V, 2002, VIROLOGY, V297, P270, DOI 10.1006/viro.2002.1434; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Wang JJ, 2001, APPL IMMUNOHISTO M M, V9, P371, DOI 10.1097/00022744-200112000-00014; WILLS JW, 1991, AIDS, V5, P639, DOI 10.1097/00002030-199106000-00002; Wodrich H, 2000, NUCLEIC ACIDS RES, V28, P901, DOI 10.1093/nar/28.4.901; YU XF, 1992, J VIROL, V66, P4966, DOI 10.1128/JVI.66.8.4966-4971.1992	52	187	201	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 11	2005	120	5					663	674		10.1016/j.cell.2004.12.023	http://dx.doi.org/10.1016/j.cell.2004.12.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766529	Bronze			2022-12-24	WOS:000227771400012
J	Hegi, ME; Diserens, A; Gorlia, T; Hamou, M; de Tribolet, N; Weller, M; Kros, JM; Hainfellner, JA; Mason, W; Mariani, L; Bromberg, JEC; Hau, P; Mirimanoff, RO; Cairncross, JG; Janzer, RC; Stupp, R				Hegi, ME; Diserens, A; Gorlia, T; Hamou, M; de Tribolet, N; Weller, M; Kros, JM; Hainfellner, JA; Mason, W; Mariani, L; Bromberg, JEC; Hau, P; Mirimanoff, RO; Cairncross, JG; Janzer, RC; Stupp, R			MGMT gene silencing and benefit from temozolomide in glioblastoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; PROMOTER HYPERMETHYLATION; MALIGNANT GLIOMA; MISMATCH REPAIR; ALKYLTRANSFERASE; METHYLATION; SURVIVAL; CANCER; PROGRESSION; CARMUSTINE	BACKGROUND: Epigenetic silencing of the MGMT (O(sup 6)-methylguanine-DNA methyltransferase) DNA-repair gene by promoter methylation compromises DNA repair and has been associated with longer survival in patients with glioblastoma who receive alkylating agents. METHODS: We tested the relationship between MGMT silencing in the tumor and the survival of patients who were enrolled in a randomized trial comparing radiotherapy alone with radiotherapy combined with concomitant and adjuvant treatment with temozolomide. The methylation status of the MGMT promoter was determined by methylation-specific polymerase-chain-reaction analysis. RESULTS: The MGMT promoter was methylated in 45 percent of 206 assessable cases. Irrespective of treatment, MGMT promoter methylation was an independent favorable prognostic factor (P<0.001 by the log-rank test; hazard ratio, 0.45; 95 percent confidence interval, 0.32 to 0.61). Among patients whose tumor contained a methylated MGMT promoter, a survival benefit was observed in patients treated with temozolomide and radiotherapy; their median survival was 21.7 months (95 percent confidence interval, 17.4 to 30.4), as compared with 15.3 months (95 percent confidence interval, 13.0 to 20.9) among those who were assigned to only radiotherapy (P=0.007 by the log-rank test). In the absence of methylation of the MGMT promoter, there was a smaller and statistically insignificant difference in survival between the treatment groups. CONCLUSIONS: Patients with glioblastoma containing a methylated MGMT promoter benefited from temozolomide, whereas those who did not have a methylated MGMT promoter did not have such a benefit.	Univ Lausanne Hosp, Dept Neurosurg, Lab Tumor Biol & Genet, Lausanne, Switzerland; Univ Lausanne Hosp, Dept Radiotherapy, Lausanne, Switzerland; Univ Lausanne Hosp, Dept Neuropathol, Lausanne, Switzerland; Univ Lausanne Hosp, Multidisciplinary Oncol Ctr, Lausanne, Switzerland; Univ Hosp Geneva, Dept Neurosurg, Geneva, Switzerland; Swiss Inst Expt Canc Res, Natl Ctr Competence Res Mol Oncol, CH-1066 Epalinges, Switzerland; Univ Bern, Inselspital, Dept Neurosurg, CH-3010 Bern, Switzerland; European Org Res Treatment Canc, Ctr Data, Brussels, Belgium; Univ Tubingen, Dept Neurol, D-7400 Tubingen, Germany; Univ Regensburg, Dept Neurol, D-8400 Regensburg, Germany; Univ Rotterdam Hosp, Div Neuropathol, Rotterdam, Netherlands; Univ Med Ctr, Utrecht, Netherlands; Med Univ Vienna, Inst Neurol, Vienna, Austria; Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada; Univ Calgary, Calgary, AB, Canada	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; Swiss Institute Experimental Cancer Research; University of Bern; University Hospital of Bern; European Organisation for Research & Treatment of Cancer; Eberhard Karls University of Tubingen; University of Regensburg; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Medical University of Vienna; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Calgary	Hegi, ME (corresponding author), CHU Vaudois, Dept Neurosurg, Lab Tumor Biol & Genet, BH19-110, CH-1011 Lausanne, Switzerland.	monika.hegi@chuv.hospvd.ch	Mariani, Luigi/AAB-9464-2019; Stupp, Roger/L-3303-2019; Hegi, Monika/O-4796-2015	Hegi, Monika/0000-0003-0855-6495; Weller, Michael/0000-0002-1748-174X				Belanich M, 1996, CANCER RES, V56, P783; Esteller M, 2000, NEW ENGL J MED, V343, P1740; Esteller M, 1999, CANCER RES, V59, P793; Friedman HS, 2000, J CLIN ONCOL, V18, P3522, DOI 10.1200/JCO.2000.18.20.3522; Friedman HS, 1998, J CLIN ONCOL, V16, P3851, DOI 10.1200/JCO.1998.16.12.3851; FRITZ G, 1991, MOL CELL BIOL, V11, P4660, DOI 10.1128/MCB.11.9.4660; Gerson SL, 2004, NAT REV CANCER, V4, P296, DOI 10.1038/nrc1319; Gorlia T, 2004, J CLIN ONCOL, V22, p859S; Grombacher T, 1996, CARCINOGENESIS, V17, P2329, DOI 10.1093/carcin/17.11.2329; Hegi ME, 2004, CLIN CANCER RES, V10, P1871, DOI 10.1158/1078-0432.CCR-03-0384; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; HOTTA T, 1994, J NEURO-ONCOL, V21, P135, DOI 10.1007/BF01052897; Jaeckle KA, 1998, J CLIN ONCOL, V16, P3310, DOI 10.1200/JCO.1998.16.10.3310; Komine C, 2003, BRAIN PATHOL, V13, P176; Liu LL, 1996, CANCER RES, V56, P5375; Ochs K, 2000, CANCER RES, V60, P5815; Palmisano WA, 2000, CANCER RES, V60, P5954; Qian XLC, 1997, CANCER RES, V57, P3672; QUINN J, 2003, P AN M AM SOC CLIN, V22, P103; Silber JR, 1999, CLIN CANCER RES, V5, P807; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Watts GS, 1997, MOL CELL BIOL, V17, P5612, DOI 10.1128/MCB.17.9.5612	22	4819	5024	9	399	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2005	352	10					997	1003		10.1056/NEJMoa043331	http://dx.doi.org/10.1056/NEJMoa043331			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904JC	15758010	Green Published			2022-12-24	WOS:000227491200008
J	Moqrich, A; Hwang, SW; Earley, TJ; Petrus, MJ; Murray, AN; Spencer, KSR; Andahazy, M; Story, GM; Patapoutian, A				Moqrich, A; Hwang, SW; Earley, TJ; Petrus, MJ; Murray, AN; Spencer, KSR; Andahazy, M; Story, GM; Patapoutian, A			Impaired thermosensation in mice lacking TRPV3, a heat and camphor sensor in the skin	SCIENCE			English	Article							ION-CHANNEL; 2-AMINOETHOXYDIPHENYL BORATE; THERMAL HYPERALGESIA; NERVE-FIBERS; RECEPTOR; KERATINOCYTES; ACTIVATION; SENSATION; EPIDERMIS	Environmental temperature is thought to be directly sensed by neurons through their projections in the skin. A subset of the mammalian transient receptor potential (TRP) family of ion channels has been implicated in this process. These "thermoTRPs" are activated at distinct temperature thresholds and are typically expressed in sensory neurons. TRPV3 is activated by heat (>33degreesC) and, unlike most thermoTRPs, is expressed in mouse keratinocytes. We found that TRPV3 null mice have strong deficits in responses to innocuous and noxious heat but not in other sensory modalities; hence, TRPV3 has a specific role in thermosensation. The natural compound camphor, which modulates sensations of warmth in humans, proved to be a specific activator of TRPV3. Camphor activated cultured primary keratinocytes but not sensory neurons, and this activity was abolished in TRPV3 null mice. Therefore, heat-activated receptors in keratinocytes are important for mammalian thermosensation.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Scripps Research Institute; Novartis	Patapoutian, A (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	ardem@scripps.edu		moqrich, aziz/0000-0002-1937-1675; Hwang, Sun Wook/0000-0001-8460-7480				Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; CAUNA N, 1973, J ANAT, V115, P277; Chung MK, 2004, J BIOL CHEM, V279, P21569, DOI 10.1074/jbc.M401872200; Chung MK, 2004, J NEUROSCI, V24, P5177, DOI 10.1523/JNEUROSCI.0934-04.2004; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; GREEN BG, 1990, J INVEST DERMATOL, V94, P662, DOI 10.1111/1523-1747.ep12876242; Guler AD, 2002, J NEUROSCI, V22, P6408; Hensel H, 1981, Monogr Physiol Soc, V38, P1; HILLIGES M, 1995, J INVEST DERMATOL, V104, P134, DOI 10.1111/1523-1747.ep12613631; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Miyakawa T, 2001, J NEUROSCI, V21, P5239, DOI 10.1523/JNEUROSCI.21-14-05239.2001; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Reichelt J, 2001, MOL BIOL CELL, V12, P1557, DOI 10.1091/mbc.12.6.1557; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Suzuki M, 2003, NEUROSCI LETT, V353, P189, DOI 10.1016/j.neulet.2003.09.041; Todaka H, 2004, J BIOL CHEM, V279, P35133, DOI 10.1074/jbc.M406260200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882	23	506	547	6	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1468	1472		10.1126/science.1108609	http://dx.doi.org/10.1126/science.1108609			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746429				2022-12-24	WOS:000227503100048
J	Scholes, RJ; Biggs, R				Scholes, RJ; Biggs, R			A biodiversity intactness index	NATURE			English	Article							PINUS-RADIATA; ASSEMBLAGES; AFFORESTATION; SAVANNA; LOWVELD	The nations of the world have set themselves a target of reducing the rate of biodiversity loss by 2010. Here, we propose a biodiversity intactness index (BII) for assessing progress towards this target that is simple and practical - but sensitive to important factors that influence biodiversity status - and which satisfies the criteria for policy relevance set by the Convention on Biological Diversity. Application of the BII is demonstrated on a large region ( 4 3 10 6 km 2) of southern Africa. The BII score in the year 2000 is about 84%: in other words, averaged across all plant and vertebrate species in the region, populations have declined to 84% of their presumed pre-modern levels. The taxonomic group with the greatest loss is mammals, at 71% of pre-modern levels, and the ecosystem type with the greatest loss is grassland, with 74% of its former populations remaining. During the 1990s, a population decline of 0.8% is estimated to have occurred.	CSIR Environmentek, ZA-0001 Pretoria, South Africa	Council for Scientific & Industrial Research (CSIR) - South Africa	Scholes, RJ (corresponding author), CSIR Environmentek, POB 395, ZA-0001 Pretoria, South Africa.	bscholes@csir.co.za	Biggs, Reinette/A-5155-2010	Biggs, Reinette/0000-0003-0300-4149; Scholes, Robert/0000-0001-5537-6935				ANDERSON JA, 2001, GONDWANA ALIVE PROMO; ARMSTRONG AJ, 1994, S AFR J WILDL RES, V24, P48; *CBD, 2003, MON IND DES NAT LEV; *CBD, 2003, PROP BIOD IND REL 20; *CIESIN IFPRI CIAT, 2004, GLOB RUR URB MAPP PR; *CSIR, 2002, SADC LANDC DAT; *CSIR, 2003, PROT AR S AFR; *CSIR, 1996, NAT LAND COV S AFR; Dean WRJ, 2002, J ARID ENVIRON, V51, P1, DOI 10.1006/jare.2001.0910; *EC, 2003, GLOB LAND COV 2000 G; Fabricius C, 2003, J APPL ECOL, V40, P392, DOI 10.1046/j.1365-2664.2003.00793.x; *FAO, 2004, FAOSTAT AGR DAT; FAO, 2001, GLOB FOR RES ASS 200; Friedmann Y, 2004, RED DATA BOOK MAMMAL; Herremans M, 1998, BIOL CONSERV, V86, P139, DOI 10.1016/S0006-3207(98)00016-0; Hilton-Taylor C., 2000, 2000 IUCN RED LIST T; Houghton J.T., 1997, CH4 EMISSIONS COAL M; *IUCN UNEP, 2003, WORLD DAT PROT AR; Jenkins M, 2003, SCIENCE, V302, P1175, DOI 10.1126/science.1088666; Johnson R, 2002, J MAMMAL, V83, P290, DOI 10.1644/1545-1542(2002)083&lt;0290:DROSMA&gt;2.0.CO;2; Joubert DF, 1999, J ARID ENVIRON, V43, P287, DOI 10.1006/jare.1999.0553; Le Roux J, 2002, BIODIVERSITY S AFRIC; LOH J, 2002, LIVING PLANET REPORT; Magurran AE., 2004, MEASURING BIOL DIVER; Meik JM, 2002, BIOL CONSERV, V106, P29, DOI 10.1016/S0006-3207(01)00226-9; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Parsons DAB, 1997, J ARID ENVIRON, V37, P319, DOI 10.1006/jare.1997.0283; Reid WV, 1993, BIODIVERSITY INDICAT; RICHARDSON DM, 1986, S AFR J BOT, V52, P309, DOI 10.1016/S0254-6299(16)31526-5; *ROYAL SOC, 2003, MEAS BIOD CONS; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Shackleton CM, 2000, BIOL CONSERV, V94, P273, DOI 10.1016/S0006-3207(00)00001-X; Smart R, 2005, BIOL CONSERV, V122, P23, DOI 10.1016/j.biocon.2004.06.016; TENBRINK BJE, 2002, TECHNISCH ONTWERP NA, V2; United Nations, 2002, WORLD SUMMIT SUSTAIN; World Conservation Monitoring Centre (WCMC), 2000, GLOB BIOD EARTHS LIV; *WWF US, 2003, SPEC DAT AFR EC	38	278	298	4	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					45	49		10.1038/nature03289	http://dx.doi.org/10.1038/nature03289			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744293				2022-12-24	WOS:000227334600037
J	Porco, CC; Baker, E; Barbara, J; Beurle, K; Brahic, A; Burns, JA; Charnoz, S; Cooper, N; Dawson, DD; Del Genio, AD; Denk, T; Dones, L; Dyudina, U; Evans, MW; Giese, B; Grazier, K; Heifenstein, P; Ingersoll, AP; Jacobson, RA; Johnson, TV; McEwen, A; Murray, CD; Neukum, G; Owen, WM; Perry, J; Roatsch, T; Spitale, J; Squyres, S; Thomas, PC; Tiscareno, M; Turtle, E; Vasavada, AR; Veverka, J; Wagner, R; West, R				Porco, CC; Baker, E; Barbara, J; Beurle, K; Brahic, A; Burns, JA; Charnoz, S; Cooper, N; Dawson, DD; Del Genio, AD; Denk, T; Dones, L; Dyudina, U; Evans, MW; Giese, B; Grazier, K; Heifenstein, P; Ingersoll, AP; Jacobson, RA; Johnson, TV; McEwen, A; Murray, CD; Neukum, G; Owen, WM; Perry, J; Roatsch, T; Spitale, J; Squyres, S; Thomas, PC; Tiscareno, M; Turtle, E; Vasavada, AR; Veverka, J; Wagner, R; West, R			Cassini Imaging Science: Initial results on Phoebe and Iapetus	SCIENCE			English	Article							DARK SIDE; IRREGULAR SATELLITES; EVOLUTION; ASTEROIDS; LAPETUS; ORIGIN	The Cassini Imaging Science Subsystem acquired high-resolution imaging data on the outer Saturnian moon, Phoebe, during Cassini's close flyby on 11 June 2004 and on lapetus during a flyby on 31 December 2004. Phoebe has a heavily cratered and ancient surface, shows evidence of ice near the surface, has distinct layering of different materials, and has a mean density that is indicative of an ice-rock mixture. lapetus's dark leading side (Cassini Regio) is ancient, heavily cratered terrain bisected by an equatorial ridge system that reaches 20 kilometers relief. Local albedo variations within and bordering Cassini Regio suggest mass wasting of ballistically deposited material, the origin of which remains unknown.	Space Sci Inst, Cassini Imaging Cent Lab Operat, Boulder, CO 80301 USA; NASA, Goddard Inst Space Studies, New York, NY 10025 USA; Univ London, Queen Mary, Astron Unit, London E1 4NS, England; Univ Paris 07, Ctr Etud Saclay, F-91191 Gif Sur Yvette, France; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA; Free Univ Berlin, Inst Geol Wissensch, D-12249 Berlin, Germany; SW Res Inst, Dept Space Sci, Boulder, CO 80302 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; German Aerosp Ctr, Inst Planetary Res, D-12489 Berlin, Germany; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of London; Queen Mary University London; UDICE-French Research Universities; Universite Paris Cite; Cornell University; University of Arizona; Free University of Berlin; California Institute of Technology; Helmholtz Association; German Aerospace Centre (DLR); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Porco, CC (corresponding author), Space Sci Inst, Cassini Imaging Cent Lab Operat, 4750 Walnut St,Suite 205, Boulder, CO 80301 USA.	carotyn@ciclops.org	Evans, Michael W/AAG-4117-2020; Tiscareno, Matthew/D-6963-2011; Del Genio, Anthony/D-4663-2012; Turtle, Elizabeth/K-8673-2012	Del Genio, Anthony/0000-0001-7450-1359; Turtle, Elizabeth/0000-0003-1423-5751; Barbara, John/0000-0002-2190-4290				Bauer JM, 2004, ASTROPHYS J, V610, pL57, DOI 10.1086/423131; BELL JF, 1985, ICARUS, V61, P192, DOI 10.1016/0019-1035(85)90101-0; Brown ME, 2000, ASTRON J, V119, P977, DOI 10.1086/301202; BURATTI BJ, 1995, ICARUS, V115, P219, DOI 10.1006/icar.1995.1093; Buratti BJ, 2002, ICARUS, V155, P375, DOI 10.1006/icar.2001.6730; BURNS JA, 1986, SATELLITES, P117; CLARK RN, 2005, IN PRESS NATURE; COLVIN TR, 1989, N2934NASA NASA STI; CRUIKSHANK DP, 1983, ICARUS, V53, P90, DOI 10.1016/0019-1035(83)90023-4; Denk T., 2000, LUN PLAN SCI C, V31, P1596; DENK T, 2000, LUNAR PLANET SCI C, V31, P1660; Gladman B, 2001, NATURE, V412, P163, DOI 10.1038/35084032; Hahn JM, 1999, ASTRON J, V117, P3041, DOI 10.1086/300891; JACOBSON RA, 2004, B AM AST SOC, V35; Lee P, 1996, ICARUS, V120, P87, DOI 10.1006/icar.1996.0039; MCKINNON WB, 1996, NEPTUNE TRITON, P807; Melosh H.J., 1989, OXFORD MONOGRAPHS GE; MORRISON D, 1975, ICARUS, V24, P17; Nesvorny D, 2003, ASTRON J, V126, P398, DOI 10.1086/375461; NEUKUM BA, 1994, HAZARDS DUE COMETS A, P359; Neukum G, 1997, THREE GALILEOS: THE MAN, THE SPACECRAFT, THE TELESCOPE, P201; NEUKUM G, 1971, EARTH PLANET SC LETT, V12, P59, DOI 10.1016/0012-821X(71)90055-0; NEUKUM G, 2001, CHRONOLOGY EVOLUTION, P53; NEUKUM G, 1998, LUNAR PLANET SCI, V29, P1742; Owen TC, 1999, ICARUS, V139, P379, DOI 10.1006/icar.1999.6116; Owen TC, 2001, ICARUS, V149, P160, DOI 10.1006/icar.2000.6521; Peale S. J., 1977, IAU C, P87; PECHMANN JB, 1979, ICARUS, V38, P243, DOI 10.1016/0019-1035(79)90181-7; Porco CC, 2004, SPACE SCI REV, V115, P363, DOI 10.1007/s11214-004-1456-7; Schubert G., 1986, SATELLITES, P224; Simonelli DP, 1999, ICARUS, V138, P249, DOI 10.1006/icar.1999.6077; SMITH BA, 1982, SCIENCE, V215, P504, DOI 10.1126/science.215.4532.504; TABAK RG, 1989, EARTH MOON PLANETS, V44, P251, DOI 10.1007/BF00054241; Wilson PD, 1996, ICARUS, V122, P92, DOI 10.1006/icar.1996.0111	34	141	141	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1237	1242		10.1126/science.1107981	http://dx.doi.org/10.1126/science.1107981			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731440				2022-12-24	WOS:000227313200039
J	Loftus, B; Anderson, I; Davies, R; Alsmark, UCM; Samuelson, J; Amedeo, P; Roncaglia, P; Berriman, M; Hirt, RP; Mann, BJ; Nozaki, T; Suh, B; Pop, M; Duchene, M; Ackers, J; Tannich, E; Leippe, M; Hofer, M; Bruchhaus, I; Willhoeft, U; Bhattacharya, A; Chillingworth, T; Churcher, C; Hance, Z; Harris, B; Harris, D; Jagels, K; Moule, S; Mungall, K; Ormond, D; Squares, R; Whitehead, S; Quail, MA; Rabbinowitsch, E; Norbertczak, H; Price, C; Wang, Z; Guillen, N; Gilchrist, C; Stroup, SE; Bhattacharya, S; Lohia, A; Foster, PG; Sicheritz-Ponten, T; Weber, C; Singh, U; Mukherjee, C; El-Sayed, NM; Petri, WA; Clark, CG; Embley, TM; Barrell, B; Fraser, CM; Hall, N				Loftus, B; Anderson, I; Davies, R; Alsmark, UCM; Samuelson, J; Amedeo, P; Roncaglia, P; Berriman, M; Hirt, RP; Mann, BJ; Nozaki, T; Suh, B; Pop, M; Duchene, M; Ackers, J; Tannich, E; Leippe, M; Hofer, M; Bruchhaus, I; Willhoeft, U; Bhattacharya, A; Chillingworth, T; Churcher, C; Hance, Z; Harris, B; Harris, D; Jagels, K; Moule, S; Mungall, K; Ormond, D; Squares, R; Whitehead, S; Quail, MA; Rabbinowitsch, E; Norbertczak, H; Price, C; Wang, Z; Guillen, N; Gilchrist, C; Stroup, SE; Bhattacharya, S; Lohia, A; Foster, PG; Sicheritz-Ponten, T; Weber, C; Singh, U; Mukherjee, C; El-Sayed, NM; Petri, WA; Clark, CG; Embley, TM; Barrell, B; Fraser, CM; Hall, N			The genome of the protist parasite Entamoeba histolytica	NATURE			English	Article							GENE; EVOLUTION; INFERENCE; PROGRAM	Entamoeba histolytica is an intestinal parasite and the causative agent of amoebiasis, which is a significant source of morbidity and mortality in developing countries(1). Here we present the genome of E. histolytica, which reveals a variety of metabolic adaptations shared with two other amitochondrial protist pathogens: Giardia lamblia and Trichomonas vaginalis. These adaptations include reduction or elimination of most mitochondrial metabolic pathways and the use of oxidative stress enzymes generally associated with anaerobic prokaryotes. Phylogenomic analysis identifies evidence for lateral gene transfer of bacterial genes into the E. histolytica genome, the effects of which centre on expanding aspects of E. histolytica's metabolic repertoire. The presence of these genes and the potential for novel metabolic pathways in E. histolytica may allow for the development of new chemotherapeutic agents. The genome encodes a large number of novel receptor kinases and contains expansions of a variety of gene families, including those associated with virulence. Additional genome features include an abundance of tandemly repeated transfer-RNA-containing arrays, which may have a structural function in the genome. Analysis of the genome provides new insights into the workings and genome evolution of a major human pathogen.	TIGR, Rockville, MD 20850 USA; Sanger Inst, Cambridge CB10 1SA, England; Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; Univ Virginia, Dept Internal Med, Charlottesville, VA 22908 USA; Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; Natl Inst Infect Dis, Dept Parasitol, Shinjuku Ku, Tokyo 1628640, Japan; Med Univ Vienna, Ctr Physiol & Pathophysiol, Div Specif Prophylaxis & Trop Med, A-1095 Vienna, Austria; Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Bernhard Nocht Inst Trop Med, Dept Mol Parasitol, D-20359 Hamburg, Germany; Univ Kiel, Inst Zool, D-24098 Kiel, Germany; Jawaharlal Nehru Univ, Sch Environm Sci, New Delhi 110067, India; Inst Pasteur, INSERM, U389, Unite Biol Cellulaire Parasitisme, F-75724 Paris 15, France; Bose Inst, Dept Biochem, Kolkata 700054, India; Nat Hist Museum, Dept Zool, London SW7 5BD, England; Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; Stanford Univ, Sch Med, Dept Internal Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Immunol, Stanford, CA 94305 USA	J. Craig Venter Institute; Wellcome Trust Sanger Institute; Newcastle University - UK; Boston University; University of Virginia; University of Virginia; National Institute of Infectious Diseases (NIID); Medical University of Vienna; University of London; London School of Hygiene & Tropical Medicine; Bernhard Nocht Institut fur Tropenmedizin; University of Kiel; Jawaharlal Nehru University, New Delhi; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Department of Science & Technology (India); Bose Institute; Natural History Museum London; Technical University of Denmark; Stanford University; Stanford University; Stanford University	Loftus, B (corresponding author), TIGR, 9712 Med Ctr Dr, Rockville, MD 20850 USA.	bjloftus@tigr.org	Hall, Neil/A-8717-2013; El-Sayed, Najib M.A./K-7266-2015; Petri, William/AAL-3642-2020; Hirt, Robert/R-5429-2017; Petri, William A./D-3639-2019; Alsmark, Cecilia/AAO-1330-2021; Willhoeft, Ute H/K-5970-2015; Duchêne, Michael/G-6659-2019; Clark, C Graham/H-3683-2011; MIRELMAN, DAVID/K-1596-2012; Puigbò, Pere/A-2214-2008; Pop, Mihai/A-7987-2013; Quail, michael/ABE-6131-2020; Leippe, Matthias/AAP-1677-2020; Sicheritz-Ponten, Thomas/A-4325-2017	Hall, Neil/0000-0002-7995-3810; El-Sayed, Najib M.A./0000-0001-7970-3312; Petri, William/0000-0002-7268-1218; Hirt, Robert/0000-0002-3760-9958; Willhoeft, Ute H/0000-0003-3313-2125; Duchêne, Michael/0000-0003-1232-3600; Clark, C Graham/0000-0002-0521-0977; Pop, Mihai/0000-0001-9617-5304; Lohia, Anuradha/0000-0003-3686-5738; Singh, Upinder/0000-0003-0630-0306; Foster, Peter/0000-0003-0194-9237; Fraser, Claire/0000-0003-1462-2428; Sicheritz-Ponten, Thomas/0000-0001-6615-1141; loftus, brendan/0000-0001-8871-8356; Embley, Thomas Martin/0000-0002-1484-340X; Hall, Neil/0000-0003-2808-0009; Roncaglia, Paola/0000-0002-2825-0621; Samuelson, John/0000-0001-9533-3040				Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Allen JE, 2004, GENOME RES, V14, P142, DOI 10.1101/gr.1562804; Azachi M, 2002, PLANT PHYSIOL, V129, P1320, DOI 10.1104/pp.001909; BAUM KF, 1989, J BIOL CHEM, V264, P21087; Cawley SE, 2001, MOL BIOCHEM PARASIT, V118, P167, DOI 10.1016/S0166-6851(01)00363-2; Coppi A, 2002, J BIOL CHEM, V277, P8083, DOI 10.1074/jbc.M111895200; Cummings MP, 2003, SYST BIOL, V52, P477, DOI 10.1080/10635150390218213; Desper R, 2004, MOL BIOL EVOL, V21, P587, DOI 10.1093/molbev.msh049; Duhon D, 2002, J MUSCLE RES CELL M, V23, P803, DOI 10.1023/A:1024435913949; FAHEY RC, 1984, SCIENCE, V224, P70, DOI 10.1126/science.6322306; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Gomes CM, 2002, J BIOL CHEM, V277, P25273, DOI 10.1074/jbc.M203886200; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUNTER T, 1991, METHOD ENZYMOL, V200, P3; Huston CD, 2004, TRENDS PARASITOL, V20, P23, DOI 10.1016/j.pt.2003.10.013; JAMES DW, 1995, PLANT CELL, V7, P309, DOI 10.2307/3869853; Jordan IK, 2003, J MOL MICROB BIOTECH, V5, P172, DOI 10.1159/000070268; Lawrence JG, 2003, MOL MICROBIOL, V50, P739, DOI 10.1046/j.1365-2958.2003.03778.x; Leon-Avila G, 2004, MICROBIOL-SGM, V150, P1245, DOI 10.1099/mic.0.26923-0; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Mazzuco A, 1997, MICRON, V28, P241, DOI 10.1016/S0968-4328(97)00024-3; Melville SE, 1999, CHROMOSOME RES, V7, P191, DOI 10.1023/A:1009247315947; Mullikin JC, 2003, GENOME RES, V13, P81, DOI 10.1101/gr.731003; PATARAPOTIKUL J, 1988, NUCLEIC ACIDS RES, V16, P4331, DOI 10.1093/nar/16.10.4331; Sicheritz-Ponten T, 2001, NUCLEIC ACIDS RES, V29, P545, DOI 10.1093/nar/29.2.545; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; Sztukowska M, 2002, MOL MICROBIOL, V44, P479, DOI 10.1046/j.1365-2958.2002.02892.x; Voigt H, 1999, CELL MICROBIOL, V1, P195, DOI 10.1046/j.1462-5822.1999.00021.x; Welter BH, 2004, MOL BIOCHEM PARASIT, V135, P183, DOI 10.1016/j.molbiopara.2004.02.002	30	630	683	5	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2005	433	7028					865	868		10.1038/nature03291	http://dx.doi.org/10.1038/nature03291			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	899VT	15729342	hybrid, Green Accepted			2022-12-24	WOS:000227174600042
J	PELLI, DG; CHAMBERLAIN, SC				PELLI, DG; CHAMBERLAIN, SC			THE VISIBILITY OF 350-DEGREES-C BLACK-BODY RADIATION BY THE SHRIMP RIMICARIS-EXOCULATA AND MAN	NATURE			English	Article									SYRACUSE UNIV,DEPT BIOENGN,SYRACUSE,NY 13244	Syracuse University	PELLI, DG (corresponding author), SYRACUSE UNIV,INST SENSORY RES,SYRACUSE,NY 13244, USA.							BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BROWNE MW, 1988, NY TIMES        0809, pB5; DRTNALL HJA, 1972, HDB SENSORY PHYSL 2, V7; Pirenne M. H., 1962, EYE, V2; STILES WS, 1974, VISION RES, V14, P195, DOI 10.1016/0042-6989(74)90101-1; THOMPSON G, 1988, CAN MINERAL, V26, P697; VANDOVER CL, 1988, MAR BIOL, V98, P209, DOI 10.1007/BF00391196; VANDOVER CL, 1989, NATURE, V337; Wyszecki G., 1982, COLOR SCI	9	45	45	0	12	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	FEB 2	1989	337	6206					460	461		10.1038/337460a0	http://dx.doi.org/10.1038/337460a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	T0720	15726721				2022-12-24	WOS:A1989T072000066
J	Lange, S; Xiang, FQ; Yakovenko, A; Vihola, A; Hackman, P; Rostkova, E; Kristensen, J; Brandmeier, B; Franzen, G; Hedberg, B; Gunnarsson, LG; Hughes, SM; Marchand, S; Sejersen, T; Richard, I; Edstrom, L; Ehler, E; Udd, B; Gautel, M				Lange, S; Xiang, FQ; Yakovenko, A; Vihola, A; Hackman, P; Rostkova, E; Kristensen, J; Brandmeier, B; Franzen, G; Hedberg, B; Gunnarsson, LG; Hughes, SM; Marchand, S; Sejersen, T; Richard, I; Edstrom, L; Ehler, E; Udd, B; Gautel, M			The kinase domain of titin controls muscle gene expression and protein turnover	SCIENCE			English	Article							SERUM RESPONSE FACTOR; M-BAND; IDENTIFICATION; INACTIVATION; ACTIVATION; MYOMESIN; DYNAMICS; MYOPATHY; DELETION; FAMILY	The giant sarcomeric protein titin contains a protein kinase domain (TK) ideally positioned to sense mechanical load. We identified a signaling complex where TK interacts with the zinc-finger protein nbr1 through a mechanically inducible conformation. Nbr1 targets the ubiquitin-associated p62/SQSTM1 to sarcomeres, and p62 in turn interacts with MuRF2, a muscle-specific RING-B-box E3 ligase and ligand of the transactivation domain of the serum response transcription factor (SRF). Nuclear translocation of MuRF2 was induced by mechanical inactivity and caused reduction of nuclear SRF and repression of transcription. A human mutation in the titin,protein kinase domain causes hereditary muscle disease by disrupting this pathway.	Univ Helsinki, Folkhalsen Inst Genet, Biomedicum, FIN-00290 Helsinki, Finland; Univ Helsinki, Dept Med Genet, Biomedicum, FIN-00290 Helsinki, Finland; Kings Coll London, Randall Div, London SE1 1UL, England; Kings Coll London, Div Cardiovasc, London SE1 1UL, England; ETH Honggerberg, Inst Cell Biol, CH-8093 Zurich, Switzerland; Karolinska Inst, Karolinska Hosp, Dept Clin Neurosci, S-17176 Stockholm, Sweden; Orebro Univ Hosp, Dept Environm Med, S-70185 Orebro, Sweden; Genethon, CNRS, UMR 8115, F-91000 Evry, France; Astrid Lindgren Childrens Hosp, Dept Woman & Child Hlth, Neuropediat Unit, S-17176 Stockholm, Sweden; Vasa Cent Hosp, Dept Neurol, Vaasa 65130, Finland; Tampere Univ Hosp, Dept Neurol, Tampere 33520, Finland	University of Helsinki; University of Helsinki; University of London; King's College London; University of London; King's College London; Swiss Federal Institutes of Technology Domain; ETH Zurich; Karolinska Institutet; Karolinska University Hospital; Orebro University; Centre National de la Recherche Scientifique (CNRS); Vaasa Central Hospital; Tampere University; Tampere University Hospital	Gautel, M (corresponding author), Univ Helsinki, Folkhalsen Inst Genet, Biomedicum, FIN-00290 Helsinki, Finland.	Bjarne.Udd@vshp.fi; mathias.gautel@kcl.ac.uk	Gautel, Mathias/AAB-9860-2019; Hughes, Simon M/S-1073-2016; Lange, Stephan/A-1422-2010; Richard, isabelle/J-8298-2013	Hughes, Simon M/0000-0001-8227-9225; Lange, Stephan/0000-0001-9361-6602; Sejersen, Thomas/0000-0001-5961-7097; Ehler, Elisabeth/0000-0001-5646-5964; Gautel, Mathias/0000-0003-4027-9803; Xiang, Fengqing/0000-0003-0892-1536	British Heart Foundation [PG/03/049/15364] Funding Source: Medline; Medical Research Council [G0300213, G0200496(63216)] Funding Source: Medline; MRC [G0300213] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Agarkova I, 2003, J MUSCLE RES CELL M, V24, P191, DOI 10.1023/A:1026094924677; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; CAMPBELL IG, 1994, HUM MOL GENET, V3, P589, DOI 10.1093/hmg/3.4.589; Centner T, 2001, J MOL BIOL, V306, P717, DOI 10.1006/jmbi.2001.4448; Ciani B, 2003, J BIOL CHEM, V278, P37409, DOI 10.1074/jbc.M307416200; Dai KS, 2001, J BIOL CHEM, V276, P23992, DOI 10.1074/jbc.M011208200; EDSTROM L, 1990, J NEUROL SCI, V96, P211, DOI 10.1016/0022-510X(90)90134-9; Fuller SJ, 1998, J BIOL CHEM, V273, P18146, DOI 10.1074/jbc.273.29.18146; Gautel M, 1999, REV PHYSIOL BIOCH P, V138, P97, DOI 10.1007/BF02346661; Geetha T, 2002, FEBS LETT, V512, P19, DOI 10.1016/S0014-5793(02)02286-X; GOTTHARDT M, 2002, J BIOL CHEM, V2, P2; Grater F, 2005, BIOPHYS J, V88, P790, DOI 10.1529/biophysj.104.052423; Hackman P, 2002, AM J HUM GENET, V71, P492, DOI 10.1086/342380; Joung I, 1996, P NATL ACAD SCI USA, V93, P5991, DOI 10.1073/pnas.93.12.5991; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Liang PQ, 1997, J BIOL CHEM, V272, P28050, DOI 10.1074/jbc.272.44.28050; Mayans O, 1998, NATURE, V395, P863, DOI 10.1038/27603; MCETHINNY MS, 2002, J CELL BIOL, V157, P125; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; Miller G, 2003, J CELL SCI, V116, P4811, DOI 10.1242/jcs.00768; Nicolao P, 1999, AM J HUM GENET, V64, P788, DOI 10.1086/302281; Obermann WMJ, 1996, J CELL BIOL, V134, P1441, DOI 10.1083/jcb.134.6.1441; Parlakian A, 2004, MOL CELL BIOL, V24, P5281, DOI 10.1128/MCB.24.12.5281-5289.2004; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pizon V, 2002, J CELL SCI, V115, P4469, DOI 10.1242/jcs.00131; Pridgeon Julia W., 2003, Biol Proced Online, V5, P228, DOI 10.1251/bpo66; SADOSHIMA J, 1992, J BIOL CHEM, V267, P10551; Spencer JA, 2000, J CELL BIOL, V150, P771, DOI 10.1083/jcb.150.4.771; Steiner F, 1999, GENOMICS, V56, P78, DOI 10.1006/geno.1998.5682; Tskhovrebova L, 2003, NAT REV MOL CELL BIO, V4, P679, DOI 10.1038/nrm1198; van der Ven PFM, 2000, J CELL SCI, V113, P1405	32	421	441	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2005	308	5728					1599	1603		10.1126/science.1110463	http://dx.doi.org/10.1126/science.1110463			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	936BH	15802564				2022-12-24	WOS:000229827000048
J	Blower, MD; Nachury, M; Heald, R; Weis, K				Blower, MD; Nachury, M; Heald, R; Weis, K			A Rae1-containing ribonucleoprotein complex is required for mitotic spindle assembly	CELL			English	Article							NUCLEAR-PORE COMPLEX; MESSENGER-RNA EXPORT; IMPORTIN-BETA; CELL-CYCLE; RAE1; PROTEIN; RAN; MICROTUBULES; NUP98; LOCALIZATION	Centrosome-independent microtubule polymerization around chromosomes has been shown to require a local gradient of RanGTP, which discharges mitotic cargoes from the nuclear import receptor importin beta. Here, we have used an activity-based assay in Xenopus egg extracts to purify the mRNA export protein Rae1 as a spindle assembly factor regulated by this pathway. Rae1 is a microtubule-associated protein that binds directly to importin beta. Depletion of Rae1 from extracts or cells severely inhibits mitotic spindle assembly. A purified Rae1 complex stabilizes microtubules in egg extracts in a RanGTP/importin beta-regulated manner. Interestingly, Rae1 exists in a large ribonucleoprotein complex, which requires RNA for its activity to control microtubule dynamics in vitro. Furthermore, we provide evidence that RNA associates with the mitotic spindle and that it plays a direct, translation-independent role in spindle assembly. Our studies reveal an unexpected function for RNA in spindle morphogenesis.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Heald, R (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	heald@socrates.berkeley.edu; kweis@berkeley.edu	Nachury, Maxence/H-3695-2019; Weis, Karsten/F-5719-2011; Nachury, Maxence/A-8759-2008	Nachury, Maxence/0000-0003-4918-1562; Weis, Karsten/0000-0001-7224-925X; Nachury, Maxence/0000-0003-4918-1562; Heald, Rebecca/0000-0001-6671-6528; Blower, Michael/0000-0002-5037-1972	NIGMS NIH HHS [GM65232] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065232] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Babu JR, 2003, J CELL BIOL, V160, P341, DOI 10.1083/jcb.200211048; Blevins MB, 2003, J BIOL CHEM, V278, P20979, DOI 10.1074/jbc.M302061200; BROWN JA, 1995, J BIOL CHEM, V270, P7411, DOI 10.1074/jbc.270.13.7411; Budde PP, 2003, CURR TOP DEV BIOL, V56, P85, DOI 10.1016/S0070-2153(03)01008-1; Deshler JO, 1997, SCIENCE, V276, P1128, DOI 10.1126/science.276.5315.1128; Fontoura BMA, 2000, J BIOL CHEM, V275, P31289, DOI 10.1074/jbc.M004651200; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Groisman I, 2000, CELL, V103, P435, DOI 10.1016/S0092-8674(00)00135-5; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; HAMILL D, 1994, J CELL BIOL, V127, P973, DOI 10.1083/jcb.127.4.973; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Kahana JA, 1999, J CELL BIOL, V146, P1205, DOI 10.1083/jcb.146.6.1205; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Kraemer D, 1997, P NATL ACAD SCI USA, V94, P9119, DOI 10.1073/pnas.94.17.9119; Kroll TT, 2002, DEVELOPMENT, V129, P5609, DOI 10.1242/dev.00160; Lieb B, 1998, EXP CELL RES, V245, P272, DOI 10.1006/excr.1998.4249; Murphy R, 1996, MOL BIOL CELL, V7, P1921, DOI 10.1091/mbc.7.12.1921; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Pritchard CEJ, 1999, J CELL BIOL, V145, P237, DOI 10.1083/jcb.145.2.237; Sampath SC, 2004, CELL, V118, P187, DOI 10.1016/j.cell.2004.06.026; Sitterlin D, 2004, GENE, V326, P107, DOI 10.1016/j.gene.2003.10.024; Tekotte H, 2002, TRENDS GENET, V18, P636, DOI 10.1016/S0168-9525(02)02819-6; Whalen WA, 1997, YEAST, V13, P1167, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1167::AID-YEA154>3.3.CO;2-F; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Yoon JH, 2000, MOL CELL BIOL, V20, P8767, DOI 10.1128/MCB.20.23.8767-8782.2000	27	218	225	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 22	2005	121	2					223	234		10.1016/j.cell.2005.02.016	http://dx.doi.org/10.1016/j.cell.2005.02.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851029	Bronze			2022-12-24	WOS:000228705000010
J	Al-Khatib, SM; Anstrom, KJ; Eisenstein, EL; Peterson, ED; Jollis, JG; Mark, DB; Li, Y; O'Connor, CM; Shaw, LK; Califf, RM				Al-Khatib, SM; Anstrom, KJ; Eisenstein, EL; Peterson, ED; Jollis, JG; Mark, DB; Li, Y; O'Connor, CM; Shaw, LK; Califf, RM			Clinical and economic implications of the multicenter automatic defibrillator implantation trial-II	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	52nd Annual Scientific Session of the American-College-of-Cardiology	MAR 30-APR 02, 2003	CHICAGO, IL	Amer Coll Cardiol			CORONARY-ARTERY-DISEASE; SUDDEN CARDIAC DEATH; COST-EFFECTIVENESS; CARDIOVERTER-DEFIBRILLATOR; MYOCARDIAL-INFARCTION; DRUG-THERAPY; HIGH-RISK; AMIODARONE; SURVIVAL; RECOMMENDATIONS	Background: The Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II demonstrated that implantable cardioverter defibrillators (ICDs) save lives when used in patients with a history of myocardial infarction (MI) and an ejection fraction of 0.3 or less. Objective: To investigate the cost-effectiveness of implanting ICDs in patients who met MADIT-II eligibility criteria and were enrolled in the Duke Cardiovascular Database between 1 January 1986 and 31 December 2001. Design: Cost-effectiveness analysis. Data Sources: Published literature, databases owned by Duke University Medical Center, and Medicare data. Target Population: Adults with a history of MI and an ejection fraction of 0.3 or less. Time Horizon: Lifetime. Perspective: societal. Interventions: ICD therapy versus conventional medical therapy. Outcomes Measures: Cost per life-year gained and incremental cost-effectiveness. Results: compared with conventional medical therapy, ICDs are projected to result in an increase of 1.80 discounted years in life expectancy and an incremental cost-effectiveness ratio of $50 500 per life-year gained. Cost-effectiveness varied dramatically with changes in time horizon: The cost-effectiveness ratio increased to $67 800 per life-year gained, $79 900 per life-year gained, $100 000 per life-year gained, $167 900 per life-year gained, and $367 200 per life-year gained for 15-year, 12-year, 9-year, 6-year, and 3-year time horizons, respectively. Changing the frequency of follow-up visits, complication rates, and battery replacements had less of an effect on the cost-effectiveness ratios than reducing the cost of ICD placement and leads. Limitations: The study was limited by the completeness of the data, referral bias, difference in medical therapy between the Duke cohort and the MADIT-II cohort, and not addressing potential upgrades to biventricular devices. Conclusions: The economic expense of defibrillator implantation in all patients who meet MADIT-II eligibility criteria is substantial. However, in the range of survival benefit observed in MADIT-II, ICD therapy for these patients is economically attractive by conventional standards.	Duke Univ, Clin Res Inst, Durham, NC 27715 USA	Duke University	Al-Khatib, SM (corresponding author), Duke Univ, Clin Res Inst, 2400 Pratt St, Durham, NC 27715 USA.		Peterson, Eric David/ABF-5033-2021	Mark, Daniel/0000-0001-6340-8087				American Heart Association, 2002, HEART DIS STROKE STA; Anderson R N, 2000, Vital Health Stat 2, P1; Bang H, 2000, BIOMETRIKA, V87, P329, DOI 10.1093/biomet/87.2.329; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; CALIFF RM, 1989, JAMA-J AM MED ASSOC, V261, P2077, DOI 10.1001/jama.261.14.2077; COX DR, 1972, J R STAT SOC B, V34, P187; Eisenstein EL, 2001, MED CARE, V39, P824, DOI 10.1097/00005650-200108000-00008; EISENSTEIN EL, ACUTE CORONARY SYSND, P723; FORTIN DF, 1995, AM J CARDIOL, V76, P1177, DOI 10.1016/S0002-9149(99)80331-2; HARRIS PJ, 1979, CIRCULATION, V60, P1259, DOI 10.1161/01.CIR.60.6.1259; Kennergren C, 1996, AM J CARDIOL, V78, P15, DOI 10.1016/S0002-9149(96)00497-3; KUPPERMANN M, 1990, CIRCULATION, V81, P91, DOI 10.1161/01.CIR.81.1.91; Larsen G, 2002, CIRCULATION, V105, P2049, DOI 10.1161/01.CIR.0000015504.57641.D0; LARSEN GC, 1992, J AM COLL CARDIOL, V19, P1323, DOI 10.1016/0735-1097(92)90341-J; MARK DB, 1994, CIRCULATION, V89, P2015, DOI 10.1161/01.CIR.89.5.2015; MARK DB, 1996, CIRCULATION, V94, P168; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Mushlin AI, 1998, CIRCULATION, V97, P2129, DOI 10.1161/01.CIR.97.21.2129; O'Brien BJ, 2001, CIRCULATION, V103, P1416, DOI 10.1161/01.CIR.103.10.1416; Owens DK, 1997, ANN INTERN MED, V126, P1, DOI 10.7326/0003-4819-126-1-199701010-00001; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; ROSATI RA, 1975, ARCH INTERN MED, V135, P1017, DOI 10.1001/archinte.135.8.1017; Sanders GD, 2001, ANN INTERN MED, V135, P870, DOI 10.7326/0003-4819-135-10-200111200-00007; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Spath MA, 2002, PHARMACOECONOMICS, V20, P727, DOI 10.2165/00019053-200220110-00002; TSEVAT J, 1993, MED DECIS MAKING, V13, P161, DOI 10.1177/0272989X9301300210; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334; 2003, MEDTRONIC PRODUCT PE, V13	31	90	89	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2005	142	8					593	600		10.7326/0003-4819-142-8-200504190-00007	http://dx.doi.org/10.7326/0003-4819-142-8-200504190-00007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	916TZ	15838065				2022-12-24	WOS:000228410400001
J	Gorgoulis, VG; Vassiliou, LVF; Karakaidos, P; Zacharatos, P; Kotsinas, A; Liloglou, T; Venere, M; DiTullio, RA; Kastrinakis, NG; Levy, B; Kletsas, D; Yoneta, A; Herlyn, M; Kittas, C; Halazonetis, TD				Gorgoulis, VG; Vassiliou, LVF; Karakaidos, P; Zacharatos, P; Kotsinas, A; Liloglou, T; Venere, M; DiTullio, RA; Kastrinakis, NG; Levy, B; Kletsas, D; Yoneta, A; Herlyn, M; Kittas, C; Halazonetis, TD			Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions	NATURE			English	Article							CELL LUNG CARCINOMAS; DOUBLE-STRAND BREAKS; P53 MUTATIONS; HISTONE H2AX; HUMAN CANCER; ALLELE LOSS; CYCLIN-E; 53BP1; EXPRESSION; PATHWAY	DNA damage checkpoint genes, such as p53, are frequently mutated in human cancer, but the selective pressure for their inactivation remains elusive(1-3). We analysed a panel of human lung hyperplasias, all of which retained wild-type p53 genes and had no signs of gross chromosomal instability, and found signs of a DNA damage response, including histone H2AX and Chk2 phosphorylation, p53 accumulation, focal staining of p53 binding protein 1 (53BP1) and apoptosis. Progression to carcinoma was associated with p53 or 53BP1 inactivation and decreased apoptosis. A DNA damage response was also observed in dysplastic nevi and in human skin xenografts, in which hyperplasia was induced by overexpression of growth factors. Both lung and experimentally-induced skin hyperplasias showed allelic imbalance at loci that are prone to DNA double-strand break formation when DNA replication is compromised ( common fragile sites). We propose that, from its earliest stages, cancer development is associated with DNA replication stress, which leads to DNA double-strand breaks, genomic instability and selective pressure for p53 mutations.	Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; Univ Athens, Sch Med, Dept Histol & Embryol, GR-11527 Athens, Greece; Univ Liverpool, Ctr Canc Res, Roy Castle Lung Canc Res Programme, Liverpool, Merseyside, England; Univ Penn, Grad Grp Biomed Sci, Philadelphia, PA 19104 USA; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Demokritos Natl Ctr Sci Res, Inst Biol, GR-15310 Athens, Greece	The Wistar Institute; Athens Medical School; National & Kapodistrian University of Athens; University of Liverpool; University of Pennsylvania; University of Pennsylvania; Icahn School of Medicine at Mount Sinai; National Centre of Scientific Research "Demokritos"	Halazonetis, TD (corresponding author), Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA.	halazonetis@wistar.upenn.edu	Halazonetis, Thanos/D-7923-2011; ZACHARATOS, PANAGIOTIS V/G-9954-2014; Karakaidos, Panagiotis/AAR-5858-2020; Gorgoulis, Vassilis/AAD-3630-2019; Kletsas, Dimitris/F-6953-2010	ZACHARATOS, PANAGIOTIS V/0000-0001-8324-5481; Karakaidos, Panagiotis/0000-0002-1156-4755; Gorgoulis, Vassilis/0000-0001-9001-4112; Kletsas, Dimitris/0000-0002-9828-3963				Arlt MF, 2003, CYTOGENET GENOME RES, V100, P92, DOI 10.1159/000072843; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Berking C, 2004, CANCER RES, V64, P807, DOI 10.1158/0008-5472.CAN-03-3438; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; Gorgoulis VG, 1998, AM J PATHOL, V153, P1749, DOI 10.1016/S0002-9440(10)65690-8; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Halazonetis TD, 2004, DNA REPAIR, V3, P1057, DOI 10.1016/j.dnarep.2004.03.036; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Karakaidos P, 2004, AM J PATHOL, V165, P1351, DOI 10.1016/S0002-9440(10)63393-7; KASTAN MB, 1991, CANCER RES, V51, P6304; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; MacPhail SH, 2003, RADIAT RES, V159, P759, DOI 10.1667/RR3003; Maitra A, 2001, AM J PATHOL, V159, P119, DOI 10.1016/S0002-9440(10)61679-3; Mao L, 1996, NAT MED, V2, P682, DOI 10.1038/nm0696-682; Mochan TA, 2003, CANCER RES, V63, P8586; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tanaka S, 2002, GENE DEV, V16, P2639, DOI 10.1101/gad.1011002; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Wistuba II, 2000, CANCER RES, V60, P1949	29	1616	1671	0	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2005	434	7035					907	913		10.1038/nature03485	http://dx.doi.org/10.1038/nature03485			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915SV	15829965				2022-12-24	WOS:000228327600043
J	Lo, B; Dornbrand, L; Dubler, NN				Lo, B; Dornbrand, L; Dubler, NN			HIPAA and patient care - The role for professional judgment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Federal health privacy regulations, commonly known as the Health Insurance Portability and Accountability Act (HIPAA) regulations, came into effect in April 2003. Many clinicians and institutions have relied on consultants and risk managers to tell them how to implement these regulations. Much of the controversy and confusion over the HIPAA regulations concern so-called incidental disclosures. Some interpretations of the privacy regulations would limit essential communication and compromise good patient care. This article analyzes misconceptions regarding what the regulations say about incidental disclosures and discusses the reasons for such misunderstandings. Many misconceptions arise from gaps in the regulations. These gaps are appropriately filled by professional judgment informed by ethical guidelines. The communication should be necessary and effective for good patient care, and the risks of a breach of confidentiality should be proportional to the likely benefit for the patient's care. The alternative for communication should be impractical. We offer specific recommendations to help physicians think through what incidental disclosures in patient care are ethically permissible and what safeguards ought to be taken. Physicians should work with risk managers and practice administrators to develop policies that promote good communication in patient care, while taking appropriate steps to protect patient privacy.	Univ Calif San Francisco, Program Med Eth, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, Div Gen Internal Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, Div Geriatr, San Francisco, CA 94143 USA; Montefiore Med Ctr, Dept Epidemiol & Social Med, New York, NY USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Montefiore Medical Center	Lo, B (corresponding author), Univ Calif San Francisco, Program Med Eth, Room C 126,521 Parnassus Ave, San Francisco, CA 94143 USA.	bernie@medicine.ucsf.edu						Annas GJ, 2003, NEW ENGL J MED, V348, P1486, DOI 10.1056/NEJMlim035027; BEAUCHAMP TL, 1989, PRINCIPLES BIOMEDICA, P329; BEAUCHAMP TL, 2001, PRINCIPLES BIOMEDICA, P303; Beauchamp Tom L, 2001, PRINCIPLES BIOMEDICA, P165; Beauchamp Tom L., 2001, PRINCIPLES BIOMEDICA, P63; CALFEE JE, 1984, VA LAW REV, V70, P965, DOI 10.2307/1072946; Childress JF, 2002, J LAW MED ETHICS, V30, P170, DOI 10.1111/j.1748-720X.2002.tb00384.x; CLARK C, 2003, SAN DIEGO UNION 0609, pA1; *CTR MED MED SERV, 2003, IS MAND ENCR HIPAA S; *DEP HLTH HUM SERV, 2003, MAY DOCT FAX EMAIL D; *DEP HLTH HUM SERV, 2004, US OCR RES FIGHT MYT; *DEP HLTH HUM SERV, 2003, CAN HLTH CAR PROV CO; *DEP HLTH HUM SERV, 2001, HHS ISS 1 GUID NEW P; *DEP HLTH HUM SERV, 2003, CAN PAT HAV FRIEND F; *DEP HLTH HUM SERV, 2003, MUST FAC PRIV SOUNDP; *DEP HLTH HUM SERV, 2003, HLTH CAR PROV CONF C; *DEP HLTH HUM SERV, 2003, WHAT SAF NEED CONT C; *DEP HLTH HUM SERV, 2003, GEN WHAT DOES HIPAA; GOSTIN LO, 2000, PUBLIC HLTH LAW, P85; *HLTH PRIV PROJ, 2003, MYTHS FACTS HLPAA PR; *HLTH PRIV WORK GR, 1999, BEST PRINC HLTH PRIV; JONSEN AR, 1978, ANN INTERN MED, V88, P827, DOI 10.7326/0003-4819-88-6-827; KISSINGER M, 2003, MILWAUKEE J SEN 1109, pA1; Lo B, 2000, JAMA-J AM MED ASSOC, V283, P801, DOI 10.1001/jama.283.6.801; LO B, 2000, RESOLVING ETHICAL DI, P43; *LTH PRIV PROJ, 2003, MED PRIV STOR; *MARKL FDN, 2004, CONN HLTH PRIV SEC W; *OFF CIV RIGHTS HI, 2002, STAND PRIV IND ID HL; *OFF CIV RIGHTS HI, 2003, MED PRIV NAT STAND P; OSTROM CM, 2004, SEATTLE TIMES   0330, pA1; SORKIN MD, 2003, ST LOUIS POST D 0629, pA12; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; STEIN R, 2003, WASH POST       0330, pA1; SUNNSTEIN CR, 1996, LEGAL REASONING POLI; TARKAN L, 2003, NY TIMES        0603, pA1; UBEL PA, 1995, AM J MED, V99, P190, DOI 10.1016/S0002-9343(99)80139-9; *US ATT OFF W DIST, 2004, SEATTL AR MAN GETS P; WEISS BD, 1982, JAMA-J AM MED ASSOC, V247, P2695, DOI 10.1001/jama.247.19.2695; 2002, FED REG, V67, P14793; 2002, FED REG, V67, P55918	40	20	20	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2005	293	14					1766	1771		10.1001/jama.293.14.1766	http://dx.doi.org/10.1001/jama.293.14.1766			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	915JS	15827316				2022-12-24	WOS:000228301100031
J	Vrakking, AM; van der Heide, A; Onwuteaka-Philipsen, BD; Keij-Deerenberg, IM; van der Maas, PJ; van der Wal, G				Vrakking, AM; van der Heide, A; Onwuteaka-Philipsen, BD; Keij-Deerenberg, IM; van der Maas, PJ; van der Wal, G			Medical end-of-life decisions made for neonates and infants in the Netherlands, 1995-2001	LANCET			English	Article							INTENSIVE-CARE	End-of-life decision-making for severely affected infants might be influenced by technical advances and societal debates. In 2001, we assessed the proportion of deaths of infants younger than 1 year that were preceded by end-of-life decisions, by replicating a questionnaire study from 1995. This proportion increased from 62% to 68% (weighted percentages), but the difference was not significant. Most of these decisions were to forgo life-sustaining treatment. Decisions to actively end the lives of infants not dependent on life-sustaining treatment remained stable at 1%. The practice of end-of-life decision-making in neonatology of 2001 has changed little since 1995.	Erasmus MC, Dept Publ Hlth, Univ Med Ctr Rotterdam, NL-3000 DR Rotterdam, Netherlands; VU Univ Med Ctr Amsterdam, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; VU Univ Med Ctr Amsterdam, Inst Res Extramural Med, Amsterdam, Netherlands; Stat Netherlands, Div Social & Spatial Stat, Voorburg, Netherlands	Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Vrakking, AM (corresponding author), Erasmus MC, Dept Publ Hlth, Univ Med Ctr Rotterdam, POB 1738, NL-3000 DR Rotterdam, Netherlands.	a.vrakking@erasmusmc.nl						Buitendijk S, 2003, EUR J OBSTET GYN R B, V111, pS66, DOI 10.1016/j.ejogrb.2003.09.007; Cuttini M, 2000, LANCET, V355, P2112, DOI 10.1016/S0140-6736(00)02378-3; Lemons JA, 2000, PEDIATRICS, V105, P454; vanderHeide A, 1997, LANCET, V350, P251, DOI 10.1016/S0140-6736(97)02315-5; Wall SN, 1997, PEDIATRICS, V99, P64, DOI 10.1542/peds.99.1.64	5	43	43	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 9	2005	365	9467					1329	1331		10.1016/S0140-6736(05)61030-6	http://dx.doi.org/10.1016/S0140-6736(05)61030-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	914HY	15823383	Green Submitted			2022-12-24	WOS:000228219600028
J	Adams, EJ; Chien, YH; Garcia, KC				Adams, EJ; Chien, YH; Garcia, KC			Structure of a gamma delta T cell receptor in complex with the nonclassical MHC T22	SCIENCE			English	Article							CRYSTAL-STRUCTURE; ANTIGEN-RECOGNITION; LIGAND; PEPTIDE; LYMPHOCYTES; SPECIFICITY	gamma delta T cell receptors (TCRs), alpha beta TCRs, and antibodies are the three lineages of somatically recombined antigen receptors. The structural basis for ligand recognition is well. defined for alpha beta TCR and antibodies but is lacking for gamma delta TCRs. We present the 3.4 angstrom structure of the murine gamma delta TCR G8 bound to its major histocompatibillity complex (MHC) class Ib ligand, T22. G8 predominantly uses germ line-en coded residues of its 8 chain complementarity-determining region 3 (CDR3) loop to bind T22 in an orientation substantially different from that seen in alpha beta TCR/peptide-MHC. That junctionaily encoded G8 residues play an ancillary role in binding suggests a fusion of innate and adaptive recognition strategies.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94035 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94035 USA; Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94035 USA	Stanford University; Stanford University; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Fairchild D319,299 Campus Dr, Stanford, CA 94035 USA.	kcgarcia@stanford.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048540, R56AI048540] Funding Source: NIH RePORTER; NIAID NIH HHS [AI048540] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allison TJ, 2001, NATURE, V411, P820, DOI 10.1038/35081115; CARDING SR, 1990, J EXP MED, V172, P1225, DOI 10.1084/jem.172.4.1225; Chien YH, 2000, SPRINGER SEMIN IMMUN, V22, P239, DOI 10.1007/PL00006752; Chien YH, 1996, ANNU REV IMMUNOL, V14, P511, DOI 10.1146/annurev.immunol.14.1.511; Crowley MP, 2000, SCIENCE, V287, P314, DOI 10.1126/science.287.5451.314; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.immunol.11.1.637; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Hayes SM, 2002, IMMUNITY, V16, P827, DOI 10.1016/S1074-7613(02)00320-5; Kabelitz D, 2003, CRIT REV IMMUNOL, V23, P339, DOI 10.1615/CritRevImmunol.v23.i56.10; Li PW, 1999, IMMUNITY, V10, P577, DOI 10.1016/S1074-7613(00)80057-6; Li PW, 2001, NAT IMMUNOL, V2, P443, DOI 10.1038/87757; Li YL, 2003, NAT STRUCT BIOL, V10, P482, DOI 10.1038/nsb930; Matis L A, 1991, Semin Immunol, V3, P75; MATIS LA, 1987, NATURE, V330, P262, DOI 10.1038/330262a0; Morita CT, 2000, SPRINGER SEMIN IMMUN, V22, P191, DOI 10.1007/s002810000042; Reich Z, 1997, NATURE, V387, P617, DOI 10.1038/42500; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; Rudolph MG, 2002, CURR OPIN IMMUNOL, V14, P52, DOI 10.1016/S0952-7915(01)00298-9; Rudolph MG, 2004, ACTA CRYSTALLOGR D, V60, P656, DOI 10.1107/S0907444904002239; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; SCHILD H, 1994, CELL, V76, P29, DOI 10.1016/0092-8674(94)90170-8; Shin S, 2005, SCIENCE, V308, P252, DOI 10.1126/science.1106480; Stanfield RL, 2004, SCIENCE, V305, P1770, DOI 10.1126/science.1101148; Sundberg EJ, 2002, CURR OPIN IMMUNOL, V14, P36, DOI 10.1016/S0952-7915(01)00296-5; Wilson IA, 1997, CURR OPIN STRUC BIOL, V7, P839, DOI 10.1016/S0959-440X(97)80156-X; Wingren C, 2000, SCIENCE, V287, P310, DOI 10.1126/science.287.5451.310	31	192	196	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2005	308	5719					227	231		10.1126/science.1106885	http://dx.doi.org/10.1126/science.1106885			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915BX	15821084				2022-12-24	WOS:000228273700045
J	Geffeney, SL; Fujimoto, E; Brodie, ED; Brodie, ED; Ruben, PC				Geffeney, SL; Fujimoto, E; Brodie, ED; Brodie, ED; Ruben, PC			Evolutionary diversification of TTX-resistant sodium channels in a predator-prey interaction	NATURE			English	Article							NA+ CHANNEL; SKELETAL-MUSCLE; OUTER VESTIBULE; GARTER SNAKES; GENES; TETRODOTOXIN; EXPRESSION; SAXITOXIN; PATTERNS; PORE	Understanding the molecular genetic basis of adaptations provides incomparable insight into the genetic mechanisms by which evolutionary diversification takes place. Whether the evolution of common traits in different lineages proceeds by similar or unique mutations, and the degree to which phenotypic evolution is controlled by changes in gene regulation as opposed to gene function, are fundamental questions in evolutionary biology that require such an understanding of genetic mechanisms(1-3). Here we identify novel changes in the molecular structure of a sodium channel expressed in snake skeletal muscle, tsNa(V)1.4, that are responsible for differences in tetrodotoxin (TTX) resistance among garter snake populations coevolving with toxic newts(4). By the functional expression of tsNa(V)1.4, we show how differences in the amino-acid sequence of the channel affect TTX binding and impart different levels of resistance in four snake populations. These results indicate that the evolution of a physiological trait has occurred through a series of unique functional changes in a gene that is otherwise highly conserved among vertebrates.	Utah State Univ, Dept Biol, Logan, UT 84322 USA; Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Utah System of Higher Education; Utah State University; Indiana University System; Indiana University Bloomington	Geffeney, SL (corresponding author), Utah State Univ, Dept Biol, Logan, UT 84322 USA.	geffeney@biology.usu.edu	Brodie, Edmund D/B-2335-2013	Geffeney, Shana/0000-0003-0504-2077				Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Beldade P, 2002, NATURE, V415, P315, DOI 10.1038/415315a; Brodie ED, 2002, EVOLUTION, V56, P2067; Brodie ED, 1999, BIOSCIENCE, V49, P557, DOI 10.2307/1313476; Choudhary G, 2003, BIOPHYS J, V84, P287, DOI 10.1016/S0006-3495(03)74849-8; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; Geffeney S, 2002, SCIENCE, V297, P1336, DOI 10.1126/science.1074310; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hoekstra HE, 2003, MOL ECOL, V12, P1185, DOI 10.1046/j.1365-294X.2003.01788.x; Huey RB, 2002, SCIENCE, V297, P1289, DOI 10.1126/science.1075987; Janzen FJ, 2002, MOL ECOL, V11, P1739, DOI 10.1046/j.1365-294X.2002.01571.x; KALLEN RG, 1990, NEURON, V4, P233, DOI 10.1016/0896-6273(90)90098-Z; Kaneko Y, 1997, BIOCHEM BIOPH RES CO, V240, P651, DOI 10.1006/bbrc.1997.7696; Lipkind GM, 2000, BIOCHEMISTRY-US, V39, P8161, DOI 10.1021/bi000486w; Penzotti JL, 1998, BIOPHYS J, V75, P2647, DOI 10.1016/S0006-3495(98)77710-0; Plummer NW, 1999, GENOMICS, V57, P323, DOI 10.1006/geno.1998.5735; Rausher MD, 1999, MOL BIOL EVOL, V16, P266, DOI 10.1093/oxfordjournals.molbev.a026108; Raymond CK, 2004, J BIOL CHEM, V279, P46234, DOI 10.1074/jbc.M406387200; SATIN J, 1992, SCIENCE, V256, P1202, DOI 10.1126/science.256.5060.1202; Schluter D, 2004, AM NAT, V163, P809, DOI 10.1086/383621; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Stefani E, 1998, METHOD ENZYMOL, V293, P300; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; TERLAU H, 1991, FEBS LETT, V293, P93, DOI 10.1016/0014-5793(91)81159-6; TRIMMER JS, 1990, DEV BIOL, V142, P360, DOI 10.1016/0012-1606(90)90356-N; Yamagishi T, 2001, J GEN PHYSIOL, V118, P171, DOI 10.1085/jgp.118.2.171; Yamamoto Y, 2004, NATURE, V431, P844, DOI 10.1038/nature02864; Yotsu-Yamashita M, 2000, BIOCHEM BIOPH RES CO, V267, P403, DOI 10.1006/bbrc.1999.1974; Zakon HH, 2002, BRAIN BEHAV EVOLUT, V59, P250, DOI 10.1159/000063562	30	163	173	0	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 7	2005	434	7034					759	763		10.1038/nature03444	http://dx.doi.org/10.1038/nature03444			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	913NU	15815629				2022-12-24	WOS:000228160700040
J	Steffens, S; Veillard, NR; Arnaud, C; Pelli, G; Burger, F; Staub, C; Zimmer, A; Frossard, JL; Mach, F				Steffens, S; Veillard, NR; Arnaud, C; Pelli, G; Burger, F; Staub, C; Zimmer, A; Frossard, JL; Mach, F			Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice	NATURE			English	Article							E-DEFICIENT MICE; LESION FORMATION; RECEPTOR-DEFICIENT; CB2 RECEPTOR; LYMPHOCYTES; DELTA-9-TETRAHYDROCANNABINOL; INFLAMMATION; EXPRESSION; CELLS; DELTA(9)-TETRAHYDROCANNABINOL	Atherosclerosis is a chronic inflammatory disease, and is the primary cause of heart disease and stroke in Western countries(1). Derivatives of cannabinoids such as delta-9-tetrahydrocannabinol (THC) modulate immune functions(2) and therefore have potential for the treatment of inflammatory diseases. We investigated the effects of THC in a murine model of established atherosclerosis. Oral administration of THC (1 mg kg(-1) per day) resulted in significant inhibition of disease progression. This effective dose is lower than the dose usually associated with psychotropic effects of THC. Furthermore, we detected the CB2 receptor ( the main cannabinoid receptor expressed on immune cells(2,3)) in both human and mouse atherosclerotic plaques. Lymphoid cells isolated from THC-treated mice showed diminished proliferation capacity and decreased interferon-gamma secretion. Macrophage chemotaxis, which is a crucial step for the development of atherosclerosis(1), was also inhibited in vitro by THC. All these effects were completely blocked by a specific CB2 receptor antagonist(4). Our data demonstrate that oral treatment with a low dose of THC inhibits atherosclerosis progression in the apolipoprotein E knockout mouse model, through pleiotropic immunomodulatory effects on lymphoid and myeloid cells. Thus, THC or cannabinoids with activity at the CB2 receptor may be valuable targets for treating atherosclerosis.	Fdn Med Res, Dept Med, Div Cardiol, CH-1211 Geneva, Switzerland; Univ Hosp, Fac Med, Div Gastroenterol, CH-1211 Geneva, Switzerland; Univ Hosp, Fac Med, Inst Legal Med, CH-1211 Geneva, Switzerland; Univ Bonn, Dept Psychiat, Mol Neurobiol Lab, D-53105 Bonn, Germany	University of Geneva; University of Geneva; University of Geneva; University of Bonn	Mach, F (corresponding author), Fdn Med Res, Dept Med, Div Cardiol, CH-1211 Geneva, Switzerland.	Francois.Mach@medecine.unige.ch	Arnaud, Claire/D-4698-2014; Steffens, Sabine/AAV-4551-2020	Arnaud, Claire/0000-0003-0964-9423; Steffens, Sabine/0000-0002-6892-9751; Karsak, Meliha/0000-0001-6612-6317				Benagiano M, 2003, P NATL ACAD SCI USA, V100, P6658, DOI 10.1073/pnas.1135726100; Brenneisen R, 1996, INT J CLIN PHARM TH, V34, P446; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; CHESHER GB, 1990, PHARMACOL BIOCHEM BE, V35, P861, DOI 10.1016/0091-3057(90)90371-N; Daugherty A, 2002, CIRC RES, V90, P1039, DOI 10.1161/01.RES.0000021397.28936.F9; Giroud C, 2001, FORENSIC SCI INT, V123, P159, DOI 10.1016/S0379-0738(01)00538-2; Hickey MJ, 2002, J IMMUNOL, V168, P4728, DOI 10.4049/jimmunol.168.9.4728; Johnson Z, 2004, J IMMUNOL, V173, P5776, DOI 10.4049/jimmunol.173.9.5776; Klein TW, 2003, J LEUKOCYTE BIOL, V74, P486, DOI 10.1189/jlb.0303101; Kwak BR, 2003, CIRCULATION, V107, P1033, DOI 10.1161/01.CIR.0000051364.70064.D1; Laurat E, 2001, CIRCULATION, V104, P197, DOI 10.1161/01.CIR.104.2.197; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lichtman AH, 2001, DRUG ALCOHOL DEPEN, V63, P107, DOI 10.1016/S0376-8716(00)00205-2; LYMAN WD, 1989, J NEUROIMMUNOL, V23, P73, DOI 10.1016/0165-5728(89)90075-1; Mach F, 2004, CIRCULATION, V109, P15, DOI 10.1161/01.CIR.0000129502.10459.fe; Malfait AM, 2000, P NATL ACAD SCI USA, V97, P9561, DOI 10.1073/pnas.160105897; Moeller F, 2003, ATHEROSCLEROSIS, V168, P49, DOI 10.1016/S0021-9150(03)00026-1; Mulhaupt F, 2003, CARDIOVASC RES, V59, P755, DOI 10.1016/S0008-6363(03)00515-7; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; REDDICK RL, 1994, ARTERIOSCLER THROMB, V14, P141, DOI 10.1161/01.ATV.14.1.141; Rinaldi-Carmona M, 1998, J PHARMACOL EXP THER, V284, P644; Song L, 2001, J CLIN INVEST, V108, P251, DOI 10.1172/JCI11380; Srivastava MD, 1998, IMMUNOPHARMACOLOGY, V40, P179, DOI 10.1016/S0162-3109(98)00041-1; Sulcova E, 1998, PHARMACOL BIOCHEM BE, V59, P347, DOI 10.1016/S0091-3057(97)00422-X; TANGIRALA RK, 1995, J LIPID RES, V36, P2320; Varvel SA, 2001, PSYCHOPHARMACOLOGY, V157, P142; Veillard NR, 2004, ARTERIOSCL THROM VAS, V24, P2339, DOI 10.1161/01.ATV.0000146532.98235.e6; Yuan M, 2002, J NEUROIMMUNOL, V133, P124, DOI 10.1016/S0165-5728(02)00370-3; Zhu LX, 2000, J IMMUNOL, V165, P373, DOI 10.4049/jimmunol.165.1.373	30	348	391	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2005	434	7034					782	786		10.1038/nature03389	http://dx.doi.org/10.1038/nature03389			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	913NU	15815632				2022-12-24	WOS:000228160700045
J	Yamaguchi, H; Calado, RT; Ly, H; Kajigaya, S; Baerlocher, GM; Chanock, SJ; Lansdorp, PM; Young, NS				Yamaguchi, H; Calado, RT; Ly, H; Kajigaya, S; Baerlocher, GM; Chanock, SJ; Lansdorp, PM; Young, NS			Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LINKED DYSKERATOSIS-CONGENITA; CATALYTIC SUBUNIT; IN-VIVO; FUNCTIONAL MULTIMERIZATION; MYELODYSPLASTIC SYNDROME; ENZYME-ACTIVITY; RNA INTERACTION; DISEASE; HAPLOINSUFFICIENCY; DEFICIENT	BACKGROUND: Mutations in TERC, the gene for the RNA component of telomerase, cause short telomeres in congenital aplastic anemia and in some cases of apparently acquired hematopoietic failure. We investigated whether mutations in genes for other components of telomerase also occur in aplastic anemia. METHODS: We screened blood or marrow cells from 124 patients with apparently acquired aplastic anemia and 282 control subjects for sequence variations in the TERT, DKC1, NHP2, and NOP10 genes; an additional 81 patients and 246 controls were examined for genetic variations in TERT. Telomere lengths and the telomerase activity of peripheral-blood leukocytes were evaluated in patients carrying genetic variants. Identified mutations were transfected into telomerase-deficient cell lines to examine their effects and their mechanism of action on telomerase function. RESULTS: Five heterozygous, nonsynonymous mutations (which cause an amino acid change in the corresponding protein) were identified in TERT, the gene for the telomerase reverse transcriptase catalytic enzyme, among seven unrelated patients. Leukocytes from these patients had short telomeres and low telomerase enzymatic activity. In three of these patients, the mutation was also detected in buccal mucosa cells. Family members carrying the mutations also had short telomeres and reduced telomerase activity but no evident hematologic abnormality. The results of coexpression of wild-type TERT and TERT with aplastic anemia-associated mutations in a telomerase-deficient cell line suggested that haploinsufficiency was the mechanism of telomere shortening due to TERT mutations. CONCLUSIONS: Heterozygous mutations in the TERT gene impair telomerase activity by haploinsufficiency and may be risk factors for marrow failure.	NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA; NCI, Pediat Oncol Branch, NIH, Bethesda, MD 20892 USA; Emory Univ, Dept Pathol & Lab Med, Div Expt Pathol, Atlanta, GA 30322 USA; Univ British Columbia, Terry Fox Lab, BC Canc Res Ctr, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Dept Med, Vancouver, BC V5Z 1M9, Canada	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Emory University; British Columbia Cancer Agency; University of British Columbia; University of British Columbia	Young, NS (corresponding author), NHLBI, Hematol Branch, NIH, 10 Ctr Dr,Bldg 10,CRC,Rm 3E-5140, Bethesda, MD 20892 USA.	youngns@mail.nih.gov	Calado, Rodrigo T./G-2619-2011	Calado, Rodrigo T./0000-0002-7966-6029; Lansdorp, Peter/0000-0001-7435-1071	NATIONAL CANCER INSTITUTE [Z01SC010083] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002315, Z01HL002315] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alter B.P., 1994, APLASTIC ANEMIA ACQU, P271; Arai K, 2002, J BIOL CHEM, V277, P8538, DOI 10.1074/jbc.M111068200; Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; Baerlocher GM, 2003, CYTOM PART A, V55A, P1, DOI 10.1002/cyto.a.10064; Ball SE, 1998, BLOOD, V91, P3582; Banik SSR, 2002, MOL CELL BIOL, V22, P6234, DOI 10.1128/MCB.22.17.6234-6246.2002; Beattie TL, 2001, MOL CELL BIOL, V21, P6151, DOI 10.1128/MCB.21.18.6151-6160.2001; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Brummendorf TH, 2001, BLOOD, V97, P895, DOI 10.1182/blood.V97.4.895; Bryan TM, 2000, MOL CELL, V6, P493, DOI 10.1016/S1097-2765(00)00048-4; Calado RT, 2002, LANCET, V360, P1608, DOI 10.1016/S0140-6736(02)11551-0; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; Dufour C, 2004, BRIT J HAEMATOL, V126, P682, DOI 10.1111/j.1365-2141.2004.05102.x; Fogarty PF, 2003, LANCET, V362, P1628, DOI 10.1016/S0140-6736(03)14797-6; Harrington L, 2003, CANCER LETT, V194, P139, DOI 10.1016/S0304-3835(02)00701-2; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Kaufman DW, 1991, DRUG ETIOLOGY AGRANU; Kiss AM, 2004, MOL CELL BIOL, V24, P5797, DOI 10.1128/MCB.24.13.5797-5807.2004; Knight SW, 1999, AM J HUM GENET, V65, P50, DOI 10.1086/302446; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Liu Y, 2001, CURR BIOL, V11, P907; Liu Y, 2000, CURR BIOL, V10, P1459, DOI 10.1016/S0960-9822(00)00805-8; Ly H, 2005, BLOOD, V105, P2332, DOI 10.1182/blood-2004-09-3659; Ly H, 2003, MOL CELL BIOL, V23, P6849, DOI 10.1128/MCB.23.19.6849-6856.2003; Ly H, 2003, GENE DEV, V17, P1078, DOI 10.1101/gad.1060803; Maciejewski JP, 2001, BLOOD, V98, P3513, DOI 10.1182/blood.V98.13.3513; Marrone A, 2004, BLOOD, V104, P3936, DOI 10.1182/blood-2004-05-1829; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Moriarty TJ, 2004, MOL CELL BIOL, V24, P3720, DOI 10.1128/MCB.24.9.3720-3733.2004; Moriarty TJ, 2002, MOL CELL BIOL, V22, P1253, DOI 10.1128/MCB.22.4.1253-1265.2002; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Packer BR, 2004, NUCLEIC ACIDS RES, V32, pD528, DOI 10.1093/nar/gkh005; Peng J, 2003, HUM IMMUNOL, V64, P896, DOI 10.1016/S0198-8859(03)00141-1; Pogacic V, 2000, MOL CELL BIOL, V20, P9028, DOI 10.1128/MCB.20.23.9028-9040.2000; Risitano AM, 2004, LANCET, V364, P355, DOI 10.1016/S0140-6736(04)16724-X; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Ruggero D, 2003, SCIENCE, V299, P259, DOI 10.1126/science.1079447; Saunthararajah Y, 2002, BLOOD, V100, P1570, DOI 10.1182/blood.V100.5.1570.h81702001570_1570_1574; Stewart SA, 2000, SEMIN CANCER BIOL, V10, P399, DOI 10.1006/scbi.2000.0339; Theimer CA, 2003, P NATL ACAD SCI USA, V100, P449, DOI 10.1073/pnas.242720799; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy T, 2004, NAT GENET, V36, P447, DOI 10.1038/ng1346; Vulliamy T, 2002, LANCET, V359, P2168, DOI 10.1016/S0140-6736(02)09087-6; Wenz C, 2001, EMBO J, V20, P3526, DOI 10.1093/emboj/20.13.3526; Yamaguchi H, 2003, BLOOD, V102, P916, DOI 10.1182/blood-2003-01-0335; Young NS, 1997, NEW ENGL J MED, V336, P1365, DOI 10.1056/NEJM199705083361906; Young NS, 2002, ANN INTERN MED, V136, P534, DOI 10.7326/0003-4819-136-7-200204020-00011; Zeng WH, 2001, J CLIN INVEST, V108, P765, DOI 10.1172/JCI12687; Zhang AJ, 2003, AM J HUM GENET, V72, P940, DOI 10.1086/374565	53	514	556	2	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 7	2005	352	14					1413	1424		10.1056/NEJMoa042980	http://dx.doi.org/10.1056/NEJMoa042980			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	913IP	15814878				2022-12-24	WOS:000228145200005
J	Eisenberg, RS				Eisenberg, RS			Learning the value of drugs - Is rofecoxib a regulatory success story?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Michigan, Sch Law, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Eisenberg, RS (corresponding author), Univ Michigan, Sch Law, Ann Arbor, MI 48109 USA.							DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Eisenberg RS, 2001, HEALTH AFFAIR, V20, P119, DOI 10.1377/hlthaff.20.5.119; Mathews Anna Wilde, 2004, Wall St J (East Ed), pA7; Merrill RA, 1996, VA LAW REV, V82, P1753, DOI 10.2307/1073689; Topol EJ, 2004, NEW ENGL J MED, V351, P1707, DOI 10.1056/NEJMp048286	5	14	14	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2005	352	13					1285	1287		10.1056/NEJMp048358	http://dx.doi.org/10.1056/NEJMp048358			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	911JL	15800222	Green Submitted			2022-12-24	WOS:000227998300002
J	Spiliotis, ET; Kinoshita, M; Nelson, WJ				Spiliotis, ET; Kinoshita, M; Nelson, WJ			A mitotic septin scaffold required for mammalian chromosome congression and segregation	SCIENCE			English	Article							CENP-E; MICROTUBULE CAPTURE; BUDDING YEAST; PROTEIN-E; CHECKPOINT; CYTOKINESIS; COMPONENT; ACTIN; KINETOCHORES; ORGANIZATION	Coordination of cytokinesis with chromosome congression and segregation is critical for proper cell division, but the mechanism is unknown. Here, septins, a conserved family of polymerizing guanosine triphosphate-binding proteins, localized to the metaphase plate during mitosis. Septin depletion resulted in chromosome loss from the metaphase plate, lack of chromosome segregation and spindle elongation, and incomplete cytokinesis upon delayed mitotic exit. These defects correlated with loss of the mitotic motor and the checkpoint regulator centromere-associated protein E (CENP-E) from the kinetochores of congressing chromosomes. Mammalian septins may thus form a mitotic scaffold for CENP-E and other effectors to coordinate cytokinesis with chromosome congression and segregation.	Stanford Univ, Sch Med, Beckman Ctr Mol & Genet Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Kyoto Univ, Grad Sch Med, Biochem & Cell Biol Unit, Horizontal Med Res Org, Kyoto 6068501, Japan	Stanford University; Kyoto University	Nelson, WJ (corresponding author), Stanford Univ, Sch Med, Beckman Ctr Mol & Genet Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.	wjnelson@stanford.edu			NIGMS NIH HHS [R37 GM035527, GM35527, R01 GM035527] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035527, R01GM035527] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barral Y, 1999, GENE DEV, V13, P176, DOI 10.1101/gad.13.2.176; Carroll CW, 1998, J CELL BIOL, V143, P709, DOI 10.1083/jcb.143.3.709; Castillon GA, 2003, CURR BIOL, V13, P654, DOI 10.1016/S0960-9822(03)00247-1; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Dobbelaere J, 2004, SCIENCE, V305, P393, DOI 10.1126/science.1099892; Gladfelter AS, 2001, CURR OPIN MICROBIOL, V4, P681, DOI 10.1016/S1369-5274(01)00269-7; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; Kinoshita M, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-236; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kinoshita M, 1997, GENE DEV, V11, P1535, DOI 10.1101/gad.11.12.1535; Kline-Smith SL, 2004, MOL BIOL CELL, V15, P1146, DOI 10.1091/mbc.E03-08-0581; Kusch J, 2002, GENE DEV, V16, P1627, DOI 10.1101/gad.222602; Lippincott J, 1998, J CELL BIOL, V140, P355, DOI 10.1083/jcb.140.2.355; Longtine MS, 2000, MOL CELL BIOL, V20, P4049, DOI 10.1128/MCB.20.11.4049-4061.2000; Longtine MS, 2003, TRENDS CELL BIOL, V13, P403, DOI 10.1016/S0962-8924(03)00151-X; Longtine MS, 1996, CURR OPIN CELL BIOL, V8, P106, DOI 10.1016/S0955-0674(96)80054-8; Maney T, 1998, J CELL BIOL, V142, P787, DOI 10.1083/jcb.142.3.787; Mao YH, 2003, CELL, V114, P87, DOI 10.1016/S0092-8674(03)00475-6; McEwen BF, 2001, MOL BIOL CELL, V12, P2776, DOI 10.1091/mbc.12.9.2776; Nagata K, 2003, J BIOL CHEM, V278, P18538, DOI 10.1074/jbc.M205246200; Putkey FR, 2002, DEV CELL, V3, P351, DOI 10.1016/S1534-5807(02)00255-1; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Weaver BAA, 2003, J CELL BIOL, V162, P551, DOI 10.1083/jcb.200303167; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; YEN TJ, 1992, NATURE, V359, P536, DOI 10.1038/359536a0	27	188	197	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2005	307	5716					1781	1785		10.1126/science.1106823	http://dx.doi.org/10.1126/science.1106823			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774761	Green Accepted			2022-12-24	WOS:000227883900047
J	Snow, RW; Guerra, CA; Noor, AM; Myint, HY; Hay, SI				Snow, RW; Guerra, CA; Noor, AM; Myint, HY; Hay, SI			The global distribution of clinical episodes of Plasmodium falciparum malaria	NATURE			English	Article							MORTALITY; AFRICA; BURDEN; TRANSMISSION; POPULATION; MORBIDITY; CHILDREN; ABSENCE; DISEASE; WORLD	Interest in mapping the global distribution of malaria is motivated by a need to define populations at risk for appropriate resource allocation(1,2) and to provide a robust framework for evaluating its global economic impact(3,4). Comparison of older(5-7) and more recent(1,4) malaria maps shows how the disease has been geographically restricted, but it remains entrenched in poor areas of the world with climates suitable for transmission. Here we provide an empirical approach to estimating the number of clinical events caused by Plasmodium falciparum worldwide, by using a combination of epidemiological, geographical and demographic data. We estimate that there were 515 ( range 300 - 660) million episodes of clinical P. falciparum malaria in 2002. These global estimates are up to 50% higher than those reported by the World Health Organization ( WHO) and 200% higher for areas outside Africa, reflecting the WHO's reliance upon passive national reporting for these countries. Without an informed understanding of the cartography of malaria risk, the global extent of clinical disease caused by P. falciparum will continue to be underestimated.	KEMRI Wellcome Trust Res Labs, Publ Hlth Grp, Nairobi 00100, Kenya; Univ Oxford, John Radcliffe Hosp, Ctr Trop Med, Oxford OX3 9DS, England; Univ Oxford, Dept Zool, TALA Res Grp, Oxford OX1 3PS, England; Mahidol Univ, Fac Trop Med, Bangkok 10400, Thailand	University of Oxford; University of Oxford; Mahidol University	Snow, RW (corresponding author), KEMRI Wellcome Trust Res Labs, Publ Hlth Grp, POB 43640, Nairobi 00100, Kenya.	rsnow@wtnairobi.mimcom.net	Hay, Simon Iain/F-8967-2015; Snow, Robert William/AFR-1436-2022	Hay, Simon Iain/0000-0002-0611-7272; Snow, Robert William/0000-0003-3725-6088	Wellcome Trust [058992, 081829, 069045] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alles HK, 1998, PARASITOL TODAY, V14, P369, DOI 10.1016/S0169-4758(98)01296-4; [Anonymous], ITOGI NAUKI MEDICINS; Carter R, 2002, CLIN MICROBIOL REV, V15, P564, DOI 10.1128/CMR.15.4.564-594.2002; Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; *INT ASS MED ASS T, 2004, WORLD MAL RISK CHART; Kiszewski A, 2004, AM J TROP MED HYG, V70, P486, DOI 10.4269/ajtmh.2004.70.486; LYSENKO AJ, 1969, B WORLD HEALTH ORGAN, V40, P383; Maitland K, 1997, T ROY SOC TROP MED H, V91, P562, DOI 10.1016/S0035-9203(97)90026-2; MAYFONG M, 2004, TRENDS PARASITOL, V20, P233; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; METSELAAR D., 1959, Tropical and Geographical Medicine, V11, P157; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Murray CJL., 1996, GLOBAL HLTH STAT COM, V1996; Prusty SKR, 2001, ANN TROP MED PARASIT, V95, P133, DOI 10.1080/00034980120041080; RUSSELL PF, 1956, AM J TROP MED HYG, V5, P937, DOI 10.4269/ajtmh.1956.5.937; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; Snow RW, 1996, PARASITOL TODAY, V12, P455, DOI 10.1016/S0169-4758(96)30032-X; United Nations Development Program, 2003, HUM DEV REP 2003 MIL; *WHO, 2003, INT TRAV HLTH SIT 1; *WO, 1999, WORLD HLTH REP 1999	23	1988	2067	5	377	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 10	2005	434	7030					214	217		10.1038/nature03342	http://dx.doi.org/10.1038/nature03342			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15759000	Green Accepted			2022-12-24	WOS:000227494500045
J	McMahon, BJ; Bruden, DL; Petersen, KM; Bulkow, LR; Parkinson, AJ; Nainan, O; Khristova, M; Zanis, C; Peters, H; Margolis, HS				McMahon, BJ; Bruden, DL; Petersen, KM; Bulkow, LR; Parkinson, AJ; Nainan, O; Khristova, M; Zanis, C; Peters, H; Margolis, HS			Antibody levels and protection after hepatitis B vaccination: Results of a 15-year follow-up	ANNALS OF INTERNAL MEDICINE			English	Article							YUPIK ESKIMO POPULATION; HEALTH-CARE WORKERS; LONG-TERM EFFICACY; VIRUS-INFECTION; SURFACE-ANTIGEN; CHILDHOOD VACCINATION; ALASKA NATIVES; CHILDREN; IMMUNOGENICITY; INFANTS	Background: The duration of protection afforded by hepatitis B vaccination is unknown. Objective: To determine antibody persistence and protection from hepatitis B virus (HBV) infection. Design: Prospective cohort study. Setting: 15 villages in southwest Alaska. Participants: 1578 Alaska Natives vaccinated at age 6 months or older. Intervention: During 1981-1982, participants received 3 doses of plasma-derived hepatitis 8 vaccine. This cohort was followed annually over the first 11 years, and 841 (53%) persons were tested at 15 years. Measurements: Antibody to hepatitis B surface antigen (anti-HBs), markers of HBV infection, and testing to identify HBV variants. Results: Levels of anti-HBs in the cohort decreased from a geometric mean concentration of 822 mIU/mL after vaccination to 27 mIU/mL at 15 years. Initial anti-HBs level, older age at vaccination, and male sex were associated with persistence of higher anti-HBs levels at 15 years when analyzed by a longitudinal linear mixed model. After adjustment for initial anti-HBs level and sex, those vaccinated at age 6 months to 4 years had the lowest anti-HBs level at 15 years. Asymptomatic breakthrough infections were detected in 16 participants and occurred more frequently in persons who did not respond to vaccination than those who responded (P = 0.01). Among infected persons with viremia, 2 were infected with wild-type HBV and 4 had HBV surface glycoprotein variants, generally accompanied by wild-type HBV. Limitations: The loss of participants to follow-up at 15 years was 47%. However, characteristics of persons tested were similar to those of persons lost to follow-up. Conclusions: Hepatitis B vaccination strongly protected against infection for at least 15 years in all age groups. Antibody levels decreased the most among persons immunized at 4 years of age or younger.	Ctr Dis Control & Prevent, Arct Invest Program, Natl Ctr Infect Dis, Anchorage, AK 99508 USA; Alaska Native Med Ctr, Anchorage, AK USA; Ctr Dis Control & Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Alaska Native Medical Center; Centers for Disease Control & Prevention - USA	McMahon, BJ (corresponding author), Ctr Dis Control & Prevent, Arct Invest Program, Natl Ctr Infect Dis, 4055 Tudor Ctr Dr, Anchorage, AK 99508 USA.	bdm9@cdc.gov			ODCDC CDC HHS [U50/CCU022279] Funding Source: Medline	ODCDC CDC HHS		Barash C, 1999, ARCH INTERN MED, V159, P1481, DOI 10.1001/archinte.159.13.1481; Brechot C, 2001, HEPATOLOGY, V34, P194, DOI 10.1053/jhep.2001.25172; Bulkow LR, 1998, CLIN INFECT DIS, V26, P933, DOI 10.1086/513939; CARMAN WF, 1990, LANCET, V336, P325, DOI 10.1016/0140-6736(90)91874-A; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DING LM, 1993, CLIN INFECT DIS, V17, P475; FORTUIN M, 1994, J INFECT DIS, V169, P1374, DOI 10.1093/infdis/169.6.1374; GOH KT, 1992, B WORLD HEALTH ORGAN, V70, P233; HADLER SC, 1986, NEW ENGL J MED, V315, P209, DOI 10.1056/NEJM198607243150401; HADLER SC, 1991, VIRAL HEPATITIS AND LIVER DISEASE, P766; Harpaz R, 2000, J INFECT DIS, V181, P413, DOI 10.1086/315259; HEYWARD WL, 1985, AM J EPIDEMIOL, V121, P914, DOI 10.1093/oxfordjournals.aje.a114061; Hino K, 1999, HEPATOLOGY, V30, p300A; Hsu HY, 1997, HEPATOLOGY, V26, P786, DOI 10.1053/jhep.1997.v26.pm0009303514; Huang LM, 1999, HEPATOLOGY, V29, P954, DOI 10.1002/hep.510290349; LAI CL, 1993, HEPATOLOGY, V18, P763, DOI 10.1002/hep.1840180403; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; MCMAHON BJ, 1993, AM J EPIDEMIOL, V138, P544; McMahon BJ, 2001, ANN INTERN MED, V135, P759, DOI 10.7326/0003-4819-135-9-200111060-00006; McMahon BJ, 2000, VIRAL HEPATITIS REV, V6, P229; MILNE A, 1994, J MED VIROL, V44, P113, DOI 10.1002/jmv.1890440202; Nainan OV, 1996, J VIROL METHODS, V61, P127, DOI 10.1016/0166-0934(96)02077-0; Nainan OV, 2002, J MED VIROL, V68, P319, DOI 10.1002/jmv.10206; Ni YH, 2001, ANN INTERN MED, V135, P796, DOI 10.7326/0003-4819-135-9-200111060-00009; Ogata N, 1999, HEPATOLOGY, V30, P779, DOI 10.1002/hep.510300309; PASKO MT, 1990, AM J PUBLIC HEALTH, V80, P590, DOI 10.2105/AJPH.80.5.590; Rehermann B, 1996, NAT MED, V2, P1104, DOI 10.1038/nm1096-1104; STEVENS CE, 1992, PEDIATRICS, V90, P170; TABOR E, 1993, J MED VIROL, V40, P204, DOI 10.1002/jmv.1890400307; WAINWRIGHT RB, 1989, JAMA-J AM MED ASSOC, V261, P2362, DOI 10.1001/jama.261.16.2362; Wainwright RB, 1997, J INFECT DIS, V175, P674, DOI 10.1093/infdis/175.3.674; WAINWRIGHT RB, 1991, ARCH INTERN MED, V151, P1634, DOI 10.1001/archinte.151.8.1634; WHITTLE HC, 1991, LANCET, V337, P747, DOI 10.1016/0140-6736(91)91367-4; Williams JL, 2001, VACCINE, V19, P4081, DOI 10.1016/S0264-410X(01)00112-8; Wu JS, 1999, J INFECT DIS, V179, P1319, DOI 10.1086/314768; XU ZY, 1995, J INFECT DIS, V171, P54, DOI 10.1093/infdis/171.1.54; Yotsuyanagi H, 1998, HEPATOLOGY, V27, P1377, DOI 10.1002/hep.510270526; YVONNET B, 1987, J MED VIROL, V22, P315, DOI 10.1002/jmv.1890220404	38	215	227	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2005	142	5					333	341		10.7326/0003-4819-142-5-200503010-00008	http://dx.doi.org/10.7326/0003-4819-142-5-200503010-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	902BB	15738452				2022-12-24	WOS:000227325100003
J	Machens, CK; Romo, R; Brody, CD				Machens, CK; Romo, R; Brody, CD			Flexible control of mutual inhibition: A neural model of two-interval discrimination	SCIENCE			English	Article							PARAMETRIC WORKING-MEMORY; PREFRONTAL CORTEX; DECISION-MAKING; PERSISTENT ACTIVITY; RECURRENT NETWORK; PREMOTOR CORTEX; REVERBERATION; MECHANISMS; DYNAMICS; STIMULI	Networks adapt to environmental demands by switching between distinct dynamical behaviors. The activity of frontal-lobe neurons during two-interval discrimination tasks is an example of these adaptable dynamics. Subjects first perceive a stimulus, then hold it in working memory, and finally make a decision by comparing it with a second stimulus. We present a simple mutual-inhibition network model that captures all three task phases within a single framework. The model integrates both working memory and decision making because its dynamical properties are easily controlled without changing its connectivity. Mutual inhibition between nonlinear units is a useful design motif for networks that must display multiple behaviors.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico	Cold Spring Harbor Laboratory; Universidad Nacional Autonoma de Mexico	Brody, CD (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	brody@cshl.edu		Machens, Christian/0000-0003-1717-1562; romo, ranulfo/0000-0003-3529-3635	NIMH NIH HHS [1R01MH067991-01] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067991] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abarbanel HD, 2001, CURR OPIN NEUROBIOL, V11, P423, DOI 10.1016/S0959-4388(00)00229-4; BRODY C, UNPUB; Brody CD, 2003, CEREB CORTEX, V13, P1196, DOI 10.1093/cercor/bhg100; Brody CD, 2003, CURR OPIN NEUROBIOL, V13, P204, DOI 10.1016/S0959-4388(03)00050-3; BROWN E, IN PRESS INT J BIFUR; Carmichael ST, 1995, J COMP NEUROL, V363, P642, DOI 10.1002/cne.903630409; Cowan Nelson, 1999, MODELS WORKING MEMOR; Dayan P., 2001, THEORETICAL NEUROSCI; Green DM, 1966, SIGNAL DETECTION THE; Hernandez A, 1997, J NEUROSCI, V17, P6391; Hernandez A, 2002, NEURON, V33, P959, DOI 10.1016/S0896-6273(02)00613-X; HOPPENSTEADT FC, 1997, INTRO MATH NEURONS, P155; Koulakov AA, 2002, NAT NEUROSCI, V5, P775, DOI 10.1038/nn893; Link SW, 1992, WAVE THEORY DIFFEREN; Loewenstein Y, 2003, NAT NEUROSCI, V6, P961, DOI 10.1038/nn1109; Luce R.D., 1991, RESPONSE TIMES THEIR; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller P, 2003, CEREB CORTEX, V13, P1208, DOI 10.1093/cercor/bhg101; Moody SL, 1998, J NEUROSCI, V18, P399; MORISHITA I, 1972, KYBERNETIK, V11, P154, DOI 10.1007/BF00270672; RATCLIFF R, 1981, PSYCHOL REV, V88, P552, DOI 10.1037/0033-295X.88.6.552; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Romo R, 2001, ANNU REV NEUROSCI, V24, P107, DOI 10.1146/annurev.neuro.24.1.107; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Romo R, 2004, NEURON, V41, P165, DOI 10.1016/S0896-6273(03)00817-1; Romo R, 2002, NAT NEUROSCI, V5, P1217, DOI 10.1038/nn950; Rudolph U, 2004, ANNU REV PHARMACOL, V44, P475, DOI 10.1146/annurev.pharmtox.44.101802.121429; Salinas E, 2004, J NEUROSCI, V24, P1113, DOI 10.1523/JNEUROSCI.4569-03.2004; Salinas E, 2003, NEURAL COMPUT, V15, P1439, DOI 10.1162/089976603321891756; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Seung HS, 2000, J COMPUT NEUROSCI, V9, P171, DOI 10.1023/A:1008971908649; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; Seung HS., 2003, HDB BRAIN THEORY NEU, V2, P94; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Wilson H.R., 1999, SPIKES DECISIONS ACT; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	39	337	339	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2005	307	5712					1121	1124		10.1126/science.1104171	http://dx.doi.org/10.1126/science.1104171			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ED	15718474				2022-12-24	WOS:000227197300052
J	Kaufman, FR				Kaufman, FR			Intensive management of type 1 diabetes in young children	LANCET			English	Editorial Material							MELLITUS		Univ So Calif, Childrens Hosp, Keck Sch Med, Ctr Diabet Endocrinol & Metab, Los Angeles, CA 90027 USA	Children's Hospital Los Angeles; University of Southern California	Kaufman, FR (corresponding author), Univ So Calif, Childrens Hosp, Keck Sch Med, Ctr Diabet Endocrinol & Metab, Los Angeles, CA 90027 USA.	fkaufman@chla.usc.edu						Dahlquist G, 2000, ACTA PAEDIATR, V89, P1231, DOI 10.1080/080352500750027628; DCCT Res Grp, 1994, J PEDIATR-US, V125, P177, DOI 10.1016/S0022-3476(94)70190-3; Kaufman FR, 1999, DIABETES-METAB RES, V15, P338, DOI 10.1002/(SICI)1520-7560(199909/10)15:5<338::AID-DMRR57>3.3.CO;2-P; Kaufman FR, 2003, PEDIATR REV, V24, P291, DOI 10.1542/pir.24-9-291; Kaufman FR, 1999, J DIABETES COMPLICAT, V13, P31, DOI 10.1016/S1056-8727(98)00029-4; Kaufman Francine Ratner, 2002, Pediatr Diabetes, V3, P179, DOI 10.1034/j.1399-5448.2002.30402.x; Ryan CM, 1999, ENDOCRIN METAB CLIN, V28, P883, DOI 10.1016/S0889-8529(05)70107-9; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Weinzimer SA, 2004, PEDIATRICS, V114, P1601, DOI 10.1542/peds.2004-0092	9	8	8	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB-MAR	2005	365	9461					737	738						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LZ	15733703				2022-12-24	WOS:000227285300008
J	Spiegel, PB				Spiegel, PB			Differences in world responses to natural disasters and complex emergencies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MORTALITY; HEALTH; WAR; POPULATIONS; ATTITUDES; KOSOVO; DARFUR; SUDAN		UN High Commissioner Refugees, CH-1211 Geneva, Switzerland		Spiegel, PB (corresponding author), UN High Commissioner Refugees, Case Postale 2500, CH-1211 Geneva, Switzerland.	spiegel@unhcr.ch	Spiegel, Paul/AAL-3238-2021	Spiegel, Paul/0000-0002-6158-6661				Anderson Mary B., 1999, DO NO HARM AID CAN S; [Anonymous], 2004, SUDAN DARFUR RAPE WE; [Anonymous], 2004, DEMOCRATIC REPUBLIC; [Anonymous], 1997, PUBLIC HLTH CONSEQUE; BECKER E, 2005, US NEARLY TRIPLES TS; Cardozo BL, 2000, JAMA-J AM MED ASSOC, V284, P569, DOI 10.1001/jama.284.5.569; Connolly MA, 2004, LANCET, V364, P1974, DOI 10.1016/S0140-6736(04)17481-3; CORDER M, 2005, FEARS TSUNAMI DEAD C; de Goyet CD, 2000, LANCET, V356, P762, DOI 10.1016/S0140-6736(00)02642-8; Depoortere E, 2004, LANCET, V364, P1315, DOI 10.1016/S0140-6736(04)17187-0; Deutsche Presse Agentur, 2005, INDONESIA ACEH REBEL; *EUR PROGR INT EP, RETR MORT SURV INT D; Grandesso F, 2005, JAMA-J AM MED ASSOC, V293, P1490, DOI 10.1001/jama.293.12.1490; GURR T, 2003, EARLY WARNING SYSTEM; HOGE W, 2005, UN OFFICIAL SAYS PLE; *IRC, 2004, IRC STUD REV 31 000; King Dennis, 2002, PAYING ULTIMATE PRIC; LECHAT MF, 1990, EPIDEMIOL REV, V12, P192, DOI 10.1093/oxfordjournals.epirev.a036053; LEWIS D, 2005, 9 UN PEACEKEEPERS KI; MISHIYAMA G, 2005, UNICEF CONF TSUN CHI; NAKASHIMA E, 2005, ACEH REBELS DESCRIBE; *PAN AM HLTH ORG, 1981, EM HLTH MAN NAT DIS, V407; Pham PN, 2004, JAMA-J AM MED ASSOC, V292, P602, DOI 10.1001/jama.292.5.602; PINE A, 1993, US SOLDIERS KILLED 2; Salama P, 2004, LANCET, V364, P1801, DOI 10.1016/S0140-6736(04)17405-9; Sen A.K., 1999, DEV FREEDOM; Sheik M, 2000, BRIT MED J, V321, P166, DOI 10.1136/bmj.321.7254.166; Spiegel PB, 2000, LANCET, V355, P2204, DOI 10.1016/S0140-6736(00)02404-1; TOOLE MJ, 1990, JAMA-J AM MED ASSOC, V263, P3296, DOI 10.1001/jama.263.24.3296; TOOLE MJ, 1993, JAMA-J AM MED ASSOC, V270, P600, DOI 10.1001/jama.270.5.600; *UN, 2004, PLEDG C UN RAIS 520; *UNICEF, 2005, PROT CHILDR TSUN ZON; World Health Organization, 2003, MENT SOC ASP HLTH PO; 2005, WORLD LEADERS WARNED; 2004, MEASLES MALNUTRITION; SITUATION DARFUR SAV; 2005, SITUATION REPORTS S; 1998, WORLD S ASIA UN WARN	38	23	23	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2005	293	15					1915	1918		10.1001/jama.293.15.1915	http://dx.doi.org/10.1001/jama.293.15.1915			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QW	15840867				2022-12-24	WOS:000228401700031
J	Nakajima, M; Imai, K; Ito, H; Nishiwaki, T; Murayama, Y; Iwasaki, H; Oyarna, T; Kondo, T				Nakajima, M; Imai, K; Ito, H; Nishiwaki, T; Murayama, Y; Iwasaki, H; Oyarna, T; Kondo, T			Reconstitution of circadian oscillation of cyanobacterial KaiC phosphorylation in vitro	SCIENCE			English	Article							CLOCK SYSTEM; EXPRESSION; FEEDBACK; GENETICS; TIME	Kai proteins globally regulate circadian gene expression of cyanobacteria. The KaiC phosphorylation cycle, which persists even without transcription or translation, is assumed to be a basic timing process of the circadian clock. We have reconstituted the self-sustainable oscillation of KaiC phosphorylation in vitro by incubating KaiC with KaiA, KaiB, and adenosine triphosphate. The period of the in vitro oscillation was stable despite temperature change (temperature compensation), and the circadian periods observed in vivo in KaiC mutant strains were consistent with those measured in vitro. The enigma of the circadian clock can now be studied in vitro by examining the interactions between three Kai proteins.	Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; JST, CREST, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Nagoya University; Japan Science & Technology Agency (JST)	Kondo, T (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	kondo@bio.nagoya-u.ac.jp	Ito, Hiroshi/A-7782-2010; Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Iwasaki, Hideo/0000-0002-3754-4955				Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; Dunlap JC, 2004, J BIOL RHYTHM, V19, P414, DOI 10.1177/0748730404269116; Hayashi F, 2003, GENES CELLS, V8, P287, DOI 10.1046/j.1365-2443.2003.00633.x; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; Kitayama Y, 2003, EMBO J, V22, P2127, DOI 10.1093/emboj/cdg212; KONDO T, 1993, P NATL ACAD SCI USA, V90, P5672, DOI 10.1073/pnas.90.12.5672; Mori T, 2002, P NATL ACAD SCI USA, V99, P17203, DOI 10.1073/pnas.262578499; Nakahira Y, 2004, P NATL ACAD SCI USA, V101, P881, DOI 10.1073/pnas.0307411100; Nishiwaki T, 2004, P NATL ACAD SCI USA, V101, P13927, DOI 10.1073/pnas.0403906101; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; Xu Y, 2004, P NATL ACAD SCI USA, V101, P13933, DOI 10.1073/pnas.0404768101; Xu Y, 2003, EMBO J, V22, P2117, DOI 10.1093/emboj/cdg168; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	15	739	775	5	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2005	308	5720					414	415		10.1126/science.1108451	http://dx.doi.org/10.1126/science.1108451			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15831759				2022-12-24	WOS:000228492000053
J	Miller, LG; Perdreau-Remington, F; Rieg, G; Mehdi, S; Perlroth, J; Bayer, AS; Tang, AW; Phung, TO; Spellberg, B				Miller, LG; Perdreau-Remington, F; Rieg, G; Mehdi, S; Perlroth, J; Bayer, AS; Tang, AW; Phung, TO; Spellberg, B			Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PANTON-VALENTINE LEUKOCIDIN; FIELD GEL-ELECTROPHORESIS; SOFT-TISSUE INFECTIONS; STREPTOCOCCAL INFECTIONS; ACQUIRED PNEUMONIA; VIRULENCE FACTORS; UNITED-STATES; RISK-FACTORS; SKIN; IDENTIFICATION	BACKGROUND: Necrotizing fasciitis is a life-threatening infection requiring urgent surgical and medical therapy. Staphylococcus aureus has been a very uncommon cause of necrotizing fasciitis, but we have recently noted an alarming number of these infections caused by community-associated methicillin-resistant S. aureus (MRSA). METHODS: We reviewed the records of 843 patients whose wound cultures grew MRSA at our center from January 15, 2003, to April 15, 2004. Among this cohort, 14 were identified as patients presenting from the community with clinical and intraoperative findings of necrotizing fasciitis, necrotizing myositis, or both. Results: The median age of the patients was 46 years (range, 28 to 68), and 71 percent were men. Coexisting conditions or risk factors included current or past injection-drug use (43 percent); previous MRSA infection, diabetes, and chronic hepatitis C (21 percent each); and cancer and human immunodeficiency virus infection or the acquired immunodeficiency syndrome (7 percent each). Four patients (29 percent) had no serious coexisting conditions or risk factors. All patients received combined medical and surgical therapy, and none died, but they had serious complications, including the need for reconstructive surgery and prolonged stay in the intensive care unit. Wound cultures were monomicrobial for MRSA in 86 percent, and 40 percent of patients (4 of 10) for whom blood cultures were obtained had positive results. All MRSA isolates were susceptible in vitro to clindamycin, trimethoprim-sulfamethoxazole, and rifampin. All recovered isolates belonged to the same genotype (multilocus sequence type ST8, pulsed-field type USA300, and staphylococcal cassette chromosome mec type IV [SCCmecIV]) and carried the Panton-Valentine leukocidin (pvl), lukD, and lukE genes, but no other toxin genes were detected. CONCLUSIONS: Necrotizing fasciitis caused by community-associated MRSA is an emerging clinical entity. In areas in which community-associated MRSA infection is endemic, empirical treatment of suspected necrotizing fasciitis should include antibiotics predictably active against this pathogen.	Harbor UCLA Med Ctr, Div Infect Dis, Torrance, CA 90509 USA; Harbor UCLA Med Ctr, Div HIV Med, Torrance, CA 90509 USA; Harbor UCLA Med Ctr, Dept Internal Med, Torrance, CA 90509 USA; Harbor UCLA Med Ctr, Los Angeles Biomed Inst, Torrance, CA 90509 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; St Mary Hosp, Long Beach, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California San Francisco	Miller, LG (corresponding author), Harbor UCLA Med Ctr, Div Infect Dis, Torrance, CA 90509 USA.		a, a/M-9467-2013		ODCDC CDC HHS [R01/CCR923417-01] Funding Source: Medline	ODCDC CDC HHS		Baggett HC, 2004, J INFECT DIS, V189, P1565, DOI 10.1086/383247; Bancroft E, 2003, 41 ANN M INF DIS SOC; Bisno AL, 1996, NEW ENGL J MED, V334, P240, DOI 10.1056/NEJM199601253340407; Blevins JS, 2002, INFECT IMMUN, V70, P470, DOI 10.1128/IAI.70.2.470-480.2002; Boussaud V, 2003, INTENS CARE MED, V29, P1840, DOI 10.1007/s00134-003-1918-5; BROOK I, 1995, ARCH SURG-CHICAGO, V130, P786; BROOK I, 1995, J CLIN MICROBIOL, V33, P2382, DOI 10.1128/JCM.33.9.2382-2387.1995; Carleton HA, 2004, J INFECT DIS, V190, P1730, DOI 10.1086/425019; Carratala J, 2003, EUR J CLIN MICROBIOL, V22, P151, DOI 10.1007/s10096-003-0902-x; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P88; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Charlebois ED, 2002, CLIN INFECT DIS, V34, P425, DOI 10.1086/338069; CRIBIER B, 1992, DERMATOLOGY, V185, P175, DOI 10.1159/000247443; Davies HD, 1996, NEW ENGL J MED, V335, P547, DOI 10.1056/NEJM199608223350803; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Diep BA, 2004, J CLIN MICROBIOL, V42, P2080, DOI 10.1128/JCM.42.5.2080-2084.2004; Diep BA, 2003, J CLIN MICROBIOL, V41, P4559, DOI 10.1128/JCM.41.10.4559-4564.2003; Eady EA, 2003, CURR OPIN INFECT DIS, V16, P103, DOI 10.1097/00001432-200304000-00007; Eguia Jose M., 2003, Curr Infect Dis Rep, V5, P459, DOI 10.1007/s11908-003-0087-6; Elliott D, 2000, AM J SURG, V179, P361, DOI 10.1016/S0002-9610(00)00360-3; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; File Thomas M. Jr., 2000, Comprehensive Therapy, V26, P73, DOI 10.1007/s12019-000-0015-8; Fontes R A Jr, 2000, J Am Acad Orthop Surg, V8, P151; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; FRAZEE B, IN PRESS ANN EMERG M; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Headley AJ, 2003, AM FAM PHYSICIAN, V68, P323; Imamura Yuzo, 1995, Journal of Dermatology (Tokyo), V22, P960; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P3677; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Klein JL, 2003, INTENS CARE MED, V29, P1399, DOI 10.1007/s00134-003-1844-6; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Ma XX, 2002, ANTIMICROB AGENTS CH, V46, P1147, DOI 10.1128/AAC.46.4.1147-1152.2002; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; MCHENRY CR, 1995, ANN SURG, V221, P558, DOI 10.1097/00000658-199505000-00013; MILLER LG, 2004, 42 ANN M INF DIS SOC; Mongkolrattanothai K, 2003, CLIN INFECT DIS, V37, P1050, DOI 10.1086/378277; Moore PCL, 2001, J CLIN MICROBIOL, V39, P2760, DOI 10.1128/JCM.39.8.2760-2767.2001; MORFELDT E, 1995, EMBO J, V14, P4569, DOI 10.1002/j.1460-2075.1995.tb00136.x; Munckhof Wendy J., 2003, International Journal of Infectious Diseases, V7, P259, DOI 10.1016/S1201-9712(03)90104-4; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Osterlund A, 2002, SCAND J INFECT DIS, V34, P763, DOI 10.1080/0036554021000026927; Pan ES, 2003, CLIN INFECT DIS, V37, P1384, DOI 10.1086/379019; PERDREAUREMINGT.F, 2003, 43 INT C ANT AG CHEM; PREVOST G, 1995, J MED MICROBIOL, V42, P237, DOI 10.1099/00222615-42-4-237; Purcell K, 2002, PEDIATR INFECT DIS J, V21, P988, DOI 10.1097/00006454-200210000-00028; Rezende NA, 2002, AM J MED SCI, V323, P117, DOI 10.1097/00000441-200203000-00001; Roth A, 2003, ARCH ORTHOP TRAUM SU, V123, P429, DOI 10.1007/s00402-003-0535-7; Sande MA, 2004, SANFORD GUIDE ANTIMI; Sattler CA, 2002, PEDIATR INFECT DIS J, V21, P910, DOI 10.1097/00006454-200210000-00005; Seal DV, 2001, CURR OPIN INFECT DIS, V14, P127, DOI 10.1097/00001432-200104000-00003; Siberry GK, 2003, CLIN INFECT DIS, V37, P1257, DOI 10.1086/377501; SIGURDSSON AF, 1989, SCAND J INFECT DIS, V21, P537, DOI 10.3109/00365548909037882; SWARTZ MN, 2000, MANDELL DOUGLAS BENN, P1037; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; WARD PD, 1980, INFECT IMMUN, V28, P393; Witte W., 2004, EUROSURVEILLANCE, V9, P1; Wong CH, 2003, J BONE JOINT SURG AM, V85A, P1454, DOI 10.2106/00004623-200308000-00005; Wu Kun-Chan, 2002, Journal of Microbiology Immunology and Infection, V35, P53; 2003, MMWR MORB MORTAL WKL, V52, P793; 2003, MMWR MORB MORTAL WKL, V52, P992; 2003, JAMA, V289, P1377	67	732	758	1	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 7	2005	352	14					1445	1453		10.1056/NEJMoa042683	http://dx.doi.org/10.1056/NEJMoa042683			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	913IP	15814880				2022-12-24	WOS:000228145200008
J	Chacinska, A; Lind, M; Frazier, AE; Dudek, J; Meisinger, C; Geissler, A; Sickmann, A; Meyer, HE; Truscott, KN; Guiard, B; Pfanner, N; Rehling, P				Chacinska, A; Lind, M; Frazier, AE; Dudek, J; Meisinger, C; Geissler, A; Sickmann, A; Meyer, HE; Truscott, KN; Guiard, B; Pfanner, N; Rehling, P			Mitochondrial presequence translocase: Switching between TOM tethering and motor recruitment involves Tim21 and Tim17	CELL			English	Article							PROTEIN IMPORT MOTOR; PREPROTEIN TRANSLOCASE; INTERMEMBRANE SPACE; CONTACT SITES; MEMBRANES; MATRIX; TIM50; INNER; COCHAPERONE; COMPONENT	The presequence translocase of the inner mitochondrial membrane (TIM23 complex) operates at a central junction of protein import. It accepts preproteins from the outer membrane TOM complex and directs them to inner membrane insertion or, in cooperation with the presequence translocase-associated motor (PAM), to the matrix. Little is known of how the TIM23 complex coordinates these tasks. We have identified Tim21 (YGR033c) that interacts with the TOM complex. Tim21 is specific for a TIM23 form that cooperates with TOM and promotes inner membrane insertion. Protein translocation into the matrix requires a switch to a Tim21-free, PAM bound presequence translocase. Tim17 is crucial for the switch by performing two separable functions: promotion of inner membrane insertion and binding of Pam18 to form the functional TIM-PAM complex. Thus, the presequence translocase is not a static complex but switches between TOM tethering and PAM binding in a reaction cycle involving Tim21 and Tim17.	Univ Freiburg, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; Uppsala Univ, Evolut Biol Ctr, Dept Comparat Physiol, SE-75236 Uppsala, Sweden; Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97078 Wurzburg, Germany; Ruhr Univ Bochum, Med Proteom Ctr, D-44780 Bochum, Germany; La Trobe Univ, Dept Biochem, Melbourne, Vic 3086, Australia; Univ Paris 06, CNRS, Lab Propre, F-91190 Gif Sur Yvette, France	University of Freiburg; Uppsala University; University of Freiburg; University of Wurzburg; Ruhr University Bochum; La Trobe University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay	Pfanner, N (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, Hermann Herder Str 7, D-79104 Freiburg, Germany.	nikolaus.pfanner@biochemie.uni-freiburg.de; peter.rehling@biochemie.uni-freiburg.de	Truscott, Kaye/D-3362-2012; Sickmann, Albert/A-1010-2011; Pfanner, Nikolaus/AAV-7878-2021; Meisinger, Chris/J-1110-2014	Sickmann, Albert/0000-0002-2388-5265; Meisinger, Chris/0000-0002-8326-3548; Frazier, Ann/0000-0002-6491-3437; Truscott, Kaye/0000-0002-5352-9835; Chacinska, Agnieszka/0000-0002-2832-2568				Bauer MF, 2000, TRENDS CELL BIOL, V10, P25, DOI 10.1016/S0962-8924(99)01684-0; Chacinska A, 2003, EMBO J, V22, P5370, DOI 10.1093/emboj/cdg532; D'Silva PD, 2003, P NATL ACAD SCI USA, V100, P13839, DOI 10.1073/pnas.1936150100; Dekker PJT, 1997, EMBO J, V16, P5408, DOI 10.1093/emboj/16.17.5408; Donzeau M, 2000, CELL, V101, P401, DOI 10.1016/S0092-8674(00)80850-8; Frazier AE, 2004, NAT STRUCT MOL BIOL, V11, P226, DOI 10.1038/nsmb735; Frazier AE, 2003, MOL CELL BIOL, V23, P7818, DOI 10.1128/MCB.23.21.7818-7828.2003; Geissler A, 2002, CELL, V111, P507, DOI 10.1016/S0092-8674(02)01073-5; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; Jensen RE, 2001, NAT STRUCT BIOL, V8, P1008, DOI 10.1038/nsb1201-1008; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Kozany C, 2004, NAT STRUCT MOL BIOL, V11, P234, DOI 10.1038/nsmb734; Li YF, 2004, J BIOL CHEM, V279, P38047, DOI 10.1074/jbc.M404319200; Mokranjac D, 2003, EMBO J, V22, P4945, DOI 10.1093/emboj/cdg485; Mokranjac D, 2003, EMBO J, V22, P816, DOI 10.1093/emboj/cdg090; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; Ryan MT, 2001, METHOD CELL BIOL, V65, P189, DOI 10.1016/S0091-679X(01)65012-X; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; Truscott KN, 2003, J CELL BIOL, V163, P707, DOI 10.1083/jcb.200308004; Truscott KN, 2001, NAT STRUCT BIOL, V8, P1074, DOI 10.1038/nsb726; VOOS W, 1993, J CELL BIOL, V123, P119, DOI 10.1083/jcb.123.1.119; Yamamoto H, 2002, CELL, V111, P519, DOI 10.1016/S0092-8674(02)01053-X	22	263	271	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 25	2005	120	6					817	829		10.1016/j.cell.2005.01.011	http://dx.doi.org/10.1016/j.cell.2005.01.011			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	912HF	15797382	hybrid			2022-12-24	WOS:000228067500011
J	Fields, S; Johnston, M				Fields, S; Johnston, M			Whither model organism research?	SCIENCE			English	Editorial Material									Univ Washington, Howard Hughes Med Inst, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Dept Med, Seattle, WA 98195 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Washington University (WUSTL)	Fields, S (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Genome Sci, Seattle, WA 98195 USA.	fields@u.washington.edu; mj@genetics.wustl.edu	Johnston, Mark/K-3543-2019; Johnston, Mark/R-6156-2019	Johnston, Mark/0000-0002-4932-7229; 					0	79	85	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2005	307	5717					1885	1886		10.1126/science.1108872	http://dx.doi.org/10.1126/science.1108872			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910UI	15790833				2022-12-24	WOS:000227957300035
J	Okie, S				Okie, S			Safety in numbers - Monitoring risk in approved drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Dai CL, 2005, ARCH INTERN MED, V165, P171, DOI 10.1001/archinte.165.2.171; *GEN ACC OFF, 1990, GAOPEMD9015; HARRIS G, 2005, NY TIMES        0220, pA28; Psaty BM, 2004, JAMA-J AM MED ASSOC, V292, P2622, DOI 10.1001/jama.292.21.2622	4	46	48	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2005	352	12					1173	1176		10.1056/NEJMp058029	http://dx.doi.org/10.1056/NEJMp058029			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	909AW	15788493				2022-12-24	WOS:000227832300002
J	Reyburn, H; Mbatia, R; Drakeley, C; Bruce, J; Carneiro, I; Olomi, R; Cox, J; Nkya, WMMM; Lemnge, M; Greenwood, BM; Riley, EM				Reyburn, H; Mbatia, R; Drakeley, C; Bruce, J; Carneiro, I; Olomi, R; Cox, J; Nkya, WMMM; Lemnge, M; Greenwood, BM; Riley, EM			Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TANZANIAN CHILDREN; SEVERE ANEMIA; RISK-FACTORS; 2 AREAS; MORTALITY; MORBIDITY; PARASITE; ADMISSION; ALTITUDE; INFANTS	Context There are concerns that malaria control measures such as use of insecticide-treated bed nets, by delaying acquisition of immunity, might result in an increase in the more severe manifestations of malaria. An understanding of the relationships among the level of exposure to Plasmodium falciparum, age, and severity of malaria can provide evidence of whether this is likely. Objective To describe the clinical manifestations and case fatality of severe P falciparum malaria at varying altitudes resulting in varying levels of transmission. Design, Setting, and Patients A total of 1984 patients admitted for severe malaria to 10 hospitals serving populations living at levels of transmission varying from very low (altitude >1200 m) to very high (altitude <600 m) in a defined area of northeastern Tanzania, studied prospectively from February 2002 to February 2003. Data were analyzed in a logistic regression model and adjusted for potential clustering within hospitals. Main Outcome Measures Specific syndromes of severe malaria; mortality. Results The median age of patients was 1 year in high transmission, 3 years in moderate transmission, and 5 years in low transmission areas. The odds of severe malarial anemia (hemoglobin <5 g/dL) peaked at 1 year of age at high transmission and at 2 years at moderate and low transmission intensities and then decreased with increasing age (P=.002). Odds were highest in infants (0-1 year: referent; 2-4 years: odds ratio [OR], 0.83; 95% confidence interval [0], 0.72-0.96), 5 to <15 years: OR, 0.44; 95% Cl, 0.27-0.72; >= 15 years: OR, 0.44; 95% Cl, 0.27-0.73; P<.001) and high transmission intensity areas (altitude <600 in: referent; 600 In to 1200 in: OR, 0.55; 95% Cl, 0.35-0.84; >1200 in: OR, 0.55; 95% Cl, 0.26-1.15; P for trend =.03). The odds of cerebral malaria were significantly higher in low transmission intensity areas (altitude of residence <600 in: referent; 600 in to 1200 m: OR, 3.17; 95% Cl, 1.32-7.60; >1200 in: OR, 3.76; 95% Cl, 1.96-7.18; P for trend=.003) and with age 5 years and older (0-1 year: referent; 2-4 years: OR, 1.57; 95% Cl, 0.82-2.99; 5 to <15 years: OR, 6.07; 95% Cl, 2.98-12.38; >= 15 years: OR, 6.24; 95% Cl, 3.47-11.21; P<.001). The overall case-fatality rate of 7% (139 deaths) was similar at high and moderate levels of transmission but increased to 13% in low transmission areas (P=.03), an increase explained by the increase in the proportion of cases with cerebral malaria. Conclusions Age and level of exposure independently influence the clinical presentation of severe malaria. Our study suggests that an increase in the proportion of cases with more fatal manifestations of severe malaria is likely to occur only after transmission has been reduced to low levels where the overall incidence is likely to be low.	Kilimanjaro Christian Med Ctr, Joint Malaria Programme, Moshi, Tanzania; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Natl Inst Med Res, Amani, Tanzania	Kilimanjaro Christian Medical Centre; University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research	Reyburn, H (corresponding author), Kilimanjaro Christian Med Ctr, Joint Malaria Programme, POB 2228, Moshi, Tanzania.	hugh.reyburn@lshtm.ac.uk; eleanor.riley@lshtm.ac.uk	Riley, Eleanor M/C-8960-2013; Riley, Eleanor/AAL-1382-2020	Riley, Eleanor M/0000-0003-3447-3570; Riley, Eleanor/0000-0003-3447-3570				[Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; Baird JK, 1998, J INFECT DIS, V178, P592, DOI 10.1086/517482; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Binka FN, 2002, T ROY SOC TROP MED H, V96, P597, DOI 10.1016/S0035-9203(02)90321-4; Bodker R, 2003, J MED ENTOMOL, V40, P706, DOI 10.1603/0022-2585-40.5.706; Diallo DA, 2004, B WORLD HEALTH ORGAN, V82, P85; DRAKELEY C, IN PRESS J INFECT DI; GREENBERG AE, 1990, ANN INTERN MED, V113, P326, DOI 10.7326/0003-4819-113-4-326; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; Kahigwa E, 2002, TROP MED INT HEALTH, V7, P823, DOI 10.1046/j.1365-3156.2002.00938.x; Lengeler C, 1997, PARASITOL TODAY, V13, P123, DOI 10.1016/S0169-4758(97)84870-3; Lindblade KA, 2004, JAMA-J AM MED ASSOC, V291, P2571, DOI 10.1001/jama.291.21.2571; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Marsh K, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P241; Marsh K, 1997, PHILOS T R SOC B, V352, P1385, DOI 10.1098/rstb.1997.0124; Maxwell CA, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-28; *MIN HLTH, 2001, 16 HIVAIDSSTI MIN HL; Ministry of Health, 2000, NAT GUID MAL DIAGN T; Modiano D, 1998, AM J TROP MED HYG, V59, P539, DOI 10.4269/ajtmh.1998.59.539; Molineaux L, 1996, ANN TROP MED PARASIT, V90, P379, DOI 10.1080/00034983.1996.11813067; Mutabingwa T, 2001, LANCET, V358, P1218, DOI 10.1016/S0140-6736(01)06344-9; Nabarro DN, 1998, SCIENCE, V280, P2067, DOI 10.1126/science.280.5372.2067; Pearce RJ, 2003, ANTIMICROB AGENTS CH, V47, P1347, DOI 10.1128/AAC.47.4.1347-1354.2003; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Riley EM, 1999, IMMUNOL TODAY, V20, P228, DOI 10.1016/S0167-5699(99)01456-5; Schellenberg D, 1999, AM J TROP MED HYG, V61, P431, DOI 10.4269/ajtmh.1999.61.431; Schellenberg D, 2003, B WORLD HEALTH ORGAN, V81, P581; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; Schellenberg JA, 2003, LANCET, V361, P561, DOI 10.1016/S0140-6736(03)12515-9; SLUTSKER L, 1994, T ROY SOC TROP MED H, V88, P548, DOI 10.1016/0035-9203(94)90157-0; Smith TA, 2001, TRENDS PARASITOL, V17, P145, DOI 10.1016/S1471-4922(00)01814-6; SNOW RW, 1994, ACTA TROP, V57, P289, DOI 10.1016/0001-706X(94)90074-4; SNOW RW, 1994, INT J EPIDEMIOL, V23, P1013, DOI 10.1093/ije/23.5.1013; Snow RW, 2002, ADV PARASIT, V52, P235, DOI 10.1016/S0065-308X(02)52013-3; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Snow RW, 1998, J INFECT DIS, V177, P819, DOI 10.1086/517818; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; TRAPE JF, 1987, T ROY SOC TROP MED H, V81, P34; Trape JF, 1996, PARASITOL TODAY, V12, P236, DOI 10.1016/0169-4758(96)10015-6; *WHO, 2003, PUBL WHO, P1093	40	211	212	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2005	293	12					1461	1470		10.1001/jama.293.12.1461	http://dx.doi.org/10.1001/jama.293.12.1461			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	908KA	15784869	Green Accepted, Bronze			2022-12-24	WOS:000227784700025
J	Lai, ZC; Wei, XM; Shimizu, T; Ramos, E; Rohrbaugh, M; Nikolaidis, N; Ho, LL; Li, Y				Lai, ZC; Wei, XM; Shimizu, T; Ramos, E; Rohrbaugh, M; Nikolaidis, N; Ho, LL; Li, Y			Control of cell proliferation and apoptosis by Mob as tumor suppressor, Mats	CELL			English	Article							PROTEIN-KINASE; DROSOPHILA-MELANOGASTER; PROMOTES APOPTOSIS; GENETIC MOSAICS; GROWTH-CONTROL; HUMAN HOMOLOG; CYCLE EXIT; HIPPO; DEATH; FAMILY	Appropriate cell number and organ size in a multicellular organism are determined by coordinated cell growth, proliferation, and apoptosis. Disruption of these processes can cause cancer. Recent studies have identified the Large tumor suppressor (Lats)/ Warts (Wts) protein kinase as a key component of a pathway that controls the coordination between cell proliferation and apoptosis. Here we describe growth inhibitory functions for a Mob superfamily protein, termed Mats (Mob as tumor suppressor), in Drosophila. Loss of Mats function results in increased cell proliferation, defective apoptosis, and induction of tissue overgrowth. We show that mats and wts function in a common pathway. Mats physically associates with Wts to stimulate the catalytic activity of the Wts kinase. A human Mats ortholog (Mats1) can rescue the lethality associated with loss of Mats function in Drosophila. As Mats1 is mutated in human tumors, Mats-mediated growth inhibition and tumor suppression is likely conserved in humans.	Penn State Univ, Dept Biol, University Pk, PA 16802 USA; Penn State Univ, Intercoll Program Genet, University Pk, PA 16802 USA; Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; Penn State Univ, Integrat Biosci Grad Degree Program, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Lai, ZC (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	zcl1@psu.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020293] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM20293] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Baker NE, 2001, SEMIN CELL DEV BIOL, V12, P499, DOI 10.1006/scdb.2001.0274; Bichsel SJ, 2004, J BIOL CHEM, V279, P35228, DOI 10.1074/jbc.M404542200; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen B, 1998, GENETICS, V149, P157; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Devroe E, 2004, J BIOL CHEM, V279, P24444, DOI 10.1074/jbc.M401999200; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hay BA, 2003, DEV CELL, V5, P361, DOI 10.1016/S1534-5807(03)00270-3; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kamikubo Y, 2003, J BIOL CHEM, V278, P17609, DOI 10.1074/jbc.M211974200; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Komarnitsky SI, 1998, MOL CELL BIOL, V18, P2100, DOI 10.1128/MCB.18.4.2100; Lee LA, 2003, ANNU REV GENET, V37, P545, DOI 10.1146/annurev.genet.37.110801.143149; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li YY, 2003, COMMUN PUR APPL ANAL, V2, P1; Luca FC, 1998, MOL BIOL CELL, V9, P29, DOI 10.1091/mbc.9.1.29; Macleod K, 2000, CURR OPIN GENET DEV, V10, P81, DOI 10.1016/S0959-437X(99)00041-6; Mah AS, 2001, P NATL ACAD SCI USA, V98, P7325, DOI 10.1073/pnas.141098998; McPherson JP, 2004, EMBO J, V23, P3677, DOI 10.1038/sj.emboj.7600371; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Richardson H, 2002, J IMMUNOL METHODS, V265, P21, DOI 10.1016/S0022-1759(02)00068-6; Rothenberg ME, 2003, NATURE, V425, P469, DOI 10.1038/425469a; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Ryoo HD, 2003, NAT CELL BIOL, V5, P853, DOI 10.1038/ncb1003-853; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Stavridi ES, 2003, STRUCTURE, V11, P1163, DOI 10.1016/S0969-2126(03)00182-5; Stewart RA, 2003, ONCOGENE, V22, P6436, DOI 10.1038/sj.onc.1206820; Tamaskovic R, 2003, FEBS LETT, V546, P73, DOI 10.1016/S0014-5793(03)00474-5; Tao WF, 1999, NAT GENET, V21, P177, DOI 10.1038/5960; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Toji S, 2004, GENES CELLS, V9, P383, DOI 10.1111/j.1356-9597.2004.00732.x; Treisman JE, 1998, CURR TOP DEV BIOL, V39, P119, DOI 10.1016/S0070-2153(08)60454-8; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Weiss EL, 2002, J CELL BIOL, V158, P885, DOI 10.1083/jcb.200203094; Winey M, 2002, ONCOGENE, V21, P6161, DOI 10.1038/sj.onc.1205712; Wolff Tanya, 1993, P1277; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Xia H, 2002, ONCOGENE, V21, P1233, DOI 10.1038/sj.onc.1205174; XU T, 1993, DEVELOPMENT, V117, P1223; XU TA, 1995, DEVELOPMENT, V121, P1053	47	433	460	1	50	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 11	2005	120	5					675	685		10.1016/j.cell.2004.12.036	http://dx.doi.org/10.1016/j.cell.2004.12.036			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766530	Bronze			2022-12-24	WOS:000227771400013
J	Larson, G; Dobney, K; Albarella, U; Fang, MY; Matisoo-Smith, E; Robins, J; Lowden, S; Finlayson, H; Brand, T; Willerslev, E; Rowley-Conwy, P; Andersson, L; Cooper, A				Larson, G; Dobney, K; Albarella, U; Fang, MY; Matisoo-Smith, E; Robins, J; Lowden, S; Finlayson, H; Brand, T; Willerslev, E; Rowley-Conwy, P; Andersson, L; Cooper, A			Worldwide phylogeography of wild boar reveals multiple centers of pig domestication	SCIENCE			English	Article							MITOCHONDRIAL-DNA; GENETIC-EVIDENCE; ORIGINS; PHYLOGENIES; SULAWESI	Mitochondrial DNA (mtDNA) sequences from 686 wild and domestic pig specimens place the origin of wild boar in island Southeast Asia (ISEA), where they dispersed across Eurasia. Previous morphological and genetic evidence suggested pig domestication took place in a limited number of locations (principally the Near East and Far East). in contrast, new genetic data reveal multiple centers of domestication across Eurasia and that European, rather than Near Eastern, wild boar are the principal source of modern European domestic pigs.	Univ Oxford, Dept Zool, Henry Wellcome Ancient Biomol Ctr, Oxford OX1 3PS, England; Univ Durham, Dept Archaeol, Durham DH1 3L, England; Univ Sheffield, Dept Archaeol, Sheffield S1 4ET, S Yorkshire, England; Uppsala Univ, Uppsala Biomed Ctr, Dept Med Biochem & Microbiol, SE-75124 Uppsala, Sweden; Swedish Univ Agr Sci, Dept Anim Breeding & Genet, SE-75124 Uppsala, Sweden; Univ Auckland, Dept Anthropol, Auckland 1, New Zealand; Univ Auckland, Allan Wilson Ctr Mol Ecol & Evolut, Auckland 1, New Zealand; Jurox Pty Ltd, Rutherford, NSW 2320, Australia; Roslin Inst, Dept Genom & Bioinformat, Roslin EH25 9PS, Midlothian, Scotland; Univ Copenhagen, Inst Zool, Dept Evolutionary Biol, DK-2100 Copenhagen O, Denmark	University of Oxford; Durham University; University of Sheffield; Uppsala University; Swedish University of Agricultural Sciences; University of Auckland; Massey University; University of Auckland; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Copenhagen	Larson, G (corresponding author), Univ Oxford, Dept Zool, Henry Wellcome Ancient Biomol Ctr, S Parks Rd, Oxford OX1 3PS, England.	greger.larson@zoo.ox.ac.uk; alan.cooper@adelaide.edu.au	Willerslev, Eske/A-9619-2011; Willerslev, Eske/AAA-5686-2019; Cooper, Alan/E-8171-2012	Willerslev, Eske/0000-0002-7081-6748; Cooper, Alan/0000-0002-7738-7851; Matisoo-Smith, Elizabeth/0000-0002-3500-8307; Dobney, Keith/0000-0001-9036-4681				APOLLONIO M, 1988, B ZOOL, V3, P213; B?k?nyi S., 1974, HIST DOMESTIC MAMMAL; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Benecke N, 1993, EXPLOITATION ANIMAUX, P233; BULMER S, 1975, J SOC OCEANISTES, V31, P7, DOI DOI 10.3406/JSO.1975.2688; EPSTEIN J, 1984, EVOLUTION DOMESTICAT, P145; Ervynck A, 2002, PALEORIENT, V27, P47, DOI DOI 10.3406/paleo.2001.4731; Evans BJ, 1999, BIOL J LINN SOC, V66, P539, DOI 10.1111/j.1095-8312.1999.tb01925.x; Giuffra E, 2000, GENETICS, V154, P1785; Golson J., 1976, J SOC OCEAN, V36, P294; GROVES CP, 1981, TECH B DEP PREHISTOR, V3; Heise-Pavlov PM, 2003, WILDLIFE BIOL, V9, P21, DOI 10.2981/wlb.2003.060; Hurles ME, 2003, TRENDS ECOL EVOL, V18, P531, DOI 10.1016/S0169-5347(03)00245-3; Jansen T, 2002, P NATL ACAD SCI USA, V99, P10905, DOI 10.1073/pnas.152330099; Jing Y, 2002, ANTIQUITY, V76, P724, DOI 10.1017/S0003598X00091171; KAKOI H, 1994, Z ZOOL SYST EVOL, V32, P1; Kijas JMH, 2001, J MOL EVOL, V52, P302, DOI 10.1007/s002390010158; Kirch P, 2000, ROAD WINDS ARCHAEOLO; Matisoo-Smith E, 2004, P NATL ACAD SCI USA, V101, P9167, DOI 10.1073/pnas.0403120101; Oppenheimer SJ, 2001, NATURE, V410, P166, DOI 10.1038/35065520; Peters Joris, 2000, Paleorient, V25, P27; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rowley-Conwy P., 2003, WIDENING HARVEST NEO, P99; Ruedi M, 1996, BIOL J LINN SOC, V58, P197, DOI 10.1006/bijl.1996.0032; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Troy CS, 2001, NATURE, V410, P1088, DOI 10.1038/35074088; VIGNE JD, 1988, GALLIA PREHISTORIE S, V26	27	578	625	7	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2005	307	5715					1618	1621		10.1126/science.1106927	http://dx.doi.org/10.1126/science.1106927			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15761152				2022-12-24	WOS:000227622400046
J	Levy, B; Gibot, S; Franck, P; Cravoisy, A; Bollaert, PE				Levy, B; Gibot, S; Franck, P; Cravoisy, A; Bollaert, PE			Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study	LANCET			English	Article							SKELETAL-MUSCLE; AEROBIC CONDITIONS; LACTIC-ACIDOSIS; HYPOXIA; TISSUE; MICRODIALYSIS; METABOLISM; GLYCOLYSIS; TRANSPORT; PERFUSION	Background Hyperlactataemia during septic shock is often viewed as evidence of tissue hypoxia. However this blood, disorder is not usually correlated with indicators of perfusion or diminished with increased oxygen delivery. Muscles can generate lactate under aerobic conditions in a process linking glycolytic ATP supply to stimulation of Na+K+ ATPase. Using in-vivo microdialysis, we tested whether inhibition of Na+K+ ATPase can reduce muscle lactate. Methods In 14 patients with septic shock, two microdialysis probes were inserted into the quadriceps muscles and infused with lactate-free Ringer's solution in the absence or presence of 10(-7) mol/L ouabain, a specific inhibitor of Na+K+ ATPase. We measured lactate and pyruvate concentrations in both the dialysate fluid and arterial blood samples. Findings All patients had increased blood lactate concentrations (mean 4.0 mmol/L; SD 2.1). Lactate and pyruvate concentrations were consistently higher in muscle than in arteries during the study period, with a mean positive gradient of 1.98 mmol/L (SD 0.2; p = 0.001) and 230 mumol/L (30; p = 0.01), respectively. Ouabain infusion stopped over production of muscle lactate and pyruvate (p = 0.0001). Muscle lactate to pyruvate ratios remained unchanged during ouabain infusion with no differences between blood and muscle. Interpretation Skeletal muscle could be a leading source of lactate formation as a result of exaggerated aerobic glycolysis through Na+K+ ATPase stimulation during septic shock. Lactate clearance as an end-point of resuscitation could therefore prove useful. Relevance to clinical practice In patients with septic shock, a high lactate concentration should be interpreted as a marker of disease, portending a bad outcome. The presence of hyperlactataemia in resuscitated septic patients should not be taken as proof of oxygen debt needing increases in systemic or regional oxygen transport to supranormal values. Lactate, instead of being regarded only as a marker of hypoxia, might be an important metabolic signal.	Hop Cent, Serv Reanimat Med, F-54035 Nancy, France; Hop Cent, Biochim Lab, F-54035 Nancy, France	CHU de Nancy; CHU de Nancy	Levy, B (corresponding author), Hop Cent, Serv Reanimat Med, F-54035 Nancy, France.	b.levy@chu-nancy.fr						Barron JT, 2000, AM J PHYSIOL-HEART C, V279, pH2872, DOI 10.1152/ajpheart.2000.279.6.H2872; Binnert C, 2002, CURR OPIN CLIN NUTR, V5, P185, DOI 10.1097/00075197-200203000-00011; Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X; BROOKS GA, 1986, FASEB J, V45, P2924; Bundgaard H, 2003, AM J PHYSIOL-HEART C, V284, pH1028, DOI 10.1152/ajpheart.00639.2002; Clausen T, 2003, PHYSIOL REV, V83, P1269, DOI 10.1152/physrev.00011.2003; CLAUSEN T, 1980, BRIT J PHARMACOL, V68, P749, DOI 10.1111/j.1476-5381.1980.tb10868.x; CLUTTER WE, 1980, J CLIN INVEST, V66, P94, DOI 10.1172/JCI109840; DANIEL AM, 1978, SURG GYNECOL OBSTET, V147, P697; DIETZ MR, 1980, J BIOL CHEM, V255, P2301; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; Gore DC, 1996, ANN SURG, V224, P97, DOI 10.1097/00000658-199607000-00015; GREEVER CJ, 1959, CIRC RES, V7, P192, DOI 10.1161/01.RES.7.2.192; HAYES MA, 1994, NEW ENGL J MED, V330, P1717, DOI 10.1056/NEJM199406163302404; Henriksson J, 1999, P NUTR SOC, V58, P919, DOI 10.1017/S0029665199001226; HOTCHKISS RS, 1992, JAMA-J AM MED ASSOC, V267, P1503, DOI 10.1001/jama.267.11.1503; James JH, 1999, LANCET, V354, P505, DOI 10.1016/S0140-6736(98)91132-1; James JH, 1996, J CLIN INVEST, V98, P2388, DOI 10.1172/JCI119052; Kemper WF, 2001, P NATL ACAD SCI USA, V98, P723, DOI 10.1073/pnas.011387598; Kline JA, 2000, SHOCK, V14, P215, DOI 10.1097/00024382-200014020-00023; Leverve XM, 2002, CRIT CARE, V6, P284; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Luchette FA, 2002, J TRAUMA, V52, P415, DOI 10.1097/00005373-200203000-00001; MAZZEO RS, 1989, J APPL PHYSIOL, V67, P1319, DOI 10.1152/jappl.1989.67.4.1319; MIZOCK BA, 1992, CRIT CARE MED, V20, P80, DOI 10.1097/00003246-199201000-00020; MIZOCK BA, 1995, AM J MED, V98, P75, DOI 10.1016/S0002-9343(99)80083-7; PISON CM, 1995, AM J PHYSIOL-ENDOC M, V268, pE965, DOI 10.1152/ajpendo.1995.268.5.E965; Rosdahl H, 1997, ACTA PHYSIOL SCAND, V159, P261, DOI 10.1046/j.1365-201X.1997.123358000.x; Sair M, 2001, CRIT CARE MED, V29, P1343, DOI 10.1097/00003246-200107000-00008; Schurr A, 1997, J NEUROCHEM, V69, P423	30	308	324	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2005	365	9462					871	875		10.1016/S0140-6736(05)71045-X	http://dx.doi.org/10.1016/S0140-6736(05)71045-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	903RZ	15752531				2022-12-24	WOS:000227444600029
J	Kinchen, JM; Cabello, J; Klingele, D; Wong, K; Feichtinger, R; Schnabel, H; Schnabel, R; Hengartner, MO				Kinchen, JM; Cabello, J; Klingele, D; Wong, K; Feichtinger, R; Schnabel, H; Schnabel, R; Hengartner, MO			Two pathways converge at CED-10 to mediate actin rearrangement and corpse removal in C-elegans	NATURE			English	Article							PROGRAMMED CELL-DEATH; CAENORHABDITIS-ELEGANS; APOPTOTIC CELLS; CRKII/DOCK180/RAC PATHWAY; PROTEIN CED-6; ENGULFMENT; PHAGOCYTOSIS; MIGRATION; CLEARANCE; GENETICS	The removal of apoptotic cells is essential for the physiological well being of the organism(1-3). In Caenorhabditis elegans, two conserved, partially redundant genetic pathways regulate this process(4-6). In the first pathway, the proteins CED-2, CED-5 and CED-12 ( mammalian homologues CrkII, Dock180 and ELMO, respectively) function to activate CED-10 (Rac1)(7,8). In the second group, the candidate receptor CED-1 (CD91/LRP/SREC) probably recognizes an unknown ligand on the apoptotic cell(9) and signals via its cytoplasmic tail to the adaptor protein CED-6 (hCED-6/GULP)(10,11), whereas CED-7 (ABCA1) is thought to play a role in membrane dynamics(12). Molecular understanding of how the second pathway promotes engulfment of the apoptotic cell is lacking. Here, we show that CED-1, CED-6 and CED-7 are required for actin reorganization around the apoptotic cell corpse, and that CED-1 and CED-6 colocalize with each other and with actin around the dead cell. Furthermore, we find that the CED-10( Rac) GTPase acts genetically downstream of these proteins to mediate corpse removal, functionally linking the two engulfment pathways and identifying the CED-1, - 6 and - 7 signalling module as upstream regulators of Rac activation.	Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland; SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11743 USA; TU Braunschweig, Inst Genet, D-38106 Braunschweig, Germany	University of Zurich; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Braunschweig University of Technology	Hengartner, MO (corresponding author), Univ Zurich, Inst Mol Biol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	Michael.Hengartner@molbio.unizh.ch	Kinchen, Jason/ABC-5663-2021; Cabello, Juan/AAM-1683-2020; Hengartner, Michael O/A-7058-2008; Hengartner, Michael O/E-6235-2011	Cabello, Juan/0000-0002-3835-0116; Hengartner, Michael/0000-0002-7584-596X; Kinchen, Jason/0000-0001-8430-2265				Aballay A, 2001, P NATL ACAD SCI USA, V98, P2735, DOI 10.1073/pnas.041613098; BRENNER S, 1974, GENETICS, V77, P71; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Chung SB, 2000, NAT CELL BIOL, V2, P931, DOI 10.1038/35046585; Conradt B, 2001, DEV CELL, V1, P445, DOI 10.1016/S1534-5807(01)00065-X; ELLIS RE, 1991, GENETICS, V129, P79; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hamon Y, 2002, BBA-MOL CELL BIOL L, V1585, P64, DOI 10.1016/S1388-1981(02)00325-6; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Harris TW, 2003, NUCLEIC ACIDS RES, V31, P133, DOI 10.1093/nar/gkg053; HENGARTNER MO, 1992, NATURE, V356, P494, DOI 10.1038/356494a0; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hoeppner DJ, 2001, NATURE, V412, P202, DOI 10.1038/35084103; Liu QA, 1999, CURR BIOL, V9, P1347, DOI 10.1016/S0960-9822(00)80061-5; Liu QA, 1998, CELL, V93, P961, DOI 10.1016/S0092-8674(00)81202-7; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; Praitis V, 2001, GENETICS, V157, P1217; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Soto MC, 2002, GENE DEV, V16, P620, DOI 10.1101/gad.955702; Stergiou L, 2004, CELL DEATH DIFFER, V11, P21, DOI 10.1038/sj.cdd.4401340; STROME S, 1986, J CELL BIOL, V103, P2241, DOI 10.1083/jcb.103.6.2241; Su HP, 2002, J BIOL CHEM, V277, P11772, DOI 10.1074/jbc.M109336200; Wu YC, 2000, GENE DEV, V14, P536; Wu YC, 2001, DEV CELL, V1, P491, DOI 10.1016/S1534-5807(01)00056-9; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	30	206	228	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2005	434	7029					93	99		10.1038/nature03263	http://dx.doi.org/10.1038/nature03263			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902ED	15744306				2022-12-24	WOS:000227334600050
J	Schippers, A; Neretin, LN; Kallmeyer, J; Ferdelman, TG; Cragg, BA; Parkes, RJ; Jorgensen, BB				Schippers, A; Neretin, LN; Kallmeyer, J; Ferdelman, TG; Cragg, BA; Parkes, RJ; Jorgensen, BB			Prokaryotic cells of the deep sub-seafloor biosphere identified as living bacteria	NATURE			English	Article							IN-SITU HYBRIDIZATION; CATALYZED REPORTER DEPOSITION; SUBSEAFLOOR SEDIMENTS; MARINE-BACTERIA; METHANE HYDRATE; COPY NUMBER; COMMUNITY; OCEAN; QUANTIFICATION; DISSOCIATION	Chemical analyses of the pore waters from hundreds of deep ocean sediment cores have over decades provided evidence for ongoing processes that require biological catalysis by prokaryotes(1-3). This sub-seafloor activity of microorganisms may influence the surface Earth by changing the chemistry of the ocean and by triggering the emission of methane, with consequences for the marine carbon cycle and even the global climate(4-6). Despite the fact that only about 1% of the total marine primary production of organic carbon is available for deep-sea microorganisms(7,8), subseafloor sediments harbour over half of all prokaryotic cells on Earth(7). This estimation has been calculated from numerous microscopic cell counts in sediment cores of the Ocean Drilling Program(1,9). Because these counts cannot differentiate between dead and alive cells, the population size of living microorganisms is unknown(10,11). Here, using ribosomal RNA as a target for the technique known as catalysed reporter deposition-fluorescence in situ hybridization (CARD-FISH), we provide direct quantification of live cells as defined by the presence of ribosomes. We show that a large fraction of the sub-seafloor prokaryotes is alive, even in very old (16 million yr) and deep (>400 m) sediments. All detectable living cells belong to the Bacteria and have turnover times of 0.25-22 yr, comparable to surface sediments.	Fed Inst Geosci & Nat Resources, Sect Geomicrobiol, D-30655 Hannover, Germany; Max Planck Inst Marine Microbiol, Dept Biogeochem, D-28359 Bremen, Germany; Geoforschungszentrum Potsdam, D-14473 Potsdam, Germany; Univ Wales Coll Cardiff, Sch Earth Ocean & Planetary Sci, Cardiff CF10 3YE, S Glam, Wales	Max Planck Society; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Cardiff University	Schippers, A (corresponding author), Fed Inst Geosci & Nat Resources, Sect Geomicrobiol, Stilleweg 2, D-30655 Hannover, Germany.	a.schippers@bgr.de	Schippers, Axel/AAB-3919-2021; Cragg, Barry/D-2690-2009; Jorgensen, Bo B/C-2214-2013; Kallmeyer, Jens/I-3554-2012; Kallmeyer, Jens/AAF-6906-2020; Ferdelman, Timothy G/A-3758-2013; Parkes, Ronald/B-1731-2010	Schippers, Axel/0000-0002-4469-9883; Jorgensen, Bo B/0000-0001-9398-8027; Kallmeyer, Jens/0000-0002-6440-1140; Kallmeyer, Jens/0000-0002-6440-1140; Ferdelman, Timothy G/0000-0002-9701-3793; Parkes, Ronald/0000-0001-9402-5943				Bach W, 2003, GEOCHIM COSMOCHIM AC, V67, P3871, DOI 10.1016/S0016-7037(03)00304-1; Berg P, 1998, LIMNOL OCEANOGR, V43, P1500, DOI 10.4319/lo.1998.43.7.1500; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; D'Hondt S. L., 2003, CONTROLS MICROBIAL C; DAVIS BD, 1986, J BACTERIOL, V166, P439, DOI 10.1128/jb.166.2.439-445.1986; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Fogel GB, 1999, MICROB ECOL, V38, P93, DOI 10.1007/s002489900162; HEDGES J, 1993, MAR CHEM, V39, P67; HEIJNEN JJ, 1992, BIOTECHNOL BIOENG, V39, P833, DOI 10.1002/bit.260390806; Hesselbo SP, 2000, NATURE, V406, P392, DOI 10.1038/35019044; Holland H.D., 1984, CHEM EVOLUTION ATMOS; JORGENSEN BB, 1982, NATURE, V296, P643, DOI 10.1038/296643a0; Kallmeyer J, 2004, LIMNOL OCEANOGR-METH, V2, P171, DOI 10.4319/lom.2004.2.171; Kennett JP, 2000, SCIENCE, V288, P128, DOI 10.1126/science.288.5463.128; KEPNER RL, 1994, MICROBIOL REV, V58, P603, DOI 10.1128/MMBR.58.4.603-615.1994; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Loferer-Krossbacher M, 1999, ARCH HYDROBIOL SPEC, V54, P185; Morita RY, 1997, BACTERIA OLIGOTROPHI; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Parkes RJ, 2000, HYDROGEOL J, V8, P11, DOI 10.1007/PL00010971; PARKES RJ, 1994, NATURE, V371, P410, DOI 10.1038/371410a0; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Ravenschlag K, 2001, APPL ENVIRON MICROB, V67, P387, DOI 10.1128/AEM.67.1.387-395.2001; Sekar R, 2003, APPL ENVIRON MICROB, V69, P2928, DOI 10.1128/AEm.69.5.2928-2935.2003; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; Takai K, 2000, APPL ENVIRON MICROB, V66, P5066, DOI 10.1128/AEM.66.11.5066-5072.2000; Teira E, 2004, APPL ENVIRON MICROB, V70, P4411, DOI 10.1128/AEM.70.7.4411-4414.2004; Webster G, 2003, J MICROBIOL METH, V55, P155, DOI 10.1016/S0167-7012(03)00140-4; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Zubkov MV, 2001, APPL ENVIRON MICROB, V67, P5210, DOI 10.1128/AEM.67.11.5210-5218.2001	30	326	350	1	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2005	433	7028					861	864		10.1038/nature03302	http://dx.doi.org/10.1038/nature03302			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	899VT	15729341				2022-12-24	WOS:000227174600041
J	Claus, EB; Petruzella, S; Matloff, E; Carter, D				Claus, EB; Petruzella, S; Matloff, E; Carter, D			Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ONSET BREAST-CANCER; POPULATION-BASED SERIES; OVARIAN-CANCER; GERMLINE MUTATIONS; FAMILY-HISTORY; JEWISH WOMEN; CARRIER FREQUENCY; 185DELAG MUTATION; SEQUENCE-ANALYSIS; SINGLE-FAMILY	Context The distribution of BRCA1 and BRCA2 mutations in women diagnosed with noninvasive breast carcinoma is unknown. Objective To estimate the BRCA1 and BRCA2 mutation prevalence in women with ductal carcinoma in situ (DCIS), unselected for age, family history, or ethnicity. Design, Setting, and Participants The data were 369 DCIS cases diagnosed among female residents aged 20 to 79 years from the state of Connecticut between September 15,1994, and March 14, 1998. These women were participants in a large population-based case-control study of breast carcinoma in situ. Telephone interviews were used to collect risk factor information and blood or buccal specimens were collected for BRCA1 and BRCA2 mutation testing. Main Outcome Measures Prevalence of disease-associated mutations of BRCA1 and BRCA2 in women diagnosed with DCIS. Results Three (0.8%) and 9 (2.4%) of 369 DCIS cases had disease-associated mutations in BRCA1 or BRCA2, respectively. One woman had a mutation in both genes (BRCA1 W321X and BRCA2 3398del5). Carriers were significantly more likely than noncarriers to report a first-degree (mother, sister, or daughter) family history of breast cancer (odds ratio [OR], 3.7; 95% confidence interval [CI], 1.1 -12.4), as well as a personal history of ovarian cancer. In addition, carriers were more likely than noncarriers to be diagnosed at an early age (<50 years) (OR, 3.4; 95% Cl, 1.0-11.7), as well as to report at least 1 first-degree relative diagnosed with breast cancer before 50 years (OR, 10.6; 95% Cl, 3.0-37.0). Conclusions Ductal carcinoma in situ is a part of the breast/ovarian cancer syndromes defined by BRCA1 and BRCA2, with mutation rates similar to those found for invasive breast cancer. These findings suggest that patients with breast cancer with an appropriate personal or family history of breast and/or ovarian cancer should be screened and followed according to high-risk protocols, regardless of whether they are diagnosed with in situ or invasive breast cancer.	Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Yale Comprehens Canc Ctr, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; Brigham & Womens Hosp, Dept Neurosurg, Boston, MA USA	Yale University; Yale University; Harvard University; Brigham & Women's Hospital	Claus, EB (corresponding author), Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Yale Comprehens Canc Ctr, 60 Coll St,POB 208034, New Haven, CT 06520 USA.	elizabeth.claus@yale.edu			NCI NIH HHS [R01-CA81393] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA081393] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adem C, 2003, CANCER, V97, P1, DOI 10.1002/cncr.11048; Anton-Culver H, 2000, EUR J CANCER, V36, P1200, DOI 10.1016/S0959-8049(00)00110-6; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Armes JE, 1998, CANCER-AM CANCER SOC, V83, P2335, DOI 10.1002/(SICI)1097-0142(19981201)83:11<2335::AID-CNCR13>3.3.CO;2-E; Armes JE, 2002, PATHOLOGY, V34, P309, DOI 10.1080/00313020220147113; Caldes T, 2002, J MED GENET, V39, DOI 10.1136/jmg.39.8.e44; Claus EB, 2003, BREAST, V12, P451, DOI 10.1016/S0960-9776(03)00152-8; Claus EB, 2003, BREAST CANCER RES TR, V81, P129, DOI 10.1023/A:1025728524310; Claus EB, 2003, BREAST CANCER RES TR, V78, P7, DOI 10.1023/A:1022147920262; CLAUS EB, 1993, CANCER, V71, P147, DOI 10.1002/1097-0142(19930101)71:1<147::AID-CNCR2820710124>3.0.CO;2-V; Claus EB, 2001, J NATL CANCER I, V93, P1811, DOI 10.1093/jnci/93.23.1811; Couch FJ, 1997, NEW ENGL J MED, V336, P1409, DOI 10.1056/NEJM199705153362002; de Sanjose S, 2003, INT J CANCER, V106, P588, DOI 10.1002/ijc.11271; FitzGerald MG, 1996, NEW ENGL J MED, V334, P143, DOI 10.1056/NEJM199601183340302; FORD D, 1995, AM J HUM GENET, V57, P1457; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Frank TS, 1998, J CLIN ONCOL, V16, P2417, DOI 10.1200/JCO.1998.16.7.2417; Frank TS, 2002, J CLIN ONCOL, V20, P1480, DOI 10.1200/JCO.20.6.1480; Friedman E, 1998, AM J HUM GENET, V63, P1224, DOI 10.1086/302040; Ganguly A, 2001, AM J MED GENET, V101, P146, DOI 10.1002/1096-8628(20010615)101:2<146::AID-AJMG1342>3.0.CO;2-E; Gershoni-Baruch R, 1997, EUR J CANCER, V33, P2283, DOI 10.1016/S0959-8049(97)00223-2; Hoogerbrugge N, 2003, J CLIN ONCOL, V21, P41, DOI 10.1200/JCO.2003.02.137; Jacquemier J, 1996, LANCET, V348, P1098, DOI 10.1016/S0140-6736(05)64441-8; Johannesdottir G, 1996, CANCER RES, V56, P3663; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Krainer M, 1997, NEW ENGL J MED, V336, P1416, DOI 10.1056/NEJM199705153362003; Lakhani SR, 1997, LANCET, V349, P1505; Langston AA, 1996, NEW ENGL J MED, V334, P137, DOI 10.1056/NEJM199601183340301; Liede A, 1998, AM J HUM GENET, V62, P1543, DOI 10.1086/301889; Loader S, 1998, GENET TEST, V2, P75, DOI 10.1089/gte.1998.2.75; Loman N, 2001, JNCI-J NATL CANCER I, V93, P1215, DOI 10.1093/jnci/93.16.1215; Malone KE, 1998, JAMA-J AM MED ASSOC, V279, P922, DOI 10.1001/jama.279.12.922; Martin AM, 2001, J CLIN ONCOL, V19, P2247, DOI 10.1200/JCO.2001.19.8.2247; Neuhausen S, 1996, NAT GENET, V13, P126, DOI 10.1038/ng0596-126; Newman B, 1998, JAMA-J AM MED ASSOC, V279, P915, DOI 10.1001/jama.279.12.915; Offit K, 1996, LANCET, V347, P1643, DOI 10.1016/S0140-6736(96)91484-1; Peto J, 1999, J NATL CANCER I, V91, P943, DOI 10.1093/jnci/91.11.943; Ramus SJ, 1997, NAT GENET, V15, P14, DOI 10.1038/ng0197-14; Randall TC, 1998, GYNECOL ONCOL, V70, P432, DOI 10.1006/gyno.1998.5081; ShattuckEidens D, 1997, JAMA-J AM MED ASSOC, V278, P1242, DOI 10.1001/jama.278.15.1242; Smith RA, 2003, CA-CANCER J CLIN, V53, P141, DOI 10.3322/canjclin.53.3.141; StoppaLyonnet D, 1996, AM J HUM GENET, V59, P479; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; Sun CC, 1996, LANCET, V348, P408, DOI 10.1016/S0140-6736(05)65027-1; Syrjakoski K, 2000, J NATL CANCER I, V92, P1529, DOI 10.1093/jnci/92.18.1529; Tesoriero A, 1999, AM J HUM GENET, V65, P567, DOI 10.1086/302503; Thorlacius S, 1997, AM J HUM GENET, V60, P1079; Tsongalis GJ, 1998, ARCH PATHOL LAB MED, V122, P548; Unger MA, 2000, AM J HUM GENET, V67, P841, DOI 10.1086/303076; Verhoog LC, 1998, LANCET, V351, P316, DOI 10.1016/S0140-6736(97)07065-7	51	65	66	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2005	293	8					964	969		10.1001/jama.293.8.964	http://dx.doi.org/10.1001/jama.293.8.964			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	899LR	15728167	Bronze			2022-12-24	WOS:000227146400018
J	Wang, YX; Klijn, JGM; Zhang, Y; Sieuwerts, A; Look, MP; Yang, F; Talantov, D; Timmermans, M; Meijer-van Gelder, ME; Yu, J; Jatkoe, T; Berns, EMJJ; Atkins, D; Foekens, JA				Wang, YX; Klijn, JGM; Zhang, Y; Sieuwerts, A; Look, MP; Yang, F; Talantov, D; Timmermans, M; Meijer-van Gelder, ME; Yu, J; Jatkoe, T; Berns, EMJJ; Atkins, D; Foekens, JA			Gene-expression pro-files to predict distant metastasis of lymph-node-negative primary breast cancer	LANCET			English	Article							PROGNOSTIC VALUE; PROFILES; RECEPTORS; SIGNATURE; CONSENSUS; SURVIVAL; ESTROGEN; THERAPY	Background Genome-wide measures of gene expression can identify patterns of gene activity that subclassify tumours and might provide a better means than is currently available for individual risk assessment in patients with lymph-node-negative breast cancer. Methods We analysed, with Affymetrix Human U133a GeneChips, the expression of 22 000 transcripts from total RNA of frozen tumour samples from 286 lymph-node-negative patients who had not received adjuvant systemic treatment. Findings In a training set of 115 tumours, we identified a 76-gene signature consisting of 60 genes for patients positive for oestrogen receptors (ER) and 16 genes for ER-negative patients. This signature showed 93% sensitivity and 48% specificity in a subsequent independent testing set of 171 lymph-node-negative patients. The gene profile was highly informative in identifying patients who developed distant metastases within 5 years (hazard ratio 5.67 [95% CI 2.59-12.4]), even when corrected for traditional prognostic factors in multivariate analysis (5.55 [2.46-12.5]). The 76-gene profile also represented a strong prognostic factor for the development of metastasis in the subgroups of 84 premenopausal patients (9.60 [2.28-40.5]), 87 postmenopausal patients (4.04 [1.57-10.4]), and 79 patients with tumours of 10-20 mm (14.1 [3.34-59.2]), a group of patients for whom prediction of prognosis is especially difficult. Interpretation The identified signature provides a powerful tool for identification of patients at high risk of distant recurrence. The ability to identify patients who have a favourable prognosis could, after independent confirmation, allow clinicians to avoid adjuvant systemic therapy or to choose less aggressive therapeutic options.	Veridex LLC, San Diego, CA USA; Veridex LLC, Warren, NY USA; Erasmus MC Daniel den Hoed, Dept Med Oncol, Rotterdam, Netherlands	Johnson & Johnson; Johnson & Johnson USA; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute	Foekens, JA (corresponding author), Erasmus MC, Josephine Nefkens Inst, Rm BE-426,Dr Molewaterpl 50, NL-3015 GE Rotterdam, Netherlands.	j.foekens@erasmusmc.nl	li, jie/A-3133-2011					ABE O, 1995, NEW ENGL J MED, V333, P1444; Abe O, 1998, LANCET, V352, P930; Ahr A, 2002, LANCET, V359, P131, DOI 10.1016/S0140-6736(02)07337-3; Chang JC, 2003, LANCET, V362, P362, DOI 10.1016/S0140-6736(03)14023-8; Clarke M, 1998, LANCET, V351, P1451; EFRON B, 1981, J AM STAT ASSOC, V76, P312, DOI 10.2307/2287832; Eifel P, 2001, JNCI-J NATL CANCER I, V93, P979; FOEKENS JA, 1989, CANCER RES, V49, P5823; FOEKENS JA, 1989, CANCER RES, V49, P7002; Goldhirsch A, 2003, J CLIN ONCOL, V21, P3357, DOI 10.1200/JCO.2003.04.576; Gruvberger S, 2001, CANCER RES, V61, P5979; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Herrera-Gayol A, 1999, EXP MOL PATHOL, V66, P149, DOI 10.1006/exmp.1999.2251; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Keyomarsi K, 2002, NEW ENGL J MED, V347, P1566, DOI 10.1056/NEJMoa021153; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Ntzani EE, 2003, LANCET, V362, P1439, DOI 10.1016/S0140-6736(03)14686-7; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ransohoff DF, 2004, NAT REV CANCER, V4, P309, DOI 10.1038/nrc1322; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Sotiriou C, 2002, BREAST CANCER RES, V4, DOI 10.1186/bcr433; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2004, J CLIN ONCOL, V22, P1564, DOI 10.1200/JCO.2004.08.186; Woelfle U, 2003, CANCER RES, V63, P5679	30	2128	2267	3	133	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 19	2005	365	9460					671	679		10.1016/S0140-6736(05)17947-1	http://dx.doi.org/10.1016/S0140-6736(05)17947-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	898SP	15721472				2022-12-24	WOS:000227096800024
J	Collins, S; Ruina, A; Tedrake, R; Wisse, M				Collins, S; Ruina, A; Tedrake, R; Wisse, M			Efficient bipedal robots based on passive-dynamic walkers	SCIENCE			English	Article							WALKING; REINFORCEMENT; LOCOMOTION	Passive-dynamic walkers are simple mechanical devices, composed of solid parts connected by joints, that walk stably down a slope. They have no motors or controllers, yet can have remarkably humanlike motions. This suggests that these machines are useful models of human locomotion; however, they cannot walk on level. ground. Here we present three robots based on passive-dynamics, with small active power sources substituted for gravity, which can walk on level ground. These robots use less control and less energy than other powered robots, yet walk more naturally, further suggesting the importance of passive-dynamics in human locomotion.	Cornell Univ, Ithaca, NY 14853 USA; Univ Michigan, Ann Arbor, MI 48104 USA; MIT, Ctr Bits & Atoms, Cambridge, MA 02139 USA; Delft Univ Technol, NL-2628 CD Delft, Netherlands	Cornell University; University of Michigan System; University of Michigan; Massachusetts Institute of Technology (MIT); Delft University of Technology	Ruina, A (corresponding author), Cornell Univ, Ithaca, NY 14853 USA.	ruina@cornell.edu	Ruina, Andy L/A-8725-2018	Ruina, Andy L/0000-0001-5493-6048; Collins, Steve/0000-0002-3997-3374				Atzler E, 1927, PFLUG ARCH GES PHYS, V215, P291, DOI 10.1007/BF01731318; Benbrahim H, 1997, ROBOT AUTON SYST, V22, P283, DOI 10.1016/S0921-8890(97)00043-2; Chevallereau C, 2003, IEEE CONTR SYST MAG, V23, P57, DOI 10.1109/MCS.2003.1234651; Collins SH, 2001, INT J ROBOT RES, V20, P607, DOI 10.1177/02783640122067561; Donelan JM, 2002, J EXP BIOL, V205, P3717; Garcia M, 2000, DYNAM STABIL SYST, V15, P75, DOI 10.1080/713603737; Kato I., 1973, P CISM IFTOMM S THEO, p[12, 12]; KUN A, 1996, P IEEE INT C ROB AUT; Kuo AD, 2002, J BIOMECH ENG-T ASME, V124, P113, DOI 10.1115/1.1427703; MCGEER T, 1990, INT J ROBOT RES, V9, P62, DOI 10.1177/027836499000900206; MCGEER T, 1993, J THEOR BIOL, V163, P277, DOI 10.1006/jtbi.1993.1121; MOLEN NH, 1972, P K NED AKAD C BIOL, V75, P305; Pfeiffer F, 2002, 2002 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS I-IV, PROCEEDINGS, P3129, DOI 10.1109/ROBOT.2002.1013708; RUINA A, IN PRESS J THEOR BIO; Sakagami Y, 2002, 2002 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-3, PROCEEDINGS, P2478, DOI 10.1109/IRDS.2002.1041641; Seung HS, 2003, NEURON, V40, P1063, DOI 10.1016/S0896-6273(03)00761-X; TEDRAKE R, 2004, P IEEE INT C ROB AUT; Tedrake R., 2004, P IEEE RSJ INT C INT; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; WILSON JE, Patent No. 2140275; Winter DA., 2009, BIOMECHANICS MOTOR C; WISSE M, IN PRESS IEEE T ROBO; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359; [No title captured]; [No title captured]	25	1248	1325	12	386	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2005	307	5712					1082	1085		10.1126/science.1107799	http://dx.doi.org/10.1126/science.1107799			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ED	15718465				2022-12-24	WOS:000227197300040
J	Rouxel, OJ; Bekker, A; Edwards, KJ				Rouxel, OJ; Bekker, A; Edwards, KJ			Iron isotope constraints on the Archean and Paleoproterozoic ocean redox state	SCIENCE			English	Article							FE ISOTOPE; ATMOSPHERIC OXYGEN; REACTIVE IRON; BLACK-SEA; FRACTIONATION; SEDIMENTS; EARTH; CHEMISTRY; SULFUR; ADSORPTION	The response of the ocean redox state to the rise of atmospheric oxygen about 2.3 billion years ago (Ga) is a matter of controversy. Here we provide iron isotope evidence that the change in the ocean iron cycle occurred at the same time as the change in the atmospheric redox state. Variable and negative iron isotope values in pyrites older than about 2.3 Ga suggest that an iron-rich global ocean was strongly affected by the deposition of iron oxides. Between 2.3 and 1.8 Ga, positive iron isotope values of pyrite likely reflect an increase in the precipitation of iron sulfides relative to iron oxides in a redox stratified ocean.	Woods Hole Oceanog Inst, Marine Chem & Geochem Dept, Geomicrobiol Grp, Woods Hole, MA 02543 USA; Carnegie Inst Washington, Geophys Lab, Washington, DC 20015 USA	Woods Hole Oceanographic Institution; Carnegie Institution for Science	Rouxel, OJ (corresponding author), Woods Hole Oceanog Inst, Marine Chem & Geochem Dept, Geomicrobiol Grp, Mail Stop 8, Woods Hole, MA 02543 USA.	orouxel@whoi.edu	Rouxel, Olivier J/F-3954-2014	Rouxel, Olivier J/0000-0002-1431-222X; Bekker, Andrey/0000-0002-1154-0585				Anbar AD, 2002, SCIENCE, V297, P1137, DOI 10.1126/science.1069651; Anderson TF, 2004, AM J SCI, V304, P203, DOI 10.2475/ajs.304.3.203; Arnold GL, 2004, SCIENCE, V304, P87, DOI 10.1126/science.1091785; Beard BL, 2004, REV MINERAL GEOCHEM, V55, P319, DOI 10.2138/gsrmg.55.1.319; Beard BL, 2003, GEOLOGY, V31, P629, DOI 10.1130/0091-7613(2003)031<0629:IICOFC>2.0.CO;2; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; BEKKER A, IN PRESS PRECAMBRIAN; BEUKES NJ, 1990, ECON GEOL BULL SOC, V85, P663, DOI 10.2113/gsecongeo.85.4.663; Bjerrum CJ, 2002, NATURE, V417, P159, DOI 10.1038/417159a; BRATERMAN PS, 1983, NATURE, V303, P163, DOI 10.1038/303163a0; Bullen TD, 2001, GEOLOGY, V29, P699, DOI 10.1130/0091-7613(2001)029<0699:DOSAII>2.0.CO;2; Butler IB, 2003, GEOCHIM COSMOCHIM AC, V67, pA51; CANFIELD DE, 1989, GEOCHIM COSMOCHIM AC, V53, P619, DOI 10.1016/0016-7037(89)90005-7; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Croal LR, 2004, GEOCHIM COSMOCHIM AC, V68, P1227, DOI 10.1016/j.gca.2003.09.011; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Holland H.D., 1984, CHEM EVOLUTION ATMOS; Icopini GA, 2004, GEOLOGY, V32, P205, DOI 10.1130/G20184.1; Isley AE, 1999, J GEOPHYS RES-SOL EA, V104, P15461, DOI 10.1029/1999JB900066; Johnson CM, 2003, CONTRIB MINERAL PETR, V144, P523, DOI 10.1007/s00410-002-0418-x; Johnson CM, 2004, REV MINERAL GEOCHEM, V55, P359, DOI 10.2138/gsrmg.55.1.359; Karhu JA, 1996, GEOLOGY, V24, P867, DOI 10.1130/0091-7613(1996)024<0867:CIATRO>2.3.CO;2; Levasseur S, 2004, EARTH PLANET SC LETT, V224, P91, DOI 10.1016/j.epsl.2004.05.010; Matthews A, 2004, GEOCHIM COSMOCHIM AC, V68, P3107, DOI 10.1016/j.gca.2004.01.019; Polyakov VB, 2000, GEOCHIM COSMOCHIM AC, V64, P849, DOI 10.1016/S0016-7037(99)00329-4; Rouxel O, 2004, GEOCHIM COSMOCHIM AC, V68, P2295, DOI 10.1016/j.gca.2003.11.029; Rouxel O, 2003, CHEM GEOL, V202, P155, DOI 10.1016/j.chemgeo.2003.08.011; SEVERMANN S, 2003, EOS S, V84; Shen Y, 2003, NATURE, V423, P632, DOI 10.1038/nature01651; Summons RE, 1999, NATURE, V400, P554, DOI 10.1038/23005; Vargas M, 1998, NATURE, V395, P65, DOI 10.1038/25720; Welch SA, 2003, GEOCHIM COSMOCHIM AC, V67, P4231, DOI 10.1016/S0016-7037(03)00266-7; WIDDEL F, 1993, NATURE, V362, P834, DOI 10.1038/362834a0; Wijsman JWM, 2001, MAR CHEM, V74, P261, DOI 10.1016/S0304-4203(01)00019-6	34	378	416	1	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2005	307	5712					1088	1091		10.1126/science.1105692	http://dx.doi.org/10.1126/science.1105692			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ED	15718467	Green Published			2022-12-24	WOS:000227197300042
J	Conboy, IM; Conboy, MJ; Wagers, AJ; Girma, ER; Weissman, IL; Rando, TA				Conboy, IM; Conboy, MJ; Wagers, AJ; Girma, ER; Weissman, IL; Rando, TA			Rejuvenation of aged progenitor cells by exposure to a young systemic environment	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; SKELETAL-MUSCLE; SATELLITE CELLS; C/EBP-ALPHA; OLD RATS; HETEROGENEITY; REGENERATION; PLASTICITY; PARABIOSIS; EXPRESSION	The decline of tissue regenerative potential is a hallmark of ageing and may be due to age-related changes in tissue-specific stem cells(1-5). A decline in skeletal muscle stem cell ( satellite cell) activity due to a loss of Notch signalling results in impaired regeneration of aged muscle(1,6). The decline in hepatic progenitor cell proliferation owing to the formation of a complex involving cEBP-alpha and the chromatin remodelling factor brahma (Brm) inhibits the regenerative capacity of aged liver(7). To examine the influence of systemic factors on aged progenitor cells from these tissues, we established parabiotic pairings ( that is, a shared circulatory system) between young and old mice (heterochronic parabioses), exposing old mice to factors present in young serum. Notably, heterochronic parabiosis restored the activation of Notch signalling as well as the proliferation and regenerative capacity of aged satellite cells. The exposure of satellite cells from old mice to young serum enhanced the expression of the Notch ligand ( Delta), increased Notch activation, and enhanced proliferation in vitro. Furthermore, heterochronic parabiosis increased aged hepatocyte proliferation and restored the cEBP-alpha complex to levels seen in young animals. These results suggest that the age-related decline of progenitor cell activity can be modulated by systemic factors that change with age.	Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; VA Palo Alto Hlth Care Syst, GRECC, Palo Alto, CA 94304 USA; VA Palo Alto Hlth Care Syst, Neurol Serv, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Rando, TA (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	rando@stanford.edu	Ladoux, Benoit/A-9879-2013	Rando, Thomas/0000-0001-5843-8564				Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; CARLSON BM, 1989, AM J PHYSIOL, V256, pC1262; Carlson BM, 2001, J GERONTOL A-BIOL, V56, pB224, DOI 10.1093/gerona/56.5.B224; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; FINERTY JC, 1952, PHYSIOL REV, V32, P277, DOI 10.1152/physrev.1952.32.3.277; FULLER J, 2002, SCI AGING KNOWLEDGE, pE11; Golden TR, 2002, AGING CELL, V1, P117, DOI 10.1046/j.1474-9728.2002.00015.x; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Hekimi S, 2003, SCIENCE, V299, P1351, DOI 10.1126/science.1082358; Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0; Kuhn HG, 1996, J NEUROSCI, V16, P2027; MCCAY CM, 1957, GERONTOLOGY, V1, P7, DOI 10.1159/000210677; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Partridge TA, 2002, GENE THER, V9, P752, DOI 10.1038/sj.gt.3301764; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Sell S, 2001, HEPATOLOGY, V33, P738, DOI 10.1053/jhep.2001.21900; Sherwood RI, 2004, STEM CELLS, V22, P1292, DOI 10.1634/stemcells.2004-0090; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; SIDORENKO AV, 1986, MECH AGEING DEV, V36, P41, DOI 10.1016/0047-6374(86)90137-5; SIGAL SH, 1992, AM J PHYSIOL, V263, P139; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; TAUCHI H, 1977, MECH AGEING DEV, V6, P333, DOI 10.1016/0047-6374(77)90034-3; Timchenko NA, 1998, NUCLEIC ACIDS RES, V26, P3293, DOI 10.1093/nar/26.13.3293; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278	26	1532	1624	13	198	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2005	433	7027					760	764		10.1038/nature03260	http://dx.doi.org/10.1038/nature03260			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897XH	15716955				2022-12-24	WOS:000227039200043
J	Dougan, S; Gilbart, VL; Sinka, K; Evans, BG				Dougan, S; Gilbart, VL; Sinka, K; Evans, BG			HIV infections acquired through heterosexual intercourse in the United Kingdom: findings from national surveillance	BRITISH MEDICAL JOURNAL			English	Article									Hlth Protect Agcy Ctr Infect, London NW9 5EQ, England	Health Protection Agency	Dougan, S (corresponding author), Hlth Protect Agcy Ctr Infect, London NW9 5EQ, England.	sarah.dougan@hpa.org.uk						Health Protection Agency Scottish Centre for Infection and Environmental Health National Public Health Service for Wales Communicable Disease Surveillance Centre Northern Ireland Unlinked Anonymous Surveys Steering Group, 2003, REN FOC HIV OTH SEX; *PUBL HLTH LAB SER, 2001, HIV AIDS UK EP REV 2; *UK COLL GROUP HIV, 2004, FOC PREV HIV OTH SEX	3	15	15	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 4	2005	330	7503					1303	1304		10.1136/bmj.38393.572188.EB	http://dx.doi.org/10.1136/bmj.38393.572188.EB			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	933TL	15764624	Green Published, Bronze			2022-12-24	WOS:000229655700022
J	Seagroatt, V				Seagroatt, V			MMR vaccine and Crohn's disease: ecological study of hospital admissions in England, 1991 to 2002	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INFLAMMATORY-BOWEL-DISEASE; MEASLES VACCINATION; RISK		Univ Oxford, Dept Publ Hlth, Unit Hlth Care Epidemiol, Oxford OX3 7LF, England	University of Oxford	Seagroatt, V (corresponding author), Univ Oxford, Dept Publ Hlth, Unit Hlth Care Epidemiol, Oxford OX3 7LF, England.	valerie.seagroatt@dphpc.ox.ac.uk						Davis RL, 2001, ARCH PEDIAT ADOL MED, V155, P354, DOI 10.1001/archpedi.155.3.354; Department of Health, HOSP EP STAT; *HLTH PROT AG, COMPL PRIM COURS VAC; Montgomery SM, 1999, GASTROENTEROLOGY, V116, P796, DOI 10.1016/S0016-5085(99)70062-4; Pebody RG, 1998, BRIT MED J, V316, P1745; Seagroatt V, 2003, J EPIDEMIOL COMMUN H, V57, P883, DOI 10.1136/jech.57.11.883; Smeeth L, 2004, LANCET, V364, P963, DOI 10.1016/S0140-6736(04)17020-7; THOMPSON NP, 1995, LANCET, V345, P1071, DOI 10.1016/S0140-6736(95)90816-1; WHEELER JG, 2001, JOINT C SOC SOC MED	9	14	14	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2005	330	7500					1120	1121		10.1136/bmj.38449.476759.AE	http://dx.doi.org/10.1136/bmj.38449.476759.AE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927BH	15837703	Bronze, Green Published			2022-12-24	WOS:000229166900019
J	Castilla, J; Saa, P; Hetz, C; Soto, C				Castilla, J; Saa, P; Hetz, C; Soto, C			In vitro generation of infectious scrapie prions	CELL			English	Article							CYCLIC AMPLIFICATION; ALPHA-HELICES; PROTEIN; CONVERSION; CONFORMATIONS; PROPAGATION; DISEASES	Prions are unconventional infectious agents responsible for transmissible spongiform encephalopathy (TSE) diseases. They are thought to be composed exclusively of the protease-resistant prion protein (PrPres) that replicates in the body by inducing the misfolding of the cellular prion protein (PrPc). Although compelling evidence supports this hypothesis, generation of infectious prion particles in vitro has not been convincingly demonstrated. Here we show that PrPc -> PrPres conversion can be mimicked in vitro by cyclic amplification of protein misfolding, resulting in indefinite amplification of PrPres. The in vitro-generated forms of PrPres share similar biochemical and structural properties with PrPres derived from sick brains. Inoculation of wild-type hamsters with in vitro-produced PrPres led to a scrapie disease identical to the illness produced by brain infectious material. These findings demonstrate that prions can be generated in vitro and provide strong evidence in support of the protein-only hypothesis of prion transmission.	Univ Texas, Med Branch, Dept Neurol, Galveston, TX 77555 USA; Univ Autonoma Madrid, Ctr Mol Biol, E-28049 Madrid, Spain; Univ Chile, Inst Ciencias Biomed, Santiago, Chile	University of Texas System; University of Texas Medical Branch Galveston; Autonomous University of Madrid; Universidad de Chile	Soto, C (corresponding author), Univ Texas, Med Branch, Dept Neurol, Galveston, TX 77555 USA.	clsoto@utmb.edu	Hetz, Claudio/I-1900-2013; Castilla, Joaquín/J-8414-2019; Castilla, Joaquin/D-5261-2011; Saa, Paula/AAB-6607-2019; Hetz, Claudio/ABD-7514-2021	Hetz, Claudio/0000-0001-7724-1767; Castilla, Joaquín/0000-0002-2216-1361; Castilla, Joaquin/0000-0002-2216-1361; Saa, Paula/0000-0001-6077-4532; 	NIA NIH HHS [R03 AG0224642] Funding Source: Medline; PHS HHS [R01 N549173] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Baskakov IV, 2000, BIOCHEMISTRY-US, V39, P2792, DOI 10.1021/bi9923353; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; Bieschke J, 2004, P NATL ACAD SCI USA, V101, P12207, DOI 10.1073/pnas.0404650101; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Castilla J, 2004, J NEUROSCI, V24, P5063, DOI 10.1523/JNEUROSCI.5400-03.2004; Castilla J, 2004, TECHNIQUES PRION RES, P198, DOI [10.1007/978-3-0348-7949-1_14, DOI 10.1007/978-3-0348-7949-1_14]; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; Chen YM, 2000, J LAW ECON ORGAN, V16, P209, DOI 10.1093/jleo/16.1.209; Chesebro B, 1998, SCIENCE, V279, P42, DOI 10.1126/science.279.5347.42; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; GABIZON R, 1988, P NATL ACAD SCI USA, V85, P6617, DOI 10.1073/pnas.85.18.6617; Ghetti B, 1996, BRAIN PATHOL, V6, P127, DOI 10.1111/j.1750-3639.1996.tb00796.x; Hill AF, 1999, J GEN VIROL, V80, P11, DOI 10.1099/0022-1317-80-1-11; Jackson GS, 1999, SCIENCE, V283, P1935, DOI 10.1126/science.283.5409.1935; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Lee S, 2003, NAT STRUCT BIOL, V10, P725, DOI 10.1038/nsb961; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Lehmann S, 1996, P NATL ACAD SCI USA, V93, P5610, DOI 10.1073/pnas.93.11.5610; Lucassen R, 2003, BIOCHEMISTRY-US, V42, P4127, DOI 10.1021/bi027218d; May BCH, 2004, TRENDS BIOCHEM SCI, V29, P162, DOI 10.1016/j.tibs.2004.02.008; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Mestel R, 1996, SCIENCE, V273, P184, DOI 10.1126/science.273.5272.184; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Piening N, 2005, BIOCHEM BIOPH RES CO, V326, P339, DOI 10.1016/j.bbrc.2004.11.039; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saa Paula, 2004, V299, P53; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; SIGURDSSON BJORN, 1954, BRIT VET JOUR, V110, P255; Soto C, 2005, FEBS LETT, V579, P638, DOI 10.1016/j.febslet.2004.12.035; Soto C, 2004, NAT MED, V10, pS63, DOI 10.1038/nm1069; Soto C, 2002, TRENDS NEUROSCI, V25, P390, DOI 10.1016/S0166-2236(02)02195-1; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; WESTAWAY D, 1994, CELL, V76, P117, DOI 10.1016/0092-8674(94)90177-5; Wille H, 2000, J STRUCT BIOL, V130, P323, DOI 10.1006/jsbi.2000.4242; ZHANG H, 1995, J MOL BIOL, V250, P514, DOI 10.1006/jmbi.1995.0395	45	624	656	0	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 22	2005	121	2					195	206		10.1016/j.cell.2005.02.011	http://dx.doi.org/10.1016/j.cell.2005.02.011			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851027	Bronze			2022-12-24	WOS:000228705000008
J	Segev, DL; Gentry, SE; Warren, DS; Reel, B; Montgomery, RA				Segev, DL; Gentry, SE; Warren, DS; Reel, B; Montgomery, RA			Kidney paired donation and optimizing the use of live donor organs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RENAL-TRANSPLANTATION; CADAVERIC KIDNEYS; HLA ANTIGENS; PLASMAPHERESIS; RECIPIENTS; REJECTION; ALGORITHM; SURVIVAL; GLOBULIN; ANTIBODY	Context Blood type and crossmatch incompatibility will exclude at least one third of patients in need from receiving a live donor kidney transplant. Kidney paired donation (KPD) offers incompatible donor/recipient pairs the opportunity to match for compatible transplants. Despite its increasing popularity, very few transplants have resulted from KPD. Objective To determine the potential impact of improved matching schemes on the number and quality of transplants achievable with KPD. Design, Setting, and Population We developed a model that simulates pools of incompatible donor/recipient pairs. We designed a mathematically verifiable optimized matching algorithm and compared it with the scheme currently used in some centers and regions. Simulated patients from the general community with characteristics drawn from distributions describing end-stage renal disease patients eligible for renal transplantation and their willing and eligible live donors. Main Outcome Measures Number of kidneys matched, HLA mismatch of matched kidneys, and number of grafts surviving 5 years after transplantation. Results A national optimized matching algorithm would result in more transplants (47.7% vs 42.0%, P < .001), better HLA concordance (3.0 vs 4.5 mismatched antigens; P < .001), more grafts surviving at 5 years (34.9% vs 28.7%; P < .001), and a reduction in the number of pairs required to travel (2.9% vs 18.4%; P < .001) when compared with an extension of the currently used first-accept scheme to a national level. Furthermore, highly sensitized patients would benefit 6-fold from a national optimized scheme (2.3% vs 14.1% successfully matched; P < .001). Even if only 7% of patients awaiting kidney transplantation participated in an optimized national KPD program, the health care system could save as much as $750 million. Conclusions The combination of a national KPD program and a mathematically optimized matching algorithm yields more matches with lower HLA disparity. Optimized matching affords patients the flexibility of customizing their matching priorities and the security of knowing that the greatest number of high-quality matches will be found and distributed equitably.	Johns Hopkins Univ, Sch Med, Dept Surg, Div Transplantat, Baltimore, MD 21287 USA; MIT, Informat & Decis Syst Lab, Cambridge, MA 02139 USA	Johns Hopkins University; Massachusetts Institute of Technology (MIT)	Segev, DL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Surg, Div Transplantat, 720 Rutland Ave,Ross 765, Baltimore, MD 21287 USA.	dorry@jhmi.edu	Gentry, Sommer/H-7101-2019	Gentry, Sommer/0000-0003-4530-8917				Delmonico FL, 2004, AM J TRANSPLANT, V4, P1628, DOI 10.1111/j.1600-6143.2004.00572.x; Doxiadis IIN, 1996, LANCET, V348, P850, DOI 10.1016/S0140-6736(96)02296-9; Doxiadis IIN, 1996, TRANSPLANT P, V28, P224; Duquesnoy RJ, 2002, HUM IMMUNOL, V63, P339, DOI 10.1016/S0198-8859(02)00382-8; EDMONDS J, 1965, CANADIAN J MATH, V17, P449, DOI 10.4153/CJM-1965-045-4; GJERTSON DW, 1991, NEW ENGL J MED, V324, P1032, DOI 10.1056/NEJM199104113241505; Jordan Stanley C, 2003, Clin Transpl, P193; LEFFELL MS, 1994, TRANSPLANTATION, V58, P1119, DOI 10.1097/00007890-199411270-00011; LOVASZ L, 1986, MATCHING THEORY, P369; MARTIN S, 1993, TRANSPLANT P, V25, P265; Montgomery RA, 2004, AM J TRANSPLANT, V4, P1011, DOI 10.1111/j.1600-6143.2004.00496.x; Montgomery RA, 2000, TRANSPLANTATION, V70, P887, DOI 10.1097/00007890-200009270-00006; Montgomery Robert A, 2003, Clin Transpl, P199; Opelz G, 1997, TRANSPLANTATION, V64, P1473, DOI 10.1097/00007890-199711270-00017; Ross LF, 1997, NEW ENGL J MED, V336, P1752, DOI 10.1056/NEJM199706123362412; Ross LF, 2000, TRANSPLANTATION, V69, P1539; Roth AE, 2004, Q J ECON, V119, P457, DOI 10.1162/0033553041382157; Sonnenday CJ, 2004, AM J TRANSPLANT, V4, P1315, DOI 10.1111/j.1600-6143.2004.00507.x; Stegall MD, 2004, TRANSPLANTATION, V78, P635, DOI 10.1097/01.tp.0000136263.46262.0d; Takemoto SK, 2000, NEW ENGL J MED, V343, P1078, DOI 10.1056/NEJM200010123431504; Takemoto SK, 2004, AM J TRANSPLANT, V4, P1033, DOI 10.1111/j.1600-6143.2004.00500.x; Thompson JS, 2002, TRANSPLANTATION, V73, P1274, DOI 10.1097/00007890-200204270-00015; *UNOS, 2004, CONC PROP NAT LIV DO; *UNOS, UNOS ORG PROC TRANSP; *US REN DAT SYST, 2003, US REN DAT SYST ANN; Warren DS, 2004, AM J TRANSPLANT, V4, P561, DOI 10.1111/j.1600-6143.2004.00364.x; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Zachary AA, 2003, TRANSPLANTATION, V76, P1519, DOI 10.1097/01.TP.0000090868.88895.E0; Zenios SA, 2002, MANAGE SCI, V48, P328, DOI 10.1287/mnsc.48.3.328.7732; Zenios SA, 2001, TRANSPLANTATION, V72, P648, DOI 10.1097/00007890-200108270-00015	30	291	294	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2005	293	15					1883	1890		10.1001/jama.293.15.1883	http://dx.doi.org/10.1001/jama.293.15.1883			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QW	15840863	Bronze			2022-12-24	WOS:000228401700027
J	Mace, KA; Pearson, JC; McGinnis, W				Mace, KA; Pearson, JC; McGinnis, W			An epidermal barrier wound repair pathway in Drosophila is mediated by grainy head	SCIENCE			English	Article							DEVELOPMENTAL TRANSCRIPTION FACTORS; DOPA DECARBOXYLASE GENE; HOMEOTIC GENES; MELANOGASTER; CUTICLE; FAMILY; IDENTIFICATION; EXPRESSION; INDUCTION; IMMUNITY	We used wounded Drosophila embryos to define an evolutionarily conserved pathway for repairing the epidermal surface barrier. This pathway includes a wound response enhancer from the Ddc gene that requires grainy head (grh) function and binding sites for the Grh transcription factor. At the signaling level, tyrosine kinase and extracellular signal-regulated kinase (ERK) activities are induced in epidermal cells near wounds, and activated ERK is required for a robust wound response. The conservation of this Grh-dependent pathway suggests that the repair of insect cuticle and mammal skin is controlled by an ancient, shared control system for constructing and heating the animal body surface barrier.	Univ Calif San Diego, Div Biol, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	McGinnis, W (corresponding author), Univ Calif San Diego, Div Biol, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	wmcginnis@ucsd.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240] Funding Source: NIH RePORTER; NICHD NIH HHS [R01HD28315] Funding Source: Medline; NIGMS NIH HHS [T32GM07240] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASHIDA M, 1995, P NATL ACAD SCI USA, V92, P10698, DOI 10.1073/pnas.92.23.10698; Barolo S, 2004, BIOTECHNIQUES, V36, P436, DOI 10.2144/04363ST03; BOMAN HG, 1981, TRENDS BIOCHEM SCI, V6, P306, DOI 10.1146/annurev.mi.41.100187.000535; BRAY SJ, 1991, GENE DEV, V5, P1672, DOI 10.1101/gad.5.9.1672; Chen L, 2002, MECH DEVELOP, V114, P95, DOI 10.1016/S0925-4773(02)00064-3; Dieckgraefe BK, 1999, AM J PHYSIOL-GASTR L, V276, pG322, DOI 10.1152/ajpgi.1999.276.2.G322; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; Hemphala J, 2003, DEVELOPMENT, V130, P249, DOI 10.1242/dev.00218; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Jacinto A, 2001, NAT CELL BIOL, V3, pE117, DOI 10.1038/35074643; Kockel L, 2001, ONCOGENE, V20, P2347, DOI 10.1038/sj.onc.1204300; Kudryavtseva EI, 2003, DEV DYNAM, V226, P604, DOI 10.1002/dvdy.10255; Lee HY, 2004, MECH DEVELOP, V121, P37, DOI 10.1016/j.mod.2003.11.002; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li GC, 2003, DEV CELL, V4, P865, DOI 10.1016/S1534-5807(03)00159-X; Liaw GJ, 1995, GENE DEV, V9, P3163, DOI 10.1101/gad.9.24.3163; Macias A, 1996, EMBO J, V15, P334, DOI 10.1002/j.1460-2075.1996.tb00363.x; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Nappi AJ, 2000, BIOESSAYS, V22, P469, DOI 10.1002/(SICI)1521-1878(200005)22:5<469::AID-BIES9>3.0.CO;2-4; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; Ostrowski S, 2002, GENETICS, V161, P171; Ramet M, 2002, DEV BIOL, V241, P145, DOI 10.1006/dbio.2001.0502; SCHAEFER J, 1987, SCIENCE, V235, P1200, DOI 10.1126/science.3823880; SCHOLNICK SB, 1986, SCIENCE, V234, P998, DOI 10.1126/science.3095924; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; STRUHL G, 1983, J EMBRYOL EXP MORPH, V76, P297; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; Ting SB, 2003, NAT MED, V9, P1513, DOI 10.1038/nm961; Ting SB, 2003, BIOCHEM J, V370, P953, DOI 10.1042/BJ20021476; Uv AE, 1997, MOL CELL BIOL, V17, P6727, DOI 10.1128/MCB.17.11.6727; Venkatesan K, 2003, NUCLEIC ACIDS RES, V31, P4304, DOI 10.1093/nar/gkg644; Walsh PN, 2002, ESSAYS BIOCHEM, V38, P95, DOI 10.1042/bse0380095; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wiellette EL, 1999, DEVELOPMENT, V126, P5373; Wilanowski T, 2002, MECH DEVELOP, V114, P37, DOI 10.1016/S0925-4773(02)00046-1; Wood W, 2002, NAT CELL BIOL, V4, P907, DOI 10.1038/ncb875; Wright TRF, 1996, J HERED, V87, P175, DOI 10.1093/oxfordjournals.jhered.a022983	38	178	180	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2005	308	5720					381	385		10.1126/science.1107573	http://dx.doi.org/10.1126/science.1107573			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15831751				2022-12-24	WOS:000228492000043
J	Emison, ES; McCallion, AS; Kashuk, CS; Bush, RT; Grice, E; Lin, S; Portnoy, ME; Cutler, DJ; Green, ED; Chakravarti, A				Emison, ES; McCallion, AS; Kashuk, CS; Bush, RT; Grice, E; Lin, S; Portnoy, ME; Cutler, DJ; Green, ED; Chakravarti, A			A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease risk	NATURE			English	Article							GENOME-WIDE ASSOCIATION; DIABETES-MELLITUS; HIV-1 INFECTION; MOUSE MODEL; EXPRESSION; HAPLOTYPE; GENE; TRANSMISSION; DISEQUILIBRIUM; IDENTIFICATION	The identification of common variants that contribute to the genesis of human inherited disorders remains a significant challenge. Hirschsprung disease (HSCR) is a multifactorial, non-mendelian disorder in which rare high-penetrance coding sequence mutations in the receptor tyrosine kinase RET contribute to risk in combination with mutations at other genes. We have used family-based association studies to identify a disease interval, and integrated this with comparative and functional genomic analysis to prioritize conserved and functional elements within which mutations can be sought. We now show that a common non-coding RET variant within a conserved enhancer-like sequence in intron 1 is significantly associated with HSCR susceptibility and makes a 20-fold greater contribution to risk than rare alleles do. This mutation reduces in vitro enhancer activity markedly, has low penetrance, has different genetic effects in males and females, and explains several features of the complex inheritance pattern of HSCR. Thus, common low-penetrance variants, identified by association studies, can underlie both common and rare diseases.	Johns Hopkins Univ, Sch Med, KcKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; NHGRI, NIH Intramural Sequencing Ctr, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Chakravarti, A (corresponding author), Johns Hopkins Univ, Sch Med, KcKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	aravinda@jhmi.edu		Grice, Elizabeth/0000-0003-3939-2200; Lin, Shin/0000-0003-0118-0413	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000060, Z01HG000196, ZIBHG000196, Z01HG000060] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ALLISON AC, 1960, NATURE, V186, P531, DOI 10.1038/186531a0; ALLISON AC, 1961, BRIT MED J, V5236, P1346; Batourina E, 2001, NAT GENET, V27, P74, DOI 10.1038/83792; Bolk S, 2000, P NATL ACAD SCI USA, V97, P268, DOI 10.1073/pnas.97.1.268; Borrego S, 2000, J MED GENET, V37, P572, DOI 10.1136/jmg.37.8.572; Bray N, 2003, GENOME RES, V13, P97, DOI 10.1101/gr.789803; Cann HM, 2002, SCIENCE, V296, P261; Carrasquillo MM, 2002, NAT GENET, V32, P237, DOI 10.1038/ng998; CHAKRAVARTI A, 2001, METABOLIC MOL BASES, P251; Collins FS, 1998, SCIENCE, V282, P682, DOI 10.1126/science.282.5389.682; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; FALCONER DS, 1967, ANN HUM GENET, V31, P1; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Gabriel SB, 2002, NAT GENET, V31, P89, DOI 10.1038/ng868; Garcia-Barcelo MM, 2003, J MED GENET, V40; Haldane J.B.S., 1949, HEREDITAS, V35, P267; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; Lin S, 2004, GENOME RES, V14, P1624, DOI 10.1101/gr.2204604; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Margulies EH, 2003, GENOME RES, V13, P2507, DOI 10.1101/gr.1602203; McCallion AS, 2003, COLD SPRING HARB SYM, V68, P373, DOI 10.1101/sqb.2003.68.373; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; MOTULSKY ARNO G., 1960, HUMAN BIOL, V32, P28; Nobrega MA, 2004, J PHYSIOL-LONDON, V554, P31, DOI 10.1113/jphysiol.2003.050948; Pitera JE, 2001, AM J PATHOL, V159, P2321, DOI 10.1016/S0002-9440(10)63082-9; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Sancandi M, 2003, J MED GENET, V40, P714, DOI 10.1136/jmg.40.9.714; Sato Takeshi, 2000, Research Communications in Biochemistry and Cell and Molecular Biology, V4, P3; Shepherd IT, 2004, DEVELOPMENT, V131, P241, DOI 10.1242/dev.00912; Shepherd IT, 2001, DEV BIOL, V231, P420, DOI 10.1006/dbio.2000.0145; Shoba T, 2002, NEUROSCI LETT, V318, P129, DOI 10.1016/S0304-3940(01)02491-0; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Uyama T, 2003, J BIOL CHEM, V278, P3072, DOI 10.1074/jbc.M209446200; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	42	338	350	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2005	434	7035					857	863		10.1038/nature03467	http://dx.doi.org/10.1038/nature03467			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915SV	15829955				2022-12-24	WOS:000228327600031
J	Hunt, JH; Amdam, GV				Hunt, JH; Amdam, GV			Bivoltinism as an antecedent to eusociality in the paper wasp genus Polistes	SCIENCE			English	Article							SOCIAL WASP; HYMENOPTERA; DIAPAUSE; BEHAVIOR; MOTH; PROTEINS; CASTE; FOOD	To learn the evolutionary trajectories of caste differentiation in eusocial species is a major goal of sociobiology. We present an explanatory framework for caste evolution in the eusocial wasp genus Polistes (Vespidae), which is a model system for insect eusocial evolution. We hypothesize that Polistes worker and gyne castes stem from two developmental pathways that characterized the bivoltine life cycle of a solitary ancestor. Through individual-based simulations, we show that our mechanistic framework can reproduce colony-level characteristics of Polistes and, thereby, that social castes can emerge from solitary regulatory pathways. Our explanatory framework illustrates, by specific example, a changed perspective for understanding insect social evolution.	Univ Missouri, Dept Biol, St Louis, MO 63121 USA; Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, N-1432 As, Norway	University of Missouri System; University of Missouri Saint Louis; University of California System; University of California Davis; Norwegian University of Life Sciences	Hunt, JH (corresponding author), Univ Missouri, Dept Biol, 1 Univ Blvd, St Louis, MO 63121 USA.	jimhunt@umst.edu; gvamdam@ucdavis.edu	Hunt, James/D-1740-2009		NIA NIH HHS [P01 AG 22500, P01 AG022500, P01 AG022500-03] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG022500] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Amdam GV, 2004, P NATL ACAD SCI USA, V101, P11350, DOI 10.1073/pnas.0403073101; BOHM MK, 1972, J INSECT PHYSIOL, V18, P1875, DOI 10.1016/0022-1910(72)90158-8; BOYNE JV, 1986, J ENTOMOL SCI, V21, P301, DOI 10.18474/0749-8004-21.4.301; Cervo Rita, 1996, P98; Cowan D.P., 1991, P33; DAPPORTO L, IN PRESS ANN ZOOL FE; Eickwort G.C., 1981, P199; Field J, 1999, BEHAV ECOL SOCIOBIOL, V45, P378, DOI 10.1007/s002650050574; Gadagkar R, 2001, SOCIAL BIOL ROPALIDI; Godlewski J, 2001, J INSECT PHYSIOL, V47, P759, DOI 10.1016/S0022-1910(01)00050-6; Hunt J.H., 1991, P426; Hunt JH, 2003, J INSECT PHYSIOL, V49, P785, DOI 10.1016/S0022-1910(03)00115-X; Hunt JH, 2002, ECOL ENTOMOL, V27, P467, DOI 10.1046/j.1365-2311.2002.00369.x; HUNT JH, 1982, EVOLUTION, V36, P1318, DOI 10.1111/j.1558-5646.1982.tb05501.x; ISHAY J, 1968, ANIM BEHAV, V16, P298, DOI 10.1016/0003-3472(68)90013-4; Karsai I, 2002, ENVIRON ENTOMOL, V31, P99, DOI 10.1603/0046-225X-31.1.99; Marchal P., 1897, Compte Rendu des Seances de la Societe de Biologie, P557; MEAD F, 1995, INSECT SOC, V42, P385, DOI 10.1007/BF01242167; Michener C.D., 1990, P77; Munyiri FN, 2004, J INSECT PHYSIOL, V50, P295, DOI 10.1016/j.jinsphys.2004.01.005; O'Donnell S, 1998, ANNU REV ENTOMOL, V43, P323, DOI 10.1146/annurev.ento.43.1.323; ONeill K.M, 2001, CORNELL S ARTHR BIOL; PAGE RE, 1989, AM NAT, V134, P731, DOI 10.1086/285008; Reeve HK, 1998, P NATL ACAD SCI USA, V95, P13737, DOI 10.1073/pnas.95.23.13737; Roubaud E, 1916, ANN SCI NATUR Z, V1, P1; SEGER J, 1983, NATURE, V301, P59, DOI 10.1038/301059a0; STEINBERG S, 1992, ENTOMOL EXP APPL, V62, P269, DOI 10.1007/BF00353446; STRASSMANN JE, 1983, ANIM BEHAV, V31, P431, DOI 10.1016/S0003-3472(83)80063-3; STRASSMANN JE, 1989, J KANSAS ENTOMOL SOC, V62, P353; STRASSMANN JE, 1981, BEHAV ECOL SOCIOBIOL, V8, P55, DOI 10.1007/BF00302844; Suzuki T, 1998, ETHOL ECOL EVOL, V10, P347, DOI 10.1080/08927014.1998.9522848; West Eberhard M. J., 1969, Miscellaneous Publications Museum of Zoology University of Michigan, VNo. 140, P1; WEST-EBERHARD M J, 1978, Journal of the Kansas Entomological Society, V51, P832; WHEELER DE, 1986, AM NAT, V128, P13, DOI 10.1086/284536	34	123	124	3	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2005	308	5719					264	267		10.1126/science.1109724	http://dx.doi.org/10.1126/science.1109724			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915BX	15821094	Green Accepted			2022-12-24	WOS:000228273700057
J	Maizel, A; Busch, MA; Tanahashi, T; Perkovic, J; Kato, M; Hasebe, M; Weigel, D				Maizel, A; Busch, MA; Tanahashi, T; Perkovic, J; Kato, M; Hasebe, M; Weigel, D			The floral regulator LEAFY evolves by substitutions in the DNA binding domain	SCIENCE			English	Article							HOMEOTIC GENE; HOX PROTEIN; EVOLUTION; ARABIDOPSIS; EXPRESSION; DIVERSIFICATION; REPRESSION; INDUCTION; PRIMORDIA; HOMOLOGS	The plant-specific transcription factor LEAFY controls general aspects of the life cycle in a basal plant, the moss Physcomitrella patens. In contrast, LEAFY has more specialized functions in angiosperms, where it specifically induces floral fate during the reproductive phase. This raises the question of a concomitant change in the biochemical function of LEAFY during the evolution of land plants. We report that the DNA binding domain of LEAFY, although largely conserved, has diverged in activity. On the contrary, other, more rapidly evolving portions of the protein have few effects on LEAFY activity.	Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan	Max Planck Society; Salk Institute; University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Weigel, D (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany.	weiget@weigelworld.org	Weigel, Detlef/GSJ-0799-2022; Weigel, Detlef/C-1418-2008; Weigel, Detlef/AAR-3312-2021; Maizel, Alexis/D-3560-2012	Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Maizel, Alexis/0000-0001-6843-1059; Hasebe, Mitsuyasu/0000-0001-7425-8758				Blazquez MA, 1997, DEVELOPMENT, V124, P3835; Bomblies K, 2003, DEVELOPMENT, V130, P2385, DOI 10.1242/dev.00457; Busch MA, 1999, SCIENCE, V285, P585, DOI 10.1126/science.285.5427.585; Carroll SB, 2000, CELL, V101, P577, DOI 10.1016/S0092-8674(00)80868-5; Frohlich MW, 2000, SYST BOT, V25, P155, DOI 10.2307/2666635; Frohlich MW, 2000, MOL BIOL EVOL, V17, P1914, DOI 10.1093/oxfordjournals.molbev.a026293; Galant R, 2002, NATURE, V415, P910, DOI 10.1038/nature717; Gebelein B, 2002, DEV CELL, V3, P487, DOI 10.1016/S1534-5807(02)00257-5; Himi S, 2001, J MOL EVOL, V53, P387, DOI 10.1007/s002390010228; Kozmik Z, 2003, DEV CELL, V5, P773, DOI 10.1016/S1534-5807(03)00325-3; Lamb RS, 2002, DEVELOPMENT, V129, P2079; Litt A, 2003, GENETICS, V165, P821; Lohmann JU, 2001, CELL, V105, P793, DOI 10.1016/S0092-8674(01)00384-1; Lynch M, 2000, GENETICS, V154, P459; Mellerowicz EJ, 1998, PLANTA, V206, P619, DOI 10.1007/s004250050440; Parcy F, 1998, NATURE, V395, P561, DOI 10.1038/26903; Ronshaugen M, 2002, NATURE, V415, P914, DOI 10.1038/nature716; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Tanahashi T, 2005, DEVELOPMENT, V132, P1727, DOI 10.1242/dev.01709; Wada M, 2002, PLANT MOL BIOL, V49, P567, DOI 10.1023/A:1015544207121; William DA, 2004, P NATL ACAD SCI USA, V101, P1775, DOI 10.1073/pnas.0307842100	21	146	163	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2005	308	5719					260	263		10.1126/science.1108229	http://dx.doi.org/10.1126/science.1108229			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915BX	15821093				2022-12-24	WOS:000228273700056
J	Hillier, LW; Graves, TA; Fulton, RS; Fulton, LA; Pepin, KH; Minx, P; Wagner-McPherson, C; Layman, D; Wylie, K; Sekhon, M; Becker, MC; Fewell, GA; Delehaunty, KD; Miner, TL; Nash, WE; Kremitzki, C; Oddy, L; Du, H; Sun, H; Bradshaw-Cordum, H; Ali, J; Carter, J; Cordes, M; Harris, A; Isak, A; van Brunt, A; Nguyen, C; Du, FY; Courtney, L; Kalicki, J; Ozersky, P; Abbott, S; Armstrong, J; Belter, EA; Caruso, L; Cedroni, M; Cotton, M; Davidson, T; Desai, A; Elliott, G; Erb, T; Fronick, C; Gaige, T; Haakenson, W; Haglund, K; Holmes, A; Harkins, R; Kim, K; Kruchowski, SS; Strong, CM; Grewal, N; Goyea, E; Hou, S; Levy, A; Martinka, S; Mead, K; McLellan, MD; Meyer, R; Maher, JR; Tomlinson, C; Kohlberg, SD; Kozlowicz-Reilly, A; Shah, N; Swearengen-Shahid, S; Snider, J; Strong, JT; Thompson, J; Yoakum, M; Leonard, S; Pearman, C; Trani, L; Radionenko, M; Waligorski, JE; Wang, CY; Rock, SM; Tin-Wollam, AM; Maupin, R; Latreille, P; Wendl, MC; Yang, SP; Pohl, C; Wallis, JW; Spieth, J; Bieri, TA; Berkowicz, N; Nelson, JO; Osborne, J; Ding, L; Meyer, R; Sabo, A; Shotland, Y; Sinha, P; Wohldmann, PE; Cook, LL; Hickenbotham, MT; Eldred, J; Williams, D; Jones, TA; She, XW; Ciccarelli, FD; Izaurralde, E; Taylor, J; Schmutz, J; Myers, RM; Cox, DR; Huang, XQ; McPherson, JD; Mardis, ER; Clifton, SW; Warren, WC; Chinwalla, AT; Eddy, SR; Marra, MA; Ovcharenko, I; Furey, TS; Miller, W; Eichler, EE; Bork, P; Suyama, M; Torrents, D; Waterston, RH; Wilson, RK				Hillier, LW; Graves, TA; Fulton, RS; Fulton, LA; Pepin, KH; Minx, P; Wagner-McPherson, C; Layman, D; Wylie, K; Sekhon, M; Becker, MC; Fewell, GA; Delehaunty, KD; Miner, TL; Nash, WE; Kremitzki, C; Oddy, L; Du, H; Sun, H; Bradshaw-Cordum, H; Ali, J; Carter, J; Cordes, M; Harris, A; Isak, A; van Brunt, A; Nguyen, C; Du, FY; Courtney, L; Kalicki, J; Ozersky, P; Abbott, S; Armstrong, J; Belter, EA; Caruso, L; Cedroni, M; Cotton, M; Davidson, T; Desai, A; Elliott, G; Erb, T; Fronick, C; Gaige, T; Haakenson, W; Haglund, K; Holmes, A; Harkins, R; Kim, K; Kruchowski, SS; Strong, CM; Grewal, N; Goyea, E; Hou, S; Levy, A; Martinka, S; Mead, K; McLellan, MD; Meyer, R; Maher, JR; Tomlinson, C; Kohlberg, SD; Kozlowicz-Reilly, A; Shah, N; Swearengen-Shahid, S; Snider, J; Strong, JT; Thompson, J; Yoakum, M; Leonard, S; Pearman, C; Trani, L; Radionenko, M; Waligorski, JE; Wang, CY; Rock, SM; Tin-Wollam, AM; Maupin, R; Latreille, P; Wendl, MC; Yang, SP; Pohl, C; Wallis, JW; Spieth, J; Bieri, TA; Berkowicz, N; Nelson, JO; Osborne, J; Ding, L; Meyer, R; Sabo, A; Shotland, Y; Sinha, P; Wohldmann, PE; Cook, LL; Hickenbotham, MT; Eldred, J; Williams, D; Jones, TA; She, XW; Ciccarelli, FD; Izaurralde, E; Taylor, J; Schmutz, J; Myers, RM; Cox, DR; Huang, XQ; McPherson, JD; Mardis, ER; Clifton, SW; Warren, WC; Chinwalla, AT; Eddy, SR; Marra, MA; Ovcharenko, I; Furey, TS; Miller, W; Eichler, EE; Bork, P; Suyama, M; Torrents, D; Waterston, RH; Wilson, RK			Generation and annotation of the DNA sequences of human chromosomes 2 and 4	NATURE			English	Article							HUMAN-GENOME; CPG ISLANDS; GENE; MAP; MOUSE; INTEGRATION; ALIGNMENTS; EVOLUTION; INSIGHTS; QUALITY	Human chromosome 2 is unique to the human lineage in being the product of a head-to-head fusion of two intermediate-sized ancestral chromosomes. Chromosome 4 has received attention primarily related to the search for the Huntington's disease gene, but also for genes associated with Wolf-Hirschhorn syndrome, polycystic kidney disease and a form of muscular dystrophy. Here we present approximately 237 million base pairs of sequence for chromosome 2, and 186 million base pairs for chromosome 4, representing more than 99.6% of their euchromatic sequences. Our initial analyses have identified 1,346 protein-coding genes and 1,239 pseudogenes on chromosome 2, and 796 protein-coding genes and 778 pseudogenes on chromosome 4. Extensive analyses confirm the underlying construction of the sequence, and expand our understanding of the structure and evolution of mammalian chromosomes, including gene deserts, segmental duplications and highly variant regions.	Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Univ Washington, Sch Med, Seattle, WA 98195 USA; European Mol Biol Lab, D-69117 Heidelberg, Germany; Penn State Univ, Dept Biol, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; Penn State Univ, Dept Comp Sci, University Pk, PA 16802 USA; Stanford Univ, Sch Med, Dept Genet, Stanford Human Genome Ctr, Stanford, CA 94305 USA; Iowa State Univ, Dept Comp Sci, Ames, IA 50011 USA; Lawrence Livermore Natl Lab, EEBI Div, Livermore, CA 94550 USA; Lawrence Livermore Natl Lab, Genome Biol Div, Livermore, CA 94550 USA; Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA	Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL); University of Washington; University of Washington Seattle; European Molecular Biology Laboratory (EMBL); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Stanford University; Iowa State University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Santa Cruz	Wilson, RK (corresponding author), Washington Univ, Sch Med, Genome Sequencing Ctr, Campus Box 8501,4444 Forest Pk Ave, St Louis, MO 63108 USA.	rwilson@watson.wustl.edu	Izaurralde, Elisa/G-3239-2012; Bork, Peer/F-1813-2013; Wilson, Richard K./AAF-4139-2019; Mardis, Elaine/W-2202-2019; McPherson, John D/D-2633-2017; Wendl, Michael C/A-2741-2008; Sekhon, Mandeep/L-4665-2018; Taylor, James/F-1026-2011; Schmutz, Jeremy/N-3173-2013; Marra, Marco A/B-5987-2008; Torrents, David/G-5785-2015; Ciccarelli, Francesca/D-5380-2014	Bork, Peer/0000-0002-2627-833X; Wilson, Richard K./0000-0002-1992-1358; McPherson, John D/0000-0001-8049-9347; Sekhon, Mandeep/0000-0002-9993-6938; Taylor, James/0000-0001-5079-840X; Schmutz, Jeremy/0000-0001-8062-9172; Marra, Marco A/0000-0001-7146-7175; Izaurralde, Elisa/0000-0001-7365-2649; Kremitzki, Colin/0000-0001-9175-3136; Furey, Terry/0000-0001-5546-9672; Eddy, Sean/0000-0001-6676-4706; Suyama, Mikita/0000-0001-9526-3193; Chinwalla, Asif/0000-0001-7831-3996; Waligorski, Jason/0000-0001-8422-6004; Shiina, Takashi/0000-0002-2067-6708; Torrents, David/0000-0002-6086-9037; MCLELLAN, MICHAEL/0000-0002-2703-8784; Ciccarelli, Francesca/0000-0002-9325-0900				ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Ashburner M, 2001, GENOME RES, V11, P1425; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2002, AM J HUM GENET, V70, P83, DOI 10.1086/338458; Birney E, 2000, GENOME RES, V10, P547, DOI 10.1101/gr.10.4.547; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; Ciccarelli FD, 2005, GENOME RES, V15, P343, DOI 10.1101/gr.3266405; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Eddy SR, 2002, CELL, V109, P137, DOI 10.1016/S0092-8674(02)00727-4; Fan Y, 2002, GENOME RES, V12, P1651, DOI 10.1101/gr.337602; Felsenfeld A, 1999, GENOME RES, V9, P1; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hillier LW, 2003, NATURE, V424, P157, DOI 10.1038/nature01782; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202. Article published online before March 2002, 10.1101/gr.229202]; Kolbe D, 2004, GENOME RES, V14, P700, DOI 10.1101/gr.1976004; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Korf I, 2001, Bioinformatics, V17 Suppl 1, pS140; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liu CX, 2000, GENOMICS, V69, P271, DOI 10.1006/geno.2000.6331; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Mishmar D, 2004, HUM MUTAT, V23, P125, DOI 10.1002/humu.10304; Mulder Nicola J, 2002, Brief Bioinform, V3, P225; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; Olivier M, 2001, SCIENCE, V291, P1298, DOI 10.1126/science.1057437; Ovcharenko I, 2005, GENOME RES, V15, P137, DOI 10.1101/gr.3015505; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Riethman HC, 2001, NATURE, V409, P948, DOI 10.1038/35057180; Roest Crollius H, 2000, NAT GENET, V25, P235, DOI 10.1038/76118; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Schmutz J, 2003, COLD SPRING HARB SYM, V68, P31, DOI 10.1101/sqb.2003.68.31; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Suyama M, 2004, BIOINFORMATICS, V20, P1968, DOI 10.1093/bioinformatics/bth172; Torrents D, 2003, GENOME RES, V13, P2559, DOI 10.1101/gr.1455503; Wang Y, 2004, BIOINFORMATICS, V20, P1170, DOI 10.1093/bioinformatics/bth059; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang ZL, 2004, TRENDS GENET, V20, P62, DOI 10.1016/j.tig.2003.12.005	50	59	1622	3	49	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 7	2005	434	7034					724	731		10.1038/nature03466	http://dx.doi.org/10.1038/nature03466			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	913NU	15815621	Bronze			2022-12-24	WOS:000228160700031
J	Honda, K; Yanai, H; Negishi, H; Asagiri, M; Sato, M; Mizutani, T; Shimada, N; Ohba, Y; Takaoka, A; Yoshida, N; Taniguchi, T				Honda, K; Yanai, H; Negishi, H; Asagiri, M; Sato, M; Mizutani, T; Shimada, N; Ohba, Y; Takaoka, A; Yoshida, N; Taniguchi, T			IRF-7 is the master regulator of type-I interferon-dependent immune responses	NATURE			English	Article							PLASMACYTOID DENDRITIC CELLS; SINGLE-STRANDED RNA; TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTORS; POSITIVE FEEDBACK; ALPHA PRODUCTION; DISTINCT; RECOGNITION; INDUCTION; MYD88	The type-I interferon (IFN-alpha/beta) response is critical to immunity against viruses and can be triggered in many cell types by cytosolic detection of viral infection, or in differentiated plasmacytoid dendritic cells by the Toll-like receptor 9 (TLR9) subfamily, which generates signals via the adaptor MyD88 to elicit robust IFN induction(1-4). Using mice deficient in the Irf7 gene (Irf7(-/-) mice), we show that the transcription factor IRF-7 is essential for the induction of IFN-alpha/beta genes via the virus-activated, MyD88-independent pathway and the TLR-activated, MyD88-dependent pathway. Viral induction of MyD88-independent IFN-alpha/beta genes is severely impaired in Irf7(-/-) fibroblasts. Consistently, Irf7(-/-) mice are more vulnerable than Myd88(-/-) mice to viral infection, and this correlates with a marked decrease in serum IFN levels, indicating the importance of the IRF-7-dependent induction of systemic IFN responses for innate antiviral immunity. Furthermore, robust induction of IFN production by activation of the TLR9 subfamily in plasmacytoid dendritic cells is entirely dependent on IRF-7, and this MyD88-IRF-7 pathway governs the induction of CD8(+) T-cell responses. Thus, all elements of IFN responses, whether the systemic production of IFN in innate immunity or the local action of IFN from plasmacytoid dendritic cells in adaptive immunity, are under the control of IRF-7.	Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Fac Med, Tokyo 1130033, Japan; Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; JST, PRESTO, Informat & Cell Funct, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Taniguchi, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	tada@m.u-tokyo.ac.jp	Ohba, Yusuke/E-7944-2011; Yang, Chen/G-1379-2010; Honda, Kenya/N-5297-2015; Yanai, Hideyuki/AGK-5933-2022; Mizutani, Tatsuaki/AAA-5044-2021	Yanai, Hideyuki/0000-0002-0115-9000; Mizutani, Tatsuaki/0000-0002-4323-4347; Honda, Kenya/0000-0001-8937-9835				Ahonen CL, 2004, J EXP MED, V199, P775, DOI 10.1084/jem.20031591; Asselin-Paturel C, 2003, J IMMUNOL, V171, P6466, DOI 10.4049/jimmunol.171.12.6466; Balachandran S, 2004, NATURE, V432, P401, DOI 10.1038/nature03124; Barchet W, 2002, J EXP MED, V195, P507, DOI 10.1084/jem.20011666; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2003, J IMMUNOL, V170, P3059, DOI 10.4049/jimmunol.170.6.3059; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Qing J, 2004, MOL CELL BIOL, V24, P1411, DOI 10.1128/MCB.24.3.1411-1425.2004; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Verthelyi D, 2001, J IMMUNOL, V166, P2372, DOI 10.4049/jimmunol.166.4.2372; Wagner H, 2004, CURR OPIN BIOTECH, V15, P538, DOI 10.1016/j.copbio.2004.09.006; Wagner H, 2004, TRENDS IMMUNOL, V25, P381, DOI 10.1016/j.it.2004.04.011; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	30	1660	1734	3	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2005	434	7034					772	777		10.1038/nature03464	http://dx.doi.org/10.1038/nature03464			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	913NU	15800576				2022-12-24	WOS:000228160700043
J	Glasson, SS; Askew, R; Sheppard, B; Carito, B; Blanchet, T; Ma, HL; Flannery, CR; Peluso, D; Kanki, K; Yang, ZY; Majumdar, MK; Morris, EA				Glasson, SS; Askew, R; Sheppard, B; Carito, B; Blanchet, T; Ma, HL; Flannery, CR; Peluso, D; Kanki, K; Yang, ZY; Majumdar, MK; Morris, EA			Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis	NATURE			English	Article							HUMAN SYNOVIAL-FLUID; AGGRECAN FRAGMENTS; EXPLANTS; CLONING; CLEAVES	Human osteoarthritis is a progressive disease of the joints characterized by degradation of articular cartilage. Although disease initiation may be multifactorial, the cartilage destruction appears to be a result of uncontrolled proteolytic extracellular matrix destruction. A major component of the cartilage extracellular matrix is aggrecan, a proteoglycan that imparts compressive resistance to the tissue. Aggrecan is cleaved at a specific 'aggrecanase' site in human osteoarthritic cartilage(1-2); this cleavage can be performed by several members of ADAMTS family of metalloproteases(3-9). The relative contribution of individual ADAMTS proteases to cartilage destruction during osteoarthritis has not been resolved. Here we describe experiments with a genetically modified mouse in which the catalytic domain of ADAMTS5 (aggrecanase-2) was deleted. After surgically induced joint instability, there was significant reduction in the severity of cartilage destruction in the ADAMTS5 knockout mice compared with wild-type mice. This is the first report of a single gene deletion capable of abrogating the course of cartilage destruction in an animal model of osteoarthritis. These results demonstrate that ADAMTS5 is the primary 'aggrecanase' responsible for aggrecan degradation in a murine model of osteoarthritis, and suggest rational strategies for therapeutic intervention in osteoarthritis.	Wyeth Res, Dept Womens Hlth & Bone, Cambridge, MA 02140 USA; Wyeth Res, Genom, Cambridge, MA 02140 USA; Wyeth Res, Drug Safety & Metab, Cambridge, MA 02140 USA	Pfizer; Pfizer; Pfizer	Morris, EA (corresponding author), Wyeth Res, Dept Womens Hlth & Bone, 200 CambridgePk Dr, Cambridge, MA 02140 USA.	Emorris@Wyeth.com						Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; Chambers MG, 2001, ARTHRITIS RHEUM-US, V44, P1455, DOI 10.1002/1529-0131(200106)44:6<1455::AID-ART241>3.0.CO;2-J; Clements KM, 2003, ARTHRITIS RHEUM-US, V48, P3452, DOI 10.1002/art.11355; Collins-Racie LA, 2004, MATRIX BIOL, V23, P219, DOI 10.1016/j.matbio.2004.05.004; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Glasson SS, 2004, ARTHRITIS RHEUM-US, V50, P2547, DOI 10.1002/art.20558; Hughes Clare E, 2003, Methods Mol Biol, V225, P89; Kuno K, 2000, FEBS LETT, V478, P241, DOI 10.1016/S0014-5793(00)01854-8; Little CB, 2003, T ORTHOP RES SOC, V28, P699; LOHMANDER LS, 1993, ARTHRITIS RHEUM, V36, P1214; Rodriguez-Manzaneque JC, 2002, BIOCHEM BIOPH RES CO, V293, P501; SANDY JD, 1992, J CLIN INVEST, V89, P1512, DOI 10.1172/JCI115742; SANDY JD, 1991, J BIOL CHEM, V266, P8683; Somerville RPT, 2003, J BIOL CHEM, V278, P9503, DOI 10.1074/jbc.M211009200; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; YAMAJI N, 2004, Patent No. 6716613	16	932	995	3	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2005	434	7033					644	648		10.1038/nature03369	http://dx.doi.org/10.1038/nature03369			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911NN	15800624				2022-12-24	WOS:000228011000045
J	Nakagawa, T; Shimizu, S; Watanabe, T; Yamaguchi, O; Otsu, K; Yamagata, H; Inohara, H; Kubo, T; Tsujimoto, Y				Nakagawa, T; Shimizu, S; Watanabe, T; Yamaguchi, O; Otsu, K; Yamagata, H; Inohara, H; Kubo, T; Tsujimoto, Y			Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death	NATURE			English	Article							CYTOCHROME-C RELEASE; CYCLOSPORINE-A; PORE; RAT; BAX; DYSFUNCTION; ACTIVATION; CA2+	Mitochondria play an important role in energy production, Ca2+ homeostasis and cell death. In recent years, the role of the mitochondria in apoptotic and necrotic cell death has attracted much attention(1,2). In apoptosis and necrosis, the mitochondrial permeability transition (mPT), which leads to disruption of the mitochondrial membranes and mitochondrial dysfunction, is considered to be one of the key events, although its exact role in cell death remains elusive. We therefore created mice lacking cyclophilin D (CypD), a protein considered to be involved in the mPT, to analyse its role in cell death. CypD-deficient mice were developmentally normal and showed no apparent anomalies, but CypD-deficient mitochondria did not undergo the cyclosporin A-sensitive mPT. CypD-deficient cells died normally in response to various apoptotic stimuli, but showed resistance to necrotic cell death induced by reactive oxygen species and Ca2+ overload. In addition, CypD-deficient mice showed a high level of resistance to ischaemia/reperfusion-induced cardiac injury. Our results indicate that the CypD-dependent mPT regulates some forms of necrotic death, but not apoptotic death.	Osaka Univ, Sch Med, Dept Postgenom & Dis, Mol Genet Lab, Suita, Osaka 5650871, Japan; Osaka Univ, Sch Med, Dept Otolaryngol & Sensory Organ Surg, Suita, Osaka 5650871, Japan; Osaka Univ, Sch Med, Dept Internal Med & Therapeut, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, SORST, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Tsujimoto, Y (corresponding author), Osaka Univ, Sch Med, Dept Postgenom & Dis, Mol Genet Lab, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	tsujimot@gene.med.osaka-u.ac.jp	Nakagawa, Takashi/F-3015-2010	Nakagawa, Takashi/0000-0001-5539-7605; Yamaguchi, Osamu/0000-0002-7461-369X				BROEKEMEIER KM, 1989, J BIOL CHEM, V264, P7826; Byrne AM, 1999, HEPATOLOGY, V29, P1523, DOI 10.1002/hep.510290521; Crompton M, 2003, CURR MED CHEM, V10, P1473, DOI 10.2174/0929867033457197; Eskes R, 1998, J CELL BIOL, V143, P217, DOI 10.1083/jcb.143.1.217; Finucane DM, 1999, J BIOL CHEM, V274, P2225, DOI 10.1074/jbc.274.4.2225; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; GALAT A, 1995, PROG BIOPHYS MOL BIO, V63, P67, DOI 10.1016/0079-6107(94)00009-X; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Halestrap AP, 2004, NATURE, V430, DOI 10.1038/nature02816; Hatano E, 2000, J BIOL CHEM, V275, P11814, DOI 10.1074/jbc.275.16.11814; He LH, 2002, FEBS LETT, V512, P1, DOI 10.1016/S0014-5793(01)03314-2; Javadov SA, 2003, J PHYSIOL-LONDON, V549, P513, DOI 10.1113/jphysiol.2003.034231; Khaspekov L, 1999, EUR J NEUROSCI, V11, P3194, DOI 10.1046/j.1460-9568.1999.00743.x; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Li YM, 2004, BIOCHEM J, V383, P101, DOI 10.1042/BJ20040669; Matsumoto S, 1999, J CEREBR BLOOD F MET, V19, P736, DOI 10.1097/00004647-199907000-00002; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; SHIMIZU S, 1994, TRANSPLANTATION, V57, P1562; Shimizu S, 1996, ONCOGENE, V12, P2251; Shimizu S, 1998, P NATL ACAD SCI USA, V95, P1455, DOI 10.1073/pnas.95.4.1455; Shinzawa K, 2003, J CELL BIOL, V163, P1219, DOI 10.1083/jcb.200306159; Trollinger DR, 1997, BIOCHEM BIOPH RES CO, V236, P738, DOI 10.1006/bbrc.1997.7042; Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254; von Ahsen O, 2000, J CELL BIOL, V150, P1027, DOI 10.1083/jcb.150.5.1027; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; Yamashita N, 1999, J EXP MED, V189, P1699, DOI 10.1084/jem.189.11.1699; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073	30	1269	1327	3	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2005	434	7033					652	658		10.1038/nature03317	http://dx.doi.org/10.1038/nature03317			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911NN	15800626				2022-12-24	WOS:000228011000047
J	Pandolfi, JM; Jackson, JBC; Baron, N; Bradbury, RH; Guzman, HM; Hughes, TP; Kappel, CV; Micheli, F; Ogden, JC; Possingham, HP; Sala, E				Pandolfi, JM; Jackson, JBC; Baron, N; Bradbury, RH; Guzman, HM; Hughes, TP; Kappel, CV; Micheli, F; Ogden, JC; Possingham, HP; Sala, E			Ecology - Are US coral reefs on the slippery slope to slime?	SCIENCE			English	Article							RESILIENCE; ECOSYSTEMS		Univ Queensland, Ctr Marine Studies, St Lucia, Qld 4072, Australia; Univ Queensland, Dept Earth Sci, St Lucia, Qld 4072, Australia; Univ Queensland, Dept Math, St Lucia, Qld 4072, Australia; Univ Queensland, Sch Life Sci, St Lucia, Qld 4072, Australia; Univ Calif San Diego, Scripps Inst Oceanog, Ctr Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; Smithsonian Trop Res Inst, Balboa, Panama; Natl ctr Ecol Anal & Synth, Santa Barbara, CA USA; Australian Natl Univ, Ctr Resource & Environm Studies, Canberra, ACT 0200, Australia; James Cook Univ N Queensland, Sch Marine Biol, Ctr Coral Reef Biodivers, Townsville, Qld 4811, Australia; Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; Florida Inst Oceanog, St Petersburg, FL 33701 USA	University of Queensland; University of Queensland; University of Queensland; University of Queensland; University of California System; University of California San Diego; Scripps Institution of Oceanography; Smithsonian Institution; Smithsonian Tropical Research Institute; National Center for Ecological Analysis & Synthesis; Australian National University; James Cook University; Stanford University	Pandolfi, JM (corresponding author), Univ Queensland, Ctr Marine Studies, St Lucia, Qld 4072, Australia.	j.pandolfi@uq.edu.au	Possingham, Hugh/B-1337-2008; Hughes, Terry P/L-4721-2013; POSSINGHAM, HUGH/R-8310-2019; Kappel, Carrie Vanessa/B-9534-2009; Pandolfi, John M/A-3121-2009	Possingham, Hugh/0000-0001-7755-996X; Hughes, Terry P/0000-0002-5257-5063; POSSINGHAM, HUGH/0000-0001-7755-996X; Kappel, Carrie Vanessa/0000-0003-2507-8042; Pandolfi, John M/0000-0003-3047-6694; Micheli, Fiorenza/0000-0002-6865-1438; Guzman, Hector M./0000-0001-9928-8523; Bradbury, Roger/0000-0002-0940-3493				Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bohnsack James A., 2003, Gulf and Caribbean Research, V14, P1; BRUMBAUGH DR, 2003, P FOR 2003 C NASS BA; Bryant D., 1998, REEFS RISK MAP BASED; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; ESTRADA R, 2003, SISTEMA NACL AREAS M; *FL KEYS NATL MAR, 1995, DRAFT MAN PLAN ENV I, V1, P1; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; *INT UN CONS NAT N, RED LIST THREAT SPEC; JAAP WC, 2003, ENV PROTECTION AGENC; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JARAGOS J, 2002, CORAL REEF ECOSYSTEM; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Porter James W., 2002, P749; SAFINA C, 2003, EYE ALBATROSS; WILKINSON CR, IN PRESS STATUS CORA, V1; [No title captured]	22	345	364	1	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2005	307	5716					1725	1726		10.1126/science.1104258	http://dx.doi.org/10.1126/science.1104258			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909TP	15774744				2022-12-24	WOS:000227883900028
J	Birkhead, TR; Pellatt, EJ; Brekke, P; Yeates, R; Castillo-Juarez, H				Birkhead, TR; Pellatt, EJ; Brekke, P; Yeates, R; Castillo-Juarez, H			Genetic effects on sperm design in the zebra finch	NATURE			English	Article							EJACULATE QUALITY; COMPETITION; SELECTION; EVOLUTION; POPULATION; DETERMINES; MOBILITY; LENGTH	Sperm design and function are important determinants of male reproductive success and are expected to be under strong selection(1,2). The way that spermatozoa phenotypes evolve is poorly understood, because there have been few studies of the quantitative genetics of sperm(3-5). Here we show, in the zebra finch Taeniopygia guttata, an extraordinary degree of inter-male variation in sperm design that is independent of sperm swimming velocity. A quantitative genetics study using data from over 900 zebra finches in a complex breeding experiment showed that sperm head, mid-piece and flagellum length are heritable, that negative genetic correlations exist between sperm traits, and that significant indirect ( maternal) genetic effects exist. Selection on the zebra finch sperm phenotype may be low because sperm competition is infrequent in this species(6), and this, in combination with negative genetic correlations and maternal genetic effects, may account for the variation in sperm phenotype between males. These results have important implications for the evolution of sperm in other taxa.	Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; Univ Autonoma Metropolitana Xochimilco, Mexico City 04960, DF, Mexico	University of Sheffield; Universidad Autonoma Metropolitana - Mexico	Birkhead, TR (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	T.R.Birkhead@sheffield.ac.uk		Castillo-Juarez, Hector/0000-0002-5550-4180				Anderson MJ, 2002, NATURE, V416, P496, DOI 10.1038/416496a; BEATTY RA, 1970, BIOL REV, V45, P73, DOI 10.1111/j.1469-185X.1970.tb01076.x; BIRKHEAD TR, 1990, BEHAV ECOL SOCIOBIOL, V27, P315, DOI 10.1007/BF00164002; BIRKHEAD TR, 1993, J THEOR BIOL, V161, P51, DOI 10.1006/jtbi.1993.1039; Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; BIRKHEAD TR, 1995, NATURE, V377, P422, DOI 10.1038/377422a0; Birkhead TR, 1995, P ROY SOC B-BIOL SCI, V262, P329, DOI 10.1098/rspb.1995.0213; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P1759, DOI 10.1098/rspb.1999.0843; Boldman K.G., 1995, MANUAL USE MTDFREML; CARDULLO RA, 1991, CELL MOTIL CYTOSKEL, V19, P180, DOI 10.1002/cm.970190306; CHEVERUD JM, 1983, GENET RES, V42, P65, DOI 10.1017/S0016672300021492; COHEN J, 1974, J REPROD FERTIL, V39, P297, DOI 10.1530/jrf.0.0390297; Cohen J., 1977, REPRODUCTION; Frank SA, 1996, NATURE, V383, P224, DOI 10.1038/383224a0; Froman DP, 1998, BIOL REPROD, V58, P379, DOI 10.1095/biolreprod58.2.379; Gemmell NJ, 2004, TRENDS ECOL EVOL, V19, P238, DOI 10.1016/j.tree.2004.02.002; Jamieson BGM, 1999, MALE GAMETE: FROM BASIC SCIENCE TO CLINICAL APPLICATIONS, P303; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Lynch M., 1998, AM J HUM GENET; MCFARLANE RW, 1963, P 13 INT ORN C ITH N, P91; Morrow EH, 2001, HEREDITY, V87, P356, DOI 10.1046/j.1365-2540.2001.00921.x; Morrow EH, 2001, J ZOOL, V254, P147, DOI 10.1017/S0952836901000656; Parker G.A., 1998, SPERM COMPETITION SE, P3, DOI DOI 10.1016/B978-012100543-6/50026-X; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; Roff D, 2000, HEREDITY, V84, P135, DOI 10.1046/j.1365-2540.2000.00695.x; Royle NJ, 2003, FUNCT ECOL, V17, P472, DOI 10.1046/j.1365-2435.2003.00752.x; SEH J, 2004, P R SOC LOND B S, V271, pS306; Simmons LW, 2002, EVOLUTION, V56, P1622, DOI 10.1111/j.0014-3820.2002.tb01474.x; Wolf JB, 1998, TRENDS ECOL EVOL, V13, P64, DOI 10.1016/S0169-5347(97)01233-0; Zann RA., 1996, ZEBRA FINCH SYNTHESI	30	156	158	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					383	387		10.1038/nature03374	http://dx.doi.org/10.1038/nature03374			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772662				2022-12-24	WOS:000227715100052
J	Plusa, B; Hadjantonakis, AK; Gray, D; Piotrowska-Nitsche, K; Jedrusik, A; Papaioannou, VE; Glover, DM; Zernicka-Goetz, M				Plusa, B; Hadjantonakis, AK; Gray, D; Piotrowska-Nitsche, K; Jedrusik, A; Papaioannou, VE; Glover, DM; Zernicka-Goetz, M			The first cleavage of the mouse zygote predicts the blastocyst axis	NATURE			English	Article							1ST CLEAVAGE; BLASTOMERES; DIVISION; EGG	One of the unanswered questions in mammalian development is how the embryonic - abembryonic axis of the blastocyst is first established. It is possible that the first cleavage division contributes to this process, because in most mouse embryos the progeny of one two-cell blastomere primarily populate the embryonic part of the blastocyst and the progeny of its sister populate the abembryonic part(1-4). However, it is not known whether the embryonic - abembryonic axis is set up by the first cleavage itself, by polarity in the oocyte that then sets the first cleavage plane with respect to the animal pole, or indeed whether it can be divorced entirely from the first cleavage and established in relation to the animal pole. Here we test the importance of the orientation of the first cleavage by imposing an elongated shape on the zygote so that the division no longer passes close to the animal pole, marked by the second polar body. Non-invasive lineage tracing shows that even when the first cleavage occurs along the short axis imposed by this experimental treatment, the progeny of the resulting two-cell blastomeres tend to populate the respective embryonic and abembryonic parts of the blastocyst. Thus, the first cleavage contributes to breaking the symmetry of the embryo, generating blastomeres with different developmental characteristics.	Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA	University of Cambridge; University of Cambridge; Columbia University	Zernicka-Goetz, M (corresponding author), Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QR, England.	mzg@mole.bio.cam.ac.uk		Hadjantonakis, Anna-Katerina/0000-0002-7580-5124; Plusa, Berenika/0000-0003-2214-5940; Papaioannou, Virginia/0000-0001-7558-8601; Zernicka-Goetz, Magdalena/0000-0002-7004-2471; Glover, David/0000-0003-0956-0103	Wellcome Trust [064421] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		DONAHUE RP, 1972, J EXP ZOOL, V180, P305, DOI 10.1002/jez.1401800303; Fujimori T, 2003, DEVELOPMENT, V130, P5113, DOI 10.1242/dev.00725; Gardner RL, 1997, DEVELOPMENT, V124, P289; Gardner RL, 2001, DEVELOPMENT, V128, P839; GARNER W, 1974, J EMBRYOL EXP MORPH, V32, P495; Gray D, 2004, CURR BIOL, V14, P397, DOI 10.1016/j.cub.2004.02.031; Hadjantonakis AK, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-33; Hiiragi T, 2004, NATURE, V430, P360, DOI 10.1038/nature02595; Mayer W, 2000, J CELL BIOL, V148, P629, DOI 10.1083/jcb.148.4.629; Piotrowska K, 2001, DEVELOPMENT, V128, P3739; Piotrowska K, 2001, NATURE, V409, P517, DOI 10.1038/35054069; Piotrowska-Nitsche K, 2005, DEVELOPMENT, V132, P479, DOI 10.1242/dev.01602; Piotrowska-Nitsche K, 2005, MECH DEVELOP, V122, P487, DOI 10.1016/j.mod.2004.11.014; Plusa B, 2002, NAT CELL BIOL, V4, P811, DOI 10.1038/ncb860	14	107	119	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2005	434	7031					391	395		10.1038/nature03388	http://dx.doi.org/10.1038/nature03388			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907KG	15772664				2022-12-24	WOS:000227715100054
J	Vasan, RS; Sullivan, LM; Wilson, PWF; Sempos, CT; Sundstrom, J; Kannel, WB; Levy, D; D'Agostino, RB				Vasan, RS; Sullivan, LM; Wilson, PWF; Sempos, CT; Sundstrom, J; Kannel, WB; Levy, D; D'Agostino, RB			Relative importance of borderline and elevated levels of coronary heart disease risk factors	ANNALS OF INTERNAL MEDICINE			English	Article							BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; SERUM-CHOLESTEROL; TASK-FORCE; PREVENTION; POPULATION; PREDICTION; MORTALITY; SMOKING	Background: Clinical trials indicate that a sizable proportion of adults have multiple borderline coronary risk factors and may benefit from treatment. Objective: To estimate the relative and absolute contributions of borderline and elevated risk factors to the population burden of coronary heart disease (CHD) events. Design: A prospective cohort study and a national crosssectional survey. Setting: The Framingham Study and the Third National Health and Nutrition Examination Survey (NHANES III). Participants: White non-Hispanic persons in the Framingham Study and in NHANES III who were between 35 to 74 years of age and had no CHD. Measurements: Occurrence of first CHD events according to 5 major CHD risk factors: blood pressure, low-density lipoprotein and high-density lipoprotein cholesterol levels, glucose intolerance, and smoking. Three categories - optimal, borderline, and elevated-were defined for each risk factor per national guide-lines. Sex-specific 10-year CHD event rates from the Framingham Study were applied to numbers of at-risk individuals estimated from NHANES III and the 2000 U.S. Census. Results: Twenty-six percent of men and 41% of women had at least 1 borderline risk factor in NHANES III. According to estimates, more than 90% of CHD events will occur in individuals with at least 1 elevated risk factor, and approximately 8% will occur in people with only borderline levels of multiple risk factors. Absolute 10-year CHD risk exceeded 10% in men older than age 45 years who had 1 elevated risk factor and 4 or more borderline risk factors and in those who had at least 2 elevated risk factors. In women, absolute CHD risk exceeded 10% only in those older than age 55 years who had at least 3 elevated risk factors. Limitations: The generalizability of the findings to persons of other ethnic backgrounds is unknown. Conclusions: Borderline CHD risk factors alone account for a small proportion of CHD events.	Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA; Med Univ S Carolina, Charleston, SC 29425 USA; SUNY Buffalo, Buffalo, NY 14260 USA; NHLBI, Bethesda, MD 20892 USA; Boston Univ, Boston, MA 02215 USA	Framingham Heart Study; Medical University of South Carolina; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University	Vasan, RS (corresponding author), Framingham Heart Dis Epidemiol Study, 73 Mt Wayne Ave,Suite 2, Framingham, MA 01702 USA.	vasan@bu.edu	Levy, Daniel/ABF-6873-2021; Sundstrom, Johan/R-2139-2019; Sundström, Johan/A-6286-2009; Wilson, Peter W.F./J-2455-2016; Levy, Daniel/ABB-2752-2021	Levy, Daniel/0000-0003-1843-8724; Sundstrom, Johan/0000-0003-2247-8454; Sundström, Johan/0000-0003-2247-8454; Sullivan, Lisa/0000-0003-0726-7149; Ramachandran, Vasan/0000-0001-7357-5970				Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; [Anonymous], 1994, VITAL HLTH STAT, V1, P1, DOI DOI 10.1136/BMJ.L42; Benjamin EJ, 2002, J AM COLL CARDIOL, V40, P588, DOI 10.1016/S0735-1097(02)02082-X; Burns DM, 2003, PROG CARDIOVASC DIS, V46, P11, DOI 10.1016/S0033-0620(03)00079-3; *CDCP, 1996, NHANES 3 1988 94 REF; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P4; Chobanian AV, 2000, HYPERTENSION, V35, P858, DOI 10.1161/01.HYP.35.4.858; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; De Backer G, 2003, EUR J CARDIOV PREV R, V10, pS1, DOI 10.1097/01.hjr.0000087913.96265.e2; Eide GE, 2001, STAT METHODS MED RES, V10, P159, DOI 10.1191/096228001680195148; Ford ES, 2003, CIRCULATION, V107, P2185, DOI 10.1161/01.CIR.0000066320.27195.B4; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Grundy SM, 1999, CIRCULATION, V100, P988, DOI 10.1161/01.CIR.100.9.988; Jousilahti P, 1998, CIRCULATION, V97, P1087, DOI 10.1161/01.CIR.97.11.1087; KANNEL WB, 1995, CIRCULATION, V92, P3350, DOI 10.1161/01.CIR.92.11.3350; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kannel WB., 1987, SECTION 34 SOME RISK; Keil U, 1998, EUR HEART J, V19, P1197, DOI 10.1053/euhj.1998.1089; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Law MR, 2002, BMJ-BRIT MED J, V324, P1570, DOI 10.1136/bmj.324.7353.1570; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Lloyd-Jones DM, 1999, LANCET, V353, P89, DOI 10.1016/S0140-6736(98)10279-9; Magnus P, 2001, ARCH INTERN MED, V161, P2657, DOI 10.1001/archinte.161.22.2657; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; *NAT CTR HLTH STAT, 2003, HLTH US 2003 CHARTB, P95; NEATON JD, 1992, ARCH INTERN MED, V152, P56, DOI 10.1001/archinte.152.1.56; Pasternak Richard C., 2003, Journal of the American College of Cardiology, V41, P1863, DOI 10.1016/S0735-1097(03)00358-9; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; Vasan RS, 2002, CIRCULATION, V105, P48, DOI 10.1161/hc0102.101774; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	36	142	151	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2005	142	6					393	402		10.7326/0003-4819-142-6-200503150-00005	http://dx.doi.org/10.7326/0003-4819-142-6-200503150-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906DQ	15767617				2022-12-24	WOS:000227621100001
J	Barrios-Rodiles, M; Brown, KR; Ozdamar, B; Bose, R; Liu, Z; Donovan, RS; Shinjo, F; Liu, YM; Dembowy, J; Taylor, IW; Luga, V; Przulj, N; Robinson, M; Suzuki, H; Hayashizaki, Y; Jurisica, I; Wrana, JL				Barrios-Rodiles, M; Brown, KR; Ozdamar, B; Bose, R; Liu, Z; Donovan, RS; Shinjo, F; Liu, YM; Dembowy, J; Taylor, IW; Luga, V; Przulj, N; Robinson, M; Suzuki, H; Hayashizaki, Y; Jurisica, I; Wrana, JL			High-throughput mapping of a dynamic signaling network in mammalian cells	SCIENCE			English	Article							GROWTH-FACTOR-BETA; PROTEIN INTERACTIONS; TRANSDUCTION; MAP	Signaling pathways transmit information through protein interaction networks that are dynamically regulated by complex extracellular cues. We developed LUMIER (for luminescence-based mammalian interactome mapping), an automated high-throughput technology, to map protein-protein interaction networks systematically in mammalian cells and applied it to the transforming growth factor-beta (TGFbeta) pathway. Analysis using self-organizing maps and k-means clustering identified links of the TGFbeta pathway to the p21 activated kinase (PAK) network, to the polarity complex, and to Occludin, a structural component of tight junctions. We show that Occludin regulates TGFbeta type I receptor localization for efficient TGFbeta-dependent dissolution of tight junctions during epithelial-to-mesenchymal transitions.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5S 2M9, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Comp Sci, Toronto, ON M5S 3H5, Canada; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; RIKEN Genom Sci Ctr, Yokohama Inst, Lab Genome Explorat Res Grp, Yokohama, Kanagawa 2300045, Japan; Princess Margaret Hosp, Ontario Canc Inst, Div Canc Informat, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University of Toronto; RIKEN; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Wrana, JL (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	wrana@mshri.on.ca	Wrana, Jeffrey/F-8857-2013; Robinson, Mark D/A-6432-2015; Suzuki, Harukazu/N-9553-2015; Przulj, Natasa/AAO-2850-2020; Robinson, Mark D./O-2254-2019; Bose, Rohit/O-9825-2018	Robinson, Mark D/0000-0002-3048-5518; Suzuki, Harukazu/0000-0002-8087-0836; Robinson, Mark D./0000-0002-3048-5518; Bose, Rohit/0000-0002-6785-0697; Przulj, Natasa/0000-0002-1290-853X; Brown, Kevin/0000-0002-5514-2538	NIGMS NIH HHS [P50 GM-62413] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM062413] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; BARRIOSRODILES M, UNPUB; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Chen W, 2004, J BIOL CHEM, V279, P11129, DOI 10.1074/jbc.M313562200; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; OZDAMAR B, IN PRESS; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Seton-Rogers SE, 2004, P NATL ACAD SCI USA, V101, P1257, DOI 10.1073/pnas.0308090100; Stagljar I, 2002, TRENDS BIOCHEM SCI, V27, P559, DOI 10.1016/S0968-0004(02)02197-7; Sultan M, 2002, Bioinformatics, V18 Suppl 1, pS111; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wilkes MC, 2003, MOL CELL BIOL, V23, P8878, DOI 10.1128/MCB.23.23.8878-8889.2003; Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636	23	539	566	4	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2005	307	5715					1621	1625		10.1126/science.1105776	http://dx.doi.org/10.1126/science.1105776			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15761153				2022-12-24	WOS:000227622400047
J	Lang, D; Lu, MM; Huang, L; Engleka, KA; Zhang, MZ; Chu, EY; Lipner, S; Skoultchi, A; Millar, SE; Epstein, JA				Lang, D; Lu, MM; Huang, L; Engleka, KA; Zhang, MZ; Chu, EY; Lipner, S; Skoultchi, A; Millar, SE; Epstein, JA			Pax3 functions at a nodal point in melanocyte stem cell differentiation	NATURE			English	Article							HAIR FOLLICLE DEVELOPMENT; TRANSCRIPTION FACTOR; NEURAL CREST; BETA-CATENIN; WAARDENBURG-SYNDROME; SOX10; MITF; MORPHOGENESIS; INITIATION; INTERACTS	Most stem cells are not totipotent. Instead, they are partially committed but remain undifferentiated. Upon appropriate stimulation they are capable of regenerating mature cell types(1). Little is known about the genetic programmes that maintain the undifferentiated phenotype of lineage-restricted stem cells. Here we describe the molecular details of a nodal point in adult melanocyte stem cell differentiation in which Pax3 simultaneously functions to initiate a melanogenic cascade while acting downstream to prevent terminal differentiation. Pax3 activates expression of Mitf, a transcription factor critical for melanogenesis(2,3), while at the same time it competes with Mitf for occupancy of an enhancer required for expression of dopachrome tautomerase, an enzyme that functions in melanin synthesis(4). Pax3-expressing melanoblasts are thus committed but undifferentiated until Pax3-mediated repression is relieved by activated beta-catenin. Thus, a stem cell transcription factor can both determine cell fate and simultaneously maintain an undifferentiated state, leaving a cell poised to differentiate in response to external stimuli.	Univ Penn, Dept Med, Div Cardiovasc, Philadelphia, PA 19104 USA; Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	University of Pennsylvania; University of Pennsylvania; Yeshiva University; Albert Einstein College of Medicine	Epstein, JA (corresponding author), Univ Penn, Dept Med, Div Cardiovasc, Philadelphia, PA 19104 USA.	epsteinj@mail.med.upenn.edu		Lang, Deborah/0000-0003-1057-0923; Millar, Sarah/0000-0001-8792-6890; Epstein, Jonathan/0000-0001-8637-4465				Aksan I, 1998, MOL CELL BIOL, V18, P6930, DOI 10.1128/MCB.18.12.6930; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Ashery-Padan R, 2001, CURR OPIN CELL BIOL, V13, P706, DOI 10.1016/S0955-0674(00)00274-X; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bertolotto C, 1998, J CELL BIOL, V142, P827, DOI 10.1083/jcb.142.3.827; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Brault V, 2001, DEVELOPMENT, V128, P1253; Cai Y, 2003, EMBO J, V22, P5522, DOI 10.1093/emboj/cdg536; Chu EY, 2004, DEVELOPMENT, V131, P4819, DOI 10.1242/dev.01347; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Eberhard D, 2000, EMBO J, V19, P2292, DOI 10.1093/emboj/19.10.2292; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Garcia-Castro MI, 2002, SCIENCE, V297, P848, DOI 10.1126/science.1070824; Hari L, 2002, J CELL BIOL, V159, P867, DOI 10.1083/jcb.200209039; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Jin ZX, 2002, J IMMUNOL, V169, P3783, DOI 10.4049/jimmunol.169.7.3783; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Potterf SB, 2000, HUM GENET, V107, P1, DOI 10.1007/s004390050001; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; STEEL KP, 1992, DEVELOPMENT, V115, P1111; TSUKAMOTO K, 1992, EMBO J, V11, P519, DOI 10.1002/j.1460-2075.1992.tb05082.x; Watanabe A, 1998, NAT GENET, V18, P283, DOI 10.1038/ng0398-283; Widlund HR, 2003, ONCOGENE, V22, P3035, DOI 10.1038/sj.onc.1206443; Yasumoto K, 2002, EMBO J, V21, P2703, DOI 10.1093/emboj/21.11.2703	30	283	300	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2005	433	7028					884	887		10.1038/nature03292	http://dx.doi.org/10.1038/nature03292			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	899VT	15729346				2022-12-24	WOS:000227174600047
J	Sinclair, J; Green, J				Sinclair, J; Green, J			Understanding resolution of deliberate self harm: qualitative interview study of patients' experiences	BRITISH MEDICAL JOURNAL			English	Article							SUICIDE; DISORDERS; ADOLESCENTS; TRIAL	Objective To explore the accounts of those with a history of deliberate self harm but who no longer do so, to understand how they perceive this resolution and to identify potential implications for provision of health services. Design Qualitative in-depth interview study. Setting Interviews in a community setting. Participants 20 participants selected from a representative cohort identified in 1997 after an episode of deliberate self poisoning that resulted hospital treatment. Participants were included if they had no further episodes for at least two years before interview Results We identified three recurrent themes: the resolution of adolescent distress; the recognition of the role of alcohol as a precipitating and maintaining factor in self harm; and the understanding of deliberate self harm as a symptom of untreated or unrecognised illness. Conclusion Patients with a history of deliberate self harm who no longer harm themselves talk about their experiences in terms of lack of control over their lives, either through alcohol dependence, untreated depression, or, in adolescents, uncertainty within their family relationships. Hospital management of deliberate self harm has a role in the identification and treatment of depression and alcohol misuse, although in adolescents such interventions may be less appropriate.	Univ Oxford, Warneford Hosp, Ctr Suicide Res, Dept Psychiat, Oxford OX3 7JX, England; Univ London London Sch Hyg & Trop Med, Hlth Serv Res Unit, London WC1E 7HT, England	University of Oxford; University of London; London School of Hygiene & Tropical Medicine	Sinclair, J (corresponding author), Univ Oxford, Warneford Hosp, Ctr Suicide Res, Dept Psychiat, Oxford OX3 7JX, England.	julia.sinclair@psych.ox.ac.uk	Sinclair, Julia/AAD-8049-2019	Sinclair, Julia/0000-0002-1905-2025; Green, Judith/0000-0002-2315-5326; Houston, Mary/0000-0002-8837-4503				Beck A.T., 1974, DEV SUICIDAL INTENT; Bennett S, 2003, SOC SCI MED, V57, P289, DOI 10.1016/S0277-9536(02)00347-7; Channaz K., 1999, QUAL HEALTH RES, V9, P362, DOI DOI 10.1177/104973239900900306; Coggan C, 1997, SOC SCI MED, V45, P1563, DOI 10.1016/S0277-9536(97)00098-1; Crawford M, 2004, LANCET, V364, P1334, DOI 10.1016/S0140-6736(04)17190-0; Everall RD., 2000, CAN J COUNS, V34, P111; Frank A, 1997, WOUNDED STORY TELLER; Green J, 1998, BMJ-BRIT MED J, V316, P1064; Green J., 2004, QUALITATIVE METHODS, V4th; Hammersley M, 1992, WHATS WRONG ETHNOGRA, P85; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; Haw C, 2001, BRIT J PSYCHIAT, V178, P48, DOI 10.1192/bjp.178.1.48; Hawton K, 2002, BMJ-BRIT MED J, V325, P1207, DOI 10.1136/bmj.325.7374.1207; Hawton K, 2003, J CHILD PSYCHOL PSYC, V44, P1191, DOI 10.1111/1469-7610.00200; Hawton K, 2003, AM J PSYCHIAT, V160, P1494, DOI 10.1176/appi.ajp.160.8.1494; Hawton K, 1998, BRIT MED J, V317, P441; National Institute of Clinical Excellence, 2004, SHORT TERM PHYS PSYC; Pirkola SP, 2004, CNS DRUGS, V18, P423, DOI 10.2165/00023210-200418070-00002; PLATT S, 1992, ACTA PSYCHIAT SCAND, V85, P97, DOI 10.1111/j.1600-0447.1992.tb01451.x; Redley M, 2003, SOCIOL HEALTH ILL, V25, P348, DOI 10.1111/1467-9566.00350; Strauss AL., 1987, QUALITATIVE ANAL SOC, Vxv, P319; Tyrer P, 2003, PSYCHOL MED, V33, P969, DOI 10.1017/S0033291703008171	22	83	84	0	14	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 14	2005	330	7500					1112	1115		10.1136/bmj.38441.503333.8F	http://dx.doi.org/10.1136/bmj.38441.503333.8F			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	927BH	15843425	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000229166900016
J	Nilsson, C; Reidy, CA; Dynesius, M; Revenga, C				Nilsson, C; Reidy, CA; Dynesius, M; Revenga, C			Fragmentation and flow regulation of the world's large river systems	SCIENCE			English	Article							CONSERVATION; DAM; RESERVOIR; ZONE; FISH	A global overview of dam-based impacts on large river systems shows that over half (172 out of 292) are affected by dams, including the eight most biogeographicalty diverse. Dam-impacted catchments experience higher irrigation pressure and about 25 times more economic activity per unit of water than do unaffected catchments. In view of projected changes in climate and water resource use, these findings can be used to identify ecological risks associated with further impacts on large river systems.	Umea Univ, Dept Ecol & Environm Sci, Landscape Ecol Grp, SE-90187 Umea, Sweden; Nature Conservancy, Global Prior Grp, Arlington, VA 22203 USA	Umea University; Nature Conservancy	Nilsson, C (corresponding author), Umea Univ, Dept Ecol & Environm Sci, Landscape Ecol Grp, SE-90187 Umea, Sweden.	christer.nilsson@emg.umu.se	Dynesius, Mats/A-6219-2009; Nilsson, Christer/AAI-1354-2019	Dynesius, Mats/0000-0003-0628-4203; 				ARTHINGTON AH, 1995, CONDITION WORLDS AQU; Avakyan A. B., 1998, Lakes Reservoirs Research and Management, V3, P45, DOI 10.1111/j.1440-1770.1998.tb00031.x; Bubb DH, 2004, FRESHWATER BIOL, V49, P357, DOI 10.1111/j.1365-2426.2003.01178.x; Chang SP, 1998, WATER SCI TECHNOL, V37, P325, DOI 10.1016/S0273-1223(98)00040-7; DYNESIUS M, 1994, SCIENCE, V266, P753, DOI 10.1126/science.266.5186.753; FEKETE B, 1999, 22 WORLD MET ORG GLO; Gehrke PC, 2002, RIVER RES APPL, V18, P265, DOI 10.1002/rra.669; Gillett RM, 2002, AM J HUM BIOL, V14, P50, DOI 10.1002/ajhb.10019; GORMITZ V, 2000, SEA LEVEL RISE HIST, P97; Humborg C, 1997, NATURE, V386, P385, DOI 10.1038/386385a0; Indrabudi H, 1998, LAND DEGRAD DEV, V9, P311, DOI 10.1002/(SICI)1099-145X(199807/08)9:4<311::AID-LDR294>3.0.CO;2-X; *INT COMM LARG DAM, 2003, WORLD REG DAMS 2003; Jansson R, 2000, ECOLOGY, V81, P899, DOI 10.1890/0012-9658(2000)081[0899:FORFIR]2.0.CO;2; Lemly AD, 2000, ENVIRON MANAGE, V25, P485, DOI 10.1007/s002679910039; Levine JM, 2003, ECOLOGY, V84, P1215, DOI 10.1890/0012-9658(2003)084[1215:APMATT]2.0.CO;2; McCully P., 1996, SILENCED RIVERS; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nilsson C, 2000, BIOSCIENCE, V50, P783, DOI 10.1641/0006-3568(2000)050[0783:AORECB]2.0.CO;2; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Penczak T, 2000, ECOL FRESHW FISH, V9, P109, DOI 10.1034/j.1600-0633.2000.90113.x; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; Prowse TD, 2002, WATER INT, V27, P58, DOI 10.1080/02508060208686978; Pusey BJ, 2003, MAR FRESHWATER RES, V54, P1, DOI 10.1071/MF02041; QING D, 1998, RIVER DRAGON COM 3 G; Rosa LP, 2004, CLIMATIC CHANGE, V66, P9, DOI 10.1023/B:CLIM.0000043158.52222.ee; SHIKLOMANOV A, 1997, COMPREHENSIVE ASSESS; SIEBERT S, 2001, GLOBAL MAP IRRIGATED; St Louis VL, 2000, BIOSCIENCE, V50, P766, DOI 10.1641/0006-3568(2000)050[0766:RSASOG]2.0.CO;2; STGEORGES M, 1995, CAN J ZOOL, V73, P755, DOI 10.1139/z95-089; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; World Commission on Dams, 2000, REP WORLD COMM DAMS	31	2235	2378	45	1121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2005	308	5720					405	408		10.1126/science.1107887	http://dx.doi.org/10.1126/science.1107887			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15831757				2022-12-24	WOS:000228492000050
J	Westall, F				Westall, F			Life on the early earth: A sedimentary view	SCIENCE			English	Editorial Material							GREENSTONE-BELT; SOUTH-AFRICA; MICROFOSSILS; FOSSILS; ROCKS		CNRS, Ctr Biophys Mol, F-45071 Orleans, France	Centre National de la Recherche Scientifique (CNRS)	Westall, F (corresponding author), CNRS, Ctr Biophys Mol, Rue Charles Sadron, F-45071 Orleans, France.	westall@cnrs-orleans.fr						Brasier MD, 2002, NATURE, V416, P76, DOI 10.1038/416076a; Furnes H, 2004, SCIENCE, V304, P578, DOI 10.1126/science.1095858; Garcia-Ruiz JM, 2003, SCIENCE, V302, P1194, DOI 10.1126/science.1090163; Rasmussen B, 2000, NATURE, V405, P676, DOI 10.1038/35015063; Schopf JW, 2002, NATURE, V416, P73, DOI 10.1038/416073a; SCHOPF JW, 1993, SCIENCE, V260, P640, DOI 10.1126/science.260.5108.640; Tice MM, 2004, NATURE, V431, P549, DOI 10.1038/nature02888; TYLER SA, 1954, SCIENCE, V119, P606, DOI 10.1126/science.119.3096.606; Ueno Y, 2001, INT GEOL REV, V43, P196, DOI 10.1080/00206810109465008; van Zuilen MA, 2002, NATURE, V418, P627, DOI 10.1038/nature00934; WALSH MM, 1992, PRECAMBRIAN RES, V54, P271, DOI 10.1016/0301-9268(92)90074-X; Walsh MM, 2004, ASTROBIOLOGY, V4, P429, DOI 10.1089/ast.2004.4.429; Westall F, 2003, CR PALEVOL, V2, P485, DOI 10.1016/j.crpv.2003.09.009; Westall F, 2003, PRECAMBRIAN RES, V126, P313, DOI 10.1016/S0301-9268(03)00102-5; Westall F, 2001, PRECAMBRIAN RES, V106, P93, DOI 10.1016/S0301-9268(00)00127-3; WESTALL F, ASTROBIOLOGY FUTURE, P287	16	54	56	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 15	2005	308	5720					366	367		10.1126/science.1107227	http://dx.doi.org/10.1126/science.1107227			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15831746				2022-12-24	WOS:000228492000038
J	Armstrong, K; Micco, E; Carney, A; Stopfer, J; Putt, M				Armstrong, K; Micco, E; Carney, A; Stopfer, J; Putt, M			Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AFRICAN-AMERICAN FAMILIES; GENERAL-POPULATION; ETHNIC-DIFFERENCES; HEREDITARY BREAST; INCREASED RISK; HEALTH-CARE; MUTATIONS; DECISIONS; ATTITUDES; RACE	Context Given the current context of racial disparities in health and health care and the historical context of eugenics, racial disparities in the use of genetic susceptibility testing have been widely anticipated. However, to our knowledge there are no published studies examining the magnitude and determinants of racial differences in the use of genetic susceptibility testing. Objectives To investigate the relationship between race and the use of BRCA1/2 counseling among women with a family history of breast or ovarian cancer and to determine the contribution of socioeconomic characteristics, cancer risk perception and worry, attitudes about genetic testing, and interactions with primary care physicians to racial differences in utilization. Design, Setting, and Participants Case-control study (December 1999-August 2003) of 408 women with a family history of breast or ovarian cancer, of whom 217 underwent genetic counseling for BRCA1/2 testing (cases) and 191 women did not (controls). Participants received primary care within a large health system in greater Philadelphia, Pa. Main Outcome Measures Probability of carrying a BRCA1/2 mutation, socioeconomic characteristics, perception of breast and ovarian cancer risk, worry about breast and ovarian cancer, attitudes about BRCA1/2 testing, and primary care physician discussion of BRCA1/2 testing were measured prior to undergoing BRCA1/2 counseling for cases and at the time of enrollment for controls. Results African American women with a family history of breast or ovarian cancer were significantly less likely to undergo genetic counseling for BRCA1/2 testing than were white women with a family history of breast or ovarian cancer (odds ratio, 0.22; 95% confidence interval, 0.12-0.40). This association persisted after adjustment for probability of BRCA1/2 mutation, socioeconomic characteristics, breast and ovarian cancer risk perception and worry, attitudes about the risks and benefits of BRCA1/2 testing, and primary care physician discussion of BRCA1/2 testing (adjusted odds ratio for African American vs white, 0.28; 95% confidence interval, 0.09-0.89). Conclusions Racial disparities in the use of BRCA1/2 counseling are large and do not appear to be explained by differences in risk factors for carrying a BRCA1/2 mutation, socioeconomic factors, risk perception, attitudes, or primary care physician recommendations. The benefit of predictive genetic testing will not be fully realized unless these disparities can be addressed.	Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center	Armstrong, K (corresponding author), 1204 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	karmstro@mail.med.upenn.edu						American Cancer Society, 2002, CANC FACTS FIG 2002; Andrykowski MA, 1997, J CLIN ONCOL, V15, P2139, DOI 10.1200/JCO.1997.15.5.2139; Armstrong K, 2002, PREV MED, V34, P590, DOI 10.1006/pmed.2002.1022; Armstrong K, 2000, MED DECIS MAKING, V20, P308, DOI 10.1177/0272989X0002000307; Armstrong K, 2003, AM J MED GENET A, V117A, P154, DOI 10.1002/ajmg.a.10928; Armstrong K, 2000, CANCER EPIDEM BIOMAR, V9, P1251; Ashton CM, 2003, J GEN INTERN MED, V18, P146, DOI 10.1046/j.1525-1497.2003.20532.x; Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; Berry DA, 2002, J CLIN ONCOL, V20, P2701, DOI 10.1200/JCO.2002.05.121; Berwick DM, 2003, JAMA-J AM MED ASSOC, V289, P1969, DOI 10.1001/jama.289.15.1969; Bluman LG, 1999, J CLIN ONCOL, V17, P1040, DOI 10.1200/JCO.1999.17.3.1040; Bosompra K, 2000, PREV MED, V30, P155, DOI 10.1006/pmed.1999.0610; Centers for Disease Control and Prevention, BEH RISK FACT SURV S; Chen WY, 2002, J CLIN ONCOL, V20, P4485, DOI 10.1200/JCO.2002.08.147; Corbie-Smith G, 2002, ARCH INTERN MED, V162, P2458, DOI 10.1001/archinte.162.21.2458; Domchek SM, 2003, J CLIN ONCOL, V21, P593, DOI 10.1200/JCO.2003.07.007; Frank TS, 2002, J CLIN ONCOL, V20, P1480, DOI 10.1200/JCO.20.6.1480; Gao Q, 2000, HUM GENET, V107, P186, DOI 10.1007/s004390000290; Gao Q, 1997, AM J HUM GENET, V60, P1233; Gao Q, 2001, HUM GENET, V109, P239, DOI 10.1007/s004390100533; Grann VR, 2002, J CLIN ONCOL, V20, P2520, DOI 10.1200/JCO.2002.10.101; Grieco EM, 2001, OVERVIEW RACE HISPAN; HOLTZMAN NA, 1992, AM J HUM GENET, V50, P457; Hughes C, 1997, PATIENT EDUC COUNS, V32, P51, DOI 10.1016/S0738-3991(97)00064-5; Hughes C, 1996, BREAST CANCER RES TR, V40, P25, DOI 10.1007/BF01806000; *I MED, 2002, UN TREATM CONFR RAC; Lee SC, 2002, CANCER-AM CANCER SOC, V94, P1876, DOI 10.1002/cncr.10420; Lerman C, 1996, JAMA-J AM MED ASSOC, V275, P1885, DOI 10.1001/jama.275.24.1885; LERMAN C, 1991, ANN INTERN MED, V114, P657, DOI 10.7326/0003-4819-114-8-657; Lerman C, 1999, CANCER EPIDEM BIOMAR, V8, P361; Lerman C, 2000, PREV MED, V31, P75, DOI 10.1006/pmed.2000.0684; Mefford HC, 1999, AM J HUM GENET, V65, P575, DOI 10.1086/302511; Meijers-Heijboer H, 2003, J CLIN ONCOL, V21, P1675, DOI 10.1200/JCO.2003.09.052; Olopade Olufunmilayo I., 2003, Cancer, V97, P236, DOI 10.1002/cncr.11019; Panguluri RCK, 1999, HUM GENET, V105, P28, DOI 10.1007/s004390051059; Peters N, 2004, CANCER EPIDEM BIOMAR, V13, P361; Rose A, 2004, J GEN INTERN MED, V19, P57, DOI 10.1111/j.1525-1497.2004.21146.x; STRUEWING JP, 1995, CANCER EPIDEM BIOMAR, V4, P169; Tambor ES, 1997, AM J MED GENET, V68, P43, DOI 10.1002/(SICI)1096-8628(19970110)68:1<43::AID-AJMG8>3.0.CO;2-Z; Thompson D, 2002, JNCI-J NATL CANCER I, V94, P1358, DOI 10.1093/jnci/94.18.1358; Thompson HS, 2002, CANCER EPIDEM BIOMAR, V11, P1579; MUTATION PREVALENCE	42	325	324	1	41	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2005	293	14					1729	1736		10.1001/jama.293.14.1729	http://dx.doi.org/10.1001/jama.293.14.1729			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	915JS	15827311	Bronze			2022-12-24	WOS:000228301100026
J	Foster, GR				Foster, GR			Apoptotic cell death: the caspase-cleavage "gold rush"	LANCET			English	Editorial Material									Barts & London NHS Trust, Queen Marys Sch Med & Dent, London E1 2AT, England	Barts Health NHS Trust; University of London; Queen Mary University London	Foster, GR (corresponding author), Barts & London NHS Trust, Queen Marys Sch Med & Dent, London E1 2AT, England.	g.r.foster@qmul.ac.uk		Foster, Graham/0000-0002-3704-386X				Bantel H, 2004, HEPATOLOGY, V40, P1078, DOI 10.1002/hep.20411; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Matteucci C, 1999, CYTOMETRY, V35, P145, DOI 10.1002/(SICI)1097-0320(19990201)35:2<145::AID-CYTO6>3.0.CO;2-2; Que FG, 1996, GASTROENTEROLOGY, V110, P1238, DOI 10.1053/gast.1996.v110.pm8613014; Zeuzem S, 2004, GASTROENTEROLOGY, V127, P1724, DOI 10.1053/j.gastro.2004.09.050	5	3	3	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 9	2005	365	9467					1293	1294		10.1016/S0140-6736(05)61009-4	http://dx.doi.org/10.1016/S0140-6736(05)61009-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	914HY	15823368				2022-12-24	WOS:000228219600010
J	Jones, EM; Surewicz, WK				Jones, EM; Surewicz, WK			Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids	CELL			English	Article							MOLECULAR-BASIS; HAMSTER PRP; PROTEIN; CONVERSION; SCRAPIE; TRANSMISSION; VARIANT; YEAST; PROPAGATION; OXIDATION	Spongiform encephalopathies are believed to be transmitted by self-perpetuating conformational conversion of the prion protein. It was shown recently that fundamental aspects of mammalian prion propagation can be reproduced in vitro in a seeded fibrillization of the recombinant prion protein variant Y145Stop (PrP23-144). Here we demonstrate that PrP23-144 amyloids from different species adopt distinct secondary structures and morphologies, and that these structural differences are controlled by one or two residues in a critical region. These sequence-specific structural characteristics correlate strictly with the seeding specificity of amyloid fibrils. However, cross-seeding of PrP23-144 from one species with preformed fibrils from another species may overcome natural sequence-based structural preferences, resulting in a new amyloid strain that inherits the secondary structure and morphology of the template. These data provide direct biophysical evidence that protein conformations are transmitted in PrP amyloid strains, establishing a foundation for a structural basis of mammalian prion transmission barriers.	Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Surewicz, WK (corresponding author), Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA.	witold.surewicz@case.edu			NHLBI NIH HHS [HL007653] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; ANFINSEN CB, 1961, P NATL ACAD SCI USA, V47, P1309, DOI 10.1073/pnas.47.9.1309; Baskakov IV, 2004, J BIOL CHEM, V279, P7671, DOI 10.1074/jbc.M310594200; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESSEN RA, 1995, NATURE, V375, P698, DOI 10.1038/375698a0; Bruce M E, 1991, Curr Top Microbiol Immunol, V172, P125; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; Caughey B, 2001, TRENDS BIOCHEM SCI, V26, P235, DOI 10.1016/S0968-0004(01)01792-3; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Chien P, 2003, NATURE, V424, P948, DOI 10.1038/nature01894; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; COME JH, 1993, P NATL ACAD SCI USA, V90, P5959, DOI 10.1073/pnas.90.13.5959; Derkatch IL, 1996, GENETICS, V144, P1375; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Kad NM, 2003, J MOL BIOL, V330, P785, DOI 10.1016/S0022-2836(03)00583-7; KIMBERLIN RH, 1978, J GEN VIROL, V39, P487, DOI 10.1099/0022-1317-39-3-487; KIMBERLIN RH, 1977, J GEN VIROL, V34, P295, DOI 10.1099/0022-1317-34-2-295; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; KOCISKO DA, 1995, P NATL ACAD SCI USA, V92, P3923, DOI 10.1073/pnas.92.9.3923; Kundu B, 2003, P NATL ACAD SCI USA, V100, P12069, DOI 10.1073/pnas.2033281100; Lee S, 2003, NAT STRUCT BIOL, V10, P725, DOI 10.1038/nsb961; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Miller MW, 2004, CURR TOP MICROBIOL, V284, P193; Morillas M, 1999, J BIOL CHEM, V274, P36859, DOI 10.1074/jbc.274.52.36859; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; PRIOLA SA, 1995, J VIROL, V69, P7754, DOI 10.1128/JVI.69.12.7754-7758.1995; Priola SA, 2001, J VIROL, V75, P4673, DOI 10.1128/JVI.75.10.4673-4680.2001; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Raymond GJ, 1997, NATURE, V388, P285, DOI 10.1038/40876; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Scott Michael, 2004, VVolume 41, P435; Scott MR, 1999, P NATL ACAD SCI USA, V96, P15137, DOI 10.1073/pnas.96.26.15137; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Supattapone S, 2004, J MOL MED, V82, P348, DOI 10.1007/s00109-004-0534-3; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; Vanik DL, 2004, MOL CELL, V14, P139, DOI 10.1016/S1097-2765(04)00155-8; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Wickner RB, 2000, J STRUCT BIOL, V130, P310, DOI 10.1006/jsbi.2000.4250; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904	50	214	219	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 8	2005	121	1					63	72		10.1016/j.cell.2005.01.034	http://dx.doi.org/10.1016/j.cell.2005.01.034			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	915YU	15820679	Bronze			2022-12-24	WOS:000228348500010
J	Levesque, LE; Brophy, JM; Zhang, B				Levesque, LE; Brophy, JM; Zhang, B			The risk for myocardial infarction with cyclooxygenase-2 inhibitors: A population study of elderly adults	ANNALS OF INTERNAL MEDICINE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CARDIOVASCULAR THROMBOTIC EVENTS; RANDOMIZED CONTROLLED-TRIAL; CORONARY HEART-DISEASE; GASTROINTESTINAL TOXICITY; RHEUMATOID-ARTHRITIS; NAPROXEN; COX-2; ROFECOXIB; HYPERTENSION	Background: Cyclooxygenase-2 (COX-2) selective inhibitors have been marketed since 1999 as safer alternatives to nonsterok dal anti-inflammatory drugs (NSAIDs). Debate about their cardiac safety has culminated in the recent withdrawal of rofecoxib. Additional studies are needed to better understand this risk and to determine whether this safety concern represents a class effect. Objective: To assess the influence of various NSAIDs on the risk for a first myocardial infarction (MI). Design: Population-based, retrospective cohort study analyzed using a time-matched, nested case-control approach. Setting: Quebec, Canada. Participants: 113 927 elderly persons without previous MI and newly treated with an NSAID between 1 January 1999 and 30 June 2002. Measurements: NSAID exposure and occurrence of MI assessed by using Quebec's administrative health databases. Results: Compared with no use of NSAIDs in the year preceding the event, current use of rofecoxib was associated with an increased risk for an acute MI (rate ratio [11111, 1.24 [95% Cl, 1.05 to 1.46]) that was more pronounced at higher doses (RR, 1.73 [Cl, 1.09 to 2.76]). The concomitant use of aspirin appears to decrease the risk associated with low-dose rofecoxib (1111, 1.00 [CI, 0.77 to 1.28]) but not with high-dose rofecoxib (1111, 2.36 [Cl, 1.27 to 4.391). No increased risks were observed with celecoxib (1111, 0.99 [Cl, 0.85 to 1.161) or the other NSAIDs. Limitations: The study could not completely account for all potential confounders, including over-the-counter use of aspirin and ibuprofen. Conclusions: These results provide evidence of an increased risk for acute MI in current users of rofecoxib among elderly persons with no history of MI. This risk appears greater at higher doses. Aspirin use mitigates the risk associated with low-dose but not high-dose rofecoxib. There was no evidence of an increased risk with the other NSAIDs.	McGill Univ, Royal Victoria Hosp, Ctr Hlth, Div Cardiol, Montreal, PQ H3A 1A1, Canada	McGill University; Royal Victoria Hospital	Brophy, JM (corresponding author), McGill Univ, Royal Victoria Hosp, Ctr Hlth, Div Cardiol, Room M4-76,687 Pine Ave W, Montreal, PQ H3A 1A1, Canada.	james.brophy@mcgill.ca	brophy, james/H-6673-2019	brophy, james/0000-0001-8049-6875				ABRAHAM C, 2004, GLOBE MAIL      0901, pA1; [Anonymous], 2000, PHARMACOEPIDEM DR S; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Beaulieu MD, 2004, QJM-INT J MED, V97, P21, DOI 10.1093/qjmed/hch006; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Brassard P, 2003, AM HEART J, V145, DOI 10.1016/S0002-8703(03)00087-5; Brassard P, 2003, STROKE, V34, DOI 10.1161/01.STR.0000085831.91042.BF; Breslow NL, 1987, STAT METHODS CANC RE, VII, P178; Brophy JM, 2003, CAN MED ASSOC J, V169, P1153; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711; Collet D, 1999, MODELLING BINARY DAT, P223; Cryer B, 1998, AM J MED, V104, P413, DOI 10.1016/S0002-9343(98)00091-6; *FDA ADV COMM, 2001, CARD SAF REV ROF; FitzGerald GA, 2001, CLIN EXP RHEUMATOL, V19, pS31; Garbe E, 1997, JAMA-J AM MED ASSOC, V277, P722, DOI 10.1001/jama.277.9.722; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Hosmer D.W., 2004, APPL LOGISTIC REGRES, VSecond; Jick SS, 2000, PHARMACOTHERAPY, V20, P741, DOI 10.1592/phco.20.9.741.35209; Juni P, 2004, LANCET, V364, P2021, DOI 10.1016/S0140-6736(04)17514-4; Kimmel SE, 2005, ANN INTERN MED, V142, P157, DOI 10.7326/0003-4819-142-3-200502010-00005; Konstam MA, 2001, CIRCULATION, V104, P2280, DOI 10.1161/hc4401.100078; LEVESQUE L, 2004, PHARMACOEPIDEMIOL S1, V13, pS49; Levy AR, 1999, CAN J CARDIOL, V15, P1277; Mamdani M, 2003, ARCH INTERN MED, V163, P481, DOI 10.1001/archinte.163.4.481; Marnett LJ, 1999, J BIOL CHEM, V274, P22903, DOI 10.1074/jbc.274.33.22903; MORROW JD, 2001, GOODMAN GILMANS PHAR; Mukherjee D, 2001, JAMA-J AM MED ASSOC, V286, P954, DOI 10.1001/jama.286.8.954; NEILAN T, 2004, NY TIMES        0930; Patrono Carlo, 2001, American Journal of Medicine, V110, p62S, DOI 10.1016/S0002-9343(00)00645-8; Rahme E, 2002, ARCH INTERN MED, V162, P1111, DOI 10.1001/archinte.162.10.1111; Rahme E, 2000, ARTHRITIS RHEUM-US, V43, P917, DOI 10.1002/1529-0131(200004)43:4<917::AID-ANR25>3.0.CO;2-F; Ray WA, 2002, LANCET, V360, P1071, DOI 10.1016/S0140-6736(02)11131-7; Ray WA, 2002, LANCET, V359, P118, DOI 10.1016/S0140-6736(02)07370-1; Reicin AS, 2002, AM J CARDIOL, V89, P204, DOI 10.1016/S0002-9149(01)02201-9; Roberts LJMJ, 2001, GOODMAN GILMANS PHAR; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Singh G, 1998, AM J MED, V105, p31S, DOI DOI 10.1016/S0002-9343(98)00072-2; Solomon DH, 2004, CIRCULATION, V109, P2068, DOI 10.1161/01.CIR.0000127578.21885.3E; Solomon DH, 2002, ARCH INTERN MED, V162, P1099, DOI 10.1001/archinte.162.10.1099; TAMBLYN R, 1995, J CLIN EPIDEMIOL, V48, P999, DOI 10.1016/0895-4356(94)00234-H; *US FOOD DRUG ADM, FDA PUBL HLTH ADV SA; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; VELENTGAS P, 2001, PHARMACOEPIDEM DR S, V10, pS103; VONKORFF M, 1992, J CLIN EPIDEMIOL, V45, P197, DOI 10.1016/0895-4356(92)90016-G; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; Watson DJ, 2002, ARCH INTERN MED, V162, P1105, DOI 10.1001/archinte.162.10.1105; White WB, 2003, AM J CARDIOL, V92, P411, DOI 10.1016/S0002-9149(03)00659-3; Wright JM, 2002, CAN MED ASSOC J, V167, P1131	50	178	184	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 5	2005	142	7					481	489		10.7326/0003-4819-142-7-200504050-00113	http://dx.doi.org/10.7326/0003-4819-142-7-200504050-00113			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	913QL	15809459				2022-12-24	WOS:000228167800001
J	Venter, L				Venter, L			Firms fill antiretroviral gap in South Africa	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Venter, L (corresponding author), The Lancet, London NW1 7BY, England.	lester.venter@btopenworld.com						*AS BUS COAL AIDS, 2002, WELC THAIL BUS COAL; *AV, 2005, HIV THAIL; BLOOM D, 2005, BUSINESS HIV AIDS CO; UNAIDS, UNAIDS S AFR; *WHO UNAIDS, 2004, UNAIDS S AFR; 2004, WORLD EC FOR GLOB HL; 2004, WORLD EC FOR US DIR; 2004, WORLD EC FOR RAP ASS; 2004, WORLD EC FOR PROV CO; 2004, WORLD EC FOR CHANG B	10	7	7	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 2	2005	365	9466					1215	1216		10.1016/S0140-6736(05)74793-0	http://dx.doi.org/10.1016/S0140-6736(05)74793-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	912VI	15811443				2022-12-24	WOS:000228107600010
J	Hashizume, K; Chaussidon, M				Hashizume, K; Chaussidon, M			A non-terrestrial O-16-rich isotopic composition for the protosolar nebula	NATURE			English	Article							EARLY SOLAR-SYSTEM; OXYGEN ISOTOPES; METEORITES; HETEROGENEITY; INCLUSIONS; RESERVOIR; NITROGEN; SAMPLES; GRAINS; ORIGIN	The discovery in primitive components of meteorites(1,2) of large oxygen isotopic variations that could not be attributed to mass-dependent fractionation effects has raised a fundamental question: what is the composition of the protosolar gas from which the host grains formed? This composition is probably preserved in the outer layers of the Sun, but the resolution of astronomical spectroscopic measurements is still too poor to be useful for comparison with planetary material(3,4). Here we report a precise determination of the oxygen isotopic composition of the solar wind from particles implanted in the outer hundreds of nanometres of metallic grains in the lunar regolith. These layers of the grains are enriched in O-16 by >20 +/- 4 parts per thousand relative to the Earth, Mars and bulk meteorites, which implies the existence in the solar accretion disk of reactions-as yet unknown-that were able to change the O-17/O-16 and O-18/O-16 ratios in a way that was not dependent strictly on the mass of the isotope. Photochemical self-shielding of the CO gas irradiated by ultraviolet light(5-7) may be one of these key processes, because it depends on the abundance of the isotopes, rather than their masses.	Osaka Univ, Grad Sch Sci, Dept Earth & Space Sci, Osaka 5600043, Japan; CNRS, CRPG, F-54501 Vandoeuvre Les Nancy, France	Osaka University; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Hashizume, K (corresponding author), Osaka Univ, Grad Sch Sci, Dept Earth & Space Sci, Osaka 5600043, Japan.	kohash@ess.sci.osaka-u.ac.jp	Chaussidon, Marc/E-7067-2017					Chaussidon M, 1999, NATURE, V402, P270, DOI 10.1038/46235; CLAYTON, 1974, P LUNAR PLANET SCI C, V2, P1801; CLAYTON RN, 1993, ANNU REV EARTH PL SC, V21, P115, DOI 10.1146/annurev.earth.21.1.115; Clayton RN, 2002, NATURE, V415, P860, DOI 10.1038/415860b; CLAYTON RN, 1973, SCIENCE, V182, P485, DOI 10.1126/science.182.4111.485; EPSTEIN S, 1973, P LUNAR PLANET SCI C, P1559; Hashizume K, 2000, SCIENCE, V290, P1142, DOI 10.1126/science.290.5494.1142; Hashizume K, 2004, ASTROPHYS J, V600, P480, DOI 10.1086/379637; Hashizume K, 2002, EARTH PLANET SC LETT, V202, P201, DOI 10.1016/S0012-821X(02)00781-1; IRELAND TR, 1992, GEOCHIM COSMOCHIM AC, V56, P2503, DOI 10.1016/0016-7037(92)90205-W; IRELAND TR, 2004, LUNAR PLANET SCI, V35, P1448; Kobayashi S, 2003, GEOCHEM J, V37, P663, DOI 10.2343/geochemj.37.663; Krot AN, 2002, SCIENCE, V295, P1051, DOI 10.1126/science.1068200; LYONS JR, 2004, LUNAR PLANET SCI, V35, P1970; McKeegan KD, 1998, SCIENCE, V280, P414, DOI 10.1126/science.280.5362.414; Messenger S, 2003, SCIENCE, V300, P105, DOI 10.1126/science.1080576; Morris R.V., 1980, P 11 LUN PLAN SCI C, P1697; Nagashima K, 2004, NATURE, V428, P921, DOI 10.1038/nature02510; ROBERT F, 1992, EARTH PLANET SC LETT, V108, P1, DOI 10.1016/0012-821X(92)90055-Z; Taylor Jr. H. P., 1973, P 4 LUN SCI C, P1657; THIEMENS MH, 1983, SCIENCE, V219, P1073, DOI 10.1126/science.219.4588.1073; Thiemens MH, 1999, SCIENCE, V283, P341, DOI 10.1126/science.283.5400.341; Wiechert U, 2001, SCIENCE, V294, P345, DOI 10.1126/science.1063037; Wieler R, 1998, SPACE SCI REV, V85, P303, DOI 10.1023/A:1005166904225; Wiens RC, 1999, METEORIT PLANET SCI, V34, P99, DOI 10.1111/j.1945-5100.1999.tb01735.x; Wiens RC, 2004, EARTH PLANET SC LETT, V222, P697, DOI 10.1016/j.epsl.2004.03.025; Wimmer-Schweingruber RF, 2003, AIP CONF PROC, V679, P577, DOI 10.1063/1.1618662; Young ED, 1998, SCIENCE, V282, P452, DOI 10.1126/science.282.5388.452; Yurimoto H, 2004, SCIENCE, V305, P1763, DOI 10.1126/science.1100989; Ziegler J.F, 1985, STOPPING RANGE IONS	30	84	86	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2005	434	7033					619	622		10.1038/nature03432	http://dx.doi.org/10.1038/nature03432			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911NN	15800617				2022-12-24	WOS:000228011000038
J	Sakatani, T; Kaneda, A; Iacobuzio-Donahue, CA; Carter, MG; Witzel, SD; Okano, H; Ko, MSH; Ohlsson, R; Longo, DL; Feinberg, AP				Sakatani, T; Kaneda, A; Iacobuzio-Donahue, CA; Carter, MG; Witzel, SD; Okano, H; Ko, MSH; Ohlsson, R; Longo, DL; Feinberg, AP			Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice	SCIENCE			English	Article							COLORECTAL-CANCER; CELL-DIFFERENTIATION; STEM-CELL; GROWTH; GENE; MARKER; MOUSE; EXPRESSION; NEOPLASIA; DELETION	Loss of imprinting (LOI) of the insulin-like growth factor II gene (IGF2) is an epigenetic alteration that results in a modest increase in IGF2 expression, and it is present in the normal colonic mucosa of about 30% of patients with colorectal cancer. To investigate its role in intestinal tumorigenesis, we created a mouse model of lgf2 LOI by crossing female H19(+/-) mice with mate Apc(+/min) mice. Mice with LOI developed twice as many intestinal tumors as did control littermates. Notably, these mice also showed a shift toward a less differentiated normal intestinal epithelium, reflected by an increase in crypt length and increased staining with progenitor,cell markers. A similar shift in differentiation was seen in the normal colonic mucosa of humans with LOI. Thus, altered maturation of nonneoplastic tissue may be one mechanism. by which epigenetic changes affect cancer risk.	Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Ctr Oncol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; NIA, Genet Lab, NIH, Baltimore, MD 21224 USA; Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan; Uppsala Univ, Dept Genet & Dev, S-75236 Uppsala, Sweden	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Keio University; Uppsala University	Feinberg, AP (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	afeinberg@jhu.edu	Feinberg, Andrew/AAY-7666-2020; Longo, Dan L./F-6022-2011; Carter, Mark/B-5089-2010; Okano, Hideyuki/I-7584-2019; Ko, Minoru S. H./B-7969-2009	Ko, Minoru S. H./0000-0002-3530-3015; Feinberg, Andrew/0000-0002-8364-1991; Kaneda, Atsushi/0000-0002-6980-5515	NCI NIH HHS [R01CA65145, K08CA106610] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K08CA106610, R01CA065145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000656, Z01AG000662] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; BECKWITH J B, 1990, Pediatric Pathology, V10, P1; Bennett WR, 2003, DEVELOPMENT, V130, P1079, DOI 10.1242/dev.00333; Borkowski OMD, 1995, DEVELOPMENT, V121, P4183; CHRISTOFORI G, 1995, NAT GENET, V10, P196, DOI 10.1038/ng0695-196; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Feinberg AP, 2004, SEMIN CANCER BIOL, V14, P427, DOI 10.1016/j.semcancer.2004.06.005; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Hassan AB, 2000, CANCER RES, V60, P1070; Howe LR, 2003, CANCER RES, V63, P1906; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Li YM, 1998, J BIOL CHEM, V273, P28247, DOI 10.1074/jbc.273.43.28247; LIPKIN M, 1976, CANCER RES, V36, P2665; Pant V, 2003, GENE DEV, V17, P586, DOI 10.1101/gad.254903; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; Ravenel JD, 2001, JNCI-J NATL CANCER I, V93, P1698, DOI 10.1093/jnci/93.22.1698; Ripoche MA, 1997, GENE DEV, V11, P1596, DOI 10.1101/gad.11.12.1596; SEGAL GH, 1997, HISTOLOGY PATHOLOGIS, P495; SELL S, 1994, LAB INVEST, V70, P6; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Thiery JP, 2004, NAT MED, V10, P777, DOI 10.1038/nm0804-777; Torrance CJ, 2000, NAT MED, V6, P1024, DOI 10.1038/79534; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; WEST AB, 1988, GASTROENTEROLOGY, V94, P343, DOI 10.1016/0016-5085(88)90421-0; Woodson K, 2004, JNCI-J NATL CANCER I, V96, P407, DOI 10.1093/jnci/djh042; Yang WC, 2003, CANCER RES, V63, P4990	28	252	268	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2005	307	5717					1976	1978		10.1126/science.1108080	http://dx.doi.org/10.1126/science.1108080			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910UI	15731405				2022-12-24	WOS:000227957300061
J	De Smet, PAGM				De Smet, PAGM			Herbal medicine in Europe - Relaxing regulatory standards	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Sci Inst Dutch Pharmacists, The Hague, Netherlands; Univ Med Ctr St Radboud, Dept Clin Pharm, Nijmegen, Netherlands	Radboud University Nijmegen	De Smet, PAGM (corresponding author), Sci Inst Dutch Pharmacists, The Hague, Netherlands.		Smet, P.A.G.M./L-4654-2015						0	74	74	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2005	352	12					1176	1178		10.1056/NEJMp048083	http://dx.doi.org/10.1056/NEJMp048083			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	909AW	15788494				2022-12-24	WOS:000227832300003
J	Gendrin, A; Mangold, N; Bibring, JP; Langevin, Y; Gondet, B; Poulet, F; Bonello, G; Quantin, C; Mustard, J; Arvidson, R; LeMouelic, S				Gendrin, A; Mangold, N; Bibring, JP; Langevin, Y; Gondet, B; Poulet, F; Bonello, G; Quantin, C; Mustard, J; Arvidson, R; LeMouelic, S			Suffates in martian layered terrains: the OMEGA/Mars Express view	SCIENCE			English	Article							EARLY MARS; VALLES-MARINERIS; MERIDIANI; EVOLUTION; SULFATE; HISTORY; SOIL	The OMEGA/Mars Express hyperspectral imager identified hydrated sulfates on light-toned layered terrains on Mars. Outcrops in Valles Marineris, Margaritifer Sinus, and Terra Meridiani show evidence for kieserite, gypsum, and polyhydrated sulfates. This identification has its basis in vibrational absorptions between 1.3 and 2.5 micrometers. These minerals constitute direct records of the past aqueous activity on Mars.	Inst Astrophys Spatiale, F-91405 Orsay, France; Interact & Dynam Environm Surface, F-91405 Orsay, France; Lab Sci Terre, F-69100 Villeurbanne, France; Brown Univ, Providence, RI 02912 USA; Washington Univ, St Louis, MO 63130 USA; Univ Nantes, F-44322 Nantes, France	UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Brown University; Washington University (WUSTL); Nantes Universite	Gendrin, A (corresponding author), Inst Astrophys Spatiale, Batiment 121, F-91405 Orsay, France.	Aline_Gendrin@brown.edu	Quantin, Cathy/H-1516-2014	Le Mouelic, Stephane/0000-0001-5260-1367				Arvidson RE, 2005, SCIENCE, V307, P1591, DOI 10.1126/science.1109509; ARVIDSON RE, 2003, J GEOPHYS RES, V108; Banin A, 1997, J GEOPHYS RES-PLANET, V102, P13341, DOI 10.1029/97JE01160; Bibring J.-P., 2004, EUR SPACE AGENCY SPE, V1240, P37; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; BISHOP J, IN PRESS AM MINER; Bullock MA, 2004, ICARUS, V170, P404, DOI 10.1016/j.icarus.2004.03.016; Catling DC, 1999, J GEOPHYS RES-PLANET, V104, P16453, DOI 10.1029/1998JE001020; Chapman MG, 2002, ICARUS, V155, P324, DOI 10.1006/icar.2001.6735; CLARK RN, 1990, J GEOPHYS RES-SOLID, V95, P12653, DOI 10.1029/JB095iB08p12653; Crowley JK., 2003, GEOCHEM-EXPLOR ENV A, V3, P219, DOI DOI 10.1144/1467-7873/03-001; Fairen AG, 2004, NATURE, V431, P423, DOI 10.1038/nature02911; GREEN, 1993, IEEE T GEOSC REM SEN, V26, P65; Hunten D. M., 1971, Comments on Astrophysics and Space Physics, V3, P1; Huston DL, 2004, EARTH PLANET SC LETT, V220, P41, DOI 10.1016/S0012-821X(04)00034-2; Hynek BM, 2004, NATURE, V431, P156, DOI 10.1038/nature02902; Lane MD, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021231; Langevin Y, 2005, SCIENCE, V307, P1584, DOI 10.1126/science.1109091; LUCCHITTA BK, 1994, J GEOPHYS RES-PLANET, V99, P3783, DOI 10.1029/93JE03095; LUCCHITTA BK, 1982, 85127 NASA, P233; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; MCCAULEY JF, 1972, ICARUS, V17, P289, DOI 10.1016/0019-1035(72)90003-6; Mustard JF, 2005, SCIENCE, V307, P1594, DOI 10.1126/science.1109098; NEDELL SS, 1987, ICARUS, V70, P409, DOI 10.1016/0019-1035(87)90086-8; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Vaniman DT, 2004, NATURE, V431, P663, DOI 10.1038/nature02973; WARREN J, 1999, EVAPORITES THEIR EVO	27	765	778	3	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2005	307	5715					1587	1591		10.1126/science.1109087	http://dx.doi.org/10.1126/science.1109087			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906ED	15718429				2022-12-24	WOS:000227622400037
J	Zhao, RM; Davey, M; Hsu, YC; Kaplanek, P; Tong, A; Parsons, AB; Krogan, N; Cagney, G; Mai, D; Greenblatt, J; Boone, C; Emili, A; Houry, WA				Zhao, RM; Davey, M; Hsu, YC; Kaplanek, P; Tong, A; Parsons, AB; Krogan, N; Cagney, G; Mai, D; Greenblatt, J; Boone, C; Emili, A; Houry, WA			Navigating the chaperone network: An integrative map of physical and genetic interactions mediated by the Hsp90 chaperone	CELL			English	Article							ATPASE ACTIVITY; CRYSTAL-STRUCTURE; MOLECULAR CLAMP; GLOBAL ANALYSIS; PROTEIN; YEAST; COMPLEX; ACTIVATION; DOMAIN; CO	Physical, genetic, and chemical-genetic interactions centered on the conserved chaperone Hsp90 were mapped at high resolution in yeast using systematic proteomic and genomic methods. Physical interactions were identified using genome-wide two hybrid screens combined with large-scale affinity purification of Hsp90-containing protein complexes. Genetic interactions were uncovered using synthetic genetic array technology and by a microarray-based chemical-genetic screen of a set of about 4700 viable yeast gene deletion mutants for hypersensitivity to the Hsp90 inhibitor geldanamycin. An extended network, consisting of 198 putative physical interactions and 451 putative genetic and chemical-genetic interactions, was found to connect Hsp90 to cofactors; and substrates involved in a wide range of cellular functions. Two novel Hsp90 cofactors, Tah1 (YCR060W) and Pih1 (YHR034C), were also identified. These cofactors interact physically and functionally with the conserved AAA(+)-type DNA helicases Rvb1/Rvb2, which are key components of several chromatin remodeling factors, thereby linking Hsp90 to epigenetic gene regulation.	Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University of Toronto	Emili, A (corresponding author), Univ Toronto, Banting & Best Dept Med Res, 112 Coll St, Toronto, ON M5S 1A8, Canada.	andrew.emili@utoronto.ca; walid.houry@utoronto.ca	Cagney, Gerard/A-4648-2009	Zhao, Rongmin/0000-0003-1300-5882; Cagney, Gerard/0000-0001-7189-9496; Davey, Michael/0000-0002-1172-5934				BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; CHANG HCJ, 1994, J BIOL CHEM, V269, P24983; CSERMELY P, 1994, BIOCHEM BIOPH RES CO, V202, P1657, DOI 10.1006/bbrc.1994.2124; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Frydman J, 1997, TRENDS BIOCHEM SCI, V22, P87, DOI 10.1016/S0968-0004(97)01005-0; Garnier C, 2002, J BIOL CHEM, V277, P12208, DOI 10.1074/jbc.M111874200; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; GUARENTE L, 1992, TRENDS GENET, V8, P27, DOI 10.1016/0168-9525(92)90021-U; Hernandez MP, 2002, J BIOL CHEM, V277, P38294, DOI 10.1074/jbc.M206566200; Houry WA, 2001, CURR PROTEIN PEPT SC, V2, P227, DOI 10.2174/1389203013381134; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Imai J, 2003, EMBO J, V22, P3557, DOI 10.1093/emboj/cdg349; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jonsson ZO, 2004, MOL CELL, V16, P465, DOI 10.1016/j.molcel.2004.09.033; Jonsson ZO, 2001, J BIOL CHEM, V276, P16279, DOI 10.1074/jbc.M011523200; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Lan CG, 2004, J BIOL CHEM, V279, P27607, DOI 10.1074/jbc.M402777200; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; Louvion JF, 1998, MOL BIOL CELL, V9, P3071, DOI 10.1091/mbc.9.11.3071; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; MURPHY SM, 1993, MOL CELL BIOL, V13, P5290, DOI 10.1128/MCB.13.9.5290; Nathan DF, 1997, P NATL ACAD SCI USA, V94, P12949, DOI 10.1073/pnas.94.24.12949; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Pearl LH, 2000, CURR OPIN STRUC BIOL, V10, P46, DOI 10.1016/S0959-440X(99)00047-0; Pearl LH, 2002, ADV PROTEIN CHEM, V59, P157; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Prodromou C, 1997, NAT STRUCT BIOL, V4, P477, DOI 10.1038/nsb0697-477; Prodromou C, 2003, CURR CANCER DRUG TAR, V3, P301, DOI 10.2174/1568009033481877; Riggs DL, 2003, EMBO J, V22, P1158, DOI 10.1093/emboj/cdg108; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Rutherford SL, 2003, NAT REV GENET, V4, P263, DOI 10.1038/nrg1041; Savchenko A, 2003, PROTEINS, V50, P392, DOI 10.1002/prot.10282; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Stemmann O, 2002, P NATL ACAD SCI USA, V99, P8585, DOI 10.1073/pnas.082223899; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Young JC, 2000, EMBO J, V19, P5930, DOI 10.1093/emboj/19.21.5930; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Zhu H, 2003, ANNU REV BIOCHEM, V72, P783, DOI 10.1146/annurev.biochem.72.121801.161511	56	617	642	0	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 11	2005	120	5					715	727		10.1016/j.cell.2004.12.024	http://dx.doi.org/10.1016/j.cell.2004.12.024			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	908EY	15766533	Bronze			2022-12-24	WOS:000227771400016
J	Mueller, KL; Hoon, MA; Erlenbach, I; Chandrashekar, J; Zuker, CS; Ryba, NJP				Mueller, KL; Hoon, MA; Erlenbach, I; Chandrashekar, J; Zuker, CS; Ryba, NJP			The receptors and coding logic for bitter taste	NATURE			English	Article							MAMMALIAN SWEET; MICE; SACCHARIN; RESPONSES; PATHWAYS; STIMULI; FAMILY; MOUSE; CELLS	The sense of taste provides animals with valuable information about the nature and quality of food. Bitter taste detection functions as an important sensory input to warn against the ingestion of toxic and noxious substances. T2Rs are a family of approximately 30 highly divergent G-protein-coupled receptors (GPCRs)(1,2) that are selectively expressed in the tongue and palate epithelium(1) and are implicated in bitter taste sensing(1-8). Here we demonstrate, using a combination of genetic, behavioural and physiological studies, that T2R receptors are necessary and sufficient for the detection and perception of bitter compounds, and show that differences in T2Rs between species ( human and mouse) can determine the selectivity of bitter taste responses. In addition, we show that mice engineered to express a bitter taste receptor in 'sweet cells'(9) become strongly attracted to its cognate bitter tastants, whereas expression of the same receptor ( or even a novel GPCR) in T2R-expressing cells resulted in mice that are averse to the respective compounds. Together these results illustrate the fundamental principle of bitter taste coding at the periphery: dedicated cells act as broadly tuned bitter sensors that are wired to mediate behavioural aversion.	Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Zuker, CS (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	charles@flyeye.ucsd.edu; nick.ryba@nih.gov		Ryba, Nicholas/0000-0002-2060-8393; Chandrashekar, jayaram/0000-0001-6412-0114	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000561] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Behrens M, 2004, BIOCHEM BIOPH RES CO, V319, P479, DOI 10.1016/j.bbrc.2004.05.019; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Caicedo A, 2001, SCIENCE, V291, P1557, DOI 10.1126/science.1056670; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Coward P, 1998, P NATL ACAD SCI USA, V95, P352, DOI 10.1073/pnas.95.1.352; Dahl M, 1997, BRAIN RES, V756, P22, DOI 10.1016/S0006-8993(97)00131-5; Danilova V, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-5; FARBMAN AI, 1965, DEV BIOL, V11, P110, DOI 10.1016/0012-1606(65)90040-0; Franchini LF, 2003, NEUROSCIENCE, V121, P875, DOI 10.1016/S0306-4522(03)00485-8; Glendinning JI, 2002, CHEM SENSES, V27, P461, DOI 10.1093/chemse/27.5.461; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Kuhn C, 2004, J NEUROSCI, V24, P10260, DOI 10.1523/JNEUROSCI.1225-04.2004; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; McBride K, 2003, CHEM SENSES, V28, P659, DOI 10.1093/chemse/bjg053; Nakashima K, 1999, CELL PHYSIOL BIOCHEM, V9, P90, DOI 10.1159/000016305; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Pronin AN, 2004, CHEM SENSES, V29, P583, DOI 10.1093/chemse/bjh064; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	21	354	384	2	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2005	434	7030					225	229		10.1038/nature03352	http://dx.doi.org/10.1038/nature03352			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904JU	15759003				2022-12-24	WOS:000227494500048
J	Jones, RH; Flynn, KJ				Jones, RH; Flynn, KJ			Nutritional status and diet composition affect the value of diatoms as copepod prey	SCIENCE			English	Article							MARINE PLANKTONIC COPEPOD; EGG-PRODUCTION; ACARTIA-TONSA; FOOD QUALITY; REPRODUCTIVE SUCCESS; CALANUS-FINMARCHICUS; HATCHING SUCCESS; GROWTH; PHYTOPLANKTON; RECRUITMENT	The role of diatoms as key food for copepods at the base of pelagic food chains has been questioned recently on the grounds of toxicity. We show, using unialgal versus mixed algal diets of different nutritional status (i.e., nitrogen:carbon ratio) fed to Acartia tonsa, that diatoms per se are not toxic but that single-diatom diets are inadequate. Additionally, the nutritional state of the phytoplankton has a profound effect on copepod growth and growth efficiency. The ecological significance of laboratory demonstrations of diatom toxicity needs to be reconsidered.	Univ Coll Swansea, Inst Environm Sustainabil, Swansea SA2 8PP, W Glam, Wales	Swansea University	Flynn, KJ (corresponding author), Univ Coll Swansea, Inst Environm Sustainabil, Swansea SA2 8PP, W Glam, Wales.	k.j.flynn@swansea.ac.uk	Flynn, Kevin/AAA-3253-2021; Jones, Ruth/R-5773-2016	Flynn, Kevin/0000-0001-6913-5884; Jones, Ruth/0000-0001-5811-8827				Alonzo F, 2001, MAR ECOL PROG SER, V209, P231, DOI 10.3354/meps209231; Andersen T, 2004, ECOL LETT, V7, P884, DOI 10.1111/j.1461-0248.2004.00646.x; Ban SH, 1997, MAR ECOL PROG SER, V157, P287, DOI 10.3354/meps157287; Breteler WCMK, 1999, MAR BIOL, V135, P191, DOI 10.1007/s002270050616; Carotenuto Y, 2002, J EXP MAR BIOL ECOL, V276, P49, DOI 10.1016/S0022-0981(02)00237-X; CHECKLEY DM, 1980, LIMNOL OCEANOGR, V25, P430, DOI 10.4319/lo.1980.25.3.0430; Colin SP, 2002, LIMNOL OCEANOGR, V47, P1430, DOI 10.4319/lo.2002.47.5.1430; Ianora A, 1996, MAR BIOL, V125, P279, DOI 10.1007/BF00346308; Ianora A, 2004, NATURE, V429, P403, DOI 10.1038/nature02526; Irigoien X, 2002, NATURE, V419, P387, DOI 10.1038/nature01055; Irigoien X, 2000, LIMNOL OCEANOGR, V45, P44, DOI 10.4319/lo.2000.45.1.0044; JONASDOTTIR SH, 1994, MAR BIOL, V121, P67, DOI 10.1007/BF00349475; Jonasdottir SH, 1996, MAR BIOL, V125, P743, DOI 10.1007/BF00349257; Jonasdottir SH, 1998, MAR ECOL PROG SER, V172, P305, DOI 10.3354/meps172305; Jones RH, 2002, MAR ECOL PROG SER, V235, P147, DOI 10.3354/meps235147; Kiorboe T, 1996, MAR ECOL PROG SER, V143, P65, DOI 10.3354/meps143065; KIORBOE T, 1989, MAR ECOL PROG SER, V55, P229, DOI 10.3354/meps055229; Kuijper LDJ, 2004, J PLANKTON RES, V26, P213, DOI 10.1093/plankt/fbh020; Marshall S. M., 1955, BIOL MARINE COPEPOD; Meyer-Harms B, 1999, LIMNOL OCEANOGR, V44, P154, DOI 10.4319/lo.1999.44.1.0154; Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023; POULET SA, 1994, MAR ECOL PROG SER, V111, P79, DOI 10.3354/meps111079; REEVE MR, 1977, J EXP MAR BIOL ECOL, V29, P211, DOI 10.1016/0022-0981(77)90066-1; Roman MR, 1997, LIMNOL OCEANOGR, V42, P623, DOI 10.4319/lo.1997.42.4.0623; Shin K, 2003, PROG OCEANOGR, V57, P265, DOI 10.1016/S0079-6611(03)00101-0; Starr M, 1999, SARSIA, V84, P379, DOI 10.1080/00364827.1999.10807345	26	161	163	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2005	307	5714					1457	1459		10.1126/science.1107767	http://dx.doi.org/10.1126/science.1107767			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904MT	15746424				2022-12-24	WOS:000227503100043
J	Stokin, GB; Lillo, C; Falzone, TL; Brusch, RG; Rockenstein, E; Mount, SL; Raman, R; Davies, P; Masliah, E; Williams, DS; Goldstein, LSB				Stokin, GB; Lillo, C; Falzone, TL; Brusch, RG; Rockenstein, E; Mount, SL; Raman, R; Davies, P; Masliah, E; Williams, DS; Goldstein, LSB			Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease	SCIENCE			English	Article							AMYLOID-PRECURSOR-PROTEIN; AXONAL-TRANSPORT; TRANSGENIC MICE; PLAQUE-FORMATION; NERVE-TERMINALS; BASAL FOREBRAIN; BETA-SECRETASE; PRESENILIN-1; BRAIN; ACCUMULATION	We identified axonal defects in mouse models of Alzheimer's disease that preceded known disease-related pathology by more than a year; we observed similar axonal defects in the early stages of Alzheimer's disease in humans. Axonal defects consisted of swellings that accumulated abnormal amounts of microtubule-associated and molecular motor proteins, organelles, and vesicles. Impairing axonal transport by reducing the dosage of a kinesin molecular motor protein enhanced the frequency of axonal defects and increased amyloid-beta peptide levels and amyloid deposition. Reductions in microtubule-dependent transport may stimulate proteolytic processing of beta-amyloid precursor protein, resulting in the development of senile plaques and Alzheimer's disease.	Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Family & Prevent Med, La Jolla, CA 92093 USA; Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Yeshiva University; Albert Einstein College of Medicine	Goldstein, LSB (corresponding author), Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, 9500 Gilman Dr, La Jolla, CA 92093 USA.	lgoldstein@ucsd.edu	Stokin, Gorazd Bernard/D-9480-2015; Lillo, Concepcion/A-6321-2009; Falzone, Tomás/W-2528-2019	Stokin, Gorazd Bernard/0000-0001-8430-8755; Lillo, Concepcion/0000-0001-5814-9826; Falzone, Tomas/0000-0002-7984-1149	NEI NIH HHS [EY13408, EY12598, R01 EY007042-19, R01 EY007042, R01 EY013408-02, R01 EY013408] Funding Source: Medline; NIA NIH HHS [P50 AG05131] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013408, R01EY007042, P30EY012598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005131] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Cash AD, 2003, AM J PATHOL, V162, P1623, DOI 10.1016/S0002-9440(10)64296-4; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; DAVIES P, 1976, LANCET, V2, P1403; Dhaenens CM, 2004, NEUROSCI LETT, V368, P290, DOI 10.1016/j.neulet.2004.07.040; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Hernandez D, 2001, NEUROREPORT, V12, P1377, DOI 10.1097/00001756-200105250-00018; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; KAWARABAYASHI T, 1993, NEUROSCI LETT, V153, P73, DOI 10.1016/0304-3940(93)90080-5; KITT CA, 1984, SCIENCE, V226, P1443, DOI 10.1126/science.6505701; MASLIAH E, 1993, AM J PATHOL, V142, P871; MASLIAH E, 1993, J NEUROPATH EXP NEUR, V52, P619, DOI 10.1097/00005072-199311000-00009; MORIN PJ, 1993, J NEUROCHEM, V61, P464; MULLER U, 1994, CELL, V79, P755, DOI 10.1016/0092-8674(94)90066-3; Papp H, 2002, NEUROCHEM INT, V41, P429, DOI 10.1016/S0197-0186(02)00014-1; Prasher VP, 1998, ANN NEUROL, V43, P380, DOI 10.1002/ana.410430316; Redwine JM, 2003, P NATL ACAD SCI USA, V100, P1381, DOI 10.1073/pnas.242746599; Roher AE, 2002, BIOCHEMISTRY-US, V41, P11080, DOI 10.1021/bi026173d; Rose SE, 2000, J NEUROL NEUROSUR PS, V69, P528, DOI 10.1136/jnnp.69.4.528; Salehi A, 2003, TRENDS NEUROSCI, V26, P73, DOI 10.1016/S0166-2236(02)00038-3; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Sheng JG, 2003, EXP NEUROL, V184, P1053, DOI 10.1016/j.expneurol.2003.08.018; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; TERRY RD, 1964, AM J PATHOL, V44, P269; Terry RD, 1996, J NEUROPATH EXP NEUR, V55, P1023, DOI 10.1097/00005072-199655100-00001; Torroja L, 1999, CURR BIOL, V9, P489, DOI 10.1016/S0960-9822(99)80215-2; UCHIHARA T, 1995, ACTA NEUROPATHOL, V90, P51; WEBSTER HDF, 1962, J CELL BIOL, V12, P361; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; Wirths O, 2002, BRAIN PATHOL, V12, P275, DOI 10.1111/j.1750-3639.2002.tb00442.x; Wong TP, 1999, J NEUROSCI, V19, P2706; YAGISHITA S, 1978, VIRCHOWS ARCH A, V378, P181, DOI 10.1007/BF00427359	36	906	956	1	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1282	1288		10.1126/science.1105681	http://dx.doi.org/10.1126/science.1105681			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731448				2022-12-24	WOS:000227313200051
J	Young, DT; Berthelier, JJ; Blanc, M; Burch, JL; Bolton, S; Coates, AJ; Crary, FJ; Goldstein, R; Grande, M; Hill, TW; Johnson, RE; Baragiola, RA; Kelha, V; McComas, DJ; Mursula, K; Sittler, EC; Svenes, KR; Szego, K; Tanskanen, P; Thomsen, MF; Bakshi, S; Barraclough, BL; Bebesi, Z; Delapp, D; Dunlop, MW; Gosling, JT; Furman, JD; Gilbert, LK; Glenn, D; Holmlund, C; Illiano, JM; Lewis, GR; Linder, DR; Maurice, S; McAndrews, HJ; Narheim, BT; Pallier, E; Reisenfeld, D; Rymer, AM; Smith, HT; Tokar, RL; Vilppola, J; Zinsmeyer, C				Young, DT; Berthelier, JJ; Blanc, M; Burch, JL; Bolton, S; Coates, AJ; Crary, FJ; Goldstein, R; Grande, M; Hill, TW; Johnson, RE; Baragiola, RA; Kelha, V; McComas, DJ; Mursula, K; Sittler, EC; Svenes, KR; Szego, K; Tanskanen, P; Thomsen, MF; Bakshi, S; Barraclough, BL; Bebesi, Z; Delapp, D; Dunlop, MW; Gosling, JT; Furman, JD; Gilbert, LK; Glenn, D; Holmlund, C; Illiano, JM; Lewis, GR; Linder, DR; Maurice, S; McAndrews, HJ; Narheim, BT; Pallier, E; Reisenfeld, D; Rymer, AM; Smith, HT; Tokar, RL; Vilppola, J; Zinsmeyer, C			Composition and dynamics of plasma in Saturn's magnetosphere	SCIENCE			English	Article							WATER ICE; MODEL; INJECTIONS; TRANSPORT	During Cassini's initial orbit, we observed a dynamic magnetosphere composed primarily of a complex mixture of water-derived atomic and molecular ions. We have identified four distinct regions characterized by differences in both bulk plasma properties and ion composition. Protons are the dominant species outside about 9 R-s (where R-s is the radial distance from the center of Saturn), whereas inside, the plasma consists primarily of a corotating comet-like mix of water-derived ions with similar to3% N+. Over the A and B rings, we found an ionosphere in which O-2(+) and O+ are dominant, which suggests the possible existence of a layer of O-2. gas similar to the atmospheres of Europa and Ganymede.	SW Res Inst, San Antonio, TX 78238 USA; Observ St Maur, Ctr Etud Environm Terr & Planetaires, F-94107 St Maur, France; Observ Midi Pyrenees, F-31400 Toulouse, France; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; UCL, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; Rutherford Appleton Lab, Didcot OX11 0QX, Oxon, England; Rice Univ, Dept Phys & Astron, Houston, TX 77251 USA; Univ Virginia, Charlottesville, VA USA; Univ Oulu, Dept Phys Sci, Oulu 90014, Finland; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Norwegian Def Res Estab, Div Elect, N-2027 Kjeller, Norway; KFKI Res Inst Particle & Nucl Phys, H-1525 Budapest, Hungary; Los Alamos Natl Lab, Space & Atmospher Sci Grp, Los Alamos, NM 87545 USA; Univ Montana, Dept Phys & Astron, Missoula, MT 59812 USA	Southwest Research Institute; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of London; University College London; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Rice University; University of Virginia; University of Oulu; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Norwegian Defence Research Establishment; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Wigner Research Centre for Physics; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Montana System; University of Montana	Young, DT (corresponding author), SW Res Inst, San Antonio, TX 78238 USA.	dyoung@swri.edu	Bolton, Scott/M-4392-2019; Smith, Howard/H-4662-2016; dunlop, malcolm w/F-1347-2010; Grande, Manuel/C-2242-2013; Mursula, Kalevi/L-8952-2014; Reisenfeld, Daniel/F-7614-2015; McComas, David J/H-6202-2011; Coates, Andrew/C-2396-2008	Smith, Howard/0000-0003-3537-3360; dunlop, malcolm w/0000-0002-8195-5137; Grande, Manuel/0000-0002-2233-2618; Mursula, Kalevi/0000-0003-4892-5056; McComas, David J/0000-0001-6160-1158; Coates, Andrew/0000-0002-6185-3125; bolton, scott/0000-0002-9115-0789; Holmlund, Christer/0000-0002-6116-6632				[Anonymous], 1984, SATURN; BALSIGER H, 1986, NATURE, V321, P330, DOI 10.1038/321330a0; BRIDGE HS, 1982, SCIENCE, V215, P563, DOI 10.1126/science.215.4532.563; BRIDGE HS, 1981, SCIENCE, V212, P217, DOI 10.1126/science.212.4491.217; CUMMINGS WD, 1967, J GEOPHYS RES, V72, P1007, DOI 10.1029/JZ072i003p01007; Delitsky ML, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2002JE001855; Dougherty MK, 2005, SCIENCE, V307, P1266, DOI 10.1126/science.1106098; EVIATAR A, 1984, J GEOPHYS RES-SPACE, V89, P3821, DOI 10.1029/JA089iA06p03821; FRANK LA, 1980, J GEOPHYS RES-SPACE, V85, P5695, DOI 10.1029/JA085iA11p05695; Gurnett DA, 2005, SCIENCE, V307, P1255, DOI 10.1126/science.1105356; HASEGAWA A, 1978, J GEOPHYS RES-SPACE, V83, P1117, DOI 10.1029/JA083iA03p01117; Hill TW, 1974, GEOPHYS RES LETT, V1, DOI 10.1029/GL001i001p00003; IP WH, 1995, ICARUS, V115, P295, DOI 10.1006/icar.1995.1098; Johnson RE, 1997, J GEOPHYS RES-PLANET, V102, P10985, DOI 10.1029/97JE00068; Johnson RE, 2003, ASTROBIOLOGY, V3, P823, DOI 10.1089/153110703322736123; Johnson RE, 2004, CAMB PLANET, P485; JOHNSON RE, 1989, ICARUS, V77, P311, DOI 10.1016/0019-1035(89)90092-4; Jurac S, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015855; Jurac S, 2001, PLANET SPACE SCI, V49, P319, DOI 10.1016/S0032-0633(00)00153-7; Kargel JS, 1996, ICARUS, V119, P385, DOI 10.1006/icar.1996.0026; KNUDSEN DJ, 1992, J GEOPHYS RES-SPACE, V97, P77, DOI 10.1029/91JA02300; LAZARUS AJ, 1983, J GEOPHYS RES-SPACE, V88, P8831, DOI 10.1029/JA088iA11p08831; MAUK BH, 1983, J GEOPHYS RES-SPACE, V88, P11, DOI 10.1029/JA088iA12p10011; Mauk BH, 1997, GEOPHYS RES LETT, V24, P2949, DOI 10.1029/97GL03026; Maurice S, 1996, J GEOPHYS RES-SPACE, V101, P15211, DOI 10.1029/96JA00765; NISHIDA A, 1966, J GEOPHYS RES, V71, P5669, DOI 10.1029/JZ071i023p05669; PONTIUS DH, 1986, GEOPHYS RES LETT, V13, P1097, DOI 10.1029/GL013i011p01097; Richardson JD, 1998, REV GEOPHYS, V36, P501, DOI 10.1029/98RG01691; Richardson JD, 1998, J GEOPHYS RES-PLANET, V103, P20245, DOI 10.1029/98JE01127; RICHARDSON JD, 1995, GEOPHYS RES LETT, V22, P1177, DOI 10.1029/95GL01018; RICHARDSON JD, 1990, J GEOPHYS RES-SPACE, V95, P12019, DOI 10.1029/JA095iA08p12019; SHEMANSKY DE, 1993, NATURE, V363, P329, DOI 10.1038/363329a0; Shi M, 1995, J GEOPHYS RES-PLANET, V100, P26387, DOI 10.1029/95JE03099; SITTLER EC, 1983, J GEOPHYS RES-SPACE, V88, P8847, DOI 10.1029/JA088iA11p08847; Smith HT, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020580; Young DT, 2004, SPACE SCI REV, V114, P1, DOI 10.1007/s11214-004-1406-4	36	265	265	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2005	307	5713					1262	1266		10.1126/science.1106151	http://dx.doi.org/10.1126/science.1106151			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	901WP	15731443				2022-12-24	WOS:000227313200045
J	Chen, B; Vogan, EM; Gong, HY; Skehel, JJ; Wiley, DC; Harrison, SC				Chen, B; Vogan, EM; Gong, HY; Skehel, JJ; Wiley, DC; Harrison, SC			Structure of an unliganded simian immunodeficiency virus gp120 core	NATURE			English	Article							ENVELOPE GLYCOPROTEIN; TYPE-1 GP120; NEUTRALIZATION SENSITIVITY; CD4 INDEPENDENCE; HIV-1 ENVELOPE; SOLUBLE CD4; RECEPTOR; PROTEIN; ANTIBODY; GP41	Envelope glycoproteins of human and simian immunodeficiency virus (HIV and SIV) undergo a series of conformational changes when they interact with receptor (CD4) and co-receptor on the surface of a potential host cell, leading ultimately to fusion of viral and cellular membranes. Structures of fragments of gp120 and gp41 from the envelope protein are known, in conformations corresponding to their post-attachment and postfusion states, respectively. We report the crystal structure, at 4 A resolution, of a fully glycosylated SIV gp120 core, in a conformation representing its prefusion state, before interaction with CD4. Parts of the protein have a markedly different organization than they do in the CD4-bound state. Comparison of the unliganded and CD4-bound structures leads to a model for events that accompany receptor engagement of an envelope glycoprotein trimer. The two conformations of gp120 also present distinct antigenic surfaces. We identify the binding site for a compound that inhibits viral entry.	Harvard Univ, Childrens Hosp, Sch Med, Mol Med Lab, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Natl Inst Med Res, Ridgeway, London NW7 1AA, England	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Harrison, SC (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Mol Med Lab, 320 Longwood Ave, Boston, MA 02115 USA.	harrison@crystal.harvard.edu		Vogan, Erik/0000-0002-2939-8070	Medical Research Council [MC_U117512711] Funding Source: Medline; MRC [MC_U117512711] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALLAN JS, 1985, SCIENCE, V228, P1091, DOI 10.1126/science.2986290; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Center RJ, 2002, J VIROL, V76, P7863, DOI 10.1128/JVI.76.15.7863-7867.2002; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chen B, 2004, J VIROL, V78, P4508, DOI 10.1128/JVI.78.9.4508-4516.2004; CHEN B, IN PRESS STRUCTURE C; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Etemad-Moghadam B, 1998, J VIROL, V72, P8437, DOI 10.1128/JVI.72.10.8437-8445.1998; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Ferrer M, 1999, J VIROL, V73, P5795, DOI 10.1128/JVI.73.7.5795-5802.1999; Guo Q, 2003, J VIROL, V77, P10528, DOI 10.1128/JVI.77.19.10528-10536.2003; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kolchinsky P, 2001, J VIROL, V75, P2041, DOI 10.1128/JVI.75.5.2041-2050.2001; Kwong PD, 2000, J VIROL, V74, P1961, DOI 10.1128/JVI.74.4.1961-1972.2000; Kwong PD, 1999, J BIOL CHEM, V274, P4115, DOI 10.1074/jbc.274.7.4115; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Lin PF, 2003, P NATL ACAD SCI USA, V100, P11013, DOI 10.1073/pnas.1832214100; Madani N, 2004, J VIROL, V78, P3742, DOI 10.1128/JVI.78.7.3742-3752.2004; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Moore JP, 1996, J VIROL, V70, P1863, DOI 10.1128/JVI.70.3.1863-1872.1996; MOORE JP, 1990, SCIENCE, V250, P1139, DOI 10.1126/science.2251501; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; POLLARD SR, 1991, P NATL ACAD SCI USA, V88, P11320, DOI 10.1073/pnas.88.24.11320; Puffer BA, 2004, VIROLOGY, V327, P16, DOI 10.1016/j.virol.2004.03.016; Puffer BA, 2002, J VIROL, V76, P2595, DOI 10.1128/JVI.76.6.2595-2605.2002; Pugach P, 2004, VIROLOGY, V321, P8, DOI 10.1016/j.virol.2003.12.012; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; RUD EW, 1992, VACCINE, V92, P229; SATTENTAU QJ, 1991, J EXP MED, V174, P407, DOI 10.1084/jem.174.2.407; SATTENTAU QJ, 1993, J VIROL, V67, P7383, DOI 10.1128/JVI.67.12.7383-7393.1993; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; TURNER S, 1992, P NATL ACAD SCI USA, V89, P1335, DOI 10.1073/pnas.89.4.1335; VERONESE FD, 1985, SCIENCE, V229, P1402, DOI 10.1126/science.2994223; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; WYATT R, 1993, J VIROL, V67, P4557, DOI 10.1128/JVI.67.8.4557-4565.1993; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Zwick MB, 2003, J VIROL, V77, P6965, DOI 10.1128/JVI.77.12.6965-6978.2003	50	439	462	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2005	433	7028					834	841		10.1038/nature03327	http://dx.doi.org/10.1038/nature03327			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	899VT	15729334				2022-12-24	WOS:000227174600034
J	Fraser, L				Fraser, L			Pre-eclampsia: a first hand account	LANCET			English	Editorial Material									Insurance Australia Grp, Sydney, NSW, Australia		Fraser, L (corresponding author), Insurance Australia Grp, Sydney, NSW, Australia.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB-MAR	2005	365	9461					800	800						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901LZ	15733722				2022-12-24	WOS:000227285300028
